Citrus Sinensis ID: 026720

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230----
Protein Sequence
MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA
Secondary Structure (PSIPRED)
ccccccccccEEEEEcccccHHHHHHHHHHcccccccccEEEEEEEEccccEEEEEEEccHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHccccccccccccEEEEcccEEEEcccccccccccccccccEEEEcccccHHHcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccEEHHHHHHHHccccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHccccccccHHHHHHHHHHcccHHHHHHHHHHHHHHcccccccEEHHHHHHHHHHHcHHHHccccHHHccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccHHccccccccccccHHHHcccc
Coil and Loop (DISEMBL)
mklanenpnsVTLVSLVSACTGLinvragesiHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLadnsrgndaislhrqgyfhrdlkpsnllvskgvikigdlgmvkeidsnlpctdyvttrwyrgpevllfseiygpevdkwAMGAIMFEMLSfgilfpgkssaDQIYKICQligsptkdswplgIQLASNlnwklpqmggvnllavmpsa
Flexible Loop (DISEMBL)
mklanenpnsVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFhrdlkpsnllVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA
Low Complexity Region (SEG)
MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA
Disordered region (IsUnstruct)
**********VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAV****
Disordered Region (DISOPRED)
**************SLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNL***********MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS*
Disordered Region (DISEMBL)
*********SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA
Disordered Region (DISPRO)
*****ENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	234	2.2.26 [Sep-21-2011]
Q6Z8C8	459	Cyclin-dependent kinase F	yes	no	0.581	0.296	0.580	4e-43
P20793	622	Serine/threonine-protein	yes	no	0.585	0.220	0.507	5e-40
Q04859	622	Serine/threonine-protein	yes	no	0.585	0.220	0.507	5e-40
P20794	623	Serine/threonine-protein	yes	no	0.585	0.219	0.5	5e-39
Q84SN3	433	Cyclin-dependent kinase F	no	no	0.585	0.316	0.496	1e-37
Q9UPZ9	632	Serine/threonine-protein	no	no	0.585	0.216	0.507	1e-36
Q62726	629	Serine/threonine-protein	no	no	0.585	0.217	0.507	8e-36
Q9JKV2	629	Serine/threonine-protein	no	no	0.585	0.217	0.507	8e-36
Q55FJ6	507	Probable serine/threonine	yes	no	0.585	0.270	0.464	2e-33
P43294	443	Serine/threonine-protein	no	no	0.615	0.325	0.424	9e-33

>sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1

 Score =  174 bits (442), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 79/136 (58%), Positives = 98/136 (72%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +H++GYFHRDLKP NLLVSK VIK+ D G+ +E+ S  P T+YV+TRWYR PEVLL S I
Sbjct: 116 MHQRGYFHRDLKPENLLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLLQSSI 175

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
           Y   VD WAMGAIM E+L+   LFPG S AD+I KIC +IGSP + SWP G+ LA  + +
Sbjct: 176 YDSAVDMWAMGAIMAELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAETMKF 235

Query: 218 KLPQMGGVNLLAVMPS 233
           + PQ+ G  L  VM S
Sbjct: 236 QFPQVSGNQLAEVMTS 251

Oryza sativa subsp. japonica (taxid: 39947)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2

 Score =  164 bits (415), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 70/138 (50%), Positives = 100/138 (72%), Gaps = 1/138 (0%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct: 116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
           +Y   +D WA+G+IM E+ +F  LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct: 176 VYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query: 217 WKLPQMGGVNLLAVMPSA 234
           ++ PQ   +NL  ++P+A
Sbjct: 236 FRFPQCIPINLKTLIPNA 253

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2

 Score =  164 bits (415), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 70/138 (50%), Positives = 100/138 (72%), Gaps = 1/138 (0%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct: 116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
           +Y   +D WA+G+IM E+ +F  LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct: 176 VYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query: 217 WKLPQMGGVNLLAVMPSA 234
           ++ PQ   +NL  ++P+A
Sbjct: 236 FRFPQCIPINLKTLIPNA 253

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2

 Score =  160 bits (406), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 69/138 (50%), Positives = 98/138 (71%), Gaps = 1/138 (0%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct: 116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
           +Y   +D WA+G+IM E+     LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct: 176 VYSSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query: 217 WKLPQMGGVNLLAVMPSA 234
           ++ PQ   +NL  ++P+A
Sbjct: 236 FRFPQCVPINLKTLIPNA 253

Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1

 Score =  156 bits (394), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 68/137 (49%), Positives = 93/137 (67%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +H  GYFHRDLKP NLLV+ G +KI D G+ +E+ S+ P TDYV+TRWYR PEVLL S  
Sbjct: 116 MHNNGYFHRDLKPENLLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLLQSSA 175

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
           Y P +D WA+GAI+ E+ +   LFPG S  DQ+YKIC ++G+P    WP G+ L  + ++
Sbjct: 176 YTPAIDMWAVGAILAELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPRSSSF 235

Query: 218 KLPQMGGVNLLAVMPSA 234
              Q+   NL  ++P+A
Sbjct: 236 NFFQIPPRNLWELIPNA 252

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1

 Score =  153 bits (386), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 70/138 (50%), Positives = 94/138 (68%), Gaps = 1/138 (0%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H+ G+FHRDLKP NLL +   ++KI D G+ +EI S  P TDYV+TRWYR PEVLL S 
Sbjct: 116 IHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRST 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   +D WA+G IM E+ +   LFPG S  D I+KICQ++G+P K  WP G QL+S +N
Sbjct: 176 NYSSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMN 235

Query: 217 WKLPQMGGVNLLAVMPSA 234
           ++ PQ    NL  ++P+A
Sbjct: 236 FRWPQCVPNNLKTLIPNA 253

May play a key role in the development of multiple organ systems and particularly in cardiac development.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1

 Score =  150 bits (379), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 70/138 (50%), Positives = 93/138 (67%), Gaps = 1/138 (0%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H+ G+FHRDLKP NLL +   ++KI D G+ +EI S  P TDYV+TRWYR PEVLL S 
Sbjct: 116 IHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRST 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   +D WA+G IM E+ +   LFPG S  D I+KICQ++G+P K  WP G QL+S +N
Sbjct: 176 NYSSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMN 235

Query: 217 WKLPQMGGVNLLAVMPSA 234
           +  PQ    NL  ++P+A
Sbjct: 236 FIWPQCIPNNLKTLIPNA 253

May play a role in cardiac development.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2

 Score =  150 bits (379), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 70/138 (50%), Positives = 93/138 (67%), Gaps = 1/138 (0%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H+ G+FHRDLKP NLL +   ++KI D G+ +EI S  P TDYV+TRWYR PEVLL S 
Sbjct: 116 IHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRST 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   +D WA+G IM E+ +   LFPG S  D I+KICQ++G+P K  WP G QL+S +N
Sbjct: 176 NYSSPIDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMN 235

Query: 217 WKLPQMGGVNLLAVMPSA 234
           +  PQ    NL  ++P+A
Sbjct: 236 FLWPQCIPNNLKTLIPNA 253

May play a role in cardiac development.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1

 Score =  142 bits (359), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 65/140 (46%), Positives = 95/140 (67%), Gaps = 3/140 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +H  G+FHRDLKP N+++    +KI D G+ +EI+S  P TDY++TRWYR PEVLL    
Sbjct: 116 MHTNGFFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTY 175

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
           Y   +D WA+GAIM E+ S   +FPG S  DQ++KIC ++GSPT  +W  GI+LA+++ +
Sbjct: 176 YNAPIDIWAVGAIMAELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGF 235

Query: 218 KLP--QMGGVNLLA-VMPSA 234
             P  Q   +N L+ ++P+A
Sbjct: 236 TFPNVQPPSINPLSTLLPNA 255

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2

 Score =  140 bits (352), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 65/153 (42%), Positives = 96/153 (62%), Gaps = 9/153 (5%)

Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYV 141
           M+ GLA          +H+ GYFHRDLKP NLLV+  ++KI D G+ +E+ S  P T+YV
Sbjct: 117 MLQGLA---------HMHKNGYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYV 167

Query: 142 TTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
           +TRWYR PEVLL S +Y P VD WA+GAI+ E+ +   LFPG+S  DQ+YKIC ++G P 
Sbjct: 168 STRWYRAPEVLLQSSLYTPAVDMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPD 227

Query: 202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA 234
             ++P    ++  ++    +     +  ++P+A
Sbjct: 228 WTTFPEAKSISRIMSISHTEFPQTRIADLLPNA 260

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	234
255557681	455	mak, putative [Ricinus communis] gi|2235	0.863	0.443	0.462	5e-47
357484657	449	Serine/threonine protein kinase ICK [Med	0.863	0.449	0.462	1e-46
399106782	425	MAP kinase [Nicotiana tabacum]	0.670	0.369	0.532	2e-46
399106784	470	MAP kinase [Nicotiana tabacum]	0.670	0.334	0.550	2e-46
9758733	530	serine/threonine-protein kinase Mak (mal	0.585	0.258	0.635	5e-46
18422554	499	conserved peptide upstream open reading	0.585	0.274	0.635	8e-46
15450860	499	serine/threonine-protein kinase Mak (mal	0.585	0.274	0.635	9e-46
334188209	497	conserved peptide upstream open reading	0.585	0.275	0.635	9e-46
255575673	302	mak, putative [Ricinus communis] gi|2235	0.653	0.506	0.527	5e-45
356559079	414	PREDICTED: cyclin-dependent kinase F-4-l	0.666	0.376	0.518	6e-45

>gi|255557681|ref|XP_002519870.1| mak, putative [Ricinus communis] gi|223540916|gb|EEF42474.1| mak, putative [Ricinus communis]

 Score =  193 bits (490), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 100/216 (46%), Positives = 133/216 (61%), Gaps = 14/216 (6%)

Query: 24  INVRAGESIHSYAVVNGLELDVAIGT----ALVEMYSKCGHVEKAFKVFNLMREKNLQSW 79
           +N+R  +S+      N ++L   I        V  Y  C   +       L  E  +++W
Sbjct: 46  VNLREVKSLRRMNHPNIVKLKEVIRENDILYFVFEYMDCNLYQLIKDRVKLFPEAEVRNW 105

Query: 80  TIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCT 138
              +  GLA          +H++GYFHRDLKP NLLV+KG+IKI D G+ +EI+S  P T
Sbjct: 106 CFQVFQGLA---------YMHQRGYFHRDLKPENLLVTKGIIKIADFGLAREINSQPPYT 156

Query: 139 DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
           +YV+TRWYR PEVLL S +Y  +VD WAMGAIM E+ +   LFPG S AD+IYKIC +IG
Sbjct: 157 EYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMAELFTLRPLFPGTSEADEIYKICNIIG 216

Query: 199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA 234
           SPTKDSW  G+ LA  +N++ PQ GGV L A++PSA
Sbjct: 217 SPTKDSWADGLNLARAINYQFPQFGGVQLSALIPSA 252

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484657|ref|XP_003612616.1| Serine/threonine protein kinase ICK [Medicago truncatula] gi|355513951|gb|AES95574.1| Serine/threonine protein kinase ICK [Medicago truncatula]

 Score =  191 bits (486), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 100/216 (46%), Positives = 136/216 (62%), Gaps = 14/216 (6%)

Query: 24  INVRAGESIHSYAVVNGLELDVAIGTA----LVEMYSKCGHVEKAFKVFNLMREKNLQSW 79
           +N+R  +S+      N ++L   I  +     V  Y +C   +       L  E  +++W
Sbjct: 46  VNLREVKSLRKMNHPNIVKLKEVIRESDILYFVFEYMECNLYQLMKDREKLFSEGEIRNW 105

Query: 80  TIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCT 138
              +  GLA          +H++GYFHRDLKP NLLV+K VIKI D G+ +EI+S  P T
Sbjct: 106 CFQVFQGLA---------YMHQRGYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYT 156

Query: 139 DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
           +YV+TRWYR PEVLL S IY  +VD WAMGAIM E+ S   LFPG S AD+IYKIC +IG
Sbjct: 157 EYVSTRWYRAPEVLLQSYIYSSKVDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIG 216

Query: 199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA 234
           +PT DSW  G++LA ++N++ PQ+ GVNL A++PSA
Sbjct: 217 NPTTDSWADGLKLARDINYQFPQLAGVNLSALIPSA 252

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|399106782|gb|AFP20224.1| MAP kinase [Nicotiana tabacum]

 Score =  191 bits (486), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 89/167 (53%), Positives = 116/167 (69%), Gaps = 10/167 (5%)

Query: 69  NLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGM 127
            L  E  +++W   +  GLA          +HR+GYFHRDLKP NLL S+ +IKI D G+
Sbjct: 65  KLFSESEVRNWCFQVFQGLA---------YIHRRGYFHRDLKPENLLASQDIIKIADFGL 115

Query: 128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA 187
            +EI+S  P T+YV+TRWYR PE+LL S IYGP VD WAMGAIM E+ S   LFPG S A
Sbjct: 116 AREINSQPPFTEYVSTRWYRAPEILLQSPIYGPAVDMWAMGAIMAELFSLRPLFPGSSEA 175

Query: 188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA 234
           D+IYKIC +IG+P+K  W  G+QLAS +N++ PQ+ GV+L  ++PSA
Sbjct: 176 DEIYKICSVIGTPSKREWAQGLQLASAINYQFPQIAGVDLALLIPSA 222

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|399106784|gb|AFP20225.1| MAP kinase [Nicotiana tabacum]

 Score =  191 bits (485), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 92/167 (55%), Positives = 116/167 (69%), Gaps = 10/167 (5%)

Query: 69  NLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGM 127
            L  E  +++W   I  GLA          +H++GYFHRDLKP NLLVSK  IKI D G+
Sbjct: 116 KLFLESEVRNWCFQIFQGLA---------YMHQRGYFHRDLKPENLLVSKDTIKIADFGL 166

Query: 128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA 187
            +EI+S  P T+YV+TRWYR PEVLL S IYGP VD WAMGAIM E+L+   LFPG S A
Sbjct: 167 AREINSQPPYTEYVSTRWYRAPEVLLQSPIYGPAVDMWAMGAIMAELLTLRPLFPGSSEA 226

Query: 188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA 234
           D+IYKIC +IG+P+K  W  G +LAS +N++ PQ+ GVNL  ++PSA
Sbjct: 227 DEIYKICSVIGTPSKSEWAHGHELASAINYQFPQVAGVNLSLLLPSA 273

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|9758733|dbj|BAB09171.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana]

 Score =  190 bits (482), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 87/137 (63%), Positives = 109/137 (79%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDS+ P T+YV+TRWYR PEVLL S +
Sbjct: 124 MHQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYV 183

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
           Y  +VD WAMGAIM E+LS   LFPG S AD+IYKIC +IGSPT+++W  G+ LAS +N+
Sbjct: 184 YTSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINY 243

Query: 218 KLPQMGGVNLLAVMPSA 234
           + PQ  GV+L +VMP A
Sbjct: 244 QFPQFPGVHLSSVMPYA 260

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18422554|ref|NP_568646.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] gi|24899765|gb|AAN65097.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana] gi|332007866|gb|AED95249.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana]

 Score =  189 bits (480), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 87/137 (63%), Positives = 109/137 (79%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDS+ P T+YV+TRWYR PEVLL S +
Sbjct: 116 MHQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYV 175

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
           Y  +VD WAMGAIM E+LS   LFPG S AD+IYKIC +IGSPT+++W  G+ LAS +N+
Sbjct: 176 YTSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINY 235

Query: 218 KLPQMGGVNLLAVMPSA 234
           + PQ  GV+L +VMP A
Sbjct: 236 QFPQFPGVHLSSVMPYA 252

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15450860|gb|AAK96701.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana]

 Score =  189 bits (480), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 87/137 (63%), Positives = 109/137 (79%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDS+ P T+YV+TRWYR PEVLL S +
Sbjct: 116 MHQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYV 175

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
           Y  +VD WAMGAIM E+LS   LFPG S AD+IYKIC +IGSPT+++W  G+ LAS +N+
Sbjct: 176 YTSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINY 235

Query: 218 KLPQMGGVNLLAVMPSA 234
           + PQ  GV+L +VMP A
Sbjct: 236 QFPQFPGVHLSSVMPYA 252

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334188209|ref|NP_001190473.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] gi|332007867|gb|AED95250.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana]

 Score =  189 bits (479), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 87/137 (63%), Positives = 109/137 (79%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDS+ P T+YV+TRWYR PEVLL S +
Sbjct: 116 MHQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYV 175

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
           Y  +VD WAMGAIM E+LS   LFPG S AD+IYKIC +IGSPT+++W  G+ LAS +N+
Sbjct: 176 YTSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINY 235

Query: 218 KLPQMGGVNLLAVMPSA 234
           + PQ  GV+L +VMP A
Sbjct: 236 QFPQFPGVHLSSVMPYA 252

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255575673|ref|XP_002528736.1| mak, putative [Ricinus communis] gi|223531830|gb|EEF33648.1| mak, putative [Ricinus communis]

 Score =  186 bits (473), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 86/163 (52%), Positives = 114/163 (69%), Gaps = 10/163 (6%)

Query: 73  EKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEI 131
           E  +++W   I  GLA          +H+QGYFHRDLKP NLLV    +KIGDLG+ +EI
Sbjct: 101 ESEVKNWCFQIFQGLA---------YMHKQGYFHRDLKPENLLVRHNTVKIGDLGLAREI 151

Query: 132 DSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY 191
           +S  P TDYV TRWYR PE+LL S +YG +VD W++G IM E+ +F  LF GKS ADQ+Y
Sbjct: 152 NSKPPYTDYVVTRWYRAPELLLRSSLYGSKVDMWSLGVIMAELFTFTPLFRGKSEADQMY 211

Query: 192 KICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPSA 234
            IC++IGSPTK SWP GI LA N+ ++ P+ GG++L  ++P+A
Sbjct: 212 NICRIIGSPTKMSWPYGIDLARNIRYQFPEFGGMDLSQLIPTA 254

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356559079|ref|XP_003547829.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max]

 Score =  186 bits (472), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 86/166 (51%), Positives = 115/166 (69%), Gaps = 10/166 (6%)

Query: 69  NLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGM 127
            L  E  +++W   +  GLA          +H++GYFHRDLKP NLLV+KGVIKI D G+
Sbjct: 95  KLFSENEVRNWCFQVFQGLA---------YMHQRGYFHRDLKPENLLVTKGVIKIADFGL 145

Query: 128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA 187
            +EI S  P T+YV+TRWYR PEVLL S +Y  +VD WAMGAIM E+ +   LFPG S A
Sbjct: 146 AREISSQPPYTEYVSTRWYRAPEVLLQSHLYSSKVDMWAMGAIMAELFTLRPLFPGSSEA 205

Query: 188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS 233
           D+IYKIC +IGSPT +SW  G++LA ++N++ PQ+  V+L  ++PS
Sbjct: 206 DEIYKICSVIGSPTTESWADGLKLARDINYQFPQLASVHLSTLIPS 251

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	234
TAIR|locus:2163583	499	AT5G45430 [Arabidopsis thalian	0.585	0.274	0.635	6.4e-44
TAIR|locus:2134746	464	AT4G19110 [Arabidopsis thalian	0.730	0.368	0.480	1.5e-42
MGI|MGI:96913	622	Mak "male germ cell-associated	0.585	0.220	0.507	5.5e-37
RGD|3036	622	Mak "male germ cell-associated	0.585	0.220	0.507	5.5e-37
UNIPROTKB|P20793	622	Mak "Serine/threonine-protein	0.585	0.220	0.507	5.5e-37
UNIPROTKB|F1RV90	624	MAK "Uncharacterized protein"	0.585	0.219	0.5	9.6e-37
UNIPROTKB|E2RE89	589	MAK "Uncharacterized protein"	0.585	0.232	0.5	1.3e-36
UNIPROTKB|B3KUS6	288	MAK "cDNA FLJ40512 fis, clone	0.585	0.475	0.5	1.3e-36
UNIPROTKB|Q8IXN4	457	MAK "MAK protein" [Homo sapien	0.585	0.299	0.5	1.3e-36
UNIPROTKB|E2RP10	623	MAK "Uncharacterized protein"	0.585	0.219	0.5	2.1e-36

TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)]

 Score = 463 (168.0 bits), Expect = 6.4e-44, P = 6.4e-44
 Identities = 87/137 (63%), Positives = 109/137 (79%)

Query:    98 LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
             +H++GYFHRDLKP NLLVSK VIKI DLG+ +EIDS+ P T+YV+TRWYR PEVLL S +
Sbjct:   116 MHQRGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYV 175

Query:   158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW 217
             Y  +VD WAMGAIM E+LS   LFPG S AD+IYKIC +IGSPT+++W  G+ LAS +N+
Sbjct:   176 YTSKVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINY 235

Query:   218 KLPQMGGVNLLAVMPSA 234
             + PQ  GV+L +VMP A
Sbjct:   236 QFPQFPGVHLSSVMPYA 252

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0045727 "positive regulation of translation" evidence=RCA

TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)]

 Score = 450 (163.5 bits), Expect = 1.5e-42, P = 1.5e-42
 Identities = 87/181 (48%), Positives = 124/181 (68%)

Query:    55 YSKCGHVEKAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNL 113
             Y +C   +       L  E ++++W   +  GL+          +H++GYFHRDLKP NL
Sbjct:    81 YMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLS---------YMHQRGYFHRDLKPENL 131

Query:   114 LVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE 173
             LVSK +IKI D G+ +E++S+ P T+YV+TRWYR PEVLL S +Y  +VD WAMGAIM E
Sbjct:   132 LVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMAE 191

Query:   174 MLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS 233
             +LS   +FPG S AD+IYKIC +IG+PT+++W  G+ LA+ +N++ PQ+ GV L ++MPS
Sbjct:   192 LLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQLPGVPLSSLMPS 251

Query:   234 A 234
             A
Sbjct:   252 A 252

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)]

 Score = 401 (146.2 bits), Expect = 5.5e-37, P = 5.5e-37
 Identities = 70/138 (50%), Positives = 100/138 (72%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+ +F  LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCIPINLKTLIPNA 253

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001750 "photoreceptor outer segment" evidence=IDA

GO:0001917 "photoreceptor inner segment" evidence=ISO

GO:0003713 "transcription coactivator activity" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005929 "cilium" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030496 "midbody" evidence=ISO

GO:0042995 "cell projection" evidence=IEA

GO:0045494 "photoreceptor cell maintenance" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0072686 "mitotic spindle" evidence=ISO

GO:2001141 "regulation of RNA biosynthetic process" evidence=ISO

RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)]

 Score = 401 (146.2 bits), Expect = 5.5e-37, P = 5.5e-37
 Identities = 70/138 (50%), Positives = 100/138 (72%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+ +F  LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCIPINLKTLIPNA 253

GO:0001750 "photoreceptor outer segment" evidence=ISO;ISS

GO:0001917 "photoreceptor inner segment" evidence=ISO;ISS

GO:0003713 "transcription coactivator activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;ISS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO;ISS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO;ISS

GO:0007275 "multicellular organismal development" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0030154 "cell differentiation" evidence=IEA

GO:0030496 "midbody" evidence=ISO;ISS

GO:0045494 "photoreceptor cell maintenance" evidence=ISO;ISS

GO:0046777 "protein autophosphorylation" evidence=ISO;ISS

GO:0072686 "mitotic spindle" evidence=ISO;ISS

UNIPROTKB|P20793 Mak "Serine/threonine-protein kinase MAK" [Rattus norvegicus (taxid:10116)]

 Score = 401 (146.2 bits), Expect = 5.5e-37, P = 5.5e-37
 Identities = 70/138 (50%), Positives = 100/138 (72%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+ +F  LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCIPINLKTLIPNA 253

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 399 (145.5 bits), Expect = 9.6e-37, P = 9.6e-37
 Identities = 69/138 (50%), Positives = 99/138 (71%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+ +   LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCAPINLKTLIPNA 253

GO:0072686 "mitotic spindle" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045494 "photoreceptor cell maintenance" evidence=IEA

GO:0030496 "midbody" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0003713 "transcription coactivator activity" evidence=IEA

GO:0001917 "photoreceptor inner segment" evidence=IEA

GO:0001750 "photoreceptor outer segment" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2RE89 MAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 396 (144.5 bits), Expect = 1.3e-36, P = 1.3e-36
 Identities = 69/138 (50%), Positives = 99/138 (71%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+ +   LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCVPINLKTLIPNA 253

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|B3KUS6 MAK "cDNA FLJ40512 fis, clone TESTI2046439, highly similar to Serine/threonine-protein kinase MAK (EC 2.7.11.22)" [Homo sapiens (taxid:9606)]

 Score = 394 (143.8 bits), Expect = 1.3e-36, P = 1.3e-36
 Identities = 69/138 (50%), Positives = 98/138 (71%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+     LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCVPINLKTLIPNA 253

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q8IXN4 MAK "MAK protein" [Homo sapiens (taxid:9606)]

 Score = 394 (143.8 bits), Expect = 1.3e-36, P = 1.3e-36
 Identities = 69/138 (50%), Positives = 98/138 (71%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+     LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCVPINLKTLIPNA 253

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RP10 MAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 396 (144.5 bits), Expect = 2.1e-36, P = 2.1e-36
 Identities = 69/138 (50%), Positives = 99/138 (71%)

Query:    98 LHRQGYFHRDLKPSNLL-VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
             +H+ G+FHRD+KP NLL +   ++KI D G+ +E+ S  P TDYV+TRWYR PEVLL S 
Sbjct:   116 IHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSS 175

Query:   157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
             +Y   +D WA+G+IM E+ +   LFPG S  D+I+KICQ++G+P K  WP G QLAS++N
Sbjct:   176 VYSSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMN 235

Query:   217 WKLPQMGGVNLLAVMPSA 234
             ++ PQ   +NL  ++P+A
Sbjct:   236 FRFPQCVPINLKTLIPNA 253

GO:0072686 "mitotic spindle" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045494 "photoreceptor cell maintenance" evidence=IEA

GO:0030496 "midbody" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0003713 "transcription coactivator activity" evidence=IEA

GO:0001917 "photoreceptor inner segment" evidence=IEA

GO:0001750 "photoreceptor outer segment" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	AT5G45430	protein kinase, putative; protein kinase, putative; FUNCTIONS IN- protein serine/threonine kinase activity, protein kinase activity, kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- cellular_component unknown; EXPRESSED IN- sperm cell, male gametophyte, pollen tube; EXPRESSED DURING- M germinated pollen stage; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Serine/threonine protein kinase (InterPro-IPR002290), Serine/threonine protein kinase-related (InterPro-IPR01744 [...] (499 aa)
		(Arabidopsis thaliana)
Predicted Functional Partners:
	AT5G10100	trehalose-6-phosphate phosphatase, putative; trehalose-6-phosphate phosphatase, putative; FUNCT [...] (369 aa)							•		0.579
	AT2G16870	disease resistance protein (TIR-NBS-LRR class), putative; disease resistance protein (TIR-NBS-L [...] (1109 aa)							•		0.565
	AT4G22590	trehalose-6-phosphate phosphatase, putative; trehalose-6-phosphate phosphatase, putative; FUNCT [...] (377 aa)							•		0.563
	AT1G29790	unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biological_process unkn [...] (378 aa)				•					0.546
	AT1G29800	phosphoinositide binding / zinc ion binding; phosphoinositide binding / zinc ion binding; FUNCT [...] (510 aa)				•					0.543
	AT4G12400	stress-inducible protein, putative; stress-inducible protein, putative; FUNCTIONS IN- binding; [...] (558 aa)							•		0.539
	AT2G14080	disease resistance protein (TIR-NBS-LRR class), putative; disease resistance protein (TIR-NBS-L [...] (1215 aa)							•		0.539
	AT4G19500	ATP binding / nucleoside-triphosphatase/ nucleotide binding / protein binding / transmembrane r [...] (1309 aa)				•					0.532
	AT2G17580	polynucleotide adenylyltransferase family protein; polynucleotide adenylyltransferase family pr [...] (757 aa)				•					0.528
	AT5G49830	unknown protein; EXPRESSED IN- 22 plant structures; EXPRESSED DURING- 13 growth stages; CONTAIN [...] (814 aa)				•					0.524

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	234
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-64
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-49
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-44
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-40
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-40
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-40
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-37
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-36
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-34
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-33
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-33
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-33
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-32
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-31
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-30
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-30
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-29
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-29
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-29
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-28
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-27
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-27
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-27
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-27
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-27
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-26
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-26
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-26
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-26
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-26
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-26
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-25
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-25
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-25
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-25
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-25
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-24
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-24
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-24
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-24
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-24
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-24
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-23
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-22
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-22
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-22
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-22
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-21
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-20
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-20
PLN03077	857	PLN03077, PLN03077, Protein ECB2; Provisional	1e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-19
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-19
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-19
PLN03077	857	PLN03077, PLN03077, Protein ECB2; Provisional	1e-17
PLN03077	857	PLN03077, PLN03077, Protein ECB2; Provisional	9e-17
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-16
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-16
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-15
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
PLN03077	857	PLN03077, PLN03077, Protein ECB2; Provisional	2e-13
PLN03081	697	PLN03081, PLN03081, pentatricopeptide (PPR) repeat	2e-13
PLN03081	697	PLN03081, PLN03081, pentatricopeptide (PPR) repeat	2e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-12
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-12
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-11
PLN03081	697	PLN03081, PLN03081, pentatricopeptide (PPR) repeat	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-11
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-09
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-08
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-08
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-08
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-08
PLN03077	857	PLN03077, PLN03077, Protein ECB2; Provisional	1e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-07
pfam13041	50	pfam13041, PPR_2, PPR repeat family	6e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-06
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-06
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-06
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-05
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-05
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-05
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-04
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.001
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.001
pfam01535	31	pfam01535, PPR, PPR repeat	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.001
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	0.002
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	0.002
pfam13812	34	pfam13812, PPR_3, Pentatricopeptide repeat domain	0.002
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.002
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.002
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.003
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	0.003
TIGR00756	35	TIGR00756, PPR, pentatricopeptide repeat domain (P	0.003
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.004
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	0.004

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  201 bits (515), Expect = 1e-64
 Identities = 73/138 (52%), Positives = 95/138 (68%), Gaps = 1/138 (0%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H+ G+FHRDLKP NLLVS   V+KI D G+ +EI S  P TDYV+TRWYR PE+LL S 
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD WA+G IM E+ +   LFPG S  DQ+YKIC ++G+PTK  WP G +LAS L 
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234

Query: 217 WKLPQMGGVNLLAVMPSA 234
           ++ PQ    +L  ++P+A
Sbjct: 235 FRFPQFAPTSLHQLIPNA 252

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  162 bits (413), Expect = 2e-49
 Identities = 61/139 (43%), Positives = 83/139 (59%), Gaps = 2/139 (1%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-NLPCTDYVTTRWYRGPEVLLFS 155
            H  G  HRDLKP NLL++  GV+K+ D G+ +   S   P T YV TRWYR PE+LL  
Sbjct: 114 CHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD 173

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
           + Y   VD W++G I  E+LS   LFPGKS  DQ++KI + +G+P  + WP    LA N 
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233

Query: 216 NWKLPQMGGVNLLAVMPSA 234
            +  P+  G+ L  + P+A
Sbjct: 234 KFSFPKKAGMPLPKLFPNA 252

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 1e-44
 Identities = 55/138 (39%), Positives = 81/138 (58%), Gaps = 3/138 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
            H     HRDLKP N+L+++ GV+K+ D G+ +     L   T  V T WYR PE+LL S
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
           + Y   VD W++G I  EM++   LFPG S  DQ++KI Q++G+PT++SWP G+    + 
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP-GVTKLPDY 232

Query: 216 NWKLPQMGGVNLLAVMPS 233
               P+    +L  V+P 
Sbjct: 233 KPTFPKFPPKDLEKVLPR 250

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  140 bits (354), Expect = 1e-40
 Identities = 50/103 (48%), Positives = 70/103 (67%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           +HR G FHRD+KP N+L+   ++K+ D G  + I S  P T+Y++TRWYR PE LL    
Sbjct: 116 MHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGY 175

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
           YGP++D WA+G + FE+LS   LFPG +  DQI KI  ++G+P
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP 218

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 2e-40
 Identities = 47/112 (41%), Positives = 70/112 (62%), Gaps = 3/112 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS--NLPCTDYVTTRWYRGPEVLLF 154
           LH  G  HRD+K SN+L++  GV+K+ D G+ +      +   T+ V T WYR PE+LL 
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           +  YGPEVD W++G I+ E+     +F G +  +Q+ KI +L GSPT ++WP
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  139 bits (352), Expect = 3e-40
 Identities = 53/111 (47%), Positives = 73/111 (65%), Gaps = 2/111 (1%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFS 155
           LH     HRDLK SNLL++ +G++KI D G+ +E  S L P T  V T WYR PE+LL +
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           + Y   +D W++G I  E+L+   LFPGKS  DQ+ KI +L+G+PT+  WP
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  133 bits (336), Expect = 2e-37
 Identities = 51/147 (34%), Positives = 81/147 (55%), Gaps = 14/147 (9%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPC----TDYVTTRWYRGPEVL 152
           LH     HRDLKPSN+LV+    +KI D G+ + +D +       T+YV TRWYR PE+L
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           L S  Y   +D W++G I  E+L+   LFPG+   DQ+  I +++G+P+++     ++  
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED----LKFI 234

Query: 213 SNLNWK-----LPQMGGVNLLAVMPSA 234
           ++   +     LP+     L  + P A
Sbjct: 235 TSEKARNYLKSLPKKPKKPLSKLFPGA 261

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 7e-36
 Identities = 51/108 (47%), Positives = 66/108 (61%), Gaps = 4/108 (3%)

Query: 95  AIS-LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPE 150
           AI+  H     HRD+KP N+LVS+ GV+K+ D G  + +      P TDYV TRWYR PE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
           +L+    YG  VD WA+G IM E+L    LFPG S  DQ+Y I + +G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  122 bits (309), Expect = 9e-34
 Identities = 52/135 (38%), Positives = 76/135 (56%), Gaps = 12/135 (8%)

Query: 75  NLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI- 131
           +++S+ +M   GL           LH     HRDLKP+NLL++  GV+K+ D G+ +   
Sbjct: 103 DIKSYMLMTLRGLE---------YLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Query: 132 DSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY 191
             N   T  V TRWYR PE+L  +  YG  VD W++G I  E+L      PG S  DQ+ 
Sbjct: 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG 213

Query: 192 KICQLIGSPTKDSWP 206
           KI + +G+PT+++WP
Sbjct: 214 KIFEALGTPTEENWP 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  123 bits (310), Expect = 1e-33
 Identities = 57/145 (39%), Positives = 79/145 (54%), Gaps = 8/145 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK------EIDSNLPCTDYVTTRWYRGPE 150
           +H     HRDLKPSN+L+ S   +K+ D G+ +      E   N   TDYV TRWYR PE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-DSWPLGI 209
           +LL S  Y   VD W++G I+ EML    LFPG S+ +Q+ KI ++IG P+  D   +  
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242

Query: 210 QLASNLNWKLPQMGGVNLLAVMPSA 234
             A+ +   LP      L  ++P A
Sbjct: 243 PFAATMLDSLPSRPRKPLDELLPKA 267

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  121 bits (305), Expect = 2e-33
 Identities = 48/120 (40%), Positives = 69/120 (57%), Gaps = 2/120 (1%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH  G  HRDLKP N LL   GV+KI D G+ K++  S+   T +V T WY  PEVLL  
Sbjct: 114 LHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             YGP+VD W++G I++E+L+    F G++  DQ+  I +++G P +   P     +   
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233

Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 2e-33
 Identities = 49/110 (44%), Positives = 63/110 (57%), Gaps = 2/110 (1%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV+  G +KI D G+ +     +  T  V T WYR PEVLL S 
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS 182

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            Y   VD W++G I  E+     LF G S ADQ+ KI  +IG P+++ WP
Sbjct: 183 -YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  120 bits (304), Expect = 4e-33
 Identities = 47/112 (41%), Positives = 70/112 (62%), Gaps = 3/112 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC--TDYVTTRWYRGPEVLLF 154
           +H  G  HRDLKP+NLL+S  GV+KI D G+ +      P   +  V TRWYR PE+L  
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           +  Y P VD WA+G I  E+L+   LFPG++  +Q+  + + +G+P +++WP
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  116 bits (293), Expect = 8e-32
 Identities = 42/110 (38%), Positives = 62/110 (56%), Gaps = 5/110 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH +G  HRDLKP N+L+   G +K+ D G+ +++D     T +V T  Y  PEVLL  +
Sbjct: 113 LHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GK 171

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            YG  VD W++G I++E+L+    FPG     +++K    IG P     P
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPP 218

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 5e-31
 Identities = 51/133 (38%), Positives = 76/133 (57%), Gaps = 7/133 (5%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLFSEIYGP 160
           HRDLKP NLL+ + G +K+ D G+ +     +P   Y   V T WYR PE+LL S  Y  
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSRQYST 179

Query: 161 EVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLP 220
            VD W++G I  EM++   LFPG S  DQ+++I + +G+P +D WP G+    +     P
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP-GVTSLPDYKPTFP 238

Query: 221 QMGGVNLLAVMPS 233
           +    +L  V+P+
Sbjct: 239 KWARQDLSKVVPN 251

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 4e-30
 Identities = 46/113 (40%), Positives = 67/113 (59%), Gaps = 5/113 (4%)

Query: 97  SLHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEV 151
            +H     HRDLKPSNLL++    +KI D G+ +  D         T+YV TRWYR PE+
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
           +L S+ Y   +D W++G I+ EMLS   LFPGK    Q+  I  ++G+P+++ 
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  112 bits (283), Expect = 6e-30
 Identities = 45/122 (36%), Positives = 67/122 (54%), Gaps = 13/122 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC------------TDYVTTR 144
           LH     HRD+K +N+L+  +G++KI D G+ +  D   P             T+ V TR
Sbjct: 131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190

Query: 145 WYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
           WYR PE+LL    Y   VD W +G +  EM +   +  GKS  DQ++ I +L G+PT+++
Sbjct: 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET 250

Query: 205 WP 206
           WP
Sbjct: 251 WP 252

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  112 bits (283), Expect = 7e-30
 Identities = 58/152 (38%), Positives = 78/152 (51%), Gaps = 20/152 (13%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           LH     HRDLK SNLL++ KG +KI D G+ +     LP       V T WYR PE+LL
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLL 181

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP------- 206
               Y   +D WA+G I+ E+L+   L PGKS  +Q+  I QL+G+P +  WP       
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 207 -----LGIQLASNLNWKLPQMG--GVNLLAVM 231
                L  Q  +NL  K P +   G+ LL  +
Sbjct: 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFL 273

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  111 bits (280), Expect = 1e-29
 Identities = 53/140 (37%), Positives = 79/140 (56%), Gaps = 7/140 (5%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL++K G +K+ D G+ +     +P   +   V T WYR P+VLL 
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
           S  Y   +D W++G IM EM++   LFPG ++ DQ+ KI +++G+PT+ +WP GI     
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQLPE 233

Query: 215 LNWKLPQMGGVNLLAVMPSA 234
                P+    +L  + P A
Sbjct: 234 YKPTFPRYPPQDLQQLFPHA 253

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  111 bits (280), Expect = 1e-29
 Identities = 59/151 (39%), Positives = 81/151 (53%), Gaps = 19/151 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVL 152
            H+ G  HRDLKP NLLV   KG++KI DLG+ +    ++P   Y   + T WYR PEVL
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHEIVTLWYRAPEVL 183

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S  Y   VD W++G I  EM     LFPG S   Q+  I +L+G+PT+  WP   +L 
Sbjct: 184 LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243

Query: 212 ---------ASNLNWKLPQMG--GVNLLAVM 231
                      +L+  +P +   G++LL  M
Sbjct: 244 DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKM 274

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  111 bits (280), Expect = 2e-29
 Identities = 49/110 (44%), Positives = 66/110 (60%), Gaps = 8/110 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLP------CTDYVTTRWYRGPE 150
           +H     HRDLKPSNLLV++   ++IGD GM + + S+ P       T+YV TRWYR PE
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS-PTEHKYFMTEYVATRWYRAPE 181

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
           +LL    Y   +D W++G I  EML    LFPGK+   Q+  I  ++GSP
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  109 bits (275), Expect = 6e-29
 Identities = 47/104 (45%), Positives = 65/104 (62%), Gaps = 6/104 (5%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC---TDYVTTRWYRGPEVLLF 154
           H+    HRD+KP N+L++K G IK+ D G  + +    P    TDYV TRWYR PE+L+ 
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLVG 174

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
              YGP VD WA+G +  E+L+   L+PGKS  DQ+Y I + +G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  109 bits (273), Expect = 1e-28
 Identities = 47/103 (45%), Positives = 64/103 (62%), Gaps = 2/103 (1%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-NLPCTDYVTTRWYRGPEVLLFS 155
            H     HRD+KP N+LVS+ GV+K+ D G  + + +     TDYV TRWYR PE+L+  
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
             YG  VD WA+G ++ EML+   LFPG S  DQ+Y I + +G
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  106 bits (266), Expect = 1e-27
 Identities = 49/140 (35%), Positives = 77/140 (55%), Gaps = 8/140 (5%)

Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           H     HRDLKP NLL+      +K+ D G+ +     +P   +   V T WYR PE+LL
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILL 176

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLAS 213
            S  Y   VD W++G I  EM++   LFPG S  D+++KI +++G+P +++WP G+    
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP-GVTSLP 235

Query: 214 NLNWKLPQMGGVNLLAVMPS 233
           +     P+    +L  V+P+
Sbjct: 236 DYKSAFPKWPPKDLATVVPT 255

Length = 294

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  105 bits (264), Expect = 2e-27
 Identities = 51/112 (45%), Positives = 69/112 (61%), Gaps = 6/112 (5%)

Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H +   HRDLKP NLL+ +KGVIK+ D G+ +     +P   Y   V T WYR PEVLL 
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLG 175

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S  Y   VD W++G I  EM +   LF G S  DQ+++I +++G+PT+D WP
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  106 bits (267), Expect = 3e-27
 Identities = 53/128 (41%), Positives = 73/128 (57%), Gaps = 6/128 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKPSN+ V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 191

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM E+L+   LFPG    DQ+ +I  L+G+P  +     I   S  N
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD-EELLQKISSESARN 250

Query: 217 W--KLPQM 222
           +   LPQM
Sbjct: 251 YIQSLPQM 258

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  104 bits (262), Expect = 4e-27
 Identities = 46/112 (41%), Positives = 65/112 (58%), Gaps = 6/112 (5%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL++  G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 5e-27
 Identities = 51/128 (39%), Positives = 73/128 (57%), Gaps = 18/128 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNL-PCTD---YVTTRWYRG 148
           LH     HRDLKP+N+LV      +GV+KIGDLG+ +  ++ L P  D    V T WYR 
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG-----KSS----ADQIYKICQLIGS 199
           PE+LL +  Y   +D WA+G I  E+L+   +F G     K S     DQ+ +I +++G+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243

Query: 200 PTKDSWPL 207
           PT+  WP 
Sbjct: 244 PTEKDWPD 251

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  103 bits (259), Expect = 1e-26
 Identities = 53/115 (46%), Positives = 64/115 (55%), Gaps = 2/115 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV S G +K+ D G+ +     +  T  V T WYR PEVLL S 
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS- 182

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL 211
            Y   VD W++G I  EM     LF G S ADQ+ KI  LIG P +D WP  + L
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  103 bits (259), Expect = 1e-26
 Identities = 48/112 (42%), Positives = 72/112 (64%), Gaps = 6/112 (5%)

Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           HR+   HRDLKP NLL++ +G +K+ D G+ +    ++P   Y   V T WYR P+VLL 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S  Y  ++D W +G I FEM S   LFPG +  D+++ I +L+G+PT+++WP
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  103 bits (259), Expect = 2e-26
 Identities = 47/107 (43%), Positives = 65/107 (60%), Gaps = 3/107 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKPSN+L+++   +KI D G+ +  D  +  T YV+TR+YR PE++L  +
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIMLTWQ 181

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y  EVD W+ G I  EML    LFPGK   +Q   I  L+G+P  D
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-26
 Identities = 47/113 (41%), Positives = 72/113 (63%), Gaps = 7/113 (6%)

Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H++   HRDLKP NLL+S +G +K+ D G+ +    ++P   Y   V T WYR P+VLL 
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVLLG 177

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA-DQIYKICQLIGSPTKDSWP 206
           S  Y   +D W +G I +EM +   LFPG +   DQ++KI +++G+PT+++WP
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  102 bits (255), Expect = 5e-26
 Identities = 44/112 (39%), Positives = 72/112 (64%), Gaps = 6/112 (5%)

Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           HR+   HRDLKP NLL++ +G +K+ D G+ +    ++P   Y   V T WYR P++LL 
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S  Y  ++D W +G I +EM +   LFPG +  +Q++ I +++G+PT+++WP
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  102 bits (257), Expect = 5e-26
 Identities = 50/144 (34%), Positives = 72/144 (50%), Gaps = 11/144 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFS 155
           +H     HRDLKPSNLL+ +   +KI D G+ +         T+YV TRWYR PE+LL  
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             Y   +D W++G I  E+L    LFPGK    Q+  I +L+GSP+++     +    N 
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED----LGFIRNE 239

Query: 216 NWK-----LPQMGGVNLLAVMPSA 234
             +     LP     +   + P A
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHA 263

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  102 bits (257), Expect = 6e-26
 Identities = 47/107 (43%), Positives = 65/107 (60%), Gaps = 2/107 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 192

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+   +LFPG    DQ  KI + +G+P+ +
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  102 bits (255), Expect = 1e-25
 Identities = 47/130 (36%), Positives = 73/130 (56%), Gaps = 16/130 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV---------------KEIDSNLPCTDYV 141
           LH+  + HRDL P+N+ + SKG+ KI D G+                + +      T  V
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194

Query: 142 TTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
            T WYR PE+L+ +E Y   VD W++G I  E+L+   LFPG++  DQ+ +I +L+G+P 
Sbjct: 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPN 254

Query: 202 KDSWPLGIQL 211
           +D+WP   +L
Sbjct: 255 EDNWPQAKKL 264

Length = 335

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  100 bits (250), Expect = 2e-25
 Identities = 53/130 (40%), Positives = 71/130 (54%), Gaps = 10/130 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           +H Q   HRDLKP NLL+S  G +K+ D G+ +    ++P   Y   V T WYR P+VLL
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA-DQIYKICQLIGSPTKDSWPLGIQLA 212
            +  Y   +D W  G I  EML     FPG S   +Q+ KI  ++G PT+D+WP G+   
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP-GVSKL 235

Query: 213 SNLN--WKLP 220
            N    W LP
Sbjct: 236 PNYKPEWFLP 245

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  100 bits (250), Expect = 2e-25
 Identities = 52/142 (36%), Positives = 80/142 (56%), Gaps = 12/142 (8%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL++K G +K+ D G+ +     +P   Y   V T WYR P+VL  
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQLIGSPTKDSWPLGIQLAS 213
           +++Y   +D W+ G I  E+ + G  LFPG    DQ+ +I +L+G+PT++SWP   +L  
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP- 232

Query: 214 NLNWK-LPQMGGV-NLLAVMPS 233
             ++K  P      +L+ V+P 
Sbjct: 233 --DYKPYPMYPATTSLVNVVPK 252

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 99.9 bits (249), Expect = 3e-25
 Identities = 45/116 (38%), Positives = 68/116 (58%), Gaps = 3/116 (2%)

Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK--EIDSNLPCTDYVTTRWYRGPEVLLFS 155
           H++ + HRD+K SN+L++ KG IK+ D G+ +    + + P T+ V T WYR PE+LL  
Sbjct: 133 HKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 192

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL 211
           E YGP +D W+ G I+ E+ +   +F       Q+  I +L GSP    WP  I+L
Sbjct: 193 ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKL 248

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 99.7 bits (248), Expect = 3e-25
 Identities = 44/112 (39%), Positives = 72/112 (64%), Gaps = 6/112 (5%)

Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H++   HRDLKP NLL++ KG +K+ D G+ +    ++P   Y   V T WYR P+VLL 
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLG 177

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S  Y   +D W +G I++EM +   +FPG +  ++++ I +L+G+PT+++WP
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  100 bits (250), Expect = 4e-25
 Identities = 56/139 (40%), Positives = 82/139 (58%), Gaps = 4/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V++   +KI D G+ ++ DS +  T YV TRWYR PEV+L   
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM--TGYVVTRWYRAPEVILNWM 191

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-SWPLGIQLASNL 215
            Y   VD W++G IM EML+   LF G    DQ+ +I ++ G+P+K+    L  + A N 
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251

Query: 216 NWKLPQMGGVNLLAVMPSA 234
             KLP+    +  +++P+A
Sbjct: 252 VKKLPRFRKKDFRSLLPNA 270

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 99.0 bits (247), Expect = 1e-24
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 7/144 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-----CTDYVTTRWYRGPEV 151
           +H     HRDLKP NLLV +   +KI D G+ +    N        T+YV TRWYR PE+
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-LGIQ 210
           +L  + Y   +D W++G I+ E+L    +F GK   DQ+ +I Q++G+P +++   +G  
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240

Query: 211 LASNLNWKLPQMGGVNLLAVMPSA 234
            A N    LP +      ++ P+A
Sbjct: 241 KAQNYIRSLPNIPKKPFESIFPNA 264

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 99.4 bits (247), Expect = 1e-24
 Identities = 44/107 (41%), Positives = 67/107 (62%), Gaps = 3/107 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKPSN+ V++   ++I D G+ ++ D  +  T YV TRWYR PE++L   
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLNWM 191

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM E+L    LFPG    DQ+ +I +++G+P+ +
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 97.4 bits (242), Expect = 2e-24
 Identities = 54/125 (43%), Positives = 67/125 (53%), Gaps = 4/125 (3%)

Query: 91  RGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP 149
           RG D +  HR    HRDLKP N+LV S G IK+ D G+ +     +  T  V T WYR P
Sbjct: 121 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
           EVLL S  Y   VD W++G I  EM     LF G S  DQ+ KI  +IG P ++ WP  +
Sbjct: 179 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 210 QLASN 214
            L   
Sbjct: 238 ALPRQ 242

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 98.1 bits (244), Expect = 3e-24
 Identities = 53/139 (38%), Positives = 75/139 (53%), Gaps = 4/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V++   +KI D G+ +  D+ +  T YV TRWYR PEV+L   
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILNWM 190

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-SWPLGIQLASNL 215
            Y   VD W++G IM EML+   LF GK   DQ+ +I ++ G P  +    L  + A + 
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 216 NWKLPQMGGVNLLAVMPSA 234
              LP+    +   + P A
Sbjct: 251 IKSLPKYPRKDFSTLFPKA 269

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 98.2 bits (244), Expect = 4e-24
 Identities = 54/139 (38%), Positives = 75/139 (53%), Gaps = 4/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 193

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-LGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253

Query: 216 NWKLPQMGGVNLLAVMPSA 234
              L QM  +N   V   A
Sbjct: 254 IQSLTQMPKMNFANVFIGA 272

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 96.7 bits (241), Expect = 7e-24
 Identities = 47/130 (36%), Positives = 69/130 (53%), Gaps = 6/130 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM-----VKEIDSNLPCTDYVTTRWYRGPEV 151
           +HR    HRD+K +N+L++K G++K+ D G+     + +       T+ V T WYR PE+
Sbjct: 135 IHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL 211
           LL    YGP +D W  G IM EM +   +  G +   Q+  I QL GS T + WP   +L
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254

Query: 212 ASNLNWKLPQ 221
                 +LPQ
Sbjct: 255 ELFKKMELPQ 264

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 95.2 bits (237), Expect = 5e-23
 Identities = 47/107 (43%), Positives = 64/107 (59%), Gaps = 3/107 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           LH  G  HRD+KP NLLV S  V+KI D G+  V+E D +   T  V T++YR PE+L+ 
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
           S  Y   VD W++G I  E+L   ILF  +S   Q+  I  L+G+P+
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 91.5 bits (228), Expect = 1e-22
 Identities = 31/83 (37%), Positives = 44/83 (53%), Gaps = 3/83 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVLLF 154
           LH  G  HRDLKP N+L+    G +K+ D G+ K + S+       V T  Y  PEVLL 
Sbjct: 108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167

Query: 155 SEIYGPEVDKWAMGAIMFEMLSF 177
              Y  + D W++G I++E+   
Sbjct: 168 KGYYSEKSDIWSLGVILYELPEL 190

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 93.3 bits (232), Expect = 2e-22
 Identities = 46/114 (40%), Positives = 68/114 (59%), Gaps = 8/114 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC----TDYVTTRWYRGPEVL 152
           +H    FHRDLKP N+L  +   +KI D G+ +   ++ P     TDYV TRWYR PE+ 
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 153 --LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
              FS+ Y P +D W++G I  E+L+   LFPGK+   Q+  I  L+G+P+ ++
Sbjct: 179 GSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 93.2 bits (231), Expect = 3e-22
 Identities = 49/136 (36%), Positives = 72/136 (52%), Gaps = 2/136 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   +N   T YV TR+YR PEV+L   
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM E++   ++F G    DQ  K+ + +G+P+ +          N  
Sbjct: 199 -YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257

Query: 217 WKLPQMGGVNLLAVMP 232
              PQ  G++   + P
Sbjct: 258 ENRPQYPGISFEELFP 273

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 92.4 bits (229), Expect = 5e-22
 Identities = 47/104 (45%), Positives = 64/104 (61%), Gaps = 2/104 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 92.1 bits (228), Expect = 6e-22
 Identities = 47/104 (45%), Positives = 64/104 (61%), Gaps = 2/104 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 193

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 88.5 bits (219), Expect = 5e-21
 Identities = 45/103 (43%), Positives = 65/103 (63%), Gaps = 4/103 (3%)

Query: 99  HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEID--SNLPCTDYVTTRWYRGPEVLLFS 155
           H+    HRD+KP NLL+S   V+K+ D G  + +   SN   T+YV TRWYR PE+LL +
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
             YG  VD W++G I+ E+     LFPG+S  DQ++ I +++G
Sbjct: 177 P-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 88.9 bits (220), Expect = 1e-20
 Identities = 46/137 (33%), Positives = 76/137 (55%), Gaps = 4/137 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV--IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H +   HRDLKP NLL+      +K+ D G  K + +      Y+ +R+YR PE++L +
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             Y   +D W++G I+ EM+    +F G+SS DQ+ +I Q++G+PT+D   L     +  
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ--LKEMNPNYA 303

Query: 216 NWKLPQMGGVNLLAVMP 232
           + K P +   +L  V P
Sbjct: 304 DIKFPDVKPKDLKKVFP 320

Length = 440

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 87.4 bits (216), Expect = 2e-20
 Identities = 46/114 (40%), Positives = 67/114 (58%), Gaps = 7/114 (6%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           +H++   HRDLKP NLL+S  G +K+ D G+ +    ++P   Y   V T WYR P+VLL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPG-KSSADQIYKICQLIGSPTKDSWP 206
            S  Y   +D W +G I  EM+     FPG K   DQ+ +I  ++G+P +D+WP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|215561 PLN03077, PLN03077, Protein ECB2; Provisional

 Score = 86.8 bits (215), Expect = 1e-19
 Identities = 50/134 (37%), Positives = 80/134 (59%), Gaps = 5/134 (3%)

Query: 1   MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGH 60
           M+  N +P+ +T+ S++SAC  L ++  G  +H  A   GL   V +  AL+EMYSKC  
Sbjct: 380 MEQDNVSPDEITIASVLSACACLGDLDVGVKLHELAERKGLISYVVVANALIEMYSKCKC 439

Query: 61  VEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL-LVS--K 117
           ++KA +VF+ + EK++ SWT +I+GL  N+R  +A+   RQ      LKP+++ L++   
Sbjct: 440 IDKALEVFHNIPEKDVISWTSIIAGLRLNNRCFEALIFFRQMLLT--LKPNSVTLIAALS 497

Query: 118 GVIKIGDLGMVKEI 131
              +IG L   KEI
Sbjct: 498 ACARIGALMCGKEI 511

Length = 857

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 4e-19
 Identities = 34/81 (41%), Positives = 48/81 (59%), Gaps = 3/81 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFS 155
           LH  G  +RDLKP N+L+ + G IK+ D G+ KE+ S       +  T  Y  PEVLL  
Sbjct: 109 LHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
             YG  VD W++G +++EML+
Sbjct: 169 G-YGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 82.6 bits (205), Expect = 4e-19
 Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 18/119 (15%)

Query: 63  KAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVI 120
           K F       E  ++ +T  I  GLA          LH  G  HRD+K +N+LV S GV+
Sbjct: 93  KKFGKLP---EPVIRKYTRQILEGLA---------YLHSNGIVHRDIKGANILVDSDGVV 140

Query: 121 KIGDLG---MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS 176
           K+ D G    + +I++         T ++  PEV +  E YG   D W++G  + EM +
Sbjct: 141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRGEEYGRAADIWSLGCTVIEMAT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 83.3 bits (206), Expect = 9e-19
 Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 10/106 (9%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSNLPCTDY----VTTRWYRGPEV 151
           +H     HRDLKP+N+ ++    V+KIGD G+ + +D +     Y    + T+WYR P +
Sbjct: 130 IHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL 189

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
           LL    Y   +D WA G I  EML+   LF G    +Q+    QLI
Sbjct: 190 LLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM----QLI 231

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|215561 PLN03077, PLN03077, Protein ECB2; Provisional

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 34/94 (36%), Positives = 54/94 (57%)

Query: 7   NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFK 66
           +P+ +T+ S++SAC  L + R G  +H Y V  G  +DV++  +L++MY   G   +A K
Sbjct: 285 DPDLMTITSVISACELLGDERLGREMHGYVVKTGFAVDVSVCNSLIQMYLSLGSWGEAEK 344

Query: 67  VFNLMREKNLQSWTIMISGLADNSRGNDAISLHR 100
           VF+ M  K+  SWT MISG   N   + A+  + 
Sbjct: 345 VFSRMETKDAVSWTAMISGYEKNGLPDKALETYA 378

Length = 857

>gnl|CDD|215561 PLN03077, PLN03077, Protein ECB2; Provisional

 Score = 78.4 bits (193), Expect = 9e-17
 Identities = 32/99 (32%), Positives = 59/99 (59%), Gaps = 1/99 (1%)

Query: 3   LANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVE 62
           L    PNSVTL++ +SAC  +  +  G+ IH++ +  G+  D  +  AL+++Y +CG + 
Sbjct: 482 LLTLKPNSVTLIAALSACARIGALMCGKEIHAHVLRTGIGFDGFLPNALLDLYVRCGRMN 541

Query: 63  KAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQ 101
            A+  FN   EK++ SW I+++G   + +G+ A+ L  +
Sbjct: 542 YAWNQFNS-HEKDVVSWNILLTGYVAHGKGSMAVELFNR 579

Length = 857

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 32/110 (29%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDS------------NLPCTDYVTT 143
           S+H+ G+ HRD+KP N+L+ + G IK+ D G+ K+++             NL   D V  
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 144 RW------------------YRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           R                   Y  PEVL     YG E D W++G I++EML
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.6 bits (186), Expect = 2e-16
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 3/98 (3%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH Q   HRDLK +N LLV+  ++KIGDLG+ K +  N+  T  + T  Y  PEV     
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVWK-GR 176

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            Y  + D W++G +++EM +F   F  +S  D  YK+ 
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 76.3 bits (186), Expect = 3e-16
 Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 14/123 (11%)

Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDS-------NLPCTDYVTTRWYRG 148
           LH +G  HRD+KP N+L+ +   V+K+ D G+ K +             +  V T  Y  
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 149 PEVLLFSEI--YGPEVDKWAMGAIMFEMLSFGILFPGKSSA---DQIYKICQLIGSPTKD 203
           PEVLL   +       D W++G  ++E+L+    F G+ ++    Q  KI   + +P+  
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 204 SWP 206
           S  
Sbjct: 237 SPL 239

Length = 384

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 74.3 bits (182), Expect = 1e-15
 Identities = 44/126 (34%), Positives = 63/126 (50%), Gaps = 18/126 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSNL-PCTDY---VTTRWYRG 148
           LH     HRDLKP+N+LV      +G +KI D+G  +  +S L P  D    V T WYR 
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---------ADQIYKICQLIGS 199
           PE+LL +  Y   +D WA+G I  E+L+   +F  +            DQ+ +I  ++G 
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Query: 200 PTKDSW 205
           P    W
Sbjct: 244 PADKDW 249

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 74.3 bits (182), Expect = 1e-15
 Identities = 44/126 (34%), Positives = 63/126 (50%), Gaps = 18/126 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSNL-PCTDY---VTTRWYRG 148
           LH     HRDLKP+N+LV      +G +KI D+G  +  +S L P  D    V T WYR 
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---------ADQIYKICQLIGS 199
           PE+LL +  Y   +D WA+G I  E+L+   +F  +            DQ+ +I  ++G 
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243

Query: 200 PTKDSW 205
           P    W
Sbjct: 244 PADKDW 249

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 71.8 bits (177), Expect = 4e-15
 Identities = 28/105 (26%), Positives = 49/105 (46%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV +  V+KI D G+ +++       DY          RW   P
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYRKRGGKLPIRWM-AP 172

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E L     +  + D W+ G +++E+ + G   +PG S+ + +  +
Sbjct: 173 ESLKEG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 70.7 bits (174), Expect = 1e-14
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV +  V+KI D G+ +++       DY          RW   P
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYKVKGGKLPIRWM-AP 173

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E L     +  + D W+ G +++E+ + G   +PG S+A+ +  +
Sbjct: 174 ESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 5/96 (5%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +LH  GY HRDLKP N L+ + G IK+ D G+ K I +       V +  Y  PEV L  
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--ANSVVGSPDYMAPEV-LRG 172

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY 191
           + Y   VD W++G +++E L     F G S+ ++ +
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETW 207

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.3 bits (172), Expect = 3e-14
 Identities = 36/81 (44%), Positives = 51/81 (62%), Gaps = 3/81 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LHR G  +RDLK  N+L+ ++G  K+ D GM KE I + +  T +  T  Y  PE+L   
Sbjct: 112 LHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E YGP VD WA+G +M+EM++
Sbjct: 172 E-YGPSVDWWALGVLMYEMMA 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.8 bits (169), Expect = 5e-14
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)

Query: 105 HRDLKPSNL-LVSKGVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           HRDLKP+N+ L +   +K+GD G+ K +   +     YV T +Y  PE L     Y  + 
Sbjct: 133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN-HMSYDEKS 191

Query: 163 DKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           D W++G +++E+ +    F  ++      KI +
Sbjct: 192 DIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 8e-14
 Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 3/98 (3%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH+QG  +RDLKP N LL ++G +K+ D G+ KE I        +  T  Y  PE+L+ S
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS 175

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             +G  VD W++GA+M++ML+    F  ++    I KI
Sbjct: 176 G-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.0 bits (167), Expect = 9e-14
 Identities = 35/109 (32%), Positives = 50/109 (45%), Gaps = 13/109 (11%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLG---------MVKEIDSNLPCTDYVTTRWYR 147
           LH  G  HRDLKP N+L+   G +K+ D G          +   D        V T  Y 
Sbjct: 109 LHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
            PEV+L  + +   VD W++G I++E L  GI  F G++  +    I  
Sbjct: 169 APEVIL-GQGHSKTVDWWSLGCILYEFL-VGIPPFHGETPEEIFQNILN 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.6 bits (168), Expect = 1e-13
 Identities = 39/93 (41%), Positives = 53/93 (56%), Gaps = 13/93 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG------PE 150
           LH +G  +RDLK  N+L+ S+G IKI D GM KE    +     VTT  + G      PE
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE---GI--LGGVTTSTFCGTPDYIAPE 166

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG 183
           +L +   YGP VD WA+G +++EML+    F G
Sbjct: 167 ILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|215561 PLN03077, PLN03077, Protein ECB2; Provisional

 Score = 68.3 bits (167), Expect = 2e-13
 Identities = 34/98 (34%), Positives = 51/98 (52%)

Query: 1   MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGH 60
           M  A   P+  T   ++  C G+ ++  G  +H++ V  G ELDV +  AL+ MY KCG 
Sbjct: 178 MLWAGVRPDVYTFPCVLRTCGGIPDLARGREVHAHVVRFGFELDVDVVNALITMYVKCGD 237

Query: 61  VEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL 98
           V  A  VF+ M  ++  SW  MISG  +N    + + L
Sbjct: 238 VVSARLVFDRMPRRDCISWNAMISGYFENGECLEGLEL 275

Length = 857

>gnl|CDD|215563 PLN03081, PLN03081, pentatricopeptide (PPR) repeat-containing protein; Provisional

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 32/93 (34%), Positives = 52/93 (55%)

Query: 7   NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFK 66
           +    T V ++ A  GL + RAG+ +H   +  G+  D  +  AL++MYSKCG +E A  
Sbjct: 221 DAEPRTFVVMLRASAGLGSARAGQQLHCCVLKTGVVGDTFVSCALIDMYSKCGDIEDARC 280

Query: 67  VFNLMREKNLQSWTIMISGLADNSRGNDAISLH 99
           VF+ M EK   +W  M++G A +    +A+ L+
Sbjct: 281 VFDGMPEKTTVAWNSMLAGYALHGYSEEALCLY 313

Length = 697

>gnl|CDD|215563 PLN03081, PLN03081, pentatricopeptide (PPR) repeat-containing protein; Provisional

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 29/87 (33%), Positives = 47/87 (54%)

Query: 12  TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLM 71
           T   ++   + L  +   +  H+  +  G  LD+   TALV++YSK G +E A  VF+ M
Sbjct: 327 TFSIMIRIFSRLALLEHAKQAHAGLIRTGFPLDIVANTALVDLYSKWGRMEDARNVFDRM 386

Query: 72  REKNLQSWTIMISGLADNSRGNDAISL 98
             KNL SW  +I+G  ++ RG  A+ +
Sbjct: 387 PRKNLISWNALIAGYGNHGRGTKAVEM 413

Length = 697

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 67.0 bits (164), Expect = 3e-13
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 4/96 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH +G  HRD+KP N+L+  +G + I D  +  ++  +   T    T  Y  PEV L  +
Sbjct: 116 LHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV-LCRQ 174

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSS--ADQI 190
            Y   VD W++G   +E L     + G S    DQI
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.7 bits (163), Expect = 6e-13
 Identities = 37/89 (41%), Positives = 52/89 (58%), Gaps = 10/89 (11%)

Query: 94  DAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPE 150
           DAI  H  G+ HRD+KP N+L+ K G +K+ D G   ++D+N  + C   V T  Y  PE
Sbjct: 156 DAI--HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213

Query: 151 VLLFSE----IYGPEVDKWAMGAIMFEML 175
           VL  S+     YG E D W++G  ++EML
Sbjct: 214 VLK-SQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 66.0 bits (161), Expect = 6e-13
 Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 2/80 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH++   +RDLKP N+L+   G ++I DLG+  E+           T  Y  PEVL   E
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ-GE 169

Query: 157 IYGPEVDKWAMGAIMFEMLS 176
           +Y   VD +A+G  ++EM++
Sbjct: 170 VYDFSVDWFALGCTLYEMIA 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.7 bits (160), Expect = 1e-12
 Identities = 34/81 (41%), Positives = 47/81 (58%), Gaps = 3/81 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+   G  K+ D GM KE I +    + +  T  Y  PE+L   
Sbjct: 112 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ-E 170

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
            +YGP VD WAMG +++EML 
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 11/118 (9%)

Query: 59  GHVEKAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-S 116
           G + K  K +    E  ++ +T  I  GL           LH +   HRD+K +N+LV +
Sbjct: 87  GSLAKLLKKYGSFPEPVIRLYTRQILLGLE---------YLHDRNTVHRDIKGANILVDT 137

Query: 117 KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM 174
            GV+K+ D GM K++        +  + ++  PEV+     YG   D W++G  + EM
Sbjct: 138 NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 64.8 bits (159), Expect = 1e-12
 Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 3/100 (3%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH +   HRD+KP N  L S G++K+GD G+ K + S +      V T +Y  PE+   +
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ-N 177

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           + Y  + D W++G +++E+ +    F G++  +   KI +
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 39/109 (35%), Positives = 53/109 (48%), Gaps = 16/109 (14%)

Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN------LPCTDYVTTRWYRGP 149
           S+H+ GY HRD+KP N+L+ + G IK+ D G    + +N      LP    V T  Y  P
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP----VGTPDYIAP 172

Query: 150 EVLL-----FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           EVL          YG E D W++G I +EM+     F   +SA     I
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 2e-12
 Identities = 32/82 (39%), Positives = 48/82 (58%), Gaps = 5/82 (6%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE--IDSNLPCTDYVTTRWYRGPEVLLF 154
           LH +G  +RDLK  N+++ ++G IKI D GM KE         T +  T  Y  PE++ +
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIAY 175

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
            + YG  VD WA G +++EML+
Sbjct: 176 -QPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 2e-12
 Identities = 38/122 (31%), Positives = 51/122 (41%), Gaps = 42/122 (34%)

Query: 95  AI-SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY------------ 140
           AI S+H+ GY HRD+KP NLL+ +KG IK+ D G+   +  +     Y            
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 141 ---------------------------VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE 173
                                      V T  Y  PEV L +  Y  E D W++G IM+E
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYE 231

Query: 174 ML 175
           ML
Sbjct: 232 ML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.5 bits (158), Expect = 3e-12
 Identities = 35/84 (41%), Positives = 45/84 (53%), Gaps = 14/84 (16%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           LH     +RDLKP NLL+ S G IKI D G  K +          T     T  Y  PE+
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------TYTLCGTPEYLAPEI 169

Query: 152 LLFSEIYGPEVDKWAMGAIMFEML 175
           +L S+ YG  VD WA+G +++EML
Sbjct: 170 IL-SKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.4 bits (155), Expect = 5e-12
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 4/101 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH +G  +RDLKP NLL+ S G +K+ D G  K++ S      +  T  Y  PE++L ++
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL-NK 167

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
            Y   VD W++G +++E+L+    F      +   +I   I
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPFGE--DDEDPMEIYNDI 206

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 63.0 bits (154), Expect = 5e-12
 Identities = 24/79 (30%), Positives = 41/79 (51%), Gaps = 2/79 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRD+K +N+L+ S G +K+ D G+  ++         V T ++  PEV +  +
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV-INGK 172

Query: 157 IYGPEVDKWAMGAIMFEML 175
            Y  + D W++G    E+ 
Sbjct: 173 PYDYKADIWSLGITAIELA 191

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 6e-12
 Identities = 39/104 (37%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
           S+H+ GY HRD+KP N+L+ K G I++ D G    +  D  +     V T  Y  PE+L 
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 154 FSE----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             E     YGPE D W++G  M+EML     F  +S  +   KI
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 6e-12
 Identities = 31/81 (38%), Positives = 44/81 (54%), Gaps = 2/81 (2%)

Query: 96  ISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
             LHR+   +RDLKP N+L+   G I+I DLG+  EI         V T  Y  PEV+  
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK- 174

Query: 155 SEIYGPEVDKWAMGAIMFEML 175
           +E Y    D W +G +++EM+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.5 bits (154), Expect = 7e-12
 Identities = 40/102 (39%), Positives = 60/102 (58%), Gaps = 14/102 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG------PE 150
           LHR+G  +RDLK  N+++ S+G IKI D GM KE        D VTTR + G      PE
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-----HMVDGVTTRTFCGTPDYIAPE 171

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           ++ + + YG  VD WA G +++EML+    F G+   D++++
Sbjct: 172 IIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.8 bits (153), Expect = 8e-12
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 5/131 (3%)

Query: 95  AIS-LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEV 151
           A+S +H+ G  HRD+K  N+ ++K G+IK+GD G+ K + S     + V  T +Y  PE+
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLG-IQ 210
               + Y  + D WA+G +++E+L+    F   +  + + KI Q   +P    +    I 
Sbjct: 173 CQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELIS 231

Query: 211 LASNLNWKLPQ 221
           L  +L  + P+
Sbjct: 232 LVHSLLQQDPE 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 62.6 bits (153), Expect = 1e-11
 Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 6/96 (6%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           HRD+KPSNLL+ SKG +KI D G+ K +++ L  C  +V T  Y  PE +   E Y    
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ-GESYSYAA 181

Query: 163 DKWAMGAIMFEMLS--FGILFPGKSS-ADQIYKICQ 195
           D W++G  + E     F  L PG+ S  + +  IC 
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD 217

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 62.6 bits (152), Expect = 1e-11
 Identities = 38/112 (33%), Positives = 60/112 (53%), Gaps = 10/112 (8%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTR-------WYRGP 149
           LH +G  HRD+K +N+LV +KG IKI D G+ K++++N   T     R       ++  P
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
           EV+     Y  + D W++G ++ EML+    FP  +    I+KI +   SP 
Sbjct: 182 EVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPE 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.9 bits (153), Expect = 1e-11
 Identities = 35/81 (43%), Positives = 49/81 (60%), Gaps = 3/81 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ ++G IK+ D GM KE I      + +  T  Y  PE+L   
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR-G 170

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E YG  VD WA+G +MFEM++
Sbjct: 171 EDYGFSVDWWALGVLMFEMMA 191

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.9 bits (153), Expect = 1e-11
 Identities = 33/80 (41%), Positives = 44/80 (55%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 111 LHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 171 D-YGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|215563 PLN03081, PLN03081, pentatricopeptide (PPR) repeat-containing protein; Provisional

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 29/90 (32%), Positives = 51/90 (56%)

Query: 12  TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLM 71
           T  +LV AC  L ++R  ++++ +   +G E D  +   ++ M+ KCG +  A ++F+ M
Sbjct: 125 TYDALVEACIALKSIRCVKAVYWHVESSGFEPDQYMMNRVLLMHVKCGMLIDARRLFDEM 184

Query: 72  REKNLQSWTIMISGLADNSRGNDAISLHRQ 101
            E+NL SW  +I GL D     +A +L R+
Sbjct: 185 PERNLASWGTIIGGLVDAGNYREAFALFRE 214

Length = 697

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 39/102 (38%), Positives = 61/102 (59%), Gaps = 14/102 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG------PE 150
           LH +G  +RDLK  N+++ S+G IKI D GM KE   N+   D VTT+ + G      PE
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NM--WDGVTTKTFCGTPDYIAPE 171

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           ++ + + YG  VD WA G +++EML+    F G+   D++++
Sbjct: 172 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 211

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.0 bits (148), Expect = 6e-11
 Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 3/81 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLKP N+L+ S+G + + D G+ KE I+ +   + +  T  Y  PEVL   
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR-K 170

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           + Y   VD W +GA+++EML 
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 60.2 bits (147), Expect = 6e-11
 Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 16/106 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + + HRDL   N LV++  V+KI D G+ ++I       DY           +W   
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE----DDYYRKRGGGKLPIKWM-A 172

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
           PE L     +  + D W+ G +++E+ + G   +PG S+ + +  +
Sbjct: 173 PESLKDG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 60.3 bits (147), Expect = 7e-11
 Identities = 40/127 (31%), Positives = 53/127 (41%), Gaps = 28/127 (22%)

Query: 94  DAIS-LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLP--------------- 136
            A+  LH +G  HRDLKP N+L+ K   IKI D G  K +D N                 
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 137 ------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
                    +V T  Y  PE+L      G   D WA+G I+++ML+    F G +     
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNE---- 227

Query: 191 YKICQLI 197
           Y   Q I
Sbjct: 228 YLTFQKI 234

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.4 bits (146), Expect = 7e-11
 Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 7/86 (8%)

Query: 97  SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
           S+H+  Y HRD+KP N+L+   G I++ D G   ++  D  +  +  V T  Y  PE+L 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 154 FSE----IYGPEVDKWAMGAIMFEML 175
             E     YGPE D W++G  M+EML
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 60.2 bits (146), Expect = 9e-11
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 3/98 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH  G  +RDLKP N+L+  +G IK+ D G+ KE ID       +  T  Y  PEV+   
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NR 172

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             +    D W+ G +MFEML+  + F GK   + +  I
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 5/84 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID---SNLPCTDYVTTRWYRGPEVL- 152
           LH +G  HRDLK  NLLV   G+ KI D G+ K+ D    N        + ++  PEV+ 
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
            +S+ Y  +VD W++G ++ EM +
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFA 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 1e-10
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 11/106 (10%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ S+G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-G 170

Query: 156 EIYGPEVDKWAMGAIMFEMLS----FGIL----FPGKSSADQIYKI 193
           E YG  VD WA+G +MFEM++    F I+     P +++ D ++++
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 216

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 31/80 (38%), Positives = 45/80 (56%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKP-SNLLVSKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  S LL S G +K+ D G   ++   +P     V T ++  PEV+   
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS-R 189

Query: 156 EIYGPEVDKWAMGAIMFEML 175
             YG EVD W++G ++ EM+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 3/108 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H +   HRDLK  N+L+ K   V+KIGD G+ K + S       V T  Y  PE L   
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEG 175

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
           + Y  + D WA+G +++E+ S    F   +    + KI     +P  D
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 8/87 (9%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSN-LPC----TDYVTTRWYRGPEV 151
           LH  G  HRD+KP+N  L   GVIK+GD G   ++ +N             T  Y  PEV
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 152 LLFSEI--YGPEVDKWAMGAIMFEMLS 176
           +   +   +G   D W++G ++ EM +
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMAT 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 11/126 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+   G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR-G 170

Query: 156 EIYGPEVDKWAMGAIMFEMLS----FGILF--PGKSSADQIYKICQLIGSPTKDSWPLGI 209
           E YG  VD WA+G +MFEM++    F I+   P  ++ D ++++  ++  P +    L +
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--ILEKPIRIPRFLSV 228

Query: 210 QLASNL 215
           + +  L
Sbjct: 229 KASHVL 234

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 39/101 (38%), Positives = 47/101 (46%), Gaps = 30/101 (29%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           LH  G  HRDLKP NLL+ S G IK+ D G+ K    +L      TT  Y G        
Sbjct: 117 LHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL------TTNLYEGHIEKDTRE 170

Query: 149 --------------PEVLLFSEIYGPEVDKWAMGAIMFEML 175
                         PEV+L  + YG  VD WAMG I++E L
Sbjct: 171 FLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+   G IKI D GM KE +  +     +  T  Y  PE+LL  
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL-G 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + Y   VD W+ G +++EML
Sbjct: 171 QKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 58.7 bits (143), Expect = 2e-10
 Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 14/105 (13%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV +  V+KI D G+ +++  +     Y          RW   P
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLPIRWM-AP 176

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E L    I+  + D W+ G +++E+ + G   +PG S+ + +  +
Sbjct: 177 ESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)

Query: 96  ISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           + LH     +RD+KP N+L+  +G  ++ DLG+  E+      T    T  Y  PE+L  
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK- 167

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
            E Y   VD +AMG  ++EM++
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVA 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.3 bits (141), Expect = 4e-10
 Identities = 32/80 (40%), Positives = 47/80 (58%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++G  +RDLK  N+L+ K G IKI D GM KE ++     + +  T  Y  PE+L   
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK-G 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + Y   VD W+ G +++EML
Sbjct: 171 QKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (141), Expect = 4e-10
 Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 2/79 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK-EIDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH+    +RDLKP N+L+ + G I + D G+ K  +  N     +  T  Y  PEVLL  
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 156 EIYGPEVDKWAMGAIMFEM 174
           + Y   VD W++G ++FEM
Sbjct: 172 KGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 5e-10
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 111 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 171 D-YGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 2/79 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LHR+   +RDLKP N+L+   G I+I DLG+  +I         V T  Y  PEVL  ++
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN-NQ 176

Query: 157 IYGPEVDKWAMGAIMFEML 175
            Y    D W +G +++EM+
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.8 bits (139), Expect = 6e-10
 Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 7/86 (8%)

Query: 97  SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
           S+H+  Y HRD+KP N+L+   G I++ D G   ++  D  +  +  V T  Y  PE+L 
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 154 FSE----IYGPEVDKWAMGAIMFEML 175
             E     YGPE D W++G  M+EML
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLL 153
           ++H  G  HRD+KP N+L+ K G +K+ D G   ++D    + C   V T  Y  PEVL 
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216

Query: 154 FS---EIYGPEVDKWAMGAIMFEML 175
                  YG E D W++G  +FEML
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 33/80 (41%), Positives = 47/80 (58%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLKP N+L+ S+G I + D G+ KE I+ N   + +  T  Y  PEVL   
Sbjct: 112 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-HK 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + Y   VD W +GA+++EML
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.0 bits (137), Expect = 1e-09
 Identities = 33/81 (40%), Positives = 47/81 (58%), Gaps = 5/81 (6%)

Query: 98  LHRQGYFHRDLKP-SNLLVSKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  S LL S G IK+ D G   ++   +P     V T ++  PEV+  S
Sbjct: 134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI--S 191

Query: 156 EI-YGPEVDKWAMGAIMFEML 175
            + YG EVD W++G ++ EM+
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 41/129 (31%), Positives = 69/129 (53%), Gaps = 8/129 (6%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFS 155
           LH +   HRDLK  N+ +++  +IK+GDLG+ + +++     +  + T +Y  PE  LFS
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE--LFS 175

Query: 156 -EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ--LIGSPTKDSWPLGIQLA 212
            + Y  + D WA+G  ++EM +    F  K     +Y+I +  L   P   S  LG  +A
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235

Query: 213 SNLNWKLPQ 221
           + L+ K P+
Sbjct: 236 TMLS-KRPE 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 38/160 (23%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSW--------TIMISGLADNSRGNDAIS----- 97
           +V+ Y  CG  +    VF  M+  +L  +         I++ G    ++G   +S     
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 98  ----------LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDY------ 140
                     L  Q + HRDL   N LV   + +KIGD GM +++ S    TDY      
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRVGGH 184

Query: 141 --VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
             +  RW   PE +++ + +  E D W+ G I++E+ ++G
Sbjct: 185 TMLPIRWMP-PESIMYRK-FTTESDVWSFGVILWEIFTYG 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 56.8 bits (137), Expect = 1e-09
 Identities = 32/81 (39%), Positives = 42/81 (51%), Gaps = 4/81 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLF 154
           LH     HRD+K  N+LV+   GV+KI D G  K +    PCT+  T T  Y  PEV+  
Sbjct: 124 LHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 155 SEI-YGPEVDKWAMGAIMFEM 174
               YG   D W++G  + EM
Sbjct: 184 GPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 56.4 bits (136), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 3/98 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K  NL +     +KIGDLG+ K + D+       V T +Y  PE L   
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCED 175

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + Y  + D WA+G +++E  +    F   +    I KI
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 3/88 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLK  NLL+  +G +KI D G+ KE +      + +  T  +  PEVL   
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT-E 175

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPG 183
             Y   VD W +G +++EML     FPG
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.1 bits (135), Expect = 2e-09
 Identities = 32/87 (36%), Positives = 49/87 (56%), Gaps = 15/87 (17%)

Query: 100 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRGPE 150
           RQ Y HRDL   N+LV S+  +KIGD G+ K I+++    +Y T +        WY  PE
Sbjct: 128 RQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDLDSPVFWY-APE 182

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSF 177
            L+ S+ Y    D W+ G  ++E+L++
Sbjct: 183 CLIQSKFYIAS-DVWSFGVTLYELLTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 32/85 (37%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLG--MVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           ++H  G+ HRD+KP N+L+ K G +K+ D G  M    +  + C   V T  Y  PEVL 
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216

Query: 154 FS---EIYGPEVDKWAMGAIMFEML 175
                  YG E D W++G  ++EML
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH Q   HRD+K  N+L+SK G +K+ D G   ++          V T ++  PEV+   
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YGP+VD W++G +  EM 
Sbjct: 192 D-YGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 29/80 (36%), Positives = 48/80 (60%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   +I  ++P     V T ++  PEV+  +
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT 192

Query: 156 EIYGPEVDKWAMGAIMFEML 175
             YG EVD W++G ++ EM+
Sbjct: 193 -PYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 5/81 (6%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   ++   +P     V T ++  PE  L S
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE--LIS 189

Query: 156 EI-YGPEVDKWAMGAIMFEML 175
            + YGPEVD W++G ++ EM+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 5/79 (6%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH++G  HRD+KP NLL+ + G +K+ D G+ +    N     +V T  Y  PE +L   
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVG 169

Query: 157 IYGPEVDKWAMGAIMFEML 175
                 D W++G ++FE L
Sbjct: 170 -DDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 31/80 (38%), Positives = 46/80 (57%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLKP N+L+ S+G + + D G+ KE ++     + +  T  Y  PEVL   
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLR-K 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           E Y   VD W +GA+++EML
Sbjct: 171 EPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 12/83 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW----YRGPEVL 152
           LH +   +RDLKP NLL+ +KG +K+ D G  K++       D   T      Y  PEV+
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTPEYLAPEVI 187

Query: 153 LFSEIYGPEVDKWAMGAIMFEML 175
             S+ +G  VD W MG +++E +
Sbjct: 188 Q-SKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 18/87 (20%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRW-------YRGP 149
           LH +   +RDLKP N+L+ K G IK+ D G  K++             W       Y  P
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---------RDRTWTLCGTPEYLAP 167

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLS 176
           EV+  S+ +   VD WA+G +++EML 
Sbjct: 168 EVIQ-SKGHNKAVDWWALGILIYEMLV 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 14/130 (10%)

Query: 70  LMREKNLQSWTIMIS-GLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG--VIKIGDLG 126
           L  E  + SW + IS GL           +H +   HRD+K  N+ +SK   V K+GD G
Sbjct: 97  LFSEDQILSWFVQISLGLK---------HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFG 147

Query: 127 MVKEI-DSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
           + +++ DS       V T +Y  PE+   +  Y  + D W++G +++E+ +    F G +
Sbjct: 148 IARQLNDSMELAYTCVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Query: 186 SADQIYKICQ 195
               + KICQ
Sbjct: 207 LHQLVLKICQ 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.0 bits (132), Expect = 5e-09
 Identities = 29/79 (36%), Positives = 44/79 (55%), Gaps = 2/79 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L R+   +RDLKP N+L+  +G I+I DLG+  +I         V T  Y  PEV+  +E
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN-NE 176

Query: 157 IYGPEVDKWAMGAIMFEML 175
            Y    D W +G +++EM+
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 54.8 bits (132), Expect = 5e-09
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 12/117 (10%)

Query: 92  GNDAISLHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSN----LPCTDYVTTRWY 146
           G + +S H   + HRDL   N LV +G  +KI D G+ ++I S     +     +  RW 
Sbjct: 136 GMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM 193

Query: 147 RGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI--CQLIGSP 200
             PE +L+ + +  E D W+ G +++E+ S+G+  + G S+ + I  I   QL+  P
Sbjct: 194 -PPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP 248

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 54.7 bits (132), Expect = 5e-09
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 5/102 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-NLPCTDYVTTRWYRGPEVLLFS 155
           +H +   HRD+KP+N+ ++  GV+K+GDLG+ +   S        V T +Y  PE  +  
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IHE 180

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
             Y  + D W++G +++EM +    F G      +Y +C+ I
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.0 bits (132), Expect = 5e-09
 Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 2/80 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH++   +RDLKP N+L+   G I+I DLG+   +         V T  Y  PEV+  +E
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-NE 176

Query: 157 IYGPEVDKWAMGAIMFEMLS 176
            Y    D WA+G +++EM++
Sbjct: 177 RYTFSPDWWALGCLLYEMIA 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 5e-09
 Identities = 28/82 (34%), Positives = 46/82 (56%), Gaps = 7/82 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVLLFS 155
           LH QG  HRD+K +N+L +K GV+K+ D G+  +++         V T ++  PEV+   
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI--- 171

Query: 156 EIYGPEV--DKWAMGAIMFEML 175
           E+ G     D W++G  + E+L
Sbjct: 172 EMSGASTASDIWSLGCTVIELL 193

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 54.6 bits (131), Expect = 5e-09
 Identities = 40/128 (31%), Positives = 62/128 (48%), Gaps = 11/128 (8%)

Query: 98  LHRQGYFHRDLKPSNL-LVSKGVIKIGDLGMVKEIDS--NLPCTDYVTTRWYRGPEVLLF 154
           +H +   HRD+K  N+ L   G +K+GD G  + + S     CT YV T +Y  PE+   
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWE- 173

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
           +  Y  + D W++G I++E+ +    F   S  + I K+CQ  GS      PL    +  
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--GSYK----PLPSHYSYE 227

Query: 215 LNWKLPQM 222
           L   + QM
Sbjct: 228 LRSLIKQM 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 54.6 bits (131), Expect = 5e-09
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 5/102 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCT-DYVTTRWYRGPEVLLFS 155
           +H +   HRD+KP+N+ ++  GV+K+GDLG+ +   S        V T +Y  PE  +  
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHE 180

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
             Y  + D W++G +++EM +    F G      +Y +C+ I
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 7e-09
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 9/116 (7%)

Query: 98  LHRQGYFHRDLKPSNL-LVSKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLL 153
           +H +   HRDLK +N+ L+  G+IK+GD G  K+   ++     + +  T +Y  PE L 
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LW 243

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
             + Y  + D W++G I++E+L+    F G S  +    I Q +     D +P  +
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKYDPFPCPV 295

Length = 478

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 54.3 bits (130), Expect = 8e-09
 Identities = 35/130 (26%), Positives = 68/130 (52%), Gaps = 15/130 (11%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVT-------TRWYRGP 149
           + R+ Y HRDL+ +N+LVS+ ++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN----EYTAREGAKFPIKW-TAP 173

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + F   +  + D W+ G +++E++++G I +PG S++D +  + +    P  ++ P  
Sbjct: 174 EAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232

Query: 209 IQLASNLNWK 218
           +       WK
Sbjct: 233 LYDIMKTCWK 242

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 15/118 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVT-------TRWYRGP 149
           + ++ Y HRDL+ +N+LVS  ++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKW-TAP 172

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
           E + F   +  + D W+ G ++ E++++G I +PG S+ + I  + +    P  ++ P
Sbjct: 173 EAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 229

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 28/158 (17%)

Query: 60  HVEKAFKVFNLMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG 118
           +++K +K+F  + E  +   T  ++  LA      D  +  R    HRDLKP N+ +S G
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER--VLHRDLKPQNIFLSTG 161

Query: 119 ------------------VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF-SEIYG 159
                             + KIGD G+ K I         V T +Y  PE+LL  ++ Y 
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD 221

Query: 160 PEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
            + D WA+G I++E+ S      GK+   +     QLI
Sbjct: 222 DKSDMWALGCIIYELCS------GKTPFHKANNFSQLI 253

Length = 1021

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 6/105 (5%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  Y  + D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-YSVQSD 184

Query: 164 KWAMGAIMFEML--SFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            W+MG  + EM    + I  P     + ++  C + G P +    
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDAKELELMFG-CPVEGDPAESETS 228

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 25/79 (31%), Positives = 47/79 (59%), Gaps = 2/79 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVLLFS 155
           +H+ G  HRD+K +N+LV+  G +K+ D G+   ++ N    + +V T ++  PEV+   
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 156 EIYGPEVDKWAMGAIMFEM 174
           + Y  + D W++G  ++EM
Sbjct: 177 KYYDTKADIWSLGITIYEM 195

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 18/91 (19%)

Query: 97  SLHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYR 147
           SLH   + HRDL   N LV +G V+KIGD GM ++I S    TDY        +  RW  
Sbjct: 140 SLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLPIRWMP 192

Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            PE +L+ + +  E D W+ G +++E+ ++G
Sbjct: 193 -PESILYRK-FTTESDIWSFGVVLWEIFTYG 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+++ + G IKI D GM KE +  +   + +  T  Y  PE+L   
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + Y   VD W+ G +++EML
Sbjct: 172 K-YTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 33/80 (41%), Positives = 44/80 (55%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 111 LHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 171 D-YGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 31/80 (38%), Positives = 46/80 (57%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLKP N+L+ S+G + + D G+ KE I  +   T +  T  Y  PEV+   
Sbjct: 112 LHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR-K 170

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + Y   VD W +GA+++EML
Sbjct: 171 QPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 3/73 (4%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  ++ YG  V
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAV 177

Query: 163 DKWAMGAIMFEML 175
           D W +G +M+EM+
Sbjct: 178 DWWGLGVVMYEMM 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 7/87 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPC----TDYVTTRWYRGPEVL 152
           L  + + HRDL   N LV +  V+KI D G+ + I S         D +  RW   PE +
Sbjct: 146 LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMP-PESI 204

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGI 179
            ++  Y  E D WA G +++E+ S+G+
Sbjct: 205 FYNR-YTTESDVWAYGVVLWEIFSYGM 230

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 3e-08
 Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID----SNLPCTDYVTTRWYRGPEVL 152
           LH     HRD+K +N+L  S G +K+GD G  K +     S         T ++  PEV+
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
              E YG + D W++G  + EML+
Sbjct: 180 S-GEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 31/73 (42%), Positives = 43/73 (58%), Gaps = 5/73 (6%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           HRD+KPSN+LV S+G IK+ D G+  + IDS      +V TR Y  PE L  +  Y  + 
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTH-YTVQS 179

Query: 163 DKWAMGAIMFEML 175
           D W++G  + EM 
Sbjct: 180 DIWSLGLSLVEMA 192

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.6 bits (126), Expect = 3e-08
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 20/95 (21%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG------VIKIGDLGMVKEIDSNLPCTDY--------VTT 143
           L +  + HRDL   N LVS+       V+KIGD G+ ++I  +    DY        +  
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS----DYYRKEGEGLLPV 177

Query: 144 RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           RW   PE LL    +  + D W+ G +M+E+L+ G
Sbjct: 178 RWM-APESLL-DGKFTTQSDVWSFGVLMWEILTLG 210

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 5/102 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCT-DYVTTRWYRGPEVLLFS 155
           +H +   HRD+KP+N+ ++  GV+K+GDLG+ +   S        V T +Y  PE  +  
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHE 180

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
             Y  + D W++G +++EM +    F G      ++ +CQ I
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.4 bits (125), Expect = 4e-08
 Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 38/116 (32%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV------------KEIDSNLPCTDYV-- 141
           S+H+ G+ HRD+KP NLL+ SKG +K+ D G+             + ++ +LP +D+   
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP-SDFTFQ 174

Query: 142 -------TTRWYRGPEVLLFSEI-----YGPEV----------DKWAMGAIMFEML 175
                     W R    L FS +       PEV          D W++G IM+EML
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           L  Q Y HRDL   N+LV S+ ++KI D G+ K +  +    DY   +        WY  
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED---KDYYYVKEPGESPIFWY-A 180

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L  S+      D W+ G  ++E+ ++G
Sbjct: 181 PECLRTSKFSS-ASDVWSFGVTLYELFTYG 209

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 27/164 (16%)

Query: 51  LVEMYSKCGHVEKAFKV---------FNLMREKNLQ-SWTIMISGLADNSRGNDAISLHR 100
           LV++Y  C   +  + V          N +R++  + S  +++S   D   G +   L R
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME--YLER 118

Query: 101 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVL 152
             + HRDL   N LVS  GV+K+ D GM + +  +    +Y ++       +W   PEV 
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD----EYTSSSGAKFPVKW-SPPEVF 173

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
            FS+ Y  + D W+ G +M+E+ + G + F  KS+ + +  I +
Sbjct: 174 NFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)

Query: 98  LHRQGYF-HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++    HRDL P+N +L     + I D G+ K+       T  V T  Y  PE++  +
Sbjct: 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK-N 187

Query: 156 EIYGPEVDKWAMGAIMFEM 174
           E YG + D WA G I+++M
Sbjct: 188 EPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 51.6 bits (124), Expect = 6e-08
 Identities = 25/83 (30%), Positives = 37/83 (44%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEV 151
           LH  G  HRD+K  N+L+   G +KI D G+   +      T      +V T  +  PEV
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 152 LLFSEIYGPEVDKWAMGAIMFEM 174
           +     Y  + D W+ G    E+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 6e-08
 Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 9/94 (9%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI-DSNLPCTDYVTTRW---YRGPEVL 152
           L   G+ HRDL   N LV    V+K+ D G+ + + D     +    T++   +  PEV 
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS--QGTKFPVKWAPPEVF 173

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKS 185
            +S  +  + D W+ G +M+E+ S G + +   S
Sbjct: 174 DYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 51.2 bits (123), Expect = 8e-08
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 6/80 (7%)

Query: 98  LHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLF 154
           LH +    HRD+KPSN+LV S+G IK+ D G+  + ++S      +V T  Y  PE +  
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKTFVGTSSYMAPERIQ- 172

Query: 155 SEIYGPEVDKWAMGAIMFEM 174
              Y  + D W++G  + E+
Sbjct: 173 GNDYSVKSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|215561 PLN03077, PLN03077, Protein ECB2; Provisional

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 1/94 (1%)

Query: 8   PNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKV 67
            +    V+L   C     V  G  + S A+ +   L V +G A++ M+ + G +  A+ V
Sbjct: 84  VDEDAYVALFRLCEWKRAVEEGSRVCSRALSSHPSLGVRLGNAMLSMFVRFGELVHAWYV 143

Query: 68  FNLMREKNLQSWTIMISGLADNSRGNDAISL-HR 100
           F  M E++L SW +++ G A     ++A+ L HR
Sbjct: 144 FGKMPERDLFSWNVLVGGYAKAGYFDEALCLYHR 177

Length = 857

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 30/81 (37%), Positives = 46/81 (56%), Gaps = 3/81 (3%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++   +RDLKP N LL + G ++I DLG+  E+ D       Y  T  +  PE+L   
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E Y   VD +A+G  ++EM++
Sbjct: 173 E-YDFSVDYFALGVTLYEMIA 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 34/128 (26%), Positives = 52/128 (40%), Gaps = 50/128 (39%)

Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLG----------------------------- 126
           ++H+ G+ HRD+KP N+L+ + G IK+ D G                             
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175

Query: 127 ----MVKEIDSNLPCTDYVTTRWYRGPEVLLFS----------EI-----YGPEVDKWAM 167
                V  I+  +   D + T W +   ++ +S          EI     YG E D W++
Sbjct: 176 RNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234

Query: 168 GAIMFEML 175
           GAIMFE L
Sbjct: 235 GAIMFECL 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 14/89 (15%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV  +G +K+ D G+ + +  +    +Y ++       RW   P
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD----EYTSSVGSKFPVRW-SPP 170

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           EVLL+S+ +  + D WA G +M+E+ S G
Sbjct: 171 EVLLYSK-FSSKSDVWAFGVLMWEVYSLG 198

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 3/98 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY-VTTRWYRGPEVLLFS 155
           +H +   HRD+K  N+ ++K G IK+GD G+ + ++S +      + T +Y  PE+   +
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE-N 175

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             Y  + D WA+G +++EM +    F   +  + + KI
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 50.5 bits (120), Expect = 2e-07
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 15/92 (16%)

Query: 96  ISLHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDY--------VTTRWY 146
           + L  Q + HRDL   N LV + + +KIGD GM +++ S    TDY        +  RW 
Sbjct: 134 VYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS----TDYYRVGGHTMLPIRWM 189

Query: 147 RGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
             PE +++ + +  E D W++G +++E+ ++G
Sbjct: 190 P-PESIMYRK-FTTESDVWSLGVVLWEIFTYG 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 28/99 (28%), Positives = 52/99 (52%), Gaps = 2/99 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSE 156
           +H++   HRDLK  N+ +   ++KIGD G+ + +  +    T +  T +Y  PE L   +
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK-HQ 180

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
            Y  + D W++G I++EM      F G++    + +I +
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 46/130 (35%), Positives = 62/130 (47%), Gaps = 18/130 (13%)

Query: 94  DAIS-LHRQGYFHRDLKPSNLLVS-KGV---IKIGDLGM------VKEIDSN--LPCTDY 140
           DA++  H QG  HRDLKP N++VS  GV    K+ D G+      V++ D       T+ 
Sbjct: 90  DALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEV 149

Query: 141 VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
           + T  Y  PE L   E   P  D +A G I  E L+   +  G S A+ +Y+  QL  SP
Sbjct: 150 LGTPTYCAPEQLR-GEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ--QL--SP 204

Query: 201 TKDSWPLGIQ 210
              S P  I 
Sbjct: 205 VDVSLPPWIA 214

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 27/71 (38%), Positives = 43/71 (60%), Gaps = 3/71 (4%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KPSN+LV ++G +K+ D G+  ++ +++  T YV T  Y  PE +   E YG   D
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-YVGTNAYMAPERIS-GEQYGIHSD 175

Query: 164 KWAMGAIMFEM 174
            W++G    E+
Sbjct: 176 VWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 7/79 (8%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGM---VKEIDSNLPCTD-YVTTRWYRGPEVLLFSEIYG 159
           HRDL   N+LV++  V+KI D G+   +  ID     T+  +  +W   PE L F  +Y 
Sbjct: 155 HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWM-APEAL-FDRVYT 212

Query: 160 PEVDKWAMGAIMFEMLSFG 178
            + D W+ G +++E+ + G
Sbjct: 213 HQSDVWSFGVLLWEIFTLG 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 15/90 (16%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q + HRDL   N LV    V+KIGD GM +++ +    TDY        +  RW   
Sbjct: 138 LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----TDYYRVGGHTMLPIRWM-P 192

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE +++ + +  E D W+ G +++E+ ++G
Sbjct: 193 PESIMYRK-FTTESDVWSFGVVLWEIFTYG 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.8 bits (119), Expect = 3e-07
 Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 4/84 (4%)

Query: 97  SLHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
            LH+ G  +RD+K  N LL S+G + + D G+ KE   +       +  T  Y  PEV+ 
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 154 FSEI-YGPEVDKWAMGAIMFEMLS 176
                +   VD W++G + FE+L+
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 31/113 (27%), Positives = 51/113 (45%), Gaps = 11/113 (9%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKG-VIKIGDLGMVKEIDSNLPCTD-----YVTTRWYRGPE 150
           LH     HRD+K +NLL+ S G  ++I D G    + +            + T  +  PE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ---IYKICQLIGSP 200
           VL   E YG   D W++G ++ EM +    +  +  ++    I+KI     +P
Sbjct: 179 VLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-R 189

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YGP+VD W++G +  EM+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-R 190

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YGP+VD W++G +  EM+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 25/107 (23%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL  KG   V KI D GM ++I        Y  + + +G     
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI--------YRASYYRKGGRAML 183

Query: 149 ------PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                 PE  L   I+  + D W+ G +++E+ S G + +PG+++ +
Sbjct: 184 PIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 26/86 (30%), Positives = 48/86 (55%), Gaps = 15/86 (17%)

Query: 103 YFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLL 153
           + H+DL   N+L+ + + +KI DLG+ +EI S     DY        +  RW   PE ++
Sbjct: 145 FVHKDLAARNILIGEQLHVKISDLGLSREIYS----ADYYRVQPKSLLPIRWMP-PEAIM 199

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGI 179
           + + +  + D W+ G +++E+ SFG+
Sbjct: 200 YGK-FSSDSDIWSFGVVLWEIFSFGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.3 bits (117), Expect = 5e-07
 Identities = 28/71 (39%), Positives = 43/71 (60%), Gaps = 3/71 (4%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  Y  + D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-YSVQSD 184

Query: 164 KWAMGAIMFEM 174
            W+MG  + E+
Sbjct: 185 IWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|205222 pfam13041, PPR_2, PPR repeat family

 Score = 44.7 bits (107), Expect = 6e-07
 Identities = 15/44 (34%), Positives = 28/44 (63%), Gaps = 4/44 (9%)

Query: 49 TALVEMYSKCGHVEKAFKVFNLMREKNLQ----SWTIMISGLAD 88
            L++ Y K G VE+A K+FN M+++ ++    +++I+I GL  
Sbjct: 7  NTLIDGYCKKGKVEEALKLFNEMKKRGIKPNVYTYSILIDGLCK 50

This repeat has no known function. It is about 35 amino acids long and is found in up to 18 copies in some proteins. The family appears to be greatly expanded in plants and fungi. The repeat has been called PPR. Length = 50

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.8 bits (116), Expect = 6e-07
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 4/88 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLF 154
           LH+ G  +RD+K  N+L+ S G + + D G+ KE   D       +  T  Y  P+++  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 155 SEI-YGPEVDKWAMGAIMFEMLSFGILF 181
            +  +   VD W+MG +M+E+L+    F
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 48.9 bits (117), Expect = 6e-07
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 16/98 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  + + HRDL   N +V++   +KIGD GM ++I      TDY        +  RW   
Sbjct: 135 LAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----TDYYRKGGKGLLPVRWM-A 189

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKS 185
           PE L    ++  + D W+ G +++EM +     + G S
Sbjct: 190 PESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 48.8 bits (116), Expect = 6e-07
 Identities = 26/82 (31%), Positives = 46/82 (56%), Gaps = 3/82 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLF 154
           LH+ G  +RD+K  N+L+ S+G + + D G+ KE   +       +  T  Y  PE++  
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
              +G  VD W++G ++FE+L+
Sbjct: 181 KGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.3 bits (115), Expect = 6e-07
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 4/81 (4%)

Query: 97  SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +LHR+G   RDL P+N+L+  +G I++       E++ +  C        Y  PEV   S
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGIS 157

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E      D W++GAI+FE+L+
Sbjct: 158 EE-TEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 48.5 bits (116), Expect = 6e-07
 Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 11/88 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L    Y HRDL   N+LV+   V K+ D G+ + ++ +     Y T       RW   PE
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGKIPIRW-TAPE 178

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + +   +    D W+ G +M+E++S+G
Sbjct: 179 AIAY-RKFTSASDVWSFGIVMWEVMSYG 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.9 bits (116), Expect = 7e-07
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 38/116 (32%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV--------KEIDSNL---PCTDY---- 140
           ++H+ G+ HRD+KP NLL+ +KG +K+ D G+          E   NL   P +D+    
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 141 ---------------------VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
                                V T  Y  PEV + +  Y    D W++G IM+EML
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 20/167 (11%)

Query: 49  TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRD 107
           +  VE Y   G ++   K +  + E   + +T  I  G++          LH     HRD
Sbjct: 82  SIFVE-YMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS---------YLHSNMIVHRD 131

Query: 108 LKPSNLLV-SKGVIKIGDLGMVKEID----SNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           +K +N+L  S G +K+GD G  K I     S         T ++  PEV+   E YG + 
Sbjct: 132 IKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI-SGEGYGRKA 190

Query: 163 DKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
           D W++   + EML+     P  +  + +  I ++   PTK   P G+
Sbjct: 191 DVWSVACTVVEMLTEK---PPWAEYEAMAAIFKIATQPTKPMLPDGV 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 2/79 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKP+N+L+ + G ++I DLG+  +     P    V T  Y  PEVL    
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGT 171

Query: 157 IYGPEVDKWAMGAIMFEML 175
            Y    D +++G ++F++L
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 48.2 bits (115), Expect = 8e-07
 Identities = 38/163 (23%), Positives = 77/163 (47%), Gaps = 24/163 (14%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSW-------TIMISGLADNSR--GNDAISLHRQ 101
           L+++Y+ C   E  + V  LM+  +L  +        + +  L D +    +    L  Q
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 102 GYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLL 153
            Y HRDL   N+LV +  + K+ D G+ + I  +     Y          +W   PE  L
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKW-TAPEAAL 177

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQ 195
           ++  +  + D W+ G ++ E++++G + +PG ++A+ + ++ Q
Sbjct: 178 YNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 48.7 bits (116), Expect = 9e-07
 Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 8/96 (8%)

Query: 86  LADNSRG--NDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYV 141
           LAD +R   +    LHR+   HRD+KPSNLL+ S   +KI D G+ + +   + PC   V
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229

Query: 142 TTRWYRGPEVL---LFSEIY-GPEVDKWAMGAIMFE 173
            T  Y  PE +   L    Y G   D W++G  + E
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 48.5 bits (115), Expect = 9e-07
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 6/80 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRD+K  N+L+S+ G++K+GD G    +    P   +V T ++  PEV+L  +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187

Query: 157 --IYGPEVDKWAMGAIMFEM 174
              Y  +VD W++G    E+
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 9e-07
 Identities = 29/81 (35%), Positives = 45/81 (55%), Gaps = 3/81 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH+    +RDLKP N+L+  +G I + D G+ K    +   T+ +  T  Y  PE+LL  
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-G 167

Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
             Y   VD W +G +++EML+
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 2/93 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKP+N+L+ + G ++I DLG+  +     P    V T  Y  PEVL    
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 171

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ 189
            Y    D +++G ++F++L     F    + D+
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 18/102 (17%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVT-------TRWYRGPEVLLF 154
           HRDL   N+L++ G ++KI D G+ ++I  DSN     YV         +W   PE + F
Sbjct: 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSN-----YVVKGNARLPVKWM-APESI-F 216

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           + +Y  E D W+ G +++E+ S G   +PG     + YK+ +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 48.2 bits (114), Expect = 1e-06
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-R 189

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YGP+VD W++G +  EM+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 33/124 (26%), Positives = 48/124 (38%), Gaps = 46/124 (37%)

Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMV--------------------------K 129
           S+H+ G+ HRD+KP N+L+ + G IK+ D G+                           +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 130 EIDSNLPCT------------------DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIM 171
           E      C                     V T  Y  PEVLL +  Y    D W++G I+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL 234

Query: 172 FEML 175
           +EML
Sbjct: 235 YEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 14/88 (15%)

Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S   V+KI D G+ ++I  +    DYV         +W   PE + F  
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APETI-FDR 256

Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASPYPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 48.2 bits (114), Expect = 1e-06
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-R 189

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YGP+VD W++G +  EM+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 15/104 (14%)

Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY 140
           M+ G+A   +      L   GY HRDL   N+LV S  V K+ D G+ + ++ + P   Y
Sbjct: 111 MLRGIASGMK-----YLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEAAY 164

Query: 141 VTT------RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            T       RW   PE + + + +    D W+ G +M+E++S+G
Sbjct: 165 TTRGGKIPIRW-TAPEAIAYRK-FTSASDVWSYGIVMWEVMSYG 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 8/85 (9%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPC--TDYVTTRWYRGPEVLLFSEIYG 159
           HRDL   N+L+++G ++KI D G+ ++I  DSN     + ++  +W   PE + F  +Y 
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APESI-FDNLYT 317

Query: 160 PEVDKWAMGAIMFEMLSF-GILFPG 183
              D W+ G +++E+ S  G  +PG
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 28/72 (38%), Positives = 40/72 (55%), Gaps = 4/72 (5%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           +RDLKP NLL+ K G IK+ D G  K +D+         T  Y  PE+LL +  +G   D
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILL-NVGHGKAAD 210

Query: 164 KWAMGAIMFEML 175
            W +G  ++E+L
Sbjct: 211 WWTLGIFIYEIL 222

Length = 340

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 37/128 (28%), Positives = 58/128 (45%), Gaps = 16/128 (12%)

Query: 55  YSKCGHVEKAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNL 113
           Y   G V+   K +  + E   + +T  I  G++          LH     HRD+K +N+
Sbjct: 87  YMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS---------YLHSNMIVHRDIKGANI 137

Query: 114 LV-SKGVIKIGDLGMVKEID----SNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMG 168
           L  S G +K+GD G  K +     S         T ++  PEV+   E YG + D W++G
Sbjct: 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI-SGEGYGRKADVWSLG 196

Query: 169 AIMFEMLS 176
             + EML+
Sbjct: 197 CTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + + HRDL   N LLV++   KI D GM + + +    +DY           +WY  
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG---SDYYRATTAGRWPLKWY-A 166

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE + +   +  + D W+ G  ++E  S+G
Sbjct: 167 PECINYG-KFSSKSDVWSYGVTLWEAFSYG 195

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 32/130 (24%), Positives = 61/130 (46%), Gaps = 15/130 (11%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVT-------TRWYRGP 149
           + R  Y HRDL+ +N+LV   ++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN----EYTARQGAKFPIKW-TAP 172

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E  L+   +  + D W+ G ++ E+++ G + +PG  + + + ++ +    P     P  
Sbjct: 173 EAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPES 231

Query: 209 IQLASNLNWK 218
           +     L WK
Sbjct: 232 LHELMKLCWK 241

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 15/90 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ +++++     DY        +  +W   
Sbjct: 153 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN----IDYYKKTTNGRLPVKWM-A 207

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 208 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S+ G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 177 A-YDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 16/90 (17%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC-TDYVTTR--------WYR 147
           L  + Y HRDL   N+LV S+  +KIGD G+ K     LP   +Y   R        WY 
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV----LPQDKEYYKVREPGESPIFWY- 178

Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
            PE L  S  +    D W+ G +++E+ ++
Sbjct: 179 APESLTES-KFSVASDVWSFGVVLYELFTY 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S+ G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 177 A-YDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 6/80 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRD+K  N+L+++ G +K+ D G    +    P   +V T ++  PEV+L  +
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSFVGTPYWMAPEVILAMD 187

Query: 157 --IYGPEVDKWAMGAIMFEM 174
              Y  +VD W++G    E+
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 46.8 bits (111), Expect = 3e-06
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 15/118 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-------TRWYRGP 149
           + R+ Y HRDL+ +N+LVS+ +  KI D G+ + I+ N    +Y          +W   P
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAP 172

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
           E + +   +  + D W+ G ++ E++++G I +PG ++ + I  + +    P  D+ P
Sbjct: 173 EAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 36/156 (23%), Positives = 74/156 (47%), Gaps = 15/156 (9%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSW-------TIMISGLAD-NSRGNDAIS-LHRQ 101
           L+ +++ C   E  + +  LM + +L ++        + ++ L D   +  + ++ L  Q
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 102 GYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIY 158
              HRDL   N+LV +  V K+ D G+ + I  D  L     +  +W   PE       +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPEAASHGT-F 181

Query: 159 GPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
             + D W+ G +++EM ++G + +PG ++ +   +I
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 3/86 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH +   HRD+KPSN+L++ KG +K+ D G+  E+ ++L  T +  T +Y  PE +   +
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERIQ-GK 178

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFP 182
            Y    D W++G  + E+      FP
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 27/72 (37%), Positives = 43/72 (59%), Gaps = 3/72 (4%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KPSN+LV S+G IK+ D G+  E+ +++  T +V T  Y  PE +     Y  + D
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPERIQ-GGKYTVKSD 184

Query: 164 KWAMGAIMFEML 175
            W++G  + E+ 
Sbjct: 185 VWSLGISIIELA 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 4e-06
 Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 3/80 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVLLFS 155
           LH +G  HRD+K +N+L+S+ G +K+ D G+  ++ S       +V T ++  PEV+  S
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 156 EIYGPEVDKWAMGAIMFEML 175
             Y  + D W++G    E+ 
Sbjct: 174 G-YDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 38/142 (26%), Positives = 58/142 (40%), Gaps = 18/142 (12%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMR----------EKNLQSWTIMISGLADNSRGNDAISLHR 100
           LV++Y  C        VF  M           ++   S   ++    D   G     L  
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEG--MAYLES 118

Query: 101 QGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVT---TRWYRGPEVLLFSE 156
               HRDL   N LV +  V+K+ D GM + +  +   +   T    +W   PEV  FS+
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW-SSPEVFSFSK 177

Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            Y  + D W+ G +M+E+ S G
Sbjct: 178 -YSSKSDVWSFGVLMWEVFSEG 198

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 8/89 (8%)

Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYG 159
           HRDL   N LV    V+KI D GM +E +  +         +  +W   PE L +   Y 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALNYGR-YT 173

Query: 160 PEVDKWAMGAIMFEMLSFGIL-FPGKSSA 187
            E D W+ G +++E  S G   +PG S+ 
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQ 202

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 15/95 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVT-------TRWYRGP 149
           + R  Y HRDL+ +N+LV  G++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN----EYTARQGAKFPIKW-TAP 172

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG 183
           E  L+   +  + D W+ G ++ E+++ G + +PG
Sbjct: 173 EAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 4e-06
 Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 2/48 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK-EIDSNLPCTDYVTT 143
           LHR G  HRDLKP N+L+S +G IK+ D G+ K  ++  L   D +TT
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.2 bits (109), Expect = 6e-06
 Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 7/110 (6%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRD+K  N+L+++ G +K+ D G   +     P   +V T ++  PEV+L  +
Sbjct: 137 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMD 193

Query: 157 --IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
              Y  +VD W++G    E+          ++   +Y I Q   SPT  S
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLQS 242

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID----SNLPCTDYVTTRWYRGPEVL 152
           LH     HRD+K +N+L  S G +K+GD G  K +     S         T ++  PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
              E YG + D W++G  + EML+
Sbjct: 182 -SGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 45.7 bits (108), Expect = 6e-06
 Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L    + HRDL   N+LVS+  V K+ D G+ KE  S+   T  +  +W   PE L   +
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKW-TAPEALR-EK 174

Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            +  + D W+ G +++E+ SFG
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFG 196

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 14/88 (15%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S+  V+KI D G+ ++I  +    DYV         +W   PE + F +
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGSARLPLKWM-APESI-FDK 251

Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.0 bits (109), Expect = 7e-06
 Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 13/82 (15%)

Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S   V+KI D G+ ++I  +    DYV         +W   PE + F +
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APESI-FDK 250

Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
           +Y  + D W+ G +++E+ S G
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLG 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 45.9 bits (108), Expect = 7e-06
 Identities = 25/80 (31%), Positives = 41/80 (51%), Gaps = 6/80 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRD+K  N+L+++ G +K+ D G         P   +V T ++  PEV+L  +
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEVILAMD 197

Query: 157 --IYGPEVDKWAMGAIMFEM 174
              Y  +VD W++G    E+
Sbjct: 198 EGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S +G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 177 A-YDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 9e-06
 Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 16/86 (18%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWY--------RG 148
           LH     HRD+K  N+ ++  G + +GD G      +  P  D    ++Y          
Sbjct: 198 LHENRIIHRDIKAENIFINHPGDVCLGDFGA-----ACFP-VDINANKYYGWAGTIATNA 251

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEM 174
           PE LL  + YGP VD W+ G ++FEM
Sbjct: 252 PE-LLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 45.0 bits (106), Expect = 9e-06
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 7/94 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           L  +   HRDL   N LV +  V+KI D GM ++ D  +  +     +  +W   PE L 
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPEALN 167

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSS 186
           +   Y  E D W+ G +++E  S G+  +PG ++
Sbjct: 168 YGR-YSSESDVWSYGILLWETFSLGVCPYPGMTN 200

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH  G  HRD+K +N LL   G +K+ D G+  ++ + +     ++ T ++  PEV    
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 156 EI--YGPEVDKWAMGAIMFEM 174
               Y  + D WA+G    E+
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 15/105 (14%)

Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY 140
           M+ G+A   +      L    Y HRDL   N+LV S  V K+ D G+ + ++ +     Y
Sbjct: 111 MLRGIAAGMK-----YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165

Query: 141 VTT-------RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            ++       RW   PE + + + +    D W+ G +M+E++S+G
Sbjct: 166 TSSLGGKIPIRW-TAPEAIAYRK-FTSASDVWSYGIVMWEVMSYG 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 22/95 (23%)

Query: 105 HRDLKPSNLLVSKG-----------------VIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           H DLKP N+L+                     ++I DLG     D     T  V+TR YR
Sbjct: 255 HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAIVSTRHYR 312

Query: 148 GPEVLL-FSEIYGPEVDKWAMGAIMFEMLSFGILF 181
            PEV+L    +Y    D W+MG I++E+ +  +L+
Sbjct: 313 SPEVVLGLGWMY--STDMWSMGCIIYELYTGKLLY 345

Length = 467

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 31/139 (22%)

Query: 87  ADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM-------VKEIDSNLPCT 138
           AD +RG D +S  ++ + HRDL   N+LV +  V KI D G+       VK+    LP  
Sbjct: 131 ADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 186

Query: 139 DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQLI 197
                RW    E L +S +Y    D W+ G +++E++S  G  + G + A+   K+    
Sbjct: 187 ----VRWM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 236

Query: 198 GSPTKDSWPLGIQLASNLN 216
                   P G +L   LN
Sbjct: 237 --------PQGYRLEKPLN 247

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 18/100 (18%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVT-------TRWYRGPEVLLF 154
           HRD+   N+L++ G V KI D G+ ++I  DSN     YV         +W   PE + F
Sbjct: 235 HRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-----YVVKGNARLPVKWM-APESI-F 287

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
             +Y  + D W+ G +++E+ S G   +PG     + YK+
Sbjct: 288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 18/100 (18%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVT-------TRWYRGPEVLLF 154
           HRDL   N+L++ G + KI D G+ ++I  DSN     YV         +W   PE + F
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSN-----YVVKGNARLPVKWM-APESI-F 289

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           + +Y  E D W+ G +++E+ S G   +PG     + YK+
Sbjct: 290 NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 10/88 (11%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L    Y HRDL   N+LV S    K+ D G+ + ++ + P   Y T+      RW   PE
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD-PEGTYTTSGGKIPIRW-TAPE 180

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +M+E++SFG
Sbjct: 181 AIAYRK-FTSASDVWSFGIVMWEVMSFG 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 10/98 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS--NLP-CTDYVTTRWYRGPEVLL 153
           LH +G  HRD+K  N+ + +     +GD G   ++D+  + P C  +  T     PE LL
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE-LL 259

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS-----FGILFPGKSS 186
             + Y  + D W+ G ++FEM       FG      SS
Sbjct: 260 ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297

Length = 392

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 14/88 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           LH Q Y HRDL   N+L+    ++KIGD G+ K +       +Y   R        WY  
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-A 178

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLS 176
            E L  ++      D W+ G  ++E+L+
Sbjct: 179 VECLKENKFSYAS-DVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 34/154 (22%), Positives = 70/154 (45%), Gaps = 16/154 (10%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSW-------TIMISGLADNSR--GNDAISLHRQ 101
           LV++Y+ C   E  + V   M + +L  +        + +  L D +         L  +
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 102 GYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRW---YRGPEVLLFSEI 157
            Y HRDL   N+LV +  V KI D G+ + I+ +         ++   +  PE   +   
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGR- 180

Query: 158 YGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQI 190
           +  + D W+ G ++ E++++G + +PG ++ + +
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 27/79 (34%), Positives = 40/79 (50%), Gaps = 7/79 (8%)

Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD----YVTTRWYRGPEVLLFSEIYG 159
           HRDL   N LV+ K V+KI D GM +E +  +  +      +  +W   PE L +   Y 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEALNYGR-YS 174

Query: 160 PEVDKWAMGAIMFEMLSFG 178
            E D W+ G +++E  S G
Sbjct: 175 SESDVWSFGILLWEAFSLG 193

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 28/100 (28%), Positives = 55/100 (55%), Gaps = 7/100 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTD----YVTTRWYRGPEVL 152
           +H +   HRD+K +N LL S G++K+GD G  K + +     D    +  T +Y  PE+ 
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDDVGRTFCGTPYYVAPEIW 217

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
              + Y  + D +++G +++E+L+    F G++  + ++K
Sbjct: 218 R-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256

Length = 496

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 15/83 (18%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLLFS 155
           HRDL   N+LV++  V+KI D G+ ++I       DY        +  +W   PE L F 
Sbjct: 163 HRDLAARNVLVTEDNVMKIADFGLARDIHH----IDYYKKTTNGRLPVKWM-APEAL-FD 216

Query: 156 EIYGPEVDKWAMGAIMFEMLSFG 178
            IY  + D W+ G +++E+ + G
Sbjct: 217 RIYTHQSDVWSFGVLLWEIFTLG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 43.8 bits (103), Expect = 3e-05
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           L  + + HRDL   N LLV++   KI D G+ K + ++     Y   R        WY  
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD---DSYYKARSAGKWPLKWY-A 166

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE + F + +    D W+ G  M+E  S+G
Sbjct: 167 PECINFRK-FSSRSDVWSYGITMWEAFSYG 195

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.8 bits (103), Expect = 3e-05
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 7/79 (8%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGM---VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYG 159
           HRDL   N+LV++G  +KI D G+   V E DS +      +  +W    E L F  IY 
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWM-AIESL-FDHIYT 207

Query: 160 PEVDKWAMGAIMFEMLSFG 178
            + D W+ G +++E+++ G
Sbjct: 208 TQSDVWSFGVLLWEIVTLG 226

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.9 bits (103), Expect = 3e-05
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDS----NLPCTDYVTTRWYRGPEVLLFSEIYG 159
           H+DL   N+LV  K  +KI DLG+ +E+ +     L     +  RW   PE +++ + + 
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIMYGK-FS 204

Query: 160 PEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            + D W+ G +++E+ S+G+  + G S+ D I  I
Sbjct: 205 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.9 bits (103), Expect = 3e-05
 Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 15/90 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ +++ +     DY        +  +W   
Sbjct: 150 LASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN----IDYYKKTTNGRLPVKWM-A 204

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +++E+ + G
Sbjct: 205 PEAL-FDRVYTHQSDVWSFGVLLWEIFTLG 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.5 bits (102), Expect = 4e-05
 Identities = 36/128 (28%), Positives = 48/128 (37%), Gaps = 50/128 (39%)

Query: 97  SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID----------------------- 132
           S+H+ G+ HRD+KP N+L+   G IK+ D G+                            
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 133 -----SNLPCTD--------------------YVTTRWYRGPEVLLFSEIYGPEVDKWAM 167
                SN  C D                     V T  Y  PEVLL  + Y    D W++
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSV 234

Query: 168 GAIMFEML 175
           G I+FEML
Sbjct: 235 GVILFEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 43.4 bits (102), Expect = 4e-05
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 7/79 (8%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGM---VKEIDSNLPCTD-YVTTRWYRGPEVLLFSEIYG 159
           HRDL   N+LV++  V+KI D G+   V +ID     ++  +  +W   PE L F  +Y 
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEAL-FDRVYT 214

Query: 160 PEVDKWAMGAIMFEMLSFG 178
            + D W+ G +M+E+ + G
Sbjct: 215 HQSDVWSFGILMWEIFTLG 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 23/79 (29%), Positives = 40/79 (50%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L++ +G  K+ D G+  ++ D+       + T ++  PEV+   
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    EM
Sbjct: 175 G-YNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 43.1 bits (101), Expect = 4e-05
 Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 4/81 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH +G  HRD+K +N+L++  G +K+ D G+  +I + +     ++ T ++  PEV    
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 156 EI--YGPEVDKWAMGAIMFEM 174
               Y    D WA+G    E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 5e-05
 Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 12/86 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLG-----MVKEIDSNLPCTDYVTTRWYRGPEV 151
           LH Q   HRD+K  N+ +     + IGDLG     +V      L  T  V T     PEV
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT--VETN---APEV 227

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSF 177
           L   + Y  + D W+ G ++FEML++
Sbjct: 228 LA-RDKYNSKADIWSAGIVLFEMLAY 252

Length = 357

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 12/89 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   N+L+ S   +KIGD G+++ +  N    D+     +         P
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN---EDHYVMEEHLKVPFAWCAP 169

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L     +    D W  G  ++EM ++G
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYG 197

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 34/128 (26%), Positives = 49/128 (38%), Gaps = 50/128 (39%)

Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK-------------------------- 129
           S+H+ G+ HRD+KP N+L+ + G IK+ D G+                            
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 130 --EIDSNLPCTD--------------------YVTTRWYRGPEVLLFSEIYGPEVDKWAM 167
                +N  C D                     V T  Y  PEVLL +  Y    D W++
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSV 234

Query: 168 GAIMFEML 175
           G I++EML
Sbjct: 235 GVILYEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 42.7 bits (100), Expect = 7e-05
 Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH     HRDLK  N+L++  G IK+ D G+  +    L   D ++ T ++  PEV++  
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 156 EI----YGPEVDKWAMGAIMFEM 174
            +    Y  + D W++G  + EM
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 11/86 (12%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI--------DSNLPCTDYVTTRWYRG 148
           LH     HRD+K +N +L+  G+IK+ D G  + +         SN+  + + T  W   
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM-A 176

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEM 174
           PEV+  S  YG + D W++G  +FEM
Sbjct: 177 PEVINESG-YGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 26/95 (27%), Positives = 49/95 (51%), Gaps = 15/95 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVT-------TRWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 118 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 172

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG 183
           E  L+   +  + D W+ G ++ E+ + G + +PG
Sbjct: 173 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 30/87 (34%), Positives = 39/87 (44%), Gaps = 19/87 (21%)

Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLL 153
           + HRDL   N LV K   IKI D GM      NL  +DY        +  RW     VLL
Sbjct: 151 FVHRDLATRNCLVGKNYTIKIADFGM----SRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206

Query: 154 --FSEIYGPEVDKWAMGAIMFEMLSFG 178
             F+     + D WA G  ++E+L+  
Sbjct: 207 GKFTT----KSDVWAFGVTLWEILTLC 229

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY--VTTRWYRGPEVLLF 154
           +H +   HRD+K  N+ ++  G I +GD G     +      DY  V T     PE+L  
Sbjct: 283 IHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA- 341

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
            + Y    D W+ G I+ +MLS
Sbjct: 342 GDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 7/79 (8%)

Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNL--PCTDYVTTRWYRGPEVLLFSEIYG 159
           HRDL   N+L+ +G ++KI D G+ ++I  DSN     + ++  +W   PE  +F+ +Y 
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APES-IFNNLYT 319

Query: 160 PEVDKWAMGAIMFEMLSFG 178
              D W+ G +++E+ + G
Sbjct: 320 TLSDVWSFGILLWEIFTLG 338

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 4/81 (4%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH +G  HRD+K +N LL   G +K+ D G+  +I + +     ++ T ++  PEV    
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 156 EI--YGPEVDKWAMGAIMFEM 174
           +   Y    D WA+G    E+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L  + + HRDL   N+LVS+  V K+ D G+ KE       +  +  +W   PE L   +
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKW-TAPEALREKK 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            +  + D W+ G +++E+ SFG
Sbjct: 176 -FSTKSDVWSFGILLWEIYSFG 196

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH     HRDLK  N+L +  G IK+ D G+  +    +   D ++ T ++  PEV++  
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 156 ----EIYGPEVDKWAMGAIMFEM 174
                 Y  + D W++G  + EM
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 25/73 (34%), Positives = 41/73 (56%), Gaps = 3/73 (4%)

Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV- 162
           HRD+KPSN+L+   G IK+ D G+  ++  ++  T     R Y  PE +  S   G +V 
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVR 190

Query: 163 -DKWAMGAIMFEM 174
            D W++G  ++E+
Sbjct: 191 SDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTT-----RWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APEC 169

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 170 MNYYK-FSSKSDVWSFGVLMWEAFSYG 195

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 28/84 (33%), Positives = 37/84 (44%), Gaps = 15/84 (17%)

Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLL 153
           + HRDL   N LV K   IKI D GM +    NL   DY        +  RW     +LL
Sbjct: 151 FVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSGDYYRIQGRAVLPIRWMSWESILL 206

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSF 177
               +    D WA G  ++E+L+ 
Sbjct: 207 GK--FTTASDVWAFGVTLWEILTL 228

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 16/94 (17%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMV----KEIDSNLPCTDYVTTRWYRGPEVL 152
           LH+  + H DL   N LL +   +KIGD G+     KE     P   +V  RW   PE  
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APE-- 172

Query: 153 LFSEIYG--------PEVDKWAMGAIMFEMLSFG 178
           L  E++G         E + W++G  ++E+   G
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG 206

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 40.3 bits (94), Expect = 3e-04
 Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L  +   HRDL   N+LVS+ GV K+ D G+ + + S       +  +W   PE L   +
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKW-TAPEALKHKK 173

Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            +  + D W+ G +++E+ S+G
Sbjct: 174 -FSSKSDVWSYGVLLWEVFSYG 194

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.5 bits (94), Expect = 4e-04
 Identities = 23/83 (27%), Positives = 44/83 (53%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH+    HRD+K  N+L+++   +K+ D G+  ++D  +   + ++ T ++  PEV+   
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 156 E----IYGPEVDKWAMGAIMFEM 174
           E     Y  + D W++G    EM
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLF- 154
           LH     HRDLK  N LL   G +K+ D G+  +  S L   D ++ T ++  PEV+   
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 155 ---SEIYGPEVDKWAMGAIMFEM 174
                 Y  + D W++G  + E+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 29/127 (22%)

Query: 77  QSWTIM-------ISGLADNSRGN----DAIS------------LHRQGYFHRDLKPSNL 113
           Q W +M       ++ L  N++GN    D I+            LH     HRD+K  N+
Sbjct: 93  QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152

Query: 114 LVSKGV-IKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFSE----IYGPEVDKWAM 167
           L+++   +K+ D G+  ++D  +   + ++ T ++  PEV+   E     Y    D W++
Sbjct: 153 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212

Query: 168 GAIMFEM 174
           G    EM
Sbjct: 213 GITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 4e-04
 Identities = 27/93 (29%), Positives = 40/93 (43%), Gaps = 31/93 (33%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDL----------------GMVKEIDSNLPCTDY 140
           +H +G  HRD+K  N+LV+    I +GD                 G+   +D+N      
Sbjct: 276 IHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN------ 329

Query: 141 VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE 173
                   PEVL   + Y P VD W+ G ++FE
Sbjct: 330 -------APEVLA-GDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 5e-04
 Identities = 33/120 (27%), Positives = 48/120 (40%), Gaps = 34/120 (28%)

Query: 98  LHRQGYFHRDLKPSNLL------------------------VSKGVIKIGDLGMVKEI-- 131
           LH  G  +RDLKP N+L                        VSK + K      V  I  
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 132 -----DSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKS 185
                + +     +V T  Y  PEV+   + +G  VD W +G +++EML +G   F G +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEML-YGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 39.8 bits (93), Expect = 6e-04
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 17/104 (16%)

Query: 91  RGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY-------VT 142
            G D +S  R  + HRDL   N LV S+  +K+  L + K++ ++    +Y       + 
Sbjct: 128 LGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS----EYYKLRNALIP 181

Query: 143 TRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKS 185
            RW   PE +   + +  + D W+ G +M+E+ + G L F G S
Sbjct: 182 LRWL-APEAV-QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 39.4 bits (92), Expect = 8e-04
 Identities = 23/91 (25%), Positives = 46/91 (50%), Gaps = 7/91 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLG---MVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           L ++ + HRDL   N LV +  ++K+ D G   ++               +W   PE L 
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW-TAPESLA 178

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +++ +  + D WA G +++E+ ++G+  +PG
Sbjct: 179 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.6 bits (92), Expect = 8e-04
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 16/89 (17%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGM-------VKEIDSNLPCTDYVTTRWYRGP 149
           L  + + HRDL   N+LV + +  KI D G+       VK+    LP       RW    
Sbjct: 135 LSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP------VRWM-AI 187

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L +S +Y  + D W+ G +++E++S G
Sbjct: 188 ESLNYS-VYTTKSDVWSFGVLLWEIVSLG 215

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 15/89 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L+ + + HRDL   N +V+    +KIGD GM ++I      TDY        +  RW   
Sbjct: 135 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLPVRWM-A 189

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
           PE L    ++    D W+ G +++E+ S 
Sbjct: 190 PESLK-DGVFTTSSDMWSFGVVLWEITSL 217

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 38.7 bits (91), Expect = 0.001
 Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 6/82 (7%)

Query: 97  SLHRQGYFHRDLKPSNLL--VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
            LH+    H D+K  N+L   +K  I + D G+ K I +  P     T  ++  PE +  
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--PSCYDGTLDYF-SPEKIKG 180

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
              Y    D WA+G + +E+L+
Sbjct: 181 -HNYDVSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 28/105 (26%), Positives = 49/105 (46%), Gaps = 12/105 (11%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLG----MVKEI-DSNLPCTDYVTTRWYRGPEVLLFSEIY 158
           HRD+KP+N+LV   G +K+ D G    +V  +  +N+ C  Y+     +       +  Y
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKS-GGPNQNPTY 184

Query: 159 GPEVDKWAMGAIMFEMLSFGILFPGKSSAD---QIYKICQLIGSP 200
             + D W++G  + EM      +P ++ A+   Q+  I    G P
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP 227

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|144943 pfam01535, PPR, PPR repeat

 Score = 35.1 bits (82), Expect = 0.001
 Identities = 10/28 (35%), Positives = 18/28 (64%)

Query: 49 TALVEMYSKCGHVEKAFKVFNLMREKNL 76
           +L+  Y K G +E+A ++F  M+EK +
Sbjct: 4  NSLISGYCKAGKLEEALELFKEMKEKGV 31

This repeat has no known function. It is about 35 amino acids long and found in up to 18 copies in some proteins. This family appears to be greatly expanded in plants. This repeat occurs in PET309, which may be involved in RNA stabilisation. This domain occurs in crp1 that is involved in RNA processing. This repeat is associated with a predicted plant protein that has a domain organisation similar to the human BRCA1 protein. The repeat has been called PPR. Length = 31

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 16/89 (17%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGM-------VKEIDSNLPCTDYVTTRWYRGP 149
           L ++ + HRDL   N+LV +  + KI D G+       VK+    LP       RW    
Sbjct: 128 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP------VRWM-AI 180

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L +S +Y    D W+ G +++E++S G
Sbjct: 181 ESLNYS-VYTTNSDVWSYGVLLWEIVSLG 208

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 11/88 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY------VTTRWYRGPE 150
           L  +   HRDL   N+LV +   +KI D G+ K +D +    +Y      V  +W    E
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKWM-ALE 181

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            +L   IY  + D W+ G  ++E+++FG
Sbjct: 182 SILHR-IYTHKSDVWSYGVTVWELMTFG 208

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 4/74 (5%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL---LFSEIYGP 160
           HRD+KPSN+L+++ G +K+ D G+   +  ++  T     + Y  PE +   L  + Y  
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDV 186

Query: 161 EVDKWAMGAIMFEM 174
           + D W++G  M E+
Sbjct: 187 KSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|205985 pfam13812, PPR_3, Pentatricopeptide repeat domain

 Score = 34.8 bits (81), Expect = 0.002
 Identities = 8/29 (27%), Positives = 13/29 (44%)

Query: 49 TALVEMYSKCGHVEKAFKVFNLMREKNLQ 77
           AL+   +K G  + A  V   M+   L+
Sbjct: 5  NALLLALAKAGDPDLALAVLEEMKASGLK 33

This family matches additional variants of the PPR repeat that were not captured by the model for pfam01535. The exact function is not known. Length = 34

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 32/104 (30%), Positives = 44/104 (42%), Gaps = 23/104 (22%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK----------EIDSNLPCTDY------- 140
           H +G  HRDLKP N+L+   G + I D G             +ID +     Y       
Sbjct: 130 HSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPG 189

Query: 141 --VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFP 182
             V T  Y  PE LL         D +A+G I+++ML+    FP
Sbjct: 190 KIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLS--FP 230

Length = 932

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.5 bits (89), Expect = 0.002
 Identities = 31/79 (39%), Positives = 40/79 (50%), Gaps = 8/79 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLG----MVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LHR G  HRD+KP NLLV+  G +KI D G    M   I+ N P    +  R Y  PE L
Sbjct: 325 LHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPR-YSPPEEL 382

Query: 153 LFSEIYGPEVDKWAMGAIM 171
           +  +   P     AM A++
Sbjct: 383 VMPQSC-PRAPAPAMAALL 400

Length = 507

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 38.1 bits (88), Expect = 0.002
 Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 15/90 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L+   + HRDL   N +V++   +KIGD GM ++I      TDY        +  RW   
Sbjct: 135 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLPVRWM-S 189

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L    ++    D W+ G +++E+ +  
Sbjct: 190 PESLK-DGVFTTYSDVWSFGVVLWEIATLA 218

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 7/101 (6%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT---RWYRGPEVLL 153
           L  + + HRD+   N+LV S   +K+GD G+ + ++              +W   PE + 
Sbjct: 123 LESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-APESIN 181

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           F   +    D W  G  M+E+L  G+  F G  + D I +I
Sbjct: 182 FRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 37.6 bits (87), Expect = 0.003
 Identities = 27/84 (32%), Positives = 35/84 (41%), Gaps = 15/84 (17%)

Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLL 153
           + HRDL   N LV     IKI D GM +    NL   DY        +  RW     +LL
Sbjct: 150 FVHRDLATRNCLVGNHYTIKIADFGMSR----NLYSGDYYRIQGRAVLPIRWMAWESILL 205

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSF 177
               +    D WA G  ++EM + 
Sbjct: 206 GK--FTTASDVWAFGVTLWEMFTL 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|213555 TIGR00756, PPR, pentatricopeptide repeat domain (PPR motif)

 Score = 34.0 bits (79), Expect = 0.003
 Identities = 9/29 (31%), Positives = 18/29 (62%)

Query: 49 TALVEMYSKCGHVEKAFKVFNLMREKNLQ 77
            L++   K G VE+A ++F  M+E+ ++
Sbjct: 4  NTLIDGLCKAGRVEEALELFKEMKERGIE 32

This model describes a domain called the PPR motif, or pentatricopeptide repeat. Its consensus sequence is 35 positions long and typically is found in four or more tandem copies. This family is strongly represented in plant proteins, particularly those sorted to chloroplasts or mitochondria. The pfam model pfam01535, domain of unknown function DUF17, consists of 6 copies of this repeat. This family has a similar consensus to the TPR domain (tetratricopeptide), pfam pfam00515, a 33-residue repeat. It is predicted to form a pair of antiparallel helices similar to that of TPR. Length = 35

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVLL-- 153
           LH     HRD+K +N LL ++G +K+ D G+  ++ S  L     V T ++  PEV+   
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199

Query: 154 --FSEIYGPEVDKWAMGAIMFEM 174
                 Y    D W++G    E+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 37.3 bits (87), Expect = 0.004
 Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH     HRD+K  N LL     +K+ D G+  ++DS L   + ++ T ++  PEV+   
Sbjct: 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188

Query: 156 E----IYGPEVDKWAMGAIMFEM 174
           E     Y    D W++G    E+
Sbjct: 189 EQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	234
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.95
PLN03081	697	pentatricopeptide (PPR) repeat-containing protein;	99.93
PLN03077	857	Protein ECB2; Provisional	99.93
PLN03077	857	Protein ECB2; Provisional	99.93
PLN03081	697	pentatricopeptide (PPR) repeat-containing protein;	99.93
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.92
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.9
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.89
PLN03218	1060	maturation of RBCL 1; Provisional	99.89
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.88
PLN03218	1060	maturation of RBCL 1; Provisional	99.87
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.87
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.87
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.85
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.85
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.84
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.83
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.81
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.8
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.8
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.79
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.78
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.78
KOG0589	426	consensus Serine/threonine protein kinase [General	99.77
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.77
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.77
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.77
KOG0198	313	consensus MEKK and related serine/threonine protei	99.77
KOG0578	550	consensus p21-activated serine/threonine protein k	99.76
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.75
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.74
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.74
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.74
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.73
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.72
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.72
PHA02988	283	hypothetical protein; Provisional	99.72
PTZ00036	440	glycogen synthase kinase; Provisional	99.7
PTZ00283	496	serine/threonine protein kinase; Provisional	99.69
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.69
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.68
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.68
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.67
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.67
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.67
PTZ00267	478	NIMA-related protein kinase; Provisional	99.67
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.67
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.67
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.67
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.67
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.66
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.66
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.66
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.66
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.65
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.65
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.65
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.64
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.64
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.64
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.64
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.64
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.64
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.64
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.63
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.63
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.63
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.63
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.63
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.63
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.63
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.63
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.63
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.63
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.63
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.62
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.62
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.62
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.62
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.62
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.62
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.62
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.62
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.62
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.62
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.62
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.62
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.62
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.62
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.61
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.61
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.61
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.61
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.61
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.61
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.61
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.61
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.61
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.61
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.61
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.6
KOG0584	632	consensus Serine/threonine protein kinase [General	99.6
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.6
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.6
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.6
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.6
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.6
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.6
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.6
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.6
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.6
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.6
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.6
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.6
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.6
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.6
PTZ00284	467	protein kinase; Provisional	99.6
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.6
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.6
PHA02882	294	putative serine/threonine kinase; Provisional	99.6
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.59
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.59
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.59
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.59
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.59
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.59
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.59
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.59
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.59
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.59
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.59
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.59
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.59
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.58
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.58
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.58
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.58
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.58
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.58
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.58
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.58
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.58
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.58
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.58
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.58
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.58
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.58
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.57
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.57
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.57
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.57
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.57
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.57
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.57
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.57
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.57
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.57
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.57
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.57
KOG0605	550	consensus NDR and related serine/threonine kinases	99.56
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.56
PF13041	50	PPR_2: PPR repeat family	99.56
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.56
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.56
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.56
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.56
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.56
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.56
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.56
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.56
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.56
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.56
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.56
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.56
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.56
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.56
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.56
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.55
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.55
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.55
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.55
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.55
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.55
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.55
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.55
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.55
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.55
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.55
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.55
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.55
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.55
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.55
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.55
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.55
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.55
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.54
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.54
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.54
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.54
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.54
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.54
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.54
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.54
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.54
PHA03207	392	serine/threonine kinase US3; Provisional	99.54
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.54
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.54
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.54
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.54
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.54
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.54
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.53
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.53
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.53
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.53
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.53
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.53
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.53
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.53
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.53
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.53
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.53
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.53
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.53
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.53
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.53
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.53
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.53
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.52
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.52
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.52
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.52
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.52
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.52
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.52
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.52
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.52
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.52
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.52
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.52
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.52
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.51
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.51
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.51
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.51
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.51
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.51
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.51
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.51
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.51
PHA03212	391	serine/threonine kinase US3; Provisional	99.51
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.51
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.51
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.51
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.51
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.51
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.51
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.51
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.51
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.51
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.51
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.5
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.5
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.5
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.5
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.5
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.5
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.5
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.5
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.5
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.5
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.5
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.5
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.5
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.49
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.49
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.49
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.49
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.49
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.49
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.49
KOG0610	459	consensus Putative serine/threonine protein kinase	99.49
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.49
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.49
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.49
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.49
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.48
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.48
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.48
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.48
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.48
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.48
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.48
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.48
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.48
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.48
PHA03209	357	serine/threonine kinase US3; Provisional	99.48
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.48
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.48
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.48
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.47
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.47
PLN00009	294	cyclin-dependent kinase A; Provisional	99.47
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.47
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.47
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.47
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.47
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.47
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.47
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.47
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.47
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.47
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.47
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.47
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.46
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.46
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.46
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.46
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.46
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.46
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.46
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.46
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.46
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.46
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.46
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.46
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.45
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.45
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.45
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.45
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.45
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.45
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.45
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.45
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.45
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.44
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.44
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.44
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.44
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.44
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.43
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.43
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.43
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.43
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.43
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.43
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.42
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.42
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.42
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.42
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.41
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.41
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.41
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.41
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.41
PHA03211	461	serine/threonine kinase US3; Provisional	99.41
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.41
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.41
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.41
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.41
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.4
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.4
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.39
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.39
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.39
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.38
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.38
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.38
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.37
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.37
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.37
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.37
PHA03210	501	serine/threonine kinase US3; Provisional	99.37
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.37
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.36
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.36
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.36
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.36
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.35
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.35
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.35
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.34
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.34
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.33
PLN00181	793	protein SPA1-RELATED; Provisional	99.33
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.33
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.32
PF13041	50	PPR_2: PPR repeat family	99.32
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.31
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.29
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.28
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.23
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.23
PF12854	34	PPR_1: PPR repeat	99.22
KOG0586	596	consensus Serine/threonine protein kinase [General	99.19
KOG3653	534	consensus Transforming growth factor beta/activin	99.19
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.18
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.16
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.15
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.15
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.13
PF12854	34	PPR_1: PPR repeat	99.11
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.02
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	98.91
KOG2052	513	consensus Activin A type IB receptor, serine/threo	98.89
PLN03224	507	probable serine/threonine protein kinase; Provisio	98.87
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.73
KOG0607	463	consensus MAP kinase-interacting kinase and relate	98.72
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.71
KOG1167	418	consensus Serine/threonine protein kinase of the C	98.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.62
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	98.53
TIGR00756	35	PPR pentatricopeptide repeat domain (PPR motif). T	98.48
KOG1152	772	consensus Signal transduction serine/threonine kin	98.44
PF01535	31	PPR: PPR repeat; InterPro: IPR002885 This entry re	98.37
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.35
PF13812	34	PPR_3: Pentatricopeptide repeat domain	98.35
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.33
TIGR00756	35	PPR pentatricopeptide repeat domain (PPR motif). T	98.31
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.27
PF01535	31	PPR: PPR repeat; InterPro: IPR002885 This entry re	98.2
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.14
COG0515	384	SPS1 Serine/threonine protein kinase [General func	98.13
KOG1290	590	consensus Serine/threonine protein kinase [Signal	98.1
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	98.07
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.06
PF13812	34	PPR_3: Pentatricopeptide repeat domain	98.03
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.01
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	97.92
KOG4422	625	consensus Uncharacterized conserved protein [Funct	97.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	97.8
KOG4318	1088	consensus Bicoid mRNA stability factor [RNA proces	97.75
KOG4422	625	consensus Uncharacterized conserved protein [Funct	97.71
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	97.55
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	97.52
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	97.49
PRK11788	389	tetratricopeptide repeat protein; Provisional	97.46
PRK11788	389	tetratricopeptide repeat protein; Provisional	97.26
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	96.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	96.76
PRK12274	218	serine/threonine protein kinase; Provisional	96.51
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	95.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	95.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	95.79
PF10037	429	MRP-S27: Mitochondrial 28S ribosomal protein S27;	95.65
PF06239	228	ECSIT: Evolutionarily conserved signalling interme	95.58
PF12895	84	Apc3: Anaphase-promoting complex, cyclosome, subun	95.43
TIGR02917	899	PEP_TPR_lipo putative PEP-CTERM system TPR-repeat	95.43
COG4248	637	Uncharacterized protein with protein kinase and he	95.27
PRK09188	365	serine/threonine protein kinase; Provisional	95.24
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	95.23
PRK15359	144	type III secretion system chaperone protein SscB;	95.18
TIGR02917	899	PEP_TPR_lipo putative PEP-CTERM system TPR-repeat	95.16
cd00189	100	TPR Tetratricopeptide repeat domain; typically con	95.01
PF10037	429	MRP-S27: Mitochondrial 28S ribosomal protein S27;	94.96
PF08579	120	RPM2: Mitochondrial ribonuclease P subunit (RPM2);	94.9
PF08579	120	RPM2: Mitochondrial ribonuclease P subunit (RPM2);	94.88
PF12921	126	ATP13: Mitochondrial ATPase expression; InterPro:	94.47
TIGR02552	135	LcrH_SycD type III secretion low calcium response	94.23
PF06239	228	ECSIT: Evolutionarily conserved signalling interme	94.16
PF05843	280	Suf: Suppressor of forked protein (Suf); InterPro:	93.78
TIGR02795	119	tol_pal_ybgF tol-pal system protein YbgF. Members	93.41
PF14559	68	TPR_19: Tetratricopeptide repeat; PDB: 2R5S_A 3QDN	93.31
PF13429	280	TPR_15: Tetratricopeptide repeat; PDB: 2VQ2_A 2PL2	93.18
COG5107	660	RNA14 Pre-mRNA 3'-end processing (cleavage and pol	93.12
TIGR02521	234	type_IV_pilW type IV pilus biogenesis/stability pr	93.11
TIGR02521	234	type_IV_pilW type IV pilus biogenesis/stability pr	93.08
PF09976	145	TPR_21: Tetratricopeptide repeat; InterPro: IPR018	93.07
PF13429	280	TPR_15: Tetratricopeptide repeat; PDB: 2VQ2_A 2PL2	92.99
PRK09605	535	bifunctional UGMP family protein/serine/threonine	92.33
PF04733	290	Coatomer_E: Coatomer epsilon subunit; InterPro: IP	92.2
PRK10370	198	formate-dependent nitrite reductase complex subuni	92.16
KOG0606	1205	consensus Microtubule-associated serine/threonine	91.52
KOG1914	656	consensus mRNA cleavage and polyadenylation factor	91.5
PLN03088	356	SGT1, suppressor of G2 allele of SKP1; Provisional	91.24
TIGR00990	615	3a0801s09 mitochondrial precursor proteins import	91.21
KOG4318	1088	consensus Bicoid mRNA stability factor [RNA proces	91.05
PRK15174	656	Vi polysaccharide export protein VexE; Provisional	90.75
PRK11189	296	lipoprotein NlpI; Provisional	90.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	90.59
PRK12370	553	invasion protein regulator; Provisional	90.41
PRK14879	211	serine/threonine protein kinase; Provisional	90.34
PF13432	65	TPR_16: Tetratricopeptide repeat; PDB: 3CVP_A 3CVL	90.16
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	90.06
PRK12370	553	invasion protein regulator; Provisional	90.01
PRK09782	987	bacteriophage N4 receptor, outer membrane subunit;	89.81
PF00637	143	Clathrin: Region in Clathrin and VPS; InterPro: IP	89.13
TIGR00990	615	3a0801s09 mitochondrial precursor proteins import	89.07
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	88.9
PF13432	65	TPR_16: Tetratricopeptide repeat; PDB: 3CVP_A 3CVL	88.82
KOG3941	406	consensus Intermediate in Toll signal transduction	88.31
PF14559	68	TPR_19: Tetratricopeptide repeat; PDB: 2R5S_A 3QDN	88.23
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	88.05
KOG2003	840	consensus TPR repeat-containing protein [General f	88.01
smart00090	237	RIO RIO-like kinase.	87.79
KOG3616	1636	consensus Selective LIM binding factor [Transcript	87.39
PRK11447	1157	cellulose synthase subunit BcsC; Provisional	87.28
CHL00033	168	ycf3 photosystem I assembly protein Ycf3	87.2
PRK15174	656	Vi polysaccharide export protein VexE; Provisional	87.1

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=197.43  Aligned_cols=176  Identities=46%  Similarity=0.855  Sum_probs=157.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|.+|+++..++-...--+-.++.++..|-.+ +.|+.         ++|+.+..|||++|.|+++. ....+++|||+
T Consensus        86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~---------hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLA---------HIHKHGFFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHH---------HHHhcCcccccCChhheEecccceeEeccccc
Confidence            578888888766554333222334466677776 88898         99999999999999999996 77899999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      |+++...-+...++.++||+|||++.....|+..+|+||+||+++|+.+.+++|||....|++++||+.+|.|+..+|++
T Consensus       157 ARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  157 AREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            99999988999999999999999998888899999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhccccCCCCCccccccCCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPSA  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (234)
                      ..++...|...+|+..+.++..++|.+
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~  263 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNA  263 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCccc
Confidence            999999999999999999999999864

>PLN03081 pentatricopeptide (PPR) repeat-containing protein; Provisional

Probab=99.93  E-value=2.5e-27  Score=209.81  Aligned_cols=203  Identities=23%  Similarity=0.322  Sum_probs=168.5

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHH
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWT   80 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~   80 (234)
                      |...|+.||..||+++|.+|++.+.++.|+++|..+.+.|+.+|..++|+||++|+++|++++|.++|+.|+++|+++||
T Consensus       215 M~~~g~~p~~~t~~~ll~a~~~~~~~~~~~~l~~~~~~~g~~~d~~~~n~Li~~y~k~g~~~~A~~vf~~m~~~~~vt~n  294 (697)
T PLN03081        215 MWEDGSDAEPRTFVVMLRASAGLGSARAGQQLHCCVLKTGVVGDTFVSCALIDMYSKCGDIEDARCVFDGMPEKTTVAWN  294 (697)
T ss_pred             HHHhCCCCChhhHHHHHHHHhcCCcHHHHHHHHHHHHHhCCCccceeHHHHHHHHHHCCCHHHHHHHHHhCCCCChhHHH
Confidence            45678889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCCCCCcccCcccccccccccccC
Q 026720           81 IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI  157 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  157 (234)
                      ++|.+|+++|+.++|+.+|.+ |...|+.|+..++.   .++++.+.+..+.+++..+...+..       |+...    
T Consensus       295 ~li~~y~~~g~~~eA~~lf~~-M~~~g~~pd~~t~~~ll~a~~~~g~~~~a~~i~~~m~~~g~~-------~d~~~----  362 (697)
T PLN03081        295 SMLAGYALHGYSEEALCLYYE-MRDSGVSIDQFTFSIMIRIFSRLALLEHAKQAHAGLIRTGFP-------LDIVA----  362 (697)
T ss_pred             HHHHHHHhCCCHHHHHHHHHH-HHHcCCCCCHHHHHHHHHHHHhccchHHHHHHHHHHHHhCCC-------CCeee----
Confidence            999999999999999999999 67789999999984   4567888888888887765443322       55544    


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhh-------------hhhhhccccCCCCC
Q 026720          158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQ-------------LASNLNWKLPQMGG  224 (234)
Q Consensus       158 ~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~  224 (234)
                      |+.++|+|+.                .+..+.+.++|+.|..++..+|+..+.             .+.+|...+...+.
T Consensus       363 ~~~Li~~y~k----------------~G~~~~A~~vf~~m~~~d~~t~n~lI~~y~~~G~~~~A~~lf~~M~~~g~~Pd~  426 (697)
T PLN03081        363 NTALVDLYSK----------------WGRMEDARNVFDRMPRKNLISWNALIAGYGNHGRGTKAVEMFERMIAEGVAPNH  426 (697)
T ss_pred             hHHHHHHHHH----------------CCCHHHHHHHHHhCCCCCeeeHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCCH
Confidence            7899999998                678899999999999999999985444             34444445555555


Q ss_pred             ccccccC
Q 026720          225 VNLLAVM  231 (234)
Q Consensus       225 ~~~~~~~  231 (234)
                      .+|..++
T Consensus       427 ~T~~~ll  433 (697)
T PLN03081        427 VTFLAVL  433 (697)
T ss_pred             HHHHHHH
Confidence            5555443

>PLN03077 Protein ECB2; Provisional

Probab=99.93  E-value=1.2e-26  Score=209.72  Aligned_cols=183  Identities=25%  Similarity=0.391  Sum_probs=161.0

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHH
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWT   80 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~   80 (234)
                      |...|+.||.+||+++|.+|++.++++.|+++|.+|++.|+.||..+||+||.+|+++|++++|.++|++|+.+|+++||
T Consensus       279 M~~~g~~Pd~~ty~~ll~a~~~~g~~~~a~~l~~~~~~~g~~~d~~~~n~Li~~y~k~g~~~~A~~vf~~m~~~d~~s~n  358 (857)
T PLN03077        279 MRELSVDPDLMTITSVISACELLGDERLGREMHGYVVKTGFAVDVSVCNSLIQMYLSLGSWGEAEKVFSRMETKDAVSWT  358 (857)
T ss_pred             HHHcCCCCChhHHHHHHHHHHhcCChHHHHHHHHHHHHhCCccchHHHHHHHHHHHhcCCHHHHHHHHhhCCCCCeeeHH
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCCCCCcccCcccccccccccccC
Q 026720           81 IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI  157 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  157 (234)
                      ++|.+|+++|+.++|+.+|.+ |...++.|+..++.   .++++.+++..+.+++..+...+..       |+...    
T Consensus       359 ~li~~~~~~g~~~~A~~lf~~-M~~~g~~Pd~~t~~~ll~a~~~~g~~~~a~~l~~~~~~~g~~-------~~~~~----  426 (857)
T PLN03077        359 AMISGYEKNGLPDKALETYAL-MEQDNVSPDEITIASVLSACACLGDLDVGVKLHELAERKGLI-------SYVVV----  426 (857)
T ss_pred             HHHHHHHhCCCHHHHHHHHHH-HHHhCCCCCceeHHHHHHHHhccchHHHHHHHHHHHHHhCCC-------cchHH----
Confidence            999999999999999999999 67789999999995   3566777888888877754433322       44433    


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhh
Q 026720          158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL  211 (234)
Q Consensus       158 ~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  211 (234)
                      |+.++++|+.                .+..+.+.++++.|..++..+|+..+..
T Consensus       427 ~n~Li~~y~k----------------~g~~~~A~~vf~~m~~~d~vs~~~mi~~  464 (857)
T PLN03077        427 ANALIEMYSK----------------CKCIDKALEVFHNIPEKDVISWTSIIAG  464 (857)
T ss_pred             HHHHHHHHHH----------------cCCHHHHHHHHHhCCCCCeeeHHHHHHH
Confidence            6889999997                6788999999999999999999866544

>PLN03077 Protein ECB2; Provisional

Probab=99.93  E-value=9.2e-27  Score=210.47  Aligned_cols=183  Identities=25%  Similarity=0.392  Sum_probs=159.1

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHH
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWT   80 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~   80 (234)
                      |...|+.||.+||+++|++|++.+.++.|.++|.+|++.|+.||..++|+||.+|+++|++++|.++|++|+++|+++||
T Consensus       178 M~~~g~~Pd~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~n~Li~~y~k~g~~~~A~~lf~~m~~~d~~s~n  257 (857)
T PLN03077        178 MLWAGVRPDVYTFPCVLRTCGGIPDLARGREVHAHVVRFGFELDVDVVNALITMYVKCGDVVSARLVFDRMPRRDCISWN  257 (857)
T ss_pred             HHHcCCCCChhHHHHHHHHhCCccchhhHHHHHHHHHHcCCCcccchHhHHHHHHhcCCCHHHHHHHHhcCCCCCcchhH
Confidence            45679999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCCCCCcccCcccccccccccccC
Q 026720           81 IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI  157 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  157 (234)
                      ++|.+|+++|+.++|+.+|.+ |...|+.|+.+++.   .++++.+++..+++++..+...+..       |+...    
T Consensus       258 ~li~~~~~~g~~~eAl~lf~~-M~~~g~~Pd~~ty~~ll~a~~~~g~~~~a~~l~~~~~~~g~~-------~d~~~----  325 (857)
T PLN03077        258 AMISGYFENGECLEGLELFFT-MRELSVDPDLMTITSVISACELLGDERLGREMHGYVVKTGFA-------VDVSV----  325 (857)
T ss_pred             HHHHHHHhCCCHHHHHHHHHH-HHHcCCCCChhHHHHHHHHHHhcCChHHHHHHHHHHHHhCCc-------cchHH----
Confidence            999999999999999999999 67789999999995   3456777777788877755433322       66555    


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhh
Q 026720          158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL  211 (234)
Q Consensus       158 ~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  211 (234)
                      |+.++++|+.                .+.++.+.++++.|..|+..+|+..+..
T Consensus       326 ~n~Li~~y~k----------------~g~~~~A~~vf~~m~~~d~~s~n~li~~  363 (857)
T PLN03077        326 CNSLIQMYLS----------------LGSWGEAEKVFSRMETKDAVSWTAMISG  363 (857)
T ss_pred             HHHHHHHHHh----------------cCCHHHHHHHHhhCCCCCeeeHHHHHHH
Confidence            7888999987                5778888899999988888888854443

>PLN03081 pentatricopeptide (PPR) repeat-containing protein; Provisional

Probab=99.93  E-value=6.5e-27  Score=207.13  Aligned_cols=155  Identities=23%  Similarity=0.371  Sum_probs=136.7

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHH
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWT   80 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~   80 (234)
                      |...|+.||.+||+++|++|++.+.+++|+++|.+|++.|+.+|.+++|+||++|+++|++++|.++|++|.++|+++||
T Consensus       316 M~~~g~~pd~~t~~~ll~a~~~~g~~~~a~~i~~~m~~~g~~~d~~~~~~Li~~y~k~G~~~~A~~vf~~m~~~d~~t~n  395 (697)
T PLN03081        316 MRDSGVSIDQFTFSIMIRIFSRLALLEHAKQAHAGLIRTGFPLDIVANTALVDLYSKWGRMEDARNVFDRMPRKNLISWN  395 (697)
T ss_pred             HHHcCCCCCHHHHHHHHHHHHhccchHHHHHHHHHHHHhCCCCCeeehHHHHHHHHHCCCHHHHHHHHHhCCCCCeeeHH
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCCCC-CcccCccccccccccccc
Q 026720           81 IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLPCT-DYVTTRWYRGPEVLLFSE  156 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~~~-~~~~~~~~~~pe~~~~~~  156 (234)
                      +||.||+++|+.++|+.+|.+ |...|+.||.+++.   .++++.+.+..+..++..|... +.       .|+..    
T Consensus       396 ~lI~~y~~~G~~~~A~~lf~~-M~~~g~~Pd~~T~~~ll~a~~~~g~~~~a~~~f~~m~~~~g~-------~p~~~----  463 (697)
T PLN03081        396 ALIAGYGNHGRGTKAVEMFER-MIAEGVAPNHVTFLAVLSACRYSGLSEQGWEIFQSMSENHRI-------KPRAM----  463 (697)
T ss_pred             HHHHHHHHcCCHHHHHHHHHH-HHHhCCCCCHHHHHHHHHHHhcCCcHHHHHHHHHHHHHhcCC-------CCCcc----
Confidence            999999999999999999999 67889999999994   3466677777777777665321 21       25543    


Q ss_pred             CCCCcchHHHH
Q 026720          157 IYGPEVDKWAM  167 (234)
Q Consensus       157 ~~~~~~d~~s~  167 (234)
                      +|++++|.++.
T Consensus       464 ~y~~li~~l~r  474 (697)
T PLN03081        464 HYACMIELLGR  474 (697)
T ss_pred             chHhHHHHHHh
Confidence            38899999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.92  E-value=1.6e-24  Score=162.82  Aligned_cols=169  Identities=37%  Similarity=0.670  Sum_probs=135.3

Q ss_pred             HHHHHhhcCChHHHHHHHHhhcc---------------CccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEE
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMRE---------------KNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLL  114 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~---------------~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~  114 (234)
                      ||+.|...+.+.-+   |+.|+.               .|+.+|..| +.|+.         ++|...++|+|++|+|.+
T Consensus        66 LiD~F~~~~~l~lV---fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~---------y~H~~~IlHRDlKPnNLL  133 (318)
T KOG0659|consen   66 LIDVFPHKSNLSLV---FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLA---------YCHSKWILHRDLKPNNLL  133 (318)
T ss_pred             hhhhccCCCceEEE---EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHH---------HHHhhhhhcccCCccceE
Confidence            67777766655433   333431               267899998 99999         999988999999999999


Q ss_pred             e-eCCeeeEeeccccccccCCCCCCC-cccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 026720          115 V-SKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK  192 (234)
Q Consensus       115 ~-~~~~~~~~~~~~a~~~~~~~~~~~-~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~  192 (234)
                      + .++..++.|||+++.+........ .+.++||+|||.+.|.+.|..-+|+||.||++.|++.|.+.|+|.++.+++..
T Consensus       134 is~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~  213 (318)
T KOG0659|consen  134 ISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK  213 (318)
T ss_pred             EcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence            9 578999999999999876554333 37899999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          193 ICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       193 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ||+..|.|.++.|++....-.....+  +++.++...+|+.
T Consensus       214 If~~LGTP~~~~WP~~~~lpdY~~~~--~~P~~~~~~lf~a  252 (318)
T KOG0659|consen  214 IFRALGTPTPDQWPEMTSLPDYVKIQ--QFPKPPLNNLFPA  252 (318)
T ss_pred             HHHHcCCCCcccCccccccccHHHHh--cCCCCcccccccc
Confidence            99999999999999654443222222  3444444445554

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.90  E-value=5.1e-24  Score=166.57  Aligned_cols=174  Identities=33%  Similarity=0.509  Sum_probs=142.9

Q ss_pred             HHHHHHHHHHhhcCChHHHHHHH---HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCe
Q 026720           46 AIGTALVEMYSKCGHVEKAFKVF---NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGV  119 (234)
Q Consensus        46 ~~~~~li~~~~~~g~~~~a~~~~---~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~  119 (234)
                      .+|..||.+|+-....+...+..   ..|+.-++.-|+.+ .+|++         ++|..++.|+|++|.|++++  ++.
T Consensus        94 ~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~---------yLh~~~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   94 EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLA---------YLHSHGICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHH---------HHHhcCcccCCCChheEEEcCCCCe
Confidence            57889999999876665555421   34666688889888 89999         99999999999999999994  689


Q ss_pred             eeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          120 IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      .+++|||.|+.+...-+...+++|++|+|||.+.+...|++.+|+||.||++.||+.|+++|+|.+..+++..|++..|.
T Consensus       165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999999999988878888999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      |..+.-..+--.  ...-+.|+..+.++.++
T Consensus       245 Pt~e~I~~mn~~--y~~~~~p~ik~~~~~~~  273 (364)
T KOG0658|consen  245 PTREDIKSMNPN--YTEFKFPQIKAHPWHKV  273 (364)
T ss_pred             CCHHHHhhcCcc--cccccCcccccccceee
Confidence            886532211111  11334555555555443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.89  E-value=4.1e-23  Score=159.87  Aligned_cols=168  Identities=37%  Similarity=0.652  Sum_probs=138.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccC----ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREK----NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~----~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .||+.||.+    +...+.+.|+++    .+.+...+ ++|+.         ++|...++|+|++|.|.++ ..+..+++
T Consensus       153 y~VMe~~Eh----DLksl~d~m~q~F~~~evK~L~~QlL~glk---------~lH~~wilHRDLK~SNLLm~~~G~lKia  219 (419)
T KOG0663|consen  153 YIVMEYVEH----DLKSLMETMKQPFLPGEVKTLMLQLLRGLK---------HLHDNWILHRDLKTSNLLLSHKGILKIA  219 (419)
T ss_pred             eeeHHHHHh----hHHHHHHhccCCCchHHHHHHHHHHHHHHH---------HHhhceeEecccchhheeeccCCcEEec
Confidence            577888875    455677888864    45555555 88988         9999999999999999999 57899999


Q ss_pred             eccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          124 DLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       124 ~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |||+|++..... +....+.+-||++||++.+.+.|++.+|+||.||++.|+++++++|+|.+..+++.+||+.+|.|..
T Consensus       220 DFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  220 DFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE  299 (419)
T ss_pred             ccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence            999999987753 3455678899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcchhhhhhhh-ccccCCCCCccccccC
Q 026720          203 DSWPLGIQLASNL-NWKLPQMGGVNLLAVM  231 (234)
Q Consensus       203 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (234)
                      ..|+ .+.++... ...+++.+...+..-|
T Consensus       300 ~iwp-g~~~lp~~k~~~f~~~pyn~lr~kF  328 (419)
T KOG0663|consen  300 AIWP-GYSELPAVKKMTFSEHPYNNLRKKF  328 (419)
T ss_pred             ccCC-CccccchhhccccCCCCchhhhhhc
Confidence            9998 66666544 3455555555444433

>PLN03218 maturation of RBCL 1; Provisional

Probab=99.89  E-value=1.9e-24  Score=195.48  Aligned_cols=135  Identities=16%  Similarity=0.214  Sum_probs=82.2

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc------cC
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR------EK   74 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~------~~   74 (234)
                      |...|+.||.+||+++|++|++.|++++|.++|..|.+.|+.||.++||+||.+|++.|.+++|.++|++|.      .|
T Consensus       498 M~~~Gv~PdvvTynaLI~gy~k~G~~eeAl~lf~~M~~~Gv~PD~vTYnsLI~a~~k~G~~deA~~lf~eM~~~~~gi~P  577 (1060)
T PLN03218        498 MVNAGVEANVHTFGALIDGCARAGQVAKAFGAYGIMRSKNVKPDRVVFNALISACGQSGAVDRAFDVLAEMKAETHPIDP  577 (1060)
T ss_pred             HHHcCCCCCHHHHHHHHHHHHHCcCHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhcCCCCC
Confidence            344566666666666666666666666666666666666666666666666666666666666666666663      24


Q ss_pred             ccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCC
Q 026720           75 NLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLP  136 (234)
Q Consensus        75 ~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~  136 (234)
                      |.++||++|.+|++.|+.++|.++|.. |...++.|+..+++   .++++.+++..|..++..|.
T Consensus       578 D~vTynaLI~ay~k~G~ldeA~elf~~-M~e~gi~p~~~tynsLI~ay~k~G~~deAl~lf~eM~  641 (1060)
T PLN03218        578 DHITVGALMKACANAGQVDRAKEVYQM-IHEYNIKGTPEVYTIAVNSCSQKGDWDFALSIYDDMK  641 (1060)
T ss_pred             cHHHHHHHHHHHHHCCCHHHHHHHHHH-HHHcCCCCChHHHHHHHHHHHhcCCHHHHHHHHHHHH
Confidence            666666666666666666666666665 45556666555552   23445555555555554443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.2e-22  Score=154.03  Aligned_cols=168  Identities=24%  Similarity=0.398  Sum_probs=136.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhh--c--ccccCCcCCCcEEe-eCCe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHR--Q--GYFHRDLKPSNLLV-SKGV  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~--~--~~~~~~l~p~~~~~-~~~~  119 (234)
                      .++.+||.+|++...++-|..    .+++.|--|-.+ .+|+.         +.|.  .  .++|+|++|.|+.+ .++.
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~---------~cH~~~~r~~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALY---------HCHSKIPRGTVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHH---------HHhccccccceeeccCcchheEEcCCCc
Confidence            488999999999999888865    445565555444 66766         5665  3  38899999999999 5789


Q ss_pred             eeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 026720          120 IKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG  198 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~  198 (234)
                      ++++|||+++.+..... ...++++|.|++||++...+ |+.++|+||+||+++||+.-.+||.|+.-.+.-.+|.+.--
T Consensus       167 vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~  245 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY  245 (375)
T ss_pred             eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence            99999999998876432 34579999999999998544 99999999999999999999999999966666666766544


Q ss_pred             CCCC-CCCcchhhhhhhhccccCCCCCccc
Q 026720          199 SPTK-DSWPLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       199 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      .|-+ +.|++.+++++++|...+..+||+.
T Consensus       246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  246 PPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            4455 7899999999999999999999974

>PLN03218 maturation of RBCL 1; Provisional

Probab=99.87  E-value=8.3e-24  Score=191.28  Aligned_cols=138  Identities=16%  Similarity=0.192  Sum_probs=124.8

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc----cCcc
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR----EKNL   76 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~----~~~~   76 (234)
                      |...|+.||.+||+++|++|++.|++++|.++|.+|.+.|+.||..+||+||.+|+++|++++|.++|++|.    .||+
T Consensus       640 M~~~Gv~PD~~TynsLI~a~~k~G~~eeA~~l~~eM~k~G~~pd~~tynsLI~ay~k~G~~eeA~~lf~eM~~~g~~Pdv  719 (1060)
T PLN03218        640 MKKKGVKPDEVFFSALVDVAGHAGDLDKAFEILQDARKQGIKLGTVSYSSLMGACSNAKNWKKALELYEDIKSIKLRPTV  719 (1060)
T ss_pred             HHHcCCCCCHHHHHHHHHHHHhCCCHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHhCCCHHHHHHHHHHHHHcCCCCCH
Confidence            567899999999999999999999999999999999999999999999999999999999999999999996    4899


Q ss_pred             ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCCCCC
Q 026720           77 QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLPCTD  139 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~~~~  139 (234)
                      ++||++|.+|++.|+.++|+++|.+ |...|+.|+.++|.   .++++.+++..+..++..|...+
T Consensus       720 vtyN~LI~gy~k~G~~eeAlelf~e-M~~~Gi~Pd~~Ty~sLL~a~~k~G~le~A~~l~~~M~k~G  784 (1060)
T PLN03218        720 STMNALITALCEGNQLPKALEVLSE-MKRLGLCPNTITYSILLVASERKDDADVGLDLLSQAKEDG  784 (1060)
T ss_pred             HHHHHHHHHHHHCCCHHHHHHHHHH-HHHcCCCCCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHcC
Confidence            9999999999999999999999999 67789999999884   45667778888888887665444

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.87  E-value=3.9e-23  Score=158.16  Aligned_cols=143  Identities=33%  Similarity=0.609  Sum_probs=119.0

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ||.+||...-+++..+.-..+++.-+..|..+ |.|..         ..|+.+++|+|++|.|+++ ..+..+++|||.|
T Consensus        78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~---------~cHk~n~IHRDIKPENILit~~gvvKLCDFGFA  148 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIH---------FCHKNNCIHRDIKPENILITQNGVVKLCDFGFA  148 (396)
T ss_pred             EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhh---------hhhhcCeecccCChhheEEecCCcEEeccchhh
Confidence            45566666666666555455555567788777 77777         7899999999999999999 4789999999999


Q ss_pred             cccc-CCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          129 KEID-SNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       129 ~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+. ..-...+++.++||+|||.+.+...|..-+|+||.||++.||++|.+.|||.++.|+++.|....|...+
T Consensus       149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            9887 3334667899999999999998778999999999999999999999999999999999999877775443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-22  Score=158.08  Aligned_cols=143  Identities=38%  Similarity=0.640  Sum_probs=123.2

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccccccccC---CCCCCCcccCcccccccccccccCC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS---NLPCTDYVTTRWYRGPEVLLFSEIY  158 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~  158 (234)
                      ++|+-         ++|+.+++|+|++|.|++++ +.-.+++|||+|+....   .-...+++.|+||.|||++.....|
T Consensus       135 LrgLK---------yiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Y  205 (359)
T KOG0660|consen  135 LRGLK---------YIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEY  205 (359)
T ss_pred             HHhcc---------hhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccc
Confidence            66666         88999999999999999995 34469999999998853   2234568899999999999878889


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhh-hhhhhccccCCCCCccccccCCCC
Q 026720          159 GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQ-LASNLNWKLPQMGGVNLLAVMPSA  234 (234)
Q Consensus       159 ~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (234)
                      +..+|+||.||++.||++|++.|+|.+..+++..|.+..|.|+.+.....-. .+..+....|+.++.+|.++||+|
T Consensus       206 t~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a  282 (359)
T KOG0660|consen  206 TKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNA  282 (359)
T ss_pred             cchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCC
Confidence            9999999999999999999999999999999999999999998877653332 245677789999999999999975

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.85  E-value=8.3e-22  Score=154.53  Aligned_cols=174  Identities=22%  Similarity=0.329  Sum_probs=143.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccc-cHHHHHHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQ-SWTIMISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~-~~~~~i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      -+++.+|+.+|+++.+.......+++-+- .-.++|+|+.         ++|. ..++|||+||.|+++ ..+..+++||
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~---------YLh~~~~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLS---------YLHEERKIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHhhccCeeeccCCHHHeeeccCCCEEeccc
Confidence            46899999999999998876666665443 4456699999         9995 779999999999999 4788999999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhhCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK-----SSADQIYKICQLIGSP  200 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~-----~~~~~~~~i~~~~~~~  200 (234)
                      |..+.+..+ ...+++|+..|++||.+. +..|+...|+||+|..++|+..|+-||+..     +-.+.+..|+......
T Consensus       224 GVS~~lvnS-~a~tfvGT~~YMsPERi~-g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~  301 (364)
T KOG0581|consen  224 GVSGILVNS-IANTFVGTSAYMSPERIS-GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR  301 (364)
T ss_pred             cccHHhhhh-hcccccccccccChhhhc-CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC
Confidence            999999887 567889999999999998 456999999999999999999999999874     3344444455543333


Q ss_pred             CCC-CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKD-SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      -+. .|+..++.+...|..-++..|++..+++.+
T Consensus       302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            334 499999999999999999999999998765

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.85  E-value=3.6e-21  Score=150.44  Aligned_cols=149  Identities=39%  Similarity=0.730  Sum_probs=122.3

Q ss_pred             CccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC-CCCcccCccccccc
Q 026720           74 KNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPE  150 (234)
Q Consensus        74 ~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe  150 (234)
                      +.+.+|..+ +.|+.         ++|+.+++|+|++|.|+++ .++..++.|||.|+.....+. ....+.+-+|.+||
T Consensus       120 ~~ik~~m~Qll~gl~---------~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPE  190 (323)
T KOG0594|consen  120 RLIKSFMRQLLRGLA---------FLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPE  190 (323)
T ss_pred             HHHHHHHHHHHHHHH---------HHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHH
Confidence            457777777 88999         9999999999999999999 467889999999997664443 44567788999999


Q ss_pred             ccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCC-Cccccc
Q 026720          151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMG-GVNLLA  229 (234)
Q Consensus       151 ~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  229 (234)
                      ++.+...|+.-+|+||+||++.||+++++.|+|....+++.+||+.+|.|+...|+... .+.+..-..++++ +.++..
T Consensus       191 vLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~-~~~~~k~~f~~~~~~~~l~~  269 (323)
T KOG0594|consen  191 VLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS-SLPDYKAPFPKWPGPKDLSS  269 (323)
T ss_pred             HhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc-ccccccccCcCCCCccchHH
Confidence            99988889999999999999999999999999999999999999999999999998433 3333333455555 444444


Q ss_pred             cCC
Q 026720          230 VMP  232 (234)
Q Consensus       230 ~~~  232 (234)
                      .+|
T Consensus       270 ~~~  272 (323)
T KOG0594|consen  270 ILP  272 (323)
T ss_pred             hcc
Confidence            443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.7e-21  Score=158.07  Aligned_cols=148  Identities=35%  Similarity=0.602  Sum_probs=125.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      +||.+|+.+....-+..---.+.++++..|-.+ +.|+.         ++|..+++|+|++..|+++ +.+..++.|||+
T Consensus       194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~---------~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLE---------YCHSRGVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHH---------HHhhcCeeeccccccceEEcCCCCEEeccccc
Confidence            577778777655444332223445677777766 88998         9999999999999999999 578999999999


Q ss_pred             cccccCC--CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          128 VKEIDSN--LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       128 a~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |+.....  ......+.+.||++||++.|...|+..+|+||.||++.||+.|+++|+|....+++.+||+..|.|....|
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            9955432  24455678899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             c
Q 026720          206 P  206 (234)
Q Consensus       206 ~  206 (234)
                      +
T Consensus       345 ~  345 (560)
T KOG0600|consen  345 P  345 (560)
T ss_pred             c
Confidence            8

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.83  E-value=6.1e-21  Score=154.93  Aligned_cols=178  Identities=24%  Similarity=0.334  Sum_probs=138.6

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcc-cccCCcCCCcEEee-CC-eeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQG-YFHRDLKPSNLLVS-KG-VIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~-~~~~~l~p~~~~~~-~~-~~~~~~~  125 (234)
                      .++|.+|+..|.+.+...--    .+....+-..+....+..++.+  ++|... ++|+|++|+|+++. .. .++++||
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~--YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGME--YLHSEGPIIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHH--HHhcCCCeeecccChhhEEEcCCCCEEEECCC
Confidence            47999999999999876542    2223333333333333333333  888888 89999999999994 54 8999999


Q ss_pred             cccccccCC-CCCCCcccCccccccccccc-ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC-C
Q 026720          126 GMVKEIDSN-LPCTDYVTTRWYRGPEVLLF-SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT-K  202 (234)
Q Consensus       126 ~~a~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~-~  202 (234)
                      |.++..... .......++..|+|||++.. ...|+.++|+||+|+++||+++|+.||.+......+..+...-.+|+ +
T Consensus       189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p  268 (362)
T KOG0192|consen  189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP  268 (362)
T ss_pred             ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence            999887754 33344678899999999974 34599999999999999999999999999998667766766656665 4


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..++..||..++..||+|.+|++
T Consensus       269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  269 KECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            558889999999999999999999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.81  E-value=1.8e-21  Score=160.27  Aligned_cols=174  Identities=25%  Similarity=0.440  Sum_probs=143.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHH-HHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMIS-GLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~-~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      ++|++||..|.+-+..+--+.|...-.+.|..-|. |+-         |||...++|+|++.-|+++. .-..+++|||.
T Consensus       188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~---------YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMN---------YLHLHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhH---------HHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence            68999999999998876544454445677877644 333         67766789999999999994 56889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHhhCCCCCCCCc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI-CQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i-~~~~~~~~~~~~~  206 (234)
                      .+++........+.++..|+|||++. +...+.++|+||+|++||||++|+.||.+.+...+.+.+ .+.+.-|-+.+++
T Consensus       259 S~e~~~~STkMSFaGTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  259 SKELSDKSTKMSFAGTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP  337 (904)
T ss_pred             hHhhhhhhhhhhhhhhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCc
Confidence            99887655566788999999999997 555799999999999999999999999988777665554 2455668889999


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++..|++.||+-.+..||+|..|+.+
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            999999999999999999999988653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.80  E-value=4.1e-20  Score=146.61  Aligned_cols=137  Identities=26%  Similarity=0.451  Sum_probs=117.2

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHH-HHHhcCCchhhhHhhhcccccCCcCCCcEEeeC-------Ce
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMIS-GLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-------GV  119 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~-~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~-------~~  119 (234)
                      +-.||.+||..|++..-++.....++..+..|..+|. |+.         .+|+..++|+|+||.|+++..       ..
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq---------~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQ---------FLHENNIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeccCCcceEEeccCCCCCCCce
Confidence            5579999999999999888777777667777777744 455         678888999999999999942       56


Q ss_pred             eeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 026720          120 IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC  194 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~  194 (234)
                      .++.|||.|+.+.......+.+|++.|+|||++. ..+|+.+.|+||.|+++|++++|+.||+.....+.+..+-
T Consensus       154 LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~  227 (429)
T KOG0595|consen  154 LKIADFGFARFLQPGSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK  227 (429)
T ss_pred             EEecccchhhhCCchhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence            7999999999998877777889999999999997 5679999999999999999999999999888888776553

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=4.9e-20  Score=150.58  Aligned_cols=173  Identities=20%  Similarity=0.337  Sum_probs=137.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .||.+|+..|++.+-.+--+.  ...+....|.++ -.|++         +|.+...+|||+...|++. ...+++++||
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~---------YLes~~~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMA---------YLESKNYIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHH---------HHHhCCccchhhhhhheeeccCceEEEccc
Confidence            689999999999887654111  111234455555 33444         7888889999999999999 5678999999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |+|+.+...-.  ..+-.-...|.|||.+..+ .|+.++|+||+|++|||+++ |+.|+++....+.+..+-+...-|.+
T Consensus       348 GLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P  426 (468)
T KOG0197|consen  348 GLARLIGDDEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP  426 (468)
T ss_pred             ccccccCCCceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC
Confidence            99995543221  1222223468999999854 48999999999999999997 77999999999999999999999999


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+-.+++.||+..+.+||||+.+++
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999999999997654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.79  E-value=2.7e-19  Score=138.03  Aligned_cols=137  Identities=37%  Similarity=0.598  Sum_probs=125.5

Q ss_pred             hHhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           96 ISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        96 ~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      .++|+.+++|+|++|.++.+. ....++.+||.+......+....++.++.|.|||++.+.. |...+|+||.||++.||
T Consensus       132 k~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEl  210 (369)
T KOG0665|consen  132 KHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEL  210 (369)
T ss_pred             HHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHH
Confidence            389999999999999999994 5677999999999877666677889999999999999777 89999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.|+..|+|....++..++.+..|.|++........-...+....|+.+..+|+++||+
T Consensus       211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD  269 (369)
T KOG0665|consen  211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPD  269 (369)
T ss_pred             hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCc
Confidence            99999999999999999999999999999988777777888889999999999999986

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.78  E-value=2.2e-19  Score=128.47  Aligned_cols=169  Identities=31%  Similarity=0.631  Sum_probs=127.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc----CccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE----KNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~----~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      +||..||.    ++..+.|+.+..    .-+.++-.+ ++|++         ..|+..+.|++++|.+.+++ ++..++.
T Consensus        77 tlvfe~cd----qdlkkyfdslng~~d~~~~rsfmlqllrgl~---------fchshnvlhrdlkpqnllin~ngelkla  143 (292)
T KOG0662|consen   77 TLVFEFCD----QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLG---------FCHSHNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_pred             EEeHHHhh----HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhh---------hhhhhhhhhccCCcceEEeccCCcEEec
Confidence            56777765    344566666542    123344444 88887         77888899999999999994 6788999


Q ss_pred             eccccccccCCCCC-CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          124 DLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       124 ~~~~a~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +||+++.+.....+ ...+.+-+|.+|+++.+...|++.+|+||.||++.|+.. |+++|||.+..+++.+||...|.|.
T Consensus       144 dfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~  223 (292)
T KOG0662|consen  144 DFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_pred             ccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCc
Confidence            99999987764432 345678899999999988899999999999999999995 7799999999999999999999999


Q ss_pred             CCCCcchhhhhhhhccccCCC-CCccccccCCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQM-GGVNLLAVMPS  233 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (234)
                      .+.|+...+ +..+.- .|-+ ...+|..|+|+
T Consensus       224 ed~wps~t~-lpdyk~-yp~ypattswsqivp~  254 (292)
T KOG0662|consen  224 EDQWPSMTK-LPDYKP-YPIYPATTSWSQIVPK  254 (292)
T ss_pred             cccCCcccc-CCCCcc-cCCccccchHHHHhhh
Confidence            999995433 332221 1222 23455555554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2.2e-20  Score=148.26  Aligned_cols=177  Identities=23%  Similarity=0.253  Sum_probs=132.5

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C---CeeeE
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K---GVIKI  122 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~---~~~~~  122 (234)
                      +.+||.+|...|++-+-.---..+.+..-..|-.+ +.|.-         ++|+.++.|||++|+|+++. +   .+.++
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avk---------YLH~~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVK---------YLHSQGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHH---------HHHHcCcccccCCcceEEeccCCcceEEEe
Confidence            34888999999987664322222222223333333 77777         99999999999999999994 3   57899


Q ss_pred             eeccccccccCCCCCCCcccCccccccccccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCC
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE--IYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD-QIYKICQLIGS  199 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~-~~~~i~~~~~~  199 (234)
                      .|||+|+..+.....++.+|++.|.|||++.+..  .|+.++|+||+||+++-+++|.+||++..... ...+|.+.--.
T Consensus       321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            9999999988666677889999999999986533  46679999999999999999999999865444 55566665445


Q ss_pred             CCCCCCcchhhhhh---hhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLAS---NLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..|.+.-++..   +.....++..|++..+.+++
T Consensus       401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            55667766555544   44556789999999988764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.77  E-value=2.5e-19  Score=145.76  Aligned_cols=174  Identities=22%  Similarity=0.391  Sum_probs=151.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++.+||..|++.+++.--.  ..+++-+.-|-.+ +.|..         ++|...++|+++++.|+.+ .+..++++|
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~---------ylH~~~iLHRDlK~~Nifltk~~~VkLgD  149 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVN---------YLHENRVLHRDLKCANIFLTKDKKVKLGD  149 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHH---------HHHhhhhhcccchhhhhhccccCceeecc
Confidence            568899999999999876544  2445677888777 67777         8998889999999999998 455669999


Q ss_pred             ccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          125 LGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       125 ~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      ||.++.+.... ....+++++.|++||++.+. .|+.+.|+||+||+++||+.-++.|.+.+......+|++....|.+.
T Consensus       150 fGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~  228 (426)
T KOG0589|consen  150 FGLAKILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS  228 (426)
T ss_pred             hhhhhhcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc
Confidence            99999988765 55678999999999999854 49999999999999999999999999999999999999999999999


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .|...+..+..-+....+..||+..+++.
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~  257 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSALELLR  257 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence            99999999998888888899999988875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.77  E-value=6.1e-19  Score=138.44  Aligned_cols=156  Identities=26%  Similarity=0.298  Sum_probs=118.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||..|...|.+---.+--...++..+..|.+= +.|+.         +||+.++++||++|+|+++ ..+.+++.|||+
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~---------~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALG---------YLHSKGIIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHH---------HHHhCCeeeccCCHHHeeecCCCcEEEecccc
Confidence            456667777776554433233344445667665 77777         9999999999999999999 578999999999


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++.... .....+.+||+-|+|||++... .|+..+|.||+|+++|||++|.+||.+........+|.+.-....+..++
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls  250 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS  250 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC
Confidence            996544 3456678999999999999854 58999999999999999999999999998888877777655444444455


Q ss_pred             chhhhhhhh
Q 026720          207 LGIQLASNL  215 (234)
Q Consensus       207 ~~~~~~~~~  215 (234)
                      ..-..+.+.
T Consensus       251 ~~ardll~~  259 (357)
T KOG0598|consen  251 EEARDLLKK  259 (357)
T ss_pred             HHHHHHHHH
Confidence            444444333

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=3.4e-19  Score=147.65  Aligned_cols=175  Identities=23%  Similarity=0.281  Sum_probs=139.2

Q ss_pred             HHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEee
Q 026720           47 IGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGD  124 (234)
Q Consensus        47 ~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~  124 (234)
                      .+.+|+-++|..|++.+..+.-..+.++-+..|..+ +.|+-         ++|+..++|||++..|+.++ ....+++|
T Consensus        91 ~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~Glk---------YLH~~~IiHRDLKLGNlfL~~~~~VKIgD  161 (592)
T KOG0575|consen   91 NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLK---------YLHSLGIIHRDLKLGNLFLNENMNVKIGD  161 (592)
T ss_pred             CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHH---------HHHhcCceecccchhheeecCcCcEEecc
Confidence            345788899999999988775555667788888888 78888         99999999999999999995 45789999


Q ss_pred             ccccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-hhCCCCC
Q 026720          125 LGMVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ-LIGSPTK  202 (234)
Q Consensus       125 ~~~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~-~~~~~~~  202 (234)
                      ||+|..+... -...+.+|||.|.|||++. ...++.-+|+||+||++|.++.|+|||....-.+...+|-. ....|. 
T Consensus       162 FGLAt~le~~~Erk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~-  239 (592)
T KOG0575|consen  162 FGLATQLEYDGERKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS-  239 (592)
T ss_pred             cceeeeecCcccccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc-
Confidence            9999998743 3567889999999999998 44478999999999999999999999998877777777644 333343 


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       +-+..-..|+.-.....+-.||++++++.+
T Consensus       240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             323333444555556677899999998764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.77  E-value=7.9e-19  Score=143.81  Aligned_cols=170  Identities=26%  Similarity=0.338  Sum_probs=135.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      +.+.+|++.|++-+-++-+....+-...-|++. |.++-         ++|+.+++|||++|+|+++ .++..++.|||.
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAle---------ylH~~GIIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALE---------YLHSNGIIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHH---------HHHhcCceeccCChhheeEcCCCcEEEeeccc
Confidence            356678999998888777776666666778887 88888         9999999999999999999 578999999999


Q ss_pred             cccccCCC--------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 026720          128 VKEIDSNL--------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI  193 (234)
Q Consensus       128 a~~~~~~~--------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i  193 (234)
                      |+.+....              ....++|+-.|.+||++.+.. .+...|+|++||++|+|+.|.+||.+...+..+++|
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            98763321              113467888899999998654 478899999999999999999999999999999999


Q ss_pred             HHhhCCCCCCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          194 CQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      ....-..++.. ++....|.+.....++.+|++.++|
T Consensus       300 ~~l~y~fp~~f-p~~a~dLv~KLLv~dp~~Rlt~~qI  335 (604)
T KOG0592|consen  300 QALDYEFPEGF-PEDARDLIKKLLVRDPSDRLTSQQI  335 (604)
T ss_pred             HHhcccCCCCC-CHHHHHHHHHHHccCccccccHHHH
Confidence            88655544443 3556666666666777788777665

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.77  E-value=1.7e-19  Score=142.75  Aligned_cols=177  Identities=23%  Similarity=0.309  Sum_probs=138.8

Q ss_pred             HHHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC--CeeeEe
Q 026720           48 GTALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK--GVIKIG  123 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~--~~~~~~  123 (234)
                      .-+++.+|+..|++.+-..-+. .++++.+..|+.+ +.|+.         ++|+++++|+|++|+|+++..  ..+++.
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~---------ylHs~g~vH~DiK~~NiLl~~~~~~~Kla  160 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLA---------YLHSKGIVHCDIKPANILLDPSNGDVKLA  160 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEeccCcccceEEEeCCCCeEEec
Confidence            3457789999999999988877 6888999999999 99999         999999999999999999943  689999


Q ss_pred             eccccccccC--C--CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhhC
Q 026720          124 DLGMVKEIDS--N--LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG-KSSADQIYKICQLIG  198 (234)
Q Consensus       124 ~~~~a~~~~~--~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~-~~~~~~~~~i~~~~~  198 (234)
                      |||.+.....  .  .......+++.|++||++..+......+|+||+||++.||++|++|+.+ ....+...++-..-.
T Consensus       161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~  240 (313)
T KOG0198|consen  161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS  240 (313)
T ss_pred             cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC
Confidence            9998887663  1  1223467899999999997422122389999999999999999999998 344444444432222


Q ss_pred             C-CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 S-PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      . +-+.+-+...+.+...|-...+..|+|+++++.+
T Consensus       241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            2 2344555667777888999999999999998864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.2e-18  Score=143.31  Aligned_cols=171  Identities=23%  Similarity=0.411  Sum_probs=132.2

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      .|++|...|.+.+...-+. |.+..+.+.. ..+.|+.         +||..+++|+|++.|++++ .++..++.|||.+
T Consensus       347 VVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~---------fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFc  416 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLK---------FLHARGIIHRDIKSDNILLTMDGSVKLTDFGFC  416 (550)
T ss_pred             EEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHH---------HHHhcceeeeccccceeEeccCCcEEEeeeeee
Confidence            3455666666665544322 3333332222 2256666         8999999999999999999 5788999999999


Q ss_pred             ccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC---CC
Q 026720          129 KEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK---DS  204 (234)
Q Consensus       129 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~---~~  204 (234)
                      .++.... ...+.+|++.|+|||++. ...|..++|+||+|+.++||+.|++||-.....-.++.|... |.|..   +.
T Consensus       417 aqi~~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~k  494 (550)
T KOG0578|consen  417 AQISEEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEK  494 (550)
T ss_pred             eccccccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccc
Confidence            9998876 455789999999999997 456999999999999999999999999987777666666553 44443   45


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      -+..++.+.+.|...+..+|.+..|+|.+
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            55678888888999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.9e-18  Score=144.55  Aligned_cols=174  Identities=21%  Similarity=0.237  Sum_probs=134.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      +|+-+|...|.+-+..-.-..++++...-|-.+ |.|..         +.|...+.|+|++|.|.++. ..-.++.|||.
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~---------yCH~~~icHRDLKpENlLLd~~~nIKIADFGM  158 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVS---------YCHAFNICHRDLKPENLLLDVKNNIKIADFGM  158 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHH---------HHhhhcceeccCCchhhhhhcccCEeeeccce
Confidence            456667777766555444444555555544444 88888         88888899999999999993 34489999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      |..-.......+.+|++.|.+||++.+.+......|+||+|++|+.+++|+.||+|+.-...+.++.+..=..+ ..-+.
T Consensus       159 AsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP-s~Is~  237 (786)
T KOG0588|consen  159 ASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP-SNISS  237 (786)
T ss_pred             eecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC-CcCCH
Confidence            87655555567789999999999999888778999999999999999999999998888888888876433322 23334


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .-|.|.......++-.|++.++|+++
T Consensus       238 eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  238 EAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HHHHHHHHHhccCccccccHHHHhhC
Confidence            55667777778899999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.74  E-value=4.7e-18  Score=130.00  Aligned_cols=153  Identities=25%  Similarity=0.297  Sum_probs=128.5

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      +-.||..|...|.+-.-.+--.+.+++....|.+. +.|+-         ++|+..++.||++|.|+++ ..++.++.||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAle---------ylH~~~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALE---------YLHSLDIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHH---------HHHhcCeeeccCChHHeeeccCCcEEEEec
Confidence            34577888888888887777777888888899988 77787         8999999999999999999 5799999999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |-|+.+..+  ..+.+++|-|+|||++.. ..|+..+|.||+|++++||+.|.+||.+......-.+|++.-...+...-
T Consensus       189 GFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs  265 (355)
T KOG0616|consen  189 GFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFS  265 (355)
T ss_pred             cceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccC
Confidence            999998875  566899999999999984 45899999999999999999999999999998888888876555555444


Q ss_pred             cchhhhh
Q 026720          206 PLGIQLA  212 (234)
Q Consensus       206 ~~~~~~~  212 (234)
                      +..-+++
T Consensus       266 ~~~kdLl  272 (355)
T KOG0616|consen  266 SDAKDLL  272 (355)
T ss_pred             HHHHHHH
Confidence            4444433

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.74  E-value=2.2e-18  Score=143.98  Aligned_cols=116  Identities=33%  Similarity=0.622  Sum_probs=100.9

Q ss_pred             ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCCCCCcccCccccccc
Q 026720           75 NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPE  150 (234)
Q Consensus        75 ~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe  150 (234)
                      .+.+++.+ +.++.         .|+..+++|+|+||.||++.   ..-.++.|||.+-......  ..++-+++|+|||
T Consensus       290 ~ir~~~~Qil~~L~---------~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--ytYiQSRfYRAPE  358 (586)
T KOG0667|consen  290 LVRKFAQQILTALL---------FLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV--YTYIQSRFYRAPE  358 (586)
T ss_pred             HHHHHHHHHHHHHH---------HHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc--eeeeeccccccch
Confidence            44556655 77777         88888999999999999994   3457999999988876643  3788999999999


Q ss_pred             ccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       151 ~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      ++.+.+ |+..+||||+||++.||.+|.++|||....|++..|.+..|.|+.
T Consensus       359 VILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  359 VILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             hhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            999665 899999999999999999999999999999999999999998886

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=5.2e-18  Score=140.62  Aligned_cols=172  Identities=22%  Similarity=0.353  Sum_probs=142.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..||+.||- |+-.+..+|... |.+-.+...+.- +.|++         ++|+..++|+|++..|+++ ..+.++++||
T Consensus       101 aWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLa---------YLHS~~~IHRDiKAGNILLse~g~VKLaDF  170 (948)
T KOG0577|consen  101 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLA---------YLHSHNRIHRDIKAGNILLSEPGLVKLADF  170 (948)
T ss_pred             HHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHH---------HHHHhhHHhhhccccceEecCCCeeeeccc
Confidence            458889996 777777777654 433334444444 78888         9999999999999999999 4789999999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-CCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-GSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-~~~~~  202 (234)
                      |.|.....   -+.++|+|+|+|||++..+  ..|..++|+||+|+.+.|+..+++|+-++.....++.|.+.- ..-..
T Consensus       171 GSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs  247 (948)
T KOG0577|consen  171 GSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS  247 (948)
T ss_pred             cchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC
Confidence            98877553   5778999999999998543  369999999999999999999999999999999999998643 33446


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..|++.+..+.+.|..-++-+|++-+++|.+
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            7999999999999999999999999988764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=9.6e-18  Score=137.31  Aligned_cols=175  Identities=22%  Similarity=0.330  Sum_probs=132.5

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCcccc-HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C-CeeeEee
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQS-WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K-GVIKIGD  124 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~-~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~-~~~~~~~  124 (234)
                      ...+|.+||..|++-+...--..+.+..... +-.+++|..         ++|..++.|||++|.|+++. . ...++.|
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~---------y~H~~gi~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVA---------YCHSRGIVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHH---------HHHhCCEeeCCCCHHHEEecCCCCCEEEec
Confidence            3678888999888877755544455544433 444588988         99999999999999999994 4 6889999


Q ss_pred             ccccccc-cCCCCCCCcccCcccccccccccccCC-CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hCCCC
Q 026720          125 LGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSEIY-GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL-IGSPT  201 (234)
Q Consensus       125 ~~~a~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~-~~~~~  201 (234)
                      ||.+... .......+.+|++.|.|||++.+...| ...+|+||+|++++.|+.|..||.+........++... ...|.
T Consensus       165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~  244 (370)
T KOG0583|consen  165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS  244 (370)
T ss_pred             cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC
Confidence            9999987 344456778999999999999876624 69999999999999999999999997666666665442 22233


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ... +.....+.......++.+|+++.+|+.
T Consensus       245 ~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  245 YLL-SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             CcC-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            331 445566666666667777999999874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=4.5e-18  Score=136.20  Aligned_cols=174  Identities=18%  Similarity=0.276  Sum_probs=137.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCcccc-HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQS-WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~-~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+++.||..|.+.+..+.-.-+.+.-+.. ---++.|+.         ++|.+..+|+++++.++++ ..+.+++.|||.
T Consensus        87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~---------ylH~~~kiHrDIKaanil~s~~g~vkl~DfgV  157 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLD---------YLHSEKKIHRDIKAANILLSESGDVKLADFGV  157 (467)
T ss_pred             HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhh---------hhhhcceecccccccceeEeccCcEEEEecce
Confidence            47888999999888766533333332222 223366776         8898889999999999999 467899999999


Q ss_pred             cccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +.++..... ..+++++++|+|||++. ...|+.+.|+||+|+..+||++|.+|+.+....-.+.-|-+.-...-...|+
T Consensus       158 a~ql~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S  236 (467)
T KOG0201|consen  158 AGQLTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFS  236 (467)
T ss_pred             eeeeechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccC
Confidence            998866543 37889999999999998 5569999999999999999999999999987755554444433322336899


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++++...|....+..|++..+++.+
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            999999999999999999999988754

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.72  E-value=1.1e-17  Score=125.10  Aligned_cols=149  Identities=23%  Similarity=0.310  Sum_probs=121.0

Q ss_pred             ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEeeccccccccCCCCCCCcccCcccccc
Q 026720           75 NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP  149 (234)
Q Consensus        75 ~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~p  149 (234)
                      ++.-|..+ +.++.         +.|..+++|++++|.+.++.    .+-.++++||.|.++.......+.+++|+|++|
T Consensus       111 ~aSH~~rQiLeal~---------yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  111 DASHCIQQILEALA---------YCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSP  181 (355)
T ss_pred             HHHHHHHHHHHHHH---------HHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCH
Confidence            33445554 56666         78999999999999999983    356799999999999877777889999999999


Q ss_pred             cccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhh---hhhccccCCCCCcc
Q 026720          150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA---SNLNWKLPQMGGVN  226 (234)
Q Consensus       150 e~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  226 (234)
                      |++. ...|+.-+|+|++|++++-++.|.+||.|.+......+|.+.-...+...|+....+.   .+.....++.+|+|
T Consensus       182 Evvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt  260 (355)
T KOG0033|consen  182 EVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT  260 (355)
T ss_pred             HHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc
Confidence            9997 4458999999999999999999999999988888888888866666666676555554   44456778889999


Q ss_pred             ccccCCC
Q 026720          227 LLAVMPS  233 (234)
Q Consensus       227 ~~~~~~~  233 (234)
                      ..|-+++
T Consensus       261 a~EAL~H  267 (355)
T KOG0033|consen  261 ADEALKH  267 (355)
T ss_pred             HHHHhCC
Confidence            8877654

>PHA02988 hypothetical protein; Provisional

Probab=99.72  E-value=1.5e-17  Score=132.46  Aligned_cols=174  Identities=18%  Similarity=0.134  Sum_probs=126.7

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEee
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      +..++.+|+..|++.+...--..++......+... +.|+.         ++|. .++.|++++|.++++ .+...++.+
T Consensus        96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~~~~Hrdlkp~nill~~~~~~kl~d  166 (283)
T PHA02988         96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLY---------NLYKYTNKPYKNLTSVSFLVTENYKLKIIC  166 (283)
T ss_pred             ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHH---------HHHhcCCCCCCcCChhhEEECCCCcEEEcc
Confidence            34688899999999887542111221222222222 34444         6775 367899999999999 467789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      ||.++.+...  .....++..|+|||++.+. ..|+..+|+||+|+++||+++|+.||.+....+....+......+.. 
T Consensus       167 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  244 (283)
T PHA02988        167 HGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP  244 (283)
T ss_pred             cchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence            9988765432  1234567789999998642 45889999999999999999999999988766666555544434333 


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..++..||..++.+||++.+++.
T Consensus       245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        245 LDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            367788999999999999999999999875

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.70  E-value=1.1e-16  Score=135.05  Aligned_cols=142  Identities=32%  Similarity=0.533  Sum_probs=114.1

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C-CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGP  160 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~-~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  160 (234)
                      +.|+.         ++|+.+++|+|++|.|+++. . ...+++|||.++.+..........+++.|+|||++.+...|+.
T Consensus       180 ~~gL~---------yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  250 (440)
T PTZ00036        180 CRALA---------YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTT  250 (440)
T ss_pred             HHHHH---------HHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCc
Confidence            66777         89999999999999999994 3 3689999999987755444445677899999999876666899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC----------------------------CCcchhhhh
Q 026720          161 EVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD----------------------------SWPLGIQLA  212 (234)
Q Consensus       161 ~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~----------------------------~~~~~~~~~  212 (234)
                      .+|+||+||+++||++|.+||.+....+.+.++.+..+.|...                            ..+.....+
T Consensus       251 ~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l  330 (440)
T PTZ00036        251 HIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINF  330 (440)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHH
Confidence            9999999999999999999999999989888888776655421                            112344556


Q ss_pred             hhhccccCCCCCccccccCCC
Q 026720          213 SNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...++..++.+|++..+++.+
T Consensus       331 i~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        331 ISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHCCCChhHCcCHHHHhCC
Confidence            677888899999998887753

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=5.8e-17  Score=138.37  Aligned_cols=173  Identities=22%  Similarity=0.356  Sum_probs=130.8

Q ss_pred             HHHHHHhhcCChHHHHHHHH----hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN----LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~----~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .++..|+..|++.+...-..    .+++..+..+.. ++.|+.         ++|..+++|++++|+|+++ .....+++
T Consensus       115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~---------~lH~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVH---------HVHSKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence            47788999999987654211    111222233333 366666         8999999999999999999 46778999


Q ss_pred             eccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 026720          124 DLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       124 ~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      |||.++......   ......+++.|++||++.+ ..|+...|+||+|+++||+++|+.||.+....+...++......+
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999987654321   1234567889999999874 347899999999999999999999999887766666665544445


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+...+..+..+...++...+.+|+++.++++
T Consensus       265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            55667778888999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.69  E-value=4.2e-18  Score=144.79  Aligned_cols=172  Identities=20%  Similarity=0.308  Sum_probs=138.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH---HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM---ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~---i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|.+|+.+|.||.-.+.-+     .-+++..+   ++|.+   -+  ..+|-+.+.+|+|+...|++.+ ...+++.||
T Consensus       706 MIiTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIA---sG--MkYLsdm~YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIA---SG--MKYLSDMNYVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHH---HH--hHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence            57899999999998766433     22455444   44444   22  2367777889999999999995 567899999


Q ss_pred             cccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCC
Q 026720          126 GMVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       126 ~~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      |+.+.+....+    ..+-.....|.|||.+. .+.+++.+|+||+|+++||+++ |++||=+..+.+....|-+..+-|
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP  854 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP  854 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence            99997654321    11112235699999998 4568999999999999999885 779999999999999999999999


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..++.++..|+.-||..+...||+|.+|++
T Consensus       855 pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            99999999999999999999999999998864

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.68  E-value=5.3e-17  Score=129.55  Aligned_cols=174  Identities=29%  Similarity=0.534  Sum_probs=123.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+. |.+.+...... .++...+..+.. ++.|+.         ++|+.+++|++++|+|+++ .+...+++|||
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG  148 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLS---------YCHKRKILHRDLKPQNLLINEKGELKLADFG  148 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCHHHEEECCCCCEEECcCc
Confidence            35566665 34444322111 122223333333 366677         8999999999999999999 46678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+....... ......+++.|++||.+.+...++..+|+||+|++++++++|++||++....+.+..+.+..+.|....|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07871         149 LARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW  228 (288)
T ss_pred             ceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence            887654321 1233456788999999875556889999999999999999999999999888888888888777766555


Q ss_pred             cch-----------------------------hhhhhhhccccCCCCCccccccCCC
Q 026720          206 PLG-----------------------------IQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..                             ...+...+...++.+|+|+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            432                             1223444556678889999998865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.68  E-value=8.2e-17  Score=132.62  Aligned_cols=175  Identities=23%  Similarity=0.318  Sum_probs=121.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.+...--..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------~lH~~givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID---------SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEecCCCHHHeEECCCCCEEEeecc
Confidence            4688889999998877654334444555556555 66666         8999999999999999999 46778999999


Q ss_pred             ccccccCCC------------------------------------CCCCcccCcccccccccccccCCCCcchHHHHHHH
Q 026720          127 MVKEIDSNL------------------------------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI  170 (234)
Q Consensus       127 ~a~~~~~~~------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~  170 (234)
                      .+..+....                                    .....++++.|+|||++.+ ..|+..+|+||+|++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvi  225 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVI  225 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHH
Confidence            887543210                                    0123468889999999874 447899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhh---CCCCCCCCcchhhh-hhhhc-cccCCCCCccccccCCC
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQLI---GSPTKDSWPLGIQL-ASNLN-WKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~  233 (234)
                      ++||++|..||.+....+...++....   ..|+....+..... +.+++ ....+..|+++++++++
T Consensus       226 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         226 MYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999999999888777776666422   12332223333333 33433 22233456777777654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.67  E-value=7.7e-17  Score=129.50  Aligned_cols=176  Identities=28%  Similarity=0.481  Sum_probs=120.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..+..+....-...++...+..+... +.|+.         ++|+.+++|++++|.|+++ .....+++|||
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          78 LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS---------YIHQRYILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             EEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEECCCCCEEECCCC
Confidence            4566677753322222111111233334444433 66777         8999999999999999999 45678999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhhCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA-DQIYKICQLIGSPTKDS  204 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~-~~~~~i~~~~~~~~~~~  204 (234)
                      .+...... .......+++.|+|||++.+...++..+|+||+|++++++++|..||++..+. +.+.+++...+.|....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (303)
T cd07869         149 LARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT  228 (303)
T ss_pred             cceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence            88754321 12233456788999999876566788999999999999999999999986544 45555666555554443


Q ss_pred             Cc-------------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WP-------------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      |+                               .....+...+...++.+|+|..+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            32                               223355566777889999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.67  E-value=2.4e-16  Score=125.68  Aligned_cols=136  Identities=36%  Similarity=0.576  Sum_probs=110.4

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|+|+++ .....+++|||.+.............+++.|+|||.+.. ..++..+|+||+|++++|++
T Consensus       125 ~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~  203 (290)
T cd07862         125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMF  203 (290)
T ss_pred             HHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHH
Confidence            8899999999999999999 467789999999876554333344567888999999864 34788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCCCCc--------------------------chhhhhhhhccccCCCCCccccc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKDSWP--------------------------LGIQLASNLNWKLPQMGGVNLLA  229 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~  229 (234)
                      +|++||.+....+.+.++.+..+.|.+..|+                          +....+...+....+.+|++..+
T Consensus       204 ~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  283 (290)
T cd07862         204 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  283 (290)
T ss_pred             cCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence            9999999999999998888877766554443                          23345667788889999999999


Q ss_pred             cCCC
Q 026720          230 VMPS  233 (234)
Q Consensus       230 ~~~~  233 (234)
                      ++++
T Consensus       284 ~l~h  287 (290)
T cd07862         284 ALSH  287 (290)
T ss_pred             HhcC
Confidence            8864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.67  E-value=1.3e-16  Score=123.07  Aligned_cols=122  Identities=39%  Similarity=0.737  Sum_probs=104.5

Q ss_pred             ccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eC----CeeeEeeccccccccCCC----CCCCcccCccc
Q 026720           77 QSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SK----GVIKIGDLGMVKEIDSNL----PCTDYVTTRWY  146 (234)
Q Consensus        77 ~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~----~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~  146 (234)
                      .+..-+ |+|..         ++|+.-++|+|++|.|+++ .+    +..+++|+|.++.+....    .....+.+.+|
T Consensus       135 KsilwQil~Gv~---------YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWY  205 (438)
T KOG0666|consen  135 KSILWQILDGVH---------YLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWY  205 (438)
T ss_pred             HHHHHHHHhhhH---------HHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEe
Confidence            344334 78888         9998889999999999998 44    789999999999876533    22346778999


Q ss_pred             ccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHHhhCCCCCCCCcc
Q 026720          147 RGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK---------SSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       147 ~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~---------~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +|||.+.+.++|+.++|+|+.||++.|+++.+++|.+.         ...+++.+||+.+|.|....|+.
T Consensus       206 RAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~  275 (438)
T KOG0666|consen  206 RAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPD  275 (438)
T ss_pred             cChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchh
Confidence            99999999999999999999999999999999999874         46789999999999999999983

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.67  E-value=1.5e-16  Score=135.51  Aligned_cols=174  Identities=21%  Similarity=0.378  Sum_probs=129.9

Q ss_pred             HHHHHHHhhcCChHHHHHHH-H-h--hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeE
Q 026720           49 TALVEMYSKCGHVEKAFKVF-N-L--MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKI  122 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~-~-~--m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~  122 (234)
                      ..||..|+..|++.+...-. . .  +.+..+..+.. ++.|+.         ++|..+++|+|++|.|+++ .....++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~---------~lH~~~ivHrDlkp~NIll~~~~~~kL  210 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD---------EVHSRKMMHRDLKSANIFLMPTGIIKL  210 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCEEECCcCHHhEEECCCCcEEE
Confidence            46788899999998754321 1 1  11112222222 255565         8899999999999999999 4677899


Q ss_pred             eeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          123 GDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       123 ~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      .|||.+..+.....   .....+++.|++||++.+ ..++..+|+||+|++++++++|+.||.+....+....+......
T Consensus       211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  289 (478)
T PTZ00267        211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD  289 (478)
T ss_pred             EeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999987644321   233467889999999864 45789999999999999999999999988777777666654444


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.+..++..+..++..++...+..|+++++++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            455566778888888899999999999998865

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.67  E-value=7.8e-17  Score=128.34  Aligned_cols=174  Identities=29%  Similarity=0.450  Sum_probs=123.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|.++...+.-..++...+..+... +.|+.         ++|..+++|++++|+|+++ .....+++|||.
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH---------WCHKNDIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence            477788887766544322122333333444443 56666         8899999999999999999 466789999999


Q ss_pred             cccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC---
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK---  202 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~---  202 (234)
                      +..+....  ......+++.|++||++.+. .++...|+||+|++++|+++|++||++....+.+..+.+..+..+.   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07848         147 ARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM  225 (287)
T ss_pred             cccccccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence            88764321  12234677889999998743 4788999999999999999999999988777766655443221110   


Q ss_pred             ----------------------------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 ----------------------------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                  ...+..+..+.+.+...++.+|+++++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                        0123346677788889999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.67  E-value=6.8e-17  Score=131.55  Aligned_cols=173  Identities=24%  Similarity=0.322  Sum_probs=127.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+...-...+++..+..|... +.|+.         ++|..+++|++++|+|+++ .....++.|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD---------ALHELGYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCCHHHEEECCCCCEEEEeCc
Confidence            4577888999998876544333443344444433 66776         8999999999999999999 46678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh---CCCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI---GSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~---~~~~~~  203 (234)
                      .+.....  ......+++.|++||++.+. .++..+|+||+|++++||++|..||.+....+....+....   ..|...
T Consensus       147 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  223 (333)
T cd05600         147 LSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD  223 (333)
T ss_pred             CCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence            9887654  23445788899999998744 57899999999999999999999999877666555554322   122221


Q ss_pred             ----CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 ----SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                          ..+..+..+...++..++..|+++++++.+
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                335566667777778899999999988754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.67  E-value=1.4e-16  Score=129.84  Aligned_cols=174  Identities=27%  Similarity=0.415  Sum_probs=120.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+. +++.+...-...++...+..+... +.|+.         ++|+.+++|++++|+|+++ ..+..+++|||.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALK---------YIHTANVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence            56777875 555544332222333333333333 66676         8999999999999999999 456789999999


Q ss_pred             cccccCCC----CCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNL----PCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~----~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.......    ......+++.|+|||++... ..++..+|+||+|++++|+++|++||++......+..+.+..+.|..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            87653221    12345678899999987532 45788999999999999999999999987766655444444333321


Q ss_pred             C------------------------------CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 D------------------------------SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .                              ..+..+..+...++...+.+|+++++++.+
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            1                              122344567777888899999999998864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.67  E-value=1.1e-16  Score=127.56  Aligned_cols=174  Identities=21%  Similarity=0.286  Sum_probs=123.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++..|+..|++........  .+++..+..+... +.|+.         ++|+.+++|++++|.|+++ .....++.|
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~iiH~dikp~Nill~~~~~~kl~D  145 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE---------DLQRERIVYRDLKPENILLDDRGHIRISD  145 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEEeCCCCHHHEEECCCCCEEEee
Confidence            457778888898876543211  1222233344333 66666         8899999999999999999 457789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC---CCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG---SPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~---~~~  201 (234)
                      ||.+.............++..|++||++.+ ..|+..+|+||+|++++++++|+.||.+.........+.....   ...
T Consensus       146 fg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05631         146 LGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY  224 (285)
T ss_pred             CCCcEEcCCCCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccC
Confidence            999887644333344567889999999874 4578999999999999999999999997654333223322222   222


Q ss_pred             CCCCcchhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      ....+..+..+.+.++...+.+|++     ++++++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            3345667788888889988999986     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.66  E-value=8.5e-17  Score=132.85  Aligned_cols=171  Identities=20%  Similarity=0.279  Sum_probs=126.1

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      +|.+||.. ++....+--..|++..+...... ++|+-         ++|+..+.|++++|.++++ ..+..++++||.|
T Consensus        78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~---------yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~A  147 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALY---------YLHSNRILHRDMKPQNILLEKGGTLKLCDFGLA  147 (808)
T ss_pred             EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHH---------HHHhcCcccccCCcceeeecCCCceeechhhhh
Confidence            56677764 66666665566777777666665 88888         8999889999999999999 5678999999999


Q ss_pred             ccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          129 KEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       129 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +.+.... -.....++|.|+|||++.+ ..|+..+|+||+||++||+..|++||....-......|...-..|+. .-+.
T Consensus       148 r~m~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~-~~S~  225 (808)
T KOG0597|consen  148 RAMSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS-TASS  225 (808)
T ss_pred             hhcccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc-cccH
Confidence            9875432 3445678999999999984 45899999999999999999999999876555555555544333333 2222


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+.+--...++-+|++|.+++.+
T Consensus       226 ~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  226 SFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHHHHHHHHhhcChhhcccHHHHhcC
Confidence            33334444445577888888877654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.66  E-value=1.6e-16  Score=127.02  Aligned_cols=170  Identities=21%  Similarity=0.199  Sum_probs=124.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+..+-...+++..+..|... +.|+.         ++|+.+++|++++|+|+++ ..+..++.|||.
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE---------YLHSKEIVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecCCCHHHeEECCCCCEEEEecCc
Confidence            356677888887765543333333344444444 66777         8999999999999999999 466789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +......  .....+++.|+|||++.+ ..++..+|+||+|++++++++|+.||.+.........+...-. .-+...+.
T Consensus       148 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~  223 (291)
T cd05612         148 AKKLRDR--TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFPRHLDL  223 (291)
T ss_pred             chhccCC--cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-CCCccCCH
Confidence            8876542  223467888999999864 4478899999999999999999999998776666555544321 22234466


Q ss_pred             hhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          208 GIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      .+..+.+.++..++.+|++     +++++.
T Consensus       224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            7778888888888888885     776654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.66  E-value=7.9e-17  Score=131.93  Aligned_cols=173  Identities=25%  Similarity=0.344  Sum_probs=127.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...-...++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.|||.
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD---------SVHKLGFIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHeEECCCCCEEeecCCC
Confidence            567788888888776543322333333334333 66666         8899999999999999999 466789999998


Q ss_pred             cccccCCC------------------------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhC
Q 026720          128 VKEIDSNL------------------------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF  177 (234)
Q Consensus       128 a~~~~~~~------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~  177 (234)
                      +..+....                              ......+++.|+|||++.+. .++..+|+||+|++++|+++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccC
Confidence            87654432                              12335678889999998744 578999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHH---hhCCCCCCCCcchhhhhhhhccccCCCCCcc-ccccCCC
Q 026720          178 GILFPGKSSADQIYKICQ---LIGSPTKDSWPLGIQLASNLNWKLPQMGGVN-LLAVMPS  233 (234)
Q Consensus       178 ~~~f~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  233 (234)
                      +.||.+........++..   ....|....++..+..++..+.. ++.+|++ +++++.+
T Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            999998887766666655   22334444567777888777776 7778888 8888764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=4.9e-16  Score=124.25  Aligned_cols=137  Identities=31%  Similarity=0.506  Sum_probs=119.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHH-HHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMIS-GLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~-~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      ..|++|+..|++---++.+.+..+|..+.|.+-|. |+-         .+|+.+++.++++.||+++ ..+..++.|||.
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLF---------FLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLF---------FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhh---------hhhcCCeeeeeccccceEeccCCceEeeeccc
Confidence            35788999999988888889999999999988754 444         6889999999999999999 578999999999


Q ss_pred             ccc-ccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 026720          128 VKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       128 a~~-~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~  196 (234)
                      +++ +.......++++++-|+|||++.+.+ |...+|.||+|++|+||+.|.+||+|.+..+....|.+.
T Consensus       497 cKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh  565 (683)
T KOG0696|consen  497 CKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH  565 (683)
T ss_pred             ccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence            886 44455667889999999999998544 899999999999999999999999999998888888764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.65  E-value=3.7e-16  Score=128.32  Aligned_cols=171  Identities=30%  Similarity=0.462  Sum_probs=121.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+..+.. .  ..++...+..+.. ++.|+.         ++|+.+++|++++|+|+++ .....+++|||.
T Consensus        98 ~lv~e~~~~~l~~~~-~--~~l~~~~~~~~~~qi~~aL~---------~LH~~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          98 YLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIK---------HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             EEEhhhhcccHHHHH-h--hcCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence            467777765433221 1  1122222333333 366666         8999999999999999999 456789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC---
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS---  204 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~---  204 (234)
                      +.............+++.|++||++.+ ..++..+|+||+|++++++++|+.||++....+....+.+..+.+.+..   
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            987655444445677889999999864 4478899999999999999999999999887777776666554432110   


Q ss_pred             --------------------------------------CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 --------------------------------------WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 --------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                            .+..+..+...+...++.+|+++.+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                                  11234556677788899999999998864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.65  E-value=2.8e-16  Score=123.23  Aligned_cols=173  Identities=20%  Similarity=0.267  Sum_probs=123.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+....-..+++..+..+... +.++.         ++|+.+++|++++|.++++ .....+++|++.
T Consensus        71 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~  141 (257)
T cd05116          71 MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK---------YLEETNFVHRDLAARNVLLVTQHYAKISDFGL  141 (257)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeecccchhhEEEcCCCeEEECCCcc
Confidence            467778888888765433222333344444443 55555         8899999999999999999 456789999998


Q ss_pred             cccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +..+.....    ......+..|++||.... ..++...|+||+|++++|+++ |..||.+....+....+-+....+.+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~  220 (257)
T cd05116         142 SKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP  220 (257)
T ss_pred             ccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence            877643221    111122357899998753 346789999999999999997 89999887666555555433333344


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..++..|+..++..||++++|..
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            556788899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.65  E-value=4.6e-16  Score=126.89  Aligned_cols=135  Identities=20%  Similarity=0.321  Sum_probs=101.5

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|+|++|.|+++. ....+++|||.++.+....   ......++..|++||.+.+ ..|+..+|+||+|+++|
T Consensus       189 ~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~  267 (338)
T cd05102         189 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLW  267 (338)
T ss_pred             HHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHH
Confidence            78999999999999999994 6778999999987653321   1112234467999999863 44789999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHh-hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQL-IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||++....+........ ...+.+...+..+..+...|+...+.+||++.+++.
T Consensus       268 el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         268 EIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9997 99999986654444343332 222233455667888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=5.9e-16  Score=130.25  Aligned_cols=160  Identities=28%  Similarity=0.379  Sum_probs=115.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      ..|+.|...|++-.-.+ -+..+++....|.+= +.|+.         ++|..++++||++.||+++ ..+++++.|||+
T Consensus       445 ~fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~---------fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQ---------FLHENGIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             EEEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHH---------HHHhcCceeeecchhheEEcccCcEEeccccc
Confidence            35667777776322111 112233445556554 77777         8999999999999999999 579999999999


Q ss_pred             ccccc-CCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEID-SNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +++.. ......+++||+-|+|||++.. ..|+..+|.||+|+++|||+.|..||+|++..+..-.|...-..-+..--.
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~  593 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK  593 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH
Confidence            99865 4456778999999999999984 559999999999999999999999999998888777765533322222222


Q ss_pred             chhhhhhhhccccC
Q 026720          207 LGIQLASNLNWKLP  220 (234)
Q Consensus       207 ~~~~~~~~~~~~~~  220 (234)
                      +++.-+.++..+.|
T Consensus       594 ea~~il~~ll~k~p  607 (694)
T KOG0694|consen  594 EAIAIMRRLLRKNP  607 (694)
T ss_pred             HHHHHHHHHhccCc
Confidence            34444444444443

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.64  E-value=3e-16  Score=127.27  Aligned_cols=167  Identities=25%  Similarity=0.335  Sum_probs=120.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.........+++..+..|... +.|+.         ++|..+++|++++|.|+++ .....+++|||.
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~  147 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF---------FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEEecCCCHHHeEECCCCcEEEccCCC
Confidence            478889999988776554444444444555444 66777         8899999999999999999 467789999998


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +..... ........+++.|+|||++.+ ..++..+|+||+|++++|+++|+.||.+....+....+.+..... +...+
T Consensus       148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s  225 (323)
T cd05616         148 CKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-PKSMS  225 (323)
T ss_pred             ceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCcCC
Confidence            875432 222334567889999999874 447899999999999999999999999887777666665533222 22344


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      .....+...+...++.+|++.
T Consensus       226 ~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         226 KEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHHHHHHHcccCHHhcCCC
Confidence            555556665666666666653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.64  E-value=1.5e-16  Score=129.07  Aligned_cols=173  Identities=24%  Similarity=0.265  Sum_probs=122.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+.+...--..+.+..+..+... +.|+.         ++|+.+++|+|++|+|+++ .....++.|||
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG  140 (323)
T cd05571          70 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG---------YLHSCDVVYRDLKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEeCCCCHHHEEECCCCCEEEeeCC
Confidence            3577888888888655432222333333334333 66666         8999999999999999999 46678999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .++..... .......+++.|+|||++.+ ..|+..+|+||+|++++|+++|..||.+.........+..... .-+...
T Consensus       141 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~p~~~  218 (323)
T cd05571         141 LCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTL  218 (323)
T ss_pred             CCcccccCCCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Confidence            88764322 12234567889999999864 4478999999999999999999999987765554444433222 223455


Q ss_pred             cchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      +..+..+...++..++.+|+     +..++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            66778888888888888888     6666654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.64  E-value=5.6e-17  Score=131.88  Aligned_cols=175  Identities=22%  Similarity=0.231  Sum_probs=124.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+.....-...+++..+..+... +.|+.         ++|..+++|++++|+|+++ .....+++|||
T Consensus        71 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~---------~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          71 LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE---------HLHKYDIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             EEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeccCCHHHeEECCCCCEEEecCC
Confidence            4677888988888765443333444444444443 77777         8999999999999999999 45678999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+...... .......++..|++||.+.+...++...|+||+|+++++|++|..||.+.........+............
T Consensus       142 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  221 (330)
T cd05586         142 LSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVL  221 (330)
T ss_pred             cCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            88764332 22334567889999999865555788999999999999999999999987665555555433233333345


Q ss_pred             cchhhhhhhhccccCCCCCc----cccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGV----NLLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~  232 (234)
                      +.....+...++..++.+|+    ++++++.
T Consensus       222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            56667777777777777886    4555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.64  E-value=3e-16  Score=127.10  Aligned_cols=167  Identities=25%  Similarity=0.267  Sum_probs=121.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.....--..+++..+..+... +.|+.         ++|..+++|++++|.|+++ .....+++|||.
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~---------~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~  142 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALM---------FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM  142 (320)
T ss_pred             EEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence            477788888888765443333343344444444 66777         8999999999999999999 466789999998


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +..... ........+++.|+|||++.+ ..++..+|+||+|++++++++|+.||.+....+....+..... ..+...+
T Consensus       143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~  220 (320)
T cd05590         143 CKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLS  220 (320)
T ss_pred             CeecCcCCCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCC
Confidence            876432 112234567889999999864 4478899999999999999999999998877666666654322 2223455


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..+..+...+...++.+|++.
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCC
Confidence            666777777777888888886

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.64  E-value=2.2e-16  Score=128.42  Aligned_cols=171  Identities=19%  Similarity=0.222  Sum_probs=123.3

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|++.+..+-....++..+..|... +.|+.         ++|..+++|++++|.|+++ .....+++|||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE---------YLHSKDIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecCCCHHHEEECCCCCEEEeecc
Confidence            3577778888888765443222333333334333 66676         8999999999999999999 46778999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      .+......  .....+++.|+|||++.+ ..++..+|+||+|++++++++|..||.+........++.+.. .+-+...+
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~  239 (329)
T PTZ00263        164 FAKKVPDR--TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFD  239 (329)
T ss_pred             CceEcCCC--cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCC
Confidence            98876442  223467888999999874 346889999999999999999999999877666655554421 12233455


Q ss_pred             chhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          207 LGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      ..+..+...++..++.+|++     +++++.
T Consensus       240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            66777888888888888875     566654

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.64  E-value=4.1e-16  Score=118.51  Aligned_cols=178  Identities=21%  Similarity=0.254  Sum_probs=129.2

Q ss_pred             HHHHHHHHHHhhcCChHHHHHHHHhhccC-ccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEe
Q 026720           46 AIGTALVEMYSKCGHVEKAFKVFNLMREK-NLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        46 ~~~~~li~~~~~~g~~~~a~~~~~~m~~~-~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      -+|-.||..++..|.+-+-..---.+.++ .....-.++.|.+         ++|...++|+|++|.|+++. ..-.++.
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVe---------ylHa~~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVE---------YLHARNIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHH---------HHHHhhhhhcccChhheeeccccceEEe
Confidence            35667888888888665432211111111 1112234466666         89988899999999999994 4567999


Q ss_pred             eccccccccCCCCCCCcccCccccccccccc-----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF-----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG  198 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~  198 (234)
                      |||.+.++...-.....+++|+|.|||.+..     .+.|+.-+|+|++|++++.++.|.+||--......+.-|.+.--
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            9999999988777888999999999999743     45689999999999999999999999976666666666666444


Q ss_pred             CCCCCCCc---chhhhhhhhccccCCCCCccccccCC
Q 026720          199 SPTKDSWP---LGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       199 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.....|.   +....++..+...++.+|++-.+.+.
T Consensus       246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            44444454   44445555566778888888877664

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=1.9e-15  Score=123.55  Aligned_cols=123  Identities=32%  Similarity=0.486  Sum_probs=101.1

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++.++++|.|.++ ..+++++.|||.|+.+......-++++++-|.|||++.... ....+|.||+|++++|++
T Consensus       535 YLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL  613 (732)
T KOG0614|consen  535 YLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELL  613 (732)
T ss_pred             HHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHH
Confidence            7899999999999999999 68999999999999998877778899999999999998444 468899999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHh---hCCCCCCCCcchhhhhhhhccccCC
Q 026720          176 SFGILFPGKSSADQIYKICQL---IGSPTKDSWPLGIQLASNLNWKLPQ  221 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  221 (234)
                      +|++||++.+....-..|.+.   +..|...+. .+.++...+|...|.
T Consensus       614 ~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k-~a~~Lik~LCr~~P~  661 (732)
T KOG0614|consen  614 TGSPPFSGVDPMKTYNLILKGIDKIEFPRRITK-TATDLIKKLCRDNPT  661 (732)
T ss_pred             cCCCCCCCCchHHHHHHHHhhhhhhhcccccch-hHHHHHHHHHhcCcH
Confidence            999999999877766666553   334433332 356666677776654

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.63  E-value=5.5e-16  Score=138.58  Aligned_cols=174  Identities=23%  Similarity=0.352  Sum_probs=128.9

Q ss_pred             HHHHHHhhcCChHHHHHHH----HhhccCccccHHHH-HHHHHhcCCchhhhHhhh-------cccccCCcCCCcEEeeC
Q 026720           50 ALVEMYSKCGHVEKAFKVF----NLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-------QGYFHRDLKPSNLLVSK  117 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~----~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-------~~~~~~~l~p~~~~~~~  117 (234)
                      .||..|+..|.+.+.+.-.    ..+++..+..|... +.|+.         ++|.       ..++|++++|.++++..
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALa---------YLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA---------YCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHhcccccccCCceeccCcHHHeEeec
Confidence            5788899999998766532    12333444444443 66666         7776       34899999999999842


Q ss_pred             ------------------CeeeEeeccccccccCCCCCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCC
Q 026720          118 ------------------GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFG  178 (234)
Q Consensus       118 ------------------~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~  178 (234)
                                        ..+++.|||.+..+..........+++.|+|||++.+. ..++..+|+||+||++|+|++|.
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                              23689999998876443333445788999999998542 34788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          179 ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       179 ~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .||........+...............+..+..++..++...+.+||++.+++.
T Consensus       241 ~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        241 TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999987777776665554333333455677888889999999999999998874

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.63  E-value=3e-16  Score=127.65  Aligned_cols=174  Identities=21%  Similarity=0.254  Sum_probs=120.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...--..+++..+..|.. ++.|+.         ++|+.+++|+|++|.|+++ .....+++|||.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~  151 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE---------HLHKLGIVYRDIKLENILLDSEGHVVLTDFGL  151 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence            47788898888876543322333334444543 366666         8999999999999999999 466789999999


Q ss_pred             cccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---DQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~---~~~~~i~~~~~~~~~  202 (234)
                      +.......  ......++..|++||++.+...++...|+||+|++++|+++|..||......   ....+.......+.+
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         152 SKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             CccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            87653322  1223567889999999875545788999999999999999999999754322   222221112222333


Q ss_pred             CCCcchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      ...+..+..+...++..++.+|+     +.+++++
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            44566777888888888888888     5556654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.63  E-value=4.8e-16  Score=126.13  Aligned_cols=167  Identities=25%  Similarity=0.329  Sum_probs=119.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+...-...++++....|... +.|+.         ++|..+++|++++|+|+++ ..+..++.|||.
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF---------FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM  147 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCHHHeEEcCCCCEEEeecCc
Confidence            477788888988766544334444455555544 67777         8999999999999999999 466789999998


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +..... ........+++.|++||++.+ ..++..+|+||+|++++++++|+.||.+....+....+.+.... -+...+
T Consensus       148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-~~~~~~  225 (324)
T cd05587         148 CKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLS  225 (324)
T ss_pred             ceecCCCCCceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCC
Confidence            775321 112233567889999999874 34788999999999999999999999988776666665543222 223344


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      .....+...++...+.+|++.
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         226 KEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHHHHHHHHhhcCHHHcCCC
Confidence            455556666666666677654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.63  E-value=5e-16  Score=125.59  Aligned_cols=172  Identities=22%  Similarity=0.238  Sum_probs=121.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.....--..++...+..|... +.|+.         ++|..+++|++++|.|+++ .....++.|||
T Consensus        71 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          71 LFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQ---------FLHSKGIIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             EEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCHHHeEECCCCCEEeCccC
Confidence            3578889998888765432122222333334333 66776         8999999999999999999 45678999999


Q ss_pred             ccccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+..... ........+++.|+|||++.+ ..++..+|+||+|++++|+++|..||.+.........+... ....+...
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~  219 (316)
T cd05620         142 MCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWI  219 (316)
T ss_pred             CCeecccCCCceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCC
Confidence            8875322 112234567889999999874 44788999999999999999999999987665554444322 22223345


Q ss_pred             cchhhhhhhhccccCCCCCcccc-ccC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLL-AVM  231 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~-~~~  231 (234)
                      +..+..+++.++..++.+|+++. ++.
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            66777788888888888898874 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.63  E-value=4e-16  Score=125.67  Aligned_cols=137  Identities=34%  Similarity=0.613  Sum_probs=106.2

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|+.+++|++++|.|+++ .....++.|||.+....... ......++..|.+||.+.+...++...|+||+|++++++
T Consensus       119 ~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el  198 (309)
T cd07872         119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM  198 (309)
T ss_pred             HHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            8899999999999999999 46678999999887643321 122345677899999987555678999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc-----------------------------chhhhhhhhccccCCCCCc
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSWP-----------------------------LGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~  225 (234)
                      ++|++||++....+....+.+..+.|....|+                             .....+...+...++.+|+
T Consensus       199 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  278 (309)
T cd07872         199 ASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI  278 (309)
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC
Confidence            99999999988888877777776665544432                             2333455566677888999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      +..+++.+
T Consensus       279 t~~e~l~h  286 (309)
T cd07872         279 SAEEAMKH  286 (309)
T ss_pred             CHHHHhcC
Confidence            99988764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.63  E-value=5.5e-16  Score=125.34  Aligned_cols=168  Identities=24%  Similarity=0.303  Sum_probs=122.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.....-...+++..+..|... +.|+.         ++|..+++|++++|+|+++ .....++.|||.
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~---------~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~  142 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQ---------FLHKKGIIYRDLKLDNVLLDKDGHIKIADFGM  142 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEEeCCCCHHHeEECCCCCEEEccCcC
Confidence            477888888888766543333444445555544 67777         8999999999999999999 467789999999


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +...... .......+++.|++||.+.+ ..++...|+||+|++++|+++|+.||.+.........+... ....+...+
T Consensus       143 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~  220 (316)
T cd05592         143 CKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWIS  220 (316)
T ss_pred             CeECCCCCCccccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Confidence            8764322 12234567889999999874 34789999999999999999999999988776665555432 122234455


Q ss_pred             chhhhhhhhccccCCCCCcccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                      ..+..+...++...+.+|++..
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCCh
Confidence            6677777778888888888764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.63  E-value=4.1e-16  Score=122.95  Aligned_cols=175  Identities=19%  Similarity=0.261  Sum_probs=127.6

Q ss_pred             HHHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           48 GTALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++|..|+..|.+++...... .++...+..|... +.|+.         ++|+.+++|++++|+++++ .+...++.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~---------~lH~~~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK---------YLSEMGYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeeccccHhhEEEcCCCcEEECC
Confidence            3568889999999987654321 2333333344333 55666         8899999999999999999 456778888


Q ss_pred             ccccccccCCCCCC--CcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          125 LGMVKEIDSNLPCT--DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      ++............  ....+..|.+||.+.+ ..++..+|+||+|++++|+++ |..||.+....+.+..+.+....|.
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~  229 (266)
T cd05064         151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA  229 (266)
T ss_pred             CcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence            88665432221111  1223457899998864 447889999999999999875 9999998877776666655555566


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..+...||...+.+||++++|++
T Consensus       230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            6777888888899999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.63  E-value=5.7e-16  Score=125.03  Aligned_cols=168  Identities=23%  Similarity=0.247  Sum_probs=120.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+.+...--..++...+..+... +.|+.         ++|..+++|++++|.|+++ .....+++|||
T Consensus        68 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg  138 (312)
T cd05585          68 LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALE---------NLHKFNVIYRDLKPENILLDYQGHIALCDFG  138 (312)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEeCCCCHHHeEECCCCcEEEEECc
Confidence            4577788888888765432222333333334333 56666         8899999999999999999 46778999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+....... ......+++.|++||++.+ ..++..+|+||+|++++++++|..||.+.........+.... ...+...
T Consensus       139 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~  216 (312)
T cd05585         139 LCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGF  216 (312)
T ss_pred             ccccCccCCCccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcC
Confidence            887543221 2234567889999999874 447899999999999999999999999877666555554322 2223445


Q ss_pred             cchhhhhhhhccccCCCCCccc
Q 026720          206 PLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      +..+..+...++..++.+|+++
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~  238 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGY  238 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCC
Confidence            6677788888888899999765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.63  E-value=2.9e-16  Score=128.20  Aligned_cols=171  Identities=21%  Similarity=0.165  Sum_probs=122.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+...--..+++..+..|... +.|+.         ++|+.+++|++++|.|+++ ..+..+++|||
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE---------YLQSLNIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEccCCCHHHEEECCCCCEEEecCC
Confidence            3578888998988776543323333334444444 66666         8899999999999999999 46778999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      .+..+...  .....+++.|+|||++.+ ..++..+|+||+|++++||++|..||.+........++.+..... +...+
T Consensus       177 ~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~~  252 (340)
T PTZ00426        177 FAKVVDTR--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF-PKFLD  252 (340)
T ss_pred             CCeecCCC--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCC
Confidence            98865432  234567889999999864 447889999999999999999999999887766666665543322 23445


Q ss_pred             chhhhhhhhccccCCCCCc-----cccccCC
Q 026720          207 LGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      .....+++.+....+.+|.     ++++++.
T Consensus       253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            5566666666666666663     6666654

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.63  E-value=5.8e-16  Score=125.34  Aligned_cols=168  Identities=26%  Similarity=0.338  Sum_probs=122.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+..-..-...+++..+..+... +.|+.         ++|+.+++|++++|.|+++ .....++.|||
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~---------~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          71 LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQ---------FLHERGIIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEccCCCHHHeEECCCCcEEecccC
Confidence            3577788888888655433223444444444444 66666         8899999999999999999 46678999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+...... .......++..|++||++.+ ..++...|+||+|++++++++|..||.+.........+..... ..+...
T Consensus       142 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~  219 (318)
T cd05570         142 MCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWL  219 (318)
T ss_pred             CCeecCcCCCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcC
Confidence            88653221 12233457788999999874 4478899999999999999999999998776665555543322 223456


Q ss_pred             cchhhhhhhhccccCCCCCccc
Q 026720          206 PLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      +..+..+++.++..++.+|++.
T Consensus       220 ~~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         220 SKEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             CHHHHHHHHHHccCCHHHcCCC
Confidence            6778888889999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.62  E-value=1.1e-16  Score=119.70  Aligned_cols=184  Identities=18%  Similarity=0.255  Sum_probs=129.0

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      ...|+..|.+.|++.+-.+...  .+.+.++=...+.-+...-++.++++-+.....|+|++|.|++++ +....+.|||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence            3456778889998777554321  134555555555555444455554444443489999999999995 5788999999


Q ss_pred             ccccccCCCC----------CCCcccCccccccccccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCC---ChHHHHH
Q 026720          127 MVKEIDSNLP----------CTDYVTTRWYRGPEVLLFSE--IYGPEVDKWAMGAIMFEMLSFGILFPGK---SSADQIY  191 (234)
Q Consensus       127 ~a~~~~~~~~----------~~~~~~~~~~~~pe~~~~~~--~~~~~~d~~s~g~~l~e~~~~~~~f~~~---~~~~~~~  191 (234)
                      .+.+......          .....++..|+|||.+.-..  ..+.++|+||+||++|+++.|..||.-.   +..-++.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            9887533211          11123566799999985322  2368999999999999999999999832   2222221


Q ss_pred             HHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          192 KICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       192 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      -.-.++..|....+++.+..+++.+...++.+||++.+++++
T Consensus       255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            122366778888899999999999999999999999998764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.62  E-value=4.4e-16  Score=126.29  Aligned_cols=172  Identities=24%  Similarity=0.284  Sum_probs=120.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.....--..+++..+..+.. ++.|+.         ++|..+++|+|++|+|+++ .....+++|||.
T Consensus        71 ~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  141 (323)
T cd05595          71 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE---------YLHSRDVVYRDIKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCHHHEEEcCCCCEEecccHH
Confidence            57788888888865432211222233333433 366666         8999999999999999999 466789999998


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +...... .......+++.|++||++.+ ..++..+|+||+|++++|+++|+.||.+.........+...-.. .+..++
T Consensus       142 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~p~~~~  219 (323)
T cd05595         142 CKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FPRTLS  219 (323)
T ss_pred             hccccCCCCccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCC
Confidence            7754321 12234567889999999864 44789999999999999999999999877666555554432222 233556


Q ss_pred             chhhhhhhhccccCCCCCc-----cccccCC
Q 026720          207 LGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      ..+..+...++...+.+|+     +..++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            6777787778877777776     5555543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.62  E-value=3.9e-16  Score=126.45  Aligned_cols=166  Identities=26%  Similarity=0.274  Sum_probs=119.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+.....-...+++..+..|... +.|+.         ++|+.+++|++++|+|+++ .....+++|||
T Consensus        71 ~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALM---------FLHRHGVIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHeEECCCCCEEEeecc
Confidence            3578888888888765443223333333334333 66666         8899999999999999999 46778999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+...... .......+++.|+|||++.+ ..|+..+|+||+|++++++++|+.||.+....+....+...... .+...
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-~p~~~  219 (321)
T cd05591         142 MCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-YPVWL  219 (321)
T ss_pred             cceecccCCccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Confidence            88754321 12234567888999999863 44788999999999999999999999988877776666553222 22334


Q ss_pred             cchhhhhhhhccccCCCCCc
Q 026720          206 PLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +..+..+...+...++.+|+
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~  239 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRL  239 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcC
Confidence            55666677777777888887

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.62  E-value=4.7e-16  Score=128.51  Aligned_cols=137  Identities=32%  Similarity=0.495  Sum_probs=105.3

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|.|+++ .....+++|||.+.......  ......+++.|++||.+.+...|+...|+||+||+++|
T Consensus       118 ~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e  197 (372)
T cd07853         118 YLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE  197 (372)
T ss_pred             HHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence            8899999999999999999 45678999999887643221  12234567889999998766668899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhCCCCCC-------------------------------CCcchhhhhhhhccccCCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIGSPTKD-------------------------------SWPLGIQLASNLNWKLPQM  222 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~  222 (234)
                      +++|+.||.+....+++..+.+..+.|...                               ..++....+...+...++.
T Consensus       198 l~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  277 (372)
T cd07853         198 LLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD  277 (372)
T ss_pred             HHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh
Confidence            999999999988888777776654433221                               1233444566667788999


Q ss_pred             CCccccccCCC
Q 026720          223 GGVNLLAVMPS  233 (234)
Q Consensus       223 ~~~~~~~~~~~  233 (234)
                      +|+++.+++.+
T Consensus       278 ~R~t~~e~l~h  288 (372)
T cd07853         278 KRISAADALAH  288 (372)
T ss_pred             hCcCHHHHhcC
Confidence            99999988764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.62  E-value=2.5e-16  Score=130.38  Aligned_cols=175  Identities=23%  Similarity=0.341  Sum_probs=118.5

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      +..+|..|+..|++.+...-...+++..+..|... +.|+.         ++|+.+++|++++|+|+++ .....++.||
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~---------~LH~~givHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE---------AVHKLGFIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHHHEEECCCCCEEEeec
Confidence            45678889999998876554444444444445444 67777         8999999999999999999 4677899999


Q ss_pred             cccccccCCCC------------------------------------------------CCCcccCcccccccccccccC
Q 026720          126 GMVKEIDSNLP------------------------------------------------CTDYVTTRWYRGPEVLLFSEI  157 (234)
Q Consensus       126 ~~a~~~~~~~~------------------------------------------------~~~~~~~~~~~~pe~~~~~~~  157 (234)
                      |.++.......                                                ....++++.|+|||++. ...
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~  224 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQG  224 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCC
Confidence            98864321000                                                00135788899999986 345


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---hCCCCCCCCcchhhhhhhhccccCCC--CCccccccCC
Q 026720          158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL---IGSPTKDSWPLGIQLASNLNWKLPQM--GGVNLLAVMP  232 (234)
Q Consensus       158 ~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  232 (234)
                      |+..+|+||+||+++|+++|.+||.+....+....+...   ...|+....+.....+...+...|+.  .|++..+++.
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~  304 (377)
T cd05629         225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKS  304 (377)
T ss_pred             CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhc
Confidence            789999999999999999999999987776666665542   22233333444444444333333332  2556666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.62  E-value=5.2e-16  Score=126.09  Aligned_cols=168  Identities=25%  Similarity=0.285  Sum_probs=118.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.....--..+++..+..|... +.|+.         ++|+.+++|++++|.|+++ .....+++|||.
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~---------~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN---------FLHERGIIYRDLKLDNVLLDADGHIKLTDYGM  142 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHEEEeCCCCEEEecccc
Confidence            578888998988765433233444444455444 66777         8999999999999999999 467789999998


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHhhCCC
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK------SSADQIYKICQLIGSP  200 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~------~~~~~~~~i~~~~~~~  200 (234)
                      +..... ........+++.|+|||++.+ ..++..+|+||+|++++++++|..||...      ...+...+.......+
T Consensus       143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (327)
T cd05617         143 CKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR  221 (327)
T ss_pred             ceeccCCCCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC
Confidence            875322 122334567889999999864 45788999999999999999999999632      2333333433332333


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccc
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      .+...+.....+...+...++.+|++.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            344555666777777777778888764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.62  E-value=5.3e-16  Score=126.14  Aligned_cols=168  Identities=24%  Similarity=0.284  Sum_probs=116.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.....--..+++..+..|... +.|+.         ++|..+++|++++|+|+++ .....+++|||
T Consensus        71 ~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          71 LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN---------FLHERGIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCHHHeEECCCCCEEECcCc
Confidence            3688889999988665433233444455555544 66777         8999999999999999999 46678999999


Q ss_pred             ccccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHhh
Q 026720          127 MVKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--------SADQIYKICQLI  197 (234)
Q Consensus       127 ~a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--------~~~~~~~i~~~~  197 (234)
                      .+..... ........++..|++||++.+ ..++..+|+||+|++++++++|+.||+..+        ..+...+.....
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  220 (329)
T cd05588         142 MCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK  220 (329)
T ss_pred             cccccccCCCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC
Confidence            8875322 112334567889999999874 457889999999999999999999996321        222232322222


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCcc
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (234)
                      ...-+...+..+..+.+.+....+.+|++
T Consensus       221 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~  249 (329)
T cd05588         221 QIRIPRSLSVKASSVLKGFLNKDPKERLG  249 (329)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            22223445556677777788888888876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.62  E-value=5.9e-16  Score=128.31  Aligned_cols=175  Identities=24%  Similarity=0.352  Sum_probs=119.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.++.+|+..|++.+...-...+++..+..|... +.|+.         ++|..+++|+|++|.|+++ .....++.|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~---------~LH~~givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIE---------SVHKMGFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeecCCcHHHEEECCCCCEEEeeCc
Confidence            4578889999998877654444444444444443 66666         8999999999999999999 46678999999


Q ss_pred             ccccccCCC------------------------------------------------CCCCcccCcccccccccccccCC
Q 026720          127 MVKEIDSNL------------------------------------------------PCTDYVTTRWYRGPEVLLFSEIY  158 (234)
Q Consensus       127 ~a~~~~~~~------------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~  158 (234)
                      .+..+....                                                .....++++.|+|||++.+ ..|
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~  225 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGY  225 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCC
Confidence            865321000                                                0113467889999999864 447


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC---CCCCCCCc-chhhhhhhhcc-ccCCCCCccccccCCC
Q 026720          159 GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG---SPTKDSWP-LGIQLASNLNW-KLPQMGGVNLLAVMPS  233 (234)
Q Consensus       159 ~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~---~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (234)
                      +..+|+||+||+++|+++|..||.+....+...++.....   .|.....+ +..+.+.+++. ...+..|+++++++.+
T Consensus       226 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             CCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            8999999999999999999999998877666666654222   22222223 34444445433 3334458888887653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.62  E-value=1.1e-15  Score=121.38  Aligned_cols=137  Identities=36%  Similarity=0.677  Sum_probs=106.8

Q ss_pred             HhhhcccccCCcCCCcEEeeCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh
Q 026720           97 SLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS  176 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~  176 (234)
                      ++|..+++|++++|+++.+.....++.++|.+..+..........++..|.+||.......++...|+||+|++++|+++
T Consensus       115 ~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~  194 (282)
T cd07831         115 HMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS  194 (282)
T ss_pred             HHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence            88999999999999999996578899999998877654444445667889999987544556889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHhhCCCCC----------------------------CCCcchhhhhhhhccccCCCCCcccc
Q 026720          177 FGILFPGKSSADQIYKICQLIGSPTK----------------------------DSWPLGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       177 ~~~~f~~~~~~~~~~~i~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                      |.+||++....+....+.+..+.+..                            ...+..+..++..++...+.+|++++
T Consensus       195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  274 (282)
T cd07831         195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK  274 (282)
T ss_pred             CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence            99999988776666555544433222                            12245666677778888999999999


Q ss_pred             ccCCC
Q 026720          229 AVMPS  233 (234)
Q Consensus       229 ~~~~~  233 (234)
                      +++.+
T Consensus       275 ~~l~~  279 (282)
T cd07831         275 QALRH  279 (282)
T ss_pred             HHhhC
Confidence            98864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.62  E-value=1.9e-16  Score=141.06  Aligned_cols=176  Identities=21%  Similarity=0.287  Sum_probs=132.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+.+.||+.|.+.+..+.-...++--..-|+.+ +.|.+         ++|.++++|++++|.|+++ ..+..+++|||
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla---------~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLA---------YLHEHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHH---------HHHhcCceecCCCccceeeecCCcEEeeccc
Confidence            3578899999999998776433333333455555 88999         9999999999999999999 46789999999


Q ss_pred             ccccccCCC-----CCCCcccCccccccccccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhhC
Q 026720          127 MVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSE--IYGPEVDKWAMGAIMFEMLSFGILFPGK-SSADQIYKICQLIG  198 (234)
Q Consensus       127 ~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~--~~~~~~d~~s~g~~l~e~~~~~~~f~~~-~~~~~~~~i~~~~~  198 (234)
                      .|..+....     ......|++.|+|||++++..  ....+.|+||+||++.||++|+.|+... ..|.+-+++-....
T Consensus      1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK 1459 (1509)
T ss_pred             ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC
Confidence            999876542     134578999999999998644  2457889999999999999999999964 56777777754433


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+-+..-+.+=..+..-|...++.+|-+..+++++
T Consensus      1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            33344444444445666888888888766556543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.2e-15  Score=135.55  Aligned_cols=180  Identities=18%  Similarity=0.267  Sum_probs=139.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhc-cCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMR-EKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~-~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|+|..-++--+.-+ .+...+---+|....+..++.+  +|.+...+|+|+...|.++ ....++++|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~--YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMN--YLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhH--HHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            57789999999987655321111 1233444455555555555555  7777778999999999999 467889999999


Q ss_pred             cccccCCCCC--CCc-ccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          128 VKEIDSNLPC--TDY-VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       128 a~~~~~~~~~--~~~-~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      |+.+...-..  .+. .....|++||.+.. ..|++++|+||+|+++||+++ |..||++..+.+...-+.+...-+.+.
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~  927 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS  927 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence            9976553211  111 23346899999974 568999999999999999997 669999999999998888877778889


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+++.+=.++.-||+..+.+|++|..|++
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            99999999999999999999999999875

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.62  E-value=4.7e-16  Score=126.41  Aligned_cols=173  Identities=23%  Similarity=0.272  Sum_probs=119.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+.....--..+.+..+..+.. ++.|+.         ++|..+++|++++|.|+++ .....+++|||
T Consensus        70 ~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDikp~NIll~~~~~~kL~DfG  140 (328)
T cd05593          70 LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD---------YLHSGKIVYRDLKLENLMLDKDGHIKITDFG  140 (328)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEecccCHHHeEECCCCcEEEecCc
Confidence            357788888888865543222233333333433 366666         8999999999999999999 46678999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+...... .......+++.|++||++.+ ..++...|+||+|++++++++|+.||.+.........+... ..+-+...
T Consensus       141 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~  218 (328)
T cd05593         141 LCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTL  218 (328)
T ss_pred             CCccCCCcccccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCCCC
Confidence            88764321 12233567889999999864 44789999999999999999999999887665554444322 11223345


Q ss_pred             cchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      +..+..+.+.+...++.+|+     ++.+++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            55666677767777777775     6666654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.62  E-value=4.6e-16  Score=128.18  Aligned_cols=173  Identities=25%  Similarity=0.340  Sum_probs=118.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.+|..|+..|++.+...--..+++..+..|... +.|+.         ++|+.+++|++++|.|+++ ..+..++.|||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAID---------SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeccCCHHHeEECCCCCEEEeecc
Confidence            4577788888888776543223344445555544 67777         8999999999999999999 46778999999


Q ss_pred             ccccccCCC---------------------------------------CCCCcccCcccccccccccccCCCCcchHHHH
Q 026720          127 MVKEIDSNL---------------------------------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAM  167 (234)
Q Consensus       127 ~a~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~  167 (234)
                      .+..+....                                       .....++++.|+|||++.. ..|+..+|+||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  225 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSL  225 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecc
Confidence            887543211                                       0012357889999999863 447899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHhh---CCCCCCCCcchhhhhhhhccccCCCCCcc---ccccCC
Q 026720          168 GAIMFEMLSFGILFPGKSSADQIYKICQLI---GSPTKDSWPLGIQLASNLNWKLPQMGGVN---LLAVMP  232 (234)
Q Consensus       168 g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (234)
                      ||+++|+++|..||.+....+...++.+..   ..|....++.....++..+.. .+.+|++   +++++.
T Consensus       226 G~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         226 GVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999999999999999887776666555422   223333444455555443333 4556665   666554

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.62  E-value=1.9e-15  Score=122.09  Aligned_cols=137  Identities=31%  Similarity=0.536  Sum_probs=103.1

Q ss_pred             HhhhcccccCCcCCCcEEee-----CCeeeEeeccccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAM  167 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-----~~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~  167 (234)
                      ++|+.+++|+|++|.|+++.     ....+++|||.+.......    ......+++.|+|||++.+...|+..+|+||+
T Consensus       123 ~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  202 (317)
T cd07868         123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI  202 (317)
T ss_pred             HHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence            88999999999999999982     3468999999987654322    12345678889999998766668899999999


Q ss_pred             HHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhhCCCCCCCCcc-------------------------------
Q 026720          168 GAIMFEMLSFGILFPGKS---------SADQIYKICQLIGSPTKDSWPL-------------------------------  207 (234)
Q Consensus       168 g~~l~e~~~~~~~f~~~~---------~~~~~~~i~~~~~~~~~~~~~~-------------------------------  207 (234)
                      |++++++++|++||.+..         ..+++.++++.++.|....|+.                               
T Consensus       203 G~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (317)
T cd07868         203 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH  282 (317)
T ss_pred             HHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhc
Confidence            999999999999997543         2456666777666655444432                               


Q ss_pred             ------hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 ------GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ------~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                            ....+...+...++.+|+|+++++++
T Consensus       283 ~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         283 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  12234555667789999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.61  E-value=2.5e-15  Score=119.34  Aligned_cols=137  Identities=46%  Similarity=0.830  Sum_probs=110.2

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..++.|++++|+++++. ....++.+++.+.............++..|.+||.+.....++...|+||+|+++++++
T Consensus       114 ~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~  193 (283)
T cd07830         114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY  193 (283)
T ss_pred             HHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHH
Confidence            78888999999999999994 57789999999887765434444566778999998865555788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCCCCc-----------------------------chhhhhhhhccccCCCCCcc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKDSWP-----------------------------LGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~  226 (234)
                      +|+++|++....+...++....+.+....|.                             ..+..+.+.|+..++.+|++
T Consensus       194 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt  273 (283)
T cd07830         194 TLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT  273 (283)
T ss_pred             hCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence            9999999998888888877766665543332                             34556677788999999999


Q ss_pred             ccccCCC
Q 026720          227 LLAVMPS  233 (234)
Q Consensus       227 ~~~~~~~  233 (234)
                      +++++..
T Consensus       274 ~~ei~~~  280 (283)
T cd07830         274 ASQALQH  280 (283)
T ss_pred             HHHHhhC
Confidence            9998764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.61  E-value=2.8e-15  Score=119.41  Aligned_cols=136  Identities=38%  Similarity=0.600  Sum_probs=107.6

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|+.+++|++++|+|+++ .....++.|||.+.............++..|++||++.+ ..++..+|+||+|+++++++
T Consensus       123 ~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~  201 (288)
T cd07863         123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMF  201 (288)
T ss_pred             HHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHH
Confidence            8899999999999999999 466789999998877654333344566788999999864 34789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCCCCc--------------------------chhhhhhhhccccCCCCCccccc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKDSWP--------------------------LGIQLASNLNWKLPQMGGVNLLA  229 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~  229 (234)
                      +|.++|.+....+.+.++....+.+....|+                          +....+...+...++.+|+++.+
T Consensus       202 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~  281 (288)
T cd07863         202 RRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR  281 (288)
T ss_pred             hCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence            9999999988888888888877655544443                          23345556667778999999998


Q ss_pred             cCCC
Q 026720          230 VMPS  233 (234)
Q Consensus       230 ~~~~  233 (234)
                      ++.+
T Consensus       282 ~l~h  285 (288)
T cd07863         282 ALQH  285 (288)
T ss_pred             HhcC
Confidence            8764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.61  E-value=9.8e-16  Score=126.53  Aligned_cols=175  Identities=25%  Similarity=0.351  Sum_probs=120.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.+...-. .+++..+..|.. ++.|+.         ++|+.+++|++++|.|+++ ..+..+++|||
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALD---------AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHEEEcCCCCEEEEecc
Confidence            45788899999887764321 123333333433 366666         8999999999999999999 46788999999


Q ss_pred             ccccccCCC--CCCCcccCccccccccccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh---C
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSE---IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI---G  198 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~---~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~---~  198 (234)
                      .+.......  ......+++.|+|||++....   .++..+|+||+|++++|+++|+.||.+........++....   .
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  267 (370)
T cd05596         188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT  267 (370)
T ss_pred             ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC
Confidence            988764321  223456888999999985422   36789999999999999999999999887766666665432   2


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCC--CccccccCCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMG--GVNLLAVMPS  233 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  233 (234)
                      .|+....+.....++..+...++..  |+++++++++
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            2333334455555554444333333  7888888653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.61  E-value=2e-16  Score=124.30  Aligned_cols=173  Identities=24%  Similarity=0.359  Sum_probs=123.4

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|.+.+...-.  ..++......|... +.|+.         ++|+..++|+++.|.++++. ....+++++
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~---------~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f  147 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALS---------YLHSNNIIHGNLSPSNILLDSNGQVKLSDF  147 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHH---------HHHHTTEEEST-SGGGEEEETTTEEEEEST
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---------cccccccccccccccccccccccccccccc
Confidence            5677889989888875543  22222233333333 55555         78888899999999999995 678899999


Q ss_pred             cccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          126 GMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       126 ~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +.........   ..........|.+||.+.... ++...|+||+|+++||+++ ++.||.+....+...++.+....+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~  226 (259)
T PF07714_consen  148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI  226 (259)
T ss_dssp             TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS
T ss_pred             cccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccee
Confidence            9888762211   112233455688999986443 7899999999999999999 6799998877777777755555555


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..+...||...+.+||+|.+++.
T Consensus       227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            6778889999999999999999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.61  E-value=1.1e-15  Score=123.58  Aligned_cols=171  Identities=24%  Similarity=0.280  Sum_probs=120.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.+..+--..++.+.+..|... +.|+.         ++|+.+++|++++|+|+++ .....+++|||
T Consensus        71 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~---------~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          71 LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQ---------FLHSKGIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEeCCCCHHHEEECCCCCEEEccCC
Confidence            3477888988988766543222333333334333 66666         8899999999999999999 45678999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+...... .......++..|++||++.+ ..++..+|+||+|++++|+++|+.||.+....+....+... ....+..+
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~  219 (316)
T cd05619         142 MCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPCYPRWL  219 (316)
T ss_pred             cceECCCCCCceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCccC
Confidence            88754221 12234567888999999864 44789999999999999999999999987765555444322 22223345


Q ss_pred             cchhhhhhhhccccCCCCCcccc-cc
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLL-AV  230 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~-~~  230 (234)
                      +..+..+...++...+.+|+++. ++
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l  245 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDI  245 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHH
Confidence            66677777778888888888886 44

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.61  E-value=2.3e-15  Score=117.71  Aligned_cols=174  Identities=25%  Similarity=0.374  Sum_probs=130.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...-..  .+++..+..+.. ++.++.         ++|+.++.|++++|.++++.  ....++.+
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lh~~~i~h~dl~~~nil~~~~~~~~~l~d  145 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH---------HVHTKLILHRDLKTQNILLDKHKMVVKIGD  145 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence            46666777788776654321  122233333333 366666         88988999999999999994  34678999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      ++.+.............++..|++||...+ ..++...|+||+|++++++++|+.||.+........++......+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd08220         146 FGISKILSSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR  224 (256)
T ss_pred             CCCceecCCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCC
Confidence            999887765444444567788999999864 3467889999999999999999999998877776666665544445556


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+..+...|+..++.+|+++++++.+
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            77788888899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.61  E-value=8.7e-16  Score=122.03  Aligned_cols=135  Identities=22%  Similarity=0.310  Sum_probs=106.4

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..++.|++++|.|+++ .....++.+||.+.......   ......++..|+|||.... ..++...|+||+|++++
T Consensus       139 ~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~  217 (283)
T cd05048         139 YLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLW  217 (283)
T ss_pred             HHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHH
Confidence            7888899999999999999 45678999999887654321   1122344567999998764 34788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||.+....+....+......+.+...+..+..+...||...+.+|+++.+|++
T Consensus       218 el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~  278 (283)
T cd05048         218 EIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHT  278 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9997 99999987776665555554444555677889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.61  E-value=1.9e-15  Score=120.14  Aligned_cols=175  Identities=29%  Similarity=0.474  Sum_probs=123.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.++........++...+..+... +.++.         ++|..+++|++++|.++++ .....++.++|.
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~---------~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN---------FCHKHNCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCceecCCChhhEEEcCCCcEEECcccc
Confidence            466677777777665433222333333444443 55665         8898899999999999999 467789999998


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC-------
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS-------  199 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~-------  199 (234)
                      +..+.... ......++..|.+||.+.+...++...|+||+|++++++++|++||++....+.+..+....+.       
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07847         147 ARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  226 (286)
T ss_pred             ceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            88765432 2233456678999999865556788999999999999999999999988877766554432211       


Q ss_pred             -------------CCC----------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 -------------PTK----------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 -------------~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                   |+.          ...+..+..+...|+..++.+|+++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                         111          1223445567777899999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.61  E-value=2.4e-16  Score=128.18  Aligned_cols=175  Identities=26%  Similarity=0.339  Sum_probs=125.4

Q ss_pred             HHHHHHHhhcCChHHHHHHH-HhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..+|..|+..|.+.+..+-. ..+++..+..|.. ++.|+.         ++|..+++|++++|.|+++ ..+..+++||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~---------~lH~~~i~H~Dlkp~NIll~~~~~~kL~Df  146 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH---------SVHQMGYVHRDIKPENVLIDRTGHIKLADF  146 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEcccCchHheEECCCCCEEeccC
Confidence            45788889899888765443 2233333333433 366666         8899999999999999999 4577899999


Q ss_pred             cccccccCCCC--CCCcccCccccccccccc-----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLF-----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG  198 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~-----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~  198 (234)
                      |.+..+.....  .....+++.|++||++..     ...++...|+||+|++++|+++|..||.+........++.....
T Consensus       147 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~  226 (330)
T cd05601         147 GSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR  226 (330)
T ss_pred             CCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence            99887643221  122357788999999853     23467899999999999999999999998877666666654322


Q ss_pred             ---CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 ---SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                         .|+....+..+..+.+.+.. .+.+|+++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence               23333456666777666666 77899999988764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.61  E-value=1.5e-15  Score=120.46  Aligned_cols=175  Identities=19%  Similarity=0.222  Sum_probs=121.5

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      +..+|..|+..|.+.....-...  .....+..+... +.|+.         ++|+.+++|++++|.|+++ .....++.
T Consensus        67 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~ivH~dikp~Nili~~~~~~~l~  137 (277)
T cd05607          67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGIL---------HLHSMDIVYRDMKPENVLLDDQGNCRLS  137 (277)
T ss_pred             eEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHH---------HHHHCCEEEccCChHhEEEcCCCCEEEe
Confidence            35688889988888765432211  111222333332 55555         8899999999999999999 45678999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC----C
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG----S  199 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~----~  199 (234)
                      |||.+.............++..|.+||++.+.. ++..+|+||+|++++++++|+.||.+.........+.+...    .
T Consensus       138 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  216 (277)
T cd05607         138 DLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK  216 (277)
T ss_pred             eceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc
Confidence            999887765433333446778899999987544 88999999999999999999999986533222222222211    1


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ......+..+..+...++..++.+|++..+++.
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            222356777888888899999999999976553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.61  E-value=1.5e-15  Score=120.95  Aligned_cols=174  Identities=22%  Similarity=0.265  Sum_probs=124.9

Q ss_pred             HHHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++..|+..|++.+.....  ..++++.+..+... +.|+.         ++|+.+++|++++|.|+++ ....+++.|
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~Nil~~~~~~~~l~D  145 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE---------DLHRERIVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcEecCCCHHHEEECCCCCEEEee
Confidence            56888899999987654321  12333344444443 66666         8999999999999999999 456789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC---CCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG---SPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~---~~~  201 (234)
                      ||.+.............++..|++||.+.. ..++...|+||+|++++++++|..||.+.........+.....   ...
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05605         146 LGLAVEIPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY  224 (285)
T ss_pred             CCCceecCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc
Confidence            998887644333334567788999999864 3478889999999999999999999998765443333322221   122


Q ss_pred             CCCCcchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      ....+..+..+...++..++.+|+     ++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            234567788888999999999999     6667754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.60  E-value=7.2e-16  Score=127.85  Aligned_cols=172  Identities=24%  Similarity=0.353  Sum_probs=115.3

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.+|..|+..|++.+...-...+++..+..|... +.|+.         ++|..+++|++++|+|+++ ..+..++.|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~---------~lH~~~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVE---------SVHKMGFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEECCCCCEEEeECC
Confidence            3678889999988776543222333334444443 66666         8899999999999999999 46778999999


Q ss_pred             ccccccCC------------------------------------------------CCCCCcccCcccccccccccccCC
Q 026720          127 MVKEIDSN------------------------------------------------LPCTDYVTTRWYRGPEVLLFSEIY  158 (234)
Q Consensus       127 ~a~~~~~~------------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~  158 (234)
                      .+..+...                                                ......++++.|+|||++.+ ..|
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~  225 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGY  225 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCC
Confidence            87532100                                                00112467888999999864 458


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC---CCCCCCC-cchhhhhhhhccccCCCCCcc---ccccC
Q 026720          159 GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG---SPTKDSW-PLGIQLASNLNWKLPQMGGVN---LLAVM  231 (234)
Q Consensus       159 ~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~  231 (234)
                      +..+|+||+||+++||++|.+||.+....+...++.....   .|..... ++..+.+.+++.  .+.+|++   +++++
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~--~p~~R~~~~~~~ei~  303 (382)
T cd05625         226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR--GPEDRLGKNGADEIK  303 (382)
T ss_pred             CCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc--CHhHcCCCCCHHHHh
Confidence            8999999999999999999999998877766666654322   2222222 334444555543  4455554   55554


Q ss_pred             C
Q 026720          232 P  232 (234)
Q Consensus       232 ~  232 (234)
                      .
T Consensus       304 ~  304 (382)
T cd05625         304 A  304 (382)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.60  E-value=8.9e-16  Score=127.99  Aligned_cols=171  Identities=25%  Similarity=0.322  Sum_probs=142.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhc--ccccCCcCCCcEEee--CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQ--GYFHRDLKPSNLLVS--KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~--~~~~~~l~p~~~~~~--~~~~~~~~  124 (234)
                      .+|.+++-+|.|..-++-+.++.-+-+..|..+ +.|+.         +||.+  .++|++++-||+.++  .+-.+++|
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~---------yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD  189 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLV---------YLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD  189 (632)
T ss_pred             eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhh---------hhhcCCCCccccccccceEEEcCCcCceeecc
Confidence            467889999999999998988887888999999 88988         88854  799999999999994  56789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +|+|.......... .+|||-++|||..-  .+|+.++|+||+|.+++||+++.-||+.+.+.-+.++-.-....|..-.
T Consensus       190 LGLAtl~r~s~aks-vIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  190 LGLATLLRKSHAKS-VIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS  266 (632)
T ss_pred             hhHHHHhhccccce-eccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence            99999876543333 79999999999874  7799999999999999999999999999999998888766555555422


Q ss_pred             C--cchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 W--PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .  .-..+.++..|... ...|++..+++.+
T Consensus       267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  267 KVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            2  23566777888877 8899999988865

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.60  E-value=1.3e-15  Score=123.64  Aligned_cols=172  Identities=24%  Similarity=0.293  Sum_probs=118.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...-...+.+..+..+.. ++.|+.         ++|+.+++|++++|.|+++ .....+++|||.
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE---------HLHQQGIIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHeEECCCCCEEEeeCcC
Confidence            46667777777755432211122222233333 356666         8899999999999999999 467789999998


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++...... ......+++.|++||.+.+ ..++..+|+||+|++++|+++|+.||.+........++..... .-+...+
T Consensus       147 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  224 (323)
T cd05584         147 CKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLT  224 (323)
T ss_pred             CeecccCCCcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Confidence            87543322 2234567889999999864 3467899999999999999999999998877766666654322 2223345


Q ss_pred             chhhhhhhhccccCCCCCc-----cccccCC
Q 026720          207 LGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      ..+..+.+.++...+.+|+     +.+++++
T Consensus       225 ~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         225 PEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            5667777778877777887     5555543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.60  E-value=1.1e-15  Score=124.33  Aligned_cols=169  Identities=25%  Similarity=0.291  Sum_probs=115.6

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.....--..+++..+..|... +.|+.         ++|..+++|++++|.|+++ .....+++|||
T Consensus        71 ~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~---------~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          71 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN---------YLHERGIIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeCCCCHHHEEECCCCCEEEeeCC
Confidence            3577888998988665432223333344444444 66666         8899999999999999999 46778999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHhh
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK--------SSADQIYKICQLI  197 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~--------~~~~~~~~i~~~~  197 (234)
                      .+...... .......+++.|++||++.+ ..++..+|+||+|++++++++|+.||...        ...+...+.....
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~  220 (329)
T cd05618         142 MCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  220 (329)
T ss_pred             ccccccCCCCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC
Confidence            88764321 12334567889999999874 44788999999999999999999999632        1122222222221


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccc
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ...-+...+..+..+.+.++..++.+|++.
T Consensus       221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            222233445566677777888888888873

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.60  E-value=2.2e-15  Score=120.71  Aligned_cols=135  Identities=20%  Similarity=0.272  Sum_probs=103.0

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|+.+++|++++|+|+++ .+...++.+||.+..............+..|++||...+ ..++..+|+||+|++++||+
T Consensus       134 ~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~  212 (297)
T cd05089         134 YLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIV  212 (297)
T ss_pred             HHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHH
Confidence            8899999999999999999 456778999998765332111111122345899998864 34788999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          176 S-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       176 ~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      + |..||.+....+...++.+....+.+..++..+..+...|+...+.+|+++++++.
T Consensus       213 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  270 (297)
T cd05089         213 SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV  270 (297)
T ss_pred             cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7 99999887776666655554444445567778888999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.60  E-value=4.5e-15  Score=122.11  Aligned_cols=134  Identities=36%  Similarity=0.572  Sum_probs=103.4

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|+.+++|++++|.|+++ ..+..+++|||.+.............+++.|++||.+.+ ..++..+|+||+|+++++++
T Consensus       138 ~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~  216 (359)
T cd07876         138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELV  216 (359)
T ss_pred             HHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHH
Confidence            8999999999999999999 467889999999887654433444567888999999874 44788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      +|+.||.+....+....+.+..+.|....++.......++....|.....++.+++
T Consensus       217 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (359)
T cd07876         217 KGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELF  272 (359)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhc
Confidence            99999999988888888888888777655544433344444445555555554443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.60  E-value=1.4e-15  Score=125.63  Aligned_cols=175  Identities=25%  Similarity=0.361  Sum_probs=119.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.+|..|+..|++.+...-. .+++..+..+... +.|+.         ++|+.+++|++++|.|+++ .....+++|||
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALD---------AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHH---------HHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            45778889999887765321 2333333334433 66666         8899999999999999999 46778999999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccc---cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC---
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFS---EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG---  198 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~---~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~---  198 (234)
                      .+..+....  ......+++.|+|||++...   ..++..+|+||+|++++||++|..||.+........++.....   
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence            988764321  22345688999999998642   2378899999999999999999999998877666666654322   


Q ss_pred             CCCCCCCcchhhhhhhhccccCCC--CCccccccCCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQM--GGVNLLAVMPS  233 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  233 (234)
                      .|+....+.....++..+..-|+.  .|+++++++++
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            233334444555554443332322  36677776653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.60  E-value=5.8e-15  Score=120.69  Aligned_cols=148  Identities=32%  Similarity=0.536  Sum_probs=111.9

Q ss_pred             ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCccccccccc
Q 026720           75 NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL  152 (234)
Q Consensus        75 ~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~  152 (234)
                      .+..+... +.|+.         ++|..+++|++++|.|+++ .....++.|||.+......  .....+++.|++||++
T Consensus       119 ~~~~i~~qi~~aL~---------~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~  187 (343)
T cd07878         119 HVQFLIYQLLRGLK---------YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIM  187 (343)
T ss_pred             HHHHHHHHHHHHHH---------HHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHh
Confidence            33334333 66666         8899999999999999999 4667899999998876543  3345678899999998


Q ss_pred             ccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC----------------------------
Q 026720          153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS----------------------------  204 (234)
Q Consensus       153 ~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~----------------------------  204 (234)
                      .+...++..+|+||+|++++++++|..||++....+.+.++.+..+.+....                            
T Consensus       188 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (343)
T cd07878         188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF  267 (343)
T ss_pred             cCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhc
Confidence            7555688999999999999999999999998887777777766554433211                            


Q ss_pred             --CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 --WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        .+..+..+...+...++.+|+++.+++.+
T Consensus       268 ~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         268 RGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              12233455666778889999999988764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.60  E-value=4.2e-15  Score=122.50  Aligned_cols=133  Identities=37%  Similarity=0.596  Sum_probs=102.0

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|.|+++ .....+++|||.+.............+++.|+|||++.+ ..++..+|+||+|+++++++
T Consensus       141 ~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell  219 (364)
T cd07875         141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI  219 (364)
T ss_pred             HHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHH
Confidence            8899899999999999999 467789999999987654433344577889999999874 44788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      +|+.||++....+...++.+..+.|.+..++..-..........|.....+++.+
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (364)
T cd07875         220 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL  274 (364)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhh
Confidence            9999999999999888888888877665444333333334444555555444443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.60  E-value=1.2e-15  Score=126.00  Aligned_cols=175  Identities=26%  Similarity=0.362  Sum_probs=118.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.+|..|+..|++.+...-. .+++..+..|... +.|+.         ++|+.+++|++++|.|+++ .....+++|||
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~---------~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALD---------AIHSMGLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCHHHEEECCCCCEEEEecc
Confidence            45788889999988765422 2333333444443 66666         8899999999999999999 46788999999


Q ss_pred             ccccccCCC--CCCCcccCccccccccccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSE---IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--  199 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~---~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--  199 (234)
                      .+..+....  ......+++.|+|||++...+   .++..+|+||+|+++++|++|..||.+........++......  
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  267 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN  267 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC
Confidence            988764321  223456889999999986432   3678999999999999999999999988776666666543222  


Q ss_pred             -CCCCCCcchhhhhhhhccccCC--CCCccccccCCC
Q 026720          200 -PTKDSWPLGIQLASNLNWKLPQ--MGGVNLLAVMPS  233 (234)
Q Consensus       200 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  233 (234)
                       |.....+.....+...+...++  ..|+++++++++
T Consensus       268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             2222233334444333322222  236777777653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.60  E-value=1.7e-15  Score=124.26  Aligned_cols=175  Identities=27%  Similarity=0.304  Sum_probs=138.4

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C----Ceee
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K----GVIK  121 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~----~~~~  121 (234)
                      .-.+|.++|..|.+-+...-. ...+++......+ +.++.         ++|..+++|++++|+|+++. .    ...+
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~---------~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVK---------YLHSLGVVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHH---------HHHhCCceeccCCHHHeeeccccCCCCcEE
Confidence            346788888888877654332 2555666666555 66777         89999999999999999993 1    3689


Q ss_pred             EeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       122 ~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +.|||++......-.....++++.|+|||++.. ..|+..+|+||.|+++|.|+.|.+||.+.........|.+.--..+
T Consensus       180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~  258 (382)
T KOG0032|consen  180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT  258 (382)
T ss_pred             EeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC
Confidence            999999998877555677899999999999963 4589999999999999999999999999998888888877666677


Q ss_pred             CCCCcchhhhhh---hhccccCCCCCccccccCCC
Q 026720          202 KDSWPLGIQLAS---NLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...|+..-..+.   ......++..|.++.+++++
T Consensus       259 ~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  259 SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            777776554444   44556678999999887764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.60  E-value=4.9e-15  Score=122.51  Aligned_cols=135  Identities=21%  Similarity=0.350  Sum_probs=100.6

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.|+++. ....+++|||.+..+.....   ......+..|++||++.. ..++..+|+||+|++++
T Consensus       227 yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~  305 (374)
T cd05106         227 FLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLW  305 (374)
T ss_pred             HHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHH
Confidence            78888999999999999994 56789999999876543211   111223456999999853 44789999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhh-CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLI-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |+.||++........++.... ..+.+...+..+..++..|+...+.+||++++++.
T Consensus       306 ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         306 EIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9997 999998765544444444322 22223344677888889999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.60  E-value=1.1e-15  Score=123.99  Aligned_cols=168  Identities=24%  Similarity=0.257  Sum_probs=118.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|.+.+...--..+.+..+..+.. ++.|+.         ++|..+++|++++|.|+++ .....++.|||.
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~  142 (325)
T cd05602          72 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG---------YLHSLNIVYRDLKPENILLDSQGHIVLTDFGL  142 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCHHHeEECCCCCEEEccCCC
Confidence            56778888888876554322233333333333 367777         8999999999999999999 466789999998


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +...... .......+++.|++||++.+ ..++..+|+||+|+++++|++|..||.+....+....+........ ...+
T Consensus       143 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~  220 (325)
T cd05602         143 CKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK-PNIT  220 (325)
T ss_pred             CcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC-CCCC
Confidence            8764321 12334567889999999874 4578899999999999999999999998777666555554322222 2345


Q ss_pred             chhhhhhhhccccCCCCCcccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                      ..+..+...+....+.+|++..
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAK  242 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCC
Confidence            5666666666666777777655

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.60  E-value=3.4e-15  Score=121.53  Aligned_cols=172  Identities=26%  Similarity=0.359  Sum_probs=121.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhc-ccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|++.+...-...+++..+..+.. ++.|+.         ++|.. +++|++++|.|+++ .....++.|||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA---------YLREKHQIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHhhcCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence            57788899899987654333233333333333 355665         78864 48999999999999 45678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh----------
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL----------  196 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~----------  196 (234)
                      .+..+.... .....++..|++||++.+ ..++...|+||+|++++|+++|+.||++....+. ..+...          
T Consensus       150 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  226 (331)
T cd06649         150 VSGQLIDSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIFGRPVVDGEEGEP  226 (331)
T ss_pred             ccccccccc-cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccccCCc
Confidence            987764432 234567889999999874 4478999999999999999999999986544332 111110          


Q ss_pred             ---------------------------------hC---CC--CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          197 ---------------------------------IG---SP--TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       197 ---------------------------------~~---~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                       +.   .+  +....+..+..++..|+...+.+|+++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                             00   00  112345667788889999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.60  E-value=4.1e-16  Score=129.23  Aligned_cols=174  Identities=22%  Similarity=0.291  Sum_probs=141.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV  128 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a  128 (234)
                      .+|.++|.+|.+++..+-+     ++.++....+.-+.+++++.+  ++|+..++|||+-..|.++. ....+++|||++
T Consensus       237 ~ivmEl~~gGsL~~~L~k~-----~~~v~~~ek~~~~~~AA~Gl~--YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKN-----KKSLPTLEKLRFCYDAARGLE--YLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             EEEEEecCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHhHHH--HHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            5788999999999986543     335666666777777777776  79988899999999999995 467799999998


Q ss_pred             ccccCCCCCC-CcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH-HHhhCCCCCCCC
Q 026720          129 KEIDSNLPCT-DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKI-CQLIGSPTKDSW  205 (234)
Q Consensus       129 ~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i-~~~~~~~~~~~~  205 (234)
                      +.-....... .......|+|||.+.. ..|+.+.|+||+|+++||+.. |..||+|....+...+| .+....+.+..-
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence            8754221111 2233456899999974 479999999999999999997 77999999999999998 567777777788


Q ss_pred             cchhhhhhhhccccCCCCCccccccC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ++.+..++..||...+.+|++|.++.
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHH
Confidence            88999999999999999999998764

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.60  E-value=2.1e-15  Score=120.78  Aligned_cols=175  Identities=34%  Similarity=0.564  Sum_probs=125.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..+|..|+ .|++.+..+--. .++...+..+... +.|+.         ++|..++.|++++|+++++ ..+..+++++
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE---------YLHSNWILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeecCCChhhEEEcCCCCEEEccc
Confidence            35777788 777766543211 1222233334333 55555         8898899999999999999 4667899999


Q ss_pred             cccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +.+....... .......++.|.+||.+.+...++...|+||+|++++++++|.++|++....+...++++..+.|....
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (298)
T cd07841         147 GLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN  226 (298)
T ss_pred             eeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence            9887664421 122234566799999886555678899999999999999999999999988888888887766555444


Q ss_pred             Cc---------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WP---------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      |+                           +.+..+...++...+.+|+++.+++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            32                           334456677888899999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00284 protein kinase; Provisional

Probab=99.60  E-value=3.6e-15  Score=126.83  Aligned_cols=134  Identities=23%  Similarity=0.309  Sum_probs=99.3

Q ss_pred             Hhhh-cccccCCcCCCcEEeeC-C----------------eeeEeeccccccccCCCCCCCcccCcccccccccccccCC
Q 026720           97 SLHR-QGYFHRDLKPSNLLVSK-G----------------VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIY  158 (234)
Q Consensus        97 ~l~~-~~~~~~~l~p~~~~~~~-~----------------~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  158 (234)
                      ++|. .+++|+|++|.|+++.. .                ..+++|||.+.....  ......+++.|+|||++.+ ..|
T Consensus       246 yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~  322 (467)
T PTZ00284        246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG-LGW  322 (467)
T ss_pred             HHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc-CCC
Confidence            7886 48999999999999942 1                378999997754322  2234578889999999874 448


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC----------------------------------
Q 026720          159 GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS----------------------------------  204 (234)
Q Consensus       159 ~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~----------------------------------  204 (234)
                      +..+|+||+||++|||++|+.||++....+.+..+.+..+.++...                                  
T Consensus       323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
T PTZ00284        323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA  402 (467)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcc
Confidence            8999999999999999999999999888777766655544332110                                  


Q ss_pred             -------CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 -------WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                             ....+..++..+...++.+|++.++++.+
T Consensus       403 ~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        403 RPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             cchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence                   01123345566778889999999998764

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.60  E-value=2.7e-15  Score=118.95  Aligned_cols=174  Identities=22%  Similarity=0.317  Sum_probs=125.3

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh--------------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL--------------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~--------------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      ..++..|+..|.+.+..+-...              ++...+..+... +.++.         ++|..+++|++++|+++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~---------~lH~~~i~h~dlkp~ni  153 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV---------YLASQHFVHRDLATRNC  153 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHH---------HHhhCCeeccccccceE
Confidence            4566678888888776543210              111122222222 55555         78888999999999999


Q ss_pred             Ee-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 026720          114 LV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSAD  188 (234)
Q Consensus       114 ~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~  188 (234)
                      ++ .....++.+++.+..+.....   ......+..|+|||.+.+. .++..+|+||+|++++|+++ |..||.+....+
T Consensus       154 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             EEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99 467889999998876543211   1122335679999998743 47889999999999999998 999998877766


Q ss_pred             HHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          189 QIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       189 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....+......+.+..++..+..+...|+..++.+|+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66555544444455677888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=3e-15  Score=120.53  Aligned_cols=175  Identities=19%  Similarity=0.247  Sum_probs=131.5

Q ss_pred             HHHHHHhhcCChHHHHHH-H-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKV-F-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~-~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .+|..|+.+|++-+.++- | +.|.+.-+.+...- +.|+.         |+|..+.+||++++.++++ .++..++++|
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~---------YLH~~G~IHRdvKAgnILi~~dG~VkLadF  170 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALD---------YLHQNGHIHRDVKAGNILIDSDGTVKLADF  170 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHH---------HHHhcCceecccccccEEEcCCCcEEEcCc
Confidence            368889999988776442 2 22334333333333 66777         8999999999999999999 5789999999


Q ss_pred             cccccccCCC-----CCCCcccCccccccccc-ccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          126 GMVKEIDSNL-----PCTDYVTTRWYRGPEVL-LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       126 ~~a~~~~~~~-----~~~~~~~~~~~~~pe~~-~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      +....+...-     ....++++++|+|||++ .....|+.+.||||+|+...|+..|..||........+....+.-..
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp  250 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP  250 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence            8766554321     12567899999999994 33445999999999999999999999999988877776555443221


Q ss_pred             -C-----C---CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 -P-----T---KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 -~-----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       +     +   ...+++.+++++..|...++.+|+|.+++++.
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence             1     1   12455678889999999999999999999875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.60  E-value=5e-15  Score=118.54  Aligned_cols=135  Identities=16%  Similarity=0.086  Sum_probs=102.0

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC--------CCCCcccCcccccccccccccCCCCcchHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAM  167 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~  167 (234)
                      ++|+.+++|+|++|+|+++. ....+++|||.+..+....        ......+++.|++||+..+ ..++..+|+||+
T Consensus       141 ~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSl  219 (294)
T PHA02882        141 YIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESL  219 (294)
T ss_pred             HHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHH
Confidence            88998999999999999994 5667899999987653211        1122357888999998874 447899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHH-----HHhhC--CCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          168 GAIMFEMLSFGILFPGKSSADQIYKI-----CQLIG--SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       168 g~~l~e~~~~~~~f~~~~~~~~~~~i-----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |++++|+++|+.||.+..........     ...+.  .......++.+..+.+.|+...+.+||+++++..
T Consensus       220 G~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        220 GYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            99999999999999987543332221     12222  1223455678889999999999999999998764

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.59  E-value=3.1e-15  Score=117.80  Aligned_cols=176  Identities=23%  Similarity=0.375  Sum_probs=126.7

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      +..++..|+..+.+.+..+-...++...+..+... +.++.         ++|+.+++|++++|.++++ .....++.++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~---------~lH~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN---------YLHNRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHH---------HHHhcCcccccCCHHHEEEcCCCCEEeccc
Confidence            34567778888887776544333443333344333 55555         7888899999999999999 4567899999


Q ss_pred             cccccccCCCC-------CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 026720          126 GMVKEIDSNLP-------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG  198 (234)
Q Consensus       126 ~~a~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~  198 (234)
                      +.+..+.....       .....++..|++||...+. .++...|+||+|++++++++|..||.+........++.....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  229 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS  229 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC
Confidence            98877653211       1123456779999988643 467889999999999999999999998766555444444323


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+++.+..+++.++...+.+|+++.++++.
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            33345677888889999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.59  E-value=1.8e-15  Score=120.34  Aligned_cols=137  Identities=30%  Similarity=0.569  Sum_probs=102.9

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|..+++|++++|+|+++ .....++.|||.+........ .....++..|.+||.+.+...++...|+||+|++++++
T Consensus       114 ~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  193 (284)
T cd07839         114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL  193 (284)
T ss_pred             HHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHH
Confidence            8898899999999999999 466789999998876543221 12234567899999987655578899999999999999


Q ss_pred             HhCCCC-CCCCChHHHHHHHHHhhCCCCCCCC----------------------------cchhhhhhhhccccCCCCCc
Q 026720          175 LSFGIL-FPGKSSADQIYKICQLIGSPTKDSW----------------------------PLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       175 ~~~~~~-f~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~  225 (234)
                      ++|+.| |++....+.+..+++..+.++...|                            +.....+.+.++..++.+|+
T Consensus       194 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  273 (284)
T cd07839         194 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI  273 (284)
T ss_pred             HhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC
Confidence            998866 5666666666666666555443333                            23344567778888999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++.+
T Consensus       274 t~~~il~h  281 (284)
T cd07839         274 SAEEALQH  281 (284)
T ss_pred             CHHHHhcC
Confidence            99998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.59  E-value=2.5e-15  Score=119.50  Aligned_cols=174  Identities=31%  Similarity=0.512  Sum_probs=123.1

Q ss_pred             HHHHHHhhcCChHHHHHHHH---hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN---LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~---~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      .++..|+. |.+.+..+...   .++...+..+... +.|+.         ++|..+++|++++|+++++ .+...++.+
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~~i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL---------FCHSRRVLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHH---------HHHhCCeeecCCCHHHEEEcCCCcEEECc
Confidence            45666765 45544433221   1222333344443 66666         8899999999999999999 567789999


Q ss_pred             ccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          125 LGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       125 ~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +|.+........ .....++..|++||.+.+...++..+|+||+|++++++++|++||.+....+.+..+++..+.+...
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd07861         145 FGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED  224 (285)
T ss_pred             ccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            998876533211 1223456779999988655557889999999999999999999999988888877777666554433


Q ss_pred             CC----------------------------cchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SW----------------------------PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .|                            +.....++..++..++.+|+++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            33                            2334457777888899999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.59  E-value=2.6e-15  Score=117.49  Aligned_cols=175  Identities=22%  Similarity=0.334  Sum_probs=130.3

Q ss_pred             HHHHHHHhhcCChHHHHHHH---------HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C
Q 026720           49 TALVEMYSKCGHVEKAFKVF---------NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K  117 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~---------~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~  117 (234)
                      ..++..|+..|.+.+..+-.         ..+++..+..+... +.|+.         ++|..+++|++++|+++++. .
T Consensus        71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~---------~lH~~~i~H~di~p~nili~~~  141 (262)
T cd00192          71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME---------YLASKKFVHRDLAARNCLVGED  141 (262)
T ss_pred             eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH---------HHHcCCcccCccCcceEEECCC
Confidence            45777788888888765543         22333344444444 66777         89999999999999999994 5


Q ss_pred             CeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 026720          118 GVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKI  193 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i  193 (234)
                      ...++.+++.+.......   .......+..|.+||..... .++...|+||+|++++++++ |..||++....+....+
T Consensus       142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  220 (262)
T cd00192         142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL  220 (262)
T ss_pred             CcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            788999999888765431   12233456679999988643 57889999999999999998 58999988766666666


Q ss_pred             HHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          194 CQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ......+.+...+..+..+...++...+.+|+++++++..
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            5544444556667788888888999999999999998754

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.59  E-value=4.2e-15  Score=116.24  Aligned_cols=174  Identities=24%  Similarity=0.380  Sum_probs=125.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .++..|+..+.+.+..+-..  .++...+..+.. ++.++.         ++|..++.|++++|+++.+. ....++.+|
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~---------~lH~~~i~h~dl~~~nili~~~~~~~l~df  145 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---------HLHSKKILHRDIKSLNLFLDAYDNVKIGDL  145 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCcceEEEeCCCCEEEccc
Confidence            56667788888876544321  111112222222 345555         78888999999999999994 567899999


Q ss_pred             cccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +.+..+.... ......++..|.+||+.... .++...|+||+|++++++++|+.||..........++.+....+....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd08529         146 GVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM  224 (256)
T ss_pred             ccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            9887654322 12234566789999998643 478899999999999999999999998876666666655444444446


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...|+..++.+|+++.+++..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            67788889999999999999999998864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.59  E-value=3.8e-15  Score=118.31  Aligned_cols=172  Identities=17%  Similarity=0.293  Sum_probs=120.7

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++.+|+..|++.+...... .++.+.+..|... +.|+.         ++|..+++|++++|+|+++. ....++.|||
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY---------YLEEHRMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHHCCEeccccCcceEEEcCCCcEEEcCCc
Confidence            46778888888877654321 2233334444433 45555         88988899999999999994 5678999999


Q ss_pred             ccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhC-CCC
Q 026720          127 MVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIG-SPT  201 (234)
Q Consensus       127 ~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~-~~~  201 (234)
                      .++.+....   ......++..|++||...+ ..++...|+||+|+++||+++ |..||.+...... .++.+... .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~  232 (279)
T cd05111         155 VADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQ  232 (279)
T ss_pred             cceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCC
Confidence            987654321   1122334557999998864 347899999999999999998 8999987654433 33333222 233


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..+...||...+.+||+++++++
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         233 PQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4455666777888899999999999998864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.59  E-value=2.7e-15  Score=119.68  Aligned_cols=173  Identities=21%  Similarity=0.306  Sum_probs=123.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh-------------hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEE
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL-------------MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLL  114 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~-------------m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~  114 (234)
                      ..++..|+..|.+.+...-...             ++.+.+..+.. ++.++.         ++|..+++|++++|++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~---------~lH~~~i~H~dlkp~Nil  152 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMV---------YLASQHFVHRDLATRNCL  152 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeecccCcceEE
Confidence            4577778888888776542210             11122222322 255555         789999999999999999


Q ss_pred             e-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 026720          115 V-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQ  189 (234)
Q Consensus       115 ~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~  189 (234)
                      + .....++.+|+.+..+...-.   .....++..|++||.+.+ ..++...|+||+|+++++|++ |.+||.+....+.
T Consensus       153 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~  231 (288)
T cd05093         153 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  231 (288)
T ss_pred             EccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9 466789999998876543211   111233557999998863 457889999999999999998 8899988776666


Q ss_pred             HHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          190 IYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       190 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ...+.+....+.....+..+..+...|+...+.+|+++++++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         232 IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            655655443444456677888899999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.59  E-value=3.3e-15  Score=117.07  Aligned_cols=174  Identities=21%  Similarity=0.324  Sum_probs=124.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..|.+.+...-.. .++...+..+.. ++.|+.         ++|..++.|++++|+|+.+ .....++.++
T Consensus        74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME---------YLERNSFIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHH---------HHHHCCccccccCcceEEEcCCCeEEECCC
Confidence            357778888898876543211 111122222222 244444         7888899999999999999 4567899999


Q ss_pred             cccccccCCCCC--CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLPC--TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.+.........  .....+..|++||...+ ..++...|+||+|++++++++ |+.||.+....+.+.++.+....+.+
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~  223 (256)
T cd05114         145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP  223 (256)
T ss_pred             CCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence            988765432211  12233446899999863 347889999999999999999 89999988877777777665444455


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..+...||...+.+||++++++.
T Consensus       224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         224 KLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            566777888888999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.59  E-value=4.5e-15  Score=117.20  Aligned_cols=172  Identities=16%  Similarity=0.208  Sum_probs=122.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhc-cCccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMR-EKNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~-~~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~  120 (234)
                      .++..|+..|.+.+.... +... .+...++..+       +.|+.         ++|..+++|++++|+|+++. ....
T Consensus        82 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~  151 (272)
T cd05075          82 VVILPFMKHGDLHSFLLY-SRLGDCPQYLPTQMLVKFMTDIASGME---------YLSSKSFIHRDLAARNCMLNENMNV  151 (272)
T ss_pred             EEEEEeCCCCcHHHHHHH-hcccCCcccCCHHHHHHHHHHHHHHHH---------HHHHCCeeccccchhheEEcCCCCE
Confidence            567788888888765422 2211 1222333333       44444         78888999999999999994 5678


Q ss_pred             eEeeccccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 026720          121 KIGDLGMVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~  196 (234)
                      +++|||.+..+......   .....++.|.+||.... ..++...|+||+|++++|+++ |+.||++.........+.+.
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  230 (272)
T cd05075         152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG  230 (272)
T ss_pred             EECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            89999998876432211   11123456889998863 457889999999999999998 78999987766555545443


Q ss_pred             hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          197 IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+....++..+..+...|+..++.+|+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         231 NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            333445567778888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.59  E-value=1.3e-15  Score=123.48  Aligned_cols=167  Identities=23%  Similarity=0.264  Sum_probs=116.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.....--..+++..+..|... +.|+.         ++|..+++|++++|+|+++ .....++.|||.
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~givH~dikp~NIll~~~~~~kl~Dfg~  142 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG---------YLHSLNIIYRDLKPENILLDSQGHVVLTDFGL  142 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeCCCCHHHeEECCCCcEEEeccCC
Confidence            577888998888665432222333333334333 66666         8899999999999999999 467889999998


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +....... ......+++.|++||.+.+ ..++..+|+||+|++++++++|..||.+....+....+........ ...+
T Consensus       143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~  220 (323)
T cd05575         143 CKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK-PNIS  220 (323)
T ss_pred             CcccccCCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCC
Confidence            87643221 2233467888999999874 4478899999999999999999999998776665555554322222 2235


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..+..+.+.+...++.+|++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~  241 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGA  241 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCC
Confidence            566666666777777777765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.59  E-value=2.3e-15  Score=121.47  Aligned_cols=103  Identities=35%  Similarity=0.580  Sum_probs=92.3

Q ss_pred             cCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCccccccc
Q 026720           73 EKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPE  150 (234)
Q Consensus        73 ~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe  150 (234)
                      ++.++.|.+- +.|+-         ++|.+.++.+|++|.|+++ ..+.++++|+|+|..+....+..+-+++.+|+|||
T Consensus       286 e~ra~FYAAEi~cGLe---------hlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPE  356 (591)
T KOG0986|consen  286 EQRARFYAAEIICGLE---------HLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPE  356 (591)
T ss_pred             hHHHHHHHHHHHhhHH---------HHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHH
Confidence            4567788887 77888         9999999999999999999 57899999999999999888888789999999999


Q ss_pred             ccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 026720          151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS  185 (234)
Q Consensus       151 ~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~  185 (234)
                      ++. +..|+...|.||+||++|||+.|+.||....
T Consensus       357 vl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  357 VLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             HHc-CCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            998 4559999999999999999999999998654

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.59  E-value=3.8e-15  Score=120.82  Aligned_cols=166  Identities=27%  Similarity=0.356  Sum_probs=116.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.....-...++++.+..+... +.|+.         ++|..+++|++++|+|+++ .....+++|||.
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~---------~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~  147 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF---------FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHeEECCCCCEEEecccc
Confidence            577889998988776544344444455555444 66666         8899999999999999999 466789999998


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +...... .......+++.|+|||++.+ ..++..+|+||+|++++++++|..||.+.........+.+.-.. .+...+
T Consensus       148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-~p~~~~  225 (323)
T cd05615         148 CKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YPKSLS  225 (323)
T ss_pred             ccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCccCC
Confidence            8764321 12233457889999999864 44788999999999999999999999988776666655543222 122334


Q ss_pred             chhhhhhhhccccCCCCCcc
Q 026720          207 LGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~  226 (234)
                      .....+...+....+.+|++
T Consensus       226 ~~~~~li~~~l~~~p~~R~~  245 (323)
T cd05615         226 KEAVSICKGLMTKHPSKRLG  245 (323)
T ss_pred             HHHHHHHHHHcccCHhhCCC
Confidence            44455555555555566655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.59  E-value=4.3e-15  Score=120.07  Aligned_cols=172  Identities=17%  Similarity=0.299  Sum_probs=119.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+...-.. .++...+..|... +.|+.         ++|+.+++|++++|+|+++ .....+++|||
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~---------~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN---------YLEERRLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHH---------HHHhcCeeccccchhheEecCCCcEEEcccc
Confidence            47777888888876543211 1111222233322 45555         8899999999999999999 45678999999


Q ss_pred             ccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh-hCCCC
Q 026720          127 MVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQL-IGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~-~~~~~  201 (234)
                      .+..+......   .....+..|++||.+. ...++..+|+||+|+++||+++ |..||.+....+. ..+... ...|.
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~  232 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQ  232 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCC
Confidence            98876432111   1122345689999886 3457889999999999999997 8899987655443 344432 23344


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..++..||...+.+|+++.+++.
T Consensus       233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~  263 (316)
T cd05108         233 PPICTIDVYMIMVKCWMIDADSRPKFRELII  263 (316)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            4556677888889999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.58  E-value=1.9e-15  Score=122.46  Aligned_cols=167  Identities=23%  Similarity=0.232  Sum_probs=115.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.....--..+++..+..|... +.|+.         ++|..+++|+|++|.|+++ ..+..+++|||.
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  142 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG---------YLHSLNIIYRDLKPENILLDSQGHVVLTDFGL  142 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeccCCHHHeEECCCCCEEEccCCC
Confidence            467788888888654332222333334444443 66777         8899999999999999999 467889999998


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +..... ........+++.|++||.+.. ..++...|+||+|++++|+++|..||.+.........+...... .+...+
T Consensus       143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~  220 (321)
T cd05603         143 CKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ-LPGGKT  220 (321)
T ss_pred             CccCCCCCCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCC
Confidence            875322 112233567889999999863 44788999999999999999999999987665555444433221 122344


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..+..+...+...++.+|++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~  241 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGA  241 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCC
Confidence            556666666777777777654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.58  E-value=3.7e-15  Score=116.85  Aligned_cols=173  Identities=20%  Similarity=0.254  Sum_probs=122.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...--..+++..+..|... +.++.         ++|..++.|++++|.++++ .....++++|+.
T Consensus        71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lh~~~i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          71 MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMA---------YLESKHFVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHH---------HHhhcCeeccCcccceEEEcCCCcEEeccccc
Confidence            466667777777665432222223333344333 55555         8888889999999999999 466789999998


Q ss_pred             cccccCCCCCC-C---cccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNLPCT-D---YVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~~~-~---~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.......... .   ...+..|.+||...+ ..++...|+||+|++++++++ |..||......+....+......+.+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  220 (257)
T cd05060         142 SRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP  220 (257)
T ss_pred             cceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC
Confidence            88664322111 0   111235899998863 447889999999999999997 89999877665555445444334555


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..++..|+..++.+||++.+++.
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            677788889999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.58  E-value=2.8e-15  Score=121.64  Aligned_cols=166  Identities=23%  Similarity=0.302  Sum_probs=118.2

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.....- ..+.++.+..|... +.|+.         ++|+.+++|++++|.|+++ .....+++|||
T Consensus        77 ~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~---------~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQ---------YLHENKIVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHH---------HHHhCCeEecCCCHHHeEECCCCcEEeCccc
Confidence            3577788888887654321 12233333444443 56666         8899999999999999999 46788999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+...... .......+++.|++||.+.+ ..++...|+||+|++++++++|+.||.+....+....+...... .+...
T Consensus       147 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-~p~~~  224 (324)
T cd05589         147 LCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFL  224 (324)
T ss_pred             CCccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCC
Confidence            87754321 12234567889999999874 45788999999999999999999999988777666665543222 22345


Q ss_pred             cchhhhhhhhccccCCCCCcc
Q 026720          206 PLGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~  226 (234)
                      +..+..+...++...+.+|++
T Consensus       225 ~~~~~~li~~~L~~dP~~R~~  245 (324)
T cd05589         225 SREAISIMRRLLRRNPERRLG  245 (324)
T ss_pred             CHHHHHHHHHHhhcCHhHcCC
Confidence            566667777778777888873

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.58  E-value=5.5e-15  Score=118.11  Aligned_cols=176  Identities=32%  Similarity=0.520  Sum_probs=125.1

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      +..++..|+. +.+.+....... +....+..+... +.|+.         ++|..+++|++++|.++++ .....++.+
T Consensus        80 ~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~i~H~dl~p~nili~~~~~~~l~d  149 (293)
T cd07843          80 KIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVA---------HLHDNWILHRDLKTSNLLLNNRGILKICD  149 (293)
T ss_pred             cEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeccCCHHHEEECCCCcEEEee
Confidence            3456667776 455554332111 222333334333 56666         8898899999999999999 457889999


Q ss_pred             ccccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          125 LGMVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       125 ~~~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +|.+...... .......++..|++||.+.+...++...|+||+|++++++++|.+||.+....+...+++...+.|...
T Consensus       150 ~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (293)
T cd07843         150 FGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK  229 (293)
T ss_pred             cCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence            9988876543 122334556779999998755556889999999999999999999999988887777776655543332


Q ss_pred             C-------------------------------CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 S-------------------------------WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .                               +++.+..+++.++...+.+|+++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2                               23445566777888899999999998864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.58  E-value=5.4e-16  Score=125.86  Aligned_cols=173  Identities=24%  Similarity=0.270  Sum_probs=119.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..+|..|+..|.+.....--..+++..+..+... +.|+.         ++|+ .+++|++++|+|+++ ..+..++.||
T Consensus        70 ~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------~lH~~~~ivHrDikp~NIll~~~~~~kL~Df  140 (325)
T cd05594          70 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD---------YLHSEKNVVYRDLKLENLMLDKDGHIKITDF  140 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhcCCEEecCCCCCeEEECCCCCEEEecC
Confidence            4578889998888654332222333333344333 56666         8886 679999999999999 4677899999


Q ss_pred             cccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.+...... .......+++.|+|||++.+ ..++..+|+||+|++++++++|..||.+.........+..... .-+..
T Consensus       141 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~-~~p~~  218 (325)
T cd05594         141 GLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRT  218 (325)
T ss_pred             CCCeecCCCCcccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-CCCCC
Confidence            988754321 22334567889999999864 4478999999999999999999999988766555444433221 22334


Q ss_pred             CcchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      .+..+..+...++..++.+|+     +..+++.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            556677777777777777775     6666654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.58  E-value=3.8e-15  Score=117.84  Aligned_cols=174  Identities=19%  Similarity=0.283  Sum_probs=122.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+....- .++...+..+... +.++.         ++|..++.|++++|+++.+ .....++.+++
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~---------~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLE---------YLHEEGKIHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCHHHEEECCCCCEEEcccc
Confidence            34666778888887664421 2222233333333 55555         7888889999999999999 46678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC-
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS-  204 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~-  204 (234)
                      .+..+.... ......++..|.+||...+.. ++...|+||+|++++++++|..||.+.........+-.......... 
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  222 (274)
T cd06609         144 VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNK  222 (274)
T ss_pred             cceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccc
Confidence            988775532 223345667799999987444 78999999999999999999999987654444433333222111222 


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+.+.|+..++.+|+++++++.+
T Consensus       223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         223 FSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            56678888888999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.58  E-value=3.9e-15  Score=118.62  Aligned_cols=174  Identities=21%  Similarity=0.309  Sum_probs=124.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++..|+..|++.+......  .++...+..|... +.|+.         ++|..+++|++++|+|+++ .....++.|
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~iiH~dikp~Nil~~~~~~~~l~D  145 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE---------DLHQERIVYRDLKPENILLDDHGHIRISD  145 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCEEeCCCCHHHEEECCCCCEEEee
Confidence            457788888888877553221  1333344455444 66777         8899999999999999999 456789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---ADQIYKICQLIGSPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~---~~~~~~i~~~~~~~~  201 (234)
                      ||.+.............++..|++||.+.. ..++...|+||+|++++++++|..||.+...   .+.............
T Consensus       146 fg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05630         146 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY  224 (285)
T ss_pred             ccceeecCCCccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhc
Confidence            998876544333333467888999999874 3478899999999999999999999987543   233333333333333


Q ss_pred             CCCCcchhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      ....+..+..+...++..++.+|++     ++++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            3455667788888899999999998     556654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.58  E-value=4.1e-15  Score=118.01  Aligned_cols=137  Identities=39%  Similarity=0.710  Sum_probs=109.6

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|..++.|++++|+++++. ....++.+++.+....... ......+...|.+||...+...++...|+||+|++++++
T Consensus       113 ~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l  192 (283)
T cd05118         113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAEL  192 (283)
T ss_pred             HHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHH
Confidence            88999999999999999994 5678999999887765533 222345667799999987554678899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc-----------------------------hhhhhhhhccccCCCCCc
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSWPL-----------------------------GIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~  225 (234)
                      ++|+.+|++....+...++.+..+.+....|..                             .+..++..|+..++.+|+
T Consensus       193 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  272 (283)
T cd05118         193 LSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI  272 (283)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc
Confidence            999999999988888888877766665544333                             444677889999999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++..
T Consensus       273 ~~~~ll~~  280 (283)
T cd05118         273 TAEQALAH  280 (283)
T ss_pred             CHHHHhhC
Confidence            99998764

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.58  E-value=8e-16  Score=127.31  Aligned_cols=174  Identities=22%  Similarity=0.319  Sum_probs=117.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.+|..|+..|++.+...-...+++..+..|.. ++.|+.         ++|..+++|++++|.|+++ .....+++|||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIE---------SVHKMGFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            356788999999888765433333333344443 367777         8999999999999999999 46778999999


Q ss_pred             ccccccC--------------------------------------------CCCCCCcccCcccccccccccccCCCCcc
Q 026720          127 MVKEIDS--------------------------------------------NLPCTDYVTTRWYRGPEVLLFSEIYGPEV  162 (234)
Q Consensus       127 ~a~~~~~--------------------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~  162 (234)
                      .+..+..                                            ........+++.|+|||++.+ ..++..+
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  225 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLC  225 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcce
Confidence            8743210                                            000112467889999999864 4478899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC---CCCCCCcchhhhhhhhccccCCCCCc---cccccCCC
Q 026720          163 DKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS---PTKDSWPLGIQLASNLNWKLPQMGGV---NLLAVMPS  233 (234)
Q Consensus       163 d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  233 (234)
                      |+||+||+++|+++|+.||.+....+....+......   |.....+.....+...... ++.+|+   ++++++++
T Consensus       226 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h  301 (376)
T cd05598         226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCC
Confidence            9999999999999999999988776665555432222   2222333333333322222 566676   77777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.58  E-value=5.3e-16  Score=125.51  Aligned_cols=167  Identities=24%  Similarity=0.312  Sum_probs=121.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+...--..+++..+..|... +.|+.         ++|..+++|++++|+|+++ .....+++|||.
T Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~  144 (318)
T cd05582          74 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD---------HLHSLGIIYRDLKPENILLDEEGHIKLTDFGL  144 (318)
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEecCCCCHHHeEECCCCcEEEeeccC
Confidence            477888888887665432222333444455444 66666         8899999999999999999 466789999998


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +...... .......+++.|++||.+.+ ..++...|+||+|++++|+++|+.||.+....+....+.+.... .+...+
T Consensus       145 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~-~p~~~~  222 (318)
T cd05582         145 SKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-MPQFLS  222 (318)
T ss_pred             CcccCCCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC-CCCCCC
Confidence            8765433 12234567888999999864 34688999999999999999999999988776666655543222 223455


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..+..+.+.++..++.+|++.
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a  243 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGA  243 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCC
Confidence            677778888888888999883

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.58  E-value=6.3e-15  Score=116.32  Aligned_cols=174  Identities=16%  Similarity=0.213  Sum_probs=122.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh------hccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL------MREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVI  120 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~------m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~  120 (234)
                      ..++..|+..|++.........      ++...+..+. .++.|+.         ++|+.+++|++++|+|+++. ....
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~---------~lH~~~i~H~dlkp~Nil~~~~~~~  152 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME---------YLSNRNFIHRDLAARNCMLREDMTV  152 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHH---------HHHhCCeeccccchheEEECCCCeE
Confidence            4566778888888876543211      1111222222 2355555         88998999999999999994 5578


Q ss_pred             eEeeccccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 026720          121 KIGDLGMVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~  196 (234)
                      ++++||.++........   .....+..|.+||... ...++..+|+||+|++++|+++ |..||.+....+....+...
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~  231 (273)
T cd05035         153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG  231 (273)
T ss_pred             EECCccceeeccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999998876543211   1112234688999875 3447889999999999999998 88999887776665555443


Q ss_pred             hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          197 IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+.+..++..+..+...|+...+.+|+++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333344566778888888899999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.58  E-value=3.6e-15  Score=116.93  Aligned_cols=175  Identities=20%  Similarity=0.303  Sum_probs=127.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..|.+.+...-.. .++...+..+... +.|+.         ++|..++.|++++|.++++ .+...+++++
T Consensus        74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA---------YLESKQFIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccccCcceEEEcCCCCEEECCC
Confidence            367788888888877643211 1222233333333 55566         7898899999999999999 4567899999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+..+.....  .....++..|.+||...+. .++...|+||+|++++++++ |..||......+...++.+....+.+
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05113         145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP  223 (256)
T ss_pred             ccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC
Confidence            98876543211  1112233568999998643 37889999999999999998 89999887776666666655444555


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+..+...||..++.+|+++.+++..
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            6677888899999999999999999998754

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.58  E-value=5.2e-15  Score=116.43  Aligned_cols=173  Identities=16%  Similarity=0.274  Sum_probs=122.1

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-..  .++...+..+... +.|+.         ++|..+++|++++|.++++ .....++.++
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~---------~lH~~~i~H~dlkp~nil~~~~~~~kl~df  148 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME---------YLEKKNFIHRDLAARNCLVGENHLVKVADF  148 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEeecccCcceEEEcCCCcEEeCCC
Confidence            46667777788877543211  1111222233333 56666         8899999999999999999 4677899999


Q ss_pred             cccccccCCCCC--CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLPC--TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+.........  .....+..|.+||...+ ..++...|+||+|++++|+++ |..||++....+....+......+.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (263)
T cd05052         149 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP  227 (263)
T ss_pred             ccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence            988765432111  11122446999998864 446888999999999999998 88999987665554444443344445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..+...|+..++.+||++.+++.
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            667788888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.58  E-value=3.9e-15  Score=119.50  Aligned_cols=137  Identities=31%  Similarity=0.597  Sum_probs=105.4

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|+.+++|++++|+|+++ .....++++||.+....... ......++..|.+||...+...++...|+||+|+++++|
T Consensus       119 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el  198 (301)
T cd07873         119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM  198 (301)
T ss_pred             HHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHH
Confidence            8899999999999999999 45678999999887654321 122334567899999986555578899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc-----------------------------chhhhhhhhccccCCCCCc
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSWP-----------------------------LGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~  225 (234)
                      ++|++||++....+....+.+..+.|....|+                             ..+..++..+...++.+|+
T Consensus       199 ~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~  278 (301)
T cd07873         199 STGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI  278 (301)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc
Confidence            99999999888777777777666655444443                             2334566667788899999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      +.++++.+
T Consensus       279 t~~eil~h  286 (301)
T cd07873         279 SAEEAMKH  286 (301)
T ss_pred             CHHHHhcC
Confidence            99998864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.57  E-value=4.2e-15  Score=116.71  Aligned_cols=174  Identities=21%  Similarity=0.342  Sum_probs=125.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++..|+..|.+.+...-..  ..+...+..|... +.|+.         ++|..+++|++++|.|+++ .....++.+
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~---------~LH~~~i~H~dl~p~nili~~~~~~~l~d  146 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA---------YIERKNYIHRDLRAANVLVSESLMCKIAD  146 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccccchhhEEecCCCcEEECC
Confidence            356777888888877643211  0111122233332 45555         7888889999999999999 456789999


Q ss_pred             ccccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          125 LGMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      |+.+........  ......+..|++||.... ..++...|+||+|++++++++ |..||++....+....+.+....+.
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05072         147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR  225 (261)
T ss_pred             CccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999887644221  122233456999998864 346788999999999999998 8999998877776666665555555


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....++.+..+...|+..++.+||+++++++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         226 MENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            5667788888999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.57  E-value=1.2e-14  Score=113.69  Aligned_cols=174  Identities=21%  Similarity=0.404  Sum_probs=123.3

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..+++.+...-.  ..++...+..+.. ++.++.         ++|+.+++|++++|+++++ .....++.+|
T Consensus        76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~---------~lH~~~i~H~di~p~nil~~~~~~~~l~df  146 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ---------YLHEKHILHRDLKTQNVFLTRTNIIKVGDL  146 (257)
T ss_pred             EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCchhEEEecCCcEEEecc
Confidence            4677788888876654321  0122222333322 355666         8899999999999999999 4567899999


Q ss_pred             cccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +.+......- ......+++.|++||...+ ..++...|+||+|++++++++|+.||++.........+......+.+..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (257)
T cd08223         147 GIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD  225 (257)
T ss_pred             cceEEecccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence            9887653321 1223456778999999864 3467889999999999999999999987766555555444332233345


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...++...+.+|+++.+++.+
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         226 YSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            66778888888999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.57  E-value=2.4e-15  Score=118.48  Aligned_cols=175  Identities=19%  Similarity=0.331  Sum_probs=122.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+.......++...+..+... +.|+.         ++|..++.|++++|.|+++. ....++.++|.
T Consensus        82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~  152 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA---------YLHSKGKMHRDIKGANILLTDNGDVKLADFGV  152 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCCHHHEEECCCCCEEECcCcc
Confidence            456777888888776543222333333344333 55555         88988999999999999994 56689999998


Q ss_pred             cccccCCCC-CCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC----C
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS----P  200 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~----~  200 (234)
                      +..+..... .....++..|++||.+..  ...++...|+||+|++++|+++|+.||.+....+....+......    +
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06646         153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK  232 (267)
T ss_pred             ceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCc
Confidence            887643221 223456778999998742  233677899999999999999999999765544333332221111    1


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +...|+..+..+.+.|+..++.+|+++++++..
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            224577788889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.57  E-value=7.4e-15  Score=115.34  Aligned_cols=174  Identities=21%  Similarity=0.327  Sum_probs=123.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...-...+++..+..|.. ++.|+.         ++|..+++|++++|.|+++ .....++.+||.
T Consensus        80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE---------YLHSNMIVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            45556777777776554332233222333333 366666         8899999999999999999 456789999998


Q ss_pred             cccccCCCCC----CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC-CCC
Q 026720          128 VKEIDSNLPC----TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS-PTK  202 (234)
Q Consensus       128 a~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~-~~~  202 (234)
                      +.........    ....++..|.+||...+. .++...|+||+|+++|++++|+.||.+........++...-.. +.+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP  229 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence            8765332111    223456789999998754 3788999999999999999999999877666555554333222 223


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+..++..++...+..|+++.++++.
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         230 SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            4556778888899999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.57  E-value=6.7e-15  Score=116.96  Aligned_cols=175  Identities=18%  Similarity=0.293  Sum_probs=124.5

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.....-.+ .+++..+..+... +.|+.         ++|+.++.|++++|.++++ .....+++++|
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~---------~LH~~~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN---------YLHENKIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecCCCcccEEEccCCCEEEcccc
Confidence            46667788787766432211 1222333333333 55555         8899899999999999998 45678999999


Q ss_pred             ccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--  199 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--  199 (234)
                      .+....... ......++..|++||.+..    ...++...|+||+|+++|++++|++||.+.........+......  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd06643         149 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL  228 (282)
T ss_pred             ccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC
Confidence            887654321 1223456778999998732    233677899999999999999999999987776666665443221  


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.+..++..+..++..|+..++.+|+++++++..
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2334577888999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.57  E-value=1.8e-16  Score=121.98  Aligned_cols=169  Identities=19%  Similarity=0.318  Sum_probs=126.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh-ccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM-REKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m-~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|.+||.+|++.+..++-+.- .+..+.+... -+.|+-         ++|...-+|++++..|++++ .+.+++.|||
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~---------YLH~~~KIHRDIKAGNILLNT~G~AKLADFG  174 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQ---------YLHDLKKIHRDIKAGNILLNTDGIAKLADFG  174 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHH---------HHHHHHHHHhhcccccEEEcccchhhhhhcc
Confidence            4789999999999998875442 2222222211 155555         66655468999999999994 7899999999


Q ss_pred             ccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC---
Q 026720          127 MVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK---  202 (234)
Q Consensus       127 ~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~---  202 (234)
                      .|.++...|. .++.+++++|+|||++. -..|++..|+||+|+...||..|++||.+....-.   ||-..-.|++   
T Consensus       175 VAGQLTDTMAKRNTVIGTPFWMAPEVI~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF~  250 (502)
T KOG0574|consen  175 VAGQLTDTMAKRNTVIGTPFWMAPEVIE-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTFK  250 (502)
T ss_pred             ccchhhhhHHhhCccccCcccccHHHHH-HhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCCC
Confidence            9999988874 56789999999999985 23489999999999999999999999987644433   5555555554   


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                        +-|+..+..+.+.|.--.+.+|.+.-.++
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~  281 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLC  281 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHh
Confidence              57888888888888766666666554444

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.57  E-value=1.3e-15  Score=126.65  Aligned_cols=175  Identities=19%  Similarity=0.295  Sum_probs=125.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ++|..+|+...|-.-.++-+     .-+-.|..|...-+..++..  |||...|+|+|++.+||.+ .++.++++|||++
T Consensus       463 AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~--YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMD--YLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             eeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhh--hhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence            45555555544443332211     22344555665555555555  8898889999999999999 4588999999987


Q ss_pred             cc---ccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhhCCCCC
Q 026720          129 KE---IDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY-KICQLIGSPTK  202 (234)
Q Consensus       129 ~~---~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~-~i~~~~~~~~~  202 (234)
                      ..   +...+......++..|+|||++..  ...|+..+|+||+|+++|||++|..||. ....++.+ .+=+....|+.
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccc
Confidence            64   233344455677888999999853  2248999999999999999999999999 44555443 34445455664


Q ss_pred             ----CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 ----DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                          ...+++..+|..-||+..+.+||.|..|+.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                466678888888899999999999998864

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.57  E-value=5.5e-15  Score=116.44  Aligned_cols=175  Identities=18%  Similarity=0.326  Sum_probs=123.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+.......+++..+..+... +.|+.         ++|..+++|++++|.++++ .....++.+||.
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY---------YLHSKGKMHRDIKGANILLTDNGHVKLADFGV  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEECCCCCEEECccee
Confidence            466778888888887654443443333333333 56666         8898899999999999999 456788999998


Q ss_pred             cccccCCCC-CCCcccCcccccccccc--cccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC----
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLL--FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP----  200 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~--~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~----  200 (234)
                      +........ .....++..|++||.+.  ....++..+|+||+|+++++++++..||.+................+    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd06645         153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK  232 (267)
T ss_pred             eeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence            876543221 23346778899999863  12346789999999999999999999987665444333332221111    


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +...|+..+..+...++...+.+|+++++++.+
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            123567778888888999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.57  E-value=5.1e-15  Score=119.22  Aligned_cols=174  Identities=32%  Similarity=0.510  Sum_probs=120.6

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+.. .+.+..... ..+....+..+... +.|+.         ++|..+++|++++|.++++ .....++.++|
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ---------YLHENFIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEECCCCCEEECccc
Confidence            466666653 343332211 11222333334333 56666         8899999999999999999 45678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+....... .......+..|.+||.+.+...++...|+||+|++++++++|.+||++....+.+..+.+..+.+....|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         154 LARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            888765421 1122234567999999865556789999999999999999999999998888888777776665544333


Q ss_pred             -----------------------------cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 -----------------------------PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                   +.....++..+...++.+|+++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                                         2223345666777888999999988764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.57  E-value=6.9e-15  Score=116.91  Aligned_cols=170  Identities=24%  Similarity=0.306  Sum_probs=118.6

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeE
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKI  122 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~  122 (234)
                      ..++..|+..|.+.........    ++++.+..+... +.|+.         ++|+.+++|++++|+|+++ .....++
T Consensus        68 ~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~Nili~~~~~~~l  138 (280)
T cd05608          68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE---------HLHQRRIIYRDLKPENVLLDNDGNVRI  138 (280)
T ss_pred             EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCCEEE
Confidence            4578889999998765432211    223333444443 66666         8999999999999999999 4567899


Q ss_pred             eeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC-
Q 026720          123 GDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP-  200 (234)
Q Consensus       123 ~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~-  200 (234)
                      .+||.+..+.... ......+++.|++||.+.+ ..++...|+||+|++++++++|+.||.+.........+.+..... 
T Consensus       139 ~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  217 (280)
T cd05608         139 SDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS  217 (280)
T ss_pred             eeCccceecCCCCccccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC
Confidence            9999887654322 1234567788999999874 447889999999999999999999998765433333333322221 


Q ss_pred             --CCCCCcchhhhhhhhccccCCCCCcccc
Q 026720          201 --TKDSWPLGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       201 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                        .+...+..+..+...++..++.+|++++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  247 (280)
T cd05608         218 VTYPDKFSPASKSFCEALLAKDPEKRLGFR  247 (280)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence              1233556677777788888889998553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.57  E-value=7.5e-15  Score=116.98  Aligned_cols=169  Identities=22%  Similarity=0.302  Sum_probs=120.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++..|+..|.+.+...-..  .++...+..+... +.|+.         ++|+.+++|++++|.|+++ .....++.|
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~---------~lH~~~iiH~dikp~Nili~~~~~~kl~D  145 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE---------DLHRENTVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeecCCCHHHEEECCCCCEEEec
Confidence            457777888888876543211  1333344444444 66666         8899999999999999999 456789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC---CC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS---PT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~---~~  201 (234)
                      ||.+.............++..|++||.+.+ ..++...|+||+|++++++++|..||.+.........+......   ..
T Consensus       146 fg~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05632         146 LGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY  224 (285)
T ss_pred             CCcceecCCCCcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc
Confidence            998876543333334567888999999864 44788999999999999999999999987655444444333322   22


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccc
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ....+..+..+...++..++.+|++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGC  250 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCC
Confidence            23455667778888899899999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.57  E-value=6.5e-15  Score=115.64  Aligned_cols=172  Identities=22%  Similarity=0.348  Sum_probs=123.6

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...--  ..++.+.+..+.. ++.++.         ++|+.+++|++++|+|+++. ....++.++
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~---------~lH~~~i~H~di~p~Nili~~~~~~~l~df  146 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA---------YIERMNYIHRDLRSANILVGDGLVCKIADF  146 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCccceEEEeCCceEEeCCc
Confidence            4777788888887765321  1122222333332 355566         88988999999999999994 557889999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+..+.....  .....++..|++||.... ..++...|+||+|++++++++ |..||++....+....+......+.+
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05070         147 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP  225 (260)
T ss_pred             eeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            98876543211  112233456999998763 346789999999999999998 88999988777766666554444445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ...+..+..+...|+..++.+||++.++.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            66777888999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.56  E-value=3.8e-15  Score=122.24  Aligned_cols=150  Identities=31%  Similarity=0.461  Sum_probs=115.9

Q ss_pred             HHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           47 IGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        47 ~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      .|-+||++|.-.|++.....-.+-+++.-...|.+- +.|..         .+|+.+.+|+|++|+|.++ ..++.++.|
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~---------~iH~~gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIE---------SIHQLGYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHH---------HHHHcCcccccCChhheeecCCCCEeecc
Confidence            355789999999998887665555666556667665 66666         7899999999999999999 578999999


Q ss_pred             ccccccccC---------------C---------------------------------CCCCCcccCccccccccccccc
Q 026720          125 LGMVKEIDS---------------N---------------------------------LPCTDYVTTRWYRGPEVLLFSE  156 (234)
Q Consensus       125 ~~~a~~~~~---------------~---------------------------------~~~~~~~~~~~~~~pe~~~~~~  156 (234)
                      ||++..+..               .                                 ......+|+|-|+|||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            999764321               0                                 0011235788899999998654


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---hCCCCCCCCc
Q 026720          157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL---IGSPTKDSWP  206 (234)
Q Consensus       157 ~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~---~~~~~~~~~~  206 (234)
                       |+...|.||+||+++||+.|-+||.+....+...+|...   +..|+.+.-.
T Consensus       365 -Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s  416 (550)
T KOG0605|consen  365 -YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLS  416 (550)
T ss_pred             -CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCccc
Confidence             999999999999999999999999999988888888753   3455554433

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.56  E-value=1.4e-15  Score=125.22  Aligned_cols=137  Identities=26%  Similarity=0.435  Sum_probs=102.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.+|..|+..|++.+...--..+++..+..|... +.|+.         ++|+.+++|++++|+|+++ ..+..++.|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~---------~lH~~givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID---------AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEccCCCHHHEEECCCCCEEEeecc
Confidence            3677888888888776543333444444555554 66666         8899999999999999999 46778999999


Q ss_pred             ccccccCCC------------------------------------CCCCcccCcccccccccccccCCCCcchHHHHHHH
Q 026720          127 MVKEIDSNL------------------------------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI  170 (234)
Q Consensus       127 ~a~~~~~~~------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~  170 (234)
                      .+..+....                                    .....++++.|+|||++.+ ..|+..+|+||+||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvi  225 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVI  225 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccce
Confidence            877542210                                    0113467889999999874 447899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      ++||++|..||.+........++..
T Consensus       226 lyel~tG~~Pf~~~~~~~~~~~i~~  250 (360)
T cd05627         226 MYEMLIGYPPFCSETPQETYRKVMN  250 (360)
T ss_pred             eeecccCCCCCCCCCHHHHHHHHHc
Confidence            9999999999998877766666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PF13041 PPR_2: PPR repeat family

Probab=99.56  E-value=4e-15  Score=86.55  Aligned_cols=50  Identities=18%  Similarity=0.163  Sum_probs=48.6

Q ss_pred             CCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhh
Q 026720            8 PNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSK   57 (234)
Q Consensus         8 ~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~   57 (234)
                      ||++|||++|++|++.|++++|.+++.+|.+.|+.||..||++||.+||+
T Consensus         1 P~~~~yn~li~~~~~~~~~~~a~~l~~~M~~~g~~P~~~Ty~~li~~~~k   50 (50)
T PF13041_consen    1 PDVVTYNTLISGYCKAGKFEEALKLFKEMKKRGIKPDSYTYNILINGLCK   50 (50)
T ss_pred             CchHHHHHHHHHHHHCcCHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHcC
Confidence            89999999999999999999999999999999999999999999999986

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.56  E-value=7.3e-15  Score=116.58  Aligned_cols=173  Identities=17%  Similarity=0.273  Sum_probs=118.8

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+..+-. ..++...+..|... +.|+.         ++|+.+++|++++|+|+++ .....+++|||
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS---------YLEEVRLVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccccccceEEEcCCCcEEECCCC
Confidence            3566677778876543321 11222233344333 55555         8899999999999999999 45678999999


Q ss_pred             ccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          127 MVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       127 ~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      .+..+.....   ......+..|++||.... ..++..+|+||+|+++||+++ |..||.+....+....+-.....+.+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP  233 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence            8886643211   111223456899999863 347889999999999999998 88998876655544333322223334


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..+...|+..++.+|+++.+++.
T Consensus       234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         234 PICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            556777888889999999999999998864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.56  E-value=2.7e-15  Score=129.07  Aligned_cols=178  Identities=20%  Similarity=0.269  Sum_probs=136.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----h-cc---CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----M-RE---KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m-~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~  120 (234)
                      +||.+|+..|+|.+-.+.-.-    + ..   |-..+=.-++....|...+.+  +|.+.-.+|+|+-..|.++. ....
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~--YLs~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGME--YLSSHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHH--HHHhCcccccchhhhhceeccceEE
Confidence            588999999999987664211    0 00   111334444555555555555  55555579999999999994 5678


Q ss_pred             eEeeccccccccCCCCCC---CcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 026720          121 KIGDLGMVKEIDSNLPCT---DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~  196 (234)
                      |++|||+.+.+..+-..+   .-.....|++||.+..+ .|++.+|+||+|++|||+++ |+.|+.|..+.+....|-+.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g  721 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG  721 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence            999999999886542211   11234568999999854 48999999999999999996 77999999999999888887


Q ss_pred             hCCCCCCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          197 IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      ..-+-++.++..+-.++..||...+.+||+|.+|
T Consensus       722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            7788889999999999999999999999999886

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.56  E-value=6.8e-15  Score=115.42  Aligned_cols=175  Identities=20%  Similarity=0.338  Sum_probs=122.5

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..+.+.+....- ..+++..+..+... +.|+.         ++|..++.|++++|+++++ .....++.++|
T Consensus        76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~---------~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA---------YLHETGKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHHhCCceecCCChhhEEECCCCCEEECccc
Confidence            3556667777777654332 22333333333332 55555         8888899999999999999 45678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC---
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP---  200 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~---  200 (234)
                      .+..+.... ......++..|.+||.....  ..++..+|+||+|+++++|++|++||.+.........+....-.+   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  226 (262)
T cd06613         147 VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL  226 (262)
T ss_pred             cchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccc
Confidence            887655422 12334566779999998643  246788999999999999999999999877655554443321111   


Q ss_pred             -CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 -TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       ....++..+..+.+.++...+..|+++++++..
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             223456678888999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.56  E-value=7.5e-15  Score=116.83  Aligned_cols=137  Identities=35%  Similarity=0.594  Sum_probs=106.4

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|.++.+ ....+++.+++.+.......  ......++..|++||+......++...|+||+|+++++
T Consensus       115 ~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~  194 (288)
T cd07833         115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE  194 (288)
T ss_pred             HHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHH
Confidence            7888889999999999999 46778999999988765543  23345667889999998755467899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhCCCCC-------------------------------CCCcchhhhhhhhccccCCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIGSPTK-------------------------------DSWPLGIQLASNLNWKLPQM  222 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~  222 (234)
                      +++|.+||++....+.+.++....+...+                               ...+..+..+++.|+..++.
T Consensus       195 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  274 (288)
T cd07833         195 LLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPK  274 (288)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCch
Confidence            99999999988777776665543332111                               01144566777889999999


Q ss_pred             CCccccccCCC
Q 026720          223 GGVNLLAVMPS  233 (234)
Q Consensus       223 ~~~~~~~~~~~  233 (234)
                      +|+++++++..
T Consensus       275 ~Rps~~~il~~  285 (288)
T cd07833         275 ERLTCDELLQH  285 (288)
T ss_pred             hcccHHHHhcC
Confidence            99999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.56  E-value=5.5e-15  Score=115.84  Aligned_cols=175  Identities=17%  Similarity=0.259  Sum_probs=124.2

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..+.+.+...... .++.+.+..+.. ++.|+.         ++|..++.|++++|.++.+ .++..+++||
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dl~p~ni~i~~~~~~kl~df  144 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME---------YLESNGFIHRDLAARNCLVGEDNVVKVSDF  144 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHHCCcccccccHhhEEECCCCcEEECCc
Confidence            457777888888776543211 111122223322 255556         8899899999999999999 4677899999


Q ss_pred             cccccccCCCCC--CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLPC--TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+.........  .....+..|.+||...+ ..++...|+||+|+++|++++ |..||.+....+....+......+.+
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05059         145 GLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP  223 (256)
T ss_pred             ccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            988765432111  11122346899998864 447889999999999999998 78999877766666555544444555


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++..+..+...|+...+.+|+++++++..
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            6678889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.56  E-value=7.2e-15  Score=115.32  Aligned_cols=173  Identities=19%  Similarity=0.220  Sum_probs=120.1

Q ss_pred             HHHHHHhhcCChHHHHHH-HHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKV-FNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~-~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+.... ...++.+.+..+... +.|+.         ++|..+++|++++|+++++ .....++.+||
T Consensus        70 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg  140 (257)
T cd05115          70 MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMK---------YLEGKNFVHRDLAARNVLLVNQHYAKISDFG  140 (257)
T ss_pred             EEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHhcCeeecccchheEEEcCCCcEEeccCC
Confidence            577788888888765432 111222233333332 44555         7898899999999999999 45678999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .+........    ......+..|++||.... ..++...|+||+|++++++++ |..||.+....+....+......+.
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (257)
T cd05115         141 LSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC  219 (257)
T ss_pred             ccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence            8875433211    111112346899998763 346789999999999999996 9999998877666544443333333


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +...+..+..++..||...+.+|+++.++.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3455678888999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.56  E-value=1.5e-14  Score=113.66  Aligned_cols=173  Identities=21%  Similarity=0.313  Sum_probs=121.9

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-..  .++...+..+... +.|+.         ++|..+++|++++|.|+++ .....++++|
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~~l~df  147 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA---------YLEAQNYIHRDLAARNVLVGENNICKVADF  147 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeccCCcceEEEcCCCCEEECCc
Confidence            57777887787776543211  1111122222222 44444         7888899999999999999 4567899999


Q ss_pred             cccccccCCCCC--CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLPC--TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+.........  .+......|++||...+ ..++...|+||+|++++++++ |+.||++.........+.+....+.+
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  226 (261)
T cd05068         148 GLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP  226 (261)
T ss_pred             ceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            988776532111  11112246899998863 447889999999999999998 99999987766666555444444555


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+++.+..+...|+...+.+||++.+++.
T Consensus       227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         227 PGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            667788889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.56  E-value=1.2e-14  Score=116.16  Aligned_cols=137  Identities=37%  Similarity=0.616  Sum_probs=107.4

Q ss_pred             HhhhcccccCCcCCCcEEee--CCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|.++++.  ....++.+||.+....... .......++.|.+||.+.+...++...|+||+|+++++
T Consensus       125 ~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~  204 (295)
T cd07837         125 HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE  204 (295)
T ss_pred             HHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHH
Confidence            78888999999999999994  5678999999887653321 11222456679999988755567899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC---------------------------cchhhhhhhhccccCCCCCcc
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIGSPTKDSW---------------------------PLGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~  226 (234)
                      +++|..||++........++++..+.|....|                           +..+..++..++...+.+|++
T Consensus       205 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~  284 (295)
T cd07837         205 MSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS  284 (295)
T ss_pred             HHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC
Confidence            99999999999888888888776665544333                           344555677788889999999


Q ss_pred             ccccCCC
Q 026720          227 LLAVMPS  233 (234)
Q Consensus       227 ~~~~~~~  233 (234)
                      +.+++.+
T Consensus       285 ~~eil~~  291 (295)
T cd07837         285 AKAALTH  291 (295)
T ss_pred             HHHHhcC
Confidence            9998864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.56  E-value=8.6e-15  Score=116.94  Aligned_cols=174  Identities=23%  Similarity=0.304  Sum_probs=121.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh--------hc-c-CccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCcCCC
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL--------MR-E-KNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDLKPS  111 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~--------m~-~-~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l~p~  111 (234)
                      ..++..|+..|.+.+.......        .+ . ....++...       +.++.         ++|..+++|++++|.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~---------~lH~~~i~H~dlkp~  152 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV---------YLASQHFVHRDLATR  152 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeecccCcc
Confidence            4677788888988876543210        00 0 111233322       44555         889999999999999


Q ss_pred             cEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 026720          112 NLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSS  186 (234)
Q Consensus       112 ~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~  186 (234)
                      |+++ .....++.++|.+........   .....++..|++||...+ ..++...|+||+|++++|+++ |..||.+...
T Consensus       153 Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             eEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999 467789999998876543211   112334567999998864 447888999999999999998 9999987766


Q ss_pred             HHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          187 ADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       187 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+....+...........++..+..+...|+...+.+|+++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         232 TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            5554444332222333455677888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.56  E-value=8.1e-15  Score=115.13  Aligned_cols=173  Identities=21%  Similarity=0.341  Sum_probs=122.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+..+-...  ++.+.+..+... +.|+.         ++|+.+++|++++|+|+++ .....++.+|
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~---------~lH~~~i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA---------YIERMNYIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEeecccCcceEEEcCCCeEEECCC
Confidence            477778888887765432110  111222333322 44555         7888899999999999999 4567899999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.+.......  .......+..|.+||...+ ..++...|+||+|++++++++ |..||++....+....+.+....+..
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05069         147 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP  225 (260)
T ss_pred             ccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            9887654321  1112233456899998764 336789999999999999998 89999988777666555544344445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..+...|+..++.+|++++++++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            566788899999999999999999988753

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.56  E-value=9.6e-15  Score=116.16  Aligned_cols=175  Identities=30%  Similarity=0.490  Sum_probs=120.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+++....-..+....+..+.. ++.++.         ++|+.++.|++++|+++.+ .....++.+++.
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE---------FCHSHNIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCCHHHEEECCCCcEEEEeeee
Confidence            45566677666665432111111112222222 244454         7888899999999999999 466789999998


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC------
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP------  200 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~------  200 (234)
                      +..+.... ......++..|.+||+..+...++...|+||+|++++++++|+++|++....+...++....+..      
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07846         147 ARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE  226 (286)
T ss_pred             eeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence            87654422 22334567789999998655556788999999999999999999999887766666655432221      


Q ss_pred             --------------C----------CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 --------------T----------KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 --------------~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                    .          ....+..+..+...|+...+.+|+++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                          1          01234567778888999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.56  E-value=1.9e-15  Score=122.68  Aligned_cols=168  Identities=23%  Similarity=0.233  Sum_probs=113.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+..-..--..+++..+..|... +.|+.         ++|..+++|++++|.|+++ ..+..++.|||
T Consensus        71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~---------~lH~~givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          71 LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG---------YLHSINIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecCCCHHHeEECCCCCEEEeecC
Confidence            3577788888888654332222333344444443 66777         8999999999999999999 46778999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+....... ......+++.|++||++.+ ..++..+|+||+|+++++|++|..||.+....+....+........+ ..
T Consensus       142 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~-~~  219 (325)
T cd05604         142 LCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP-GA  219 (325)
T ss_pred             CcccCCCCCCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC-CC
Confidence            887643221 2234567888999999864 44788999999999999999999999987766665555543222222 22


Q ss_pred             cchhhhhhhhccccCCCCCccc
Q 026720          206 PLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      +..+..+.+.+....+.+|++.
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~  241 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGA  241 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCC
Confidence            3344444444555555555544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.56  E-value=4.3e-15  Score=118.66  Aligned_cols=169  Identities=20%  Similarity=0.325  Sum_probs=128.5

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccc-cHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQ-SWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~-~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      +|++|+..|.+-+-+.--..++++... .|-.++++..         +.|+..++|++++..|+++ .++..++.|||+.
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVh---------YCHknrVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVH---------YCHKNRVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHH---------HHhhccceecccchhheeecCCCCeeeeccchh
Confidence            677888888877665555555554333 3444466666         7888889999999999999 4567899999998


Q ss_pred             ccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC-CCCCCCcc
Q 026720          129 KEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS-PTKDSWPL  207 (234)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~-~~~~~~~~  207 (234)
                      ..........++++++.|.+||++++.+.-..-+|.||+|+++|.+..|.+||+|.++.....+|.+.--. |...+   
T Consensus       201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PS---  277 (668)
T KOG0611|consen  201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPS---  277 (668)
T ss_pred             hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCc---
Confidence            88777666678899999999999998887789999999999999999999999999888888777664332 33222   


Q ss_pred             hhhhhhhhccccCCCCCccccccC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      --..+++......+..|-++++|-
T Consensus       278 dA~gLIRwmLmVNP~RRATieDiA  301 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATIEDIA  301 (668)
T ss_pred             hHHHHHHHHHhcCcccchhHHHHh
Confidence            224455555566666677777654

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.56  E-value=9.5e-15  Score=114.99  Aligned_cols=171  Identities=17%  Similarity=0.184  Sum_probs=115.3

Q ss_pred             HHHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC-------
Q 026720           49 TALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG-------  118 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~-------  118 (234)
                      ..++..|+..|.++...... ..+.......+... +.|+.         ++|+.+++|++++|+|+++. ..       
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS---------YLEDKDLVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HhhhCCeECCCCCcccEEEecCCccCCCCc
Confidence            45777888888876543221 11222222333333 45555         88999999999999999994 22       


Q ss_pred             eeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhh
Q 026720          119 VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~-~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ..++.++|.+......   ....++..|++||.+.....++..+|+||+|+++||++ .|..||.+....+. .+... .
T Consensus       150 ~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~-~  224 (262)
T cd05077         150 FIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYE-G  224 (262)
T ss_pred             eeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHh-c
Confidence            2678888877655432   23456677999998865566888999999999999998 57788876543332 22222 1


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+.....+..+..++..|+..++.+||+|.+|+..
T Consensus       225 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            222223344567788899999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.56  E-value=8.8e-15  Score=115.26  Aligned_cols=173  Identities=19%  Similarity=0.303  Sum_probs=124.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..|.+++...-.. .++.+.+..+... +.|+.         ++|+.++.|++++|.|+++. ....++.+|+
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~Lh~~~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK---------YLSEMNYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCcceEEEcCCCCEEECccc
Confidence            46777888888877654311 1222233333322 45555         88999999999999999994 5678999999


Q ss_pred             ccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          127 MVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       127 ~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      .+.......   .......+..|.+||...+ ..++...|+||+|++++++++ |..||.+.........+.+....+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  230 (266)
T cd05033         152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP  230 (266)
T ss_pred             hhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            888764211   1111223456899998863 447889999999999999997 88999877666655555444445666


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+++.+..+...|+...+.+||++++++.
T Consensus       231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~  260 (266)
T cd05033         231 MDCPSALYQLMLDCWQKDRNERPTFSQIVS  260 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            778889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.55  E-value=9.4e-15  Score=115.37  Aligned_cols=175  Identities=19%  Similarity=0.297  Sum_probs=124.3

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-..  .+++..+..+.. ++.|+.         ++|+.+++|++++|.++++ .....++.||
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~---------~LH~~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS---------HLHQHKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence            47778888888877654321  122222233333 356666         8899999999999999999 4567899999


Q ss_pred             cccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-CC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-GS  199 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-~~  199 (234)
                      |.+....... ......++..|++||++..    ...|+...|+||+|+++||+++|+.||.+.........+.... ..
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence            9987654322 1233456778999998752    2246788999999999999999999998766555444443321 12


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .....++..+..+...|+..++.+|+++.+++.+
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            2234567788889999999999999999998764

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.55  E-value=2.1e-14  Score=118.88  Aligned_cols=135  Identities=20%  Similarity=0.348  Sum_probs=102.0

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|++++|.|+++. ....+++|||.+........   ......+..|++||...+ ..++...|+||+|++++
T Consensus       229 ~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~  307 (375)
T cd05104         229 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLW  307 (375)
T ss_pred             HHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHH
Confidence            78888999999999999994 55689999999886543211   111223456999999864 44789999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||++........+...... ...+...+..+..++..|+..++.+||++.+++.
T Consensus       308 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         308 EIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             HHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            9997 8899988766555555544332 2223344567888899999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.55  E-value=2.5e-15  Score=129.49  Aligned_cols=176  Identities=19%  Similarity=0.245  Sum_probs=134.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      .|+++||++|.+.+.+.-  +..  +-.+-..+|..+++..+...++|.....++|||+|..|+++ ..+.-++||||.|
T Consensus       118 llLmEyC~gg~Lvd~mn~--Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNT--RLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EeehhhccCCcHHHHHHH--HHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            478899999988876432  111  22677778888888888888778778789999999999999 4677899999998


Q ss_pred             ccccCCCCCC----------CcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 026720          129 KEIDSNLPCT----------DYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       129 ~~~~~~~~~~----------~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~  196 (234)
                      ..........          .-..++.|++||.+.-  +...+.++|||++||+||.++.+..||.+.+..-++.   ..
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln---g~  270 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN---GN  270 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe---cc
Confidence            7654432110          0124678999999732  2335799999999999999999999999776554432   24


Q ss_pred             hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          197 IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...|+...|...+..|++.+..-.+.+|+++..++.
T Consensus       271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence            556777788899999999999999999999887653

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.55  E-value=8.5e-15  Score=114.93  Aligned_cols=171  Identities=17%  Similarity=0.200  Sum_probs=115.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC-------
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG-------  118 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~-------  118 (234)
                      ..+|..|+..|.+.+..+--. .++......+... +.|+.         ++|+.+++|++++|.++++. +.       
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~iiH~dlkp~nili~~~~~~~~~~~  144 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALH---------FLEDKGLTHGNVCAKNVLLIREEDRKTGNP  144 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCccceEEEecccccccCCC
Confidence            347778899998877643211 1222222233222 45555         88999999999999999994 21       


Q ss_pred             -eeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHh
Q 026720          119 -VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQL  196 (234)
Q Consensus       119 -~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~  196 (234)
                       +.++++++.+.....   .....++..|++||.+.+...++...|+||+|++++++++|. .||........ ..+...
T Consensus       145 ~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~  220 (258)
T cd05078         145 PFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYED  220 (258)
T ss_pred             ceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHc
Confidence             357888887765433   122456677999999875556788999999999999999985 56555444332 333333


Q ss_pred             hCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          197 IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ....+...| ..+..+...|+...+.+|+++++++..
T Consensus       221 ~~~~~~~~~-~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 RHQLPAPKW-TELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cccCCCCCc-HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            222222333 467788888999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.55  E-value=1e-14  Score=115.85  Aligned_cols=174  Identities=20%  Similarity=0.298  Sum_probs=118.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+...--..++...+..|... +.|+.         ++|+.+++|++++|.|+++ .+...++.|||
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~---------~lH~~~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE---------HMHNRFVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEEcCCCCHHHEEECCCCCEEEccCc
Confidence            3467788888888765432222333344444444 55666         8899999999999999999 46678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS--ADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~--~~~~~~i~~~~~~~~~~~  204 (234)
                      .+..+... ......++..|++||.......++..+|+||+|++++++++|+.||.+...  .....+........-+..
T Consensus       143 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (278)
T cd05606         143 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS  221 (278)
T ss_pred             CccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCc
Confidence            88765432 223346788899999986444578899999999999999999999987632  222222222212222233


Q ss_pred             CcchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      ++..+..+...+...++..|+     +..++++
T Consensus       222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            456666777777777777777     7766654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.55  E-value=6.2e-15  Score=115.38  Aligned_cols=174  Identities=23%  Similarity=0.440  Sum_probs=126.2

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|++.+......  ..++..+..|... +.|+.         ++|+.++.|++++|+++++ .....++.+|
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~---------~lH~~~i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ---------HIHEKRVLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHhhCCcccCCCCcceEEECCCCcEEEccc
Confidence            46677888887766443211  1122233344333 56666         8899899999999999999 4567889999


Q ss_pred             cccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.+........ .....++..|++||+..+ ..++...|+||+|++++++++|..||.+.........+......+.+..
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (255)
T cd08219         145 GSARLLTSPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSH  223 (255)
T ss_pred             CcceeecccccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence            98876543221 223456778999999864 3468899999999999999999999987766555555554434444566


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+..+...++...+.+|+++.+++..
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            77788888899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.55  E-value=2.5e-14  Score=115.51  Aligned_cols=137  Identities=31%  Similarity=0.548  Sum_probs=101.2

Q ss_pred             HhhhcccccCCcCCCcEEee-----CCeeeEeeccccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAM  167 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-----~~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~  167 (234)
                      ++|+.+++|++++|+|+++.     ....+++|||.+.......    ......++..|++||++.+...++...|+||+
T Consensus       123 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  202 (317)
T cd07867         123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI  202 (317)
T ss_pred             HHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence            88999999999999999982     3468999999988654322    12234567889999998765668899999999


Q ss_pred             HHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhhCCCCCCCCcc-------------------------------
Q 026720          168 GAIMFEMLSFGILFPGKS---------SADQIYKICQLIGSPTKDSWPL-------------------------------  207 (234)
Q Consensus       168 g~~l~e~~~~~~~f~~~~---------~~~~~~~i~~~~~~~~~~~~~~-------------------------------  207 (234)
                      |++++|+++|++||.+..         ..+++.+++..++.+....|..                               
T Consensus       203 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (317)
T cd07867         203 GCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKH  282 (317)
T ss_pred             HHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcc
Confidence            999999999999997532         2345555666666555444432                               


Q ss_pred             ------hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 ------GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ------~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                            .+..+...+...++.+|+|.++++.+
T Consensus       283 ~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         283 KVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             cCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence                  12234555778899999999998864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.55  E-value=7.5e-15  Score=115.02  Aligned_cols=171  Identities=20%  Similarity=0.334  Sum_probs=119.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+..+--..  ++.+.+..+.. ++.|+.         ++|..+++|++++|.|+++ .+...+++||
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~nil~~~~~~~kl~df  146 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME---------YLEANNFVHRDLAARNVLVSEDNVAKVSDF  146 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEeccccchheEEEcCCCcEEecCC
Confidence            466777777877765332110  11112222222 245555         8898899999999999999 4677899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.+.......  .....+..|++||+.. ...++...|+||+|++++++++ |+.||+.....+....+.+.........
T Consensus       147 g~~~~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05082         147 GLTKEASSTQ--DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  223 (256)
T ss_pred             ccceeccccC--CCCccceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            9887654321  2223345799999886 3447889999999999999997 8899987665555544544333333456


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..+..+...|+...+.+|+++.+++.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            6778888899999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.55  E-value=1.8e-14  Score=114.57  Aligned_cols=135  Identities=22%  Similarity=0.293  Sum_probs=106.9

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|++++|.|+++. ....+++|||.++.+.....   ......++.|++||...+. .++...|+||+|++++
T Consensus       139 ~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~  217 (283)
T cd05091         139 FLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLW  217 (283)
T ss_pred             HHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHH
Confidence            78999999999999999984 56689999998876543221   1223345679999998643 3788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||.+....+....+.+....+.+...+..+..+...|+...+..||++.+|+.
T Consensus       218 el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         218 EVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            9997 78899887777666666655555556677888899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.55  E-value=9.5e-15  Score=115.15  Aligned_cols=173  Identities=18%  Similarity=0.306  Sum_probs=123.6

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+...-- ..++...+..+... +.|+.         ++|..++.|++++|.|+++ .+...++.+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~---------~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK---------YLSDMNYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccccchhhEEEcCCCcEEECCCc
Confidence            4777888888887754321 11122222222222 44555         7888899999999999999 45678899999


Q ss_pred             ccccccCCCCCC----CcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLPCT----DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .+..........    ....+..|.+||...+ ..++...|+||+|++++|+++ |..||......+....+.+....|.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~  231 (268)
T cd05063         153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA  231 (268)
T ss_pred             cceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC
Confidence            887654321110    1112345899998864 447889999999999999997 9999987777666666665555666


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....+..+..+...|+..++.+||+++++++
T Consensus       232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6677788888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.55  E-value=2.2e-14  Score=112.54  Aligned_cols=174  Identities=19%  Similarity=0.323  Sum_probs=126.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHH-HHHHHHhcCCchhhhHhh-----hcccccCCcCCCcEEee-CC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTI-MISGLADNSRGNDAISLH-----RQGYFHRDLKPSNLLVS-KG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~-----~~~~~~~~l~p~~~~~~-~~  118 (234)
                      .++..|+..|.+.+..+-...    ++...+..|.. ++.|+.         ++|     ..+++|++++|.++++. ..
T Consensus        77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~---------~lH~~~~~~~~i~h~dl~p~nili~~~~  147 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY---------ECHNRSDPGNTVLHRDLKPANIFLDANN  147 (265)
T ss_pred             EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH---------HHhcCccccCcceecCCCHHHEEEecCC
Confidence            577888888888877654321    22223333433 355666         788     77899999999999994 57


Q ss_pred             eeeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          119 VIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ..++.+++.+........ .....++..|.+||.+.. ..++...|+||+|++++++++|..||.+.........+....
T Consensus       148 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  226 (265)
T cd08217         148 NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK  226 (265)
T ss_pred             CEEEecccccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC
Confidence            789999998887654332 334566778999999864 336788999999999999999999999776444443343333


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+.+..++..+..+...++...+.+|+++.+|+..
T Consensus       227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            333445667788888888999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.55  E-value=8.5e-15  Score=119.16  Aligned_cols=176  Identities=26%  Similarity=0.348  Sum_probs=118.6

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..+|..|+..|++.+...-+. .+++..+..|... +.|+.         ++|..+++|++++|+|+++ .....++.||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~Nill~~~~~~kl~Df  146 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID---------SVHQLGYVHRDIKPDNVLLDKNGHIRLADF  146 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEECCCCHHHEEECCCCCEEEEEC
Confidence            467888998899887665432 2444444555444 66777         8999999999999999999 4677899999


Q ss_pred             cccccccCCCC--CCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      |.+..+.....  .....+++.|++||++..    ...++..+|+||+|++++++++|+.||.+....+...++......
T Consensus       147 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~  226 (331)
T cd05597         147 GSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH  226 (331)
T ss_pred             CceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc
Confidence            98876543221  122357889999999852    234678899999999999999999999988776666665543221


Q ss_pred             ---CC-CCCCcchhhhhhhhccccCC--CCCccccccCCC
Q 026720          200 ---PT-KDSWPLGIQLASNLNWKLPQ--MGGVNLLAVMPS  233 (234)
Q Consensus       200 ---~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  233 (234)
                         ++ ....++....+++.....++  ..|+++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence               11 12234445555433222232  336677766653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.55  E-value=1e-14  Score=115.88  Aligned_cols=175  Identities=19%  Similarity=0.273  Sum_probs=124.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+.......  +++..+..+.. ++.++.         ++|..+++|++++|.++++ .....++.++
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~---------~LH~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA---------HLHAHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence            588889998888876543221  11111222222 355666         8899999999999999999 4567899999


Q ss_pred             cccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-CC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-GS  199 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-~~  199 (234)
                      +.+....... ......++..|++||.+..    ...++..+|+||+|++++|+++|..||.+.........+.+.. ..
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  245 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK  245 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence            9887654321 1233456778999998742    2346788999999999999999999998766544443332211 11


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .....++..+..+++.|+..++.+|+++.+++..
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            2234577888999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.55  E-value=8.9e-15  Score=120.08  Aligned_cols=170  Identities=23%  Similarity=0.326  Sum_probs=115.9

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      +|..|+..|.+.....    ..+..+..+.. ++.|+.         ++|..+++|+|++|.|+++ .....++.|||.+
T Consensus       149 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        149 VLLEFMDGGSLEGTHI----ADEQFLADVARQILSGIA---------YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             EEEecCCCCccccccc----CCHHHHHHHHHHHHHHHH---------HHHHCCEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            5667777776643211    11112222322 355666         8899999999999999999 4567899999998


Q ss_pred             ccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHH-HHHhhCCC
Q 026720          129 KEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--SADQIYK-ICQLIGSP  200 (234)
Q Consensus       129 ~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--~~~~~~~-i~~~~~~~  200 (234)
                      ..+.... ......++..|++||.+..    ...++..+|+||+|+++||+++|+.||....  .+..... +.......
T Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  295 (353)
T PLN00034        216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE  295 (353)
T ss_pred             eecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC
Confidence            8765432 2234567889999998742    1223468999999999999999999997432  3332222 11111222


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .....+..+..++..|+..++.+|+++.+++.+
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            234566778888999999999999999999864

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=2.2e-14  Score=118.38  Aligned_cols=171  Identities=22%  Similarity=0.311  Sum_probs=117.4

Q ss_pred             HHHHHhhcCChHHHHHHHHh---hccCcc-ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeecc
Q 026720           51 LVEMYSKCGHVEKAFKVFNL---MREKNL-QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLG  126 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~---m~~~~~-~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~  126 (234)
                      .+.+.+++|+.|-+.-+-..   ++.--+ .-|-.|+-+.-         .+|.++++|.|++|.|.++..+..++.|||
T Consensus       434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~---------~IH~~gIVHSDLKPANFLlVkG~LKLIDFG  504 (677)
T KOG0596|consen  434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVK---------TIHQHGIVHSDLKPANFLLVKGRLKLIDFG  504 (677)
T ss_pred             eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHH---------HHHHhceeecCCCcccEEEEeeeEEeeeec
Confidence            44455666766555332211   111111 23444455555         789999999999999999988999999999


Q ss_pred             ccccccCCC---CCCCcccCcccccccccccccC----------CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 026720          127 MVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEI----------YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI  193 (234)
Q Consensus       127 ~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~----------~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i  193 (234)
                      .|..+....   .....+|+..|++||.++.+..          .+..+|+||+||++|+|+.|++||..-.  ....++
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl  582 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKL  582 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHH
Confidence            999875432   2345689999999999864321          2478999999999999999999995432  222233


Q ss_pred             HHhhCCCCC------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          194 CQLIGSPTK------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       194 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .. +-.|+.      -+-+..+..+++-|...++.+|+++.+++++
T Consensus       583 ~a-I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  583 HA-ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             Hh-hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            22 223322      1212236777888999999999999999875

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.55  E-value=1.1e-14  Score=115.59  Aligned_cols=135  Identities=23%  Similarity=0.312  Sum_probs=103.4

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|++++|+++++ .....++.+||.+........   ......+..|.+||...+ ..++...|+||+|++++
T Consensus       137 ~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~  215 (280)
T cd05092         137 YLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLW  215 (280)
T ss_pred             HHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHH
Confidence            7898999999999999999 456789999998876543211   111223456899998864 34788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |.+||.+....+....+........+...+..+..+...|+..++.+|+++++++.
T Consensus       216 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         216 EIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            9998 88999887776666555444333444556678888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.55  E-value=1.7e-14  Score=117.53  Aligned_cols=175  Identities=31%  Similarity=0.527  Sum_probs=123.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+. |.+.+...--..++...+..+... +.|+.         ++|..+++|++++|.++++ .....++.+|+
T Consensus        95 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~---------~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         95 INLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLN---------VLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            445666665 555554332112233333444444 56666         8899999999999999999 45678899999


Q ss_pred             ccccccCC---------------CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 026720          127 MVKEIDSN---------------LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY  191 (234)
Q Consensus       127 ~a~~~~~~---------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~  191 (234)
                      .+......               .......++..|.+||.+.+...++...|+||+|++++++++|.+||++....+.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            87765410               011122346679999998755557889999999999999999999999999888888


Q ss_pred             HHHHhhCCCCCCCCc---------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          192 KICQLIGSPTKDSWP---------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       192 ~i~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++...+.|....|+                           ..+..+...++...+.+|+++++++..
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            888777666555443                           334455666778889999999998864

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.55  E-value=7.2e-15  Score=118.12  Aligned_cols=174  Identities=19%  Similarity=0.275  Sum_probs=117.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh----------------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCC
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL----------------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPS  111 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~----------------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~  111 (234)
                      ..++..|+..|.+.+..+.-..                ++.+.+..+... +.|+.         ++|+.+++|++++|+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~---------~LH~~gi~H~dlkp~  153 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD---------YLSQKQFIHRDLAAR  153 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHH---------HHHhCCccccccchh
Confidence            4567778888888776442211                111122333332 45555         789999999999999


Q ss_pred             cEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 026720          112 NLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQ  189 (234)
Q Consensus       112 ~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~  189 (234)
                      |+++ .....++.+||.+..............+..|.+||...+ ..++..+|+||+|++++|+++ |..||.+....+.
T Consensus       154 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  232 (303)
T cd05088         154 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  232 (303)
T ss_pred             eEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence            9999 466789999998864332111111122345899998864 347889999999999999998 9999987766555


Q ss_pred             HHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+-.....+.+...+..+..+...|+...+.+|+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  275 (303)
T cd05088         233 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  275 (303)
T ss_pred             HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            4444322222223344567778888899999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.54  E-value=1.8e-14  Score=117.34  Aligned_cols=173  Identities=26%  Similarity=0.355  Sum_probs=119.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhc-ccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      -.++..|+..|++.+..+--..++...+..+... +.|+.         ++|.. +++|++++|+|+++ .....++.||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~~ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---------YLREKHKIMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhcCCEEecCCChhhEEEcCCCCEEEeeC
Confidence            3477888988998876543222333333334333 55555         78864 58999999999999 4567899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----------
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC-----------  194 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~-----------  194 (234)
                      |.+..+.... .....++..|++||.+.+ ..++...|+||+|++++++++|+.||+.....+.. .+.           
T Consensus       149 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  225 (333)
T cd06650         149 GVSGQLIDSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAES  225 (333)
T ss_pred             Ccchhhhhhc-cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCcccc
Confidence            9887664432 233467788999999864 44788999999999999999999999865432221 111           


Q ss_pred             ------------------------------Hhh-CCC----CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          195 ------------------------------QLI-GSP----TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       195 ------------------------------~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                    ... ..+    .....+..+..+...|+..++.+|+++++++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                          100 000    011234567788899999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.54  E-value=1.3e-14  Score=114.45  Aligned_cols=175  Identities=20%  Similarity=0.286  Sum_probs=125.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH----hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN----LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~----~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .++..|+..+.+.+..+...    .+.+..+..+.. ++.|+.         ++|+.+++|++++|+++.+ .....++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~---------~lH~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA---------YLHENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH---------HHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence            47778888888887765433    122222233333 356666         8899899999999999999 46678999


Q ss_pred             eccccccccCCCC-CCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 026720          124 DLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG  198 (234)
Q Consensus       124 ~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~  198 (234)
                      +++.+........ .....++..|++||.+..    ...++...|+||+|++++++++|.+||.+........++.....
T Consensus       156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            9998876543222 223456778999998743    22467789999999999999999999987666665555443222


Q ss_pred             C--CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 S--PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .  .....|+..+..+++.|+..++.+|+++++++..
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1  1223477788899999999999999999998764

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.54  E-value=1.5e-14  Score=114.94  Aligned_cols=174  Identities=30%  Similarity=0.546  Sum_probs=124.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+ .+++.+...... .+.+..+..+.. ++.++.         ++|+.++.|++++|+++++. ....++.+++
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA---------YMHANGIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCcCHHHEEEcCCCcEEEeeee
Confidence            5677777 777776543221 122223333333 356666         88988999999999999994 5678899999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      .+.......  ......++..|.+||.+.....++...|+||+|++++++++|.++|++..+.....++....+.+....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07832         145 LARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET  224 (286)
T ss_pred             ecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHH
Confidence            887664432  122345677899999986555578899999999999999999999998888777777776655543322


Q ss_pred             C-----------------------------cchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 W-----------------------------PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      |                             +..+..+.+.+....+.+|+++++++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            2                             2344456667778899999999998865

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.54  E-value=1.6e-14  Score=116.02  Aligned_cols=173  Identities=18%  Similarity=0.320  Sum_probs=121.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hc--------cCccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MR--------EKNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~--------~~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .++..|+..|.+.+...--..  +.        .....+|..+       +.|+.         ++|..+++|++++|+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~---------~LH~~givH~dlkp~N  167 (304)
T cd05101          97 YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGME---------YLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHH---------HHHHCCeeecccccce
Confidence            477788888888776543110  00        0122344322       44555         8898899999999999


Q ss_pred             EEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++ .....+++|+|.+..+.....   ......++.|++||.+.+ ..++...|+||+|++++++++ |..||++....
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            999 456789999999886643211   111233456999998864 447889999999999999998 78899887666


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....+........+...+..+..+...|+...+.+|+++.+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            555555443333344556678888889999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.54  E-value=9.9e-15  Score=115.30  Aligned_cols=174  Identities=19%  Similarity=0.275  Sum_probs=115.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh----------------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCC
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL----------------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPS  111 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~----------------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~  111 (234)
                      ..++..|+..|++.+....-..                ++.+.+..+... +.|+.         ++|+.+++|++++|+
T Consensus        71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~---------~lH~~~i~H~dikp~  141 (270)
T cd05047          71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD---------YLSQKQFIHRDLAAR  141 (270)
T ss_pred             ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeecccccc
Confidence            3577778888888766432110                111122222222 44444         788889999999999


Q ss_pred             cEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 026720          112 NLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQ  189 (234)
Q Consensus       112 ~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~  189 (234)
                      |+++ .....++.+||.+..............+..|.+||.... ..++..+|+||+|++++|+++ |..||.+....+.
T Consensus       142 nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~  220 (270)
T cd05047         142 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  220 (270)
T ss_pred             eEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH
Confidence            9999 466789999998764322111111122345899998863 447889999999999999996 9999987765555


Q ss_pred             HHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+-.....+.+...+..+..+...|+...+.+||++++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         221 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            4444332222222334456777888899999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.54  E-value=1.7e-14  Score=113.27  Aligned_cols=173  Identities=20%  Similarity=0.310  Sum_probs=124.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-..  .+....+..|... +.|+.         ++|..++.|++++|.|+++ .+...+++++
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~---------~lH~~~i~h~dl~~~nilv~~~~~~kl~d~  148 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA---------YLEEQNSIHRDLAARNILVGEDLVCKVADF  148 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccccCcceEEEcCCceEEEccc
Confidence            46777888888877653211  0111122233332 55666         8899999999999999999 4667899999


Q ss_pred             cccccccCCCCC-CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          126 GMVKEIDSNLPC-TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       126 ~~a~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +.+......... .....+..|.+||.... ..++...|+||+|++++++++ |+.||++....+....+......+.+.
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  227 (261)
T cd05148         149 GLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA  227 (261)
T ss_pred             cchhhcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCC
Confidence            988776443211 12233456899998763 347889999999999999998 889998877666666655544455566


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++.+..++..|+..++.+||++.+++.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         228 KCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            77788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.54  E-value=7.1e-15  Score=119.66  Aligned_cols=138  Identities=30%  Similarity=0.443  Sum_probs=102.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..+|..|+..|++.+...-.. .+++..+..|... +.|+.         ++|+.+++|++++|.|+++ .+...++.||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~---------~lH~~~iiHrDlkp~Nili~~~~~~kL~Df  146 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID---------SVHQLHYVHRDIKPDNILMDMNGHIRLADF  146 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCHHHEEECCCCCEEEeec
Confidence            457888999999887765432 2333344444443 56666         8899999999999999999 4677899999


Q ss_pred             cccccccCCC--CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      |.+..+....  ......+++.|++||++..    ...++..+|+||+|++++|+++|+.||.+....+...++..
T Consensus       147 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~  222 (332)
T cd05623         147 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (332)
T ss_pred             chheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence            9887654321  1223467889999999752    23478899999999999999999999998877776666654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.54  E-value=2.8e-14  Score=113.11  Aligned_cols=174  Identities=33%  Similarity=0.546  Sum_probs=121.7

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+. +.+.+...-. ..++...+..+.. ++.++.         ++|..++.|++++|+++++. ....++.++|
T Consensus        74 ~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~---------~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g  143 (282)
T cd07829          74 YLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA---------YCHSHRILHRDLKPQNILINRDGVLKLADFG  143 (282)
T ss_pred             EEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCChheEEEcCCCCEEEecCC
Confidence            34555665 3555443322 1222223333322 255555         88988999999999999994 5778999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+....... .......+..|.+||.......++...|+||+|++++|+++|.+||.+....+.+.++.+..+.++...|
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
T cd07829         144 LARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW  223 (282)
T ss_pred             cccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence            887764432 1222344567899999865445788999999999999999999999998888888777776665555433


Q ss_pred             ----------------------------cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 ----------------------------PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                  +..+..+.+-++..++.+|+++++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                                        2345556677888899999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.54  E-value=1.5e-14  Score=115.05  Aligned_cols=176  Identities=20%  Similarity=0.252  Sum_probs=124.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHH----hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeE
Q 026720           49 TALVEMYSKCGHVEKAFKVFN----LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKI  122 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~----~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~  122 (234)
                      ..++..|+..|.+.+...-..    .+++..+..+... +.|+.         ++|..++.|++++|+++++. ....++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ---------HLHVNKTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH---------HHHhCCccccCCCHHhEEECCCCCEEE
Confidence            368888999999887643211    1111122223322 45555         88888899999999999994 556889


Q ss_pred             eeccccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          123 GDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       123 ~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      .+||.+..+.... ......++..|++||++..    ...++...|+||+|++++|+++|+.||.+........++....
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  245 (286)
T cd06638         166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP  245 (286)
T ss_pred             ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence            9999887654322 2233457788999998742    2346789999999999999999999998776555544432221


Q ss_pred             --CCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          198 --GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       198 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ...++..++..+..++..++..++.+|+++.+++.+
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              112344567778889999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.54  E-value=2.6e-14  Score=118.97  Aligned_cols=149  Identities=21%  Similarity=0.335  Sum_probs=106.3

Q ss_pred             ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccc
Q 026720           75 NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGP  149 (234)
Q Consensus        75 ~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~p  149 (234)
                      .+..|... +.|+.         ++|..+++|++++|+|+++ .....++.|||.+..+.....   .....+++.|++|
T Consensus       186 ~~~~i~~ql~~aL~---------~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP  256 (392)
T PHA03207        186 QAITIQRRLLEALA---------YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP  256 (392)
T ss_pred             HHHHHHHHHHHHHH---------HHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCH
Confidence            44444443 56666         8899999999999999999 456789999999876544321   2245678899999


Q ss_pred             cccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCCC------------------------
Q 026720          150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS---SADQIYKICQLIGSPTK------------------------  202 (234)
Q Consensus       150 e~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~---~~~~~~~i~~~~~~~~~------------------------  202 (234)
                      |++.+ ..|+..+|+||+|++++|+++|+.||.+..   ....+..+.+..+..+.                        
T Consensus       257 E~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (392)
T PHA03207        257 ELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPP  335 (392)
T ss_pred             hHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCC
Confidence            99864 447889999999999999999999997653   33444444443332111                        


Q ss_pred             ---------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 ---------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                               ..++..++.++..+....+.+|++..+++.+
T Consensus       336 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        336 YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     1123344556667778888899999998764

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.54  E-value=3.7e-14  Score=107.96  Aligned_cols=134  Identities=20%  Similarity=0.295  Sum_probs=109.0

Q ss_pred             hcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHh
Q 026720          100 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLS  176 (234)
Q Consensus       100 ~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~  176 (234)
                      +++++|++++|.|+++ ..+..+++|||.+..+..++......+-+.|++||.+.-  .+.|....|+||+|+.++|+.+
T Consensus       210 KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT  289 (391)
T KOG0983|consen  210 KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT  289 (391)
T ss_pred             hcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc
Confidence            4579999999999999 578899999999999888776666667778999999843  4568999999999999999999


Q ss_pred             CCCCCCCC-ChHHHHHHHHHhhCC--CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          177 FGILFPGK-SSADQIYKICQLIGS--PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       177 ~~~~f~~~-~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      |..||+++ .+.+.+.++.+....  |....++.-++++...|...+..+||...+++++
T Consensus       290 g~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  290 GQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            99999986 467777778774331  1123367778888888999999999988888764

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.54  E-value=1.7e-14  Score=114.32  Aligned_cols=182  Identities=19%  Similarity=0.265  Sum_probs=123.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhcc----CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEe
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMRE----KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~----~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      ..++..|+..|++.+..+-.....+    ....++..++....+.-...  .++|..+++|++++|.|+++. ....++.
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l--~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM--AYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH--HHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            4577888888988876543222111    11223333322222111111  178888999999999999994 5678999


Q ss_pred             eccccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 026720          124 DLGMVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       124 ~~~~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      +||.+..+......   .....+..|++||.+.+ ..++...|+||+|++++|+++ +..||.+.........+.+....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99988765432211   11233456999999864 347889999999999999998 68999887665555444443333


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.+...+..+..+...|+..++.+|+++.+++..
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3345566778889999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.54  E-value=1.6e-14  Score=113.06  Aligned_cols=171  Identities=18%  Similarity=0.291  Sum_probs=121.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .++..|+..|.+.+.......  ++.+.+..+.. ++.|+.         ++|+.+++|++++|+++++. ....++.||
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~~~H~dl~p~nili~~~~~~kl~Df  144 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME---------YLESKKLVHRDLAARNILVSEDGVAKVSDF  144 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccccCcceEEEcCCCcEEECCC
Confidence            467778888888776543211  12222233333 255666         88999999999999999994 567899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.+.......  ........|.+||.+.. ..++...|+||+|++++++++ |..||++....+....+.+....+....
T Consensus       145 g~~~~~~~~~--~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  221 (254)
T cd05083         145 GLARVGSMGV--DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEG  221 (254)
T ss_pred             ccceeccccC--CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCc
Confidence            9887654321  12233456899998763 347889999999999999997 8999988766555444433333333455


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..+..+...|+...+.+|+++.+++.
T Consensus       222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         222 CPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6778888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.54  E-value=2.3e-14  Score=112.73  Aligned_cols=176  Identities=20%  Similarity=0.297  Sum_probs=126.3

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      +..++..|+..|.+.+...-...++++.+..+... +.++.         ++|..++.|++++|.++++ .....++.+|
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~nil~~~~~~~~l~df  146 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA---------YLHNNCVVHRDIKGNNVMLMPNGIIKLIDF  146 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCcCHHhEEECCCCeEEeccc
Confidence            34577778888888877543333444444444333 55666         8888889999999999999 4677899999


Q ss_pred             cccccccCCC-------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 026720          126 GMVKEIDSNL-------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG  198 (234)
Q Consensus       126 ~~a~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~  198 (234)
                      +.+.......       ......++..|.+||...+ ..++...|+||+|++++++++|..||.+.........+.....
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (265)
T cd06631         147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG  225 (265)
T ss_pred             hhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence            9877642210       1123456778999999864 3468899999999999999999999987765554444333211


Q ss_pred             --CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 --SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        .+.+..++..+..+++.++..++.+|+++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              22334567788888999999999999999998864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.54  E-value=2.3e-14  Score=112.12  Aligned_cols=174  Identities=22%  Similarity=0.361  Sum_probs=123.1

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|++.+...-..  ..+...+..+.. ++.++.         ++|+.++.|++++|.++++ .....++.++
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~  145 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS---------YIHKAGILHRDIKTLNIFLTKAGLIKLGDF  145 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHH---------HHHhCCccccCCChHhEEEeCCCCEEECcC
Confidence            44566777788776543210  111223333333 356666         8898899999999999999 4567899999


Q ss_pred             cccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +.+....... ......++..|.+||...+. .++...|+||+|++++++++|..||++....+....+...-..+....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd08221         146 GISKILGSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV  224 (256)
T ss_pred             cceEEcccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            9887654322 12334567889999988643 367889999999999999999999998776666666644333333344


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...|+..++.+|+++++++..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         225 YSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            56677788888998889999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.54  E-value=1.7e-14  Score=113.24  Aligned_cols=174  Identities=17%  Similarity=0.237  Sum_probs=119.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..|.+.+..+-... ....++..|... +.|+.         ++|..+++|++++|.++++ .....++++|
T Consensus        72 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlk~~nili~~~~~~kl~df  142 (262)
T cd05058          72 PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME---------YLASKKFVHRDLAARNCMLDESFTVKVADF  142 (262)
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCccccccCcceEEEcCCCcEEECCc
Confidence            3467778888888776432111 111222333323 55555         8898899999999999999 4567899999


Q ss_pred             cccccccCCC-----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 026720          126 GMVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       126 ~~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      |.+..+....     .......+..|.+||.... ..++...|+||+|++++|+++ +.+||++....+....+......
T Consensus       143 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (262)
T cd05058         143 GLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL  221 (262)
T ss_pred             cccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9887654311     1112233456899998763 347889999999999999999 46788877666655444433223


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.+...+..+..+...|+...+.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            333445667888889999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.53  E-value=1.8e-14  Score=114.08  Aligned_cols=175  Identities=19%  Similarity=0.268  Sum_probs=122.2

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhc----cCccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-e
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMR----EKNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-S  116 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~----~~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~  116 (234)
                      ..++..|+..|.+.+...-.....    ......+...       +.|+.         ++|..+++|++++|+++++ .
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~di~p~nill~~  154 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA---------YLAAKKFVHRDLAARNCMVAE  154 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCccccccChheEEEcC
Confidence            456667888888877654321111    0111223222       45555         7888899999999999999 4


Q ss_pred             CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 026720          117 KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYK  192 (234)
Q Consensus       117 ~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~  192 (234)
                      ....++++||.+..+.....   .....++..|.+||.... ..++...|+||+|++++|+++ |..||.+....+....
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  233 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF  233 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence            56788999998876543211   112233557999998763 347888999999999999998 8899987766555544


Q ss_pred             HHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          193 ICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       193 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +......+.+..++..+..+...|+...+.+|+++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            44332233455677888899999999999999999988653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.53  E-value=1.3e-14  Score=115.05  Aligned_cols=181  Identities=17%  Similarity=0.256  Sum_probs=120.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc-CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC----CeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE-KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK----GVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~-~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~----~~~~~~~  124 (234)
                      .++..|+..|.+.+...-...... ....++...+....+.....+  ++|..+++|++++|+++++..    ...++++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~--~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK--YLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHH--HHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            467778888888776543321111 122333333332222221111  788888999999999999942    3578999


Q ss_pred             ccccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCC
Q 026720          125 LGMVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       125 ~~~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      +|.+..+......   .....+..|++||...+ ..++..+|+||+|++++|+++ |..||++....+....+.......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9988876432111   11122346899999863 347899999999999999996 889999877666544443322222


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+...+..+..+...|+..++.+|+++.+++..
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            234556677888888999999999999998754

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.53  E-value=7e-14  Score=104.01  Aligned_cols=139  Identities=22%  Similarity=0.502  Sum_probs=117.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~  125 (234)
                      -+||.+|..+-++..   ++..+...|+.-|... +.++.         +.|+.+++|++++|.|+.+.  .-..++.|+
T Consensus       110 paLiFE~v~n~Dfk~---ly~tl~d~dIryY~~elLkALd---------yCHS~GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQ---LYPTLTDYDIRYYIYELLKALD---------YCHSMGIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             chhHhhhhccccHHH---HhhhhchhhHHHHHHHHHHHHh---------HHHhcCcccccCCcceeeechhhceeeeeec
Confidence            468888888776654   4555677888888776 88888         88999999999999999994  456799999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      |+|+..|..+..+--+.++.+..||.+..-+.|.-..|+||+||.+.+|+..+ +.|.|.++.+++.+|.+..|.
T Consensus       178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt  252 (338)
T KOG0668|consen  178 GLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT  252 (338)
T ss_pred             chHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence            99999998887776778899999999998888888999999999999999877 556699999999999887764

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.53  E-value=1.6e-14  Score=114.77  Aligned_cols=174  Identities=21%  Similarity=0.305  Sum_probs=119.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|++.+.......+++..+..+... +.|+.         ++|..+++|++++|+|+++ .....++.||+
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~---------~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE---------HMHNRFVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcCCCCCCHHHEEECCCCCEEEccCC
Confidence            3577889999998765443333444444444443 56666         8899999999999999999 46678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhCCCCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--SADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--~~~~~~~i~~~~~~~~~~~  204 (234)
                      .+....... .....++..|++||.......++...|+||+|++++++++|..||.+..  ......+........-+..
T Consensus       143 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (279)
T cd05633         143 LACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS  221 (279)
T ss_pred             cceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccc
Confidence            887554322 2234577889999987544457889999999999999999999997543  2223222222222222334


Q ss_pred             CcchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      ++..+..++..++...+.+|+     ++.++++
T Consensus       222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            566777777788888888887     4666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.53  E-value=3e-14  Score=113.83  Aligned_cols=176  Identities=19%  Similarity=0.301  Sum_probs=120.9

Q ss_pred             HHHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      -.++..|+..|.+.....-. ..+.+..+..+... +.++.         ++|..+++|++++|.|+++. ....++.+|
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~---------~lH~~~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQ---------YLHSMKIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHhcCCeeecCCCcceEEEcCCCCEEEccC
Confidence            45677788888776543211 11223333333333 45555         78888999999999999994 567899999


Q ss_pred             cccccccCCCC-CCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC-
Q 026720          126 GMVKEIDSNLP-CTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS-  199 (234)
Q Consensus       126 ~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~-  199 (234)
                      |.+........ .....++..|.+||.+..    ...++..+|+||+|+++|++++|+.||.+........++...... 
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  234 (292)
T cd06644         155 GVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT  234 (292)
T ss_pred             ccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc
Confidence            98776433221 223456678999998742    233678899999999999999999999876655444444322111 


Q ss_pred             -CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 -PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       +.+..++..+..++..++...+.+|+++++++.+
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             1234566677788888999999999999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.53  E-value=7.8e-15  Score=115.36  Aligned_cols=173  Identities=24%  Similarity=0.358  Sum_probs=118.4

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..+.+.+..... ..++...+..+... +.++.         ++|+ .+++|++++|+++++ ..+..++.++
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~  145 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLT---------YLHEKHKIIHRDVKPSNILVNSRGQIKLCDF  145 (265)
T ss_pred             EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHH---------HHcCCCCeecCCCCHHHEEECCCCCEEEeec
Confidence            3555677777776654432 22222233333333 55666         7888 889999999999999 4567899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhhCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-----SADQIYKICQLIGSP  200 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-----~~~~~~~i~~~~~~~  200 (234)
                      |.+.......... ..++..|.+||...+. .++...|+||+|++++++++|+.||.+..     ..+...++.+.....
T Consensus       146 g~~~~~~~~~~~~-~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  223 (265)
T cd06605         146 GVSGQLVNSLAKT-FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR  223 (265)
T ss_pred             ccchhhHHHHhhc-ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC
Confidence            9887664332212 4566779999998643 57889999999999999999999997652     222322222221111


Q ss_pred             CCCC-CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKDS-WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+.. ++..+..++..|+..++.+|+++.+++.+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1122 67778888999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.53  E-value=2.5e-14  Score=112.50  Aligned_cols=173  Identities=21%  Similarity=0.314  Sum_probs=121.8

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-..  .++...+..+... +.++.         ++|+.+++|++++|.|+++ .....++.+|
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~---------~lH~~~i~H~dl~p~Nill~~~~~~~L~df  146 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA---------YVERMNYVHRDLRAANILVGENLVCKVADF  146 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHH---------HHHHCCccccccCcccEEEcCCCcEEeccC
Confidence            47777888888877653210  0111122233322 44555         7888899999999999999 4567889999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+..+.....  .....++..|++||.... ..++...|+||+|++++++++ |..||++....+....+......+..
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (262)
T cd05071         147 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP  225 (262)
T ss_pred             CceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCc
Confidence            98876543221  112234456999998763 347889999999999999999 88899887766665555444444445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..+...|+..++.+|+++.+++.
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            566778888999999999999999988753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.53  E-value=4e-14  Score=113.78  Aligned_cols=172  Identities=16%  Similarity=0.292  Sum_probs=118.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+....-. .++...+..|... +.|+.         ++|..+++|++++|+|+++ .....++++||
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~---------~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM---------YLEERRLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHhhcCeeccccccceeeecCCCceEEcccc
Confidence            47778888888876543211 1222233333333 55555         8898899999999999999 45678999999


Q ss_pred             ccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh-CCCC
Q 026720          127 MVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLI-GSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~-~~~~  201 (234)
                      .+..+.....   ......+..|++||...+ ..++...|+||+|++++|+++ |+.||.+....+. .++.... ..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~  232 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLPQ  232 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCC
Confidence            8886543221   112233457899998863 447889999999999999997 8899987654443 3333322 2333


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..+...||..++.+|+++.+++.
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~  263 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKFKELAA  263 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3445566777888899999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=9.5e-15  Score=111.26  Aligned_cols=121  Identities=35%  Similarity=0.641  Sum_probs=100.2

Q ss_pred             cccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC-CeeeEeeccccccccCCC--CCCCcccCcccccccc
Q 026720           76 LQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEV  151 (234)
Q Consensus        76 ~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~-~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~  151 (234)
                      +..|..+ ++|+-         ++|+.++.|++++|.|.+.++ ...+++|||+++.....-  .....+.+-.|++||+
T Consensus       158 vKVFlYQILRGLK---------YLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEi  228 (449)
T KOG0664|consen  158 VKVFVYQILRGLK---------YLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPEL  228 (449)
T ss_pred             hhhhHHHHHhhhH---------HHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHH
Confidence            3345555 88888         999999999999999999964 457999999998653321  1122356678999999


Q ss_pred             cccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       152 ~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      +.+.++|+..+|+||.||++.|++.++.+|...+...++.-|.+-.|.|..+..
T Consensus       229 LMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  229 LMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             hhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence            999999999999999999999999999999999999999999998888876543

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.53  E-value=2e-14  Score=113.31  Aligned_cols=173  Identities=23%  Similarity=0.329  Sum_probs=116.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...-...++.+.+..+... +.|+.         ++|..+++|++++|.++++ .....++.++|.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~---------~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS---------YLHSNMIVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence            456677777777765543222332333333332 55555         7888899999999999999 456789999998


Q ss_pred             cccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC-C
Q 026720          128 VKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT-K  202 (234)
Q Consensus       128 a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~-~  202 (234)
                      +..+....    ......++..|.+||...+ ..++...|+||+|++++|+++|+.||.+........++......|. +
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP  231 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence            87653211    1122345677999999864 4478899999999999999999999987765554444332222222 1


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...++.+..+. .|+...+.+|+++++++++
T Consensus       232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         232 SHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            23345566666 3666799999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.53  E-value=1.9e-14  Score=117.38  Aligned_cols=135  Identities=20%  Similarity=0.319  Sum_probs=100.8

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.|+++. ....+++|||.+..+....   ......++..|++||.+.+ ..++.+.|+||+|++++
T Consensus       188 ~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~  266 (337)
T cd05054         188 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLW  266 (337)
T ss_pred             HHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHH
Confidence            88999999999999999994 5678999999988764321   1122334456999998864 44788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHh-hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQL-IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||++....+...+.... .....+..++..+..+...|+...+.+||+++++++
T Consensus       267 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~  328 (337)
T cd05054         267 EIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE  328 (337)
T ss_pred             HHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9997 99999876555544444332 222233455566777777799999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.53  E-value=2.7e-14  Score=113.49  Aligned_cols=137  Identities=35%  Similarity=0.619  Sum_probs=106.7

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..++.|++++|.++++ ..+..++++++.+.......  .......+..|++||.+.+...++...|+||+|+++++
T Consensus       115 ~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~e  194 (287)
T cd07840         115 YLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAE  194 (287)
T ss_pred             HHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHH
Confidence            7888899999999999999 46778999999888765432  12223456679999987655557889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc------------------------------chhhhhhhhccccCCCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIGSPTKDSWP------------------------------LGIQLASNLNWKLPQMG  223 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~  223 (234)
                      +++|+.||.+....+...++.+..+.++...|+                              ..+..+.+.++...+.+
T Consensus       195 l~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~  274 (287)
T cd07840         195 LFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKK  274 (287)
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhh
Confidence            999999999888877777777776666555443                              33344566778889999


Q ss_pred             CccccccCCC
Q 026720          224 GVNLLAVMPS  233 (234)
Q Consensus       224 ~~~~~~~~~~  233 (234)
                      |++.++++..
T Consensus       275 Rp~~~~~l~~  284 (287)
T cd07840         275 RISADQALQH  284 (287)
T ss_pred             CcCHHHHhhC
Confidence            9999988753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.53  E-value=3.4e-14  Score=113.17  Aligned_cols=173  Identities=20%  Similarity=0.342  Sum_probs=119.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...- ..++...+..+... +.++.         ++|+.++.|++++|.|+++ .....++.+++.
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~  161 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALS---------FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF  161 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCChhhEEEcCCCcEEEccccc
Confidence            455667777777665432 12222223333333 55555         7888899999999999999 456789999987


Q ss_pred             cccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC--CCC
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT--KDS  204 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~--~~~  204 (234)
                      +........ .....++..|++||...+. .++...|+||+|++++++++|..||.+........++........  ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
T cd06648         162 CAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK  240 (285)
T ss_pred             chhhccCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCccccc
Confidence            765543322 1234567789999998643 478899999999999999999999987665555544433311111  122


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+.+.++..++.+|+++++++.+
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            45678888888999999999999998863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.53  E-value=2.7e-14  Score=115.35  Aligned_cols=173  Identities=17%  Similarity=0.307  Sum_probs=119.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh---------c-cCccccHHH-------HHHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM---------R-EKNLQSWTI-------MISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m---------~-~~~~~~~~~-------~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .++..|+..|.+.+...-....         . .....++..       ++.|+.         ++|+.+++|++++|.|
T Consensus        94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~---------~lH~~gi~H~dlkp~N  164 (314)
T cd05099          94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGME---------YLESRRCIHRDLAARN  164 (314)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHH---------HHHHCCeeecccccee
Confidence            4667788888887765432110         0 011233332       245555         8899999999999999


Q ss_pred             EEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++. ....++.+||.++.......   ......+..|++||.+.+ ..++...|+||+|++++++++ |..||++....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9994 66789999999886643211   111122346899998863 457889999999999999998 88999877655


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....+........+...+..+..+...|+..++.+|+++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            555444433222233445567778888999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.53  E-value=4.8e-14  Score=112.09  Aligned_cols=136  Identities=37%  Similarity=0.606  Sum_probs=105.9

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..++.|++++|+++++ .....++++|+.+.............++..|.+||...+. .++...|+||+|+++++++
T Consensus       122 ~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~  200 (287)
T cd07838         122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELF  200 (287)
T ss_pred             HHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHH
Confidence            7888889999999999999 4677899999988776543333344566779999998643 4788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCCCCc--------------------------chhhhhhhhccccCCCCCccccc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKDSWP--------------------------LGIQLASNLNWKLPQMGGVNLLA  229 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~  229 (234)
                      +|.++|.+....+...++.+....+....|+                          ..+..+...|+..++.+|+++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  280 (287)
T cd07838         201 RRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE  280 (287)
T ss_pred             hCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence            9999999988888888887765443322222                          23345667788999999999999


Q ss_pred             cCCC
Q 026720          230 VMPS  233 (234)
Q Consensus       230 ~~~~  233 (234)
                      ++..
T Consensus       281 il~~  284 (287)
T cd07838         281 ALQH  284 (287)
T ss_pred             HhcC
Confidence            8764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.53  E-value=3.3e-14  Score=112.85  Aligned_cols=176  Identities=17%  Similarity=0.267  Sum_probs=127.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..|.+.+..+-.+ .+++..+..+... +.++.         ++|..+++|++++|+++++ .....++.++
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~---------~lh~~~i~h~dl~p~nili~~~~~~~l~d~  147 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALN---------FLHSHKVIHRDLKAGNILLTLDGDVKLADF  147 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCChhhEEECCCCCEEEccC
Confidence            457778899999988755432 2344444444444 56666         8899999999999999999 4667899999


Q ss_pred             cccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC--
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG--  198 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~--  198 (234)
                      |.+....... ......++..|.+||.+..    ...++...|+||+|+++|++++|+.||.+........++.....  
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  227 (280)
T cd06611         148 GVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT  227 (280)
T ss_pred             ccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC
Confidence            8776554322 1223456778999998742    22356789999999999999999999988766655555433211  


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..|+..+..+...++...+.+|+++++++.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11234677788888899999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=6.7e-14  Score=105.47  Aligned_cols=112  Identities=38%  Similarity=0.731  Sum_probs=96.6

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC-----CCCcccCcccccccccccccCCCCcchHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP-----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI  170 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~  170 (234)
                      ++|...++|++++|.|+++. ++..++.|||+++.+..+-.     ...-+.+-+|.+||.+.+-+.|...+|+|+.||+
T Consensus       139 ~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCi  218 (376)
T KOG0669|consen  139 YIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCI  218 (376)
T ss_pred             HHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHH
Confidence            78887899999999999994 68999999999987644321     1122446789999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcch
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLG  208 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  208 (234)
                      +.||+++.+.|.|.....++.-|..--|...++.|++.
T Consensus       219 maeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  219 MAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             HHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            99999999999999999999999999999999999853

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.52  E-value=2.7e-14  Score=114.04  Aligned_cols=176  Identities=19%  Similarity=0.266  Sum_probs=122.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh----hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeE
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKI  122 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~  122 (234)
                      ..++..|...|.+.+..+....    +++..+..+.. ++.++.         ++|..+++|++++|+++++ .....++
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ---------HLHNNRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence            3577888888888886553211    11111122222 244444         7888899999999999999 4556799


Q ss_pred             eeccccccccCCC-CCCCcccCccccccccccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          123 GDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSE----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       123 ~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~----~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      .++|.+..+.... ......++..|.+||.+....    .++..+|+||+|++++++++|+.||.+......+.++.+..
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  249 (291)
T cd06639         170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP  249 (291)
T ss_pred             eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence            9999887654321 122345667799999875332    25789999999999999999999998876655555544332


Q ss_pred             CC--CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          198 GS--PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       198 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..  .++..++..+..++..|+...+.+|+++.+++.+
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            21  2234566678888888999999999999998864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.52  E-value=1.9e-14  Score=112.98  Aligned_cols=173  Identities=21%  Similarity=0.358  Sum_probs=122.5

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+....-.  .++...+..+.. ++.++.         ++|..+++|++++|.++.+ .....++.++
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~---------~LH~~~i~H~dl~p~ni~i~~~~~~~l~df  146 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA---------FIERKNYIHRDLRAANILVSETLCCKIADF  146 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHhcCCeecccccHHhEEEcCCCCEEEccC
Confidence            56677778888776543211  111112222222 245555         7888899999999999999 4567899999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+........  ......+..|.+||.... ..++...|+||+|++++++++ |+.||++....+....+.+....+..
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05067         147 GLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP  225 (260)
T ss_pred             cceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Confidence            98876652211  112233456899998864 336788999999999999998 99999988776666665554444555


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..+...|+...+.+|+++++++.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         226 DNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            666778888999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.52  E-value=2.1e-14  Score=114.83  Aligned_cols=173  Identities=21%  Similarity=0.356  Sum_probs=121.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...- ..+....+..+... +.|+.         ++|+.+++|++++|.|+++ .....++.+||.
T Consensus        95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~---------~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~  164 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALS---------YLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF  164 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHH---------HHHHCCEeecCCCHHHEEEcCCCCEEEccCcc
Confidence            456667777777664321 11222223333333 55666         8898899999999999999 456789999998


Q ss_pred             cccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCCC
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKDS  204 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~~  204 (234)
                      +........ .....++..|++||.... ..++...|+||+|++++|+++|..||.+.........+......  ++...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T cd06658         165 CAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHK  243 (292)
T ss_pred             hhhcccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccc
Confidence            876533221 223456778999999863 34788999999999999999999999887666555444333222  22234


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...++..++.+|+++++++.+
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            55677888888899999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.52  E-value=3.1e-14  Score=111.38  Aligned_cols=175  Identities=21%  Similarity=0.309  Sum_probs=121.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+..+-...+....+..+.. ++.|+.         ++|..++.|++++|+++.+ .....++.+++.
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLE---------YLHDRNTVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence            35566777777765543322222222222322 356666         8898999999999999999 467789999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC-CCCCc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT-KDSWP  206 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~-~~~~~  206 (234)
                      +.............++..|.+||.......++...|+||+|++++++++|+.||......+...++-.....+. +...+
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (258)
T cd06632         149 AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS  228 (258)
T ss_pred             ceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcC
Confidence            87665433234455677899999875333367889999999999999999999987765555555433222222 23456


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+...++...+..|+++++++..
T Consensus       229 ~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         229 DEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            677788888998899999999998864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.52  E-value=1.9e-14  Score=116.98  Aligned_cols=137  Identities=34%  Similarity=0.580  Sum_probs=108.1

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l  171 (234)
                      ++|..++.|++++|.++++ .....+++++|.+.......    ......++..|.+||.+.+...++...|+||+|+++
T Consensus       118 ~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il  197 (330)
T cd07834         118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF  197 (330)
T ss_pred             HHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHH
Confidence            8898899999999999999 45678999999888765432    123345677899999987554678899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC------------------------------cchhhhhhhhccccCC
Q 026720          172 FEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW------------------------------PLGIQLASNLNWKLPQ  221 (234)
Q Consensus       172 ~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~  221 (234)
                      +++++|.+||++....+....+....+.+....+                              +..+..+...++..++
T Consensus       198 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  277 (330)
T cd07834         198 AELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP  277 (330)
T ss_pred             HHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence            9999999999999888877777776665554322                              2344567777888899


Q ss_pred             CCCccccccCCC
Q 026720          222 MGGVNLLAVMPS  233 (234)
Q Consensus       222 ~~~~~~~~~~~~  233 (234)
                      .+|+++++++.+
T Consensus       278 ~~Rpt~~~ll~~  289 (330)
T cd07834         278 KKRITADEALAH  289 (330)
T ss_pred             hhCCCHHHHHhC
Confidence            999999988753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.52  E-value=2.3e-14  Score=114.95  Aligned_cols=150  Identities=33%  Similarity=0.567  Sum_probs=111.5

Q ss_pred             ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC--CCCCcccCccccccc
Q 026720           75 NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPE  150 (234)
Q Consensus        75 ~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe  150 (234)
                      .+..+... +.|+.         ++|..+++|++++|.++++ .....++.++|.+.......  .......+..|.+||
T Consensus       117 ~~~~i~~qi~~aL~---------~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE  187 (302)
T cd07864         117 HIKSFMKQLLEGLN---------YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE  187 (302)
T ss_pred             HHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChH
Confidence            33444444 55666         8898899999999999999 45678999999887654322  112223456789999


Q ss_pred             ccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC-------------------------
Q 026720          151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-------------------------  205 (234)
Q Consensus       151 ~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~-------------------------  205 (234)
                      .......++...|+||+|++++++++|++||......+.+..+.+..+.+.+..|                         
T Consensus       188 ~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd07864         188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE  267 (302)
T ss_pred             HhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh
Confidence            8765455678899999999999999999999988777777777665555443332                         


Q ss_pred             ----cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 ----PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                          +..+..+...++..++.+|++++++++.
T Consensus       268 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         268 FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                3455667777889999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.52  E-value=1.7e-14  Score=117.49  Aligned_cols=173  Identities=30%  Similarity=0.498  Sum_probs=119.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+. |.+.+...-...++...+..+... +.|+.         ++|..+++|++++|+++++ ..+..++++||.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLK---------YIHSANVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEEcCCCcEEeccccc
Confidence            46666775 444443322222333333333333 56666         8898899999999999999 467789999998


Q ss_pred             cccccCCCC-----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNLP-----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +........     .....++..|.+||.+.....++...|+||+|++++++++|+.||++......+..+....+.|..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            876543211     123456778999999765455788999999999999999999999988766655544444343321


Q ss_pred             -----------------------C-------CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 -----------------------D-------SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 -----------------------~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                                             .       ..++.+..+.+.++...+.+|+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                                   1       12445666778888899999999998775

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.52  E-value=2.3e-14  Score=113.08  Aligned_cols=174  Identities=18%  Similarity=0.238  Sum_probs=119.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhcc-----CccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMRE-----KNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIK  121 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~-----~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~  121 (234)
                      ..++..|+..|++.+...-......     .....|.. ++.|+.         ++|+.+++|++++|.|+++ .+...+
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~Nill~~~~~~k  140 (269)
T cd05042          70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL---------WLHQADFIHSDLALRNCQLTADLSVK  140 (269)
T ss_pred             eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHH---------HHHhcCEecccccHhheEecCCCcEE
Confidence            4678888888998876544322211     11223333 356666         8899999999999999999 456789


Q ss_pred             EeeccccccccCCC---CCCCcccCccccccccccc------ccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 026720          122 IGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLF------SEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIY  191 (234)
Q Consensus       122 ~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~------~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~  191 (234)
                      +.+||.+.......   .......+..|.+||+...      ...++...|+||+|++++|+++ +..||++....+.+.
T Consensus       141 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~  220 (269)
T cd05042         141 IGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK  220 (269)
T ss_pred             EeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence            99999876543211   1112233456899998642      2235778999999999999998 778998887777666


Q ss_pred             HHHHhhCC--CC---CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          192 KICQLIGS--PT---KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       192 ~i~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+......  +.   ...++..+..++++||. ++.+||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~  265 (269)
T cd05042         221 QVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHE  265 (269)
T ss_pred             HHhhccCccCCCCcccccCCHHHHHHHHHHhc-CcccccCHHHHHH
Confidence            65543321  11   23566677778888885 8889999998865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.52  E-value=4.6e-14  Score=113.43  Aligned_cols=174  Identities=20%  Similarity=0.267  Sum_probs=118.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh--hcc-----------CccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL--MRE-----------KNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDL  108 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~--m~~-----------~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l  108 (234)
                      ..++..|+..|.+.+-......  ...           ....+|...       +.|+.         ++|+.+++|+++
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~---------~lH~~~ivH~dl  164 (304)
T cd05096          94 LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK---------YLSSLNFVHRDL  164 (304)
T ss_pred             eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH---------HHHHCCccccCc
Confidence            4678889999998776433211  100           012233322       44455         788889999999


Q ss_pred             CCCcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh--CCCCCC
Q 026720          109 KPSNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS--FGILFP  182 (234)
Q Consensus       109 ~p~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~--~~~~f~  182 (234)
                      +|+|+++. ....+++|||.+..+.....   .....++..|++||++.. ..++...|+||+|++++|+++  +..||.
T Consensus       165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            99999994 56789999999886543211   112233567999998864 347899999999999999986  557777


Q ss_pred             CCChHHHHHHHHHhhC-------CCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          183 GKSSADQIYKICQLIG-------SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       183 ~~~~~~~~~~i~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....+....+.+...       ...+...+..+..++..||..++.+||++++|.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            7655554443322111       1122345678889999999999999999998753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.52  E-value=2.5e-14  Score=112.30  Aligned_cols=174  Identities=25%  Similarity=0.327  Sum_probs=124.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..+.+.+...-...++...+..+... +.++.         ++|. .++.|++++|+++.+ .....++.+|+
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~---------~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD---------YLHTKRHIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHhccCCCccCCCCHHHEEECCCCCEEEccCc
Confidence            456678888888777554333333333344333 66666         8898 889999999999999 46678999999


Q ss_pred             ccccccCCCCC-CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHH-HHHHHHhhCCCCC
Q 026720          127 MVKEIDSNLPC-TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--SADQ-IYKICQLIGSPTK  202 (234)
Q Consensus       127 ~a~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--~~~~-~~~i~~~~~~~~~  202 (234)
                      .+..+...... ....++..|.+||.... ..++...|+||+|++++++++|..||.+..  .... ...+......+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  224 (264)
T cd06623         146 ISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP  224 (264)
T ss_pred             cceecccCCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCC
Confidence            88876543322 23456678999998763 457889999999999999999999998774  3333 3333322222233


Q ss_pred             CC-CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DS-WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .. +++.+..+...++...+.+|++++++++.
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            34 67788999999999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.52  E-value=2.3e-14  Score=112.82  Aligned_cols=173  Identities=21%  Similarity=0.381  Sum_probs=119.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .++..|+..|.+.........    +++..+..+... +.|+.         ++|..++.|++++|+++++ .+...++.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~LH~~~i~H~dl~~~nil~~~~~~~~l~  148 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE---------HMHSRRVMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHH---------HHhhCCeeCCCCCHHHEEEcCCCCEEEC
Confidence            456677888888766543221    222223333333 55666         8899999999999999999 45668899


Q ss_pred             eccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCC
Q 026720          124 DLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-SADQIYKICQLIGSPT  201 (234)
Q Consensus       124 ~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-~~~~~~~i~~~~~~~~  201 (234)
                      +++.+........ .....++..|++||...+ ..++...|+||+|+++|++++|+.||.+.. +.............+.
T Consensus       149 d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T cd08228         149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP  227 (267)
T ss_pred             ccccceeccchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence            9998776543211 123456677999998864 346788999999999999999999987543 2233333333333332


Q ss_pred             C--CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 K--DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .  ...+..+..++..||...+.+||++++++.
T Consensus       228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            2  345677888999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.52  E-value=4.2e-14  Score=114.83  Aligned_cols=174  Identities=25%  Similarity=0.269  Sum_probs=123.4

Q ss_pred             HHHHHHHHHhhcCChHHHHHHHHhh--ccCcc-ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeE
Q 026720           47 IGTALVEMYSKCGHVEKAFKVFNLM--REKNL-QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKI  122 (234)
Q Consensus        47 ~~~~li~~~~~~g~~~~a~~~~~~m--~~~~~-~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~  122 (234)
                      ..-+||..||..|.+...-.  +.+  .+... .-+--++.|+-         +||.++++|+|++|.|.++ ..+.+++
T Consensus       183 ~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLE---------YLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  183 DKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLE---------YLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             CceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHH---------HHHhcCeeccccchhheEEcCCCcEEe
Confidence            34578888998887765310  000  00000 01122466776         9999999999999999999 5789999


Q ss_pred             eeccccccccCCC------CCCCcccCccccccccccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 026720          123 GDLGMVKEIDSNL------PCTDYVTTRWYRGPEVLLFSE---IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI  193 (234)
Q Consensus       123 ~~~~~a~~~~~~~------~~~~~~~~~~~~~pe~~~~~~---~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i  193 (234)
                      +|||.+.......      .....+|+|.++|||......   ..+.++|+||+|+.+|-++.|+.||-+..-.+..-+|
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            9999988662211      122368999999999986522   2368899999999999999999999988877777777


Q ss_pred             HHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          194 CQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       194 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ...-- .|....-++..+.++.....-++.+|+++.+|-
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik  370 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK  370 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence            65433 344444456777777666677788899988764

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.52  E-value=6.7e-14  Score=112.65  Aligned_cols=171  Identities=22%  Similarity=0.356  Sum_probs=120.5

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+. |.+.+..... ..+..+.+..+... +.|+.         ++|..+++|++++|.++++ .....++.+|+
T Consensus        91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~---------~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLA---------YLHSHERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHH---------HHHHCCceecCCCcccEEECCCCCEEEeecC
Confidence            46777776 5544433211 11222333333333 55566         8898889999999999999 45678999999


Q ss_pred             ccccccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hCCCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL-IGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~-~~~~~~~  203 (234)
                      .+.....   .....+++.|++||.+..  ...++...|+||+|+++||+++|.+||.+.........+... .......
T Consensus       161 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (307)
T cd06607         161 SASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN  237 (307)
T ss_pred             cceecCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCch
Confidence            8765432   233456778999998742  234778999999999999999999999887766665554322 1122234


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .|++.+..+...|+..++.+|+++++++..
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            588888999999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.51  E-value=1.1e-13  Score=109.97  Aligned_cols=137  Identities=34%  Similarity=0.622  Sum_probs=106.1

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|..+++|++++|.++++ .+...++.+|+.+..+..... .....++..|.+||...+...++...|+||+|++++++
T Consensus       115 ~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l  194 (284)
T cd07860         115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM  194 (284)
T ss_pred             HHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHH
Confidence            7888899999999999999 466789999998876543211 12234567799999887555567889999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc----------------------------chhhhhhhhccccCCCCCcc
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSWP----------------------------LGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~  226 (234)
                      ++|+.||++....+...++.+..+.+....|+                            ..+..+...++..++.+|++
T Consensus       195 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  274 (284)
T cd07860         195 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS  274 (284)
T ss_pred             HHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC
Confidence            99999999998888888888777766543332                            23334666778889999999


Q ss_pred             ccccCCC
Q 026720          227 LLAVMPS  233 (234)
Q Consensus       227 ~~~~~~~  233 (234)
                      +++++.+
T Consensus       275 ~~~~l~~  281 (284)
T cd07860         275 AKAALAH  281 (284)
T ss_pred             HHHHhcC
Confidence            9998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.51  E-value=2.3e-14  Score=116.90  Aligned_cols=137  Identities=33%  Similarity=0.532  Sum_probs=101.2

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|..+++|++++|.|+++ .....++.+||.+....... ......++..|.+||.+.....++...|+||+|++++++
T Consensus       123 ~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  202 (337)
T cd07858         123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL  202 (337)
T ss_pred             HHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHH
Confidence            8898899999999999999 45678999999887664321 122345677899999876444578899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCC------------------------------CCcchhhhhhhhccccCCCCC
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKD------------------------------SWPLGIQLASNLNWKLPQMGG  224 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~  224 (234)
                      ++|++||++.........+.+..+.+...                              ..+..+..+.+.|+..++.+|
T Consensus       203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  282 (337)
T cd07858         203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR  282 (337)
T ss_pred             HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhc
Confidence            99999998876544444444333322111                              223445567778889999999


Q ss_pred             ccccccCCC
Q 026720          225 VNLLAVMPS  233 (234)
Q Consensus       225 ~~~~~~~~~  233 (234)
                      +++++++.+
T Consensus       283 ps~~ell~h  291 (337)
T cd07858         283 ITVEEALAH  291 (337)
T ss_pred             cCHHHHHcC
Confidence            999998864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.51  E-value=1.1e-14  Score=116.32  Aligned_cols=174  Identities=18%  Similarity=0.285  Sum_probs=118.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh----------ccCccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM----------REKNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m----------~~~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .++..|+..|.+....+-....          ......++..+       +.|+.         ++|..+++|++++|+|
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~---------~LH~~~ivH~dlkp~N  162 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGME---------FLASKKCIHRDLAARN  162 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHH---------HHHHCCccccccceee
Confidence            5677788888887765432110          00112233222       45555         7888899999999999


Q ss_pred             EEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++ .....+++|||.+..+.....   ......+..|.+||... ...++..+|+||+|++++|+++ |..||++....
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            999 467789999999887654221   11112335689999875 3457889999999999999997 88999877655


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +....+......+.+...+..+..+...|+...+.+|+++.+++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5444443332223333445667777888998889999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.51  E-value=3.1e-14  Score=114.37  Aligned_cols=174  Identities=20%  Similarity=0.344  Sum_probs=122.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~  124 (234)
                      ..++..|+..|++.+..+--..  ++.+.+..+... +.|+.         ++|..+++|++++|.++++. ....++++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~---------~lH~~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA---------FLASKNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeehhhhccceEEEcCCCeEEECC
Confidence            3577778888888776432111  233334444433 55666         88988999999999999994 56778999


Q ss_pred             ccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh-CC
Q 026720          125 LGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLI-GS  199 (234)
Q Consensus       125 ~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~-~~  199 (234)
                      ||.+..+.....   ......+..|++||.+... .++...|+||+|++++++++ |..||++....+...+..... ..
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM  263 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence            998876543211   1112334569999988643 36889999999999999998 899999877666655554432 22


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.+...+..+..+...|+..++.+|+++.+++.
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            223345678888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.51  E-value=3.3e-14  Score=112.78  Aligned_cols=174  Identities=17%  Similarity=0.286  Sum_probs=121.3

Q ss_pred             HHHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++.+|+..|.+.+...-- ..+++..+..|... +.|+.         ++|+.+++|++++|+++++ .....++.+|
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~i~H~di~p~nil~~~~~~~kL~df  153 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS---------YLEEKRLVHRDLAARNVLVKTPQHVKITDF  153 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCEEecccCcceEEEcCCCeEEECCC
Confidence            45677788888887654321 11222233333333 45555         8888999999999999999 4567899999


Q ss_pred             cccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          126 GMVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       126 ~~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +.+..+......   .....+..|++||.... ..++...|+||+|++++|+++ |+.||.+....+....+......+.
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (279)
T cd05057         154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ  232 (279)
T ss_pred             cccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            988765432111   11122346899998753 346889999999999999998 9999998766665555544333444


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +...+..+..+...||..++..||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4555667777888899999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.51  E-value=2.9e-14  Score=111.88  Aligned_cols=173  Identities=20%  Similarity=0.290  Sum_probs=123.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...--.  .++...+..|... +.|+.         ++|..+++|++++|+++++ .....++.++
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~---------~lh~~~i~h~di~p~nili~~~~~~~l~d~  147 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA---------YLESRNYIHRDLAARNILVGENLVCKIADF  147 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCcchheEEEcCCCCEEECcc
Confidence            56666777777766543211  1122233333333 45555         8888899999999999999 4667899999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.+..+.....  ......+..|.+||...+ ..++...|+||+|++++++++ |+.||.+........++......+.+
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  226 (261)
T cd05034         148 GLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP  226 (261)
T ss_pred             ccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            98876543211  111223356899998864 346889999999999999998 99999988777777776665555555


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+..+..+...++...+.+|+++.+++.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            666778888888889889999999988753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.51  E-value=6.8e-14  Score=111.13  Aligned_cols=137  Identities=34%  Similarity=0.596  Sum_probs=104.8

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|..++.|++++|.++++ .....++.+++.+........ .....++..|++||++.+...++...|+||+|++++++
T Consensus       114 ~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l  193 (283)
T cd07835         114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEM  193 (283)
T ss_pred             HHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHH
Confidence            7888889999999999999 466789999998876533211 12223466799999886555578899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCC----------------------------cchhhhhhhhccccCCCCCcc
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSW----------------------------PLGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~  226 (234)
                      ++|.+||++....+...++++..+.|....|                            +..+..+...|+..++.+|++
T Consensus       194 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  273 (283)
T cd07835         194 VNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS  273 (283)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC
Confidence            9999999998888887777766554443222                            234555677788889999999


Q ss_pred             ccccCCC
Q 026720          227 LLAVMPS  233 (234)
Q Consensus       227 ~~~~~~~  233 (234)
                      +++++..
T Consensus       274 ~~~il~~  280 (283)
T cd07835         274 AKAALQH  280 (283)
T ss_pred             HHHHhcC
Confidence            9998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=2.2e-14  Score=117.76  Aligned_cols=179  Identities=18%  Similarity=0.270  Sum_probs=134.4

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe--eCCe
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV--SKGV  119 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~--~~~~  119 (234)
                      |..|--+||.+++..|++-+-+.-.++ +.+.-..-|-++ +.+..         +.|+--++|++++|.|+.|  .-++
T Consensus        87 DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~---------YCHqLHVVHRDLKPENVVFFEKlGl  157 (864)
T KOG4717|consen   87 DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAIS---------YCHQLHVVHRDLKPENVVFFEKLGL  157 (864)
T ss_pred             cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHH---------HHhhhhhhcccCCcceeEEeeecCc
Confidence            333444567777777777665433222 222222344444 66665         6666558999999999988  4678


Q ss_pred             eeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hC
Q 026720          120 IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL-IG  198 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~-~~  198 (234)
                      .++.|||....+.......+.+++-.|.|||++.+......++|+||+|+++|-+..|.+||....+.+.+..|++. +-
T Consensus       158 VKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt  237 (864)
T KOG4717|consen  158 VKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT  237 (864)
T ss_pred             eEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc
Confidence            99999999988887777788899999999999997666679999999999999999999999999999999888874 33


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      -|+..+  +.-..+++-....++.+|-++++|.+.
T Consensus       238 vPshvS--~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  238 VPSHVS--KECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             Cchhhh--HHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            444443  345566766777788899999988764

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.51  E-value=3.8e-14  Score=110.74  Aligned_cols=173  Identities=22%  Similarity=0.320  Sum_probs=119.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..|++.+...-.. .++.+.+..+... +.|+.         ++|..+++|++++|+|+++. ....++.+|+
T Consensus        69 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg  139 (252)
T cd05084          69 YIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME---------YLESKHCIHRDLAARNCLVTEKNVLKISDFG  139 (252)
T ss_pred             EEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCccccccchheEEEcCCCcEEECccc
Confidence            46777888888876543211 1222233333333 55555         78888899999999999994 5678999999


Q ss_pred             ccccccCCCCCC--Cc-ccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          127 MVKEIDSNLPCT--DY-VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       127 ~a~~~~~~~~~~--~~-~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      .+..........  .. .....|.+||.+.+. .++...|+||+|++++|+++ |..||......+....+......+.+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  218 (252)
T cd05084         140 MSREEEDGVYASTGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP  218 (252)
T ss_pred             cCcccccccccccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCc
Confidence            887644321110  01 112358999988643 47889999999999999997 88888766655444334333334445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..+...|+...+.+|+++.+++.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            566778888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.51  E-value=1.2e-13  Score=114.92  Aligned_cols=136  Identities=25%  Similarity=0.366  Sum_probs=95.4

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCC--CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|+|+++ .....+++|||.+......  .......+++.|++||++.+ ..|+..+|+||+|++++|
T Consensus       197 ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~e  275 (391)
T PHA03212        197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFE  275 (391)
T ss_pred             HHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHH
Confidence            8899999999999999999 4567899999998653221  12234568889999999874 447899999999999999


Q ss_pred             HHhCCCCCCCCC-------hHHHHHHHHHhhCCCCCC----------------------------CC------cchhhhh
Q 026720          174 MLSFGILFPGKS-------SADQIYKICQLIGSPTKD----------------------------SW------PLGIQLA  212 (234)
Q Consensus       174 ~~~~~~~f~~~~-------~~~~~~~i~~~~~~~~~~----------------------------~~------~~~~~~~  212 (234)
                      +++|..||.+..       ....+..+.+..+.++..                            .|      +..+..+
T Consensus       276 lltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L  355 (391)
T PHA03212        276 MATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYL  355 (391)
T ss_pred             HHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHH
Confidence            999997664321       223333344433322111                            11      1234445


Q ss_pred             hhhccccCCCCCccccccCCC
Q 026720          213 SNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+...++.+|++.++++.+
T Consensus       356 i~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        356 ICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHhcCChhhCCCHHHHhcC
Confidence            666778889999999998764

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.51  E-value=5.2e-14  Score=112.76  Aligned_cols=173  Identities=22%  Similarity=0.359  Sum_probs=120.3

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+.+...- ..+....+..+.. ++.|+.         ++|..++.|++++|+++++ .+...++.+||
T Consensus        92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~---------~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALE---------FLHSNQVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEEcCCCCEEECccc
Confidence            4577788888888775421 1112222223322 355555         8899999999999999999 45678999999


Q ss_pred             ccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC---CC
Q 026720          127 MVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP---TK  202 (234)
Q Consensus       127 ~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~---~~  202 (234)
                      .+........ .....+++.|.+||.... ..++...|+||+|++++++++|+.||.+.........+.. .+.+   .+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~  239 (296)
T cd06654         162 FCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP  239 (296)
T ss_pred             cchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCCCCCc
Confidence            8776533221 122456678999998864 3467899999999999999999999987766554443322 1222   22


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+..++..|+..++..|+++++++..
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            3345567778888999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.51  E-value=3.7e-14  Score=111.40  Aligned_cols=174  Identities=21%  Similarity=0.332  Sum_probs=121.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ..++..|+..|.+.+...--.  .++...+..|.. ++.++.         ++|..+++|++++|+|+++ .....++.+
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~---------~lH~~~i~H~dl~p~ni~i~~~~~~~l~d  145 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA---------FIEQRNYIHRDLRAANILVSASLVCKIAD  145 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHH---------HHHhCCccccccCcceEEEcCCCcEEECC
Confidence            356777888888776543211  011112233333 244555         7888899999999999999 456789999


Q ss_pred             ccccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          125 LGMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      ++.+..+.....  ......+..|.+||.... ..++...|+||+|++++++++ |..||++....+....+.+....+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  224 (260)
T cd05073         146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR  224 (260)
T ss_pred             CcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence            998876543211  111223455899998864 347889999999999999998 8999998777666655555444445


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....+..+..+...|+..++.+|+++.+++.
T Consensus       225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         225 PENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             cccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            5567778888888999999999999887753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.51  E-value=3.1e-14  Score=112.99  Aligned_cols=135  Identities=14%  Similarity=0.201  Sum_probs=101.7

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|++++|.++++ .....++.++|.++.+.....   .....++..|++||.... ..++..+|+||+|+++|
T Consensus       132 ~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~  210 (280)
T cd05043         132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLW  210 (280)
T ss_pred             HHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHH
Confidence            8899999999999999999 456789999999876543211   111233456899998863 34788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |+.||.+....+....+......+.....++.+..+...|+..++.+||++.+++.
T Consensus       211 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         211 ELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9998 99999887665554444333332334445677888899999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.51  E-value=3.4e-14  Score=111.40  Aligned_cols=173  Identities=24%  Similarity=0.302  Sum_probs=123.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...--..+++..+..|... +.++.         ++|..++.|++++|.++++ .....++.+++.
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~---------~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE---------YLHSKGIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            345567777777665432212222233333333 55666         8898899999999999999 456789999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCCCCCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS--ADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~--~~~~~~i~~~~~~~~~~~~  205 (234)
                      +.............++..|.+||..... .++...|+||+|++++++++|..||.....  .+...........+.+..+
T Consensus       147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (258)
T cd05578         147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW  225 (258)
T ss_pred             ccccCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccC
Confidence            8776543333344566779999998643 378899999999999999999999997664  4444444333344555677


Q ss_pred             cchhhhhhhhccccCCCCCccc--cccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNL--LAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~  232 (234)
                      +..+..++..++..++.+|+++  .+++.
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         226 STEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            8888889999999999999999  77765

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.51  E-value=4.9e-14  Score=110.61  Aligned_cols=170  Identities=22%  Similarity=0.278  Sum_probs=122.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+....+-...++...+..+... +.|+.         ++|..++.|++++|+++++ .....++.+|+.
T Consensus        73 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~---------~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~  143 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE---------DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGL  143 (260)
T ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHeEECCCCcEEEeeccc
Confidence            577788999998886654333444444555444 66666         8899999999999999999 456788999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC---CCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT---KDS  204 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~---~~~  204 (234)
                      +.....   .....+...|.+||...+.. ++...|+||+|++++++++|..||.+.........+........   ...
T Consensus       144 ~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (260)
T cd05611         144 SRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEF  219 (260)
T ss_pred             ceeccc---cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCccccc
Confidence            775433   22345666799999987544 78899999999999999999999987766555444433222211   123


Q ss_pred             CcchhhhhhhhccccCCCCCccc---cccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNL---LAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  232 (234)
                      .+..+..+...++...+..|++.   ++++.
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            46677778888888889999944   56654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.51  E-value=1.3e-14  Score=118.02  Aligned_cols=138  Identities=30%  Similarity=0.452  Sum_probs=102.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..+|..|+..|++.+...-.. .+++..+..|... +.|+.         ++|+.+++|++++|.|+++ .....++.||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~---------~lH~~~iiHrDlkp~Nill~~~~~~kl~Df  146 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH---------SIHQLHYVHRDIKPDNVLLDMNGHIRLADF  146 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeccCchHHEEEcCCCCEEEEec
Confidence            468888999999988765432 2333334444433 66666         7899999999999999999 4567899999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFS----EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~----~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      |.+........  .....+++.|++||++.+.    ..++..+|+||+|++++++++|+.||.+....+...++..
T Consensus       147 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05624         147 GSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             cceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc
Confidence            99876543221  1224578899999987532    3467889999999999999999999998877666665554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.51  E-value=8.4e-14  Score=108.84  Aligned_cols=175  Identities=19%  Similarity=0.311  Sum_probs=126.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~  124 (234)
                      ..++..|+..|.+.+.......  .+...+..+... +.++.         ++|+.++.|++++|+++++. ....++.+
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~---------~lh~~~~~h~dl~~~nil~~~~~~~~l~d  146 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGME---------YLESKNFIHRDLAARNCLVGENLVVKISD  146 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHH---------HHhcCCeeecccccceEEEccCCeEEEcc
Confidence            4567778888888776544322  333344444443 66666         88888999999999999994 55789999


Q ss_pred             ccccccccCCCCCCC--cccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          125 LGMVKEIDSNLPCTD--YVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +|.+...........  ...+..|.+||... ...++...|+||+|++++++++ |.+||.+....+....+......+.
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (258)
T smart00219      147 FGLSRDLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK  225 (258)
T ss_pred             cCCceecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            998887654321111  12446789999885 4457889999999999999998 7888887666666655555444444


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ....+..+..+.+.++..++.+|+++.+++..
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  257 (258)
T smart00219      226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEI  257 (258)
T ss_pred             CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence            55567778888889999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.51  E-value=3.8e-14  Score=113.62  Aligned_cols=172  Identities=19%  Similarity=0.333  Sum_probs=119.9

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ++..|+..|.+.....- ..+.+..+..+... +.|+.         ++|..+++|++++|.|+++ .....++.++|.+
T Consensus        95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~---------~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~  164 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALC---------YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC  164 (297)
T ss_pred             EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence            45556776776653221 11222333344333 66666         8898899999999999999 4677899999988


Q ss_pred             ccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC--CCCCC
Q 026720          129 KEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP--TKDSW  205 (234)
Q Consensus       129 ~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~--~~~~~  205 (234)
                      ..+..... .....++..|.+||.+.+. .++...|+||+|++++|+++|+.||......+....+.......  ....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (297)
T cd06659         165 AQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI  243 (297)
T ss_pred             hhcccccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCC
Confidence            76543322 2334567789999998643 46889999999999999999999998776666554443221111  11234


Q ss_pred             cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..+..+.+.++..++.+|+++++++..
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            5667788888999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.51  E-value=4.3e-14  Score=113.86  Aligned_cols=172  Identities=24%  Similarity=0.338  Sum_probs=120.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+..+....+++..+..|... +.|+.         ++|+ .+++|++++|+|+++ .....++.+||
T Consensus        75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLT---------YLREKHKIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhhCCEEECCCChHHEEEecCCcEEEccCC
Confidence            477788998999887654433443334444444 55666         7886 469999999999999 45678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC-------
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS-------  199 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~-------  199 (234)
                      .+..+.... .....+++.|.+||...+ ..++...|+||+|++++++++|+.||++..... ...++.....       
T Consensus       146 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  222 (308)
T cd06615         146 VSGQLIDSM-ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKES  222 (308)
T ss_pred             Ccccccccc-cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCC
Confidence            887665432 233567788999998764 347888999999999999999999997654322 2222211100       


Q ss_pred             -----------------------------C--CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 -----------------------------P--TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 -----------------------------~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                   |  +...++..+..++..|+...+.+|+++.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                         0  011244567778888999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.51  E-value=6.1e-14  Score=103.73  Aligned_cols=140  Identities=16%  Similarity=0.246  Sum_probs=95.2

Q ss_pred             hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCccccc
Q 026720           71 MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG  148 (234)
Q Consensus        71 m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~  148 (234)
                      +++..+..|... +.|+.         ++|..+      +|.|+++. +...++  ||.+.......    ..+++.|+|
T Consensus        14 l~~~~~~~i~~qi~~~L~---------~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~~y~a   72 (176)
T smart00750       14 LNEEEIWAVCLQCLRALR---------ELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDPYFMA   72 (176)
T ss_pred             CCHHHHHHHHHHHHHHHH---------HHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcccccC
Confidence            334444444444 55665         777663      89999884 444555  77766544321    256788999


Q ss_pred             ccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhhCCCC------CCCCcc--hhhhhhhhcccc
Q 026720          149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI-YKICQLIGSPT------KDSWPL--GIQLASNLNWKL  219 (234)
Q Consensus       149 pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~-~~i~~~~~~~~------~~~~~~--~~~~~~~~~~~~  219 (234)
                      ||++.+ ..|+.++|+||+|+++||+++|+.||.+....... ..+...+....      ...+.+  .+..+...|+..
T Consensus        73 PE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~  151 (176)
T smart00750       73 PEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR  151 (176)
T ss_pred             hHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence            999974 45789999999999999999999999876544333 33333333221      122233  467788889999


Q ss_pred             CCCCCccccccCC
Q 026720          220 PQMGGVNLLAVMP  232 (234)
Q Consensus       220 ~~~~~~~~~~~~~  232 (234)
                      .+.+|+++.+++.
T Consensus       152 ~p~~Rp~~~~ll~  164 (176)
T smart00750      152 LPQRREAANHYLA  164 (176)
T ss_pred             ccccccCHHHHHH
Confidence            9999999998864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.50  E-value=4.6e-14  Score=111.85  Aligned_cols=172  Identities=13%  Similarity=0.171  Sum_probs=117.7

Q ss_pred             HHHHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC--------
Q 026720           48 GTALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK--------  117 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~--------  117 (234)
                      +..+|..|+..|.++...+-- ..++......+... +.|+.         ++|..+++|++++|.|+++..        
T Consensus        90 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          90 ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALS---------YLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            346888999999987765321 11222333334333 45555         889999999999999999842        


Q ss_pred             CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHh
Q 026720          118 GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~-~~~~~f~~~~~~~~~~~i~~~  196 (234)
                      ...++.++|.+......   ....++..|++||.+.....++...|+||+|+++||++ .|..||.+....+.. .....
T Consensus       161 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~  236 (274)
T cd05076         161 PFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYEK  236 (274)
T ss_pred             ceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HHHHh
Confidence            23678888876554321   12345567999998865455788999999999999985 688999876554432 33332


Q ss_pred             hCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          197 IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ... .+......+..++..||...+.+|+++.+++..
T Consensus       237 ~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 KHR-LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ccC-CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            222 222233467778888999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.50  E-value=5.9e-14  Score=110.26  Aligned_cols=175  Identities=21%  Similarity=0.302  Sum_probs=123.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      -.++..|...|.+.+...-...++...+..|.. ++.|+.         ++|+.+++|++++|+++++ .....++.+|+
T Consensus        68 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~---------~lH~~~~~h~dl~~~nilv~~~~~~~l~df~  138 (262)
T cd05572          68 IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFE---------YLHNRGIIYRDLKPENLLLDSNGYVKLVDFG  138 (262)
T ss_pred             cEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHhhCCcccCCCCHHHEEEcCCCCEEEeeCC
Confidence            356777888888876644322233333333433 366666         8999999999999999999 46678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhC-CCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--SADQIYKICQLIG-SPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--~~~~~~~i~~~~~-~~~~~  203 (234)
                      .+.............+++.|++||.+.. ..++...|+||+|++++++++|..||.+..  ......++..... .+.+.
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (262)
T cd05572         139 FAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN  217 (262)
T ss_pred             cccccCcccccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc
Confidence            9887765432333456778999998763 346888999999999999999999998765  4344444432111 12223


Q ss_pred             CCcchhhhhhhhccccCCCCCcc-----ccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVN-----LLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  233 (234)
                      ..+..+..+...++...+.+|++     +.+++++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            34667888888888888899998     7777653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.50  E-value=4.1e-14  Score=110.35  Aligned_cols=176  Identities=19%  Similarity=0.258  Sum_probs=120.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      ..++..|+..|.+.+...-..     ....+...+....+.....  .++|..+++|++++|+++.+ .+...++.++|.
T Consensus        67 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l--~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~  139 (250)
T cd05085          67 IYIVMELVPGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGM--AYLESKNCIHRDLAARNCLVGENNVLKISDFGM  139 (250)
T ss_pred             cEEEEECCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHH--HHHHhCCeeecccChheEEEcCCCeEEECCCcc
Confidence            457778888888877643211     1122333222222111111  17788889999999999999 456789999998


Q ss_pred             cccccCCCCCC--CcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          128 VKEIDSNLPCT--DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       128 a~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +..........  ....+..|.+||...+ ..++...|+||+|++++++++ |..||++.........+........+..
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  218 (250)
T cd05085         140 SRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK  218 (250)
T ss_pred             ceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            87654332111  1122346899998863 447888999999999999998 8899998866665555544333333445


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..+..+...|+...+.+|+++.+++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6678888889999999999999998864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.50  E-value=4.2e-14  Score=110.69  Aligned_cols=175  Identities=20%  Similarity=0.290  Sum_probs=122.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      -.++..|+..|.+.+...... .++.+.+..+... +.++.         ++|..+++|++++|.|+.+ .+...++.++
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~  144 (256)
T cd05112          74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA---------YLESSNVIHRDLAARNCLVGENQVVKVSDF  144 (256)
T ss_pred             eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHH---------HHHHCCccccccccceEEEcCCCeEEECCC
Confidence            356777888888766543211 1222233334333 45555         7888889999999999999 4567899999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.+........  ......+..|.+||...+ ..++...|+||+|++++|+++ |..||.+.........+.+......+
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05112         145 GMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP  223 (256)
T ss_pred             cceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC
Confidence            98776533211  112233457899998864 447889999999999999998 88999877766666555544343444


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+..+...|+..++.+|+++.+++..
T Consensus       224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            4556788888899999999999999988753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.50  E-value=8.8e-15  Score=114.60  Aligned_cols=174  Identities=24%  Similarity=0.370  Sum_probs=122.7

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a  128 (234)
                      ++..|+..+.+.+...--..++...+..+... +.|+.         ++|+.++.|++++|+|+++. ....++.|||.+
T Consensus        75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~---------~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALA---------YLHSKGIVHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHH---------HHHHTTEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             cccccccccccccccccccccccccccccccccccccc---------ccccccccccccccccccccccccccccccccc
Confidence            66677777777765552222222233333333 66666         89999999999999999994 677899999998


Q ss_pred             ccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC---CCC
Q 026720          129 KEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT---KDS  204 (234)
Q Consensus       129 ~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~---~~~  204 (234)
                      ..... ........++..|.+||.......++...|+||+|++++++++|..||.+....+....+.+....+.   ...
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T PF00069_consen  146 VKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ  225 (260)
T ss_dssp             EESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc
Confidence            75311 12234456778899999986345578999999999999999999999998744444444444333211   111


Q ss_pred             C---cchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 W---PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +   ...+..+...++...+.+|+++.+++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1   2678888888999999999999998865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.50  E-value=1.5e-13  Score=112.78  Aligned_cols=136  Identities=35%  Similarity=0.540  Sum_probs=104.3

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|.|+++ .....++.+||.+.............++..|++||...+ ..++...|+||+|+++++++
T Consensus       133 ~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~  211 (353)
T cd07850         133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI  211 (353)
T ss_pred             HHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHH
Confidence            8899999999999999999 456789999999887655433334456778999999864 44788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCC------------------------------------------CCcchhhhhh
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKD------------------------------------------SWPLGIQLAS  213 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~------------------------------------------~~~~~~~~~~  213 (234)
                      +|+.||++....+...++....+.|...                                          ..++.+..+.
T Consensus       212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  291 (353)
T cd07850         212 RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL  291 (353)
T ss_pred             HCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHH
Confidence            9999999887777666665544443210                                          1122345667


Q ss_pred             hhccccCCCCCccccccCCC
Q 026720          214 NLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+...++.+|+++.+++.+
T Consensus       292 ~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         292 SKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHcCCChhhCcCHHHHhcC
Confidence            77888899999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.50  E-value=5.9e-14  Score=109.88  Aligned_cols=174  Identities=20%  Similarity=0.289  Sum_probs=119.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-..  .++...+..+... +.|+.         ++|..++.|++++|.++++ .....++.+|
T Consensus        71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~---------~lH~~~i~H~di~p~nil~~~~~~~kl~df  141 (257)
T cd05040          71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR---------YLESKRFIHRDLAARNILLASDDKVKIGDF  141 (257)
T ss_pred             EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHH---------HHHhCCccccccCcccEEEecCCEEEeccc
Confidence            45556677777766543211  1112222333322 45555         7888899999999999999 4677899999


Q ss_pred             cccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhC-C
Q 026720          126 GMVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIG-S  199 (234)
Q Consensus       126 ~~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~-~  199 (234)
                      |.+..+.....    .....++..|.+||...+ ..++...|+||+|++++++++ |..||.+....+....+..... .
T Consensus       142 g~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  220 (257)
T cd05040         142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL  220 (257)
T ss_pred             cccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC
Confidence            98877643211    111234567999998763 347888999999999999998 9999988777666555543221 1


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.+...+..+..+...|+...+.+|+++.+++..
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~  254 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREF  254 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence            2233445677778888999999999999988753

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.50  E-value=5e-14  Score=112.42  Aligned_cols=135  Identities=19%  Similarity=0.277  Sum_probs=101.3

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.++++ .....++++||.+..+.....   ......+..|.+||... ...++...|+||+|++++
T Consensus       142 ~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~  220 (290)
T cd05045         142 YLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLW  220 (290)
T ss_pred             HHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHH
Confidence            7888899999999999999 456789999998876543211   11122345689999875 344788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||++.........+-+....+.+..++..+..+...|+..++.+||++.+++.
T Consensus       221 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         221 EIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            9998 99999876655444333333333445566778888899999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.50  E-value=1.1e-13  Score=109.34  Aligned_cols=174  Identities=17%  Similarity=0.188  Sum_probs=114.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhcc--C---ccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMRE--K---NLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIK  121 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~--~---~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~  121 (234)
                      ..++..|+..|++.+...-......  .   .+..+.. ++.|+.         ++|+.+++|++++|+++++. ....+
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~i~H~dlkp~nil~~~~~~~k  140 (269)
T cd05087          70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL---------HLHKNNFIHSDLALRNCLLTADLTVK  140 (269)
T ss_pred             cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHH---------HHHHCCEeccccCcceEEEcCCCcEE
Confidence            4577888888988776543221111  1   1122322 244555         78888999999999999994 56789


Q ss_pred             EeeccccccccCCC---CCCCcccCccccccccccccc------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 026720          122 IGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSE------IYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIY  191 (234)
Q Consensus       122 ~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~------~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~  191 (234)
                      +.|||.+.......   ......++..|++||++....      .++...|+||+|++++|+++ |+.||+.....+...
T Consensus       141 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  220 (269)
T cd05087         141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT  220 (269)
T ss_pred             ECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence            99999886543321   111234456799999875321      24678999999999999996 999998776665544


Q ss_pred             HHHHhhCC--CCC---CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          192 KICQLIGS--PTK---DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       192 ~i~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ........  +++   ...++.+..+++.||. ++.+||++++|..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~-~P~~Rpt~~~l~~  265 (269)
T cd05087         221 YTVREQQLKLPKPRLKLPLSDRWYEVMQFCWL-QPEQRPSAEEVHL  265 (269)
T ss_pred             HHhhcccCCCCCCccCCCCChHHHHHHHHHhc-CcccCCCHHHHHH
Confidence            33322111  111   1334566678888995 6789999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.50  E-value=6.6e-14  Score=109.62  Aligned_cols=171  Identities=19%  Similarity=0.304  Sum_probs=118.7

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .++..|+..|.+.+..+--.  .+..+.+..+... +.++.         ++|..++.|++++|.++++. ....++.++
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lh~~~i~H~di~p~Nili~~~~~~~l~d~  146 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME---------YLEEKNFVHRDLAARNVLVSEDLVAKVSDF  146 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCccchhcccceEEEeCCCCEEEccc
Confidence            46666777777766543211  1222223333333 55666         88988999999999999994 567899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +.+........  .......|.+||.... ..++...|+||+|++++++++ |..||......+....+........+..
T Consensus       147 g~~~~~~~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05039         147 GLAKEASQGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG  223 (256)
T ss_pred             ccccccccccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence            98887643221  2233456899998763 347789999999999999997 8899987765554444433323333445


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .++.+..+...|+...+.+|+++++++.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            6677888888899989999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.50  E-value=5.1e-14  Score=110.07  Aligned_cols=174  Identities=20%  Similarity=0.321  Sum_probs=120.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..+.+.+....... ++...+..+.. ++.|+.         ++|..++.|++++|+++.+ .....++.+++
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~---------~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE---------YLHSNKKIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCcceEEECCCCcEEEcccc
Confidence            456777787888776543221 12222223333 255666         7888889999999999999 46678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKD  203 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~  203 (234)
                      .+..+.... ......++..|.+||.+.+ ..++...|+||+|++++++++|+.||.+.........+......  ..+.
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd06612         145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE  223 (256)
T ss_pred             cchhcccCccccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchh
Confidence            888765432 1222345678999999864 34788999999999999999999999876554443332221111  1123


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .++..+..+++.|+..++.+|+++.+++..
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            455677788888999999999999998864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.50  E-value=4.3e-14  Score=112.06  Aligned_cols=175  Identities=17%  Similarity=0.249  Sum_probs=119.8

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      +..++..|+..|.+.+..+- ..+++..+..+... +.++.         ++|..+++|++++|.++++. ....++.++
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~---------~lh~~~ivH~dl~p~Nil~~~~~~~~l~df  145 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLD---------YLHSEKKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHH---------HHHhCCccCcCCChhhEEEcCCCCEEEccc
Confidence            35677788888888765431 11222222233222 44444         78888899999999999994 567889999


Q ss_pred             cccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +.+..+.... ......++..|.+||...+. .++...|+||+|++++|+++|..||.+.........+.......-...
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (277)
T cd06640         146 GVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE  224 (277)
T ss_pred             ccceeccCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchh
Confidence            9887654322 12233456678999998643 368899999999999999999999987665544433322111111223


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...|+...+.+|+++++++..
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         225 FSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            45567778888999999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.50  E-value=5.6e-14  Score=110.90  Aligned_cols=173  Identities=20%  Similarity=0.293  Sum_probs=121.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+...-.. .++...+..+. .++.|+.         ++|..+++|++++|+++++. ....++.+++
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA---------YLESKRFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccccChheEEEecCCCeEEccCc
Confidence            36667888888876543211 12222222222 2355555         78888999999999999994 5678999999


Q ss_pred             ccccccCCCCCC--CcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNLPCT--DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+..........  ....+..|++||.... ..++...|+||+|++++|+++ |..||.+....+...++.+....+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  231 (270)
T cd05056         153 LSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP  231 (270)
T ss_pred             eeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            887654432111  1122346899998763 447889999999999999986 999999888777766665544444455


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+..+..++..++...+.+|+++.+++.
T Consensus       232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         232 NCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            66678888888899999999999988764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.49  E-value=4.3e-14  Score=110.61  Aligned_cols=174  Identities=21%  Similarity=0.429  Sum_probs=124.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .++..|+..+.+.+....-.  ..++..+..|... +.++.         ++|..++.|++++|.++++. ....++.++
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~i~h~~l~~~nil~~~~~~~~l~d~  145 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK---------HVHDRKILHRDIKSQNIFLTKDGTIKLGDF  145 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEecCCCCHHHEEEcCCCCEEEeec
Confidence            46677777777765433211  1122223333333 55555         78888999999999999994 567899999


Q ss_pred             cccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      +.+........ .....++..|.+||...+. .++.+.|+||+|++++++++|+.||......+...++......+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd08218         146 GIARVLNSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSH  224 (256)
T ss_pred             cceeecCcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCccc
Confidence            98876544221 1223456679999998643 467889999999999999999999998777777666654443344556


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+..++..|+...+.+|+++.+++.+
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            67778888889999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.49  E-value=1.5e-13  Score=107.38  Aligned_cols=173  Identities=27%  Similarity=0.423  Sum_probs=124.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .++..|+..+++.+...--..    +....+..+. .++.|+.         ++|..++.|++++|+++.+ .....++.
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~---------~lh~~~i~h~~l~~~ni~~~~~~~~kl~  145 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ---------ALHEQKILHRDLKSANILLVANDLVKIG  145 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHhhCCcccCCCCcceEEEecCCcEEEe
Confidence            456667777777665432110    1111222232 2355666         7888889999999999999 45678999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +++.+....... .....++..|.+||...+ ..++...|+||+|++++++++|..||...........+......+.+.
T Consensus       146 d~g~~~~~~~~~-~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd08530         146 DLGISKVLKKNM-AKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP  223 (256)
T ss_pred             eccchhhhccCC-cccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCch
Confidence            999887765542 223456678999999864 446778999999999999999999999877665555554433334445


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .++..+..+...++..++.+|+++.+++..
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            677778888888999999999999998764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.49  E-value=5.1e-14  Score=113.35  Aligned_cols=181  Identities=19%  Similarity=0.312  Sum_probs=119.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh--h-------c-cCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL--M-------R-EKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K  117 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~--m-------~-~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~  117 (234)
                      ..++..|+..|.+.+...-...  +       . .....++..++....+.....+  ++|..+++|++++|+|+++. .
T Consensus        99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~--~lH~~gi~H~dlkp~Nill~~~  176 (307)
T cd05098          99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGME--YLASKKCIHRDLAARNVLVTED  176 (307)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHH--HHHHCCcccccccHHheEEcCC
Confidence            3467778888888776543211  0       0 0123455444433332222222  78888999999999999994 5


Q ss_pred             CeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 026720          118 GVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKI  193 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i  193 (234)
                      ...+++++|.+........   ......+..|++||.+.+ ..++...|+||+|++++++++ |..||++....+....+
T Consensus       177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             CcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            6789999998876543211   111122356999998864 447889999999999999998 88899876543333333


Q ss_pred             HHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          194 CQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      -.....+.+...+..+..+...|+...+.+|+++.+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         256 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            222222333456677888888899999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.49  E-value=5.2e-14  Score=110.25  Aligned_cols=172  Identities=19%  Similarity=0.187  Sum_probs=117.4

Q ss_pred             HHHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC------
Q 026720           48 GTALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG------  118 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~------  118 (234)
                      ...++..|+..|.+.+-..... .++...+..+... +.|+.         ++|..+++|++++|.|+++. ..      
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~---------~LH~~~i~H~dlkp~Nill~~~~~~~~~~  144 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALH---------YLEDKKLVHGNVCGKNILVARYGLNEGYV  144 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHhhCCeecccCccceEEEecCccccCCc
Confidence            3457778888888877544322 2333333444332 55566         88998999999999999994 33      


Q ss_pred             -eeeEeeccccccccCCCCCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 026720          119 -VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       119 -~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~  195 (234)
                       ..+++|++.+......   ....+...|.+||.+.+. ..++...|+||+|++++++++ +..||........ ...+.
T Consensus       145 ~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~~  220 (259)
T cd05037         145 PFIKLSDPGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQ  220 (259)
T ss_pred             eeEEeCCCCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHHh
Confidence             5899999988875441   223445678999998654 357889999999999999998 4677766543222 22222


Q ss_pred             hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          196 LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      . ....+......+..+...|+..++.+|+++.+++..
T Consensus       221 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  257 (259)
T cd05037         221 D-QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD  257 (259)
T ss_pred             c-CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            2 222222233577788888999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.49  E-value=3.3e-14  Score=123.99  Aligned_cols=197  Identities=15%  Similarity=0.209  Sum_probs=134.9

Q ss_pred             HHHHHHhccchhHHHH---------HHHHHHHhhcCChHHHHHHHH---hhccC-------ccccHHHHHHHHHhcCCch
Q 026720           33 HSYAVVNGLELDVAIG---------TALVEMYSKCGHVEKAFKVFN---LMREK-------NLQSWTIMISGLADNSRGN   93 (234)
Q Consensus        33 ~~~~~~~g~~~~~~~~---------~~li~~~~~~g~~~~a~~~~~---~m~~~-------~~~~~~~~i~~~~~~g~~~   93 (234)
                      ...|...|-.+|+++.         ..+|..|+..|++.+-.+--+   .....       +..+..-+++.--|..++.
T Consensus       352 l~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GM  431 (609)
T KOG0200|consen  352 LNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGM  431 (609)
T ss_pred             HHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHH
Confidence            3344455666665432         456778999999888765544   11111       1233333333333333333


Q ss_pred             hhhHhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCC--Ccc--cCcccccccccccccCCCCcchHHHHH
Q 026720           94 DAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCT--DYV--TTRWYRGPEVLLFSEIYGPEVDKWAMG  168 (234)
Q Consensus        94 ~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~--~~~--~~~~~~~pe~~~~~~~~~~~~d~~s~g  168 (234)
                      +  ++.+..++|+|+..-|+++. ...++++|||+++.....-...  ...  ....|+|||.+.. ..|+.++|+||+|
T Consensus       432 e--~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfG  508 (609)
T KOG0200|consen  432 E--YLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFG  508 (609)
T ss_pred             H--HHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHH
Confidence            3  77777789999999999995 5588999999999655432211  111  2234899999975 6699999999999


Q ss_pred             HHHHHHHh-CCCCCCCCC-hHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          169 AIMFEMLS-FGILFPGKS-SADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       169 ~~l~e~~~-~~~~f~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +++||+++ |..||++.. ..+....+-+......+..++..+=.+++.||+..+.+||+|.++.+
T Consensus       509 I~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  509 ILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            99999996 669999976 55554434444444666777778888999999999999999998753

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.49  E-value=4.4e-14  Score=111.48  Aligned_cols=173  Identities=19%  Similarity=0.320  Sum_probs=120.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..|.+++-.+.... +....+..+.. ++.|+.         ++|..+++|++++|+++++. ....++.+|+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~---------~lH~~g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK---------YLSEMNYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeecccChheEEEcCCCcEEECCCc
Confidence            466778888887665332111 11122222322 245555         78888999999999999994 5677899999


Q ss_pred             ccccccCCCCCCCc------ccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 026720          127 MVKEIDSNLPCTDY------VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       127 ~a~~~~~~~~~~~~------~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      .+............      ..+..|.+||...+ ..++...|+||+|++++|+++ |..||.+....+....+......
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~  230 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL  230 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            87655332111111      11235899999864 347889999999999999886 89999887777666666554445


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |.+...+..+..+...|+...+.+||++++++.
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            555667778888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.49  E-value=1.1e-13  Score=112.75  Aligned_cols=137  Identities=34%  Similarity=0.564  Sum_probs=102.5

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l  171 (234)
                      ++|..+++|++++|.|+++ .....++.+||.+........    .....++..|++||.+.....++...|+||+|+++
T Consensus       121 ~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil  200 (336)
T cd07849         121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL  200 (336)
T ss_pred             HHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence            8899999999999999999 456789999998876543211    12245677899999875445578899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC------------------------------CcchhhhhhhhccccCC
Q 026720          172 FEMLSFGILFPGKSSADQIYKICQLIGSPTKDS------------------------------WPLGIQLASNLNWKLPQ  221 (234)
Q Consensus       172 ~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~  221 (234)
                      +++++|++||++.........+.+..+.+....                              .+..+..+...++...+
T Consensus       201 ~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP  280 (336)
T cd07849         201 AEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNP  280 (336)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCCh
Confidence            999999999998776666555555444432211                              12345566777888899


Q ss_pred             CCCccccccCCC
Q 026720          222 MGGVNLLAVMPS  233 (234)
Q Consensus       222 ~~~~~~~~~~~~  233 (234)
                      .+|+++.+++++
T Consensus       281 ~~Rpt~~e~l~h  292 (336)
T cd07849         281 HKRITVEEALAH  292 (336)
T ss_pred             hhCcCHHHHhcC
Confidence            999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.49  E-value=5.9e-14  Score=112.13  Aligned_cols=142  Identities=26%  Similarity=0.365  Sum_probs=108.9

Q ss_pred             HHHHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           48 GTALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      |.+|+..||..|++..+++--  ...++..+..|.+= +.|+-         +||-.+++.+|++|+|+++ .++...+.
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALE---------YLHmlGivYRDLKPENILvredGHIMLs  221 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALE---------YLHMLGIVYRDLKPENILVREDGHIMLS  221 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHH---------HHHhhceeeccCCcceeEEecCCcEEee
Confidence            678999999999998886531  12334456667665 66777         8999999999999999999 67888888


Q ss_pred             eccccccccC-----------------------------C----------------------------CCCCCcccCccc
Q 026720          124 DLGMVKEIDS-----------------------------N----------------------------LPCTDYVTTRWY  146 (234)
Q Consensus       124 ~~~~a~~~~~-----------------------------~----------------------------~~~~~~~~~~~~  146 (234)
                      ||.+..+...                             .                            ...+.++++.-|
T Consensus       222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY  301 (459)
T KOG0610|consen  222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY  301 (459)
T ss_pred             eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence            8876543200                             0                            011234566779


Q ss_pred             ccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          147 RGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       147 ~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      .|||++.+.. ...++|.|++|+++|||+.|..||.|.++.+.+..|..+-..
T Consensus       302 lAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~  353 (459)
T KOG0610|consen  302 LAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK  353 (459)
T ss_pred             ccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc
Confidence            9999998655 478999999999999999999999999999998887665443

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.49  E-value=7.5e-14  Score=111.44  Aligned_cols=169  Identities=25%  Similarity=0.296  Sum_probs=121.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+..+-...++...+..|... +.|+.         ++|..+++|++++|.++++ .....++.+|+.
T Consensus        77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~---------~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~  147 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE---------YLHSLDIVYRDLKPENLLLDSDGYIKITDFGF  147 (290)
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence            466778878888766544333443333444333 66666         8899999999999999999 466789999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +......  .....+++.|.+||.+... .++...|+||+|++++++++|..||.+.........+... ..+-+..++.
T Consensus       148 ~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  223 (290)
T cd05580         148 AKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSP  223 (290)
T ss_pred             ccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCH
Confidence            8876543  2334567789999988643 4678899999999999999999999877755544444422 2233445677


Q ss_pred             hhhhhhhhccccCCCCCc-----cccccC
Q 026720          208 GIQLASNLNWKLPQMGGV-----NLLAVM  231 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~-----~~~~~~  231 (234)
                      .+..+.+.++...+.+|+     ++++++
T Consensus       224 ~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             HHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            888888888888888887     555554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.49  E-value=1.8e-13  Score=110.02  Aligned_cols=137  Identities=34%  Similarity=0.606  Sum_probs=104.0

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC------------CCCcccCcccccccccccccCCCCcch
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP------------CTDYVTTRWYRGPEVLLFSEIYGPEVD  163 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~------------~~~~~~~~~~~~pe~~~~~~~~~~~~d  163 (234)
                      ++|..++.|++++|.++++ .....++.+++.+........            .....+++.|.+||...+...++...|
T Consensus       130 ~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  209 (311)
T cd07866         130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVD  209 (311)
T ss_pred             HHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhH
Confidence            7899999999999999999 456789999998875533211            112244667999998765555788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc-----------------------------chhhhhhh
Q 026720          164 KWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-----------------------------LGIQLASN  214 (234)
Q Consensus       164 ~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~-----------------------------~~~~~~~~  214 (234)
                      +||+|++++|+++|++||.+.........++...+.+.+..|+                             ..+..+..
T Consensus       210 v~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  289 (311)
T cd07866         210 IWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLS  289 (311)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHH
Confidence            9999999999999999999988888888887766654433222                             23345666


Q ss_pred             hccccCCCCCccccccCCC
Q 026720          215 LNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+....+.+|++..+++.+
T Consensus       290 ~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         290 KLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHcccCcccCcCHHHHhcC
Confidence            6777788999999988764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=2.3e-14  Score=126.63  Aligned_cols=156  Identities=31%  Similarity=0.424  Sum_probs=124.2

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      |-+||+.|+-.|++-....-|+.+|+.-...|++= +-|+.         .+|..+.+|+|++|||+++ ..++.++.||
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAld---------slH~mgyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALD---------SLHSMGYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHH---------HHHhccceeccCCcceeEecccCcEeeccc
Confidence            34688899999999999988888888777777765 66676         7899999999999999999 5789999999


Q ss_pred             cccccccCC--CCCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---h
Q 026720          126 GMVKEIDSN--LPCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ---L  196 (234)
Q Consensus       126 ~~a~~~~~~--~~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~---~  196 (234)
                      |.+..+...  ......+|||-|.+||++..    ...|..-.|.||+|+++|||+.|..||+.+...+.--+|..   .
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~  299 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES  299 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence            999887532  23455789999999999843    24588999999999999999999999998887777777765   3


Q ss_pred             hCCCCCCCCcchhhhh
Q 026720          197 IGSPTKDSWPLGIQLA  212 (234)
Q Consensus       197 ~~~~~~~~~~~~~~~~  212 (234)
                      ...|+....++....+
T Consensus       300 l~FP~~~~VSeeakdL  315 (1317)
T KOG0612|consen  300 LSFPDETDVSEEAKDL  315 (1317)
T ss_pred             cCCCcccccCHHHHHH
Confidence            4456444444443333

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.49  E-value=1.3e-13  Score=112.36  Aligned_cols=137  Identities=35%  Similarity=0.527  Sum_probs=104.2

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC------CCCCcccCcccccccccccccCCCCcchHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGA  169 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~  169 (234)
                      ++|..++.|++++|.++++ ..+..+++++|.+..+....      ......++..|++||.+.+...++..+|+||+|+
T Consensus       122 ~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~  201 (337)
T cd07852         122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGC  201 (337)
T ss_pred             HHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHH
Confidence            7898899999999999999 46778999999887654321      1223456778999998865555788999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC------------------------------CCCcchhhhhhhhcccc
Q 026720          170 IMFEMLSFGILFPGKSSADQIYKICQLIGSPTK------------------------------DSWPLGIQLASNLNWKL  219 (234)
Q Consensus       170 ~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~  219 (234)
                      +++++++|+.||++....+...++....+.+..                              ...+..+..++..++..
T Consensus       202 ~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (337)
T cd07852         202 ILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVF  281 (337)
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccC
Confidence            999999999999988777766665554433221                              11234455667778888


Q ss_pred             CCCCCccccccCCC
Q 026720          220 PQMGGVNLLAVMPS  233 (234)
Q Consensus       220 ~~~~~~~~~~~~~~  233 (234)
                      .+.+|+++.++++.
T Consensus       282 ~P~~Rps~~~il~~  295 (337)
T cd07852         282 NPNKRLTAEEALEH  295 (337)
T ss_pred             CcccccCHHHHhhC
Confidence            99999999988764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.48  E-value=8.2e-14  Score=110.00  Aligned_cols=172  Identities=20%  Similarity=0.235  Sum_probs=121.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC-eeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG-VIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~-~~~~~~~  125 (234)
                      ..+|..|+..|++.+...--..++++.+..|... +.|+.         ++|+.+++|++++|.++++. .. ..+++++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALN---------DLHKHNIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            4677788888888876543333444455555554 66666         89999999999999999994 44 6889999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCC--CCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ-IYKICQLIGS--PTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~-~~~i~~~~~~--~~~  202 (234)
                      +.+......   ....++..|++||++.+ ..++...|+||+|++++++++|..||.+....+. ..........  +..
T Consensus       155 g~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T PHA03390        155 GLCKIIGTP---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI  230 (267)
T ss_pred             ccceecCCC---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence            987765432   22356778999999864 3478889999999999999999999986543322 1222222221  222


Q ss_pred             CCCcchhhhhhhhccccCCCCCc-cccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGV-NLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  233 (234)
                      ...+..+..++..++...+.+|+ ++++++++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            34667777777778888888887 57988764

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.48  E-value=8.2e-14  Score=113.49  Aligned_cols=173  Identities=18%  Similarity=0.314  Sum_probs=119.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--h--------ccCccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--M--------REKNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m--------~~~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .++..|+..|.+.+.......  +        ......+|...       +.|+.         ++|..+++|++++|+|
T Consensus        94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~---------~LH~~givH~dlkp~N  164 (334)
T cd05100          94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGME---------YLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHH---------HHHHCCeeccccccce
Confidence            466778888888765432110  0        00122344332       44555         7898899999999999


Q ss_pred             EEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++. ....++++|+.+........   ......+..|++||...+ ..++...|+||+|++++|+++ |..||++....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9994 66789999998876543211   111122346899998863 447889999999999999998 88999887665


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....+......+.+...+..+..+...|+...+.+|+++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~  288 (334)
T cd05100         244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE  288 (334)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            555445444333444455667888888999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.48  E-value=6.1e-14  Score=111.09  Aligned_cols=172  Identities=20%  Similarity=0.353  Sum_probs=117.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+..+. ..++...+..+... +.++.         ++|..++.|++++|+++.+ .....++.+++.
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~---------~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALK---------YIHKVGVIHRDIKAANILVTNTGNVKLCDFGV  147 (277)
T ss_pred             EEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCcCHHHEEEcCCCCEEEccCCc
Confidence            466777888877664322 11222222222222 44444         7888899999999999999 467789999998


Q ss_pred             cccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC--CCC
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT--KDS  204 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~--~~~  204 (234)
                      +........ .....++..|.+||.......++...|+||+|+++|++++|..||.+.........+.. ...+.  ...
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  226 (277)
T cd06917         148 AALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNG  226 (277)
T ss_pred             eeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCccc
Confidence            876544321 22345667799999886545568899999999999999999999987654433222211 11111  122


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++..+..+...|+..++.+|+++.+++.
T Consensus       227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         227 YSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            5667778888899999999999998865

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.48  E-value=8.2e-14  Score=109.64  Aligned_cols=172  Identities=23%  Similarity=0.327  Sum_probs=118.9

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ++..|...+.+.+...-...++...+..|... +.++.         ++|..+++|++++|.++.+ .+...++.+||.+
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~---------~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS---------YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence            45567777777665443222333333444443 55566         8899999999999999999 4566889999988


Q ss_pred             ccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC-CCC
Q 026720          129 KEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP-TKD  203 (234)
Q Consensus       129 ~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~-~~~  203 (234)
                      .......    ......++..|.+||...+ ..++...|+||+|++++++++|++||.+........++......+ -+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~  232 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD  232 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCc
Confidence            8654311    1123456778999999864 336788999999999999999999998876666554443221111 234


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++.+..+.+.++..+ ..|++.++++.+
T Consensus       233 ~~~~~~~~~i~~~l~~~-~~r~~~~~~~~~  261 (264)
T cd06653         233 GVSDACRDFLKQIFVEE-KRRPTAEFLLRH  261 (264)
T ss_pred             ccCHHHHHHHHHHhcCc-ccCccHHHHhcC
Confidence            55567888888888754 999999888764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.48  E-value=7.5e-14  Score=109.76  Aligned_cols=174  Identities=20%  Similarity=0.267  Sum_probs=120.4

Q ss_pred             HHHHHhhcCChHHHHHHHH---hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           51 LVEMYSKCGHVEKAFKVFN---LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~---~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      ++..|+..+.+.+..+--.   .+++..+..+.. ++.++.         ++|..++.|++++|+++.+. ....++.++
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~---------~lh~~~i~h~~l~p~ni~~~~~~~~~l~df  146 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE---------YLHSNGQIHRDIKAGNILLGEDGSVKIADF  146 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHhEEEcCCCCEEEccc
Confidence            6666777777766543211   122223333333 366666         88999999999999999994 567889999


Q ss_pred             cccccccCCCCC-----CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 026720          126 GMVKEIDSNLPC-----TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       126 ~~a~~~~~~~~~-----~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      +.+.........     ....++..|++||.+.....++...|+||+|++++++++|+.||.+........++.......
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (267)
T cd06610         147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS  226 (267)
T ss_pred             chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCC
Confidence            987765442211     223567789999998644357889999999999999999999998776665555544431111


Q ss_pred             CC-----CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TK-----DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..     ...+..+..+...|+...+.+|+++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11     1334566777888888889999999998864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.48  E-value=6.4e-14  Score=110.46  Aligned_cols=174  Identities=21%  Similarity=0.328  Sum_probs=124.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..|.+.+...-.. .++.+.+..+.. ++.|+.         ++|+.+++|++++|+++++ .....++.+|
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~i~h~dlkp~nili~~~~~~~l~df  150 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK---------YLSDMGYVHRDLAARNILVNSNLVCKVSDF  150 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeehhhchhcEEECCCCeEEeCCC
Confidence            467788888888877654221 112222233322 245555         8898899999999999999 4567889999


Q ss_pred             cccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCC
Q 026720          126 GMVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       126 ~~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      |.+..+.....    ......+..|++||.+.+ ..++...|+||+|++++++++ |..||.+....+....+.+....|
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (267)
T cd05066         151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP  229 (267)
T ss_pred             CcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC
Confidence            98876543211    011112346899999864 347889999999999999886 999998877666665565554445


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .....+..+..+...|+...+.+|+++.+++.
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         230 APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            55666778899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.48  E-value=1.6e-13  Score=111.69  Aligned_cols=137  Identities=31%  Similarity=0.548  Sum_probs=103.8

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC-----CCCcccCcccccccccccccCCCCcchHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI  170 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~  170 (234)
                      ++|..+++|++++|.|+++ .....++.+||.+..+.....     .....++..|.+||...+...++...|+||+|++
T Consensus       120 ~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~  199 (332)
T cd07857         120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI  199 (332)
T ss_pred             HHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence            8899999999999999999 456789999998886543211     1234567789999987654557889999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC------------------------------CcchhhhhhhhccccC
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS------------------------------WPLGIQLASNLNWKLP  220 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~  220 (234)
                      +++++.|++||.+....+.+.++....+.|+...                              .+..+..+...+....
T Consensus       200 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  279 (332)
T cd07857         200 LAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD  279 (332)
T ss_pred             HHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC
Confidence            9999999999998877777776666555443211                              1234555666677888


Q ss_pred             CCCCccccccCCC
Q 026720          221 QMGGVNLLAVMPS  233 (234)
Q Consensus       221 ~~~~~~~~~~~~~  233 (234)
                      +.+|+++.+++.+
T Consensus       280 P~~R~t~~~ll~~  292 (332)
T cd07857         280 PTKRISVEEALEH  292 (332)
T ss_pred             cccCCCHHHHhcC
Confidence            9999999988753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.48  E-value=9.9e-14  Score=110.46  Aligned_cols=175  Identities=22%  Similarity=0.319  Sum_probs=122.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      -.++..|+..+.+.+...-.. .++......+.. ++.|+.         ++|..++.|++++|.++.+. ....++.++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~---------~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE---------YLHSQNVIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeCCCChhhEEEcCCCCEEECcc
Confidence            346667788788877655432 222222233322 255666         88989999999999999994 567889999


Q ss_pred             cccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTK  202 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~  202 (234)
                      +.+....... ......++..|.+||.+.+. .++...|+||+|++++++++|..||.+.........+......  ++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd06614         161 GFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP  239 (286)
T ss_pred             chhhhhccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcch
Confidence            8766543321 11223456679999987643 4788999999999999999999999877665555444432222  222


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++..+..+...|+...+..|+++.+++..
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            3377888889999999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.48  E-value=1.2e-13  Score=110.62  Aligned_cols=172  Identities=21%  Similarity=0.325  Sum_probs=118.1

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccH-HHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSW-TIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~-~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ++..|+..|.+.+...- ..++...+... ..++.++.         ++|+.++.|++++|+|+++ .....++.+|+.+
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~---------~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~  162 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALE---------FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC  162 (296)
T ss_pred             EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence            55567777777664321 01111122222 12344555         7888899999999999999 4677899999987


Q ss_pred             ccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCCCC
Q 026720          129 KEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKDSW  205 (234)
Q Consensus       129 ~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~~~  205 (234)
                      ........ .....++..|++||.+.. ..++...|+||+|++++++++|+.||.+.........+......  ..+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T cd06655         163 AQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL  241 (296)
T ss_pred             hhcccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccC
Confidence            76543211 122356678999998863 34678899999999999999999999988766655544332111  122344


Q ss_pred             cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..+..++..|+..++.+|+++++++.+
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            5677788888999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.48  E-value=6.2e-14  Score=111.14  Aligned_cols=170  Identities=22%  Similarity=0.281  Sum_probs=117.8

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ++|..|+..|.+.+...-..  .+++..+..|... +.++.         ++|..+++|++++|+++++ .....++.+|
T Consensus        69 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~---------~lH~~~i~H~di~p~Nil~~~~~~~~l~df  139 (277)
T cd05577          69 CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE---------HLHQRRIVYRDLKPENVLLDDHGNVRISDL  139 (277)
T ss_pred             EEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCHHHEEECCCCCEEEccC
Confidence            47777888888876543322  2333344444433 66666         8899999999999999999 4567899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---DQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~---~~~~~i~~~~~~~~~  202 (234)
                      +.+.............++..|.+||...+.. ++...|+||+|++++++++|+.||.+....   ..+.+.........+
T Consensus       140 g~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  218 (277)
T cd05577         140 GLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP  218 (277)
T ss_pred             cchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC
Confidence            9887654322233345567799999986544 788899999999999999999999876542   222221111122223


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccc
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLA  229 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (234)
                      ..++..+..+...++..++.+|+++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCc
Confidence            345667788888888889999996655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.48  E-value=6.4e-14  Score=115.21  Aligned_cols=136  Identities=23%  Similarity=0.355  Sum_probs=94.0

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|.|+++ .....++.+||.+..........+..++..|++||++.+ ..|+..+|+||+|+++||++
T Consensus       172 ~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell  250 (357)
T PHA03209        172 YLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEML  250 (357)
T ss_pred             HHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHH
Confidence            8899999999999999999 456789999998875433323344567888999999874 44789999999999999999


Q ss_pred             hCC-CCCCCCCh---------HHHHHHHHHhhCCCCCC---------------------------------CCcchhhhh
Q 026720          176 SFG-ILFPGKSS---------ADQIYKICQLIGSPTKD---------------------------------SWPLGIQLA  212 (234)
Q Consensus       176 ~~~-~~f~~~~~---------~~~~~~i~~~~~~~~~~---------------------------------~~~~~~~~~  212 (234)
                      ++. ++|.+...         ...+.++....+..+..                                 ..+.....+
T Consensus       251 ~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  330 (357)
T PHA03209        251 AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFL  330 (357)
T ss_pred             HcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHH
Confidence            865 44443211         22333333333221111                                 111122235


Q ss_pred             hhhccccCCCCCccccccCCC
Q 026720          213 SNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..++..++.+|++..+++++
T Consensus       331 i~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        331 VHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHHHHcCCcccCcCHHHHhcC
Confidence            667888899999999999864

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.48  E-value=8.3e-14  Score=110.65  Aligned_cols=137  Identities=33%  Similarity=0.586  Sum_probs=105.7

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|..++.|++++|.++++ .....++.+++.+........ .....++..|++||.+.+...++...|+||+|++++++
T Consensus       115 ~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l  194 (284)
T cd07836         115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEM  194 (284)
T ss_pred             HHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence            7888899999999999999 456789999998875533211 12234567799999886555578899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCC----------------------------cchhhhhhhhccccCCCCCcc
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSW----------------------------PLGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~  226 (234)
                      ++|+.||.+....+...++.+....|....|                            +..+..+...++..++.+|++
T Consensus       195 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  274 (284)
T cd07836         195 ITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS  274 (284)
T ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC
Confidence            9999999998888888777776665554333                            233445666788888999999


Q ss_pred             ccccCCC
Q 026720          227 LLAVMPS  233 (234)
Q Consensus       227 ~~~~~~~  233 (234)
                      +.++++.
T Consensus       275 ~~~~l~~  281 (284)
T cd07836         275 AHDALQH  281 (284)
T ss_pred             HHHHhcC
Confidence            9998864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.48  E-value=5.9e-14  Score=109.53  Aligned_cols=174  Identities=22%  Similarity=0.316  Sum_probs=119.9

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|...+.+.+..+-. ..+....+..+... +.++.         ++|..+++|++++|+++++ .....++.+++
T Consensus        68 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~---------~lH~~~i~h~di~p~nili~~~~~~~l~d~g  138 (251)
T cd05041          68 YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGME---------YLESKNCIHRDLAARNCLVGENNVLKISDFG  138 (251)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEehhhcCcceEEEcCCCcEEEeecc
Confidence            4566677777666543221 11222233333332 45555         7888889999999999999 45678999999


Q ss_pred             ccccccCCCCC-C--CcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          127 MVKEIDSNLPC-T--DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       127 ~a~~~~~~~~~-~--~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      .+......... .  .......|.+||.+.+. .++...|+||+|++++++++ +..||.+.........+......+.+
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~  217 (251)
T cd05041         139 MSREEEGGIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP  217 (251)
T ss_pred             ccccccCCcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCC
Confidence            88765432111 1  11123358999988643 47889999999999999998 88999887766655555444444445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..++.+...|+...+.+|+++++++..
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~  248 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNE  248 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            5667788889999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.48  E-value=2.9e-13  Score=107.63  Aligned_cols=135  Identities=20%  Similarity=0.316  Sum_probs=102.7

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|+++++ .....++.|||.+..+.....   ......+..|.+||...+. .++...|+||+|++++
T Consensus       139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~  217 (283)
T cd05090         139 YLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLW  217 (283)
T ss_pred             HHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHH
Confidence            7898899999999999999 456689999999887643221   1122334569999988643 3788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||.+....+....+-.....+.+...+..+..+...|+...+..||++.++.+
T Consensus       218 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  278 (283)
T cd05090         218 EIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT  278 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            9998 88999877655554444433333444556778888899999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.47  E-value=1.5e-13  Score=108.25  Aligned_cols=174  Identities=21%  Similarity=0.299  Sum_probs=119.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhc-cCccccHHHH-------HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC-
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMR-EKNLQSWTIM-------ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG-  118 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~-~~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~-  118 (234)
                      ..++..|+..|.+.+...--..-. .....++...       +.|+.         ++|..+++|++++|.++++. .. 
T Consensus        74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~i~H~dl~p~nil~~~~~~  144 (269)
T cd05044          74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV---------YLEQMHFIHRDLAARNCLVSEKGY  144 (269)
T ss_pred             eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH---------HHHhCCcccCCCChheEEEecCCC
Confidence            356667777787776543211100 1122333333       34444         78888899999999999984 33 


Q ss_pred             ----eeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 026720          119 ----VIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQI  190 (234)
Q Consensus       119 ----~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~  190 (234)
                          ..++.+|+.+..+.....   ......+..|.+||.+.. ..++...|+||+|++++++++ |..||+.....+..
T Consensus       145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~  223 (269)
T cd05044         145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL  223 (269)
T ss_pred             CCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence                678999998876533211   111233457899998864 347889999999999999998 99999987777666


Q ss_pred             HHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          191 YKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       191 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+............++.+..++..|+...+.+|+++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         224 QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            555433333334455677888899999999999999998764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.47  E-value=1e-13  Score=109.02  Aligned_cols=173  Identities=23%  Similarity=0.397  Sum_probs=119.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .++..|+..|.+.+...-...    ++...+..|... +.|+.         ++|..++.|++++|+++.+ .....++.
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~i~h~dl~p~nil~~~~~~~~l~  148 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE---------HMHSKRIMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHH---------HHHhCCEecCCcChhhEEECCCCcEEEe
Confidence            466778888888776443211    122233444443 66666         8899899999999999999 45677899


Q ss_pred             eccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHH-HHHHhhCCC
Q 026720          124 DLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-SADQIY-KICQLIGSP  200 (234)
Q Consensus       124 ~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-~~~~~~-~i~~~~~~~  200 (234)
                      +++.+..+.... ......++..|.+||...+ ..++...|+||+|++++++++|..||.+.. +..... .+......+
T Consensus       149 d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T cd08224         149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP  227 (267)
T ss_pred             ccceeeeccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC
Confidence            999877654321 1223456677999998863 447889999999999999999999996543 222222 222222222


Q ss_pred             CCC-CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKD-SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+. ..+..+..++..|+...+.+|+++.+|++
T Consensus       228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            222 56667888889999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.47  E-value=4.2e-13  Score=107.30  Aligned_cols=137  Identities=34%  Similarity=0.626  Sum_probs=105.1

Q ss_pred             HhhhcccccCCcCCCcEEee--CCeeeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|.++++.  ....++.+||.+........ .....++..|++||.+.+...++...|+||+|+++++
T Consensus       117 ~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~  196 (294)
T PLN00009        117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAE  196 (294)
T ss_pred             HHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHH
Confidence            88989999999999999995  34578999998876543221 1233456789999988655557889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc----------------------------chhhhhhhhccccCCCCCc
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIGSPTKDSWP----------------------------LGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~  225 (234)
                      +++|.+||.+....+...++++..+.|....|+                            .....+...+....+.+|+
T Consensus       197 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  276 (294)
T PLN00009        197 MVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI  276 (294)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc
Confidence            999999999888888888888777766555443                            2233455567777889999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      +.++++++
T Consensus       277 s~~~~l~~  284 (294)
T PLN00009        277 TARAALEH  284 (294)
T ss_pred             CHHHHhcC
Confidence            99988764

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.47  E-value=1.3e-13  Score=110.10  Aligned_cols=137  Identities=32%  Similarity=0.517  Sum_probs=98.3

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|..+++|++++|.|+++ .....+++|||.+....... ......++..|++||...+...++...|+||+|++++++
T Consensus       118 ~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l  197 (291)
T cd07870         118 YIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM  197 (291)
T ss_pred             HHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHH
Confidence            7898899999999999999 46678999999887543221 122334567899999986544577889999999999999


Q ss_pred             HhCCCCCCCCCh-HHHHHHHHHhhCCCCCCC-------------------------------CcchhhhhhhhccccCCC
Q 026720          175 LSFGILFPGKSS-ADQIYKICQLIGSPTKDS-------------------------------WPLGIQLASNLNWKLPQM  222 (234)
Q Consensus       175 ~~~~~~f~~~~~-~~~~~~i~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~  222 (234)
                      ++|..||.+... .+.+.++....+.|....                               .+..+..+...+...++.
T Consensus       198 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~  277 (291)
T cd07870         198 LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK  277 (291)
T ss_pred             HhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence            999999986543 334444444333322111                               123445566667788999


Q ss_pred             CCccccccCCC
Q 026720          223 GGVNLLAVMPS  233 (234)
Q Consensus       223 ~~~~~~~~~~~  233 (234)
                      .|+++.+++.+
T Consensus       278 ~R~t~~~~l~h  288 (291)
T cd07870         278 DRISAQDALLH  288 (291)
T ss_pred             cCcCHHHHhcC
Confidence            99999988764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.47  E-value=1e-13  Score=111.42  Aligned_cols=137  Identities=31%  Similarity=0.534  Sum_probs=99.9

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC-----CCCcccCcccccccccccccCCCCcchHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP-----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI  170 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~  170 (234)
                      ++|..+++|++++|.++++ .....++.++|.+........     .....++..|++||.+.+...++..+|+||+|++
T Consensus       134 ~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~  213 (310)
T cd07865         134 YIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCI  213 (310)
T ss_pred             HHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHH
Confidence            8898899999999999999 456789999998876543211     1223456679999988765557789999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC-------------------------------cchhhhhhhhcccc
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-------------------------------PLGIQLASNLNWKL  219 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~  219 (234)
                      ++++++|.+||.+......+..+.+..+..+...|                               +..+..++..++..
T Consensus       214 l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~  293 (310)
T cd07865         214 MAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL  293 (310)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcC
Confidence            99999999999887665554444443332222111                               12233567778888


Q ss_pred             CCCCCccccccCCC
Q 026720          220 PQMGGVNLLAVMPS  233 (234)
Q Consensus       220 ~~~~~~~~~~~~~~  233 (234)
                      .+.+|+++++++.+
T Consensus       294 ~P~~R~t~~e~l~h  307 (310)
T cd07865         294 DPAKRIDADTALNH  307 (310)
T ss_pred             ChhhccCHHHHhcC
Confidence            99999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.47  E-value=9.7e-14  Score=112.75  Aligned_cols=176  Identities=15%  Similarity=0.161  Sum_probs=113.9

Q ss_pred             HHHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~  124 (234)
                      ..+|..|+..|.+.+...-.  ..++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.+
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~---------~LH~~~iiH~dlkp~Nil~~~~~~~~l~~  144 (327)
T cd08227          74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALD---------YIHHMGYVHRSVKASHILISVDGKVYLSG  144 (327)
T ss_pred             EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCEecCCCChhhEEEecCCcEEEcc
Confidence            35677888888888765321  11333333333333 56666         88999999999999999984 44556666


Q ss_pred             ccccccccCCC--------CCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          125 LGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       125 ~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      ++.........        ......++..|++||++... ..|+..+|+||+|++++|+++|+.||.+............
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  224 (327)
T cd08227         145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  224 (327)
T ss_pred             cchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc
Confidence            65433221100        00112345568999998643 3478999999999999999999999987665444333221


Q ss_pred             hhCC---------------------------------------------CCCCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          196 LIGS---------------------------------------------PTKDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       196 ~~~~---------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      ....                                             +....++..+..+...|+..++.+|++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el  304 (327)
T cd08227         225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL  304 (327)
T ss_pred             CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence            1100                                             0011223456678888999999999999999


Q ss_pred             CCC
Q 026720          231 MPS  233 (234)
Q Consensus       231 ~~~  233 (234)
                      +++
T Consensus       305 l~~  307 (327)
T cd08227         305 LNH  307 (327)
T ss_pred             hcC
Confidence            764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.47  E-value=1e-13  Score=108.19  Aligned_cols=174  Identities=22%  Similarity=0.430  Sum_probs=124.3

Q ss_pred             HHHHHHhhcCChHHHHHHHH----hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN----LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~----~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      .++..|+..+.+.+-.+-..    ..+...+..+.. ++.|+.         ++|..++.|++++|+++++. ....++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lh~~~~~H~dl~~~nil~~~~~~~~l~  145 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK---------YLHSRKILHRDIKPQNIFLTSNGLVKLG  145 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHH---------HHHhCCEecccCChHHeEEcCCCcEEEC
Confidence            45666777777766443321    111112223322 355666         88988999999999999994 5678899


Q ss_pred             eccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          124 DLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       124 ~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +++.+....... ......+++.|.+||.... ..++...|+||+|++++++++|..||.............+....+.+
T Consensus       146 d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (258)
T cd08215         146 DFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP  224 (258)
T ss_pred             CccceeecccCcceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence            999887654432 1223456677999998763 34788999999999999999999999877765555555444344445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+++.+..+.+.++...+.+|+++.+++..
T Consensus       225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         225 SQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            5677888889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.47  E-value=1.8e-13  Score=108.88  Aligned_cols=173  Identities=20%  Similarity=0.312  Sum_probs=115.7

Q ss_pred             HHHHHhhcCChHHHHHHH---HhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEee
Q 026720           51 LVEMYSKCGHVEKAFKVF---NLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~---~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ++..|+..+.+....+.-   ..+++..+..+... +.++.         ++|. .+++|++++|.++++ .....++++
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~LH~~~~i~H~dl~p~nil~~~~~~~~l~d  146 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK---------FLKEEHNIIHRDVKPTNVLVNGNGQVKLCD  146 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHH---------HHHhcCCEeeCCCCHHHEEECCCCCEEEee
Confidence            566788888886654321   01222222223222 44555         7775 379999999999999 456789999


Q ss_pred             ccccccccCCCCCCCcccCccccccccccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE-----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG-  198 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~-  198 (234)
                      ||.+..+.... .....+++.|.+||.+.+..     .++...|+||+|++++++++|+.||+..........+..... 
T Consensus       147 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  225 (286)
T cd06622         147 FGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG  225 (286)
T ss_pred             cCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc
Confidence            99887764432 22335667899999875322     257789999999999999999999986544333322222111 


Q ss_pred             C--CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 S--PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .  ..+..+++.+..+...++...+.+|++++++++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1  2223456677778888899999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.47  E-value=1.2e-13  Score=109.77  Aligned_cols=173  Identities=20%  Similarity=0.340  Sum_probs=117.6

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+...- ..++...+..+... +.|+.         ++|..+++|++++|.|+++ .....++.+||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~---------~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMA---------YLHSQHYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccccChheEEEcCCCcEEEeecc
Confidence            3477788888888765432 12333333344333 55555         8898899999999999999 45678999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--------------HH
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS--------------AD  188 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~--------------~~  188 (234)
                      .+........    .....++..|.+||.... ..++...|+||+|++++|+++|..|+.....              ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV  231 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence            8876643211    111223445889998763 3468899999999999999999988764321              11


Q ss_pred             HHHHHH-HhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          189 QIYKIC-QLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       189 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+.... .....+.+...+..+..+...|+...+.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            111111 12222334556778888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=3.9e-14  Score=119.99  Aligned_cols=164  Identities=23%  Similarity=0.357  Sum_probs=119.8

Q ss_pred             cCChHHHHH-HHHhhcc--CccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEeeccccccc
Q 026720           58 CGHVEKAFK-VFNLMRE--KNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEI  131 (234)
Q Consensus        58 ~g~~~~a~~-~~~~m~~--~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~  131 (234)
                      .|++....+ .+.-|.+  ...-.|+.+ +.|+.         ++|...++|++++-||++++  +++++++|||.++.+
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLk---------YLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL  726 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLK---------YLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL  726 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhh---------hhhhcceeeccccCCcEEEeeccceEEecccccchhh
Confidence            455555433 2334432  234456766 78888         99988899999999999995  689999999999987


Q ss_pred             cCCCC-CCCcccCccccccccccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----hhCCCCCCCC
Q 026720          132 DSNLP-CTDYVTTRWYRGPEVLLFSE-IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ----LIGSPTKDSW  205 (234)
Q Consensus       132 ~~~~~-~~~~~~~~~~~~pe~~~~~~-~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~----~~~~~~~~~~  205 (234)
                      -.--+ ..++.++-.|+|||++.-++ .|....||||+||.+.||.+|++||-..++...+  +|+    +...|.+..-
T Consensus       727 AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkVGmyKvHP~iPeel  804 (1226)
T KOG4279|consen  727 AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKVGMYKVHPPIPEEL  804 (1226)
T ss_pred             ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhhcceecCCCCcHHH
Confidence            65433 34678888999999985443 5999999999999999999999999988877765  333    2233444554


Q ss_pred             cchhhhhhhhccccCCCCCccccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..-+.++..|-.-++.+|++..+++.
T Consensus       805 saeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  805 SAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            545555566666667777777776664

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.47  E-value=8.3e-14  Score=110.57  Aligned_cols=169  Identities=21%  Similarity=0.308  Sum_probs=118.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+..-    ..++++.+..+... +.|+.         ++|+.+++|++++|+|+++ .....++.+||.
T Consensus        75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLT---------YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHH---------HHHHCCEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            467778888877542    23444444444443 56666         8899999999999999999 467889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhhCCC----
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD---QIYKICQLIGSP----  200 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~---~~~~i~~~~~~~----  200 (234)
                      +..+... ......++..|.+||...+. .++...|+||+|++++++++|+.||.......   ......+....+    
T Consensus       142 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (279)
T cd06619         142 STQLVNS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV  219 (279)
T ss_pred             ceecccc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence            8876442 23345677889999998743 47889999999999999999999997532211   111222222211    


Q ss_pred             -CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 -TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       ....++..+..++..++..++.+|+++++++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             123355667778888999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.47  E-value=1.9e-13  Score=110.53  Aligned_cols=134  Identities=21%  Similarity=0.356  Sum_probs=104.6

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|+++.+ .....++.+++.+.....   .....++..|.+||.+..  ...++...|+||+|+++++
T Consensus       140 ~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~e  216 (317)
T cd06635         140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  216 (317)
T ss_pred             HHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHH
Confidence            8898899999999999999 456789999997765432   223456678999998742  2346788999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++|..||.+.........+..... ......|+..+..+...|+...+.+|+++.+++..
T Consensus       217 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         217 LAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             HHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence            9999999988766666655544332 23345677788889999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.47  E-value=2.3e-13  Score=106.86  Aligned_cols=175  Identities=21%  Similarity=0.330  Sum_probs=117.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...--..+....+..+. .++.|+.         ++|+.++.|++++|+++++ .....++.+++.
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA---------YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCCEEEccccc
Confidence            4566677778887754321112222223332 3366666         8899899999999999999 456789999998


Q ss_pred             cccccCCCCC-----CCcccCccccccccccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhC-
Q 026720          128 VKEIDSNLPC-----TDYVTTRWYRGPEVLLFSE--IYGPEVDKWAMGAIMFEMLSFGILFPGKS-SADQIYKICQLIG-  198 (234)
Q Consensus       128 a~~~~~~~~~-----~~~~~~~~~~~pe~~~~~~--~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-~~~~~~~i~~~~~-  198 (234)
                      +.........     ....++..|.+||.+.+..  .++...|+||+|++++++++|..||.+.. .+.....+..... 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  225 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP  225 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC
Confidence            8776443221     1234567899999986433  26788999999999999999999997653 3333333322111 


Q ss_pred             -CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 -SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       .|+....+..+..+...|+..++.+|+++++++.+
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             11112225567778888999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.47  E-value=1.3e-13  Score=109.80  Aligned_cols=135  Identities=24%  Similarity=0.369  Sum_probs=100.0

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.++++ .....++.+||.+..+.....   ......+..|.+||...+ ..++...|+||+|++++
T Consensus       145 ~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~  223 (288)
T cd05050         145 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLW  223 (288)
T ss_pred             HHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHH
Confidence            7888899999999999998 466789999998876543211   111233456899998764 44788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++++ +..||.+....+....+...-..+.+...+..+..++..|+..++.+|+++.+++.
T Consensus       224 el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         224 EIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            9997 77888877766655444332222223344567778888899999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.46  E-value=1.2e-13  Score=111.62  Aligned_cols=174  Identities=22%  Similarity=0.281  Sum_probs=120.9

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .+|..|+..|.+.+...-..  ..++..+..|... +.|+.         ++|..+++|++++|+|+++ .+...++.++
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~Nili~~~~~~~l~df  147 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE---------YLHLLGIVYRDLKPENILLHESGHIMLSDF  147 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCChHHeEEcCCCCEEEeec
Confidence            56777888888877543210  1111122223222 55555         7898899999999999999 4567889999


Q ss_pred             cccccccCCC------------------------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720          126 GMVKEIDSNL------------------------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus       126 ~~a~~~~~~~------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      +.+.......                              ......++..|++||...+. .++...|+||+|+++++++
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHh
Confidence            8776542211                              11123566779999998744 3678999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhC-CCCCCCCcchhhhhhhhccccCCCCCcc----ccccCCC
Q 026720          176 SFGILFPGKSSADQIYKICQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVN----LLAVMPS  233 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  233 (234)
                      +|+.||.+........++..... .+.....+..+..+.+.++...+..|++    .++++..
T Consensus       227 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         227 YGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            99999998877766666554222 2222335677888889999999999999    7777653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.46  E-value=3.8e-13  Score=109.98  Aligned_cols=135  Identities=36%  Similarity=0.527  Sum_probs=102.5

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|.++++ .....++.+||.+......  .....++..|++||.+.....++...|+||+|++++|++
T Consensus       132 ~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~  209 (342)
T cd07879         132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML  209 (342)
T ss_pred             HHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence            7888889999999999999 4677899999988765432  233456778999999865445788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCC------------------------------CCCcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTK------------------------------DSWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|+.||.+......+..+....+.+.+                              ...+..+..++..++..++.+|+
T Consensus       210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  289 (342)
T cd07879         210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL  289 (342)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence            999999987766666555443332211                              12234456777788899999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++.+
T Consensus       290 ~~~e~l~h  297 (342)
T cd07879         290 TATEALEH  297 (342)
T ss_pred             CHHHHhcC
Confidence            99988753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.46  E-value=2.2e-13  Score=113.48  Aligned_cols=134  Identities=20%  Similarity=0.322  Sum_probs=100.7

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.|+++. ....+++|||.+........   .....++..|++||.+.+ ..++...|+||+|++++
T Consensus       252 ~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~  330 (400)
T cd05105         252 FLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLW  330 (400)
T ss_pred             HHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHH
Confidence            78888899999999999994 56789999999876543211   112234566999998864 34788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhh-CCCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLI-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      |+++ |..||++....+......... ..+.+..++..+..++..|+...+.+||++.++.
T Consensus       331 ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  391 (400)
T cd05105         331 EIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS  391 (400)
T ss_pred             HHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence            9997 889998765544444433322 2333456677888889999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.46  E-value=2.5e-13  Score=108.17  Aligned_cols=137  Identities=23%  Similarity=0.324  Sum_probs=99.5

Q ss_pred             Hhhhc-ccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccc--cCCCCcchHHHHHHHHH
Q 026720           97 SLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~  172 (234)
                      ++|.. +++|++++|.++++ .....++.+||.+..+..........++..|.+||.+...  ..++...|+||+|++++
T Consensus       122 ~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~  201 (288)
T cd06616         122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY  201 (288)
T ss_pred             HHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHH
Confidence            66654 79999999999999 4567899999998776544333344567789999998644  35788999999999999


Q ss_pred             HHHhCCCCCCCCChH-HHHHHHHHhh-CC---CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          173 EMLSFGILFPGKSSA-DQIYKICQLI-GS---PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       173 e~~~~~~~f~~~~~~-~~~~~i~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++++|+.||+..... +...++.... ..   ......+..+..++..|+..++.+|+++++++.+
T Consensus       202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         202 EVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            999999999865421 2222222110 01   1112355667788888999999999999998764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.46  E-value=1.8e-13  Score=110.46  Aligned_cols=134  Identities=21%  Similarity=0.371  Sum_probs=104.2

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|+++++ .....++.+++.+.....   .....++..|.+||.+..  ...++...|+||+|+++++
T Consensus       136 ~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~e  212 (313)
T cd06633         136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  212 (313)
T ss_pred             HHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHH
Confidence            8898999999999999999 456789999998765332   233456778999998742  2347788999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++|..||.+........++..... ......|+..+..+...++...+.+|+++++++..
T Consensus       213 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         213 LAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999999998877676666544322 12224567778889999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.46  E-value=2.2e-13  Score=107.56  Aligned_cols=174  Identities=17%  Similarity=0.242  Sum_probs=116.6

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh-hccC---ccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeE
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL-MREK---NLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKI  122 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~-m~~~---~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~  122 (234)
                      ..++..|+..|++.+...-... ....   .+..+.. ++.|+.         ++|+.+++|++++|.++++ .....++
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~---------~lH~~~i~H~dikp~nil~~~~~~~~l  140 (268)
T cd05086          70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT---------HMHKHNFLHSDLALRNCFLTSDLTVKV  140 (268)
T ss_pred             cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHH---------HHHHCCeeccCCccceEEEcCCccEEe
Confidence            4678889998888776542111 0111   1112222 245555         7898899999999999999 4567899


Q ss_pred             eeccccccccCCC---CCCCcccCcccccccccccc------cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 026720          123 GDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFS------EIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYK  192 (234)
Q Consensus       123 ~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~------~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~  192 (234)
                      .|||.+.......   ......++..|++||+....      ..++...|+||+|++++|+++ +..||.+....+...+
T Consensus       141 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  220 (268)
T cd05086         141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH  220 (268)
T ss_pred             cccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999876432211   11223456779999987321      124678999999999999996 5678887777666666


Q ss_pred             HHHhhCC----CC-CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          193 ICQLIGS----PT-KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       193 i~~~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +......    |. ...+++.+..+.++|| .++.+||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         221 VIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            5543221    11 2346677778888899 55789999998864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.46  E-value=1.2e-13  Score=110.27  Aligned_cols=174  Identities=30%  Similarity=0.540  Sum_probs=113.7

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+. +++.+...-.. .++...+..+.. ++.|+.         ++|+.+++|++++|.++++ ..+..++.+||
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~---------~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA---------YCHQRRVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecccCCHHHEEEcCCCCEEECccc
Confidence            46666766 45544322111 112222333332 355555         8899899999999999999 45678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-SADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-~~~~~~~i~~~~~~~~~~~  204 (234)
                      .+....... .......+..|.+||...+...++...|+||+|++++++++|..||++.. ..+.+..+.+.++.+....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (291)
T cd07844         149 LARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET  228 (291)
T ss_pred             cccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence            876543211 11222346678999988655557889999999999999999999998776 5556656666666554444


Q ss_pred             Cc-------------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WP-------------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      |+                               .....+...+....+..|+++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            32                               112233444556678888998888754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.46  E-value=9.8e-14  Score=111.24  Aligned_cols=172  Identities=22%  Similarity=0.361  Sum_probs=119.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccH-HHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSW-TIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~-~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...- ..++...+..+ ..++.++.         ++|+.+++|++++|+|+++ .....++.|||.
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~---------~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~  161 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALD---------FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  161 (297)
T ss_pred             EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence            567778888887775321 11222222222 22355565         8898899999999999999 466789999998


Q ss_pred             cccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC---CC
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT---KD  203 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~---~~  203 (234)
                      +........ .....+++.|.+||...+ ..++...|+||+|++++++++|..||.+......+..+.. .+.+.   +.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~  239 (297)
T cd06656         162 CAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPE  239 (297)
T ss_pred             ceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCCCCcc
Confidence            876533221 223456678999998864 4467889999999999999999999987655444333322 12222   23


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+..+...++..++.+|+++++++.+
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            445667778888998888999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.46  E-value=2.2e-13  Score=107.40  Aligned_cols=174  Identities=21%  Similarity=0.336  Sum_probs=122.2

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh----hccCccccHH-HHHHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL----MREKNLQSWT-IMISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIK  121 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~  121 (234)
                      ..++..|+..+.+.+...-...    ++...+..+. .++.++.         ++|. .++.|++++|.++++ .....+
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR---------YLHKEKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HhccCCceeecCCCHHHEEECCCCcEE
Confidence            4567777777777766533211    1111112221 2344555         7774 568999999999999 456789


Q ss_pred             EeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       122 ~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +.+||.+.............++..|.+||...+ ..++...|+||+|+++|++++|+.||...........+.+....|.
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL  233 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence            999998876554322233456677999999874 3478899999999999999999999987766665555554443333


Q ss_pred             CC-CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KD-SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .. .++..+..++..|+..++..|+++.++..
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~  265 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSA  265 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence            33 56778888999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.46  E-value=9.2e-14  Score=110.13  Aligned_cols=173  Identities=17%  Similarity=0.256  Sum_probs=114.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...- ..+.+..+..+.. ++.|+.         ++|..+++|++++|+++.+ .....++.+|+.
T Consensus        78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~---------~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLD---------YLHSERKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHH---------HHhcCCeeccCCChheEEEeCCCCEEEccccc
Confidence            456667777777654321 1111112222222 244444         7888889999999999999 456789999998


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +..+.... ......++..|.+||...+. .++...|+||+|++++|+++|..||.+.........+............+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (277)
T cd06642         148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYS  226 (277)
T ss_pred             cccccCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccC
Confidence            87654322 11223456779999998643 47889999999999999999999998665444443332211111122345


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+...|+...+.+|+++.+++.+
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            567777888999999999999998753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.46  E-value=2.6e-13  Score=107.75  Aligned_cols=137  Identities=21%  Similarity=0.285  Sum_probs=101.8

Q ss_pred             Hhhhc-ccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccc---cCCCCcchHHHHHHHH
Q 026720           97 SLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS---EIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~~d~~s~g~~l  171 (234)
                      ++|+. +++|++++|.++++ .....++.+||.+.............++..|.+||.+.+.   ..++...|+||+|+++
T Consensus       118 ~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l  197 (283)
T cd06617         118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM  197 (283)
T ss_pred             HHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHH
Confidence            77875 79999999999999 4667899999998876543333334566779999987542   2367889999999999


Q ss_pred             HHHHhCCCCCCCCC-hHHHHHHHHHhhCC-CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          172 FEMLSFGILFPGKS-SADQIYKICQLIGS-PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       172 ~e~~~~~~~f~~~~-~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++++|+.||.+.. ..+....+...... .+...+++.+..++..++...+.+|+++++++..
T Consensus       198 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         198 IELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             HHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            99999999997533 33444444332221 2234567788888889999999999999998763

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.46  E-value=2e-13  Score=106.15  Aligned_cols=174  Identities=18%  Similarity=0.303  Sum_probs=121.1

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..+.+.+..... ..++...+..+. .++.++.         ++|..++.|++++|.++.+. ....++.+++
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE---------YLHSNGIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHH---------HhhcCCEecCCCCHHHEEEccCCeEEEeecc
Confidence            4566677777776654332 112222222222 2355555         78888899999999999994 5678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC--CCCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG--SPTKDS  204 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~--~~~~~~  204 (234)
                      .+.............++..|.+||...+.. ++...|+||+|++++++++|+.||.................  .+....
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (253)
T cd05122         144 LSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEK  222 (253)
T ss_pred             ccccccccccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccc
Confidence            887765533223445667899999986443 67889999999999999999999987755554444333211  122333


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      |+..+..+...++..++.+|+++.+++.+
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            46778888889999999999999998764

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.45  E-value=1.3e-13  Score=111.15  Aligned_cols=137  Identities=34%  Similarity=0.607  Sum_probs=99.8

Q ss_pred             HhhhcccccCCcCCCcEEe-e----CCeeeEeeccccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-S----KGVIKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAM  167 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~----~~~~~~~~~~~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~  167 (234)
                      ++|..+++|++++|+|+++ .    ....++.|||.+..+.....    .....++..|.+||...+...++..+|+||+
T Consensus       123 ~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  202 (316)
T cd07842         123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI  202 (316)
T ss_pred             HHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence            8899999999999999999 4    57889999998886643221    2234556789999988765567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChH---------HHHHHHHHhhCCCCCCCC---------------------------------
Q 026720          168 GAIMFEMLSFGILFPGKSSA---------DQIYKICQLIGSPTKDSW---------------------------------  205 (234)
Q Consensus       168 g~~l~e~~~~~~~f~~~~~~---------~~~~~i~~~~~~~~~~~~---------------------------------  205 (234)
                      |++++++++|.+||.+....         +.+.++++.++.++...|                                 
T Consensus       203 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (316)
T cd07842         203 GCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH  282 (316)
T ss_pred             HHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhc
Confidence            99999999999999865432         244455555554433222                                 


Q ss_pred             ---cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 ---PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                         +.....+...+....+.+|+++++++.+
T Consensus       283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         283 KKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             cCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               2233345555677788999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.45  E-value=1.7e-13  Score=107.93  Aligned_cols=172  Identities=21%  Similarity=0.296  Sum_probs=112.0

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a  128 (234)
                      ++..|+..|.+.+...-...+.......|... +.++.         ++|+.+++|++++|.++++. ....++.|||.+
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS---------YLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            56677777887765432222222222333332 44555         78888999999999999994 567899999988


Q ss_pred             ccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC-CC
Q 026720          129 KEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT-KD  203 (234)
Q Consensus       129 ~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~-~~  203 (234)
                      ..+....    ......++..|++||...+ ..++...|+||+|++++++++|+.||.+........++......+. +.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP  232 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCch
Confidence            7653211    1122346678999999864 3467889999999999999999999987655544433332211111 12


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+..+...++. .+.+|+++++++..
T Consensus       233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         233 HVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            223344455555554 67899999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.45  E-value=5.3e-13  Score=109.14  Aligned_cols=135  Identities=35%  Similarity=0.565  Sum_probs=104.5

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|+.+++|++++|.++++ .+...++.+||.+......  .....++..|.+||.......++...|+||+|+++++++
T Consensus       133 ~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell  210 (343)
T cd07851         133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  210 (343)
T ss_pred             HHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHH
Confidence            8899899999999999999 4567899999998876543  234456778999998754345678999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCC------------------------------CCCcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTK------------------------------DSWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|..||++....+.+..+.+..+.++.                              ...+..+..+...++..++.+|+
T Consensus       211 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp  290 (343)
T cd07851         211 TGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI  290 (343)
T ss_pred             hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC
Confidence            999999988777776666555443321                              12244555667778888999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++.+
T Consensus       291 t~~ell~h  298 (343)
T cd07851         291 TAAEALAH  298 (343)
T ss_pred             CHHHHhcC
Confidence            99998764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.45  E-value=3.1e-13  Score=106.01  Aligned_cols=174  Identities=19%  Similarity=0.405  Sum_probs=119.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~  124 (234)
                      .++..|+..+.+.....-...    +++.....|... +.|+.         ++|+.++.|++++|+++.+.....++.+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~i~h~~l~~~nili~~~~~~l~d  148 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH---------YMHQRRILHRDLKAKNIFLKNNLLKIGD  148 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHH---------HHHHcCccccCCChhheEeecCCEeecc
Confidence            456667777777665432111    111122223222 44444         7888899999999999999766789999


Q ss_pred             ccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          125 LGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       125 ~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      ++.+........ .....+++.|.+||...+ ..++...|+||+|+++++++++..||++........++.......-+.
T Consensus       149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd08222         149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE  227 (260)
T ss_pred             cCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcc
Confidence            998876544322 223446677999998753 346778999999999999999999998766655554443322222233


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .++..+..++..++...+..|+++++++.+
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            556677778888898899999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.45  E-value=2.8e-13  Score=108.00  Aligned_cols=175  Identities=19%  Similarity=0.296  Sum_probs=120.9

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhcc----C------ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMRE----K------NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-  115 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~----~------~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-  115 (234)
                      ...++..|+..|.+.+-.+-.....+    .      ++..+... +.|+.         ++|+.++.|++++|+|+++ 
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~i~H~dikp~nili~  153 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA---------YLNAKKFVHRDLAARNCMVA  153 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCCcCCCCChheEEEc
Confidence            35788889999999887654322111    1      11122222 44555         7888899999999999999 


Q ss_pred             eCCeeeEeeccccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 026720          116 SKGVIKIGDLGMVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIY  191 (234)
Q Consensus       116 ~~~~~~~~~~~~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~  191 (234)
                      .....++.+||.++.+......   .....+..|.+||...+ ..++...|+||+|++++|+++ +..||.+....+...
T Consensus       154 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~  232 (288)
T cd05061         154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK  232 (288)
T ss_pred             CCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            4567899999988765432111   11123456899998864 346889999999999999998 788998766655444


Q ss_pred             HHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          192 KICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       192 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+......+.+...+..+..+...|+..++.+|+++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  273 (288)
T cd05061         233 FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN  273 (288)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            44433222333444567888889999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.45  E-value=3e-13  Score=113.40  Aligned_cols=169  Identities=24%  Similarity=0.359  Sum_probs=122.3

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe--eCCeeeEee
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV--SKGVIKIGD  124 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~--~~~~~~~~~  124 (234)
                      ...+|..+.+.|.+-+.+..-.... .-..-|.+. +.++.         ++|.++++|+|++|+|+++  +....++.+
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~---------~LH~~gvvhRDLkp~NIL~~~~~g~lrlty  459 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVD---------YLHEQGVVHRDLKPGNILLDGSAGHLRLTY  459 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHH---------HHHhcCeeecCCChhheeecCCCCcEEEEE
Confidence            3456666777666655543222221 222336555 66666         8999999999999999999  356789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-C
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-D  203 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-~  203 (234)
                      ||.++++...  +.+..-+..|.|||+.. ...|+...|+||+|++||+|++|..||....+.   ..+...++.+.- +
T Consensus       460 FG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s~  533 (612)
T KOG0603|consen  460 FGFWSELERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFSE  533 (612)
T ss_pred             echhhhCchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcccc
Confidence            9999998775  22334456789999997 556999999999999999999999999866555   445555555432 3


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .-+..-..|.+.....++..|++..++.-
T Consensus       534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  534 CVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            44456667778888889999999887753

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.45  E-value=3.9e-13  Score=107.17  Aligned_cols=173  Identities=22%  Similarity=0.382  Sum_probs=119.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .++..|+..|.+.+.......    ++...+..+.. ++.++.         ++|..++.|++++|+++++ .....++.
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~---------~lH~~~i~H~dl~~~nil~~~~~~~~l~  147 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS---------YLHSRKIIHRDIKPSNILLTRKGQVKLC  147 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEEecCCeEEEe
Confidence            467778888888765332111    11112223333 366677         8899999999999999999 45678999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhhC
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-----SADQIYKICQLIG  198 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-----~~~~~~~i~~~~~  198 (234)
                      +++.+........ ....++..|++||...+ ..++...|+||+|+++|++++|+.||....     ..+....+.....
T Consensus       148 dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd06621         148 DFGVSGELVNSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN  225 (287)
T ss_pred             ecccccccccccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc
Confidence            9998876554322 22345677999998863 457889999999999999999999998662     2232222222111


Q ss_pred             ----C--CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 ----S--PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ----~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                          .  +....|++.+..+...|+...+-+||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                0  1113577788889999999999999999988764

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.45  E-value=2.3e-13  Score=108.95  Aligned_cols=181  Identities=19%  Similarity=0.236  Sum_probs=117.2

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhc-----cCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeE
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMR-----EKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKI  122 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~-----~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~  122 (234)
                      ..++..|+..|++.+-..-...-.     .....++..++....+.-...+  ++|+.+++|++++|+|+++ .....++
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~--~lH~~~i~H~dlkp~Nili~~~~~~~l  171 (296)
T cd05095          94 LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMK--YLSSLNFVHRDLATRNCLVGKNYTIKI  171 (296)
T ss_pred             cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHH--HHHHCCeecccCChheEEEcCCCCEEe
Confidence            357777888888866543211000     0112333333222221111111  7888899999999999999 4567899


Q ss_pred             eeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHH--
Q 026720          123 GDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS--FGILFPGKSSADQIYKICQ--  195 (234)
Q Consensus       123 ~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~--~~~~f~~~~~~~~~~~i~~--  195 (234)
                      .+||.+..+.....   ......+..|++||.... ..++...|+||+|+++||+++  +..||.+....+......+  
T Consensus       172 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~  250 (296)
T cd05095         172 ADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF  250 (296)
T ss_pred             ccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHH
Confidence            99998886643221   111223456889998754 347889999999999999998  6688876554444333221  


Q ss_pred             -h----hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          196 -L----IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       196 -~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       .    ...+.+..++..+..+...|+..++.+||++.++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         251 RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             hhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             1    112344566778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.45  E-value=2.9e-13  Score=108.82  Aligned_cols=169  Identities=28%  Similarity=0.349  Sum_probs=115.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|++.+..+-...+++..+..+.. ++.|+.         ++|..+++|++++|.|+++ ..+..++.+||.
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE---------YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCchHHEEECCCCCEEEeeCCC
Confidence            57788888888877754332233222222222 245555         8898999999999999999 456788999997


Q ss_pred             cccccCCC----------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 026720          128 VKEIDSNL----------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY  191 (234)
Q Consensus       128 a~~~~~~~----------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~  191 (234)
                      ++.....+                ......++..|.+||.+.. ..++...|+||+|++++|+++|..||.+....+...
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~  226 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG  226 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            76311100                0011345667999998764 347889999999999999999999999876665555


Q ss_pred             HHHHhhC-CCCC-CCCcchhhhhhhhccccCCCCCcccc
Q 026720          192 KICQLIG-SPTK-DSWPLGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       192 ~i~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                      ++..... .|.. ...+..+..+...++..++.+|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  265 (305)
T cd05609         227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG  265 (305)
T ss_pred             HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCcc
Confidence            5544322 2222 24566678888889999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.44  E-value=2.3e-13  Score=106.39  Aligned_cols=174  Identities=22%  Similarity=0.461  Sum_probs=119.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C-CeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K-GVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~-~~~~~~~  124 (234)
                      .+|..|+..+.+.+...-...  +++..+..|.. ++.++.         ++|..++.|++++|.++++. . ...++++
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~i~H~dl~~~nil~~~~~~~~~l~d  145 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK---------HIHDRKILHRDIKSQNIFLSKNGMVAKLGD  145 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccccCCHHHEEEcCCCCeEEecc
Confidence            356667777777665432111  11112222222 244444         78888899999999999994 3 3468999


Q ss_pred             ccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          125 LGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       125 ~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      ++.+........ .....+++.|.+||..... .++...|+||+|++++++++|..||.+.........+......+...
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (257)
T cd08225         146 FGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP  224 (257)
T ss_pred             cccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCC
Confidence            988776544321 1223567779999987643 36789999999999999999999998776555554444433334444


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+..+...++..++.+|+++.+++.+
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         225 NFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            566778888888999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.44  E-value=2.4e-13  Score=108.16  Aligned_cols=173  Identities=23%  Similarity=0.346  Sum_probs=116.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..|+..|+..|.+.+...-...++...+..+... +.++.         ++|. .+++|++++|.++++ .....++.++
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLT---------YLYNVHRIMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHH---------HHHHhcCeeccCCCHHHEEECCCCcEEEccC
Confidence            3578889999988776443222222223333332 44444         6775 468999999999999 4567899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHhhC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA-------DQIYKICQLIG  198 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~-------~~~~~i~~~~~  198 (234)
                      |.+....... .....++..|.+||.+.. ..++...|+||+|++++++++|..||++....       ..+....+.+.
T Consensus       149 gl~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         149 GVSGELINSI-ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             Ccccchhhhc-cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            9876553321 223456778999998763 35778999999999999999999999865432       11112222221


Q ss_pred             -CCC----CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          199 -SPT----KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       199 -~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       .+.    ....+..+..+...|+...+.+|+++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~  265 (284)
T cd06620         227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA  265 (284)
T ss_pred             hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             111    1224556777888899999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.44  E-value=2.4e-13  Score=107.07  Aligned_cols=172  Identities=24%  Similarity=0.430  Sum_probs=115.5

Q ss_pred             HHHHHhhcCChHHHHHHHHh----hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           51 LVEMYSKCGHVEKAFKVFNL----MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      ++..|+..|.+.+..+-...    +++..+..+.. ++.|+.         ++|+.++.|++++|+++++ .....++.+
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~LH~~~i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE---------HMHSRRVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEEcCCCCEEECc
Confidence            45556677777765443221    11112223332 355666         8899999999999999999 456789999


Q ss_pred             ccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhhCCCC-
Q 026720          125 LGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS-ADQIYKICQLIGSPT-  201 (234)
Q Consensus       125 ~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~-~~~~~~i~~~~~~~~-  201 (234)
                      ++.+........ .....++..|.+||...+ ..++...|+||+|++++++++|..||.+... .....+.......++ 
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  228 (267)
T cd08229         150 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL  228 (267)
T ss_pred             chhhhccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence            998776543221 223456778999998864 3367889999999999999999999976532 222222222222221 


Q ss_pred             -CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 -KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       ....+..+..+...|+..++.+||++.+++.
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence             2345678888889999999999999997653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.44  E-value=1.7e-13  Score=110.41  Aligned_cols=134  Identities=22%  Similarity=0.379  Sum_probs=103.6

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|.++++ .....++.++|.+.....   .....++..|.+||.+..  ...++...|+||+|+++++
T Consensus       130 ~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e  206 (308)
T cd06634         130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  206 (308)
T ss_pred             HHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHH
Confidence            7888899999999999999 456789999998776543   223456678999998742  2346778999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++|..||.+....+....+.+... ......++..+..++..|+...+.+|+++++++..
T Consensus       207 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            9999999987766665555444322 12234677788889999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.44  E-value=2.8e-13  Score=108.27  Aligned_cols=135  Identities=21%  Similarity=0.291  Sum_probs=98.3

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.|+++. ....++++||.+..+....   .......+..|++||.... ..++...|+||+|++++
T Consensus       145 ~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~  223 (296)
T cd05051         145 YLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLW  223 (296)
T ss_pred             HHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHH
Confidence            78888999999999999994 5678999999887654321   1112334567999998864 34789999999999999


Q ss_pred             HHHh--CCCCCCCCChHHHHHHHHHhh---C----CCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS--FGILFPGKSSADQIYKICQLI---G----SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~--~~~~f~~~~~~~~~~~i~~~~---~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++  +..||......+....+....   .    .+.+...+..+..+...|+..++.+||++.++++
T Consensus       224 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         224 EILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            9998  667887666555544443221   1    1222234467788888899999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.43  E-value=3.4e-13  Score=105.75  Aligned_cols=173  Identities=24%  Similarity=0.260  Sum_probs=120.4

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ++..|+..|.+.+...-...++...+..+... +.|+.         ++|..++.|++++|+++++ .....++.+|+.+
T Consensus        70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~---------~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~  140 (265)
T cd05579          70 LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALE---------YLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLS  140 (265)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHcCeecCCCCHHHeEEcCCCCEEEEecccc
Confidence            45567777777766544333444444444443 66666         8899999999999999999 4567889999987


Q ss_pred             ccccCCC---------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-C
Q 026720          129 KEIDSNL---------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-G  198 (234)
Q Consensus       129 ~~~~~~~---------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-~  198 (234)
                      .......         ......++..|.+||...... ++...|+||+|++++++++|..||......+....+.... .
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  219 (265)
T cd05579         141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE  219 (265)
T ss_pred             hhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC
Confidence            7543321         112234566789999886433 6788999999999999999999998777655554443311 1


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccc---cccCCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNL---LAVMPS  233 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (234)
                      .|.....+..+..+...++...+.+|+++   .++++.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            12222236677778888888899999999   666653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.7e-13  Score=102.27  Aligned_cols=171  Identities=23%  Similarity=0.248  Sum_probs=126.3

Q ss_pred             HHHHHHhhcCChHHHHH--HHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFK--VFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~--~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      +||.+|+..|.+-...+  ......++-..+|..+ .+|+.         ++|...++|++++|.|.++ ..+-.++.||
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~---------y~h~k~VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALL---------YCHLKRVIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHH---------HhccCCcccCCCCHHHhccCCCCCeeccCC
Confidence            56777888887665544  2222334444566555 56666         8888889999999999999 4677899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |-...... ....+.+++--|.+||...+. .+...+|+|++|++++|++.|.+||......+.-.+|. +.....+.+-
T Consensus       169 GwsV~~p~-~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~-k~~~~~p~~i  245 (281)
T KOG0580|consen  169 GWSVHAPS-NKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR-KVDLKFPSTI  245 (281)
T ss_pred             CceeecCC-CCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH-HccccCCccc
Confidence            97665542 234567888889999999744 46899999999999999999999999888555555554 3444444666


Q ss_pred             cchhhhhhhhccccCCCCCccccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++.-..++-.+....+.+|.++.+++.
T Consensus       246 s~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  246 SGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ChhHHHHHHHHhccCccccccHHHHhh
Confidence            667777777777778888888887754

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.43  E-value=3e-13  Score=110.60  Aligned_cols=135  Identities=19%  Similarity=0.304  Sum_probs=98.1

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|++++|.|+++ .....++++||.+........   .....++..|++||...+ ..++...|+||+|++++
T Consensus       194 ~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~  272 (343)
T cd05103         194 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLW  272 (343)
T ss_pred             HHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHH
Confidence            7888899999999999999 467789999998876533211   112223456899998763 44788999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCC-CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGS-PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++++ |..||++................ +.+...+..+..+...||...+.+|+++.+++.
T Consensus       273 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~  334 (343)
T cd05103         273 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  334 (343)
T ss_pred             HHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9996 88999876654444444332222 223334456666777799999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.43  E-value=4.9e-13  Score=105.60  Aligned_cols=176  Identities=23%  Similarity=0.392  Sum_probs=117.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+..+-...++..-+..+.. ++.++.         ++|+.+++|++++|.++++ .....++.+++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA---------YLHSKGILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHhhCCeeecCCChhhEEEcCCCeEEEeecc
Confidence            346667777787776544332222211222222 245555         7888899999999999999 46778999999


Q ss_pred             ccccccCCC---CCCCcccCccccccccccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC--
Q 026720          127 MVKEIDSNL---PCTDYVTTRWYRGPEVLLFSE-IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP--  200 (234)
Q Consensus       127 ~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~-~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~--  200 (234)
                      .+.......   ......++..|.+||...... .++...|+||+|++++++++|..||.+.........+......+  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI  233 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence            887654311   112234567799999876433 36788999999999999999999998765555444433221111  


Q ss_pred             CCC---CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKD---SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..   ..+..+..+...++..++..|+++++++.+
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111   224566667778889999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.43  E-value=4.1e-13  Score=105.73  Aligned_cols=174  Identities=21%  Similarity=0.349  Sum_probs=119.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C-CeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K-GVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~-~~~~~~~~~  126 (234)
                      .++..|+..+.+.+...-...++++.+..|... +.|+.         ++|+.+++|++++|.++++. . ...++.+|+
T Consensus        79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~---------~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS---------YLHENQIIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence            355667777788776543333444444444444 66777         89999999999999999994 3 357899999


Q ss_pred             ccccccCCCC-----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---hC
Q 026720          127 MVKEIDSNLP-----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL---IG  198 (234)
Q Consensus       127 ~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~---~~  198 (234)
                      .+........     .....++..|.+||.... ..++...|+||+|++++++++|..||...........+.+.   ..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT  228 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC
Confidence            8876643211     122356678999999863 44788999999999999999999999755433222223222   22


Q ss_pred             CCCC-CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 SPTK-DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .++. ...+..+..+...++..++.+|++..+++++
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            2222 2345567777788888899999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.43  E-value=6e-14  Score=106.42  Aligned_cols=129  Identities=23%  Similarity=0.366  Sum_probs=100.4

Q ss_pred             ccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccC-CCCcchHHHHHHHHHHHHhCCC
Q 026720          102 GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI-YGPEVDKWAMGAIMFEMLSFGI  179 (234)
Q Consensus       102 ~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~~d~~s~g~~l~e~~~~~~  179 (234)
                      .++|++++|.|+++ ..+..+++|||.+.++..+..+..-.+-+.|+|||.+..... |...+|+||+|+.++|+.+|.-
T Consensus       188 kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~f  267 (361)
T KOG1006|consen  188 KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNF  267 (361)
T ss_pred             hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCC
Confidence            48999999999999 478899999999999887665554566678999999866555 8999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHH-hhCCCCC-------CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          180 LFPGKSSADQIYKICQ-LIGSPTK-------DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       180 ~f~~~~~~~~~~~i~~-~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+.+-.+  ++.++++ ..|.|+.       ..++..+...++.|..-+...|+++.++..
T Consensus       268 Pyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  268 PYRKWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CcchHHH--HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            9986433  3333443 2233332       345567778889999999999998887653

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.42  E-value=4.1e-13  Score=108.34  Aligned_cols=175  Identities=16%  Similarity=0.219  Sum_probs=114.8

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-.  ..+++..+..+.. ++.|+.         ++|..+++|++++|.++++. ....++.++
T Consensus        75 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~---------~LH~~~ivH~dlk~~Nili~~~~~~kl~d~  145 (314)
T cd08216          75 YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD---------YIHSKGFIHRSVKASHILLSGDGKVVLSGL  145 (314)
T ss_pred             EEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCcceEEEecCCceEEecC
Confidence            4566778888887765432  1123223333333 255566         88999999999999999994 567888888


Q ss_pred             cccccccCCCC--------CCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-
Q 026720          126 GMVKEIDSNLP--------CTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ-  195 (234)
Q Consensus       126 ~~a~~~~~~~~--------~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~-  195 (234)
                      +.+......-.        ......+..|++||++... ..|+...|+||+|++++|+++|..||.+............ 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~  225 (314)
T cd08216         146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG  225 (314)
T ss_pred             ccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            87765432110        1123455679999998543 3478899999999999999999999987655544332211 


Q ss_pred             hhCC-------C-------------------------CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          196 LIGS-------P-------------------------TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       196 ~~~~-------~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ....       +                         .....+..+..+...|+..++-+|+++++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         226 TVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            1000       0                         001112344557777899999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.42  E-value=5.4e-13  Score=104.03  Aligned_cols=174  Identities=21%  Similarity=0.357  Sum_probs=120.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...-...+++..+..+... +.++.         ++|+.++.|++++|.++.+. ....++.+++.
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA---------YLHEQGVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHH---------HHhhCCcccCCCCHHHEEECCCCCEEEecccc
Confidence            345556666666655433222222222222222 55555         78888999999999999994 56789999998


Q ss_pred             cccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +........ .....++..|.+||...... +....|+|++|++++++++|..||.+........++......+.+...+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (254)
T cd06627         146 ATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGIS  224 (254)
T ss_pred             ceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCC
Confidence            887655332 12345667799999876433 6788999999999999999999998777655555544322222333456


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.+..+...++..++.+|++.++++..
T Consensus       225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         225 PELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            678888888888999999999998764

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.42  E-value=7.4e-14  Score=114.66  Aligned_cols=101  Identities=34%  Similarity=0.689  Sum_probs=83.7

Q ss_pred             Hhh-hcccccCCcCCCcEEee--CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLH-RQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~-~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      .++ ..+++|.+++|||++.+  ....++|+||.|..+... ....+..+++|.|||++.|.+ |..-+|+||.||.|||
T Consensus       550 klLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYE  627 (752)
T KOG0670|consen  550 KLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYE  627 (752)
T ss_pred             HHHHhcCeeecccCccceEeccCcceeeeccCccccccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEE
Confidence            444 56899999999999994  568899999999887653 344567889999999999665 7889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      +-+|+.+|||..+.+.+.-.++.-|.
T Consensus       628 lYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  628 LYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eeccceecCCCCcHHHHHHHHHhcCC
Confidence            99999999999988877665554443

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.42  E-value=1.1e-12  Score=107.31  Aligned_cols=172  Identities=24%  Similarity=0.431  Sum_probs=113.8

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEeeccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGM  127 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~  127 (234)
                      ++..|+. +.+.+...- ..+++..+..|... +.|+.         ++|..+++|++++|.++++.  ....++.+||.
T Consensus        93 lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~---------~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          93 IVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLK---------YIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             EEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence            5555665 344332210 11223334444444 56666         88988999999999999994  34678999998


Q ss_pred             cccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          128 VKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       128 a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      +..+.....    .....++..|.+||.+.....++..+|+||+|++++++++|+.||.+....+....+.+....++. 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            876532211    112345678999998765455788999999999999999999999987766665554433221111 


Q ss_pred             ----------------------------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 ----------------------------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                  ...+.....+...++..++.+|+++++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                                        1123344556777888899999999998864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.41  E-value=4.7e-13  Score=103.18  Aligned_cols=165  Identities=24%  Similarity=0.297  Sum_probs=116.3

Q ss_pred             HHHHhhccCccccHHHH-HHHH-HhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEeeccccccccCCCCCCC
Q 026720           66 KVFNLMREKNLQSWTIM-ISGL-ADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTD  139 (234)
Q Consensus        66 ~~~~~m~~~~~~~~~~~-i~~~-~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~~~~a~~~~~~~~~~~  139 (234)
                      ++|.++.++.-..|+-- .+.. -+.|  ....++|+.++.|+|++|.|.+|.    ++..+++|||.|+.........+
T Consensus       145 eLfsriq~~g~~afTErea~eI~~qI~--~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~T  222 (400)
T KOG0604|consen  145 ELFSRIQDRGDQAFTEREASEIMKQIG--LAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMT  222 (400)
T ss_pred             HHHHHHHHcccccchHHHHHHHHHHHH--HHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccC
Confidence            45666666554444432 1111 1111  122278988999999999999993    46789999999999876555666


Q ss_pred             cccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhhCCCCCCCCcchhhh---h
Q 026720          140 YVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS----ADQIYKICQLIGSPTKDSWPLGIQL---A  212 (234)
Q Consensus       140 ~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~---~  212 (234)
                      .+-+++|.|||++- ...|...-|+||+|+++|-++.|-+||.+...    ...-.+|....-..+...|++.-+.   +
T Consensus       223 Pc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdl  301 (400)
T KOG0604|consen  223 PCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDL  301 (400)
T ss_pred             CcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHH
Confidence            77889999999984 56688889999999999999999999997643    3333344444344556667654444   4


Q ss_pred             hhhccccCCCCCccccccCCC
Q 026720          213 SNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++...+..+.+|.++++++++
T Consensus       302 IR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  302 IRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HHHHhcCCchhheeHHHhhcC
Confidence            444557788999999988754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.41  E-value=9.2e-13  Score=102.60  Aligned_cols=173  Identities=25%  Similarity=0.309  Sum_probs=118.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...-...++...+..+... +.++.         ++|..++.|++++|+++.+ .....++.+++.
T Consensus        69 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~---------~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~  139 (250)
T cd05123          69 YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE---------YLHSLGIIYRDLKPENILLDADGHIKLTDFGL  139 (250)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCceecCCCcceEEEcCCCcEEEeecCc
Confidence            455556666666555433222333333344333 56666         8898999999999999999 456788999998


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +...... .......++..|.+||..... .++...|+||+|++++++++|..||..........++.+ ...+.+...+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  217 (250)
T cd05123         140 AKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLS  217 (250)
T ss_pred             ceecccCCCcccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCC
Confidence            8776443 122334566789999988643 357889999999999999999999987765444444433 2223333445


Q ss_pred             chhhhhhhhccccCCCCCccc---cccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNL---LAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (234)
                      ..+..+.+.++..++..|+++   +++.++
T Consensus       218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         218 PEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             HHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            677778888999999999999   666543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.41  E-value=4.2e-13  Score=106.14  Aligned_cols=175  Identities=17%  Similarity=0.309  Sum_probs=120.6

Q ss_pred             HHHHHHHHhhcCChHHHHHHHH---------hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-e
Q 026720           48 GTALVEMYSKCGHVEKAFKVFN---------LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-S  116 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~---------~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~  116 (234)
                      +..++..|+..|.+.+......         .++...+..+... +.++.         ++|+.+++|++++|+|+++ .
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~---------~LH~~~i~H~dlkp~Nili~~  152 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD---------HLSNARFVHRDLAARNCLVSS  152 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHH---------HhhhcCcccCcCccceEEEeC
Confidence            3467778888888887755432         1222233333333 55566         8899999999999999999 4


Q ss_pred             CCeeeEeeccccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 026720          117 KGVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKI  193 (234)
Q Consensus       117 ~~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i  193 (234)
                      ....++.+++.+.......  ......++..|.+||...+. .++...|+||+|++++++++ |..||.+.........+
T Consensus       153 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             CCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            5667888888776543211  11222344568999987633 36788999999999999998 77899876555544444


Q ss_pred             HH-hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          194 CQ-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       194 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .. ....+.....+..+..+...|+...+.+|+++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~  271 (275)
T cd05046         232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS  271 (275)
T ss_pred             HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            32 1122334566778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.41  E-value=6e-13  Score=112.86  Aligned_cols=169  Identities=19%  Similarity=0.256  Sum_probs=129.8

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCcc------ccHHHHHH-HHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNL------QSWTIMIS-GLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVI  120 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~------~~~~~~i~-~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~  120 (234)
                      -.||.+++.+|++-+..+-    ..++.      .-|..+|. |+.         +|-....+|+|+...|+++ ..-..
T Consensus       185 ~mMV~ELaplGSLldrLrk----a~~~~llv~~Lcdya~QiA~aM~---------YLeskrlvHRDLAARNlllasprtV  251 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK----AKKAILLVSRLCDYAMQIAKAMQ---------YLESKRLVHRDLAARNLLLASPRTV  251 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh----ccccceeHHHHHHHHHHHHHHHH---------HHhhhhhhhhhhhhhhheeccccee
Confidence            4689999999998876543    11222      23433322 233         5555668999999999988 45688


Q ss_pred             eEeeccccccccCCCCCCCc----ccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 026720          121 KIGDLGMVKEIDSNLPCTDY----VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~~~~----~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~  195 (234)
                      +++|||+.+.+...-....+    ...-.|-+||.+. .+.|+.++|+|++|+.+|||++ |++|+.|+.-..++.+|=+
T Consensus       252 KI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~  330 (1039)
T KOG0199|consen  252 KICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA  330 (1039)
T ss_pred             eeecccceeccCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc
Confidence            99999998887553222211    1223588999997 5668999999999999999997 6699999999999988877


Q ss_pred             hhCCCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          196 LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      +-.-+.+..+++.|=.++.-||...+-+|++|..|.
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair  366 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR  366 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence            667788888999999999999999999999999885

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=7.4e-13  Score=111.40  Aligned_cols=137  Identities=20%  Similarity=0.320  Sum_probs=113.8

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAI  170 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~  170 (234)
                      .+|+..++|++++..|+++ .++-.++.|||......... ..-.++|+|+|+|||++..    ...|....|+||+|+.
T Consensus       145 ~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGIT  224 (1187)
T KOG0579|consen  145 WLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGIT  224 (1187)
T ss_pred             HHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhH
Confidence            7899899999999999999 57888999999876654433 3345899999999999743    2348899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQLIGS--PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      |.||..+.+|-......-.+++|.+.-..  -.+..|+..+..+...|..-.+..|++..++|.+
T Consensus       225 LIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  225 LIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            99999999999999999999888764332  2357899999999999998888889988888764

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.41  E-value=3.4e-13  Score=113.96  Aligned_cols=136  Identities=24%  Similarity=0.357  Sum_probs=95.9

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.|+++. ....++.|||.+..+....   ......++..|++||++.+ ..++..+|+||+|+++|
T Consensus       275 yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~  353 (461)
T PHA03211        275 YIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIF  353 (461)
T ss_pred             HHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHH
Confidence            88999999999999999994 5678999999987653321   1223567889999999874 44789999999999999


Q ss_pred             HHHhCCC-CCCCC------ChHHHHHHHHHhhCCCC----------------------------CCCCc------chhhh
Q 026720          173 EMLSFGI-LFPGK------SSADQIYKICQLIGSPT----------------------------KDSWP------LGIQL  211 (234)
Q Consensus       173 e~~~~~~-~f~~~------~~~~~~~~i~~~~~~~~----------------------------~~~~~------~~~~~  211 (234)
                      |++.+.. +|...      ....++.++.+......                            ...|.      .....
T Consensus       354 El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  433 (461)
T PHA03211        354 EAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEY  433 (461)
T ss_pred             HHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHH
Confidence            9998774 44322      12234444444322110                            11222      24455


Q ss_pred             hhhhccccCCCCCccccccCCC
Q 026720          212 ASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+...++.+|+++.+++.+
T Consensus       434 li~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        434 LVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHcccChhhCcCHHHHhhC
Confidence            6777889999999999999864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.41  E-value=8.7e-14  Score=116.55  Aligned_cols=171  Identities=20%  Similarity=0.308  Sum_probs=133.5

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHHH-HHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~i-~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|.+++..|.+.+-.+.-. .++-....-|..+| .+++         ++++...+|+|+...|++. +.-+.+++|||
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~tala---------YLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALA---------YLESKRFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHH---------HHHhhchhhhhhhhhheeecCcceeeecccc
Confidence            36777888888877655421 23334455566664 3455         7887779999999999999 45688999999


Q ss_pred             ccccccCCCCCCCccc--CcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNLPCTDYVT--TRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~--~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +.+.+..........+  ..-|++||.+++ +.|++++|+|-+|+++||+++ |..||.|..+.|..-++-+.-..|-+.
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~  615 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP  615 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC
Confidence            9998876543322222  345899999985 448999999999999999875 779999999999888887777778888


Q ss_pred             CCcchhhhhhhhccccCCCCCcccccc
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      .++..+=.++-.||...+-+||+|-+|
T Consensus       616 nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  616 NCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             CCChHHHHHHHHHhccCcccCCcHHHH
Confidence            888888889999999999999999876

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.41  E-value=5.7e-13  Score=103.97  Aligned_cols=174  Identities=22%  Similarity=0.330  Sum_probs=121.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|...+.+.+...-........+..+.. ++.++.         ++|+.++.|++++|+++.+. ....++.+++.
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~  147 (260)
T cd06606          77 NIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLA---------YLHSNGIVHRDIKGANILVDSDGVVKLADFGC  147 (260)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCCHHHEEEcCCCCEEEccccc
Confidence            45666777777766544332222222222222 355555         88989999999999999994 56778999998


Q ss_pred             cccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-hhCCCCC
Q 026720          128 VKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS-ADQIYKICQ-LIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~-~~~~~~i~~-~~~~~~~  202 (234)
                      +........   .....++..|.+||..... .++...|+||+|++++++++|..||.+... .....++.. ......+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (260)
T cd06606         148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP  226 (260)
T ss_pred             EEecccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence            887665432   2334566779999988643 368899999999999999999999987662 223333321 1222334


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++..+..++..|+...+.+|+++.+++.+
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            5567788888888999899999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.41  E-value=1.1e-12  Score=107.48  Aligned_cols=135  Identities=35%  Similarity=0.541  Sum_probs=100.5

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|.|+++ ..+..++.++|.+......  .....++..|.+||...+...++...|+||+|+++++++
T Consensus       135 ~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  212 (345)
T cd07877         135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  212 (345)
T ss_pred             HHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence            7899999999999999999 4667899999988765442  233456778999998764445788899999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCC------------------------------CCcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKD------------------------------SWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|+.||++......+.++.+..+.+...                              .++..+..++..+...++.+|+
T Consensus       213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  292 (345)
T cd07877         213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI  292 (345)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence            9999999877666655554443322111                              1233444555667778888999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      +..+++.+
T Consensus       293 t~~e~l~h  300 (345)
T cd07877         293 TAAQALAH  300 (345)
T ss_pred             CHHHHhcC
Confidence            98888764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.41  E-value=1.5e-12  Score=104.17  Aligned_cols=137  Identities=20%  Similarity=0.298  Sum_probs=100.6

Q ss_pred             Hhhh-cccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccc---cCCCCcchHHHHHHHH
Q 026720           97 SLHR-QGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS---EIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~~d~~s~g~~l  171 (234)
                      ++|. .+++|++++|.++++ .....++.+||.+..+..........++..|.+||.+.+.   ..++...|+||+|+++
T Consensus       129 ~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il  208 (296)
T cd06618         129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISL  208 (296)
T ss_pred             HHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHH
Confidence            7885 479999999999999 4677899999988766543322333456679999987533   2367889999999999


Q ss_pred             HHHHhCCCCCCCCCh-HHHHHHHHHhhC--CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          172 FEMLSFGILFPGKSS-ADQIYKICQLIG--SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       172 ~e~~~~~~~f~~~~~-~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++++|+.||..... .+.+.++.....  .+....+++.+..+...|+..++.+||++++++..
T Consensus       209 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         209 VELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999999999976433 334444443321  12222356778888889999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.40  E-value=7.4e-13  Score=105.97  Aligned_cols=174  Identities=20%  Similarity=0.235  Sum_probs=116.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh---h---ccCccccHHH-------HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL---M---REKNLQSWTI-------MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV  115 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~---m---~~~~~~~~~~-------~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~  115 (234)
                      ..++..|+..|++.+...-...   .   .......+..       ++.|+.         ++|..+++|++++|.|+++
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~---------~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK---------YLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHH---------HHHhcCeeccccChhhEEE
Confidence            4578888998988776532110   0   0001122322       244444         7888899999999999999


Q ss_pred             e-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 026720          116 S-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS--FGILFPGKSSADQ  189 (234)
Q Consensus       116 ~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~--~~~~f~~~~~~~~  189 (234)
                      . ....++.+||.+..+.....   ......+..|.+||.... ..++..+|+||+|++++++++  +..||......+.
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            4 55689999998876543211   111233457999998764 347899999999999999987  5678876655554


Q ss_pred             HHHHHH---hhCC----CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQ---LIGS----PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+.+   ....    ..+...+..+..+...|+..++.+||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            443322   1111    122334567888889999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.40  E-value=9.2e-13  Score=103.86  Aligned_cols=175  Identities=20%  Similarity=0.263  Sum_probs=116.9

Q ss_pred             HHHHHHhhcCChHHHHHHH-Hhh--ccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLM--REKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m--~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~  123 (234)
                      .++..|+..+.+.....-- ...  +...+..+.. ++.|+.         ++|..++.|++++|.++++.  ....+++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK---------YLHDNQIVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHH---------HHHHCCEeecCCCHHHEEEcCCCCeEEEe
Confidence            4566677778887765421 111  1122233333 355666         88999999999999999994  4578999


Q ss_pred             eccccccccCCC-CCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC--C
Q 026720          124 DLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG--S  199 (234)
Q Consensus       124 ~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~--~  199 (234)
                      +++.+....... ......++..|.+||..... ..++..+|+||+|++++++++|..||.................  .
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  231 (268)
T cd06624         152 DFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP  231 (268)
T ss_pred             cchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC
Confidence            999887653321 12223466789999987543 2367899999999999999999999986544333222111111  1


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .-+...++.+..+...|+...+.+|+++++++.+
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            1123345567778888999999999999998764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.39  E-value=5.7e-13  Score=108.29  Aligned_cols=176  Identities=17%  Similarity=0.239  Sum_probs=114.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~  124 (234)
                      ..++..|+..|.+.+......  .+++..+..+... +.|+.         ++|+.+++|++++|.|+++. ....++.+
T Consensus        74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~---------~lH~~~ivHrDlkp~Nill~~~~~~~~~~  144 (328)
T cd08226          74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLN---------YLHQNGYIHRNIKASHILISGDGLVSLSG  144 (328)
T ss_pred             eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEeCCCcEEEec
Confidence            345667777778776544321  1333333344444 56666         88998999999999999984 55667777


Q ss_pred             ccccccccCCCCC--------CCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          125 LGMVKEIDSNLPC--------TDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       125 ~~~a~~~~~~~~~--------~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      ++.+.........        ....+...|++||++.+. ..++..+|+||+|++++++++|+.||.+............
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  224 (328)
T cd08226         145 LSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK  224 (328)
T ss_pred             hHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc
Confidence            6543322111000        001233458999998643 2367899999999999999999999988766555444332


Q ss_pred             hhC----------------------------------------------CCCCCCCcchhhhhhhhccccCCCCCccccc
Q 026720          196 LIG----------------------------------------------SPTKDSWPLGIQLASNLNWKLPQMGGVNLLA  229 (234)
Q Consensus       196 ~~~----------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (234)
                      ...                                              .+....++..+..+...++..++.+|+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e  304 (328)
T cd08226         225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS  304 (328)
T ss_pred             CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence            110                                              0111223345667778899999999999999


Q ss_pred             cCCC
Q 026720          230 VMPS  233 (234)
Q Consensus       230 ~~~~  233 (234)
                      ++.+
T Consensus       305 ~l~~  308 (328)
T cd08226         305 LLSH  308 (328)
T ss_pred             HhhC
Confidence            8764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.39  E-value=4e-13  Score=104.18  Aligned_cols=162  Identities=22%  Similarity=0.293  Sum_probs=112.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+...-...++...+..|... +.|+.         ++|+.+++|++++|+|+++ .....++.+++
T Consensus        60 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~  130 (237)
T cd05576          60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD---------ALHREGIVCRDLNPNNILLDDRGHIQLTYFS  130 (237)
T ss_pred             EEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHHHEEEcCCCCEEEeccc
Confidence            3567788888988776544334555566666655 66776         8899999999999999999 45678899998


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      .+..+....  .....+..|++||.... ..++...|+||+|++++|+++|..++......     +........+...+
T Consensus       131 ~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~  202 (237)
T cd05576         131 RWSEVEDSC--DGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVS  202 (237)
T ss_pred             chhcccccc--ccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCC
Confidence            776654421  22344567999998753 33677899999999999999999887643211     11011111223345


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..+..+...+...++.+|++.
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCC
Confidence            566677777888888888875

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.39  E-value=3.4e-13  Score=114.22  Aligned_cols=131  Identities=27%  Similarity=0.379  Sum_probs=97.1

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-----CCeeeE
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-----KGVIKI  122 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-----~~~~~~  122 (234)
                      ...++.+||.+|++....+-.+.-.   =.+=+.++.-+...+.+..  +|+..+++|||++|.|+...     .-.-++
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~---GLpE~e~l~lL~d~~~al~--~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAY---GLPESEFLDLLSDLVSALR--HLRENGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCccccc---CCCHHHHHHHHHHHHHHHH--HHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence            3568899999999987643322111   1122222222222222222  67788999999999999883     235699


Q ss_pred             eeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG  183 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~  183 (234)
                      .|||-|+.+.........+|+..|.+||..-....|+..+|.||+|+.+|+.++|..||--
T Consensus       166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999999998887888899999999999986445699999999999999999999999873

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=2.5e-13  Score=105.90  Aligned_cols=128  Identities=31%  Similarity=0.363  Sum_probs=99.3

Q ss_pred             cccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCC-CCCCCcccCccccccccc
Q 026720           76 LQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVL  152 (234)
Q Consensus        76 ~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~-~~~~~~~~~~~~~~pe~~  152 (234)
                      ...|.+- ++++.         ++|+..++.++++..|.++ .++..++.|||++++-... ....+++++|-|.|||++
T Consensus       270 tRFYGaEIvsAL~---------YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  270 TRFYGAEIVSALG---------YLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             hhhhhHHHHHHhh---------hhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhh
Confidence            3455554 88888         9999999999999999999 5899999999999975432 345678999999999999


Q ss_pred             ccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhh
Q 026720          153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLAS  213 (234)
Q Consensus       153 ~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  213 (234)
                      -. ..|...+|.|+.|+++|||+.|+.||...++.....-|...-.+.+..--+++-.++.
T Consensus       341 eD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  341 ED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS  400 (516)
T ss_pred             cc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence            74 4489999999999999999999999999888777666654333333333344444443

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.38  E-value=5.9e-13  Score=106.53  Aligned_cols=172  Identities=22%  Similarity=0.359  Sum_probs=116.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccH-HHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSW-TIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~-~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...- ..++...+..+ ..++.|+.         ++|+.++.|++++|.++.+ .....++.+++.
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~---------~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALE---------FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHH---------HHHhCCEeeccCCHHHEEEcCCCCEEEccCcc
Confidence            456667777777665421 01111222222 23355666         8899999999999999999 456788999997


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC---CC
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT---KD  203 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~---~~  203 (234)
                      +....... ......+++.|.+||.... ..++...|+||+|+++|++++|..||.+....+....+.. .+.+.   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~  239 (293)
T cd06647         162 CAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPE  239 (293)
T ss_pred             eecccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCCCcc
Confidence            76543321 1223456677999998864 4478899999999999999999999987765554333321 12221   22


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+..+++.|+...+.+|+++++++.+
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            234567778888999999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.38  E-value=2.5e-12  Score=107.14  Aligned_cols=171  Identities=19%  Similarity=0.271  Sum_probs=125.3

Q ss_pred             HHHHHHhhcCChHHHHHHHH--h-hccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--L-MREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~-m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ++|..|+.+|++.+-..--+  . +..+.+-..+.+-+|++         +|-+-.++|+++.+.|.+. .....++++|
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgma---------YLes~nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMA---------YLESLNFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHH---------HHHhhchhhccccccceeecCcccEEecCc
Confidence            68999999999988654321  1 11222233333355666         7777779999999999999 4677899999


Q ss_pred             cccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhhCC-
Q 026720          126 GMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS--FGILFPGKSSADQIYKICQLIGS-  199 (234)
Q Consensus       126 ~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~--~~~~f~~~~~~~~~~~i~~~~~~-  199 (234)
                      |.++.+...-.   ....+....|+|+|.+. ...+++++|+|++|+.+||+++  ...||.+..+.+.......-... 
T Consensus       682 gmsR~lysg~yy~vqgr~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~  760 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ  760 (807)
T ss_pred             ccccccccCCceeeecceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC
Confidence            99997754321   12234557799999987 4558999999999999999875  67999987766655554432221 


Q ss_pred             ------CCCCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          200 ------PTKDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       200 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                            +.+..++..+-+++--||.....+||+|+++
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l  797 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL  797 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence                  3346677788888999999999999999986

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.37  E-value=1e-12  Score=104.22  Aligned_cols=173  Identities=17%  Similarity=0.277  Sum_probs=117.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      ..++..|+..|.+.+..+- ..+..+.+..+... +.++.         ++|..++.|++++|.++.+ .....++.+++
T Consensus        77 ~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~---------~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg  146 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD---------YLHSEKKIHRDIKAANVLLSEHGEVKLADFG  146 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHH---------HHccCCeecCCCCHHhEEECCCCCEEEeecc
Confidence            4577778888877765421 11222222233222 45555         7888889999999999999 45678899999


Q ss_pred             ccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC-CCCC
Q 026720          127 MVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP-TKDS  204 (234)
Q Consensus       127 ~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~-~~~~  204 (234)
                      .+..+..... .....++..|.+||.... ..++...|+||+|++++++++|..||.+.........+... ..+ ....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  224 (277)
T cd06641         147 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NPPTLEGN  224 (277)
T ss_pred             cceecccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CCCCCCcc
Confidence            8776543211 122345677899998863 34577899999999999999999999876654444443222 222 2234


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...|+...+.+|+++.+++..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            45677778888999889999999988763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.37  E-value=1.1e-12  Score=104.57  Aligned_cols=173  Identities=20%  Similarity=0.279  Sum_probs=114.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+-......++...+..+.. ++.++.         ++|..+++|++++|.++++ .+...++.+|+.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~---------~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  151 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE---------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  151 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence            46777888887766544322233333334432 355555         8898999999999999999 567789999998


Q ss_pred             cccccCCC--CCCCcccCccccccccccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---hhCCCC
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFSE-IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ---LIGSPT  201 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~-~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~---~~~~~~  201 (234)
                      +.......  ......++..|++||...... .++...|+||+|++++++++|..||...........+.+   ....+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (290)
T cd05613         152 SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  231 (290)
T ss_pred             ceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC
Confidence            87654321  112345677899999875432 356789999999999999999999975433222222222   122333


Q ss_pred             CCCCcchhhhhhhhccccCCCCCc-----cccccC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGV-----NLLAVM  231 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  231 (234)
                      +...+..+..+...++..++.+|+     ++++++
T Consensus       232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~  266 (290)
T cd05613         232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK  266 (290)
T ss_pred             CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence            344556677777778877777775     555544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=2.5e-13  Score=111.09  Aligned_cols=175  Identities=19%  Similarity=0.223  Sum_probs=121.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCc-cccHHHHHHHHHhcCCchhhhHhhhc---ccccCCcCCCcEEee-CCeeeEe
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKN-LQSWTIMISGLADNSRGNDAISLHRQ---GYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~-~~~~~~~i~~~~~~g~~~~a~~l~~~---~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      -.||..|+..|++++..  +..   .. ..+|...+.......++.+  +||..   .++|+|++|.|+++. +..++++
T Consensus       147 ~~LVYEym~nGsL~d~L--~~~---~~~~L~W~~R~kIa~g~A~gL~--yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHL--HGK---KGEPLDWETRLKIALGAARGLA--YLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EEEEEEccCCCCHHHHh--CCC---CCCCCCHHHHHHHHHHHHHHHH--HHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            36888999999998853  222   22 6799999988887777766  45532   489999999999994 6789999


Q ss_pred             eccccccccC-CCCCCCc-ccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHH-----
Q 026720          124 DLGMVKEIDS-NLPCTDY-VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS---SADQIYKI-----  193 (234)
Q Consensus       124 ~~~~a~~~~~-~~~~~~~-~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~---~~~~~~~i-----  193 (234)
                      |||+++.... ....... .++.+|.+||+... ...+.++|+||+|+++.|+++|+.+.+...   ......++     
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999977654 3322222 78889999999863 446889999999999999999998887431   11122211     


Q ss_pred             ---HHhhCCCCC--CCCc--chhhh---hhhhccccCCCCCccccccC
Q 026720          194 ---CQLIGSPTK--DSWP--LGIQL---ASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       194 ---~~~~~~~~~--~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~  231 (234)
                         ...+..|..  ..+.  +....   +...|....+..||++.+++
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence               112222221  2333  23332   33557777888999988764

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.37  E-value=1.6e-12  Score=102.83  Aligned_cols=172  Identities=26%  Similarity=0.374  Sum_probs=121.3

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ++..|+..|++.+..+-...++...+..+... +.|+.         ++|..++.|++++|.++.+ .....++.+|+.+
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~---------~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE---------YLHSKGIIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecCCCHHHeEECCCCCEEecCCccc
Confidence            45567777777765543322333333333333 66666         7888899999999999999 4567889999987


Q ss_pred             ccccCCCC---------------------CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 026720          129 KEIDSNLP---------------------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA  187 (234)
Q Consensus       129 ~~~~~~~~---------------------~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~  187 (234)
                      ........                     .....++..|.+||.... ..++...|+||+|++++++++|..||......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            76543221                     112344567899998763 33678899999999999999999999987765


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccc----cccCCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNL----LAVMPS  233 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  233 (234)
                      ....++.+ .....+..+++.+..+.+.++...+.+|+++    ++++.+
T Consensus       229 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 LTFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHHHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            55544442 2333445667788888888999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.37  E-value=3.8e-12  Score=109.13  Aligned_cols=136  Identities=21%  Similarity=0.294  Sum_probs=94.1

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|+|++|+|+++ .....++.|||.+..+....  ......++..|++||++.+ ..|+..+|+||+|++++|
T Consensus       282 yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~e  360 (501)
T PHA03210        282 YIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLD  360 (501)
T ss_pred             HHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHH
Confidence            7888899999999999999 46778999999998764422  1223568889999999874 447899999999999999


Q ss_pred             HHhCCCC-CCCC--ChHHHHHHHHHhhCCCCCCC-------------------------------Ccchhhhhhhhcccc
Q 026720          174 MLSFGIL-FPGK--SSADQIYKICQLIGSPTKDS-------------------------------WPLGIQLASNLNWKL  219 (234)
Q Consensus       174 ~~~~~~~-f~~~--~~~~~~~~i~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~  219 (234)
                      |++++.+ +.+.  .....+.++.+....+....                               .+..+..++..+...
T Consensus       361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~  440 (501)
T PHA03210        361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF  440 (501)
T ss_pred             HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence            9998854 4332  23345555544333221110                               111122223446677


Q ss_pred             CCCCCccccccCCC
Q 026720          220 PQMGGVNLLAVMPS  233 (234)
Q Consensus       220 ~~~~~~~~~~~~~~  233 (234)
                      ++.+|++..+++.+
T Consensus       441 DP~~Rpsa~elL~h  454 (501)
T PHA03210        441 DWHLRPGAAELLAL  454 (501)
T ss_pred             CcccCcCHHHHhhC
Confidence            88899999988753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.37  E-value=1.9e-12  Score=99.90  Aligned_cols=174  Identities=27%  Similarity=0.415  Sum_probs=119.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|...+.+.+...-....+...+..+. .++.++.         ++|..++.|+++.|.++.+. ....++.+++.
T Consensus        63 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~  133 (244)
T smart00220       63 YLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALE---------YLHSNGIIHRDLKPENILLDEDGHVKLADFGL  133 (244)
T ss_pred             EEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHH---------HHHHcCeecCCcCHHHeEECCCCcEEEccccc
Confidence            3455566666666654322111111222222 2245555         78888999999999999994 46788999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC---
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS---  204 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~---  204 (234)
                      +.............++..|.+||... ...++...|+|++|+++++++++..||......+...+.......+....   
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~pE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (244)
T smart00220      134 ARQLDPGGLLTTFVGTPEYMAPEVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWK  212 (244)
T ss_pred             eeeeccccccccccCCcCCCCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccccc
Confidence            88766543333455677899999886 34467899999999999999999999987555555545444333222222   


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+..+...++..++.+|+++.++++.
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            66677788888999999999999998763

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.36  E-value=5.4e-12  Score=105.18  Aligned_cols=135  Identities=19%  Similarity=0.308  Sum_probs=102.6

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|++++|.++++. ...+++.|||.+.......   ......++..|++||.+... .++...|+||+|++++
T Consensus       254 ~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~  332 (401)
T cd05107         254 FLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLW  332 (401)
T ss_pred             HHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHH
Confidence            78888999999999999994 5678999999987643211   11122345679999988643 4688899999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHh-hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQL-IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||++....+........ ...+.+...+..+..+...||...+.+||++.+|+.
T Consensus       333 e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~  394 (401)
T cd05107         333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH  394 (401)
T ss_pred             HHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9998 88999877666655554332 222334456778888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.36  E-value=3.5e-12  Score=100.72  Aligned_cols=135  Identities=16%  Similarity=0.197  Sum_probs=97.7

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|++++|.++++. ...+++.+||.+........   ......+..|.+||.... ..++...|+||+|++++
T Consensus       128 ~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~  206 (273)
T cd05074         128 YLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMW  206 (273)
T ss_pred             HHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHH
Confidence            88988999999999999994 56678999998886643211   111223345788998753 34678899999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++++ |.+||.+....+....+......+.....+..+..+...|+...+..|+++.+++.
T Consensus       207 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         207 EIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             HHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9998 88999877665544444332222223345567777888899999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.36  E-value=7.6e-12  Score=101.73  Aligned_cols=135  Identities=34%  Similarity=0.540  Sum_probs=100.1

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|.++++ .....++.+|+.+......  .....++..|.+||.+.+...++...|+||+|+++++++
T Consensus       123 ~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~  200 (328)
T cd07856         123 YVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML  200 (328)
T ss_pred             HHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence            8898899999999999999 4567899999988765432  233456678999998765455789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCC-----------------------C-------CCCcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPT-----------------------K-------DSWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~-----------------------~-------~~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|.+||++.........+.+..+.+.                       .       ...+..+..++..++...+.+|+
T Consensus       201 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  280 (328)
T cd07856         201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI  280 (328)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence            99999998765444333333222211                       1       12345666777778888999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++..
T Consensus       281 t~~ell~~  288 (328)
T cd07856         281 SAAEALAH  288 (328)
T ss_pred             CHHHHhcC
Confidence            99988754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.36  E-value=1.8e-12  Score=103.02  Aligned_cols=173  Identities=19%  Similarity=0.326  Sum_probs=114.8

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|...|.+.+...-- ..++......+... +.|+.         ++|..+++|++++|+|+++ .....++.+|+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~---------~LH~~~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME---------YLGSKRYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHH---------HHHHCCceeccCCHhhEEECCCCeEEECCCc
Confidence            4677788888887764321 11222223333332 55666         8899999999999999999 45678999999


Q ss_pred             ccccccCCCCC----CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---------------
Q 026720          127 MVKEIDSNLPC----TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---------------  187 (234)
Q Consensus       127 ~a~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~---------------  187 (234)
                      .+..+......    ........|.+||...+ ..++...|+||+|++++|++++..++.+....               
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05081         154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV  232 (284)
T ss_pred             ccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence            88865432211    11122335889998864 34788999999999999999987655432111               


Q ss_pred             HHHHHHHH-hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQ-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+..+.. ....+.....+..+..+...|+...+.+|+++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            01111111 1122344566778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.35  E-value=1.9e-12  Score=105.96  Aligned_cols=135  Identities=36%  Similarity=0.553  Sum_probs=98.9

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|.++++ .....++.+||.+......  .....+++.|++||.+.+...++...|+||+|+++++++
T Consensus       133 ~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~  210 (343)
T cd07880         133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML  210 (343)
T ss_pred             HHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            8899999999999999999 4667899999988765442  223456778999998865445788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCC------------------------------CCCcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTK------------------------------DSWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|..||.+........+++...+.+..                              ...+..+..+...+...++.+|+
T Consensus       211 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  290 (343)
T cd07880         211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI  290 (343)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC
Confidence            999999988776666665543322110                              01122334445556677888899


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      +..+++.+
T Consensus       291 t~~~~l~~  298 (343)
T cd07880         291 TAAEALAH  298 (343)
T ss_pred             CHHHHhcC
Confidence            99888753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.35  E-value=2.4e-12  Score=102.95  Aligned_cols=173  Identities=20%  Similarity=0.345  Sum_probs=117.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...- ..+....+..+... +.++.         ++|..+++|++++|.|+.+. ....++.+|+.
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~---------~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~  162 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALS---------VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF  162 (292)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEECCCCCEEEccccc
Confidence            456667777777664321 11222223333333 55566         88888999999999999994 56789999998


Q ss_pred             cccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC--CCCC
Q 026720          128 VKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP--TKDS  204 (234)
Q Consensus       128 a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~--~~~~  204 (234)
                      +..+..... .....++..|.+||.... ..++...|+||+|++++++++|..||.+.........+.......  ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (292)
T cd06657         163 CAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHK  241 (292)
T ss_pred             ceecccccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCccc
Confidence            776543221 223456678999998763 346788999999999999999999998776555444333322211  1223


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...++...+.+|+++++++.+
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            45566777778888889999999988764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.35  E-value=1.6e-12  Score=103.50  Aligned_cols=174  Identities=20%  Similarity=0.367  Sum_probs=114.0

Q ss_pred             HHHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..|.+.+...-- ..++...+..+... +.++.         ++|+.+++|++++|+|+++ .....++.+|
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~---------~lH~~gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD---------YLGSRQYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecccchheEEEcCCCCEEECCC
Confidence            35777888888887754211 01111222222222 44444         7899999999999999999 4567899999


Q ss_pred             cccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC--------------CChH
Q 026720          126 GMVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG--------------KSSA  187 (234)
Q Consensus       126 ~~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~--------------~~~~  187 (234)
                      |.+..+.....    .....++..|.+||...+ ..++...|+||+|+++++++++..+...              ....
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05079         154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV  232 (284)
T ss_pred             ccccccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence            98876643221    112334456899998764 3477889999999999999987654322              1112


Q ss_pred             HHHHHHHH-hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQ-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ........ ....+.....+..+..+...|+...+.+|+++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            22222222 1223334456677888889999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.34  E-value=2.7e-12  Score=114.70  Aligned_cols=171  Identities=22%  Similarity=0.237  Sum_probs=106.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh---hcc--CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL---MRE--KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~---m~~--~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .++..|+..|++.+...-...   .++  ....++...+..+.+.....+  ++|+.+++|+|++|+|+++ ..+..++.
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~--yLHs~GIIHRDLKPeNILLd~dg~vKLi  155 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE--YVHSKGVLHRDLKPDNILLGLFGEVVIL  155 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHH--HHHHCCccccCCchheEEEcCCCCEEEE
Confidence            466778888888876543211   111  111223322222222211111  7888899999999999999 45678899


Q ss_pred             eccccccccCC------------------CC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 026720          124 DLGMVKEIDSN------------------LP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK  184 (234)
Q Consensus       124 ~~~~a~~~~~~------------------~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~  184 (234)
                      |||.+......                  +. ....++++.|+|||...+ ..++..+|+||+|++++|+++|+.||.+.
T Consensus       156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            99998765110                  00 112457889999999874 34789999999999999999999999875


Q ss_pred             ChHHHHHHHHHhhCCCC----CCCCcchhhhhhhhccccCCCCCc
Q 026720          185 SSADQIYKICQLIGSPT----KDSWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       185 ~~~~~~~~i~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      ........  .....|.    ....+..+..+...++...+.+|+
T Consensus       235 ~~~ki~~~--~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~  277 (932)
T PRK13184        235 KGRKISYR--DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY  277 (932)
T ss_pred             chhhhhhh--hhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence            44333222  1222221    123445555666566666666664

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.34  E-value=2e-12  Score=115.31  Aligned_cols=141  Identities=28%  Similarity=0.429  Sum_probs=98.5

Q ss_pred             HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccccccc---C----------------CCCCC
Q 026720           79 WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID---S----------------NLPCT  138 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~---~----------------~~~~~  138 (234)
                      |--++.|++         |+|+.+|+|||++|.|+.+ ...-.+++|||+|....   .                .....
T Consensus       703 FreIlEGLa---------YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T  773 (1351)
T KOG1035|consen  703 FREILEGLA---------YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT  773 (1351)
T ss_pred             HHHHHHHHH---------HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence            344688888         9999999999999999999 45678999999998721   0                01223


Q ss_pred             CcccCccccccccccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HhhCCCCC-C-CCcchhhh-
Q 026720          139 DYVTTRWYRGPEVLLFSE--IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC--QLIGSPTK-D-SWPLGIQL-  211 (234)
Q Consensus       139 ~~~~~~~~~~pe~~~~~~--~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~--~~~~~~~~-~-~~~~~~~~-  211 (234)
                      +.+||-.|.|||++.+..  .|+.++|+||+|+++.||+.-   |+  ..++.+..+-  +....|.+ . .-++...+ 
T Consensus       774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~--TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~  848 (1351)
T KOG1035|consen  774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FG--TSMERASILTNLRKGSIPEPADFFDPEHPEEA  848 (1351)
T ss_pred             cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CC--chHHHHHHHHhcccCCCCCCcccccccchHHH
Confidence            457778899999998766  699999999999999999864   43  3334332222  22222222 2 22333333 


Q ss_pred             -hhhhccccCCCCCccccccCCC
Q 026720          212 -ASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       +++.....++-+||+..+++++
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhhc
Confidence             3444557789999999998875

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.33  E-value=1.7e-12  Score=103.01  Aligned_cols=174  Identities=21%  Similarity=0.361  Sum_probs=117.3

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      ..++..|+..|.+.+...... .++...+..+... +.|+.         ++|..++.|++++|+++++ .....+++++
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~---------~lH~~~i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD---------YLGSQRYIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHhEEEcCCCCEEEccc
Confidence            456777888888877654321 1222233333332 55555         7888899999999999999 4567899999


Q ss_pred             cccccccCCCCC----CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--------------
Q 026720          126 GMVKEIDSNLPC----TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA--------------  187 (234)
Q Consensus       126 ~~a~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~--------------  187 (234)
                      +.+.........    ........|.+||..... .++...|+||+|++++|+++|..|+......              
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05038         154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV  232 (284)
T ss_pred             ccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence            988876532111    112233458889987643 4678899999999999999999888754221              


Q ss_pred             HHHHHHHH-hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQ-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ........ ....+.+...+..+..+...|+...+.+|+++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11122222 2223334455677888889999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.33  E-value=2.5e-12  Score=116.04  Aligned_cols=138  Identities=17%  Similarity=0.204  Sum_probs=89.7

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C-------------------CeeeEeeccccccccCC--------
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K-------------------GVIKIGDLGMVKEIDSN--------  134 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~-------------------~~~~~~~~~~a~~~~~~--------  134 (234)
                      +.|+.         ++|..+++|+|++|.|+++. .                   ...++.+||.++.....        
T Consensus        90 ~~al~---------~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~  160 (793)
T PLN00181         90 VEIVN---------AAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKL  160 (793)
T ss_pred             HHHHH---------HHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhh
Confidence            66677         89999999999999999993 1                   23455666666532110        


Q ss_pred             ---------CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC-CCC
Q 026720          135 ---------LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT-KDS  204 (234)
Q Consensus       135 ---------~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~-~~~  204 (234)
                               .......++++|+|||++.+. .|+..+|+||+||+++||+++.+++.....  ....+......+. ...
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  237 (793)
T PLN00181        161 EEVKKQPFPMKQILAMEMSWYTSPEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLN  237 (793)
T ss_pred             hccccCCCcccccccCCCcceEChhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhc
Confidence                     001123567889999998744 479999999999999999998887764321  1112221111111 122


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++. ..+...++...+.+|+++.+++.+
T Consensus       238 ~~~~-~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        238 WPKE-ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             CHHH-HHHHHHhCCCChhhCcChHHHhhc
Confidence            3332 233445778889999999998753

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.33  E-value=6.6e-12  Score=100.21  Aligned_cols=134  Identities=14%  Similarity=0.221  Sum_probs=109.2

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCC--CCc-ccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC--TDY-VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~--~~~-~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|.|+...|-.+. ..-.++.|-.+.+.++..-..  .+. -....|++||.+. +..|+..+|+||+|+++|
T Consensus       411 hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllW  489 (563)
T KOG1024|consen  411 HLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLW  489 (563)
T ss_pred             HHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHH
Confidence            88999999999999888884 345688888888877653210  111 1123489999987 677999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      |+++ |+.|+.+.+..+...-+.+....-.+..+++.+-..+..||...+.+||+|+.++
T Consensus       490 ELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  490 ELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             HHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            9996 7799998888888877888888888889999999999999999999999999875

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.32  E-value=5.3e-12  Score=100.59  Aligned_cols=172  Identities=20%  Similarity=0.251  Sum_probs=112.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+....-..++...+..|... +.++.         ++|..++.|++++|.++++ .+...++.+|+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~---------~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~  151 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD---------HLHQLGIIYRDIKLENILLDSEGHVVLTDFGL  151 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHeEECCCCCEEEEECcc
Confidence            367778877777665432111222233334333 55555         7888889999999999999 456789999998


Q ss_pred             cccccCCCC--CCCcccCccccccccccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---hhCCCC
Q 026720          128 VKEIDSNLP--CTDYVTTRWYRGPEVLLFSE-IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ---LIGSPT  201 (234)
Q Consensus       128 a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~-~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~---~~~~~~  201 (234)
                      +..+.....  .....++..|.+||...+.. ..+...|+||+|++++++++|..||...+.......+.+   ....+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF  231 (288)
T ss_pred             ccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC
Confidence            876544322  12234677899999875432 256789999999999999999999975432222222211   222233


Q ss_pred             CCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      +...+..+..+...++..++..|+++.++
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~  260 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANGA  260 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence            34455667777777888888899886543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PF13041 PPR_2: PPR repeat family

Probab=99.32  E-value=2.1e-12  Score=74.99  Aligned_cols=46  Identities=33%  Similarity=0.578  Sum_probs=43.4

Q ss_pred             hhHHHHHHHHHHHhhcCChHHHHHHHHhhcc----CccccHHHHHHHHHh
Q 026720           43 LDVAIGTALVEMYSKCGHVEKAFKVFNLMRE----KNLQSWTIMISGLAD   88 (234)
Q Consensus        43 ~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~----~~~~~~~~~i~~~~~   88 (234)
                      ||.++||+||.+|++.|++++|.++|++|.+    ||..|||++|+||++
T Consensus         1 P~~~~yn~li~~~~~~~~~~~a~~l~~~M~~~g~~P~~~Ty~~li~~~~k   50 (50)
T PF13041_consen    1 PDVVTYNTLISGYCKAGKFEEALKLFKEMKKRGIKPDSYTYNILINGLCK   50 (50)
T ss_pred             CchHHHHHHHHHHHHCcCHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHcC
Confidence            7999999999999999999999999999985    799999999999984

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.31  E-value=1.4e-12  Score=112.92  Aligned_cols=170  Identities=20%  Similarity=0.318  Sum_probs=131.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH--HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM--ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~--i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      .||.+||..|++.+..+-+..  |. ...++|...  +.|+.         ++|...++|++++-+|+++ ..+-+++.|
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~-E~~IaYI~re~lrgl~---------HLH~nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLK-EEWIAYILREILRGLA---------HLHNNKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchh-hHHHHHHHHHHHHHHH---------HHhhcceeeecccCceEEEeccCcEEEee
Confidence            478999999999888765541  22 133444443  44555         8998889999999999999 467889999


Q ss_pred             ccccccccCCC-CCCCcccCccccccccccccc----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          125 LGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSE----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       125 ~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~----~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      ||...++.... ..++.+++++|+|||++...+    -|....|+||+|+...||..|.+|+-+.-..-.   +|.+...
T Consensus       167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRN  243 (953)
T KOG0587|consen  167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRN  243 (953)
T ss_pred             eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hccCCCC
Confidence            99999886643 456789999999999986544    367899999999999999999999988765555   4555555


Q ss_pred             CCC-----CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTK-----DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |++     .-|.+.+..++..|..-+-.+|++..+++.
T Consensus       244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            554     467777777777788888888888888765

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=1.1e-11  Score=97.27  Aligned_cols=119  Identities=33%  Similarity=0.469  Sum_probs=92.3

Q ss_pred             HHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccc
Q 026720           54 MYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI  131 (234)
Q Consensus        54 ~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~  131 (234)
                      +|...|++-=-.+--+++|+.....|.+- +-++-         ++|.++++.++++.+|+++ ..+..++.++|.+++-
T Consensus       331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~---------flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALN---------FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHH---------HHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            45555554332333344555555667665 44455         7889999999999999999 5788999999999875


Q ss_pred             cCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCC
Q 026720          132 DSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFP  182 (234)
Q Consensus       132 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~  182 (234)
                      ... -...+++++|.|.|||++. +..|...+|.|++|+++.||+.|+.||+
T Consensus       402 l~~gd~tstfcgtpnyiapeilr-geeygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             CCCCcccccccCCCcccchhhhc-ccccCceehHHHHHHHHHHHHcCCCCcc
Confidence            443 3456789999999999998 5568999999999999999999999998

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.28  E-value=1e-11  Score=104.46  Aligned_cols=132  Identities=19%  Similarity=0.386  Sum_probs=102.2

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      +|-+...+|+++...|.+. ...+.++.|||+++.+.....  ..+..-.+-|.|||-+.++. |+.++|+|++|++|||
T Consensus       380 YLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWE  458 (1157)
T KOG4278|consen  380 YLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWE  458 (1157)
T ss_pred             HHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccc-cccchhhHHHHHHHHH
Confidence            5666678999999999888 456789999999988754321  11112234589999987544 7899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHH-hhCCCCCCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          174 MLS-FGILFPGKSSADQIYKICQ-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       174 ~~~-~~~~f~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      +.+ |+.||||.+ ..+.+.+.+ ......++.++...-+|++-||+--+-+|++|.++
T Consensus       459 IATYGMsPYPGid-lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  459 IATYGMSPYPGID-LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHhcCCCCCCCcc-HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            997 678998765 455556655 44556678899999999999999999999999876

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.23  E-value=1.1e-12  Score=108.26  Aligned_cols=118  Identities=26%  Similarity=0.382  Sum_probs=94.0

Q ss_pred             HhhhcccccCCcCCCcEEeeCC----eeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~~~----~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|+|++|.|++++++    -.+++|||.|+.+.+..-.+..++++.|.|||++. +..||...|+||.|+++|
T Consensus       679 ~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLr-nkGyNrSLDMWSVGVIiY  757 (888)
T KOG4236|consen  679 YLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLR-NKGYNRSLDMWSVGVIIY  757 (888)
T ss_pred             HhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHh-hccccccccceeeeEEEE
Confidence            8888889999999999999532    36999999999998877777899999999999997 556999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhcc
Q 026720          173 EMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNW  217 (234)
Q Consensus       173 e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  217 (234)
                      --++|..||..+.++..-++-..-|  -++..|.+.-.+++++.-
T Consensus       758 VsLSGTFPFNEdEdIndQIQNAaFM--yPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  758 VSLSGTFPFNEDEDINDQIQNAAFM--YPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             EEecccccCCCccchhHHhhccccc--cCCCchhhcCHHHHHHHH
Confidence            9999999999776666544433333  345567765555554433

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.23  E-value=2.6e-11  Score=105.12  Aligned_cols=135  Identities=21%  Similarity=0.274  Sum_probs=88.4

Q ss_pred             HhhhcccccCCcCCCcEEee--CCeeeEeeccccccccCCC--CCCCcccCccccccccccccc----------------
Q 026720           97 SLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSE----------------  156 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~----------------  156 (234)
                      ++|+.+++|+|++|.|+++.  ....+++|||.+..+....  ......+++.|++||.+....                
T Consensus       270 yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp  349 (566)
T PLN03225        270 GLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP  349 (566)
T ss_pred             HHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccc
Confidence            88999999999999999995  3578999999998654321  223456788999999653211                


Q ss_pred             -----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC--------CCCCc------c-------hhh
Q 026720          157 -----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT--------KDSWP------L-------GIQ  210 (234)
Q Consensus       157 -----~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~--------~~~~~------~-------~~~  210 (234)
                           .++..+|+||+||+++||+.+..  +.......+.+.+...+...        ....+      +       ...
T Consensus       350 ~l~~~~~~~k~DVwSlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  427 (566)
T PLN03225        350 VLWQLNLPDRFDIYSAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGW  427 (566)
T ss_pred             hhccccCCCCcccHHHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHH
Confidence                 23445699999999999998554  33444444444433221100        00000      0       011


Q ss_pred             hhhhhccccCCCCCccccccCCC
Q 026720          211 LASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+...+...++.+|++..+++.+
T Consensus       428 dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        428 ELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHHccCCcccCCCHHHHhCC
Confidence            35555667789999999998864

>PF12854 PPR_1: PPR repeat

Probab=99.22  E-value=1.5e-11  Score=64.92  Aligned_cols=33  Identities=39%  Similarity=0.700  Sum_probs=26.8

Q ss_pred             ccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc
Q 026720           40 GLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR   72 (234)
Q Consensus        40 g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~   72 (234)
                      |+.||.+|||+||.+||+.|++++|.++|++|+
T Consensus         2 G~~Pd~~ty~~lI~~~Ck~G~~~~A~~l~~~M~   34 (34)
T PF12854_consen    2 GCEPDVVTYNTLIDGYCKAGRVDEAFELFDEMK   34 (34)
T ss_pred             CCCCcHhHHHHHHHHHHHCCCHHHHHHHHHhCc
Confidence            677888888888888888888888888888774

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.19  E-value=4.9e-12  Score=105.71  Aligned_cols=134  Identities=26%  Similarity=0.442  Sum_probs=109.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCcc-ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNL-QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~-~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      +||.+|+..|.+.+...-..+|.+... .-|..++++..         ++|...++|++++..|+++. ....+++|||.
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsave---------YcH~k~ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVE---------YCHSKNIVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHH---------HHhhcceeccccchhhcccccccceeeecccc
Confidence            466788888888888777777776433 34555688877         89999999999999999995 44589999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK  192 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~  192 (234)
                      ...+.......+.++++.|.+||+..+...-...+|+|++|+++|.++.|..||+|....+.--+
T Consensus       202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r  266 (596)
T KOG0586|consen  202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR  266 (596)
T ss_pred             ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch
Confidence            88887666677889999999999999777668999999999999999999999998754443333

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.19  E-value=2.5e-11  Score=98.82  Aligned_cols=169  Identities=24%  Similarity=0.328  Sum_probs=110.0

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhh---------hcccccCCcCCCcEEe-eCCee
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLH---------RQGYFHRDLKPSNLLV-SKGVI  120 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~---------~~~~~~~~l~p~~~~~-~~~~~  120 (234)
                      ||.+|-..|++.+-.       ..++++|+.+.+......++..  +||         +..+.|||++..|+++ ++..+
T Consensus       285 LVt~fh~kGsL~dyL-------~~ntisw~~~cria~SmarGLa--~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL-------KANTISWNSLCRIAESMARGLA--HLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             EEeeeccCCcHHHHH-------HhccccHHHHHHHHHHHHHHHH--HhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            455555566655532       2588999865332211111111  444         4458999999999999 67888


Q ss_pred             eEeeccccccccCCCCC---CCcccCcccccccccccccCCC-----CcchHHHHHHHHHHHHhCCCCCC-CC-------
Q 026720          121 KIGDLGMVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYG-----PEVDKWAMGAIMFEMLSFGILFP-GK-------  184 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~-----~~~d~~s~g~~l~e~~~~~~~f~-~~-------  184 (234)
                      .++|||+|..+...++.   .+.+|++.|+|||++-+.-++.     ..+|+||+|.++||++++-..+. |.       
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            99999999988765543   3468999999999997654443     57999999999999998654442 11       


Q ss_pred             --------ChHHHHHH-HHH-hhCCCCCCCCc-----chhhhhhhhccccCCCCCcccc
Q 026720          185 --------SSADQIYK-ICQ-LIGSPTKDSWP-----LGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       185 --------~~~~~~~~-i~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                              ...+..+. +.+ +....-+..|-     ..+.+.+.-||..++..|.|.+
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                    23333333 222 33333344554     3455556669999988887754

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=1.6e-11  Score=103.42  Aligned_cols=100  Identities=33%  Similarity=0.596  Sum_probs=78.9

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccc---cC---------------------------------------
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI---DS---------------------------------------  133 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~---~~---------------------------------------  133 (234)
                      .+|+.+.+|+|++|||+++ .++..++.|||++..+   |.                                       
T Consensus       744 sVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h  823 (1034)
T KOG0608|consen  744 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQH  823 (1034)
T ss_pred             HHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhh
Confidence            4688899999999999999 5899999999998743   10                                       


Q ss_pred             -CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          134 -NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       134 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                       +..-...++++.|+|||++. ...|+.+-|.||.|++|+||+.|.+||-+....+.-.+|..+-
T Consensus       824 ~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~  887 (1034)
T KOG0608|consen  824 QRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR  887 (1034)
T ss_pred             hhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh
Confidence             00112246788899999997 4558999999999999999999999999877666655655443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.16  E-value=4e-11  Score=95.23  Aligned_cols=121  Identities=28%  Similarity=0.511  Sum_probs=89.6

Q ss_pred             HHHHhhccCccccHH---------HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C------------------
Q 026720           66 KVFNLMREKNLQSWT---------IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K------------------  117 (234)
Q Consensus        66 ~~~~~m~~~~~~~~~---------~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~------------------  117 (234)
                      .+|+.|++-+..+|-         .++.+.+         .+|+..+.|.|++|.|+++. +                  
T Consensus       176 S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~---------fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  176 STFDFLKENNYIPFPIDHIRHMGYQLLESVA---------FLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             hHHHHhccCCccccchHHHHHHHHHHHHHHH---------HHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence            467777775554442         1244444         78888899999999999983 1                  


Q ss_pred             --CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          118 --GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       118 --~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                        ...++.|||.|..-+.  .....+.|+.|.|||++.+.+ |+.--|+||.||+|.|+.+|..+|..-.+.+.+.-+-+
T Consensus       247 ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer  323 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER  323 (415)
T ss_pred             CCcceEEEecCCcceecc--CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence              1235667777766544  235678899999999998544 88999999999999999999999998888887744434


Q ss_pred             hhC
Q 026720          196 LIG  198 (234)
Q Consensus       196 ~~~  198 (234)
                      ..|
T Consensus       324 IlG  326 (415)
T KOG0671|consen  324 ILG  326 (415)
T ss_pred             hhC
Confidence            444

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.15  E-value=1.1e-10  Score=85.76  Aligned_cols=99  Identities=27%  Similarity=0.456  Sum_probs=76.3

Q ss_pred             Hhhhc-ccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCccccccccccc---ccCCCCcchHHHHHHHH
Q 026720           97 SLHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF---SEIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~-~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~~d~~s~g~~l  171 (234)
                      ++|++ .++|+|++|.|++++ .+-.+++|||.+.-+..++...--.+-..|+|||.+..   ...|+.++|+||+|+.+
T Consensus       163 ~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItm  242 (282)
T KOG0984|consen  163 FLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITM  242 (282)
T ss_pred             HHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhh
Confidence            66654 489999999999994 67889999999888877654432233346899999743   22589999999999999


Q ss_pred             HHHHhCCCCCCCCC-hHHHHHHHHH
Q 026720          172 FEMLSFGILFPGKS-SADQIYKICQ  195 (234)
Q Consensus       172 ~e~~~~~~~f~~~~-~~~~~~~i~~  195 (234)
                      .|+..++.||+.-+ ..+++.++.+
T Consensus       243 iElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  243 IEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhhhccccccccCCHHHHHHHHhc
Confidence            99999999998644 4555555554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.15  E-value=2.4e-11  Score=112.10  Aligned_cols=166  Identities=13%  Similarity=0.105  Sum_probs=99.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhh---hcccccCCcCCCcEEeeC-CeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLH---RQGYFHRDLKPSNLLVSK-GVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~---~~~~~~~~l~p~~~~~~~-~~~~~~~  124 (234)
                      .+|.+|+..|.+.+..+   .++.+....+... ..|+.         ++|   ..+++|++++|.++++.. ...++. 
T Consensus       759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~---------yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-  825 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALR---------FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-  825 (968)
T ss_pred             EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHH---------HhccCCCCCeecCCCCHHhEEECCCCceEEE-
Confidence            57788888888887653   2222222222222 34444         677   457999999999999843 222322 


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHH-H----
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS----SADQIYKIC-Q----  195 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~----~~~~~~~i~-~----  195 (234)
                      ++.......   .....++..|+|||+..+ ..|+.++|+||+|+++||+++|+.||+...    ......+.. .    
T Consensus       826 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  901 (968)
T PLN00113        826 LSLPGLLCT---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL  901 (968)
T ss_pred             ecccccccc---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch
Confidence            333322211   122356788999999874 458899999999999999999999986421    111111110 0    


Q ss_pred             -hhCCCCC-----CCCcc--hhhhhhhhccccCCCCCccccccCC
Q 026720          196 -LIGSPTK-----DSWPL--GIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       196 -~~~~~~~-----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       ....|..     ..+.+  .+..+...||..++.+||++++++.
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  946 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK  946 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence             0001111     11111  2233455699999999999998864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.13  E-value=5.6e-10  Score=96.75  Aligned_cols=172  Identities=17%  Similarity=0.272  Sum_probs=121.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh-hccCccccHHHHH-HHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~i-~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      --||..|.-.|.+.+-.+.-+. +-.++...|..+| .|+-         +++.+.++|+++...|++. ...+.++.+|
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~---------YLe~qrlVHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMK---------YLEEQRLVHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHH---------HHHhcchhhhhhhhhheeecCCCeEEEEec
Confidence            5788889999998887665332 4446778888884 4555         7888889999999999999 4678899999


Q ss_pred             cccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh-hCCC
Q 026720          126 GMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQL-IGSP  200 (234)
Q Consensus       126 ~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~-~~~~  200 (234)
                      |+++.+...-.   ..+....+.|+|-|.+. .+.|+..+|+||+|+.+||+++ |..|+.|....++- ..++. -.-+
T Consensus       843 gla~ll~~d~~ey~~~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle~geRLs  920 (1177)
T KOG1025|consen  843 GLAKLLAPDEKEYSAPGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLEKGERLS  920 (1177)
T ss_pred             chhhccCcccccccccccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHhccccCC
Confidence            99987654211   11122234577778776 5568999999999999999997 55888887655543 33332 2233


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      .+..++--.=-.+-.||..|...|++|.++.
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence            3444432222234459999999999998763

>PF12854 PPR_1: PPR repeat

Probab=99.11  E-value=4e-11  Score=63.23  Aligned_cols=34  Identities=15%  Similarity=0.103  Sum_probs=32.3

Q ss_pred             CCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHH
Q 026720            4 ANENPNSVTLVSLVSACTGLINVRAGESIHSYAV   37 (234)
Q Consensus         4 ~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~   37 (234)
                      .|+.||.+|||+||+++|+.|++++|.+++++|+
T Consensus         1 ~G~~Pd~~ty~~lI~~~Ck~G~~~~A~~l~~~M~   34 (34)
T PF12854_consen    1 RGCEPDVVTYNTLIDGYCKAGRVDEAFELFDEMK   34 (34)
T ss_pred             CCCCCcHhHHHHHHHHHHHCCCHHHHHHHHHhCc
Confidence            4899999999999999999999999999999984

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.02  E-value=1.8e-10  Score=99.58  Aligned_cols=137  Identities=24%  Similarity=0.255  Sum_probs=95.5

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC------CeeeEeeccccccccCCC----CCCCcccCccccccccc
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVL  152 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~------~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~  152 (234)
                      ..|++         +||+-.++|+|++|.|+++..      ..+++.|||+++.+....    ...+..|+.+|+|||.+
T Consensus       616 ~~Gla---------HLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L  686 (903)
T KOG1027|consen  616 ASGLA---------HLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQL  686 (903)
T ss_pred             HHHHH---------HHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHH
Confidence            77888         999999999999999999942      467899999999875432    24567889999999999


Q ss_pred             ccccCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhh----CCCCCCCCcchhhhhhhhccccCCCCCccc
Q 026720          153 LFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQLI----GSPTKDSWPLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       153 ~~~~~~~~~~d~~s~g~~l~e~~~~-~~~f~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ...+. +..+|++|+||++++.++| +.||-+.-..+.  .|....    .-.+...| ++.+++.+| .+..+-.|++.
T Consensus       687 ~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~-eA~dLI~~m-l~~dP~~RPsa  761 (903)
T KOG1027|consen  687 REDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDC-EAKDLISRM-LNPDPQLRPSA  761 (903)
T ss_pred             hcccc-CcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchH-HHHHHHHHh-cCCCcccCCCH
Confidence            75443 6789999999999998876 799965433322  222211    11222233 444444444 34556677887


Q ss_pred             cccCCC
Q 026720          228 LAVMPS  233 (234)
Q Consensus       228 ~~~~~~  233 (234)
                      .+++.+
T Consensus       762 ~~VL~H  767 (903)
T KOG1027|consen  762 TDVLNH  767 (903)
T ss_pred             HHHhCC
Confidence            777654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.00  E-value=1.3e-09  Score=83.13  Aligned_cols=126  Identities=33%  Similarity=0.535  Sum_probs=88.6

Q ss_pred             HHHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      ..++.+|+..+.+.+....... +....+..+... +.++.         ++|..++.|++++|.++.+. ....++.++
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~i~h~di~~~ni~v~~~~~~~l~d~  142 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALE---------YLHSLGIVHRDLKPENILLGMDGLVKLADF  142 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEcCCCCEEEeeC
Confidence            3466667777777665543322 222223333222 45555         78888899999999999994 467789999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG  183 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~  183 (234)
                      +.+.......  ......++..|.+||.......++...|+|++|++++++++|+.||++
T Consensus       143 g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      143 GLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            9888776532  223345666789999873334467799999999999999999999987

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=1.5e-09  Score=88.38  Aligned_cols=176  Identities=24%  Similarity=0.337  Sum_probs=118.0

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhh--hcccccCCcCCCcEEee----
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLH--RQGYFHRDLKPSNLLVS----  116 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~--~~~~~~~~l~p~~~~~~----  116 (234)
                      |.-+|.+ |.+||...+++=-.+-...|.++...+..-+ ++++.         ++-  +..++|.+++|.++++.    
T Consensus       539 DtdsFCT-VLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~---------YLNEikpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  539 DTDSFCT-VLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALK---------YLNEIKPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             cccccee-eeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHH---------HHhccCCCeeeeccCCccEEEecCcc
Confidence            3334433 4579999999887777777887766655544 56655         442  45699999999999993    


Q ss_pred             CCeeeEeeccccccccCCCC--------CCCcccCcccccccccccc---cCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 026720          117 KGVIKIGDLGMVKEIDSNLP--------CTDYVTTRWYRGPEVLLFS---EIYGPEVDKWAMGAIMFEMLSFGILFPGKS  185 (234)
Q Consensus       117 ~~~~~~~~~~~a~~~~~~~~--------~~~~~~~~~~~~pe~~~~~---~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~  185 (234)
                      ++-.++.|||+.+.+.....        .....++-||.+||.++-.   +..+.++|+||.|+++|+.+.|+.||-..-
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            34568999999887644221        1234678899999997533   356899999999999999999999997543


Q ss_pred             h-HHHHHH--HHH--hhCCCCCCCCcchhhhhhhhccccCCCCCccccc
Q 026720          186 S-ADQIYK--ICQ--LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLA  229 (234)
Q Consensus       186 ~-~~~~~~--i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (234)
                      . .+++..  |.+  ....|.....+.+-+.+++.|...-..+|++..+
T Consensus       689 sQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~q  737 (775)
T KOG1151|consen  689 SQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ  737 (775)
T ss_pred             hHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence            2 233322  221  2233444444445666777777666666655443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=2.4e-09  Score=86.90  Aligned_cols=175  Identities=24%  Similarity=0.332  Sum_probs=111.3

Q ss_pred             hhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhc--------ccccCCcCCCcEE
Q 026720           43 LDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQ--------GYFHRDLKPSNLL  114 (234)
Q Consensus        43 ~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~--------~~~~~~l~p~~~~  114 (234)
                      .+..|.-.||..|-..|++-+-.      . ++.++-+.+++-......+..  +||.+        .|.|||++.-|++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL------~-r~tv~~~~ml~LalS~AsGLa--HLH~eI~GTqgKPaIAHRDlKSKNIL  348 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYL------N-RNTVTTEGMLKLALSIASGLA--HLHMEIVGTQGKPAIAHRDLKSKNIL  348 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHH------h-hccCCHHHHHHHHHHHhhhHH--HHHHHHhcCCCCchhhccccccccEE
Confidence            34555567888999999887642      2 355555555443222222222  55532        3899999999999


Q ss_pred             e-eCCeeeEeeccccccccCCC-----CCCCcccCcccccccccccccC---C--CCcchHHHHHHHHHHHHh-------
Q 026720          115 V-SKGVIKIGDLGMVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSEI---Y--GPEVDKWAMGAIMFEMLS-------  176 (234)
Q Consensus       115 ~-~~~~~~~~~~~~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~---~--~~~~d~~s~g~~l~e~~~-------  176 (234)
                      . .++.+.+.|+|+|..-....     ..+.-+++..|+|||++....+   |  =...|+||+|.++||++.       
T Consensus       349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi  428 (513)
T KOG2052|consen  349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI  428 (513)
T ss_pred             EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence            9 56788999999988654321     3345678999999999853221   1  157899999999999864       


Q ss_pred             ---CCCCCCCCC----hHHHHHHH-H-HhhCCCCCCCCcc-----hhhhhhhhccccCCCCCcc
Q 026720          177 ---FGILFPGKS----SADQIYKI-C-QLIGSPTKDSWPL-----GIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       177 ---~~~~f~~~~----~~~~~~~i-~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  226 (234)
                         ..+||.+..    +.+...++ | ++.+.+.+.-|..     .+..+++-||...+-.|.+
T Consensus       429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence               346777653    34444443 2 3333444455552     3333556699887766654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=98.87  E-value=1.6e-08  Score=86.29  Aligned_cols=137  Identities=24%  Similarity=0.335  Sum_probs=83.8

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCC--cccCcccccccccccccC----------------
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTD--YVTTRWYRGPEVLLFSEI----------------  157 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~----------------  157 (234)
                      ++|..+++|++++|.|+++ .....++.|||.+...........  ...++.|.+||.+.....                
T Consensus       324 ~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~  403 (507)
T PLN03224        324 KLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPF  403 (507)
T ss_pred             HHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhh
Confidence            7888889999999999999 456789999999876543222111  223678999998742210                


Q ss_pred             ---C--CCcchHHHHHHHHHHHHhCCC-CCCCCChHHHHHHH-------HHhh--CCCCCCCCc----chhhhhhhhccc
Q 026720          158 ---Y--GPEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKI-------CQLI--GSPTKDSWP----LGIQLASNLNWK  218 (234)
Q Consensus       158 ---~--~~~~d~~s~g~~l~e~~~~~~-~f~~~~~~~~~~~i-------~~~~--~~~~~~~~~----~~~~~~~~~~~~  218 (234)
                         |  ....|+||+|+++++|+.+.. +|.+......-.+.       ++..  ...+...|+    ...+.+.++...
T Consensus       404 ~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~  483 (507)
T PLN03224        404 AWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITK  483 (507)
T ss_pred             HHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhcc
Confidence               1  134799999999999999874 77643222211111       1111  111212222    233344444444


Q ss_pred             cCC--CCCccccccCCC
Q 026720          219 LPQ--MGGVNLLAVMPS  233 (234)
Q Consensus       219 ~~~--~~~~~~~~~~~~  233 (234)
                      .|+  .+|+|..+++.+
T Consensus       484 ~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        484 RDQANRGRLSVGQALSH  500 (507)
T ss_pred             CCCCcccCCCHHHHhCC
Confidence            443  679999988865

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.73  E-value=2.9e-08  Score=88.19  Aligned_cols=112  Identities=21%  Similarity=0.213  Sum_probs=79.3

Q ss_pred             eEeeccccccccCC---CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          121 KIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       121 ~~~~~~~a~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ...+++.++.+...   ......++++.|++||++.+. .|+..+|+||+||++||+++|..||.+....+.+..+....
T Consensus       518 ~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~-~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~  596 (669)
T cd05610         518 IGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGK-PHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRD  596 (669)
T ss_pred             ccccCCCchhhhcccccccCCceeeCccccCHHHcCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC
Confidence            44555555443221   112345789999999999754 48899999999999999999999999888777776665432


Q ss_pred             CC-CCC-CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          198 GS-PTK-DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       198 ~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .. +.. ...+..+..+...++..++.+|+++.+++.+
T Consensus       597 ~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h  634 (669)
T cd05610         597 IPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQH  634 (669)
T ss_pred             CCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHhC
Confidence            22 111 2233445556777888899999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=98.72  E-value=5.6e-08  Score=76.28  Aligned_cols=136  Identities=27%  Similarity=0.357  Sum_probs=91.3

Q ss_pred             HhhhcccccCCcCCCcEEeeC----CeeeEeeccccccccCCCCC--------CCcccCccccccccccc----ccCCCC
Q 026720           97 SLHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPC--------TDYVTTRWYRGPEVLLF----SEIYGP  160 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~~----~~~~~~~~~~a~~~~~~~~~--------~~~~~~~~~~~pe~~~~----~~~~~~  160 (234)
                      .+|..++.|++++|.|++..+    .-.+++||.++..++..-++        .+.+++--|+|||++.-    ...|..
T Consensus       191 FlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDK  270 (463)
T KOG0607|consen  191 FLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDK  270 (463)
T ss_pred             HHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccc
Confidence            578889999999999999931    23589999888776543222        22345556999998621    235788


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC-----------ChHHHHHHHHHhhC----CCCCCCCcchhhhhhhhcc---ccCCC
Q 026720          161 EVDKWAMGAIMFEMLSFGILFPGK-----------SSADQIYKICQLIG----SPTKDSWPLGIQLASNLNW---KLPQM  222 (234)
Q Consensus       161 ~~d~~s~g~~l~e~~~~~~~f~~~-----------~~~~~~~~i~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~  222 (234)
                      .-|.||+|+++|-|+.|=+||.|.           .=...-.++|+.+.    ..+...|.-.-.+..++..   ..+.+
T Consensus       271 rCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~  350 (463)
T KOG0607|consen  271 RCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAK  350 (463)
T ss_pred             cccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHH
Confidence            899999999999999999999863           12233344555443    4555667644444444433   34666


Q ss_pred             CCccccccCC
Q 026720          223 GGVNLLAVMP  232 (234)
Q Consensus       223 ~~~~~~~~~~  232 (234)
                      +|.+...+++
T Consensus       351 ~rlsa~~vln  360 (463)
T KOG0607|consen  351 QRLSAAQVLN  360 (463)
T ss_pred             hhhhhhhccC
Confidence            6666666655

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.71  E-value=9.1e-09  Score=87.47  Aligned_cols=170  Identities=19%  Similarity=0.300  Sum_probs=126.6

Q ss_pred             HHHhhcCChHHHHHHHHhhccCccccHHHH--HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccccc
Q 026720           53 EMYSKCGHVEKAFKVFNLMREKNLQSWTIM--ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK  129 (234)
Q Consensus        53 ~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~--i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~  129 (234)
                      ..||..|.+++...+-.-+. .+-++|-+.  +.|+.         ++|+.+-+||+++-.|++++ .+-.++.|||.+.
T Consensus        91 MEycgggslQdiy~~Tgpls-elqiayvcRetl~gl~---------ylhs~gk~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLS-ELQIAYVCRETLQGLK---------YLHSQGKIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             EEecCCCcccceeeecccch-hHHHHHHHhhhhccch---------hhhcCCcccccccccceeecccCceeecccCchh
Confidence            46788888888765543322 233445444  55555         88988878999999999994 5678999999988


Q ss_pred             cccCCC-CCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC----CCCC
Q 026720          130 EIDSNL-PCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG----SPTK  202 (234)
Q Consensus       130 ~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~----~~~~  202 (234)
                      ++.... ....+++++.|+|||+..-  ...|+.+.|+|++|+...|+-.-.+|..+.-....+.-..+..-    ..|+
T Consensus       161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk  240 (829)
T KOG0576|consen  161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK  240 (829)
T ss_pred             hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence            876543 3456899999999999632  23499999999999999999888877765555444444433322    3566


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..|.+.++.+.+....-.+++|++-+.++.
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            899999999999999999999999888764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=98.65  E-value=2.5e-08  Score=80.46  Aligned_cols=102  Identities=32%  Similarity=0.561  Sum_probs=74.7

Q ss_pred             HhhhcccccCCcCCCcEEee--CCeeeEeecccccccc---------------CC--C--------------C-------
Q 026720           97 SLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEID---------------SN--L--------------P-------  136 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~---------------~~--~--------------~-------  136 (234)
                      ++|..+++|+|++|.|++++  ..-..+.|||+|....               ..  +              +       
T Consensus       147 ~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~  226 (418)
T KOG1167|consen  147 HLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRC  226 (418)
T ss_pred             hhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceecc
Confidence            67889999999999999995  4456788888877210               00  0              0       


Q ss_pred             -------CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhhC
Q 026720          137 -------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFP-GKSSADQIYKICQLIG  198 (234)
Q Consensus       137 -------~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~-~~~~~~~~~~i~~~~~  198 (234)
                             .....|+++|.+||++...+.-+..+|+||.|+++..++++..||- ...+.+.+.++.-..|
T Consensus       227 ~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG  296 (418)
T KOG1167|consen  227 NDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFG  296 (418)
T ss_pred             CCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhC
Confidence                   0012477899999999877777899999999999999999996655 4455566666654444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.62  E-value=2.2e-08  Score=87.12  Aligned_cols=146  Identities=23%  Similarity=0.275  Sum_probs=101.9

Q ss_pred             HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCC-----CCCCCcccCccccccccc
Q 026720           79 WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYRGPEVL  152 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~-----~~~~~~~~~~~~~~pe~~  152 (234)
                      +=.++.|..         ++|..++.|++++|++.++. .+..++.|||.+.-....     ....+.+++..|.|||+.
T Consensus       426 fKqL~~Gv~---------y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~  496 (601)
T KOG0590|consen  426 FKQLLRGVK---------YLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVL  496 (601)
T ss_pred             HHHHHHHHH---------HHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccc
Confidence            334466766         89999999999999999994 568899999987765332     234567899999999999


Q ss_pred             ccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhhCCCCCCCCcchhhhhh-------hhccccCCCCC
Q 026720          153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY-KICQLIGSPTKDSWPLGIQLAS-------NLNWKLPQMGG  224 (234)
Q Consensus       153 ~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  224 (234)
                      .+.......+|+||.|+++..|..++.|+.-....+... ..-..............+.++.       .-.....+.+|
T Consensus       497 ~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R  576 (601)
T KOG0590|consen  497 TGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKR  576 (601)
T ss_pred             cccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhe
Confidence            877766889999999999999999998887544333321 1111112222222222333332       22346789999


Q ss_pred             ccccccCCC
Q 026720          225 VNLLAVMPS  233 (234)
Q Consensus       225 ~~~~~~~~~  233 (234)
                      +++++|+++
T Consensus       577 ~ti~~i~~d  585 (601)
T KOG0590|consen  577 ITIEQILND  585 (601)
T ss_pred             ecHHHHhhC
Confidence            999998864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=98.53  E-value=1.4e-07  Score=70.72  Aligned_cols=117  Identities=33%  Similarity=0.572  Sum_probs=76.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC--CeeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK--GVIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~--~~~~~~~  124 (234)
                      ..++..|...+.+.+-..-.. ..+...+..+. .++.++.         ++|..++.|++++|.|+.+..  ....+.+
T Consensus        66 ~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~---------~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d  136 (215)
T cd00180          66 LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLE---------YLHSNGIIHRDLKPENILLDSDNGKVKLAD  136 (215)
T ss_pred             EEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHhhEEEeCCCCcEEEec
Confidence            345666666666665433211 11112222222 2245555         788888999999999999954  6788999


Q ss_pred             ccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720          125 LGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus       125 ~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++.+....... ..........|.+||.......++...|+|++|++++++
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         137 FGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            98887665432 122244566788899886432567889999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>TIGR00756 PPR pentatricopeptide repeat domain (PPR motif)

Probab=98.48  E-value=1.2e-07  Score=50.13  Aligned_cols=34  Identities=21%  Similarity=0.213  Sum_probs=30.0

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchh
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELD   44 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~   44 (234)
                      +|||++|++|++.+++++|.++|.+|.+.|+.||
T Consensus         1 ~~~n~li~~~~~~~~~~~a~~~~~~M~~~g~~p~   34 (35)
T TIGR00756         1 VTYNTLIDGLCKAGRVEEALELFKEMLERGIEPD   34 (35)
T ss_pred             CcHHHHHHHHHHCCCHHHHHHHHHHHHHcCCCCC
Confidence            4789999999999999999999999998888886

This family has a similar consensus to the TPR domain (tetratricopeptide), pfam pfam00515, a 33-residue repeat. It is predicted to form a pair of antiparallel helices similar to that of TPR.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=98.44  E-value=9.3e-08  Score=80.36  Aligned_cols=86  Identities=34%  Similarity=0.538  Sum_probs=74.0

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|+++++||+++-.|+.+ ..+++++.|||.+.-.... +.-.++++..|.|||++-+.+.-..-.|+|++|+++|.+.
T Consensus       685 hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv  763 (772)
T KOG1152|consen  685 HLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV  763 (772)
T ss_pred             cccccCceecccccccEEEecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE
Confidence            8899999999999999999 6789999999988876553 5666889999999999987665578899999999999988


Q ss_pred             hCCCCCCC
Q 026720          176 SFGILFPG  183 (234)
Q Consensus       176 ~~~~~f~~  183 (234)
                      ..+-||.+
T Consensus       764 ykenpyyn  771 (772)
T KOG1152|consen  764 YKENPYYN  771 (772)
T ss_pred             eccCCCcC
Confidence            88877753

>PF01535 PPR: PPR repeat; InterPro: IPR002885 This entry represents the PPR repeat

Probab=98.37  E-value=3.8e-07  Score=46.77  Aligned_cols=31  Identities=19%  Similarity=0.184  Sum_probs=19.2

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhcc
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGL   41 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~   41 (234)
                      +|||++|++|++.+++++|.+++.+|.+.|+
T Consensus         1 v~y~~li~~~~~~~~~~~a~~~~~~M~~~g~   31 (31)
T PF01535_consen    1 VTYNSLISGYCKMGQFEEALEVFDEMRERGI   31 (31)
T ss_pred             CcHHHHHHHHHccchHHHHHHHHHHHhHCcC
Confidence            3566666666666666666666666665553

Pentatricopeptide repeat (PPR) proteins are characterised by tandem repeats of a degenerate 35 amino acid motif []. Most of PPR proteins have roles in mitochondria or plastid []. PPR repeats were discovered while screening Arabidopsis proteins for those predicted to be targeted to mitochondria or chloroplast [, ]. Some of these proteins have been shown to play a role in post-transcriptional processes within organelles and they are thought to be sequence-specific RNA-binding proteins [, , ]. Plant genomes have between one hundred to five hundred PPR genes per genome whereas non-plant genomes encode two to six PPR proteins. Although no PPR structures are yet known, the motif is predicted to fold into a helix-turn-helix structure similar to those found in the tetratricopeptide repeat (TPR) family (see PDOC50005 from PROSITEDOC) []. The plant PPR protein family has been divided in two subfamilies on the basis of their motif content and organisation [, ]. Examples of PPR repeat-containing proteins include PET309 P32522 from SWISSPROT, which may be involved in RNA stabilisation [], and crp1, which is involved in RNA processing []. The repeat is associated with a predicted plant protein O49549 from SWISSPROT that has a domain organisation similar to the human BRCA1 protein.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.35  E-value=1.9e-07  Score=79.13  Aligned_cols=90  Identities=33%  Similarity=0.493  Sum_probs=72.8

Q ss_pred             hHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           96 ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        96 ~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      .++|+-++++++.++.++.+ ..+..++.+|++.+.....-..   +++.-|++||++.+   .....|.||+|++.+|+
T Consensus       111 d~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~g---h~~a~D~ws~gvl~fel  184 (612)
T KOG0603|consen  111 DHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIING---HLSAADWWSFGVLAFEL  184 (612)
T ss_pred             hhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhhc---cCCcccchhhhhhHHHH
Confidence            36777788999999999999 5788999999998887653222   67778999999973   46889999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHH
Q 026720          175 LSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      ++|..||-+    +....|.+
T Consensus       185 ltg~~pf~~----~~~~~Il~  201 (612)
T KOG0603|consen  185 LTGTLPFGG----DTMKRILK  201 (612)
T ss_pred             hhCCCCCch----HHHHHHhh
Confidence            999999987    44444444

>PF13812 PPR_3: Pentatricopeptide repeat domain

Probab=98.35  E-value=4.8e-07  Score=47.50  Aligned_cols=34  Identities=18%  Similarity=0.162  Sum_probs=29.0

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccch
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLEL   43 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~   43 (234)
                      +.|||++|.+|++.|+++.|.+++.+|.+.|+.|
T Consensus         1 v~ty~~ll~a~~~~g~~~~a~~~~~~M~~~gv~P   34 (34)
T PF13812_consen    1 VHTYNALLRACAKAGDPDAALQLFDEMKEQGVKP   34 (34)
T ss_pred             CcHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCCC
Confidence            3688888999888888888888888888888776

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.33  E-value=6.8e-07  Score=80.05  Aligned_cols=102  Identities=38%  Similarity=0.536  Sum_probs=81.6

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC----------------CCCCcccCcccccccccccccCCC
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL----------------PCTDYVTTRWYRGPEVLLFSEIYG  159 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~----------------~~~~~~~~~~~~~pe~~~~~~~~~  159 (234)
                      ++|.-+++|++++|++.++ .-+..++.||++.+.....+                .-...++++.|.+||++. ...|.
T Consensus       158 ylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil-rqgyg  236 (1205)
T KOG0606|consen  158 YLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL-RQGYG  236 (1205)
T ss_pred             hhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh-hhccC
Confidence            6788889999999999999 46788999999876542211                223457889999999986 45589


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          160 PEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       160 ~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      .=+|.|++|+++||.+-|..||.|+...+.+-++......
T Consensus       237 kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  237 KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            9999999999999999999999999887777776654443

>TIGR00756 PPR pentatricopeptide repeat domain (PPR motif)

Probab=98.31  E-value=5e-07  Score=47.59  Aligned_cols=34  Identities=24%  Similarity=0.597  Sum_probs=25.4

Q ss_pred             ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCC
Q 026720           77 QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPS  111 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~  111 (234)
                      ++||++|++|++.|+.++|.++|.. |...|+.|+
T Consensus         1 ~~~n~li~~~~~~~~~~~a~~~~~~-M~~~g~~p~   34 (35)
T TIGR00756         1 VTYNTLIDGLCKAGRVEEALELFKE-MLERGIEPD   34 (35)
T ss_pred             CcHHHHHHHHHHCCCHHHHHHHHHH-HHHcCCCCC
Confidence            3677888888888888888888777 556677775

This family has a similar consensus to the TPR domain (tetratricopeptide), pfam pfam00515, a 33-residue repeat. It is predicted to form a pair of antiparallel helices similar to that of TPR.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.27  E-value=1.9e-06  Score=66.50  Aligned_cols=93  Identities=13%  Similarity=0.109  Sum_probs=72.5

Q ss_pred             cccCcccccccccccccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HhhCCCCCCCCcchhhhhhhhc
Q 026720          140 YVTTRWYRGPEVLLFSEIY--GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC-QLIGSPTKDSWPLGIQLASNLN  216 (234)
Q Consensus       140 ~~~~~~~~~pe~~~~~~~~--~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~  216 (234)
                      -.-++.|++||.+...+..  -...|+||+++++||+-+++.||.+-...+.--+|. +......+..-+.-...+++.|
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~ic  425 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNIC  425 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHH
Confidence            3456789999998654421  256799999999999999999999999999887764 4444333333344667788999


Q ss_pred             cccCCCCCccccccCC
Q 026720          217 WKLPQMGGVNLLAVMP  232 (234)
Q Consensus       217 ~~~~~~~~~~~~~~~~  232 (234)
                      ..-++-+||.|..|+|
T Consensus       426 mnedpgkrpkfdmivp  441 (448)
T KOG0195|consen  426 MNEDPGKRPKFDMIVP  441 (448)
T ss_pred             hcCCCCcCCCcceehh
Confidence            9999999999999887

>PF01535 PPR: PPR repeat; InterPro: IPR002885 This entry represents the PPR repeat

Probab=98.20  E-value=1.4e-06  Score=44.61  Aligned_cols=30  Identities=37%  Similarity=0.610  Sum_probs=21.4

Q ss_pred             HHHHHHHHHHhhcCChHHHHHHHHhhccCc
Q 026720           46 AIGTALVEMYSKCGHVEKAFKVFNLMREKN   75 (234)
Q Consensus        46 ~~~~~li~~~~~~g~~~~a~~~~~~m~~~~   75 (234)
                      ++||+||.+|++.|.+++|.++|++|.+.+
T Consensus         1 v~y~~li~~~~~~~~~~~a~~~~~~M~~~g   30 (31)
T PF01535_consen    1 VTYNSLISGYCKMGQFEEALEVFDEMRERG   30 (31)
T ss_pred             CcHHHHHHHHHccchHHHHHHHHHHHhHCc
Confidence            367777777777777777777777776543

Pentatricopeptide repeat (PPR) proteins are characterised by tandem repeats of a degenerate 35 amino acid motif []. Most of PPR proteins have roles in mitochondria or plastid []. PPR repeats were discovered while screening Arabidopsis proteins for those predicted to be targeted to mitochondria or chloroplast [, ]. Some of these proteins have been shown to play a role in post-transcriptional processes within organelles and they are thought to be sequence-specific RNA-binding proteins [, , ]. Plant genomes have between one hundred to five hundred PPR genes per genome whereas non-plant genomes encode two to six PPR proteins. Although no PPR structures are yet known, the motif is predicted to fold into a helix-turn-helix structure similar to those found in the tetratricopeptide repeat (TPR) family (see PDOC50005 from PROSITEDOC) []. The plant PPR protein family has been divided in two subfamilies on the basis of their motif content and organisation [, ]. Examples of PPR repeat-containing proteins include PET309 P32522 from SWISSPROT, which may be involved in RNA stabilisation [], and crp1, which is involved in RNA processing []. The repeat is associated with a predicted plant protein O49549 from SWISSPROT that has a domain organisation similar to the human BRCA1 protein.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.14  E-value=1.1e-06  Score=69.40  Aligned_cols=118  Identities=19%  Similarity=0.286  Sum_probs=70.1

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccccc-------cCCCCcchHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-------EIYGPEVDKWAMG  168 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~~d~~s~g  168 (234)
                      .+|..+++|.+++|+++++ .++...+++|+...........  ......+.+||.....       -.++...|.|++|
T Consensus       160 ~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG  237 (288)
T PF14531_consen  160 NLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG  237 (288)
T ss_dssp             HHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred             HHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence            7889999999999999999 4678889999876665443222  2333567778776432       1368899999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCC
Q 026720          169 AIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQ  221 (234)
Q Consensus       169 ~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (234)
                      +++|.++.+..||...........   ......  ..++..+.++.......+
T Consensus       238 ~~ly~lWC~~lPf~~~~~~~~~~~---~f~~C~--~~Pe~v~~LI~~lL~~~~  285 (288)
T PF14531_consen  238 ITLYSLWCGRLPFGLSSPEADPEW---DFSRCR--DMPEPVQFLIRGLLQRNP  285 (288)
T ss_dssp             HHHHHHHHSS-STCCCGGGSTSGG---GGTTSS-----HHHHHHHHHHT-SSG
T ss_pred             HHHHHHHHccCCCCCCCccccccc---cchhcC--CcCHHHHHHHHHHccCCc
Confidence            999999999999985421111100   222222  556666666654444333

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=98.13  E-value=9.8e-06  Score=64.78  Aligned_cols=140  Identities=31%  Similarity=0.434  Sum_probs=96.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH---hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC-C-eeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN---LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-G-VIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~---~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~-~-~~~~~  123 (234)
                      .++..|+..+.+.+......   .+.......+... +.++.         ++|..+++|++++|.++++.. . ..++.
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---------~~H~~~~~hrd~kp~nil~~~~~~~~~l~  144 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE---------YLHSKGIIHRDIKPENILLDRDGRVVKLI  144 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHHHeeecCCCCeEEEe
Confidence            46666777777762222111   2222333334333 44433         788888999999999999953 3 58999


Q ss_pred             eccccccccCCC-------CCCCcccCcccccccccccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHH
Q 026720          124 DLGMVKEIDSNL-------PCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---ADQIY  191 (234)
Q Consensus       124 ~~~~a~~~~~~~-------~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~---~~~~~  191 (234)
                      +||.+.......       ......++..|.+||...+.  ..++...|+|++|+.+++++.+..||.....   .....
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~  224 (384)
T COG0515         145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL  224 (384)
T ss_pred             ccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence            999988554332       23556788999999998753  4678999999999999999999999887764   44444


Q ss_pred             HHHHhhC
Q 026720          192 KICQLIG  198 (234)
Q Consensus       192 ~i~~~~~  198 (234)
                      .......
T Consensus       225 ~~~~~~~  231 (384)
T COG0515         225 KIILELP  231 (384)
T ss_pred             HHHHhcC
Confidence            5444444

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.10  E-value=5.2e-06  Score=68.76  Aligned_cols=78  Identities=36%  Similarity=0.543  Sum_probs=60.2

Q ss_pred             CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC---C---ChHHHHH
Q 026720          118 GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG---K---SSADQIY  191 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~---~---~~~~~~~  191 (234)
                      .-+++.|||.|-+++..  ...-+-++-|++||++.+.+ |++-.||||.+|+++|+++|..+|.-   .   .+.+-+.
T Consensus       391 i~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  391 IRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             eeEEEeeccchhhhhhh--hchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            45789999999988763  33446788999999999665 89999999999999999999999972   1   2444555


Q ss_pred             HHHHhhC
Q 026720          192 KICQLIG  198 (234)
Q Consensus       192 ~i~~~~~  198 (234)
                      .|.+-.|
T Consensus       468 ~i~ELLG  474 (590)
T KOG1290|consen  468 LIMELLG  474 (590)
T ss_pred             HHHHHHh
Confidence            5555444

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=98.07  E-value=2.9e-06  Score=65.49  Aligned_cols=130  Identities=23%  Similarity=0.438  Sum_probs=81.4

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCcc-ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-e--CCeeeEeecc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNL-QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-S--KGVIKIGDLG  126 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~-~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~--~~~~~~~~~~  126 (234)
                      .+.+|+-.|++.+...- ..+-+-+. .....+.++..         ++|+..++|++++.+|+++ .  .--.+++|||
T Consensus        99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~---------fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIE---------FMHSKNLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHH---------HhhccchhhcccccceEEEecCCccEEEeeecc
Confidence            34556666666654321 00111111 12344566666         7899999999999999988 2  2357899999


Q ss_pred             ccccccCCCCCCCcccCcccccccccc----cccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLL----FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK  192 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~  192 (234)
                      ..............  ...|.+||...    ..-..+...|+|.+|++++..++|..|+......+.-+.
T Consensus       169 ~t~k~g~tV~~~~~--~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~  236 (378)
T KOG1345|consen  169 LTRKVGTTVKYLEY--VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW  236 (378)
T ss_pred             cccccCceehhhhh--hcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence            88876543222222  22355566531    111246889999999999999999999985544444333

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.06  E-value=6.5e-06  Score=74.41  Aligned_cols=167  Identities=18%  Similarity=0.264  Sum_probs=102.9

Q ss_pred             HHHHHHHHhhcCChHHH-HHHHHhhccCccccHHHH--HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEe
Q 026720           48 GTALVEMYSKCGHVEKA-FKVFNLMREKNLQSWTIM--ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a-~~~~~~m~~~~~~~~~~~--i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      +.+||..|.++..+|.. .+-|-..-+   ..|.+.  +.|+.         ..|..++.|.|+|..|+++. -+.+.+.
T Consensus        95 AAylvRqyvkhnLyDRlSTRPFL~~iE---KkWiaFQLL~al~---------qcH~~gVcHGDIKsENILiTSWNW~~Lt  162 (1431)
T KOG1240|consen   95 AAYLVRQYVKHNLYDRLSTRPFLVLIE---KKWIAFQLLKALS---------QCHKLGVCHGDIKSENILITSWNWLYLT  162 (1431)
T ss_pred             HHHHHHHHHhhhhhhhhccchHHHHHH---HHHHHHHHHHHHH---------HHHHcCccccccccceEEEeeechhhhh
Confidence            46788888888776654 111211111   245443  77887         88999999999999999994 3456677


Q ss_pred             eccccccccCCC--C--C----CCcccCccccccccccccc----------CCCCcchHHHHHHHHHHHHh-CCCCCCC-
Q 026720          124 DLGMVKEIDSNL--P--C----TDYVTTRWYRGPEVLLFSE----------IYGPEVDKWAMGAIMFEMLS-FGILFPG-  183 (234)
Q Consensus       124 ~~~~a~~~~~~~--~--~----~~~~~~~~~~~pe~~~~~~----------~~~~~~d~~s~g~~l~e~~~-~~~~f~~-  183 (234)
                      ||..-+...-.-  +  .    -+.--..+|.|||.+....          ......||+|.||++.|++. |.++|.= 
T Consensus       163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS  242 (1431)
T KOG1240|consen  163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS  242 (1431)
T ss_pred             cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence            776554431100  0  0    0111234699999986422          13578999999999999986 6788851 


Q ss_pred             ------CChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          184 ------KSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       184 ------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                            .+..+...++.+++..       ..++.+.......++.+|.+.++++++
T Consensus       243 QL~aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  243 QLLAYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence                  0111222222222221       245566666677788888888887654

>PF13812 PPR_3: Pentatricopeptide repeat domain

Probab=98.03  E-value=3.4e-06  Score=44.12  Aligned_cols=33  Identities=15%  Similarity=0.362  Sum_probs=16.7

Q ss_pred             ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCC
Q 026720           77 QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKP  110 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p  110 (234)
                      .+||++|.+|++.|+.+.|..+++. |...|++|
T Consensus         2 ~ty~~ll~a~~~~g~~~~a~~~~~~-M~~~gv~P   34 (34)
T PF13812_consen    2 HTYNALLRACAKAGDPDAALQLFDE-MKEQGVKP   34 (34)
T ss_pred             cHHHHHHHHHHHCCCHHHHHHHHHH-HHHhCCCC
Confidence            3455555555555555555555555 33344444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.01  E-value=4e-06  Score=69.94  Aligned_cols=119  Identities=29%  Similarity=0.423  Sum_probs=84.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      -.+.+-+|+.+.+++-++--+.   ...-++..++.-+-+.+...+.     .+.+|++++|.++.+. +...++++|++
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhh
Confidence            4455556665655554221111   1334677777777777776553     4478899999999883 44578999998


Q ss_pred             cccccCCC-------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh
Q 026720          128 VKEIDSNL-------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS  176 (234)
Q Consensus       128 a~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~  176 (234)
                      .......-       .....+++.+|++||-+. +..|+..+|+|++|.+++|++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHH
Confidence            77654322       234467889999999998 5679999999999999999987

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=97.92  E-value=2.1e-05  Score=66.37  Aligned_cols=172  Identities=21%  Similarity=0.286  Sum_probs=105.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH---HHHHHHhcCCchhhhHhhhccc-ccCCcCCCcEEe-eCCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI---MISGLADNSRGNDAISLHRQGY-FHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~---~i~~~~~~g~~~~a~~l~~~~~-~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      +.|..||.+|.+.+.... +.+.....+.+..   ++.|+.         ++|...+ .|..++..+-+. .....++.+
T Consensus        23 ~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~---------ylh~s~i~~hg~l~s~nClvd~~w~lklt~   92 (484)
T KOG1023|consen   23 IVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLA---------YLHNSPIGYHGALKSSNCLVDSRWVLKLTD   92 (484)
T ss_pred             EEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHH---------HHhcCcceeeeeeccccceeeeeEEEEech
Confidence            356678999999887554 1222111122211   244555         7786544 677777777777 345678888


Q ss_pred             ccccccccCC---CCCCCcccCcccccccccccccC------CCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHH
Q 026720          125 LGMVKEIDSN---LPCTDYVTTRWYRGPEVLLFSEI------YGPEVDKWAMGAIMFEMLSFGILFPGKS----SADQIY  191 (234)
Q Consensus       125 ~~~a~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~------~~~~~d~~s~g~~l~e~~~~~~~f~~~~----~~~~~~  191 (234)
                      +|........   ...........|.+||.+.+...      -+...|+||+|++++|++.++.||+...    ..+...
T Consensus        93 ~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~  172 (484)
T KOG1023|consen   93 FGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIIL  172 (484)
T ss_pred             hhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHH
Confidence            8876654320   11111123345789999865311      3567899999999999999999999632    234555


Q ss_pred             HHHHhhCC----CCCC---CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          192 KICQLIGS----PTKD---SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       192 ~i~~~~~~----~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++.+ .+.    |+..   ..+...-.+.+-||.-++..||+|..+-.
T Consensus       173 ~~~~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  173 RVKK-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             HHHh-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            5444 222    2222   11223444567799999999999987643

>KOG4422 consensus Uncharacterized conserved protein [Function unknown]

Probab=97.83  E-value=4.5e-05  Score=62.41  Aligned_cols=61  Identities=15%  Similarity=0.152  Sum_probs=37.4

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHh----HHHHHHHHhccchhHHHHHHHHHHHhhcCCh
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGE----SIHSYAVVNGLELDVAIGTALVEMYSKCGHV   61 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~----~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~   61 (234)
                      |....+.||..|||++|++.++.|+++.|+    ++..+|++-|++|...+|-.+|.-+++-++-
T Consensus       264 Misqkm~Pnl~TfNalL~c~akfg~F~~ar~aalqil~EmKeiGVePsLsSyh~iik~f~re~dp  328 (625)
T KOG4422|consen  264 MISQKMTPNLFTFNALLSCAAKFGKFEDARKAALQILGEMKEIGVEPSLSSYHLIIKNFKRESDP  328 (625)
T ss_pred             HHHhhcCCchHhHHHHHHHHHHhcchHHHHHHHHHHHHHHHHhCCCcchhhHHHHHHHhcccCCc
Confidence            334556666666666666666666555433    4556666666666666666666666665543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=97.80  E-value=0.00015  Score=59.12  Aligned_cols=129  Identities=23%  Similarity=0.287  Sum_probs=79.2

Q ss_pred             HhhhcccccCCcCCCcEEee---CC--eeeEeeccccc--cccC-CCCC----CCcccCccccccccccccc------CC
Q 026720           97 SLHRQGYFHRDLKPSNLLVS---KG--VIKIGDLGMVK--EIDS-NLPC----TDYVTTRWYRGPEVLLFSE------IY  158 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~---~~--~~~~~~~~~a~--~~~~-~~~~----~~~~~~~~~~~pe~~~~~~------~~  158 (234)
                      +++++++.|+|++.||+++.   +.  ...+.|||=+.  ..+. ..+.    .+.-+.-..+|||+.+..+      +|
T Consensus       356 hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny  435 (598)
T KOG4158|consen  356 HLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNY  435 (598)
T ss_pred             HHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeecc
Confidence            88999999999999999983   22  34566776433  2211 1111    1122334578999976443      23


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC-CCCCcchhhhhhhhccccCCCCCcc
Q 026720          159 GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT-KDSWPLGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       159 ~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  226 (234)
                       .+.|.|+.|.+.||++...-||.+.+....-.+-+++-.-|. +...+-..+.+..-..+.++-+|++
T Consensus       436 -~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvs  503 (598)
T KOG4158|consen  436 -EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVS  503 (598)
T ss_pred             -chhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCC
Confidence             678999999999999999999998765554444454433332 3444444444443333444444443

>KOG4318 consensus Bicoid mRNA stability factor [RNA processing and modification]

Probab=97.75  E-value=1.3e-05  Score=70.66  Aligned_cols=85  Identities=16%  Similarity=0.169  Sum_probs=76.7

Q ss_pred             ccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHH
Q 026720            2 KLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI   81 (234)
Q Consensus         2 ~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~   81 (234)
                      ...|+.||.+||.++|.-||.-|+.+.|- +|..|.-..+.-...+++.+|.+-.++++.+.+.       ++..-+|+.
T Consensus        17 e~~gi~PnRvtyqsLiarYc~~gdieaat-if~fm~~ksLpv~e~vf~~lv~sh~~And~Enpk-------ep~aDtyt~   88 (1088)
T KOG4318|consen   17 EISGILPNRVTYQSLIARYCTKGDIEAAT-IFPFMEIKSLPVREGVFRGLVASHKEANDAENPK-------EPLADTYTN   88 (1088)
T ss_pred             HHhcCCCchhhHHHHHHHHcccCCCcccc-chhhhhcccccccchhHHHHHhcccccccccCCC-------CCchhHHHH
Confidence            45799999999999999999999999888 9999988888889999999999999999998874       566779999


Q ss_pred             HHHHHHhcCCchh
Q 026720           82 MISGLADNSRGND   94 (234)
Q Consensus        82 ~i~~~~~~g~~~~   94 (234)
                      ++.+|.+.|+...
T Consensus        89 Ll~ayr~hGDli~  101 (1088)
T KOG4318|consen   89 LLKAYRIHGDLIL  101 (1088)
T ss_pred             HHHHHHhccchHH
Confidence            9999999999754

>KOG4422 consensus Uncharacterized conserved protein [Function unknown]

Probab=97.71  E-value=8.5e-05  Score=60.86  Aligned_cols=100  Identities=13%  Similarity=0.042  Sum_probs=52.0

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc----cCccccHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR----EKNLQSWTIMIS   84 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~----~~~~~~~~~~i~   84 (234)
                      +.-|+++||.+.|+....+.|.+++.+-.......+..+||.+|..-.-.    ..+++..+|.    .||+.|+|+++.
T Consensus       206 T~et~s~mI~Gl~K~~~~ERA~~L~kE~~~~k~kv~~~aFN~lI~~~S~~----~~K~Lv~EMisqkm~Pnl~TfNalL~  281 (625)
T KOG4422|consen  206 TDETVSIMIAGLCKFSSLERARELYKEHRAAKGKVYREAFNGLIGASSYS----VGKKLVAEMISQKMTPNLFTFNALLS  281 (625)
T ss_pred             CchhHHHHHHHHHHHHhHHHHHHHHHHHHHhhheeeHHhhhhhhhHHHhh----ccHHHHHHHHHhhcCCchHhHHHHHH
Confidence            34466666666666666666666665555555555555666655432211    1133333343    256666666666


Q ss_pred             HHHhcCCchhhhHh----hhcccccCCcCCCcE
Q 026720           85 GLADNSRGNDAISL----HRQGYFHRDLKPSNL  113 (234)
Q Consensus        85 ~~~~~g~~~~a~~l----~~~~~~~~~l~p~~~  113 (234)
                      ..++.|+++.|..-    ..+ |..-|+.|.--
T Consensus       282 c~akfg~F~~ar~aalqil~E-mKeiGVePsLs  313 (625)
T KOG4422|consen  282 CAAKFGKFEDARKAALQILGE-MKEIGVEPSLS  313 (625)
T ss_pred             HHHHhcchHHHHHHHHHHHHH-HHHhCCCcchh
Confidence            66666655554432    233 34445555433

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=97.55  E-value=2.7e-05  Score=69.42  Aligned_cols=111  Identities=27%  Similarity=0.325  Sum_probs=75.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+||..|+..|.+.+.+.....+.+..+..|... +.|+.         ++|..+++|++++|.|+++ .....++.|||
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~---------yLH~~gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD---------YLHRHGIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            4677888888888877654443333333444333 56666         8898899999999999999 46778999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHH
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMG  168 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g  168 (234)
                      .++...... ......+++.|.+|+.......-....++|++|
T Consensus       150 ls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g  192 (669)
T cd05610         150 LSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLG  192 (669)
T ss_pred             CCccccCCcccccccccCccccCccccccCCCCceeeeeeecC
Confidence            998764322 234456777888887654332223445556655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=97.52  E-value=0.00019  Score=65.31  Aligned_cols=120  Identities=20%  Similarity=0.247  Sum_probs=88.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--------CCe
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--------KGV  119 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--------~~~  119 (234)
                      +.|+..|...|.+-++..--..|.+--++.+.+. ++..-         ++|...|+|.|++|||.++.        ..-
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive---------~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVE---------HLHAMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHH---------HHHhcceecccCCcceeEeecccCCCCcccc
Confidence            5688999999999999885555666555666555 55555         89999999999999999883        134


Q ss_pred             eeEeecccccccc---CCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC
Q 026720          120 IKIGDLGMVKEID---SNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG  178 (234)
Q Consensus       120 ~~~~~~~~a~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~  178 (234)
                      .++.|||.+--+.   ......+...+..+.++|...+ +.|+-.+|.|+++-+++-|+.|+
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence            5788998766432   2223334455666777888874 45889999999999998888776

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=97.49  E-value=0.0012  Score=53.61  Aligned_cols=92  Identities=25%  Similarity=0.378  Sum_probs=67.8

Q ss_pred             HhhhcccccCCcCCCcEEeeC------CeeeEeeccccc--cccCCC--------C-CCCcccCcccccccccccccCCC
Q 026720           97 SLHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVK--EIDSNL--------P-CTDYVTTRWYRGPEVLLFSEIYG  159 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~~------~~~~~~~~~~a~--~~~~~~--------~-~~~~~~~~~~~~pe~~~~~~~~~  159 (234)
                      ++|+.+.+|+|++|+|+.+..      ....+.|||.++  .....-        . .....++..|.++....+.. .+
T Consensus       137 ~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~  215 (322)
T KOG1164|consen  137 DLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QG  215 (322)
T ss_pred             HHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cC
Confidence            789999999999999999942      357889999998  321110        1 12234667788777765433 57


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 026720          160 PEVDKWAMGAIMFEMLSFGILFPGKSSADQ  189 (234)
Q Consensus       160 ~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~  189 (234)
                      ..-|+||++-.+.++..|..|+.+......
T Consensus       216 r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  216 RRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             CchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            889999999999999999999977654333

>PRK11788 tetratricopeptide repeat protein; Provisional

Probab=97.46  E-value=0.00035  Score=58.09  Aligned_cols=102  Identities=14%  Similarity=0.046  Sum_probs=71.7

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--CccccHHHHHHHHHh
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQSWTIMISGLAD   88 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~~~~~~i~~~~~   88 (234)
                      .++..+...+.+.|+.++|.+++..+.+........+++.+...|++.|..++|...++.+.+  |+...++.+...+.+
T Consensus       215 ~~~~~la~~~~~~g~~~~A~~~~~~~~~~~p~~~~~~~~~l~~~~~~~g~~~~A~~~l~~~~~~~p~~~~~~~la~~~~~  294 (389)
T PRK11788        215 RASILLGDLALAQGDYAAAIEALERVEEQDPEYLSEVLPKLMECYQALGDEAEGLEFLRRALEEYPGADLLLALAQLLEE  294 (389)
T ss_pred             HHHHHHHHHHHHCCCHHHHHHHHHHHHHHChhhHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCchHHHHHHHHHHH
Confidence            355566677788888888888888887654333345677788888888888888888777653  555556667778888


Q ss_pred             cCCchhhhHhhhcccccCCcCCCcEEe
Q 026720           89 NSRGNDAISLHRQGYFHRDLKPSNLLV  115 (234)
Q Consensus        89 ~g~~~~a~~l~~~~~~~~~l~p~~~~~  115 (234)
                      .|+.++|+.++... +.  ..|+...+
T Consensus       295 ~g~~~~A~~~l~~~-l~--~~P~~~~~  318 (389)
T PRK11788        295 QEGPEAAQALLREQ-LR--RHPSLRGF  318 (389)
T ss_pred             hCCHHHHHHHHHHH-HH--hCcCHHHH
Confidence            88888888888763 32  24665444

>PRK11788 tetratricopeptide repeat protein; Provisional

Probab=97.26  E-value=0.0017  Score=54.03  Aligned_cols=117  Identities=9%  Similarity=0.066  Sum_probs=86.3

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc--cccHHHHHHHHHh
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN--LQSWTIMISGLAD   88 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~--~~~~~~~i~~~~~   88 (234)
                      +..+...+.+.++.++|...+.++.+... .+...+..+...|.+.|+.++|.+.++++.+  ++  ...++.+..+|.+
T Consensus       183 ~~~la~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~la~~~~~~g~~~~A~~~~~~~~~~~p~~~~~~~~~l~~~~~~  261 (389)
T PRK11788        183 YCELAQQALARGDLDAARALLKKALAADP-QCVRASILLGDLALAQGDYAAAIEALERVEEQDPEYLSEVLPKLMECYQA  261 (389)
T ss_pred             HHHHHHHHHhCCCHHHHHHHHHHHHhHCc-CCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHChhhHHHHHHHHHHHHHH
Confidence            45566678889999999999999987542 2455778888999999999999999999774  33  3467888999999


Q ss_pred             cCCchhhhHhhhcccccCCcCCCcEEe---eCCeeeEeeccccccccC
Q 026720           89 NSRGNDAISLHRQGYFHRDLKPSNLLV---SKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        89 ~g~~~~a~~l~~~~~~~~~l~p~~~~~---~~~~~~~~~~~~a~~~~~  133 (234)
                      .|+.++|...+.. +..  ..|+...+   ...+.+.+++..+.....
T Consensus       262 ~g~~~~A~~~l~~-~~~--~~p~~~~~~~la~~~~~~g~~~~A~~~l~  306 (389)
T PRK11788        262 LGDEAEGLEFLRR-ALE--EYPGADLLLALAQLLEEQEGPEAAQALLR  306 (389)
T ss_pred             cCCHHHHHHHHHH-HHH--hCCCchHHHHHHHHHHHhCCHHHHHHHHH
Confidence            9999999999887 333  24554322   123445566666666554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=96.79  E-value=0.0071  Score=48.58  Aligned_cols=101  Identities=27%  Similarity=0.374  Sum_probs=72.0

Q ss_pred             HhhhcccccCCcCCCcEEee------CCeeeEeeccccccccCC-----CC---CCCcccCcccccccccccccCCCCcc
Q 026720           97 SLHRQGYFHRDLKPSNLLVS------KGVIKIGDLGMVKEIDSN-----LP---CTDYVTTRWYRGPEVLLFSEIYGPEV  162 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~------~~~~~~~~~~~a~~~~~~-----~~---~~~~~~~~~~~~pe~~~~~~~~~~~~  162 (234)
                      ++|...++.+|++|+|.++.      .....+.|||.|++....     .+   .....++-.|++.....+.+ -+..-
T Consensus       139 ~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRD  217 (449)
T KOG1165|consen  139 YVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRD  217 (449)
T ss_pred             HHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhh
Confidence            67877799999999999993      256789999999976331     11   12345566677776665433 46778


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          163 DKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       163 d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      |+=|+|=++...+.|..|+.|......- .-.+++|.
T Consensus       218 DLEaLGHvFmYFLRGsLPWQGLKA~tnK-~kYeKIGe  253 (449)
T KOG1165|consen  218 DLEALGHVFMYFLRGSLPWQGLKADTNK-EKYEKIGE  253 (449)
T ss_pred             hHHHhhhhhhhhccCCCccccccCcchH-HHHHHhcc
Confidence            9999999999999999999987554332 23344443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=96.76  E-value=0.00041  Score=60.92  Aligned_cols=174  Identities=26%  Similarity=0.336  Sum_probs=110.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhh-hcccccCCcCCCcEEe-eCC-eeeE
Q 026720           49 TALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLH-RQGYFHRDLKPSNLLV-SKG-VIKI  122 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~-~~~~~~~~l~p~~~~~-~~~-~~~~  122 (234)
                      ..++..|+..|.+-+-..-.+  .++.++...|... .+++.         ++| .....|++++|++.++ .+. ..+.
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~---------~~H~~~~~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLS---------YLHPENGVTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCcc---------ccCcccccccCCCCCccchhccCCCcccC
Confidence            344555555554433221111  2334455555555 55555         677 7778999999998877 344 5788


Q ss_pred             eeccccccccC-C---CCCCCccc-CcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          123 GDLGMVKEIDS-N---LPCTDYVT-TRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       123 ~~~~~a~~~~~-~---~~~~~~~~-~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      .+++.|..... .   .......+ ++.|.+||...+........|+||.|+++..++.|..|.......+.-+.-+...
T Consensus       167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~  246 (601)
T KOG0590|consen  167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN  246 (601)
T ss_pred             CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence            88888887654 1   12233455 8889999999864456789999999999999999998877544443222211111


Q ss_pred             -CCCCCCCCcchhhhhhhhccccC---CCCCccccccC
Q 026720          198 -GSPTKDSWPLGIQLASNLNWKLP---QMGGVNLLAVM  231 (234)
Q Consensus       198 -~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  231 (234)
                       +......|+..-....++.++..   +-.|.+.+++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence             23356778766666777766655   56666666553

>PRK12274 serine/threonine protein kinase; Provisional

Probab=96.51  E-value=0.0065  Score=46.08  Aligned_cols=120  Identities=19%  Similarity=0.166  Sum_probs=69.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCc-CCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDL-KPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l-~p~~~~~~-~~~~~~~~~~~  127 (234)
                      +++..|...+.+.+.      .+..+...+..++.++.         ++|..+++|+|+ +|.|+++. .+..++.|||.
T Consensus        74 ~lvmeyI~G~~L~~~------~~~~~~~~~~qi~~~L~---------~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~  138 (218)
T PRK12274         74 HLDRSYLAGAAMYQR------PPRGDLAYFRAARRLLQ---------QLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQL  138 (218)
T ss_pred             EEEEeeecCccHHhh------hhhhhHHHHHHHHHHHH---------HHHHCcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence            566666665555432      11122222333355555         789999999999 79999994 56688999999


Q ss_pred             cccccCCCCC------CCc--------ccCcccccccccccccCCCCcchHH-HHHHHHHHHHhCCCCCCCC
Q 026720          128 VKEIDSNLPC------TDY--------VTTRWYRGPEVLLFSEIYGPEVDKW-AMGAIMFEMLSFGILFPGK  184 (234)
Q Consensus       128 a~~~~~~~~~------~~~--------~~~~~~~~pe~~~~~~~~~~~~d~~-s~g~~l~e~~~~~~~f~~~  184 (234)
                      +.........      .+.        ...+.+..|+-.......+-...+| +.|+-++.++++..+.-++
T Consensus       139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            9865543211      000        0122334443322111123334455 5899999999998766543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=95.82  E-value=0.0051  Score=45.97  Aligned_cols=76  Identities=20%  Similarity=0.190  Sum_probs=48.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccH-HHHHHHHHhcCCchhhhHhhh-cccccCCcCCCcEEeeCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSW-TIMISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLVSKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~-~~~i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~~~~~~~~~~~~  126 (234)
                      +.|+.+|+..+.+..-...-..++..+...+ ..++.++.         ++|. .+++|+|++|.|+++.....++.|||
T Consensus        92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~---------~lH~~~givHrDlkP~NIll~~~~~~liDFG  162 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMR---------RLYQEAGLVHGDLSEYNILYHDGKPYIIDVS  162 (190)
T ss_pred             CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHH---------HHHHhCCEecCCCChhhEEEECCCEEEEEcc
Confidence            4688899876643221100011222233222 23356666         8888 89999999999999976678899999


Q ss_pred             ccccccC
Q 026720          127 MVKEIDS  133 (234)
Q Consensus       127 ~a~~~~~  133 (234)
                      .+..+..
T Consensus       163 ~a~~~~~  169 (190)
T cd05145         163 QAVELDH  169 (190)
T ss_pred             cceecCC
Confidence            8876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=95.81  E-value=0.0031  Score=47.22  Aligned_cols=74  Identities=20%  Similarity=0.127  Sum_probs=48.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHh-hhcccccCCcCCCcEEeeCCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISL-HRQGYFHRDLKPSNLLVSKGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l-~~~~~~~~~l~p~~~~~~~~~~~~~~~~  126 (234)
                      ..|+.+|+..+.+.....--..++...+..+.. ++.++.         ++ |..+++|+|++|.|+++.....++.|||
T Consensus        92 ~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~---------~l~H~~giiHrDlkP~NIli~~~~v~LiDFG  162 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMR---------ILYQDCRLVHADLSEYNLLYHDGKLYIIDVS  162 (190)
T ss_pred             CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHH---------HHHHhCCcccCCCCHHHEEEECCcEEEEEcc
Confidence            368888888765543211111122223333333 355555         67 5778999999999999976778999999


Q ss_pred             ccccc
Q 026720          127 MVKEI  131 (234)
Q Consensus       127 ~a~~~  131 (234)
                      .+...
T Consensus       163 ~a~~~  167 (190)
T cd05147         163 QSVEH  167 (190)
T ss_pred             ccccC
Confidence            87654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=95.79  E-value=0.029  Score=43.20  Aligned_cols=122  Identities=21%  Similarity=0.316  Sum_probs=77.5

Q ss_pred             HhhhcccccCCcCCCcEEee----CCeeeEeeccccccccCCC-----C---CCCcccCcccccccccccccCCCCcchH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNL-----P---CTDYVTTRWYRGPEVLLFSEIYGPEVDK  164 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~----~~~~~~~~~~~a~~~~~~~-----~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~  164 (234)
                      ++|....+|+|++|||.+..    ..-..+.|||+++....--     +   -....++-.|.+.....+.. -+..-|+
T Consensus       126 yvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDm  204 (341)
T KOG1163|consen  126 YVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDM  204 (341)
T ss_pred             HHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhh
Confidence            67877899999999999983    3345789999999754311     1   11233444454444333221 2456688


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHH---HHH-hhCCCCC---CCCcchhhhhhhhcccc
Q 026720          165 WAMGAIMFEMLSFGILFPGKSSADQIYK---ICQ-LIGSPTK---DSWPLGIQLASNLNWKL  219 (234)
Q Consensus       165 ~s~g~~l~e~~~~~~~f~~~~~~~~~~~---i~~-~~~~~~~---~~~~~~~~~~~~~~~~~  219 (234)
                      =|.|-++...-.|..|+.|.......++   |.+ ++..|..   ..++.++....++|..+
T Consensus       205 eSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L  266 (341)
T KOG1163|consen  205 ESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGL  266 (341)
T ss_pred             hhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhc
Confidence            8999999999999999999876665554   332 3333333   34555555666666644

>PF10037 MRP-S27: Mitochondrial 28S ribosomal protein S27; InterPro: IPR019266 Ribosomes are the particles that catalyse mRNA-directed protein synthesis in all organisms

Probab=95.65  E-value=0.038  Score=46.43  Aligned_cols=61  Identities=23%  Similarity=0.127  Sum_probs=39.1

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR   72 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~   72 (234)
                      |..++|+-|-..+..+++..+...=+..|+-||.+++|.|++.|.+.|+...|.++...|-
T Consensus       105 t~ha~vR~~l~~~~~~~~l~~L~n~~~yGiF~D~~s~n~Lmd~fl~~~~~~~A~~V~~~~~  165 (429)
T PF10037_consen  105 THHALVRQCLELGAEDELLELLKNRLQYGIFPDNFSFNLLMDHFLKKGNYKSAAKVATEMM  165 (429)
T ss_pred             cHHHHHHHHHhcCCHHHHHHHHhChhhcccCCChhhHHHHHHHHhhcccHHHHHHHHHHHH
Confidence            4456666666666666666666665566666666666666666666666666666655543

The codons of the mRNA are exposed on the ribosome to allow tRNA binding. This leads to the incorporation of amino acids into the growing polypeptide chain in accordance with the genetic information. Incoming amino acid monomers enter the ribosomal A site in the form of aminoacyl-tRNAs complexed with elongation factor Tu (EF-Tu) and GTP. The growing polypeptide chain, situated in the P site as peptidyl-tRNA, is then transferred to aminoacyl-tRNA and the new peptidyl-tRNA, extended by one residue, is translocated to the P site with the aid the elongation factor G (EF-G) and GTP as the deacylated tRNA is released from the ribosome through one or more exit sites [, ]. About 2/3 of the mass of the ribosome consists of RNA and 1/3 of protein. The proteins are named in accordance with the subunit of the ribosome which they belong to - the small (S1 to S31) and the large (L1 to L44). Usually they decorate the rRNA cores of the subunits. Many ribosomal proteins, particularly those of the large subunit, are composed of a globular, surfaced-exposed domain with long finger-like projections that extend into the rRNA core to stabilise its structure. Most of the proteins interact with multiple RNA elements, often from different domains. In the large subunit, about 1/3 of the 23S rRNA nucleotides are at least in van der Waal's contact with protein, and L22 interacts with all six domains of the 23S rRNA. Proteins S4 and S7, which initiate assembly of the 16S rRNA, are located at junctions of five and four RNA helices, respectively. In this way proteins serve to organise and stabilise the rRNA tertiary structure. While the crucial activities of decoding and peptide transfer are RNA based, proteins play an active role in functions that may have evolved to streamline the process of protein synthesis. In addition to their function in the ribosome, many ribosomal proteins have some function 'outside' the ribosome [, ]. This entry represents a family of small ribosomal proteins possessing one of three conserved sequence blocks found in proteins that stimulate the dissociation of guanine nucleotides from G-proteins. This leaves open the possibility that they may be functional partners of GTP-binding ribosomal proteins [].

>PF06239 ECSIT: Evolutionarily conserved signalling intermediate in Toll pathway; InterPro: IPR010418 Activation of NF-kappaB as a consequence of signalling through the Toll and IL-1 receptors is a major element of innate immune responses

Probab=95.58  E-value=0.024  Score=42.76  Aligned_cols=61  Identities=11%  Similarity=0.084  Sum_probs=51.0

Q ss_pred             CccCCCCCCeehHHHHHHHhcCc----------------hhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCCh
Q 026720            1 MKLANENPNSVTLVSLVSACTGL----------------INVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHV   61 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~----------------~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~   61 (234)
                      |.+.|+.-|..+|+.||+.+=+.                ..-+.|..+..+|...|+.||..++..|++-|++.+.-
T Consensus        78 M~efgv~kDL~~Y~~LLDvFPKg~fvp~n~fQ~~F~hyp~Qq~c~i~lL~qME~~gV~Pd~Et~~~ll~iFG~~s~p  154 (228)
T PF06239_consen   78 MDEFGVEKDLEVYKALLDVFPKGKFVPRNFFQAEFMHYPRQQECAIDLLEQMENNGVMPDKETEQMLLNIFGRKSHP  154 (228)
T ss_pred             HHHcCCcccHHHHHHHHHhCCCCCcccccHHHHHhccCcHHHHHHHHHHHHHHHcCCCCcHHHHHHHHHHhccccHH
Confidence            56789999999999999976542                23357888999999999999999999999999888763

ECSIT plays an important role in signalling to NF-kappaB, functioning as the intermediate in the signalling pathways between TRAF-6 and MEKK-1 [].

>PF12895 Apc3: Anaphase-promoting complex, cyclosome, subunit 3; PDB: 3KAE_D 3Q4A_B 2C2L_D 3Q47_B 3Q49_B 2XPI_A 3ULQ_A

Probab=95.43  E-value=0.078  Score=33.68  Aligned_cols=79  Identities=14%  Similarity=0.078  Sum_probs=56.2

Q ss_pred             chhhhhHhHHHHHHHHhccc-hhHHHHHHHHHHHhhcCChHHHHHHHHhhc--cCccccHHHHHHHHHhcCCchhhhHhh
Q 026720           23 LINVRAGESIHSYAVVNGLE-LDVAIGTALVEMYSKCGHVEKAFKVFNLMR--EKNLQSWTIMISGLADNSRGNDAISLH   99 (234)
Q Consensus        23 ~~~~~~~~~~~~~~~~~g~~-~~~~~~~~li~~~~~~g~~~~a~~~~~~m~--~~~~~~~~~~i~~~~~~g~~~~a~~l~   99 (234)
                      .++.+.|..++..+++.... ++...+-.+-..|.+.|+.++|..+++...  ..+....-..-.++.+.|+.++|+..+
T Consensus         2 ~~~y~~Ai~~~~k~~~~~~~~~~~~~~~~la~~~~~~~~y~~A~~~~~~~~~~~~~~~~~~l~a~~~~~l~~y~eAi~~l   81 (84)
T PF12895_consen    2 QGNYENAIKYYEKLLELDPTNPNSAYLYNLAQCYFQQGKYEEAIELLQKLKLDPSNPDIHYLLARCLLKLGKYEEAIKAL   81 (84)
T ss_dssp             TT-HHHHHHHHHHHHHHHCGTHHHHHHHHHHHHHHHTTHHHHHHHHHHCHTHHHCHHHHHHHHHHHHHHTT-HHHHHHHH
T ss_pred             CccHHHHHHHHHHHHHHCCCChhHHHHHHHHHHHHHCCCHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHhCCHHHHHHHH
Confidence            36788899999999987663 355555668999999999999999997732  123222222366688899999999887


Q ss_pred             hc
Q 026720          100 RQ  101 (234)
Q Consensus       100 ~~  101 (234)
                      ..
T Consensus        82 ~~   83 (84)
T PF12895_consen   82 EK   83 (84)
T ss_dssp             HH
T ss_pred             hc
Confidence            53

>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein

Probab=95.43  E-value=0.083  Score=48.36  Aligned_cols=90  Identities=13%  Similarity=0.010  Sum_probs=37.7

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      .+|..+...+.+.++.++|...+..+++... .+...+..+...|.+.|+.++|...++.+.+   .+..+|+.+...+.
T Consensus       602 ~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~l~~~~~  680 (899)
T TIGR02917       602 EAWLMLGRAQLAAGDLNKAVSSFKKLLALQP-DSALALLLLADAYAVMKNYAKAITSLKRALELKPDNTEAQIGLAQLLL  680 (899)
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CChHHHHHHHHHHHHcCCHHHHHHHHHHHHhcCCCCHHHHHHHHHHHH
Confidence            3344444444444444444444444443221 1233344444444444444444444444322   12334444444444


Q ss_pred             hcCCchhhhHhhhc
Q 026720           88 DNSRGNDAISLHRQ  101 (234)
Q Consensus        88 ~~g~~~~a~~l~~~  101 (234)
                      ..|+.++|..++..
T Consensus       681 ~~~~~~~A~~~~~~  694 (899)
T TIGR02917       681 AAKRTESAKKIAKS  694 (899)
T ss_pred             HcCCHHHHHHHHHH
Confidence            44444444444433

This protein family occurs in strictly within a subset of Gram-negative bacterial species with the proposed PEP-CTERM/exosortase system, analogous to the LPXTG/sortase system common in Gram-positive bacteria. This protein occurs in a species if and only if a transmembrane histidine kinase (TIGR02916) and a DNA-binding response regulator (TIGR02915) also occur. The present of tetratricopeptide repeats (TPR) suggests protein-protein interaction, possibly for the regulation of PEP-CTERM protein expression, since many PEP-CTERM proteins in these genomes are preceded by a proposed DNA binding site for the response regulator.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=95.27  E-value=0.098  Score=43.82  Aligned_cols=88  Identities=17%  Similarity=0.182  Sum_probs=60.0

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccc-c---ccCCCCcchHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL-F---SEIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~-~---~~~~~~~~d~~s~g~~l  171 (234)
                      .+|..+-.-.|+++++++.+ +....+.+-..-..-.......+.+++..|++||.-+ .   +-......|.+++|+++
T Consensus       132 ~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLi  211 (637)
T COG4248         132 TLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLI  211 (637)
T ss_pred             HHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHH
Confidence            67888777789999999984 4455555433211111222334567888899999854 1   11135778999999999


Q ss_pred             HHHHhC-CCCCCCC
Q 026720          172 FEMLSF-GILFPGK  184 (234)
Q Consensus       172 ~e~~~~-~~~f~~~  184 (234)
                      .+++.| +.||+|.
T Consensus       212 F~lL~ggrHPysGI  225 (637)
T COG4248         212 FHLLFGGRHPYSGI  225 (637)
T ss_pred             HHHHhcCCCCCCcc
Confidence            999886 7999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=95.24  E-value=0.039  Score=45.62  Aligned_cols=89  Identities=22%  Similarity=0.322  Sum_probs=58.3

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCc-CCCcEEe-eCCeeeEeec
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDL-KPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l-~p~~~~~-~~~~~~~~~~  125 (234)
                      ..|+..|+..+.+...    .  +. ....|... +.++.         ++|..+++|+|+ +|.|+++ .....++.||
T Consensus        93 ~~LVmE~~~G~~L~~~----~--~~-~~~~~~~~i~~aL~---------~lH~~gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA----R--PH-GDPAWFRSAHRALR---------DLHRAGITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             cEEEEEccCCCCHHHh----C--cc-chHHHHHHHHHHHH---------HHHHCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            4678888887777521    1  11 11233333 55666         889999999999 9999999 3556899999


Q ss_pred             cccccccCCCCC---------CCcccCcccccccccc
Q 026720          126 GMVKEIDSNLPC---------TDYVTTRWYRGPEVLL  153 (234)
Q Consensus       126 ~~a~~~~~~~~~---------~~~~~~~~~~~pe~~~  153 (234)
                      |.+..+......         ....+...|.+||.+.
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            999976543211         1233444567787763

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=95.23  E-value=0.011  Score=45.46  Aligned_cols=95  Identities=17%  Similarity=0.242  Sum_probs=60.5

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      ..|+.+|+....+.+....    .   ......+..++.         .+|..+++|+|++|.|+++. .+ ..+.||+.
T Consensus       118 ~~lvmEyi~G~tL~~~~~~----~---~~~~~~i~~~l~---------~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        118 YIMLIEYIEGVELNDMPEI----S---EDVKAKIKASIE---------SLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             eEEEEEEECCccHHHhhhc----c---HHHHHHHHHHHH---------HHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence            4567788887777665211    1   111223344444         78999999999999999994 45 88999987


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ........            +.+.+.--+.|+...|+|++|+.+.
T Consensus       181 ~~~~~e~~------------a~d~~vler~y~~~~di~~lg~~~~  213 (232)
T PRK10359        181 KRCTAQRK------------AKDRIDLERHYGIKNEIKDLGYYLL  213 (232)
T ss_pred             cccccchh------------hHHHHHHHhHhcccccccceeEeeh
Confidence            66543211            1122222334678899999987654

>PRK15359 type III secretion system chaperone protein SscB; Provisional

Probab=95.18  E-value=0.14  Score=36.43  Aligned_cols=88  Identities=9%  Similarity=-0.127  Sum_probs=66.2

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +...-.++...|++++|...+...+.... .+...+..+-..+.+.|+.++|...|+....   .+...|..+-..+.+.
T Consensus        27 ~~~~g~~~~~~g~~~~A~~~~~~al~~~P-~~~~a~~~lg~~~~~~g~~~~A~~~y~~Al~l~p~~~~a~~~lg~~l~~~  105 (144)
T PRK15359         27 VYASGYASWQEGDYSRAVIDFSWLVMAQP-WSWRAHIALAGTWMMLKEYTTAINFYGHALMLDASHPEPVYQTGVCLKMM  105 (144)
T ss_pred             HHHHHHHHHHcCCHHHHHHHHHHHHHcCC-CcHHHHHHHHHHHHHHhhHHHHHHHHHHHHhcCCCCcHHHHHHHHHHHHc
Confidence            33444566778888888888888776543 2566778888888888999999888887554   3566777777778888


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus       106 g~~~eAi~~~~~  117 (144)
T PRK15359        106 GEPGLAREAFQT  117 (144)
T ss_pred             CCHHHHHHHHHH
Confidence            999998888876

>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein

Probab=95.16  E-value=0.099  Score=47.85  Aligned_cols=54  Identities=20%  Similarity=0.351  Sum_probs=22.3

Q ss_pred             HHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           48 GTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        48 ~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +..+...|.+.|+.++|..+++.+..   .+...|..+...+.+.|+.++|+..+..
T Consensus       570 ~~~l~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~A~~~~~~  626 (899)
T TIGR02917       570 ALALAQYYLGKGQLKKALAILNEAADAAPDSPEAWLMLGRAQLAAGDLNKAVSSFKK  626 (899)
T ss_pred             HHHHHHHHHHCCCHHHHHHHHHHHHHcCCCCHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence            33344444444444444444443321   1233344444444444444444444433

This protein family occurs in strictly within a subset of Gram-negative bacterial species with the proposed PEP-CTERM/exosortase system, analogous to the LPXTG/sortase system common in Gram-positive bacteria. This protein occurs in a species if and only if a transmembrane histidine kinase (TIGR02916) and a DNA-binding response regulator (TIGR02915) also occur. The present of tetratricopeptide repeats (TPR) suggests protein-protein interaction, possibly for the regulation of PEP-CTERM protein expression, since many PEP-CTERM proteins in these genomes are preceded by a proposed DNA binding site for the response regulator.

>cd00189 TPR Tetratricopeptide repeat domain; typically contains 34 amino acids [WLF]-X(2)-[LIM]-[GAS]-X(2)-[YLF]-X(8)-[ASE]-X(3)-[FYL]-X(2)-[ASL]-X(4)-[PKE] is the consensus sequence; found in a variety of organisms including bacteria, cyanobacteria, yeast, fungi, plants, and humans in various subcellular locations; involved in a variety of functions including protein-protein interactions, but common features in the interaction partners have not been defined; involved in chaperone, cell-cycle, transciption, and protein transport complexes; the number of TPR motifs varies among proteins (1,3-11,13 15,16,19); 5-6 tandem repeats generate a right-handed helical structure with an amphipathic channel that is thought to accomodate an alpha-helix of a target protein; it has been proposed that TPR proteins preferably interact with WD-40 repeat proteins, but in many instances several TPR-proteins seem to aggregate to multi-protein complexes; examples of TPR-proteins include, Cdc16p, Cdc23p and C

Probab=95.01  E-value=0.14  Score=31.95  Aligned_cols=88  Identities=15%  Similarity=0.070  Sum_probs=67.3

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +..+-..+...+++++|...+....+... .+..++..+...|...|..++|...++....   .+..+|..+...+...
T Consensus         3 ~~~~a~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (100)
T cd00189           3 LLNLGNLYYKLGDYDEALEYYEKALELDP-DNADAYYNLAAAYYKLGKYEEALEDYEKALELDPDNAKAYYNLGLAYYKL   81 (100)
T ss_pred             HHHHHHHHHHHhcHHHHHHHHHHHHhcCC-ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCcchhHHHHHHHHHHHH
Confidence            34455566678889999999998877543 2346777888889999999999999887543   3445777778888889


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|...+..
T Consensus        82 ~~~~~a~~~~~~   93 (100)
T cd00189          82 GKYEEALEAYEK   93 (100)
T ss_pred             HhHHHHHHHHHH
Confidence            999999988866

>PF10037 MRP-S27: Mitochondrial 28S ribosomal protein S27; InterPro: IPR019266 Ribosomes are the particles that catalyse mRNA-directed protein synthesis in all organisms

Probab=94.96  E-value=0.12  Score=43.62  Aligned_cols=108  Identities=10%  Similarity=0.021  Sum_probs=81.5

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHh--ccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc----CccccHH
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVN--GLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE----KNLQSWT   80 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~--g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~----~~~~~~~   80 (234)
                      ..+.+....+++.+.....++++..+.-....+  ....--.|..++|..|-+.|..+++..+...=..    +|-.|+|
T Consensus        63 ~vS~~dld~fvn~~~~~~~~d~~~~~L~k~R~s~~~~~~~~~t~ha~vR~~l~~~~~~~~l~~L~n~~~yGiF~D~~s~n  142 (429)
T PF10037_consen   63 PVSSLDLDIFVNNVESKDDLDEVEDVLYKFRHSPNCSYLLPSTHHALVRQCLELGAEDELLELLKNRLQYGIFPDNFSFN  142 (429)
T ss_pred             CCcHHHHHHHHhhcCCHhHHHHHHHHHHHHHcCcccccccCccHHHHHHHHHhcCCHHHHHHHHhChhhcccCCChhhHH
Confidence            446778888999999999998888776665544  2211223445999999999999999988654222    6899999


Q ss_pred             HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe
Q 026720           81 IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV  115 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~  115 (234)
                      .++..+.+.|++..|..+...+|.+. ...+..+.
T Consensus       143 ~Lmd~fl~~~~~~~A~~V~~~~~lQe-~~~~~~t~  176 (429)
T PF10037_consen  143 LLMDHFLKKGNYKSAAKVATEMMLQE-EFDNPSTQ  176 (429)
T ss_pred             HHHHHHhhcccHHHHHHHHHHHHHhh-ccCCchHH
Confidence            99999999999999999998866554 33444443

The codons of the mRNA are exposed on the ribosome to allow tRNA binding. This leads to the incorporation of amino acids into the growing polypeptide chain in accordance with the genetic information. Incoming amino acid monomers enter the ribosomal A site in the form of aminoacyl-tRNAs complexed with elongation factor Tu (EF-Tu) and GTP. The growing polypeptide chain, situated in the P site as peptidyl-tRNA, is then transferred to aminoacyl-tRNA and the new peptidyl-tRNA, extended by one residue, is translocated to the P site with the aid the elongation factor G (EF-G) and GTP as the deacylated tRNA is released from the ribosome through one or more exit sites [, ]. About 2/3 of the mass of the ribosome consists of RNA and 1/3 of protein. The proteins are named in accordance with the subunit of the ribosome which they belong to - the small (S1 to S31) and the large (L1 to L44). Usually they decorate the rRNA cores of the subunits. Many ribosomal proteins, particularly those of the large subunit, are composed of a globular, surfaced-exposed domain with long finger-like projections that extend into the rRNA core to stabilise its structure. Most of the proteins interact with multiple RNA elements, often from different domains. In the large subunit, about 1/3 of the 23S rRNA nucleotides are at least in van der Waal's contact with protein, and L22 interacts with all six domains of the 23S rRNA. Proteins S4 and S7, which initiate assembly of the 16S rRNA, are located at junctions of five and four RNA helices, respectively. In this way proteins serve to organise and stabilise the rRNA tertiary structure. While the crucial activities of decoding and peptide transfer are RNA based, proteins play an active role in functions that may have evolved to streamline the process of protein synthesis. In addition to their function in the ribosome, many ribosomal proteins have some function 'outside' the ribosome [, ]. This entry represents a family of small ribosomal proteins possessing one of three conserved sequence blocks found in proteins that stimulate the dissociation of guanine nucleotides from G-proteins. This leaves open the possibility that they may be functional partners of GTP-binding ribosomal proteins [].

>PF08579 RPM2: Mitochondrial ribonuclease P subunit (RPM2); InterPro: IPR013888 Ribonuclease P (RNase P) generates mature tRNA molecules by cleaving their 5' ends

Probab=94.90  E-value=0.074  Score=35.87  Aligned_cols=56  Identities=9%  Similarity=-0.061  Sum_probs=44.1

Q ss_pred             ccCCC-CCCeehHHHHHHHhcCchh--------hhhHhHHHHHHHHhccchhHHHHHHHHHHHhh
Q 026720            2 KLANE-NPNSVTLVSLVSACTGLIN--------VRAGESIHSYAVVNGLELDVAIGTALVEMYSK   57 (234)
Q Consensus         2 ~~~g~-~~~~~t~~~ll~~~~~~~~--------~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~   57 (234)
                      ++.|+ -|++-+|+.+|.+.++...        +-+..-++..|+.+++.|+..+||.+|..+.+
T Consensus        52 kRN~i~lPsv~~Yn~VL~Si~~R~lD~~~ie~kl~~LLtvYqDiL~~~lKP~~etYnivl~~Llk  116 (120)
T PF08579_consen   52 KRNGITLPSVELYNKVLKSIAKRELDSEDIENKLTNLLTVYQDILSNKLKPNDETYNIVLGSLLK  116 (120)
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHccccchhHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHH
Confidence            45788 8999999999998776432        22445578888899999999999999988765

Rpm2 is a protein subunit of the yeast mitochondrial RNase P. It has the ability to act as a transcriptional activator in the nucleus, where it plays a role in defining the steady-state levels of mRNAs for some nucleus-encoded mitochondrial components. Rpm2p is also involved in maturation of Rpm1 and in translation of mitochondrial mRNAs [, , ].

>PF08579 RPM2: Mitochondrial ribonuclease P subunit (RPM2); InterPro: IPR013888 Ribonuclease P (RNase P) generates mature tRNA molecules by cleaving their 5' ends

Probab=94.88  E-value=0.25  Score=33.36  Aligned_cols=75  Identities=12%  Similarity=0.171  Sum_probs=56.4

Q ss_pred             HHHHHHhcCchhhhhHhHHHHHHHHhcc-chhHHHHHHHHHHHhhcCChH--------HHHHHHHhhc----cCccccHH
Q 026720           14 VSLVSACTGLINVRAGESIHSYAVVNGL-ELDVAIGTALVEMYSKCGHVE--------KAFKVFNLMR----EKNLQSWT   80 (234)
Q Consensus        14 ~~ll~~~~~~~~~~~~~~~~~~~~~~g~-~~~~~~~~~li~~~~~~g~~~--------~a~~~~~~m~----~~~~~~~~   80 (234)
                      ...|..|...+++..-..++.-++++|+ .|++.+||.++...++...-.        ++..++..|-    .|+--+||
T Consensus        29 i~~I~~~~~~~d~N~I~~lYqslkRN~i~lPsv~~Yn~VL~Si~~R~lD~~~ie~kl~~LLtvYqDiL~~~lKP~~etYn  108 (120)
T PF08579_consen   29 IDNINSCFENEDYNIINPLYQSLKRNGITLPSVELYNKVLKSIAKRELDSEDIENKLTNLLTVYQDILSNKLKPNDETYN  108 (120)
T ss_pred             HHHHHHHHhhcchHHHHHHHHHHHhcCCCCCcHHHHHHHHHHHHHccccchhHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence            3566777777999999999999999999 999999999999998875432        2233444443    36777888


Q ss_pred             HHHHHHHh
Q 026720           81 IMISGLAD   88 (234)
Q Consensus        81 ~~i~~~~~   88 (234)
                      .+|..+.+
T Consensus       109 ivl~~Llk  116 (120)
T PF08579_consen  109 IVLGSLLK  116 (120)
T ss_pred             HHHHHHHH
Confidence            88876653

Rpm2 is a protein subunit of the yeast mitochondrial RNase P. It has the ability to act as a transcriptional activator in the nucleus, where it plays a role in defining the steady-state levels of mRNAs for some nucleus-encoded mitochondrial components. Rpm2p is also involved in maturation of Rpm1 and in translation of mitochondrial mRNAs [, , ].

>PF12921 ATP13: Mitochondrial ATPase expression; InterPro: IPR024319 ATPase expression protein 2 (also known as ATP13 in some species) is necessary for the expression of subunit 9 of mitochondrial ATPase

Probab=94.47  E-value=0.11  Score=35.99  Aligned_cols=76  Identities=14%  Similarity=0.165  Sum_probs=55.6

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHH---------------HHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYA---------------VVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~---------------~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      |+.++.++|-++++.|+++..+.+....               ..+.+.|+..+-.+++..|+..|++..|.++.+...+
T Consensus         1 de~~~~~ii~al~r~g~~~~i~~~i~~~WgI~~~~~~~~~~~~~~spl~Pt~~lL~AIv~sf~~n~~i~~al~~vd~fs~   80 (126)
T PF12921_consen    1 DEELLCNIIYALGRSGQLDSIKSYIKSVWGIDVNGKKKEGDYPPSSPLYPTSRLLIAIVHSFGYNGDIFSALKLVDFFSR   80 (126)
T ss_pred             ChHHHHHHHHHHhhcCCHHHHHHHHHHhcCCCCCCccccCccCCCCCCCCCHHHHHHHHHHHHhcccHHHHHHHHHHHHH
Confidence            5678999999999999998777655322               1122357788889999999999999999998887654


Q ss_pred             C-----ccccHHHHHH
Q 026720           74 K-----NLQSWTIMIS   84 (234)
Q Consensus        74 ~-----~~~~~~~~i~   84 (234)
                      .     +-..|..++.
T Consensus        81 ~Y~I~i~~~~W~~Ll~   96 (126)
T PF12921_consen   81 KYPIPIPKEFWRRLLE   96 (126)
T ss_pred             HcCCCCCHHHHHHHHH
Confidence            2     2346666643

The protein has a basic amino terminal signal sequence that is cleaved upon import into mitochondria [].

>TIGR02552 LcrH_SycD type III secretion low calcium response chaperone LcrH/SycD

Probab=94.23  E-value=0.33  Score=33.63  Aligned_cols=88  Identities=8%  Similarity=-0.005  Sum_probs=69.6

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      ...+...+...++.++|...+......+. .+...+..+-..|.+.|+.++|...++....   .+...|..+-..+.+.
T Consensus        20 ~~~~a~~~~~~~~~~~A~~~~~~~~~~~p-~~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~p~~~~~~~~la~~~~~~   98 (135)
T TIGR02552        20 IYALAYNLYQQGRYDEALKLFQLLAAYDP-YNSRYWLGLAACCQMLKEYEEAIDAYALAAALDPDDPRPYFHAAECLLAL   98 (135)
T ss_pred             HHHHHHHHHHcccHHHHHHHHHHHHHhCC-CcHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCChHHHHHHHHHHHHc
Confidence            44556677788999999999999877653 3667788888889999999999998887543   3556666666788899


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus        99 g~~~~A~~~~~~  110 (135)
T TIGR02552        99 GEPESALKALDL  110 (135)
T ss_pred             CCHHHHHHHHHH
Confidence            999999999876

ScyD/LcrH contains three central tetratricopeptide-like repeats that are predicted to fold into an all-alpha-helical array.

>PF06239 ECSIT: Evolutionarily conserved signalling intermediate in Toll pathway; InterPro: IPR010418 Activation of NF-kappaB as a consequence of signalling through the Toll and IL-1 receptors is a major element of innate immune responses

Probab=94.16  E-value=0.15  Score=38.60  Aligned_cols=85  Identities=16%  Similarity=0.196  Sum_probs=58.8

Q ss_pred             CCCeehHHHHHHHhcCc-----hhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCCh-----------------HHH
Q 026720            7 NPNSVTLVSLVSACTGL-----INVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHV-----------------EKA   64 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~-----~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~-----------------~~a   64 (234)
                      ..|-.||..+|+.+.+.     |.++-...-...|.+-|++.|..+|+.|++.|=+ |.+                 +-|
T Consensus        44 ~k~K~~F~~~V~~f~~~~~~RRGHVeFI~aAL~~M~efgv~kDL~~Y~~LLDvFPK-g~fvp~n~fQ~~F~hyp~Qq~c~  122 (228)
T PF06239_consen   44 AKDKATFLEAVDIFKQRDVRRRGHVEFIYAALKKMDEFGVEKDLEVYKALLDVFPK-GKFVPRNFFQAEFMHYPRQQECA  122 (228)
T ss_pred             cccHHHHHHHHHHHHhcCCCCcChHHHHHHHHHHHHHcCCcccHHHHHHHHHhCCC-CCcccccHHHHHhccCcHHHHHH
Confidence            45777888888887654     5666667778888899999999999999999876 433                 223


Q ss_pred             HHHHHhhcc----CccccHHHHHHHHHhcCCc
Q 026720           65 FKVFNLMRE----KNLQSWTIMISGLADNSRG   92 (234)
Q Consensus        65 ~~~~~~m~~----~~~~~~~~~i~~~~~~g~~   92 (234)
                      +++.+.|.+    ||..++..+++.|++.+..
T Consensus       123 i~lL~qME~~gV~Pd~Et~~~ll~iFG~~s~p  154 (228)
T PF06239_consen  123 IDLLEQMENNGVMPDKETEQMLLNIFGRKSHP  154 (228)
T ss_pred             HHHHHHHHHcCCCCcHHHHHHHHHHhccccHH
Confidence            445555553    4555666666666555543

ECSIT plays an important role in signalling to NF-kappaB, functioning as the intermediate in the signalling pathways between TRAF-6 and MEKK-1 [].

>PF05843 Suf: Suppressor of forked protein (Suf); InterPro: IPR008847 This domain consists of several eukaryotic suppressor of forked (Suf) like proteins

Probab=93.78  E-value=0.28  Score=39.13  Aligned_cols=89  Identities=17%  Similarity=0.161  Sum_probs=58.8

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhc-cchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNG-LELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g-~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      +|..++...-+.+..+.|+.+|....+.+ +..++.+..+++. |.-.++.+.|.++|+....   .+..-|..-|.-+.
T Consensus         3 v~i~~m~~~~r~~g~~~aR~vF~~a~~~~~~~~~vy~~~A~~E-~~~~~d~~~A~~Ife~glk~f~~~~~~~~~Y~~~l~   81 (280)
T PF05843_consen    3 VWIQYMRFMRRTEGIEAARKVFKRARKDKRCTYHVYVAYALME-YYCNKDPKRARKIFERGLKKFPSDPDFWLEYLDFLI   81 (280)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCCCCS-THHHHHHHHHH-HHTCS-HHHHHHHHHHHHHHHTT-HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCChHHHHHHHHHHHcCCCCCHHHHHHHHHHH-HHhCCCHHHHHHHHHHHHHHCCCCHHHHHHHHHHHH
Confidence            56677777777777888888888887653 3456656555553 3334556668888877543   46666777777777


Q ss_pred             hcCCchhhhHhhhc
Q 026720           88 DNSRGNDAISLHRQ  101 (234)
Q Consensus        88 ~~g~~~~a~~l~~~  101 (234)
                      +.++.++|..+|..
T Consensus        82 ~~~d~~~aR~lfer   95 (280)
T PF05843_consen   82 KLNDINNARALFER   95 (280)
T ss_dssp             HTT-HHHHHHHHHH
T ss_pred             HhCcHHHHHHHHHH
Confidence            88888888888877

The Drosophila melanogaster suppressor of forked [Su(f)] protein shares homology with the Saccharomyces cerevisiae RNA14 protein and the 77 kDa subunit of Homo sapiens cleavage stimulation factor, which are proteins involved in mRNA 3' end formation. This suggests a role for Su(f) in mRNA 3' end formation in Drosophila. The su(f) gene produces three transcripts; two of them are polyadenylated at the end of the transcription unit, and one is a truncated transcript, polyadenylated in intron 4. It is thought that su(f) plays a role in the regulation of poly(A) site utilisation and the GU-rich sequence is important for this regulation to occur [].; GO: 0006397 mRNA processing, 0005634 nucleus; PDB: 2L9B_B 2OND_B 2OOE_A 4E85_B 4EBA_C 4E6H_A 2UY1_B.

>TIGR02795 tol_pal_ybgF tol-pal system protein YbgF

Probab=93.41  E-value=1.1  Score=29.94  Aligned_cols=90  Identities=11%  Similarity=-0.057  Sum_probs=68.0

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccch--hHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc----cccHHHHH
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLEL--DVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN----LQSWTIMI   83 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~--~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~----~~~~~~~i   83 (234)
                      ++-.+...+.+.++.++|...+..+++.....  ....+..+...|.+.|+.++|...++....  |+    ..++..+-
T Consensus         4 ~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~p~~~~~~~~~~~~~   83 (119)
T TIGR02795         4 AYYDAALLVLKAGDYADAIQAFQAFLKKYPKSTYAPNAHYWLGEAYYAQGKYADAAKAFLAVVKKYPKSPKAPDALLKLG   83 (119)
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHHCCCccccHHHHHHHHHHHHhhccHHHHHHHHHHHHHHCCCCCcccHHHHHHH
Confidence            34455666777899999999999998754221  133556688889999999999999988653  33    33566667


Q ss_pred             HHHHhcCCchhhhHhhhc
Q 026720           84 SGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~  101 (234)
                      ..+.+.|+..+|...+..
T Consensus        84 ~~~~~~~~~~~A~~~~~~  101 (119)
T TIGR02795        84 MSLQELGDKEKAKATLQQ  101 (119)
T ss_pred             HHHHHhCChHHHHHHHHH
Confidence            778889999999999887

Members of this protein family are the product of one of seven genes regularly clustered in operons to encode the proteins of the tol-pal system, which is critical for maintaining the integrity of the bacterial outer membrane. The gene for this periplasmic protein has been designated orf2 and ybgF. All members of the seed alignment were from unique tol-pal gene regions from completed bacterial genomes. The architecture of this protein is a signal sequence, a low-complexity region usually rich in Asn and Gln, a well-conserved region with tandem repeats that resemble the tetratricopeptide (TPR) repeat, involved in protein-protein interaction.

>PF14559 TPR_19: Tetratricopeptide repeat; PDB: 2R5S_A 3QDN_B 3QOU_A 3ASG_A 3ASD_A 3AS5_A 3AS4_A 3ASH_B 3FP3_A 3LCA_A

Probab=93.31  E-value=0.6  Score=27.92  Aligned_cols=51  Identities=12%  Similarity=0.110  Sum_probs=38.7

Q ss_pred             CchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720           22 GLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      ..|++++|.+++......... +....-.+...|.+.|++++|..+++.+..
T Consensus         3 ~~~~~~~A~~~~~~~l~~~p~-~~~~~~~la~~~~~~g~~~~A~~~l~~~~~   53 (68)
T PF14559_consen    3 KQGDYDEAIELLEKALQRNPD-NPEARLLLAQCYLKQGQYDEAEELLERLLK   53 (68)
T ss_dssp             HTTHHHHHHHHHHHHHHHTTT-SHHHHHHHHHHHHHTT-HHHHHHHHHCCHG
T ss_pred             hccCHHHHHHHHHHHHHHCCC-CHHHHHHHHHHHHHcCCHHHHHHHHHHHHH
Confidence            357788888888888776543 555666788889999999999998888764

...

>PF13429 TPR_15: Tetratricopeptide repeat; PDB: 2VQ2_A 2PL2_B

Probab=93.18  E-value=0.29  Score=38.85  Aligned_cols=88  Identities=17%  Similarity=0.092  Sum_probs=34.1

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhc-cchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNG-LELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGL   86 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g-~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~   86 (234)
                      ..+..++..+.+.++.+++..++....... ...+...|..+-..|.+.|..++|.+.++...+  | |....+.++..+
T Consensus       111 ~~l~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~a~~~~~~G~~~~A~~~~~~al~~~P~~~~~~~~l~~~l  190 (280)
T PF13429_consen  111 RYLLSALQLYYRLGDYDEAEELLEKLEELPAAPDSARFWLALAEIYEQLGDPDKALRDYRKALELDPDDPDARNALAWLL  190 (280)
T ss_dssp             -------H-HHHTT-HHHHHHHHHHHHH-T---T-HHHHHHHHHHHHHCCHHHHHHHHHHHHHHH-TT-HHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHhHHHHHHHHHHHHHhccCCCCCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCCCCHHHHHHHHHHH
Confidence            334444444444555555555544443221 223444444444445555555555555544322  2 233444444445


Q ss_pred             HhcCCchhhhHh
Q 026720           87 ADNSRGNDAISL   98 (234)
Q Consensus        87 ~~~g~~~~a~~l   98 (234)
                      ...|+.+++..+
T Consensus       191 i~~~~~~~~~~~  202 (280)
T PF13429_consen  191 IDMGDYDEAREA  202 (280)
T ss_dssp             CTTCHHHHHHHH
T ss_pred             HHCCChHHHHHH
Confidence            555554444333

>COG5107 RNA14 Pre-mRNA 3'-end processing (cleavage and polyadenylation) factor [RNA processing and modification]

Probab=93.12  E-value=0.28  Score=41.26  Aligned_cols=90  Identities=16%  Similarity=0.194  Sum_probs=71.3

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhc-cchhHHHHHHHHHHHhhcCChHHHHHHHHh-hcc-CccccHHHH-HHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNG-LELDVAIGTALVEMYSKCGHVEKAFKVFNL-MRE-KNLQSWTIM-ISGL   86 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g-~~~~~~~~~~li~~~~~~g~~~~a~~~~~~-m~~-~~~~~~~~~-i~~~   86 (234)
                      +.|...|++--+...++.|+.+|.+..+.| ..+++.++++++.-||. |+..-|.++|+. |.. +|+-.|-.- +.-+
T Consensus       398 ~v~C~~~N~v~r~~Gl~aaR~~F~k~rk~~~~~h~vyi~~A~~E~~~~-~d~~ta~~ifelGl~~f~d~~~y~~kyl~fL  476 (660)
T COG5107         398 FVFCVHLNYVLRKRGLEAARKLFIKLRKEGIVGHHVYIYCAFIEYYAT-GDRATAYNIFELGLLKFPDSTLYKEKYLLFL  476 (660)
T ss_pred             hHHHHHHHHHHHHhhHHHHHHHHHHHhccCCCCcceeeeHHHHHHHhc-CCcchHHHHHHHHHHhCCCchHHHHHHHHHH
Confidence            456778888888888999999999999999 56889999999988887 667788888875 543 676666444 7777


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      ...++-+.|..+|..
T Consensus       477 i~inde~naraLFet  491 (660)
T COG5107         477 IRINDEENARALFET  491 (660)
T ss_pred             HHhCcHHHHHHHHHH
Confidence            778888888888864

>TIGR02521 type_IV_pilW type IV pilus biogenesis/stability protein PilW

Probab=93.11  E-value=0.77  Score=34.36  Aligned_cols=91  Identities=18%  Similarity=0.063  Sum_probs=70.1

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      ..+..+-..+...++.++|...+....+... .+...+..+...|...|+.++|...++...+   .+...|..+...+.
T Consensus        32 ~~~~~la~~~~~~~~~~~A~~~~~~~l~~~p-~~~~~~~~la~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~  110 (234)
T TIGR02521        32 KIRVQLALGYLEQGDLEVAKENLDKALEHDP-DDYLAYLALALYYQQLGELEKAEDSFRRALTLNPNNGDVLNNYGTFLC  110 (234)
T ss_pred             HHHHHHHHHHHHCCCHHHHHHHHHHHHHhCc-ccHHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCCCCHHHHHHHHHHHH
Confidence            3455566777888899999999988876542 2456778888889999999999998877543   34456777777888


Q ss_pred             hcCCchhhhHhhhcc
Q 026720           88 DNSRGNDAISLHRQG  102 (234)
Q Consensus        88 ~~g~~~~a~~l~~~~  102 (234)
                      ..|+.++|...+...
T Consensus       111 ~~g~~~~A~~~~~~~  125 (234)
T TIGR02521       111 QQGKYEQAMQQFEQA  125 (234)
T ss_pred             HcccHHHHHHHHHHH
Confidence            999999999998773

Members of this family are designated PilF in ref (PubMed:8973346) and PilW in ref (PubMed:15612916). This outer membrane protein is required both for pilus stability and for pilus function such as adherence to human cells. Members of this family contain copies of the TPR (tetratricopeptide repeat) domain.

>TIGR02521 type_IV_pilW type IV pilus biogenesis/stability protein PilW

Probab=93.08  E-value=0.78  Score=34.34  Aligned_cols=91  Identities=12%  Similarity=0.008  Sum_probs=71.8

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccC-----ccccHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK-----NLQSWTIMIS   84 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~-----~~~~~~~~i~   84 (234)
                      ...+..+-..+...|+.++|...+....+... .+...+..+...|...|++++|...++.....     +...|..+-.
T Consensus        65 ~~~~~~la~~~~~~~~~~~A~~~~~~al~~~~-~~~~~~~~~~~~~~~~g~~~~A~~~~~~~~~~~~~~~~~~~~~~l~~  143 (234)
T TIGR02521        65 YLAYLALALYYQQLGELEKAEDSFRRALTLNP-NNGDVLNNYGTFLCQQGKYEQAMQQFEQAIEDPLYPQPARSLENAGL  143 (234)
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCC-CCHHHHHHHHHHHHHcccHHHHHHHHHHHHhccccccchHHHHHHHH
Confidence            44566677788889999999999999887653 34557778888899999999999999886431     2345666677


Q ss_pred             HHHhcCCchhhhHhhhc
Q 026720           85 GLADNSRGNDAISLHRQ  101 (234)
Q Consensus        85 ~~~~~g~~~~a~~l~~~  101 (234)
                      .+...|+.++|...+..
T Consensus       144 ~~~~~g~~~~A~~~~~~  160 (234)
T TIGR02521       144 CALKAGDFDKAEKYLTR  160 (234)
T ss_pred             HHHHcCCHHHHHHHHHH
Confidence            78889999999999877

Members of this family are designated PilF in ref (PubMed:8973346) and PilW in ref (PubMed:15612916). This outer membrane protein is required both for pilus stability and for pilus function such as adherence to human cells. Members of this family contain copies of the TPR (tetratricopeptide repeat) domain.

>PF09976 TPR_21: Tetratricopeptide repeat; InterPro: IPR018704 This domain, found in various hypothetical prokaryotic proteins, has no known function

Probab=93.07  E-value=0.97  Score=31.97  Aligned_cols=87  Identities=8%  Similarity=-0.023  Sum_probs=36.7

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchh--HHHHHHHHHHHhhcCChHHHHHHHHhhccC--cc----ccHHHHHH
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELD--VAIGTALVEMYSKCGHVEKAFKVFNLMREK--NL----QSWTIMIS   84 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~--~~~~~~li~~~~~~g~~~~a~~~~~~m~~~--~~----~~~~~~i~   84 (234)
                      |..++.+.. .++...+...+..+++......  ....-.+-..+...|++++|...|+.....  |.    .....+-.
T Consensus        15 y~~~~~~~~-~~~~~~~~~~~~~l~~~~~~s~ya~~A~l~lA~~~~~~g~~~~A~~~l~~~~~~~~d~~l~~~a~l~LA~   93 (145)
T PF09976_consen   15 YEQALQALQ-AGDPAKAEAAAEQLAKDYPSSPYAALAALQLAKAAYEQGDYDEAKAALEKALANAPDPELKPLARLRLAR   93 (145)
T ss_pred             HHHHHHHHH-CCCHHHHHHHHHHHHHHCCCChHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHhhCCCHHHHHHHHHHHHH
Confidence            344444442 3444444444555544432221  112222334455555555555555543321  11    12222334


Q ss_pred             HHHhcCCchhhhHhhh
Q 026720           85 GLADNSRGNDAISLHR  100 (234)
Q Consensus        85 ~~~~~g~~~~a~~l~~  100 (234)
                      .+...|+.++|+..+.
T Consensus        94 ~~~~~~~~d~Al~~L~  109 (145)
T PF09976_consen   94 ILLQQGQYDEALATLQ  109 (145)
T ss_pred             HHHHcCCHHHHHHHHH
Confidence            4455555555555553

>PF13429 TPR_15: Tetratricopeptide repeat; PDB: 2VQ2_A 2PL2_B

Probab=92.99  E-value=0.21  Score=39.58  Aligned_cols=122  Identities=12%  Similarity=0.136  Sum_probs=77.9

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc---cCccccHHHHH
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR---EKNLQSWTIMI   83 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~---~~~~~~~~~~i   83 (234)
                      ..|...|..+-..+.+.|+.++|.+.+...++.... |....+.++..+...|+.+++..++....   ..|...|..+-
T Consensus       143 ~~~~~~~~~~a~~~~~~G~~~~A~~~~~~al~~~P~-~~~~~~~l~~~li~~~~~~~~~~~l~~~~~~~~~~~~~~~~la  221 (280)
T PF13429_consen  143 PDSARFWLALAEIYEQLGDPDKALRDYRKALELDPD-DPDARNALAWLLIDMGDYDEAREALKRLLKAAPDDPDLWDALA  221 (280)
T ss_dssp             -T-HHHHHHHHHHHHHCCHHHHHHHHHHHHHHH-TT--HHHHHHHHHHHCTTCHHHHHHHHHHHHHHH-HTSCCHCHHHH
T ss_pred             CCCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCCC-CHHHHHHHHHHHHHCCChHHHHHHHHHHHHHCcCHHHHHHHHH
Confidence            345556666667788899999999999999886532 46678889999999999998777766543   34677888889


Q ss_pred             HHHHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEeecccccccc
Q 026720           84 SGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEID  132 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~~~~~a~~~~  132 (234)
                      .++...|+.++|+..+... ..  ..|++...    ...+...+....|..+.
T Consensus       222 ~~~~~lg~~~~Al~~~~~~-~~--~~p~d~~~~~~~a~~l~~~g~~~~A~~~~  271 (280)
T PF13429_consen  222 AAYLQLGRYEEALEYLEKA-LK--LNPDDPLWLLAYADALEQAGRKDEALRLR  271 (280)
T ss_dssp             HHHHHHT-HHHHHHHHHHH-HH--HSTT-HHHHHHHHHHHT------------
T ss_pred             HHhcccccccccccccccc-cc--ccccccccccccccccccccccccccccc
Confidence            9999999999999998773 22  34554333    23445566665555543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=92.33  E-value=0.088  Score=46.05  Aligned_cols=67  Identities=24%  Similarity=0.287  Sum_probs=48.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeecccc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMV  128 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a  128 (234)
                      ..+|..|+..+.+.+....       .......+..++.         ++|..+++|+|++|.|+++.....++.|||.+
T Consensus       411 ~~lv~E~~~g~~L~~~l~~-------~~~~~~~i~~~L~---------~lH~~giiHrDlkp~NILl~~~~~~liDFGla  474 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLEG-------NPELVRKVGEIVA---------KLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLG  474 (535)
T ss_pred             CEEEEEecCCCcHHHHHHH-------HHHHHHHHHHHHH---------HHHhCCCccCCCChHHEEEECCcEEEEeCccc
Confidence            4577888888887765431       0112223345555         88999999999999999997677889999987


Q ss_pred             ccc
Q 026720          129 KEI  131 (234)
Q Consensus       129 ~~~  131 (234)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            663

>PF04733 Coatomer_E: Coatomer epsilon subunit; InterPro: IPR006822 Proteins synthesised on the ribosome and processed in the endoplasmic reticulum are transported from the Golgi apparatus to the trans-Golgi network (TGN), and from there via small carrier vesicles to their final destination compartment

Probab=92.20  E-value=0.79  Score=36.77  Aligned_cols=107  Identities=9%  Similarity=0.043  Sum_probs=58.0

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccC--ccc-c--HHHHHHHHHhcCCch
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK--NLQ-S--WTIMISGLADNSRGN   93 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~--~~~-~--~~~~i~~~~~~g~~~   93 (234)
                      .+...|+.++|.++....      .+.......|..|.+-++.+.|.+.++.|.+-  |.. +  ..+-++.........
T Consensus       111 i~~~~~~~~~AL~~l~~~------~~lE~~al~Vqi~L~~~R~dlA~k~l~~~~~~~eD~~l~qLa~awv~l~~g~e~~~  184 (290)
T PF04733_consen  111 ILFHEGDYEEALKLLHKG------GSLELLALAVQILLKMNRPDLAEKELKNMQQIDEDSILTQLAEAWVNLATGGEKYQ  184 (290)
T ss_dssp             HHCCCCHHHHHHCCCTTT------TCHHHHHHHHHHHHHTT-HHHHHHHHHHHHCCSCCHHHHHHHHHHHHHHHTTTCCC
T ss_pred             HHHHcCCHHHHHHHHHcc------CcccHHHHHHHHHHHcCCHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHhCchhHH
Confidence            366677888887776542      23344456777888888888888888888753  211 1  111122222234678


Q ss_pred             hhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccC
Q 026720           94 DAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        94 ~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~  133 (234)
                      +|.++|.+ +..+ ..++..+++   ......+++..|.....
T Consensus       185 ~A~y~f~E-l~~~-~~~t~~~lng~A~~~l~~~~~~eAe~~L~  225 (290)
T PF04733_consen  185 DAFYIFEE-LSDK-FGSTPKLLNGLAVCHLQLGHYEEAEELLE  225 (290)
T ss_dssp             HHHHHHHH-HHCC-S--SHHHHHHHHHHHHHCT-HHHHHHHHH
T ss_pred             HHHHHHHH-HHhc-cCCCHHHHHHHHHHHHHhCCHHHHHHHHH
Confidence            88888877 4332 223333332   12335566666665533

This traffic is bidirectional, to ensure that proteins required to form vesicles are recycled. Vesicles have specific coat proteins (such as clathrin or coatomer) that are important for cargo selection and direction of transfer []. While clathrin mediates endocytic protein transport, and transport from ER to Golgi, coatomers primarily mediate intra-Golgi transport, as well as the reverse Golgi to ER transport of dilysine-tagged proteins []. For example, the coatomer COP1 (coat protein complex 1) is responsible for reverse transport of recycled proteins from Golgi and pre-Golgi compartments back to the ER, while COPII buds vesicles from the ER to the Golgi []. Coatomers reversibly associate with Golgi (non-clathrin-coated) vesicles to mediate protein transport and for budding from Golgi membranes []. Activated small guanine triphosphatases (GTPases) attract coat proteins to specific membrane export sites, thereby linking coatomers to export cargos. As coat proteins polymerise, vesicles are formed and budded from membrane-bound organelles. Coatomer complexes also influence Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors. In mammals, coatomer complexes can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins. Coatomer complexes are hetero-oligomers composed of at least an alpha, beta, beta', gamma, delta, epsilon and zeta subunits. This entry represents the epsilon subunit of the coatomer complex, which is involved in the regulation of intracellular protein trafficking between the endoplasmic reticulum and the Golgi complex []. More information about these proteins can be found at Protein of the Month: Clathrin [].; GO: 0005198 structural molecule activity, 0006890 retrograde vesicle-mediated transport, Golgi to ER, 0030126 COPI vesicle coat; PDB: 3MV2_B 3MV3_F 3MKR_A.

>PRK10370 formate-dependent nitrite reductase complex subunit NrfG; Provisional

Probab=92.16  E-value=1.7  Score=32.69  Aligned_cols=92  Identities=14%  Similarity=0.068  Sum_probs=58.1

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHH-HhhcCC--hHHHHHHHHhhcc---CccccHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEM-YSKCGH--VEKAFKVFNLMRE---KNLQSWTIM   82 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~-~~~~g~--~~~a~~~~~~m~~---~~~~~~~~~   82 (234)
                      |...|..+-..|...++.++|...+....+.... |...+..+-.. |...|.  .++|.+++++..+   .++..+..+
T Consensus        72 ~~~~w~~Lg~~~~~~g~~~~A~~a~~~Al~l~P~-~~~~~~~lA~aL~~~~g~~~~~~A~~~l~~al~~dP~~~~al~~L  150 (198)
T PRK10370         72 NSEQWALLGEYYLWRNDYDNALLAYRQALQLRGE-NAELYAALATVLYYQAGQHMTPQTREMIDKALALDANEVTALMLL  150 (198)
T ss_pred             CHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCC-CHHHHHHHHHHHHHhcCCCCcHHHHHHHHHHHHhCCCChhHHHHH
Confidence            4445555556677777777777777777665432 44455555554 355565  4777777776543   255566666


Q ss_pred             HHHHHhcCCchhhhHhhhc
Q 026720           83 ISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~  101 (234)
                      -..+.+.|+.++|+..+..
T Consensus       151 A~~~~~~g~~~~Ai~~~~~  169 (198)
T PRK10370        151 ASDAFMQADYAQAIELWQK  169 (198)
T ss_pred             HHHHHHcCCHHHHHHHHHH
Confidence            6666777777777777766

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=91.52  E-value=0.27  Score=45.66  Aligned_cols=52  Identities=29%  Similarity=0.395  Sum_probs=42.5

Q ss_pred             CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 026720          138 TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI  190 (234)
Q Consensus       138 ~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~  190 (234)
                      ....+++.|.+||...+..+ ....|.|+.|..+.|.+.|.++|.+.......
T Consensus       993 ~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen  993 HAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred             ccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhhhh
Confidence            34567788999999986665 57789999999999999999999987655444

>KOG1914 consensus mRNA cleavage and polyadenylation factor I complex, subunit RNA14 [RNA processing and modification]

Probab=91.50  E-value=1.1  Score=38.55  Aligned_cols=103  Identities=17%  Similarity=0.237  Sum_probs=74.8

Q ss_pred             CCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccch-hHHHHHHHHHHHhhcCChHHHHHHHHh-hcc-CccccHH-H
Q 026720            6 ENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLEL-DVAIGTALVEMYSKCGHVEKAFKVFNL-MRE-KNLQSWT-I   81 (234)
Q Consensus         6 ~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~-m~~-~~~~~~~-~   81 (234)
                      ..|+. +|.-.++.--+...+..|+.+|.+..+.+-.+ ++.++++++.-||. ++-.-|.++|+. |.. +|.-.|- .
T Consensus       363 ~~~tL-v~~~~mn~irR~eGlkaaR~iF~kaR~~~r~~hhVfVa~A~mEy~cs-kD~~~AfrIFeLGLkkf~d~p~yv~~  440 (656)
T KOG1914|consen  363 IDLTL-VYCQYMNFIRRAEGLKAARKIFKKAREDKRTRHHVFVAAALMEYYCS-KDKETAFRIFELGLKKFGDSPEYVLK  440 (656)
T ss_pred             cCCce-ehhHHHHHHHHhhhHHHHHHHHHHHhhccCCcchhhHHHHHHHHHhc-CChhHHHHHHHHHHHhcCCChHHHHH
Confidence            34444 67777888878888999999999999988766 88899999988887 566678888875 443 4554443 3


Q ss_pred             HHHHHHhcCCchhhhHhhhcccccCCcCCC
Q 026720           82 MISGLADNSRGNDAISLHRQGYFHRDLKPS  111 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~  111 (234)
                      -+.-+.+-++-..|.-+|.. .+.+.+.|+
T Consensus       441 YldfL~~lNdd~N~R~LFEr-~l~s~l~~~  469 (656)
T KOG1914|consen  441 YLDFLSHLNDDNNARALFER-VLTSVLSAD  469 (656)
T ss_pred             HHHHHHHhCcchhHHHHHHH-HHhccCChh
Confidence            36777777888888888877 455444444

>PLN03088 SGT1, suppressor of G2 allele of SKP1; Provisional

Probab=91.24  E-value=1.1  Score=37.12  Aligned_cols=81  Identities=9%  Similarity=-0.095  Sum_probs=52.6

Q ss_pred             hcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhh
Q 026720           20 CTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAI   96 (234)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~   96 (234)
                      +...+++++|...+...++... .+...+..+-..|.+.|++++|...++...+   .+...|..+-.++.+.|++++|+
T Consensus        12 a~~~~~~~~Ai~~~~~Al~~~P-~~~~a~~~~a~~~~~~g~~~eAl~~~~~Al~l~P~~~~a~~~lg~~~~~lg~~~eA~   90 (356)
T PLN03088         12 AFVDDDFALAVDLYTQAIDLDP-NNAELYADRAQANIKLGNFTEAVADANKAIELDPSLAKAYLRKGTACMKLEEYQTAK   90 (356)
T ss_pred             HHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCcCCHHHHHHHHHHHHHhCCHHHHH
Confidence            3355677777777777776443 2445666666777777777777777766543   24456666666677777777777


Q ss_pred             Hhhhc
Q 026720           97 SLHRQ  101 (234)
Q Consensus        97 ~l~~~  101 (234)
                      ..+..
T Consensus        91 ~~~~~   95 (356)
T PLN03088         91 AALEK   95 (356)
T ss_pred             HHHHH
Confidence            76654

>TIGR00990 3a0801s09 mitochondrial precursor proteins import receptor (72 kDa mitochondrial outermembrane protein) (mitochondrial import receptor for the ADP/ATP carrier) (translocase of outermembrane tom70)

Probab=91.21  E-value=1.2  Score=39.76  Aligned_cols=89  Identities=12%  Similarity=-0.039  Sum_probs=61.8

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~   88 (234)
                      +|..+-..+...|+.++|...+...++... .+..++..+-..|...|++++|...|+...+  | ++..|..+-..+.+
T Consensus       367 ~~~~la~~~~~~g~~~eA~~~~~~al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~kal~l~P~~~~~~~~la~~~~~  445 (615)
T TIGR00990       367 SYIKRASMNLELGDPDKAEEDFDKALKLNS-EDPDIYYHRAQLHFIKGEFAQAGKDYQKSIDLDPDFIFSHIQLGVTQYK  445 (615)
T ss_pred             HHHHHHHHHHHCCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCccCHHHHHHHHHHHHH
Confidence            555566666777788888888887766532 2355677777778888888888888776543  2 44556556666777


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus       446 ~g~~~eA~~~~~~  458 (615)
T TIGR00990       446 EGSIASSMATFRR  458 (615)
T ss_pred             CCCHHHHHHHHHH
Confidence            7888888887766

>KOG4318 consensus Bicoid mRNA stability factor [RNA processing and modification]

Probab=91.05  E-value=0.3  Score=44.29  Aligned_cols=83  Identities=13%  Similarity=0.038  Sum_probs=62.9

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc----CccccHHHH
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE----KNLQSWTIM   82 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~----~~~~~~~~~   82 (234)
                      .||..+|..++++-...|+.+-|+.+..+|++.|+.-+..-|..|+-+   .+....+..+...|.+    |+.-|+..-
T Consensus       201 ~~~s~~l~a~l~~alaag~~d~Ak~ll~emke~gfpir~HyFwpLl~g---~~~~q~~e~vlrgmqe~gv~p~seT~ady  277 (1088)
T KOG4318|consen  201 APTSETLHAVLKRALAAGDVDGAKNLLYEMKEKGFPIRAHYFWPLLLG---INAAQVFEFVLRGMQEKGVQPGSETQADY  277 (1088)
T ss_pred             CCChHHHHHHHHHHHhcCchhhHHHHHHHHHHcCCCcccccchhhhhc---CccchHHHHHHHHHHHhcCCCCcchhHHH
Confidence            488888888888888888888899999999888887777767777755   6777777777777764    566677666


Q ss_pred             HHHHHhcCCc
Q 026720           83 ISGLADNSRG   92 (234)
Q Consensus        83 i~~~~~~g~~   92 (234)
                      +..+..+|..
T Consensus       278 vip~l~N~~t  287 (1088)
T KOG4318|consen  278 VIPQLSNGQT  287 (1088)
T ss_pred             HHhhhcchhh
Confidence            6655555553

>PRK15174 Vi polysaccharide export protein VexE; Provisional

Probab=90.75  E-value=1.6  Score=39.35  Aligned_cols=91  Identities=9%  Similarity=0.062  Sum_probs=67.3

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--CccccHHH-HHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQSWTI-MISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~~~~~-~i~~~   86 (234)
                      ...+..+-..+.+.|+.++|...+....+.... +...+..+...|.+.|+.++|...++.+..  |+...+.. +...+
T Consensus       284 ~~a~~~lg~~l~~~g~~~eA~~~l~~al~l~P~-~~~a~~~La~~l~~~G~~~eA~~~l~~al~~~P~~~~~~~~~a~al  362 (656)
T PRK15174        284 VRIVTLYADALIRTGQNEKAIPLLQQSLATHPD-LPYVRAMYARALRQVGQYTAASDEFVQLAREKGVTSKWNRYAAAAL  362 (656)
T ss_pred             HHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCC-CHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCccchHHHHHHHHHH
Confidence            346667777788888899999888888775432 344567788889999999999998888663  44333333 35668


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      .+.|+.++|+..+..
T Consensus       363 ~~~G~~deA~~~l~~  377 (656)
T PRK15174        363 LQAGKTSEAESVFEH  377 (656)
T ss_pred             HHCCCHHHHHHHHHH
Confidence            888999999988866

>PRK11189 lipoprotein NlpI; Provisional

Probab=90.59  E-value=2.1  Score=34.34  Aligned_cols=82  Identities=13%  Similarity=-0.072  Sum_probs=62.2

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcCCchhh
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNSRGNDA   95 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g~~~~a   95 (234)
                      .+.+.|+.++|...+...++... .+...|+.+-..|...|+.++|...|+...+  | +..+|..+-..+...|+.++|
T Consensus        73 ~~~~~g~~~~A~~~~~~Al~l~P-~~~~a~~~lg~~~~~~g~~~~A~~~~~~Al~l~P~~~~a~~~lg~~l~~~g~~~eA  151 (296)
T PRK11189         73 LYDSLGLRALARNDFSQALALRP-DMADAYNYLGIYLTQAGNFDAAYEAFDSVLELDPTYNYAYLNRGIALYYGGRYELA  151 (296)
T ss_pred             HHHHCCCHHHHHHHHHHHHHcCC-CCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHCCCHHHH
Confidence            45667788888888877776443 2466788888889999999999888887643  3 456677777777888999999


Q ss_pred             hHhhhc
Q 026720           96 ISLHRQ  101 (234)
Q Consensus        96 ~~l~~~  101 (234)
                      +..+..
T Consensus       152 ~~~~~~  157 (296)
T PRK11189        152 QDDLLA  157 (296)
T ss_pred             HHHHHH
Confidence            888866

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=90.59  E-value=0.55  Score=36.49  Aligned_cols=43  Identities=26%  Similarity=0.463  Sum_probs=33.3

Q ss_pred             HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecccccc
Q 026720           79 WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE  130 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~  130 (234)
                      |..+..++.         ++|..+++|+|++|.|+++. .....+.||+.+..
T Consensus       148 ~~~i~~~l~---------~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        148 WQAIGQLIA---------RFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHH---------HHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            555566666         89999999999999999994 44577888875554

>PRK12370 invasion protein regulator; Provisional

Probab=90.41  E-value=1.6  Score=38.39  Aligned_cols=121  Identities=13%  Similarity=-0.028  Sum_probs=77.1

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cccc-cHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQ-SWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~-~~~~~i~~~   86 (234)
                      ..++..+=..+...|+.++|...+...++.... +...+..+-..|...|+.++|...+++..+  |+.. .+..+...+
T Consensus       338 ~~a~~~lg~~~~~~g~~~~A~~~~~~Al~l~P~-~~~a~~~lg~~l~~~G~~~eAi~~~~~Al~l~P~~~~~~~~~~~~~  416 (553)
T PRK12370        338 PQALGLLGLINTIHSEYIVGSLLFKQANLLSPI-SADIKYYYGWNLFMAGQLEEALQTINECLKLDPTRAAAGITKLWIT  416 (553)
T ss_pred             HHHHHHHHHHHHHccCHHHHHHHHHHHHHhCCC-CHHHHHHHHHHHHHCCCHHHHHHHHHHHHhcCCCChhhHHHHHHHH
Confidence            344555545566788899999999998876532 344677788889999999999999888654  3322 333344456


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCcEE----eeCCeeeEeeccccccccC
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSNLL----VSKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~~~----~~~~~~~~~~~~~a~~~~~  133 (234)
                      ...|+.++|+..+.. ..... .|+...    +...+...+++..|.....
T Consensus       417 ~~~g~~eeA~~~~~~-~l~~~-~p~~~~~~~~la~~l~~~G~~~eA~~~~~  465 (553)
T PRK12370        417 YYHTGIDDAIRLGDE-LRSQH-LQDNPILLSMQVMFLSLKGKHELARKLTK  465 (553)
T ss_pred             HhccCHHHHHHHHHH-HHHhc-cccCHHHHHHHHHHHHhCCCHHHHHHHHH
Confidence            678889999988866 22211 233221    1223445666666666544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=90.34  E-value=0.25  Score=37.21  Aligned_cols=69  Identities=22%  Similarity=0.240  Sum_probs=44.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCcccc-HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeeccc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQS-WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGM  127 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~-~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~  127 (234)
                      ..++..|+..+.+.+.....   .. .... ...+..++.         ++|..+++|+|++|.|+++......+.||+.
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~---------~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~  140 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSN---GM-EELELSREIGRLVG---------KLHSAGIIHGDLTTSNMILSGGKIYLIDFGL  140 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHH---------HHHhCCcccCCCCcccEEEECCCEEEEECCc
Confidence            34667777777776654221   11 1111 112233333         7888889999999999999756677889987


Q ss_pred             ccc
Q 026720          128 VKE  130 (234)
Q Consensus       128 a~~  130 (234)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            665

>PF13432 TPR_16: Tetratricopeptide repeat; PDB: 3CVP_A 3CVL_A 3CVQ_A 3CV0_A 2GW1_B 3CVN_A 3QKY_A 2PL2_B

Probab=90.16  E-value=1.1  Score=26.49  Aligned_cols=47  Identities=17%  Similarity=0.318  Sum_probs=20.7

Q ss_pred             HhhcCChHHHHHHHHhhccC---ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           55 YSKCGHVEKAFKVFNLMREK---NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        55 ~~~~g~~~~a~~~~~~m~~~---~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      |.+.|++++|...|+...+.   +.-.|..+-..+.+.|+.++|+..+..
T Consensus         7 ~~~~g~~~~A~~~~~~~l~~~P~~~~a~~~lg~~~~~~g~~~~A~~~~~~   56 (65)
T PF13432_consen    7 LYQQGDYDEAIAAFEQALKQDPDNPEAWYLLGRILYQQGRYDEALAYYER   56 (65)
T ss_dssp             HHHCTHHHHHHHHHHHHHCCSTTHHHHHHHHHHHHHHTT-HHHHHHHHHH
T ss_pred             HHHcCCHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence            44445555555555444332   223333334444445555555544443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=90.06  E-value=0.32  Score=36.29  Aligned_cols=66  Identities=23%  Similarity=0.298  Sum_probs=44.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeeccccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVK  129 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a~  129 (234)
                      .++..|+..+.+.+...-      ........+..++.         ++|..+++|++++|.|+++......+.||+.+.
T Consensus        73 ~lv~e~~~g~~l~~~~~~------~~~~~~~~i~~~l~---------~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~  137 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEE------GNDELLREIGRLVG---------KLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGK  137 (199)
T ss_pred             EEEEEEECCccHHHHHhh------cHHHHHHHHHHHHH---------HHHHCCeecCCCCcceEEEECCcEEEEECCCCc
Confidence            567777777777654321      11022233345555         788889999999999999976677888998765


Q ss_pred             c
Q 026720          130 E  130 (234)
Q Consensus       130 ~  130 (234)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            5

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK12370 invasion protein regulator; Provisional

Probab=90.01  E-value=2.2  Score=37.57  Aligned_cols=79  Identities=6%  Similarity=-0.190  Sum_probs=55.0

Q ss_pred             CchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcCCchhhhHh
Q 026720           22 GLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNSRGNDAISL   98 (234)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g~~~~a~~l   98 (234)
                      ..+..++|...+...++... -+...+..+-..+...|+.++|...+++..+  | +...|..+-..+.+.|+.++|+..
T Consensus       316 ~~~~~~~A~~~~~~Al~ldP-~~~~a~~~lg~~~~~~g~~~~A~~~~~~Al~l~P~~~~a~~~lg~~l~~~G~~~eAi~~  394 (553)
T PRK12370        316 KQNAMIKAKEHAIKATELDH-NNPQALGLLGLINTIHSEYIVGSLLFKQANLLSPISADIKYYYGWNLFMAGQLEEALQT  394 (553)
T ss_pred             cchHHHHHHHHHHHHHhcCC-CCHHHHHHHHHHHHHccCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHCCCHHHHHHH
Confidence            44567778887777776432 2455666666677788888888888877543  3 344666667777888888888888


Q ss_pred             hhc
Q 026720           99 HRQ  101 (234)
Q Consensus        99 ~~~  101 (234)
                      +..
T Consensus       395 ~~~  397 (553)
T PRK12370        395 INE  397 (553)
T ss_pred             HHH
Confidence            776

>PRK09782 bacteriophage N4 receptor, outer membrane subunit; Provisional

Probab=89.81  E-value=1.9  Score=40.74  Aligned_cols=104  Identities=13%  Similarity=-0.021  Sum_probs=68.3

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHH
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMI   83 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i   83 (234)
                      .|+...+..+-..+.+.|+.++|...+...++... .+...++.+-..+...|+.++|...++...+  | +...+..+-
T Consensus       606 ~P~~~a~~~LA~~l~~lG~~deA~~~l~~AL~l~P-d~~~a~~nLG~aL~~~G~~eeAi~~l~~AL~l~P~~~~a~~nLA  684 (987)
T PRK09782        606 APSANAYVARATIYRQRHNVPAAVSDLRAALELEP-NNSNYQAALGYALWDSGDIAQSREMLERAHKGLPDDPALIRQLA  684 (987)
T ss_pred             CCCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCCCHHHHHHHH
Confidence            45555666666677777777777777777766432 1344566666677777888888777766432  2 455677777


Q ss_pred             HHHHhcCCchhhhHhhhcccccCCcCCCcEE
Q 026720           84 SGLADNSRGNDAISLHRQGYFHRDLKPSNLL  114 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~  114 (234)
                      ..+.+.|+.++|+..+.. .+  .+.|+..-
T Consensus       685 ~al~~lGd~~eA~~~l~~-Al--~l~P~~a~  712 (987)
T PRK09782        685 YVNQRLDDMAATQHYARL-VI--DDIDNQAL  712 (987)
T ss_pred             HHHHHCCCHHHHHHHHHH-HH--hcCCCCch
Confidence            777788888888877766 33  24465543

>PF00637 Clathrin: Region in Clathrin and VPS; InterPro: IPR000547 Proteins synthesized on the ribosome and processed in the endoplasmic reticulum are transported from the Golgi apparatus to the trans-Golgi network (TGN), and from there via small carrier vesicles to their final destination compartment

Probab=89.13  E-value=0.75  Score=32.34  Aligned_cols=84  Identities=17%  Similarity=0.095  Sum_probs=65.5

Q ss_pred             HHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchh
Q 026720           15 SLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGND   94 (234)
Q Consensus        15 ~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~   94 (234)
                      .+++.+.+.+......+.....++.+-..+....|.|+..|++.+..+...+.++   ..+-.-...++.-|-+.|..++
T Consensus        12 ~vi~~~~~~~~~~~l~~yLe~~~~~~~~~~~~~~~~L~~ly~~~~~~~~l~~~L~---~~~~yd~~~~~~~c~~~~l~~~   88 (143)
T PF00637_consen   12 EVISAFEERNQPEELIEYLEALVKENKENNPDLHTLLLELYIKYDPYEKLLEFLK---TSNNYDLDKALRLCEKHGLYEE   88 (143)
T ss_dssp             CCHHHCTTTT-GGGCTCCHHHHHHTSTC-SHHHHHHHHHHHHCTTTCCHHHHTTT---SSSSS-CTHHHHHHHTTTSHHH
T ss_pred             HHHHHHHhCCCHHHHHHHHHHHHhcccccCHHHHHHHHHHHHhcCCchHHHHHcc---cccccCHHHHHHHHHhcchHHH
Confidence            4577888888888888999999887766778889999999999988888877655   3333555667888888899999


Q ss_pred             hhHhhhc
Q 026720           95 AISLHRQ  101 (234)
Q Consensus        95 a~~l~~~  101 (234)
                      |..++..
T Consensus        89 a~~Ly~~   95 (143)
T PF00637_consen   89 AVYLYSK   95 (143)
T ss_dssp             HHHHHHC
T ss_pred             HHHHHHH
Confidence            9998876

These vesicles have specific coat proteins (such as clathrin or coatomer) that are important for cargo selection and direction of transport []. Clathrin coats contain both clathrin (acts as a scaffold) and adaptor complexes that link clathrin to receptors in coated vesicles. Clathrin-associated protein complexes are believed to interact with the cytoplasmic tails of membrane proteins, leading to their selection and concentration. The two major types of clathrin adaptor complexes are the heterotetrameric adaptor protein (AP) complexes, and the monomeric GGA (Golgi-localising, Gamma-adaptin ear domain homology, ARF-binding proteins) adaptors [, ]. Clathrin is a trimer composed of three heavy chains and three light chains, each monomer projecting outwards like a leg; this three-legged structure is known as a triskelion [, ]. The heavy chains form the legs, their N-terminal beta-propeller regions extending outwards, while their C-terminal alpha-alpha-superhelical regions form the central hub of the triskelion. Peptide motifs can bind between the beta-propeller blades. The light chains appear to have a regulatory role, and may help orient the assembly and disassembly of clathrin coats as they interact with hsc70 uncoating ATPase []. Clathrin triskelia self-polymerise into a curved lattice by twisting individual legs together. The clathrin lattice forms around a vesicle as it buds from the TGN, plasma membrane or endosomes, acting to stabilise the vesicle and facilitate the budding process []. The multiple blades created when the triskelia polymerise are involved in multiple protein interactions, enabling the recruitment of different cargo adaptors and membrane attachment proteins []. This entry represents the 7-fold alpha-alpha-superhelical ARM-type repeat found at the C-terminal of clathrin heavy chains and in VPS (vacuolar protein sorting-associated) proteins. In clathrin heavy chains, the C-terminal 7-fold ARM-type repeats interact to form the central hub of the triskelion. VPS proteins are required for vacuolar assembly and vacuolar traffick, and contain one clathrin-type repeat []. More information about these proteins can be found at Protein of the Month: Clathrin [].; GO: 0006886 intracellular protein transport, 0016192 vesicle-mediated transport; PDB: 3LVH_A 3LVG_C 1B89_A 3QIL_L.

>TIGR00990 3a0801s09 mitochondrial precursor proteins import receptor (72 kDa mitochondrial outermembrane protein) (mitochondrial import receptor for the ADP/ATP carrier) (translocase of outermembrane tom70)

Probab=89.07  E-value=2.5  Score=37.78  Aligned_cols=98  Identities=11%  Similarity=-0.090  Sum_probs=67.7

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchh-HHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELD-VAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~-~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ..++.+-..+...|+.++|...+...++.  .|+ ...|..+...|...|+.++|...|+...+   .+...|..+-..+
T Consensus       332 ~a~~~lg~~~~~~g~~~eA~~~~~kal~l--~P~~~~~~~~la~~~~~~g~~~eA~~~~~~al~~~p~~~~~~~~lg~~~  409 (615)
T TIGR00990       332 IALNLRGTFKCLKGKHLEALADLSKSIEL--DPRVTQSYIKRASMNLELGDPDKAEEDFDKALKLNSEDPDIYYHRAQLH  409 (615)
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHHc--CCCcHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHH
Confidence            34555555566778888888888887764  343 44677777778888888888888876543   3456777777778


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      ...|+.++|+..|... +  .+.|++.
T Consensus       410 ~~~g~~~~A~~~~~ka-l--~l~P~~~  433 (615)
T TIGR00990       410 FIKGEFAQAGKDYQKS-I--DLDPDFI  433 (615)
T ss_pred             HHcCCHHHHHHHHHHH-H--HcCccCH
Confidence            8888888888888763 2  2445543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=88.90  E-value=0.98  Score=33.75  Aligned_cols=36  Identities=31%  Similarity=0.349  Sum_probs=30.0

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeecccccccc
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID  132 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~  132 (234)
                      ++|..+++|+|++|.|+++. ....++.|||.+....
T Consensus       140 ~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         140 KAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             HHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            78888899999999999994 5677899999775543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PF13432 TPR_16: Tetratricopeptide repeat; PDB: 3CVP_A 3CVL_A 3CVQ_A 3CV0_A 2GW1_B 3CVN_A 3QKY_A 2PL2_B

Probab=88.82  E-value=0.92  Score=26.89  Aligned_cols=54  Identities=11%  Similarity=-0.017  Sum_probs=44.6

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      .+.+.|++++|...+...++... -+.-.+..+-..+.+.|+.++|...|+...+
T Consensus         6 ~~~~~g~~~~A~~~~~~~l~~~P-~~~~a~~~lg~~~~~~g~~~~A~~~~~~a~~   59 (65)
T PF13432_consen    6 ALYQQGDYDEAIAAFEQALKQDP-DNPEAWYLLGRILYQQGRYDEALAYYERALE   59 (65)
T ss_dssp             HHHHCTHHHHHHHHHHHHHCCST-THHHHHHHHHHHHHHTT-HHHHHHHHHHHHH
T ss_pred             HHHHcCCHHHHHHHHHHHHHHCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHH
Confidence            45567899999999999998763 3677888899999999999999999988643

>KOG3941 consensus Intermediate in Toll signal transduction pathway (ECSIT) [Signal transduction mechanisms]

Probab=88.31  E-value=0.67  Score=36.72  Aligned_cols=67  Identities=13%  Similarity=0.097  Sum_probs=53.4

Q ss_pred             CccCCCCCCeehHHHHHHHhcCch----------------hhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCC-hHH
Q 026720            1 MKLANENPNSVTLVSLVSACTGLI----------------NVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGH-VEK   63 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~----------------~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~-~~~   63 (234)
                      |.++|+..|..+|+.||+.+-+..                .-+.+..+.++|.--|+.||..+...||+.|++-+. +..
T Consensus        98 m~eyGVerDl~vYk~LlnvfPKgkfiP~nvfQ~~F~HYP~QQ~C~I~vLeqME~hGVmPdkE~e~~lvn~FGr~~~p~~K  177 (406)
T KOG3941|consen   98 MKEYGVERDLDVYKGLLNVFPKGKFIPQNVFQKVFLHYPQQQNCAIKVLEQMEWHGVMPDKEIEDILVNAFGRWNFPTKK  177 (406)
T ss_pred             HHHhcchhhHHHHHHHHHhCcccccccHHHHHHHHhhCchhhhHHHHHHHHHHHcCCCCchHHHHHHHHHhccccccHHH
Confidence            567899999999999999776532                123567789999999999999999999999999886 333


Q ss_pred             HHHH
Q 026720           64 AFKV   67 (234)
Q Consensus        64 a~~~   67 (234)
                      ..++
T Consensus       178 ~~Rm  181 (406)
T KOG3941|consen  178 VKRM  181 (406)
T ss_pred             HHHH
Confidence            3333

>PF14559 TPR_19: Tetratricopeptide repeat; PDB: 2R5S_A 3QDN_B 3QOU_A 3ASG_A 3ASD_A 3AS5_A 3AS4_A 3ASH_B 3FP3_A 3LCA_A

Probab=88.23  E-value=0.74  Score=27.53  Aligned_cols=46  Identities=13%  Similarity=0.183  Sum_probs=37.6

Q ss_pred             hhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           56 SKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        56 ~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      .+.|++++|.+.|+....  | |...+..+...+.+.|+.++|..++..
T Consensus         2 l~~~~~~~A~~~~~~~l~~~p~~~~~~~~la~~~~~~g~~~~A~~~l~~   50 (68)
T PF14559_consen    2 LKQGDYDEAIELLEKALQRNPDNPEARLLLAQCYLKQGQYDEAEELLER   50 (68)
T ss_dssp             HHTTHHHHHHHHHHHHHHHTTTSHHHHHHHHHHHHHTT-HHHHHHHHHC
T ss_pred             hhccCHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence            467899999999988653  3 566677789999999999999999987

...

>cd05119 RIO RIO kinase family, catalytic domain

Probab=88.05  E-value=1.2  Score=32.73  Aligned_cols=37  Identities=41%  Similarity=0.535  Sum_probs=30.7

Q ss_pred             Hhhh-cccccCCcCCCcEEeeCCeeeEeeccccccccC
Q 026720           97 SLHR-QGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        97 ~l~~-~~~~~~~l~p~~~~~~~~~~~~~~~~~a~~~~~  133 (234)
                      .+|. .+++|+|++|.|+++......+.|||.+.....
T Consensus       129 ~lh~~~~ivH~Dl~p~Nili~~~~~~liDfg~a~~~~~  166 (187)
T cd05119         129 KLYREAGLVHGDLSEYNILVDDGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             HHhhccCcCcCCCChhhEEEECCcEEEEECcccccccC
Confidence            6777 789999999999999766778999998876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG2003 consensus TPR repeat-containing protein [General function prediction only]

Probab=88.01  E-value=1.7  Score=36.76  Aligned_cols=109  Identities=18%  Similarity=0.240  Sum_probs=77.4

Q ss_pred             ccCCCCC-CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHh--hccCcccc
Q 026720            2 KLANENP-NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNL--MREKNLQS   78 (234)
Q Consensus         2 ~~~g~~~-~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~--m~~~~~~~   78 (234)
                      +...+-| |...++.|-+-|-+.|+-..|.+.|-+--+ =+..++.+.-.|-.-|....-.+.++..|++  +-+|++..
T Consensus       583 q~~slip~dp~ilskl~dlydqegdksqafq~~ydsyr-yfp~nie~iewl~ayyidtqf~ekai~y~ekaaliqp~~~k  661 (840)
T KOG2003|consen  583 QANSLIPNDPAILSKLADLYDQEGDKSQAFQCHYDSYR-YFPCNIETIEWLAAYYIDTQFSEKAINYFEKAALIQPNQSK  661 (840)
T ss_pred             HhcccCCCCHHHHHHHHHHhhcccchhhhhhhhhhccc-ccCcchHHHHHHHHHHHhhHHHHHHHHHHHHHHhcCccHHH
Confidence            3445555 455566677778888877777777655322 2445677777777777777788889999987  44799999


Q ss_pred             HHHHHHH-HHhcCCchhhhHhhhcccccCCcCCCcEE
Q 026720           79 WTIMISG-LADNSRGNDAISLHRQGYFHRDLKPSNLL  114 (234)
Q Consensus        79 ~~~~i~~-~~~~g~~~~a~~l~~~~~~~~~l~p~~~~  114 (234)
                      |--||.. +.+.|.+.+|+.+++.  +|+.+ |.++-
T Consensus       662 wqlmiasc~rrsgnyqka~d~yk~--~hrkf-pedld  695 (840)
T KOG2003|consen  662 WQLMIASCFRRSGNYQKAFDLYKD--IHRKF-PEDLD  695 (840)
T ss_pred             HHHHHHHHHHhcccHHHHHHHHHH--HHHhC-ccchH
Confidence            9999655 5677999999999987  46554 44443

>smart00090 RIO RIO-like kinase

Probab=87.79  E-value=0.78  Score=35.60  Aligned_cols=35  Identities=34%  Similarity=0.516  Sum_probs=29.0

Q ss_pred             Hhhhcc-cccCCcCCCcEEeeCCeeeEeeccccccc
Q 026720           97 SLHRQG-YFHRDLKPSNLLVSKGVIKIGDLGMVKEI  131 (234)
Q Consensus        97 ~l~~~~-~~~~~l~p~~~~~~~~~~~~~~~~~a~~~  131 (234)
                      ++|..+ ++|++++|.|+++.....++.||+.+...
T Consensus       163 ~LH~~g~iiH~Dikp~NIli~~~~i~LiDFg~a~~~  198 (237)
T smart00090      163 KLYKEGELVHGDLSEYNILVHDGKVVIIDVSQSVEL  198 (237)
T ss_pred             HHHhcCCEEeCCCChhhEEEECCCEEEEEChhhhcc
Confidence            788888 99999999999997556778888876653

>KOG3616 consensus Selective LIM binding factor [Transcription]

Probab=87.39  E-value=1.6  Score=39.31  Aligned_cols=78  Identities=17%  Similarity=0.221  Sum_probs=58.5

Q ss_pred             HHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccC--ccccHHHHHHHHHhcCCc
Q 026720           15 SLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK--NLQSWTIMISGLADNSRG   92 (234)
Q Consensus        15 ~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~--~~~~~~~~i~~~~~~g~~   92 (234)
                      -+-.-|++.|.++.|.++|.+.         -.++--|++|.++|.+.+|.++-++...|  .+..|.+.-.-+-..|++
T Consensus       770 ~iadhyan~~dfe~ae~lf~e~---------~~~~dai~my~k~~kw~da~kla~e~~~~e~t~~~yiakaedldehgkf  840 (1636)
T KOG3616|consen  770 EIADHYANKGDFEIAEELFTEA---------DLFKDAIDMYGKAGKWEDAFKLAEECHGPEATISLYIAKAEDLDEHGKF  840 (1636)
T ss_pred             HHHHHhccchhHHHHHHHHHhc---------chhHHHHHHHhccccHHHHHHHHHHhcCchhHHHHHHHhHHhHHhhcch
Confidence            3455688889999998888653         23566789999999999999987765444  456777777777888888


Q ss_pred             hhhhHhhhc
Q 026720           93 NDAISLHRQ  101 (234)
Q Consensus        93 ~~a~~l~~~  101 (234)
                      -+|..++..
T Consensus       841 ~eaeqlyit  849 (1636)
T KOG3616|consen  841 AEAEQLYIT  849 (1636)
T ss_pred             hhhhheeEE
Confidence            888777643

>PRK11447 cellulose synthase subunit BcsC; Provisional

Probab=87.28  E-value=4.1  Score=39.44  Aligned_cols=87  Identities=10%  Similarity=0.011  Sum_probs=45.3

Q ss_pred             HHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccC---ccccHHHHHHHHHhcC
Q 026720           14 VSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK---NLQSWTIMISGLADNS   90 (234)
Q Consensus        14 ~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~---~~~~~~~~i~~~~~~g   90 (234)
                      ..+-..+.+.|+.++|...+...++... .+...+..+...|...|+.++|...++.....   +...+..+-..+.+.|
T Consensus       607 ~~La~~~~~~g~~~~A~~~y~~al~~~P-~~~~a~~~la~~~~~~g~~~eA~~~l~~ll~~~p~~~~~~~~la~~~~~~g  685 (1157)
T PRK11447        607 LTLADWAQQRGDYAAARAAYQRVLTREP-GNADARLGLIEVDIAQGDLAAARAQLAKLPATANDSLNTQRRVALAWAALG  685 (1157)
T ss_pred             HHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHCCCHHHHHHHHHHHhccCCCChHHHHHHHHHHHhCC
Confidence            3344445555566666666665555432 13445555555666666666666665554431   2233344444455556


Q ss_pred             CchhhhHhhhc
Q 026720           91 RGNDAISLHRQ  101 (234)
Q Consensus        91 ~~~~a~~l~~~  101 (234)
                      +.++|..++..
T Consensus       686 ~~~eA~~~~~~  696 (1157)
T PRK11447        686 DTAAAQRTFNR  696 (1157)
T ss_pred             CHHHHHHHHHH
Confidence            66666665554

>CHL00033 ycf3 photosystem I assembly protein Ycf3

Probab=87.20  E-value=6.1  Score=28.54  Aligned_cols=87  Identities=10%  Similarity=-0.124  Sum_probs=50.4

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccch--hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLEL--DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~--~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      |..+...+...++.++|...+.........+  ...++..+-..|.+.|..++|...++....   ....+++.+...+.
T Consensus        38 ~~~~g~~~~~~g~~~~A~~~~~~al~l~~~~~~~~~~~~~lg~~~~~~g~~~eA~~~~~~Al~~~~~~~~~~~~la~i~~  117 (168)
T CHL00033         38 YYRDGMSAQSEGEYAEALQNYYEAMRLEIDPYDRSYILYNIGLIHTSNGEHTKALEYYFQALERNPFLPQALNNMAVICH  117 (168)
T ss_pred             HHHHHHHHHHcCCHHHHHHHHHHHHhccccchhhHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCcCcHHHHHHHHHHHH
Confidence            3444445555677777777777776543222  223666677777778888888777766432   12234444444444


Q ss_pred             -------hcCCchhhhHhh
Q 026720           88 -------DNSRGNDAISLH   99 (234)
Q Consensus        88 -------~~g~~~~a~~l~   99 (234)
                             ..|+.++|+..+
T Consensus       118 ~~~~~~~~~g~~~~A~~~~  136 (168)
T CHL00033        118 YRGEQAIEQGDSEIAEAWF  136 (168)
T ss_pred             HhhHHHHHcccHHHHHHHH
Confidence                   556666555444

>PRK15174 Vi polysaccharide export protein VexE; Provisional

Probab=87.10  E-value=3.2  Score=37.42  Aligned_cols=85  Identities=19%  Similarity=0.206  Sum_probs=39.4

Q ss_pred             HHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHH----HHHHHHhhcc--C-ccccHHHHHHHHHh
Q 026720           16 LVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEK----AFKVFNLMRE--K-NLQSWTIMISGLAD   88 (234)
Q Consensus        16 ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~----a~~~~~~m~~--~-~~~~~~~~i~~~~~   88 (234)
                      +..++.+.|+.++|.+.+....+... .+...+..+-..|.+.|..++    |...|+....  | +...|..+-..+.+
T Consensus       218 l~~~l~~~g~~~eA~~~~~~al~~~p-~~~~~~~~Lg~~l~~~G~~~eA~~~A~~~~~~Al~l~P~~~~a~~~lg~~l~~  296 (656)
T PRK15174        218 AVDTLCAVGKYQEAIQTGESALARGL-DGAALRRSLGLAYYQSGRSREAKLQAAEHWRHALQFNSDNVRIVTLYADALIR  296 (656)
T ss_pred             HHHHHHHCCCHHHHHHHHHHHHhcCC-CCHHHHHHHHHHHHHcCCchhhHHHHHHHHHHHHhhCCCCHHHHHHHHHHHHH
Confidence            33445555555555555555554332 123344445555555555543    3444444321  1 23344444444444


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus       297 ~g~~~eA~~~l~~  309 (656)
T PRK15174        297 TGQNEKAIPLLQQ  309 (656)
T ss_pred             CCCHHHHHHHHHH
Confidence            4555555444443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	234
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-22
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-22
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-21
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-21
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-21
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-20
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-20
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-20
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-20
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-20
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-20
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-20
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-20
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-20
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-20
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-20
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-20
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-20
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-20
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-20
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-20
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-20
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-20
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-20
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-20
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-20
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-20
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-20
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-19
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-19
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-19
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-19
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-19
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-19
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-19
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-19
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-19
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-19
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-19
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-19
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-19
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-19
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-19
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-19
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-19
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-19
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-19
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-19
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-19
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-19
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-19
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-19
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-19
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-19
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-19
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-19
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-19
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-19
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-19
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-19
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-19
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-19
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-19
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-19
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-19
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-19
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-19
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-19
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-19
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-19
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-19
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-19
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-19
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-19
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-19
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-19
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-19
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-19
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-19
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-19
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-19
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-19
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-19
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-19
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-19
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-19
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-19
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-19
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-19
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-19
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-19
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-19
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-19
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-19
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-19
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-19
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-19
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-19
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-19
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-19
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-19
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-19
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-18
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-18
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-18
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-18
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-18
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-18
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-18
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-18
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-18
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-18
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-18
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-18
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-18
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-18
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-18
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-18
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-18
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-18
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-18
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-17
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-17
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-17
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-17
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-17
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-17
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-17
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-17
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-17
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-17
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-16
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-16
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-16
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-16
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-15
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-08
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-08
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-08
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-08
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-08
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-08
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-08
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-08
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-08
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-08
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-08
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-08
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-08
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-05
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-05
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-05
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-05
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		9e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		9e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-04
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-04
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-04
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-04
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-04
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-04
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-04
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-04
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-04
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-04
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-04
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-04
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-04
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-04
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-04
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-04
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-04
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-04
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-04
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-04
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-04
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-04
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-04
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-04
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-04
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-04
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-04
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-04
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-04
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-04
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-04
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-04
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-04
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-04
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-04

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 51/123 (41%), Positives = 73/123 (59%), Gaps = 2/123 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-NLPCTDYVTTRWYRGPEVLLFS 155
           LH+    HRDLKP+NLL+ + GV+K+ D G+ K   S N      V TRWYR PE+L  +
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
            +YG  VD WA+G I+ E+L      PG S  DQ+ +I + +G+PT++ WP    L   +
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247
Query: 216 NWK 218
            +K
Sbjct: 248 TFK 250

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  100 bits (248), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 80/138 (57%), Gaps = 6/138 (4%)
Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           HRQ   HRDLKP NLL++ +G +K+ D G+ +    ++P   Y   V T WYR P++LL 
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
           S  Y  ++D W +G I +EM +   LFPG +  +Q++ I +++G+PT+++WP  +     
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 215 LNWKLPQMGGVNLLAVMP 232
             +  P+     LL+  P
Sbjct: 235 KTYNYPKYRAEALLSHAP 252

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/143 (39%), Positives = 81/143 (56%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL+ +   +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++    GI L 
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLK 261
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 262 ARNYLLSLPHKNKVPWNRLFPNA 284

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 71/137 (51%), Gaps = 5/137 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV S G +K+ D G+ +     +  T  V T WYR PEVLL S 
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS- 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G I  EM     LF G S ADQ+ KI  LIG P +D WP  + L     
Sbjct: 195 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-- 252
Query: 217 WKLPQMGGVNLLAVMPS 233
              P  G   + +V+P 
Sbjct: 253 -AFPPRGPRPVQSVVPE 268

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 235
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 236 YKPSFPKWARQDFSKVVP 253

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 235
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 236 YKPSFPKWARQDFSKVVP 253

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 235
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 236 YKPSFPKWARQDFSKVVP 253

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 235
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 236 YKPSFPKWARQDFSKVVP 253

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 237
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 238 YKPSFPKWARQDFSKVVP 255

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 235
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 236 YKPSFPKWARQDFSKVVP 253

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 237
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 238 YKPSFPKWARQDFSKVVP 255

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 238
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 239 YKPSFPKWARQDFSKVVP 256

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 237
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 238 YKPSFPKWARQDFSKVVP 255

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 70/137 (51%), Gaps = 5/137 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV S G +K+ D G+ +     +     V T WYR PEVLL S 
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQS- 186
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G I  EM     LF G S ADQ+ KI  LIG P +D WP  + L     
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-- 244
Query: 217 WKLPQMGGVNLLAVMPS 233
              P  G   + +V+P 
Sbjct: 245 -AFPPRGPRPVQSVVPE 260

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 237
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 238 YKPSFPKWARQDFSKVVP 255

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 235
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 236 YKPSFPKWARQDFSKVVP 253

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 236
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 237 YKPSFPKWARQDFSKVVP 254

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 239
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 240 YKPSFPKWARQDFSKVVP 257

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 239
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 240 YKPSFPKWARQDFSKVVP 257

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 238
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 239 YKPSFPKWARQDFSKVVP 256

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 123 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 239
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 240 YKPSFPKWARQDFSKVVP 257

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 181
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 240
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 241 YKPSFPKWARQDFSKVVP 258

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 239
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 240 YKPSFPKWARQDFSKVVP 257

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 237
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 238 YKPSFPKWARQDFSKVVP 255

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 181
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 240
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 241 YKPSFPKWARQDFSKVVP 258

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 238
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 239 YKPSFPKWARQDFSKVVP 256

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 184
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 243
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 244 YKPSFPKWARQDFSKVVP 261

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 239
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 240 YKPSFPKWARQDFSKVVP 257

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 238
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 239 YKPSFPKWARQDFSKVVP 256

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 239
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 240 YKPSFPKWARQDFSKVVP 257

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 261
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 262 ARNYLLSLPHKNKVPWNRLFPNA 284

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLK 259
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNA 282

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 75/138 (54%), Gaps = 7/138 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL+ ++G IK+ D G+ +     +P   Y   V T WYR PE+LL 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 184
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
            + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    +
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPD 243
Query: 215 LNWKLPQMGGVNLLAVMP 232
                P+    +   V+P
Sbjct: 244 YKPSFPKWARQDFSKVVP 261

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 70/137 (51%), Gaps = 5/137 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV S G +K+ D G+ +     +     V T WYR PEVLL S 
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQS- 186
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G I  EM     LF G S ADQ+ KI  LIG P +D WP  + L     
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-- 244
Query: 217 WKLPQMGGVNLLAVMPS 233
              P  G   + +V+P 
Sbjct: 245 -AFPPRGPRPVQSVVPE 260

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 261
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 262 ARNYLLSLPHKNKVPWNRLFPNA 284

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNA 282

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLK 259
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNA 282

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 257
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 258 ARNYLLSLPHKNKVPWNRLFPNA 280

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 264
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 265 ARNYLLSLPHKNKVPWNRLFPNA 287

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 146 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 265
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 266 ARNYLLSLPHKNKVPWNRLFPNA 288

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 137 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 256
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 257 ARNYLLSLPHKNKVPWNRLFPNA 279

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNA 286

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNA 286

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 148 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 267
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 268 ARNYLLSLPHKNKVPWNRLFPNA 290

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNA 282

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNA 282

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 279
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 280 ARNYLLSLPHKNKVPWNRLFPNA 302

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNA 286

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 279
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 280 ARNYLLSLPHKNKVPWNRLFPNA 302

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNA 286

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 70/137 (51%), Gaps = 5/137 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV S G +K+ D G+ +     +     V T WYR PEVLL S 
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQS- 186
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G I  EM     LF G S ADQ+ KI  LIG P +D WP  + L     
Sbjct: 187 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG-- 244
Query: 217 WKLPQMGGVNLLAVMPS 233
              P  G   + +V+P 
Sbjct: 245 -AFPPRGPRPVQSVVPE 260

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 80/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNA 286

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 79/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP ++     I L 
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLK 257
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 258 ARNYLLSLPHKNKVPWNRLFPNA 280

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 46/112 (41%), Positives = 69/112 (61%), Gaps = 6/112 (5%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H +   HRDLKP NLL+++ G +KI D G+ +     +P   Y   V T WYR P+VL+ 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S+ Y   +D W++G I  EM++   LFPG S ADQ+ +I +++G+P   +WP
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWP 226

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 54/122 (44%), Positives = 67/122 (54%), Gaps = 4/122 (3%)
Query: 91  RGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP 149
           RG D +  HR    HRDLKP N+LV S G IK+ D G+ +     +  T  V T WYR P
Sbjct: 131 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
           EVLL S  Y   VD W++G I  EM     LF G S  DQ+ KI  +IG P ++ WP  +
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 210 QL 211
            L
Sbjct: 248 AL 249

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 54/122 (44%), Positives = 67/122 (54%), Gaps = 4/122 (3%)
Query: 91  RGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP 149
           RG D +  HR    HRDLKP N+LV S G IK+ D G+ +     +  T  V T WYR P
Sbjct: 131 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
           EVLL S  Y   VD W++G I  EM     LF G S  DQ+ KI  +IG P ++ WP  +
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 210 QL 211
            L
Sbjct: 248 AL 249

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 54/122 (44%), Positives = 67/122 (54%), Gaps = 4/122 (3%)
Query: 91  RGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP 149
           RG D +  HR    HRDLKP N+LV S G IK+ D G+ +     +  T  V T WYR P
Sbjct: 131 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
           EVLL S  Y   VD W++G I  EM     LF G S  DQ+ KI  +IG P ++ WP  +
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 210 QL 211
            L
Sbjct: 248 AL 249

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 46/112 (41%), Positives = 69/112 (61%), Gaps = 6/112 (5%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H +   HRDLKP NLL+++ G +KI D G+ +     +P   Y   V T WYR P+VL+ 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMG 174
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S+ Y   +D W++G I  EM++   LFPG S ADQ+ +I +++G+P   +WP
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 45/112 (40%), Positives = 69/112 (61%), Gaps = 6/112 (5%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H +   HRDLKP NLL+++ G +KI D G+ +     +P   Y   + T WYR P+VL+ 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S+ Y   +D W++G I  EM++   LFPG S ADQ+ +I +++G+P   +WP
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 75/136 (55%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L + 
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNAM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/142 (37%), Positives = 74/142 (52%), Gaps = 12/142 (8%)
Query: 99  HRQGYFHRDLKPSNLLVS------KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGP 149
           H +   HRDLKP NLL+S        V+KIGD G+ +     +P   +   + T WYR P
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPP 206
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
           E+LL S  Y   VD W++  I  EML    LFPG S  DQ++KI +++G P   +WP G+
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP-GV 265
Query: 210 QLASNLNWKLPQMGGVNLLAVM 231
               +     P+  G  L  V+
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVL 287

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 44/107 (41%), Positives = 67/107 (62%), Gaps = 3/107 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKPSN+ V++   ++I D G+ ++ D  +  T YV TRWYR PE++L   
Sbjct: 139 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWM 196
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM E+L    LFPG    DQ+ +I +++G+P+ +
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 243

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/143 (38%), Positives = 79/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDY----VTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +   T +    V TRWYR PE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNA 286

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/143 (38%), Positives = 79/143 (55%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDY----VTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +  D +   T +    V TRWYR PE++
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L 
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 264
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 265 ARNYLLSLPHKNKVPWNRLFPNA 287

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/139 (39%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V++   +KI D G+ +  D+ +  T YV TRWYR PEV+L   
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILSWM 199
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP-TKDSWPLGIQLASNL 215
            Y   VD W++G IM EML+   LF GK   DQ+ +I ++ G P T+    L  + A + 
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259
Query: 216 NWKLPQMGGVNLLAVMPSA 234
              LPQ    +   + P A
Sbjct: 260 IQSLPQTPRKDFTQLFPRA 278

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/139 (39%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V++   +KI D G+ +  D+ +  T YV TRWYR PEV+L   
Sbjct: 160 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILSWM 217
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP-TKDSWPLGIQLASNL 215
            Y   VD W++G IM EML+   LF GK   DQ+ +I ++ G P T+    L  + A + 
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277
Query: 216 NWKLPQMGGVNLLAVMPSA 234
              LPQ    +   + P A
Sbjct: 278 IQSLPQTPRKDFTQLFPRA 296

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 44/107 (41%), Positives = 67/107 (62%), Gaps = 3/107 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKPSN+ V++   ++I D G+ ++ D  +  T YV TRWYR PE++L   
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWM 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM E+L    LFPG    DQ+ +I +++G+P+ +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 44/107 (41%), Positives = 67/107 (62%), Gaps = 3/107 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKPSN+ V++   ++I D G+ ++ D  +  T YV TRWYR PE++L   
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWM 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM E+L    LFPG    DQ+ +I +++G+P+ +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 66/107 (61%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P+ +
Sbjct: 201 GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 66/107 (61%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P+ +
Sbjct: 201 GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 265 IQSLAQMPKMNFANVF 280

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 265 IQSLTQMPKMNFANVF 280

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 208
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 268
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 269 IQSLAQMPKMNFANVF 284

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLAQMPKMNFANVF 274

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 255 IQSLAQMPKMNFANVF 270

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 66/107 (61%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P+ +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 203
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 264 IQSLTQMPKMNFANVF 279

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 265 IQSLTQMPKMNFANVF 280

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 66/107 (61%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P+ +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 203
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 264 IQSLTQMPKMNFANVF 279

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 195
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 255
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 256 IQSLTQMPKMNFANVF 271

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 197
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 257
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 258 IQSLTQMPKMNFANVF 273

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 266 IQSLTQMPKMNFANVF 281

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 255 IQSLAQMPKMNFANVF 270

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 255 IQSLTQMPKMNFANVF 270

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 217
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 277
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 278 IQSLAQMPKMNFANVF 293

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 203
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 264 IQSLTQMPKMNFANVF 279

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 196
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 256
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 257 IQSLTQMPKMNFANVF 272

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 210
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 270
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 271 IQSLTQMPKMNFANVF 286

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 210
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 270
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 271 IQSLTQMPKMNFANVF 286

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 218
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 279 IQSLAQMPKMNFANVF 294

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 46/112 (41%), Positives = 65/112 (58%), Gaps = 6/112 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H+    HRDLKP NLL+ S G +K+ D G+ +     +P   Y   V T WYR P+VL+ 
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S+ Y   VD W++G I  EM++   LFPG +  DQ+ KI  ++G+P    WP
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 261 IQSLTQMPKMNFANVF 276

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 46/112 (41%), Positives = 65/112 (58%), Gaps = 6/112 (5%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H+    HRDLKP NLL+ S G +K+ D G+ +     +P   Y   V T WYR P+VL+ 
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S+ Y   VD W++G I  EM++   LFPG +  DQ+ KI  ++G+P    WP
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 210
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 270
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 271 IQSLTQMPKMNFANVF 286

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 203
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 264 IQSLTQMPKMNFANVF 279

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 261 IQSLTQMPKMNFANVF 276

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 195
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 255
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 256 IQSLTQMPKMNFANVF 271

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 218
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 279 IQSLTQMPKMNFANVF 294

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 209
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 269
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 270 IQSLTQMPKMNFANVF 285

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 261 IQSLTQMPKMNFANVF 276

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 217
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 277
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 278 IQSLTQMPKMNFANVF 293

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 221
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 281
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 282 IQSLTQMPKMNFANVF 297

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 66/107 (61%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P+ +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 54/143 (37%), Positives = 78/143 (54%), Gaps = 6/143 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVK----EIDSNLPCTDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL++    +KI D G+ +    E D     T+ V TRWYR PE++
Sbjct: 160 IHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL- 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I + 
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMK 279
Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P +
Sbjct: 280 ARNYLQSLPSKTKVAWAKLFPKS 302

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 265 IQSLTQMPKMNFANVF 280

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 209
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 269
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 270 IQSLTQMPKMNFANVF 285

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 261 ENRPKYAGLTFPKLFPDS 278

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 261 IQSLTQMPKMNFANVF 276

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 261 ENRPKYAGLTFPKLFPDS 278

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 238
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 299 ENRPKYAGLTFPKLFPDS 316

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 238
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 299 ENRPKYAGLTFPKLFPDS 316

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 261 ENRPKYAGLTFPKLFPDS 278

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 195 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 254
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 255 ENRPKYAGLTFPKLFPDS 272

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 261 ENRPKYAGLTFPKLFPDS 278

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 261 ENRPKYAGLTFPKLFPDS 278

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 193
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 254 ENRPKYAGLTFPKLFPDS 271

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 202 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 261
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 262 ENRPKYAGLTFPKLFPDS 279

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 202 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 261
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 262 ENRPKYAGLTFPKLFPDS 279

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 261 ENRPKYAGLTFPKLFPDS 278

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 195 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 254
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 255 ENRPKYAGLTFPKLFPDS 272

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 141 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 199
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 200 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 259
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 260 ENRPKYAGLTFPKLFPDS 277

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 193
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 254 ENRPKYAGLTFPKLFPDS 271

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 66/107 (61%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P+ +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 66/107 (61%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P+ +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 72/136 (52%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 227
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-LGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    +Q+ +I +L G+P       +    A N 
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNY 287
Query: 216 NWKLPQMGGVNLLAVM 231
              LPQM   N   V 
Sbjct: 288 INSLPQMPKRNFADVF 303

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/136 (38%), Positives = 74/136 (54%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/136 (38%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +    YV TRWYR PE++L   
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGYVATRWYRAPEIMLNWM 221
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 281
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 282 IQSLTQMPKMNFANVF 297

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 47/104 (45%), Positives = 64/104 (61%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P
Sbjct: 202 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 47/104 (45%), Positives = 64/104 (61%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/104 (45%), Positives = 64/104 (61%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 147 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P
Sbjct: 206 GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 249

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/104 (45%), Positives = 64/104 (61%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P
Sbjct: 195 GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 238

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/110 (41%), Positives = 66/110 (60%), Gaps = 6/110 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-----DSNLPCTDYVTTRWYRGPEV 151
           +H     HRDLKPSNLLV++   +KIGD GM + +     +     T+YV TRWYR PE+
Sbjct: 174 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
           +L    Y   +D W++G I  EML+   LFPGK+   Q+  I  ++G+P+
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/136 (38%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +     +  T YV TRWYR PE++L   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIMLNWM 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 266 IQSLTQMPKMNFANVF 281

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 65/112 (58%), Gaps = 6/112 (5%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLLF 154
           H     HRDLKP NLL++K G +K+GD G+ +     +P   +   V T WYR P+VL+ 
Sbjct: 125 HENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           S  Y   +D W+ G I+ EM++   LFPG +  +Q+  I  ++G+P +  WP
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/136 (38%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +     +  T YV TRWYR PE++L   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIMLNWM 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 266 IQSLTQMPKMNFANVF 281

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/136 (38%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D  + +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/136 (38%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +     +  T YV TRWYR PE++L   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIMLNWM 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 266 IQSLTQMPKMNFANVF 281

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +    +V TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLAQMPKMNFANVF 274

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/136 (38%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +  T  V TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGXVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/136 (38%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI   G+ +  D  +  T YV TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 46/110 (41%), Positives = 66/110 (60%), Gaps = 6/110 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-----DSNLPCTDYVTTRWYRGPEV 151
           +H     HRDLKPSNLLV++   +KIGD GM + +     +     T+YV TRWYR PE+
Sbjct: 175 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
           +L    Y   +D W++G I  EML+   LFPGK+   Q+  I  ++G+P+
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 284

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +    +V TRWYR PE++L   
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLNWM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 259 IQSLTQMPKMNFANVF 274

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 73/136 (53%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +    +V TRWYR PE++L   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLNWM 194
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 255 IQSLAQMPKMNFANVF 270

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 42/111 (37%), Positives = 68/111 (61%), Gaps = 3/111 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFSE 156
           H +   HRDLKP NLL+++ G +K+ + G+ +     + C +  V T WYR P+VL  ++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 157 IYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
           +Y   +D W+ G I  E+ + G  LFPG    DQ+ +I +L+G+PT++ WP
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 42/111 (37%), Positives = 67/111 (60%), Gaps = 3/111 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFSE 156
           H +   HRDLKP NLL+++ G +K+ D G+ +     + C +  V T WYR P+VL  ++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 157 IYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
           +Y   +D W+ G I  E+ +    LFPG    DQ+ +I +L+G+PT++ WP
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 46/106 (43%), Positives = 64/106 (60%), Gaps = 8/106 (7%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY----VTTRWYRGPEVLL 153
           H+    HRD+KP N+L++K  VIK+ D G  + +      +DY    V TRWYR PE+L+
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP---SDYYDDEVATRWYRSPELLV 175
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS 199
               YGP VD WA+G +  E+LS   L+PGKS  DQ+Y I + +G 
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 72/136 (52%), Gaps = 4/136 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V++   +KI D G+ +  D  +     V TRWYR PE++L   
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGXVATRWYRAPEIMLNWM 218
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW-PLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 216 NWKLPQMGGVNLLAVM 231
              L QM  +N   V 
Sbjct: 279 IQSLAQMPKMNFANVF 294

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 45/104 (43%), Positives = 63/104 (60%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++     +V TR+YR PEV+L   
Sbjct: 144 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL-GM 202
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P
Sbjct: 203 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 246

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 46/104 (44%), Positives = 63/104 (60%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T  V TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 71/130 (54%), Gaps = 23/130 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGM------VKEIDSNLPC------------- 137
           LH  G  HRD+KPSN+L++    +K+ D G+      ++ + +N+P              
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 138 ---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
              TDYV TRWYR PE+LL S  Y   +D W++G I+ E+L    +FPG S+ +Q+ +I 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 195 QLIGSPTKDS 204
            +I  P+ + 
Sbjct: 245 GVIDFPSNED 254

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 68/109 (62%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLLV+     +K+ D G  K++  + P    + +R+YR PE++L +
Sbjct: 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGA 216
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y P +D W++G +  E++    LF G++S DQ+ +I Q++G+PTK+ 
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 2/108 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 143 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 202
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 250

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 2/108 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 2/108 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 166 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 225
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 273

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 2/108 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 176 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 235
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 283

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 2/108 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 217 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 276
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 324

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 44/107 (41%), Positives = 64/107 (59%), Gaps = 2/107 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   +N   T YV TR+YR PEV+L   
Sbjct: 140 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL-GM 198
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
            Y   VD W++G IM E++   ++F G    DQ  K+ + +G+P+ +
Sbjct: 199 GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 245

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 71/137 (51%), Gaps = 2/137 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   +N   T YV TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM E++   ++F G    DQ  K+ + +G+P+ +          N  
Sbjct: 201 GYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 260
Query: 217 WKLPQMGGVNLLAVMPS 233
              P+  G+    + P 
Sbjct: 261 ENRPKYPGIKFEELFPD 277

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 65/108 (60%), Gaps = 2/108 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 174 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 233
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 281

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 65/109 (59%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 65/109 (59%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 151 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 210
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 259

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 65/109 (59%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 65/109 (59%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 44/103 (42%), Positives = 60/103 (58%), Gaps = 2/103 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFSE 156
           H     HRD+KP N+LVS+ GV+K+ D G  + + +      D V TRWYR PE+L+   
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS 199
            YG  VD WA+G ++ EM     LFPG S  DQ+Y I   +G+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V++   +KI D G+ ++ DS +     V TRWYR PEV+L   
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGX--VVTRWYRAPEVILNWM 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-SWPLGIQLASNL 215
            Y   VD W++G IM EM++   LF G    DQ+ +I ++ G+P  +    L    A N 
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 216 NWKLPQMGGVNLLAVMPSA 234
              LP++   +  +++ +A
Sbjct: 262 MKGLPELEKKDFASILTNA 280

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 45/104 (43%), Positives = 62/104 (59%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++      V TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P
Sbjct: 201 GYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 45/104 (43%), Positives = 62/104 (59%), Gaps = 2/104 (1%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++      V TR+YR PEV+L   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL-GM 200
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P
Sbjct: 201 GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/119 (37%), Positives = 64/119 (53%), Gaps = 12/119 (10%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP-----------CTDYVTTRW 145
           LH     HRDLKPSNLL++    +K+ D G+ + ID +              T+YV TRW
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
           YR PEV+L S  Y   +D W+ G I+ E+     +FPG+    Q+  I  +IG+P  D+
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 73/127 (57%), Gaps = 4/127 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+    GV+K+ D G  K + +  P    + +R+YR PE++  +
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGA 216
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             Y   +D W+ G +M E++    LFPG+S  DQ+ +I +++G+P+++   +     + +
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ--IKTMNPNYM 274
Query: 216 NWKLPQM 222
             K PQ+
Sbjct: 275 EHKFPQI 281

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 44/115 (38%), Positives = 63/115 (54%), Gaps = 6/115 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK--EIDSNLPCTDY---VTTRWYRGPEV 151
           +HR    HRD+K +N+L+++ GV+K+ D G+ +   +  N     Y   V T WYR PE+
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           LL    YGP +D W  G IM EM +   +  G +   Q+  I QL GS T + WP
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 44/115 (38%), Positives = 63/115 (54%), Gaps = 6/115 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK--EIDSNLPCTDY---VTTRWYRGPEV 151
           +HR    HRD+K +N+L+++ GV+K+ D G+ +   +  N     Y   V T WYR PE+
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           LL    YGP +D W  G IM EM +   +  G +   Q+  I QL GS T + WP
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 44/115 (38%), Positives = 63/115 (54%), Gaps = 6/115 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK--EIDSNLPCTDY---VTTRWYRGPEV 151
           +HR    HRD+K +N+L+++ GV+K+ D G+ +   +  N     Y   V T WYR PE+
Sbjct: 140 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 199
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           LL    YGP +D W  G IM EM +   +  G +   Q+  I QL GS T + WP
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 44/115 (38%), Positives = 63/115 (54%), Gaps = 6/115 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK--EIDSNLPCTDY---VTTRWYRGPEV 151
           +HR    HRD+K +N+L+++ GV+K+ D G+ +   +  N     Y   V T WYR PE+
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           LL    YGP +D W  G IM EM +   +  G +   Q+  I QL GS T + WP
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 64/108 (59%), Gaps = 2/108 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 231
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 142 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 201
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 250

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 157 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 216
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 265

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 146 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 205
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 254

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 139 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 198
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 247

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 2/109 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P    + +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 66/101 (65%), Gaps = 2/101 (1%)
Query: 105 HRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           HRD+KP N+LV++  G +K+ D G  K++  + P   Y+ +R+YR PE++  ++ Y   V
Sbjct: 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAV 213
Query: 163 DKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
           D W++G I  EM+    +F G +SA Q+++I +++G P+++
Sbjct: 214 DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 1/104 (0%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDL P N LL     I I D  + +E  ++   T YVT RWYR PE+++  +
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            +   VD W+ G +M EM +   LF G +  +Q+ KI +++G+P
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 1/104 (0%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDL P N LL     I I D  + +E  ++   T YVT RWYR PE+++  +
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
            +   VD W+ G +M EM +   LF G +  +Q+ KI +++G+P
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 44/119 (36%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP-----------CTDYVTTRW 145
           LH     HRDLKPSNLL++    +K+ D G+ + ID +              T+ V TRW
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
           YR PEV+L S  Y   +D W+ G I+ E+     +FPG+    Q+  I  +IG+P  D+
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 63/119 (52%), Gaps = 12/119 (10%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLP-----------CTDYVTTRW 145
           LH     HRDLKPSNLL++    +K+ D G+ + ID +               ++V TRW
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
           YR PEV+L S  Y   +D W+ G I+ E+     +FPG+    Q+  I  +IG+P  D+
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 67/201 (33%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI----DSNL----------------- 135
           +H  G  HRDLKP+N L+++   +K+ D G+ + I    D+N+                 
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 136 --PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF-----------GILFP 182
               T +V TRWYR PE++L  E Y   +D W+ G I  E+L+              LFP
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 183 G-----------------KSSADQIYKICQLIGSPTKDSW-----PLGIQLAS------- 213
           G                 KS+ DQ+  I  +IG+PT+D       P  I+          
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 214 -NLNWKLPQMG--GVNLLAVM 231
            NL  K P +   G+NLL  M
Sbjct: 325 INLKQKYPSISDDGINLLESM 345

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 61/198 (30%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEID------SNLPC------------- 137
           +H  G  HRDLKP+N LV++   +K+ D G+ + +D      S LP              
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 138 ---------TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF----------- 177
                    T +V TRWYR PE++L  E Y   +D W++G I  E+L+            
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 178 GILFPGKS--------------------SADQIYKICQLIGSPT-KDSWPLGIQLASNLN 216
           G LFPG S                    + DQ+  I  ++G+P+ +D   L  + A    
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351
Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G +L    P++
Sbjct: 352 RIFPKREGTDLAERFPAS 369

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 63/126 (50%), Gaps = 18/126 (14%)
Query: 98  LHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSNL-PCTDY---VTTRWYRG 148
           LH     HRDLKP+N+LV      +G +KI D+G  +  +S L P  D    V T WYR 
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---------ADQIYKICQLIGS 199
           PE+LL +  Y   +D WA+G I  E+L+   +F  +            DQ+ +I  ++G 
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
Query: 200 PTKDSW 205
           P    W
Sbjct: 264 PADKDW 269

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSNLPCTDYVT----TRWYRGPEV 151
           +H     HRDLKP+NL ++    V+KIGD G+ + +D +     +++    T+WYR P +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
           LL    Y   +D WA G I  EML+   LF G    +Q+  I + I
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 55/162 (33%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPC------------------- 137
           +H  G  HRDLKP+N L+++   +KI D G+ + I+S+                      
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 138 -------TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGI----------- 179
                  T +V TRWYR PE++L  E Y   +D W+ G I  E+L+              
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 180 LFPG-----------------KSSADQIYKICQLIGSPTKDS 204
           LFPG                 KS+ DQ+  I  +IG+P ++ 
Sbjct: 267 LFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEED 308

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 78/145 (53%), Gaps = 12/145 (8%)
Query: 64  AFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIG 123
           +  ++ L+++   Q +++ +     +S      +LH+    H DLKP N+L+ +     G
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ----G 237
Query: 124 DLGMVKEIDSNLPCTDY------VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
             G +K ID    C ++      + +R+YR PEV+L +  YG  +D W++G I+ E+L+ 
Sbjct: 238 RSG-IKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTG 295
Query: 178 GILFPGKSSADQIYKICQLIGSPTK 202
             L PG+   DQ+  + +L+G P++
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQ 320

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 78/145 (53%), Gaps = 12/145 (8%)
Query: 64  AFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIG 123
           +  ++ L+++   Q +++ +     +S      +LH+    H DLKP N+L+ +     G
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ----G 237
Query: 124 DLGMVKEIDSNLPCTDY------VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
             G +K ID    C ++      + +R+YR PEV+L +  YG  +D W++G I+ E+L+ 
Sbjct: 238 RSG-IKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTG 295
Query: 178 GILFPGKSSADQIYKICQLIGSPTK 202
             L PG+   DQ+  + +L+G P++
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQ 320

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 12/145 (8%)
Query: 64  AFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIG 123
           +  ++ L+++   Q +++ +     +S      +LH+    H DLKP N+L+ +     G
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ----G 237
Query: 124 DLGMVKEIDSNLPCTDY------VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
             G +K ID    C ++      + +R+YR PEV+L +  YG  +D W++G I+ E+L+ 
Sbjct: 238 RSG-IKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTG 295
Query: 178 GILFPGKSSADQIYKICQLIGSPTK 202
             L PG+   DQ+  + +L+G P +
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPXQ 320

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH     HRDLKP N+++  G    + KI DLG  KE+D    CT++V T  Y  PE LL
Sbjct: 138 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE-LL 196
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS-FGILFP 182
             + Y   VD W+ G + FE ++ F    P
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH     HRDLKP N+++  G    + KI DLG  KE+D    CT++V T  Y  PE LL
Sbjct: 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE-LL 195
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS-FGILFP 182
             + Y   VD W+ G + FE ++ F    P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 67/132 (50%), Gaps = 15/132 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV---IKIGDLGMVKEIDSNLPCTDY--VTTR----WYRG 148
           LH QG  HRD+KP N L S      IK+ D G+ KE    L   +Y  +TT+    ++  
Sbjct: 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF-YKLNNGEYYGMTTKAGTPYFVA 242
Query: 149 PEVL-LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ---LIGSPTKDS 204
           PEVL   +E YGP+ D W+ G ++  +L   + FPG + AD I ++        +P  + 
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV 302
Query: 205 W-PLGIQLASNL 215
             PL   L SNL
Sbjct: 303 LSPLARDLLSNL 314

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 73/139 (52%), Gaps = 11/139 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++G  +RDLKP N++++ +G +K+ D G+ KE I        +  T  Y  PE+L+ S
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI--CQLIGSPTKDSWPLGIQLAS 213
             +   VD W++GA+M++ML+    F G++    I KI  C+L      +  P   Q A 
Sbjct: 197 G-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------NLPPYLTQEAR 249
Query: 214 NLNWKLPQMGGVNLLAVMP 232
           +L  KL +    + L   P
Sbjct: 250 DLLKKLLKRNAASRLGAGP 268

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 73/139 (52%), Gaps = 11/139 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++G  +RDLKP N++++ +G +K+ D G+ KE I        +  T  Y  PE+L+ S
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI--CQLIGSPTKDSWPLGIQLAS 213
             +   VD W++GA+M++ML+    F G++    I KI  C+L      +  P   Q A 
Sbjct: 197 G-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------NLPPYLTQEAR 249
Query: 214 NLNWKLPQMGGVNLLAVMP 232
           +L  KL +    + L   P
Sbjct: 250 DLLKKLLKRNAASRLGAGP 268

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 105 HRDLKPSNLLV---SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPE 161
           H DLKP N+L+    +  IKI D G   ++   +     + +R+YR PEVLL    Y   
Sbjct: 163 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQXIQSRFYRSPEVLL-GMPYDLA 219
Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
           +D W++G I+ EM +   LF G +  DQ+ KI +++G P
Sbjct: 220 IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 258

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 105 HRDLKPSNLLV---SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPE 161
           H DLKP N+L+    +  IKI D G   ++   +     + +R+YR PEVLL    Y   
Sbjct: 182 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQXIQSRFYRSPEVLL-GMPYDLA 238
Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
           +D W++G I+ EM +   LF G +  DQ+ KI +++G P
Sbjct: 239 IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 105 HRDLKPSNLLV---SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPE 161
           H DLKP N+L+    +  IKI D G   ++   +     + +R+YR PEVLL    Y   
Sbjct: 182 HCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRI--YQXIQSRFYRSPEVLL-GMPYDLA 238
Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
           +D W++G I+ EM +   LF G +  DQ+ KI +++G P
Sbjct: 239 IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 63/131 (48%), Gaps = 25/131 (19%)
Query: 69  NLMREKNLQSWTIMISGLADNSRG---------NDAIS-LHRQGYFHRDLKPSNLLVS-K 117
            L R++NL+ W      L D   G          +A+  LH +G  HRDLKPSN+  +  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 118 GVIKIGDLGMVKEIDSN-------LPCTDYVT------TRWYRGPEVLLFSEIYGPEVDK 164
            V+K+GD G+V  +D +        P   Y T      T+ Y  PE  +    Y  +VD 
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ-IHGNNYSHKVDI 259
Query: 165 WAMGAIMFEML 175
           +++G I+FE+L
Sbjct: 260 FSLGLILFELL 270

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+  +G  K+ D GM KE I + +    +  T  Y  PE+L   
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ-E 198
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD 188
            +YGP VD WAMG +++EML     F  ++  D
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 59/97 (60%), Gaps = 4/97 (4%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++G  +RDLK  N+++ S+G IKI D GM KE +   +   ++  T  Y  PE++ + 
Sbjct: 136 LHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAY- 194
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           + YG  VD WA G +++EML+    F G+   D++++
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQ 230

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 63/107 (58%), Gaps = 9/107 (8%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           H +G  HRD+KP N+++   +  +++ D G+ +      P  +Y   V +R+++GPE+L+
Sbjct: 149 HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH---PAQEYNVRVASRYFKGPELLV 205
Query: 154 FSEIYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
             ++Y   +D W++G ++  M+      F G+ + DQ+ +I +++G+
Sbjct: 206 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT 252

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 19/141 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ S+G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR-G 195
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS---PTKDSWPLGIQLA 212
           E YG  VD WA+G +MFEM++      G+S  D       ++GS   P +++     Q+ 
Sbjct: 196 EDYGFSVDWWALGVLMFEMMA------GRSPFD-------IVGSSDNPDQNTEDYLFQVI 242
Query: 213 SNLNWKLPQMGGVNLLAVMPS 233
                ++P+   V   +V+ S
Sbjct: 243 LEKQIRIPRSMSVKAASVLKS 263

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 70/130 (53%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R+ Y HRDL+ +N+LVS+ ++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 126 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN----EYTAREGAKFPIKW-TAP 180
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + F   +  + D W+ G +++E++++G I +PG+++AD +  + Q    P  ++ P  
Sbjct: 181 EAINFG-CFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDE 239
Query: 209 IQLASNLNWK 218
           +     + WK
Sbjct: 240 LYDIMKMCWK 249

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 11/106 (10%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ S+G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-G 227
Query: 156 EIYGPEVDKWAMGAIMFEMLS----FGIL----FPGKSSADQIYKI 193
           E YG  VD WA+G +MFEM++    F I+     P +++ D ++++
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 63/107 (58%), Gaps = 9/107 (8%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           H +G  HRD+KP N+++   +  +++ D G+ +      P  +Y   V +R+++GPE+L+
Sbjct: 154 HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYH---PAQEYNVRVASRYFKGPELLV 210
Query: 154 FSEIYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
             ++Y   +D W++G ++  M+      F G+ + DQ+ +I +++G+
Sbjct: 211 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT 257

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 11/106 (10%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ S+G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR-G 180
Query: 156 EIYGPEVDKWAMGAIMFEMLS----FGIL----FPGKSSADQIYKI 193
           E YG  VD WA+G +MFEM++    F I+     P +++ D ++++
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 226

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 61/106 (57%), Gaps = 11/106 (10%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ S+G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR-G 184
Query: 156 EIYGPEVDKWAMGAIMFEMLS----FGIL----FPGKSSADQIYKI 193
           E YG  VD WA+G +MFEM++    F I+     P +++ D ++++
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH  G  +RDLKP N+L+  +G IK+ D G+ KE ID       +  T  Y  PEV+   
Sbjct: 146 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN-R 204
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           + +    D W+ G +MFEML+  + F GK   + +  I +
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILK 244

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 58/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 99  ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 158
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T+   T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 159 LTDFGFAKETTSHNSLTEPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 211

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH  G  +RDLKP N+L+  +G IK+ D G+ KE ID       +  T  Y  PEV+   
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NR 201
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
             +    D W+ G +MFEML+  + F GK   + +  I +
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 241

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH  G  +RDLKP N+L+  +G IK+ D G+ KE ID       +  T  Y  PEV+   
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NR 200
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
             +    D W+ G +MFEML+  + F GK   + +  I +
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 90  SRGNDAISLHRQGYFHRDLKPSNL-LVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG 148
           ++G D I  H +   HRDLKPSN+ LV    +KIGD G+V  + ++   T    T  Y  
Sbjct: 146 TKGVDYI--HSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEML 175
           PE +  S+ YG EVD +A+G I+ E+L
Sbjct: 204 PEQIS-SQDYGKEVDLYALGLILAELL 229

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 97  SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
           S+H+  Y HRD+KP N+L+   G I++ D G   ++  D  +  +  V T  Y  PE+L 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 154 FSE----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             E     YGPE D W++G  M+EML     F  +S  +   KI
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH  G  +RDLKP N+L+  +G IK+ D G+ KE ID       +  T  Y  PEV+   
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN-R 200
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
             +    D W+ G +MFEML+  + F GK   + +  I +
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 203 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 202 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLL 153
           ++H  G  HRD+KP N+L+ K G +K+ D G   ++D    + C   V T  Y  PEVL 
Sbjct: 189 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 154 F---SEIYGPEVDKWAMGAIMFEML 175
                  YG E D W++G  +FEML
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 203 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 202 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 223 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 25/131 (19%)
Query: 69  NLMREKNLQSWTIMISGLADNSRG---------NDAIS-LHRQGYFHRDLKPSNLLVS-K 117
            L R++NL+ W      + +  R           +A+  LH +G  HRDLKPSN+  +  
Sbjct: 95  QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 154
Query: 118 GVIKIGDLGMVKEIDSN---------LPC----TDYVTTRWYRGPEVLLFSEIYGPEVDK 164
            V+K+GD G+V  +D +         +P     T  V T+ Y  PE  +    Y  +VD 
Sbjct: 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDI 213
Query: 165 WAMGAIMFEML 175
           +++G I+FE+L
Sbjct: 214 FSLGLILFELL 224

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 70/130 (53%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R+ Y HRDL+ +N+LVS+ ++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 125 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN----EYTAREGAKFPIKW-TAP 179
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + F   +  + + W+ G +++E++++G I +PG+++AD +  + Q    P  ++ P  
Sbjct: 180 EAINFG-CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDE 238
Query: 209 IQLASNLNWK 218
           +     + WK
Sbjct: 239 LYDIMKMCWK 248

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 202 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 202 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 202 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 204 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H QG  HRD+KP N+++   + K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI--LFPGKSSADQIYKICQLIGS 199
            Y   +D W++G  MF  + F     F G  + DQ+ KI +++G+
Sbjct: 202 DYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 97  SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
           S+H+  Y HRD+KP N+L+   G I++ D G   ++  D  +  +  V T  Y  PE+L 
Sbjct: 206 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 154 FSE----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             E     YGPE D W++G  M+EML     F  +S  +   KI
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 309

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 97  SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
           S+H+  Y HRD+KP N+L+   G I++ D G   ++  D  +  +  V T  Y  PE+L 
Sbjct: 190 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 154 FSE----IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             E     YGPE D W++G  M+EML     F  +S  +   KI
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/82 (39%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP NLL +       +KI D G+ K ++  +       T  Y  PE+L 
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR 223
Query: 154 FSEIYGPEVDKWAMGAIMFEML 175
               YGPEVD W++G I + +L
Sbjct: 224 GCA-YGPEVDMWSVGIITYILL 244

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ K G IKI D GM KE +  +    ++  T  Y  PE+LL  
Sbjct: 135 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL-G 193
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + Y   VD W+ G +++EML     F G+   +  + I
Sbjct: 194 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK----GVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 115 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 174
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 175 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 227

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/80 (41%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLKP N+L+ S+G I + D G+ KE I+ N   + +  T  Y  PEVL   
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL-HK 213
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + Y   VD W +GA+++EML
Sbjct: 214 QPYDRTVDWWCLGAVLYEML 233

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 12/117 (10%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++E+  Q++T   +       G     LH     HRD+KP NLL +      V+K
Sbjct: 112 ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171
Query: 122 IGDLGMVKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE   N    PC     T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 172 LTDFGFAKETTQNALQTPC----YTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 107 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 166
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 167 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 219

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 99  ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 158
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 159 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 211

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 105 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 164
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 165 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 217

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 100 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 159
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 160 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 212

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 12/117 (10%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++E+  Q++T   +       G     LH     HRD+KP NLL +      V+K
Sbjct: 93  ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 152
Query: 122 IGDLGMVKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE   N    PC     T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 153 LTDFGFAKETTQNALQTPC----YTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 204

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 161 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 161 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 106 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 165
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 166 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           L  +G  +RDLK  N+++ S+G IKI D GM KE I   +    +  T  Y  PE++ + 
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY- 516
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           + YG  VD WA G +++EML+    F G+   D++++
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 552

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 151 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 210
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 211 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 263

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 145 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G IM+ +L
Sbjct: 205 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILL 257

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+L+     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 60/125 (48%), Gaps = 13/125 (10%)
Query: 65  FKVFNLMREKNLQSWTIMISGLADNSRGN------DAIS-LHRQGYFHRDLKPSNLLVSK 117
           F VF+LMR+  L  +      L++    +      +A+S LH     HRDLKP N+L+  
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235
Query: 118 GV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI-----YGPEVDKWAMGAIM 171
            + I++ D G    ++      +   T  Y  PE+L  S       YG EVD WA G I+
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 172 FEMLS 176
           F +L+
Sbjct: 296 FTLLA 300

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           L  +G  +RDLK  N+++ S+G IKI D GM KE I   +    +  T  Y  PE++ + 
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY- 195
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           + YG  VD WA G +++EML+    F G+   D++++
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 231

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 58/111 (52%), Gaps = 8/111 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    HRDLKP NLL+       +IKI D G+    ++     + + T +Y  PEVL 
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL- 210
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
             + Y  + D W++G I+F +L+    F G++  + + K+ +  G  T DS
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDS 258

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP N+L+        IKI D G+      N    D + T +Y  PEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
            +  Y  + D W+ G I++ +LS    F GK+  D + ++
Sbjct: 197 GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 48/82 (58%), Gaps = 5/82 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   ++   +P     V T ++  PE  L S
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE--LIS 189
Query: 156 EI-YGPEVDKWAMGAIMFEMLS 176
            + YGPEVD W++G ++ EM+ 
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVD 211

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   ++   +P     V T ++  PE L+  
Sbjct: 143 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISR 201
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
             YGPEVD W++G ++ EM+ 
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVD 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP N+L+        IKI D G+      N    D + T +Y  PEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
            +  Y  + D W+ G I++ +LS    F GK+  D + ++
Sbjct: 197 GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 48/82 (58%), Gaps = 5/82 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   ++   +P     V T ++  PE  L S
Sbjct: 136 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE--LIS 193
Query: 156 EI-YGPEVDKWAMGAIMFEMLS 176
            + YGPEVD W++G ++ EM+ 
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVD 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/82 (36%), Positives = 48/82 (58%), Gaps = 5/82 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   ++   +P     V T ++  PE  L S
Sbjct: 141 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE--LIS 198
Query: 156 EI-YGPEVDKWAMGAIMFEMLS 176
            + YGPEVD W++G ++ EM+ 
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVD 220

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP N+L+        IKI D G+      N    D + T +Y  PEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
            +  Y  + D W+ G I++ +LS    F GK+  D + ++
Sbjct: 197 GT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E        ++  +  Y  PE+    + 
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ K G IKI D GM KE +  +     +  T  Y  PE+LL  
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL-G 192
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + Y   VD W+ G +++EML     F G+   +  + I
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 66  KVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIK 121
           ++F+ ++++  Q++T   +     S G     LH     HRD+KP NLL +      ++K
Sbjct: 145 ELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204
Query: 122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
           + D G  KE  S+   T    T +Y  PEV L  E Y    D W++G I + +L
Sbjct: 205 LTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCDXWSLGVIXYILL 257

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   ++   +P     V T ++  PE L+  
Sbjct: 186 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISR 244
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
             YGPEVD W++G ++ EM+ 
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVD 265

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY-VTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   ++   +P     V T ++  PE L+  
Sbjct: 263 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISR 321
Query: 156 EIYGPEVDKWAMGAIMFEML 175
             YGPEVD W++G ++ EM+
Sbjct: 322 LPYGPEVDIWSLGIMVIEMV 341

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 256

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 99  HRQGYFHRDLKPSNLLVSKGVIKIG--DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++     K+   D G+ +           V +R+++GPE+L+  +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 157 IYGPEVDKWAMGAIMFEML-SFGILFPGKSSADQIYKICQLIGS 199
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLL 153
           ++H  G+ HRD+KP N+L+ K G +K+ D G   +++    + C   V T  Y  PEVL 
Sbjct: 188 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 154 F---SEIYGPEVDKWAMGAIMFEML 175
                  YG E D W++G  ++EML
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLL 153
           ++H  G+ HRD+KP N+L+ K G +K+ D G   +++    + C   V T  Y  PEVL 
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 154 F---SEIYGPEVDKWAMGAIMFEML 175
                  YG E D W++G  ++EML
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLL 153
           ++H  G+ HRD+KP N+L+ K G +K+ D G   +++    + C   V T  Y  PEVL 
Sbjct: 188 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 154 F---SEIYGPEVDKWAMGAIMFEML 175
                  YG E D W++G  ++EML
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/81 (40%), Positives = 47/81 (58%), Gaps = 5/81 (6%)
Query: 98  LHRQGYFHRDLKP-SNLLVSKGVIKIGDLGMVKEIDSNLPCTDY-VTTRWYRGPEVLLFS 155
           LH QG  HRD+K  S LL S G IK+ D G   ++   +P     V T ++  PEV+  S
Sbjct: 157 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI--S 214
Query: 156 EI-YGPEVDKWAMGAIMFEML 175
            + YG EVD W++G ++ EM+
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMI 235

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    H DLKP N+L+S     G IKI D GM ++I       + + T  Y  PE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLAS 213
           +  I     D W +G I + +L+    F G+ + +    I Q+    +++++    QLA+
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265
Query: 214 NL 215
           + 
Sbjct: 266 DF 267

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 48/80 (60%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  ++L++  G +K+ D G   +I  ++P     V T ++  PEV+  S
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRS 216
Query: 156 EIYGPEVDKWAMGAIMFEML 175
            +Y  EVD W++G ++ EM+
Sbjct: 217 -LYATEVDIWSLGIMVIEMV 235

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 54/108 (50%), Gaps = 9/108 (8%)
Query: 97  SLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVL- 152
           S+HR GY HRD+KP N+L+ + G I++ D G   ++  D  +     V T  Y  PE+L 
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 153 -----LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
                  +  YGPE D WA+G   +EM      F   S+A+   KI  
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 16/94 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVK---------EIDS-NLP-----CTDYV 141
           +H QG  HRDLKP N+ + +   +KIGD G+ K         ++DS NLP      T  +
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 142 TTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
            T  Y   EVL  +  Y  ++D +++G I FEM+
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 16/94 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVK---------EIDS-NLP-----CTDYV 141
           +H QG  HRDLKP N+ + +   +KIGD G+ K         ++DS NLP      T  +
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 142 TTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
            T  Y   EVL  +  Y  ++D +++G I FEM+
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +  +  Y  PE+    + 
Sbjct: 128 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 10/113 (8%)
Query: 96  ISLHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPE 150
           +  H+ G  HRDLKP NLL++       +K+ D G+  E+  +      +  T  Y  PE
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
           VL   E YG  VD WA G I++ +L   + +P     DQ +K+ Q I +   D
Sbjct: 177 VLR-KEAYGKPVDIWACGVILYILL---VGYPPFWDEDQ-HKLYQQIKAGAYD 224

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +  +  Y  PE+    + 
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +  +  Y  PE+    + 
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +  +  Y  PE+    + 
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +  +  Y  PE+    + 
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    HRD+KP N+L+        IKI D G+      +    D + T +Y  PEVL 
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL- 220
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             + Y  + D W+ G IM+ +L     F G++  D I K+
Sbjct: 221 -KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +  +  Y  PE+    + 
Sbjct: 131 HQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 38/160 (23%)
Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSW--------TIMISGLADNSRGNDAIS----- 97
           +V+ Y  CG  +    VF  M+  +L  +         I++ G    ++G   +S     
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 98  ----------LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDY------ 140
                     L  Q + HRDL   N LV   + +KIGD GM +++ S    TDY      
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRVGGH 194
Query: 141 --VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
             +  RW   PE +++ + +  E D W+ G I++E+ ++G
Sbjct: 195 TMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYG 232

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +     Y  PE+    + 
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSE 156
           HR    HRDLKP NLL+ + + +KI D G+   + D N   T    +  Y  PEV+    
Sbjct: 130 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAPEVISGKL 188
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
             GPEVD W+ G I++ ML   + F  +S
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSE 156
           HR    HRDLKP NLL+ + + +KI D G+   + D N   T    +  Y  PEV+    
Sbjct: 129 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAPEVISGKL 187
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
             GPEVD W+ G I++ ML   + F  +S
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 13/125 (10%)
Query: 65  FKVFNLMREKNLQSWTIMISGLADNSRGN------DAI-SLHRQGYFHRDLKPSNLLVSK 117
           F VF+LM++  L  +      L++           + I +LH+    HRDLKP N+L+  
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159
Query: 118 GV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-----EIYGPEVDKWAMGAIM 171
            + IK+ D G   ++D      +   T  Y  PE++  S       YG EVD W+ G IM
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 172 FEMLS 176
           + +L+
Sbjct: 220 YTLLA 224

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 13/125 (10%)
Query: 65  FKVFNLMREKNLQSWTIMISGLADNSRGN------DAI-SLHRQGYFHRDLKPSNLLVSK 117
           F VF+LM++  L  +      L++           + I +LH+    HRDLKP N+L+  
Sbjct: 87  FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 146
Query: 118 GV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-----EIYGPEVDKWAMGAIM 171
            + IK+ D G   ++D      +   T  Y  PE++  S       YG EVD W+ G IM
Sbjct: 147 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206
Query: 172 FEMLS 176
           + +L+
Sbjct: 207 YTLLA 211

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLV---SKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP NLL+   SK   I+I D G+    +++    D + T +Y  PEVL 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
               Y  + D W+ G I++ +LS    F G +  D + K+
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLV---SKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP NLL+   SK   I+I D G+    +++    D + T +Y  PEVL 
Sbjct: 165 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 223
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
               Y  + D W+ G I++ +LS    F G +  D + K+
Sbjct: 224 -HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 262

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLV---SKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP NLL+   SK   I+I D G+    +++    D + T +Y  PEVL 
Sbjct: 166 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 224
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
               Y  + D W+ G I++ +LS    F G +  D + K+
Sbjct: 225 -HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 263

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+   + IKI D G   E         +     Y  PE+    + 
Sbjct: 130 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSE 156
           HR    HRDLKP NLL+ + + +KI D G+   + D N   T    +  Y  PEV+    
Sbjct: 124 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAPEVISGKL 182
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
             GPEVD W+ G I++ ML   + F  +S
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSE 156
           HR    HRDLKP NLL+ + + +KI D G+   + D N   T    +  Y  PEV+    
Sbjct: 120 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAPEVISGKL 178
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
             GPEVD W+ G I++ ML   + F  +S
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCT-DYVTTRWYRGPEVLLFS 155
           +H +   HRD+KP+N+ ++  GV+K+GDLG+ +   S        V T +Y  PE  +  
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHE 210
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
             Y  + D W++G +++EM +    F G      +Y +C+ I
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKI 250

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLV---SKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP NLL+   SK   I+I D G+    +++    D + T +Y  PEVL 
Sbjct: 148 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
               Y  + D W+ G I++ +LS    F G +  D + K+
Sbjct: 207 -HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 245

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 1/88 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H++   HRDLK  NLL+     IKI D G   E         +     Y  PE+    + 
Sbjct: 130 HQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKS 185
            GPEVD W++G I++ ++S  + F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 45/81 (55%), Gaps = 2/81 (2%)
Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
            LHR+   +RDLKP N+L+   G I+I DLG+   +         V T  Y  PEV+  +
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-N 359
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E Y    D WA+G +++EM++
Sbjct: 360 ERYTFSPDWWALGCLLYEMIA 380

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 45/81 (55%), Gaps = 2/81 (2%)
Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
            LHR+   +RDLKP N+L+   G I+I DLG+   +         V T  Y  PEV+  +
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-N 359
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E Y    D WA+G +++EM++
Sbjct: 360 ERYTFSPDWWALGCLLYEMIA 380

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 13/125 (10%)
Query: 65  FKVFNLMREKNLQSWTIMISGLADNSRGN------DAI-SLHRQGYFHRDLKPSNLLVSK 117
           F VF+LM++  L  +      L++           + I +LH+    HRDLKP N+L+  
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159
Query: 118 GV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-----EIYGPEVDKWAMGAIM 171
            + IK+ D G   ++D          T  Y  PE++  S       YG EVD W+ G IM
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 172 FEMLS 176
           + +L+
Sbjct: 220 YTLLA 224

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 99  HRQGYFHRDLKPSNLLV---SKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           H+    HRDLKP NLL+   SK   I+I D G+    +++    D + T +Y  PEVL  
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHG 202
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           +  Y  + D W+ G I++ +LS    F G +  D + K+
Sbjct: 203 T--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/87 (39%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 90  SRGNDAISLHRQGYFHRDLKPSNL-LVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG 148
           ++G D I  H +   +RDLKPSN+ LV    +KIGD G+V  + ++        T  Y  
Sbjct: 132 TKGVDYI--HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEML 175
           PE +  S+ YG EVD +A+G I+ E+L
Sbjct: 190 PEQIS-SQDYGKEVDLYALGLILAELL 215

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 181 D-YGRAVDWWGLGVVMYEMM 199

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 124 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 183
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 184 D-YGRAVDWWGLGVVMYEMM 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 181 D-YGRAVDWWGLGVVMYEMM 199

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH++   +RDLKP N+L+   G ++I DLG+  E+ +    T  Y  T  +  PE+LL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-G 363
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E Y   VD +A+G  ++EM++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIA 384

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH++   +RDLKP N+L+   G ++I DLG+  E+ +    T  Y  T  +  PE+LL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-G 363
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E Y   VD +A+G  ++EM++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIA 384

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH++   +RDLKP N+L+   G ++I DLG+  E+ +    T  Y  T  +  PE+LL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-G 363
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E Y   VD +A+G  ++EM++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIA 384

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH++   +RDLKP N+L+   G ++I DLG+  E+ +    T  Y  T  +  PE+LL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-G 363
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           E Y   VD +A+G  ++EM++
Sbjct: 364 EEYDFSVDYFALGVTLYEMIA 384

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 181 D-YGRAVDWWGLGVVMYEMM 199

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 126 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 185
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 186 D-YGRAVDWWGLGVVMYEMM 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 181 D-YGRAVDWWGLGVVMYEMM 199

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 10/113 (8%)
Query: 96  ISLHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPE 150
           +  H+ G  HRDLKP NLL++       +K+ D G+  E++        +  T  Y  PE
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 194
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
           VL   + YG  VD WA G I++ +L   + +P     DQ +++ Q I +   D
Sbjct: 195 VLR-KDPYGKPVDLWACGVILYILL---VGYPPFWDEDQ-HRLYQQIKAGAYD 242

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   +RD+K  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + YG  VD W +G +M+EM+
Sbjct: 181 D-YGRAVDWWGLGVVMYEMM 199

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 48/85 (56%), Gaps = 15/85 (17%)
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLL 153
           + HRDL   N LV +G V+KIGD GM ++I S    TDY        +  RW   PE +L
Sbjct: 156 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLPIRWM-PPESIL 210
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + +  E D W+ G +++E+ ++G
Sbjct: 211 YRK-FTTESDVWSFGVVLWEIFTYG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 50/107 (46%), Gaps = 16/107 (14%)
Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRW-------- 145
           LH +G  HRDLKP N+L         +KI D G+   I  N  C+   T           
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 146 YRGPEVL-LFSE---IYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD 188
           Y  PEV+  FSE   IY    D W++G I++ +LS    F G+  +D
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 48/85 (56%), Gaps = 15/85 (17%)
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLL 153
           + HRDL   N LV +G V+KIGD GM ++I S    TDY        +  RW   PE +L
Sbjct: 150 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLPIRWM-PPESIL 204
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + +  E D W+ G +++E+ ++G
Sbjct: 205 YRK-FTTESDVWSFGVVLWEIFTYG 228

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/82 (40%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 99  HRQGYFHRDLKPSNLLV---SKG-VIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLL 153
           H  G  HRDLKP NLL+   SKG  +K+ D G+  E+  +      +  T  Y  PEVL 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 154 FSEIYGPEVDKWAMGAIMFEML 175
             + YG  VD WA G I++ +L
Sbjct: 180 -KDPYGKPVDMWACGVILYILL 200

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 48/85 (56%), Gaps = 15/85 (17%)
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLL 153
           + HRDL   N LV +G V+KIGD GM ++I S    TDY        +  RW   PE +L
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLPIRWM-PPESIL 233
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + +  E D W+ G +++E+ ++G
Sbjct: 234 YRK-FTTESDVWSFGVVLWEIFTYG 257

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/82 (40%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 99  HRQGYFHRDLKPSNLLV---SKG-VIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLL 153
           H  G  HRDLKP NLL+   SKG  +K+ D G+  E+  +      +  T  Y  PEVL 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 154 FSEIYGPEVDKWAMGAIMFEML 175
             + YG  VD WA G I++ +L
Sbjct: 180 -KDPYGKPVDMWACGVILYILL 200

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 16/94 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVK---------EIDS-NLP-----CTDYV 141
           +H QG  HR+LKP N+ + +   +KIGD G+ K         ++DS NLP      T  +
Sbjct: 132 IHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 142 TTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
            T  Y   EVL  +  Y  ++D +++G I FE +
Sbjct: 192 GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY-VTTRWYRGPEVLLFS 155
           +H +   HRD+K  N+ ++K G +++GD G+ + ++S +      + T +Y  PE+   +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE-N 199
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + Y  + D WA+G +++E+ +    F   S  + + KI
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/82 (41%), Positives = 45/82 (54%), Gaps = 10/82 (12%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVL--- 152
           LH Q   HRD+KPSNLLV + G IKI D G+  E   S+   ++ V T  +  PE L   
Sbjct: 153 LHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET 212
Query: 153 --LFSEIYGPEVDKWAMGAIMF 172
             +FS   G  +D WAMG  ++
Sbjct: 213 RKIFS---GKALDVWAMGVTLY 231

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 43/78 (55%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G IK+ D G+ K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 98  LHRQ-GYFHRDLKPSNLLVSKG-------VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP 149
           +HR+ G  H D+KP N+L+           IKI DLG     D +   T+ + TR YR P
Sbjct: 147 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSP 204
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILF-PGKSSA-----DQIYKICQLIGS 199
           EVLL +  +G   D W+   ++FE+++   LF P +  +     D I +I +L+G 
Sbjct: 205 EVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 98  LHRQ-GYFHRDLKPSNLLVSKG-------VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP 149
           +HR+ G  H D+KP N+L+           IKI DLG     D +   T+ + TR YR P
Sbjct: 147 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSP 204
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILF-PGKSSA-----DQIYKICQLIGS 199
           EVLL +  +G   D W+   ++FE+++   LF P +  +     D I +I +L+G 
Sbjct: 205 EVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    HRDLKP NLL+       +IKI D G+    +      + + T +Y  PEVL 
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL- 178
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             + Y  + D W+ G I++ +L     F G++  + + ++
Sbjct: 179 -RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 217

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    HRDLKP NLL+       +IKI D G+    +      + + T +Y  PEVL 
Sbjct: 137 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL- 195
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
             + Y  + D W+ G I++ +L     F G++  + + ++
Sbjct: 196 -RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 234

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 100 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIY 158
           +    HRD+KPSN+LV S+G IK+ D G+  ++   +   ++V TR Y  PE L  +  Y
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM-ANEFVGTRSYMSPERLQGTH-Y 183
Query: 159 GPEVDKWAMGAIMFEM 174
             + D W+MG  + EM
Sbjct: 184 SVQSDIWSMGLSLVEM 199

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 99  HRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           H  G  HR+LKP NLL++       +K+ D G+  E++ +     +  T  Y  PEVL  
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK- 203
Query: 155 SEIYGPEVDKWAMGAIMFEML 175
            + Y   VD WA G I++ +L
Sbjct: 204 KDPYSKPVDIWACGVILYILL 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVL-L 153
           LH     HRD+K  N+L++   GV+KI D G  K +    PCT+  T T  Y  PE++  
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
               YG   D W++G  + EM +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMAT 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVL-L 153
           LH     HRD+K  N+L++   GV+KI D G  K +    PCT+  T T  Y  PE++  
Sbjct: 124 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 183
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
               YG   D W++G  + EM +
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMAT 206

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  ++ YG  V
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAV 330
Query: 163 DKWAMGAIMFEML 175
           D W +G +M+EM+
Sbjct: 331 DWWGLGVVMYEMM 343

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 54/111 (48%), Gaps = 10/111 (9%)
Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVL 152
           +H+    HRDLKP NLL++       +K+ D G+  E+         +  T  Y  PEVL
Sbjct: 146 IHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL 205
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
              + YG  VD WA G I++ +L   + +P     DQ +K+ Q I +   D
Sbjct: 206 R-KDPYGKPVDIWACGVILYILL---VGYPPFWDEDQ-HKLYQQIKAGAYD 251

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSE 156
           HR    HRDLKP NLL+   + +KI D G+   + D N   T    +  Y  PEV+    
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAPEVINGKL 183
Query: 157 IYGPEVDKWAMGAIMFEML 175
             GPEVD W+ G +++ ML
Sbjct: 184 YAGPEVDVWSCGIVLYVML 202

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 14/100 (14%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVT-------TRWYRGPEVLLFSE 156
           HRDL   N+LV+ G V+KI D G+ ++I S+   ++YV         +W   PE  LF  
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSD---SNYVVRGNARLPVKW-MAPES-LFEG 249
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQ 195
           IY  + D W+ G +++E+ S G+  +PG       YK+ Q
Sbjct: 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  ++ YG  V
Sbjct: 133 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-YGRAV 191
Query: 163 DKWAMGAIMFEML 175
           D W +G +M+EM+
Sbjct: 192 DWWGLGVVMYEMM 204

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  ++ YG  V
Sbjct: 132 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-YGRAV 190
Query: 163 DKWAMGAIMFEML 175
           D W +G +M+EM+
Sbjct: 191 DWWGLGVVMYEMM 203

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  ++ YG  V
Sbjct: 275 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAV 333
Query: 163 DKWAMGAIMFEML 175
           D W +G +M+EM+
Sbjct: 334 DWWGLGVVMYEMM 346

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G IK+ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 13/132 (9%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDS----NLPCTDYVTTRWYRGPEVL 152
           L  + + HRDL   N LV +  V+KI D G+ + I S         D +  RW   P   
Sbjct: 190 LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM--PPES 247
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ--LIGSPTKDSWPLGI 209
           +F   Y  E D WA G +++E+ S+G+  + G +  + IY +    ++  P  ++ PL +
Sbjct: 248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP--ENCPLEL 305
Query: 210 QLASNLNW-KLP 220
                L W KLP
Sbjct: 306 YNLMRLCWSKLP 317

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/73 (42%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
           +RDLK  NL++ K G IKI D G+ KE I        +  T  Y  PEVL  ++ YG  V
Sbjct: 134 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-YGRAV 192
Query: 163 DKWAMGAIMFEML 175
           D W +G +M+EM+
Sbjct: 193 DWWGLGVVMYEMM 205

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLAGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 99  HRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           H  G  HR+LKP NLL++       +K+ D G+  E++ +     +  T  Y  PEVL  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK- 180
Query: 155 SEIYGPEVDKWAMGAIMFEML 175
            + Y   VD WA G I++ +L
Sbjct: 181 KDPYSKPVDIWACGVILYILL 201

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 99  HRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           H  G  HR+LKP NLL++       +K+ D G+  E++ +     +  T  Y  PEVL  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK- 180
Query: 155 SEIYGPEVDKWAMGAIMFEML 175
            + Y   VD WA G I++ +L
Sbjct: 181 KDPYSKPVDIWACGVILYILL 201

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 43/71 (60%), Gaps = 3/71 (4%)
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  Y  + D
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-YSVQSD 204
Query: 164 KWAMGAIMFEM 174
            W+MG  + EM
Sbjct: 205 IWSMGLSLVEM 215

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 44/77 (57%), Gaps = 3/77 (3%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
            +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH- 241
Query: 158 YGPEVDKWAMGAIMFEM 174
           Y  + D W+MG  + EM
Sbjct: 242 YSVQSDIWSMGLSLVEM 258

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 60/141 (42%), Gaps = 12/141 (8%)
Query: 99  HRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           H+    HRDLKP N L         +K+ D G+             V T +Y  P+VL  
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-- 180
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ-LIGSPTKDSW----PLGI 209
             +YGPE D+W+ G +M+ +L     F   +  + + KI +     P KD W    P   
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKD-WLNVSPQAE 239
Query: 210 QLASNLNWKLPQMGGVNLLAV 230
            L   L  K P+    +L A+
Sbjct: 240 SLIRRLLTKSPKQRITSLQAL 260

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 99  HRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           H  G  HR+LKP NLL++       +K+ D G+  E++ +     +  T  Y  PEVL  
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK- 179
Query: 155 SEIYGPEVDKWAMGAIMFEML 175
            + Y   VD WA G I++ +L
Sbjct: 180 KDPYSKPVDIWACGVILYILL 200

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 60/141 (42%), Gaps = 12/141 (8%)
Query: 99  HRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           H+    HRDLKP N L         +K+ D G+             V T +Y  P+VL  
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-- 197
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ-LIGSPTKDSW----PLGI 209
             +YGPE D+W+ G +M+ +L     F   +  + + KI +     P KD W    P   
Sbjct: 198 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKD-WLNVSPQAE 256
Query: 210 QLASNLNWKLPQMGGVNLLAV 230
            L   L  K P+    +L A+
Sbjct: 257 SLIRRLLTKSPKQRITSLQAL 277

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       ++ V T ++  PEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVT-R 190
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           + YGP+VD W++G +  EM+ 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIE 211

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 234
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 235 GYNKAVDWWALGVLIYEM 252

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 154 F--SEIYGPEVDKWAMGAIMFEMLS 176
              +  Y   VD W++G I+F  LS
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLS 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 10/113 (8%)
Query: 96  ISLHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPE 150
           +  H+ G  HR+LKP NLL++       +K+ D G+  E++        +  T  Y  PE
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
           VL   + YG  VD WA G I++ +L   + +P     DQ +++ Q I +   D
Sbjct: 184 VLR-KDPYGKPVDLWACGVILYILL---VGYPPFWDEDQ-HRLYQQIKAGAYD 231

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 1/78 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           HR    HRDLKP N+L+   +  KI D G+   +       D   +  Y  PEV+     
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 158 YGPEVDKWAMGAIMFEML 175
            GPEVD W+ G I++ +L
Sbjct: 188 AGPEVDIWSCGVILYALL 205

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 154 F--SEIYGPEVDKWAMGAIMFEMLS 176
              +  Y   VD W++G I+F  LS
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 154 F--SEIYGPEVDKWAMGAIMFEMLS 176
              +  Y   VD W++G I+F  LS
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 154 F--SEIYGPEVDKWAMGAIMFEMLS 176
              +  Y   VD W++G I+F  LS
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLS 213

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 234
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 235 GYNKAVDWWALGVLIYEM 252

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 100 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIY 158
           +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-Y 180
Query: 159 GPEVDKWAMGAIMFEM 174
             + D W+MG  + EM
Sbjct: 181 SVQSDIWSMGLSLVEM 196

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 154 F--SEIYGPEVDKWAMGAIMFEMLS 176
              +  Y   VD W++G I+F  LS
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLS 214

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 200
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 201 GYNKAVDWWALGVLIYEM 218

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 207 GYNKAVDWWALGVLIYEM 224

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEYLAPEIIL-SK 199
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 200 GYNKAVDWWALGVLIYEM 217

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLXGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 207 GYNKAVDWWALGVLIYEM 224

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 100 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIY 158
           +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-Y 180
Query: 159 GPEVDKWAMGAIMFEM 174
             + D W+MG  + EM
Sbjct: 181 SVQSDIWSMGLSLVEM 196

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 3/76 (3%)
Query: 100 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIY 158
           +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  Y
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-Y 180
Query: 159 GPEVDKWAMGAIMFEM 174
             + D W+MG  + EM
Sbjct: 181 SVQSDIWSMGLSLVEM 196

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 10/84 (11%)
Query: 102 GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPEVLLF 154
           GY HRDL   N+LV S  V K+ D G+ + ++ + P   Y TT      RW   PE + F
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWT-APEAIAF 228
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFG 178
              +    D W+ G +M+E+L++G
Sbjct: 229 -RTFSSASDVWSFGVVMWEVLAYG 251

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--ATWTLCGTPEYLAPEIIL-SK 234
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 235 GYNKAVDWWALGVLIYEM 252

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 44/77 (57%), Gaps = 3/77 (3%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
            +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH- 206
Query: 158 YGPEVDKWAMGAIMFEM 174
           Y  + D W+MG  + EM
Sbjct: 207 YSVQSDIWSMGLSLVEM 223

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 208
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 209 GYNKAVDWWALGVLIYEM 226

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 44/77 (57%), Gaps = 3/77 (3%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
            +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH- 179
Query: 158 YGPEVDKWAMGAIMFEM 174
           Y  + D W+MG  + EM
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 44/77 (57%), Gaps = 3/77 (3%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
            +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH- 179
Query: 158 YGPEVDKWAMGAIMFEM 174
           Y  + D W+MG  + EM
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G I++ D G+ K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 15/92 (16%)
Query: 96  ISLHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDY--------VTTRWY 146
           + L  Q + HRDL   N LV + + +KIGD GM +++ S    TDY        +  RW 
Sbjct: 142 VYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS----TDYYRVGGHTMLPIRWM 197
Query: 147 RGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
             PE +++ + +  E D W++G +++E+ ++G
Sbjct: 198 -PPESIMYRK-FTTESDVWSLGVVLWEIFTYG 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 10/101 (9%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           L  + + HRDL   N LV+ +GV+K+ D G+ + +   +           RW   PEVL+
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW-SPPEVLM 194
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL----FPGKSSADQI 190
           +S+ +  + D WA G +M+E+ S G +    F    +A+ I
Sbjct: 195 YSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 22/120 (18%)
Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVT--------TRW 145
           LH +G  HRDLKP N+L         +KI D  +   +  N  CT   T        +  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 146 YRGPEVL-LFSE---IYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD------QIYKICQ 195
           Y  PEV+ +F++    Y    D W++G +++ MLS    F G   AD      ++ ++CQ
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 246

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 1/97 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           HR    HRDLKP N+L+   +  KI D G+   +           +  Y  PEV+     
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192
Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            GPEVD W+ G I++ +L   + F          KIC
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 328
Query: 154 F--SEIYGPEVDKWAMGAIMFEMLS 176
              +  Y   VD W++G I+F  LS
Sbjct: 329 SVGTAGYNRAVDCWSLGVILFICLS 353

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 16/104 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTR------WYRGPE 150
           L  + + HRDL   N LV+ +GV+K+ D G+ + +  +    +Y ++R       +  PE
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSRGSKFPVRWSPPE 176
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL----FPGKSSADQI 190
           VL++S+ +  + D WA G +M+E+ S G +    F    +A+ I
Sbjct: 177 VLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 15/105 (14%)
Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDY 140
           M+ G+A   R      L    Y HRDL   N+LV+  ++ K+ D G+ + ++ N     Y
Sbjct: 121 MLRGIASGMR-----YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 141 VTT-------RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            ++       RW   PE + F + +    D W+ G +M+E++SFG
Sbjct: 176 TSSLGGKIPIRWT-APEAIAFRK-FTSASDAWSYGIVMWEVMSFG 218

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 99  HRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLL 153
           H     HRD+KP N+L++       +K+GD G+  ++ +S L     V T  +  PEV+ 
Sbjct: 147 HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPG 183
             E YG  VD W  G I+F +LS  + F G
Sbjct: 207 -REPYGKPVDVWGCGVILFILLSGCLPFYG 235

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 16/107 (14%)
Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRW-------- 145
           LH +G  HRDLKP N+L         +KI D  +   I  N  C+   T           
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 146 YRGPEVL-LFSE---IYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD 188
           Y  PEV+  FSE   IY    D W++G I++ +LS    F G+  +D
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 18/105 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV+ +GV+K+ D G+ + +  +    +Y ++       RW   P
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRW-SPP 174
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL----FPGKSSADQI 190
           EVL++S+ +  + D WA G +M+E+ S G +    F    +A+ I
Sbjct: 175 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 218

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 15/118 (12%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + ++ Y HRDL+ +N+LVS  ++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 127 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKW-TAP 181
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
           E + F   +  + D W+ G ++ E++++G I +PG S+ + I  + +    P  ++ P
Sbjct: 182 EAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 238

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 18/105 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV+ +GV+K+ D G+ + +  +    +Y ++       RW   P
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRW-SPP 170
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL----FPGKSSADQI 190
           EVL++S+ +  + D WA G +M+E+ S G +    F    +A+ I
Sbjct: 171 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 18/105 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV+ +GV+K+ D G+ + +  +    +Y ++       RW   P
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRW-SPP 175
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL----FPGKSSADQI 190
           EVL++S+ +  + D WA G +M+E+ S G +    F    +A+ I
Sbjct: 176 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 154 F--SEIYGPEVDKWAMGAIMFEMLS 176
              +  Y   VD W++G I+F  LS
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLS 339

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 18/105 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV+ +GV+K+ D G+ + +  +    +Y ++       RW   P
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRW-SPP 190
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL----FPGKSSADQI 190
           EVL++S+ +  + D WA G +M+E+ S G +    F    +A+ I
Sbjct: 191 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVK-EIDSNLPCTDYVTTRWYRGPEVL 152
           +H  G  HRDLKP NLL +       IKI D G  + +   N P      T  Y  PE L
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-L 180
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILF 181
           L    Y    D W++G I++ MLS  + F
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 18/105 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV+ +GV+K+ D G+ + +  +    +Y ++       RW   P
Sbjct: 127 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRW-SPP 181
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL----FPGKSSADQI 190
           EVL++S+ +  + D WA G +M+E+ S G +    F    +A+ I
Sbjct: 182 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 225

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-R 190
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           + YGP+VD W++G +  EM+ 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIE 211

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 133 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT-R 191
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           + YGP+VD W++G +  EM+ 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIE 212

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 15/89 (16%)
Query: 98  LHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYR 147
           LH QG  HRDLKPSN+L      +   I+I D G  K++ +       PC     T  + 
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC----YTANFV 187
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLS 176
            PEVL   + Y    D W++G +++ ML+
Sbjct: 188 APEVLE-RQGYDAACDIWSLGVLLYTMLT 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT-R 190
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           + YGP+VD W++G +  EM+ 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIE 211

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 15/118 (12%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + ++ Y HRDL+ +N+LVS  ++ KI D G+ + I+ N    +Y          +W   P
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKW-TAP 354
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
           E + F   +  + D W+ G ++ E++++G I +PG S+ + I  + +    P  ++ P
Sbjct: 355 EAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G ++++M
Sbjct: 214 GYNKAVDWWALGVLIYQM 231

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 43/71 (60%), Gaps = 3/71 (4%)
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L  +  Y  + D
Sbjct: 138 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMAPERLQGTH-YSVQSD 195
Query: 164 KWAMGAIMFEM 174
            W+MG  + E+
Sbjct: 196 IWSMGLSLVEL 206

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 45/82 (54%), Gaps = 8/82 (9%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVT--TRWYRGPEVLLF 154
           LH +   +RDLKP N+L+ K G IKI D G  K +    P   Y    T  Y  PEV+  
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVS- 176
Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
           ++ Y   +D W+ G +++EML+
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLA 198

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           + R  Y HRDL+ +N+LV  G+I KI D G+ + I+ N            +W   PE  L
Sbjct: 121 IERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL 179
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G + +PG ++ + + ++ +    P     P+ +   
Sbjct: 180 YGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 238
Query: 213 SNLNWK 218
               WK
Sbjct: 239 MIHCWK 244

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 15/104 (14%)
Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDY 140
           M+ G+A   R      L   GY HRDL   N+LV+  ++ K+ D G+ + I+ + P   Y
Sbjct: 150 MLRGIAAGMR-----YLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD-PEAVY 203
Query: 141 VTT------RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            TT      RW   PE + + + +    D W+ G +M+E++S+G
Sbjct: 204 TTTGGKIPVRW-TAPEAIQYRK-FTSASDVWSYGIVMWEVMSYG 245

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 6/92 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
            H Q   H+DLKP N+L         IKI D G+ +   S+   T+   T  Y  PEV  
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-- 197
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
           F      + D W+ G +M+ +L+  + F G S
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 7/82 (8%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT---TRWYRGPEVLL 153
           LH  G  HRDL  SNLL+++ + IKI D G+  ++   +P   + T   T  Y  PE+  
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIAT 185
Query: 154 FSEIYGPEVDKWAMGAIMFEML 175
            S  +G E D W++G + + +L
Sbjct: 186 RSA-HGLESDVWSLGCMFYTLL 206

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K +    IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
            + E  G E D W++G I + +LS    F G +  + +  I  +     ++ +    +LA
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 213 SNLNWKL 219
            +   KL
Sbjct: 250 KDFIRKL 256

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NL++  +G I++ D G  K +           T  Y  PE+++ S+
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPEIII-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K +    IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
            + E  G E D W++G I + +LS    F G +  + +  I  +     ++ +    +LA
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 213 SNLNWKL 219
            +   KL
Sbjct: 250 KDFIRKL 256

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKP+N+L+ + G ++I DLG+  +     P    V T  Y  PEVL    
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ 189
            Y    D +++G ++F++L     F    + D+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKP+N+L+ + G ++I DLG+  +     P    V T  Y  PEVL    
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ 189
            Y    D +++G ++F++L     F    + D+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKP+N+L+ + G ++I DLG+  +     P    V T  Y  PEVL    
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ 189
            Y    D +++G ++F++L     F    + D+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKP+N+L+ + G ++I DLG+  +     P    V T  Y  PEVL    
Sbjct: 307 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 365
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ 189
            Y    D +++G ++F++L     F    + D+
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K +    IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
            + E  G E D W++G I + +LS    F G +  + +  I  +     ++ +    +LA
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 213 SNLNWKL 219
            +   KL
Sbjct: 250 KDFIRKL 256

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K +    IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
            + E  G E D W++G I + +LS    F G +  + +  I  +     ++ +    +LA
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 213 SNLNWKL 219
            +   KL
Sbjct: 250 KDFIRKL 256

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K +    IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
            + E  G E D W++G I + +LS    F G +  + +  I  +     ++ +    +LA
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 213 SNLNWKL 219
            +   KL
Sbjct: 250 KDFIRKL 256

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K +    IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
            + E  G E D W++G I + +LS    F G +  + +  I  +     ++ +    +LA
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 213 SNLNWKL 219
            +   KL
Sbjct: 250 KDFIRKL 256

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 53/112 (47%), Gaps = 16/112 (14%)
Query: 98  LHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYR 147
           LH QG  HRDLKPSN+L      +   ++I D G  K++ +       PC     T  + 
Sbjct: 137 LHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC----YTANFV 192
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS 199
            PEVL   + Y    D W++G +++ ML+    F     +D   +I   IGS
Sbjct: 193 APEVLK-RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGS 242

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 16/118 (13%)
Query: 92  GNDAISLHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSN-----LPCTDYV 141
           G     LH QG  HRDLKPSN+L      +   ++I D G  K++ +       PC    
Sbjct: 131 GKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC---- 186
Query: 142 TTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS 199
            T  +  PEVL   + Y    D W++G +++ ML+    F     +D   +I   IGS
Sbjct: 187 YTANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGS 242

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/111 (27%), Positives = 60/111 (54%), Gaps = 11/111 (9%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           + ++ Y HRDL+ +N+LVS  ++ KI D G+ + + +  P       +W   PE + F  
Sbjct: 294 IEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VGAKFPI------KW-TAPEAINFGS 345
Query: 157 IYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
            +  + D W+ G ++ E++++G I +PG S+ + I  + +    P  ++ P
Sbjct: 346 -FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 395

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 103 YFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTR-----WYRGPEVLLFSE 156
           Y HRDL   N+LV S+  +KIGD G+ K I+++         R     WY  PE L+ S+
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSK 205
Query: 157 IYGPEVDKWAMGAIMFEMLSF 177
            Y    D W+ G  + E+L++
Sbjct: 206 FYIAS-DVWSFGVTLHELLTY 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRD+K  N+L+S+ G++K+GD G    +    P   +V T ++  PEV+L  +
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 226
Query: 157 --IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
              Y  +VD W++G    E+          ++   +Y I Q
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T  Y  P ++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEYLAPAIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 103 YFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTR-----WYRGPEVLLFSE 156
           Y HRDL   N+LV S+  +KIGD G+ K I+++         R     WY  PE L+ S+
Sbjct: 135 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSK 193
Query: 157 IYGPEVDKWAMGAIMFEMLSF 177
            Y    D W+ G  + E+L++
Sbjct: 194 FYIAS-DVWSFGVTLHELLTY 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S +G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 136 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 196 -AYDSKADIWSLGITAIEL 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSN--LPCTDYVTTRWYRGPEVLLFSEIYG 159
           HRD+   N+L++ G V KIGD G+ ++I  DSN  +     +  +W   PE  +F  +Y 
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW-MAPES-IFDCVYT 244
Query: 160 PEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQ 195
            + D W+ G +++E+ S G+  +PG     + YK+ +
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSN--LPCTDYVTTRWYRGPEVLLFSEIYG 159
           HRD+   N+L++ G V KIGD G+ ++I  DSN  +     +  +W   PE  +F  +Y 
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM-APES-IFDCVYT 244
Query: 160 PEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQ 195
            + D W+ G +++E+ S G+  +PG     + YK+ +
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSN--LPCTDYVTTRWYRGPEVLLFSEIYG 159
           HRD+   N+L++ G V KIGD G+ ++I  DSN  +     +  +W   PE  +F  +Y 
Sbjct: 175 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM-APES-IFDCVYT 232
Query: 160 PEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQ 195
            + D W+ G +++E+ S G+  +PG     + YK+ +
Sbjct: 233 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 269

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 17/108 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 219 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 273
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
           PE L F  +Y  + D W+ G +M+E+ +  G  +PG    ++++K+ +
Sbjct: 274 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 319

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 38/78 (48%), Gaps = 1/78 (1%)
Query: 99  HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           HR    HRDLKP N+L+   +  KI D G+   +           +  Y  PEV+     
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 158 YGPEVDKWAMGAIMFEML 175
            GPEVD W+ G I++ +L
Sbjct: 188 AGPEVDIWSCGVILYALL 205

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRD+K  N+L+S+ G++K+GD G    +    P   +V T ++  PEV+L  +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187
Query: 157 --IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
              Y  +VD W++G    E+          ++   +Y I Q
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSN--LPCTDYVTTRWYRGPEVLLFSEIYG 159
           HRD+   N+L++ G V KIGD G+ ++I  DSN  +     +  +W   PE  +F  +Y 
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM-APES-IFDCVYT 238
Query: 160 PEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQ 195
            + D W+ G +++E+ S G+  +PG     + YK+ +
Sbjct: 239 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 275

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HR++K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 133 LHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-R 191
Query: 156 EIYGPEVDKWAMGAIMFEMLS 176
           + YGP+VD W++G +  EM+ 
Sbjct: 192 KAYGPKVDIWSLGIMAIEMIE 212

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSN--LPCTDYVTTRWYRGPEVLLFSEIYG 159
           HRD+   N+L++ G V KIGD G+ ++I  DSN  +     +  +W   PE  +F  +Y 
Sbjct: 183 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM-APES-IFDCVYT 240
Query: 160 PEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQ 195
            + D W+ G +++E+ S G+  +PG     + YK+ +
Sbjct: 241 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 277

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 160 LASQKCIHRDLTARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 214
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 215 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 243

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSN--LPCTDYVTTRWYRGPEVLLFSEIYG 159
           HRD+   N+L++ G V KIGD G+ ++I  DSN  +     +  +W   PE  +F  +Y 
Sbjct: 189 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW-MAPES-IFDCVYT 246
Query: 160 PEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQ 195
            + D W+ G +++E+ S G+  +PG     + YK+ +
Sbjct: 247 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 283

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 227
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 228 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 256

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S+ G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 140 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 199
Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 200 -AYDSKADIWSLGITAIEL 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 216
Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 217 VYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 16/96 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 162 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 216
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSF-GILFPG 183
           PE L F  +Y  + D W+ G +M+E+ +  G  +PG
Sbjct: 217 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 251

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 165 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 219
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 220 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 248

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKNTTNGRLPVKWM-A 227
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 228 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 256

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI---DSNLPCTD-YVTTRWYRGPEVL 152
           L  Q   HRDL   N+LV++  V+KI D G+ ++I   D     T+  +  +W   PE L
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWM-APEAL 231
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
            F  +Y  + D W+ G +M+E+ +  G  +PG    ++++K+ +
Sbjct: 232 -FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 273

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LL 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 207 TEKSASKSSDLWALGCIIYQLVA 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 216
Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 217 VYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 227
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 228 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 256

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S+ G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 195 -AYDSKADIWSLGITAIEL 212

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 227
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 228 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 256

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI---DSNLPCTD-YVTTRWYRGPEVL 152
           L  Q   HRDL   N+LV++  V+KI D G+ ++I   D     T+  +  +W   PE L
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWM-APEAL 231
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
            F  +Y  + D W+ G +M+E+ +  G  +PG    ++++K+ +
Sbjct: 232 -FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 273

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 17/108 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 227
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
           PE L F  +Y  + D W+ G +M+E+ +  G  +PG    ++++K+ +
Sbjct: 228 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 273

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 98  LHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LHR G  HRDLKP NLL      +  I I D G+ K        +    T  Y  PEVL 
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA 195
Query: 154 FSEIYGPEVDKWAMGAIMFEML 175
             + Y   VD W++G I + +L
Sbjct: 196 -QKPYSKAVDCWSIGVIAYILL 216

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY        +  +W   
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 227
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 228 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 256

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 102 GYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPEVLLF 154
           GY HRDL   N+LV   ++ K+ D G+ + ++ + P     TT      RW   PE + F
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAXTTTGGKIPIRWT-APEAIAF 228
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFG 178
              +    D W+ G +M+E+L++G
Sbjct: 229 -RTFSSASDVWSFGVVMWEVLAYG 251

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S+ G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 120 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 180 -AYDSKADIWSLGITAIEL 197

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LHR    HRDLK  NL +++ + +KIGD G+  +++ +      +  T  Y  PEVL   
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-K 189
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G IM+ +L
Sbjct: 190 KGHSFEVDVWSIGCIMYTLL 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 19/107 (17%)
Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDY 140
           M+ G+A   R      L    Y HRDL   N+LV+  ++ K+ D G+ + ++ N   +D 
Sbjct: 123 MLRGIASGMR-----YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN--SSDP 175
Query: 141 VTT---------RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
             T         RW   PE + F + +    D W+ G +M+E++SFG
Sbjct: 176 TETSSLGGKIPIRWT-APEAIAFRK-FTSASDAWSYGIVMWEVMSFG 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S+ G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 120 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 180 -AYDSKADIWSLGITAIEL 197

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LHR    HRDLK  NL +++ + +KIGD G+  +++ +      +  T  Y  PEVL   
Sbjct: 137 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS-K 195
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G IM+ +L
Sbjct: 196 KGHSFEVDVWSIGCIMYTLL 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LHR    HRDLK  NL +++ + +KIGD G+  +++ +      +  T  Y  PEVL   
Sbjct: 155 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-K 213
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G IM+ +L
Sbjct: 214 KGHSFEVDVWSIGCIMYTLL 233

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 225
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LHR    HRDLK  NL +++ + +KIGD G+  +++ +      +  T  Y  PEVL   
Sbjct: 133 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS-K 191
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G IM+ +L
Sbjct: 192 KGHSFEVDVWSIGCIMYTLL 211

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 98  LHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYR 147
           LH QG  HRDLKPSN+L      +   I+I D G  K++ +       PC     T  + 
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC----YTANFV 187
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLS 176
            PEVL   + Y    D W++G +++  L+
Sbjct: 188 APEVLE-RQGYDAACDIWSLGVLLYTXLT 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LHR    HRDLK  NL +++ + +KIGD G+  +++ +      +  T  Y  PEVL   
Sbjct: 133 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS-K 191
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G IM+ +L
Sbjct: 192 KGHSFEVDVWSIGCIMYTLL 211

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LHR    HRDLK  NL +++ + +KIGD G+  +++ +      +  T  Y  PEVL   
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-K 215
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G IM+ +L
Sbjct: 216 KGHSFEVDVWSIGCIMYTLL 235

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 173 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 227
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 228 VYTIQSDVWSFGVLLWEIFSLGASPYPG 255

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 214 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 268
Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 269 VYTIQSDVWSFGVLLWEIFSLGASPYPG 296

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T     PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWXLCGTPEALAPEIIL-SK 213
Query: 157 IYGPEVDKWAMGAIMFEM 174
            Y   VD WA+G +++EM
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S+  V+KI D G+ ++I  N    DYV         +W   PE + F +
Sbjct: 222 HRDLAARNILLSENNVVKICDFGLARDIYKN---PDYVRKGDTRLPLKWM-APESI-FDK 276
Query: 157 IYGPEVDKWAMGAIMFEMLSF-GILFPG 183
           IY  + D W+ G +++E+ S  G  +PG
Sbjct: 277 IYSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 167 HRDLAARNILLSEKNVVKIXDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 221
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 222 VYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 208 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 262
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 263 VYTIQSDVWSFGVLLWEIFSLGASPYPG 290

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 270
Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 218
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 217
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 218
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 218
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 217
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 218
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 167 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 221
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 222 VYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 179 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 237
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 238 YHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 232
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 217
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 221 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 275
Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 276 VYTIQSDVWSFGVLLWEIFSLGASPYPG 303

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 185
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLFSE 156
           HRDL   N+L+S K V+KI D G+ ++I  +    DYV         +W   PE  +F  
Sbjct: 223 HRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWM-APET-IFDR 277
Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           +Y  + D W+ G +++E+ S G   +PG
Sbjct: 278 VYTIQSDVWSFGVLLWEIFSLGASPYPG 305

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 140 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TAPE 197
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + F + +    D W+ G +M+E++S+G
Sbjct: 198 AIAFRK-FTSASDVWSYGIVMWEVVSYG 224

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 217
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID---SNLPCTDYVTTRWYRGPEVLL 153
           LH QG  H+D+KP NLL++  G +KI  LG+ + +    ++  C     +  ++ PE+  
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 154 FSEIY-GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS 199
             + + G +VD W+ G  ++ + +    F G    D IYK+ + IG 
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYKLFENIGK 227

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 232
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 224
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 232
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 207 TEKSAXKSSDLWALGCIIYQLVA 229

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 204
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 205
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LL 207
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVA 230

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGL--ADNSRG------NDAISLHRQG 102
           LV++Y  C        VF  M    L  +     GL  A+   G           L    
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
             HRDL   N LV +  VIK+ D GM + +  D     T       +  PEV  FS  Y 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YS 182
Query: 160 PEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
            + D W+ G +M+E+ S G I +  +S+++ +  I
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 15/90 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRG 148
           L  Q   HRDL   N+LV++  V++I D G+ ++I++     DY        +  +W   
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMRIADFGLARDINN----IDYYKKTTNGRLPVKWM-A 227
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L F  +Y  + D W+ G +M+E+ + G
Sbjct: 228 PEAL-FDRVYTHQSDVWSFGVLMWEIFTLG 256

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 190
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSN---------LPCTDYVTTRWYR 147
           H+ G  HRD+KP+N+L+S    +K+ D G+ + I DS          +    Y++    R
Sbjct: 133 HQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           G  V   S++Y       ++G +++E+L+    F G S     Y+
Sbjct: 193 GDSVDARSDVY-------SLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 190
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 189
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 189
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 212
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 213 YHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LL 203
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVA 226

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 20/91 (21%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSNLPCTDYVTTRWYRGPEVLL 153
           HRDL   N+L+S K V+KI D G+ ++I          D+ LP       +W   PE  +
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP------LKWM-APET-I 213
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           F  +Y  + D W+ G +++E+ S G   +PG
Sbjct: 214 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 190
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 20/91 (21%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSNLPCTDYVTTRWYRGPEVLL 153
           HRDL   N+L+S K V+KI D G+ ++I          D+ LP       +W   PE  +
Sbjct: 162 HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP------LKWM-APET-I 213
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPG 183
           F  +Y  + D W+ G +++E+ S G   +PG
Sbjct: 214 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 185
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 209
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 210 TEKSACKSSDLWALGCIIYQLVA 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVA 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVA 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVA 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 207
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVA 230

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 185
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 20/91 (21%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSNLPCTDYVTTRWYRGPEVLL 153
           HRDL   N+L+S K V+KI D G+ ++I          D+ LP       +W   PE  +
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP------LKWM-APET-I 222
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           F  +Y  + D W+ G +++E+ S G   +PG
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCT---------DYVTTRWYR 147
           H+ G  HRD+KP+N+++S    +K+ D G+ + I DS    T          Y++    R
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           G  V   S++Y       ++G +++E+L+    F G S     Y+
Sbjct: 193 GDSVDARSDVY-------SLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 20/91 (21%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSNLPCTDYVTTRWYRGPEVLL 153
           HRDL   N+L+S K V+KI D G+ ++I          D+ LP       +W   PE  +
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP------LKWM-APET-I 222
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           F  +Y  + D W+ G +++E+ S G   +PG
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 204
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVA 227

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+K  N+L+  ++G +K+ D G    +   +  TD+  TR Y  PE + +  
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR 188
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +G     W++G ++++M+   I F
Sbjct: 189 YHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCT---------DYVTTRWYR 147
           H+ G  HRD+KP+N+++S    +K+ D G+ + I DS    T          Y++    R
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           G  V   S++Y       ++G +++E+L+    F G S     Y+
Sbjct: 193 GDSVDARSDVY-------SLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 204
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVA 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCT---------DYVTTRWYR 147
           H+ G  HRD+KP+N+++S    +K+ D G+ + I DS    T          Y++    R
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           G  V   S++Y       ++G +++E+L+    F G S     Y+
Sbjct: 193 GDSVDARSDVY-------SLGCVLYEVLTGEPPFTGDSPVSVAYQ 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE-LL 204
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVA 227

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVA 229

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 94  DAIS-LHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG 148
           DA+  LH  G  HRDLKP NLL         I I D G+ K  D     +    T  Y  
Sbjct: 127 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEML 175
           PEVL   + Y   VD W++G I + +L
Sbjct: 187 PEVLA-QKPYSKAVDCWSIGVIAYILL 212

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 14/90 (15%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           L  + + HRDL   N LLV++   KI D G+ K + ++     Y T R        WY  
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWY-A 181
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE + F + +    D W+ G  M+E LS+G
Sbjct: 182 PECINFRK-FSSRSDVWSYGVTMWEALSYG 210

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 204
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVA 227

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 20/91 (21%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSNLPCTDYVTTRWYRGPEVLL 153
           HRDL   N+L+S K V+KI D G+ ++I          D+ LP       +W   PE  +
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP------LKWM-APET-I 222
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           F  +Y  + D W+ G +++E+ S G   +PG
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 211
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 212 TEKSACKSSDLWALGCIIYQLVA 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 98  LHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP NLL         I I D G+ K ++ N   +    T  Y  PEVL 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLA 180
Query: 154 FSEIYGPEVDKWAMGAIMFEML 175
             + Y   VD W++G I + +L
Sbjct: 181 -QKPYSKAVDCWSIGVITYILL 201

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 52/119 (43%), Gaps = 9/119 (7%)
Query: 94  DAIS-LHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG 148
           DA+  LH  G  HRDLKP NLL         I I D G+ K  D     +    T  Y  
Sbjct: 127 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---DQIYKICQLIGSPTKDS 204
           PEVL   + Y   VD W++G I + +L     F  ++ A   +QI K      SP  D 
Sbjct: 187 PEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 244

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 52/119 (43%), Gaps = 9/119 (7%)
Query: 94  DAIS-LHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG 148
           DA+  LH  G  HRDLKP NLL         I I D G+ K  D     +    T  Y  
Sbjct: 127 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---DQIYKICQLIGSPTKDS 204
           PEVL   + Y   VD W++G I + +L     F  ++ A   +QI K      SP  D 
Sbjct: 187 PEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 244

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 188
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 189 TEKSACKSSDLWALGCIIYQLVA 211

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 203
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVA 226

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 94  DAIS-LHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG 148
           DA+  LH  G  HRDLKP NLL         I I D G+ K  D     +    T  Y  
Sbjct: 127 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 186
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEML 175
           PEVL   + Y   VD W++G I + +L
Sbjct: 187 PEVLA-QKPYSKAVDCWSIGVIAYILL 212

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 4/83 (4%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLF 154
           LH+ G  +RD+K  N+L+ S G + + D G+ KE   D      D+  T  Y  P+++  
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 155 SEI-YGPEVDKWAMGAIMFEMLS 176
            +  +   VD W++G +M+E+L+
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLT 257

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 4/100 (4%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY 191
           L   E +   VD W+ G ++  ML+  + +   S + Q Y
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEY 217

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGL--ADNSRG------NDAISLHRQG 102
           LV++Y  C        VF  M    L  +     GL  A+   G           L    
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
             HRDL   N LV +  VIK+ D GM + +  D     T       +  PEV  FS  Y 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YS 182
Query: 160 PEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
            + D W+ G +M+E+ S G I +  +S+++ +  I
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTD-YVTTRWYRGPEVLLFSEIY 158
            HRDL   N+LV++  V+KI D G+ ++I   D     T+  +  +W   PE L F  IY
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWM-APEAL-FDRIY 229
Query: 159 GPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 230 THQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 266

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCT---------DYVTTRWYR 147
           H+ G  HRD+KP+N+++S    +K+ D G+ + I DS    T          Y++    R
Sbjct: 150 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           G  V   S++Y       ++G +++E+L+    F G S     Y+
Sbjct: 210 GDSVDARSDVY-------SLGCVLYEVLTGEPPFTGDSPVSVAYQ 247

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGL--ADNSRG------NDAISLHRQG 102
           LV++Y  C        VF  M    L  +     GL  A+   G           L    
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
             HRDL   N LV +  VIK+ D GM + +  D     T       +  PEV  FS  Y 
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YS 202
Query: 160 PEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
            + D W+ G +M+E+ S G I +  +S+++ +  I
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L    + HRDL   N+LVS+  V K+ D G+ KE  S    T  +  +W   PE L   +
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALR-EK 189
Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            +  + D W+ G +++E+ SFG
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFG 211

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L    + HRDL   N+LVS+  V K+ D G+ KE  S    T  +  +W   PE L   +
Sbjct: 118 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALR-EK 174
Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            +  + D W+ G +++E+ SFG
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFG 196

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 20/91 (21%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSNLPCTDYVTTRWYRGPEVLL 153
           HRDL   N+L+S K V+KI D G+ ++I          D+ LP       +W   PE  +
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL------KWM-APET-I 222
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGI-LFPG 183
           F  +Y  + D W+ G +++E+ S G   +PG
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L    + HRDL   N+LVS+  V K+ D G+ KE  S    T  +  +W   PE L   +
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALR-EK 361
Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            +  + D W+ G +++E+ SFG
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFG 383

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 182
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVA 205

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 123 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 181
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 182 TEKSACKSSDLWALGCIIYQLVA 204

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 99  HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCT---------DYVTTRWYR 147
           H+ G  HRD+KP+N+++S    +K+ D G+ + I DS    T          Y++    R
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           G  V   S++Y       ++G +++E+L+    F G S     Y+
Sbjct: 193 GDSVDARSDVY-------SLGCVLYEVLTGEPPFTGDSPDSVAYQ 230

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 125 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 183
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 184 TEKSACKSSDLWALGCIIYQLVA 206

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGL--ADNSRG------NDAISLHRQG 102
           LV++Y  C        VF  M    L  +     GL  A+   G           L    
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
             HRDL   N LV +  VIK+ D GM + +  D     T       +  PEV  FS  Y 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YS 185
Query: 160 PEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
            + D W+ G +M+E+ S G I +  +S+++ +  I
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGL--ADNSRG------NDAISLHRQG 102
           LV++Y  C        VF  M    L  +     GL  A+   G           L    
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 103 YFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
             HRDL   N LV +  VIK+ D GM + +  D     T       +  PEV  FS  Y 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YS 180
Query: 160 PEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
            + D W+ G +M+E+ S G I +  +S+++ +  I
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLL 153
           LH +G  HRDLKP N+L+++ + I+I D G  K +           +V T  Y  PE LL
Sbjct: 126 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LL 184
Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 185 TEKSACKSSDLWALGCIIYQLVA 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L    Y HRDL   N+LV+  ++ K+ D GM + ++ + P   Y T       RW   PE
Sbjct: 132 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-PEAAYTTRGGKIPIRWT-APE 189
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +M+E++S+G
Sbjct: 190 AIAYRK-FTSASDVWSYGIVMWEVMSYG 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            PE++ + E  G E D W++G I + +LS    F G +  + +  + 
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 4/82 (4%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L    + HRDL   N+LVS+  V K+ D G+ KE  S    T  +  +W   PE L    
Sbjct: 124 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEALR-EA 180
Query: 157 IYGPEVDKWAMGAIMFEMLSFG 178
            +  + D W+ G +++E+ SFG
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFG 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S +G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 132 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 192 -AYDFKADIWSLGITAIEL 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L    Y HRDL   N+LV+  ++ K+ D GM + ++ + P   Y T       RW   PE
Sbjct: 126 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-PEAAYTTRGGKIPIRWT-APE 183
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +M+E++S+G
Sbjct: 184 AIAYRK-FTSASDVWSYGIVMWEVMSYG 210

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
            PE++ + E  G E D W++G I + +LS    F G +  + +
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 214

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            PE++ + E  G E D W++G I + +LS    F G +  + +  + 
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
            PE++ + E  G E D W++G I + +LS    F G +  + +
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 105 HRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIYGPE 161
           HRDL   N LV +  VIK+ D GM + +  D     T       +  PEV  FS  Y  +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSK 185
Query: 162 VDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKI 193
            D W+ G +M+E+ S G I +  +S+++ +  I
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 99  HRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H +G  HRD+K  N+L+   +G  K+ D G    +    P TD+  TR Y  PE +   +
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQ 214
Query: 157 IYGPEVDKWAMGAIMFEMLSFGILF 181
            +      W++G ++++M+   I F
Sbjct: 215 YHALPATVWSLGILLYDMVCGDIPF 239

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            PE++ + E  G E D W++G I + +LS    F G +  + +  + 
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            PE++ + E  G E D W++G I + +LS    F G +  + +  + 
Sbjct: 184 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            PE++ + E  G E D W++G I + +LS    F G +  + +  + 
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 134 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 191
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 192 AIAYRK-FTSASDVWSYGIVLWEVMSYG 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 25/101 (24%)
Query: 98  LHRQG--YFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYV------------- 141
           +HRQ     HRDLK  NLL+S +G IK+ D G    I S+ P  DY              
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI-SHYP--DYSWSAQRRALVEEEI 208
Query: 142 ---TTRWYRGPEVL-LFSEI-YGPEVDKWAMGAIMFEMLSF 177
              TT  YR PE++ L+S    G + D WA+G I++ +L F
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCF 248

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
            PE++ + E  G E D W++G I + +LS    F G +  + +
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 30/166 (18%)
Query: 59  GHVEKAFKV-----FNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL 113
           GH+  AF++     F  ++E N Q + +           +    LH     H DLKP N+
Sbjct: 95  GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENI 154
Query: 114 L--------------------VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           L                    V    I++ D G     D     T  V TR YR PEV+L
Sbjct: 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT-FDHEHHTT-IVATRHYRPPEVIL 212
Query: 154 FSEI-YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
             E+ +    D W++G I+FE      LF    + + +  + +++G
Sbjct: 213 --ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 134 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 191
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 192 AIAYRK-FTSASDVWSYGIVLWEVMSYG 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
            PE++ + E  G E D W++G I + +LS    F G +  + +
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 215

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 96  ISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEV 151
           + LH  G  HRD+KP NLL+  +  +KI D G+      N           T  Y  PE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           L   E +   VD W+ G ++  ML+      G+   DQ    CQ
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA------GELPWDQPSDSCQ 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
            PE++ + E  G E D W++G I + +LS    F G +  + +
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 30/166 (18%)
Query: 59  GHVEKAFKV-----FNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL 113
           GH+  AF++     F  ++E N Q + +           +    LH     H DLKP N+
Sbjct: 127 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENI 186
Query: 114 L--------------------VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           L                    V    I++ D G     D     T  V TR YR PEV+L
Sbjct: 187 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT-FDHEHHTT-IVATRHYRPPEVIL 244
Query: 154 FSEI-YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
             E+ +    D W++G I+FE      LF    + + +  + +++G
Sbjct: 245 --ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 288

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            PE++ + E  G E D W++G I + +LS    F G +  + +  + 
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
            PE++ + E  G E D W++G I + +LS    F G +  + +
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            PE++ + E  G E D W++G I + +LS    F G +  + +  + 
Sbjct: 184 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K V    IK+ D G+  +I++     +   T  +  PE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            + E  G E D W++G I + +LS    F G++  + +  I 
Sbjct: 184 NY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 104 FHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPE 161
            HRDLKP+N+ +  K  +K+GD G+ + ++ +     ++V T +Y  PE +     Y  +
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMS-YNEK 196
Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
            D W++G +++E+ +    F   S  +   KI
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K V    IK+ D G+  +I++     +   T  +  PE++
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            + E  G E D W++G I + +LS    F G++  + +  I 
Sbjct: 205 NY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 245

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 16/101 (15%)
Query: 91  RGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI-------DSNLPCTDYVT 142
           RG +AI  H +GY HRDLKP+N+L+  +G   + DLG + +           L   D+  
Sbjct: 145 RGLEAI--HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 143 TRW---YRGPEVLLFSE--IYGPEVDKWAMGAIMFEMLSFG 178
            R    YR PE+       +     D W++G +++ M+ FG
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM-FG 242

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K V    IK+ D G+  +I++     +   T  +  PE++
Sbjct: 131 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 190
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
            + E  G E D W++G I + +LS    F G++  + +  I 
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 231

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 30/166 (18%)
Query: 59  GHVEKAFKV-----FNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL 113
           GH+  AF++     F  ++E N Q + +           +    LH     H DLKP N+
Sbjct: 104 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENI 163
Query: 114 L--------------------VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           L                    V    I++ D G     D     T  V TR YR PEV+L
Sbjct: 164 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT-FDHEHHTT-IVATRHYRPPEVIL 221
Query: 154 FSEI-YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
             E+ +    D W++G I+FE      LF    + + +  + +++G
Sbjct: 222 --ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 265

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 93  NDAISLHRQGYFHRDLKPSNLL-----VSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
           N    LH     H DLKP N++     V K  IKI D G+  +ID      +   T  + 
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
            PE++ + E  G E D W++G I + +LS    F G +  + +
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 151 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 208
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 209 AIAYRK-FTSASDVWSYGIVLWEVMSYG 235

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVLLFS 155
           LH     HRDLK  NL ++  + +KIGD G+  +I+ +     D   T  Y  PEVL   
Sbjct: 158 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC-K 216
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G I++ +L
Sbjct: 217 KGHSFEVDIWSLGCILYTLL 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTD-YVTTRWYRGPEVLLFSEIY 158
            HRDL   N+LV++  V+KI D G+ ++I   D     T+  +  +W   PE L F  IY
Sbjct: 164 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEAL-FDRIY 221
Query: 159 GPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 222 THQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 258

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 17/102 (16%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLLF 154
            HRDL   N+LV++  V+KI D G+ ++I       DY        +  +W   PE L F
Sbjct: 165 IHRDLAARNVLVTEDNVMKIADFGLARDIHH----IDYYKKTTNGRLPVKWM-APEAL-F 218
Query: 155 SEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             IY  + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 219 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 259

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 17/102 (16%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLLF 154
            HRDL   N+LV++  V+KI D G+ ++I       DY        +  +W   PE L F
Sbjct: 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHH----IDYYKKTTNGRLPVKWM-APEAL-F 210
Query: 155 SEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             IY  + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 211 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 251

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 3/78 (3%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H +   HRD+KP NLL+ S G +KI D G      S+   TD   T  Y  PE ++   +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPE-MIEGRM 182
Query: 158 YGPEVDKWAMGAIMFEML 175
           +  +VD W++G + +E L
Sbjct: 183 HDEKVDLWSLGVLCYEFL 200

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSN-LPCTDYVTTRWYRGPEVLLFS 155
           LH     HRDLK  NL ++  + +KIGD G+  +I+ +     D   T  Y  PEVL   
Sbjct: 142 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC-K 200
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G I++ +L
Sbjct: 201 KGHSFEVDIWSLGCILYTLL 220

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTD-YVTTRWYRGPEVLLFSEIY 158
            HRDL   N+LV++  V+KI D G+ ++I   D     T+  +  +W   PE L F  IY
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEAL-FDRIY 229
Query: 159 GPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 230 THQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 266

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTD-YVTTRWYRGPEVLLFSEIY 158
            HRDL   N+LV++  V+KI D G+ ++I   D     T+  +  +W   PE L F  IY
Sbjct: 161 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEAL-FDRIY 218
Query: 159 GPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 219 THQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 255

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTD-YVTTRWYRGPEVLLFSEIY 158
            HRDL   N+LV++  V+KI D G+ ++I   D     T+  +  +W   PE L F  IY
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEAL-FDRIY 229
Query: 159 GPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 230 THQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 266

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 81  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 131
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KP NLL+ S G +KI D G      S+   TD   T  Y  PE ++   ++  +VD
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPE-MIEGRMHDEKVD 189
Query: 164 KWAMGAIMFEML 175
            W++G + +E L
Sbjct: 190 LWSLGVLCYEFL 201

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLLFSEIYGP 160
           HRDL   N+LV++  V+KI D G+ ++I   D     T+      +  PE L F  IY  
Sbjct: 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTH 272
Query: 161 EVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
           + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 273 QSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 307

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS---EIYGP 160
           HRD+KPSN+L+ + G IK+ D G+  ++  ++  T     R Y  PE +  S   + Y  
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDV 208
Query: 161 EVDKWAMGAIMFEMLSFGILFPGKSSA-DQIYKICQLIGSPTK 202
             D W++G  ++E+ +    +P  +S  DQ+ ++ +  G P +
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQ 249

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 17/102 (16%)
Query: 104 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY--------VTTRWYRGPEVLLF 154
            HRDL   N+LV++  V+KI D G+ ++I       DY        +  +W   PE L F
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHH----IDYYKKTTNGRLPVKWM-APEAL-F 225
Query: 155 SEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQ 195
             IY  + D W+ G +++E+ +  G  +PG    ++++K+ +
Sbjct: 226 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 266

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 3/78 (3%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           H +   HRD+KP NLL+ S G +KI D G      S+   TD   T  Y  PE ++   +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPE-MIEGRM 187
Query: 158 YGPEVDKWAMGAIMFEML 175
           +  +VD W++G + +E L
Sbjct: 188 HDEKVDLWSLGVLCYEFL 205

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 14/89 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           LH Q Y HR L   N+L+    ++KIGD G+ K +       +Y   R        WY  
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-A 182
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
           PE L   + Y    D W+ G  ++E+L++
Sbjct: 183 PECLKECKFYYAS-DVWSFGVTLYELLTY 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 14/89 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           LH Q Y HR L   N+L+    ++KIGD G+ K +       +Y   R        WY  
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-A 183
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
           PE L   + Y    D W+ G  ++E+L++
Sbjct: 184 PECLKECKFYYAS-DVWSFGVTLYELLTY 211

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 104 FHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPE 161
            HRDLKP+N+ +  K  +K+GD G+ + ++ +      +V T +Y  PE +     Y  +
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEK 196
Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
            D W++G +++E+ +    F   S  +   KI
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 130
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KP NLL+ S G +KI D G      S+   TD   T  Y  PE ++   ++  +VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPE-MIEGRMHDEKVD 188
Query: 164 KWAMGAIMFEML 175
            W++G + +E L
Sbjct: 189 LWSLGVLCYEFL 200

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 161 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 218
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 219 AIAYRK-FTSASDVWSYGIVLWEVMSYG 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L    Y HRDL   N+LV+  ++ K+ D G+ + ++ + P   Y T+      RW   PE
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRW-TAPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +M+E++++G
Sbjct: 221 AISYRK-FTSASDVWSFGIVMWEVMTYG 247

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 104 FHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFSEIYGPE 161
            HRDLKP+N+ +  K  +K+GD G+ + ++ +      +V T +Y  PE +     Y  +
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEK 196
Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
            D W++G +++E+ +    F   S  +   KI
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N    +Y          +W   P
Sbjct: 120 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAP 174
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  
Sbjct: 175 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 233
Query: 209 IQLASNLNWK 218
           +     L WK
Sbjct: 234 LYQLMRLCWK 243

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N    D+   + +R        P
Sbjct: 131 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAWCAP 187
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L  +  +    D W  G  ++EM ++G
Sbjct: 188 ESLK-TRTFSHASDTWMFGVTLWEMFTYG 215

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N    D+   + +R        P
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAWCAP 183
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L  +  +    D W  G  ++EM ++G
Sbjct: 184 ESLK-TRTFSHASDTWMFGVTLWEMFTYG 211

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N    D+   + +R        P
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHXVMQEHRKVPFAWCAP 193
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L  +  +    D W  G  ++EM ++G
Sbjct: 194 ESLK-TRTFSHASDTWMFGVTLWEMFTYG 221

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N    D+   + +R        P
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHXVMQEHRKVPFAWCAP 183
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L  +  +    D W  G  ++EM ++G
Sbjct: 184 ESLK-TRTFSHASDTWMFGVTLWEMFTYG 211

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N    D+   + +R        P
Sbjct: 131 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAWCAP 187
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L  +  +    D W  G  ++EM ++G
Sbjct: 188 ESLK-TRTFSHASDTWMFGVTLWEMFTYG 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 19/110 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           LH Q Y HR+L   N+L+    ++KIGD G+ K +       +Y   R        WY  
Sbjct: 133 LHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-A 188
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
           PE L   + Y    D W+ G  ++E+L+        SS     K  +LIG
Sbjct: 189 PECLKEYKFYYAS-DVWSFGVTLYELLTH-----CDSSQSPPTKFLELIG 232

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 38/79 (48%), Gaps = 7/79 (8%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD----YVTTRWYRGPEVLLFSEIYG 159
           HRDL   N LV+ K V+KI D GM +E    +         V  +W   PE L +   Y 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT-APEALNYGR-YS 293
Query: 160 PEVDKWAMGAIMFEMLSFG 178
            E D W+ G +++E  S G
Sbjct: 294 SESDVWSFGILLWETFSLG 312

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N    D+   + +R        P
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAWCAP 193
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L  +  +    D W  G  ++EM ++G
Sbjct: 194 ESLK-TRTFSHASDTWMFGVTLWEMFTYG 221

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 19/110 (17%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           LH Q Y HR+L   N+L+    ++KIGD G+ K +       +Y   R        WY  
Sbjct: 133 LHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-A 188
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
           PE L   + Y    D W+ G  ++E+L+        SS     K  +LIG
Sbjct: 189 PECLKEYKFYYAS-DVWSFGVTLYELLTH-----CDSSQSPPTKFLELIG 232

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR-------GP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N    D+   + +R        P
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAWCAP 183
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           E L  +  +    D W  G  ++EM ++G
Sbjct: 184 ESLK-TRTFSHASDTWMFGVTLWEMFTYG 211

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 18/100 (18%)
Query: 87  ADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM-------VKEIDSNLPCT 138
           AD +RG D +S  ++ + HRDL   N+LV +  V KI D G+       VK+    LP  
Sbjct: 139 ADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 194
Query: 139 DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
                RW    E L +S +Y    D W+ G +++E++S G
Sbjct: 195 ----VRWM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSLG 228

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N            +W   PE + 
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEAIN 183
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  +   
Sbjct: 184 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 213 SNLNWK 218
             L WK
Sbjct: 243 MRLCWK 248

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N            +W   PE + 
Sbjct: 126 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEAIN 184
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  +   
Sbjct: 185 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 243
Query: 213 SNLNWK 218
             L WK
Sbjct: 244 MRLCWK 249

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 18/100 (18%)
Query: 87  ADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM-------VKEIDSNLPCT 138
           AD +RG D +S  ++ + HRDL   N+LV +  V KI D G+       VK+    LP  
Sbjct: 149 ADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 204
Query: 139 DYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
                RW    E L +S +Y    D W+ G +++E++S G
Sbjct: 205 ----VRWM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSLG 238

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 99  HRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLL 153
           H     HRD+KP  +L++       +K+G  G+  ++ +S L     V T  +  PEV+ 
Sbjct: 149 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 208
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPG 183
             E YG  VD W  G I+F +LS  + F G
Sbjct: 209 -REPYGKPVDVWGCGVILFILLSGCLPFYG 237

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N            +W   PE + 
Sbjct: 127 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEAIN 185
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  +   
Sbjct: 186 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 244
Query: 213 SNLNWK 218
             L WK
Sbjct: 245 MRLCWK 250

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 14/90 (15%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTR--------WYRG 148
           L  + + HR+L   N LLV++   KI D G+ K + ++     Y T R        WY  
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWY-A 507
Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE + F + +    D W+ G  M+E LS+G
Sbjct: 508 PECINFRK-FSSRSDVWSYGVTMWEALSYG 536

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 8/108 (7%)
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDS----NLPCTDYVTTRWYRGPEVLLFSEIYG 159
           H+DL   N+LV  K  +KI DLG+ +E+ +     L     +  RW   PE +++ + + 
Sbjct: 168 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-APEAIMYGK-FS 225
Query: 160 PEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
            + D W+ G +++E+ S+G+  + G S+ D +  I      P  D  P
Sbjct: 226 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCP 273

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N    +Y          +W   P
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAP 179
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  
Sbjct: 180 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 209 IQLASNLNWK 218
           +     L WK
Sbjct: 239 LYQLMRLCWK 248

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V K  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 85  ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 135
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 188
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 189 DEKVDLWSLGVLCYEFL 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N            +W   PE + 
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEAIN 183
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  +   
Sbjct: 184 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 213 SNLNWK 218
             L WK
Sbjct: 243 MRLCWK 248

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N            +W   PE + 
Sbjct: 134 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEAIN 192
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  +   
Sbjct: 193 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 251
Query: 213 SNLNWK 218
             L WK
Sbjct: 252 MRLCWK 257

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 38/79 (48%), Gaps = 7/79 (8%)
Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD----YVTTRWYRGPEVLLFSEIYG 159
           HRDL   N LV+ K V+KI D GM +E    +         V  +W   PE L +   Y 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YS 293
Query: 160 PEVDKWAMGAIMFEMLSFG 178
            E D W+ G +++E  S G
Sbjct: 294 SESDVWSFGILLWETFSLG 312

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N    +Y          +W   P
Sbjct: 130 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAP 184
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  
Sbjct: 185 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 243
Query: 209 IQLASNLNWK 218
           +     L WK
Sbjct: 244 LYQLMRLCWK 253

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N            +W   PE + 
Sbjct: 131 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEAIN 189
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  +   
Sbjct: 190 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 248
Query: 213 SNLNWK 218
             L WK
Sbjct: 249 MRLCWK 254

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 14/89 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L    + HRDL   N LV + + +K+ D GM + +  +     YV++       +W   P
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKW-SAP 174
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           EV  + + Y  + D WA G +M+E+ S G
Sbjct: 175 EVFHYFK-YSSKSDVWAFGILMWEVFSLG 202

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N    +Y          +W   P
Sbjct: 131 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAP 185
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  
Sbjct: 186 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 244
Query: 209 IQLASNLNWK 218
           +     L WK
Sbjct: 245 LYQLMRLCWK 254

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 99  HRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLL 153
           H     HRD+KP  +L++       +K+G  G+  ++ +S L     V T  +  PEV+ 
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPG 183
             E YG  VD W  G I+F +LS  + F G
Sbjct: 207 -REPYGKPVDVWGCGVILFILLSGCLPFYG 235

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTD---YVTTRWYRGPEVLL 153
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N            +W   PE + 
Sbjct: 133 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-TAPEAIN 191
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  +   
Sbjct: 192 YG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 250
Query: 213 SNLNWK 218
             L WK
Sbjct: 251 MRLCWK 256

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 8/108 (7%)
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDS----NLPCTDYVTTRWYRGPEVLLFSEIYG 159
           H+DL   N+LV  K  +KI DLG+ +E+ +     L     +  RW   PE +++ + + 
Sbjct: 151 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-APEAIMYGK-FS 208
Query: 160 PEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
            + D W+ G +++E+ S+G+  + G S+ D +  I      P  D  P
Sbjct: 209 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCP 256

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/79 (26%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L  +   HRD+K  N+++++   IK+ D G    ++       +  T  Y  PEVL+ + 
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205
Query: 157 IYGPEVDKWAMGAIMFEML 175
             GPE++ W++G  ++ ++
Sbjct: 206 YRGPELEMWSLGVTLYTLV 224

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           +  + Y HRDL+ +N+LVS  +  KI D G+ + I+ N    +Y          +W   P
Sbjct: 135 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAP 189
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  
Sbjct: 190 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 248
Query: 209 IQLASNLNWK 218
           +     L WK
Sbjct: 249 LYQLMRLCWK 258

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 49/113 (43%), Gaps = 25/113 (22%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI-----------DSNLPCTDYVTTRW 145
           LH Q Y HRDL   N+L+    ++KIGD G+ K +           D + P        W
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVF------W 203
Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG 198
           Y  PE L   + Y    D W+ G  ++E+L+        SS     K  +LIG
Sbjct: 204 Y-APECLKEYKFYYAS-DVWSFGVTLYELLTH-----CDSSQSPPTKFLELIG 249

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI-DSNLPCTDYVT-TRWYRGPEVLLFS 155
           H     HRD+KP N+L+ S   +KI D G+ K + +++L  T++V  T  Y  PE     
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKG 186
Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
           E      D +++G +++EML     F G+++     K  Q       DS P    + +++
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ-------DSVP---NVTTDV 236
Query: 216 NWKLPQ 221
              +PQ
Sbjct: 237 RKDIPQ 242

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/88 (27%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   G+ HRDL   N+L++  ++ K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TSPE 220
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
            + + + +    D W+ G +++E++S+G
Sbjct: 221 AIAYRK-FTSASDVWSYGIVLWEVMSYG 247

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 84  ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY---ITELAN------ALSYCHSKRVI 134
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 187
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 188 DEKVDLWSLGVLCYEFL 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 130
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KP NLL+ S G +KI D G      S+   T+   T  Y  PE ++   ++  +VD
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TELCGTLDYLPPE-MIEGRMHDEKVD 188
Query: 164 KWAMGAIMFEML 175
            W++G + +E L
Sbjct: 189 LWSLGVLCYEFL 200

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LH     HRDLK  NL ++  + +KIGD G+  +I+ +      +  T  Y  PEVL   
Sbjct: 158 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLC-K 216
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G I++ +L
Sbjct: 217 KGHSFEVDIWSLGCILYTLL 236

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 103 YFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGPEVLLF 154
           Y HRDL   N+LV+  ++ K+ D G+ + ++ +     Y +        RW   PE + +
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPEAIQY 214
Query: 155 SEIYGPEVDKWAMGAIMFEMLSFG 178
            + +    D W+ G +M+E++S+G
Sbjct: 215 RK-FTSASDVWSYGIVMWEVMSYG 237

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 222
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 268

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 208
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 254

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 207
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 207
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 234
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 235 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 280

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 214
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 260

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 222
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 268

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFS 155
           LH     HRDLK  NL ++  + +KIGD G+  +I+ +      +  T  Y  PEVL   
Sbjct: 158 LHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLC-K 216
Query: 156 EIYGPEVDKWAMGAIMFEML 175
           + +  EVD W++G I++ +L
Sbjct: 217 KGHSFEVDIWSLGCILYTLL 236

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 208
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 254

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 224
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 225 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 270

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/95 (27%), Positives = 49/95 (51%), Gaps = 15/95 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 350
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG 183
           E  L+   +  + D W+ G ++ E+ + G + +PG
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 222
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 268

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/95 (27%), Positives = 49/95 (51%), Gaps = 15/95 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 350
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG 183
           E  L+   +  + D W+ G ++ E+ + G + +PG
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASYYRKGGCAML 199
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 200 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 245

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 55/103 (53%), Gaps = 8/103 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLL 153
           L ++ + HRDL   N LV +  ++K+ D G+ + +  +    P       +W   PE L 
Sbjct: 129 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPESLA 187
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           +++ +  + D WA G +++E+ ++G+  +PG     Q+Y++ +
Sbjct: 188 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/95 (27%), Positives = 49/95 (51%), Gaps = 15/95 (15%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 350
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG 183
           E  L+   +  + D W+ G ++ E+ + G + +PG
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 3/78 (3%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH QG  H D+KP+N+ +  +G  K+GD G++ E+ +            Y  PE+L  S 
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS- 231
Query: 157 IYGPEVDKWAMGAIMFEM 174
            YG   D +++G  + E+
Sbjct: 232 -YGTAADVFSLGLTILEV 248

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH +   HRDLK  N+L++ +G I++ D G+  +    L   D ++ T ++  PEV++  
Sbjct: 125 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 184
Query: 156 EI----YGPEVDKWAMGAIMFEM 174
            +    Y  + D W++G  + EM
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEM 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 44/81 (54%), Gaps = 10/81 (12%)
Query: 105 HRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT------RWYRGPEVLLFSEI 157
           HRDL   N+LV+  ++ K+ D GM + ++ + P   Y T       RW   PE + + + 
Sbjct: 154 HRDLAARNILVNSNLVCKVSDFGMSRVLEDD-PEAAYTTRGGKIPIRWT-APEAIAYRK- 210
Query: 158 YGPEVDKWAMGAIMFEMLSFG 178
           +    D W+ G +M+E++S+G
Sbjct: 211 FTSASDVWSYGIVMWEVMSYG 231

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N            +W   PE  L
Sbjct: 120 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL 178
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           +   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 179 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 220

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 55/103 (53%), Gaps = 8/103 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLL 153
           L ++ + HRDL   N LV +  ++K+ D G+ + +  +    P       +W   PE L 
Sbjct: 128 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPESLA 186
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           +++ +  + D WA G +++E+ ++G+  +PG     Q+Y++ +
Sbjct: 187 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 13/83 (15%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVL 152
           H +   HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEM 182
Query: 153 LFSEIYGPEVDKWAMGAIMFEML 175
           +   ++  +VD W++G + +E L
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFL 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTTRWYR------GPE 150
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y   +  +       PE
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWTAPE 434
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG 183
             L+   +  + D W+ G ++ E+ + G + +PG
Sbjct: 435 AALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 13/132 (9%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 106 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 156
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KP NLL+ S G +KI D G      S+    D   T  Y  PE ++   ++  +VD
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RDDLCGTLDYLPPE-MIEGRMHDEKVD 214
Query: 164 KWAMGAIMFEML 175
            W++G + +E L
Sbjct: 215 LWSLGVLCYEFL 226

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 106 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 156
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 209
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 210 DEKVDLWSLGVLCYEFL 226

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH +   HRDLK  N+L++ +G I++ D G+  +    L   D ++ T ++  PEV++  
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 156 EI----YGPEVDKWAMGAIMFEM 174
            +    Y  + D W++G  + EM
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 80  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 130
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 183
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 184 DEKVDLWSLGVLCYEFL 200

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 13/83 (15%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVL 152
           H +   HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  +
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEM 194
Query: 153 LFSEIYGPEVDKWAMGAIMFEML 175
           +   ++  +VD W++G + +E L
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFL 217

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 97  SLHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           S+  +   HRDLKP NLL+  G  V+KI D G   +I +++  T+   +  +  PEV   
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEG 178
Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
           S  Y  + D ++ G I++E+++
Sbjct: 179 SN-YSEKCDVFSWGIILWEVIT 199

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 84  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 134
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 187
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 188 DEKVDLWSLGVLCYEFL 204

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 97  SLHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           S+  +   HRDLKP NLL+  G  V+KI D G   +I +++  T+   +  +  PEV   
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEG 177
Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
           S  Y  + D ++ G I++E+++
Sbjct: 178 SN-YSEKCDVFSWGIILWEVIT 198

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 127 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 181
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 182 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 13/83 (15%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVL 152
           H +   HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEM 180
Query: 153 LFSEIYGPEVDKWAMGAIMFEML 175
           +   ++  +VD W++G + +E L
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFL 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 79  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 129
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 182
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 183 DEKVDLWSLGVLCYEFL 199

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 181
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 182 INYYK-FSSKSDVWSFGVLMWEAFSYG 207

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N            +W   PE  L
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL 188
Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           +   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 189 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY-APEC 185
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 186 INYYK-FSSKSDVWSFGVLMWEAFSYG 211

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 123 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 177
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 178 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 223

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 121 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 179
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 180 INYYK-FSSKSDVWSFGVLMWEAFSYG 205

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG----- 148
           L    + HRD+   N LL   G   V KIGD GM ++I        Y  + + +G     
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI--------YRASYYRKGGCAML 208
Query: 149 -----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                P       I+  + D W+ G +++E+ S G + +P KS+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 254

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 13/83 (15%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVL 152
           H +   HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  +
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYL-------PPEM 178
Query: 153 LFSEIYGPEVDKWAMGAIMFEML 175
           +   ++  +VD W++G + +E L
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFL 201

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 185
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 186 INYYK-FSSKSDVWSFGVLMWEAFSYG 211

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 77  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 127
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 180
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 181 DEKVDLWSLGVLCYEFL 197

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 13/132 (9%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 133
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           HRD+KP NLL+ S G +KI D G      S+    D   T  Y  PE ++   ++  +VD
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RDDLCGTLDYLPPE-MIEGRMHDEKVD 191
Query: 164 KWAMGAIMFEML 175
            W++G + +E L
Sbjct: 192 LWSLGVLCYEFL 203

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 184
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 185 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 191
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 192 INYYK-FSSKSDVWSFGVLMWEAFSYG 217

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 121 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 175
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 176 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 221

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 119 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 173
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 174 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 219

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 184
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 185 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 184
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 185 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 184
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 185 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 83  ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---ITELAN------ALSYCHSKRVI 133
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYL-------PPEMIEGRMH 186
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 187 DEKVDLWSLGVLCYEFL 203

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 184
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 185 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 13/104 (12%)
Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVL 152
           H +   HRD+KP NLL+ S G +KI D G      S+         DY+       P  +
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYL-------PPEM 177
Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL 196
           +   ++  +VD W++G + +E L     F   +  D   +I ++
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV 221

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 50/121 (41%), Gaps = 23/121 (19%)
Query: 98  LHRQGYFHRDLKPSNLLVSKG--------------------VIKIGDLGMVKEIDSNLPC 137
           LH     H DLKP N+L  +                      IK+ D G     D +   
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-- 191
Query: 138 TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
           +  V+TR YR PEV+L      P  D W++G I+ E      +FP   S + +  + +++
Sbjct: 192 STLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250
Query: 198 G 198
           G
Sbjct: 251 G 251

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 56/121 (46%), Gaps = 30/121 (24%)
Query: 90  SRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRW--- 145
           +RG D   LH +   HRDLK +N+ + +   +KIGD G+  E            +RW   
Sbjct: 130 ARGMDY--LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-----------KSRWSGS 176
Query: 146 -----------YRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
                      +  PEV+    S  Y  + D +A G +++E+++  + +   ++ DQI +
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236
Query: 193 I 193
           +
Sbjct: 237 M 237

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           +  + Y HR+L+ +N+LVS  +  KI D G+ + I+ N    +Y          +W   P
Sbjct: 121 IEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAP 175
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           E + +   +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P  
Sbjct: 176 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 234
Query: 209 IQLASNLNWK 218
           +     L WK
Sbjct: 235 LYQLMRLCWK 244

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 18/107 (16%)
Query: 98  LHRQGYFHRDLKPSNLLVSKGVI-KIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV + ++ K+ D G+ + I+ N    +Y          +W   P
Sbjct: 130 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAP 184
Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPG---KSSADQIYK 192
           E  L+   +  + D W+ G ++ E+ + G + +PG   +   DQ+ +
Sbjct: 185 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 143 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 201
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 202 INYYK-FSSKSDVWSFGVLMWEAFSYG 227

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 143 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 201
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 202 INYYK-FSSKSDVWSFGVLMWEAFSYG 227

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 141 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 199
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 200 INYYK-FSSKSDVWSFGVLMWEAFSYG 225

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 56/121 (46%), Gaps = 30/121 (24%)
Query: 90  SRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRW--- 145
           +RG D   LH +   HRDLK +N+ + +   +KIGD G+  E            +RW   
Sbjct: 130 ARGMDY--LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-----------KSRWSGS 176
Query: 146 -----------YRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
                      +  PEV+    S  Y  + D +A G +++E+++  + +   ++ DQI +
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236
Query: 193 I 193
           +
Sbjct: 237 M 237

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/147 (22%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 67  VFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG-VIKIGDL 125
           + + +RE N +  T ++         +    L ++ + HRDL   N LV +  V+K+ D 
Sbjct: 115 LLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADF 174
Query: 126 GMVKEIDSNLPCTDYVTTRW---YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-F 181
           G+ + +  +   T +   ++   +  PE L ++  +  + D WA G +++E+ ++G+  +
Sbjct: 175 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPY 232
Query: 182 PGKSSA------DQIYKICQLIGSPTK 202
           PG   +      ++ Y++ Q  G P K
Sbjct: 233 PGIDLSQVYDLLEKGYRMEQPEGCPPK 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 46  AIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-HRQGYF 104
           A    L+  Y+  G V +  +  +   E+   ++   I+ LA+      A+S  H +   
Sbjct: 84  ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY---ITELAN------ALSYCHSKRVI 134
Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEVLLFSEIY 158
           HRD+KP NLL+ S G +KI D G      S+   T     DY+       P  ++   ++
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYL-------PPEMIEGRMH 187
Query: 159 GPEVDKWAMGAIMFEML 175
             +VD W++G + +E L
Sbjct: 188 DEKVDLWSLGVLCYEFL 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK------EIDSNLPCTDYVTTRWYRGPE 150
           LH+ G  HRD+K  N+L+ + G ++I D G+        +I  N     +V T  +  PE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLS 176
           V+     Y  + D W+ G    E+ +
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELAT 222

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 56/121 (46%), Gaps = 30/121 (24%)
Query: 90  SRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRW--- 145
           +RG D   LH +   HRDLK +N+ + +   +KIGD G+             V +RW   
Sbjct: 118 ARGMDY--LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT-----------VKSRWSGS 164
Query: 146 -----------YRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
                      +  PEV+    S  Y  + D +A G +++E+++  + +   ++ DQI +
Sbjct: 165 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 224
Query: 193 I 193
           +
Sbjct: 225 M 225

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 94  DAIS-LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPE 150
           DA++ LH     HRDLK  N+L +  G IK+ D G+  +    +   D ++ T ++  PE
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 205
Query: 151 VLLFS----EIYGPEVDKWAMGAIMFEM 174
           V++        Y  + D W++G  + EM
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 485 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 543
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 544 INYYK-FSSKSDVWSFGVLMWEAFSYG 569

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 8/87 (9%)
Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEV 151
           L    + HRDL   N LLV++   KI D G+ K + ++       T      +WY  PE 
Sbjct: 486 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APEC 544
Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           + + + +  + D W+ G +M+E  S+G
Sbjct: 545 INYYK-FSSKSDVWSFGVLMWEAFSYG 570

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK------EIDSNLPCTDYVTTRWYRGPE 150
           LH+ G  HRD+K  N+L+ + G ++I D G+        +I  N     +V T  +  PE
Sbjct: 132 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLS 176
           V+     Y  + D W+ G    E+ +
Sbjct: 192 VMEQVRGYDFKADIWSFGITAIELAT 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L  Q   HRD+KP N+L+ + G + I D  +   +      T    T+ Y  PE  +FS 
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE--MFSS 188
Query: 157 I----YGPEVDKWAMGAIMFEML 175
                Y   VD W++G   +E+L
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELL 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/139 (23%), Positives = 67/139 (48%), Gaps = 18/139 (12%)
Query: 67  VFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG-VIKIGDL 125
           + + +RE N Q  + ++         +    L ++ + HRDL   N LV +  ++K+ D 
Sbjct: 94  LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 153
Query: 126 GMVKEIDSNLPCTDYVTT--------RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF 177
           G+     S L   D  T         +W   PE L +++ +  + D WA G +++E+ ++
Sbjct: 154 GL-----SRLMTGDTFTAHAGAKFPIKW-TAPESLAYNK-FSIKSDVWAFGVLLWEIATY 206
Query: 178 GIL-FPGKSSADQIYKICQ 195
           G+  +PG   + Q+Y++ +
Sbjct: 207 GMSPYPGIDPS-QVYELLE 224

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	234
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-49
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-48
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-44
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-44
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-44
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-42
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-42
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-42
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-42
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-42
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-41
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-41
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-41
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-41
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-41
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-41
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-41
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-40
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-40
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-40
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-40
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-39
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-38
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-38
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-38
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-38
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-38
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-37
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-35
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-32
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-23
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-21
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-20
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-20
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-18
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-17
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-17
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-16
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-16
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-16
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-16
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-15
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-15
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-15
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-14
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-14
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-14
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-14
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-13
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-12
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-12
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-12
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-12
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-12
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-11
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-10
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-10
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-10
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-10
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-10
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-10
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-10
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-10
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-10
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-10
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-09
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-09
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-09
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-09
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-09
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-09
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-09
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-09
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-09
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-09
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-09
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-09
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-09
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-08
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-08
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-08
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-08
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-08
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-08
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-08
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-08
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-08
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-08
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-08
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-08
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-08
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-08
3spa_A	1134	Mtrpol, DNA-directed RNA polymerase, mitochondrial	5e-08
3spa_A	1134	Mtrpol, DNA-directed RNA polymerase, mitochondrial	4e-04
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-08
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-08
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-07
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-07
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-07
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-07
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-07
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-06
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-06
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-06
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-06
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-06
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-06
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-06
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-04

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  162 bits (412), Expect = 4e-49
 Identities = 48/134 (35%), Positives = 68/134 (50%), Gaps = 2/134 (1%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFS 155
            H+    HRD+KP N+L++K  VIK+ D G  + +        D V TRWYR PE+L+  
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             YGP VD WA+G +  E+LS   L+PGKS  DQ+Y I + +G        +        
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237

Query: 216 NWKLPQMGGVNLLA 229
             K+P    +  L 
Sbjct: 238 GVKIPDPEDMEPLE 251

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  160 bits (407), Expect = 3e-48
 Identities = 47/126 (37%), Positives = 66/126 (52%), Gaps = 2/126 (1%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
            H     HRD+KP N+LVS+ GV+K+ D G  + + +      D V TRWYR PE+L+  
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             YG  VD WA+G ++ EM     LFPG S  DQ+Y I   +G+       L  +     
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259

Query: 216 NWKLPQ 221
             +LP+
Sbjct: 260 GVRLPE 265

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  152 bits (387), Expect = 2e-44
 Identities = 42/135 (31%), Positives = 72/135 (53%), Gaps = 4/135 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++         +  
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR--EMNPNYT 289

Query: 216 NWKLPQMGGVNLLAV 230
            +K PQ+       V
Sbjct: 290 EFKFPQIKAHPWTKV 304

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  151 bits (383), Expect = 5e-44
 Identities = 43/135 (31%), Positives = 74/135 (54%), Gaps = 4/135 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+    GV+K+ D G  K + +  P   Y+ +R+YR PE++  +
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGA 216

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             Y   +D W+ G +M E++    LFPG+S  DQ+ +I +++G+P+++         + +
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK--TMNPNYM 274

Query: 216 NWKLPQMGGVNLLAV 230
             K PQ+       V
Sbjct: 275 EHKFPQIRPHPFSKV 289

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  148 bits (377), Expect = 6e-44
 Identities = 56/138 (40%), Positives = 71/138 (51%), Gaps = 5/138 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV+  G +K+ D G+ +     +  T  V T WYR PEVLL S 
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G I  EM     LF G S ADQ+ KI  LIG P +D WP  + L     
Sbjct: 196 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP---R 251

Query: 217 WKLPQMGGVNLLAVMPSA 234
              P  G   + +V+P  
Sbjct: 252 GAFPPRGPRPVQSVVPEM 269

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  146 bits (370), Expect = 1e-42
 Identities = 54/146 (36%), Positives = 71/146 (48%), Gaps = 13/146 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+LV+  G IK+ D G+ +     +  T  V T WYR PEVLL S 
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL----- 211
            Y   VD W++G I  EM     LF G S  DQ+ KI  +IG P ++ WP  + L     
Sbjct: 196 -YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 254

Query: 212 ----ASNLNWKLPQMG--GVNLLAVM 231
               A  +   +  +   G +LL   
Sbjct: 255 HSKSAQPIEKFVTDIDELGKDLLLKC 280

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  145 bits (369), Expect = 2e-42
 Identities = 56/178 (31%), Positives = 87/178 (48%), Gaps = 28/178 (15%)

Query: 71  MREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV 128
           +   +++++ +M   GL           LH+    HRDLKP+NLL+   GV+K+ D G+ 
Sbjct: 109 LTPSHIKAYMLMTLQGLE---------YLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159

Query: 129 KEIDSNLPCTDY---VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
           K   S  P   Y   V TRWYR PE+L  + +YG  VD WA+G I+ E+L      PG S
Sbjct: 160 KSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217

Query: 186 SADQIYKICQLIGSPTKDSWP----------LGIQLASNLNWKLPQMG--GVNLLAVM 231
             DQ+ +I + +G+PT++ WP                  L+      G   ++L+  +
Sbjct: 218 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 275

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  143 bits (363), Expect = 5e-42
 Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 22/153 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
            H +   HRDLKP NLL++  G +K+ + G+ +     +P   Y   V T WYR P+VL 
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLF 174

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQLIGSPTKDSWPLGI--- 209
            +++Y   +D W+ G I  E+ + G  LFPG    DQ+ +I +L+G+PT++ WP  +   
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SMTKL 233

Query: 210 ---------QLASNLNWKLPQMG--GVNLLAVM 231
                       ++L   +P++   G +LL  +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNL 266

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  143 bits (364), Expect = 5e-42
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 20/152 (13%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
            H+    HRDLKP NLL++  G +K+ D G+ +     +P   Y   V T WYR P+VL+
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLM 192

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP------- 206
            S+ Y   VD W++G I  EM++   LFPG +  DQ+ KI  ++G+P    WP       
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252

Query: 207 -----LGIQLASNLNWKLPQMG--GVNLLAVM 231
                  +      +  +P     G++LL+ M
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNM 284

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  142 bits (360), Expect = 1e-41
 Identities = 50/149 (33%), Positives = 79/149 (53%), Gaps = 15/149 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
            H +   HRDLKP NLL++ +G +KI D G+ +     +   T  + T WYR P+VL+ S
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL---- 211
           + Y   +D W++G I  EM++   LFPG S ADQ+ +I +++G+P   +WP   +L    
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 212 -------ASNLNWKLPQMG--GVNLLAVM 231
                         L  +   G++LL+ M
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKM 264

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  142 bits (361), Expect = 2e-41
 Identities = 56/182 (30%), Positives = 93/182 (51%), Gaps = 30/182 (16%)

Query: 69  NLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG 126
           N++   N++ +   +  GLA           HRQ   HRDLKP NLL++ +G +K+ D G
Sbjct: 95  NIINMHNVKLFLFQLLRGLA---------YCHRQKVLHRDLKPQNLLINERGELKLADFG 145

Query: 127 MVKEIDSNLPCTDY---VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG 183
           + +    ++P   Y   V T WYR P++LL S  Y  ++D W +G I +EM +   LFPG
Sbjct: 146 LARAK--SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203

Query: 184 KSSADQIYKICQLIGSPTKDSWP------------LGIQLASNLNWKLPQMG--GVNLLA 229
            +  +Q++ I +++G+PT+++WP                 A  L    P++   G +LL 
Sbjct: 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLT 263

Query: 230 VM 231
            +
Sbjct: 264 KL 265

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  143 bits (363), Expect = 3e-41
 Identities = 43/140 (30%), Positives = 78/140 (55%), Gaps = 6/140 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLLV      +K+ D G  K++  + P   Y+ +R+YR PE++L +
Sbjct: 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA 216

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             Y P +D W++G +  E++    LF G++S DQ+ +I Q++G+PTK+      ++  + 
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMI---RMNPHY 273

Query: 216 NW-KLPQMGGVNLLAVMPSA 234
              + P +   +   ++P  
Sbjct: 274 TEVRFPTLKAKDWRKILPEG 293

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  141 bits (359), Expect = 3e-41
 Identities = 42/113 (37%), Positives = 65/113 (57%), Gaps = 6/113 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRGPEVLL 153
            H     HRDLKP NLL++ +G +K+GD G+ +     +P   +   V T WYR P+VL+
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLM 181

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            S  Y   +D W+ G I+ EM++   LFPG +  +Q+  I  ++G+P +  WP
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  142 bits (360), Expect = 5e-41
 Identities = 54/139 (38%), Positives = 73/139 (52%), Gaps = 4/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V     +KI D G+ +  D+ +  T YV TRWYR PEV+L   
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILSWM 199

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-LGIQLASNL 215
            Y   VD W++G IM EML+   LF GK   DQ+ +I ++ G P  +    L  + A + 
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259

Query: 216 NWKLPQMGGVNLLAVMPSA 234
              LPQ    +   + P A
Sbjct: 260 IQSLPQTPRKDFTQLFPRA 278

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  142 bits (361), Expect = 5e-41
 Identities = 52/139 (37%), Positives = 76/139 (54%), Gaps = 4/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V     +KI D G+ ++ DS +  T YV TRWYR PEV+L   
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWM 201

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS-WPLGIQLASNL 215
            Y   VD W++G IM EM++   LF G    DQ+ +I ++ G+P  +    L    A N 
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261

Query: 216 NWKLPQMGGVNLLAVMPSA 234
              LP++   +  +++ +A
Sbjct: 262 MKGLPELEKKDFASILTNA 280

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  141 bits (359), Expect = 6e-41
 Identities = 43/115 (37%), Positives = 61/115 (53%), Gaps = 6/115 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC-----TDYVTTRWYRGPEV 151
           +HR    HRD+K +N+L++  GV+K+ D G+ +             T+ V T WYR PE+
Sbjct: 140 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           LL    YGP +D W  G IM EM +   +  G +   Q+  I QL GS T + WP
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  141 bits (358), Expect = 1e-40
 Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 3/140 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDL P N+L+     I I D  + +E  ++   T YVT RWYR PE+++  +
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-LGIQLASN- 214
            +   VD W+ G +M EM +   LF G +  +Q+ KI +++G+P  +         A + 
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269

Query: 215 LNWKLPQMGGVNLLAVMPSA 234
           L   L  +      AV+P+A
Sbjct: 270 LRNSLSNVPARAWTAVVPTA 289

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  140 bits (355), Expect = 1e-40
 Identities = 53/146 (36%), Positives = 75/146 (51%), Gaps = 12/146 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVS------KGVIKIGDLGMVKEIDSNLPCTDY---VTTRWYRG 148
            H +   HRDLKP NLL+S        V+KIGD G+ +     +P   +   + T WYR 
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRP 205

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           PE+LL S  Y   VD W++  I  EML    LFPG S  DQ++KI +++G P   +WP G
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP-G 264

Query: 209 IQLASNLNWKLPQMGGVNLLAVMPSA 234
           +    +     P+  G  L  V+ + 
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGAL 290

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  141 bits (357), Expect = 2e-40
 Identities = 53/139 (38%), Positives = 72/139 (51%), Gaps = 4/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H     HRDLKPSNL V     +KI D G+ +     +  T YV TRWYR PE++L   
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIMLNWM 205

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS-WPLGIQLASNL 215
            Y   VD W++G IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265

Query: 216 NWKLPQMGGVNLLAVMPSA 234
              L QM  +N   V   A
Sbjct: 266 IQSLTQMPKMNFANVFIGA 284

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  140 bits (354), Expect = 4e-40
 Identities = 54/143 (37%), Positives = 79/143 (55%), Gaps = 6/143 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC----TDYVTTRWYRGPEVL 152
           +H     HRDLKPSNLL+ +   +KI D G+ +  D +       T+YV TRWYR PE++
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS-WPLGIQL 211
           L S+ Y   +D W++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++    +    
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263

Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
           A N    LP    V    + P+A
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNA 286

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  135 bits (343), Expect = 7e-39
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 6/143 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSNLPC----TDYVTTRWYRGPEV 151
           +H     HRDLKP+NL ++    V+KIGD G+ + +D +       ++ + T+WYR P +
Sbjct: 136 IHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL 211
           LL    Y   +D WA G I  EML+   LF G    +Q+  I + I    ++     + +
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV 255

Query: 212 ASNLNWKLPQMGGVNLLAVMPSA 234
                          L  ++P  
Sbjct: 256 IPVYIRNDMTEPHKPLTQLLPGI 278

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  137 bits (347), Expect = 1e-38
 Identities = 44/127 (34%), Positives = 63/127 (49%), Gaps = 18/127 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNL-PCTDY---VTTRWYRG 148
           LH     HRDLKP+N+LV      +G +KI D+G  +  +S L P  D    V T WYR 
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS---------SADQIYKICQLIGS 199
           PE+LL +  Y   +D WA+G I  E+L+   +F  +            DQ+ +I  ++G 
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263

Query: 200 PTKDSWP 206
           P    W 
Sbjct: 264 PADKDWE 270

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  136 bits (344), Expect = 1e-38
 Identities = 42/147 (28%), Positives = 75/147 (51%), Gaps = 6/147 (4%)

Query: 91  RGNDAISLHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG 148
           R    + L      HRD+KP N+LV  + G +K+ D G  K++  + P   Y+ +R+YR 
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLG 208
           PE++  ++ Y   VD W++G I  EM+    +F G +SA Q+++I +++G P+++     
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR-- 257

Query: 209 IQLASNLNW-KLPQMGGVNLLAVMPSA 234
            +L  +     L    G+    V    
Sbjct: 258 -KLNPSHTDVDLYNSKGIPWSNVFSDH 283

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  138 bits (349), Expect = 1e-38
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 238

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298

Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 299 ENRPKYAGLTFPKLFPDS 316

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  135 bits (343), Expect = 2e-38
 Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 14/151 (9%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC-----------TDYVTTRW 145
           LH     HRDLKPSNLL+ S   +K+ D G+ + ID +               ++V TRW
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187

Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW 205
           YR PEV+L S  Y   +D W+ G I+ E+     +FPG+    Q+  I  +IG+P  D+ 
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247

Query: 206 PLGIQ--LASNLNWKLPQMGGVNLLAVMPSA 234
              I+   A      LP      L  + P  
Sbjct: 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  135 bits (342), Expect = 3e-38
 Identities = 50/138 (36%), Positives = 71/138 (51%), Gaps = 2/138 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+  G+LFPG    DQ  K+ + +G+P  +             
Sbjct: 203 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261

Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G +   + P  
Sbjct: 262 ENRPKYAGYSFEKLFPDV 279

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  131 bits (332), Expect = 5e-37
 Identities = 32/141 (22%), Positives = 66/141 (46%), Gaps = 5/141 (3%)

Query: 99  HRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           H  G  HRD+KP N+++      +++ D G+ +           V +R+++GPE+L+  +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 157 IYGPEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQLIGSPTKDSWP--LGIQLAS 213
           +Y   +D W++G ++  M+      F G  + DQ+ +I +++G+     +     I+L  
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 214 NLNWKLPQMGGVNLLAVMPSA 234
             N  L +         + S 
Sbjct: 267 RFNDILGRHSRKRWERFVHSE 287

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  129 bits (325), Expect = 1e-35
 Identities = 43/129 (33%), Positives = 67/129 (51%), Gaps = 23/129 (17%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC------------------- 137
           LH  G  HRD+KPSN+L+ ++  +K+ D G+ +   +                       
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 138 ---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKIC 194
              TDYV TRWYR PE+LL S  Y   +D W++G I+ E+L    +FPG S+ +Q+ +I 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244

Query: 195 QLIGSPTKD 203
            +I  P+ +
Sbjct: 245 GVIDFPSNE 253

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  119 bits (300), Expect = 9e-32
 Identities = 49/198 (24%), Positives = 77/198 (38%), Gaps = 61/198 (30%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC------------------- 137
           +H  G  HRDLKP+N LV     +K+ D G+ + +D                        
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231

Query: 138 ---------TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGI--------- 179
                    T +V TRWYR PE++L  E Y   +D W++G I  E+L+            
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

Query: 180 --LFPGKS--------------------SADQIYKICQLIGSPTKDSWP-LGIQLASNLN 216
             LFPG S                    + DQ+  I  ++G+P+++    L  + A    
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351

Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G +L    P++
Sbjct: 352 RIFPKREGTDLAERFPAS 369

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  117 bits (295), Expect = 4e-31
 Identities = 51/190 (26%), Positives = 72/190 (37%), Gaps = 53/190 (27%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC------------------- 137
           +H  G  HRDLKP+N L+     +K+ D G+ + I+S                       
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204

Query: 138 ----TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGI-----------LFP 182
               T +V TRWYR PE++L  E Y   +D W+ G I  E+L+              LFP
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264

Query: 183 GKSSA-----------------DQIYKICQLIGSPTKDS-WPLGIQLASNLNWKLPQMGG 224
           G S                   DQ+  I  +IG+PT+D    +            P    
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324

Query: 225 VNLLAVMPSA 234
           +NL    PS 
Sbjct: 325 INLKQKYPSI 334

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 95.1 bits (236), Expect = 4e-23
 Identities = 35/187 (18%), Positives = 63/187 (33%), Gaps = 19/187 (10%)

Query: 26  VRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNL--QSWTIMI 83
            +       YAV N L L  A    L  ++S    V        ++    L  Q    +I
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ----LI 204

Query: 84  SGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVT 142
              A         +L  +G  H    P NL +   G + +GD+  + ++ +  P +    
Sbjct: 205 RLAA---------NLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS--SV 253

Query: 143 TRWYRGPEVLLFSEI-YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
              Y   E L  S   +   ++ W +G  ++ +    + F   +   +       +  P 
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313

Query: 202 KDSWPLG 208
            DS   G
Sbjct: 314 TDSLAFG 320

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 88.1 bits (219), Expect = 4e-21
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 4/99 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKPSN+ +     +KIGD G+V  + ++   T    T  Y  PE +  S+
Sbjct: 138 IHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS-SQ 196

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
            YG EVD +A+G I+ E+L          ++     +  
Sbjct: 197 DYGKEVDLYALGLILAELLHVC--DTAFETSKFFTDLRD 233

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 88.6 bits (220), Expect = 1e-20
 Identities = 37/109 (33%), Positives = 61/109 (55%), Gaps = 6/109 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV---SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           LH+    H DLKP N+L+    +  IK+ D G        +    Y+ +R+YR PEV+L 
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSRFYRAPEVILG 273

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
           +  YG  +D W++G I+ E+L+   L PG+   DQ+  + +L+G P++ 
Sbjct: 274 AR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 85.8 bits (213), Expect = 4e-20
 Identities = 27/105 (25%), Positives = 45/105 (42%), Gaps = 6/105 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH QG  H D+KP+N+ +   G  K+GD G++ E+ +            Y  PE+L    
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QG 230

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT 201
            YG   D +++G  + E+     L       +   ++ Q    P 
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPE 272

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 85.5 bits (212), Expect = 5e-20
 Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 36/154 (23%)

Query: 68  FNLMREKNL-----QSWTIM---ISGLADNSRGNDAISLHRQGYFHRDLKPSN-LLVSKG 118
           ++L+  +NL     + W +    +  L+          +H QG  HRDLKP N  +    
Sbjct: 103 YDLIHSENLNQQRDEYWRLFRQILEALS---------YIHSQGIIHRDLKPMNIFIDESR 153

Query: 119 VIKIGDLGMVKEIDSNLPCTDYVT---------------TRWYRGPEVLLFSEIYGPEVD 163
            +KIGD G+ K +  +L      +               T  Y   EVL  +  Y  ++D
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213

Query: 164 KWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
            +++G I FEM+       G      I K  + +
Sbjct: 214 MYSLGIIFFEMIY--PFSTGMERV-NILKKLRSV 244

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 86.2 bits (213), Expect = 6e-20
 Identities = 23/137 (16%), Positives = 51/137 (37%), Gaps = 28/137 (20%)

Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDY 140
           +I  LA         SLH  G  H  L+P ++++ + G + +     +    +       
Sbjct: 215 VIRLLA---------SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVS 262

Query: 141 VTTRWYRGPEVLLFSE----------IYGPEVDKWAMGAIMFEMLSFGIL-FPGKSS--- 186
             +R +  PE+               +     D WA+G +++ +     L     ++   
Sbjct: 263 SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC-ADLPITKDAALGG 321

Query: 187 ADQIYKICQLIGSPTKD 203
           ++ I++ C+ I  P + 
Sbjct: 322 SEWIFRSCKNIPQPVRA 338

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 85.9 bits (213), Expect = 8e-20
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 6/108 (5%)

Query: 99  HRQGYFHRDLKPSNLLV---SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
                 H DLKP N+L+    +  IKI D G   ++   +    Y+ +R+YR PEVLL  
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQSRFYRSPEVLLGM 233

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD 203
             Y   +D W++G I+ EM +   LF G +  DQ+ KI +++G P   
Sbjct: 234 P-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 85.1 bits (210), Expect = 2e-19
 Identities = 19/120 (15%), Positives = 40/120 (33%), Gaps = 18/120 (15%)

Query: 82  MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNL--PCT 138
           +I  LA         SLH  G  H  L+P ++++ + G + +     +    ++   P  
Sbjct: 220 VIRLLA---------SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG 270

Query: 139 DYVTTRWYRGPEVLLFSE----IYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
                       +L F +    +     D W +G  ++ +     L     ++      I
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC-ADLPNTDDAALGGSEWI 329

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 83.3 bits (206), Expect = 5e-19
 Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           L   G  HR++KP N++       + V K+ D G  +E++ +        T  Y  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 153 -------LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDS 204
                     + YG  VD W++G   +   + G L F       +  ++   I +     
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 205 WPLGIQLASNLNWKLPQ 221
              G+Q A N       
Sbjct: 247 AISGVQKAENGPIDWSG 263

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.0 bits (208), Expect = 5e-19
 Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 11/109 (10%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVT--TRWYRGPEVLL 153
           S+HR GY HRD+KP N+L+   G I++ D G   ++ ++      V   T  Y  PE+L 
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 154 ------FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
                  +  YGPE D WA+G   +EM  +G   F   S+A+   KI  
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMF-YGQTPFYADSTAETYGKIVH 284

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 83.7 bits (207), Expect = 5e-19
 Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           L   G  HR++KP N++       + V K+ D G  +E++ +        T  Y  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 153 -------LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDS 204
                     + YG  VD W++G   +   + G L F       +  ++   I +     
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 205 WPLGIQLASNLNWKLPQ 221
              G+Q A N       
Sbjct: 247 AISGVQKAENGPIDWSG 263

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 83.3 bits (206), Expect = 9e-19
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 9/107 (8%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLL 153
           S+H+  Y HRD+KP N+L+   G I++ D G   ++  D  +  +  V T  Y  PE+L 
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 154 FSEI----YGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
             E     YGPE D W++G  M+EML +G   F  +S  +   KI  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMN 295

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 83.2 bits (205), Expect = 1e-18
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 7/101 (6%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH     HRDLKP N+++  G    + KI DLG  KE+D    CT++V T  Y  PE+L 
Sbjct: 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE 196

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
             + Y   VD W+ G + FE ++ G   F       Q +  
Sbjct: 197 -QKKYTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWHGK 235

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 81.2 bits (201), Expect = 2e-18
 Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 18/110 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-------------TDYVTT 143
           LH +G  HRDLKPSN+  +   V+K+GD G+V  +D +                T  V T
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193

Query: 144 RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + Y  PE +     Y  +VD +++G I+FE+L     F  +    +    
Sbjct: 194 KLYMSPEQIH-GNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTD 239

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 81.5 bits (201), Expect = 2e-18
 Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 18/110 (16%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPC-------------TDYVTT 143
           LH +G  HRDLKPSN       V+K+GD G+V  +D +                T  V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 144 RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + Y  PE +     Y  +VD +++G I+FE+L     F  +    +I   
Sbjct: 240 KLYMSPEQIH-GNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITD 285

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 4/102 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LHR+   +RDLKP N+L+   G I+I DLG+   +         V T  Y  PEV+  +E
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-NE 360

Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLI 197
            Y    D WA+G +++EM++ G   F  +    +  ++ +L+
Sbjct: 361 RYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLV 401

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 81.7 bits (202), Expect = 2e-18
 Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 17/120 (14%)

Query: 98  LHRQ-GYFHRDLKPSNLLVS-------KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP 149
           +HR+ G  H D+KP N+L+           IKI DLG       +   T+ + TR YR P
Sbjct: 147 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTREYRSP 204

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA------DQIYKICQLIGSPTKD 203
           EVLL +  +G   D W+   ++FE+++   LF            D I +I +L+G     
Sbjct: 205 EVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 263

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.9 bits (202), Expect = 4e-18
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 2/79 (2%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H +   +RDLKP+N+L+   G ++I DLG+  +     P    V T  Y  PEVL    
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGV 366

Query: 157 IYGPEVDKWAMGAIMFEML 175
            Y    D +++G ++F++L
Sbjct: 367 AYDSSADWFSLGCMLFKLL 385

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.5 bits (199), Expect = 8e-18
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLL 153
           ++H  G+ HRD+KP N+L+   G +K+ D G   +++    + C   V T  Y  PEVL 
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 154 ---FSEIYGPEVDKWAMGAIMFEML 175
                  YG E D W++G  ++EML
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEML 267

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 78.6 bits (194), Expect = 2e-17
 Identities = 30/129 (23%), Positives = 62/129 (48%), Gaps = 13/129 (10%)

Query: 70  LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM 127
           L +E  +  W + +   L           +H +   HRD+K  N+ ++K G +++GD G+
Sbjct: 121 LFQEDQILDWFVQICLALK---------HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGI 171

Query: 128 VKEIDSNLPCTD-YVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS 186
            + ++S +      + T +Y  PE+   ++ Y  + D WA+G +++E+ +    F   S 
Sbjct: 172 ARVLNSTVELARACIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230

Query: 187 ADQIYKICQ 195
            + + KI  
Sbjct: 231 KNLVLKIIS 239

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 77.7 bits (192), Expect = 3e-17
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 6/85 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH+    HRDLKP N+L+     IK+ D G   ++D      +   T  Y  PE++  S 
Sbjct: 140 LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 199

Query: 157 I-----YGPEVDKWAMGAIMFEMLS 176
                 YG EVD W+ G IM+ +L+
Sbjct: 200 NDNHPGYGKEVDMWSTGVIMYTLLA 224

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 78.3 bits (193), Expect = 3e-17
 Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 11/108 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSNLP-----CTDYVTTRWYRGP 149
           LH QG  HRD+KP N L S      IK+ D G+ KE            T    T ++  P
Sbjct: 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 150 EVLLFSEI-YGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           EVL  +   YGP+ D W+ G ++  +L  G + FPG + AD I ++  
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLM-GAVPFPGVNDADTISQVLN 290

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 78.7 bits (194), Expect = 4e-17
 Identities = 33/134 (24%), Positives = 50/134 (37%), Gaps = 12/134 (8%)

Query: 98  LHRQGYFHRDLKPSNLLV------SKGVIKIGDLGMVKEID----SNLPCTDYVTTRWYR 147
           LH     HRDLKP N+L+       K    I D G+ K++     S    +    T  + 
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 148 GPEVLL--FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW 205
            PE+L     E     VD ++ G + + ++S G    GKS   Q   +            
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253

Query: 206 PLGIQLASNLNWKL 219
                +A  L  K+
Sbjct: 254 KHEDVIARELIEKM 267

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWYRGPEV 151
            H +   HRD+KP NLL+ S G +KI D G      S+         DY+       PE+
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLP------PEM 178

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           +    ++  +VD W++G + +E L  G   F   +  +   +I +
Sbjct: 179 IE-GRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISR 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 77.8 bits (192), Expect = 5e-17
 Identities = 33/83 (39%), Positives = 43/83 (51%), Gaps = 5/83 (6%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH     HRD+KP NLL  SK    ++K+ D G  KE  S+   T    T +Y  PEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             E Y    D W++G IM+ +L 
Sbjct: 237 -PEKYDKSCDMWSLGVIMYILLC 258

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.8 bits (192), Expect = 5e-17
 Identities = 30/85 (35%), Positives = 41/85 (48%), Gaps = 6/85 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRDLKP N+L+     I++ D G    ++      +   T  Y  PE+L  S 
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM 275

Query: 157 I-----YGPEVDKWAMGAIMFEMLS 176
                 YG EVD WA G I+F +L+
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLA 300

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 77.4 bits (191), Expect = 6e-17
 Identities = 31/122 (25%), Positives = 56/122 (45%), Gaps = 15/122 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDS---NLPCTDYVTTRWYRGPEVLL- 153
           +H+ G  H DLKP+N L+  G++K+ D G+  ++     ++     V T  Y  PE +  
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 154 ---------FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
                          P+ D W++G I++ M  +G   P +   +QI K+  +I    +  
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKT-PFQQIINQISKLHAIIDPNHEIE 260

Query: 205 WP 206
           +P
Sbjct: 261 FP 262

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 77.1 bits (190), Expect = 8e-17
 Identities = 26/109 (23%), Positives = 51/109 (46%), Gaps = 17/109 (15%)

Query: 94  DAIS-LHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRW 145
           ++ S +H +    HRD+KPSN+L+   G +K+ D G  + +            +++    
Sbjct: 162 NSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP--- 218

Query: 146 YRGPEVLLFSEIY-GPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
              PE       Y G +VD W++G  ++ M  + ++ F  K S  +++ 
Sbjct: 219 ---PEFFSNESSYNGAKVDIWSLGICLYVMF-YNVVPFSLKISLVELFN 263

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 77.0 bits (190), Expect = 1e-16
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 6/113 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    HRDLKP NLL+       +IKI D G+    ++     + + T +Y  PEVL 
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL- 210

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
             + Y  + D W++G I+F +L+    F G++  + + K+ +   +     W 
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 5/103 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++   +RDLKP N+L+   G ++I DLG+  E          Y  T  +  PE+LL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-G 363

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLI 197
           E Y   VD +A+G  ++EM++     F  +    +  ++ Q +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRV 405

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 75.3 bits (186), Expect = 2e-16
 Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 15/86 (17%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSNLPCT-----DYVTTRWYRGP 149
           LH  G  HRDL  SNLL+     IKI D G+    ++      T     +Y++      P
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS------P 181

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEML 175
           E+      +G E D W++G + + +L
Sbjct: 182 EIAT-RSAHGLESDVWSLGCMFYTLL 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 76.7 bits (189), Expect = 2e-16
 Identities = 33/85 (38%), Positives = 41/85 (48%), Gaps = 6/85 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314

Query: 154 FSEI--YGPEVDKWAMGAIMFEMLS 176
                 Y   VD W++G I+F  LS
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLS 339

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 75.3 bits (186), Expect = 2e-16
 Identities = 33/110 (30%), Positives = 49/110 (44%), Gaps = 16/110 (14%)

Query: 94  DAIS-LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-----DYVTTRWY 146
           DA+   H +   HRD+KP NLL+  KG +KI D G      S    T     DY+     
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLP---- 180

Query: 147 RGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
             PE++   + +  +VD W  G + +E L  G+  F   S  +   +I  
Sbjct: 181 --PEMIE-GKTHDEKVDLWCAGVLCYEFLV-GMPPFDSPSHTETHRRIVN 226

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 76.4 bits (188), Expect = 2e-16
 Identities = 29/122 (23%), Positives = 54/122 (44%), Gaps = 15/122 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVT---TRWYRGPEVLL- 153
           +H+ G  H DLKP+N L+  G++K+ D G+  ++  +       +      Y  PE +  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 154 ---------FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
                          P+ D W++G I++ M  +G   P +   +QI K+  +I    +  
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKT-PFQQIINQISKLHAIIDPNHEIE 288

Query: 205 WP 206
           +P
Sbjct: 289 FP 290

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 8/105 (7%)

Query: 98  LHRQGYF-----HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPE 150
            HR+        HRDLKP+N  L  K  +K+GD G+ + ++ +      +V T +Y  PE
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
            +     Y  + D W++G +++E+ +    F   S  +   KI +
Sbjct: 187 QMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 76.2 bits (188), Expect = 2e-16
 Identities = 28/104 (26%), Positives = 44/104 (42%), Gaps = 6/104 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L  Q   HRD+KP N+L+   G + I D  +   +      T    T+ Y  PE+    +
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190

Query: 157 I--YGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLI 197
              Y   VD W++G   +E+L  G   +  +SS     +I    
Sbjct: 191 GAGYSFAVDWWSLGVTAYELL-RGRRPYHIRSS-TSSKEIVHTF 232

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 75.3 bits (186), Expect = 2e-16
 Identities = 30/83 (36%), Positives = 42/83 (50%), Gaps = 5/83 (6%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
            H  G  HR+LKP N LL SK     +K+ D G+  E++ +     +  T  Y  PEVL 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             + Y   VD WA G I++ +L 
Sbjct: 181 -KDPYSKPVDIWACGVILYILLV 202

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 75.3 bits (186), Expect = 2e-16
 Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 15/86 (17%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSNLPCT-----DYVTTRWYRGP 149
           LHR    HRDLK  NL +     +KIGD G+    E D           +Y+       P
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA------P 184

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEML 175
           EVL   + +  EVD W++G IM+ +L
Sbjct: 185 EVLS-KKGHSFEVDVWSIGCIMYTLL 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 75.4 bits (186), Expect = 3e-16
 Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 15/86 (17%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM--VKEIDSNLPCT-----DYVTTRWYRGP 149
           LHR    HRDLK  NL +     +KIGD G+    E D           +Y+       P
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA------P 210

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEML 175
           EVL   + +  EVD W++G IM+ +L
Sbjct: 211 EVLS-KKGHSFEVDVWSIGCIMYTLL 235

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.4 bits (186), Expect = 3e-16
 Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N+++         IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
            + E  G E D W++G I + +LS
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLS 213

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 75.1 bits (185), Expect = 4e-16
 Identities = 30/122 (24%), Positives = 55/122 (45%), Gaps = 15/122 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVT---TRWYRGPEVLL- 153
           +H+ G  H DLKP+N L+  G++K+ D G+  ++  +       +   T  Y  PE +  
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 154 ---------FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS 204
                          P+ D W++G I++ M  +G   P +   +QI K+  +I    +  
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKT-PFQQIINQISKLHAIIDPNHEIE 241

Query: 205 WP 206
           +P
Sbjct: 242 FP 243

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 75.1 bits (185), Expect = 4e-16
 Identities = 33/83 (39%), Positives = 41/83 (49%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH     HRD+KP NLL  SK    V+K+ D G  KE   N        T +Y  PEVL 
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLG 202

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             E Y    D W++G IM+ +L 
Sbjct: 203 -PEKYDKSCDMWSLGVIMYILLC 224

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.1 bits (185), Expect = 5e-16
 Identities = 32/83 (38%), Positives = 43/83 (51%), Gaps = 5/83 (6%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP NLL  +      +KI D G+ K ++  +       T  Y  PE+L 
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR 223

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
               YGPEVD W++G I + +L 
Sbjct: 224 -GCAYGPEVDMWSVGIITYILLC 245

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 74.6 bits (184), Expect = 5e-16
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 7/85 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDS-NLPCTDYVTTRWYRGPEV 151
           LH QG  HRDLKPSN+L          I+I D G  K++ + N        T  +  PEV
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLS 176
           L   + Y    D W++G +++ ML+
Sbjct: 192 LE-RQGYDAACDIWSLGVLLYTMLT 215

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 74.6 bits (184), Expect = 5e-16
 Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH     H DLKP N+++      K  IKI D G+  +ID      +   T  +  PE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
            + E  G E D W++G I + +LS
Sbjct: 190 NY-EPLGLEADMWSIGVITYILLS 212

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 74.2 bits (183), Expect = 5e-16
 Identities = 32/83 (38%), Positives = 42/83 (50%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP N LL SK     IKI D G+      N    D + T +Y  PEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL- 195

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
               Y  + D W+ G I++ +LS
Sbjct: 196 -RGTYDEKCDVWSAGVILYILLS 217

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 75.1 bits (185), Expect = 6e-16
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 8/114 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP N LL SK     I+I D G+    +++    D + T +Y  PEVL 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
               Y  + D W+ G I++ +LS G   F G +  D + K+ +   +     W 
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVEKGKYTFELPQWK 252

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 74.7 bits (184), Expect = 6e-16
 Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N+++         IK+ D G+  EI+  +   +   T  +  PE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
            + E  G E D W++G I + +LS
Sbjct: 191 NY-EPLGLEADMWSIGVITYILLS 213

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 73.8 bits (182), Expect = 6e-16
 Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGV----IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
           LH +   H DLKP N +L+ K V    IK+ D G+  +I++     +   T  +  PE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
            + E  G E D W++G I + +LS
Sbjct: 184 NY-EPLGLEADMWSIGVITYILLS 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 74.2 bits (183), Expect = 7e-16
 Identities = 34/92 (36%), Positives = 45/92 (48%), Gaps = 15/92 (16%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT-DYVTTRW-----YRGPE 150
           LH Q   HRD+KPSNLLV   G IKI D G+     SN     D + +       +  PE
Sbjct: 153 LHYQKIIHRDIKPSNLLVGEDGHIKIADFGV-----SNEFKGSDALLSNTVGTPAFMAPE 207

Query: 151 VLL-FSEIY-GPEVDKWAMGAIMFEMLSFGIL 180
            L    +I+ G  +D WAMG  ++  + FG  
Sbjct: 208 SLSETRKIFSGKALDVWAMGVTLYCFV-FGQC 238

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 74.2 bits (183), Expect = 7e-16
 Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLL-VSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           LH     H D++P N++  ++    IKI + G  +++          T   Y  PEV   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
            ++     D W++G +++ +LS
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLS 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 74.8 bits (184), Expect = 7e-16
 Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           +H     H D+KP N++        +KI D G+  +++ +        T  +  PE++  
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 224

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
            E  G   D WA+G + + +LS
Sbjct: 225 -EPVGFYTDMWAIGVLGYVLLS 245

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 74.2 bits (183), Expect = 7e-16
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 5/83 (6%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVT---TRWYRGPEVLL 153
           LH +G  HRDLKP N+L+     I+I D G  K +          +   T  Y  PE+L 
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             +      D WA+G I++++++
Sbjct: 206 -EKSACKSSDLWALGCIIYQLVA 227

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 74.3 bits (183), Expect = 8e-16
 Identities = 30/124 (24%), Positives = 48/124 (38%), Gaps = 19/124 (15%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGM-----------VKEID------SNLPCTD 139
           LH     H DLKP N L V+     + +              ++  D       +   T 
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT 198

Query: 140 YVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS 199
            V TR YR PEV+L    +    D W++G I+FE      LF    + + +  + +++G 
Sbjct: 199 IVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP 257

Query: 200 PTKD 203
               
Sbjct: 258 IPSH 261

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 74.7 bits (184), Expect = 8e-16
 Identities = 37/114 (32%), Positives = 54/114 (47%), Gaps = 8/114 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    HRD+KP N LL +K     IKI D G+      +    D + T +Y  PEVL 
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL- 220

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
             + Y  + D W+ G IM+ +L  G   F G++  D I K+ +       + W 
Sbjct: 221 -KKKYNEKCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.9 bits (182), Expect = 8e-16
 Identities = 31/84 (36%), Positives = 39/84 (46%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVL 152
           +H  G  HRDLKP NLL   +     IKI D G  +     N P      T  Y  PE+L
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
                Y    D W++G I++ MLS
Sbjct: 182 N-QNGYDESCDLWSLGVILYTMLS 204

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 73.9 bits (182), Expect = 9e-16
 Identities = 30/95 (31%), Positives = 42/95 (44%), Gaps = 16/95 (16%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRW-------- 145
           LH +G  HRDLKP N+L         +KI D  +   I  N  C+   T           
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 146 YRGPEVL----LFSEIYGPEVDKWAMGAIMFEMLS 176
           Y  PEV+      + IY    D W++G I++ +LS
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 73.9 bits (182), Expect = 9e-16
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 11/85 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEV 151
            H +G  HRD+K  N+L+   +G  K+ D G        L    P TD+  TR Y  PE 
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGS-----GALLHDEPYTDFDGTRVYSPPEW 209

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLS 176
           +   + +      W++G ++++M+ 
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVC 234

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 33/85 (38%), Positives = 41/85 (48%), Gaps = 6/85 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP N+L+S      +IKI D G  K +           T  Y  PEVL+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189

Query: 154 FSEI--YGPEVDKWAMGAIMFEMLS 176
                 Y   VD W++G I+F  LS
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLS 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.7 bits (182), Expect = 1e-15
 Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 5/101 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH++G  +RDLKP N+++  +G +K+ D G+ KE I        +  T  Y  PE+L+ S
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
             +   VD W++GA+M++ML+ G   F G++    I KI +
Sbjct: 197 G-HNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDKILK 235

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 30/83 (36%), Positives = 42/83 (50%), Gaps = 5/83 (6%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
            H  G  HR+LKP N LL SK     +K+ D G+  E++ +     +  T  Y  PEVL 
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 203

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             + Y   VD WA G I++ +L 
Sbjct: 204 -KDPYSKPVDIWACGVILYILLV 225

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 74.1 bits (182), Expect = 1e-15
 Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKGV--IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           +H   Y H DLKP N++  +K    +K+ D G+   +D          T  +  PEV   
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 330

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
            +  G   D W++G + + +LS
Sbjct: 331 -KPVGYYTDMWSVGVLSYILLS 351

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 72.6 bits (179), Expect = 2e-15
 Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
            H+    HRDLKP N L         +K+ D G+             V T +Y  P+VL 
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL- 180

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
              +YGPE D+W+ G +M+ +L 
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLC 202

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 73.1 bits (180), Expect = 2e-15
 Identities = 24/84 (28%), Positives = 42/84 (50%), Gaps = 11/84 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEV 151
            H  G  HRD+K  N+L+  ++G +K+ D G        L      TD+  TR Y  PE 
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGS-----GALLKDTVYTDFDGTRVYSPPEW 219

Query: 152 LLFSEIYGPEVDKWAMGAIMFEML 175
           + +   +G     W++G ++++M+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMV 243

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 38/114 (33%), Positives = 53/114 (46%), Gaps = 8/114 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           +H+    HRDLKP N LL SK     IKI D G+      N    D + T +Y  PEVL 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL- 195

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
               Y  + D W+ G I++ +LS G   F GK+  D + ++     +     W 
Sbjct: 196 -RGTYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGKYAFDLPQWR 247

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 72.7 bits (179), Expect = 2e-15
 Identities = 33/117 (28%), Positives = 47/117 (40%), Gaps = 10/117 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
            H Q   H+DLKP N+L         IKI D G+ +   S+   T+   T  Y  PEV  
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK 199

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWPLGI 209
                  + D W+ G +M+ +L+ G L F G S  +   K       P        +
Sbjct: 200 RD--VTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQKA--TYKEPNYAVECRPL 251

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.9 bits (181), Expect = 2e-15
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 3/100 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           L  +G  +RDLK  N+++ S+G IKI D GM KE I   +    +  T  Y  PE++ + 
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
             YG  VD WA G +++EML+    F G+   +    I +
Sbjct: 518 P-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG--VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           +H+    H DLKP N+L V++    IKI D G+ +             T  +  PEV+ +
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY 262

Query: 155 SEIYGPEVDKWAMGAIMFEMLS 176
            +      D W++G I + +LS
Sbjct: 263 -DFVSFPTDMWSVGVIAYMLLS 283

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 72.6 bits (179), Expect = 3e-15
 Identities = 38/101 (37%), Positives = 53/101 (52%), Gaps = 5/101 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH  G  +RDLKP N+L+  +G IK+ D G+ KE ID       +  T  Y  PEV+   
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
             +    D W+ G +MFEML+ G L F GK   + +  I +
Sbjct: 202 G-HTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTMILK 240

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 72.3 bits (178), Expect = 3e-15
 Identities = 25/89 (28%), Positives = 43/89 (48%), Gaps = 15/89 (16%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT----DYVTTR----WYRG 148
           LH QG  H+D+KP NLL+ + G +KI  LG+     +         D   T      ++ 
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGV-----AEALHPFAADDTCRTSQGSPAFQP 179

Query: 149 PEVLLFSEIY-GPEVDKWAMGAIMFEMLS 176
           PE+    + + G +VD W+ G  ++ + +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 72.3 bits (178), Expect = 3e-15
 Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 5/83 (6%)

Query: 98  LHRQGYFHRDLKPSN-LLVSK---GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+    H DLKP N LL S    G IKI D GM ++I       + + T  Y  PE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
           + +      D W +G I + +L+
Sbjct: 207 Y-DPITTATDMWNIGIIAYMLLT 228

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 72.3 bits (178), Expect = 4e-15
 Identities = 31/124 (25%), Positives = 51/124 (41%), Gaps = 19/124 (15%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGM-----------VKEID------SNLPCTD 139
           LH     H DLKP N L V     +  +  +           +K +D       +   + 
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193

Query: 140 YVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS 199
            V+TR YR PEV+L    +    D W++G I+ E      +FP   S + +  + +++G 
Sbjct: 194 LVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGP 252

Query: 200 PTKD 203
             K 
Sbjct: 253 LPKH 256

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 72.5 bits (178), Expect = 5e-15
 Identities = 45/189 (23%), Positives = 69/189 (36%), Gaps = 39/189 (20%)

Query: 61  VEKAFKVFNLMREKNLQSWTIM---ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK 117
             K     NL  +K     +++    SG+A          LH     HRDLKP N+LVS 
Sbjct: 100 ESKNVSDENLKLQKEYNPISLLRQIASGVA---------HLHSLKIIHRDLKPQNILVST 150

Query: 118 --------------GVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEVLLFSEI- 157
                           I I D G+ K++DS              T  +R PE+L  S   
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210

Query: 158 -----YGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD-QIYKICQLIGSPTKDSWPLGIQ 210
                    +D ++MG + + +LS G   F  K S +  I +    +           I 
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIA 270

Query: 211 LASNLNWKL 219
            A++L  ++
Sbjct: 271 EATDLISQM 279

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 72.1 bits (177), Expect = 5e-15
 Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 11/85 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW-----YRGPEV 151
           L  +   HRD+K  N+++     IK+ D G      +       +   +     Y  PEV
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGS-----AAYLERGKLFYTFCGTIEYCAPEV 200

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLS 176
           L+ +   GPE++ W++G  ++ ++ 
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVF 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 71.6 bits (176), Expect = 7e-15
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 13/102 (12%)

Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW-----YRGPEVL 152
           H++   HRDLK  NLL+ +   IKI D G      SN          +     Y  PE+ 
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTVGGKLDAFCGAPPYAAPELF 185

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
              +  GPEVD W++G I++ ++S G L F G++  +   ++
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERV 226

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 71.2 bits (175), Expect = 7e-15
 Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 8/101 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYV----TTRWYRGPEVL 152
           LH +   HRDLK +N+ + +   +KIGD G+  E         +     +  W   PEV+
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW-MAPEVI 194

Query: 153 LFSEI--YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY 191
              +   Y  + D +A G +++E+++  + +   ++ DQI 
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 70.8 bits (174), Expect = 8e-15
 Identities = 41/133 (30%), Positives = 60/133 (45%), Gaps = 17/133 (12%)

Query: 66  KVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYF--HRDLKPSNLLVS--KGVI 120
           K F +M+ K L+SW   I  GL           LH +     HRDLK  N+ ++   G +
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQ---------FLHTRTPPIIHRDLKCDNIFITGPTGSV 171

Query: 121 KIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL 180
           KIGDLG+     ++       T  +   PE+  + E Y   VD +A G  M EM +    
Sbjct: 172 KIGDLGLATLKRASFAKAVIGTPEFM-APEM--YEEKYDESVDVYAFGMCMLEMATSEYP 228

Query: 181 FPGKSSADQIYKI 193
           +    +A QIY+ 
Sbjct: 229 YSECQNAAQIYRR 241

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 71.6 bits (176), Expect = 8e-15
 Identities = 29/130 (22%), Positives = 46/130 (35%), Gaps = 25/130 (19%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGM-----------------VKEID------S 133
           L +    H DLKP N LL      K                       +K ID       
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212

Query: 134 NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           +      + TR YR PEV+L    +    D W+ G ++ E+ +  +LF      + +  +
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271

Query: 194 CQLIGSPTKD 203
             +I    K+
Sbjct: 272 ESIIQPIPKN 281

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.7 bits (174), Expect = 1e-14
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           L  +G  +RDLK  N+++ S+G IKI D GM KE I   +    +  T  Y  PE++ + 
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 196

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
             YG  VD WA G +++EML+ G   F G+   +    I +
Sbjct: 197 P-YGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIME 235

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.8 bits (174), Expect = 1e-14
 Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 6/105 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE--IDSNLPCTDYVTTRWYRGPEVLLF 154
           LH+ G  +RD+K  N+L+ S G + + D G+ KE   D      D+  T  Y  P+++  
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234

Query: 155 SEI-YGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLI 197
            +  +   VD W++G +M+E+L+ G   F      +   +I + I
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRI 278

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 70.7 bits (174), Expect = 2e-14
 Identities = 35/106 (33%), Positives = 50/106 (47%), Gaps = 15/106 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW------YRGPE 150
           LH +   +RD+K  NL++   G IKI D G+ KE       +D  T +       Y  PE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-----GISDGATMKTFCGTPEYLAPE 175

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           VL  ++ YG  VD W +G +M+EM+  G L F  +        I  
Sbjct: 176 VLEDND-YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILM 219

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 30/85 (35%), Positives = 39/85 (45%), Gaps = 11/85 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW-----YRGPEV 151
            HR    HRDLKP NLL+     +KI D G+     SN+               Y  PEV
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGL-----SNIMTDGNFLKTSCGSPNYAAPEV 178

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLS 176
           +      GPEVD W+ G +++ ML 
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLV 203

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 36/106 (33%), Positives = 49/106 (46%), Gaps = 15/106 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW------YRGPE 150
           LH +G  +RDLK  N+L+   G IKI D GM KE            T        Y  PE
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-----NMLGDAKTNTFCGTPDYIAPE 188

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           +LL  + Y   VD W+ G +++EML  G   F G+   +  + I  
Sbjct: 189 ILL-GQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELFHSIRM 232

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 2e-14
 Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 5/101 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     +RDLKP N+L+ S+G I + D G+ KE I+ N   + +  T  Y  PEVL   
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH-K 213

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           + Y   VD W +GA+++EML  G+  F  +++A+    I  
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILN 253

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 69.9 bits (172), Expect = 2e-14
 Identities = 30/83 (36%), Positives = 39/83 (46%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP NLL  +      I I D G+ K   +    +    T  Y  PEVL 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLA 180

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             + Y   VD W++G I + +L 
Sbjct: 181 -QKPYSKAVDCWSIGVITYILLC 202

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 70.0 bits (172), Expect = 2e-14
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 5/102 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           +H +   HRD+KP+N+ ++  GV+K+GDLG+ +   S        V T +Y  PE +   
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-E 210

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSS--ADQIYKICQ 195
             Y  + D W++G +++EM +    F G          KI Q
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ S+G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-G 184

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIY 191
           E YG  VD WA+G +MFEM++ G   F    S+D   
Sbjct: 185 EDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPD 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ S+G IK+ D GM KE +      + +  T  Y  PE+L   
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-G 227

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIY 191
           E YG  VD WA+G +MFEM++ G   F    S+D   
Sbjct: 228 EDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPD 263

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 69.7 bits (171), Expect = 2e-14
 Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 13/93 (13%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLG----------MVKEIDSNLPCTDYVTTRWY 146
           +H +GY HRDLKP+N+L+   G   + DLG            ++  +         T  Y
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 147 RGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSF 177
           R PE+       +     D W++G +++ M+  
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 70.0 bits (172), Expect = 3e-14
 Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 12/84 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDS--NLPC--TDYVTTRWYRGPEVL 152
           LH     +RDLKP NLL+  +G I++ D G  K +       C   + +       PE++
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEII 210

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
           L S+ Y   VD WA+G +++EM +
Sbjct: 211 L-SKGYNKAVDWWALGVLIYEMAA 233

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.0 bits (172), Expect = 3e-14
 Identities = 39/106 (36%), Positives = 53/106 (50%), Gaps = 15/106 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW------YRGPE 150
           LH +G  +RDLK  N+L+  +G  K+ D GM KE    +   + VTT        Y  PE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GI--CNGVTTATFCGTPDYIAPE 194

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           +L     YGP VD WAMG +++EML  G   F  ++  D    I  
Sbjct: 195 ILQEML-YGPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILN 238

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.5 bits (171), Expect = 3e-14
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 18/87 (20%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW-------YRGP 149
           LH +   +RDLKP N+L+   G IKI D G  K +           T +       Y  P
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VT-YTLCGTPDYIAP 172

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLS 176
           EV+  ++ Y   +D W+ G +++EML+
Sbjct: 173 EVVS-TKPYNKSIDWWSFGILIYEMLA 198

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.1 bits (170), Expect = 3e-14
 Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 18/106 (16%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW---------YR 147
           LH  G  HRD+KP NLL+  +  +KI D G+     + +        R          Y 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGL-----ATVF-RYNNRERLLNKMCGTLPYV 174

Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
            PE+L   E +   VD W+ G ++  ML+ G L +   S + Q Y 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYS 219

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVL 152
            H     HRD+KP   LL SK     +K+G  G+  ++ +S L     V T  +  PEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
              E YG  VD W  G I+F +LS
Sbjct: 206 K-REPYGKPVDVWGCGVILFILLS 228

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.1 bits (172), Expect = 3e-14
 Identities = 36/102 (35%), Positives = 49/102 (48%), Gaps = 6/102 (5%)

Query: 98  LH-RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSNLPCTDYVTTRWYRGPEVLLF 154
           LH  +   +RDLK  NL++   G IKI D G+ KE I        +  T  Y  PEVL  
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           ++ YG  VD W +G +M+EM+  G L F  +        I  
Sbjct: 324 ND-YGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILM 363

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.4 bits (168), Expect = 5e-14
 Identities = 29/85 (34%), Positives = 39/85 (45%), Gaps = 11/85 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW-----YRGPEV 151
            HR    HRDLKP N+L+ +    KI D G+     SN+               Y  PEV
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL-----SNMMSDGEFLRTSCGSPNYAAPEV 181

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLS 176
           +      GPEVD W+ G I++ +L 
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLC 206

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 69.3 bits (170), Expect = 5e-14
 Identities = 31/84 (36%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDS-NLPCTDYVTTRWYRGPEVL 152
            H+ G  HR+LKP NLL  SK     +K+ D G+  E++        +  T  Y  PEVL
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLS 176
              + YG  VD WA G I++ +L 
Sbjct: 186 R-KDPYGKPVDLWACGVILYILLV 208

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 68.9 bits (169), Expect = 5e-14
 Identities = 23/112 (20%), Positives = 45/112 (40%), Gaps = 14/112 (12%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGM--VKEIDSNLPCTDYVTTR--WYR--GPEV 151
           LH +G  H+DLK  N+    G + I D G+  +  +       D +  +  W     PE+
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 152 L--------LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           +             +    D +A+G I +E+ +    F  + +   I+++  
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 68.9 bits (169), Expect = 6e-14
 Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 18/106 (16%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW---------YR 147
           LH  G  HRD+KP NLL+  +  +KI D G+     + +        R          Y 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGL-----ATVF-RYNNRERLLNKMCGTLPYV 174

Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
            PE+L   E +   VD W+ G ++  ML+ G L +   S + Q Y 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYS 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 69.4 bits (170), Expect = 6e-14
 Identities = 29/83 (34%), Positives = 39/83 (46%), Gaps = 11/83 (13%)

Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRW-----YRGPEVL 152
           HR    HRDLKP N+L+ +    KI D G+     SN+               Y  PEV+
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGL-----SNMMSDGEFLRTSCGSPNYAAPEVI 187

Query: 153 LFSEIYGPEVDKWAMGAIMFEML 175
                 GPEVD W+ G I++ +L
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALL 210

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 67.4 bits (165), Expect = 1e-13
 Identities = 32/156 (20%), Positives = 58/156 (37%), Gaps = 36/156 (23%)

Query: 61  VEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-- 117
           + + +++ +  +E  L+   + +  GL           +H     H D+KPSN+ +S+  
Sbjct: 102 ISENYRIMSYFKEAELKDLLLQVGRGLR---------YIHSMSLVHMDIKPSNIFISRTS 152

Query: 118 ------------------GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
                              + KIGDLG V  I S            +   EVL  +  + 
Sbjct: 153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHL 209

Query: 160 PEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           P+ D +A+   +        L     + DQ ++I Q
Sbjct: 210 PKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQ 242

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 67.7 bits (165), Expect = 2e-13
 Identities = 23/125 (18%), Positives = 46/125 (36%), Gaps = 19/125 (15%)

Query: 97  SLHRQGYFHRDLKPSNLLV------------SKGVIKIGDLGMVKEIDSNLPCTDYVTTR 144
            +H     H D+KP N ++                + + DLG   ++    P     T +
Sbjct: 187 QVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM-KLFPKGTIFTAK 245

Query: 145 W----YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP 200
                ++  E+L  ++ +  ++D + + A ++ ML FG     K+   +          P
Sbjct: 246 CETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCML-FGTYMKVKNEGGECKPEGLFRRLP 303

Query: 201 TKDSW 205
             D W
Sbjct: 304 HLDMW 308

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.5 bits (160), Expect = 9e-13
 Identities = 34/110 (30%), Positives = 39/110 (35%), Gaps = 15/110 (13%)

Query: 99  HRQGYFHRDLKPSNLLV---SKGVIKIGDLGMVKEIDSNLPCTD-----YVTTRWYRGPE 150
           H     HRDLK  N L+       +KI D G      S            V T  Y  PE
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPE 187

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGS 199
           VLL  E  G   D W+ G  ++ ML  G   F          K  Q I S
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPRDYRKTIQRILS 236

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 64.7 bits (158), Expect = 1e-12
 Identities = 25/136 (18%), Positives = 52/136 (38%), Gaps = 24/136 (17%)

Query: 67  VFNLMREKNLQ-SWTIMISGLADNSRGNDAIS-LHRQGYFHRDLKPSNLLVSK-GVIKIG 123
           +  +++  + Q  W+  +S   D + G   ++ LH     HRDL   N LV +   + + 
Sbjct: 94  LRGIIKSMDSQYPWSQRVSFAKDIASG---MAYLHSMNIIHRDLNSHNCLVRENKNVVVA 150

Query: 124 DLGMVKEIDSNLPCTDYV----------------TTRWYRGPEVLLFSEIYGPEVDKWAM 167
           D G+ + +       + +                   W   PE++     Y  +VD ++ 
Sbjct: 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM-APEMING-RSYDEKVDVFSF 208

Query: 168 GAIMFEMLSFGILFPG 183
           G ++ E++      P 
Sbjct: 209 GIVLCEIIGRVNADPD 224

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 31/140 (22%), Positives = 60/140 (42%), Gaps = 17/140 (12%)

Query: 68  FNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYF---HRDLKPSNLLVSKG------ 118
             ++  K +    I+++     +RG +   LH +      HRDLK SN+L+ +       
Sbjct: 94  NRVLSGKRI-PPDILVNWAVQIARGMN--YLHDEAIVPIIHRDLKSSNILILQKVENGDL 150

Query: 119 ---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML 175
              ++KI D G+ +E       +      W   PEV+  + ++    D W+ G +++E+L
Sbjct: 151 SNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPEVIR-ASMFSKGSDVWSYGVLLWELL 208

Query: 176 SFGILFPGKSSADQIYKICQ 195
           +  + F G       Y +  
Sbjct: 209 TGEVPFRGIDGLAVAYGVAM 228

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 7/98 (7%)

Query: 97  SLHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSNLPCTDYV-TTRWYRGPEVLL 153
           S+  +   HRDLKP NLL+  G  V+KI D G   +I +++  T+   +  W   PEV  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAW-MAPEVFE 176

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY 191
               Y  + D ++ G I++E+++    F          
Sbjct: 177 -GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI 213

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 32/98 (32%), Positives = 44/98 (44%), Gaps = 18/98 (18%)

Query: 98  LHRQG--YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTD-------------YV 141
           +HRQ     HRDLK  NLL+S  G IK+ D G    I      +                
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 142 TTRWYRGPEVL-LFS-EIYGPEVDKWAMGAIMFEMLSF 177
           TT  YR PE++ L+S    G + D WA+G I++ +   
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 63.9 bits (156), Expect = 2e-12
 Identities = 30/82 (36%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLF 154
           LH     HRD+K  N+L++   GV+KI D G  K +    PCT+  T T  Y  PE++  
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197

Query: 155 SEI-YGPEVDKWAMGAIMFEML 175
               YG   D W++G  + EM 
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMA 219

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 64.1 bits (156), Expect = 4e-12
 Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 11/81 (13%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVT-TRWYRGPEVLLFSE 156
           LH  G  + DLKP N+++++  +K+ DLG V  I+S      Y+  T  ++ PE++    
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS----FGYLYGTPGFQAPEIVR--- 250

Query: 157 IYGPEV--DKWAMGAIMFEML 175
             GP V  D + +G  +  + 
Sbjct: 251 -TGPTVATDIYTVGRTLAALT 270

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 27/103 (26%), Positives = 45/103 (43%), Gaps = 7/103 (6%)

Query: 98  LHRQGYF--HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYV--TTRWYRGPEVL 152
           LH +     HR+LK  NLLV K   +K+ D G+ +   S    +     T  W   PEVL
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW-MAPEVL 211

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
              E    + D ++ G I++E+ +    +   + A  +  +  
Sbjct: 212 R-DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 24/83 (28%), Positives = 32/83 (38%), Gaps = 26/83 (31%)

Query: 98  LHRQGYFHRDLKPSNLL-VSKG---VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH     HRD+KP NLL  SK    ++K+ D G                       E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETT- 171

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
             E Y    D W++G IM+ +L 
Sbjct: 172 -GEKYDKSCDMWSLGVIMYILLC 193

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 60.9 bits (148), Expect = 3e-11
 Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 9/86 (10%)

Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRG------P 149
           LH +   H D+K  N+L+S       + D G    +  +      +T  +  G      P
Sbjct: 166 LHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEML 175
           EV++       +VD W+   +M  ML
Sbjct: 226 EVVMGKP-CDAKVDIWSSCCMMLHML 250

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 60.8 bits (148), Expect = 4e-11
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 11/104 (10%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+L+ S  V K+ D G+ + ++ + P   Y T       RW   PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-PEAAYTTRGGKIPIRWT-SPE 220

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            + +   +    D W+ G +++E++S+G   +   S+ D I  +
Sbjct: 221 AIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 60.3 bits (146), Expect = 7e-11
 Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRD+   N+LV S   +K+GD G+ + ++ +     Y          +W   P
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMA-P 561

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E + F   +    D W  G  M+E+L  G+  F G  + D I +I
Sbjct: 562 ESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 59.2 bits (144), Expect = 9e-11
 Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRD+   N+LV S   +K+GD G+ + ++ +     Y          +W   P
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMA-P 186

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E + F   +    D W  G  M+E+L  G+  F G  + D I +I
Sbjct: 187 ESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 20/108 (18%), Positives = 37/108 (34%), Gaps = 17/108 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSK---------GVIKIGDLGMVKEIDSNLPCTDYVTT--RWY 146
           L      H ++   N+L+ +           IK+ D G+   +       D +     W 
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWV 184

Query: 147 RGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
             PE +   +      DKW+ G  ++E+ S G        S  ++   
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 11/104 (10%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L    Y HRDL   N+LV S  V K+ D G+ + ++ + P   Y T+      RW   PE
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRWT-APE 220

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            + +   +    D W+ G +M+E++++G   +   S+ + +  I
Sbjct: 221 AISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 24/133 (18%), Positives = 54/133 (40%), Gaps = 18/133 (13%)

Query: 68  FNLMREKNLQ-SWTIMISGLADNSRGNDAIS-LHRQGYF--HRDLKPSNLLVSKG----- 118
           ++ + +K     W++ +  + D + G   I  +  Q     HRDL+  N+ +        
Sbjct: 109 YHRLLDKAHPIKWSVKLRLMLDIALG---IEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165

Query: 119 -VIKIGDLGMVKEIDSNLPCTDYV-TTRWYRGPEVLLF-SEIYGPEVDKWAMGAIMFEML 175
              K+ D G+ ++   ++  +  +   +W   PE +    E Y  + D ++   I++ +L
Sbjct: 166 VCAKVADFGLSQQSVHSV--SGLLGNFQW-MAPETIGAEEESYTEKADTYSFAMILYTIL 222

Query: 176 SFGILFPGKSSAD 188
           +    F   S   
Sbjct: 223 TGEGPFDEYSYGK 235

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 27/105 (25%), Positives = 52/105 (49%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV    V K+ D G+ + I+ N    +Y          +W   P
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWTA-P 350

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E  L+   +  + D W+ G ++ E+ + G + +PG  + + + ++
Sbjct: 351 EAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 27/105 (25%), Positives = 52/105 (49%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + R  Y HRDL+ +N+LV    V K+ D G+ + I+ N    +Y          +W   P
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWTA-P 433

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E  L+   +  + D W+ G ++ E+ + G + +PG  + + + ++
Sbjct: 434 EAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 31/108 (28%), Positives = 46/108 (42%), Gaps = 16/108 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  +   HRDL   N LV+ K V+KI D GM +E         Y  +        +W   
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWT-A 283

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           PE L +   Y  E D W+ G +++E  S G   +P  S+      + +
Sbjct: 284 PEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 58.0 bits (141), Expect = 3e-10
 Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L      HRD+   N+LV S   +K+GD G+ + I+      DY          +W   P
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWM-SP 183

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E + F   +    D W     M+E+LSFG   F    + D I  +
Sbjct: 184 ESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 57.7 bits (140), Expect = 3e-10
 Identities = 27/83 (32%), Positives = 36/83 (43%), Gaps = 11/83 (13%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEVL-----L 153
           HRDLK  N+LV K G   I DLG+      +    D        T+ Y  PEVL     +
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
                   VD WA G +++E+  
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVAR 218

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 58.2 bits (141), Expect = 3e-10
 Identities = 26/83 (31%), Positives = 36/83 (43%), Gaps = 11/83 (13%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEVL-----L 153
           HRDLK  N+LV K G   I DLG+  +  S+    D        T+ Y  PEVL      
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224

Query: 154 FSEIYGPEVDKWAMGAIMFEMLS 176
                    D ++ G I++E+  
Sbjct: 225 NHFQSYIMADMYSFGLILWEVAR 247

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 57.6 bits (140), Expect = 4e-10
 Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 14/105 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  +   HRDL   N+LV +   +KI D G+ K + +                 +W    
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWM-AL 188

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E +L   IY  + D W+ G  ++E+++FG   + G  +++    +
Sbjct: 189 ESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 57.6 bits (140), Expect = 4e-10
 Identities = 30/105 (28%), Positives = 56/105 (53%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N LV+ +GV+K+ D G+ + +  +    +Y ++       RW   P
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWS-PP 190

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           EVL++S  +  + D WA G +M+E+ S G + +   ++++    I
Sbjct: 191 EVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 57.2 bits (139), Expect = 4e-10
 Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L    + HRDL   N LV     +K+ D GM + +  +     YV++       +W   P
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWS-AP 174

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           EV  +   Y  + D WA G +M+E+ S G + +   ++++ + K+
Sbjct: 175 EVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 57.5 bits (139), Expect = 5e-10
 Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 4/79 (5%)

Query: 98  LHRQGY-FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           L  +    HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L   
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQ-G 204

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W+MG  + EM
Sbjct: 205 THYSVQSDIWSMGLSLVEM 223

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 11/104 (10%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L   GY HRDL   N+LV S  V K+ D G+ + ++ + P   Y TT      RW   PE
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWT-APE 224

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            + F   +    D W+ G +M+E+L++G   +   ++ D I  +
Sbjct: 225 AIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 57.4 bits (139), Expect = 6e-10
 Identities = 23/83 (27%), Positives = 38/83 (45%), Gaps = 6/83 (7%)

Query: 98  LHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           L  + G  HRD+KPSN+L+  +G IK+ D G+   +  +           Y  PE +   
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199

Query: 156 EI----YGPEVDKWAMGAIMFEM 174
           +     Y    D W++G  + E+
Sbjct: 200 DPTKPDYDIRADVWSLGISLVEL 222

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 57.5 bits (139), Expect = 6e-10
 Identities = 23/107 (21%), Positives = 50/107 (46%), Gaps = 15/107 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L ++ + HR+L   N LV    ++K+ D G+ + +  +     Y          +W   P
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA-P 388

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           E L ++  +  + D WA G +++E+ ++G+  +PG   +     + +
Sbjct: 389 ESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 56.8 bits (138), Expect = 6e-10
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L      HRDL   N LV    VIK+ D GM + +  +     Y ++       +W   P
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWA-SP 174

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           EV  FS  Y  + D W+ G +M+E+ S G + +  +S+++ +  I
Sbjct: 175 EVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.9 bits (138), Expect = 7e-10
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + Y HRDL   N+LV S+  +KIGD G+ K I+++    +Y T          WY  
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDRDSPVFWY-A 197

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L+ S  +    D W+ G  + E+L++ 
Sbjct: 198 PECLMQS-KFYIASDVWSFGVTLHELLTYC 226

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 25/80 (31%), Positives = 36/80 (45%), Gaps = 8/80 (10%)

Query: 105 HRDLKPSNLLVSK-GVIKIGDLGM--VKEIDSNLPCTDYVT-TRWYRGPEVL----LFSE 156
           HRD+K  N+L+       I D G+    E   +   T     TR Y  PEVL     F  
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213

Query: 157 IYGPEVDKWAMGAIMFEMLS 176
                +D +AMG +++E+ S
Sbjct: 214 DAFLRIDMYAMGLVLWELAS 233

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 32/126 (25%), Positives = 47/126 (37%), Gaps = 18/126 (14%)

Query: 68  FNLMREKNLQSWTIMISGLADNSRG------NDAISLHRQGYFHRDLKPSNLLVSK-GVI 120
           F+ +    + +   MI      + G          +  +    HRDLK  N+LV K G  
Sbjct: 128 FDYLNRYTV-TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186

Query: 121 KIGDLGMVKEIDSNLPCTDYVT-----TRWYRGPEVL-----LFSEIYGPEVDKWAMGAI 170
            I DLG+    DS     D        T+ Y  PEVL     +         D +AMG +
Sbjct: 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246

Query: 171 MFEMLS 176
            +E+  
Sbjct: 247 FWEIAR 252

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + Y HRDL   N+LV ++  +KIGD G+ K +  +    +Y            WY  
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWY-A 216

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L  S  +    D W+ G +++E+ ++ 
Sbjct: 217 PESLTES-KFSVASDVWSFGVVLYELFTYI 245

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           LH Q Y HRDL   N+L+    ++KIGD G+ K +       +Y            WY  
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-A 205

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L     +    D W+ G  ++E+L+  
Sbjct: 206 PECLKEY-KFYYASDVWSFGVTLYELLTHC 234

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 13/105 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   NLL+ ++ ++KIGD G+++ +  N     YV          W   P
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCA-P 193

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E L     +    D W  G  ++EM ++G   + G + +  ++KI
Sbjct: 194 ESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 24/92 (26%), Positives = 37/92 (40%), Gaps = 4/92 (4%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVT-TRWYRGPEVLLFS 155
           H  G  HRD+KP N+LVS      + D G+     D  L        T +Y  PE     
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS-E 209

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA 187
                  D +A+  +++E L+    + G   +
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGDQLS 241

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  +   HRDL   N+LV S+  +KI D G+ K +  +    DY            WY  
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD---KDYYVVREPGQSPIFWY-A 198

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L  + I+  + D W+ G +++E+ ++ 
Sbjct: 199 PESLSDN-IFSRQSDVWSFGVVLYELFTYC 227

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 25/90 (27%), Positives = 43/90 (47%), Gaps = 14/90 (15%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + Y HRDL   N+LV ++  +KIGD G+ K +  +    ++            WY  
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWY-A 185

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFG 178
           PE L  S  +    D W+ G +++E+ ++ 
Sbjct: 186 PESLTES-KFSVASDVWSFGVVLYELFTYI 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 27/106 (25%), Positives = 47/106 (44%), Gaps = 15/106 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + + HR+L   N+L+ ++   KI D G+ K + ++     Y T         +WY  
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYA- 507

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           PE + F   +    D W+ G  M+E LS+G   +      + +  I
Sbjct: 508 PECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 54.9 bits (133), Expect = 3e-09
 Identities = 15/103 (14%), Positives = 34/103 (33%), Gaps = 9/103 (8%)

Query: 98  LHRQGYF--HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL- 153
           LH          L   ++++ +    +I    +     S           W   PE L  
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAPAWV-APEALQK 182

Query: 154 -FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
              +      D W+   +++E+++  + F   S+ +   K+  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL 225

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 14/105 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  +   HRDL   N+LV +   +KI D G+ K + +                 +W    
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWM-AL 188

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E +L   IY  + D W+ G  ++E+++FG   + G  +++    +
Sbjct: 189 ESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 54.6 bits (132), Expect = 4e-09
 Identities = 27/105 (25%), Positives = 46/105 (43%), Gaps = 13/105 (12%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  + + HRDL   N+L+ ++   KI D G+ K + ++     Y          +WY  P
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYA-P 182

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E + F   +    D W+ G  M+E LS+G   +      + +  I
Sbjct: 183 ECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 54.6 bits (132), Expect = 4e-09
 Identities = 25/106 (23%), Positives = 48/106 (45%), Gaps = 15/106 (14%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L    + HRDL   N+L+ ++   KI D G+ K + ++    +Y           +WY  
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWY-A 188

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           PE + +   +  + D W+ G +M+E  S+G   + G   ++    +
Sbjct: 189 PECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 54.5 bits (132), Expect = 4e-09
 Identities = 27/105 (25%), Positives = 53/105 (50%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           +  + Y HRDL+ +N+LVS     KI D G+ + I+ N    +Y          +W   P
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWT-AP 179

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E + +   +  + D W+ G ++ E+++ G + +PG ++ + I  +
Sbjct: 180 EAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 54.7 bits (132), Expect = 6e-09
 Identities = 30/105 (28%), Positives = 56/105 (53%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           + ++ Y HRDL+ +N+LVS   V KI D G+ + I+ N    +Y          +W   P
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKWT-AP 354

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E + F   +  + D W+ G ++ E++++G + +PG S+ + I  +
Sbjct: 355 EAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 54.3 bits (131), Expect = 6e-09
 Identities = 22/105 (20%), Positives = 44/105 (41%), Gaps = 14/105 (13%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L   G  HR+L   N+L+ S   +++ D G+   +  +      +         +W    
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWM-AL 186

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E + F   Y  + D W+ G  ++E+++FG   + G   A+    +
Sbjct: 187 ESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 53.8 bits (130), Expect = 8e-09
 Identities = 24/105 (22%), Positives = 49/105 (46%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L ++ + HRDL   N LV    ++K+ D G+ + +  +     Y          +W   P
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWT-AP 181

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E L ++  +  + D WA G +++E+ ++G+  +PG   +     +
Sbjct: 182 ESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 53.8 bits (130), Expect = 8e-09
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 16/106 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  Q + HRDL   N LV    ++KIGD GM +++ S     DY           RW   
Sbjct: 149 LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST----DYYRVGGHTMLPIRWM-P 203

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           PE +++   +  E D W+ G I++E+ ++G   +   S+ + I  I
Sbjct: 204 PESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 16/106 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L    + HRDL   N LV +G V+KIGD GM ++I S     DY           RW   
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYRVGGRTMLPIRWM-P 228

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           PE +L+   +  E D W+ G +++E+ ++G   +   S+ + I  I
Sbjct: 229 PESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 53.0 bits (128), Expect = 1e-08
 Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 4/80 (5%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN-LPCTDYVT-TRWYRGPEVLLFS 155
           H     HRD+KP N+L+     +KI D G+ K +    L  T++V  T  Y  PE     
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-G 186

Query: 156 EIYGPEVDKWAMGAIMFEML 175
           E      D +++G +++EML
Sbjct: 187 EATDECTDIYSIGIVLYEML 206

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH QG  HRD+K  + LL   G +K+ D G   +I  ++P     V T ++  PEV+  S
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS 216

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  EVD W++G ++ EM
Sbjct: 217 L-YATEVDIWSLGIMVIEM 234

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 5/82 (6%)

Query: 98  LHRQGY-FHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           L       HRD+KPSN+L+   G IK+ D G+  ++  ++  T     R Y  PE +  S
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200

Query: 156 EI---YGPEVDKWAMGAIMFEM 174
                Y    D W++G  ++E+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYEL 222

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 52.6 bits (127), Expect = 2e-08
 Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 16/106 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L      H+DL   N+LV     +KI DLG+ +E+ +     DY           RW   
Sbjct: 144 LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA----ADYYKLLGNSLLPIRWM-A 198

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           PE +++   +  + D W+ G +++E+ S+G+  + G S+ D +  I
Sbjct: 199 PEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 21/74 (28%), Positives = 37/74 (50%), Gaps = 4/74 (5%)

Query: 105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI---YGP 160
           HRD+KPSN+L++  G +K+ D G+   +  ++        + Y  PE +        Y  
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192

Query: 161 EVDKWAMGAIMFEM 174
           + D W++G  M E+
Sbjct: 193 KSDIWSLGITMIEL 206

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N LL   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             YGP+VD W++G +  EM
Sbjct: 192 A-YGPKVDIWSLGIMAIEM 209

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 52.6 bits (127), Expect = 2e-08
 Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 12/85 (14%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVT-------TRWYRGPE 150
           H+ G  HRD+KP+N+++S    +K+ D G+ + I  +    + VT       T  Y  PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAAVIGTAQYLSPE 189

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEML 175
                +      D +++G +++E+L
Sbjct: 190 QAR-GDSVDARSDVYSLGCVLYEVL 213

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 22/107 (20%), Positives = 46/107 (42%), Gaps = 16/107 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  Q + HRDL   N ++ +   +K+ D G+ ++I       +Y + + +R         
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR----EYYSVQQHRHARLPVKWT 195

Query: 149 -PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
             E L     +  + D W+ G +++E+L+ G   +      D  + +
Sbjct: 196 ALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 24/110 (21%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L+   + HRDL   N +V++   +KIGD GM ++I      TDY     YR         
Sbjct: 154 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDY-----YRKGGKGLLPV 204

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
               PE L    ++    D W+ G +++E+ +     + G S+   +  +
Sbjct: 205 RWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 51.7 bits (124), Expect = 4e-08
 Identities = 14/93 (15%), Positives = 26/93 (27%), Gaps = 28/93 (30%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI 157
           HR G       PS + VS  G + +     + + +                         
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN------------------------- 180

Query: 158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI 190
             P+ D   +GA ++ +L      P       +
Sbjct: 181 --PQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 51.8 bits (124), Expect = 4e-08
 Identities = 26/88 (29%), Positives = 35/88 (39%), Gaps = 16/88 (18%)

Query: 105 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---------LPCTDYVTTRWYRGPEVL-- 152
           HRDL   N+LV + G   I D G+   +  N               V T  Y  PEVL  
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202

Query: 153 ----LFSEIYGPEVDKWAMGAIMFEMLS 176
                  E    +VD +A+G I +E+  
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIFM 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 52.0 bits (125), Expect = 4e-08
 Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 15/105 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYRGPEV 151
           L    + HRDL   N+LVS   V K+ D G+ KE  S      LP       +W   PE 
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWT-APEA 357

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
           L     +  + D W+ G +++E+ SFG + +P     D + ++ +
Sbjct: 358 LREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 51.4 bits (124), Expect = 4e-08
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 15/103 (14%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-----DSNLPCTDYVTTRWYRGPEV 151
           L    + HRDL   N+LVS   V K+ D G+ KE         LP       +W   PE 
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWT-APEA 185

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           L     +  + D W+ G +++E+ SFG + +P     D + ++
Sbjct: 186 LREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 20/87 (22%), Positives = 37/87 (42%), Gaps = 10/87 (11%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLG--------MVKEIDSNLPCTDYVTTRWYRG 148
           +H  GY HR +K S++L+S  G + +  L           ++   +      V    +  
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 149 PEVLLFSEI-YGPEVDKWAMGAIMFEM 174
           PEVL  +   Y  + D +++G    E+
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACEL 230

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 51.6 bits (124), Expect = 5e-08
 Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 7/84 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTD------YVTTRWYRGPE 150
           LH+ G  HRD+K  N+L+   G ++I D G+   + +    T       +V T  +  PE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEM 174
           V+     Y  + D W+ G    E+
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIEL 220

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 51.5 bits (124), Expect = 5e-08
 Identities = 28/109 (25%), Positives = 49/109 (44%), Gaps = 19/109 (17%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTT--------RW 145
           L    + HRD+   N L++      V KIGD GM ++I        Y           +W
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASYYRKGGCAMLPVKW 211

Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
              PE  +   I+  + D W+ G +++E+ S G + +P KS+ + +  +
Sbjct: 212 M-PPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

>3spa_A Mtrpol, DNA-directed RNA polymerase, mitochondrial; single-subunit DNA-dependent RNA polymerase in mitochondria, transferase; 2.50A {Homo sapiens} Length = 1134

 Score = 52.1 bits (123), Expect = 5e-08
 Identities = 12/105 (11%), Positives = 36/105 (34%), Gaps = 9/105 (8%)

Query: 1   MKLANENPNSVTLVSLVSAC--TGLINVRAGESIHSYA--VVNGLELDVAIGTALVEMYS 56
              A  +     L++    C  T  +   A   +  +         L + +  A++  ++
Sbjct: 118 HSQAQLSGQQQRLLAFFKCCLLTDQLP-LAHHLLVVHHGQRQKRKLLTLDMYNAVMLGWA 176

Query: 57  KCGHVEKAFKVFNLMREK----NLQSWTIMISGLADNSRGNDAIS 97
           + G  ++   V  ++++     +L S+   +  +    +    I 
Sbjct: 177 RQGAFKELVYVLFMVKDAGLTPDLLSYAAALQCMGRQDQDAGTIE 221

>3spa_A Mtrpol, DNA-directed RNA polymerase, mitochondrial; single-subunit DNA-dependent RNA polymerase in mitochondria, transferase; 2.50A {Homo sapiens} Length = 1134

 Score = 40.2 bits (92), Expect = 4e-04
 Identities = 12/108 (11%), Positives = 31/108 (28%), Gaps = 7/108 (6%)

Query: 1   MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGH 60
            + A E+P    L  L+    G +++   ++         L        A  +       
Sbjct: 83  TRQAPESPWEEQLARLLQEAPGKLSLDVEQAPSGQHSQAQLSGQQQRLLAFFKCCLLTDQ 142

Query: 61  VEKAFKVFNLMREK-------NLQSWTIMISGLADNSRGNDAISLHRQ 101
           +  A  +  +   +        L  +  ++ G A      + + +   
Sbjct: 143 LPLAHHLLVVHHGQRQKRKLLTLDMYNAVMLGWARQGAFKELVYVLFM 190

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 51.2 bits (123), Expect = 7e-08
 Identities = 25/106 (23%), Positives = 47/106 (44%), Gaps = 16/106 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + + HRDL   N ++++   + + D G+ ++I S     DY           +W   
Sbjct: 153 LSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----DYYRQGCASKLPVKWL-A 207

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            E L  + +Y    D WA G  M+E+++ G   + G  +A+    +
Sbjct: 208 LESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 51.3 bits (123), Expect = 7e-08
 Identities = 20/104 (19%), Positives = 47/104 (45%), Gaps = 10/104 (9%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L  + + HRDL   N ++ +   +K+ D G+ +++      + +  T      +W    E
Sbjct: 208 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALE 266

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            L     +  + D W+ G +++E+++ G   +P  ++ D    +
Sbjct: 267 SLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 50.9 bits (122), Expect = 8e-08
 Identities = 28/109 (25%), Positives = 49/109 (44%), Gaps = 19/109 (17%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSNLPCTDYVTT--------RW 145
           L    + HRD+   N L++      V KIGD GM ++I        Y           +W
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGYYRKGGCAMLPVKW 252

Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
              PE  +   I+  + D W+ G +++E+ S G + +P KS+ + +  +
Sbjct: 253 M-PPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 50.3 bits (121), Expect = 1e-07
 Identities = 20/104 (19%), Positives = 47/104 (45%), Gaps = 10/104 (9%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT------RWYRGPE 150
           L  + + HRDL   N ++ +   +K+ D G+ +++      + +  T      +W    E
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALE 202

Query: 151 VLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            L     +  + D W+ G +++E+++ G   +P  ++ D    +
Sbjct: 203 SLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 50.4 bits (121), Expect = 1e-07
 Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 16/106 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT--------RWYRG 148
           L  + + HRDL   N ++     + + D G+ K+I S     DY           +W   
Sbjct: 163 LSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG----DYYRQGRIAKMPVKWI-A 217

Query: 149 PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
            E L    +Y  + D WA G  M+E+ + G+  +PG  + +    +
Sbjct: 218 IESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.7 bits (121), Expect = 1e-07
 Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 11/124 (8%)

Query: 88  DNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYR 147
            +             +    L+P N    K  +KI DLG       +   T+ + TR YR
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNA--EKLKVKIADLG--NACWVHKHFTEDIQTRQYR 260

Query: 148 GPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS------ADQIYKICQLIGSPT 201
             EVL+ S  Y    D W+   + FE+ +   LF   S        D I  I +L+G   
Sbjct: 261 SLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319

Query: 202 KDSW 205
           +   
Sbjct: 320 RKLI 323

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 14/104 (13%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L  +   HRDL   N+L+S+  V+KI D G+ ++I  +    DYV         +W   P
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWM-AP 264

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
           E + F  +Y  + D W+ G +++E+ S G   +PG    ++  +
Sbjct: 265 ETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 50.0 bits (120), Expect = 2e-07
 Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 24/110 (21%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  + + HRDL   N LV +  V+KI D G+ + I S     DY     Y+         
Sbjct: 190 LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS----ADY-----YKADGNDAIPI 240

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
               PE + ++  Y  E D WA G +++E+ S+G+  + G +  + IY +
Sbjct: 241 RWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N LL ++G  K+ D G+  ++ D+       + T ++  PEV+   
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y    D W++G    EM
Sbjct: 201 G-YNCVADIWSLGITAIEM 218

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 49.6 bits (119), Expect = 2e-07
 Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 24/109 (22%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  +   HRDL   N+L++ G + KI D G+ ++I ++           Y          
Sbjct: 161 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND----SN-----YVVKGNARLPV 211

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
               PE +    +Y  E D W+ G  ++E+ S G   +PG     + YK
Sbjct: 212 KWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 49.2 bits (118), Expect = 3e-07
 Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 24/109 (22%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  +   HRDL   N+L+S+  V+KI D G+ ++I  +           Y          
Sbjct: 164 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD-----YVRKGDARLPL 214

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
               PE +    +Y  + D W+ G +++E+ S G   +PG    ++  +
Sbjct: 215 KWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 48.5 bits (116), Expect = 5e-07
 Identities = 25/79 (31%), Positives = 46/79 (58%), Gaps = 3/79 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +   HRD+K +N+L+S+ G +K+ D G+  ++ D+ +    +V T ++  PEV+  S
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194

Query: 156 EIYGPEVDKWAMGAIMFEM 174
             Y  + D W++G    E+
Sbjct: 195 A-YDSKADIWSLGITAIEL 212

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 47.6 bits (114), Expect = 9e-07
 Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 24/109 (22%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  +   HRD+   N+L++ G V KIGD G+ ++I +            Y          
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN----DSN-----YIVKGNARLPV 230

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
               PE +    +Y  + D W+ G +++E+ S G+  +PG     + YK
Sbjct: 231 KWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 32/109 (29%), Positives = 48/109 (44%), Gaps = 24/109 (22%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  +   HRDL   N+LV+ G V+KI D G+ ++I S+           Y          
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD----SN-----YVVRGNARLPV 238

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYK 192
               PE L    IY  + D W+ G +++E+ S G+  +PG       YK
Sbjct: 239 KWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 23/83 (27%), Positives = 43/83 (51%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFS 155
           LH+    HRD+K  N+L+++   +K+ D G+  ++D  +     ++ T ++  PEV+   
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204

Query: 156 EI----YGPEVDKWAMGAIMFEM 174
           E     Y  + D W++G    EM
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEM 227

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 46.5 bits (111), Expect = 2e-06
 Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 17/105 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTT-------RWYRGP 149
           L ++ + HRDL   N+LV +  V KI D G+ +  +       YV         RW    
Sbjct: 158 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKTMGRLPVRWM-AI 210

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
           E L +S +Y    D W+ G +++E++S G   + G + A+   K+
Sbjct: 211 ESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 25/83 (30%), Positives = 43/83 (51%), Gaps = 6/83 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLFS 155
           LH +   HRDLK  N L+  +G I++ D G+  +    L   D ++ T ++  PEV++  
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 156 EI----YGPEVDKWAMGAIMFEM 174
            +    Y  + D W++G  + EM
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 6/80 (7%)

Query: 98  LHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     HRD+K  N LL   G++K+GD G    +        +V T ++  PEV+L  +
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMD 226

Query: 157 --IYGPEVDKWAMGAIMFEM 174
              Y  +VD W++G    E+
Sbjct: 227 EGQYDGKVDVWSLGITCIEL 246

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 45.7 bits (109), Expect = 4e-06
 Identities = 26/105 (24%), Positives = 43/105 (40%), Gaps = 24/105 (22%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L      HRDL   N+LV++G  +KI D G+ +++       D      Y          
Sbjct: 166 LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE----EDS-----YVKRSQGRIPV 216

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
                E L    IY  + D W+ G +++E+++ G   +PG     
Sbjct: 217 KWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 45.4 bits (108), Expect = 6e-06
 Identities = 29/105 (27%), Positives = 47/105 (44%), Gaps = 24/105 (22%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  +   HRDL   N+LV++  V+KI D G+ ++I       DY     Y+         
Sbjct: 207 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DY-----YKKTTNGRLPV 257

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
               PE L    IY  + D W+ G +++E+ + G   +PG    +
Sbjct: 258 KWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 7e-06
 Identities = 37/254 (14%), Positives = 78/254 (30%), Gaps = 60/254 (23%)

Query: 2   KLANEN----PNSVTLVSLVSAC-TGLINVRAGESIHSYAVVNGLELDVAIG-TALVEMY 55
           +L N+N      +V+ +         L+ +R  +++    +++G+   +  G T +    
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV----LIDGV---LGSGKTWVALDV 170

Query: 56  SKCGHVEKA--FKVF------------NLMREKNL-----QSWTIMISGLADNSRGNDAI 96
                V+    FK+F             L   + L      +WT      ++      +I
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230

Query: 97  SLHRQGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEV 151
               +         + LLV     +       +L           C   +TTR+ +  + 
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS----------CKILLTTRFKQVTDF 280

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD---QIYKI----CQLIGSPTKDS 204
           L  +      +D  +M     E+ S  + +      D   ++         +I    +D 
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD- 339

Query: 205 WPLGIQLASNLNWK 218
                      NWK
Sbjct: 340 GLATWD-----NWK 348

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 45.0 bits (107), Expect = 8e-06
 Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 24/110 (21%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY     Y+         
Sbjct: 219 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY-----YKKTTNGRLPV 269

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKI 193
               PE L    +Y  + D W+ G +M+E+ + G   +PG    +    +
Sbjct: 270 KWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.6 bits (106), Expect = 9e-06
 Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 24/105 (22%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSNLPCTDYVTTRWYRG-------- 148
           L  Q   HRDL   N+LV++  V+KI D G+ ++I++     DY     Y+         
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY-----YKKTTNGRLPV 223

Query: 149 ----PEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSAD 188
               PE L    +Y  + D W+ G +M+E+ + G   +PG    +
Sbjct: 224 KWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 11/36 (30%), Positives = 18/36 (50%), Gaps = 3/36 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG---VIKIGDLGMVKE 130
           +H   Y H D+K SNLL++      + + D G+   
Sbjct: 168 IHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 8/41 (19%), Positives = 13/41 (31%), Gaps = 4/41 (9%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG---VIKIGDLGMVKE-IDSN 134
           LH   Y H ++   N+ V       + +   G       S 
Sbjct: 175 LHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 15/44 (34%), Positives = 22/44 (50%), Gaps = 7/44 (15%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG------VIKIGDLGMVKE-IDSN 134
           +H +   +RD+KP N L+ +       VI I D  + KE ID  
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 10/36 (27%), Positives = 17/36 (47%), Gaps = 3/36 (8%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG---VIKIGDLGMVKE 130
           +H   Y H D+K +NLL+       + + D G+   
Sbjct: 167 IHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 39.6 bits (92), Expect = 5e-04
 Identities = 14/43 (32%), Positives = 24/43 (55%), Gaps = 5/43 (11%)

Query: 97  SLHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKE-IDSN 134
            +H + + HRD+KP N L+  G     + I D G+ K+  D++
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	234
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.9
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.89
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.89
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.89
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.89
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.89
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.89
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.89
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.89
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.89
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.88
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.88
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.88
4g26_A	501	Pentatricopeptide repeat-containing protein AT2G3	99.87
4g26_A	501	Pentatricopeptide repeat-containing protein AT2G3	99.85
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.84
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.83
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.8
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.8
3spa_A	1134	Mtrpol, DNA-directed RNA polymerase, mitochondrial	99.79
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.79
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.78
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.76
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.76
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.75
3niz_A	311	Rhodanese family protein; structural genomics, str	99.75
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.75
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.75
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.75
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.74
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.74
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.74
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.74
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.74
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.74
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.74
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.74
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.74
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.74
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.73
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.73
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.73
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.73
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.73
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.73
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.73
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.73
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.73
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.73
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.73
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.72
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.72
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.72
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.72
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.72
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.72
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.72
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.72
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.71
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.71
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.71
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.71
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.71
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.71
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.71
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.71
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.71
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.71
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.71
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.7
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.7
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.7
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.7
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.7
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.7
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.7
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.7
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.7
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.7
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.7
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.7
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.7
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.7
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.69
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.69
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.69
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.69
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.69
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.69
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.69
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.69
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.69
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.69
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.69
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.69
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.68
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.68
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.68
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.68
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.68
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.68
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.68
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.68
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.68
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.68
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.68
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.67
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.67
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.67
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.67
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.67
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.67
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.67
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.67
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.67
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.67
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.67
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.67
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.67
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.67
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.66
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.66
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.66
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.66
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.66
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.66
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.66
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.66
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.66
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.66
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.66
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.66
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.66
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.66
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.66
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.66
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.65
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.65
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.65
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.65
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.65
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.65
3bhy_A	283	Death-associated protein kinase 3; death associate	99.65
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.65
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.65
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.65
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.65
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.65
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.65
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.65
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.65
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.65
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.64
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.64
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.64
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.64
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.64
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.64
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.64
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.64
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.64
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.64
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.64
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.64
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.64
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.64
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.64
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.64
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.64
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.63
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.63
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.63
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.63
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.63
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.63
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.63
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.63
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.63
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.63
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.63
3spa_A	1134	Mtrpol, DNA-directed RNA polymerase, mitochondrial	99.63
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.63
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.63
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.63
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.63
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.62
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.62
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.62
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.62
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.61
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.61
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.61
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.61
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.61
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.61
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.61
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.61
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.6
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.6
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.6
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.6
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.6
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.59
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.59
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.59
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.59
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.59
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.58
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.58
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.58
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.58
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.57
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.57
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.57
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.57
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.57
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.57
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.56
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.56
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.56
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.56
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.56
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.56
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.55
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.55
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.54
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.53
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.53
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.52
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.52
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.51
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.51
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.51
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.51
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.5
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.5
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.5
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.48
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.41
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.41
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.27
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.12
3uqc_A	286	Probable conserved transmembrane protein; structur	99.11
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	98.8
2xpi_A	597	Anaphase-promoting complex subunit CUT9; cell cycl	98.44
2xpi_A	597	Anaphase-promoting complex subunit CUT9; cell cycl	98.38
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	98.12
1b89_A	449	Protein (clathrin heavy chain); triskelion, coated	97.57
1b89_A	449	Protein (clathrin heavy chain); triskelion, coated	97.37
2fo7_A	136	Synthetic consensus TPR protein; tetratricopeptide	97.24
1w3b_A	388	UDP-N-acetylglucosamine--peptide N-acetylglucosami	97.19
1na0_A	125	Designed protein CTPR3; de novo protein; HET: IPT;	97.18
2fo7_A	136	Synthetic consensus TPR protein; tetratricopeptide	97.11
3mkr_A	291	Coatomer subunit epsilon; tetratricopeptide repeat	97.1
1w3b_A	388	UDP-N-acetylglucosamine--peptide N-acetylglucosami	97.02
2kck_A	112	TPR repeat; tetratricopeptide repeat, structural g	96.72
2y4t_A	450	DNAJ homolog subfamily C member 3; chaperone, endo	96.68
2y4t_A	450	DNAJ homolog subfamily C member 3; chaperone, endo	96.63
3mkr_A	291	Coatomer subunit epsilon; tetratricopeptide repeat	96.58
4eqf_A	365	PEX5-related protein; accessory protein, tetratric	96.56
4eqf_A	365	PEX5-related protein; accessory protein, tetratric	96.56
2ho1_A	252	Type 4 fimbrial biogenesis protein PILF; type IV p	96.55
3gyz_A	151	Chaperone protein IPGC; asymmetric homodimer, tetr	96.55
2vq2_A	225	PILW, putative fimbrial biogenesis and twitching m	96.45
3k9i_A	117	BH0479 protein; putative protein binding protein,	96.38
2lni_A	133	Stress-induced-phosphoprotein 1; structural genomi	96.37
1xnf_A	275	Lipoprotein NLPI; TPR, tetratricopeptide, structur	96.36
2ho1_A	252	Type 4 fimbrial biogenesis protein PILF; type IV p	96.34
3as5_A	186	MAMA; tetratricopeptide repeats (TPR) containing p	96.31
3as5_A	186	MAMA; tetratricopeptide repeats (TPR) containing p	96.3
4gco_A	126	Protein STI-1; structural genomics, PSI-biology, m	96.29
2vq2_A	225	PILW, putative fimbrial biogenesis and twitching m	96.28
3q49_B	137	STIP1 homology and U box-containing protein 1; E3	96.25
2pl2_A	217	Hypothetical conserved protein TTC0263; TPR, prote	96.23
2vgx_A	148	Chaperone SYCD; alternative dimer assembly, tetrat	96.23
2xcb_A	142	PCRH, regulatory protein PCRH; protein transport,	96.14
1fch_A	368	Peroxisomal targeting signal 1 receptor; protein-p	96.11
3sz7_A	164	HSC70 cochaperone (SGT); TPR domain, GET4, GET5, G	96.06
3cv0_A	327	Peroxisome targeting signal 1 receptor PEX5; TPR m	96.04
2q7f_A	243	YRRB protein; TPR, protein binding; 2.49A {Bacillu	96.04
2dba_A	148	Smooth muscle cell associated protein-1, isoform 2	96.04
3hym_B	330	Cell division cycle protein 16 homolog; APC, anaph	96.01
3uq3_A	258	Heat shock protein STI1; HSP90, peptide binding, c	96.0
2q7f_A	243	YRRB protein; TPR, protein binding; 2.49A {Bacillu	96.0
1elw_A	118	TPR1-domain of HOP; HOP, TPR-domain, peptide-compl	95.97
2gw1_A	514	Mitochondrial precursor proteins import receptor;	95.92
2vyi_A	131	SGTA protein; chaperone, TPR repeat, phosphoprotei	95.92
3upv_A	126	Heat shock protein STI1; TPR-fold, adaptor protein	95.92
1elr_A	131	TPR2A-domain of HOP; HOP, TPR-domain, peptide-comp	95.83
1fch_A	368	Peroxisomal targeting signal 1 receptor; protein-p	95.77
3uq3_A	258	Heat shock protein STI1; HSP90, peptide binding, c	95.69
3cv0_A	327	Peroxisome targeting signal 1 receptor PEX5; TPR m	95.63
4i17_A	228	Hypothetical protein; TPR repeats protein, structu	95.52
1hh8_A	213	P67PHOX, NCF-2, neutrophil cytosol factor 2; cell	95.51
3u4t_A	272	TPR repeat-containing protein; structural genomics	95.42
3hym_B	330	Cell division cycle protein 16 homolog; APC, anaph	95.37
3vtx_A	184	MAMA; tetratricopeptide repeats (TPR) containing p	95.3
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	95.24
1hxi_A	121	PEX5, peroxisome targeting signal 1 receptor PEX5;	95.22
1a17_A	166	Serine/threonine protein phosphatase 5; hydrolase,	95.2
3edt_B	283	KLC 2, kinesin light chain 2; superhelical, struct	95.16
3fp2_A	537	TPR repeat-containing protein YHR117W; TOM71, mito	95.13
2pl2_A	217	Hypothetical conserved protein TTC0263; TPR, prote	95.12
3nf1_A	311	KLC 1, kinesin light chain 1; TPR, structural geno	95.1
3nf1_A	311	KLC 1, kinesin light chain 1; TPR, structural geno	95.09
2ond_A	308	Cleavage stimulation factor 77 kDa subunit; HAT do	95.05
2xev_A	129	YBGF; tetratricopeptide, alpha-helical, metal bind	95.0
2c2l_A	281	CHIP, carboxy terminus of HSP70-interacting protei	94.88
1xnf_A	275	Lipoprotein NLPI; TPR, tetratricopeptide, structur	94.85
4ga2_A	150	E3 SUMO-protein ligase ranbp2; TPR motif, nuclear	94.85
2gw1_A	514	Mitochondrial precursor proteins import receptor;	94.71
2e2e_A	177	Formate-dependent nitrite reductase complex NRFG;	94.57
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	94.45
1hh8_A	213	P67PHOX, NCF-2, neutrophil cytosol factor 2; cell	94.35
4gyw_A	723	UDP-N-acetylglucosamine--peptide N- acetylglucosam	94.32
3fp2_A	537	TPR repeat-containing protein YHR117W; TOM71, mito	94.31
2l6j_A	111	TPR repeat-containing protein associated with HSP;	94.31
3u4t_A	272	TPR repeat-containing protein; structural genomics	94.26
3ieg_A	359	DNAJ homolog subfamily C member 3; TPR motif, chap	94.24
4i17_A	228	Hypothetical protein; TPR repeats protein, structu	94.2
3edt_B	283	KLC 2, kinesin light chain 2; superhelical, struct	94.12
1p5q_A	336	FKBP52, FK506-binding protein 4; isomerase; 2.80A	94.11
4abn_A	474	Tetratricopeptide repeat protein 5; P53 cofactor,	94.06
3urz_A	208	Uncharacterized protein; tetratricopeptide repeats	94.02
4gyw_A	723	UDP-N-acetylglucosamine--peptide N- acetylglucosam	93.98
4gcn_A	127	Protein STI-1; structural genomics, PSI-biology, m	93.76
1na0_A	125	Designed protein CTPR3; de novo protein; HET: IPT;	93.72
2ond_A	308	Cleavage stimulation factor 77 kDa subunit; HAT do	93.71
1a17_A	166	Serine/threonine protein phosphatase 5; hydrolase,	93.64
3vtx_A	184	MAMA; tetratricopeptide repeats (TPR) containing p	93.51
2fbn_A	198	70 kDa peptidylprolyl isomerase, putative; sulfur	93.5
2h6f_A	382	Protein farnesyltransferase/geranylgeranyltransfer	93.48
3mv2_B	310	Coatomer subunit epsilon; vesicular membrane coat	93.46
2h6f_A	382	Protein farnesyltransferase/geranylgeranyltransfer	93.39
3ieg_A	359	DNAJ homolog subfamily C member 3; TPR motif, chap	93.36
3rkv_A	162	Putative peptidylprolyl isomerase; structural geno	93.2
3ma5_A	100	Tetratricopeptide repeat domain protein; NESG, str	92.86
2ooe_A	530	Cleavage stimulation factor 77 kDa subunit; HAT do	92.8
2vsy_A	568	XCC0866; transferase, glycosyl transferase, GT-B,	92.65
2lni_A	133	Stress-induced-phosphoprotein 1; structural genomi	92.54
4abn_A	474	Tetratricopeptide repeat protein 5; P53 cofactor,	92.39
4ga2_A	150	E3 SUMO-protein ligase ranbp2; TPR motif, nuclear	92.32
2vyi_A	131	SGTA protein; chaperone, TPR repeat, phosphoprotei	92.31
2hr2_A	159	Hypothetical protein; alpha-alpha superhelix fold,	92.23
1ouv_A	273	Conserved hypothetical secreted protein; TPR repea	92.22
1wao_1	477	Serine/threonine protein phosphatase 5; hydrolase,	91.95
2kat_A	115	Uncharacterized protein; NESG, structure, structur	91.94
2if4_A	338	ATFKBP42; FKBP-like, alpha-beta, TPR-like, alpha,	91.93
3ro3_A	164	PINS homolog, G-protein-signaling modulator 2; asy	91.9
2vsy_A	568	XCC0866; transferase, glycosyl transferase, GT-B,	91.73
1kt0_A	457	FKBP51, 51 kDa FK506-binding protein; FKBP-like pp	91.56
1ouv_A	273	Conserved hypothetical secreted protein; TPR repea	91.39
1ihg_A	370	Cyclophilin 40; ppiase immunophilin tetratricopept	91.18
2e2e_A	177	Formate-dependent nitrite reductase complex NRFG;	90.77
4a1s_A	411	PINS, partner of inscuteable; cell cycle, LGN, mit	90.43
2l6j_A	111	TPR repeat-containing protein associated with HSP;	90.36
3gw4_A	203	Uncharacterized protein; structural genomics, PSI-	90.32
3ma5_A	100	Tetratricopeptide repeat domain protein; NESG, str	90.1
3qww_A	433	SET and MYND domain-containing protein 2; methyltr	90.09
1na3_A	91	Designed protein CTPR2; de novo protein; HET: IPT;	90.07
3u3w_A	293	Transcriptional activator PLCR protein; ternary co	90.02
1wao_1	477	Serine/threonine protein phosphatase 5; hydrolase,	89.98
3mv2_B	310	Coatomer subunit epsilon; vesicular membrane coat	89.96
1na3_A	91	Designed protein CTPR2; de novo protein; HET: IPT;	89.8
3gyz_A	151	Chaperone protein IPGC; asymmetric homodimer, tetr	89.75
1qqe_A	292	Vesicular transport protein SEC17; helix-turn-heli	89.74
3n71_A	490	Histone lysine methyltransferase SMYD1; heart deve	89.55
3ro2_A	338	PINS homolog, G-protein-signaling modulator 2; TPR	89.41
3ro2_A	338	PINS homolog, G-protein-signaling modulator 2; TPR	89.15
2ooe_A	530	Cleavage stimulation factor 77 kDa subunit; HAT do	89.12
3gw4_A	203	Uncharacterized protein; structural genomics, PSI-	89.04
4a1s_A	411	PINS, partner of inscuteable; cell cycle, LGN, mit	89.02
3sf4_A	406	G-protein-signaling modulator 2; tetratricopeptide	88.98
3ro3_A	164	PINS homolog, G-protein-signaling modulator 2; asy	88.86
2qfc_A	293	PLCR protein; TPR, HTH, transcription regulation;	88.0
3sf4_A	406	G-protein-signaling modulator 2; tetratricopeptide	87.86
3u3w_A	293	Transcriptional activator PLCR protein; ternary co	87.76
2ifu_A	307	Gamma-SNAP; membrane fusion, snare complex disasse	87.74
2vgx_A	148	Chaperone SYCD; alternative dimer assembly, tetrat	87.65
2qfc_A	293	PLCR protein; TPR, HTH, transcription regulation;	87.52
1p5q_A	336	FKBP52, FK506-binding protein 4; isomerase; 2.80A	87.4
3ulq_A	383	Response regulator aspartate phosphatase F; tetrat	87.33
2r5s_A	176	Uncharacterized protein VP0806; APC090868.1, vibri	87.21
3k9i_A	117	BH0479 protein; putative protein binding protein,	86.99
1qqe_A	292	Vesicular transport protein SEC17; helix-turn-heli	86.91
2kat_A	115	Uncharacterized protein; NESG, structure, structur	86.52
2ifu_A	307	Gamma-SNAP; membrane fusion, snare complex disasse	86.5
3sz7_A	164	HSC70 cochaperone (SGT); TPR domain, GET4, GET5, G	86.47
2xcb_A	142	PCRH, regulatory protein PCRH; protein transport,	86.1
2kck_A	112	TPR repeat; tetratricopeptide repeat, structural g	86.09
3q15_A	378	PSP28, response regulator aspartate phosphatase H;	85.7
3qou_A	287	Protein YBBN; thioredoxin-like fold, tetratricopep	85.39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	85.29
2p58_C	116	Putative type III secretion protein YSCG; type III	85.17
4f3v_A	282	ESX-1 secretion system protein ECCA1; tetratricope	84.81
1elr_A	131	TPR2A-domain of HOP; HOP, TPR-domain, peptide-comp	84.8
2xev_A	129	YBGF; tetratricopeptide, alpha-helical, metal bind	84.64
4gco_A	126	Protein STI-1; structural genomics, PSI-biology, m	84.64
3qwp_A	429	SET and MYND domain-containing protein 3; SMYD3,SE	84.0
3qky_A	261	Outer membrane assembly lipoprotein YFIO; membrane	83.81
4g1t_A	472	Interferon-induced protein with tetratricopeptide	83.79
1elw_A	118	TPR1-domain of HOP; HOP, TPR-domain, peptide-compl	83.51
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	83.2
2dba_A	148	Smooth muscle cell associated protein-1, isoform 2	83.03
3upv_A	126	Heat shock protein STI1; TPR-fold, adaptor protein	82.88
3rjv_A	212	Putative SEL1 repeat protein; alpha-alpha superhel	82.84
4gcn_A	127	Protein STI-1; structural genomics, PSI-biology, m	82.79
3q49_B	137	STIP1 homology and U box-containing protein 1; E3	82.57
2kc7_A	99	BFR218_protein; tetratricopeptide repeat, all-alph	82.47
2uwj_G	115	Type III export protein PSCG; virulence, chaperone	82.12
3qky_A	261	Outer membrane assembly lipoprotein YFIO; membrane	81.96
1xi4_A	1630	Clathrin heavy chain; alpha-ZIG-ZAG, beta-propelle	80.96
3urz_A	208	Uncharacterized protein; tetratricopeptide repeats	80.75

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.90  E-value=1.8e-24  Score=174.39  Aligned_cols=173  Identities=19%  Similarity=0.331  Sum_probs=139.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||.+||..|++.+...- ..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ .++..+++|||.
T Consensus       147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~---------ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGl  216 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALS---------VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF  216 (346)
T ss_dssp             EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHH---------HHHHCCcccccCCHHHEEECCCCCEEEecCcC
Confidence            588999999999876542 33555566666655 77888         9999999999999999999 467899999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCCC
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKDS  204 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~~  204 (234)
                      ++.+.... .....++|+.|+|||++. ...|+..+|+||+||++|||++|++||.+....+.+..+.+....  +....
T Consensus       217 a~~~~~~~~~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  295 (346)
T 4fih_A          217 CAQVSKEVPRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK  295 (346)
T ss_dssp             CEECCSSSCCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGG
T ss_pred             ceecCCCCCcccccccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcccc
Confidence            99876543 345678999999999987 445899999999999999999999999998888877777654321  12234


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+..++..++..++.+|+++++++++
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            55677778888999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.90  E-value=3.1e-24  Score=169.49  Aligned_cols=172  Identities=25%  Similarity=0.347  Sum_probs=136.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcc--cccCCcCCCcEEee--CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQG--YFHRDLKPSNLLVS--KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~--~~~~~l~p~~~~~~--~~~~~~~~  124 (234)
                      .||.+|+..|++.+..+-...+++..+..|... +.|+.         ++|+.+  ++|||++|.|+++.  ++.++++|
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ---------FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHTSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCCCEEecccChhheeEECCCCCEEEEe
Confidence            588999999999988765555666666666655 77887         899887  99999999999994  46899999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC--C
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT--K  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~--~  202 (234)
                      ||.|+..... .....+||+.|+|||++.+  .|+..+|+||+||++|||++|+.||.+......+.+.......|.  +
T Consensus       176 FGla~~~~~~-~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~  252 (290)
T 3fpq_A          176 LGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             TTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred             CcCCEeCCCC-ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence            9999754432 3345689999999999863  489999999999999999999999998877776655544333322  2


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+..++..|+..++.+|+|+++++++
T Consensus       253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2344567788888999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.89  E-value=5.2e-24  Score=169.28  Aligned_cols=171  Identities=23%  Similarity=0.282  Sum_probs=140.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||.+||..|++.+..+-...+++..+..|..+ +.|+.         ++|+.+++|||++|+|+++ .++..+++|||.
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~---------ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGl  178 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE---------YLHGKGIIHRDLKPENILLNEDMHIQITDFGT  178 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence            588999999999988776566777777777766 88888         9999999999999999999 467899999999


Q ss_pred             cccccCC---CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          128 VKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       128 a~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      ++.+...   ....+.+||+.|+|||++.+ ..|+..+|+||+||+++||++|..||.+....+...++.+.-...+ ..
T Consensus       179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p-~~  256 (311)
T 4aw0_A          179 AKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP-EK  256 (311)
T ss_dssp             CEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-TT
T ss_pred             ceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-cc
Confidence            9987432   23456789999999999974 4589999999999999999999999999888888877776433332 34


Q ss_pred             CcchhhhhhhhccccCCCCCccccccC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ++.....++..+...++.+|++.++++
T Consensus       257 ~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          257 FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            556777788888888999999988864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.89  E-value=5.9e-24  Score=175.42  Aligned_cols=173  Identities=19%  Similarity=0.335  Sum_probs=141.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||.+||..|++.+..+ ...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ .++.++++|||.
T Consensus       224 ~iVmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~---------ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGl  293 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALS---------VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF  293 (423)
T ss_dssp             EEEEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHH---------HHHHCCeecccCCHHHEEEcCCCCEEEecCcc
Confidence            58899999999988654 234555566666655 78888         9999999999999999999 467899999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCCC
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKDS  204 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~~  204 (234)
                      ++.+.... .....++|+.|+|||++. ...|+..+|+||+||++|||++|++||.+....+.+..+.+....  +....
T Consensus       294 a~~~~~~~~~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  372 (423)
T 4fie_A          294 CAQVSKEVPRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK  372 (423)
T ss_dssp             CEECCSSCCCBCCCEECTTTCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred             ceECCCCCccccccccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc
Confidence            99876543 345678999999999987 445899999999999999999999999998888887777654321  22345


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+..++..++..++.+|+++++++++
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            66778888889999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.89  E-value=7.4e-25  Score=176.87  Aligned_cols=174  Identities=20%  Similarity=0.395  Sum_probs=142.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .||.+||..|++.+.+.--..  +++..+..|..+ +.|+.         ++|+.+++|||+||.|+++ .++..+++||
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~---------ylH~~~IiHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK---------HVHDRKILHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTCEETTCCGGGEEECTTCCEEECST
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeccCCHHHEEECCCCCEEEccc
Confidence            578899999999887543221  223344555555 77888         9999999999999999999 4678999999


Q ss_pred             cccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.++.+.... .....++|+.|+|||++.+ ..|+..+|+||+||++|||++|+.||.+....+.+.++.+....+.+..
T Consensus       170 Gla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~  248 (350)
T 4b9d_A          170 GIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLH  248 (350)
T ss_dssp             TEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             ccceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcc
Confidence            9998765421 1234679999999999974 4589999999999999999999999999998888888887655566677


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..+..++..++..++.+|+++++++++
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            88889999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.89  E-value=3.4e-24  Score=170.89  Aligned_cols=180  Identities=19%  Similarity=0.250  Sum_probs=138.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh----------ccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM----------REKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m----------~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~  118 (234)
                      .||.+||..|++.+...-...-          ..+...+|...+....+..++.+  ++|+.+++|+|++|.|+++ ...
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~--yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME--YLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHH--HHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHH--HHHhCCCCCCCccccceEECCCC
Confidence            5889999999999875421100          00123455444443333333333  8888899999999999999 457


Q ss_pred             eeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 026720          119 VIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKIC  194 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~  194 (234)
                      .++++|||.++.+....   ......+++.|+|||++.+ ..|+..+|+||+|+++||+++ |..||++....+....+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~  261 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR  261 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            89999999998764321   2334577889999999874 458999999999999999998 889999998888887777


Q ss_pred             HhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          195 QLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....|.+..++..+..++..||..++.+||+|.+|++
T Consensus       262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~  299 (308)
T 4gt4_A          262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS  299 (308)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            76666777888999999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.89  E-value=3.2e-24  Score=168.06  Aligned_cols=173  Identities=23%  Similarity=0.292  Sum_probs=125.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+ .|++.+...--..+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||.
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~---------ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGl  158 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVE---------YCHRHKIVHRDLKPENLLLDEHLNVKIADFGL  158 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccccCChHHeEECCCCCEEEeecCC
Confidence            4778888 4666555443334555566666665 78888         9999999999999999999 467889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      ++...........++|+.|+|||++.+.+.++..+|+||+||++++|++|+.||++.........+.+... +-+...+.
T Consensus       159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~  237 (275)
T 3hyh_A          159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSP  237 (275)
T ss_dssp             C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCH
T ss_pred             CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCH
Confidence            98776544455678999999999998666567899999999999999999999998877666666655432 23345677


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ....+...+...++.+|+|+++++++
T Consensus       238 ~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          238 GAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHcC
Confidence            78888888999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.89  E-value=2.7e-24  Score=170.85  Aligned_cols=179  Identities=21%  Similarity=0.252  Sum_probs=138.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh-------ccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM-------REKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m-------~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~  121 (234)
                      .||.+||..|++.+..+-....       ..+...+|...+....+...+.+  ++|+.+++|+|++|.|+++ .+..++
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~--yLH~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMV--YLASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHH--HHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHH--HHHhCCcccCccCHhhEEECCCCcEE
Confidence            5889999999999876542210       11233455544443333333333  8888999999999999999 467899


Q ss_pred             EeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 026720          122 IGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       122 ~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ++|||.++.......   .....+++.|+|||++.+ ..|+..+|+||+|+++||+++ |+.||.+....+....+.+..
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~  247 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  247 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999986643221   123457889999999974 458999999999999999998 899999998888887787765


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ..+.+..+++.+..++..||..++.+||+|++|.
T Consensus       248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            5566778889999999999999999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.89  E-value=8.3e-24  Score=167.93  Aligned_cols=172  Identities=23%  Similarity=0.306  Sum_probs=138.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||.+||..|++.+..+-...+++..+..|... +.|+.         ++|+.+++|||++|+|+++ ..+..+++|||.
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~---------ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD---------HLHSLGIIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence            588899999999887765555666677777666 78888         9999999999999999999 467899999999


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++..... ......++|+.|+|||++.+ ..|+..+|+||+||++|||++|+.||.+....+...++.+... +.+...+
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s  250 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLS  250 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSC
T ss_pred             ceeccCCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCC
Confidence            9876432 23456789999999999974 4589999999999999999999999999988888877776433 2345567


Q ss_pred             chhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          207 LGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      .....++..++..++.+|++     ++++++
T Consensus       251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            78888888899999999987     456654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.89  E-value=8.2e-24  Score=168.27  Aligned_cols=176  Identities=18%  Similarity=0.270  Sum_probs=127.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV  128 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a  128 (234)
                      .||.+||..|++.+.....     +...+|...+....+..++.+  ++|+.+++|+|++|.|+++. ...++++|||.+
T Consensus       107 ~iVmEy~~gGsL~~~l~~~-----~~~l~~~~~~~i~~qia~gL~--yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQ-----ETKFQMFQLIDIARQTAQGMD--YLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTS-----CCCCCHHHHHHHHHHHHHHHH--HHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             EEEEEcCCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHH--HHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence            5889999999998865321     223344333332222222222  88999999999999999995 567899999999


Q ss_pred             ccccCCC---CCCCcccCcccccccccccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hCCCC-
Q 026720          129 KEIDSNL---PCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL-IGSPT-  201 (234)
Q Consensus       129 ~~~~~~~---~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~-~~~~~-  201 (234)
                      +......   ......+|+.|+|||++.+.  ..|+.++|+||+|+++|||++|+.||++......+..+... ...|+ 
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            8654321   23446789999999998642  24889999999999999999999999998877766665543 33333 


Q ss_pred             ---CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 ---KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                         ...++..+..++..||...+.+||||.+|+.
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence               2456678888999999999999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.89  E-value=9.4e-24  Score=169.86  Aligned_cols=180  Identities=20%  Similarity=0.254  Sum_probs=131.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh---------hccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL---------MREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGV  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~---------m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~  119 (234)
                      .||.+|+..|++.+..+-...         -..+...+|...+....+..++.+  ++|+.+++|+|++|.|+++. ...
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~--yLH~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMV--YLAGLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHH--HHHHTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHH--HHhcCCeecccccHhhEEECCCCc
Confidence            588999999999886542110         011233455544444433333333  78888999999999999994 678


Q ss_pred             eeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 026720          120 IKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~  195 (234)
                      ++++|||.++.+....   ......+++.|+|||++.+ ..|+..+|+||+|+++||+++ |+.||.+....+....+.+
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  275 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ  275 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999998764432   1233567889999999874 458999999999999999998 8999999988888877776


Q ss_pred             hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          196 LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....+.+..++..+..++..||..++.+||||++|+.
T Consensus       276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            6555666788889999999999999999999998864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.88  E-value=8.7e-24  Score=169.83  Aligned_cols=172  Identities=17%  Similarity=0.165  Sum_probs=137.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC-eeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG-VIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~-~~~~~~~~  126 (234)
                      .||.+|+..|++.+..+-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++. ++ .++++|||
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~---------ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE---------YLHTRRILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHTTTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCceecccCHHHEEEeCCCCEEEEeeCC
Confidence            578899999999998776556666677777766 78888         99999999999999999994 44 58999999


Q ss_pred             ccccccCCC------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC-
Q 026720          127 MVKEIDSNL------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS-  199 (234)
Q Consensus       127 ~a~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~-  199 (234)
                      .++.+....      .....+||+.|+|||++.+ ..|+..+|+||+||++|||++|+.||.+....+...++...... 
T Consensus       197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~  275 (336)
T 4g3f_A          197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI  275 (336)
T ss_dssp             TCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG
T ss_pred             CCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc
Confidence            998764321      1233579999999999975 45899999999999999999999999988777777777654322 


Q ss_pred             -CCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          200 -PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       200 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                       ..+..++..+..++..++..++.+|+|+.+++
T Consensus       276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~  308 (336)
T 4g3f_A          276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELR  308 (336)
T ss_dssp             GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence             12345677888888999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.88  E-value=2.3e-23  Score=171.61  Aligned_cols=174  Identities=29%  Similarity=0.475  Sum_probs=133.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      +||.+|+. |++.+...--..+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++. .+..+++|||.
T Consensus       135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~---------ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLK---------YMHSAQVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence            57888886 555443322222333445556555 78888         99999999999999999994 67889999999


Q ss_pred             cccccCC-----CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSN-----LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      ++.+...     ......++|+.|+|||++.+...|+..+|+||+||+++||++|++||++....+++..|++..+.|+.
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876432     23345789999999999887667899999999999999999999999999999999999999888776


Q ss_pred             CCCc------------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWP------------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..|.                              .....++..+...++.+|+|.++++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5442                              223345556777788899999988764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.88  E-value=1.5e-23  Score=170.09  Aligned_cols=180  Identities=18%  Similarity=0.268  Sum_probs=135.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhc----------cCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMR----------EKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~----------~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~  118 (234)
                      .||.+||..|++.+..+-...-.          .+...+|..++....+..++.+  ++|+.+++|+|++|.|+++ ...
T Consensus       145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~--yLH~~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME--FLASRKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHH--HHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHH--hHhhCCeecCccCccceeeCCCC
Confidence            48899999999998865432210          1233455544433333222222  8899999999999999999 467


Q ss_pred             eeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 026720          119 VIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKIC  194 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~  194 (234)
                      .++++|||.++.+.....   .....+++.|+|||++.+ ..|+..+|+||+|+++||+++ |+.||++....+.+.++.
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i  301 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  301 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999987754321   234567888999999974 458999999999999999998 899999987656555544


Q ss_pred             H-hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          195 Q-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       195 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      . ....+.+..++..+..++..||..++.+||||.+|++
T Consensus       302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~  340 (353)
T 4ase_A          302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  340 (353)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            4 3344556677888999999999999999999999864

>4g26_A Pentatricopeptide repeat-containing protein AT2G3 mitochondrial; metallonuclease, prorp, ribonuclease, PIN, tRNA processing, NYN domain; 1.75A {Arabidopsis thaliana} PDB: 4g23_A* 4g25_A 4g24_A

Probab=99.87  E-value=1.9e-24  Score=183.31  Aligned_cols=135  Identities=14%  Similarity=0.147  Sum_probs=119.5

Q ss_pred             CccCCCCCCeehHHHHHHHhcCch---------hhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhh
Q 026720            1 MKLANENPNSVTLVSLVSACTGLI---------NVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLM   71 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~---------~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m   71 (234)
                      |...|++||.+|||+||++|++.+         .++.|.++|.+|.+.|+.||.+|||+||.+|++.|++++|.++|++|
T Consensus        52 M~~~Gv~pd~~tyn~Li~~c~~~~~~~~~~~~~~l~~A~~lf~~M~~~G~~Pd~~tyn~lI~~~~~~g~~~~A~~l~~~M  131 (501)
T 4g26_A           52 ARRNGVQLSQYHYNVLLYVCSLAEAATESSPNPGLSRGFDIFKQMIVDKVVPNEATFTNGARLAVAKDDPEMAFDMVKQM  131 (501)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHTTCCCCSSSSCCHHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             HHHcCCCCCHhHHHHHHHHHHhCCchhhhhhcchHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHhcCCHHHHHHHHHHH
Confidence            567899999999999999998765         46889999999999999999999999999999999999999999999


Q ss_pred             cc----CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEeeccccccccCCCC
Q 026720           72 RE----KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLP  136 (234)
Q Consensus        72 ~~----~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~  136 (234)
                      .+    ||++|||++|.+|++.|+.++|.++|.+ |...|+.|+..+|+   .++++.+++..+..+...|.
T Consensus       132 ~~~g~~Pd~~tyn~lI~~~~~~g~~~~A~~l~~~-M~~~G~~Pd~~ty~~Li~~~~~~g~~d~A~~ll~~Mr  202 (501)
T 4g26_A          132 KAFGIQPRLRSYGPALFGFCRKGDADKAYEVDAH-MVESEVVPEEPELAALLKVSMDTKNADKVYKTLQRLR  202 (501)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHTTCHHHHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHTTCHHHHHHHHHHHH
T ss_pred             HHcCCCCccceehHHHHHHHHCCCHHHHHHHHHH-HHhcCCCCCHHHHHHHHHHHhhCCCHHHHHHHHHHHH
Confidence            85    6999999999999999999999999999 67889999999985   34566667777776666553

>4g26_A Pentatricopeptide repeat-containing protein AT2G3 mitochondrial; metallonuclease, prorp, ribonuclease, PIN, tRNA processing, NYN domain; 1.75A {Arabidopsis thaliana} PDB: 4g23_A* 4g25_A 4g24_A

Probab=99.85  E-value=3.2e-22  Score=169.66  Aligned_cols=115  Identities=11%  Similarity=0.053  Sum_probs=109.6

Q ss_pred             CccCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc----Ccc
Q 026720            1 MKLANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE----KNL   76 (234)
Q Consensus         1 M~~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~----~~~   76 (234)
                      |...|+.||.+|||++|++|++.|++++|.+++.+|.+.|+.||.+|||+||.+|++.|++++|.++|++|.+    ||.
T Consensus        96 M~~~G~~Pd~~tyn~lI~~~~~~g~~~~A~~l~~~M~~~g~~Pd~~tyn~lI~~~~~~g~~~~A~~l~~~M~~~G~~Pd~  175 (501)
T 4g26_A           96 MIVDKVVPNEATFTNGARLAVAKDDPEMAFDMVKQMKAFGIQPRLRSYGPALFGFCRKGDADKAYEVDAHMVESEVVPEE  175 (501)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTTCCCCH
T ss_pred             HHHhCCCCCHHHHHHHHHHHHhcCCHHHHHHHHHHHHHcCCCCccceehHHHHHHHHCCCHHHHHHHHHHHHhcCCCCCH
Confidence            5678999999999999999999999999999999999999999999999999999999999999999999985    699


Q ss_pred             ccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee
Q 026720           77 QSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS  116 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~  116 (234)
                      .|||++|.+|++.|+.++|..++.+ |...++.|+..|+.
T Consensus       176 ~ty~~Li~~~~~~g~~d~A~~ll~~-Mr~~g~~ps~~T~~  214 (501)
T 4g26_A          176 PELAALLKVSMDTKNADKVYKTLQR-LRDLVRQVSKSTFD  214 (501)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHH-HHHHTSSBCHHHHH
T ss_pred             HHHHHHHHHHhhCCCHHHHHHHHHH-HHHhCCCcCHHHHH
Confidence            9999999999999999999999999 67889999988873

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.84  E-value=2.5e-21  Score=157.78  Aligned_cols=137  Identities=22%  Similarity=0.365  Sum_probs=108.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC--CeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK--GVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~--~~~~~~~~~  126 (234)
                      .||.+|+..|++.+..   ..+++..+..|..+ +.|+.         ++|+.+++|||+||+|+++..  ...+++|||
T Consensus        96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~---------ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALK---------RIHQFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            5788899999987754   44565666667666 88888         999999999999999999952  578999999


Q ss_pred             ccccccCCC-----------------------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhC
Q 026720          127 MVKEIDSNL-----------------------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF  177 (234)
Q Consensus       127 ~a~~~~~~~-----------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~  177 (234)
                      .|+......                             .....++|++|+|||++.+.+.|+..+|+||+||+++||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997653211                             122357899999999998777799999999999999999999


Q ss_pred             CCCCC-CCChHHHHHHHHHhhC
Q 026720          178 GILFP-GKSSADQIYKICQLIG  198 (234)
Q Consensus       178 ~~~f~-~~~~~~~~~~i~~~~~  198 (234)
                      +.||. +.+..+++.+|++..|
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G  265 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRG  265 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHhcC
Confidence            98874 5667778777776544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.83  E-value=3.9e-21  Score=165.92  Aligned_cols=173  Identities=20%  Similarity=0.300  Sum_probs=133.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      +||..|+..|++...+.-...+++..+..|... +.|+.         ++|+.+++|||++|+|+++ ..+.++++|||.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~---------yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE---------HMHNRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence            588899999999887766556777777778777 88888         9999999999999999999 468899999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhCCCCCCCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--SADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |+.+.... ..+.+||+.|+|||++.....|+..+|+||+||++|||++|.+||.+..  +.....+.......+-+..+
T Consensus       339 A~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~  417 (689)
T 3v5w_A          339 ACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF  417 (689)
T ss_dssp             CEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             eeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence            98876543 3457899999999999755568999999999999999999999998643  22222222222222333456


Q ss_pred             cchhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      +.....++..+...++.+|++     .+++.+
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            667777777778888888877     355554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.80  E-value=7.6e-21  Score=151.10  Aligned_cols=169  Identities=21%  Similarity=0.327  Sum_probs=113.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCc---cccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKN---LQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~---~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~  124 (234)
                      .++.+||..|++.+..+-....++.+   +..|... +.|+.         ++|+.+++|+|++|+|+++ .++..+++|
T Consensus        91 ~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~---------ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           91 YIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE---------FLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             EEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHH---------HHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence            48899999999988765322233222   3334433 77888         9999999999999999999 467899999


Q ss_pred             ccccccccCCC-------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 026720          125 LGMVKEIDSNL-------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY  191 (234)
Q Consensus       125 ~~~a~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~  191 (234)
                      ||.++.+....             ...+.+||+.|+|||++.+ ..|+..+|+||+||++|||++   ||.+.  .+...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence            99998764321             1234579999999999974 458999999999999999995   67543  33332


Q ss_pred             HHHHhhCCCCCCCCc---chhhhhhhhccccCCCCCccccccCCC
Q 026720          192 KICQLIGSPTKDSWP---LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       192 ~i~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+......+.+..++   .....++..++..++.+|+++.+++++
T Consensus       236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            333222222221122   233456777889999999999998764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.80  E-value=9.4e-21  Score=163.04  Aligned_cols=174  Identities=17%  Similarity=0.222  Sum_probs=135.4

Q ss_pred             HHHHHHhhcCChHHHHHH-HHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKV-FNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~-~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~  124 (234)
                      .||.+|+..|++.+.+.- ...+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++.   ....++.|
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~---------ylH~~~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC---------HMHENNYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeccCChhhccccCCCCCCEEEee
Confidence            477788999987654321 112344455566555 77777         99999999999999999994   25789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-  203 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-  203 (234)
                      ||.++.+.........++++.|+|||++.+ ..|+..+|+||+||++|||++|.+||.+....+.+..+......++.. 
T Consensus       301 FG~a~~~~~~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  379 (573)
T 3uto_A          301 FGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA  379 (573)
T ss_dssp             CSSCEECCTTSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG
T ss_pred             ccceeEccCCCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc
Confidence            999998866544556689999999999975 458999999999999999999999999999988888887655444433 


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        .++.....++..+...++.+|+++++++++
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              345556667777888899999999988653

>3spa_A Mtrpol, DNA-directed RNA polymerase, mitochondrial; single-subunit DNA-dependent RNA polymerase in mitochondria, transferase; 2.50A {Homo sapiens}

Probab=99.79  E-value=1.7e-20  Score=165.92  Aligned_cols=109  Identities=11%  Similarity=0.139  Sum_probs=100.4

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHH---HhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc----CccccHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAV---VNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE----KNLQSWTIM   82 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~---~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~----~~~~~~~~~   82 (234)
                      .+|||++|++||+.|++++|.++|.+|.   +.|+.||++|||+||++||+.|.+++|.++|++|.+    ||++|||++
T Consensus       127 ~~TynaLIdglcK~G~leeA~~Lf~eM~~m~~kG~~PdvvTYNtLI~Glck~G~~~eA~~Lf~eM~~~G~~PDvvTYntL  206 (1134)
T 3spa_A          127 QQRLLAFFKCCLLTDQLPLAHHLLVVHHGQRQKRKLLTLDMYNAVMLGWARQGAFKELVYVLFMVKDAGLTPDLLSYAAA  206 (1134)
T ss_dssp             HHHHHHHHHHHHHHTCHHHHHHHHHHHHHSHHHHTTCCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCHHHHHHHHHHHHHHhhcCCCCCHhHHHHHHHHHHhCCCHHHHHHHHHHHHHcCCCCcHHHHHHH
Confidence            4699999999999999999999998876   458999999999999999999999999999999975    799999999


Q ss_pred             HHHHHhcCCc-hhhhHhhhcccccCCcCCCcEEeeCCe
Q 026720           83 ISGLADNSRG-NDAISLHRQGYFHRDLKPSNLLVSKGV  119 (234)
Q Consensus        83 i~~~~~~g~~-~~a~~l~~~~~~~~~l~p~~~~~~~~~  119 (234)
                      |+|+|+.|+. ++|..+|.+ |..+|+.||.++++..+
T Consensus       207 I~glcK~G~~~e~A~~Ll~E-M~~kG~~PD~vtY~~ll  243 (1134)
T 3spa_A          207 LQCMGRQDQDAGTIERCLEQ-MSQEGLKLQALFTAVLL  243 (1134)
T ss_dssp             HHHHHHHTCCHHHHHHHHHH-HHHHTCCSHHHHHHSCC
T ss_pred             HHHHHhCCCcHHHHHHHHHH-HHHcCCCCChhhccccc
Confidence            9999999986 688999999 78889999999996444

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.79  E-value=1.2e-19  Score=146.37  Aligned_cols=174  Identities=24%  Similarity=0.297  Sum_probs=136.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+...-...+++..+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~---------~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---------YCHQKRIVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence            477788888888776654444554444444444 77777         89999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +.............+++.|+|||++.+...++..+|+||+|++++++++|+.||++....+...++.... .+.+...+.
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~  239 (328)
T 3fe3_A          161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRIPFYMST  239 (328)
T ss_dssp             CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCH
T ss_pred             ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCH
Confidence            9876554444556789999999999865544578999999999999999999999888777766665532 233445667


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+...++..++.+|+++++++++
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            78888888999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.78  E-value=3.7e-20  Score=147.55  Aligned_cols=174  Identities=25%  Similarity=0.266  Sum_probs=114.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhc--------ccccCCcCCCcEEe-eCCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQ--------GYFHRDLKPSNLLV-SKGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~--------~~~~~~l~p~~~~~-~~~~~  120 (234)
                      .||.+|+..|++.+..+-       ...+|...+....+..++..  ++|..        +++|+|++|.|+++ .++.+
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gl~--ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLA--HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHH--HHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             EEEecCCCCCcHHHHHHh-------CCCCHHHHHHHHHHHHHHHH--HHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence            589999999999887542       12333333332222211111  67754        79999999999999 46789


Q ss_pred             eEeeccccccccCCC-----CCCCcccCccccccccccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCC------
Q 026720          121 KIGDLGMVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSE-----IYGPEVDKWAMGAIMFEMLSFGILFPGK------  184 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~-----~~~~~~d~~s~g~~l~e~~~~~~~f~~~------  184 (234)
                      +++|||.++......     .....++|+.|+|||++.+..     .|+.++|+||+|+++|||++|.+||...      
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            999999998765432     122457899999999986432     2567899999999999999997765321      


Q ss_pred             --------ChHHHHHHHH-HhhCCCCC-CCCc-----chhhhhhhhccccCCCCCccccccCC
Q 026720          185 --------SSADQIYKIC-QLIGSPTK-DSWP-----LGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       185 --------~~~~~~~~i~-~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                              ...+...+.. ....+|+. ..+.     ..+..++..||..++.+||||.+|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                    1233333332 22223332 2221     24566788899999999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.76  E-value=1.4e-18  Score=143.01  Aligned_cols=173  Identities=28%  Similarity=0.461  Sum_probs=128.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+. |++....+- ..+....+..+. .++.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus        87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIK---------YLHSGGLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHH---------HHHhCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            46667776 445443321 112222222333 3367777         89999999999999999994 56789999999


Q ss_pred             cccccCC----------------------CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 026720          128 VKEIDSN----------------------LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS  185 (234)
Q Consensus       128 a~~~~~~----------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~  185 (234)
                      ++.+...                      ......+++++|+|||++.+...|+..+|+||+||+++|+++|++||++..
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865321                      112345788999999999765678999999999999999999999999999


Q ss_pred             hHHHHHHHHHhhCCCCCC----------------------------------------------CCcchhhhhhhhcccc
Q 026720          186 SADQIYKICQLIGSPTKD----------------------------------------------SWPLGIQLASNLNWKL  219 (234)
Q Consensus       186 ~~~~~~~i~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~~  219 (234)
                      ..+++.++.+..+.|...                                              ..+.....+...++..
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            999999998888776532                                              3344566677788899


Q ss_pred             CCCCCccccccCCC
Q 026720          220 PQMGGVNLLAVMPS  233 (234)
Q Consensus       220 ~~~~~~~~~~~~~~  233 (234)
                      ++.+|+++++++++
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999865

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.76  E-value=5.7e-19  Score=140.88  Aligned_cols=173  Identities=32%  Similarity=0.494  Sum_probs=132.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+. |++.+...-...  ++...+..+... +.|+.         ++|+.+++|+|++|+|+++ .....+++||
T Consensus        95 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           95 TLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD---------FLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             EEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             EEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            35555655 455554322111  222233333333 66666         8999999999999999999 4677899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |.+.............+++.|+|||++.+ ..|+..+|+||+|++++++++|++||.+....+...++++..+.+....|
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            99987765545555678899999999874 44789999999999999999999999999999999999999888877766


Q ss_pred             cc--------------------------hhhhhhhhccccCCCCCccccccCCC
Q 026720          206 PL--------------------------GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.                          .+..+...++..++.+|+++.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            43                          33456777888999999999998865

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.75  E-value=5.5e-19  Score=141.34  Aligned_cols=142  Identities=34%  Similarity=0.601  Sum_probs=117.2

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGP  160 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~  160 (234)
                      +.|+.         ++|+.+++|+|++|+|+++ .....+++|||.+....... ......+++.|+|||++.+...|+.
T Consensus       129 ~~~l~---------~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  199 (311)
T 3niz_A          129 LRGVA---------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST  199 (311)
T ss_dssp             HHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCT
T ss_pred             HHHHH---------HHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCc
Confidence            66777         8999999999999999999 46778999999998765322 2234467889999999876667899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc-----------------------------hhhh
Q 026720          161 EVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL-----------------------------GIQL  211 (234)
Q Consensus       161 ~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~-----------------------------~~~~  211 (234)
                      .+|+||+|++++++++|+.||++....+.+.++....+.+.+..|+.                             .+..
T Consensus       200 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (311)
T 3niz_A          200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID  279 (311)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHH
T ss_pred             hHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHH
Confidence            99999999999999999999999999999999999999888776653                             2334


Q ss_pred             hhhhccccCCCCCccccccCCC
Q 026720          212 ASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..++..++.+|+|+++++++
T Consensus       280 li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          280 LLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHcCCChhHCCCHHHHhcC
Confidence            6666888899999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.75  E-value=3.5e-18  Score=137.02  Aligned_cols=174  Identities=28%  Similarity=0.519  Sum_probs=129.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh------hccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL------MREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~------m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~  121 (234)
                      .+|..|+. |.+.+.......      ++...+..+. .++.|+.         ++|..+++|+|++|+|+++ ..+..+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~---------~lH~~~ivH~Dlkp~NIl~~~~~~~k  148 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA---------FCHENKILHRDLKPQNLLINKRGQLK  148 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeCCCChHHeEEcCCCCEE
Confidence            46667776 566554433221      1111222233 3366666         8999999999999999999 467789


Q ss_pred             EeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 026720          122 IGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       122 ~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      ++|||.+....... ......+++.|+|||++.+...|+..+|+||+|++++++++|+.||++....+.+..+++..+.+
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          149 LGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP  228 (317)
T ss_dssp             ECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             ECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999998765322 22345678899999998765568999999999999999999999999999999999999888876


Q ss_pred             CCCCCc---------------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKDSWP---------------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +...|+                                 ..+..+...++..++.+|+++++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            655443                                 234456677888899999999998864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.75  E-value=2.1e-18  Score=145.18  Aligned_cols=171  Identities=29%  Similarity=0.444  Sum_probs=122.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..+..+...   ..+....+..+... +.|+.         ++|+.+++|+|++|.|+++. ....+++|||.
T Consensus       143 ~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~---------~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          143 YLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK---------HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             EEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            4666666654322211   11222223333333 66777         89999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC--
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW--  205 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~--  205 (234)
                      ++............++++|+|||++.+ ..|+..+|+||+||+++||++|+.||++....+++.++.+..+.|.+..+  
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          211 ARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             C-----CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeecCCCcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            988766544556788999999999975 45899999999999999999999999999999999999998887754322  


Q ss_pred             ---------------------------------------cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 ---------------------------------------PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ---------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                             +.....+...+...++.+|+++++++++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                                   1224456666778899999999988764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.75  E-value=1.1e-18  Score=142.42  Aligned_cols=174  Identities=20%  Similarity=0.276  Sum_probs=131.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC----eeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG----VIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~----~~~~~  123 (234)
                      .+|..|+..|.+.+...-...+++..+..+... +.|+.         ++|..+++|+|++|+|+++. ..    ..+++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN---------YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence            577788888888775422112222333334333 66666         88999999999999999993 33    58999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      |||.+..+..........+++.|+|||++.+ ..|+..+|+||+|++++++++|..||.+....+....+.......+. 
T Consensus       162 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  240 (361)
T 2yab_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE  240 (361)
T ss_dssp             CCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             ecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            9999988766545556778999999999874 45889999999999999999999999998888877777654433332 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ...+..+..++..++..++.+|+++++++++
T Consensus       241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              3445667778888899999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.74  E-value=3.7e-18  Score=138.04  Aligned_cols=173  Identities=24%  Similarity=0.268  Sum_probs=130.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.....--..+++..+..|... +.|+.         ++|+.+++|++++|+|+++ ..+..++.|||.
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE---------YLHSRDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCcCCHHHEEECCCCCEEEeeccc
Confidence            577788888888766543333444444555444 67777         8999999999999999999 467889999999


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++.... ........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+.........+..... .-+..++
T Consensus       152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s  229 (337)
T 1o6l_A          152 CKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLS  229 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSC
T ss_pred             hhhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Confidence            886433 223445678999999999874 4589999999999999999999999998877766666654322 2234566


Q ss_pred             chhhhhhhhccccCCCCCc-----cccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGV-----NLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  233 (234)
                      ..+..++..++..++.+|+     ++++++++
T Consensus       230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            7788888888888888887     77776543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.74  E-value=3.1e-18  Score=142.47  Aligned_cols=142  Identities=30%  Similarity=0.559  Sum_probs=116.5

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C-CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGP  160 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~-~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  160 (234)
                      +.|+.         ++|..+++|+|++|+|+++. . ...+++|||.++.+..........+++.|+|||++.+...|+.
T Consensus       166 ~~aL~---------~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  236 (420)
T 1j1b_A          166 FRSLA---------YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS  236 (420)
T ss_dssp             HHHHH---------HHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred             HHHHH---------HHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCc
Confidence            66777         89999999999999999996 3 5679999999998765444555678999999999876556899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC----------------------------CCcchhhhh
Q 026720          161 EVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD----------------------------SWPLGIQLA  212 (234)
Q Consensus       161 ~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~----------------------------~~~~~~~~~  212 (234)
                      .+|+||+||+++||++|+.||++....+++.++.+..+.|...                            ..+.....+
T Consensus       237 ~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~L  316 (420)
T 1j1b_A          237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL  316 (420)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHH
T ss_pred             hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHH
Confidence            9999999999999999999999999999999998877655321                            123445567


Q ss_pred             hhhccccCCCCCccccccCCC
Q 026720          213 SNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...++..++.+|+++++++.+
T Consensus       317 i~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          317 CSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCChhHCCCHHHHhCC
Confidence            777888899999999888653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.74  E-value=1.1e-18  Score=142.06  Aligned_cols=167  Identities=25%  Similarity=0.281  Sum_probs=126.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++....+-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..++.|||.
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~givHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM---------FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCCcccCCCHHHEEECCCCCEEEccccc
Confidence            477888998998876655444555555556555 77777         8999999999999999999 467899999999


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++.... ........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+....+...++....... +...+
T Consensus       171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~~  248 (353)
T 3txo_A          171 CKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY-PTWLH  248 (353)
T ss_dssp             CBCSCC---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-CTTSC
T ss_pred             eeecccCCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CCCCC
Confidence            886432 223445678999999999874 447899999999999999999999999998888887776643332 23456


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..+..++..+....+.+|++.
T Consensus       249 ~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          249 EDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTS
T ss_pred             HHHHHHHHHHhhhCHHHccCC
Confidence            677777777788888888887

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.74  E-value=7.4e-18  Score=139.09  Aligned_cols=175  Identities=26%  Similarity=0.448  Sum_probs=133.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH---hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN---LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~---~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~  123 (234)
                      .+|..|+..+.+........   .++...+..|... +.|+.         ++|..+++|+|++|+|+++.  ....+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA---------YIHSIGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccCCCCCHHHEEEcCCCCcEEEe
Confidence            35666776554443322211   1222233344433 77777         89999999999999999995  6788999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      |||.++............+++.|+|||++.+...|+..+|+||+|++++|+++|+.||++....+++..+.+..+.|...
T Consensus       185 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             CCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99999887655555567789999999998766678999999999999999999999999999999999998877665421


Q ss_pred             ----------------------------CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 ----------------------------SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                  ..+..+..+...++..++.+|+++.+++.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                                        134456677778889999999999888754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.74  E-value=1.3e-18  Score=141.24  Aligned_cols=137  Identities=32%  Similarity=0.538  Sum_probs=114.4

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCC-----CCCCCcccCcccccccccccccCCCCcchHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI  170 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~  170 (234)
                      ++|+.+++|+|++|+|+++. ....+++|||.+..+...     .......+++.|+|||++.+...|+..+|+||+|++
T Consensus       139 ~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  218 (351)
T 3mi9_A          139 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI  218 (351)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred             HHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence            89999999999999999994 678899999998865421     122345678899999998766668999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcch-------------------------------hhhhhhhcccc
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLG-------------------------------IQLASNLNWKL  219 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~  219 (234)
                      ++++++|.+||.+....+....+.+..+.++...|+..                               +..++..++..
T Consensus       219 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  298 (351)
T 3mi9_A          219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL  298 (351)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence            99999999999999999999999988888877766543                               44567778889


Q ss_pred             CCCCCccccccCCC
Q 026720          220 PQMGGVNLLAVMPS  233 (234)
Q Consensus       220 ~~~~~~~~~~~~~~  233 (234)
                      ++.+|+++++++++
T Consensus       299 dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          299 DPAQRIDSDDALNH  312 (351)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhCC
Confidence            99999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.74  E-value=4.5e-18  Score=137.94  Aligned_cols=172  Identities=24%  Similarity=0.264  Sum_probs=131.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+-...++...+..|... +.|+.         ++|+.+++|++++|+|+++ ..+..+++|||.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ---------FLHSKGIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeCCCChhhEEECCCCCEEEeEChh
Confidence            577788888998876654434444444455444 67777         8999999999999999999 467889999999


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++.... ........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+....+...++..... .-+...+
T Consensus       165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s  242 (345)
T 1xjd_A          165 CKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLE  242 (345)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSC
T ss_pred             hhhcccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccC
Confidence            886532 223445678999999999874 4589999999999999999999999998887777666654322 2234566


Q ss_pred             chhhhhhhhccccCCCCCcccc-ccCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLL-AVMP  232 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~-~~~~  232 (234)
                      ..+..++..++..++.+|+++. ++..
T Consensus       243 ~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          243 KEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            7778888888888999999987 6654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.74  E-value=3.2e-18  Score=143.26  Aligned_cols=174  Identities=20%  Similarity=0.243  Sum_probs=133.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...--..+++.++..+... +.|+.         ++|+.+++|+|++|+|+++.    ....+++|
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~---------~lH~~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL---------HCHQMGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCCHHHEEEeccCCCCcEEEcc
Confidence            467788888888765543222333344444443 66776         89999999999999999994    35689999


Q ss_pred             ccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          125 LGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       125 ~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      ||.+....... ......+++.|+|||++.+ ..|+..+|+||+|++++++++|.+||.+....+....+.......+..
T Consensus       157 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  235 (444)
T 3soa_A          157 FGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP  235 (444)
T ss_dssp             CSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             CceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc
Confidence            99998765432 2345678999999999874 458999999999999999999999999988888877776655444433


Q ss_pred             ---CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 ---SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                         ..+..+..++..++..++.+|+++.+++++
T Consensus       236 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          236 EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               456677778888999999999999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.74  E-value=3.9e-18  Score=138.75  Aligned_cols=167  Identities=25%  Similarity=0.325  Sum_probs=129.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+-...+++..+..|... +.|+.         ++|..+++|+|++|+|+++ ..+..++.|||.
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~givHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF---------FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            578888988998877654444554555555555 67777         8999999999999999999 467899999999


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++.... ........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+....+...++...... -+..++
T Consensus       168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s  245 (353)
T 2i0e_A          168 CKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-YPKSMS  245 (353)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCTTSC
T ss_pred             ccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-CCCCCC
Confidence            986432 223445678999999999874 45799999999999999999999999998887777777654322 234566


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..+..++..++..++.+|++.
T Consensus       246 ~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          246 KEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             HHHHHHHHHHTCSCTTSCTTC
T ss_pred             HHHHHHHHHHhhcCHHHcCCC
Confidence            777788888888888888853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.74  E-value=2.6e-18  Score=140.28  Aligned_cols=174  Identities=20%  Similarity=0.231  Sum_probs=128.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...--..+.+.++..+... +.|+.         ++|..+++|+|++|+|+++.    ....+++|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA---------YCHSNGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeccCchHHEEEecCCCCCCEEEee
Confidence            467778888887654321111122222333322 56666         88999999999999999994    23589999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      ||.+.............+++.|+|||++.+ ..|+..+|+||+|++++++++|.+||.+.........+.......+...
T Consensus       175 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  253 (362)
T 2bdw_A          175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE  253 (362)
T ss_dssp             CTTCBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG
T ss_pred             cCcceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            999988765444455678999999999874 4588999999999999999999999998887777776665544433333


Q ss_pred             ---CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 ---WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                         .+..+..++..++..++.+|+++.+++.+
T Consensus       254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               35567777888899999999999998864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.74  E-value=3.2e-18  Score=140.64  Aligned_cols=173  Identities=20%  Similarity=0.262  Sum_probs=129.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.....--..+++..+..|... +.|+.         ++|..+++|++++|+|+++ ..+..+++|||.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------~LH~~givHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD---------YLQNQRIIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCceeccCcHHHeEECCCCCEEEeccce
Confidence            467778888888765443222333344444444 67777         8999999999999999999 467899999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhCCCCCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSFGILFPGKS--SADQIYKICQLIGSPTKD  203 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--~~~~~~~i~~~~~~~~~~  203 (234)
                      +..+..........+++.|+|||++...  ..|+..+|+||+|+++++|++|..||.+..  ..............+.+.
T Consensus       162 a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~  241 (384)
T 4fr4_A          162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS  241 (384)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT
T ss_pred             eeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC
Confidence            9887665555667899999999998642  247899999999999999999999998543  333444444444445556


Q ss_pred             CCcchhhhhhhhccccCCCCCcc-ccccC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVN-LLAVM  231 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  231 (234)
                      .|+..+..++..++...+.+|++ ++++.
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            78888888888888888888887 65554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.73  E-value=4.5e-18  Score=135.16  Aligned_cols=173  Identities=21%  Similarity=0.317  Sum_probs=132.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|++.+...- ..++...+..+... +.|+.         ++|..+++|+|++|+|+++ .....+++|||.
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  162 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALE---------FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  162 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHH---------HHHhCCceeCCCCHHHEEECCCCCEEEeeCCC
Confidence            477888888988876432 11222333344333 66676         8999999999999999999 467889999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCCC
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKDS  204 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~~  204 (234)
                      +....... ......+++.|++||++.+ ..|+..+|+||+|++++++++|..||.+.........+......  +.+..
T Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (297)
T 3fxz_A          163 CAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK  241 (297)
T ss_dssp             CEECCSTTCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGG
T ss_pred             ceecCCcccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence            88765432 2344578899999999874 45899999999999999999999999998887777666554322  22345


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...|+..++.+|+++++++++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            66778888899999999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.73  E-value=2.8e-18  Score=135.82  Aligned_cols=175  Identities=27%  Similarity=0.491  Sum_probs=127.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..+.++.....-..++...+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~---------~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG---------FCHSRNVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            355666664333322211112222333344333 66777         89999999999999999994 66789999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      +....... ......+++.|+|||++.+...|+..+|+||+|++++++++|. ++|++....+.+.++++..+.|....|
T Consensus       148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~  227 (292)
T 3o0g_A          148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred             ceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence            98764332 2334567889999999976666899999999999999999776 457788888888889998888877766


Q ss_pred             cc----------------------------hhhhhhhhccccCCCCCccccccCCC
Q 026720          206 PL----------------------------GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.                            .+..+...+...++.+|+++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            53                            23456777888899999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.73  E-value=2.2e-17  Score=135.76  Aligned_cols=174  Identities=28%  Similarity=0.480  Sum_probs=132.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~  122 (234)
                      .+|..|+. |.+.+...-+..    ++...+..|... +.|+.         ++|+.+++|+|++|+|+++.  ....++
T Consensus       114 ~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~gi~H~Dikp~Nil~~~~~~~~kl  183 (383)
T 3eb0_A          114 NVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG---------FIHSLGICHRDIKPQNLLVNSKDNTLKL  183 (383)
T ss_dssp             EEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH---------HHHTTTEECSCCCGGGEEEETTTTEEEE
T ss_pred             EEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCcCccCccCHHHEEEcCCCCcEEE
Confidence            35666666 444444332211    222233333333 67777         89999999999999999995  578999


Q ss_pred             eeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +|||.+..+..........+++.|+|||++.+...|+..+|+||+|++++|+++|+.||++....+++.++.+..+.|..
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~  263 (383)
T 3eb0_A          184 CDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTK  263 (383)
T ss_dssp             CCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999988765555556678899999999876666899999999999999999999999999999999999888776632


Q ss_pred             ----------------------------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 ----------------------------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                  ...+..+..+...++...+.+|+++.+++.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          264 EQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                                        1234456677888899999999999988764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.73  E-value=2.4e-18  Score=138.69  Aligned_cols=174  Identities=31%  Similarity=0.523  Sum_probs=126.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee------CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS------KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~------~~~~~~  122 (234)
                      .+|..|+. |++.+...-...++...+..+... +.|+.         ++|+.+++|+|++|+|+++.      ....++
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVN---------FCHSRRCLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCEECCCCCHHHEEEecCCCCccceEEE
Confidence            35666666 455544332222332333333333 66777         89999999999999999993      234799


Q ss_pred             eeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          123 GDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       123 ~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +|||.+....... ......+++.|+|||++.+...|+..+|+||+|++++++++|..||++....+.+.++++..+.|+
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             CCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            9999988764322 223346688899999997666689999999999999999999999999999999999999988888


Q ss_pred             CCCCc-----------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          202 KDSWP-----------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 ~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...|+                             ..+..+...++..++.+|+++++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            76654                             334456677888899999999998764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.73  E-value=4.3e-18  Score=149.28  Aligned_cols=167  Identities=25%  Similarity=0.330  Sum_probs=132.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||..|+..|++....+-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..++.|||.
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF---------FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEeccCChhhEEEcCCCcEEEeecce
Confidence            478889999999877665555555566666655 77777         8999999999999999999 467899999999


Q ss_pred             ccccc-CCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEID-SNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++... .........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+....+...++.+..... +...+
T Consensus       489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s  566 (674)
T 3pfq_A          489 CKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-PKSMS  566 (674)
T ss_dssp             CEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC-CTTSC
T ss_pred             eeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-CccCC
Confidence            98643 2233455788999999999974 458999999999999999999999999988888877776643332 34566


Q ss_pred             chhhhhhhhccccCCCCCccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      .....++..++..++.+|+++
T Consensus       567 ~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          567 KEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHHHHHHHHSCSSSTTCTTC
T ss_pred             HHHHHHHHHHccCCHHHCCCC
Confidence            777778888888888888887

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.73  E-value=5.1e-18  Score=139.93  Aligned_cols=168  Identities=26%  Similarity=0.298  Sum_probs=124.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.....--..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..++.|||.
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------~LH~~givHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN---------YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEEeccCCHHHEEECCCCCEEEeecce
Confidence            477888999998776554444555555556555 77777         8999999999999999999 467899999999


Q ss_pred             ccccc-CCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHhhC
Q 026720          128 VKEID-SNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--------SADQIYKICQLIG  198 (234)
Q Consensus       128 a~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--------~~~~~~~i~~~~~  198 (234)
                      ++... ........++++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+.+        ..+...+......
T Consensus       200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  278 (396)
T 4dc2_A          200 CKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  278 (396)
T ss_dssp             CBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred             eeecccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence            98633 2234456788999999999974 458999999999999999999999997542        2222333322223


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccc
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..-+..++.....++..++..++.+|++.
T Consensus       279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            33344566777788888888888888874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.73  E-value=2.5e-18  Score=138.26  Aligned_cols=142  Identities=33%  Similarity=0.597  Sum_probs=114.4

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGP  160 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~  160 (234)
                      +.|+.         ++|+.+++|+|++|+|+++ .....+++|||.+....... ......+++.|+|||++.+...|+.
T Consensus       110 ~~aL~---------~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  180 (324)
T 3mtl_A          110 LRGLA---------YCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST  180 (324)
T ss_dssp             HHHHH---------HHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCT
T ss_pred             HHHHH---------HHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCc
Confidence            66777         8999999999999999999 45678999999987654322 2233467889999999876566899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcch-----------------------------hhh
Q 026720          161 EVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLG-----------------------------IQL  211 (234)
Q Consensus       161 ~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~-----------------------------~~~  211 (234)
                      .+|+||+|++++++++|+.||++....+.+..+.+..+.|....|+..                             +..
T Consensus       181 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (324)
T 3mtl_A          181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGAD  260 (324)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHH
Confidence            999999999999999999999999999999999999999988877643                             235


Q ss_pred             hhhhccccCCCCCccccccCCC
Q 026720          212 ASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +...+...++.+|+++++++++
T Consensus       261 li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          261 LLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHcCcCcccCCCHHHHhcC
Confidence            6677888899999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.73  E-value=5.1e-18  Score=137.94  Aligned_cols=170  Identities=20%  Similarity=0.258  Sum_probs=132.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..++.|||.
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~  187 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccccCccceEEECCCCCEEEccccc
Confidence            577788888888776654334444445555544 67777         8999999999999999999 467889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +......  .....+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+....+...++..... +-+..++.
T Consensus       188 a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~  263 (350)
T 1rdq_E          188 AKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSS  263 (350)
T ss_dssp             CEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCH
T ss_pred             ceeccCC--cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCH
Confidence            9876543  344678899999999874 4588999999999999999999999998887777777765432 22345677


Q ss_pred             hhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          208 GIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      .+..++..++..++.+|++     +++++.
T Consensus       264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            8888888888888888887     666654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.73  E-value=3.6e-18  Score=139.66  Aligned_cols=170  Identities=33%  Similarity=0.476  Sum_probs=126.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+ .+++.+..+- ..++...+..+... +.|+.         ++|+.+++|+|++|+|+++. .+..+++|||.
T Consensus       106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~---------~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLR---------YIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            4555565 4455544322 12222233333333 66777         89999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC----
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD----  203 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~----  203 (234)
                      +......  .....++++|+|||++.+...|+..+|+||+||+++|+++|+.||++....+++..+.+..+.|+..    
T Consensus       175 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          175 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9876543  3446788999999998765668999999999999999999999999999999999998877765431    


Q ss_pred             --------------------------CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 --------------------------SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                                                ..+.....+...+...++.+|+++++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                      12334555666677888999999988764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.73  E-value=6e-18  Score=135.77  Aligned_cols=171  Identities=20%  Similarity=0.224  Sum_probs=130.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+--..+++..+..|... +.|+.         ++|+.+++|++++|+|+++ ..+..++.|||.
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---------YLHSKDIIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCChheEEEcCCCCEEEeecCc
Confidence            477788888888876554333333344445444 67777         8999999999999999999 467889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +......  .....+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+....+...++...... -+..++.
T Consensus       153 a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~  228 (318)
T 1fot_A          153 AKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-FPPFFNE  228 (318)
T ss_dssp             CEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-CCTTSCH
T ss_pred             ceecCCc--cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCCCH
Confidence            9876542  334678899999999874 45889999999999999999999999998887777777664322 2345566


Q ss_pred             hhhhhhhhccccCCCCCc-----cccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGV-----NLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~  233 (234)
                      .+..++..+...++.+|+     ++++++++
T Consensus       229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            777777777877888887     77776543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.73  E-value=2.4e-18  Score=142.53  Aligned_cols=174  Identities=24%  Similarity=0.345  Sum_probs=130.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+- ..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||.
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~---------~LH~~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALD---------AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence            477888888888775432 12333334444444 66777         8999999999999999999 467899999999


Q ss_pred             cccccCCC--CCCCcccCccccccccccccc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---hCC
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFSE---IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL---IGS  199 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~---~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~---~~~  199 (234)
                      ++.+....  ......+++.|+|||++....   .|+..+|+||+|++++||++|..||.+....+...++.+.   ...
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  294 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF  294 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence            98765432  233567899999999987433   2678999999999999999999999999888888888754   344


Q ss_pred             CCCCCCcchhhhhhhhccccCCCC--CccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMG--GVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  233 (234)
                      |.....+.....++..+...++..  |+++++++.+
T Consensus       295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            555566777777776666666656  8888887654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.72  E-value=3e-18  Score=143.95  Aligned_cols=172  Identities=22%  Similarity=0.339  Sum_probs=134.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|++.+..+-..  .++...+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+++||
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA---------FIEQRNYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCCHHHEEECCCCcEEEeeC
Confidence            47788899999888765322  1222233334333 66666         89999999999999999994 567899999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.++......  .......+..|+|||++.. ..|+..+|+||+|+++||+++ |+.||++....+....+.+....+.+
T Consensus       329 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~  407 (454)
T 1qcf_A          329 GLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP  407 (454)
T ss_dssp             TGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC
T ss_pred             CCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            9998764321  1223344567999999874 448899999999999999998 99999999888887777776666777


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ..++..+..++..||..++.+||+|++++
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~  436 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTFEYIQ  436 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            78888999999999999999999998875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.72  E-value=1.4e-18  Score=141.82  Aligned_cols=175  Identities=22%  Similarity=0.232  Sum_probs=118.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC--eeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG--VIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~--~~~~~~~  125 (234)
                      .+|..|+..|.+.+...-...++...+..|... +.|+.         ++|..+++|++++|.|+++. ..  ..+++||
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~---------~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS---------YCHSMQICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEEcCCCCceEEEeec
Confidence            477788888888776554344444455555544 77777         89999999999999999994 33  3899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-----CCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-----GSP  200 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-----~~~  200 (234)
                      |.+.............+++.|+|||++.+...++..+|+||+|++++++++|+.||.+........++.+..     ..|
T Consensus       163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (361)
T 3uc3_A          163 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP  242 (361)
T ss_dssp             CCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC
T ss_pred             CccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC
Confidence            998754443334456788999999998755433444899999999999999999999765433333332221     234


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +....+..+..++..++...+.+|+++++++++
T Consensus       243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            444567788888999999999999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.72  E-value=3.2e-17  Score=132.96  Aligned_cols=150  Identities=35%  Similarity=0.656  Sum_probs=121.8

Q ss_pred             ccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccc
Q 026720           75 NLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEV  151 (234)
Q Consensus        75 ~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~  151 (234)
                      .+..+... +.|+.         ++|..+++|+|++|+|+++ ..+..+++|||.+..+.... ......+++.|+|||+
T Consensus       113 ~~~~~~~qi~~~l~---------~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~  183 (346)
T 1ua2_A          113 HIKAYMLMTLQGLE---------YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL  183 (346)
T ss_dssp             HHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHH
T ss_pred             HHHHHHHHHHHHHH---------HHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchH
Confidence            33344443 66666         8999999999999999999 45678999999998764322 2334567889999999


Q ss_pred             cccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc-------------------------
Q 026720          152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-------------------------  206 (234)
Q Consensus       152 ~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~-------------------------  206 (234)
                      +.+...|+..+|+||+|++++++++|.+||++....+.+.++++..+.+....|+                         
T Consensus       184 ~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (346)
T 1ua2_A          184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA  263 (346)
T ss_dssp             HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred             hhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhcc
Confidence            8765668899999999999999999999999999999999999988887776664                         


Q ss_pred             --chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 --LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 --~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ..+..++..++..++.+|+++++++.+
T Consensus       264 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          264 AGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              345557777889999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.72  E-value=3.6e-18  Score=137.51  Aligned_cols=174  Identities=19%  Similarity=0.241  Sum_probs=129.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC----eeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG----VIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~----~~~~~  123 (234)
                      .+|..|+..|.+.+...--..++...+..+... +.|+.         ++|..+++|++++|+|+++. ..    ..+++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY---------YLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHH---------HHHHCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            467778888888775432111222233333333 56666         88999999999999999994 33    57999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      |||.+..+..........+++.|+|||++.+ ..|+..+|+||+|++++++++|..||.+....+....+......... 
T Consensus       161 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (326)
T 2y0a_A          161 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE  239 (326)
T ss_dssp             CCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred             ECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc
Confidence            9999987754444455678899999999864 44789999999999999999999999998887777666554333222 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ...+..+..++..++..++.+|+++++++.+
T Consensus       240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              3456677788888999999999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.72  E-value=7.1e-18  Score=143.11  Aligned_cols=173  Identities=23%  Similarity=0.314  Sum_probs=134.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...-...+++..+..+... +.|+.         ++|+.+++|++++|+|+++.    ....+++|
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT---------YLHKHNIVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCceeccCChhhEEEeCCCCCCcEEEEE
Confidence            477788888888765433223333344444443 67777         89999999999999999993    34589999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-  203 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-  203 (234)
                      ||.+.............+++.|+|||++.  ..|+..+|+||+|++++++++|.+||.+....+....+......++.. 
T Consensus       183 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  260 (494)
T 3lij_A          183 FGLSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE  260 (494)
T ss_dssp             CTTCEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG
T ss_pred             CCCCeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence            99998776544445567899999999985  348999999999999999999999999998888887777655544443 


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ..+..+..++..++..++.+|+++++++++
T Consensus       261 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence              345667778888999999999999998764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.72  E-value=3.3e-18  Score=142.81  Aligned_cols=174  Identities=31%  Similarity=0.498  Sum_probs=123.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+. |++.+..+--..++...+..|... +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~---------~LH~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN---------FIHESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            45555555 345444321111222233344444 67777         89999999999999999994 56789999999


Q ss_pred             cccccCCC-----------------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh--------
Q 026720          128 VKEIDSNL-----------------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS--------  176 (234)
Q Consensus       128 a~~~~~~~-----------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~--------  176 (234)
                      ++......                       .....+++++|+|||++.....|+..+|+||+||+++||++        
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            98764321                       12456789999999997656678999999999999999997        


Q ss_pred             ---CCCCCCCCC-----------------hHHHHHHHHHhhCCCCCC------------------------------CCc
Q 026720          177 ---FGILFPGKS-----------------SADQIYKICQLIGSPTKD------------------------------SWP  206 (234)
Q Consensus       177 ---~~~~f~~~~-----------------~~~~~~~i~~~~~~~~~~------------------------------~~~  206 (234)
                         +.++|+|..                 ..+++..+++..+.|...                              ..+
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence               667777765                 467888888888877642                              245


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .....+...++..++.+|+++++++.+
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            556667788889999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.72  E-value=3.2e-17  Score=129.52  Aligned_cols=142  Identities=34%  Similarity=0.620  Sum_probs=113.1

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGP  160 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~  160 (234)
                      +.|+.         ++|+.+++|++++|+|+++ .....+++|||.+....... ......+++.|+|||++.+...++.
T Consensus       110 ~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  180 (288)
T 1ob3_A          110 LNGIA---------YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST  180 (288)
T ss_dssp             HHHHH---------HHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCT
T ss_pred             HHHHH---------HHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCc
Confidence            66666         8999999999999999999 46788999999987654321 2233467889999999876566899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc----------------------------chhhhh
Q 026720          161 EVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP----------------------------LGIQLA  212 (234)
Q Consensus       161 ~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~~~~~  212 (234)
                      .+|+||+|++++++++|..||++....+.+.++.+..+.+....|+                            ..+..+
T Consensus       181 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  260 (288)
T 1ob3_A          181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL  260 (288)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHH
Confidence            9999999999999999999999999999999998888776655543                            223356


Q ss_pred             hhhccccCCCCCccccccCCC
Q 026720          213 SNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...++..++.+|+++++++++
T Consensus       261 i~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          261 LSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHcCCCcccCCCHHHHhcC
Confidence            677888899999999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.72  E-value=1e-17  Score=140.40  Aligned_cols=173  Identities=24%  Similarity=0.269  Sum_probs=130.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.....--..++...+..|... +.|+.         ++|+ .+++|+|++|+|+++ ..+..+++|||
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD---------YLHSEKNVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHH---------HHHHHTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHhhcCCEEECCCCHHHEEECCCCCEEEccCC
Confidence            477888888888766543333333444444443 67777         8897 789999999999999 46788999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+...... .......+++.|+|||++.+ ..|+..+|+||+|++++|+++|+.||.+.........+..... +.+...
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~  372 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTL  372 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTS
T ss_pred             CceeccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccC
Confidence            98864332 23345678999999999874 4589999999999999999999999998887777666655332 233456


Q ss_pred             cchhhhhhhhccccCCCCCc-----cccccCCC
Q 026720          206 PLGIQLASNLNWKLPQMGGV-----NLLAVMPS  233 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  233 (234)
                      +..+..++..++..++.+|+     ++++++++
T Consensus       373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            77888888889999999998     88887653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.71  E-value=3.2e-18  Score=136.61  Aligned_cols=175  Identities=29%  Similarity=0.432  Sum_probs=124.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+..+....++...+..+... +.|+.         ++|+.+++|++++|+|+++. ....+++|||.
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~---------~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN---------FCHKHNCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHH---------HHHHCCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            366677777766665332222222233333333 66666         89999999999999999994 67789999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC----
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK----  202 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~----  202 (234)
                      +....... ......+++.|.+||++.+...++..+|+||+|++++++++|..||++....+....+.+..+...+    
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (311)
T 4agu_A          149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  228 (311)
T ss_dssp             CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence            98765322 2234567888999999876566899999999999999999999999999988888777665443211    


Q ss_pred             --------------------------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --------------------------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                ...+..+..+...|+..++.+|+++++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                                      1334456678888999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.71  E-value=9.1e-18  Score=136.33  Aligned_cols=134  Identities=22%  Similarity=0.384  Sum_probs=112.1

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|..+++|++++|+|+++. ....+++|||.+.....   .....+++.|+|||++.+  ...|+..+|+||+|++++|
T Consensus       169 ~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~e  245 (348)
T 1u5q_A          169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE  245 (348)
T ss_dssp             HHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHH
T ss_pred             HHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHH
Confidence            88999999999999999994 57899999999877643   234578899999999853  3457899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++|+.||.+....+.+..+..... ......|++.+..++..|+...+.+|+++++++++
T Consensus       246 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          246 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            9999999999888887777665432 23346788899999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.71  E-value=7.3e-18  Score=142.74  Aligned_cols=173  Identities=22%  Similarity=0.258  Sum_probs=131.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...--..+++..+..+... +.|+.         ++|..+++|++++|+|+++.    ....+++|
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT---------YMHKHNIVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeccCchHHEEEecCCCCCCEEEEE
Confidence            466778888888765443333343444444444 67777         89999999999999999993    34689999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-  203 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-  203 (234)
                      ||.+.............+++.|+|||++.+  .|+..+|+||+|++++++++|.+||.+....+.+..+......++.. 
T Consensus       168 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (486)
T 3mwu_A          168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ  245 (486)
T ss_dssp             CSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred             CCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            999987665444455678999999999864  38999999999999999999999999998888887776654444433 


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        .++..+..++..++..++.+|+++.+++++
T Consensus       246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              345567777888999999999999988753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.71  E-value=3e-18  Score=144.43  Aligned_cols=174  Identities=24%  Similarity=0.283  Sum_probs=130.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|.+|+..|.+.+...--..+++..+..+... +.|+.         ++|..+++|+|++|+|+++. ....+++|||.
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~givHrDLkp~NIll~~~~~vkL~DFG~  162 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD---------YCHRHMVVHRDLKPENVLLDAHMNAKIADFGL  162 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHH---------HHHTTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCCCcccccHHHEEEecCCCeEEEeccc
Confidence            466777777777664321111222223333333 66666         89999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +.............+++.|.|||++.+...++..+|+||+|++++++++|..||.+........++..... ..+...+.
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~  241 (476)
T 2y94_A          163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNP  241 (476)
T ss_dssp             CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCH
T ss_pred             hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCH
Confidence            98776544445567899999999997655457899999999999999999999998887777777765432 23345567


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..++..++..++.+|+++++++++
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            78888888999999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.71  E-value=4.5e-18  Score=137.09  Aligned_cols=175  Identities=28%  Similarity=0.427  Sum_probs=125.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..+.+.+.......++...+..+... +.|+.         ++|..+++|++++|+|+++ .....+++|||.
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  170 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG---------FCHSHNIIHRDIKPENILVSQSGVVKLCDFGF  170 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHHHCCEEccCcChheEEEcCCCcEEEEeCCC
Confidence            356667776666654322222222233333333 56666         8899999999999999999 466889999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC----
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK----  202 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~----  202 (234)
                      +..+.... ......+++.|.+||.+.+...++..+|+||+|++++++++|+.||++....+....+....+...+    
T Consensus       171 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             C------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence            87654322 2234567888999999876556889999999999999999999999999998888887765543221    


Q ss_pred             --------------------------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --------------------------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                ...++.+..++..|+..++.+|+++.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                      1345677788888999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.71  E-value=1.1e-17  Score=131.43  Aligned_cols=173  Identities=23%  Similarity=0.290  Sum_probs=133.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe---e-CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV---S-KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~---~-~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...-...++...+..+... +.|+.         ++|..+++|++++|+|+++   . ....++.|
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA---------YCHKLNVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            467778888888775543333333344444443 66676         8999999999999999998   3 45689999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-  203 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-  203 (234)
                      ||.+.............+++.|.+||++.+  .++...|+||+|++++++++|..||.+....+....+.+....++.. 
T Consensus       153 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T 3f3z_A          153 FGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD  230 (277)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred             cccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence            999987765444455678889999999864  38899999999999999999999999988888777776644433332 


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ..+..+..+...++..++.+|+++.+++.+
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              566778888888999999999999998864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.71  E-value=1.4e-18  Score=140.38  Aligned_cols=173  Identities=23%  Similarity=0.273  Sum_probs=125.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+ .|.+.+...--..+++..+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE---------YCHRHKIVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence            4666677 4555444332223333344444443 67777         89999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +.............+++.|.|||++.+...++..+|+||+|++++++++|..||++........++.. .....+..++.
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s~  233 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS-CVYVMPDFLSP  233 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS-SCCCCCTTSCH
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCcccCCH
Confidence            88765544445567899999999997555447899999999999999999999987654433222211 11223445677


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..++..++..++.+|+++++++++
T Consensus       234 ~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          234 GAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            88888899999999999999998864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.71  E-value=2.1e-17  Score=130.18  Aligned_cols=174  Identities=21%  Similarity=0.252  Sum_probs=132.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C---CeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K---GVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~---~~~~~~~  124 (234)
                      .++..|+..|.+.+...--..++...+..+... +.|+.         ++|..+++|++++|+|+++. .   ...+++|
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~D  151 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA---------YCHSNGIVHRNLKPENLLLASKAKGAAVKLAD  151 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcCcCCCCHHHEEEecCCCCCcEEEee
Confidence            467778888887665443322333334444333 66666         89999999999999999993 2   3479999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.+.............+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+.........+.......+.  
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T 3kk8_A          152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE  230 (284)
T ss_dssp             CTTCEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             ceeeEEcccCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh
Confidence            999987765544455678899999999874 44789999999999999999999999998887777776654433332  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       ...+..+..+...++..++.+|+++++++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             3556778888888999999999999999874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.71  E-value=2.3e-17  Score=133.83  Aligned_cols=168  Identities=26%  Similarity=0.297  Sum_probs=122.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+...--..+++..+..|... +.|+.         ++|+.+++|++++|+|+++ ..+..+++|||.
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~  156 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN---------YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM  156 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCceecCCCHHHEEECCCCCEEEEeccc
Confidence            577888888988776554333444445555544 67777         8999999999999999999 467889999999


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHhhC
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS--------SADQIYKICQLIG  198 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~--------~~~~~~~i~~~~~  198 (234)
                      ++.... ........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+.+        ......+......
T Consensus       157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~  235 (345)
T 3a8x_A          157 CKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  235 (345)
T ss_dssp             CBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred             cccccCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence            986432 223445678999999999874 457999999999999999999999997632        2222222222222


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccc
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNL  227 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (234)
                      ..-+...+..+..++..++..++.+|++.
T Consensus       236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            23334566777788888888888888874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.71  E-value=7e-18  Score=138.12  Aligned_cols=172  Identities=19%  Similarity=0.313  Sum_probs=128.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-----------hccCccccHHH------H-HHHHHhcCCchhhhHhhhcccccCCcCCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-----------MREKNLQSWTI------M-ISGLADNSRGNDAISLHRQGYFHRDLKPS  111 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-----------m~~~~~~~~~~------~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~  111 (234)
                      .+|..|+..|.+.+..+-...           .+ ....++..      . +.|+.         ++|..+++|+|++|+
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVP-EEQMTFKDLVSCTYQLARGME---------YLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------C-CCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGG
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccc-cccCCHHHHHHHHHHHHHHHH---------HHHhCCeeccccchh
Confidence            467788888988876553211           11 11223322      2 55555         889999999999999


Q ss_pred             cEEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 026720          112 NLLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSS  186 (234)
Q Consensus       112 ~~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~  186 (234)
                      |+++ ..+..++.|||.+..+.....   .....+++.|+|||++.+ ..|+..+|+||+|+++||+++ |..||++...
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999 467889999999987654221   222345678999999874 458899999999999999998 9999998877


Q ss_pred             HHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          187 ADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       187 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+....+......+.+..++..+..++..|+...+.+|+++.+++.
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          312 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6666555555444555677888999999999999999999998864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.71  E-value=5.2e-18  Score=142.32  Aligned_cols=171  Identities=20%  Similarity=0.324  Sum_probs=129.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|++.+..+-...  ++...+..+... +.|+.         ++|+.+++|+|++|.|+++. ....+++||
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME---------YLEGNNFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence            578889999998887653211  111222333333 55666         88999999999999999994 678899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.++......  .....+..|+|||++.+ ..|+..+|+||+|+++||+++ |..||++....+....+.+....+.+..
T Consensus       334 G~a~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~  410 (450)
T 1k9a_A          334 GLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  410 (450)
T ss_dssp             TTCEECC--------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred             CCcccccccc--cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence            9988654321  22245678999999874 458899999999999999998 9999998877777766666555566677


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++..+..++..||..++.+||+|.+++.
T Consensus       411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          411 CPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8889999999999999999999998753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.70  E-value=4.3e-17  Score=134.96  Aligned_cols=142  Identities=31%  Similarity=0.538  Sum_probs=110.4

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-----CCeeeEeeccccccccCCC----CCCCcccCcccccccccc
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLL  153 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-----~~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~~  153 (234)
                      +.|+.         ++|..+++|+|++|+|+++.     ....+++|||.+.......    ......+++.|+|||++.
T Consensus       138 ~~al~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  208 (405)
T 3rgf_A          138 LDGIH---------YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL  208 (405)
T ss_dssp             HHHHH---------HHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHT
T ss_pred             HHHHH---------HHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhc
Confidence            66777         89999999999999999992     3578999999998764321    223457788999999998


Q ss_pred             cccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhhCCCCCCCCcch----------------
Q 026720          154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---------ADQIYKICQLIGSPTKDSWPLG----------------  208 (234)
Q Consensus       154 ~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~---------~~~~~~i~~~~~~~~~~~~~~~----------------  208 (234)
                      +...|+..+|+||+|++++++++|.+||.+...         .+++.++++.++.|....|...                
T Consensus       209 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  288 (405)
T 3rgf_A          209 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN  288 (405)
T ss_dssp             TCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGG
T ss_pred             CCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhcccc
Confidence            666789999999999999999999999986544         5888999999999998888543                


Q ss_pred             ---------------------hhhhhhhccccCCCCCccccccCCC
Q 026720          209 ---------------------IQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       209 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                           +..++..+...++.+|+|+++++.+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          289 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             GGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 2345666788899999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.70  E-value=2.5e-17  Score=134.93  Aligned_cols=168  Identities=25%  Similarity=0.264  Sum_probs=127.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+--..+.+..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..++.|||.
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~givHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG---------YLHSLNIVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCceecCCCHHHEEECCCCCEEEeeCcc
Confidence            577888888888776544333444444445444 67777         8999999999999999999 467899999999


Q ss_pred             cccccC-CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDS-NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++.... ........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+....+...++....... +...+
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~  263 (373)
T 2r5t_A          186 CKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL-KPNIT  263 (373)
T ss_dssp             CGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC-CSSSC
T ss_pred             ccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC-CCCCC
Confidence            987433 223455678999999999874 458899999999999999999999999988877777776643222 23456


Q ss_pred             chhhhhhhhccccCCCCCcccc
Q 026720          207 LGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                      ..+..++..++..++.+|++..
T Consensus       264 ~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          264 NSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTTT
T ss_pred             HHHHHHHHHHcccCHHhCCCCC
Confidence            6777788888888888888764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.70  E-value=8.6e-18  Score=134.87  Aligned_cols=174  Identities=20%  Similarity=0.276  Sum_probs=130.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC----eeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG----VIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~----~~~~~  123 (234)
                      .+|..|+..|++.+...-...++...+..+... +.|+.         ++|..+++|++++|+|+++. ..    ..+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~---------~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN---------YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence            467778888888776432222222233333333 56666         88999999999999999994 33    58999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      |||.+.............+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+....+....+.......+. 
T Consensus       162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  240 (321)
T 2a2a_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE  240 (321)
T ss_dssp             CCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             cCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence            9999988766544455678899999999874 44789999999999999999999999998877777666554333322 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ...+..+..+...++..++.+|+++++++++
T Consensus       241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              3456678888888999999999999998753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.70  E-value=5.4e-18  Score=141.46  Aligned_cols=174  Identities=25%  Similarity=0.311  Sum_probs=124.9

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .||..|+..|++.+...-. ..+++..+..|... +.|+.         ++|..+++|+|++|+|+++ ..+..+++|||
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~---------~LH~~giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID---------SVHQLHYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEecccCHHHeeEcCCCCEEEcchh
Confidence            5788889999988765432 22333344445444 67777         8999999999999999999 46789999999


Q ss_pred             ccccccCCCC--CCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh---
Q 026720          127 MVKEIDSNLP--CTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI---  197 (234)
Q Consensus       127 ~a~~~~~~~~--~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~---  197 (234)
                      .++.......  ....++++.|+|||++..    ...|+..+|+||+|++++||++|+.||.+....+...++....   
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence            9987644321  233578999999999862    3458899999999999999999999999998888888876533   


Q ss_pred             CCCCC-CCCcchhhhhhhhccccCCCC--CccccccCC
Q 026720          198 GSPTK-DSWPLGIQLASNLNWKLPQMG--GVNLLAVMP  232 (234)
Q Consensus       198 ~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (234)
                      ..|.. ...+.....++..+...++..  |+++++++.
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            22322 234555555554433334444  777777654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.70  E-value=1.3e-17  Score=139.16  Aligned_cols=134  Identities=28%  Similarity=0.450  Sum_probs=109.8

Q ss_pred             HhhhcccccCCcCCCcEEee-CCe--eeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGV--IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFE  173 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~--~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e  173 (234)
                      ++|+.+++|+|++|+|+++. ...  .+++|||.+......  .....+++.|+|||++.+. .|+..+|+||+|++++|
T Consensus       215 ~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~e  291 (429)
T 3kvw_A          215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAE  291 (429)
T ss_dssp             HHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHH
T ss_pred             HHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHH
Confidence            88999999999999999994 333  799999998765542  3446788999999998744 48999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHhhCCCCCC--------------------------------------------------
Q 026720          174 MLSFGILFPGKSSADQIYKICQLIGSPTKD--------------------------------------------------  203 (234)
Q Consensus       174 ~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~--------------------------------------------------  203 (234)
                      +++|.+||++....+.+..+.+..+.|...                                                  
T Consensus       292 lltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (429)
T 3kvw_A          292 LLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR  371 (429)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCS
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccch
Confidence            999999999999999998888876655422                                                  


Q ss_pred             C--------CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 S--------WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .        .+..+..++..|+..++.+|+|+++++++
T Consensus       372 ~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          372 EWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH  409 (429)
T ss_dssp             CHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence            1        12335567788999999999999998864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.70  E-value=5.4e-18  Score=140.19  Aligned_cols=174  Identities=22%  Similarity=0.257  Sum_probs=119.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~  122 (234)
                      .||..|+..|++.+...-..  .+.+..+..+... +.|+.         ++|..+++|+|++|+|+++.    ....++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ---------YLHSINIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCcCcceEEEecCCCCccEEE
Confidence            57888888888877643211  1222233333333 66666         88999999999999999994    467899


Q ss_pred             eeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhhC
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD----QIYKICQLIG  198 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~----~~~~i~~~~~  198 (234)
                      +|||.+.............+++.|++||++. ...|+..+|+||+|++++++++|..||.+.....    ...++.....
T Consensus       206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~  284 (400)
T 1nxk_A          206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  284 (400)
T ss_dssp             CCCTTCEECC-----------CTTCCGGGSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred             EecccccccCCCCccccCCCCCCccCHhhcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence            9999998765543344567789999999986 4458999999999999999999999998754322    2223332222


Q ss_pred             C-C--CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 S-P--TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 ~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      . +  ....++..+..++..++..++.+|+++++++.+
T Consensus       285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            2 2  223566778888888999999999999988753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.70  E-value=1.8e-17  Score=133.32  Aligned_cols=173  Identities=16%  Similarity=0.271  Sum_probs=130.7

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...-. ..++...+..|... +.|+.         ++|..+++|+|++|+|+++ .....+++|||
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY---------YLEEHGMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHH---------HHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHH---------HHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence            3677888888887765432 22344445555444 77777         8999999999999999999 46778999999


Q ss_pred             ccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          127 MVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       127 ~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      .+..+....   ......++..|.+||.+.+ ..++..+|+||+|++++++++ |..||.+....+....+......+.+
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP  239 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC
T ss_pred             cccccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC
Confidence            998764322   1233455668999999874 448899999999999999999 99999988776666556555455556


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..++..|+..++.+|+++.++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~  269 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELAN  269 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            667778888999999999999999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.70  E-value=1.8e-17  Score=133.02  Aligned_cols=173  Identities=30%  Similarity=0.464  Sum_probs=127.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+. |.+.+...-...  ++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.||
T Consensus        95 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           95 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD---------FLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             EEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH---------HHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence            45566666 565554332111  222222233322 55666         8899999999999999999 4667899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |.+.............+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+....+...++.+..+.|....|
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             cccccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            99877654333344567888999999874 34789999999999999999999999999999998888887776654444


Q ss_pred             --------------------------cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 --------------------------PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                +..+..+...++..++.+|+++.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                                      3344567778899999999999988764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.70  E-value=2.6e-18  Score=138.08  Aligned_cols=173  Identities=15%  Similarity=0.195  Sum_probs=129.2

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~  124 (234)
                      .+|.+|+..|++.+...--. .+++..+..+... +.|+.         ++|..+++|+|++|+|+++.   ....+++|
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~givH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ---------FLHSHNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCCCcCCCCHHHEEEccCCCCCEEEEE
Confidence            46777888888776532110 1122223333333 66666         88999999999999999994   56789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.+..+..........+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+....+....+.+....++.  
T Consensus       148 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  226 (321)
T 1tki_A          148 FGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA  226 (321)
T ss_dssp             CTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             CCCCeECCCCCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh
Confidence            999987755433344567889999999874 34688999999999999999999999998888877777765544443  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       ...+..+..+...++..++.+|++++++++
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             245667777888899999999999998865

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.70  E-value=7.8e-17  Score=131.12  Aligned_cols=137  Identities=28%  Similarity=0.496  Sum_probs=114.1

Q ss_pred             Hhh--hcccccCCcCCCcEEee--CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLH--RQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~--~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|  ..+++|+|++|+|+++.  ....+++|||.+.............+++.|+|||++.+...++..+|+||+|++++
T Consensus       144 ~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~  223 (360)
T 3e3p_A          144 CLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA  223 (360)
T ss_dssp             HHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence            566  88999999999999995  57899999999988765544555678899999999876666899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC-------------------------------CcchhhhhhhhccccCC
Q 026720          173 EMLSFGILFPGKSSADQIYKICQLIGSPTKDS-------------------------------WPLGIQLASNLNWKLPQ  221 (234)
Q Consensus       173 e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~  221 (234)
                      ++++|+.||.+....+.+..+.+..+.|....                               .+..+..+...++..++
T Consensus       224 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  303 (360)
T 3e3p_A          224 EMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP  303 (360)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred             HHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence            99999999999999999888888766654211                               23456667788999999


Q ss_pred             CCCccccccCCC
Q 026720          222 MGGVNLLAVMPS  233 (234)
Q Consensus       222 ~~~~~~~~~~~~  233 (234)
                      .+|+++.+++++
T Consensus       304 ~~Rpt~~e~l~h  315 (360)
T 3e3p_A          304 EERMKPYEALCH  315 (360)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             cccCCHHHHhcC
Confidence            999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.70  E-value=3.9e-18  Score=144.32  Aligned_cols=173  Identities=22%  Similarity=0.260  Sum_probs=130.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...--..+++..+..+... +.|+.         ++|..+++|++++|+|+++.    ....+++|
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT---------YMHKNKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            466777888887665432222222333333333 66676         89999999999999999993    45789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-  203 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-  203 (234)
                      ||.+.............+++.|+|||++.+  .|+..+|+||+|++++++++|.+||.+....+...++.+....++.. 
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  250 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ  250 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            999887655433344578899999999864  48999999999999999999999999998888888777654444433 


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ..+..+..++..++...+.+|+++.+++++
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence              345567777888999999999999998764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.70  E-value=1.2e-17  Score=140.38  Aligned_cols=148  Identities=30%  Similarity=0.568  Sum_probs=109.1

Q ss_pred             ccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC-------------------
Q 026720           77 QSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL-------------------  135 (234)
Q Consensus        77 ~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~-------------------  135 (234)
                      ..|... +.|+.         ++|+.+++|+|++|.|+++. ....+++|||.++.+....                   
T Consensus       159 ~~~~~qi~~aL~---------~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (458)
T 3rp9_A          159 KTLLYNLLVGVK---------YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT  229 (458)
T ss_dssp             HHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------------
T ss_pred             HHHHHHHHHHHH---------HHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccc
Confidence            334333 66777         89999999999999999994 5678999999998764211                   


Q ss_pred             ---------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-----------CCCCCCCCC----------
Q 026720          136 ---------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-----------FGILFPGKS----------  185 (234)
Q Consensus       136 ---------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-----------~~~~f~~~~----------  185 (234)
                               ...+.+++++|+|||++.....|+..+|+||+||+++||++           ++++|+|..          
T Consensus       230 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~  309 (458)
T 3rp9_A          230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKA  309 (458)
T ss_dssp             ---------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-------------
T ss_pred             ccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccc
Confidence                     12345678999999987656668999999999999999998           889998865          


Q ss_pred             ----------hHHHHHHHHHhhCCCCCCC------------------------------CcchhhhhhhhccccCCCCCc
Q 026720          186 ----------SADQIYKICQLIGSPTKDS------------------------------WPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       186 ----------~~~~~~~i~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~  225 (234)
                                ..+++..+++..+.|....                              .+.....+...+...++.+|+
T Consensus       310 ~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~  389 (458)
T 3rp9_A          310 GNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI  389 (458)
T ss_dssp             -------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             cccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccC
Confidence                      3677778888777765321                              234455667778888999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++++
T Consensus       390 t~~e~L~H  397 (458)
T 3rp9_A          390 TINECLAH  397 (458)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99988753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.70  E-value=1.6e-17  Score=136.05  Aligned_cols=173  Identities=19%  Similarity=0.209  Sum_probs=130.5

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~  124 (234)
                      .||.+|+..|++.+...--. .+++..+..+.. ++.|+.         ++|..+++|+|++|+|+++.   ....++.|
T Consensus       162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~D  232 (373)
T 2x4f_A          162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR---------HMHQMYILHLDLKPENILCVNRDAKQIKIID  232 (373)
T ss_dssp             EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEEEETTTTEEEECC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccccCCHHHEEEecCCCCcEEEEe
Confidence            56778888888866543211 122223333322 356666         88999999999999999982   35789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.+.............+++.|++||++.+ ..++..+|+||+|++++|+++|..||.+....+.+..+......+..  
T Consensus       233 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  311 (373)
T 2x4f_A          233 FGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE  311 (373)
T ss_dssp             CSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred             CCCceecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence            999988765444445578899999999863 45788999999999999999999999999888888888765443333  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       ...+..+..++..++..++.+|+++++++.
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             345667778888899999999999998875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.69  E-value=2.2e-17  Score=140.41  Aligned_cols=173  Identities=24%  Similarity=0.279  Sum_probs=134.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC----CeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK----GVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~----~~~~~~~  124 (234)
                      .+|..|+..|++.+...--..+++..+..+... +.|+.         ++|..+++|++++|+|+++..    ...+++|
T Consensus       122 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          122 YLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC---------YLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            577888888888776543333344444444444 67777         899999999999999999942    2579999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.+.............+++.|+|||++.  ..|+..+|+||+|++++++++|.+||.+....+....+.......+.  
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  270 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND  270 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            99998776654555667899999999986  34899999999999999999999999998888887777664433332  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       ...+..+..++..++..++.+|+++++++++
T Consensus       271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             3456677788888999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.69  E-value=2e-17  Score=135.97  Aligned_cols=173  Identities=20%  Similarity=0.328  Sum_probs=130.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----------------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----------------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----------------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+|..|+..|++.+...-...                ++...+..+... +.|+.         ++|+.+++|+|++|+|
T Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME---------YLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGG
T ss_pred             EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHH---------HHHhCCEecCCCCcce
Confidence            477788888998887654321                111222333322 55666         8899999999999999


Q ss_pred             EEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++. ....+++|||.+.......   ......+++.|.|||++.+ ..++..+|+||+|++++++++ |..||++....
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9994 6778999999998765421   1223345677999999874 457899999999999999998 99999988777


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....+.+....+.+..++..+..+...|+..++.+|+++.++++
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  345 (382)
T 3tt0_A          301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  345 (382)
T ss_dssp             HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            666666555555556677888999999999999999999998864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.69  E-value=6.4e-18  Score=139.07  Aligned_cols=174  Identities=17%  Similarity=0.226  Sum_probs=128.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~  124 (234)
                      .+|.+|+..|++.+....-. .+++..+..+... +.|+.         ++|..+++|+|++|+|+++.   ....+++|
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK---------HMHEHSIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeecccchHHeEEecCCCCceEEEe
Confidence            46677788888766432110 1222223333333 55666         88999999999999999994   34689999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.+.............+++.|+|||++.+ ..++..+|+||+|++++++++|..||.+....+.+..+.......+.  
T Consensus       195 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  273 (387)
T 1kob_A          195 FGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA  273 (387)
T ss_dssp             CTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred             cccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            999987755433334568889999999874 44789999999999999999999999998888877777654333333  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       ..++..+..++..++..++.+|+++++++++
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             3456677888888999999999999998764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.69  E-value=2.5e-17  Score=134.59  Aligned_cols=176  Identities=22%  Similarity=0.250  Sum_probs=132.4

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      ..+|..|+..|.+.+...-...++...+..+... +.|+.         ++|..+++|+|++|.|+++. .+..++.|||
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~---------~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS---------FLHANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence            3577788888888776543222333334444333 66666         88999999999999999994 5678999999


Q ss_pred             ccccccCCCCCCCcccCccccccccccc-----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLF-----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .+..+..........+++.|++||++.+     ...|+..+|+||+|++++++++|..||.+.........+......+.
T Consensus       246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  325 (365)
T 2y7j_A          246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS  325 (365)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             cccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            9887765544556678899999999853     22478899999999999999999999998877777666655433333


Q ss_pred             C---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 K---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .   ...+..+..+...++..++.+|+++++++++
T Consensus       326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            2   3445667888888999999999999998753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.69  E-value=1.2e-17  Score=140.26  Aligned_cols=173  Identities=21%  Similarity=0.318  Sum_probs=128.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|++.+..+-...  ++.+.+..+... +.|+.         ++|..+++|+|++|.|+++. ....+++||
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA---------YVERMNYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeCCCCChhhEEECCCCCEEECCC
Confidence            478888999998887543211  222333344333 56666         88999999999999999994 567899999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.+.......  ......++..|+|||.+.+ ..|+..+|+||+|+++||+++ |+.||++....+....+.+....+.+
T Consensus       325 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~  403 (452)
T 1fmk_A          325 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP  403 (452)
T ss_dssp             CTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             ccceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            9998764321  1122344567999999874 347899999999999999999 89999998888877777666556667


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+++.+..++..||...+.+||++++++.
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            788889999999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.69  E-value=9.1e-18  Score=137.74  Aligned_cols=173  Identities=21%  Similarity=0.274  Sum_probs=129.3

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+..+-.. .++...+..+... +.|+.         ++|+.+++|+|++|.|+++. ....+++|||
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME---------YLESKCCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence            57788888898887654322 1222233333333 55666         88999999999999999994 6788999999


Q ss_pred             ccccccCCCCC---CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          127 MVKEIDSNLPC---TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       127 ~a~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      .+.........   .....+..|+|||++.+ ..|+..+|+||+|+++||+++ |..||++....+....+......+.+
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  337 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP  337 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            98865432111   11123456999999874 347899999999999999998 99999988877766555555455666


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..++..||..++.+||++++++.
T Consensus       338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            778889999999999999999999998864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.69  E-value=5.7e-17  Score=132.54  Aligned_cols=135  Identities=34%  Similarity=0.524  Sum_probs=101.5

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|+.+++|++++|.|+++. ....+++|||.+......  .....++++|+|||++.+...|+..+|+||+||+++|++
T Consensus       147 ~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  224 (367)
T 2fst_X          147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  224 (367)
T ss_dssp             HHHHTTCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH
T ss_pred             HHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH
Confidence            88999999999999999994 567899999998876543  334678899999999876567899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCCC------------------------------CcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKDS------------------------------WPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|+.||++....+++..+.+..+.|....                              .+.....+...++..++.+|+
T Consensus       225 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~  304 (367)
T 2fst_X          225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI  304 (367)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence            99999999999999999988777664321                              123345566778888999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++.+
T Consensus       305 t~~e~L~h  312 (367)
T 2fst_X          305 TAAQALAH  312 (367)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99888764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.69  E-value=1.5e-17  Score=137.78  Aligned_cols=173  Identities=26%  Similarity=0.351  Sum_probs=126.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .||..|+..|++.+...-.. .+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~---------~LH~~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID---------SVHRLGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence            57888899999988765432 2444444455544 67777         8999999999999999999 46789999999


Q ss_pred             ccccccCCCC--CCCcccCccccccccccc------ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-
Q 026720          127 MVKEIDSNLP--CTDYVTTRWYRGPEVLLF------SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-  197 (234)
Q Consensus       127 ~a~~~~~~~~--~~~~~~~~~~~~pe~~~~------~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-  197 (234)
                      .++.+.....  .....+++.|+|||++..      ...|+..+|+||+|++++||++|+.||.+....+...++.... 
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            9987654322  234578999999999863      2357899999999999999999999999988888777776432 


Q ss_pred             --CCCC-CCCCcchhhhhhhhccccCCCCC---ccccccCC
Q 026720          198 --GSPT-KDSWPLGIQLASNLNWKLPQMGG---VNLLAVMP  232 (234)
Q Consensus       198 --~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (234)
                        ..|. ....+.....+++.++. ++.+|   +++++++.
T Consensus       288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence              2232 24566677777766666 55555   46776654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.69  E-value=1.9e-17  Score=134.78  Aligned_cols=171  Identities=19%  Similarity=0.256  Sum_probs=124.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----------
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----------  116 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----------  116 (234)
                      .+|..|+ .|.+.+...-...  ++...+..+... +.|+.         ++|+.+++|+|++|+|+++.          
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN---------YLRKMSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeCCCCcccEEEccccccccccc
Confidence            3566677 6677665443211  222333344333 66777         89999999999999999994          


Q ss_pred             ----------------CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCC
Q 026720          117 ----------------KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL  180 (234)
Q Consensus       117 ----------------~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~  180 (234)
                                      ....+++|||.+.....  ......+++.|+|||++.+. .|+..+|+||+|++++++++|+.|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCC
Confidence                            45679999999886544  23445788999999998744 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHhhCCCCCCC---------------------C------------------------cchhhhhhhh
Q 026720          181 FPGKSSADQIYKICQLIGSPTKDS---------------------W------------------------PLGIQLASNL  215 (234)
Q Consensus       181 f~~~~~~~~~~~i~~~~~~~~~~~---------------------~------------------------~~~~~~~~~~  215 (234)
                      |.+....+.+..+....+.++...                     |                        ++.+..+...
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            999888887777766544333110                     1                        1334467788


Q ss_pred             ccccCCCCCccccccCCC
Q 026720          216 NWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~  233 (234)
                      ++..++.+|+++.+++++
T Consensus       339 ~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             HhcCChhhCCCHHHHhcC
Confidence            899999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.69  E-value=1.7e-17  Score=132.52  Aligned_cols=173  Identities=20%  Similarity=0.258  Sum_probs=121.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHh---hccCccccHHHH-HHHHHhcCCchhhhHhhhcc--cccCCcCCCcEEee-CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL---MREKNLQSWTIM-ISGLADNSRGNDAISLHRQG--YFHRDLKPSNLLVS-KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~---m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~--~~~~~l~p~~~~~~-~~~~~~  122 (234)
                      .+|..|+..|++.+...-...   ++...+..+... +.|+.         ++|..+  ++|++++|+|+++. ....++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN---------YLHNRNPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHH---------HHHTSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH---------HHHcCCCCEECCCCChhhEEEeCCCcEEE
Confidence            577888888888876543211   333333334333 66677         889888  99999999999994 567899


Q ss_pred             eeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-CC
Q 026720          123 GDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG-SP  200 (234)
Q Consensus       123 ~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~-~~  200 (234)
                      +|||.+....... ......+++.|+|||++.+ ..++..+|+||+|++++++++|+.||.+....+....+..... .+
T Consensus       181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  259 (309)
T 3p86_A          181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE  259 (309)
T ss_dssp             CCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             CCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9999987544322 2234567889999999874 4478999999999999999999999998877766655543322 33


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..++..+..++..|+...+.+|+++.++++
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            44677888999999999999999999998764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.69  E-value=8.5e-18  Score=135.33  Aligned_cols=174  Identities=22%  Similarity=0.285  Sum_probs=124.4

Q ss_pred             HHHHHHhhcCChHHHHHH--HHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKV--FNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~--~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~  122 (234)
                      .+|..|+..|.+.+...-  ...++...+..+... +.|+.         ++|..+++|++++|+|+++.    ....++
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~---------~LH~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY---------YLHQNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence            466777777776554210  001111122233222 56666         88999999999999999994    367899


Q ss_pred             eeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      .|||.+.............+++.|++||++.+ ..++..+|+||+|++++++++|..||.+....+....+.+.......
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  254 (327)
T 3lm5_A          176 VDFGMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE  254 (327)
T ss_dssp             CCGGGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeCccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence            99999988765544455678899999999874 44789999999999999999999999998888887777665544443


Q ss_pred             ---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 ---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                         ..++..+..++..++..++.+|+++++++.+
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence               3456677778888999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.69  E-value=9.3e-18  Score=135.01  Aligned_cols=173  Identities=20%  Similarity=0.329  Sum_probs=130.3

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+..+-.. .++...+..+... +.|+.         ++|..+++|+|++|+|+++ .....+++|||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR---------YLSDLGYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence            47788888889887653211 1222223333332 55666         8899999999999999999 45678999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .+........    .....++..|++||++.+ ..++..+|+||+|++++++++ |..||.+....+....+......+.
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~  275 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA  275 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC
Confidence            9987644211    112233557999999864 447899999999999999998 9999999988888877777766777


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..++..|+..++.+|+++.+++.
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7788889999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.68  E-value=1.5e-17  Score=133.94  Aligned_cols=172  Identities=17%  Similarity=0.284  Sum_probs=127.8

Q ss_pred             HHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           51 LVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      +|.+|+..|++.+...-.. .++...+..|... +.|+.         ++|..+++|++++|+|+++ .....+++|||.
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN---------YLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence            5667788888777543311 1222233344333 66666         8999999999999999999 567899999999


Q ss_pred             cccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          128 VKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       128 a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +........   .....++..|++||.+.+ ..|+..+|+||+|++++|+++ |+.||.+....+....+......+.+.
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~  242 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  242 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             eeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc
Confidence            887643321   122344668999999874 457899999999999999999 999999877666655555555556667


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .++..+..+...|+...+.+|+++.+++.
T Consensus       243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~  271 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            77888889999999999999999998863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.68  E-value=2.7e-17  Score=128.54  Aligned_cols=173  Identities=19%  Similarity=0.253  Sum_probs=134.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+..+-... ++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.|||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA---------FLESHQFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHH---------HHHHTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCcCcceEEECCCCCEEEccCc
Confidence            477778888888877654322 333444444443 66777         8999999999999999999 46678999999


Q ss_pred             ccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+........  .....+++.|.+||.+.+ ..++..+|+||+|++++++++ |+.||.+....+....+......+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  228 (268)
T 3sxs_A          150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH  228 (268)
T ss_dssp             CEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             cceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC
Confidence            9886644321  122344557999999864 347889999999999999998 999999988888887777766666677


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+..+..+...|+...+.+|+++.++++
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (268)
T 3sxs_A          229 LASDTIYQIMYSCWHELPEKRPTFQQLLS  257 (268)
T ss_dssp             TSCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            77888999999999999999999998864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.68  E-value=1.7e-17  Score=142.29  Aligned_cols=173  Identities=22%  Similarity=0.314  Sum_probs=126.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .+|..|+..|++.+...-...  +++..+..|... +.|+.         ++|..+++|+|++|+|+++ ..+..+++||
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~---------yLH~~gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE---------DLHRERIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeccCCchheEEEeCCCCeEEEec
Confidence            577788888888765432211  222333444444 66777         8999999999999999999 4678999999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS---SADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~---~~~~~~~i~~~~~~~~~  202 (234)
                      |.+..+..........+++.|+|||++.+ ..|+..+|+||+|++++||++|..||.+..   ......+........-+
T Consensus       331 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p  409 (576)
T 2acx_A          331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS  409 (576)
T ss_dssp             TTCEECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC
T ss_pred             ccceecccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC
Confidence            99988765444445678999999999874 347899999999999999999999999764   23333333333333334


Q ss_pred             CCCcchhhhhhhhccccCCCCCc-----cccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      ..++..+..++..++..++.+|+     ++++++.
T Consensus       410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            55677788888888888888888     6676654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.68  E-value=6e-17  Score=128.41  Aligned_cols=175  Identities=22%  Similarity=0.240  Sum_probs=131.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...--..++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.+||.
T Consensus       100 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A          100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC---------ALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            567778888888776543222333333333333 66666         88999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCccccccccccc-----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLF-----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +.............+++.|.+||++.+     ...++..+|+||+|++++++++|..||.+.........+.........
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            887665444455678889999998742     334788999999999999999999999988877776666654433332


Q ss_pred             ---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 ---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                         ..++..+..+...++..++.+|+++++++.+
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence               3456678888888999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.68  E-value=1.4e-17  Score=136.11  Aligned_cols=173  Identities=17%  Similarity=0.252  Sum_probs=130.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc-Ccccc------HHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----C
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE-KNLQS------WTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----K  117 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~-~~~~~------~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~  117 (234)
                      .+|..|+..|++.+..+-...... +...+      +... +.|+.         ++|+.+++|+|++|+|+++.    .
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~~~~  220 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ---------YLEENHFIHRDIAARNCLLTCPGPG  220 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHH---------HHHhCCeeCCCCChhhEEEecCCCC
Confidence            477788888888887654332111 12223      3222 55666         88999999999999999994    2


Q ss_pred             CeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 026720          118 GVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKI  193 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i  193 (234)
                      ...+++|||.++.+....   ......+++.|+|||++.+ ..|+..+|+||+|++++|+++ |..||++....+....+
T Consensus       221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i  299 (367)
T 3l9p_A          221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  299 (367)
T ss_dssp             CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            358999999987653211   1223456778999999864 448899999999999999998 99999998888777777


Q ss_pred             HHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          194 CQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ......+.+..++..+..++..|+...+.+|+++.++++
T Consensus       300 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~  338 (367)
T 3l9p_A          300 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE  338 (367)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            665555556677888999999999999999999998864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.68  E-value=9.9e-17  Score=129.49  Aligned_cols=173  Identities=20%  Similarity=0.214  Sum_probs=129.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...-...+....+..+... +.|+.         ++|..+++|++++|+|+++. ....++.|||.
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ---------YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence            467778888888776443222333333333333 66666         88999999999999999994 56789999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +....... ......++..|.+||++.+ ..++...|+||+|++++++++|..||.+....+....+... ....+..++
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  265 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKHIN  265 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCCCTTSC
T ss_pred             ceecccCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-CCCCCccCC
Confidence            88764322 2334567888999999874 44788999999999999999999999987776666555443 223345667


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..++..++..++.+|+++++++++
T Consensus       266 ~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          266 PVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            788889999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.68  E-value=3.8e-17  Score=131.51  Aligned_cols=165  Identities=24%  Similarity=0.306  Sum_probs=119.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...-...+.+..+..+... +.|+.         ++|..+++|++++|+|+++ ..+..+++|||.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG---------HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            567778888887765543222333333334333 66676         8999999999999999999 467889999999


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +...... .......+++.|+|||++.+ ..++..+|+||+|++++++++|..||.+....+...++.+... ..+..++
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~  245 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLT  245 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSC
T ss_pred             ccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCC
Confidence            8764332 22344578899999999864 4478999999999999999999999999888777777765432 2234566


Q ss_pred             chhhhhhhhccccCCCCCc
Q 026720          207 LGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~  225 (234)
                      ..+..++..++..++.+|+
T Consensus       246 ~~~~~li~~~L~~dp~~R~  264 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRL  264 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGST
T ss_pred             HHHHHHHHHHHhcCHhhcc
Confidence            7788888888888888888

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.68  E-value=1.6e-17  Score=144.82  Aligned_cols=172  Identities=20%  Similarity=0.284  Sum_probs=129.6

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      +|..|+..|++.+..+--..+....+..+... +.|+.         ++|..+++|+|++|+|+++ .....+++|||.+
T Consensus       446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~---------yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla  516 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK---------YLEESNFVHRDLAARNVLLVTQHYAKISDFGLS  516 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred             EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence            67788888888876543222333333333333 56666         8899999999999999999 5678999999998


Q ss_pred             ccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          129 KEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       129 ~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +.+.....    .....++..|+|||++.+ ..|+..+|+||+|++++|+++ |..||.+....+....+.+....+.+.
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  595 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA  595 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            87643221    112234567999999974 448899999999999999998 999999988877776676655555667


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .++..+..++..||..++.+|+++++++.
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            78889999999999999999999998753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.68  E-value=2.1e-17  Score=134.25  Aligned_cols=174  Identities=24%  Similarity=0.303  Sum_probs=113.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...--..++...+..+... +.|+.         ++|..+++|+|++|+|+++.    ....+++|
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA---------YLHENGIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEecCCCcccEEEecCCCCCCEEEcc
Confidence            466777877877654321111112222223222 55565         88999999999999999994    56789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhhCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY-KICQLIGSPTK-  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~-~i~~~~~~~~~-  202 (234)
                      ||.+.............+++.|++||++.+ ..++..+|+||+|++++|+++|..||.+........ .+......... 
T Consensus       195 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP  273 (349)
T ss_dssp             CC----------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred             CccccccCcccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence            999887655433445678899999999874 347899999999999999999999998776665433 34333222222 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ...+..+..+...++..++.+|+++.+++.+
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              3445677778888999999999999988753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.68  E-value=1.6e-17  Score=133.60  Aligned_cols=172  Identities=19%  Similarity=0.348  Sum_probs=128.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC-eeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG-VIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~-~~~~~~~~  126 (234)
                      .++..|+..|.+.+..   ..++...+..+... +.|+.         ++|+.+++|+|++|+|+++. .. ..+++|||
T Consensus       109 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD---------YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             EEEEECCCCCCHHHHG---GGCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeccCchhHHHHH---HhCCHHHHHHHHHHHHHHHH---------HHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence            4677788888876653   33444444444444 67777         89999999999999999995 44 78999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhhCCCC----
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFP-GKSSADQIYKICQLIGSPT----  201 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~-~~~~~~~~~~i~~~~~~~~----  201 (234)
                      .+.............+++.|.+||++.+...++..+|+||+|++++++++|..||. +....+.+..+.+..+.++    
T Consensus       177 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  256 (330)
T 3nsz_A          177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  256 (330)
T ss_dssp             TCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             CceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence            99876655445556788899999998765668999999999999999999998885 4555566665554433211    


Q ss_pred             --------------------CC------------CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 --------------------KD------------SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 --------------------~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                          ..            ..+..+..++..++..++.+|+++++++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                11            135566778888999999999999998864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.68  E-value=2.3e-17  Score=132.31  Aligned_cols=172  Identities=15%  Similarity=0.202  Sum_probs=125.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~  121 (234)
                      .++..|+..|++.+.......      ++...+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+
T Consensus       107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~---------~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME---------YLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH---------HHHcCCcccCCCCcceEEEcCCCCEE
Confidence            577888999998887554321      222233333333 66666         89999999999999999994 56789


Q ss_pred             EeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 026720          122 IGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       122 ~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ++|||.+........   .....+++.|.+||.+.+ ..++..+|+||+|++++++++ |..||.+....+....+....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999887644221   112344567999999874 447899999999999999999 899999988888777777666


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ..+.+..++..+..+...|+..++.+|+++.+++
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  290 (323)
T 3qup_A          257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR  290 (323)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            6666677888899999999999999999976654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.67  E-value=2.8e-17  Score=142.78  Aligned_cols=173  Identities=19%  Similarity=0.226  Sum_probs=127.2

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|.+.+...-- ..++...+..+... +.|+.         ++|..+++|+|++|+|+++ ....++++|||
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~---------~LH~~~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK---------YLEEKNFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            4778888889887754211 01122222333332 55555         8899999999999999999 57789999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .++.+.....    .....++..|+|||++.+ ..|+..+|+||+|+++||+++ |+.||++....+....+.+....+.
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~  560 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC  560 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9987643211    111223467999999874 458999999999999999998 9999999988887777766555555


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..++..||...+.+|++|.+++.
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6678889999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.67  E-value=2.4e-17  Score=129.82  Aligned_cols=173  Identities=20%  Similarity=0.301  Sum_probs=120.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...... .++...+..+.. ++.|+.         ++|+.+++|+|++|+|+++ .....++.|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA---------YLESKRFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecccccHHHEEECCCCCEEECccc
Confidence            36677888788877654321 122222333332 356666         8899999999999999999 47788999999


Q ss_pred             ccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+........  .....+++.|.+||++.+ ..++..+|+||+|++++|+++ |..||.+....+....+......+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  240 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  240 (281)
T ss_dssp             -----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             cccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC
Confidence            9887644221  122334567999999863 447889999999999999996 899999888777777776655555566


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+..+..+...++...+.+|+++.+++.
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            77888999999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.67  E-value=2.3e-17  Score=135.84  Aligned_cols=175  Identities=16%  Similarity=0.167  Sum_probs=123.7

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|.+.+.....  ..+++..+..+... +.|+.         ++|+.+++|+|++|+|+++. ....++++|
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD---------YIHHMGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence            4677788888888765432  22333334444443 67777         89999999999999999994 677899999


Q ss_pred             cccccccCCC--------CCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 026720          126 GMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       126 ~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~  196 (234)
                      |.+.......        ......+++.|+|||++.+. ..|+..+|+||+|++++++++|+.||.+....+....+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            8776542211        11223677889999998753 45899999999999999999999999987766665544321


Q ss_pred             hCC---------------------------------------------CCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          197 IGS---------------------------------------------PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       197 ~~~---------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ...                                             +....++..+..++..++..++.+|+++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            110                                             11233455677788889999999999999998


Q ss_pred             CC
Q 026720          232 PS  233 (234)
Q Consensus       232 ~~  233 (234)
                      ++
T Consensus       333 ~h  334 (389)
T 3gni_B          333 NH  334 (389)
T ss_dssp             TS
T ss_pred             cC
Confidence            64

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.67  E-value=2.3e-17  Score=133.30  Aligned_cols=135  Identities=24%  Similarity=0.360  Sum_probs=108.3

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|+.+++|+|++|+|+++ .....+++|||.+.......   ......++..|.+||.+.+ ..++..+|+||+|++++
T Consensus       189 ~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~  267 (343)
T 1luf_A          189 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLW  267 (343)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred             HHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHH
Confidence            8899999999999999999 45678999999987654321   1223456778999999874 34789999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++++ |..||.+....+....+.+....+.+..++..+..++..|+...+.+|+++.++++
T Consensus       268 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          268 EIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            9998 99999988877776666655444556677888999999999999999999988753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.67  E-value=3.1e-17  Score=132.08  Aligned_cols=172  Identities=17%  Similarity=0.289  Sum_probs=124.6

Q ss_pred             HHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           51 LVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      +|..|+..|.+.+...-.. .++...+..|... +.|+.         ++|..+++|+|++|+|+++ .....++.|||.
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN---------YLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            5666777788776544321 1222333444433 66777         8999999999999999999 567899999999


Q ss_pred             cccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          128 VKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       128 a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      +........   .....++..|.+||.+.+ ..|+..+|+||+|++++++++ |..||.+....+....+......+.+.
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  242 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  242 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             eeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            987643221   122344567999999874 457899999999999999999 999999887777666665555566677


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .++..+..++..|+..++.+|+++.+++.
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            78888999999999999999999998864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.67  E-value=8.5e-18  Score=137.24  Aligned_cols=172  Identities=13%  Similarity=0.049  Sum_probs=122.4

Q ss_pred             HHHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEe
Q 026720           49 TALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIG  123 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~  123 (234)
                      ..||..|+ .|++.+...-. ..++...+..+... +.|+.         ++|..+++|+|++|+|+++.   ....+++
T Consensus       127 ~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~---------~lH~~~iiHrDlkp~Nill~~~~~~~~kl~  196 (364)
T 3op5_A          127 RFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILE---------YIHEHEYVHGDIKASNLLLNYKNPDQVYLV  196 (364)
T ss_dssp             EEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEEESSCTTCEEEC
T ss_pred             EEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCeEEecCCHHHEEEecCCCCeEEEE
Confidence            46788888 78888765432 11233333444333 66666         89999999999999999994   4678999


Q ss_pred             eccccccccCCC--------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          124 DLGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       124 ~~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      |||.++.+....        ......+++.|+|||++.+. .++..+|+||+|++++|+++|+.||.+............
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~  275 (364)
T 3op5_A          197 DYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSK  275 (364)
T ss_dssp             CCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHH
T ss_pred             ECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHH
Confidence            999997653321        11334588899999998744 488999999999999999999999996433222222111


Q ss_pred             -hhC---------CCCCCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          196 -LIG---------SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       196 -~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                       ...         .......+..+..++..||...+.+||++++|+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~  321 (364)
T 3op5_A          276 IRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR  321 (364)
T ss_dssp             HHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             HHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence             111         011245677889999999999999999998875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.67  E-value=4.2e-17  Score=133.49  Aligned_cols=170  Identities=28%  Similarity=0.466  Sum_probs=113.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+.. .+.+...  ..++...+..+... +.|+.         ++|..+++|+|++|+|+++. ....+++|||.
T Consensus       106 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~---------~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          106 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK---------HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             EEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHH---------HHHHCCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            456666664 3333221  11222233333333 66666         89999999999999999994 66789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC--
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW--  205 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~--  205 (234)
                      +.............+++.|+|||++.+ ..|+..+|+||+|++++++++|+.||++....+...++.+..+.|.+..+  
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            987655433445678889999999874 45889999999999999999999999999998888888776665432111  


Q ss_pred             ---------------------------------------cchhhhhhhhccccCCCCCccccccCC
Q 026720          206 ---------------------------------------PLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       206 ---------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                                                             +..+..+...+...++.+|+|++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                                   223456677788889999999998865

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.67  E-value=1.1e-16  Score=130.12  Aligned_cols=173  Identities=19%  Similarity=0.228  Sum_probs=124.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC----Cee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK----GVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~----~~~  120 (234)
                      .+|..|+..|++.+...-...    +++..+..+.. ++.|+.         ++|+.+++|+|++|+|+++..    ...
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR---------YCHDNNIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECSSSTTCCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCceeccCChHHeEEecCCCCCcE
Confidence            577888888888665432221    12222233333 366676         899999999999999999942    347


Q ss_pred             eEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 026720          121 KIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      +++|||.+........ .....+++.|+|||++.+ ..|+..+|+||+|++++++++|..||.+. .......+......
T Consensus       173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~  250 (351)
T 3c0i_A          173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYK  250 (351)
T ss_dssp             EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCC
T ss_pred             EEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCC
Confidence            9999999987654322 334578899999999874 44789999999999999999999999875 33334444443222


Q ss_pred             CCC---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTK---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+.   ...+..+..++..++..++.+|+++.+++++
T Consensus       251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            222   3456677888888999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.67  E-value=8.4e-18  Score=135.18  Aligned_cols=175  Identities=22%  Similarity=0.228  Sum_probs=123.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+...--..++...+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---------YLHGIGITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccccchHHEEEeCCCCEEEEEeec
Confidence            366677777776554321111222233333333 56666         88999999999999999994 57789999999


Q ss_pred             cccccCC---CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCC
Q 026720          128 VKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTK  202 (234)
Q Consensus       128 a~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~  202 (234)
                      +..+...   .......+++.|++||++.+...++..+|+||+|++++++++|..||.+................  +..
T Consensus       152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (323)
T 3tki_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW  231 (323)
T ss_dssp             CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTG
T ss_pred             cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcc
Confidence            8765321   12334678899999999976554577899999999999999999999877655444333332222  222


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+..+...++..++.+|+++++++++
T Consensus       232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            4456677778888999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.67  E-value=5.7e-17  Score=128.56  Aligned_cols=171  Identities=20%  Similarity=0.245  Sum_probs=123.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+-...++...+..|... +.|+.         ++|..+++|+|++|+|+++ .....++.|||.
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  157 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK---------HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI  157 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence            467788888898887654433444444444444 67777         8999999999999999999 466789999999


Q ss_pred             cccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC----C
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP----T  201 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~----~  201 (234)
                      +.......  ......+++.|++||.+.+ ..++..+|+||+|++++++++|+.||++....+...+.......+    .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV  236 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS
T ss_pred             ccccccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhc
Confidence            88764432  2233567889999999874 447889999999999999999999999988877766655432221    1


Q ss_pred             CCCCcchhhhhhhhccccCCCCCc-ccccc
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGV-NLLAV  230 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  230 (234)
                      ....+..+..++..++..++.+|+ +++++
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l  266 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEM  266 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHH
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHH
Confidence            245667788888888888888887 55544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.67  E-value=8.8e-17  Score=127.04  Aligned_cols=172  Identities=26%  Similarity=0.362  Sum_probs=130.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcc--cccCCcCCCcEEee--CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQG--YFHRDLKPSNLLVS--KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~--~~~~~l~p~~~~~~--~~~~~~~~  124 (234)
                      .+|..|+..|++.+..+-...++...+..|... +.|+.         ++|..+  ++|++++|+|+++.  ....+++|
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ---------FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHH---------HHHcCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence            577788888999887655444444444444444 66676         889888  99999999999994  56789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC--C
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT--K  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~--~  202 (234)
                      ||.+...... ......+++.|.+||++.  ..++...|+||+|++++++++|+.||.+................+.  .
T Consensus       176 fg~~~~~~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          176 LGLATLKRAS-FAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             TTGGGGCCTT-SBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred             CCCccccccc-ccccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence            9998654432 223356788999999886  3488999999999999999999999998777776665544333322  2


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+..+..++..|+..++.+|+++++++.+
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            3344577888888999999999999998864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.67  E-value=7.2e-17  Score=127.00  Aligned_cols=173  Identities=18%  Similarity=0.232  Sum_probs=128.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|.+.+..+-... ++...+..+.. ++.|+.         ++|+.+++|++++|+|+++ .....++.|||
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA---------YLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence            467778888888776543211 22223333333 366666         8899999999999999999 56788999999


Q ss_pred             ccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+........  .....++..|.+||.+.+ ..++..+|+||+|++++++++ |+.||.+....+....+......+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD  237 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred             CCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC
Confidence            9887644221  122344567999999863 447899999999999999998 999999877777666665555556667


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+..+..+...++...+.+|+++.+++.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~  266 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVC  266 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            77888999999999999999999998864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.67  E-value=2.3e-17  Score=135.16  Aligned_cols=173  Identities=19%  Similarity=0.316  Sum_probs=120.1

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|.+.+..+-.. .++...+..+.. ++.|+.         ++|..+++|+|++|+|+++ .....++.|||
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK---------YLSDMGYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence            57788888898887653211 011112222222 245555         8899999999999999999 45678999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .+........    .....++..|++||++.+ ..++..+|+||+|+++||+++ |+.||.+....+....+......+.
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~  271 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP  271 (373)
T ss_dssp             ---------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9887643211    111233557999999874 457899999999999999997 9999998888777777766666677


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..++..|+...+.+||++++++.
T Consensus       272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            7788889999999999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.66  E-value=1.8e-16  Score=125.56  Aligned_cols=173  Identities=20%  Similarity=0.214  Sum_probs=129.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...-...++...+..+... +.|+.         ++|+.+++|++++|+|+++. ....++.|||.
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ---------YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCChHhEEEcCCCCEEEEeccC
Confidence            467778888888775443222333333333333 66666         88999999999999999994 56789999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +....... ......+++.|.+||.+.+ ..++...|+||+|++++++++|..||.+....+....+... ..+.+..++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~  239 (294)
T 2rku_A          162 ATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKHIN  239 (294)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCTTSC
T ss_pred             ceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-cCCCccccC
Confidence            88764322 2334567888999999864 44788999999999999999999999988776665555432 223345667


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+...++..++.+|+++++++++
T Consensus       240 ~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          240 PVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            788889999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.66  E-value=4.5e-17  Score=128.25  Aligned_cols=173  Identities=17%  Similarity=0.292  Sum_probs=131.9

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...-. ..++...+..+... +.|+.         ++|+.+++|++++|+|+++. ....++.|||
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME---------YLESKQFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHH---------HHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence            4677788888887765321 11222233333333 56666         88999999999999999994 5678999999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+.......  ......+++.|.+||.+.+ ..++..+|+||+|++++++++ |+.||.+....+....+.+....+.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3gen_A          166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH  244 (283)
T ss_dssp             GGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             ccccccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC
Confidence            987653321  1223345567999999874 347899999999999999998 999999988888888887776666677


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++.+..+...|+...+.+|+++.+++.
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  273 (283)
T 3gen_A          245 LASEKVYTIMYSCWHEKADERPTFKILLS  273 (283)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            77888999999999999999999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.66  E-value=2.9e-17  Score=139.38  Aligned_cols=173  Identities=15%  Similarity=0.281  Sum_probs=128.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .+|..|+..|++.+..+-...  ++...+..+.. ++.|+.         ++|+.+++|+|++|.|+++ .....+++||
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME---------YLEKKNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCChhhEEECCCCcEEEeec
Confidence            477888888988876543211  11112222222 255666         8899999999999999999 4567899999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.++......  ......++..|+|||++.+ ..|+..+|+||+|+++||+++ |..||++....+....+......+.+
T Consensus       363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  441 (495)
T 1opk_A          363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  441 (495)
T ss_dssp             TCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred             ccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            9988764321  1223344567999999874 347899999999999999998 89999988776665555555555556


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..++..||..++.+|+++.++++
T Consensus       442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            778889999999999999999999998753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.66  E-value=3.4e-17  Score=131.75  Aligned_cols=174  Identities=23%  Similarity=0.253  Sum_probs=107.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC-C---eeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-G---VIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~-~---~~~~~~  124 (234)
                      .+|..|+..|++.+...--..+++..+..+... +.|+.         ++|+.+++|+|++|+|+++.. .   ..+++|
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  152 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS---------HMHDVGVVHRDLKPENLLFTDENDNLEIKIID  152 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEEEC----CEEEECC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCCeecCCCHHHEEEecCCCcccEEEec
Confidence            477888888888776543222333344444443 66676         899999999999999999942 2   689999


Q ss_pred             ccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHh
Q 026720          125 LGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS-------ADQIYKICQL  196 (234)
Q Consensus       125 ~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~-------~~~~~~i~~~  196 (234)
                      ||.+....... ......+++.|++||++.+ ..|+..+|+||+|++++++++|..||.+...       .+...++...
T Consensus       153 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             CTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cccceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            99988654322 2334567889999999864 4488999999999999999999999987543       2233333222


Q ss_pred             hCCCCCC---CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          197 IGSPTKD---SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       197 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ....+..   ..+..+..++..++..++.+|+++++++.+
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            2222222   345677778888999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.66  E-value=8.9e-17  Score=129.05  Aligned_cols=173  Identities=18%  Similarity=0.306  Sum_probs=125.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...- ..++...+..+... +.|+.         ++|..+++|+|++|+|+++. ....++.|||.
T Consensus       118 ~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~---------~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  187 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALA---------YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF  187 (321)
T ss_dssp             EEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEECCCCcEEEeeeee
Confidence            467778888888765321 01111222223222 45555         78989999999999999994 66789999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC--CCCC
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP--TKDS  204 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~--~~~~  204 (234)
                      +..+.... ......+++.|++||++.+ ..++..+|+||+|++++++++|+.||.+.........+.......  ....
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2c30_A          188 CAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK  266 (321)
T ss_dssp             CEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGG
T ss_pred             eeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCcccc
Confidence            88765432 2344578899999999864 457899999999999999999999999887766665554432211  1123


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+..+...++..++.+|+++++++.+
T Consensus       267 ~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          267 VSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            45677888888999999999999998764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.66  E-value=2.5e-16  Score=128.50  Aligned_cols=142  Identities=35%  Similarity=0.587  Sum_probs=115.2

Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC----CCCCcccCcccccccccccccC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEI  157 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~  157 (234)
                      +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.+.......    ......+++.|++||++.....
T Consensus       138 ~~aL~---------~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  208 (364)
T 3qyz_A          138 LRGLK---------YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG  208 (364)
T ss_dssp             HHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCS
T ss_pred             HHHHH---------HHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCC
Confidence            66666         89999999999999999994 5678999999988654321    1234578899999999766666


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC------------------------------CCcc
Q 026720          158 YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD------------------------------SWPL  207 (234)
Q Consensus       158 ~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~------------------------------~~~~  207 (234)
                      ++..+|+||+|++++++++|+.||++....+....+....+.|...                              ..+.
T Consensus       209 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (364)
T 3qyz_A          209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS  288 (364)
T ss_dssp             CSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCH
T ss_pred             CCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCH
Confidence            8999999999999999999999999999999888888777766532                              2344


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+...+...++.+|+++++++.+
T Consensus       289 ~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          289 KALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            56667778889999999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.66  E-value=6.7e-17  Score=126.74  Aligned_cols=173  Identities=20%  Similarity=0.228  Sum_probs=119.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .++..|+..+.+.+...-...++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.|||.
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~  157 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---------YCHRHMVVHRDLKPENVLLDAHMNAKIADFGL  157 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence            466677777788776543323333333333333 66666         88999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +.............+++.|.+||.+.+....+...|+||+|++++++++|..||.+.........+... ..+.+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  236 (276)
T 2h6d_A          158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-VFYIPEYLNR  236 (276)
T ss_dssp             GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTTSCH
T ss_pred             ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-cccCchhcCH
Confidence            887655333344567888999999875444467899999999999999999999987666555544432 2333455677


Q ss_pred             hhhhhhhhccccCCCCCccccccCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..+...++..++.+|++++++++
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHh
Confidence            8888899999999999999998865

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.66  E-value=2.4e-17  Score=129.52  Aligned_cols=174  Identities=20%  Similarity=0.312  Sum_probs=128.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcc-----cccCCcCCCcEEee-CC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQG-----YFHRDLKPSNLLVS-KG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~-----~~~~~l~p~~~~~~-~~  118 (234)
                      .+|..|+..|.+.+...-...    ++...+..+... +.|+.         ++|..+     ++|++++|+|+++. ..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK---------ECHRRSDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH---------HHHHHC------CCCCCSGGGEEECSSS
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH---------HHhcccCCCCeeEEeccchhhEEEcCCC
Confidence            577788888888877554322    222223333322 55555         788887     99999999999994 56


Q ss_pred             eeeEeeccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          119 VIKIGDLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ..++.|||.+........ .....+++.|.+||.+.+ ..++...|+||+|++++++++|..||.+....+....+....
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~  232 (279)
T 2w5a_A          154 NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK  232 (279)
T ss_dssp             CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             CEEEecCchheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence            789999998876543211 112356778999999874 347889999999999999999999999887777666666554


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+.+..++..+..+...++...+.+|+++++++.+
T Consensus       233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (279)
T 2w5a_A          233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  268 (279)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            445556778889999999999999999999999865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.66  E-value=2.1e-16  Score=130.18  Aligned_cols=137  Identities=20%  Similarity=0.314  Sum_probs=103.4

Q ss_pred             HhhhcccccCCcCCCcEEeeCCeeeEeeccccccccCCC---CCCCcccCccccccccccc----------ccCCCCcch
Q 026720           97 SLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLF----------SEIYGPEVD  163 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~----------~~~~~~~~d  163 (234)
                      ++|..+++|+|++|+|+++.....+++|||.+..+....   ......+++.|+|||++.+          ...|+..+|
T Consensus       170 ~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  249 (390)
T 2zmd_A          170 TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD  249 (390)
T ss_dssp             HHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHH
T ss_pred             HHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhh
Confidence            889999999999999999977889999999998764322   2234578999999999864          134788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhhCC-CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          164 KWAMGAIMFEMLSFGILFPGKSSA-DQIYKICQLIGS-PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       164 ~~s~g~~l~e~~~~~~~f~~~~~~-~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +||+|++++|+++|..||.+.... ..+..+...... +.+...+..+..++..|+..++.+|+++.+++.+
T Consensus       250 iwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          250 VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            999999999999999999876543 344444432222 2233445678888899999999999999998764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.66  E-value=4.7e-18  Score=139.46  Aligned_cols=165  Identities=16%  Similarity=0.198  Sum_probs=119.1

Q ss_pred             HHHHHhhcCChHHHHHHHHhhcc-------CccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeee
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMRE-------KNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIK  121 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~-------~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~  121 (234)
                      ++.+|+ .|++.+...-...+++       ..+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+
T Consensus       177 lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDikp~NIll~~~~~~k  246 (377)
T 3byv_A          177 FLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA---------SLHHYGLVHTYLRPVDIVLDQRGGVF  246 (377)
T ss_dssp             EEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred             EEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEcCCCCEE
Confidence            555566 4788777665555554       222223333 66677         89999999999999999994 67889


Q ss_pred             EeeccccccccCCCCCCCcccCcccccccccccc----------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 026720          122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS----------EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY  191 (234)
Q Consensus       122 ~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~----------~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~  191 (234)
                      ++|||.+.....  ......+ +.|+|||++.+.          ..|+..+|+||+|++++|+++|+.||.+........
T Consensus       247 L~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~  323 (377)
T 3byv_A          247 LTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE  323 (377)
T ss_dssp             ECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG
T ss_pred             EEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh
Confidence            999999986443  2233456 889999998754          258999999999999999999999998765443332


Q ss_pred             HHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          192 KICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       192 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+.     .....++..+..++..|+..++.+|+++.+++++
T Consensus       324 ~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          324 WIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             GGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             hhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            222     1234667788889999999999999999998764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.66  E-value=2e-17  Score=132.98  Aligned_cols=173  Identities=19%  Similarity=0.280  Sum_probs=125.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----------------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----------------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----------------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+|..|+..|++.+...-...                ++...+..+... +.|+.         ++|..+++|++++|+|
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~dlkp~N  172 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD---------YLSQKQFIHRDLAARN  172 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCccce
Confidence            467778888888776542211                111122223322 55666         8899999999999999


Q ss_pred             EEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 026720          113 LLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQI  190 (234)
Q Consensus       113 ~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~  190 (234)
                      +++. ....++.|||.+.............++..|.+||++.+ ..++..+|+||+|++++++++ |..||.+....+..
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~  251 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  251 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             EEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence            9994 56789999999875443322233345677999999864 347899999999999999998 99999988777766


Q ss_pred             HHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          191 YKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       191 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+......+.+..++..+..+...++...+.+|+++++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  293 (327)
T 1fvr_A          252 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  293 (327)
T ss_dssp             HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            666554444555677788889999999999999999998764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.66  E-value=2.4e-16  Score=128.41  Aligned_cols=137  Identities=28%  Similarity=0.477  Sum_probs=104.8

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|+|+++. ....+++|||.+.............+++.|.+||++.+...++..+|+||+|+++++++
T Consensus       149 ~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  228 (362)
T 3pg1_A          149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF  228 (362)
T ss_dssp             HHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred             HHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence            89999999999999999994 67789999999986555444445677888999999876566899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCC-------------------------------CCcchhhhhhhhccccCCCCC
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKD-------------------------------SWPLGIQLASNLNWKLPQMGG  224 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~~  224 (234)
                      +|+.||.+....+.+.++.+..+.|...                               ..+..+..+...++..++.+|
T Consensus       229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  308 (362)
T 3pg1_A          229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR  308 (362)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence            9999999999999998888877665422                               224456677888899999999


Q ss_pred             ccccccCCC
Q 026720          225 VNLLAVMPS  233 (234)
Q Consensus       225 ~~~~~~~~~  233 (234)
                      +++++++.+
T Consensus       309 pt~~ell~h  317 (362)
T 3pg1_A          309 ISTEQALRH  317 (362)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHHcC
Confidence            999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.66  E-value=4.9e-17  Score=127.15  Aligned_cols=173  Identities=21%  Similarity=0.316  Sum_probs=130.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|++.+..+-... ++...+..+.. ++.|+.         ++|..+++|++++|+|+++ .....++.|||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  151 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA---------YLEEACVIHRDLAARNCLVGENQVIKVSDFG  151 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHH---------HHHhCCeecCCcchheEEEcCCCCEEecccc
Confidence            467788888888776432111 11122222322 256666         8899999999999999999 45678999999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+.......  ......++..|.+||.+.+ ..++..+|+||+|++++++++ |+.||.+....+....+......+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (269)
T 4hcu_A          152 MTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR  230 (269)
T ss_dssp             GGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             ccccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCC
Confidence            988654321  1223345667999999864 447899999999999999999 999999988888887777766666677


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+..+..+...++...+.+|+++.+++.
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~  259 (269)
T 4hcu_A          231 LASTHVYQIMNHCWRERPEDRPAFSRLLR  259 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            77888999999999999999999998864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.66  E-value=5.4e-17  Score=129.52  Aligned_cols=173  Identities=19%  Similarity=0.266  Sum_probs=127.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHh------------------------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL------------------------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYF  104 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~------------------------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~  104 (234)
                      .++..|+..|.+.+...-...                        ++...+..+... +.|+.         ++|..+++
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~iv  172 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ---------YLAEMKLV  172 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHH---------HHHHTTEE
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHH---------HHHHCCCc
Confidence            467778888888877654322                        111122222222 55555         88999999


Q ss_pred             cCCcCCCcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCC
Q 026720          105 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGI  179 (234)
Q Consensus       105 ~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~  179 (234)
                      |++++|+|+++. ....+++|||.+.......   ......+++.|.+||.+.+ ..++..+|+||+|++++++++ |..
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999995 5678999999988664322   1222345667999999864 447899999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          180 LFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       180 ~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ||++.........+......+.+..+++.+..+...++..++.+|+++.+++.
T Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99988776665555544444555677888999999999999999999998764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.66  E-value=3.1e-17  Score=140.38  Aligned_cols=173  Identities=21%  Similarity=0.318  Sum_probs=131.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|++.+..+-...  +....+..+... +.|+.         ++|..+++|+|++|.|+++. ....+++||
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~---------~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA---------YVERMNYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeCCCCCHhhEEEcCCCcEEEccc
Confidence            477888888888876543211  222233333333 55666         88999999999999999994 567899999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.+..+....  ......++..|++||++.+ ..|+..+|+||+|+++||+++ |+.||++....+....+.+....+.+
T Consensus       408 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~  486 (535)
T 2h8h_A          408 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP  486 (535)
T ss_dssp             TSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             ccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            9988654311  1122344567999999874 448899999999999999999 89999998888877777666555666


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+++.+..++..||...+.+|++|++|+.
T Consensus       487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          487 PECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            778888999999999999999999998753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.66  E-value=2.4e-17  Score=135.06  Aligned_cols=173  Identities=17%  Similarity=0.239  Sum_probs=120.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+..+-... +....+..+.. ++.|+.         ++|+.+++|+|++|+|+++. ....++.|||
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK---------FLASKKFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHH---------HHHHCCEecCccchheEEECCCCCEEEeecc
Confidence            477888888888776431110 11112233332 356666         88999999999999999994 5678999999


Q ss_pred             ccccccCCC-----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCC
Q 026720          127 MVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       127 ~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      .++.+....     ......++..|++||.+.+ ..++..+|+||+|+++||+++ +.+||++....+....+.+....+
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~  316 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL  316 (373)
T ss_dssp             --------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC
Confidence            998654321     1122345567999999873 457899999999999999999 778998877777666666655555


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..++..+..++..||...+.+|+++.++++
T Consensus       317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            66677888999999999999999999998864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.65  E-value=5.1e-17  Score=131.60  Aligned_cols=174  Identities=22%  Similarity=0.258  Sum_probs=123.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC-----CeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-----GVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~-----~~~~~~  123 (234)
                      .+|.+|+..|++.+...--..+++..+..+... +.|+.         ++|+.+++|+|++|+|+++..     ...+++
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~---------~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~  162 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE---------YLHAQGVVHRDLKPSNILYVDESGNPESIRIC  162 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence            577788888888765432222333333344433 66666         899999999999999999832     247999


Q ss_pred             eccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhhCC
Q 026720          124 DLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK---SSADQIYKICQLIGS  199 (234)
Q Consensus       124 ~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~---~~~~~~~~i~~~~~~  199 (234)
                      |||.+....... ......+++.|+|||++.+ ..|+..+|+||+|++++++++|..||.+.   ...+....+......
T Consensus       163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS  241 (342)
T ss_dssp             CCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred             ECCCcccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence            999998765432 2334567889999999864 33788999999999999999999999863   233333344332222


Q ss_pred             CCC---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTK---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...   ...+..+..+...++..++.+|+++++++.+
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            222   3455677778888999999999999998864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.65  E-value=1.2e-16  Score=126.08  Aligned_cols=173  Identities=21%  Similarity=0.208  Sum_probs=122.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~  120 (234)
                      .+|..|+..|.+.+...-...    ++...+..+... +.|+.         ++|+.+++|++++|+|+++.    ....
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivH~dikp~NIl~~~~~~~~~~  166 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA---------YFHSQHVVHKDLKPENILFQDTSPHSPI  166 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCEEECCCCHHHEEEecCCCCCCE
Confidence            567778888888776543221    222233333333 66666         88999999999999999993    2468


Q ss_pred             eEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 026720          121 KIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      ++.|||.+.............+++.|.+||++.  ..++..+|+||+|++++++++|..||.+....+....+.......
T Consensus       167 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  244 (285)
T 3is5_A          167 KIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY  244 (285)
T ss_dssp             EECCCCCCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EEEeeecceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence            999999998765443344556788999999985  347899999999999999999999999887776665554433322


Q ss_pred             C--CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          201 T--KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       201 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .  ....+..+..+...++..++.+|+++.+++.+
T Consensus       245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2  23356677788888999999999999998764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.65  E-value=8.3e-17  Score=126.50  Aligned_cols=172  Identities=24%  Similarity=0.306  Sum_probs=126.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...-...++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.|||.
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS---------YCHSKRVIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHTTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCEecccCChHhEEEcCCCCEEEEeccc
Confidence            466677777777766544333333344444333 66677         8999999999999999999 466789999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +...... ......+++.|.+||.+.+ ..++...|+||+|++++++++|..||.+....+....+.. ...+.+..++.
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (279)
T 3fdn_A          156 SVHAPSS-RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTE  232 (279)
T ss_dssp             ESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-TCCCCCTTSCH
T ss_pred             cccCCcc-cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-CCCCCCCcCCH
Confidence            7654432 2234567888999999874 4578899999999999999999999998877766655544 33344456778


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..++..++...+.+|+++++++++
T Consensus       233 ~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          233 GARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhhC
Confidence            88899999999999999999998753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.65  E-value=1e-16  Score=130.45  Aligned_cols=175  Identities=19%  Similarity=0.252  Sum_probs=124.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...-...++...+..+.. ++.|+.         ++|..+++|+|++|+|+++ .....++.|||.
T Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~---------~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE---------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            47888888888887655433344334444443 366777         8999999999999999999 466789999999


Q ss_pred             cccccCCC--CCCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCCC
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---ADQIYKICQLIGSPT  201 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~---~~~~~~i~~~~~~~~  201 (234)
                      +.......  ......+++.|++||++.+. ..++..+|+||+|++++|+++|..||.....   .....+.......+.
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  285 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  285 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC
Confidence            87653221  12335688899999998743 3468899999999999999999999985432   222222222223334


Q ss_pred             CCCCcchhhhhhhhccccCCCCCc-----cccccCCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGV-----NLLAVMPS  233 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  233 (234)
                      +..++..+..++..++..++.+|+     ++++++++
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            456667788888899999999998     77777653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.65  E-value=3.7e-17  Score=130.60  Aligned_cols=172  Identities=19%  Similarity=0.251  Sum_probs=123.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+-...++...+..+... +.|+.         ++|..+++|++++|+|+++. ....+++|||.
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN---------FSHQNGIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            578889988998887654333333344444333 66676         89999999999999999994 66789999999


Q ss_pred             cccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          128 VKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       128 a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      +..+....    ......+++.|++||.+.+ ..++..+|+||+|++++++++|+.||.+....+...........+.. 
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  241 (311)
T ss_dssp             C------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence            88654321    1223457889999999874 45789999999999999999999999998888777776654443332 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                        ..++..+..++..++..++.+|++..+.+
T Consensus       242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l  272 (311)
T 3ork_A          242 RHEGLSADLDAVVLKALAKNPENRYQTAAEM  272 (311)
T ss_dssp             HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             ccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence              34667788888889999999998776654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.65  E-value=4.4e-16  Score=127.44  Aligned_cols=135  Identities=36%  Similarity=0.540  Sum_probs=108.0

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|+|+++. ....+++|||.+......  .....+++.|+|||++.+...++..+|+||+|+++++++
T Consensus       159 ~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  236 (371)
T 4exu_A          159 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML  236 (371)
T ss_dssp             HHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             HHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH
Confidence            88999999999999999994 567899999999876542  344577889999999876566899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCCC------------------------------CCcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTKD------------------------------SWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|+.||.+....+.+..+.+..+.|...                              ..+..+..++..++..++.+|+
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  316 (371)
T 4exu_A          237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL  316 (371)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC
Confidence            9999999999999888888766655321                              2345667777888899999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++++
T Consensus       317 t~~ell~h  324 (371)
T 4exu_A          317 TAAQALTH  324 (371)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.65  E-value=8.7e-17  Score=126.53  Aligned_cols=174  Identities=19%  Similarity=0.255  Sum_probs=124.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC----eeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG----VIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~----~~~~~  123 (234)
                      .++..|+..+.+.+...--..++...+..+... +.|+.         ++|..+++|++++|+|+++. ..    ..++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH---------YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence            466777777888776543222333333333333 56666         88999999999999999994 33    57999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      |||.+.............+++.|.+||++.+ ..++...|+||+|++++++++|..||.+....+....+.......+. 
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE  233 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence            9999887655434444567889999999864 44789999999999999999999999988877766665443332221 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ...++.+..+...++..++.+|+++.+++.+
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence              3456677888888999999999999988753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.65  E-value=1.8e-16  Score=135.36  Aligned_cols=168  Identities=23%  Similarity=0.343  Sum_probs=122.5

Q ss_pred             HHHHHHhhcCChHHHHHHHH----hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN----LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~----~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .+|..|+..|++.....-..    .+++..+..|... +.|+.         ++|+.+++|++++|+|+++ ..+..++.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~---------~LH~~gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE---------HLHQRNIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHH---------HHHHcCCcccCCChHHEEEeCCCCEEEe
Confidence            57788888888876543211    1222233444443 66777         8999999999999999999 46789999


Q ss_pred             eccccccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhhC
Q 026720          124 DLGMVKEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS----ADQIYKICQLIG  198 (234)
Q Consensus       124 ~~~~a~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~----~~~~~~i~~~~~  198 (234)
                      |||.+..+..... .....+++.|+|||++.+ ..|+..+|+||+|+++|||++|..||.+...    ......+... .
T Consensus       332 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~  409 (543)
T 3c4z_A          332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-A  409 (543)
T ss_dssp             CCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-C
T ss_pred             ecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-c
Confidence            9999987654332 334578999999999974 4589999999999999999999999987632    2333334332 2


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCcccc
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLL  228 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (234)
                      ..-+..++..+..++..++...+.+|+++.
T Consensus       410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          410 VTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence            222345677788888888888889998763

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.65  E-value=6.5e-17  Score=128.13  Aligned_cols=172  Identities=17%  Similarity=0.163  Sum_probs=123.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC-----eee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG-----VIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~-----~~~  121 (234)
                      .++..|+ .|++.+..+.... ++...+..+... +.|+.         ++|+.+++|++++|+|+++. ..     ..+
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ---------SIHEKSLVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHH---------HHHhCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence            4667777 7778776543221 222333333333 56666         88999999999999999994 33     289


Q ss_pred             EeeccccccccCCC--------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHH
Q 026720          122 IGDLGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS---SADQI  190 (234)
Q Consensus       122 ~~~~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~---~~~~~  190 (234)
                      ++|||.+.......        ......+++.|.|||++.+ ..++..+|+||+|++++++++|+.||.+..   .....
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            99999998765432        1234567889999999874 447899999999999999999999999743   33344


Q ss_pred             HHHHHhhCCCC----CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          191 YKICQLIGSPT----KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       191 ~~i~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+......+.    ...++..+..+...|+..++.+||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            44433222111    1367788899999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.65  E-value=3.4e-16  Score=126.77  Aligned_cols=143  Identities=21%  Similarity=0.316  Sum_probs=105.0

Q ss_pred             HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeeccccccccCCC---CCCCcccCccccccccccc----
Q 026720           82 MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLF----  154 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~----  154 (234)
                      ++.|+.         ++|..+++|+|++|+|+++.....+++|||.+..+....   ......+++.|+|||++.+    
T Consensus       117 i~~al~---------~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  187 (343)
T 3dbq_A          117 MLEAVH---------TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS  187 (343)
T ss_dssp             HHHHHH---------HHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC--
T ss_pred             HHHHHH---------HHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccc
Confidence            366676         899999999999999999988889999999998764322   1234578899999999853    


Q ss_pred             ------ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCC-CCCCCCcchhhhhhhhccccCCCCCcc
Q 026720          155 ------SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD-QIYKICQLIGS-PTKDSWPLGIQLASNLNWKLPQMGGVN  226 (234)
Q Consensus       155 ------~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~-~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (234)
                            ...|+..+|+||+|++++++++|+.||.+..... ....+...... ..+...+..+..+...|+..++.+|++
T Consensus       188 ~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt  267 (343)
T 3dbq_A          188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS  267 (343)
T ss_dssp             ---------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             ccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCC
Confidence                  2457889999999999999999999998765443 33333322222 223344557788888999999999999


Q ss_pred             ccccCCC
Q 026720          227 LLAVMPS  233 (234)
Q Consensus       227 ~~~~~~~  233 (234)
                      +.+++.+
T Consensus       268 ~~e~l~h  274 (343)
T 3dbq_A          268 IPELLAH  274 (343)
T ss_dssp             HHHHHTS
T ss_pred             HHHHHhC
Confidence            9998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.65  E-value=4.4e-17  Score=132.54  Aligned_cols=135  Identities=20%  Similarity=0.316  Sum_probs=106.9

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|+|++|+|+++ .....+++|||.+..+....   ......++..|+|||++.+ ..|+..+|+||+|++++
T Consensus       208 ~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~  286 (359)
T 3vhe_A          208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLW  286 (359)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred             HHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHH
Confidence            8899999999999999999 46678999999998664322   1223456678999999874 45889999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHh-hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQL-IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |+++ |..||++....+........ ...+.+..++..+..+...|+..++.+|+++++++.
T Consensus       287 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  348 (359)
T 3vhe_A          287 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  348 (359)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            9998 99999987765555554443 334455667788888999999999999999998864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.65  E-value=1.9e-16  Score=124.77  Aligned_cols=172  Identities=22%  Similarity=0.234  Sum_probs=128.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...-...++...+..+... +.|+.         ++|..+++|++++|+|+++ .....+++|||.
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH---------YCHERKVIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCceecCCCHHHEEEcCCCCEEEecccc
Confidence            456667777777665543322333333333333 66666         8899999999999999999 467789999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +...... ......+++.|.+||.+.+ ..++...|+||+|++++++++|..||.+....+....+.... .+.+..++.
T Consensus       161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  237 (284)
T 2vgo_A          161 SVHAPSL-RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSD  237 (284)
T ss_dssp             CEECSSS-CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCH
T ss_pred             cccCccc-ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCH
Confidence            8765432 2334567889999999874 447899999999999999999999999887777666655432 223345677


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..++..++...+.+|+++++++++
T Consensus       238 ~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          238 GSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            88889999999999999999998764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.65  E-value=1.5e-16  Score=139.16  Aligned_cols=173  Identities=20%  Similarity=0.292  Sum_probs=130.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+..+.-. .++...+..|... +.|+.         ++|..+++|+|++|+|+++ .....+++|||
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA---------YLESKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence            47788888899887654311 1222233333333 66666         8999999999999999999 47789999999


Q ss_pred             ccccccCCCCC--CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNLPC--TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+.........  ....+++.|+|||++.+ ..|+..+|+||+|+++||+++ |..||.+....+....+......+.+.
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  615 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  615 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            99876543211  12344568999999864 458899999999999999997 899999988888877776665556667


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .++..+..++..|+..++.+|+++.+++.
T Consensus       616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          616 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            77888999999999999999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.65  E-value=1.3e-16  Score=126.81  Aligned_cols=173  Identities=16%  Similarity=0.268  Sum_probs=126.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+..+- ..++...+..+.. ++.|+.         ++|..+++|++++|+|+++ .....++.|||.
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  165 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD---------YLHSEKKIHRDIKAANVLLSEHGEVKLADFGV  165 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHH---------HHHHCCCccCCCChheEEECCCCCEEEeeccc
Confidence            466667777777664321 0111112222222 255555         8898899999999999999 456789999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      +....... ......+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+.........+.+.........++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (303)
T 3a7i_A          166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYS  244 (303)
T ss_dssp             CEECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCC
T ss_pred             ceecCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccC
Confidence            87765432 2334567888999999874 447889999999999999999999999887776665555443333445677


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..+...|+...+.+|+++++++.+
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            888999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.65  E-value=1.3e-17  Score=136.55  Aligned_cols=172  Identities=13%  Similarity=0.173  Sum_probs=125.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccc-------cH-HHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQ-------SW-TIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~-------~~-~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~  120 (234)
                      .+|.+|+. |++.+...-..........       .+ ..++.|+.         ++|+.+++|+|++|+|+++ ..+..
T Consensus       164 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~---------~LH~~~ivHrDikp~NIll~~~~~~  233 (371)
T 3q60_A          164 LLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA---------NLQSKGLVHGHFTPDNLFIMPDGRL  233 (371)
T ss_dssp             EEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH---------HHHHTTEEETTCSGGGEEECTTSCE
T ss_pred             EEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHH---------HHHHCCCccCcCCHHHEEECCCCCE
Confidence            57778888 8888877665443333333       33 34578888         9999999999999999999 45689


Q ss_pred             eEeeccccccccCCCCCCCcccCccccccccccc-ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH----
Q 026720          121 KIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF-SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQI--YKI----  193 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~--~~i----  193 (234)
                      +++|||.+.......  ....+++.|+|||++.+ ...|+..+|+||+|++++|+++|+.||.+.......  ...    
T Consensus       234 kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  311 (371)
T 3q60_A          234 MLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV  311 (371)
T ss_dssp             EECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTS
T ss_pred             EEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhh
Confidence            999999998765421  13445588999999964 145899999999999999999999999876322110  000    


Q ss_pred             --HHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          194 --CQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       194 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        -.....+.....+..+..++..++..++.+|+++.+++.+
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0011112224567788888899999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.65  E-value=1.1e-16  Score=129.24  Aligned_cols=173  Identities=18%  Similarity=0.308  Sum_probs=123.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|.+.+...-.. .++...+..+... +.|+.         ++|..+++|++++|+|+++. ....+++|||
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK---------YLANMNYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence            46777888888877643211 1222222233222 55566         88998999999999999994 5678999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .+........    .....++..|.+||++.+ ..++..+|+||+|++++|+++ |..||.+....+....+.+....+.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  271 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  271 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             cchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence            9887643211    112234567999999863 457889999999999999998 9999998887777766666555566


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..++..|+...+.+|+++.++++
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6778889999999999999999999988753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.64  E-value=9.7e-17  Score=127.10  Aligned_cols=173  Identities=20%  Similarity=0.310  Sum_probs=121.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...-... ++...+..+... +.|+.         ++|+.+++|++++|+|+++ .....++.|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME---------YLGTKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHH---------HHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            478889999999887654222 333333334333 66666         8999999999999999999 46789999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---------------
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---------------  187 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~---------------  187 (234)
                      .+........    .....++..|.|||.+.+ ..++..+|+||+|++++++++|..|+......               
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            9887643211    122334566999999874 44789999999999999999999888643111               


Q ss_pred             -HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 -DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       .....+......+.+..++..+..++..|+...+.+||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             111112223334556678889999999999999999999998763

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.64  E-value=4e-17  Score=130.85  Aligned_cols=174  Identities=18%  Similarity=0.301  Sum_probs=122.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh---hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe----e-CCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL---MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----S-KGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~---m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~-~~~~  120 (234)
                      .+|..|+..|++.+..+-...   ++...+..+... +.|+.         ++|+.+++|+|++|+|+++    . ....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN---------HLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHH---------HHHHCCEecCCCCHHHEEEeccCCCCceE
Confidence            478889999998887553222   222333333333 66666         8899999999999999987    2 2357


Q ss_pred             eEeeccccccccCCCCCCCcccCccccccccccc-------ccCCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHH
Q 026720          121 KIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF-------SEIYGPEVDKWAMGAIMFEMLSFGILFPGKS----SADQ  189 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~----~~~~  189 (234)
                      +++|||.+.............+++.|.+||++..       ...|+..+|+||+|++++|+++|..||.+..    ..+.
T Consensus       156 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  235 (319)
T 4euu_A          156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (319)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred             EEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence            8999999988766544555678899999998752       2457899999999999999999999997533    3444


Q ss_pred             HHHHHHhhCCC--------------------CC----CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQLIGSP--------------------TK----DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~~~~~~--------------------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++.......                    ..    ...+..+..+...++..++.+|++++++++
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~  302 (319)
T 4euu_A          236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (319)
T ss_dssp             HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence            44444432210                    00    011234555667788999999999998875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.64  E-value=7.2e-17  Score=126.78  Aligned_cols=171  Identities=20%  Similarity=0.323  Sum_probs=122.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-...  ++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~~l~Df  161 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME---------YLEGNNFVHRDLAARNVLVSEDNVAKVSDF  161 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHH---------HHHhCCccccCCCcceEEEeCCCcEEEeec
Confidence            477778888888776543322  222333333333 66666         88999999999999999994 667899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.+.......  ....+++.|.+||.+.+ ..++..+|+||+|++++++++ |..||++....+....+.+....+.+..
T Consensus       162 g~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (278)
T 1byg_A          162 GLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  238 (278)
T ss_dssp             CC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred             cccccccccc--cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCccc
Confidence            9887654421  22345678999999863 447899999999999999998 9999998776666655555444455567


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++..+..++..|+..++.+|+++.++++
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          239 CPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            7888999999999999999999998764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.64  E-value=7.6e-17  Score=127.62  Aligned_cols=172  Identities=17%  Similarity=0.201  Sum_probs=122.9

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~  123 (234)
                      .++..|+ .|++.+...... .++...+..+... +.|+.         ++|+.+++|++++|+|+++    .....+++
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE---------YIHSKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeCCCCHHHeEEecCCCCCeEEEe
Confidence            4677788 777777654221 1222233333333 66666         8999999999999999999    35678999


Q ss_pred             eccccccccCCCC--------CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHH
Q 026720          124 DLGMVKEIDSNLP--------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---ADQIYK  192 (234)
Q Consensus       124 ~~~~a~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~---~~~~~~  192 (234)
                      |||.+........        .....+++.|.+||.+.+ ..++..+|+||+|++++++++|+.||.+...   ......
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence            9999887654321        234567889999999874 3478999999999999999999999987432   223333


Q ss_pred             HHHh-hCCCC---CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          193 ICQL-IGSPT---KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       193 i~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.+. ...+.   ...++..+..+...|+..++.+||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            3332 22221   2567788899999999999999999988753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.64  E-value=1.6e-16  Score=127.89  Aligned_cols=171  Identities=22%  Similarity=0.310  Sum_probs=121.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----------
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----------  116 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----------  116 (234)
                      .+|..|+ .|.+.+...-...  ++...+..+... +.|+.         ++|..+++|+|++|+|+++.          
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN---------FLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHH---------HHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            4666677 5666554332111  111222333333 66666         88999999999999999984          


Q ss_pred             ----------CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 026720          117 ----------KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS  186 (234)
Q Consensus       117 ----------~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~  186 (234)
                                ....+++|||.+......  .....+++.|++||++.+ ..++..+|+||+|++++|+++|..||++...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      234789999998765442  334577889999999874 4478999999999999999999999999888


Q ss_pred             HHHHHHHHHhhCCCCCC----------------CC---------------------------cchhhhhhhhccccCCCC
Q 026720          187 ADQIYKICQLIGSPTKD----------------SW---------------------------PLGIQLASNLNWKLPQMG  223 (234)
Q Consensus       187 ~~~~~~i~~~~~~~~~~----------------~~---------------------------~~~~~~~~~~~~~~~~~~  223 (234)
                      .+....+.+..+.++..                .|                           ++.+..+...++..++.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            77776666555433211                11                           234556778889999999


Q ss_pred             CccccccCCC
Q 026720          224 GVNLLAVMPS  233 (234)
Q Consensus       224 ~~~~~~~~~~  233 (234)
                      |+++.+++++
T Consensus       320 Rpt~~ell~h  329 (339)
T 1z57_A          320 RITLREALKH  329 (339)
T ss_dssp             SCCHHHHTTS
T ss_pred             ccCHHHHhcC
Confidence            9999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.64  E-value=1.2e-15  Score=121.10  Aligned_cols=174  Identities=24%  Similarity=0.257  Sum_probs=124.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+... ...++...+..+.. ++.|+.         ++|..+++|+|++|+|+++ .....++.|||.
T Consensus       114 ~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  183 (298)
T 2zv2_A          114 YMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIE---------YLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV  183 (298)
T ss_dssp             EEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHEEECCCCCEEEecCCC
Confidence            46667777776654210 00111112222322 255666         8899999999999999999 456789999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-CCCCC
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEI--YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG-SPTKD  203 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~--~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~-~~~~~  203 (234)
                      +....... ......+++.|+|||.+.+...  ++..+|+||+|++++++++|..||.+.........+..... .|...
T Consensus       184 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  263 (298)
T 2zv2_A          184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP  263 (298)
T ss_dssp             CEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSS
T ss_pred             ccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCcc
Confidence            88765432 1234578889999999864432  36778999999999999999999998776665555544322 34445


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++.+..++..++..++.+|+++.+++.+
T Consensus       264 ~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          264 DIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            677888899999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.64  E-value=3.8e-17  Score=132.00  Aligned_cols=167  Identities=17%  Similarity=0.171  Sum_probs=119.4

Q ss_pred             HHHHHhhcC-ChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           51 LVEMYSKCG-HVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        51 li~~~~~~g-~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      +|..|+..| ++.+...-...++...+..+.. ++.|+.         ++|..+++|+|++|+|+++. ....++.|||.
T Consensus       106 lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~---------~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG---------YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            455555555 5555432211222223333333 366666         88999999999999999994 56789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +..+..........+++.|++||++.+...++..+|+||+|++++++++|..||.+...      .. ......+..++.
T Consensus       177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~~~~~~~~~  249 (335)
T 3dls_A          177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV-EAAIHPPYLVSK  249 (335)
T ss_dssp             CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT-TTCCCCSSCCCH
T ss_pred             ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH-hhccCCCcccCH
Confidence            98776554445567889999999987655457889999999999999999999976321      11 112233445677


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..++..++..++.+|+++++++.+
T Consensus       250 ~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          250 ELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            88888888999999999999988753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.64  E-value=5.2e-16  Score=127.48  Aligned_cols=102  Identities=37%  Similarity=0.658  Sum_probs=85.5

Q ss_pred             Hhh--hcccccCCcCCCcEEee---CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHH
Q 026720           97 SLH--RQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~--~~~~~~~~l~p~~~~~~---~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l  171 (234)
                      ++|  ..+++|+|++|+|+++.   ....+++|||.+......  .....+++.|+|||++.+. .|+..+|+||+|+++
T Consensus       172 ~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il  248 (382)
T 2vx3_A          172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCIL  248 (382)
T ss_dssp             HHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHH
T ss_pred             HhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCC-CCCcHHHHHHHHHHH
Confidence            555  46799999999999993   456899999999877543  3446788999999999754 489999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          172 FEMLSFGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       172 ~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      +|+++|+.||.+....+.+.++.+..+.|+
T Consensus       249 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          249 VEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999999999999999988888766543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.64  E-value=9.6e-17  Score=126.95  Aligned_cols=173  Identities=20%  Similarity=0.283  Sum_probs=125.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+..+-...++...+..+... +.|+.         ++|+.+++|++++|+|+++ .....++.|||.
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK---------YLEESNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHH---------HHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence            366677777777766543222333333333333 56666         8899999999999999999 567889999999


Q ss_pred             cccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +........    .....++..|.+||.+.+. .++..+|+||+|++++++++ |..||.+....+....+......+.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP  242 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            887643221    1112345679999998643 36789999999999999998 99999988776666555544334445


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..++..|+..++.+|+++.+++.
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            677888999999999999999999998763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.64  E-value=1.1e-16  Score=129.11  Aligned_cols=173  Identities=21%  Similarity=0.341  Sum_probs=127.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----------------hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----------------MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----------------m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+|..|+..|.+.+...-...                ++...+..+.. ++.|+.         ++|..+++|++++|+|
T Consensus       117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME---------YLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGG
T ss_pred             EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHH---------HHHhCCeeCCCCccce
Confidence            467778888888876543211                11111222222 245555         7898999999999999


Q ss_pred             EEe-eCCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLV-SKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~-~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++ .....+++|||.+.......   ......+++.|.+||++.+ ..++..+|+||+|++++++++ |..||++....
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            999 46778999999988764422   1122345667999999864 347899999999999999999 99999988777


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....+......+.+..++..+..++..|+..++.+|+++.+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            766666665555556677888889999999999999999998864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.64  E-value=1.5e-16  Score=127.48  Aligned_cols=173  Identities=17%  Similarity=0.267  Sum_probs=128.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhc----------cCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMR----------EKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K  117 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~----------~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~  117 (234)
                      .+|..|+..|++.+..+-.....          ...+..+. .++.|+.         ++|..+++|++++|+|+++. .
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA---------YLNANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCSCCSGGGEEECTT
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHH---------HHHHCCCccCCCccceEEEcCC
Confidence            47778888899988766543321          11122222 2255566         88999999999999999994 5


Q ss_pred             CeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 026720          118 GVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKI  193 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i  193 (234)
                      ...++.|||.+........   .....+++.|.+||++.+ ..++..+|+||+|++++++++ |..||.+....+....+
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            6789999999886543211   112345677999999864 447899999999999999999 88999988777766666


Q ss_pred             HHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          194 CQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+....+.+..++..+..++..|+...+.+|+++.+++.
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~  292 (322)
T 1p4o_A          254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  292 (322)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            554444555677788899999999999999999998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.64  E-value=1.6e-16  Score=126.51  Aligned_cols=173  Identities=23%  Similarity=0.208  Sum_probs=127.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe---e-CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV---S-KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~---~-~~~~~~~~  124 (234)
                      .++..|+..|.+.+...-...++...+..+.. ++.|+.         ++|..+++|++++|+|+++   . ....+++|
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK---------YLHENGIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCCHHHEEEecCCCCCCEEEcc
Confidence            46667777788776543322233333333333 366666         8899999999999999998   2 45689999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC---
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT---  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~---  201 (234)
                      ||.+...... ......+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+.........+.+.....+   
T Consensus       153 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (304)
T 2jam_A          153 FGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF  230 (304)
T ss_dssp             CSTTCCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred             CCcceecCCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            9988654332 1223457888999999874 4578999999999999999999999998887777766666443322   


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ....+..+..++..++..++.+|+++++++.+
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            24556778888888999999999999998764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.64  E-value=1.7e-16  Score=127.43  Aligned_cols=175  Identities=19%  Similarity=0.296  Sum_probs=123.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|.+.+.......  ++...+..+. .++.|+.         ++|..+++|++++|+|+++. ....++.||
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A          103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS---------HLHQHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence            577788888888876553211  2222223333 2366666         88999999999999999994 567899999


Q ss_pred             cccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-C
Q 026720          126 GMVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG-S  199 (234)
Q Consensus       126 ~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~-~  199 (234)
                      |.+....... ......+++.|.+||++..    ...++..+|+||+|++++++++|..||.+.........+.+... .
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  253 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  253 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence            9887764322 2234567889999999852    23478899999999999999999999998887776655544322 2


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .....++..+..++..|+..++.+|+++++++.+
T Consensus       254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            2345678899999999999999999999998764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.64  E-value=1.7e-16  Score=128.58  Aligned_cols=134  Identities=25%  Similarity=0.402  Sum_probs=106.2

Q ss_pred             HhhhcccccCCcCCCcEEe--------------------eCCeeeEeeccccccccCCCCCCCcccCccccccccccccc
Q 026720           97 SLHRQGYFHRDLKPSNLLV--------------------SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE  156 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~--------------------~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~  156 (234)
                      ++|+.+++|+|++|+|+++                    .....+++|||.+......  .....+++.|++||++.+ .
T Consensus       138 ~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~  214 (355)
T 2eu9_A          138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-L  214 (355)
T ss_dssp             HHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-C
T ss_pred             HHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-C
Confidence            8899999999999999998                    1356799999998765442  344578899999999874 4


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC----------------CC---------------
Q 026720          157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD----------------SW---------------  205 (234)
Q Consensus       157 ~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~----------------~~---------------  205 (234)
                      .++..+|+||+|++++|+++|..||.+....+....+.+..+.++..                .|               
T Consensus       215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (355)
T 2eu9_A          215 GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK  294 (355)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred             CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC
Confidence            57899999999999999999999999988888777776665543321                11               


Q ss_pred             ------------cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 ------------PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                  +..+..++..++..++.+|+++++++++
T Consensus       295 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                        1245567788899999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.64  E-value=2.9e-17  Score=133.11  Aligned_cols=173  Identities=16%  Similarity=0.085  Sum_probs=120.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC--eeeEee
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG--VIKIGD  124 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~--~~~~~~  124 (234)
                      ..++..|+ .|++.+...-...++...+..+... +.|+.         ++|+.+++|++++|+|+++. ..  ..+++|
T Consensus       127 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~D  196 (345)
T 2v62_A          127 RFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLE---------YIHENEYVHGDIKAANLLLGYKNPDQVYLAD  196 (345)
T ss_dssp             EEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEESSSTTSEEECC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeCCCcCHHHEEEccCCCCcEEEEe
Confidence            35677777 6777665332222222233333333 55666         88999999999999999994 34  789999


Q ss_pred             ccccccccCCC--------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q 026720          125 LGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK-SSADQIYKICQ  195 (234)
Q Consensus       125 ~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~-~~~~~~~~i~~  195 (234)
                      ||.++.+....        ......+++.|+|||++.+ ..++..+|+||+|++++|+++|+.||.+. ...........
T Consensus       197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  275 (345)
T 2v62_A          197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT  275 (345)
T ss_dssp             CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHH
T ss_pred             CCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHH
Confidence            99997653211        1134567889999999874 45789999999999999999999999753 23332222222


Q ss_pred             hhC-C-CC-------CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          196 LIG-S-PT-------KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       196 ~~~-~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ... . |+       ....+..+..++..|+...+.+|++++++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          276 NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            221 1 11       1266778999999999999999999998753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.64  E-value=1.1e-16  Score=125.84  Aligned_cols=173  Identities=21%  Similarity=0.335  Sum_probs=128.1

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|..|+..|.+.+...-..  .++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.||
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA---------FIEERNYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHhhEEEcCCCCEEECCC
Confidence            46777788888877543211  1222223333332 55666         88999999999999999994 567899999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.+.......  ......++..|.+||...+ ..++..+|+||+|++++++++ |..||++....+....+.+....+.+
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (279)
T 1qpc_A          154 GLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP  232 (279)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             cccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc
Confidence            9988765432  1223345567999999863 347889999999999999999 89999988877777666665555556


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...++.+..+...|+..++.+|+++.++++
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            677888999999999999999999988753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.64  E-value=3.7e-17  Score=130.64  Aligned_cols=169  Identities=20%  Similarity=0.253  Sum_probs=115.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+ .|.+.+...-... ++...+..+... +.|+.         ++|..+++|+|++|+|+++ .....+++|||
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALA---------HLHSQGLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCEecCCCCHHHEEECCCCCEEEccce
Confidence            3555666 4455444332211 222233333333 56666         8899999999999999999 46678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC-CCCCC
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP-TKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~-~~~~~  205 (234)
                      .+.............+++.|+|||++.+  .++..+|+||+|++++|+++|..++.+...+..   +.+....+ ....+
T Consensus       203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~  277 (311)
T 3p1a_A          203 LLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGL  277 (311)
T ss_dssp             TCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTTTCCCHHHHTTS
T ss_pred             eeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HhccCCCcccccCC
Confidence            9887655444444568899999999864  489999999999999999999877765533332   22211111 12356


Q ss_pred             cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..+..+...++..++.+|+++++++.+
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            6788888899999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.63  E-value=1.5e-16  Score=124.09  Aligned_cols=173  Identities=21%  Similarity=0.323  Sum_probs=128.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+..+-... ++...+..+.. ++.|+.         ++|+.+++|++++|+|+++ .....++.|||
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg  149 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA---------YLEEACVIHRDLAARNCLVGENQVIKVSDFG  149 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCchheEEECCCCCEEEcccc
Confidence            467778888888776543211 12222223322 255666         8899999999999999999 45678999999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .+.......  ......++..|.+||+..+ ..++..+|+||+|++++++++ |..||.+....+....+......+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  228 (267)
T 3t9t_A          150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR  228 (267)
T ss_dssp             GGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cccccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCc
Confidence            887653321  1223345667999999864 347889999999999999999 899999888777777776655555566


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+..+..+...|+...+.+|+++.+++.
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          229 LASTHVYQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            77888999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.63  E-value=1.9e-16  Score=127.51  Aligned_cols=170  Identities=20%  Similarity=0.224  Sum_probs=120.0

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCe-----ee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGV-----IK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~-----~~  121 (234)
                      .+|..|+ .|++.+...... .++...+..+... +.|+.         ++|+.+++|+|++|+|+++. ...     .+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~iiHrDlkp~Nill~~~~~~~~~~~k  150 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME---------YVHSKNLIYRDVKPENFLIGRPGNKTQQVIH  150 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCCHHHeeeccCCCCCCceEE
Confidence            5777788 778877655421 1222333333333 56666         88999999999999999994 333     89


Q ss_pred             EeeccccccccCCCC--------CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHH
Q 026720          122 IGDLGMVKEIDSNLP--------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---ADQI  190 (234)
Q Consensus       122 ~~~~~~a~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~---~~~~  190 (234)
                      ++|||.+........        .....+++.|+|||++.+ ..++..+|+||+|++++|+++|..||.+...   .+..
T Consensus       151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~  229 (330)
T 2izr_A          151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY  229 (330)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred             EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence            999999987643221        234678899999999874 4478999999999999999999999997532   2333


Q ss_pred             HHHHHhh-CCCC---CCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          191 YKICQLI-GSPT---KDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       191 ~~i~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      .++.+.. ..+.   ...++ .+..+...|+..++.+||++++|.
T Consensus       230 ~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~  273 (330)
T 2izr_A          230 QKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLR  273 (330)
T ss_dssp             HHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             HHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHH
Confidence            3332211 1121   13355 788888999999999999988764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.63  E-value=9.1e-17  Score=129.96  Aligned_cols=135  Identities=24%  Similarity=0.315  Sum_probs=107.3

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|+|++|+|+++. ....+++|||.+..+.....   .....+++.|.|||.+.+ ..++..+|+||+|++++
T Consensus       187 ~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~  265 (344)
T 1rjb_A          187 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLW  265 (344)
T ss_dssp             HHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred             HHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHH
Confidence            78989999999999999994 67889999999987644321   122345667999999864 44789999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHhh-CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLS-FGILFPGKSSADQIYKICQLI-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~-~~~~f~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++++ |..||.+.........+.... ..+.+..++..+..+...|+...+.+|+++.++++
T Consensus       266 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          266 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9998 999999887666665555433 33445667788999999999999999999998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.63  E-value=1.5e-16  Score=125.56  Aligned_cols=169  Identities=14%  Similarity=0.136  Sum_probs=120.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCe-------
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGV-------  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~-------  119 (234)
                      .+|..|+..|++.+...-... ++...+..+... +.|+.         ++|+.+++|+|++|+|+++. ...       
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH---------FLEENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH---------HHhhCCeECCCcCcceEEEecCCcccccccc
Confidence            478889988999887654222 222233333333 66777         89999999999999999994 333       


Q ss_pred             -eeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhh
Q 026720          120 -IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       120 -~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~~  197 (234)
                       .++.|||.+......   ....++..|.|||++.+...++..+|+||+|++++++++|. ++|.+.. .......... 
T Consensus       159 ~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~~~~~~~~-  233 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYED-  233 (289)
T ss_dssp             EEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHHT-
T ss_pred             eeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-hHHHHHHhhc-
Confidence             899999988665331   22345678999999975466899999999999999999965 5555444 4444344333 


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....+...+..+..+...|+..++.+|++++++++
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  268 (289)
T 4fvq_A          234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR  268 (289)
T ss_dssp             TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            22333445678888999999999999999998864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.63  E-value=1.9e-16  Score=124.65  Aligned_cols=169  Identities=20%  Similarity=0.175  Sum_probs=124.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C------
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K------  117 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~------  117 (234)
                      .+|..|+..|++.+...-...    ++...+..+... +.|+.         ++|..+++|+|++|+|+++. .      
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR---------YIHSMSLVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEC--------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHH---------HHHhCCEeecCCCHHHEEEcCCCCCccc
Confidence            477788888899887654322    222333334333 66666         89999999999999999994 1      


Q ss_pred             -------------CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 026720          118 -------------GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK  184 (234)
Q Consensus       118 -------------~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~  184 (234)
                                   ...+++|||.+......   ....+++.|.+||++.+...++..+|+||+|+++++++++.+++.+.
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             ccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                         24689999988876542   22457889999999875545667999999999999999998877655


Q ss_pred             ChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          185 SSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       185 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..   ...+.+......+..++..+..+...++..++.+|+++.+++++
T Consensus       235 ~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          235 DQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             hH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            32   23333333333445677889999999999999999999998865

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.63  E-value=1.1e-15  Score=124.10  Aligned_cols=135  Identities=36%  Similarity=0.532  Sum_probs=106.7

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEML  175 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~  175 (234)
                      ++|..+++|++++|+|+++. .+..+++|||.+......  .....+++.|++||++.+...++..+|+||+|+++++++
T Consensus       141 ~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  218 (353)
T 3coi_A          141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML  218 (353)
T ss_dssp             HHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             HHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH
Confidence            88999999999999999994 567899999998875442  334567889999999876566899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHhhCCCCC------------------------------CCCcchhhhhhhhccccCCCCCc
Q 026720          176 SFGILFPGKSSADQIYKICQLIGSPTK------------------------------DSWPLGIQLASNLNWKLPQMGGV  225 (234)
Q Consensus       176 ~~~~~f~~~~~~~~~~~i~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~  225 (234)
                      +|..||.+....+.+..+.+..+.|..                              ...+..+..+...++..++.+|+
T Consensus       219 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp  298 (353)
T 3coi_A          219 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL  298 (353)
T ss_dssp             HSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC
Confidence            999999999888888877765554321                              13355667778888999999999


Q ss_pred             cccccCCC
Q 026720          226 NLLAVMPS  233 (234)
Q Consensus       226 ~~~~~~~~  233 (234)
                      ++++++.+
T Consensus       299 t~~e~l~h  306 (353)
T 3coi_A          299 TAAQALTH  306 (353)
T ss_dssp             CHHHHHTS
T ss_pred             CHHHHhcC
Confidence            99988764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.63  E-value=1.4e-16  Score=125.89  Aligned_cols=174  Identities=19%  Similarity=0.300  Sum_probs=117.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...... .++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.|||
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~---------~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD---------YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccccCccceEEECCCCCEEEccce
Confidence            36667777777765432111 1111222233332 56666         88999999999999999994 6788999999


Q ss_pred             ccccccCC---CCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC-
Q 026720          127 MVKEIDSN---LPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP-  200 (234)
Q Consensus       127 ~a~~~~~~---~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~-  200 (234)
                      .+......   .......+++.|.+||++..  ...++...|+||+|++++++++|+.||.+....+...........+ 
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP  245 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence            88754321   12233567889999999852  3346789999999999999999999999988888777766544332 


Q ss_pred             CC----CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TK----DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.    ..++..+..++..|+...+.+|+++.+++.
T Consensus       246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            21    356677888999999999999999998764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.63  E-value=1e-15  Score=124.20  Aligned_cols=137  Identities=31%  Similarity=0.532  Sum_probs=109.3

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCC-----------CCCcccCcccccccccccccCCCCcchH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLP-----------CTDYVTTRWYRGPEVLLFSEIYGPEVDK  164 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~-----------~~~~~~~~~~~~pe~~~~~~~~~~~~d~  164 (234)
                      ++|+.+++|+|++|+|+++. ....+++|||.+........           .....+++.|+|||++.....++..+|+
T Consensus       127 ~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  206 (353)
T 2b9h_A          127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV  206 (353)
T ss_dssp             HHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHH
T ss_pred             HHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhH
Confidence            88999999999999999994 56789999999887643211           1234678889999988655668899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC-------------------------------CCcchhhhhh
Q 026720          165 WAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-------------------------------SWPLGIQLAS  213 (234)
Q Consensus       165 ~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-------------------------------~~~~~~~~~~  213 (234)
                      ||+|++++++++|..||++....+.+..+....+.|...                               ..+..+..+.
T Consensus       207 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  286 (353)
T 2b9h_A          207 WSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL  286 (353)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHH
Confidence            999999999999999999999888888887776655421                               3344556777


Q ss_pred             hhccccCCCCCccccccCCC
Q 026720          214 NLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++..++.+|+++.+++++
T Consensus       287 ~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          287 QRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhcCcCcccCCCHHHHhcC
Confidence            88899999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.63  E-value=1.9e-16  Score=126.25  Aligned_cols=173  Identities=19%  Similarity=0.339  Sum_probs=126.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHh------------------hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL------------------MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKP  110 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~------------------m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p  110 (234)
                      .+|..|+..|++.+...-...                  ++...+..+.. ++.|+.         ++|..+++|++++|
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp  173 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA---------FLASKNCIHRDLAA  173 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCcc
Confidence            467777888888776543221                  11112222222 255666         88999999999999


Q ss_pred             CcEEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 026720          111 SNLLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKS  185 (234)
Q Consensus       111 ~~~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~  185 (234)
                      +|+++. ....++.|||.+........   .....+++.|.+||.+.+ ..++..+|+||+|++++++++ |..||.+..
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            999994 67789999999887654321   122345567999999864 447899999999999999998 999999877


Q ss_pred             hHHHHHHHHHhh-CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          186 SADQIYKICQLI-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       186 ~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ............ ..+.+..++..+..+...|+...+.+|+++.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            666665655433 34445667888999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.63  E-value=2e-16  Score=126.29  Aligned_cols=173  Identities=16%  Similarity=0.192  Sum_probs=123.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccH------HHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSW------TIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~------~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~  121 (234)
                      .++..|+..|.+.+.......-..+...++      ... +.|+.         ++|..+++|++++|+|+++. ....+
T Consensus       117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME---------YLSNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHH---------HHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCcceEEEcCCCcEE
Confidence            567788888888876533211111222232      222 55555         88988999999999999994 56789


Q ss_pred             EeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 026720          122 IGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       122 ~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ++|||.+.......   ......+++.|.+||.+.+ ..++..+|+||+|++++++++ |..||.+....+....+....
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            99999988764321   1122345667999999874 457899999999999999999 889999888777776666655


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+.+..++..+..+...|+..++.+|+++.+++.
T Consensus       267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            55556677788899999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.63  E-value=9.9e-17  Score=127.17  Aligned_cols=173  Identities=17%  Similarity=0.232  Sum_probs=129.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..|++.+..+--.. .+...+..|. .++.|+.         ++|+.+++|++++|+|+++. ....++.|||
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~---------~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK---------YLASKKFVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCchheEEECCCCCEEECccc
Confidence            477788888888776532110 1112223333 2366666         89999999999999999994 5678999999


Q ss_pred             ccccccCCC-----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCC
Q 026720          127 MVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       127 ~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      .+.......     ......+++.|.+||.+.+ ..++...|+||+|++++++++ +.+||++....+....+.+....+
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL  252 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC
Confidence            988653321     1223445667999999864 447899999999999999999 668888888777777777766667


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..++..+..+...|+...+.+|++++++++
T Consensus       253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            77788889999999999999999999998764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.63  E-value=3.1e-17  Score=136.38  Aligned_cols=175  Identities=22%  Similarity=0.218  Sum_probs=114.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|++.+...--..+++..+..+.. ++.|+.         ++|..+++|++++|+|+++.    ....+++|
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---------YLHENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence            36777888887754321101111112222222 256666         88999999999999999994    23589999


Q ss_pred             ccccccccCCCCCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-CCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG-SPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~-~~~  201 (234)
                      ||.+.............+++.|+|||++.+  ...|+..+|+||+|++++++++|..||++......+........ ...
T Consensus       286 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~  365 (419)
T 3i6u_A          286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  365 (419)
T ss_dssp             SSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred             cccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence            999988765444455678899999999853  34578899999999999999999999987654443333333222 221


Q ss_pred             C---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 K---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +   ...+..+..+...++..++.+|+++++++.+
T Consensus       366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1   3456677788888999999999999988753

>3spa_A Mtrpol, DNA-directed RNA polymerase, mitochondrial; single-subunit DNA-dependent RNA polymerase in mitochondria, transferase; 2.50A {Homo sapiens}

Probab=99.63  E-value=3.1e-17  Score=145.35  Aligned_cols=96  Identities=6%  Similarity=-0.076  Sum_probs=86.3

Q ss_pred             cCCCCCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCCh-HHHHHHHHhhcc----Cccc
Q 026720            3 LANENPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHV-EKAFKVFNLMRE----KNLQ   77 (234)
Q Consensus         3 ~~g~~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~-~~a~~~~~~m~~----~~~~   77 (234)
                      ..|+.||++|||+||++||+.|++++|.++|.+|.+.|+.||.+|||+||.+||+.|.. ++|.++|++|.+    ||.+
T Consensus       158 ~kG~~PdvvTYNtLI~Glck~G~~~eA~~Lf~eM~~~G~~PDvvTYntLI~glcK~G~~~e~A~~Ll~EM~~kG~~PD~v  237 (1134)
T 3spa_A          158 QKRKLLTLDMYNAVMLGWARQGAFKELVYVLFMVKDAGLTPDLLSYAAALQCMGRQDQDAGTIERCLEQMSQEGLKLQAL  237 (1134)
T ss_dssp             HHHTTCCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHTCCSHHH
T ss_pred             hcCCCCCHhHHHHHHHHHHhCCCHHHHHHHHHHHHHcCCCCcHHHHHHHHHHHHhCCCcHHHHHHHHHHHHHcCCCCChh
Confidence            45899999999999999999999999999999999999999999999999999999985 788999999985    7999


Q ss_pred             cHHHHHHHHHhcCCchhhhHh
Q 026720           78 SWTIMISGLADNSRGNDAISL   98 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l   98 (234)
                      +||+++++..+.+-......+
T Consensus       238 tY~~ll~~~eR~~vL~~Vrkv  258 (1134)
T 3spa_A          238 FTAVLLSEEDRATVLKAVHKV  258 (1134)
T ss_dssp             HHHSCCCHHHHHHHHHHHGGG
T ss_pred             hcccccChhhHHHHHHHHHHh
Confidence            999999888877555444444

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.63  E-value=1.5e-16  Score=129.20  Aligned_cols=172  Identities=13%  Similarity=0.057  Sum_probs=122.9

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCC---eeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKG---VIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~---~~~~~  123 (234)
                      .+|..|+ .|++.+...-.  ..++...+..+... +.|+.         ++|+.+++|++++|+|+++...   ..+++
T Consensus       134 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~---------~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~  203 (352)
T 2jii_A          134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALE---------FLHENEYVHGNVTAENIFVDPEDQSQVTLA  203 (352)
T ss_dssp             EEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCSCCCGGGEEEETTEEEEEEEC
T ss_pred             EEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCCHHHEEEcCCCCceEEEe
Confidence            5667788 77888776533  22333333444333 66666         8899999999999999999543   68999


Q ss_pred             eccccccccCCC--------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHH
Q 026720          124 DLGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-SADQIYKIC  194 (234)
Q Consensus       124 ~~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-~~~~~~~i~  194 (234)
                      |||.+..+....        ......+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+.. .........
T Consensus       204 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  282 (352)
T 2jii_A          204 GYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK  282 (352)
T ss_dssp             CGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHH
T ss_pred             cCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHH
Confidence            999997654321        1123467889999999874 347899999999999999999999999764 444444433


Q ss_pred             Hhh-CCCCC--------CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          195 QLI-GSPTK--------DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       195 ~~~-~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ... ..+..        ...+..+..+...|+..++.+|++++++++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          283 QKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            322 22211        134678888999999999999999998753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.63  E-value=1.3e-16  Score=131.33  Aligned_cols=172  Identities=25%  Similarity=0.319  Sum_probs=119.5

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhc-ccccCCcCCCcEEeeCC--------
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQ-GYFHRDLKPSNLLVSKG--------  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~-~~~~~~l~p~~~~~~~~--------  118 (234)
                      .+|..|+..+.++...+-- ..++...+..+... +.|+.         ++|.. +++|+|++|+|+++...        
T Consensus       121 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          121 CMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD---------YLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHH---------HHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             EEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHH---------HHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence            4666676433333322110 11222233333333 66666         88987 89999999999999422        


Q ss_pred             ------------------------------------------eeeEeeccccccccCCCCCCCcccCccccccccccccc
Q 026720          119 ------------------------------------------VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE  156 (234)
Q Consensus       119 ------------------------------------------~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~  156 (234)
                                                                ..++.|||.+......  .....+++.|+|||++.+. 
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-  268 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS-  268 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS-
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC-
Confidence                                                      5899999998876543  3345788999999998744 


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhhCCCCCC-------------------------C-
Q 026720          157 IYGPEVDKWAMGAIMFEMLSFGILFPGKS------SADQIYKICQLIGSPTKD-------------------------S-  204 (234)
Q Consensus       157 ~~~~~~d~~s~g~~l~e~~~~~~~f~~~~------~~~~~~~i~~~~~~~~~~-------------------------~-  204 (234)
                      .|+..+|+||+|++++|+++|..||.+..      ..+.+..+.+..+.++..                         . 
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            48899999999999999999999998654      455666666666554321                         0 


Q ss_pred             -----------C----cchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 -----------W----PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 -----------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                 |    +..+..+...++..++.+|+++++++++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                       1    1234567788999999999999998864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.63  E-value=5.6e-16  Score=122.27  Aligned_cols=137  Identities=20%  Similarity=0.292  Sum_probs=97.0

Q ss_pred             Hhhhc-ccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccc---cccCCCCcchHHHHHHHH
Q 026720           97 SLHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL---FSEIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~-~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~~d~~s~g~~l  171 (234)
                      ++|.. +++|++++|+|+++. ....++.|||.+.............+++.|.+||.+.   ....++..+|+||+|+++
T Consensus       124 ~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il  203 (290)
T 3fme_A          124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM  203 (290)
T ss_dssp             HHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHH
T ss_pred             HHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHH
Confidence            88987 899999999999994 5778999999988766544444456888999999972   344578899999999999


Q ss_pred             HHHHhCCCCCCCCCh-HHHHHHHHHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          172 FEMLSFGILFPGKSS-ADQIYKICQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       172 ~e~~~~~~~f~~~~~-~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++++|+.||.+... ............ ......++..+..+...++..++.+|+++++++++
T Consensus       204 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          204 IELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            999999999997443 344444443322 23334677888889999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.63  E-value=1.1e-16  Score=125.15  Aligned_cols=171  Identities=20%  Similarity=0.398  Sum_probs=120.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcc---cccCCcCCCcEEee---------
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQG---YFHRDLKPSNLLVS---------  116 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~---~~~~~l~p~~~~~~---------  116 (234)
                      .++..|+..|.+.+..+- ..++...+..+... +.|+.         ++|+.+   ++|++++|+|+++.         
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~---------~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMN---------YLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHH---------HHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHH---------HHHhCCCCceeecCCchHHEEEeccccccccc
Confidence            567778888887665320 11112222333222 56666         888887   88999999999994         


Q ss_pred             CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 026720          117 KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL  196 (234)
Q Consensus       117 ~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~  196 (234)
                      ....+++|||.+....... .....+++.|.+||.+.+ ..++...|+||+|++++++++|+.||.+.........+...
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             SCCEEECCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             CcceEEccCCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            4568999999988665432 223567889999999874 44789999999999999999999999998877776665543


Q ss_pred             h-CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          197 I-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       197 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      . ..+.+..++..+..+...|+...+.+|+++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  266 (271)
T 3dtc_A          230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD  266 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2 33445677888999999999999999999998864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.63  E-value=1.6e-16  Score=125.47  Aligned_cols=173  Identities=20%  Similarity=0.231  Sum_probs=125.9

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|.+.+...-- ..++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg  155 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK---------YLEEKNFVHRDLAARNVLLVNRHYAKISDFG  155 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHH---------HHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence            4666777777776653210 01111222233222 55565         8899999999999999999 56788999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .+........    .....++..|.+||++.+ ..++..+|+||+|++++++++ |..||.+....+....+......+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~  234 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC  234 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC
Confidence            9887643211    122334677999999864 347889999999999999998 9999998887777666655444445


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..++..|+...+.+|+++.+++.
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  265 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ  265 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            5677889999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.63  E-value=2.6e-16  Score=122.81  Aligned_cols=170  Identities=11%  Similarity=0.137  Sum_probs=123.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcc--cccCCcCCCcEEee-CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQG--YFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~--~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      .++..|+..|++.+...-...  ++...+..+... +.|+.         ++|+.+  ++|++++|+|+++. ....++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA---------FLHTLEPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHH---------HHTTSSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHH---------HHhcCCCceecCCCccceEEEcCCcceeEE
Confidence            477888888888876542111  122223333333 55666         788888  99999999999995 4566777


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC-C
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEI--YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS-P  200 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~-~  200 (234)
                      +++.+.....    ....+++.|+|||.+.+...  ++..+|+||+|++++++++|+.||.+....+....+...... +
T Consensus       156 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  231 (271)
T 3kmu_A          156 MADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT  231 (271)
T ss_dssp             GGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             eccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC
Confidence            7776554322    33567889999999874332  223699999999999999999999998888877776654433 3


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..++..+..+...++..++.+|++++++++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            34567888899999999999999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.62  E-value=4.1e-16  Score=124.54  Aligned_cols=174  Identities=19%  Similarity=0.282  Sum_probs=128.1

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+...... .++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.|||
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE---------YLHFMRKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCCcCCCcCHHHEEECCCCCEEEeecc
Confidence            46777888888877654211 1222223333332 56666         8899999999999999999 46778999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKD  203 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~  203 (234)
                      .+....... ......+++.|.+||.+.+ ..++...|+||+|++++++++|..||.+.........+......  ..+.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
T 3com_A          171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE  249 (314)
T ss_dssp             TCEECBTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGG
T ss_pred             cchhhhhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcc
Confidence            987765432 2234567888999999874 34789999999999999999999999988776665544332211  1234


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .|+..+..+...|+..++.+|+++.+++.+
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            577888899999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.62  E-value=7.2e-17  Score=128.80  Aligned_cols=173  Identities=17%  Similarity=0.218  Sum_probs=121.2

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+..+-. ..++...+..+... +.|+.         ++|+.+++|+|++|+|+++. ....+++|||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  153 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA---------YLHSMNIIHRDLNSHNCLVRENKNVVVADFG  153 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSTTSEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCCcCeEEECCCCCEEEeecc
Confidence            4677888888988876432 11222233333333 66666         89999999999999999994 5678999999


Q ss_pred             ccccccCCCCC---------------CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--
Q 026720          127 MVKEIDSNLPC---------------TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ--  189 (234)
Q Consensus       127 ~a~~~~~~~~~---------------~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~--  189 (234)
                      .+.........               ....+++.|+|||++.+ ..++..+|+||+|++++++++|..||++......  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~  232 (310)
T 3s95_A          154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF  232 (310)
T ss_dssp             TCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred             cceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence            98865432211               14568889999999874 4578999999999999999999999886422110  


Q ss_pred             HHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+........+..++..+..+...|+..++.+|+++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0011111122234556778889999999999999999988753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.62  E-value=1.7e-16  Score=125.47  Aligned_cols=172  Identities=17%  Similarity=0.209  Sum_probs=122.7

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~  123 (234)
                      .++..|+ .|++.+...... .++...+..+... +.|+.         ++|+.+++|+|++|+|+++    .....+++
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE---------YIHSKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHeeeeccCCCCeEEEe
Confidence            4677788 777777654211 1222333344333 66666         8999999999999999998    35678999


Q ss_pred             eccccccccCCCC--------CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHH
Q 026720          124 DLGMVKEIDSNLP--------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---DQIYK  192 (234)
Q Consensus       124 ~~~~a~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~---~~~~~  192 (234)
                      |||.+........        .....+++.|.+||.+.+. .++..+|+||+|++++++++|+.||.+....   ....+
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence            9999987644321        2245678899999998743 4789999999999999999999999875332   22233


Q ss_pred             HHH-hhCCCC---CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          193 ICQ-LIGSPT---KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       193 i~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.. ....+.   ...++..+..++..|+...+.+||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            322 222221   1556788999999999999999999988753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.62  E-value=2.3e-16  Score=126.20  Aligned_cols=174  Identities=16%  Similarity=0.212  Sum_probs=120.2

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+...-.. .++...+..+... +.|+.         ++|+.+++|++++|+|+++.....+++|||.
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~  175 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMG---------YLHAKGILHKDLKSKNVFYDNGKVVITDFGL  175 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCSTTEEEC--CCEECCCSC
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCccccCCChhhEEEeCCCEEEeecCC
Confidence            45666777777766532110 0111222333333 56666         8899999999999999999777789999998


Q ss_pred             cccccCC------CCCCCcccCccccccccccc--------ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 026720          128 VKEIDSN------LPCTDYVTTRWYRGPEVLLF--------SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI  193 (234)
Q Consensus       128 a~~~~~~------~~~~~~~~~~~~~~pe~~~~--------~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i  193 (234)
                      +......      .......+++.|.+||++.+        ...++..+|+||+|++++++++|..||.+.........+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            7654211      11223457788999999864        234688999999999999999999999988777666555


Q ss_pred             HHhhCCC-CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          194 CQLIGSP-TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       194 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ......+ ....++..+..+...|+...+.+|+++.+++.
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            4433222 22356778889999999999999999998763

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.62  E-value=2.1e-16  Score=126.34  Aligned_cols=175  Identities=22%  Similarity=0.203  Sum_probs=118.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC---eeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG---VIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~---~~~~~~  124 (234)
                      .+|..|+..|.+.+...-...++...+..+... +.|+.         ++|..+++|++++|+|+++. ..   ..+++|
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD---------FLHNKGIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence            577788888888876554333333344444333 66777         89999999999999999994 22   379999


Q ss_pred             ccccccccCCC--------CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-----
Q 026720          125 LGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA-----  187 (234)
Q Consensus       125 ~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~-----  187 (234)
                      ||.+.......        ......+++.|+|||++..    ...|+..+|+||+|++++++++|..||.+....     
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            99887653211        1123457889999999853    133688999999999999999999999876421     


Q ss_pred             ---------H-HHHHHHHhhCCCCC---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          188 ---------D-QIYKICQLIGSPTK---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       188 ---------~-~~~~i~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                               . ....+.......+.   ...+..+..+...++..++.+|+++++++++
T Consensus       238 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                     1 22222222111111   3456678888889999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.61  E-value=3.7e-16  Score=123.31  Aligned_cols=173  Identities=22%  Similarity=0.259  Sum_probs=126.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .++..|+..+.+.+...--..++...+..+... +.|+.         ++|..+++|++++|+|+++.    ....++.|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT---------YMHKHNIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCChhhEEEecCCCcccEEEec
Confidence            356667777777655432222332233333333 56666         88999999999999999993    23589999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.+.............+++.|.+||.+.+  .++...|+||+|++++++++|..||.+....+....+.......+.  
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (287)
T 2wei_A          168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ  245 (287)
T ss_dssp             TTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred             cCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchh
Confidence            999887655433344557788999999864  3789999999999999999999999998877776666554332222  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       ...+..+..++..++..++.+|+++.+++++
T Consensus       246 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence             3556778888899999999999999988753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.61  E-value=1.2e-16  Score=128.27  Aligned_cols=173  Identities=23%  Similarity=0.290  Sum_probs=117.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhc----------ccccCCcCCCcEEee-C
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQ----------GYFHRDLKPSNLLVS-K  117 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~----------~~~~~~l~p~~~~~~-~  117 (234)
                      .+|..|+..|++.+..+- ..++...+..+... +.|+.         ++|+.          +++|+|++|+|+++. .
T Consensus        98 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~---------~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLA---------YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHH---------HHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHH---------HHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence            578889999998886532 11222222233222 45555         77776          899999999999994 5


Q ss_pred             CeeeEeeccccccccCCCC---CCCcccCcccccccccccc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----
Q 026720          118 GVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFS----EIYGPEVDKWAMGAIMFEMLSFGILFPGKS-----  185 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~----~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-----  185 (234)
                      ...+++|||.+..+.....   .....+++.|+|||++.+.    ..++..+|+||+|+++||+++|+.||.+..     
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            6789999999987654322   2335678999999998642    234567899999999999999999998642     


Q ss_pred             ----------hHHHHHHHH-HhhCCCCCC-CCc-----chhhhhhhhccccCCCCCccccccCC
Q 026720          186 ----------SADQIYKIC-QLIGSPTKD-SWP-----LGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       186 ----------~~~~~~~i~-~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                                ......... .....|... .|.     ..+..++..|+..++.+|+++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                      222222222 222222222 222     23777888899999999999998864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.61  E-value=4.6e-16  Score=123.21  Aligned_cols=173  Identities=17%  Similarity=0.237  Sum_probs=125.5

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..|++.+...-.. .++...+..|.. ++.|+.         ++|+.+++|++++|+|+++. ....+++|||
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME---------YLAEQKFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCcceEEEcCCCcEEeCcCC
Confidence            36677777788776543210 011122233332 366666         89999999999999999994 5678999999


Q ss_pred             ccccccCC-----CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCC
Q 026720          127 MVKEIDSN-----LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSADQIYKICQLIGSP  200 (234)
Q Consensus       127 ~a~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~-~~~f~~~~~~~~~~~i~~~~~~~  200 (234)
                      .+..+...     .......++..|.+||...+ ..++..+|+||+|++++++++| .++|.+....+....+......+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  248 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP  248 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC
Confidence            98765331     12233456678999999864 4478999999999999999995 56666666666665565555566


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..++..+..+...++...+.+|+++.++++
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            67778888999999999999999999988764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.61  E-value=1.7e-15  Score=122.45  Aligned_cols=136  Identities=28%  Similarity=0.371  Sum_probs=107.8

Q ss_pred             HhhhcccccCCcCCCcEEee-CC--eeeEeeccccccccCCC-----CCCCcccCcccccccccccc-cCCCCcchHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KG--VIKIGDLGMVKEIDSNL-----PCTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAM  167 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~--~~~~~~~~~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~  167 (234)
                      ++|..+++|+|++|+|+++. ..  ..+++|||.+..+....     ......+++.|+|||++.+. ..|+..+|+||+
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            88999999999999999994 33  68999999988653311     12345678899999998642 457899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC---CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          168 GAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD---SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       168 g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |++++++++|+.||++....+....+..........   .++..+..++..++...+.+|+++.+++.
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999888888877655443332   35667888888899999999999998865

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.61  E-value=1.6e-16  Score=124.58  Aligned_cols=175  Identities=22%  Similarity=0.221  Sum_probs=119.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...--..++...+..+... +.|+.         ++|+.+++|++++|+|+++. ....++.|||.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---------YLHGIGITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHHhCCeeccCCChHHEEEccCCCEEEeeCCC
Confidence            356666666666543211111111222233322 55566         88999999999999999994 56789999998


Q ss_pred             cccccCC---CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC--CCCC
Q 026720          128 VKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG--SPTK  202 (234)
Q Consensus       128 a~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~--~~~~  202 (234)
                      +......   .......+++.|.+||.+.+...++..+|+||+|++++++++|..||.+...............  .+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (276)
T 2yex_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW  231 (276)
T ss_dssp             CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTG
T ss_pred             ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCch
Confidence            8765321   1223456788899999987555456789999999999999999999987665433333322211  1222


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++..+..+...++..++.+|+++++++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             hhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            3456778888899999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.61  E-value=3e-16  Score=128.20  Aligned_cols=134  Identities=30%  Similarity=0.424  Sum_probs=101.2

Q ss_pred             Hhhhc-ccccCCcCCCcEEee-C------CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHH
Q 026720           97 SLHRQ-GYFHRDLKPSNLLVS-K------GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMG  168 (234)
Q Consensus        97 ~l~~~-~~~~~~l~p~~~~~~-~------~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g  168 (234)
                      ++|.. +++|+|++|+|+++. .      ...+++|||.+......  .....+++.|+|||++.+. .++..+|+||+|
T Consensus       146 ~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG  222 (373)
T 1q8y_A          146 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTA  222 (373)
T ss_dssp             HHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHH
T ss_pred             HHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHH
Confidence            88987 899999999999983 1      25799999998876543  2345678899999998743 478999999999


Q ss_pred             HHHHHHHhCCCCCCCCC------hHHHHHHHHHhhCCCCCC---------------------------------------
Q 026720          169 AIMFEMLSFGILFPGKS------SADQIYKICQLIGSPTKD---------------------------------------  203 (234)
Q Consensus       169 ~~l~e~~~~~~~f~~~~------~~~~~~~i~~~~~~~~~~---------------------------------------  203 (234)
                      ++++|+++|..||.+..      ..+.+..+.+..+.++..                                       
T Consensus       223 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
T 1q8y_A          223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF  302 (373)
T ss_dssp             HHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCC
T ss_pred             HHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccC
Confidence            99999999999998654      445566666655543321                                       


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        ..+..+..++..++..++.+|+++++++++
T Consensus       303 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             CHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             CcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence              112355677888999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.61  E-value=3.8e-16  Score=127.18  Aligned_cols=173  Identities=25%  Similarity=0.330  Sum_probs=122.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhc-ccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...-...++...+..+... +.|+.         ++|.. +++|+|++|+|+++ .....+++|||
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~---------~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---------YLREKHKIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH---------HHHHhCCEEcCCccHHHEEECCCCCEEEEECC
Confidence            477788888898887654333333333344333 66666         88875 79999999999999 46678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI-------------  193 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i-------------  193 (234)
                      .+....... .....+++.|.+||++.+ ..++..+|+||+|++++++++|+.||++....+....+             
T Consensus       178 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          178 VSGQLIDSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             CCHHHHHHC-----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             CCccccccc-ccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            987654332 234577889999999874 45789999999999999999999999876554432111             


Q ss_pred             -----------------------------HHhhC-CCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          194 -----------------------------CQLIG-SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       194 -----------------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                   ..... ......++..+..++..++..++.+|+++++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                         11100 11123456678888888999999999999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.61  E-value=1.6e-16  Score=134.24  Aligned_cols=171  Identities=17%  Similarity=0.180  Sum_probs=123.2

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~  123 (234)
                      .|+..|+ .|.+.+...... .+....+..+... +.|+.         ++|..+++|+|++|+|+++    .....+++
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~---------yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~  148 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE---------FVHSKSFLHRDIKPDNFLMGLGRRANQVYII  148 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCEeecccCcceEEEecCCCCCeEEEE
Confidence            5677777 777777654321 1222333444333 66666         8999999999999999999    35678999


Q ss_pred             eccccccccCCCC--------CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHH
Q 026720          124 DLGMVKEIDSNLP--------CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS---ADQIYK  192 (234)
Q Consensus       124 ~~~~a~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~---~~~~~~  192 (234)
                      |||.++.......        .....++..|++||++.+ ..++..+|+||+|+++||+++|+.||.+...   .....+
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence            9999987654321        124568889999999874 4478999999999999999999999997543   233333


Q ss_pred             HHHhhCCCC----CCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          193 ICQLIGSPT----KDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       193 i~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      +.+......    ...++..+..++..|+...+.+|+++++|+
T Consensus       228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~  270 (483)
T 3sv0_A          228 ISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLK  270 (483)
T ss_dssp             HHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             HhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            332211111    146678889999999999999999998775

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.61  E-value=2.6e-16  Score=125.63  Aligned_cols=173  Identities=18%  Similarity=0.314  Sum_probs=123.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----------------hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----------------MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----------------m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .++..|+..|.+.+...-...                ++...+..+.. ++.|+.         ++|..+++|++++|+|
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~i~H~dikp~N  178 (316)
T 2xir_A          108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME---------FLASRKCIHRDLAARN  178 (316)
T ss_dssp             EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGG
T ss_pred             EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHH---------HHHhCCcccccCccce
Confidence            466778888888776543211                11111122222 255555         7899999999999999


Q ss_pred             EEe-eCCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLV-SKGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~-~~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++ .....++.|||.+........   .....+++.|.+||++.+ ..++..+|+||+|++++++++ |..||.+....
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999 456789999999887644221   123345677999999864 447899999999999999998 99999987655


Q ss_pred             HHHHHHHHh-hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQL-IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +........ ...+.+..++..+..+...|+...+.+|+++.+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  303 (316)
T 2xir_A          258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  303 (316)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            555444433 333445567778888999999999999999998864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.60  E-value=4.6e-16  Score=124.06  Aligned_cols=171  Identities=23%  Similarity=0.374  Sum_probs=114.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc---CccccHHHH-HHHHHhcCCchhhhHhhh---cccccCCcCCCcEEee-CC-ee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIM-ISGLADNSRGNDAISLHR---QGYFHRDLKPSNLLVS-KG-VI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~-i~~~~~~g~~~~a~~l~~---~~~~~~~l~p~~~~~~-~~-~~  120 (234)
                      .+|..|+..|++.+...-....+.   ..+..|... +.|+.         ++|.   .+++|++++|+|+++. .. ..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~---------~LH~~~~~~ivH~dlkp~NIll~~~~~~~  145 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA---------YLHSMQPKALIHRDLKPPNLLLVAGGTVL  145 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHH---------HHHTCSSSCCCCCCCSGGGEEEETTTTEE
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHH---------HHHhCCCCCeecCCCChhHEEEeCCCCEE
Confidence            577888888888876532111111   112222222 45555         7787   6799999999999994 33 47


Q ss_pred             eEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhhC
Q 026720          121 KIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA--DQIYKICQLIG  198 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~--~~~~~i~~~~~  198 (234)
                      +++|||.+......  .....+++.|++||++.+ ..++..+|+||+|++++++++|+.||.+....  .....+.....
T Consensus       146 kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  222 (307)
T 2eva_A          146 KICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR  222 (307)
T ss_dssp             EECCCCC--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC
T ss_pred             EEcccccccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC
Confidence            99999998765442  223457889999999874 45789999999999999999999999865432  22223333323


Q ss_pred             CCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          199 SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+.....+..+..++..|+...+.+|+++++++.
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3344567778888999999999999999988753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.60  E-value=2.4e-16  Score=125.18  Aligned_cols=175  Identities=18%  Similarity=0.296  Sum_probs=124.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|.+.+...-.. .++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.|||
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN---------FLHSKRIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHH---------HHhcCCcccCCCCHHHEEECCCCCEEEEECC
Confidence            46667777777766543211 1222233333333 56666         88999999999999999994 6678999999


Q ss_pred             ccccccCC-CCCCCcccCcccccccccc----cccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--
Q 026720          127 MVKEIDSN-LPCTDYVTTRWYRGPEVLL----FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--  199 (234)
Q Consensus       127 ~a~~~~~~-~~~~~~~~~~~~~~pe~~~----~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--  199 (234)
                      .+...... .......+++.|.+||++.    ....++..+|+||+|++++++++|..||.+........++......  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  242 (302)
T 2j7t_A          163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL  242 (302)
T ss_dssp             HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc
Confidence            76543211 1123346788899999873    2344788999999999999999999999988877776666554322  


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.+..|+..+..++..++...+.+|+++++++++
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            2245677788889999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.60  E-value=3.6e-16  Score=124.02  Aligned_cols=175  Identities=18%  Similarity=0.231  Sum_probs=122.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhc--cCccccHHH-------HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMR--EKNLQSWTI-------MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGV  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~--~~~~~~~~~-------~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~  119 (234)
                      .+|..|+..|.+.+...-...-.  .....++..       ++.|+.         ++|..+++|++++|+|+++ ....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~  159 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE---------YLHKNGQIHRDVKAGNILLGEDGS  159 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCSGGGEEECTTCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHH---------HHHhCCCCCCCCChhhEEEcCCCC
Confidence            46777888888877655332111  112223222       255555         7898999999999999999 4567


Q ss_pred             eeEeeccccccccCCC------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 026720          120 IKIGDLGMVKEIDSNL------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI  193 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i  193 (234)
                      .+++|||.+.......      ......+++.|.+||++.....++..+|+||+|++++++++|+.||.+..........
T Consensus       160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  239 (303)
T 2vwi_A          160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT  239 (303)
T ss_dssp             EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred             EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence            8999999887653211      1223467888999999865455789999999999999999999999988776665554


Q ss_pred             HHhhCCC---------CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          194 CQLIGSP---------TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       194 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .......         ....++..+..+...|+..++.+|+++++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            4322111         113455677788889999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.60  E-value=3.3e-16  Score=126.11  Aligned_cols=173  Identities=20%  Similarity=0.330  Sum_probs=126.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc--------------CccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEE
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE--------------KNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLL  114 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~--------------~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~  114 (234)
                      .+|..|+..|++.+...-......              ..+..+.. ++.|+.         ++|..+++|+|++|+|++
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA---------FLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGCE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHH---------HHhcCCcccCCcccceEE
Confidence            467778888888877654332211              11222222 255555         889999999999999999


Q ss_pred             ee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 026720          115 VS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQ  189 (234)
Q Consensus       115 ~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~  189 (234)
                      +. ....+++|||.+........   .....++..|.+||.+.+ ..++..+|+||+|++++++++ |..||++......
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            94 56789999999886644221   122344567999999864 447899999999999999998 8899998776666


Q ss_pred             HHHHHHhh-CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQLI-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+.... ..+.+...+..+..++..|+...+.+|+++.++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            65655433 33445566778888999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.60  E-value=2.6e-16  Score=124.07  Aligned_cols=173  Identities=16%  Similarity=0.277  Sum_probs=126.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .+|..|+..|++.+...-...  ++...+..+. .++.|+.         ++|..+++|++++|+|+++ .....++.||
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~i~H~dikp~Nil~~~~~~~~l~Df  155 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME---------YLEKKNFIHRDLAARNCLVGENHLVKVADF  155 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHH---------HHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHH---------HHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence            356677777777765432111  1111222222 2356666         8899999999999999999 4567899999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.+........  .....+++.|.+||.+.+ ..++..+|+||+|++++++++ |..||++.........+......+.+
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 3kfa_A          156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  234 (288)
T ss_dssp             CGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred             ccceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC
Confidence            99886544221  122344567999999874 347899999999999999999 99999987766666556555555666


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++..+..+...++..++.+|+++.++++
T Consensus       235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            778888999999999999999999998754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.59  E-value=4.3e-15  Score=118.62  Aligned_cols=137  Identities=28%  Similarity=0.475  Sum_probs=107.9

Q ss_pred             HhhhcccccCCcCCCcEEee--CCeeeEeeccccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI  170 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~  170 (234)
                      ++|+.+++|++++|+|+++.  ....+++|||.+.......    ......+++.|.+||.+.....++..+|+||+|++
T Consensus       135 ~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i  214 (320)
T 2i6l_A          135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI  214 (320)
T ss_dssp             HHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHH
T ss_pred             HHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHH
Confidence            88999999999999999995  4578999999988754321    12233557789999998755668899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-----------------------------CCCcchhhhhhhhccccCC
Q 026720          171 MFEMLSFGILFPGKSSADQIYKICQLIGSPTK-----------------------------DSWPLGIQLASNLNWKLPQ  221 (234)
Q Consensus       171 l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~  221 (234)
                      ++++++|+.||.+....+....+.+....+..                             ...+..+..++..++..++
T Consensus       215 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  294 (320)
T 2i6l_A          215 FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP  294 (320)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSG
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCc
Confidence            99999999999999888887777665432211                             2356677888888999999


Q ss_pred             CCCccccccCCC
Q 026720          222 MGGVNLLAVMPS  233 (234)
Q Consensus       222 ~~~~~~~~~~~~  233 (234)
                      .+|+++++++++
T Consensus       295 ~~Rpt~~ell~h  306 (320)
T 2i6l_A          295 MDRLTAEEALSH  306 (320)
T ss_dssp             GGSCCHHHHHTS
T ss_pred             cccCCHHHHhCC
Confidence            999999998764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.59  E-value=3.4e-16  Score=125.83  Aligned_cols=173  Identities=17%  Similarity=0.265  Sum_probs=126.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc-CccccHH-------HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----C
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE-KNLQSWT-------IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----K  117 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~-~~~~~~~-------~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~  117 (234)
                      .+|..|+..|.+.+...-...... +...++.       .++.|+.         ++|..+++|++++|+|+++.    .
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~---------~LH~~~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ---------YLEENHFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHH---------HHhhCCeecCcCCHhHEEEecCCCc
Confidence            467778888888776554321111 1223332       2255555         88999999999999999994    2


Q ss_pred             CeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 026720          118 GVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKI  193 (234)
Q Consensus       118 ~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i  193 (234)
                      ...+++|||.+.......   ......+++.|++||.+.+ ..++..+|+||+|++++++++ |..||.+....+....+
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            357999999887653321   1123455778999999864 347899999999999999998 88999988777766666


Q ss_pred             HHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          194 CQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ......+.+..++..+..++..|+...+.+|+++.++++
T Consensus       259 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  297 (327)
T 2yfx_A          259 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE  297 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            555444555677888999999999999999999998864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.59  E-value=6e-15  Score=117.82  Aligned_cols=137  Identities=20%  Similarity=0.264  Sum_probs=97.5

Q ss_pred             Hhhhc-ccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCccccccccccc----ccCCCCcchHHHHHHH
Q 026720           97 SLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAI  170 (234)
Q Consensus        97 ~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~  170 (234)
                      ++|.. +++|++++|+|+++ .....++.|||.+.............+++.|.+||++..    ...++..+|+||+|++
T Consensus       139 ~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i  218 (318)
T 2dyl_A          139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS  218 (318)
T ss_dssp             HHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred             HHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence            78874 89999999999999 456789999999877654433344567889999999842    3457889999999999


Q ss_pred             HHHHHhCCCCCCCCC-hHHHHHHHHHhhCC--CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          171 MFEMLSFGILFPGKS-SADQIYKICQLIGS--PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       171 l~e~~~~~~~f~~~~-~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++++++|+.||.+.. ..+....+......  +....++..+..++..|+..++.+|+++++++.+
T Consensus       219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            999999999999754 44444445443222  2223567788899999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.59  E-value=9.8e-16  Score=120.91  Aligned_cols=173  Identities=20%  Similarity=0.330  Sum_probs=125.7

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+...-.. .++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.|||
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG---------YLESKRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence            36677788888877654321 1232333333333 66666         8899999999999999999 56788999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh-CCC
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLI-GSP  200 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~-~~~  200 (234)
                      .+........    .....++..|.+||++.+ ..++...|+||+|++++++++ |..||.+....+....+.... ..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  245 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC
Confidence            9887643221    122344567999999864 346889999999999999999 999999888777666665432 234


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....++..+..++..++...+.+|+++.++++
T Consensus       246 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            45567788889999999999999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.59  E-value=8.4e-16  Score=121.16  Aligned_cols=172  Identities=16%  Similarity=0.233  Sum_probs=119.9

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcc--cccCCcCCCcEEee-CC-----e
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQG--YFHRDLKPSNLLVS-KG-----V  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~--~~~~~l~p~~~~~~-~~-----~  119 (234)
                      .++..|+..|++.+...--. .++...+..+... +.|+.         ++|..+  ++|++++|+|+++. ..     .
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~---------~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE---------YMQNQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHH---------HHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHH---------HHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence            37788888888866432100 0111122222222 55555         788888  99999999999993 22     2


Q ss_pred             eeEeeccccccccCCCCCCCcccCccccccccccc-ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHh
Q 026720          120 IKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF-SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ--IYKICQL  196 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~--~~~i~~~  196 (234)
                      .+++|||.+.....  ......+++.|.+||++.. ...++..+|+||+|++++++++|+.||.+......  ...+...
T Consensus       168 ~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          168 AKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             EEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             EEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            79999999886544  2334567889999999842 33467899999999999999999999987654333  2223222


Q ss_pred             h-CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          197 I-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       197 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      . ..+.+..++..+..++..++..++.+|++++++++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2 22334567778899999999999999999998864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.58  E-value=5.6e-16  Score=124.54  Aligned_cols=173  Identities=20%  Similarity=0.344  Sum_probs=125.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...-... ++...+..+... +.|+.         ++|+.+++|++++|+|+++ .....++.|||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~---------~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME---------YLGSRRCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence            377888888998887654322 333344444433 66777         8999999999999999999 57789999999


Q ss_pred             ccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--------------H
Q 026720          127 MVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA--------------D  188 (234)
Q Consensus       127 ~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~--------------~  188 (234)
                      .+.......    ......++..|.+||++.+ ..++..+|+||+|++++++++|..||.+....              .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence            988764322    1222346667999999864 34688999999999999999999998654321              2


Q ss_pred             HHHHHH-HhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          189 QIYKIC-QLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       189 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...... .....+.+..++..+..+...|+...+.+|+++.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222222 22334455677888999999999999999999998853

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.58  E-value=1.3e-16  Score=127.91  Aligned_cols=175  Identities=22%  Similarity=0.208  Sum_probs=119.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .+|..|+..|.+.+...-...++...+..+.. ++.|+.         ++|..+++|++++|+|+++.    ....+++|
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ---------YLHENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            46677777777765432111122222222322 356666         88999999999999999994    23489999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccc--cccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-CCCC
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLL--FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-GSPT  201 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-~~~~  201 (234)
                      ||.+.............+++.|.+||++.  ....++..+|+||+|++++++++|..||.+......+....... ....
T Consensus       161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            99988764422122345788899999974  23457899999999999999999999998765443333322221 1111


Q ss_pred             C---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 K---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +   ...++.+..+...++..++.+|+++++++.+
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1   3456677888888999999999999998764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.58  E-value=2.1e-15  Score=118.52  Aligned_cols=168  Identities=20%  Similarity=0.233  Sum_probs=122.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++..|+..|.+.+...-...  ++...+..+.. ++.|+.         ++|..+++|++++|+|+++ .....+++||
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           96 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD---------YIHSKKLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence            477788888898887653211  22222233333 366666         8899999999999999999 5678899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |.+.............+++.|.+||.+.+ ..++...|+||+|+++++++++..++.+.   .......  ........+
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~--~~~~~~~~~  240 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDL--RDGIISDIF  240 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHH--HTTCCCTTS
T ss_pred             hhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHh--hcccccccC
Confidence            99887765444445578889999999874 44789999999999999999999877532   1111111  122233556


Q ss_pred             cchhhhhhhhccccCCCCCccccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..+..++..++..++.+|+++.+++.
T Consensus       241 ~~~~~~li~~~l~~dp~~Rps~~e~l~  267 (284)
T 2a19_B          241 DKKEKTLLQKLLSKKPEDRPNTSEILR  267 (284)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            778888899999999999999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.58  E-value=1.1e-15  Score=121.88  Aligned_cols=172  Identities=17%  Similarity=0.161  Sum_probs=111.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.+..+-...++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.|||.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~  180 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD---------AAHAAGATHRDVKPENILVSADDFAYLVDFGI  180 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence            456677777787776543322333333333333 56666         8899999999999999999 466789999998


Q ss_pred             cccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC--CCC
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP--TKD  203 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~--~~~  203 (234)
                      +.......  ......+++.|.+||.+.+ ..++...|+||+|++++++++|..||.+.........+......+  ...
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRP  259 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTST
T ss_pred             CccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCC
Confidence            87654321  1233467888999999864 457889999999999999999999998765443222222221111  124


Q ss_pred             CCcchhhhhhhhccccCCCCCc-cccccC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGV-NLLAVM  231 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  231 (234)
                      .++..+..++..++...+.+|+ ++++++
T Consensus       260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~  288 (309)
T 2h34_A          260 GIPVAFDAVIARGMAKNPEDRYVTCGDLS  288 (309)
T ss_dssp             TCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence            5667888889999999999998 787764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.57  E-value=3e-16  Score=123.19  Aligned_cols=173  Identities=21%  Similarity=0.303  Sum_probs=102.3

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++..|+..|.+.+...-. ..++...+..+.. ++.|+.         ++|..+++|++++|+|+++. ....++.|||
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML---------YLHSHGILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence            4666777777776654311 0111222223322 255666         88999999999999999994 5678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .+....... ......+++.|.+||.+.+ ..++...|+||+|++++++++|+.||.+....+...++... ....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~  235 (278)
T 3cok_A          158 LATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFL  235 (278)
T ss_dssp             TCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTS
T ss_pred             ceeeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCcccc
Confidence            988764321 1233567888999999864 34688999999999999999999999876655444333211 11223456


Q ss_pred             cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..+..++..++..++.+|+++++++.+
T Consensus       236 ~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          236 SIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            6778888899999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.57  E-value=7.3e-15  Score=117.28  Aligned_cols=137  Identities=21%  Similarity=0.305  Sum_probs=100.6

Q ss_pred             HhhhcccccCCcCCCcEEeeCCeeeEeeccccccccCCC---CCCCcccCcccccccccccc----------cCCCCcch
Q 026720           97 SLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFS----------EIYGPEVD  163 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~----------~~~~~~~d  163 (234)
                      ++|..+++|++++|+|+++.....+++|||.+.......   ......+++.|.|||++.+.          ..++..+|
T Consensus       142 ~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  221 (313)
T 3cek_A          142 TIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  221 (313)
T ss_dssp             HHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHH
T ss_pred             HHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHH
Confidence            889999999999999999988889999999988764322   12234678899999998541          34788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCC-CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          164 KWAMGAIMFEMLSFGILFPGKSSAD-QIYKICQLIGS-PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       164 ~~s~g~~l~e~~~~~~~f~~~~~~~-~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +||+|++++++++|+.||.+..... ....+...... +.+...+..+..++..|+..++.+|+++.+++.+
T Consensus       222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          222 VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            9999999999999999998765433 33333322222 2234446678888999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.57  E-value=9.8e-16  Score=123.25  Aligned_cols=170  Identities=22%  Similarity=0.282  Sum_probs=101.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh---hccCccccHHHH-HHHHHhcCCchhhhHhhhcc--cccCCcCCCcEEee-CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL---MREKNLQSWTIM-ISGLADNSRGNDAISLHRQG--YFHRDLKPSNLLVS-KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~---m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~--~~~~~l~p~~~~~~-~~~~~~  122 (234)
                      .++..|+. |.+.+...-...   ++...+..+... +.|+.         ++|..+  ++|+|++|+|+++. ....++
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ---------HMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHH---------HHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence            45666665 555554332211   112222333322 55666         888888  99999999999994 567899


Q ss_pred             eeccccccccCCCCC-------------CCcccCcccccccccc--cccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 026720          123 GDLGMVKEIDSNLPC-------------TDYVTTRWYRGPEVLL--FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA  187 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~-------------~~~~~~~~~~~pe~~~--~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~  187 (234)
                      +|||.+.........             ....+++.|.+||++.  ....++..+|+||+|++++++++|..||.+....
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999998876442111             1334778899999983  2344788999999999999999999999875443


Q ss_pred             HHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...   ......+.....+..+..++..++..++.+|+++.+++.
T Consensus       260 ~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  301 (337)
T 3ll6_A          260 RIV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH  301 (337)
T ss_dssp             ---------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Hhh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHH
Confidence            322   223344555666778888999999999999999998764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.57  E-value=3.1e-15  Score=120.16  Aligned_cols=136  Identities=23%  Similarity=0.368  Sum_probs=83.9

Q ss_pred             Hhhhc-ccccCCcCCCcEEe-eCCeeeEeeccccccccCCCCCCCcccCcccccccccc---cccCCCCcchHHHHHHHH
Q 026720           97 SLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL---FSEIYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~~d~~s~g~~l  171 (234)
                      ++|.. +++|++++|+|+++ .....+++|||.+.............+++.|.+||++.   ....++...|+||+|+++
T Consensus       140 ~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il  219 (327)
T 3aln_A          140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL  219 (327)
T ss_dssp             HHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHH
T ss_pred             HHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence            78887 89999999999999 46788999999998775544334446788899999983   234478999999999999


Q ss_pred             HHHHhCCCCCCCCChH-HHHHHHHHhhCCCC-----CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          172 FEMLSFGILFPGKSSA-DQIYKICQLIGSPT-----KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       172 ~e~~~~~~~f~~~~~~-~~~~~i~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++++|..||++.... +....+... ..+.     ...++..+..++..|+..++.+|+++.+++.+
T Consensus       220 ~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          220 YELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             HHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            9999999999875432 222111111 1111     12456778888999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.57  E-value=2.7e-16  Score=126.26  Aligned_cols=171  Identities=20%  Similarity=0.264  Sum_probs=115.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCc---cccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKN---LQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~---~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~  124 (234)
                      .++..|+..|++.+..+-........   +..+.. ++.|+.         ++|+.+++|+|++|+|+++. ....+++|
T Consensus       137 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dlkp~NIll~~~~~~kL~D  207 (332)
T 3qd2_B          137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE---------FLHSKGLMHRDLKPSNIFFTMDDVVKVGD  207 (332)
T ss_dssp             EEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHH---------HHHhCCeeecCCCcccEEEeCCCCEEEee
Confidence            57788899999888654322222211   222333 367777         89999999999999999994 67889999


Q ss_pred             ccccccccCCC-------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 026720          125 LGMVKEIDSNL-------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIY  191 (234)
Q Consensus       125 ~~~a~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~  191 (234)
                      ||.+.......             ......+++.|+|||++.+ ..++..+|+||+|+++++++++..++.+   .....
T Consensus       208 fG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~  283 (332)
T 3qd2_B          208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME---RVRII  283 (332)
T ss_dssp             CTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHH
T ss_pred             cCcccccccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHH
Confidence            99988765431             2234568899999999874 4579999999999999999997655421   11111


Q ss_pred             HHHHhhCCCC-CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          192 KICQLIGSPT-KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       192 ~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ........|. ...++..+..+...++..++.+|+++++++++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            1111111111 11223455667788999999999999998754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.57  E-value=2.6e-15  Score=119.66  Aligned_cols=173  Identities=23%  Similarity=0.423  Sum_probs=113.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh----ccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM----REKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m----~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      .++..|+..|.+.+...-+..-    +...+..+.. ++.|+.         ++|..+++|++++|+|+++. ....++.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~i~H~dl~p~NIl~~~~~~~kl~  178 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE---------HMHSRRVMHRDIKPANVFITATGVVKLG  178 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHH---------HHhhCCeeCCCCcHHHEEEcCCCCEEEE
Confidence            4677788888888776544321    1122223332 256666         88999999999999999994 6678999


Q ss_pred             eccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCC
Q 026720          124 DLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-SADQIYKICQLIGSPT  201 (234)
Q Consensus       124 ~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-~~~~~~~i~~~~~~~~  201 (234)
                      |||.+....... ......+++.|.+||.+.+ ..++...|+||+|++++++++|..||.+.. ......+.......+.
T Consensus       179 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  257 (310)
T 2wqm_A          179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP  257 (310)
T ss_dssp             CC------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred             eccceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence            999887654322 1223467788999999864 447899999999999999999999998653 2223333333222222


Q ss_pred             --CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 --KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                        ...++..+..+...|+..++.+|+++.+++.
T Consensus       258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              2567788899999999999999999998764

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.56  E-value=7e-16  Score=128.00  Aligned_cols=129  Identities=15%  Similarity=0.246  Sum_probs=101.5

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCCCCCCcccCcccccccccc---------cccCCCCcchHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL---------FSEIYGPEVDKWA  166 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~---------~~~~~~~~~d~~s  166 (234)
                      ++|+.+++|+|++|+|+++. ...++++|||.+......  .....+ +.|+|||++.         ....|+..+|+||
T Consensus       226 ~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          226 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             HHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             HHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            88999999999999999994 567999999998876543  233456 8899999983         2334778999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          167 MGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       167 ~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +|+++||+++|+.||.+.........++.     .....++.+..++..++..++.+|+++.+++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHCCCCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999999999987654433322222     223556788889999999999999998888753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.56  E-value=2.2e-16  Score=127.60  Aligned_cols=172  Identities=23%  Similarity=0.281  Sum_probs=101.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~  122 (234)
                      .+|..|+..|++.+...-..  .++...+..+... +.|+.         ++|..+++|++++|+|+++.    ....++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~---------~LH~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ---------FLHSHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence            57788888888877654211  1222233333333 66666         88999999999999999994    345899


Q ss_pred             eeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-----h
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL-----I  197 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~-----~  197 (234)
                      +|||.+...... ......+++.|++||++.+ ..++..+|+||+|++++++++|..||.+...........+.     .
T Consensus       173 ~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (336)
T 3fhr_A          173 TDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY  250 (336)
T ss_dssp             CCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             eccccceecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence            999998866542 2233566888999999853 34788999999999999999999999876544432222111     1


Q ss_pred             C--CCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          198 G--SPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       198 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .  .+....++..+..+...++..++.+|++++++++
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1  1222456777888888899999999999998875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.56  E-value=1.4e-15  Score=121.88  Aligned_cols=129  Identities=22%  Similarity=0.334  Sum_probs=102.5

Q ss_pred             HhhhcccccCCcCCCcEEee--CCeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++|+.+++|+|++|+|+++.  ....+++|||.+...... ......+++.|.+||++.+...++..+|+||+|++++|+
T Consensus       164 ~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el  242 (320)
T 3a99_A          164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM  242 (320)
T ss_dssp             HHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHH
Confidence            88999999999999999995  468899999998876543 233456888999999987555456788999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          175 LSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       175 ~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++|..||.+..      .+... .......++..+..++..|+..++.+|+++++++++
T Consensus       243 ~~g~~pf~~~~------~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          243 VCGDIPFEHDE------EIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             HHSSCSCCSHH------HHHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHCCCCCCChh------hhhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            99999997542      12221 222334567788889999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.56  E-value=8.6e-16  Score=121.92  Aligned_cols=173  Identities=20%  Similarity=0.343  Sum_probs=123.7

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|++.+...-. ..++...+..+... +.|+.         ++|+.+++|++++|+|+++ .....++.|||
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~---------~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD---------YLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHH---------HhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            4778888888988875322 12333333444333 66666         8999999999999999999 57788999999


Q ss_pred             ccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC--------------CChHH
Q 026720          127 MVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG--------------KSSAD  188 (234)
Q Consensus       127 ~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~--------------~~~~~  188 (234)
                      .+.......    ......++..|.+||.+.+ ..++..+|+||+|++++++++|..|+..              .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence            988765432    1223456667999999864 3467899999999999999999876532              22222


Q ss_pred             HHHHHHH-hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          189 QIYKICQ-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       189 ~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....... ....+.+..++..+..++..|+...+.+|+++.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            3333222 2233445677888999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.56  E-value=1e-15  Score=121.40  Aligned_cols=173  Identities=24%  Similarity=0.294  Sum_probs=116.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhh--------hcccccCCcCCCcEEee-CCe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLH--------RQGYFHRDLKPSNLLVS-KGV  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~--------~~~~~~~~l~p~~~~~~-~~~  119 (234)
                      .+|..|+..|++.+..+- ..++...+..+... +.|+.         ++|        +.+++|+|++|+|+++. ...
T Consensus        82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~---------~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLA---------HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHH---------HHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHH---------HHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence            477788888888776421 01111222222222 55555         788        78899999999999994 677


Q ss_pred             eeEeeccccccccCCCC-----CCCcccCccccccccccccc-----CCCCcchHHHHHHHHHHHHhC----------CC
Q 026720          120 IKIGDLGMVKEIDSNLP-----CTDYVTTRWYRGPEVLLFSE-----IYGPEVDKWAMGAIMFEMLSF----------GI  179 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~-----~~~~~~d~~s~g~~l~e~~~~----------~~  179 (234)
                      .+++|||.+........     .....+++.|+|||++.+..     .++..+|+||+|++++|+++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            89999999876543221     22347888999999986442     233689999999999999999          88


Q ss_pred             CCCCC----ChHHHHHHHHHhhCC-CCCC------CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          180 LFPGK----SSADQIYKICQLIGS-PTKD------SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       180 ~f~~~----~~~~~~~~i~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ||.+.    .......+....... +...      ..+..+..++..|+..++.+|+++.++++
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            88653    233333333322222 1111      12245777888899999999999998864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.56  E-value=6.7e-15  Score=119.09  Aligned_cols=174  Identities=17%  Similarity=0.201  Sum_probs=122.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc--Ccccc------HHH-HHHHHHhcCCchhhhHhhh-cccccCCcCCCcEEe-eCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE--KNLQS------WTI-MISGLADNSRGNDAISLHR-QGYFHRDLKPSNLLV-SKG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~--~~~~~------~~~-~i~~~~~~g~~~~a~~l~~-~~~~~~~l~p~~~~~-~~~  118 (234)
                      .+|..|+..|++.+..+.+..+..  ....+      +.. ++.|+.         ++|. .+++|++++|+|+++ ...
T Consensus       119 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFS---------YIHNEKNICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHH---------HHHHTSCEECCCCCGGGEEECTTS
T ss_pred             EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHH---------HHhccCCEeecCCChHhEEEcCCC
Confidence            466777777777654211111111  11222      222 255666         8888 889999999999999 466


Q ss_pred             eeeEeeccccccccCCCCCCCcccCcccccccccccccCCCC-cchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHh
Q 026720          119 VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGP-EVDKWAMGAIMFEMLSFGILFPGKSS-ADQIYKICQL  196 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~~d~~s~g~~l~e~~~~~~~f~~~~~-~~~~~~i~~~  196 (234)
                      ..+++|||.+...... ......+++.|.+||++.+...++. .+|+||+|++++++++|..||.+... .+....+...
T Consensus       190 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~  268 (348)
T 2pml_X          190 RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK  268 (348)
T ss_dssp             CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred             cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence            7899999998876443 2344567889999999975534555 89999999999999999999998777 4444444332


Q ss_pred             hCCCCC------------------CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          197 IGSPTK------------------DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       197 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ....+.                  ..++..+..+...++..++.+|+++++++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            211111                  4566778888889999999999999998764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.55  E-value=4.7e-17  Score=134.34  Aligned_cols=172  Identities=19%  Similarity=0.326  Sum_probs=119.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh---hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe----e-CCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL---MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----S-KGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~---m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~-~~~~  120 (234)
                      .+|..|+..|++.+..+-...   ++...+..+... +.|+.         ++|..+++|+|++|+|+++    . ....
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~---------~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN---------HLRENGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHH---------HHHHCCEEECCcCHHHEEEeecCCCceeE
Confidence            578888888888776432211   222233333333 56666         8899999999999999987    2 2357


Q ss_pred             eEeeccccccccCCCCCCCcccCcccccccccccc-------cCCCCcchHHHHHHHHHHHHhCCCCCCCC----ChHHH
Q 026720          121 KIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS-------EIYGPEVDKWAMGAIMFEMLSFGILFPGK----SSADQ  189 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~~d~~s~g~~l~e~~~~~~~f~~~----~~~~~  189 (234)
                      +++|||.+.............+++.|++||++.+.       ..|+..+|+||+|+++||+++|+.||.+.    ...+.
T Consensus       156 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  235 (396)
T 4eut_A          156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (396)
T ss_dssp             EECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred             EEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence            89999999876554444456788999999987531       34678899999999999999999999753    33444


Q ss_pred             HHHHHHhhCCCCC--------------------------CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQLIGSPTK--------------------------DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++...  .|..                          ...+..+..+.+.++..++.+|+++.+++.
T Consensus       236 ~~~~~~~--~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          236 MYKIITG--KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHHHS--CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHHHhcC--CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            4444432  2211                          111234556667788889999999988754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.55  E-value=3.8e-15  Score=117.73  Aligned_cols=175  Identities=19%  Similarity=0.251  Sum_probs=122.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hc--cCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MR--EKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~--~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~  123 (234)
                      .++..|+..|.+.+...-... ..  ...+..+. .++.|+.         ++|..+++|++++|+|+++.  ....+++
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dl~p~Nil~~~~~~~~kl~  165 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK---------YLHDNQIVHRDIKGDNVLINTYSGVLKIS  165 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEEETTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHH---------HHHhCCEEccCCChhhEEEECCCCCEEEe
Confidence            466677777887776543110 00  11112222 3366666         88999999999999999995  5678999


Q ss_pred             eccccccccCCC-CCCCcccCccccccccccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh--hCC
Q 026720          124 DLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSE-IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL--IGS  199 (234)
Q Consensus       124 ~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~--~~~  199 (234)
                      |||.+....... ......+++.|.+||++.+.. .++...|+||+|++++++++|+.||.+.............  ...
T Consensus       166 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (295)
T 2clq_A          166 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP  245 (295)
T ss_dssp             CTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC
T ss_pred             ecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc
Confidence            999988764322 123456788999999986432 3688999999999999999999999876554433222111  122


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..++..+..++..|+..++.+|+++++++.+
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            3345677788889999999999999999998764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.54  E-value=1.8e-14  Score=114.39  Aligned_cols=135  Identities=20%  Similarity=0.296  Sum_probs=106.3

Q ss_pred             HhhhcccccCCcCCCcEEe-eCCeeeEeeccccccccCCC---CCCCcccCccccccccccccc-CCCCcchHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSE-IYGPEVDKWAMGAIM  171 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~-~~~~~~d~~s~g~~l  171 (234)
                      ++|+.+++|++++|+|+++ .....++.+|+.+.......   ......+++.|.+||+..+.. .++..+|+||+|+++
T Consensus       124 ~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il  203 (305)
T 2wtk_C          124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL  203 (305)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred             HHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence            8899999999999999999 46678999999988764321   123446788999999986433 246789999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          172 FEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       172 ~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +++++|..||.+.........+... ..+.+..++..+..+...++..++.+|+++++++.
T Consensus       204 ~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          204 YNITTGLYPFEGDNIYKLFENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCCCCCCchHHHHHHHHhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9999999999987766665555443 23334566778888999999999999999998874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.53  E-value=6.9e-16  Score=123.37  Aligned_cols=174  Identities=18%  Similarity=0.279  Sum_probs=119.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~  123 (234)
                      .+|..|+..|.+.+...-...    ++...+..+... +.|+.         ++|..+++|++++|+|+++ .....++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~---------~LH~~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE---------AIHAKGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence            377788888888876654321    111222223222 55666         8899999999999999999 45678999


Q ss_pred             eccccccccCCCCC----------CCcccCccccccccccccc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCh--HHH
Q 026720          124 DLGMVKEIDSNLPC----------TDYVTTRWYRGPEVLLFSE--IYGPEVDKWAMGAIMFEMLSFGILFPGKSS--ADQ  189 (234)
Q Consensus       124 ~~~~a~~~~~~~~~----------~~~~~~~~~~~pe~~~~~~--~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~--~~~  189 (234)
                      +||.+.........          ....+++.|.+||++.+..  .++..+|+||+|++++++++|+.||.+...  ...
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  256 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV  256 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence            99987764321100          1123477899999986432  267899999999999999999999964211  111


Q ss_pred             HHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ...+......|....++..+..++..++..++.+|+++++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  299 (317)
T 2buj_A          257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS  299 (317)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2222233344555677888999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.53  E-value=1.9e-14  Score=117.39  Aligned_cols=124  Identities=19%  Similarity=0.240  Sum_probs=95.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc-----CccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-------
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE-----KNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-------  116 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~-----~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-------  116 (234)
                      .+|..|+..|++.+..........     ..+..+... +.|+.         ++|..+++|+|++|+|+++.       
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~---------~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE---------QVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHH---------HHhhCCeecCCCCHHHEEecccccCcc
Confidence            588899999999998776544322     223334333 56666         88999999999999999994       


Q ss_pred             -----CCeeeEeeccccccccC---CCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 026720          117 -----KGVIKIGDLGMVKEIDS---NLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG  183 (234)
Q Consensus       117 -----~~~~~~~~~~~a~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~  183 (234)
                           ....+++|||.+..+..   ........+++.|+|||++.+. .|+..+|+||+|++++||++|+.||..
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCcccc
Confidence                 46789999999975432   1123445789999999999754 489999999999999999999988753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.53  E-value=4.4e-15  Score=117.60  Aligned_cols=172  Identities=23%  Similarity=0.304  Sum_probs=111.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .++..|+..|++.+...-... .+...+..+. .++.|+.         ++|..+++|++++|+|+++ .....+++|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~---------~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           91 FIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS---------YIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             EEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             EEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHH---------HHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence            467778888888876542111 1111222232 2366666         8999999999999999999 45678999999


Q ss_pred             ccccccCCC---------------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 026720          127 MVKEIDSNL---------------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS-ADQI  190 (234)
Q Consensus       127 ~a~~~~~~~---------------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~-~~~~  190 (234)
                      .+.......               ......+++.|.+||++.+...++..+|+||+|++++++++   ||..... .+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            987654321               12234577889999998755568999999999999999998   4543322 2222


Q ss_pred             HHHHHhhCCCCC---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          191 YKICQLIGSPTK---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       191 ~~i~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+.......+.   ...+..+..+...++..++.+|+++++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            223222111111   2233456778888999999999999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.52  E-value=1.2e-15  Score=122.92  Aligned_cols=173  Identities=25%  Similarity=0.351  Sum_probs=114.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhc---------ccccCCcCCCcEEee-CC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQ---------GYFHRDLKPSNLLVS-KG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~---------~~~~~~l~p~~~~~~-~~  118 (234)
                      .+|..|+..|++.+..+-.. .+...+..+.. ++.|+.         ++|..         +++|+|++|+|+++. ..
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~---------~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLA---------YLHTELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHH---------HHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             EEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHH---------HHHhhhccccccccceeecccccceEEEcCCC
Confidence            47888999999987653211 11112222222 356666         78877         899999999999994 57


Q ss_pred             eeeEeeccccccccCCC---------CCCCcccCcccccccccccc------cCCCCcchHHHHHHHHHHHHhCCC-CCC
Q 026720          119 VIKIGDLGMVKEIDSNL---------PCTDYVTTRWYRGPEVLLFS------EIYGPEVDKWAMGAIMFEMLSFGI-LFP  182 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~---------~~~~~~~~~~~~~pe~~~~~------~~~~~~~d~~s~g~~l~e~~~~~~-~f~  182 (234)
                      ..+++|||.+..+....         ......+++.|+|||++.+.      ..++..+|+||+|++++|+++|.. +|+
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            88999999998764321         12234688899999998642      235678999999999999999964 444


Q ss_pred             CCC----------------hHHHHHHHHHhhC-CCC-CCCCcc------hhhhhhhhccccCCCCCccccccCC
Q 026720          183 GKS----------------SADQIYKICQLIG-SPT-KDSWPL------GIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       183 ~~~----------------~~~~~~~i~~~~~-~~~-~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..                ..+.......... .+. +..|..      .+..++..|+..++.+|+++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            332                1112222221111 111 233332      5778888899999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.52  E-value=1.4e-15  Score=121.78  Aligned_cols=172  Identities=22%  Similarity=0.322  Sum_probs=119.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+...-- .++...+..+... +.|+.         ++|..+++|++++|+|+++. ....++.|||.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~---------~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMA---------YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHH---------HHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence            4777888888887753210 1122222333322 56666         88999999999999999994 56789999999


Q ss_pred             cccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--------------HH
Q 026720          128 VKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA--------------DQ  189 (234)
Q Consensus       128 a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~--------------~~  189 (234)
                      +.......    ......++..|.+||++.+. .++..+|+||+|++++++++|..||......              ..
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR  259 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence            88765432    12233456679999998743 4678999999999999999999998753211              11


Q ss_pred             HHHHHH-hhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          190 IYKICQ-LIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       190 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .....+ ....+.+..++..+..++..|+...+.+|+++.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            112222 2233455677888999999999999999999998864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.52  E-value=1.7e-15  Score=120.55  Aligned_cols=169  Identities=19%  Similarity=0.267  Sum_probs=116.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-------HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-------MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-------~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~  121 (234)
                      .++..|+..|.+.+......   .....++..       ++.|+.         ++|..+++|++++|+|+++. ....+
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~i~H~dlkp~Nili~~~~~~k  173 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGIN---------FLHENHHIHRDIKSANILLDEAFTAK  173 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHH---------HHhcCCeecCCCCHHHEEEcCCCcEE
Confidence            46677788888877654321   112233332       245555         78989999999999999994 56789


Q ss_pred             EeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 026720          122 IGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG  198 (234)
Q Consensus       122 ~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~  198 (234)
                      +.|||.+.......   ......+++.|.+||.+.+  .++...|+||+|++++++++|..||.+.........+.+...
T Consensus       174 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (307)
T 2nru_A          174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE  251 (307)
T ss_dssp             ECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH
T ss_pred             EeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh
Confidence            99999887654321   1223467889999998863  378899999999999999999999987654333333322211


Q ss_pred             C----------C----CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          199 S----------P----TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       199 ~----------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .          +    .....++.+..+...|+...+.+||++.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1          1    11122345667788899999999999998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.51  E-value=2.3e-15  Score=121.18  Aligned_cols=172  Identities=24%  Similarity=0.326  Sum_probs=114.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhc--------ccccCCcCCCcEEe-eCCe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQ--------GYFHRDLKPSNLLV-SKGV  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~--------~~~~~~l~p~~~~~-~~~~  119 (234)
                      .+|..|+..|++.+..+- ..++...+..+... +.|+.         ++|..        +++|+|++|+|+++ ....
T Consensus       111 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~---------~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLC---------HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHH---------HHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             EEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHH---------HHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence            578888888888876532 11222222333332 55666         78876        89999999999999 4667


Q ss_pred             eeEeeccccccccCCCC-----CCCcccCcccccccccccccCCCC------cchHHHHHHHHHHHHhC----------C
Q 026720          120 IKIGDLGMVKEIDSNLP-----CTDYVTTRWYRGPEVLLFSEIYGP------EVDKWAMGAIMFEMLSF----------G  178 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~------~~d~~s~g~~l~e~~~~----------~  178 (234)
                      .+++|||.+..+.....     .....+++.|+|||++.+.. +..      .+|+||+|+++||+++|          .
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            89999999876543221     12456888999999986443 333      38999999999999999          7


Q ss_pred             CCCCCC----ChHHHHHHHHHhhC-CCC-CC-----CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          179 ILFPGK----SSADQIYKICQLIG-SPT-KD-----SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       179 ~~f~~~----~~~~~~~~i~~~~~-~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .||.+.    .............. .+. +.     ..+..+..++..|+..++.+|+++.+++.
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            777653    23333333322211 111 11     22334667888899999999999998864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.51  E-value=4.4e-15  Score=119.33  Aligned_cols=173  Identities=20%  Similarity=0.330  Sum_probs=120.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|..|+..|++.+...-... ++...+..+.. ++.|+.         ++|..+++|++++|+|+++ .....++.|||
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME---------YLGTKRYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH---------HHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence            477888888888876543211 22222223322 255666         8898999999999999999 46788999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCCh------------HH--
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS------------AD--  188 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~------------~~--  188 (234)
                      .+........    .....++..|.+||.+.+. .++..+|+||+|++++++++|..|+.....            ..  
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence            9887644321    1223455679999998643 468899999999999999999988763210            01  


Q ss_pred             -HHHHHHHh-hCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          189 -QIYKICQL-IGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       189 -~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       .+...... ...+.+..++..+..++..|+...+.+|+++.+++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             11122222 223445677888999999999999999999998764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.51  E-value=1.5e-14  Score=125.62  Aligned_cols=174  Identities=26%  Similarity=0.296  Sum_probs=121.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH---hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC----Ceee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN---LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK----GVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~---~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~----~~~~  121 (234)
                      .+|..|+..|++.+...-..   .++...+..+... +.|+.         ++|..+++|+|++|+|+++..    ...+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~---------yLHs~gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR---------YLHENRIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHH---------HHHHTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHH---------HHHHCCCccCCCCHHHeEeecCCCceeEE
Confidence            58888999999987755332   1333344444443 66777         899999999999999999952    3478


Q ss_pred             EeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-----
Q 026720          122 IGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL-----  196 (234)
Q Consensus       122 ~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~-----  196 (234)
                      ++|||.+.............+++.|.+||++.+ ..++..+|+||+|++++++++|..||.+.............     
T Consensus       165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH  243 (676)
T ss_dssp             ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred             EcccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence            999999988766544555678899999999864 45789999999999999999999999876443322111000     


Q ss_pred             -h------C-------CCCC----CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          197 -I------G-------SPTK----DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       197 -~------~-------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       .      +       .|.+    ..++..+..+...++..++.+|+++++++++
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h  298 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV  298 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence             0      0       0111    1134556677788899999999999988764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.51  E-value=1.9e-14  Score=114.76  Aligned_cols=166  Identities=18%  Similarity=0.229  Sum_probs=116.8

Q ss_pred             HHHHH-hhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEeecc
Q 026720           51 LVEMY-SKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIGDLG  126 (234)
Q Consensus        51 li~~~-~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~  126 (234)
                      ++..| +..|.+.+...-...+....+..+... +.|+.         ++|..+++|++++|+|+++.  ....++.|||
T Consensus       115 ~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---------HCHSRGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            34444 455666665433222222233333333 56666         88988999999999999995  5678999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      .+...... ......+++.|.+||++.+...++..+|+||+|++++++++|+.||.+..      .+... .......++
T Consensus       186 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-~~~~~~~~~  257 (312)
T 2iwi_A          186 SGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-ELHFPAHVS  257 (312)
T ss_dssp             SCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-CCCCCTTSC
T ss_pred             hhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-ccCCcccCC
Confidence            98876543 23445678899999998754444558999999999999999999997532      12221 222234567


Q ss_pred             chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+..++..++...+.+|+++++++.+
T Consensus       258 ~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          258 PDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            788888999999999999999998753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.50  E-value=7.9e-14  Score=116.39  Aligned_cols=172  Identities=26%  Similarity=0.240  Sum_probs=113.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc-------CccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC----
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE-------KNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK----  117 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~-------~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~----  117 (234)
                      .++..|+. |++.+...-......       .++..+... +.|+.         ++|+.+++|+|++|+|+++..    
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDLkp~NILl~~~~~~  154 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA---------HLHSLKIIHRDLKPQNILVSTSSRF  154 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEEECCHHH
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHH---------HHHHCCccccCCChHhEEEecCccc
Confidence            45666774 566655432211111       122233333 67777         899999999999999999942    


Q ss_pred             ----------CeeeEeeccccccccCCC-----CCCCcccCccccccccccc------ccCCCCcchHHHHHHHHHHHHh
Q 026720          118 ----------GVIKIGDLGMVKEIDSNL-----PCTDYVTTRWYRGPEVLLF------SEIYGPEVDKWAMGAIMFEMLS  176 (234)
Q Consensus       118 ----------~~~~~~~~~~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~------~~~~~~~~d~~s~g~~l~e~~~  176 (234)
                                ...+++|||.+..+....     ......+++.|+|||++.+      ...++..+|+||+|++++|+++
T Consensus       155 ~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt  234 (434)
T 2rio_A          155 TADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS  234 (434)
T ss_dssp             HSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence                      368999999998765422     1223568899999999864      2457899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHhhCCCCCC------CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          177 -FGILFPGKSSADQIYKICQLIGSPTKD------SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       177 -~~~~f~~~~~~~~~~~i~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       |..||.+......  .+.......+..      ..+..+..++..++..++.+|+++.+++.+
T Consensus       235 ~g~~Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          235 KGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TSCCTTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             8999987655442  333332222211      122456677888999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.50  E-value=8.2e-15  Score=118.24  Aligned_cols=173  Identities=25%  Similarity=0.334  Sum_probs=116.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhh--------hcccccCCcCCCcEEe-eCCe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLH--------RQGYFHRDLKPSNLLV-SKGV  119 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~--------~~~~~~~~l~p~~~~~-~~~~  119 (234)
                      .+|..|+..|++.+..+-. .++...+..+... +.|+.         ++|        ..+++|+|++|+|+++ ....
T Consensus       116 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~---------~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLA---------HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHH---------HHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             EEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHH---------HHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence            5788888888888765321 1222222333322 55555         778        7789999999999999 4567


Q ss_pred             eeEeeccccccccCCC-----CCCCcccCcccccccccccccC-----CCCcchHHHHHHHHHHHHhC----------CC
Q 026720          120 IKIGDLGMVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSEI-----YGPEVDKWAMGAIMFEMLSF----------GI  179 (234)
Q Consensus       120 ~~~~~~~~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~-----~~~~~d~~s~g~~l~e~~~~----------~~  179 (234)
                      .++.|||.+.......     ......+++.|.|||++.+...     ++..+|+||+|++++|+++|          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            8999999987665432     2234567889999999864322     22579999999999999999          77


Q ss_pred             CCCCCC----hHHHHHHHH-HhhCCCCC-CCC-----cchhhhhhhhccccCCCCCccccccCC
Q 026720          180 LFPGKS----SADQIYKIC-QLIGSPTK-DSW-----PLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       180 ~f~~~~----~~~~~~~i~-~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ||.+..    ..+...+.. .....++. ..|     +..+..++..|+..++.+|+++++++.
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            887642    333333332 22222222 112     235667888899999999999998764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.50  E-value=3e-15  Score=120.11  Aligned_cols=171  Identities=20%  Similarity=0.206  Sum_probs=112.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-------HHHHHhcCCchhhhHhhhc---ccccCCcCCCcEEee-CC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-------ISGLADNSRGNDAISLHRQ---GYFHRDLKPSNLLVS-KG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-------i~~~~~~g~~~~a~~l~~~---~~~~~~l~p~~~~~~-~~  118 (234)
                      .+|..|+..|++.+...-..  ......++...       +.|+.         ++|..   +++|++++|+|+++. ..
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~---------~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERP--ESQPPLDWPKRQRIALGSARGLA---------YLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCS--TTCCCCCHHHHHHHHHHHHHHHH---------HHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             EEEEEeccCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCCCCeEeCCCchhhEEECCCC
Confidence            47778888888877643211  11112333322       44555         78887   899999999999994 56


Q ss_pred             eeeEeeccccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC-----CChHHHHH
Q 026720          119 VIKIGDLGMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG-----KSSADQIY  191 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~-----~~~~~~~~  191 (234)
                      ..+++|||.+.......  ......+++.|.+||++.+. .++..+|+||+|++++++++|..||+.     ........
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD  250 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred             CEEeccCccccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence            78999999998664321  12334578899999998643 478999999999999999999999962     11111111


Q ss_pred             HHHHhhCCCCC----------CC---CcchhhhhhhhccccCCCCCccccccCC
Q 026720          192 KICQLIGSPTK----------DS---WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       192 ~i~~~~~~~~~----------~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+.........          ..   ....+..+...|+..++.+||++.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  304 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR  304 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred             HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence            11111111100          00   1134555666789999999999998864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.48  E-value=4.2e-14  Score=117.95  Aligned_cols=173  Identities=17%  Similarity=0.135  Sum_probs=109.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----C--Ceee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----K--GVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~--~~~~  121 (234)
                      .++..|+. |.+.+...--.. .....+..+... +.|+.         ++|..+++|+|++|+|+++.    .  ...+
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~---------~LH~~~ivHrDlKp~NIll~~~~~~~~~~~k  163 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLA---------HLHSLNIVHRDLKPHNILISMPNAHGKIKAM  163 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHH---------HHHHTTCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHH---------HHHHCcCEeCCCCHHHEEEecCCCCCceeEE
Confidence            35556664 444443321110 111233334333 67777         89999999999999999993    1  2467


Q ss_pred             EeeccccccccCCC----CCCCcccCccccccccccc--ccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 026720          122 IGDLGMVKEIDSNL----PCTDYVTTRWYRGPEVLLF--SEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKIC  194 (234)
Q Consensus       122 ~~~~~~a~~~~~~~----~~~~~~~~~~~~~pe~~~~--~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~  194 (234)
                      ++|||.+..+....    ......+++.|+|||++..  ...++..+|+||+|++++|+++ |..||.+...... ..+.
T Consensus       164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~  242 (432)
T 3p23_A          164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL  242 (432)
T ss_dssp             ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT
T ss_pred             EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh
Confidence            99999998765321    2334578999999999864  2346779999999999999999 8888865543332 2222


Q ss_pred             HhhCCCC---CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          195 QLIGSPT---KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       195 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .....+.   ....+..+..++..++..++.+|+++++++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            1111111   11122345667888999999999999998764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.44  E-value=3.1e-14  Score=114.03  Aligned_cols=177  Identities=19%  Similarity=0.172  Sum_probs=111.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhcc-CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMRE-KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~-~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.+...-   -.. ....++...+..+.+.....+  ++|..+++|+|++|+|+++. ....++.|||.
T Consensus       111 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~i~~~l~--~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYG---SDLPTMSMSWEQRLEICIGAARGLH--YLHTRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             EEEEECCTTCBTGGGSSS---SCCCSCCCCHHHHHHHHHHHHHHHH--HHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhc---cCCCccccCHHHHHHHHHHHHHHHH--HhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            466677777777653210   000 112344333332222111111  78888999999999999994 56789999999


Q ss_pred             cccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhhCC--
Q 026720          128 VKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ---IYKICQLIGS--  199 (234)
Q Consensus       128 a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~---~~~i~~~~~~--  199 (234)
                      +.......   ......+++.|.+||++.+. .++..+|+||+|++++|+++|+.||.+....+.   ..........  
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            87643321   12234578889999998643 478999999999999999999999986532211   1111111111  


Q ss_pred             ------CCC-----CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 ------PTK-----DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                            +..     ...+..+..+...|+..++.+|+++.+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  308 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW  308 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                  110     111234556667899999999999998864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.41  E-value=4e-14  Score=112.35  Aligned_cols=153  Identities=20%  Similarity=0.235  Sum_probs=105.3

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~  122 (234)
                      .+|..|+..|++.+...-..  .++...+..+... +.|+.         ++|..+++|++++|+|+++.    ....++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~---------~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ---------YLHSINIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence            57788888888887655321  1233333344333 66666         88999999999999999994    467899


Q ss_pred             eeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC-
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT-  201 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~-  201 (234)
                      +|||.+.....                      ..|+..+|+||+|++++++++|..||.+.........+........ 
T Consensus       162 ~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  219 (299)
T 3m2w_A          162 TDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  219 (299)
T ss_dssp             CCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred             ecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence            99998765332                      1256789999999999999999999987654443222222111111 


Q ss_pred             --C----CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 --K----DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 --~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        +    ..++..+..+...++..++.+|+++++++++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              1    3467788888899999999999999998764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.27  E-value=6.4e-14  Score=123.19  Aligned_cols=118  Identities=20%  Similarity=0.265  Sum_probs=88.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeecccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMV  128 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a  128 (234)
                      .||..|+..|.+.+...  ..++...+..|... +.|+.         ++|+.+++|+|++|+|+++.....++.|||.+
T Consensus       160 ~lv~E~~~g~~L~~~~~--~~l~~~~~~~~~~qi~~aL~---------~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a  228 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALS---------YLHSIGLVYNDLKPENIMLTEEQLKLIDLGAV  228 (681)
T ss_dssp             EEEEECCCCEECC------CCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECSSCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHh--CCCCHHHHHHHHHHHHHHHH---------HHHHCCCeecccChHHeEEeCCcEEEEecccc
Confidence            57888888888765322  12222333334333 55666         88999999999999999997667899999999


Q ss_pred             ccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 026720          129 KEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPG  183 (234)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~  183 (234)
                      ......   ....+++.|++||++.+.  ++..+|+||+|++++++++|.++|.+
T Consensus       229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            876543   445688999999998643  47899999999999999999988875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.12  E-value=2.5e-12  Score=103.61  Aligned_cols=117  Identities=15%  Similarity=0.049  Sum_probs=84.4

Q ss_pred             HHHHHHhhcCC-hHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhh-hcccccCCcCCCcEEee-CC-------
Q 026720           50 ALVEMYSKCGH-VEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLH-RQGYFHRDLKPSNLLVS-KG-------  118 (234)
Q Consensus        50 ~li~~~~~~g~-~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~-~~~~~~~~l~p~~~~~~-~~-------  118 (234)
                      .||.+|+..|. ++...+  ..+++..+..+..+ +.|+.         ++| ..+++|+|++|+|+++. ..       
T Consensus       138 ~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~---------~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~  206 (336)
T 2vuw_A          138 FIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA---------VAEASLRFEHRDLHWGNVLLKKTSLKKLHYT  206 (336)
T ss_dssp             EEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH---------HHHHHHCCBCSCCCGGGEEEEECSCSEEEEE
T ss_pred             EEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH---------HHHHhCCEeECCCCHHHEEEeccCCcceeee
Confidence            45666777774 333211  12233344455554 77777         899 88999999999999994 33       


Q ss_pred             -------------eeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHH-HHHHHhCCCCCCC
Q 026720          119 -------------VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI-MFEMLSFGILFPG  183 (234)
Q Consensus       119 -------------~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~-l~e~~~~~~~f~~  183 (234)
                                   ..+++|||.++.....    ...+++.|+|||++.+..  +..+|+||+++. .++++.|..||++
T Consensus       207 ~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          207 LNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             ETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             ccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence                         7899999999876542    347888999999997543  789999997555 6678888888864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.11  E-value=1.7e-12  Score=102.36  Aligned_cols=144  Identities=14%  Similarity=0.114  Sum_probs=93.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHH-HHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWT-IMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+..+  +......+..+. .++.|+.         ++|..+++|+|++|+|+++. .+..++.    
T Consensus       107 ~lv~e~~~g~~L~~~l~--~~~~~~~~~~i~~ql~~aL~---------~lH~~givH~Dikp~NIll~~~g~~kl~----  171 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAAD---------AAHRAGVALSIDHPSRVRVSIDGDVVLA----  171 (286)
T ss_dssp             EEEEECCCEEEHHHHHT--TCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCSGGGEEEETTSCEEEC----
T ss_pred             EEEEEecCCCCHHHHHh--cCCChHHHHHHHHHHHHHHH---------HHHHCCCccCCCCcccEEEcCCCCEEEE----
Confidence            57778888888877642  111111222222 2356666         88999999999999999995 3444443    


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh-CCCC-----
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI-GSPT-----  201 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~-~~~~-----  201 (234)
                                     ...|.+|        ++..+|+||+|+++||+++|+.||.+....+......+.. +.+.     
T Consensus       172 ---------------~~~~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T 3uqc_A          172 ---------------YPATMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI  228 (286)
T ss_dssp             ---------------SCCCCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred             ---------------eccccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence                           1122222        5788999999999999999999999876543221111111 1111     


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ....+..+..++..|+..++.+| ++++++.
T Consensus       229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          229 DRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             ccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            13456678888888998888888 8887753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=98.80  E-value=4.4e-11  Score=102.93  Aligned_cols=113  Identities=16%  Similarity=0.152  Sum_probs=70.7

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      -.||++|+..|.|.+.++-...++...  ....++.|+.         ++|+.+++|||+||+|+++ .++..++.|||.
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~~l~~~~--I~~QIl~AL~---------ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGl  385 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGEEIDREK--ILGSLLRSLA---------ALEKQGFWHDDVRPWNVMVDARQHARLIDFGS  385 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTCCCCHHH--HHHHHHHHHH---------HHHHTTCEESCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHhCCCCCHHH--HHHHHHHHHH---------HHHHCCceeccCchHhEEECCCCCEEEeeccc
Confidence            368999999999988765333232222  1234477887         9999999999999999999 467899999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHH
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEM  174 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~  174 (234)
                      ++.+.... ...+.++|++|++||++.+.  +....|+|+.|+.++++
T Consensus       386 Ar~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l  431 (569)
T 4azs_A          386 IVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNL  431 (569)
T ss_dssp             EESCC---CCSHHHHHHHHHHHHHHC-------------------CCC
T ss_pred             CeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhh
Confidence            98765432 23446789999999999753  45678999998876543

>2xpi_A Anaphase-promoting complex subunit CUT9; cell cycle, TPR, ubiquitin ligase; 2.60A {Schizosaccharomyces pombe}

Probab=98.44  E-value=1.9e-07  Score=80.10  Aligned_cols=93  Identities=8%  Similarity=-0.108  Sum_probs=57.0

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHh-hccC-----------
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNL-MREK-----------   74 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~-m~~~-----------   74 (234)
                      .||..++..+..+|.+.|++++|..++..+..  ..+|..+++.++..|.+.|++++|.++|++ ++..           
T Consensus       114 ~p~~~~~~~l~~~~~~~g~~~~A~~~~~~~~~--~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~~~~~~~~~~~~~~~~~  191 (597)
T 2xpi_A          114 TGNPNDAFWLAQVYCCTGDYARAKCLLTKEDL--YNRSSACRYLAAFCLVKLYDWQGALNLLGETNPFRKDEKNANKLLM  191 (597)
T ss_dssp             HCCHHHHHHHHHHHHHTTCHHHHHHHHHHTCG--GGTCHHHHHHHHHHHHHTTCHHHHHHHHCSSCTTC----------C
T ss_pred             CCCchHHHHHHHHHHHcCcHHHHHHHHHHHhc--cccchhHHHHHHHHHHHHhhHHHHHHHHhccCCccccccccccccc
Confidence            34555555556666666666666666555432  245566666666777777777777666663 3332           


Q ss_pred             -------ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           75 -------NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        75 -------~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                             ++.+|+.++.+|.+.|+.++|+.+|..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~  225 (597)
T 2xpi_A          192 QDGGIKLEASMCYLRGQVYTNLSNFDRAKECYKE  225 (597)
T ss_dssp             CCSSCCHHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             cccccchhHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence                   356677777777777777777776666

>2xpi_A Anaphase-promoting complex subunit CUT9; cell cycle, TPR, ubiquitin ligase; 2.60A {Schizosaccharomyces pombe}

Probab=98.38  E-value=4.4e-07  Score=77.79  Aligned_cols=92  Identities=9%  Similarity=-0.036  Sum_probs=84.8

Q ss_pred             CCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhh--ccCccccHHHHHHH
Q 026720            8 PNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLM--REKNLQSWTIMISG   85 (234)
Q Consensus         8 ~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m--~~~~~~~~~~~i~~   85 (234)
                      ++..+|+.++.+|.+.|++++|..++..+.+  ..||..+++.+...|.+.|++++|..+|+.+  ..++..+|+.++.+
T Consensus        82 ~~~~~~~~~~~~~~~~g~~~~A~~~~~~~~~--~~p~~~~~~~l~~~~~~~g~~~~A~~~~~~~~~~~~~~~~~~~l~~~  159 (597)
T 2xpi_A           82 SREDYLRLWRHDALMQQQYKCAAFVGEKVLD--ITGNPNDAFWLAQVYCCTGDYARAKCLLTKEDLYNRSSACRYLAAFC  159 (597)
T ss_dssp             CHHHHHHHHHHHHHHTTCHHHHHHHHHHHHH--HHCCHHHHHHHHHHHHHTTCHHHHHHHHHHTCGGGTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHccCchHHHHHHHHHHh--hCCCchHHHHHHHHHHHcCcHHHHHHHHHHHhccccchhHHHHHHHH
Confidence            5778899999999999999999999999985  4567789999999999999999999999998  45789999999999


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      |.+.|+.++|+.+|.+
T Consensus       160 ~~~~g~~~~A~~~~~~  175 (597)
T 2xpi_A          160 LVKLYDWQGALNLLGE  175 (597)
T ss_dssp             HHHTTCHHHHHHHHCS
T ss_pred             HHHHhhHHHHHHHHhc
Confidence            9999999999999986

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=98.12  E-value=6e-08  Score=82.96  Aligned_cols=115  Identities=17%  Similarity=0.177  Sum_probs=84.1

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeeccc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGM  127 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~  127 (234)
                      ..||.+|+..|++.+..+      +  ...|... +.++.         ++|+.+++|+|++|+|+++.. ..++.|||.
T Consensus       414 ~~lVmE~~~ggsL~~~l~------~--~~~i~~qi~~aL~---------~LH~~gIiHrDiKp~NILl~~-~~kL~DFGl  475 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIE------D--NLDIAYKIGEIVG---------KLHKNDVIHNDLTTSNFIFDK-DLYIIDFGL  475 (540)
T ss_dssp             TEEEEECCCSEEHHHHST------T--CTHHHHHHHHHHH---------HHHHTTEECTTCCTTSEEESS-SEEECCCTT
T ss_pred             cEEEEECCCCCCHHHHHH------H--HHHHHHHHHHHHH---------HHHHCcCccCCCCHHHEEECC-eEEEEECcc
Confidence            367888888888776532      1  3444444 77777         899999999999999999977 889999999


Q ss_pred             cccccCCCC--------CCCcccCcccccccccccc-cCCCCcchHHHHHHHHHHHHhCCCCC
Q 026720          128 VKEIDSNLP--------CTDYVTTRWYRGPEVLLFS-EIYGPEVDKWAMGAIMFEMLSFGILF  181 (234)
Q Consensus       128 a~~~~~~~~--------~~~~~~~~~~~~pe~~~~~-~~~~~~~d~~s~g~~l~e~~~~~~~f  181 (234)
                      ++.......        .....+++.|++||++... ..|+...|.|+...-..+...++..|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            987644211        1245678999999998641 23677788999877766766666554

>1b89_A Protein (clathrin heavy chain); triskelion, coated vesicles, endocytosis, SELF- assembly, alpha-alpha superhelix; 2.60A {Bos taurus} SCOP: a.118.1.3

Probab=97.57  E-value=1.1e-05  Score=66.66  Aligned_cols=89  Identities=13%  Similarity=0.010  Sum_probs=16.7

Q ss_pred             CCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHH
Q 026720            8 PNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLA   87 (234)
Q Consensus         8 ~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~   87 (234)
                      +|..+|..+++++.+.|++++|...+....+.  .++..+.+.|+.+|++.|++.++.++++   .|+..+|+.+...|.
T Consensus        59 ~D~~~y~~V~~~ae~~g~~EeAi~yl~~ark~--~~~~~i~~~Li~~Y~Klg~l~e~e~f~~---~pn~~a~~~IGd~~~  133 (449)
T 1b89_A           59 DDPSSYMEVVQAANTSGNWEELVKYLQMARKK--ARESYVETELIFALAKTNRLAELEEFIN---GPNNAHIQQVGDRCY  133 (449)
T ss_dssp             ----------------------------------------------------CHHHHTTTTT---CC-------------
T ss_pred             CCHHHHHHHHHHHHhCCCHHHHHHHHHHHHHh--CccchhHHHHHHHHHHhCCHHHHHHHHc---CCcHHHHHHHHHHHH
Confidence            56678888888888888888888866665553  4556778888888888888888776654   366667877777788


Q ss_pred             hcCCchhhhHhhhc
Q 026720           88 DNSRGNDAISLHRQ  101 (234)
Q Consensus        88 ~~g~~~~a~~l~~~  101 (234)
                      ..|+.++|..+|..
T Consensus       134 ~~g~yeeA~~~Y~~  147 (449)
T 1b89_A          134 DEKMYDAAKLLYNN  147 (449)
T ss_dssp             ---CTTTHHHHHHH
T ss_pred             HcCCHHHHHHHHHH
Confidence            78888888777765

>1b89_A Protein (clathrin heavy chain); triskelion, coated vesicles, endocytosis, SELF- assembly, alpha-alpha superhelix; 2.60A {Bos taurus} SCOP: a.118.1.3

Probab=97.37  E-value=0.00023  Score=58.83  Aligned_cols=81  Identities=12%  Similarity=0.066  Sum_probs=48.8

Q ss_pred             CCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHH
Q 026720            8 PNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLA   87 (234)
Q Consensus         8 ~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~   87 (234)
                      |+..+|+.+-..|...|++++|+..+..+         ..|..|...+.+.|++++|.+.+++.  .++.+|..++.+|.
T Consensus       120 pn~~a~~~IGd~~~~~g~yeeA~~~Y~~a---------~n~~~LA~~L~~Lg~yq~AVea~~KA--~~~~~Wk~v~~aCv  188 (449)
T 1b89_A          120 PNNAHIQQVGDRCYDEKMYDAAKLLYNNV---------SNFGRLASTLVHLGEYQAAVDGARKA--NSTRTWKEVCFACV  188 (449)
T ss_dssp             C----------------CTTTHHHHHHHT---------TCHHHHHHHHHTTTCHHHHHHHHHHH--TCHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHcCCHHHHHHHHHHh---------hhHHHHHHHHHHhccHHHHHHHHHHc--CCchhHHHHHHHHH
Confidence            56667777777777777777777777754         35777888888888888888888777  36778888888888


Q ss_pred             hcCCchhhhHhh
Q 026720           88 DNSRGNDAISLH   99 (234)
Q Consensus        88 ~~g~~~~a~~l~   99 (234)
                      ..|+.+.|....
T Consensus       189 ~~~ef~lA~~~~  200 (449)
T 1b89_A          189 DGKEFRLAQMCG  200 (449)
T ss_dssp             HTTCHHHHHHTT
T ss_pred             HcCcHHHHHHHH
Confidence            888777775543

>2fo7_A Synthetic consensus TPR protein; tetratricopeptide repeat, consensus protein, superhelix, de novo protein; 2.30A {Synthetic} SCOP: k.38.1.1 PDB: 2hyz_A

Probab=97.24  E-value=0.0014  Score=43.49  Aligned_cols=88  Identities=14%  Similarity=0.090  Sum_probs=40.1

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +..+...+...++.++|...+..+.+... .+...+..+...|.+.|+.++|...++.+..   .+...|..+...+.+.
T Consensus        38 ~~~~a~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~la~~~~~~  116 (136)
T 2fo7_A           38 WYNLGNAYYKQGDYDEAIEYYQKALELDP-RSAEAWYNLGNAYYKQGDYDEAIEYYQKALELDPRSAEAWYNLGNAYYKQ  116 (136)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHTTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCHHHHHHHHHHHHHHCC-CchHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCCCChHHHHHHHHHHHHH
Confidence            33344444444455555555555444321 1233444444455555555555555544322   1233444444445555


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|...+..
T Consensus       117 ~~~~~A~~~~~~  128 (136)
T 2fo7_A          117 GDYDEAIEYYQK  128 (136)
T ss_dssp             TCHHHHHHHHHH
T ss_pred             ccHHHHHHHHHH
Confidence            555555554443

>1w3b_A UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110; OGT, glcnac, nucleoporin, O-linked glycosylation, TPR repeat, protein binding; 2.85A {Homo sapiens} SCOP: a.118.8.1

Probab=97.19  E-value=0.0012  Score=53.15  Aligned_cols=123  Identities=13%  Similarity=0.038  Sum_probs=91.3

Q ss_pred             CC-CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHH
Q 026720            7 NP-NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIM   82 (234)
Q Consensus         7 ~~-~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~   82 (234)
                      .| +..++..+...+.+.|+.++|...+..+++.... +..+++.+...|.+.|+.++|...++.+.+   .+..+|+.+
T Consensus       233 ~p~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~-~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l  311 (388)
T 1w3b_A          233 SPNHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPH-FPDAYCNLANALKEKGSVAEAEDCYNTALRLCPTHADSLNNL  311 (388)
T ss_dssp             CTTCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTCSS-CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCCC-CHHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCcccHHHHHHH
Confidence            45 4567888888999999999999999999876432 355788999999999999999999988653   467788999


Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEeeccccccccC
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~~~~~a~~~~~  133 (234)
                      ...+.+.|+.++|+..+... +.  ..|+....    ...+...+++..+.....
T Consensus       312 ~~~~~~~g~~~~A~~~~~~a-l~--~~p~~~~~~~~l~~~~~~~g~~~~A~~~~~  363 (388)
T 1w3b_A          312 ANIKREQGNIEEAVRLYRKA-LE--VFPEFAAAHSNLASVLQQQGKLQEALMHYK  363 (388)
T ss_dssp             HHHHHTTTCHHHHHHHHHHH-TT--SCTTCHHHHHHHHHHHHTTTCCHHHHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHHH-Hh--cCCCcHHHHHHHHHHHHHcCCHHHHHHHHH
Confidence            99999999999999999873 32  34654322    123344556665555443

>1na0_A Designed protein CTPR3; de novo protein; HET: IPT; 1.60A {Unidentified} SCOP: k.38.1.1 PDB: 2wqh_A 3kd7_A

Probab=97.18  E-value=0.0023  Score=41.98  Aligned_cols=91  Identities=14%  Similarity=0.093  Sum_probs=76.5

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ..++..+-..+.+.++.++|...+....+... .+..++..+...|.+.|+.++|...++.+.+   .+...|..+...+
T Consensus         9 ~~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~la~~~   87 (125)
T 1na0_A            9 AEAWYNLGNAYYKQGDYDEAIEYYQKALELDP-NNAEAWYNLGNAYYKQGDYDEAIEYYQKALELDPNNAEAWYNLGNAY   87 (125)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHHHCc-CcHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCccHHHHHHHHHHH
Confidence            35667777888899999999999999987643 3566788999999999999999999988653   4667888888899


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      .+.|+.++|...+..
T Consensus        88 ~~~~~~~~A~~~~~~  102 (125)
T 1na0_A           88 YKQGDYDEAIEYYQK  102 (125)
T ss_dssp             HHTTCHHHHHHHHHH
T ss_pred             HHhcCHHHHHHHHHH
Confidence            999999999999877

>2fo7_A Synthetic consensus TPR protein; tetratricopeptide repeat, consensus protein, superhelix, de novo protein; 2.30A {Synthetic} SCOP: k.38.1.1 PDB: 2hyz_A

Probab=97.11  E-value=0.0021  Score=42.63  Aligned_cols=89  Identities=13%  Similarity=0.091  Sum_probs=73.6

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~   88 (234)
                      .+..+...+...|++++|..++..+.+... .+...+..+...|...|+.++|...++.+..   .+...|..+...+.+
T Consensus         3 ~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~l~~~~~~   81 (136)
T 2fo7_A            3 AWYNLGNAYYKQGDYDEAIEYYQKALELDP-RSAEAWYNLGNAYYKQGDYDEAIEYYQKALELDPRSAEAWYNLGNAYYK   81 (136)
T ss_dssp             HHHHHHHHHHHHTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHcCcHHHHHHHHHHHHHcCC-cchhHHHHHHHHHHHhcCHHHHHHHHHHHHHHCCCchHHHHHHHHHHHH
Confidence            456677778888999999999999987653 3566788889999999999999999988653   355678888888999


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus        82 ~~~~~~A~~~~~~   94 (136)
T 2fo7_A           82 QGDYDEAIEYYQK   94 (136)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             hcCHHHHHHHHHH
Confidence            9999999999877

>3mkr_A Coatomer subunit epsilon; tetratricopeptide repeats (TPR), beta-hairpin, alpha-solenoi transport protein; 2.60A {Bos taurus}

Probab=97.10  E-value=0.0013  Score=51.48  Aligned_cols=102  Identities=8%  Similarity=0.011  Sum_probs=81.1

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchh-HHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHH
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELD-VAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISG   85 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~-~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~   85 (234)
                      .|+..++..+...+.+.++.++|.+.+..++..+..|+ ...+..+-..|.+.|+.++|.+.++.  ..+...+..+...
T Consensus        62 ~~~~~a~~~la~~~~~~~~~~~A~~~l~~ll~~~~~P~~~~~~~~la~~~~~~g~~~~Al~~l~~--~~~~~~~~~l~~~  139 (291)
T 3mkr_A           62 APELQAVRMFAEYLASHSRRDAIVAELDREMSRSVDVTNTTFLLMAASIYFYDQNPDAALRTLHQ--GDSLECMAMTVQI  139 (291)
T ss_dssp             CHHHHHHHHHHHHHHCSTTHHHHHHHHHHHHHSCCCCSCHHHHHHHHHHHHHTTCHHHHHHHHTT--CCSHHHHHHHHHH
T ss_pred             ChhHHHHHHHHHHHcCCCcHHHHHHHHHHHHhcccCCCCHHHHHHHHHHHHHCCCHHHHHHHHhC--CCCHHHHHHHHHH
Confidence            34666778888889999999999999999988776564 44556666889999999999999988  3567788888899


Q ss_pred             HHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           86 LADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      +.+.|+.++|...+.. +..  ..|+..
T Consensus       140 ~~~~g~~~~A~~~l~~-~~~--~~p~~~  164 (291)
T 3mkr_A          140 LLKLDRLDLARKELKK-MQD--QDEDAT  164 (291)
T ss_dssp             HHHTTCHHHHHHHHHH-HHH--HCTTCH
T ss_pred             HHHCCCHHHHHHHHHH-HHh--hCcCcH
Confidence            9999999999999887 333  246543

>1w3b_A UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110; OGT, glcnac, nucleoporin, O-linked glycosylation, TPR repeat, protein binding; 2.85A {Homo sapiens} SCOP: a.118.8.1

Probab=97.02  E-value=0.0017  Score=52.31  Aligned_cols=120  Identities=10%  Similarity=0.049  Sum_probs=88.9

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~   86 (234)
                      ...|..+-..+...+++++|...+....+... .+..++..+...|.+.|+.++|...|+.+.+  | +..+|+.+...+
T Consensus       203 ~~~~~~lg~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l~~~~  281 (388)
T 1w3b_A          203 LDAYINLGNVLKEARIFDRAVAAYLRALSLSP-NHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANAL  281 (388)
T ss_dssp             HHHHHHHHHHHHTTTCTTHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCc-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCCCCHHHHHHHHHHH
Confidence            45677777888999999999999998877543 2467889999999999999999999998754  3 456889999999


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCcEE-e---eCCeeeEeeccccccccC
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSNLL-V---SKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~~~-~---~~~~~~~~~~~~a~~~~~  133 (234)
                      .+.|+.++|+..+...+ .  +.|+... +   ...+...+++..+.....
T Consensus       282 ~~~g~~~~A~~~~~~al-~--~~p~~~~~~~~l~~~~~~~g~~~~A~~~~~  329 (388)
T 1w3b_A          282 KEKGSVAEAEDCYNTAL-R--LCPTHADSLNNLANIKREQGNIEEAVRLYR  329 (388)
T ss_dssp             HHHSCHHHHHHHHHHHH-H--HCTTCHHHHHHHHHHHHTTTCHHHHHHHHH
T ss_pred             HHcCCHHHHHHHHHHHH-h--hCcccHHHHHHHHHHHHHcCCHHHHHHHHH
Confidence            99999999999998743 2  3454432 2   122334455555555443

>2kck_A TPR repeat; tetratricopeptide repeat, structural genomics, unknown function, PSI-2, protein structure initiative; NMR {Methanococcus maripaludis}

Probab=96.72  E-value=0.01  Score=37.96  Aligned_cols=92  Identities=10%  Similarity=-0.030  Sum_probs=74.9

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---C--ccccHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---K--NLQSWTIMIS   84 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~--~~~~~~~~i~   84 (234)
                      ...+..+-..+.+.++.++|...+...++... .+...+..+-..|.+.|+.++|...++...+   .  +...|..+-.
T Consensus         6 ~~~~~~~~~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~l~~   84 (112)
T 2kck_A            6 PEEYYLEGVLQYDAGNYTESIDLFEKAIQLDP-EESKYWLMKGKALYNLERYEEAVDCYNYVINVIEDEYNKDVWAAKAD   84 (112)
T ss_dssp             TTGGGGHHHHHHSSCCHHHHHHHHHHHHHHCC-CCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTSCCTTCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhhHHHHHHHHHHHHHhCc-CCHHHHHHHHHHHHHccCHHHHHHHHHHHHHhCcccchHHHHHHHHH
Confidence            44566667778889999999999999887643 3456788888999999999999999987543   3  4667888888


Q ss_pred             HHHhc-CCchhhhHhhhcc
Q 026720           85 GLADN-SRGNDAISLHRQG  102 (234)
Q Consensus        85 ~~~~~-g~~~~a~~l~~~~  102 (234)
                      .+.+. |+.++|+..+...
T Consensus        85 ~~~~~~~~~~~A~~~~~~~  103 (112)
T 2kck_A           85 ALRYIEGKEVEAEIAEARA  103 (112)
T ss_dssp             HHTTCSSCSHHHHHHHHHH
T ss_pred             HHHHHhCCHHHHHHHHHHH
Confidence            89999 9999999999873

>2y4t_A DNAJ homolog subfamily C member 3; chaperone, endoplasmic reticulum, protein folding, tetratricopeptiderepeat, J domain, unfolded protein respons; 3.00A {Homo sapiens} PDB: 2y4u_A

Probab=96.68  E-value=0.004  Score=50.98  Aligned_cols=93  Identities=9%  Similarity=-0.085  Sum_probs=80.0

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +..++..+...+.+.|++++|..++..+++... .+..++..+...|.+.|+.++|...|+.+.+   .+...|..+...
T Consensus        25 ~~~~~~~~~~~~~~~g~~~~A~~~~~~~l~~~p-~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l~~~  103 (450)
T 2y4t_A           25 DVEKHLELGKKLLAAGQLADALSQFHAAVDGDP-DNYIAYYRRATVFLAMGKSKAALPDLTKVIQLKMDFTAARLQRGHL  103 (450)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCC-ccHHHHHHHHHHHHHCCCHHHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            445677888889999999999999999987532 3678899999999999999999999998754   356788889999


Q ss_pred             HHhcCCchhhhHhhhcc
Q 026720           86 LADNSRGNDAISLHRQG  102 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~~  102 (234)
                      +.+.|+.++|+..+...
T Consensus       104 ~~~~g~~~~A~~~~~~~  120 (450)
T 2y4t_A          104 LLKQGKLDEAEDDFKKV  120 (450)
T ss_dssp             HHHTTCHHHHHHHHHHH
T ss_pred             HHHcCCHHHHHHHHHHH
Confidence            99999999999999873

>2y4t_A DNAJ homolog subfamily C member 3; chaperone, endoplasmic reticulum, protein folding, tetratricopeptiderepeat, J domain, unfolded protein respons; 3.00A {Homo sapiens} PDB: 2y4u_A

Probab=96.63  E-value=0.007  Score=49.50  Aligned_cols=93  Identities=11%  Similarity=0.013  Sum_probs=77.4

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccC---cc---ccHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK---NL---QSWTIM   82 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~---~~---~~~~~~   82 (234)
                      +..++..+..++.+.|+.++|...+..+++... .+..++..+...|.+.|++++|...|+.+.+.   +.   ..|..+
T Consensus        59 ~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~l~~~~~~~g~~~~A~~~~~~~~~~~~~~~~~~~~~~~l  137 (450)
T 2y4t_A           59 NYIAYYRRATVFLAMGKSKAALPDLTKVIQLKM-DFTAARLQRGHLLLKQGKLDEAEDDFKKVLKSNPSENEEKEAQSQL  137 (450)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHTSCCCHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHCCCHHHHHHHHHHHHhcCC-CcHHHHHHHHHHHHHcCCHHHHHHHHHHHHhcCCCChhhHHHHHHH
Confidence            567788888999999999999999999998753 35678899999999999999999999998653   33   566665


Q ss_pred             HHH------------HHhcCCchhhhHhhhcc
Q 026720           83 ISG------------LADNSRGNDAISLHRQG  102 (234)
Q Consensus        83 i~~------------~~~~g~~~~a~~l~~~~  102 (234)
                      ...            +.+.|+.++|+..+...
T Consensus       138 ~~~~~~~~~~~~a~~~~~~~~~~~A~~~~~~~  169 (450)
T 2y4t_A          138 IKSDEMQRLRSQALNAFGSGDYTAAIAFLDKI  169 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHH
Confidence            444            88899999999999773

>3mkr_A Coatomer subunit epsilon; tetratricopeptide repeats (TPR), beta-hairpin, alpha-solenoi transport protein; 2.60A {Bos taurus}

Probab=96.58  E-value=0.0067  Score=47.27  Aligned_cols=118  Identities=14%  Similarity=0.067  Sum_probs=72.0

Q ss_pred             CCCCeehHHHHH-HHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--CccccHHHH
Q 026720            6 ENPNSVTLVSLV-SACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQSWTIM   82 (234)
Q Consensus         6 ~~~~~~t~~~ll-~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~~~~~~   82 (234)
                      ..|+..++..++ ..+.+.|+.++|.+.+..      ..+...+..+...|.+.|+.++|...++.+.+  |+.. ...+
T Consensus        96 ~~P~~~~~~~~la~~~~~~g~~~~Al~~l~~------~~~~~~~~~l~~~~~~~g~~~~A~~~l~~~~~~~p~~~-~~~l  168 (291)
T 3mkr_A           96 VDVTNTTFLLMAASIYFYDQNPDAALRTLHQ------GDSLECMAMTVQILLKLDRLDLARKELKKMQDQDEDAT-LTQL  168 (291)
T ss_dssp             CCCSCHHHHHHHHHHHHHTTCHHHHHHHHTT------CCSHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCH-HHHH
T ss_pred             cCCCCHHHHHHHHHHHHHCCCHHHHHHHHhC------CCCHHHHHHHHHHHHHCCCHHHHHHHHHHHHhhCcCcH-HHHH
Confidence            456655554443 567788888888887776      24566777888888888888888888887764  3321 1122


Q ss_pred             ----HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-e---CCeeeEeeccccccccC
Q 026720           83 ----ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-S---KGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        83 ----i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~---~~~~~~~~~~~a~~~~~  133 (234)
                          +..+...|+.++|+.+|.+. +.  ..|++... .   ..+...+++..+.....
T Consensus       169 ~~a~~~l~~~~~~~~eA~~~~~~~-l~--~~p~~~~~~~~la~~~~~~g~~~eA~~~l~  224 (291)
T 3mkr_A          169 ATAWVSLAAGGEKLQDAYYIFQEM-AD--KCSPTLLLLNGQAACHMAQGRWEAAEGVLQ  224 (291)
T ss_dssp             HHHHHHHHHCTTHHHHHHHHHHHH-HH--HSCCCHHHHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             HHHHHHHHhCchHHHHHHHHHHHH-HH--hCCCcHHHHHHHHHHHHHcCCHHHHHHHHH
Confidence                23333457888888888773 33  24544322 1   12345566666665443

>4eqf_A PEX5-related protein; accessory protein, tetratricopeptide repeat, TPR; 3.00A {Mus musculus}

Probab=96.56  E-value=0.0069  Score=48.22  Aligned_cols=91  Identities=14%  Similarity=0.207  Sum_probs=69.6

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLEL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      ++..+-..+.+.|+.++|...+..+.+..... +..++..+...|.+.|+.++|...++...+   .+...|+.+...+.
T Consensus       179 ~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l~~~~~  258 (365)
T 4eqf_A          179 LTRRMSKSPVDSSVLEGVKELYLEAAHQNGDMIDPDLQTGLGVLFHLSGEFNRAIDAFNAALTVRPEDYSLWNRLGATLA  258 (365)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHSCSSCCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhhhhHHHHHHHHHHHHHhCcCccCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHH
Confidence            34455678889999999999999998875431 577889999999999999999999988653   36778999999999


Q ss_pred             hcCCchhhhHhhhcc
Q 026720           88 DNSRGNDAISLHRQG  102 (234)
Q Consensus        88 ~~g~~~~a~~l~~~~  102 (234)
                      +.|+.++|+..+...
T Consensus       259 ~~g~~~~A~~~~~~a  273 (365)
T 4eqf_A          259 NGDRSEEAVEAYTRA  273 (365)
T ss_dssp             HTTCHHHHHHHHHHH
T ss_pred             HcCCHHHHHHHHHHH
Confidence            999999999999773

>4eqf_A PEX5-related protein; accessory protein, tetratricopeptide repeat, TPR; 3.00A {Mus musculus}

Probab=96.56  E-value=0.007  Score=48.18  Aligned_cols=92  Identities=11%  Similarity=-0.058  Sum_probs=79.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +..++..+-..+...|+.++|...+...++... .+..+++.+...|.+.|+.++|...|+...+   .+..+|..+-..
T Consensus       212 ~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l~~~  290 (365)
T 4eqf_A          212 DPDLQTGLGVLFHLSGEFNRAIDAFNAALTVRP-EDYSLWNRLGATLANGDRSEEAVEAYTRALEIQPGFIRSRYNLGIS  290 (365)
T ss_dssp             CHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHhcCCCchHHHHHHHHH
Confidence            466788888899999999999999999988643 3577899999999999999999999988653   356788889999


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus       291 ~~~~g~~~~A~~~~~~  306 (365)
T 4eqf_A          291 CINLGAYREAVSNFLT  306 (365)
T ss_dssp             HHHHTCCHHHHHHHHH
T ss_pred             HHHCCCHHHHHHHHHH
Confidence            9999999999999977

>2ho1_A Type 4 fimbrial biogenesis protein PILF; type IV pilus biogenesis, TPR, superhelix, protein binding; HET: MSE; 2.00A {Pseudomonas aeruginosa} PDB: 2fi7_A

Probab=96.55  E-value=0.0075  Score=45.14  Aligned_cols=93  Identities=5%  Similarity=-0.027  Sum_probs=76.6

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc----C-ccccHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE----K-NLQSWTIMI   83 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~----~-~~~~~~~~i   83 (234)
                      +..++..+-..+...|+.++|.+.+....+... .+..++..+...|...|+.++|...++....    + +...|..+.
T Consensus        70 ~~~~~~~la~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~la~~~~~~g~~~~A~~~~~~~~~~~~~~~~~~~~~~la  148 (252)
T 2ho1_A           70 SADAHAALAVVFQTEMEPKLADEEYRKALASDS-RNARVLNNYGGFLYEQKRYEEAYQRLLEASQDTLYPERSRVFENLG  148 (252)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHTTCTTCTTHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHCc-CcHHHHHHHHHHHHHHhHHHHHHHHHHHHHhCccCcccHHHHHHHH
Confidence            455677788888899999999999999887653 3567888899999999999999999988754    2 456777788


Q ss_pred             HHHHhcCCchhhhHhhhcc
Q 026720           84 SGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~~  102 (234)
                      ..+.+.|+.++|+..+...
T Consensus       149 ~~~~~~g~~~~A~~~~~~~  167 (252)
T 2ho1_A          149 LVSLQMKKPAQAKEYFEKS  167 (252)
T ss_dssp             HHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHHH
Confidence            8899999999999998773

>3gyz_A Chaperone protein IPGC; asymmetric homodimer, tetratricopeptide repeat, TPR, chapero virulence; 2.15A {Shigella flexneri} PDB: 3gz1_A 3gz2_A 3ks2_A

Probab=96.55  E-value=0.015  Score=40.65  Aligned_cols=89  Identities=8%  Similarity=0.014  Sum_probs=72.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~   88 (234)
                      .+..+=..+.+.|+.++|...+...++... .+...|..+-..|.+.|++++|...|++...   .+...|..+-..+.+
T Consensus        38 ~~~~lg~~~~~~g~~~eA~~~~~~al~~~P-~~~~~~~~lg~~~~~~g~~~~Ai~~~~~al~l~P~~~~~~~~lg~~~~~  116 (151)
T 3gyz_A           38 DIYSYAYDFYNKGRIEEAEVFFRFLCIYDF-YNVDYIMGLAAIYQIKEQFQQAADLYAVAFALGKNDYTPVFHTGQCQLR  116 (151)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHHccHHHHHHHHHHHHhhCCCCcHHHHHHHHHHHH
Confidence            444455567788999999999999987543 2566788888999999999999999987543   367788888888999


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..|..
T Consensus       117 lg~~~eA~~~~~~  129 (151)
T 3gyz_A          117 LKAPLKAKECFEL  129 (151)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHH
Confidence            9999999999876

>2vq2_A PILW, putative fimbrial biogenesis and twitching motility protein; secretin, TPR repeat, type IV pilus, bacterail virulence; 1.54A {Neisseria meningitidis}

Probab=96.45  E-value=0.012  Score=42.84  Aligned_cols=120  Identities=9%  Similarity=-0.062  Sum_probs=86.3

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhc-CChHHHHHHHHhhcc--C---ccccHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKC-GHVEKAFKVFNLMRE--K---NLQSWTIM   82 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~-g~~~~a~~~~~~m~~--~---~~~~~~~~   82 (234)
                      +...+..+-..+...|+.++|...+....+... .+..++..+...|... |+.++|...++...+  .   +...|..+
T Consensus        41 ~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~l~~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~~l  119 (225)
T 2vq2_A           41 NELAWLVRAEIYQYLKVNDKAQESFRQALSIKP-DSAEINNNYGWFLCGRLNRPAESMAYFDKALADPTYPTPYIANLNK  119 (225)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHTTTCCHHHHHHHHHHHHTSTTCSCHHHHHHHH
T ss_pred             chHHHHHHHHHHHHcCChHHHHHHHHHHHHhCC-CChHHHHHHHHHHHHhcCcHHHHHHHHHHHHcCcCCcchHHHHHHH
Confidence            455677778888899999999999999887643 3566788899999999 999999999988655  2   24677778


Q ss_pred             HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEeecccccccc
Q 026720           83 ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEID  132 (234)
Q Consensus        83 i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~~~~~a~~~~  132 (234)
                      ...+.+.|+.++|+..+...+ .  ..|+....    ...+...+++..+....
T Consensus       120 ~~~~~~~~~~~~A~~~~~~~~-~--~~~~~~~~~~~la~~~~~~~~~~~A~~~~  170 (225)
T 2vq2_A          120 GICSAKQGQFGLAEAYLKRSL-A--AQPQFPPAFKELARTKMLAGQLGDADYYF  170 (225)
T ss_dssp             HHHHHHTTCHHHHHHHHHHHH-H--HSTTCHHHHHHHHHHHHHHTCHHHHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHHHH-H--hCCCCchHHHHHHHHHHHcCCHHHHHHHH
Confidence            888999999999999987733 2  23443222    12233455555555443

>3k9i_A BH0479 protein; putative protein binding protein, structural genomics, joint for structural genomics, JCSG; 2.71A {Bacillus halodurans}

Probab=96.38  E-value=0.0062  Score=40.14  Aligned_cols=80  Identities=14%  Similarity=-0.041  Sum_probs=61.2

Q ss_pred             CchhhhhHhHHHHHHHHhc--cchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcCCchhhh
Q 026720           22 GLINVRAGESIHSYAVVNG--LELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNSRGNDAI   96 (234)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~g--~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g~~~~a~   96 (234)
                      ..|+.++|...+...++.+  -..+...+..+-..|.+.|+.++|...|++..+  | +...|..+-..+.+.|+.++|+
T Consensus         2 ~~g~~~~A~~~~~~al~~~~~~p~~~~~~~~lg~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~l~~~~~~~g~~~~A~   81 (117)
T 3k9i_A            2 VLGLEAQAVPYYEKAIASGLQGKDLAECYLGLGSTFRTLGEYRKAEAVLANGVKQFPNHQALRVFYAMVLYNLGRYEQGV   81 (117)
T ss_dssp             -----CCCHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHTCHHHHH
T ss_pred             CCCcHHHHHHHHHHHHHcCCCCccHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCchHHHHHHHHHHHHcCCHHHHH
Confidence            3577888999998888754  234566888899999999999999999988653  3 5567777788899999999999


Q ss_pred             Hhhhc
Q 026720           97 SLHRQ  101 (234)
Q Consensus        97 ~l~~~  101 (234)
                      ..+..
T Consensus        82 ~~~~~   86 (117)
T 3k9i_A           82 ELLLK   86 (117)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98876

>2lni_A Stress-induced-phosphoprotein 1; structural genomics, northeast structural genomics consortiu PSI-biology, protein structure initiative, chaperone; NMR {Homo sapiens}

Probab=96.37  E-value=0.013  Score=38.88  Aligned_cols=92  Identities=11%  Similarity=0.041  Sum_probs=75.1

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +...+..+-..+.+.+++++|...+....+... .+...+..+...|...|+.++|...++...+   .+...|..+-..
T Consensus        15 ~~~~~~~~~~~~~~~~~~~~A~~~~~~al~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~la~~   93 (133)
T 2lni_A           15 LALMVKNKGNECFQKGDYPQAMKHYTEAIKRNP-KDAKLYSNRAACYTKLLEFQLALKDCEECIQLEPTFIKGYTRKAAA   93 (133)
T ss_dssp             HHHHHHHHHHHHHHTTCSHHHHHHHHHHHTTCT-TCHHHHHHHHHHHTTTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCC-CcHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCchHHHHHHHHH
Confidence            445666777788889999999999999877532 2567788899999999999999999987543   356677778888


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus        94 ~~~~~~~~~A~~~~~~  109 (133)
T 2lni_A           94 LEAMKDYTKAMDVYQK  109 (133)
T ss_dssp             HHHTTCHHHHHHHHHH
T ss_pred             HHHHhhHHHHHHHHHH
Confidence            9999999999999876

>1xnf_A Lipoprotein NLPI; TPR, tetratricopeptide, structural genomi unknown function; 1.98A {Escherichia coli} SCOP: a.118.8.1

Probab=96.36  E-value=0.017  Score=43.66  Aligned_cols=92  Identities=13%  Similarity=-0.097  Sum_probs=74.8

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ..++..+-..+...|+.++|...+...++... .+..++..+...|...|+.++|...++...+   .+...|..+...+
T Consensus        43 ~~~~~~l~~~~~~~~~~~~A~~~~~~al~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~la~~~  121 (275)
T 1xnf_A           43 AQLLYERGVLYDSLGLRALARNDFSQALAIRP-DMPEVFNYLGIYLTQAGNFDAAYEAFDSVLELDPTYNYAHLNRGIAL  121 (275)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCC-CCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCTHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccHHHHHHHHHHHHHcCC-CcHHHHHHHHHHHHHccCHHHHHHHHHHHHhcCccccHHHHHHHHHH
Confidence            45666777788888999999999998887643 2567788899999999999999999887653   3677888888889


Q ss_pred             HhcCCchhhhHhhhcc
Q 026720           87 ADNSRGNDAISLHRQG  102 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~  102 (234)
                      .+.|+.++|+..+...
T Consensus       122 ~~~g~~~~A~~~~~~a  137 (275)
T 1xnf_A          122 YYGGRDKLAQDDLLAF  137 (275)
T ss_dssp             HHTTCHHHHHHHHHHH
T ss_pred             HHhccHHHHHHHHHHH
Confidence            9999999999988773

>2ho1_A Type 4 fimbrial biogenesis protein PILF; type IV pilus biogenesis, TPR, superhelix, protein binding; HET: MSE; 2.00A {Pseudomonas aeruginosa} PDB: 2fi7_A

Probab=96.34  E-value=0.017  Score=43.19  Aligned_cols=101  Identities=12%  Similarity=-0.026  Sum_probs=80.1

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ...+..+-..+...|++++|...+....+... .+...+..+...|.+.|+.++|.+.++...+   .+...|..+...+
T Consensus        37 ~~~~~~~a~~~~~~~~~~~A~~~~~~al~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~la~~~  115 (252)
T 2ho1_A           37 RDAYIQLGLGYLQRGNTEQAKVPLRKALEIDP-SSADAHAALAVVFQTEMEPKLADEEYRKALASDSRNARVLNNYGGFL  115 (252)
T ss_dssp             HHHHHHHHHHHHHTTCTGGGHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCChHHHHHHHHHHHhcCC-ChHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHCcCcHHHHHHHHHHH
Confidence            34566777788889999999999999987643 3567888999999999999999999987643   3567788888899


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCc
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+.|+.++|+..+... ...+..|..
T Consensus       116 ~~~g~~~~A~~~~~~~-~~~~~~~~~  140 (252)
T 2ho1_A          116 YEQKRYEEAYQRLLEA-SQDTLYPER  140 (252)
T ss_dssp             HHTTCHHHHHHHHHHH-TTCTTCTTH
T ss_pred             HHHhHHHHHHHHHHHH-HhCccCccc
Confidence            9999999999999883 333344543

>3as5_A MAMA; tetratricopeptide repeats (TPR) containing protein, TPR PROT protein-protein interactions, protein binding; 2.00A {Magnetospirillum magnetotacticum} PDB: 3as4_A 3asd_A 3asg_A 3ash_A 3as8_A 3asf_A

Probab=96.31  E-value=0.018  Score=40.38  Aligned_cols=86  Identities=13%  Similarity=0.060  Sum_probs=44.7

Q ss_pred             HHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCC
Q 026720           15 SLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSR   91 (234)
Q Consensus        15 ~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~   91 (234)
                      .+-..+...|+.++|...+....+... .+..++..+...|...|+.++|...++...+   .+...|..+...+.+.|+
T Consensus        13 ~~~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~   91 (186)
T 3as5_A           13 DKGISHAKAGRYSQAVMLLEQVYDADA-FDVDVALHLGIAYVKTGAVDRGTELLERSLADAPDNVKVATVLGLTYVQVQK   91 (186)
T ss_dssp             HHHHHHHHHTCHHHHHHHHTTTCCTTS-CCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHhcCHHHHHHHHHHHHHhCc-cChHHHHHHHHHHHHcCCHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHhcC
Confidence            334444555555666655555543321 2344555555556666666666655555332   233445555555555566


Q ss_pred             chhhhHhhhc
Q 026720           92 GNDAISLHRQ  101 (234)
Q Consensus        92 ~~~a~~l~~~  101 (234)
                      .++|...+..
T Consensus        92 ~~~A~~~~~~  101 (186)
T 3as5_A           92 YDLAVPLLIK  101 (186)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            6666655544

>3as5_A MAMA; tetratricopeptide repeats (TPR) containing protein, TPR PROT protein-protein interactions, protein binding; 2.00A {Magnetospirillum magnetotacticum} PDB: 3as4_A 3asd_A 3asg_A 3ash_A 3as8_A 3asf_A

Probab=96.30  E-value=0.018  Score=40.39  Aligned_cols=92  Identities=16%  Similarity=0.111  Sum_probs=70.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +..++..+-..+...|+.++|...+....+... .+...+..+...|...|+.++|...++....   .+...|..+...
T Consensus        41 ~~~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~a~~  119 (186)
T 3as5_A           41 DVDVALHLGIAYVKTGAVDRGTELLERSLADAP-DNVKVATVLGLTYVQVQKYDLAVPLLIKVAEANPINFNVRFRLGVA  119 (186)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHcCCHHHHHHHHHHHHhcCC-CCHHHHHHHHHHHHHhcCHHHHHHHHHHHHhcCcHhHHHHHHHHHH
Confidence            455666777778888889999988888877532 3456777888888888999999888877543   355677777788


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus       120 ~~~~~~~~~A~~~~~~  135 (186)
T 3as5_A          120 LDNLGRFDEAIDSFKI  135 (186)
T ss_dssp             HHHTTCHHHHHHHHHH
T ss_pred             HHHcCcHHHHHHHHHH
Confidence            8888999999888876

>4gco_A Protein STI-1; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, tetratricopeptide repeat domain; 1.60A {Caenorhabditis elegans}

Probab=96.29  E-value=0.017  Score=38.83  Aligned_cols=91  Identities=11%  Similarity=0.020  Sum_probs=73.6

Q ss_pred             HHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchh
Q 026720           18 SACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGND   94 (234)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~   94 (234)
                      ..+.+.|++++|...+...++... .+..+|..+-..|.+.|+.++|...|+...+   .+...|..+-..+.+.|+.++
T Consensus        21 ~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~~~~~~~~~~~~~~A~~~~~~al~~~p~~~~a~~~lg~~~~~~~~~~~   99 (126)
T 4gco_A           21 NEYFKKGDYPTAMRHYNEAVKRDP-ENAILYSNRAACLTKLMEFQRALDDCDTCIRLDSKFIKGYIRKAACLVAMREWSK   99 (126)
T ss_dssp             HHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHhhHHHhhccHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHCCCHHH
Confidence            456778999999999999887543 3567888899999999999999999987543   466788888889999999999


Q ss_pred             hhHhhhcccccCCcCCCc
Q 026720           95 AISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        95 a~~l~~~~~~~~~l~p~~  112 (234)
                      |+..+... +.  +.|++
T Consensus       100 A~~~~~~a-l~--l~P~~  114 (126)
T 4gco_A          100 AQRAYEDA-LQ--VDPSN  114 (126)
T ss_dssp             HHHHHHHH-HH--HCTTC
T ss_pred             HHHHHHHH-HH--HCcCC
Confidence            99999773 32  45654

>2vq2_A PILW, putative fimbrial biogenesis and twitching motility protein; secretin, TPR repeat, type IV pilus, bacterail virulence; 1.54A {Neisseria meningitidis}

Probab=96.28  E-value=0.022  Score=41.37  Aligned_cols=94  Identities=12%  Similarity=-0.023  Sum_probs=77.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +...+..+-..+...|+.++|...+....+... .+...+..+...|...|+.++|...++...+   .+...|..+...
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~l~~~   85 (225)
T 2vq2_A            7 VSNIKTQLAMEYMRGQDYRQATASIEDALKSDP-KNELAWLVRAEIYQYLKVNDKAQESFRQALSIKPDSAEINNNYGWF   85 (225)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHhhHHHHHHHHHHHHHhCc-cchHHHHHHHHHHHHcCChHHHHHHHHHHHHhCCCChHHHHHHHHH
Confidence            345667777888899999999999999887543 3466888899999999999999999988643   356788888889


Q ss_pred             HHhc-CCchhhhHhhhccc
Q 026720           86 LADN-SRGNDAISLHRQGY  103 (234)
Q Consensus        86 ~~~~-g~~~~a~~l~~~~~  103 (234)
                      +... |+.++|+..+...+
T Consensus        86 ~~~~~~~~~~A~~~~~~~~  104 (225)
T 2vq2_A           86 LCGRLNRPAESMAYFDKAL  104 (225)
T ss_dssp             HHTTTCCHHHHHHHHHHHH
T ss_pred             HHHhcCcHHHHHHHHHHHH
Confidence            9999 99999999998843

>3q49_B STIP1 homology and U box-containing protein 1; E3 ubiquitin ligase, ligase-chaperone complex; 1.54A {Mus musculus} PDB: 3q47_B 3q4a_B*

Probab=96.25  E-value=0.026  Score=37.72  Aligned_cols=92  Identities=12%  Similarity=-0.022  Sum_probs=76.0

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +...+..+-..+...+++++|...+...++... .+...+..+-..|...|+.++|...++...+   .+...|..+-..
T Consensus         8 ~~~~~~~~g~~~~~~~~~~~A~~~~~~al~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~l~~~   86 (137)
T 3q49_B            8 SAQELKEQGNRLFVGRKYPEAAACYGRAITRNP-LVAVYYTNRALCYLKMQQPEQALADCRRALELDGQSVKAHFFLGQC   86 (137)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHhCcHHHHHHHHHHHHhhCc-CcHHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCchhHHHHHHHHHH
Confidence            455666777788899999999999999887653 3467888899999999999999999887543   356788888888


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus        87 ~~~~~~~~~A~~~~~~  102 (137)
T 3q49_B           87 QLEMESYDEAIANLQR  102 (137)
T ss_dssp             HHHTTCHHHHHHHHHH
T ss_pred             HHHHhhHHHHHHHHHH
Confidence            9999999999998876

>2pl2_A Hypothetical conserved protein TTC0263; TPR, protein binding; 2.50A {Thermus thermophilus}

Probab=96.23  E-value=0.0095  Score=44.06  Aligned_cols=87  Identities=18%  Similarity=0.123  Sum_probs=38.1

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +..+=..+...|+.++|...+...++..  .+...+..+-..|...|+.++|...++...+   .+...|..+-..+.+.
T Consensus       121 ~~~lg~~~~~~g~~~~A~~~~~~al~~~--~~~~~~~~la~~~~~~g~~~~A~~~~~~al~~~P~~~~~~~~la~~~~~~  198 (217)
T 2pl2_A          121 HLQRGLVYALLGERDKAEASLKQALALE--DTPEIRSALAELYLSMGRLDEALAQYAKALEQAPKDLDLRVRYASALLLK  198 (217)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHC--CCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHSTTCHHHHHHHHHHHTC-
T ss_pred             HHHHHHHHHHcCChHHHHHHHHHHHhcc--cchHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCChHHHHHHHHHHHHc
Confidence            3333344555555555555555555544  3444555555555555666665555555322   2334455555555555


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus       199 g~~~~A~~~~~~  210 (217)
T 2pl2_A          199 GKAEEAARAAAL  210 (217)
T ss_dssp             ------------
T ss_pred             cCHHHHHHHHHH
Confidence            555555555544

>2vgx_A Chaperone SYCD; alternative dimer assembly, tetratricopeptide repeat, type III secretion; HET: MLY; 1.95A {Yersinia enterocolitica} SCOP: k.38.1.1 PDB: 2vgx_B* 2vgy_A*

Probab=96.23  E-value=0.029  Score=38.75  Aligned_cols=89  Identities=12%  Similarity=-0.091  Sum_probs=71.0

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~   88 (234)
                      .+..+-..+.+.|++++|...+...++... .+...|..+-..|.+.|+.++|...|+....   .+...|..+-..+.+
T Consensus        23 ~~~~~g~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~l~p~~~~~~~~lg~~~~~  101 (148)
T 2vgx_A           23 QLYSLAFNQYQSGXYEDAHXVFQALCVLDH-YDSRFFLGLGACRQAMGQYDLAIHSYSYGAVMDIXEPRFPFHAAECLLQ  101 (148)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCTHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCChHHHHHHHHHHHHcCc-ccHHHHHHHHHHHHHHhhHHHHHHHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            344455567788999999999998887543 2566778888889999999999999987543   366778888888999


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus       102 ~g~~~~A~~~~~~  114 (148)
T 2vgx_A          102 XGELAEAESGLFL  114 (148)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHH
Confidence            9999999998876

>2xcb_A PCRH, regulatory protein PCRH; protein transport, bacterial toxin, type III secretion, protein binding; 1.85A {Pseudomonas aeruginosa} PDB: 2xcc_A

Probab=96.14  E-value=0.035  Score=37.80  Aligned_cols=88  Identities=11%  Similarity=-0.115  Sum_probs=70.6

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +..+-..+.+.|++++|...+...++... .+...|..+-..|.+.|+.++|...|+....   .+...|..+-..+.+.
T Consensus        21 ~~~~a~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~lg~~~~~~   99 (142)
T 2xcb_A           21 LYALGFNQYQAGKWDDAQKIFQALCMLDH-YDARYFLGLGACRQSLGLYEQALQSYSYGALMDINEPRFPFHAAECHLQL   99 (142)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCTHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHccHHHHHHHHHHHHHhCC-ccHHHHHHHHHHHHHHhhHHHHHHHHHHHHhcCCCCcHHHHHHHHHHHHc
Confidence            33444567788999999999999887653 3566788888899999999999999987543   3566777888889999


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus       100 g~~~~A~~~~~~  111 (142)
T 2xcb_A          100 GDLDGAESGFYS  111 (142)
T ss_dssp             TCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHH
Confidence            999999998876

>1fch_A Peroxisomal targeting signal 1 receptor; protein-peptide complex, tetratricopeptide repeat, TPR, helical repeat, signaling protein; 2.20A {Homo sapiens} SCOP: a.118.8.1 PDB: 2j9q_A 3imz_B* 3r9a_B* 2c0m_A 2c0l_A

Probab=96.11  E-value=0.018  Score=45.60  Aligned_cols=80  Identities=16%  Similarity=0.194  Sum_probs=58.8

Q ss_pred             CchhhhhHhHHHHHHHHhccch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhH
Q 026720           22 GLINVRAGESIHSYAVVNGLEL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAIS   97 (234)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~   97 (234)
                      ..|+.++|...+..+++..... +..++..+...|.+.|+.++|...++....   .+...|+.+...+.+.|+.++|+.
T Consensus       193 ~~~~~~~A~~~~~~a~~~~p~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~l~~~~~~~g~~~~A~~  272 (368)
T 1fch_A          193 SDSLFLEVKELFLAAVRLDPTSIDPDVQCGLGVLFNLSGEYDKAVDCFTAALSVRPNDYLLWNKLGATLANGNQSEEAVA  272 (368)
T ss_dssp             HHHHHHHHHHHHHHHHHHSTTSCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             hcccHHHHHHHHHHHHHhCcCcccHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCcCCHHHHHHHHHHHHHcCCHHHHHH
Confidence            6677888888888877754321 466777788888888888888888776542   345677777777888888888888


Q ss_pred             hhhc
Q 026720           98 LHRQ  101 (234)
Q Consensus        98 l~~~  101 (234)
                      .+..
T Consensus       273 ~~~~  276 (368)
T 1fch_A          273 AYRR  276 (368)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7766

>3sz7_A HSC70 cochaperone (SGT); TPR domain, GET4, GET5, GET3, MDY2, SSA1, SSE1, chaperone regulator; 1.72A {Aspergillus fumigatus}

Probab=96.06  E-value=0.034  Score=38.80  Aligned_cols=100  Identities=17%  Similarity=0.056  Sum_probs=79.4

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ...+..+-..+.+.+++++|...+...++... .+...+..+-..|.+.|++++|...|+...+   .+...|..+-..+
T Consensus        11 a~~~~~~g~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~lg~~~   89 (164)
T 3sz7_A           11 SDKLKSEGNAAMARKEYSKAIDLYTQALSIAP-ANPIYLSNRAAAYSASGQHEKAAEDAELATVVDPKYSKAWSRLGLAR   89 (164)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHST-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-cCHHHHHHHHHHHHHccCHHHHHHHHHHHHHhCCCCHHHHHHHHHHH
Confidence            34556666778889999999999999988643 2567888999999999999999999987543   3567888888889


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      .+.|+.++|+..+... +.  +.|++.
T Consensus        90 ~~~g~~~~A~~~~~~a-l~--~~p~~~  113 (164)
T 3sz7_A           90 FDMADYKGAKEAYEKG-IE--AEGNGG  113 (164)
T ss_dssp             HHTTCHHHHHHHHHHH-HH--HHSSSC
T ss_pred             HHccCHHHHHHHHHHH-HH--hCCCch
Confidence            9999999999999773 32  345544

>3cv0_A Peroxisome targeting signal 1 receptor PEX5; TPR motifs, TPR protein, peroxin 5, PEX5, PTS1 binding domain, protein-peptide complex, receptor; 2.00A {Trypanosoma brucei} PDB: 3cvl_A 3cvn_A 3cvp_A 3cvq_A

Probab=96.04  E-value=0.023  Score=43.97  Aligned_cols=81  Identities=16%  Similarity=0.185  Sum_probs=59.8

Q ss_pred             hcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhh
Q 026720           20 CTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAI   96 (234)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~   96 (234)
                      +...++.++|...+....+... .+..++..+...|.+.|+.++|...++...+   .+...|..+...+.+.|+.++|+
T Consensus       148 ~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~A~  226 (327)
T 3cv0_A          148 FAAPNEYRECRTLLHAALEMNP-NDAQLHASLGVLYNLSNNYDSAAANLRRAVELRPDDAQLWNKLGATLANGNRPQEAL  226 (327)
T ss_dssp             TTSHHHHHHHHHHHHHHHHHST-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHcccHHHHHHHHHHHHhhCC-CCHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHHcCCHHHHH
Confidence            6677788888888888776543 2566777788888888888888888776542   34566777777788888888888


Q ss_pred             Hhhhc
Q 026720           97 SLHRQ  101 (234)
Q Consensus        97 ~l~~~  101 (234)
                      ..+..
T Consensus       227 ~~~~~  231 (327)
T 3cv0_A          227 DAYNR  231 (327)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87766

>2q7f_A YRRB protein; TPR, protein binding; 2.49A {Bacillus subtilis} SCOP: k.38.1.1

Probab=96.04  E-value=0.029  Score=41.39  Aligned_cols=91  Identities=8%  Similarity=0.027  Sum_probs=53.3

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ..++..+-..+.+.++.++|...+....+... .+..++..+...|...|+.++|...++...+   .+...|..+...+
T Consensus        57 ~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~a~~~  135 (243)
T 2q7f_A           57 AIPYINFANLLSSVNELERALAFYDKALELDS-SAATAYYGAGNVYVVKEMYKEAKDMFEKALRAGMENGDLFYMLGTVL  135 (243)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHTCCSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCC-cchHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCHHHHHHHHHHH
Confidence            34444555556666666666666666655432 2345556666666666666666666655432   2444555556666


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      .+.|+.++|+..+..
T Consensus       136 ~~~~~~~~A~~~~~~  150 (243)
T 2q7f_A          136 VKLEQPKLALPYLQR  150 (243)
T ss_dssp             HHTSCHHHHHHHHHH
T ss_pred             HHhccHHHHHHHHHH
Confidence            666666666666655

>2dba_A Smooth muscle cell associated protein-1, isoform 2; tetratricopeptide repeat, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=96.04  E-value=0.042  Score=37.01  Aligned_cols=93  Identities=10%  Similarity=-0.095  Sum_probs=74.5

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccch--hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLEL--DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMI   83 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~--~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i   83 (234)
                      +...+..+-..+.+.+++++|...+....+.....  ....+..+-..|.+.|+.++|...++...+   .+...|..+-
T Consensus        27 ~~~~~~~~a~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~a  106 (148)
T 2dba_A           27 SVEQLRKEGNELFKCGDYGGALAAYTQALGLDATPQDQAVLHRNRAACHLKLEDYDKAETEASKAIEKDGGDVKALYRRS  106 (148)
T ss_dssp             CHHHHHHHHHHHHTTTCHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCHHHHHHHHHHHHHHcccchHHHHHHHHHHHHHHHHccHHHHHHHHHHHHhhCccCHHHHHHHH
Confidence            34556667778889999999999999988754321  167788888999999999999999887543   3566777788


Q ss_pred             HHHHhcCCchhhhHhhhc
Q 026720           84 SGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~  101 (234)
                      ..+.+.|+.++|+..+..
T Consensus       107 ~~~~~~~~~~~A~~~~~~  124 (148)
T 2dba_A          107 QALEKLGRLDQAVLDLQR  124 (148)
T ss_dssp             HHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHH
Confidence            889999999999999877

>3hym_B Cell division cycle protein 16 homolog; APC, anaphase promoting complex, cell cycle, mitosis, cyclosome, TPR, ubiquitin, ubiquitin ligase, twinning; 2.80A {Homo sapiens}

Probab=96.01  E-value=0.024  Score=43.92  Aligned_cols=91  Identities=8%  Similarity=-0.079  Sum_probs=51.1

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhcc--------chhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGL--------ELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSW   79 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~--------~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~   79 (234)
                      .++..+-..+...|+.++|...+....+...        ..+..++..+...|.+.|+.++|...++...+   .+...|
T Consensus       194 ~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~a~~~~~~~~~~~  273 (330)
T 3hym_B          194 FVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKWEPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTY  273 (330)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHHTTTSCSCTTTTCCHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCSHHH
T ss_pred             HHHHHHHHHHHHcccHHHHHHHHHHHHHHhhhccccccccHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHhhCccchHHH
Confidence            4455555556666666666666665554310        12234556666666666666666666655332   244555


Q ss_pred             HHHHHHHHhcCCchhhhHhhhc
Q 026720           80 TIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        80 ~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ..+-..+.+.|+.++|...+..
T Consensus       274 ~~la~~~~~~g~~~~A~~~~~~  295 (330)
T 3hym_B          274 SAIGYIHSLMGNFENAVDYFHT  295 (330)
T ss_dssp             HHHHHHHHHHTCHHHHHHHHHT
T ss_pred             HHHHHHHHHhccHHHHHHHHHH
Confidence            5556666666666666666655

>3uq3_A Heat shock protein STI1; HSP90, peptide binding, chaperone; 2.60A {Saccharomyces cerevisiae}

Probab=96.00  E-value=0.018  Score=42.93  Aligned_cols=89  Identities=10%  Similarity=-0.067  Sum_probs=76.0

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-c-------cccHHH
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-N-------LQSWTI   81 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~-------~~~~~~   81 (234)
                      ++..+-..+.+.|++++|...+...++..  .+..++..+...|...|+.++|...++...+  + +       ...|..
T Consensus         7 ~~~~~g~~~~~~~~~~~A~~~~~~a~~~~--~~~~~~~~~~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~~~~~~   84 (258)
T 3uq3_A            7 KEKAEGNKFYKARQFDEAIEHYNKAWELH--KDITYLNNRAAAEYEKGEYETAISTLNDAVEQGREMRADYKVISKSFAR   84 (258)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHS--CCTHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccHHHHHHHHHHHHHhh--ccHHHHHHHHHHHHHcccHHHHHHHHHHHHHhCcccccchHHHHHHHHH
Confidence            45666677888899999999999999887  7788999999999999999999999987553  2 1       567888


Q ss_pred             HHHHHHhcCCchhhhHhhhcc
Q 026720           82 MISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~~  102 (234)
                      +-..+.+.|+.++|+..+...
T Consensus        85 l~~~~~~~~~~~~A~~~~~~a  105 (258)
T 3uq3_A           85 IGNAYHKLGDLKKTIEYYQKS  105 (258)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHcccHHHHHHHHHHH
Confidence            888999999999999998773

>2q7f_A YRRB protein; TPR, protein binding; 2.49A {Bacillus subtilis} SCOP: k.38.1.1

Probab=96.00  E-value=0.028  Score=41.51  Aligned_cols=92  Identities=11%  Similarity=0.016  Sum_probs=67.9

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +..++..+-..+...|+.++|...+....+... .+..++..+...|.+.|+.++|...++...+   .+...|..+...
T Consensus        90 ~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~l~~~  168 (243)
T 2q7f_A           90 AATAYYGAGNVYVVKEMYKEAKDMFEKALRAGM-ENGDLFYMLGTVLVKLEQPKLALPYLQRAVELNENDTEARFQFGMC  168 (243)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHTC-CSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhccHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCccHHHHHHHHHH
Confidence            345566667777788888888888888877543 2455677788888888888888888877543   355667777777


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus       169 ~~~~~~~~~A~~~~~~  184 (243)
T 2q7f_A          169 LANEGMLDEALSQFAA  184 (243)
T ss_dssp             HHHHTCCHHHHHHHHH
T ss_pred             HHHcCCHHHHHHHHHH
Confidence            8888888888888766

>1elw_A TPR1-domain of HOP; HOP, TPR-domain, peptide-complex, helical repeat, HSP70, protein binding, chaperone; 1.60A {Homo sapiens} SCOP: a.118.8.1

Probab=95.97  E-value=0.043  Score=35.14  Aligned_cols=90  Identities=13%  Similarity=-0.002  Sum_probs=72.8

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      ..+..+-..+...+++++|...+....+... .+...+..+...|.+.|+.++|...++...+   .+...|..+...+.
T Consensus         5 ~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~a~~~~   83 (118)
T 1elw_A            5 NELKEKGNKALSVGNIDDALQCYSEAIKLDP-HNHVLYSNRSAAYAKKGDYQKAYEDGCKTVDLKPDWGKGYSRKAAALE   83 (118)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccHHHHHHHHHHHHHHCC-CcHHHHHHHHHHHHhhccHHHHHHHHHHHHHhCcccHHHHHHHHHHHH
Confidence            3455666777788999999999999887543 2566788888899999999999999887543   35667777888899


Q ss_pred             hcCCchhhhHhhhc
Q 026720           88 DNSRGNDAISLHRQ  101 (234)
Q Consensus        88 ~~g~~~~a~~l~~~  101 (234)
                      +.|+.++|...+..
T Consensus        84 ~~~~~~~A~~~~~~   97 (118)
T 1elw_A           84 FLNRFEEAKRTYEE   97 (118)
T ss_dssp             HTTCHHHHHHHHHH
T ss_pred             HHhhHHHHHHHHHH
Confidence            99999999999877

>2gw1_A Mitochondrial precursor proteins import receptor; TPR, protein transport; 3.00A {Saccharomyces cerevisiae}

Probab=95.92  E-value=0.022  Score=47.26  Aligned_cols=87  Identities=13%  Similarity=-0.034  Sum_probs=74.3

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +...=..+.+.|++++|...+..+++..  ||..++..+...|.+.|++++|...++...+   .+...|..+...+.+.
T Consensus         9 ~~~~g~~~~~~g~~~~A~~~~~~al~~~--p~~~~~~~la~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l~~~~~~~   86 (514)
T 2gw1_A            9 LKDKGNQFFRNKKYDDAIKYYNWALELK--EDPVFYSNLSACYVSVGDLKKVVEMSTKALELKPDYSKVLLRRASANEGL   86 (514)
T ss_dssp             HHHHHHHHHHTSCHHHHHHHHHHHHHHC--CCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhccHHHHHHHHHHHHhcC--ccHHHHHhHHHHHHHHhhHHHHHHHHHHHhccChHHHHHHHHHHHHHHHH
Confidence            3344456778899999999999999876  6888999999999999999999999988653   3556888889999999


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus        87 g~~~~A~~~~~~   98 (514)
T 2gw1_A           87 GKFADAMFDLSV   98 (514)
T ss_dssp             TCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHH
Confidence            999999999877

>2vyi_A SGTA protein; chaperone, TPR repeat, phosphoprotein, tetratricopeptide repeat protein, HOST-virus interaction; 2.4A {Homo sapiens} SCOP: k.38.1.1

Probab=95.92  E-value=0.05  Score=35.53  Aligned_cols=91  Identities=13%  Similarity=0.027  Sum_probs=73.1

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ...+..+-..+...++.++|...+....+... .+...+..+...|...|+.++|...++...+   .+...|..+-..+
T Consensus        12 ~~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~~~~~   90 (131)
T 2vyi_A           12 AERLKTEGNEQMKVENFEAAVHFYGKAIELNP-ANAVYFCNRAAAYSKLGNYAGAVQDCERAICIDPAYSKAYGRMGLAL   90 (131)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHccCHHHHHHHHHHHHHcCC-CCHHHHHHHHHHHHHhhchHHHHHHHHHHHhcCccCHHHHHHHHHHH
Confidence            34556666778888999999999999887543 3566788889999999999999999887543   3556777778889


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      .+.|+.++|+..+..
T Consensus        91 ~~~~~~~~A~~~~~~  105 (131)
T 2vyi_A           91 SSLNKHVEAVAYYKK  105 (131)
T ss_dssp             HHTTCHHHHHHHHHH
T ss_pred             HHhCCHHHHHHHHHH
Confidence            999999999999877

>3upv_A Heat shock protein STI1; TPR-fold, adaptor protein for HSP70 and HSP90, C-terminal PA HSP70, peptide binding protein; 1.60A {Saccharomyces cerevisiae}

Probab=95.92  E-value=0.05  Score=35.92  Aligned_cols=88  Identities=7%  Similarity=-0.140  Sum_probs=71.5

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +...=..+.+.|++++|...+...++... .+...+..+-..|.+.|+.++|...++...+   .+...|..+-..+...
T Consensus         7 ~~~~g~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~~a~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~lg~~~~~~   85 (126)
T 3upv_A            7 ARLEGKEYFTKSDWPNAVKAYTEMIKRAP-EDARGYSNRAAALAKLMSFPEAIADCNKAIEKDPNFVRAYIRKATAQIAV   85 (126)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCHHHHHHHHHHHHHhCC-CChHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHHH
Confidence            44444567788999999999999887643 3567888999999999999999999987543   3566788888889999


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus        86 ~~~~~A~~~~~~   97 (126)
T 3upv_A           86 KEYASALETLDA   97 (126)
T ss_dssp             TCHHHHHHHHHH
T ss_pred             hCHHHHHHHHHH
Confidence            999999998876

>1elr_A TPR2A-domain of HOP; HOP, TPR-domain, peptide-complex, helical repeat, protein binding, chaperone; 1.90A {Homo sapiens} SCOP: a.118.8.1 PDB: 3esk_A 3fwv_A

Probab=95.83  E-value=0.038  Score=36.18  Aligned_cols=89  Identities=12%  Similarity=0.046  Sum_probs=71.7

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-c-------cccHHH
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-N-------LQSWTI   81 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~-------~~~~~~   81 (234)
                      .+..+-..+...+++++|...+...++... .+...+..+...|...|+.++|...++....  + +       ...|..
T Consensus         6 ~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (131)
T 1elr_A            6 KEKELGNDAYKKKDFDTALKHYDKAKELDP-TNMTYITNQAAVYFEKGDYNKCRELCEKAIEVGRENREDYRQIAKAYAR   84 (131)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHSTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCHHHHHHHHHHHHhcCC-ccHHHHHHHHHHHHHhccHHHHHHHHHHHHhhccccchhHHHHHHHHHH
Confidence            455566677788999999999999887642 3566788889999999999999999887543  1 2       567777


Q ss_pred             HHHHHHhcCCchhhhHhhhc
Q 026720           82 MISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +-..+.+.|+.++|...+..
T Consensus        85 la~~~~~~~~~~~A~~~~~~  104 (131)
T 1elr_A           85 IGNSYFKEEKYKDAIHFYNK  104 (131)
T ss_dssp             HHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHhccHHHHHHHHHH
Confidence            78889999999999999877

>1fch_A Peroxisomal targeting signal 1 receptor; protein-peptide complex, tetratricopeptide repeat, TPR, helical repeat, signaling protein; 2.20A {Homo sapiens} SCOP: a.118.8.1 PDB: 2j9q_A 3imz_B* 3r9a_B* 2c0m_A 2c0l_A

Probab=95.77  E-value=0.036  Score=43.82  Aligned_cols=93  Identities=10%  Similarity=-0.059  Sum_probs=78.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +..++..+-..+.+.|++++|...+..+++... .+..++..+...|.+.|+.++|...|+...+   .+..+|..+...
T Consensus        63 ~~~~~~~~~~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~l~~~  141 (368)
T 1fch_A           63 DHPQPFEEGLRRLQEGDLPNAVLLFEAAVQQDP-KHMEAWQYLGTTQAENEQELLAISALRRCLELKPDNQTALMALAVS  141 (368)
T ss_dssp             TCSSHHHHHHHHHHTTCHHHHHHHHHHHHHSCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHCcCHHHHHHHHHHHHhcCCCCHHHHHHHHHH
Confidence            345677778888899999999999999988643 3567888999999999999999999987643   467788889999


Q ss_pred             HHhcCCchhhhHhhhcc
Q 026720           86 LADNSRGNDAISLHRQG  102 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~~  102 (234)
                      +...|+.++|+..+...
T Consensus       142 ~~~~g~~~~A~~~~~~~  158 (368)
T 1fch_A          142 FTNESLQRQACEILRDW  158 (368)
T ss_dssp             HHHTTCHHHHHHHHHHH
T ss_pred             HHHcCCHHHHHHHHHHH
Confidence            99999999999999773

>3uq3_A Heat shock protein STI1; HSP90, peptide binding, chaperone; 2.60A {Saccharomyces cerevisiae}

Probab=95.69  E-value=0.049  Score=40.42  Aligned_cols=88  Identities=7%  Similarity=-0.140  Sum_probs=45.8

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~   89 (234)
                      +..+-..+...|+.++|...+...++... .+..++..+...|.+.|+.++|...++...+   .+...|..+-..+.+.
T Consensus       142 ~~~~~~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~l~~~~~~~  220 (258)
T 3uq3_A          142 ARLEGKEYFTKSDWPNAVKAYTEMIKRAP-EDARGYSNRAAALAKLMSFPEAIADCNKAIEKDPNFVRAYIRKATAQIAV  220 (258)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCHHHHHHHHHHHHhcCc-ccHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCHHHHHHHHHHHHHHHHH
Confidence            33444445555555666655555554332 2344555555556666666666555554332   2344455555555555


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus       221 g~~~~A~~~~~~  232 (258)
T 3uq3_A          221 KEYASALETLDA  232 (258)
T ss_dssp             TCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHH
Confidence            666666555543

>3cv0_A Peroxisome targeting signal 1 receptor PEX5; TPR motifs, TPR protein, peroxin 5, PEX5, PTS1 binding domain, protein-peptide complex, receptor; 2.00A {Trypanosoma brucei} PDB: 3cvl_A 3cvn_A 3cvp_A 3cvq_A

Probab=95.63  E-value=0.044  Score=42.31  Aligned_cols=92  Identities=13%  Similarity=-0.023  Sum_probs=74.0

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +..++..+-..+.+.|+.++|...+....+... .+..++..+...|.+.|+.++|...+++..+   .+...|..+...
T Consensus       171 ~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~l~~~  249 (327)
T 3cv0_A          171 DAQLHASLGVLYNLSNNYDSAAANLRRAVELRP-DDAQLWNKLGATLANGNRPQEALDAYNRALDINPGYVRVMYNMAVS  249 (327)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCC-CcHHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCCCCHHHHHHHHHH
Confidence            456777788888888999999999988887543 3466788888899999999999998887543   356678888888


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus       250 ~~~~g~~~~A~~~~~~  265 (327)
T 3cv0_A          250 YSNMSQYDLAAKQLVR  265 (327)
T ss_dssp             HHHTTCHHHHHHHHHH
T ss_pred             HHHhccHHHHHHHHHH
Confidence            8999999999988866

>4i17_A Hypothetical protein; TPR repeats protein, structural genomics, joint center for S genomics, JCSG, protein structure initiative; HET: MSE; 1.83A {Bacteroides fragilis}

Probab=95.52  E-value=0.053  Score=39.91  Aligned_cols=102  Identities=11%  Similarity=-0.003  Sum_probs=79.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      |...+...=..+.+.|+.++|...+...++....++...+..+-..|.+.|+.++|...++...+   .+...|..+-..
T Consensus         6 ~~~~~~~~g~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~l~~~   85 (228)
T 4i17_A            6 DPNQLKNEGNDALNAKNYAVAFEKYSEYLKLTNNQDSVTAYNCGVCADNIKKYKEAADYFDIAIKKNYNLANAYIGKSAA   85 (228)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHTTTCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTTCSHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHccCHHHHHHHHHHHHhccCCCCcHHHHHHHHHHHHhhcHHHHHHHHHHHHHhCcchHHHHHHHHHH
Confidence            34455556666778899999999999999876545666676799999999999999999988553   355678888888


Q ss_pred             HHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           86 LADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      +.+.|+.++|+..+...+ .  +.|++.
T Consensus        86 ~~~~~~~~~A~~~~~~al-~--~~p~~~  110 (228)
T 4i17_A           86 YRDMKNNQEYIATLTEGI-K--AVPGNA  110 (228)
T ss_dssp             HHHTTCHHHHHHHHHHHH-H--HSTTCH
T ss_pred             HHHcccHHHHHHHHHHHH-H--HCCCcH
Confidence            999999999999998733 2  345543

>1hh8_A P67PHOX, NCF-2, neutrophil cytosol factor 2; cell cycle, phagocyte oxidase factor, SH3 domain, repeat, TPR repeat cell cycle; HET: FLC; 1.8A {Homo sapiens} SCOP: a.118.8.1 PDB: 1wm5_A 1e96_B*

Probab=95.51  E-value=0.074  Score=38.48  Aligned_cols=94  Identities=13%  Similarity=-0.029  Sum_probs=63.9

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---Ccc-------
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNL-------   76 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~-------   76 (234)
                      .|+...+..+-..+.+.|+.++|...+...++... .+...+..+-..|.+.|+.++|...|+...+   .+.       
T Consensus        34 ~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~~-~~~~~~~~lg~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~  112 (213)
T 1hh8_A           34 DPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDK-HLAVAYFQRGMLYYQTEKYDLAIKDLKEALIQLRGNQLIDYKIL  112 (213)
T ss_dssp             SCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTTTTCSEEECGGG
T ss_pred             CCChHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCc-cchHHHHHHHHHHHHcccHHHHHHHHHHHHHhCCCccHHHHHHh
Confidence            44555666666777777788888877777766532 2455677777777888888888777766443   111       


Q ss_pred             ---------ccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           77 ---------QSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        77 ---------~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                               ..|..+-..+.+.|+.++|+..+..
T Consensus       113 ~~~~~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~  146 (213)
T 1hh8_A          113 GLQFKLFACEVLYNIAFMYAKKEEWKKAEEQLAL  146 (213)
T ss_dssp             TBCCEEEHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             ccccCccchHHHHHHHHHHHHccCHHHHHHHHHH
Confidence                     4566666677777888888877766

>3u4t_A TPR repeat-containing protein; structural genomics, PSI- protein structure initiative, northeast structural genomics consortium, NESG; 2.28A {Cytophaga hutchinsonii}

Probab=95.42  E-value=0.065  Score=40.32  Aligned_cols=91  Identities=10%  Similarity=-0.074  Sum_probs=64.7

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchh--HHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELD--VAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~--~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      ..+..+-..+...|+.++|...+...++..-.++  ...+..+-..|.+.|+.++|...|+...+   .+...|..+-..
T Consensus        38 ~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~~lg~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~l~~~  117 (272)
T 3u4t_A           38 YIYNRRAVCYYELAKYDLAQKDIETYFSKVNATKAKSADFEYYGKILMKKGQDSLAIQQYQAAVDRDTTRLDMYGQIGSY  117 (272)
T ss_dssp             TTHHHHHHHHHHTTCHHHHHHHHHHHHTTSCTTTCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCTHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhHHHHHHHHHHHHhccCchhHHHHHHHHHHHHHHHcccHHHHHHHHHHHHhcCcccHHHHHHHHHH
Confidence            3666666777788888888888888777432222  22467777778888888888888776543   355677777777


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus       118 ~~~~~~~~~A~~~~~~  133 (272)
T 3u4t_A          118 FYNKGNFPLAIQYMEK  133 (272)
T ss_dssp             HHHTTCHHHHHHHHGG
T ss_pred             HHHccCHHHHHHHHHH
Confidence            8888888888888876

>3hym_B Cell division cycle protein 16 homolog; APC, anaphase promoting complex, cell cycle, mitosis, cyclosome, TPR, ubiquitin, ubiquitin ligase, twinning; 2.80A {Homo sapiens}

Probab=95.37  E-value=0.053  Score=41.90  Aligned_cols=89  Identities=7%  Similarity=-0.133  Sum_probs=39.9

Q ss_pred             hHHHHHHHhcCch-hhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           12 TLVSLVSACTGLI-NVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        12 t~~~ll~~~~~~~-~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      .+..+-..+...| +.++|...+....+... .+...+..+...|...|+.++|...++...+   .+...|..+...+.
T Consensus        92 ~~~~l~~~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~l~~~~~  170 (330)
T 3hym_B           92 SWFAVGCYYLMVGHKNEHARRYLSKATTLEK-TYGPAWIAYGHSFAVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYG  170 (330)
T ss_dssp             HHHHHHHHHHHSCSCHHHHHHHHHHHHTTCT-TCTHHHHHHHHHHHHHTCHHHHHHHHHHHHHHTTTCSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhhHHHHHHHHHHHHHhCC-ccHHHHHHHHHHHHHccCHHHHHHHHHHHHHhccccHHHHHHHHHHHH
Confidence            3333444444444 45555555554443321 1233444455555555555555555444322   12334444444444


Q ss_pred             hcCCchhhhHhhhc
Q 026720           88 DNSRGNDAISLHRQ  101 (234)
Q Consensus        88 ~~g~~~~a~~l~~~  101 (234)
                      +.|+.++|+..+..
T Consensus       171 ~~~~~~~A~~~~~~  184 (330)
T 3hym_B          171 LTNNSKLAERFFSQ  184 (330)
T ss_dssp             HTTCHHHHHHHHHH
T ss_pred             HHhhHHHHHHHHHH
Confidence            55555555554444

>3vtx_A MAMA; tetratricopeptide repeats (TPR) containing protein, peptide protein, protein binding; 1.75A {Candidatus magnetobacterium bavaricum} PDB: 3vty_A

Probab=95.30  E-value=0.082  Score=37.33  Aligned_cols=81  Identities=10%  Similarity=0.078  Sum_probs=39.1

Q ss_pred             hcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhh
Q 026720           20 CTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAI   96 (234)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~   96 (234)
                      +...++.+.+...+....+... .+...+..+-..|.+.|+.++|...|++..+   .+...|..+-..+.+.|+.++|+
T Consensus        83 ~~~~~~~~~a~~~~~~a~~~~~-~~~~~~~~lg~~~~~~g~~~~A~~~~~~~l~~~p~~~~~~~~lg~~~~~~g~~~~A~  161 (184)
T 3vtx_A           83 NFMIDEKQAAIDALQRAIALNT-VYADAYYKLGLVYDSMGEHDKAIEAYEKTISIKPGFIRAYQSIGLAYEGKGLRDEAV  161 (184)
T ss_dssp             HHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHcCCHHHHHHHHHHHHHhCc-cchHHHHHHHHHHHHhCCchhHHHHHHHHHHhcchhhhHHHHHHHHHHHCCCHHHHH
Confidence            3333444444444444433221 1233444555555555555555555554332   23344555555555555555555


Q ss_pred             Hhhhc
Q 026720           97 SLHRQ  101 (234)
Q Consensus        97 ~l~~~  101 (234)
                      ..+..
T Consensus       162 ~~~~~  166 (184)
T 3vtx_A          162 KYFKK  166 (184)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            55544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=95.24  E-value=0.03  Score=43.49  Aligned_cols=67  Identities=25%  Similarity=0.261  Sum_probs=49.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeecccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMV  128 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a  128 (234)
                      .+|..|+..|.+.+ .      ...+...+... +.|+.         ++|..+++|+|++|.|+++..+..++.|||.+
T Consensus       176 ~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~---------~lH~~giiHrDlkp~NILl~~~~vkl~DFG~a  239 (282)
T 1zar_A          176 AVLMELIDAKELYR-V------RVENPDEVLDMILEEVA---------KFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQS  239 (282)
T ss_dssp             EEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHH---------HHHHTTEECSCCSTTSEEEETTEEEECCCTTC
T ss_pred             EEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHH---------HHHHCCCEeCCCCHHHEEEECCcEEEEECCCC
Confidence            57777887777765 2      22333334333 67777         89999999999999999998778899999988


Q ss_pred             cccc
Q 026720          129 KEID  132 (234)
Q Consensus       129 ~~~~  132 (234)
                      ....
T Consensus       240 ~~~~  243 (282)
T 1zar_A          240 VEVG  243 (282)
T ss_dssp             EETT
T ss_pred             eECC
Confidence            7543

>1hxi_A PEX5, peroxisome targeting signal 1 receptor PEX5; alpha helical, transport protein; 1.60A {Trypanosoma brucei} SCOP: a.118.8.1

Probab=95.22  E-value=0.042  Score=36.45  Aligned_cols=86  Identities=10%  Similarity=-0.018  Sum_probs=70.2

Q ss_pred             HHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcCC
Q 026720           15 SLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNSR   91 (234)
Q Consensus        15 ~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g~   91 (234)
                      .+-..+.+.|++++|...+...++... .+...|..+-..|.+.|+.++|...+++..+  | +...|..+-..+.+.|+
T Consensus        22 ~~g~~~~~~g~~~~A~~~~~~al~~~P-~~~~a~~~lg~~~~~~g~~~~A~~~~~~al~l~P~~~~~~~~la~~~~~~g~  100 (121)
T 1hxi_A           22 EEGLSMLKLANLAEAALAFEAVCQKEP-EREEAWRSLGLTQAENEKDGLAIIALNHARMLDPKDIAVHAALAVSHTNEHN  100 (121)
T ss_dssp             HHHHHHHHTTCHHHHHHHHHHHHHHST-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCHHHHHHHHHHHHHHCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHcCC
Confidence            344567788999999999999988543 2566778888889999999999999988553  3 56678888888999999


Q ss_pred             chhhhHhhhc
Q 026720           92 GNDAISLHRQ  101 (234)
Q Consensus        92 ~~~a~~l~~~  101 (234)
                      .++|+..+..
T Consensus       101 ~~~A~~~~~~  110 (121)
T 1hxi_A          101 ANAALASLRA  110 (121)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999877

>1a17_A Serine/threonine protein phosphatase 5; hydrolase, protein-protein interactions, TPR, S helix; 2.45A {Homo sapiens} SCOP: a.118.8.1 PDB: 2bug_A

Probab=95.20  E-value=0.11  Score=35.57  Aligned_cols=89  Identities=9%  Similarity=-0.096  Sum_probs=69.0

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~   88 (234)
                      ++..+-..+...+++++|...+...++... .+..++..+...|...|+.++|...++....   .+...|..+-..+.+
T Consensus        15 ~~~~~a~~~~~~~~~~~A~~~~~~al~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~a~~~~~   93 (166)
T 1a17_A           15 ELKTQANDYFKAKDYENAIKFYSQAIELNP-SNAIYYGNRSLAYLRTECYGYALGDATRAIELDKKYIKGYYRRAASNMA   93 (166)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHST-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCHHHHHHHHHHHHHhCC-CChHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCcccHHHHHHHHHHHHH
Confidence            344455567778889999999988877543 2566788888889999999999998877543   355677777778889


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus        94 ~~~~~~A~~~~~~  106 (166)
T 1a17_A           94 LGKFRAALRDYET  106 (166)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             hccHHHHHHHHHH
Confidence            9999999998877

>3edt_B KLC 2, kinesin light chain 2; superhelical, structural genomics, structural genomics conso SGC, microtubule, motor protein, phosphoprotein; 2.70A {Homo sapiens} PDB: 3ceq_A

Probab=95.16  E-value=0.072  Score=40.01  Aligned_cols=92  Identities=14%  Similarity=0.021  Sum_probs=73.9

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhc-----c--chhHHHHHHHHHHHhhcCChHHHHHHHHhhccC--------
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNG-----L--ELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK--------   74 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g-----~--~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~--------   74 (234)
                      ..++..+-..+...|+.++|...+....+..     .  .....++..+-..|...|+.++|...+++..+-        
T Consensus        85 ~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~al~~~~~~~~~~  164 (283)
T 3edt_B           85 AATLNNLAVLYGKRGKYKEAEPLCKRALEIREKVLGKFHPDVAKQLNNLALLCQNQGKAEEVEYYYRRALEIYATRLGPD  164 (283)
T ss_dssp             HHHHHHHHHHHHTTTCHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHHTTTCHHHHHHHHHHHHHHHHHHSCTT
T ss_pred             HHHHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHcCCCChHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHhcCCC
Confidence            3467778888999999999999999888751     1  234668889999999999999999988775321        


Q ss_pred             ---ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           75 ---NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        75 ---~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                         ....|..+-..+.+.|+.++|+..+..
T Consensus       165 ~~~~~~~~~~la~~~~~~g~~~~A~~~~~~  194 (283)
T 3edt_B          165 DPNVAKTKNNLASCYLKQGKYQDAETLYKE  194 (283)
T ss_dssp             CHHHHHHHHHHHHHHHHHTCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence               345777788889999999999998876

>3fp2_A TPR repeat-containing protein YHR117W; TOM71, mitochondria translocation, allosteric REG phosphoprotein, TPR repeat, ATP-binding; 1.98A {Saccharomyces cerevisiae} PDB: 3fp3_A 3fp4_A 3lca_A

Probab=95.13  E-value=0.1  Score=43.44  Aligned_cols=94  Identities=12%  Similarity=0.012  Sum_probs=68.1

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHH
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMI   83 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i   83 (234)
                      .|+..++..+-..+...++.++|...+....+... .+..++..+...|...|+.++|...++...+   .+...|..+.
T Consensus       273 ~~~~~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~la  351 (537)
T 3fp2_A          273 HPTPNSYIFLALTLADKENSQEFFKFFQKAVDLNP-EYPPTYYHRGQMYFILQDYKNAKEDFQKAQSLNPENVYPYIQLA  351 (537)
T ss_dssp             CCCHHHHHHHHHHTCCSSCCHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCSHHHHHHH
T ss_pred             CCCchHHHHHHHHHHHhcCHHHHHHHHHHHhccCC-CCHHHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCHHHHHHHH
Confidence            35555666677777888888888888887776543 2455677777888888888888888776543   3456777777


Q ss_pred             HHHHhcCCchhhhHhhhc
Q 026720           84 SGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~  101 (234)
                      ..+.+.|+.++|+..+..
T Consensus       352 ~~~~~~g~~~~A~~~~~~  369 (537)
T 3fp2_A          352 CLLYKQGKFTESEAFFNE  369 (537)
T ss_dssp             HHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHH
Confidence            778888888888887766

>2pl2_A Hypothetical conserved protein TTC0263; TPR, protein binding; 2.50A {Thermus thermophilus}

Probab=95.12  E-value=0.047  Score=40.24  Aligned_cols=101  Identities=14%  Similarity=0.055  Sum_probs=79.3

Q ss_pred             CCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHH
Q 026720            8 PNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMIS   84 (234)
Q Consensus         8 ~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~   84 (234)
                      ++...+..+-..+.+.|+.++|...+...++... .+...+..+-..|.+.|+.++|...+++..+  | +...|..+-.
T Consensus         3 ~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p-~~~~a~~~lg~~~~~~g~~~~A~~~~~~al~~~P~~~~a~~~lg~   81 (217)
T 2pl2_A            3 TAEQNPLRLGVQLYALGRYDAALTLFERALKENP-QDPEALYWLARTQLKLGLVNPALENGKTLVARTPRYLGGYMVLSE   81 (217)
T ss_dssp             -CCHHHHHHHHHHHHTTCHHHHHHHHHHHHTTSS-SCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCcHHHHHHHHH
Confidence            4566677777788889999999999999887543 2566788888999999999999999988653  3 5567888888


Q ss_pred             HHHhc-----------CCchhhhHhhhcccccCCcCCCc
Q 026720           85 GLADN-----------SRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        85 ~~~~~-----------g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+.+.           |+.++|+..+... +.  +.|+.
T Consensus        82 ~~~~~~~~~~~~~~~~g~~~~A~~~~~~a-l~--~~P~~  117 (217)
T 2pl2_A           82 AYVALYRQAEDRERGKGYLEQALSVLKDA-ER--VNPRY  117 (217)
T ss_dssp             HHHHHHHTCSSHHHHHHHHHHHHHHHHHH-HH--HCTTC
T ss_pred             HHHHhhhhhhhhcccccCHHHHHHHHHHH-HH--hCccc
Confidence            88888           9999999999773 32  45654

>3nf1_A KLC 1, kinesin light chain 1; TPR, structural genomics consortium (SGC), motor PR transport protein; 2.80A {Homo sapiens}

Probab=95.10  E-value=0.073  Score=40.70  Aligned_cols=93  Identities=13%  Similarity=-0.022  Sum_probs=74.1

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHh------cc-chhHHHHHHHHHHHhhcCChHHHHHHHHhhccC--------
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVN------GL-ELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK--------   74 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~------g~-~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~--------   74 (234)
                      ..++..+-..+...|+.++|...+....+.      +- .....++..+...|...|+.++|...++...+-        
T Consensus       111 ~~~~~~l~~~~~~~g~~~~A~~~~~~a~~~~~~~~~~~~~~~~~~~~~la~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~  190 (311)
T 3nf1_A          111 AATLNNLAVLYGKRGKYKEAEPLCKRALEIREKVLGKDHPDVAKQLNNLALLCQNQGKYEEVEYYYQRALEIYQTKLGPD  190 (311)
T ss_dssp             HHHHHHHHHHHHTTTCHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHHTTTCHHHHHHHHHHHHHHHHHTSCTT
T ss_pred             HHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHhcCCCChHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            346677778899999999999999988875      22 234567888999999999999999988775321        


Q ss_pred             ---ccccHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           75 ---NLQSWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        75 ---~~~~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                         ....|..+...+.+.|+.++|+..+...
T Consensus       191 ~~~~~~~~~~la~~~~~~g~~~~A~~~~~~a  221 (311)
T 3nf1_A          191 DPNVAKTKNNLASCYLKQGKFKQAETLYKEI  221 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHcCCHHHHHHHHHHH
Confidence               2356777888899999999999998763

>3nf1_A KLC 1, kinesin light chain 1; TPR, structural genomics consortium (SGC), motor PR transport protein; 2.80A {Homo sapiens}

Probab=95.09  E-value=0.069  Score=40.87  Aligned_cols=93  Identities=12%  Similarity=0.030  Sum_probs=74.7

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHh-------ccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---------
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVN-------GLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---------   73 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~-------g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---------   73 (234)
                      ..++..+-..+...|++++|...+....+.       .......++..+-..|...|+.++|...++...+         
T Consensus        27 ~~~~~~l~~~~~~~g~~~~A~~~~~~a~~~~~~~~~~~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~al~~~~~~~~~~  106 (311)
T 3nf1_A           27 LRTLHNLVIQYASQGRYEVAVPLCKQALEDLEKTSGHDHPDVATMLNILALVYRDQNKYKDAANLLNDALAIREKTLGKD  106 (311)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHCSSSHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHHcCCCCHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            355667778888999999999999998874       2334567888999999999999999998876532         


Q ss_pred             --CccccHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           74 --KNLQSWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        74 --~~~~~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                        .....|..+...+...|+.++|+..+...
T Consensus       107 ~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~a  137 (311)
T 3nf1_A          107 HPAVAATLNNLAVLYGKRGKYKEAEPLCKRA  137 (311)
T ss_dssp             CHHHHHHHHHHHHHHHTTTCHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHHcCcHHHHHHHHHHH
Confidence              13457778888899999999999988763

>2ond_A Cleavage stimulation factor 77 kDa subunit; HAT domain, structural protein; 2.80A {Mus musculus} SCOP: a.118.8.7

Probab=95.05  E-value=0.078  Score=41.27  Aligned_cols=123  Identities=7%  Similarity=-0.057  Sum_probs=80.3

Q ss_pred             CCCCe-ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchh-H-HHHHHHHHHHhhcCChHHHHHHHHhhccC---ccccH
Q 026720            6 ENPNS-VTLVSLVSACTGLINVRAGESIHSYAVVNGLELD-V-AIGTALVEMYSKCGHVEKAFKVFNLMREK---NLQSW   79 (234)
Q Consensus         6 ~~~~~-~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~-~-~~~~~li~~~~~~g~~~~a~~~~~~m~~~---~~~~~   79 (234)
                      +.|+. ..|..+...+.+.|+.++|..++...++.  .|+ . .+|..+...+.+.|..++|..+|++..+.   +...|
T Consensus        94 ~~p~~~~~~~~~~~~~~~~~~~~~A~~~~~~al~~--~p~~~~~~~~~~~~~~~~~~~~~~A~~~~~~a~~~~p~~~~~~  171 (308)
T 2ond_A           94 LLKKNMLLYFAYADYEESRMKYEKVHSIYNRLLAI--EDIDPTLVYIQYMKFARRAEGIKSGRMIFKKAREDARTRHHVY  171 (308)
T ss_dssp             TTTTCHHHHHHHHHHHHHTTCHHHHHHHHHHHHTS--SSSCTHHHHHHHHHHHHHHHCHHHHHHHHHHHHTSTTCCTHHH
T ss_pred             hCcccHHHHHHHHHHHHhcCCHHHHHHHHHHHHhc--cccCccHHHHHHHHHHHHhcCHHHHHHHHHHHHhcCCCCHHHH
Confidence            35644 46778888888889999999999999874  343 2 27888899999999999999999886542   23334


Q ss_pred             HHHHHH-HHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEeeccccccccC
Q 026720           80 TIMISG-LADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        80 ~~~i~~-~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~~~~~a~~~~~  133 (234)
                      ...... +...|+.++|...|...+.   ..|+...+    .......++...+..+..
T Consensus       172 ~~~a~~~~~~~~~~~~A~~~~~~al~---~~p~~~~~~~~~~~~~~~~g~~~~A~~~~~  227 (308)
T 2ond_A          172 VTAALMEYYCSKDKSVAFKIFELGLK---KYGDIPEYVLAYIDYLSHLNEDNNTRVLFE  227 (308)
T ss_dssp             HHHHHHHHHTSCCHHHHHHHHHHHHH---HHTTCHHHHHHHHHHHHTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCHHHHHHHHHHHHH---hCCCcHHHHHHHHHHHHHCCCHHHHHHHHH
Confidence            332222 1236899999999877432   34544322    112234455555555544

>2xev_A YBGF; tetratricopeptide, alpha-helical, metal binding; 1.57A {Xanthomonas campestris}

Probab=95.00  E-value=0.14  Score=33.52  Aligned_cols=84  Identities=8%  Similarity=-0.155  Sum_probs=64.7

Q ss_pred             HHhcCchhhhhHhHHHHHHHHhccchh--HHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc----cccHHHHHHHHHhc
Q 026720           18 SACTGLINVRAGESIHSYAVVNGLELD--VAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN----LQSWTIMISGLADN   89 (234)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~g~~~~--~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~----~~~~~~~i~~~~~~   89 (234)
                      ..+.+.|+.++|...+...++......  ...+..+-..|.+.|+.++|...++....  |+    ...+..+-..+.+.
T Consensus        10 ~~~~~~~~~~~A~~~~~~~~~~~p~~~~~~~~~~~lg~~~~~~~~~~~A~~~~~~~~~~~p~~~~~~~~~~~la~~~~~~   89 (129)
T 2xev_A           10 FDALKNGKYDDASQLFLSFLELYPNGVYTPNALYWLGESYYATRNFQLAEAQFRDLVSRYPTHDKAAGGLLKLGLSQYGE   89 (129)
T ss_dssp             HHHHHTTCHHHHHHHHHHHHHHCSSSTTHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTSTTHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCHHHHHHHHHHHHHHCCCCcccHHHHHHHHHHHHHhccHHHHHHHHHHHHHHCCCCcccHHHHHHHHHHHHHc
Confidence            445577899999999999888653221  14667788889999999999999988653  32    34466667788899


Q ss_pred             CCchhhhHhhhc
Q 026720           90 SRGNDAISLHRQ  101 (234)
Q Consensus        90 g~~~~a~~l~~~  101 (234)
                      |+.++|+..+..
T Consensus        90 g~~~~A~~~~~~  101 (129)
T 2xev_A           90 GKNTEAQQTLQQ  101 (129)
T ss_dssp             TCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHH
Confidence            999999999877

>2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2

Probab=94.88  E-value=0.15  Score=39.27  Aligned_cols=90  Identities=12%  Similarity=-0.030  Sum_probs=73.9

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      ..+..+-..+.+.|++++|...+...++... .+...+..+-..|.+.|++++|...++...+   .+...|..+-.++.
T Consensus         5 ~~~~~~g~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~la~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~lg~~~~   83 (281)
T 2c2l_A            5 QELKEQGNRLFVGRKYPEAAACYGRAITRNP-LVAVYYTNRALCYLKMQQPEQALADCRRALELDGQSVKAHFFLGQCQL   83 (281)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCS-CCHHHHHHHHHHHHHTTCHHHHHHHHHHHTTSCTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-ccHHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHH
Confidence            4455566677888999999999999887643 2677888899999999999999999988654   35667888888899


Q ss_pred             hcCCchhhhHhhhc
Q 026720           88 DNSRGNDAISLHRQ  101 (234)
Q Consensus        88 ~~g~~~~a~~l~~~  101 (234)
                      +.|+.++|+..+..
T Consensus        84 ~~g~~~~A~~~~~~   97 (281)
T 2c2l_A           84 EMESYDEAIANLQR   97 (281)
T ss_dssp             HTTCHHHHHHHHHH
T ss_pred             HcCCHHHHHHHHHH
Confidence            99999999998866

>1xnf_A Lipoprotein NLPI; TPR, tetratricopeptide, structural genomi unknown function; 1.98A {Escherichia coli} SCOP: a.118.8.1

Probab=94.85  E-value=0.086  Score=39.60  Aligned_cols=92  Identities=10%  Similarity=-0.164  Sum_probs=73.0

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--CccccHHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQSWTIMISGL   86 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~~~~~~i~~~   86 (234)
                      +..++..+-..+.+.|++++|...+...++... .+..++..+...|.+.|+.++|...++...+  |+...+...+..+
T Consensus        76 ~~~~~~~la~~~~~~~~~~~A~~~~~~al~~~~-~~~~~~~~la~~~~~~g~~~~A~~~~~~a~~~~~~~~~~~~~~~~~  154 (275)
T 1xnf_A           76 MPEVFNYLGIYLTQAGNFDAAYEAFDSVLELDP-TYNYAHLNRGIALYYGGRDKLAQDDLLAFYQDDPNDPFRSLWLYLA  154 (275)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCTHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHccCHHHHHHHHHHHHhcCc-cccHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCChHHHHHHHHH
Confidence            456778888889999999999999999988643 2567889999999999999999999988653  4433344444555


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      ...|+.++|+..+..
T Consensus       155 ~~~~~~~~A~~~~~~  169 (275)
T 1xnf_A          155 EQKLDEKQAKEVLKQ  169 (275)
T ss_dssp             HHHHCHHHHHHHHHH
T ss_pred             HHhcCHHHHHHHHHH
Confidence            667999999999866

>4ga2_A E3 SUMO-protein ligase ranbp2; TPR motif, nuclear pore complex component nucleocytoplasmic transport, transport protein; 0.95A {Pan troglodytes} PDB: 4ga0_A 4ga1_A*

Probab=94.85  E-value=0.15  Score=35.08  Aligned_cols=79  Identities=10%  Similarity=-0.045  Sum_probs=41.7

Q ss_pred             HHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcCCchh
Q 026720           18 SACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNSRGND   94 (234)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g~~~~   94 (234)
                      ..|.+.|+.++|...+...++... .+..+|..+-..|.+.|+.++|...|+...+  | +...|..+-..+.+.|+..+
T Consensus        39 ~~y~~~~~~~~A~~~~~~al~~~p-~~~~a~~~lg~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~la~~~~~~~~~~~  117 (150)
T 4ga2_A           39 KLYYEAKEYDLAKKYICTYINVQE-RDPKAHRFLGLLYELEENTDKAVECYRRSVELNPTQKDLVLKIAELLCKNDVTDG  117 (150)
T ss_dssp             HHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCSSSS
T ss_pred             HHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCchHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHcCChHH
Confidence            345555566666666665555322 1344555555566666666666665555332  2 34455555555555565555


Q ss_pred             hhH
Q 026720           95 AIS   97 (234)
Q Consensus        95 a~~   97 (234)
                      |..
T Consensus       118 aa~  120 (150)
T 4ga2_A          118 RAK  120 (150)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            443

>2gw1_A Mitochondrial precursor proteins import receptor; TPR, protein transport; 3.00A {Saccharomyces cerevisiae}

Probab=94.71  E-value=0.088  Score=43.51  Aligned_cols=89  Identities=10%  Similarity=-0.052  Sum_probs=39.5

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~   88 (234)
                      ++..+-..+...|+.++|...+....+.... +..++..+...|.+.|+.++|...++...+   .+...|..+...+.+
T Consensus       306 ~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~la~~~~~  384 (514)
T 2gw1_A          306 VYYHRGQMNFILQNYDQAGKDFDKAKELDPE-NIFPYIQLACLAYRENKFDDCETLFSEAKRKFPEAPEVPNFFAEILTD  384 (514)
T ss_dssp             HHHHHHHHHHHTTCTTHHHHHHHHHHHTCSS-CSHHHHHHHHHTTTTTCHHHHHHHHHHHHHHSTTCSHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCHHHHHHHHHHHHHhChh-hHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHcccCHHHHHHHHHHHHH
Confidence            3344444444444444555444444443221 233444444445555555555444444321   133344444444455


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus       385 ~~~~~~A~~~~~~  397 (514)
T 2gw1_A          385 KNDFDKALKQYDL  397 (514)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHH
Confidence            5555555544433

>2e2e_A Formate-dependent nitrite reductase complex NRFG; TPR, cytochrome C biogenesis, O157:H7 EDL933, formate- nitrite reductase complex, lyase; 2.05A {Escherichia coli}

Probab=94.57  E-value=0.14  Score=35.86  Aligned_cols=90  Identities=10%  Similarity=-0.003  Sum_probs=50.6

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHH-HhhcCCh--HHHHHHHHhhcc---CccccHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEM-YSKCGHV--EKAFKVFNLMRE---KNLQSWTIMIS   84 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~-~~~~g~~--~~a~~~~~~m~~---~~~~~~~~~i~   84 (234)
                      ..+..+-..+...++.++|...+...++... .+...+..+... |...|..  ++|...++....   .+...|..+-.
T Consensus        45 ~~~~~lg~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~la~~l~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~la~  123 (177)
T 2e2e_A           45 EQWALLGEYYLWQNDYSNSLLAYRQALQLRG-ENAELYAALATVLYYQASQHMTAQTRAMIDKALALDSNEITALMLLAS  123 (177)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHHC-SCHHHHHHHHHHHHHHTTTCCCHHHHHHHHHHHHHCTTCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHHcCC-CCHHHHHHHHHHHHHhcCCcchHHHHHHHHHHHHhCCCcHHHHHHHHH
Confidence            3444455555666666666666666655432 133344455555 5566666  666666655432   23445555555


Q ss_pred             HHHhcCCchhhhHhhhc
Q 026720           85 GLADNSRGNDAISLHRQ  101 (234)
Q Consensus        85 ~~~~~g~~~~a~~l~~~  101 (234)
                      .+.+.|+.++|+..+..
T Consensus       124 ~~~~~g~~~~A~~~~~~  140 (177)
T 2e2e_A          124 DAFMQANYAQAIELWQK  140 (177)
T ss_dssp             HHHHTTCHHHHHHHHHH
T ss_pred             HHHHcccHHHHHHHHHH
Confidence            66666666666666655

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=94.45  E-value=0.043  Score=41.90  Aligned_cols=70  Identities=13%  Similarity=0.167  Sum_probs=47.4

Q ss_pred             HHHHHHHhhc-C----ChHHHHHHHHhhccCccccHH-HHHHHHHhcCCchhhhHhh-hcccccCCcCCCcEEeeCCeee
Q 026720           49 TALVEMYSKC-G----HVEKAFKVFNLMREKNLQSWT-IMISGLADNSRGNDAISLH-RQGYFHRDLKPSNLLVSKGVIK  121 (234)
Q Consensus        49 ~~li~~~~~~-g----~~~~a~~~~~~m~~~~~~~~~-~~i~~~~~~g~~~~a~~l~-~~~~~~~~l~p~~~~~~~~~~~  121 (234)
                      ..||..|+.. |    .+.+..   ...+..+...+. .++.++.         ++| ..+++|+|++|.|+++.. ..+
T Consensus       143 ~~lVmE~~g~~g~~~~~L~~~~---~~~~~~~~~~i~~qi~~~l~---------~lH~~~givHrDlkp~NILl~~-~~~  209 (258)
T 1zth_A          143 NVLLMEFIGEDELPAPTLVELG---RELKELDVEGIFNDVVENVK---------RLYQEAELVHADLSEYNIMYID-KVY  209 (258)
T ss_dssp             TEEEEECCEETTEECCBHHHHG---GGGGGSCHHHHHHHHHHHHH---------HHHHTSCEECSSCSTTSEEESS-SEE
T ss_pred             CEEEEEecCCCCCccccHHHHh---hccChHHHHHHHHHHHHHHH---------HHHHHCCEEeCCCCHHHEEEcC-cEE
Confidence            4577788732 3    444431   122233443333 3367777         889 889999999999999976 788


Q ss_pred             Eeeccccccc
Q 026720          122 IGDLGMVKEI  131 (234)
Q Consensus       122 ~~~~~~a~~~  131 (234)
                      +.|||.+...
T Consensus       210 liDFG~a~~~  219 (258)
T 1zth_A          210 FIDMGQAVTL  219 (258)
T ss_dssp             ECCCTTCEET
T ss_pred             EEECcccccC
Confidence            9999988764

>1hh8_A P67PHOX, NCF-2, neutrophil cytosol factor 2; cell cycle, phagocyte oxidase factor, SH3 domain, repeat, TPR repeat cell cycle; HET: FLC; 1.8A {Homo sapiens} SCOP: a.118.8.1 PDB: 1wm5_A 1e96_B*

Probab=94.35  E-value=0.11  Score=37.55  Aligned_cols=83  Identities=11%  Similarity=-0.056  Sum_probs=68.1

Q ss_pred             HHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCc
Q 026720           16 LVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRG   92 (234)
Q Consensus        16 ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~   92 (234)
                      +-..+...|++++|...+...+    .++...+..+-..|.+.|+.++|...++...+   .+...|..+-..+.+.|+.
T Consensus        12 ~g~~~~~~~~~~~A~~~~~~a~----~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~lg~~~~~~~~~   87 (213)
T 1hh8_A           12 EGVLAADKKDWKGALDAFSAVQ----DPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKY   87 (213)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTSS----SCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCH
T ss_pred             HHHHHHHhCCHHHHHHHHHHHc----CCChHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCccchHHHHHHHHHHHHcccH
Confidence            3345567788999999887763    56778899999999999999999999987543   3567888888889999999


Q ss_pred             hhhhHhhhcc
Q 026720           93 NDAISLHRQG  102 (234)
Q Consensus        93 ~~a~~l~~~~  102 (234)
                      ++|+..+...
T Consensus        88 ~~A~~~~~~a   97 (213)
T 1hh8_A           88 DLAIKDLKEA   97 (213)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999773

>4gyw_A UDP-N-acetylglucosamine--peptide N- acetylglucosaminyltransferase 110 kDa subunit...; GT-B, glycosyltransferase, glcnacylation, transferase-peptid; HET: UDP NAG; 1.70A {Homo sapiens} PDB: 3pe3_A* 3pe4_A* 4ay5_A* 4ay6_A* 3tax_A* 4gyy_A* 4gz3_A* 4gz5_A* 4gz6_A*

Probab=94.32  E-value=0.13  Score=45.50  Aligned_cols=89  Identities=11%  Similarity=-0.018  Sum_probs=44.5

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~   88 (234)
                      +|+.+=..+.+.|+.++|.+.+.+.++... -+...|+.|-..|.+.|+.++|.+.|++..+   .+...|+.+-..+.+
T Consensus        45 a~~nLg~~l~~~g~~~eA~~~~~~Al~l~P-~~~~a~~nLg~~l~~~g~~~~A~~~~~kAl~l~P~~~~a~~~Lg~~~~~  123 (723)
T 4gyw_A           45 AHSNLASVLQQQGKLQEALMHYKEAIRISP-TFADAYSNMGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKD  123 (723)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHH
Confidence            344444445555555555555555544321 1233455555555555555555555554321   234455555555555


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+.+
T Consensus       124 ~g~~~eAi~~~~~  136 (723)
T 4gyw_A          124 SGNIPEAIASYRT  136 (723)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHH
Confidence            5555555555544

>3fp2_A TPR repeat-containing protein YHR117W; TOM71, mitochondria translocation, allosteric REG phosphoprotein, TPR repeat, ATP-binding; 1.98A {Saccharomyces cerevisiae} PDB: 3fp3_A 3fp4_A 3lca_A

Probab=94.31  E-value=0.13  Score=42.81  Aligned_cols=92  Identities=15%  Similarity=-0.040  Sum_probs=77.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +..++..+-..+...|+.++|...+...++... .+..++..+...|.+.|+.++|...++...+   .+...|..+...
T Consensus       309 ~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~la~~~~~~g~~~~A~~~~~~~~~~~~~~~~~~~~l~~~  387 (537)
T 3fp2_A          309 YPPTYYHRGQMYFILQDYKNAKEDFQKAQSLNP-ENVYPYIQLACLLYKQGKFTESEAFFNETKLKFPTLPEVPTFFAEI  387 (537)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCSHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCTHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCChHHHHHHHHH
Confidence            456777788888999999999999999988653 2456788999999999999999999987653   356688888999


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +.+.|+.++|+..+..
T Consensus       388 ~~~~g~~~~A~~~~~~  403 (537)
T 3fp2_A          388 LTDRGDFDTAIKQYDI  403 (537)
T ss_dssp             HHHTTCHHHHHHHHHH
T ss_pred             HHHhCCHHHHHHHHHH
Confidence            9999999999999877

>2l6j_A TPR repeat-containing protein associated with HSP; tetratricopeptide repeat (TPR), HSP90 CO-factor, protein BIN; NMR {Saccharomyces cerevisiae}

Probab=94.31  E-value=0.15  Score=32.28  Aligned_cols=91  Identities=4%  Similarity=-0.204  Sum_probs=61.6

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc-------cccHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN-------LQSWT   80 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~-------~~~~~   80 (234)
                      ...+..+=..+.+.|+.++|...+...++... .+...+..+-..|.+.|+.++|...++...+  |+       ...+.
T Consensus         4 ~~~~~~~g~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~~~~~~   82 (111)
T 2l6j_A            4 FEKQKEQGNSLFKQGLYREAVHCYDQLITAQP-QNPVGYSNKAMALIKLGEYTQAIQMCQQGLRYTSTAEHVAIRSKLQY   82 (111)
T ss_dssp             HHHHHHHHHHHHTTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHTSCSSTTSHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHhcCC-CCHHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCCCccHHHHHHHHHH
Confidence            34555666677788899999999988887543 2566778888889999999999988887553  32       22344


Q ss_pred             HHHHHHHhcCCchhhhHhhhc
Q 026720           81 IMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      .+-..+...|+.++|+..+..
T Consensus        83 ~~~~~~~~~~~~~~a~~~~~~  103 (111)
T 2l6j_A           83 RLELAQGAVGSVQIPVVEVDE  103 (111)
T ss_dssp             HHHHHHHHHHCCCCCSSSSSS
T ss_pred             HHHHHHHHHHhHhhhHhHHHH
Confidence            444445555666666555443

>3u4t_A TPR repeat-containing protein; structural genomics, PSI- protein structure initiative, northeast structural genomics consortium, NESG; 2.28A {Cytophaga hutchinsonii}

Probab=94.26  E-value=0.22  Score=37.30  Aligned_cols=88  Identities=9%  Similarity=-0.080  Sum_probs=69.9

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cccc----cHHHHHHHH
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQ----SWTIMISGL   86 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~----~~~~~i~~~   86 (234)
                      +...-..+...|++++|...+...++... .+...+..+...|.+.|+.++|...++...+  .+..    +|..+-..+
T Consensus         6 ~~~~a~~~~~~~~~~~A~~~~~~~l~~~p-~~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~~lg~~~   84 (272)
T 3u4t_A            6 EFRYADFLFKNNNYAEAIEVFNKLEAKKY-NSPYIYNRRAVCYYELAKYDLAQKDIETYFSKVNATKAKSADFEYYGKIL   84 (272)
T ss_dssp             HHHHHHHHHTTTCHHHHHHHHHHHHHTTC-CCSTTHHHHHHHHHHTTCHHHHHHHHHHHHTTSCTTTCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCHHHHHHHHHHHHHhCC-CcHHHHHHHHHHHHHHhhHHHHHHHHHHHHhccCchhHHHHHHHHHHHHH
Confidence            44445667788999999999999987543 2344788888899999999999999988654  2222    377888889


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      .+.|+.++|+..+..
T Consensus        85 ~~~~~~~~A~~~~~~   99 (272)
T 3u4t_A           85 MKKGQDSLAIQQYQA   99 (272)
T ss_dssp             HHTTCHHHHHHHHHH
T ss_pred             HHcccHHHHHHHHHH
Confidence            999999999999977

>3ieg_A DNAJ homolog subfamily C member 3; TPR motif, chaperone, endoplasmic reticulum, TPR repeat, UNF protein response; 2.51A {Mus musculus}

Probab=94.24  E-value=0.1  Score=40.74  Aligned_cols=91  Identities=9%  Similarity=-0.098  Sum_probs=75.1

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      ..+..+-..+.+.|++++|...+...++... .+..++..+...|...|+.++|...++...+   .+...|..+...+.
T Consensus         4 ~~~~~~~~~~~~~g~~~~A~~~~~~~l~~~p-~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~l~~~~~   82 (359)
T 3ieg_A            4 EKHLELGKKLLAAGQLADALSQFHAAVDGDP-DNYIAYYRRATVFLAMGKSKAALPDLTKVIALKMDFTAARLQRGHLLL   82 (359)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHhhCc-ccHHHHHHHHHHHHHccCHHHHHHHHHHHHHhCCCcchHHHHHHHHHH
Confidence            3455566677888999999999999988643 3566888899999999999999999988653   35677888888999


Q ss_pred             hcCCchhhhHhhhcc
Q 026720           88 DNSRGNDAISLHRQG  102 (234)
Q Consensus        88 ~~g~~~~a~~l~~~~  102 (234)
                      +.|+.++|+..+...
T Consensus        83 ~~~~~~~A~~~~~~~   97 (359)
T 3ieg_A           83 KQGKLDEAEDDFKKV   97 (359)
T ss_dssp             HHTCHHHHHHHHHHH
T ss_pred             HcCChHHHHHHHHHH
Confidence            999999999999873

>4i17_A Hypothetical protein; TPR repeats protein, structural genomics, joint center for S genomics, JCSG, protein structure initiative; HET: MSE; 1.83A {Bacteroides fragilis}

Probab=94.20  E-value=0.26  Score=36.07  Aligned_cols=100  Identities=7%  Similarity=-0.021  Sum_probs=77.3

Q ss_pred             CCeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-cc-------c
Q 026720            8 PNSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NL-------Q   77 (234)
Q Consensus         8 ~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~-------~   77 (234)
                      ++...+..+-.++.+.|+.++|...+...++.... +...+..+-..|.+.|+.++|...++...+  | +.       .
T Consensus        40 ~~~~~~~~~~~~~~~~~~~~~A~~~~~~al~~~p~-~~~~~~~l~~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~~~~  118 (228)
T 4i17_A           40 QDSVTAYNCGVCADNIKKYKEAADYFDIAIKKNYN-LANAYIGKSAAYRDMKNNQEYIATLTEGIKAVPGNATIEKLYAI  118 (228)
T ss_dssp             CCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTTCS-HHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCHHHHHHHHH
T ss_pred             CCcHHHHHHHHHHHHhhcHHHHHHHHHHHHHhCcc-hHHHHHHHHHHHHHcccHHHHHHHHHHHHHHCCCcHHHHHHHHH
Confidence            45556666777788899999999999998875532 567888999999999999999999987543  3 33       3


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhcccccCCcCCC
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQGYFHRDLKPS  111 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~  111 (234)
                      .|..+-..+.+.|+.++|+..+... +.  +.|+
T Consensus       119 ~~~~~g~~~~~~~~~~~A~~~~~~a-l~--~~p~  149 (228)
T 4i17_A          119 YYLKEGQKFQQAGNIEKAEENYKHA-TD--VTSK  149 (228)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHH-TT--SSCH
T ss_pred             HHHHHhHHHHHhccHHHHHHHHHHH-Hh--cCCC
Confidence            4666667788899999999999883 33  3555

>3edt_B KLC 2, kinesin light chain 2; superhelical, structural genomics, structural genomics conso SGC, microtubule, motor protein, phosphoprotein; 2.70A {Homo sapiens} PDB: 3ceq_A

Probab=94.12  E-value=0.14  Score=38.27  Aligned_cols=93  Identities=12%  Similarity=0.032  Sum_probs=73.7

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHh------cc-chhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---------
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVN------GL-ELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---------   73 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~------g~-~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---------   73 (234)
                      ..++..+-..+...|++++|...+...++.      +- .....++..+-..|...|+.++|...+++..+         
T Consensus        43 ~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~  122 (283)
T 3edt_B           43 ATMLNILALVYRDQNKYKEAAHLLNDALAIREKTLGKDHPAVAATLNNLAVLYGKRGKYKEAEPLCKRALEIREKVLGKF  122 (283)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHTCTTCHHHHHHHHHHHHHHHTTTCHHHHHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHcCCcchHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHcCCC
Confidence            345667777888899999999999988875      22 23466889999999999999999998877432         


Q ss_pred             -C-ccccHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           74 -K-NLQSWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        74 -~-~~~~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                       + ....|..+-..+...|+.++|+..+...
T Consensus       123 ~~~~~~~~~~la~~~~~~g~~~~A~~~~~~a  153 (283)
T 3edt_B          123 HPDVAKQLNNLALLCQNQGKAEEVEYYYRRA  153 (283)
T ss_dssp             CHHHHHHHHHHHHHHHTTTCHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHHcCCHHHHHHHHHHH
Confidence             1 3457777888899999999999988763

>1p5q_A FKBP52, FK506-binding protein 4; isomerase; 2.80A {Homo sapiens} SCOP: a.118.8.1 d.26.1.1 PDB: 1qz2_A

Probab=94.11  E-value=0.18  Score=39.91  Aligned_cols=90  Identities=10%  Similarity=-0.194  Sum_probs=72.0

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchh--------------HHHHHHHHHHHhhcCChHHHHHHHHhhcc---C
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELD--------------VAIGTALVEMYSKCGHVEKAFKVFNLMRE---K   74 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~--------------~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~   74 (234)
                      .+..+=..+.+.+++++|...+...++......              ...+..+-..|.+.|+.++|...++...+   .
T Consensus       149 ~~~~~g~~~~~~g~~~~A~~~y~~Al~~~p~~~~~~~~~~~~~~~~~~~~~~nla~~~~~~g~~~~A~~~~~~al~~~p~  228 (336)
T 1p5q_A          149 IVKERGTVYFKEGKYKQALLQYKKIVSWLEYESSFSNEEAQKAQALRLASHLNLAMCHLKLQAFSAAIESCNKALELDSN  228 (336)
T ss_dssp             HHHHHHHHHHHHTCHHHHHHHHHHHHHHTTTCCCCCSHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHCCCHHHHHHHHHHHHHHhhccccCChHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCC
Confidence            444555567788899999999998887543221              47889999999999999999999887543   4


Q ss_pred             ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           75 NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        75 ~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...|..+-.++.+.|+.++|+..+..
T Consensus       229 ~~~a~~~lg~~~~~~g~~~~A~~~~~~  255 (336)
T 1p5q_A          229 NEKGLSRRGEAHLAVNDFELARADFQK  255 (336)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHCCCHHHHHHHHHH
Confidence            667888888889999999999999877

>4abn_A Tetratricopeptide repeat protein 5; P53 cofactor, stress-response, DNA repair, gene regulation; 2.05A {Mus musculus}

Probab=94.06  E-value=0.15  Score=42.53  Aligned_cols=95  Identities=17%  Similarity=0.040  Sum_probs=65.7

Q ss_pred             CCCCeehHHHHHHHhcCc---------hhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhc--------CChHHHHHHH
Q 026720            6 ENPNSVTLVSLVSACTGL---------INVRAGESIHSYAVVNGLELDVAIGTALVEMYSKC--------GHVEKAFKVF   68 (234)
Q Consensus         6 ~~~~~~t~~~ll~~~~~~---------~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~--------g~~~~a~~~~   68 (234)
                      ..|+..++..+-..+...         +++++|...+...++... .+...|..+-..|...        |++++|...|
T Consensus       166 ~~p~~~~~~~lg~~~~~~~~~~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~~~~~~~~~g~~~~A~~~~  244 (474)
T 4abn_A          166 HCKNKVSLQNLSMVLRQLQTDSGDEHSRHVMDSVRQAKLAVQMDV-LDGRSWYILGNAYLSLYFNTGQNPKISQQALSAY  244 (474)
T ss_dssp             TCCCHHHHHHHHHHHTTCCCSCHHHHHHHHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHHHHTTCCHHHHHHHHHHH
T ss_pred             hCCCHHHHHHHHHHHHHhccCChhhhhhhHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHHHHhhccccchHHHHHHHH
Confidence            346655666666677777         888888888877776542 2455677777777777        7788887777


Q ss_pred             Hhhcc------CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           69 NLMRE------KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        69 ~~m~~------~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...+      .+...|..+-..+.+.|+.++|+..+..
T Consensus       245 ~~al~~~p~~~~~~~~~~~lg~~~~~~g~~~~A~~~~~~  283 (474)
T 4abn_A          245 AQAEKVDRKASSNPDLHLNRATLHKYEESYGEALEGFSQ  283 (474)
T ss_dssp             HHHHHHCGGGGGCHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHhCCCcccCHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence            76432      2556677777777778888888877765

>3urz_A Uncharacterized protein; tetratricopeptide repeats (TPR) containing protein, structur genomics, joint center for structural genomics, JCSG; HET: PG4; 2.19A {Bacteroides ovatus}

Probab=94.02  E-value=0.15  Score=37.12  Aligned_cols=91  Identities=14%  Similarity=0.160  Sum_probs=70.5

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHH----------------HHHHHhhcCChHHHHHHHHhhcc---CccccH
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTA----------------LVEMYSKCGHVEKAFKVFNLMRE---KNLQSW   79 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~----------------li~~~~~~g~~~~a~~~~~~m~~---~~~~~~   79 (234)
                      .+.+.|++++|...+...++.... +...+..                +-..|.+.|+.++|...|+...+   .+...|
T Consensus        13 ~~~~~g~~~~A~~~~~~al~~~p~-~~~~~~~~~~~~~~~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~~~   91 (208)
T 3urz_A           13 AAIEAGQNGQAVSYFRQTIALNID-RTEMYYWTNVDKNSEISSKLATELALAYKKNRNYDKAYLFYKELLQKAPNNVDCL   91 (208)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHHCHH-HHHHHHHHHSCTTSHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHH
T ss_pred             HHHHCCCHHHHHHHHHHHHHhCCC-ChHHHHHhhhcchhhhhHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHCCCCHHHH
Confidence            455778999999999998875432 3334555                88889999999999999988553   367788


Q ss_pred             HHHHHHHHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           80 TIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        80 ~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      ..+-..+...|+.++|+..+.. .+.  +.|++.
T Consensus        92 ~~lg~~~~~~g~~~~A~~~~~~-al~--~~P~~~  122 (208)
T 3urz_A           92 EACAEMQVCRGQEKDALRMYEK-ILQ--LEADNL  122 (208)
T ss_dssp             HHHHHHHHHHTCHHHHHHHHHH-HHH--HCTTCH
T ss_pred             HHHHHHHHHcCCHHHHHHHHHH-HHH--cCCCCH
Confidence            8888889999999999999987 333  456654

>4gyw_A UDP-N-acetylglucosamine--peptide N- acetylglucosaminyltransferase 110 kDa subunit...; GT-B, glycosyltransferase, glcnacylation, transferase-peptid; HET: UDP NAG; 1.70A {Homo sapiens} PDB: 3pe3_A* 3pe4_A* 4ay5_A* 4ay6_A* 3tax_A* 4gyy_A* 4gz3_A* 4gz5_A* 4gz6_A*

Probab=93.98  E-value=0.18  Score=44.60  Aligned_cols=100  Identities=12%  Similarity=0.068  Sum_probs=81.0

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ..+|+.+=..+.+.|++++|.+.+.+.++... -+...++.|-..|.+.|++++|...|++..+   .+...|+.+-..+
T Consensus         9 a~al~nLG~~~~~~G~~~eAi~~~~kAl~l~P-~~~~a~~nLg~~l~~~g~~~eA~~~~~~Al~l~P~~~~a~~nLg~~l   87 (723)
T 4gyw_A            9 ADSLNNLANIKREQGNIEEAVRLYRKALEVFP-EFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTL   87 (723)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCS-CCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHH
Confidence            45677777788899999999999999987542 2466889999999999999999999987543   3567899999999


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      .+.|+.++|+..+.+.+ .  +.|+..
T Consensus        88 ~~~g~~~~A~~~~~kAl-~--l~P~~~  111 (723)
T 4gyw_A           88 KEMQDVQGALQCYTRAI-Q--INPAFA  111 (723)
T ss_dssp             HHTTCHHHHHHHHHHHH-H--HCTTCH
T ss_pred             HHcCCHHHHHHHHHHHH-H--hCCCCH
Confidence            99999999999997733 2  456543

>4gcn_A Protein STI-1; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, tetratricopeptide repeat domain; HET: PGE; 1.85A {Caenorhabditis elegans}

Probab=93.76  E-value=0.19  Score=33.48  Aligned_cols=84  Identities=6%  Similarity=-0.017  Sum_probs=64.8

Q ss_pred             HHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-cc-------ccHHHHHHHH
Q 026720           17 VSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NL-------QSWTIMISGL   86 (234)
Q Consensus        17 l~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~-------~~~~~~i~~~   86 (234)
                      =..+.+.|++++|...+...++... .+...|+.+-..|.+.|+.++|...++...+  | +.       .+|..+-..+
T Consensus        15 G~~~~~~~~~~~A~~~y~~Al~~~p-~~~~~~~nlg~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~~a~~~~~lg~~~   93 (127)
T 4gcn_A           15 GNAAYKQKDFEKAHVHYDKAIELDP-SNITFYNNKAAVYFEEKKFAECVQFCEKAVEVGRETRADYKLIAKAMSRAGNAF   93 (127)
T ss_dssp             HHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHhHHHHHHHhhhHHHHHHHHHHHHHhCcccchhhHHHHHHHHHHHHHH
Confidence            3456778899999999999887542 2567888899999999999999998877542  2 22       2455555667


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      ...|+.++|+..+..
T Consensus        94 ~~~~~~~~A~~~~~k  108 (127)
T 4gcn_A           94 QKQNDLSLAVQWFHR  108 (127)
T ss_dssp             HHTTCHHHHHHHHHH
T ss_pred             HHcCCHHHHHHHHHH
Confidence            888999999998876

>1na0_A Designed protein CTPR3; de novo protein; HET: IPT; 1.60A {Unidentified} SCOP: k.38.1.1 PDB: 2wqh_A 3kd7_A

Probab=93.72  E-value=0.29  Score=31.29  Aligned_cols=64  Identities=16%  Similarity=0.033  Sum_probs=53.2

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      +..++..+...+.+.++.++|...+..+.+... .+..++..+...|.+.|+.++|...++...+
T Consensus        42 ~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~~~~  105 (125)
T 1na0_A           42 NAEAWYNLGNAYYKQGDYDEAIEYYQKALELDP-NNAEAWYNLGNAYYKQGDYDEAIEYYQKALE  105 (125)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCC-ccHHHHHHHHHHHHHhcCHHHHHHHHHHHHH
Confidence            455677788888899999999999999987643 3567788999999999999999999988654

>2ond_A Cleavage stimulation factor 77 kDa subunit; HAT domain, structural protein; 2.80A {Mus musculus} SCOP: a.118.8.7

Probab=93.71  E-value=0.24  Score=38.46  Aligned_cols=78  Identities=9%  Similarity=0.057  Sum_probs=60.5

Q ss_pred             hhhhhHhHHHHHHHHhccch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccc-cHHHHHHHHHhcCCchhhhHh
Q 026720           24 INVRAGESIHSYAVVNGLEL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQ-SWTIMISGLADNSRGNDAISL   98 (234)
Q Consensus        24 ~~~~~~~~~~~~~~~~g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~-~~~~~i~~~~~~g~~~~a~~l   98 (234)
                      +..++|..++...++. +.| +...|..+...+.+.|+.++|..+|++..+  | +.. .|......+.+.|+.++|...
T Consensus        78 ~~~~~A~~~~~rAl~~-~~p~~~~~~~~~~~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~~~~~~~~~~~~~~~A~~~  156 (308)
T 2ond_A           78 LFSDEAANIYERAIST-LLKKNMLLYFAYADYEESRMKYEKVHSIYNRLLAIEDIDPTLVYIQYMKFARRAEGIKSGRMI  156 (308)
T ss_dssp             HHHHHHHHHHHHHHTT-TTTTCHHHHHHHHHHHHHTTCHHHHHHHHHHHHTSSSSCTHHHHHHHHHHHHHHHCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHH-hCcccHHHHHHHHHHHHhcCCHHHHHHHHHHHHhccccCccHHHHHHHHHHHHhcCHHHHHHH
Confidence            4567888888888763 234 455788888889999999999999988654  3 333 788888888889999999999


Q ss_pred             hhcc
Q 026720           99 HRQG  102 (234)
Q Consensus        99 ~~~~  102 (234)
                      |...
T Consensus       157 ~~~a  160 (308)
T 2ond_A          157 FKKA  160 (308)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8773

>1a17_A Serine/threonine protein phosphatase 5; hydrolase, protein-protein interactions, TPR, S helix; 2.45A {Homo sapiens} SCOP: a.118.8.1 PDB: 2bug_A

Probab=93.64  E-value=0.21  Score=34.17  Aligned_cols=92  Identities=8%  Similarity=-0.090  Sum_probs=69.3

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHH--H
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIM--I   83 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~--i   83 (234)
                      +..++..+-..+...+++++|...+...++... .+...+..+-..|.+.|+.++|...++...+   .+...|..+  .
T Consensus        46 ~~~~~~~~a~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~a~~~~p~~~~~~~~~~~~  124 (166)
T 1a17_A           46 NAIYYGNRSLAYLRTECYGYALGDATRAIELDK-KYIKGYYRRAASNMALGKFRAALRDYETVVKVKPHDKDAKMKYQEC  124 (166)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCc-ccHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCHHHHHHHHHH
Confidence            445666677778888999999999999887643 3466788888899999999999999988653   244445333  4


Q ss_pred             HHHHhcCCchhhhHhhhc
Q 026720           84 SGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~  101 (234)
                      ..+.+.|+.++|+..+..
T Consensus       125 ~~~~~~~~~~~A~~~~~~  142 (166)
T 1a17_A          125 NKIVKQKAFERAIAGDEH  142 (166)
T ss_dssp             HHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcccc
Confidence            447778999999988754

>3vtx_A MAMA; tetratricopeptide repeats (TPR) containing protein, peptide protein, protein binding; 1.75A {Candidatus magnetobacterium bavaricum} PDB: 3vty_A

Probab=93.51  E-value=0.32  Score=34.13  Aligned_cols=92  Identities=10%  Similarity=0.003  Sum_probs=72.5

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +...|..+=..+.+.|++++|...+...++... -+...+..+-..|.+.|+.++|...+.....   .+...|..+-..
T Consensus         4 ~~~iy~~lG~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~la~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~   82 (184)
T 3vtx_A            4 TTTIYMDIGDKKRTKGDFDGAIRAYKKVLKADP-NNVETLLKLGKTYMDIGLPNDAIESLKKFVVLDTTSAEAYYILGSA   82 (184)
T ss_dssp             CHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHCCCHHHHHHHHHHHHhcCchhHHHHHHHHHH
Confidence            345666777778888999999999999987643 2566788899999999999999998877543   345566666677


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +...++.++|...+..
T Consensus        83 ~~~~~~~~~a~~~~~~   98 (184)
T 3vtx_A           83 NFMIDEKQAAIDALQR   98 (184)
T ss_dssp             HHHTTCHHHHHHHHHH
T ss_pred             HHHcCCHHHHHHHHHH
Confidence            8888999999988866

>2fbn_A 70 kDa peptidylprolyl isomerase, putative; sulfur SAD, PFL2275C, TPR-containing domain, structural genomics; 1.63A {Plasmodium falciparum} SCOP: a.118.8.1

Probab=93.50  E-value=0.36  Score=34.58  Aligned_cols=87  Identities=9%  Similarity=-0.091  Sum_probs=66.0

Q ss_pred             HHHHHhcCchhhhhHhHHHHHHHHhccc-h--------------hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---Ccc
Q 026720           15 SLVSACTGLINVRAGESIHSYAVVNGLE-L--------------DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNL   76 (234)
Q Consensus        15 ~ll~~~~~~~~~~~~~~~~~~~~~~g~~-~--------------~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~   76 (234)
                      .+=..+.+.+++++|...+...++.... +              ...++..+-..|.+.|+.++|...++...+   .+.
T Consensus        43 ~~g~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~~~~~~~~~~~la~~~~~~~~~~~A~~~~~~al~~~p~~~  122 (198)
T 2fbn_A           43 EEGNEFFKKNEINEAIVKYKEALDFFIHTEEWDDQILLDKKKNIEISCNLNLATCYNKNKDYPKAIDHASKVLKIDKNNV  122 (198)
T ss_dssp             HHHHHHHHTTCHHHHHHHHHHHHHTTTTCTTCCCHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCH
T ss_pred             HHHHHHHHcCCHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCcccH
Confidence            3344566778899999999888764221 1              126778888889999999999998877543   356


Q ss_pred             ccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           77 QSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ..|..+-..+.+.|+.++|+..+..
T Consensus       123 ~~~~~lg~~~~~~~~~~~A~~~~~~  147 (198)
T 2fbn_A          123 KALYKLGVANMYFGFLEEAKENLYK  147 (198)
T ss_dssp             HHHHHHHHHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccHHHHHHHHHH
Confidence            6777778888999999999998877

>2h6f_A Protein farnesyltransferase/geranylgeranyltransferase type I alpha subunit; ftase, farnesyltransferase, farnesyl transferase, prenyltransferase, CAAX, RAS, lipid modification, prenylation; HET: SUC FAR; 1.50A {Homo sapiens} SCOP: a.118.6.1 PDB: 1jcq_A* 1ld7_A* 1mzc_A* 1s63_A* 1sa4_A* 1tn6_A* 1ld8_A* 2h6g_A* 2h6h_A* 2h6i_A* 2iej_A* 3e37_A* 2f0y_A* 3ksl_A* 2zir_A* 2zis_A* 1o5m_A* 3ksq_A* 1o1t_A* 1o1s_A* ...

Probab=93.48  E-value=0.16  Score=41.15  Aligned_cols=84  Identities=7%  Similarity=-0.025  Sum_probs=38.8

Q ss_pred             HHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCC-hHHHHHHHHhhcc---CccccHHHHHHHHHhcCCc
Q 026720           17 VSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGH-VEKAFKVFNLMRE---KNLQSWTIMISGLADNSRG   92 (234)
Q Consensus        17 l~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~-~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~   92 (234)
                      -..+.+.++.++|...+...++... .+...|+.+-..|.+.|. +++|...|++...   .+...|+.+-..+.+.|+.
T Consensus       104 g~~~~~~g~~~~Al~~~~~al~l~P-~~~~a~~~~g~~l~~~g~d~~eAl~~~~~al~l~P~~~~a~~~~g~~~~~~g~~  182 (382)
T 2h6f_A          104 RAVLQRDERSERAFKLTRDAIELNA-ANYTVWHFRRVLLKSLQKDLHEEMNYITAIIEEQPKNYQVWHHRRVLVEWLRDP  182 (382)
T ss_dssp             HHHHHHTCCCHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHCCChHHHHHHHHHHHHhCc-cCHHHHHHHHHHHHHcccCHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHccCH
Confidence            3334444455555555555544321 123344455555555553 5555555544332   2334444444444444555


Q ss_pred             hhhhHhhhc
Q 026720           93 NDAISLHRQ  101 (234)
Q Consensus        93 ~~a~~l~~~  101 (234)
                      ++|+..+..
T Consensus       183 ~eAl~~~~k  191 (382)
T 2h6f_A          183 SQELEFIAD  191 (382)
T ss_dssp             TTHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            555544444

>3mv2_B Coatomer subunit epsilon; vesicular membrane coat COAT protein complex I, protein TRAN; 2.90A {Saccharomyces cerevisiae} PDB: 3mv3_B

Probab=93.46  E-value=0.26  Score=38.76  Aligned_cols=122  Identities=11%  Similarity=0.007  Sum_probs=80.3

Q ss_pred             CCCeehHHHHHHHhcCchhhhhHhHHHHHHHHhcc-chhHHHHHHHHHHHhhcCChHHHHHHHHhhccCcc-------cc
Q 026720            7 NPNSVTLVSLVSACTGLINVRAGESIHSYAVVNGL-ELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNL-------QS   78 (234)
Q Consensus         7 ~~~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~-~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~-------~~   78 (234)
                      .++..++..+-.++...|+.++|.++....+..+- .-+...+..++..|.+.|+.+.|.+.++.|.+-+.       .+
T Consensus        97 ~~~~~~~~~la~i~~~~g~~eeAL~~l~~~i~~~~~~~~lea~~l~vqi~L~~~r~d~A~k~l~~~~~~~~d~~~~~d~~  176 (310)
T 3mv2_B           97 QNSPYELYLLATAQAILGDLDKSLETCVEGIDNDEAEGTTELLLLAIEVALLNNNVSTASTIFDNYTNAIEDTVSGDNEM  176 (310)
T ss_dssp             CCCHHHHHHHHHHHHHHTCHHHHHHHHHHHHTSSCSTTHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSCHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHHHcCCHHHHHHHHHHHhccCCCcCcHHHHHHHHHHHHHCCCHHHHHHHHHHHHhcCccccccchHH
Confidence            34555555666778888999999999988766553 23667788999999999999999999998875322       33


Q ss_pred             HHHHHHH--HH--hcCCchhhhHhhhcccccCCcCCC----cEEeeCCeeeEeecccccccc
Q 026720           79 WTIMISG--LA--DNSRGNDAISLHRQGYFHRDLKPS----NLLVSKGVIKIGDLGMVKEID  132 (234)
Q Consensus        79 ~~~~i~~--~~--~~g~~~~a~~l~~~~~~~~~l~p~----~~~~~~~~~~~~~~~~a~~~~  132 (234)
                      ...+..+  ..  ..++..+|.++|.+ +...  .|+    ..+++ ...+.+++..|+...
T Consensus       177 l~~Laea~v~l~~g~~~~q~A~~~f~E-l~~~--~p~~~~~~lLln-~~~~~g~~~eAe~~L  234 (310)
T 3mv2_B          177 ILNLAESYIKFATNKETATSNFYYYEE-LSQT--FPTWKTQLGLLN-LHLQQRNIAEAQGIV  234 (310)
T ss_dssp             HHHHHHHHHHHHHTCSTTTHHHHHHHH-HHTT--SCSHHHHHHHHH-HHHHHTCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCccHHHHHHHHHH-HHHh--CCCcccHHHHHH-HHHHcCCHHHHHHHH
Confidence            3333334  22  23489999999988 4432  343    12233 333455555555543

>2h6f_A Protein farnesyltransferase/geranylgeranyltransferase type I alpha subunit; ftase, farnesyltransferase, farnesyl transferase, prenyltransferase, CAAX, RAS, lipid modification, prenylation; HET: SUC FAR; 1.50A {Homo sapiens} SCOP: a.118.6.1 PDB: 1jcq_A* 1ld7_A* 1mzc_A* 1s63_A* 1sa4_A* 1tn6_A* 1ld8_A* 2h6g_A* 2h6h_A* 2h6i_A* 2iej_A* 3e37_A* 2f0y_A* 3ksl_A* 2zir_A* 2zis_A* 1o5m_A* 3ksq_A* 1o1t_A* 1o1s_A* ...

Probab=93.39  E-value=0.29  Score=39.68  Aligned_cols=100  Identities=6%  Similarity=-0.061  Sum_probs=80.6

Q ss_pred             eehHHHHHHHhcCchh-hhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720           10 SVTLVSLVSACTGLIN-VRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~-~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      ...|+.+-..+.+.|+ +++|...+...++... .+...|+.+-..|.+.|++++|...|++..+   .+...|..+-..
T Consensus       131 ~~a~~~~g~~l~~~g~d~~eAl~~~~~al~l~P-~~~~a~~~~g~~~~~~g~~~eAl~~~~kal~ldP~~~~a~~~lg~~  209 (382)
T 2h6f_A          131 YTVWHFRRVLLKSLQKDLHEEMNYITAIIEEQP-KNYQVWHHRRVLVEWLRDPSQELEFIADILNQDAKNYHAWQHRQWV  209 (382)
T ss_dssp             HHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCCTTHHHHHHHHHHHCTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCHHHHHHHHHHHHHHCC-CCHHHHHHHHHHHHHccCHHHHHHHHHHHHHhCccCHHHHHHHHHH
Confidence            4456666667778886 9999999999988553 2567888899999999999999999988653   477889999999


Q ss_pred             HHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           86 LADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      +.+.|+.++|+..+... +.  +.|++.
T Consensus       210 ~~~~g~~~eAl~~~~~a-l~--l~P~~~  234 (382)
T 2h6f_A          210 IQEFKLWDNELQYVDQL-LK--EDVRNN  234 (382)
T ss_dssp             HHHHTCCTTHHHHHHHH-HH--HCTTCH
T ss_pred             HHHcCChHHHHHHHHHH-HH--hCCCCH
Confidence            99999999999999883 33  456543

>3ieg_A DNAJ homolog subfamily C member 3; TPR motif, chaperone, endoplasmic reticulum, TPR repeat, UNF protein response; 2.51A {Mus musculus}

Probab=93.36  E-value=0.34  Score=37.60  Aligned_cols=84  Identities=12%  Similarity=0.042  Sum_probs=71.2

Q ss_pred             HHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCch
Q 026720           17 VSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGN   93 (234)
Q Consensus        17 l~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~   93 (234)
                      -..+...|+.++|...+....+... .+..++..+...|.+.|+.++|...++...+   .+...|..+...+.+.|+.+
T Consensus       127 a~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~la~~~~~~~~~~  205 (359)
T 3ieg_A          127 ALDAFDGADYTAAITFLDKILEVCV-WDAELRELRAECFIKEGEPRKAISDLKAASKLKSDNTEAFYKISTLYYQLGDHE  205 (359)
T ss_dssp             HHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHTTCSCCHHHHHHHHHHHHHHTCHH
T ss_pred             HHHHHHccCHHHHHHHHHHHHHhCC-CchHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHcCCHH
Confidence            3667788999999999999987654 3567888999999999999999999988654   35678888888999999999


Q ss_pred             hhhHhhhc
Q 026720           94 DAISLHRQ  101 (234)
Q Consensus        94 ~a~~l~~~  101 (234)
                      +|+..+..
T Consensus       206 ~A~~~~~~  213 (359)
T 3ieg_A          206 LSLSEVRE  213 (359)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999877

>3rkv_A Putative peptidylprolyl isomerase; structural genomics, APC102156, PSI-biology, midwest center structural genomics, MCSG; 2.41A {Caenorhabditis elegans}

Probab=93.20  E-value=0.27  Score=33.93  Aligned_cols=86  Identities=7%  Similarity=-0.067  Sum_probs=68.0

Q ss_pred             HHHHhcCchhhhhHhHHHHHHHHhc-----------------cchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---Cc
Q 026720           16 LVSACTGLINVRAGESIHSYAVVNG-----------------LELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KN   75 (234)
Q Consensus        16 ll~~~~~~~~~~~~~~~~~~~~~~g-----------------~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~   75 (234)
                      .=..+.+.|++++|...+...++.-                 -..+...+..+-..|.+.|++++|...++...+   .+
T Consensus        17 ~G~~~~~~~~~~~A~~~y~~al~~~~~~~~~~~~~~~~~~~~~~~~~~~~~nla~~~~~~~~~~~A~~~~~~al~~~p~~   96 (162)
T 3rkv_A           17 KGNELFVQKDYKEAIDAYRDALTRLDTLILREKPGEPEWVELDRKNIPLYANMSQCYLNIGDLHEAEETSSEVLKREETN   96 (162)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHHHHHHHHHHHTSCTTSHHHHHHHHTHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHSTTC
T ss_pred             HHHHHHHcCCHHHHHHHHHHHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHHHHhcCcHHHHHHHHHHHHhcCCcc
Confidence            3345667888999999988887740                 112456788899999999999999999887543   46


Q ss_pred             cccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           76 LQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        76 ~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ...|..+-.++...|+.++|+..+..
T Consensus        97 ~~a~~~~g~~~~~~g~~~~A~~~~~~  122 (162)
T 3rkv_A           97 EKALFRRAKARIAAWKLDEAEEDLKL  122 (162)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhcHHHHHHHHHH
Confidence            67888888889999999999999877

>3ma5_A Tetratricopeptide repeat domain protein; NESG, structural genomics, PSI-2, protein structure initiative; 2.80A {Salinibacter ruber} PDB: 2kcl_A 2kcv_A

Probab=92.86  E-value=0.27  Score=31.02  Aligned_cols=58  Identities=14%  Similarity=0.102  Sum_probs=32.8

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNL   70 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~   70 (234)
                      .+..+=..+...|+.++|...+...++.... +...|..+-..|.+.|+.++|...+++
T Consensus         9 ~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~-~~~a~~~lg~~~~~~g~~~~A~~~~~~   66 (100)
T 3ma5_A            9 TRYALAQEHLKHDNASRALALFEELVETDPD-YVGTYYHLGKLYERLDRTDDAIDTYAQ   66 (100)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHSTT-CTHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHhCCC-cHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence            3444444555566666666666666554321 334555566666666666666666554

>2ooe_A Cleavage stimulation factor 77 kDa subunit; HAT domain, structural protein; 3.00A {Mus musculus} SCOP: a.118.8.7

Probab=92.80  E-value=0.27  Score=41.34  Aligned_cols=124  Identities=6%  Similarity=-0.065  Sum_probs=77.2

Q ss_pred             CCC-eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCcc---ccHHHH
Q 026720            7 NPN-SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNL---QSWTIM   82 (234)
Q Consensus         7 ~~~-~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~---~~~~~~   82 (234)
                      .|+ ...|..+...+.+.|+.++|..++...++........+|..+...+.+.|.+++|+.+|+...+...   ..|...
T Consensus       317 ~p~~~~l~~~~~~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~~~~~~~~~~~~~~~A~~~~~~Al~~~~~~~~~~~~~  396 (530)
T 2ooe_A          317 LKKNMLLYFAYADYEESRMKYEKVHSIYNRLLAIEDIDPTLVYIQYMKFARRAEGIKSGRMIFKKAREDARTRHHVYVTA  396 (530)
T ss_dssp             CSSCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHSSSSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCTTCCTHHHHHH
T ss_pred             CcccHHHHHHHHHHHHhcCCHHHHHHHHHHHhCccccCchHHHHHHHHHHHHhcCHHHHHHHHHHHHhccCCchHHHHHH
Confidence            453 5566677777778889999999999988743221134788888888889999999999988554221   222221


Q ss_pred             H-HHHHhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEeeccccccccC
Q 026720           83 I-SGLADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        83 i-~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~~~~~a~~~~~  133 (234)
                      . .-+...|+.++|..+|...+.   ..|++..+    .....+.++...++.+..
T Consensus       397 a~~~~~~~~~~~~A~~~~e~al~---~~p~~~~~~~~~~~~~~~~g~~~~Ar~~~~  449 (530)
T 2ooe_A          397 ALMEYYCSKDKSVAFKIFELGLK---KYGDIPEYVLAYIDYLSHLNEDNNTRVLFE  449 (530)
T ss_dssp             HHHHHHHTCCHHHHHHHHHHHHH---HHTTCHHHHHHHHHHHTTTTCHHHHHHHHH
T ss_pred             HHHHHHHcCChhHHHHHHHHHHH---HCCCCHHHHHHHHHHHHhCCCHhhHHHHHH
Confidence            1 113357889999999877433   34554322    112233455555555443

>2vsy_A XCC0866; transferase, glycosyl transferase, GT-B, OGT, protein O-GLCN; HET: NHE; 2.10A {Xanthomonas campestris PV} PDB: 2jlb_A* 2xgm_A* 2xgo_A* 2xgs_A* 2vsn_A*

Probab=92.65  E-value=0.3  Score=41.49  Aligned_cols=90  Identities=9%  Similarity=-0.078  Sum_probs=54.8

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      .++..+-..+...|+.++|.+.+....+... .+...+..+-..|.+.|+.++|...+++..+   .+...|..+...+.
T Consensus        58 ~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~la~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l~~~~~  136 (568)
T 2vsy_A           58 EAVARLGRVRWTQQRHAEAAVLLQQASDAAP-EHPGIALWLGHALEDAGQAEAAAAAYTRAHQLLPEEPYITAQLLNWRR  136 (568)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCHHHHHHHHHHHHhcCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHH
Confidence            3444555556666667777766666665432 2344566666667777777777766665432   24455566666666


Q ss_pred             hc---CCchhhhHhhhc
Q 026720           88 DN---SRGNDAISLHRQ  101 (234)
Q Consensus        88 ~~---g~~~~a~~l~~~  101 (234)
                      +.   |+.++|...+..
T Consensus       137 ~~~~~g~~~~A~~~~~~  153 (568)
T 2vsy_A          137 RLCDWRALDVLSAQVRA  153 (568)
T ss_dssp             HTTCCTTHHHHHHHHHH
T ss_pred             HhhccccHHHHHHHHHH
Confidence            66   777777777665

>2lni_A Stress-induced-phosphoprotein 1; structural genomics, northeast structural genomics consortiu PSI-biology, protein structure initiative, chaperone; NMR {Homo sapiens}

Probab=92.54  E-value=0.76  Score=29.75  Aligned_cols=77  Identities=8%  Similarity=-0.069  Sum_probs=57.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +...+..+-..+...++.++|...+....+... .+...+..+-..|.+.|+.++|...|+...+   .+...|..+-..
T Consensus        49 ~~~~~~~la~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~la~~~~~~~~~~~A~~~~~~~~~~~p~~~~~~~~l~~~  127 (133)
T 2lni_A           49 DAKLYSNRAACYTKLLEFQLALKDCEECIQLEP-TFIKGYTRKAAALEAMKDYTKAMDVYQKALDLDSSCKEAADGYQRC  127 (133)
T ss_dssp             CHHHHHHHHHHHTTTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCGGGTHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCC-CchHHHHHHHHHHHHHhhHHHHHHHHHHHHHhCCCchHHHHHHHHH
Confidence            456677777888999999999999999887643 2566788888999999999999999987543   233444444333


Q ss_pred             H
Q 026720           86 L   86 (234)
Q Consensus        86 ~   86 (234)
                      +
T Consensus       128 ~  128 (133)
T 2lni_A          128 M  128 (133)
T ss_dssp             H
T ss_pred             H
Confidence            3

>4abn_A Tetratricopeptide repeat protein 5; P53 cofactor, stress-response, DNA repair, gene regulation; 2.05A {Mus musculus}

Probab=92.39  E-value=0.39  Score=39.98  Aligned_cols=93  Identities=22%  Similarity=0.054  Sum_probs=75.1

Q ss_pred             CeehHHHHHHHhcCchhh-hhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINV-RAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~-~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~~~~~~i~~   85 (234)
                      +...+..+=..+...++. ++|...+...++... .+...+..+-..|.+.|++++|...|+...+  |+...|..+-..
T Consensus       101 ~a~~~~~lg~~~~~~g~~~~~A~~~~~~al~~~p-~~~~a~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~lg~~  179 (474)
T 4abn_A          101 EAQALMLKGKALNVTPDYSPEAEVLLSKAVKLEP-ELVEAWNQLGEVYWKKGDVTSAHTCFSGALTHCKNKVSLQNLSMV  179 (474)
T ss_dssp             CHHHHHHHHHHHTSSSSCCHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhccccHHHHHHHHHHHHhhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCCCHHHHHHHHHH
Confidence            344555666678889999 999999999887643 2466889999999999999999999988653  566677777778


Q ss_pred             HHhc---------CCchhhhHhhhcc
Q 026720           86 LADN---------SRGNDAISLHRQG  102 (234)
Q Consensus        86 ~~~~---------g~~~~a~~l~~~~  102 (234)
                      +.+.         |+.++|+..+...
T Consensus       180 ~~~~~~~~~~~~~g~~~~A~~~~~~a  205 (474)
T 4abn_A          180 LRQLQTDSGDEHSRHVMDSVRQAKLA  205 (474)
T ss_dssp             HTTCCCSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhccCChhhhhhhHHHHHHHHHHH
Confidence            8888         9999999999773

>4ga2_A E3 SUMO-protein ligase ranbp2; TPR motif, nuclear pore complex component nucleocytoplasmic transport, transport protein; 0.95A {Pan troglodytes} PDB: 4ga0_A 4ga1_A*

Probab=92.32  E-value=0.25  Score=33.92  Aligned_cols=88  Identities=10%  Similarity=0.050  Sum_probs=64.9

Q ss_pred             cCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhH
Q 026720           21 TGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAIS   97 (234)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~   97 (234)
                      -..+++++|...+........ .+...+-.|-..|.+.|+.++|.+.|++..+   .+...|..+-..+.+.|+.++|+.
T Consensus         8 ~~~~~~e~ai~~~~~a~~~~p-~~~~~~~~la~~y~~~~~~~~A~~~~~~al~~~p~~~~a~~~lg~~~~~~~~~~~A~~   86 (150)
T 4ga2_A            8 RSKADVERYIASVQGSTPSPR-QKSIKGFYFAKLYYEAKEYDLAKKYICTYINVQERDPKAHRFLGLLYELEENTDKAVE   86 (150)
T ss_dssp             CCHHHHHHHHHHHHHHSCSHH-HHHTTHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             HHcChHHHHHHHHHHhcccCc-ccHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHcCchHHHHH
Confidence            345677777777766554321 2344556788889999999999999988543   467889999899999999999999


Q ss_pred             hhhcccccCCcCCCc
Q 026720           98 LHRQGYFHRDLKPSN  112 (234)
Q Consensus        98 l~~~~~~~~~l~p~~  112 (234)
                      .+... +.  +.|++
T Consensus        87 ~~~~a-l~--~~p~~   98 (150)
T 4ga2_A           87 CYRRS-VE--LNPTQ   98 (150)
T ss_dssp             HHHHH-HH--HCTTC
T ss_pred             HHHHH-HH--hCCCC
Confidence            99873 32  45554

>2vyi_A SGTA protein; chaperone, TPR repeat, phosphoprotein, tetratricopeptide repeat protein, HOST-virus interaction; 2.4A {Homo sapiens} SCOP: k.38.1.1

Probab=92.31  E-value=0.66  Score=29.80  Aligned_cols=82  Identities=12%  Similarity=-0.075  Sum_probs=60.4

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~   85 (234)
                      +...+..+-..+...++.++|...+....+... .+...+..+...|.+.|+.++|...++...+  | +...|..+...
T Consensus        45 ~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~A~~~~~~~~~~~p~~~~~~~~l~~~  123 (131)
T 2vyi_A           45 NAVYFCNRAAAYSKLGNYAGAVQDCERAICIDP-AYSKAYGRMGLALSSLNKHVEAVAYYKKALELDPDNETYKSNLKIA  123 (131)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHhhchHHHHHHHHHHHhcCc-cCHHHHHHHHHHHHHhCCHHHHHHHHHHHHhcCccchHHHHHHHHH
Confidence            445666677778889999999999999887643 2466788888899999999999999987543  2 44555555555


Q ss_pred             HHhcCC
Q 026720           86 LADNSR   91 (234)
Q Consensus        86 ~~~~g~   91 (234)
                      +.+.|+
T Consensus       124 ~~~~~~  129 (131)
T 2vyi_A          124 ELKLRE  129 (131)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            554444

>2hr2_A Hypothetical protein; alpha-alpha superhelix fold, structural genomics, joint CENT structural genomics, JCSG, protein structure initiative; 2.54A {Chlorobium tepidum} SCOP: a.118.8.8

Probab=92.23  E-value=0.48  Score=33.29  Aligned_cols=84  Identities=12%  Similarity=0.065  Sum_probs=66.3

Q ss_pred             HHhcCchhhhhHhHHHHHHHHhccch-----------hHHHHHHHHHHHhhcCChHHHHHHHHhhc---------c-Ccc
Q 026720           18 SACTGLINVRAGESIHSYAVVNGLEL-----------DVAIGTALVEMYSKCGHVEKAFKVFNLMR---------E-KNL   76 (234)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~g~~~-----------~~~~~~~li~~~~~~g~~~~a~~~~~~m~---------~-~~~   76 (234)
                      ..+.+.|++++|...+...++.....           +...|+.+-..+.+-|++++|...+++-.         + .+.
T Consensus        19 ~~l~~~g~~eeAi~~Y~kAL~l~p~~~~~~a~~~~~~~a~a~~n~g~al~~Lgr~~eAl~~~~kAL~l~n~~~e~~pd~~   98 (159)
T 2hr2_A           19 QRQLVAGEYDEAAANCRRAMEISHTMPPEEAFDHAGFDAFCHAGLAEALAGLRSFDEALHSADKALHYFNRRGELNQDEG   98 (159)
T ss_dssp             HHHHHHTCHHHHHHHHHHHHHHHTTSCTTSCCCHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHCCTTSTHH
T ss_pred             HHHHHCCCHHHHHHHHHHHHhhCCCCcchhhhhhccchHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhhhccccCCCchH
Confidence            34566788999999999888754331           23388999999999999999999887743         2 355


Q ss_pred             ccH----HHHHHHHHhcCCchhhhHhhhc
Q 026720           77 QSW----TIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        77 ~~~----~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ..|    ...=.++..-|+.++|+..|..
T Consensus        99 ~A~~~~~~~rG~aL~~lgr~eEAl~~y~k  127 (159)
T 2hr2_A           99 KLWISAVYSRALALDGLGRGAEAMPEFKK  127 (159)
T ss_dssp             HHHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHhHHHHHHHCCCHHHHHHHHHH
Confidence            678    8888899999999999999876

>1ouv_A Conserved hypothetical secreted protein; TPR repeat, HCP repeat, cysteine rich protein, loop-helix-TU repeat protein, hydrolase; 2.00A {Helicobacter pylori} SCOP: a.118.18.1

Probab=92.22  E-value=0.64  Score=34.98  Aligned_cols=76  Identities=13%  Similarity=0.060  Sum_probs=43.6

Q ss_pred             chhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhh----cCChHHHHHHHHhhcc-CccccHHHHHHHHHh----cCCch
Q 026720           23 LINVRAGESIHSYAVVNGLELDVAIGTALVEMYSK----CGHVEKAFKVFNLMRE-KNLQSWTIMISGLAD----NSRGN   93 (234)
Q Consensus        23 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~----~g~~~~a~~~~~~m~~-~~~~~~~~~i~~~~~----~g~~~   93 (234)
                      .++.++|...+....+.+   +...+..|-..|..    .++.++|...|+...+ .+..++..+-..+.+    .++.+
T Consensus        55 ~~~~~~A~~~~~~a~~~~---~~~a~~~lg~~~~~g~~~~~~~~~A~~~~~~a~~~~~~~a~~~lg~~~~~~~~~~~~~~  131 (273)
T 1ouv_A           55 EKNLKKAASFYAKACDLN---YSNGCHLLGNLYYSGQGVSQNTNKALQYYSKACDLKYAEGCASLGGIYHDGKVVTRDFK  131 (273)
T ss_dssp             CCCHHHHHHHHHHHHHTT---CHHHHHHHHHHHHHTSSSCCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHCSSSCCCHH
T ss_pred             CCCHHHHHHHHHHHHHCC---CHHHHHHHHHHHhCCCCcccCHHHHHHHHHHHHHcCCccHHHHHHHHHHcCCCcccCHH
Confidence            556666666666666554   34445555555555    6666666666655332 244455555555555    66666


Q ss_pred             hhhHhhhc
Q 026720           94 DAISLHRQ  101 (234)
Q Consensus        94 ~a~~l~~~  101 (234)
                      +|+..+..
T Consensus       132 ~A~~~~~~  139 (273)
T 1ouv_A          132 KAVEYFTK  139 (273)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            66666655

>1wao_1 Serine/threonine protein phosphatase 5; hydrolase, protein-protein interactions, TPR, super-helix,; 2.9A {Homo sapiens} SCOP: a.118.8.1 d.159.1.3

Probab=91.95  E-value=0.48  Score=39.55  Aligned_cols=80  Identities=9%  Similarity=-0.117  Sum_probs=41.5

Q ss_pred             cCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhH
Q 026720           21 TGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAIS   97 (234)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~   97 (234)
                      .+.++.++|.+.+...++... .+..++..+-..|.+.|+.++|...+++..+   .+...|..+-..+.+.|+.++|+.
T Consensus        17 ~~~g~~~~A~~~~~~Al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~l~p~~~~~~~~lg~~~~~~g~~~eA~~   95 (477)
T 1wao_1           17 FKAKDYENAIKFYSQAIELNP-SNAIYYGNRSLAYLRTECYGYALGDATRAIELDKKYIKGYYRRAASNMALGKFRAALR   95 (477)
T ss_dssp             TTTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHSCTTCHHHHHHHHHHHHHHTCHHHHHH
T ss_pred             HHhCCHHHHHHHHHHHHHhCC-ccHHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHcCCHHHHHH
Confidence            344555555555555554321 1244555555556666666666555554332   233445555555555566666655


Q ss_pred             hhhc
Q 026720           98 LHRQ  101 (234)
Q Consensus        98 l~~~  101 (234)
                      .+..
T Consensus        96 ~~~~   99 (477)
T 1wao_1           96 DYET   99 (477)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            5544

>2kat_A Uncharacterized protein; NESG, structure, structural genomics, PSI-2, protein structure initiative; NMR {Bordetella parapertussis}

Probab=91.94  E-value=0.42  Score=30.70  Aligned_cols=57  Identities=11%  Similarity=0.145  Sum_probs=32.0

Q ss_pred             HHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           45 VAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        45 ~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ...+..+-..|.+.|+.++|...++....   .+...|..+-..+.+.|+.++|+..+..
T Consensus        19 ~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~la~~~~~~g~~~~A~~~~~~   78 (115)
T 2kat_A           19 MLLRFTLGKTYAEHEQFDAALPHLRAALDFDPTYSVAWKWLGKTLQGQGDRAGARQAWES   78 (115)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHccCHHHHHHHHHHHHHHCCCcHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence            44555555566666666666666655332   2334555555556666666666665544

>2if4_A ATFKBP42; FKBP-like, alpha-beta, TPR-like, alpha, signaling protein; 2.85A {Arabidopsis thaliana}

Probab=91.93  E-value=0.75  Score=36.34  Aligned_cols=98  Identities=11%  Similarity=-0.035  Sum_probs=71.0

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhH------------------HHHHHHHHHHhhcCChHHHHHHHHhhcc-
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDV------------------AIGTALVEMYSKCGHVEKAFKVFNLMRE-   73 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~------------------~~~~~li~~~~~~g~~~~a~~~~~~m~~-   73 (234)
                      +..+=..+.+.+++++|...+...++..  |+.                  ..|+.+-..|.+.|++++|...++...+ 
T Consensus       182 ~~~~g~~~~~~g~~~~A~~~y~~Al~~~--p~~~~~~~~~~~~~~~~~l~~~~~~nla~~~~~~g~~~~A~~~~~~al~~  259 (338)
T 2if4_A          182 RKMDGNSLFKEEKLEEAMQQYEMAIAYM--GDDFMFQLYGKYQDMALAVKNPCHLNIAACLIKLKRYDEAIGHCNIVLTE  259 (338)
T ss_dssp             HHHHHHHTCSSSCCHHHHHHHHHHHHHS--CHHHHHTCCHHHHHHHHHHHTHHHHHHHHHHHTTTCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHHHHHh--ccchhhhhcccHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHh
Confidence            3344456778899999999998877643  332                  2788899999999999999999887543 


Q ss_pred             --CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe
Q 026720           74 --KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV  115 (234)
Q Consensus        74 --~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~  115 (234)
                        .+...|..+-.++...|+.++|+..+... +.  +.|++...
T Consensus       260 ~p~~~~a~~~lg~a~~~~g~~~~A~~~l~~a-l~--l~p~~~~a  300 (338)
T 2if4_A          260 EEKNPKALFRRGKAKAELGQMDSARDDFRKA-QK--YAPDDKAI  300 (338)
T ss_dssp             CTTCHHHHHHHHHHHHTTTCHHHHHHHHHHT-TC----------
T ss_pred             CCCCHHHHHHHHHHHHHcCCHHHHHHHHHHH-HH--HCCCCHHH
Confidence              46778888888999999999999999873 32  45654433

>3ro3_A PINS homolog, G-protein-signaling modulator 2; asymmetric cell division, protein binding; 1.10A {Mus musculus}

Probab=91.90  E-value=0.44  Score=31.99  Aligned_cols=90  Identities=19%  Similarity=0.076  Sum_probs=66.1

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccch-----hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Cc----cc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLEL-----DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KN----LQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~-----~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~----~~   77 (234)
                      ++..+-..+...+++++|...+....+..-..     -..++..+-..|...|+.++|...++...+     .+    ..
T Consensus        11 ~~~~l~~~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~a~~~~~~~~~~~~~~~   90 (164)
T 3ro3_A           11 AFGNLGNTHYLLGNFRDAVIAHEQRLLIAKEFGDKAAERIAYSNLGNAYIFLGEFETASEYYKKTLLLARQLKDRAVEAQ   90 (164)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             HHHHHHHHHHHhcCHHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHhCCcHHHHH
Confidence            45555566777889999999888877642111     124788889999999999999998877432     11    34


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      .+..+-..+...|+.++|+..+..
T Consensus        91 ~~~~l~~~~~~~~~~~~A~~~~~~  114 (164)
T 3ro3_A           91 SCYSLGNTYTLLQDYEKAIDYHLK  114 (164)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhHHHHHHHHHH
Confidence            566667778889999999998866

>2vsy_A XCC0866; transferase, glycosyl transferase, GT-B, OGT, protein O-GLCN; HET: NHE; 2.10A {Xanthomonas campestris PV} PDB: 2jlb_A* 2xgm_A* 2xgo_A* 2xgs_A* 2vsn_A*

Probab=91.73  E-value=0.57  Score=39.76  Aligned_cols=91  Identities=13%  Similarity=0.008  Sum_probs=74.9

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ...+..+-..+.+.|+.++|...+....+... .+...+..+-..|.+.|+.++|...+++..+   .+...|..+-..+
T Consensus        23 ~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~la~~~  101 (568)
T 2vsy_A           23 FVAWLMLADAELGMGDTTAGEMAVQRGLALHP-GHPEAVARLGRVRWTQQRHAEAAVLLQQASDAAPEHPGIALWLGHAL  101 (568)
T ss_dssp             HHHHHHHHHHHHHHTCHHHHHHHHHHHHTTST-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHCCCHHHHHHHHHHHHhcCCCCHHHHHHHHHHH
Confidence            45666777778888999999999999887543 2466888899999999999999999987543   3567888888899


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      .+.|+.++|+..+..
T Consensus       102 ~~~g~~~~A~~~~~~  116 (568)
T 2vsy_A          102 EDAGQAEAAAAAYTR  116 (568)
T ss_dssp             HHTTCHHHHHHHHHH
T ss_pred             HHcCCHHHHHHHHHH
Confidence            999999999998876

>1kt0_A FKBP51, 51 kDa FK506-binding protein; FKBP-like ppiase, TPR repeats, isomerase; 2.70A {Homo sapiens} SCOP: a.118.8.1 d.26.1.1 d.26.1.1 PDB: 1kt1_A 3o5d_A

Probab=91.56  E-value=0.61  Score=38.60  Aligned_cols=98  Identities=11%  Similarity=-0.160  Sum_probs=72.9

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchh--------------HHHHHHHHHHHhhcCChHHHHHHHHhhcc---Cc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELD--------------VAIGTALVEMYSKCGHVEKAFKVFNLMRE---KN   75 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~--------------~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~   75 (234)
                      +..+=..+.+.+++++|...+...++......              ...|+.+-..|.+.|++++|...++...+   .+
T Consensus       271 ~~~~G~~~~~~g~~~~A~~~y~~Al~~~p~~~~~~~~~~~~~~~~~~~~~~nla~~~~~~g~~~~A~~~~~~al~~~p~~  350 (457)
T 1kt0_A          271 VKEKGTVYFKGGKYMQAVIQYGKIVSWLEMEYGLSEKESKASESFLLAAFLNLAMCYLKLREYTKAVECCDKALGLDSAN  350 (457)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHHTTCCSCCHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTC
T ss_pred             HHHHHHHHHhCCCHHHHHHHHHHHHHHhcccccCChHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHhcCCcc
Confidence            44444567788899999999998887432211              57888899999999999999999887543   46


Q ss_pred             cccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           76 LQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        76 ~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      ...|..+-.++.+.|+.++|+..|... +.  +.|++.
T Consensus       351 ~~a~~~~g~a~~~~g~~~~A~~~~~~a-l~--l~P~~~  385 (457)
T 1kt0_A          351 EKGLYRRGEAQLLMNEFESAKGDFEKV-LE--VNPQNK  385 (457)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHH-HT--TC----
T ss_pred             HHHHHHHHHHHHHccCHHHHHHHHHHH-HH--hCCCCH
Confidence            778888888999999999999999873 32  455543

>1ouv_A Conserved hypothetical secreted protein; TPR repeat, HCP repeat, cysteine rich protein, loop-helix-TU repeat protein, hydrolase; 2.00A {Helicobacter pylori} SCOP: a.118.18.1

Probab=91.39  E-value=0.9  Score=34.11  Aligned_cols=90  Identities=11%  Similarity=0.027  Sum_probs=70.0

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhh----cCChHHHHHHHHhhcc-CccccHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSK----CGHVEKAFKVFNLMRE-KNLQSWTIMIS   84 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~----~g~~~~a~~~~~~m~~-~~~~~~~~~i~   84 (234)
                      ..++..+=..+.+.++.++|...+....+.+   +...+..|-..|..    .|+.++|...|++..+ .+..+|..+-.
T Consensus         6 ~~a~~~lg~~~~~~~~~~~A~~~~~~a~~~~---~~~a~~~lg~~~~~g~~~~~~~~~A~~~~~~a~~~~~~~a~~~lg~   82 (273)
T 1ouv_A            6 PKELVGLGAKSYKEKDFTQAKKYFEKACDLK---ENSGCFNLGVLYYQGQGVEKNLKKAASFYAKACDLNYSNGCHLLGN   82 (273)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHTT---CHHHHHHHHHHHHHTSSSCCCHHHHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhCCCHHHHHHHHHHHHHCC---CHHHHHHHHHHHHcCCCcCCCHHHHHHHHHHHHHCCCHHHHHHHHH
Confidence            3345555556677789999999999988833   34567778888888    9999999999988544 46677777777


Q ss_pred             HHHh----cCCchhhhHhhhcc
Q 026720           85 GLAD----NSRGNDAISLHRQG  102 (234)
Q Consensus        85 ~~~~----~g~~~~a~~l~~~~  102 (234)
                      .+.+    .++.++|+..+...
T Consensus        83 ~~~~g~~~~~~~~~A~~~~~~a  104 (273)
T 1ouv_A           83 LYYSGQGVSQNTNKALQYYSKA  104 (273)
T ss_dssp             HHHHTSSSCCCHHHHHHHHHHH
T ss_pred             HHhCCCCcccCHHHHHHHHHHH
Confidence            7888    99999999998773

>1ihg_A Cyclophilin 40; ppiase immunophilin tetratricopeptide, isomerase; 1.80A {Bos taurus} SCOP: a.118.8.1 b.62.1.1 PDB: 1iip_A

Probab=91.18  E-value=1  Score=36.24  Aligned_cols=89  Identities=10%  Similarity=-0.058  Sum_probs=69.9

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHh--------------ccch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---C
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVN--------------GLEL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---K   74 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~--------------g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~   74 (234)
                      +..+=..+.+.+++++|...+...++.              ...| +..+++.+-..|.+.|+.++|...+++..+   .
T Consensus       226 ~~~~g~~~~~~g~~~~Ai~~y~kAl~~~~~~~~~~~~~~~~~~~~~~~~~~~nla~~~~~~g~~~~A~~~~~~al~~~p~  305 (370)
T 1ihg_A          226 LKNIGNTFFKSQNWEMAIKKYTKVLRYVEGSRAAAEDADGAKLQPVALSCVLNIGACKLKMSDWQGAVDSCLEALEIDPS  305 (370)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHHHHSCHHHHGGGHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHTTCTT
T ss_pred             HHHHHHHHHHhcCHHHHHHHHHHHHHHhhcCccccChHHHHHHHHHHHHHHHHHHHHHHhccCHHHHHHHHHHHHHhCch
Confidence            444455677788899999988888761              1222 466888899999999999999999988654   3


Q ss_pred             ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           75 NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        75 ~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...|..+-.++.+.|+.++|+..+..
T Consensus       306 ~~~a~~~lg~~~~~~g~~~eA~~~l~~  332 (370)
T 1ihg_A          306 NTKALYRRAQGWQGLKEYDQALADLKK  332 (370)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHccCHHHHHHHHHH
Confidence            566788888889999999999999877

>2e2e_A Formate-dependent nitrite reductase complex NRFG; TPR, cytochrome C biogenesis, O157:H7 EDL933, formate- nitrite reductase complex, lyase; 2.05A {Escherichia coli}

Probab=90.77  E-value=0.67  Score=32.27  Aligned_cols=82  Identities=9%  Similarity=0.012  Sum_probs=60.0

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH-HHhcCCc--
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG-LADNSRG--   92 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~-~~~~g~~--   92 (234)
                      .+...++.++|...+...++... .+...+..+-..|...|+.++|...++....   .+...|..+-.. +.+.|+.  
T Consensus        19 ~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~la~~l~~~~~~~~~   97 (177)
T 2e2e_A           19 QFASQQNPEAQLQALQDKIRANP-QNSEQWALLGEYYLWQNDYSNSLLAYRQALQLRGENAELYAALATVLYYQASQHMT   97 (177)
T ss_dssp             CCC-----CCCCHHHHHHHHHCC-SCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHCSCHHHHHHHHHHHHHHTTTCCC
T ss_pred             hhhhccCHHHHHHHHHHHHHhCC-CcHHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhcCCcch
Confidence            34567788889888888877543 3566788899999999999999999987543   355666666666 6688998  


Q ss_pred             hhhhHhhhc
Q 026720           93 NDAISLHRQ  101 (234)
Q Consensus        93 ~~a~~l~~~  101 (234)
                      ++|+..+..
T Consensus        98 ~~A~~~~~~  106 (177)
T 2e2e_A           98 AQTRAMIDK  106 (177)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999999877

>4a1s_A PINS, partner of inscuteable; cell cycle, LGN, mitotic spindle orientation, asymmetric CEL divisions; 2.10A {Drosophila melanogaster}

Probab=90.43  E-value=0.85  Score=36.40  Aligned_cols=90  Identities=10%  Similarity=-0.003  Sum_probs=54.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccc-----hhHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----C----ccc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLE-----LDVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----K----NLQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~-----~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~----~~~   77 (234)
                      ++..+-..+...|+.++|...+....+....     ....++..+-..|...|+.++|...+++...     .    ...
T Consensus       265 ~~~~la~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~  344 (411)
T 4a1s_A          265 ANSNLGNSHIFLGQFEDAAEHYKRTLALAVELGEREVEAQSCYSLGNTYTLLHEFNTAIEYHNRHLAIAQELGDRIGEAR  344 (411)
T ss_dssp             HHHHHHHHHHTTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHTCHHHHHH
T ss_pred             HHHHHHHHHHHCcCHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHCCChHHHHH
Confidence            4555566666777777777776666553211     1245566667777777777777776665432     1    123


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +|..+-..+.+.|+.++|...+..
T Consensus       345 ~~~~la~~~~~~g~~~~A~~~~~~  368 (411)
T 4a1s_A          345 ACWSLGNAHSAIGGHERALKYAEQ  368 (411)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccHHHHHHHHHH
Confidence            555556666777777777776654

>2l6j_A TPR repeat-containing protein associated with HSP; tetratricopeptide repeat (TPR), HSP90 CO-factor, protein BIN; NMR {Saccharomyces cerevisiae}

Probab=90.36  E-value=0.75  Score=28.85  Aligned_cols=59  Identities=15%  Similarity=0.139  Sum_probs=48.5

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                      +...+..+-..|.+.|+.++|...|+...+   .+...|..+-..+.+.|+.++|+..+...
T Consensus         3 ~~~~~~~~g~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~lg~~~~~~g~~~~A~~~~~~a   64 (111)
T 2l6j_A            3 QFEKQKEQGNSLFKQGLYREAVHCYDQLITAQPQNPVGYSNKAMALIKLGEYTQAIQMCQQG   64 (111)
T ss_dssp             HHHHHHHHHHHHHTTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCCHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHhcCHHHHHHHHHHH
Confidence            455677788889999999999999987543   36677888888899999999999999873

>3gw4_A Uncharacterized protein; structural genomics, PSI-2, protein structure initiative, no structural genomics consortium, NESG, DRR162B; 2.49A {Deinococcus radiodurans R1}

Probab=90.32  E-value=0.9  Score=32.07  Aligned_cols=90  Identities=8%  Similarity=-0.134  Sum_probs=53.4

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHh----ccc--hhHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Ccc----
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVN----GLE--LDVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KNL----   76 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~----g~~--~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~~----   76 (234)
                      ++..+=..+...|++++|...+....+.    +-.  .....++.+-..|...|+.++|...+++...     .+.    
T Consensus        68 ~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~  147 (203)
T 3gw4_A           68 ALHQVGMVERMAGNWDAARRCFLEERELLASLPEDPLAASANAYEVATVALHFGDLAGARQEYEKSLVYAQQADDQVAIA  147 (203)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHcCccHHHHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHHHHhccchHHHH
Confidence            3444445566677777777777666553    211  2244566677777777888887777665321     111    


Q ss_pred             ccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           77 QSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      .++..+-..+.+.|+.++|...+..
T Consensus       148 ~~~~~la~~~~~~g~~~~A~~~~~~  172 (203)
T 3gw4_A          148 CAFRGLGDLAQQEKNLLEAQQHWLR  172 (203)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCcCHHHHHHHHHH
Confidence            2234455566677777777776654

>3ma5_A Tetratricopeptide repeat domain protein; NESG, structural genomics, PSI-2, protein structure initiative; 2.80A {Salinibacter ruber} PDB: 2kcl_A 2kcv_A

Probab=90.10  E-value=0.85  Score=28.59  Aligned_cols=59  Identities=22%  Similarity=0.204  Sum_probs=49.2

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                      +...+..+-..|.+.|+.++|...|+...+   .+...|..+-..+.+.|+.++|+..+...
T Consensus         6 ~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~a~~~lg~~~~~~g~~~~A~~~~~~a   67 (100)
T 3ma5_A            6 DPFTRYALAQEHLKHDNASRALALFEELVETDPDYVGTYYHLGKLYERLDRTDDAIDTYAQG   67 (100)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCTHHHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCcHHHHHHHHHHHHHcCCHHHHHHHHHHH
Confidence            455677888889999999999999988653   35678888888999999999999988763

>3qww_A SET and MYND domain-containing protein 2; methyltransferase, HSP90, transferase-transferase inhibitor; HET: SFG; 1.80A {Mus musculus} PDB: 3qwv_A* 3s7d_A* 3s7b_A* 3s7f_A* 3s7j_A* 3tg4_A* 3tg5_A* 3rib_A*

Probab=90.09  E-value=0.79  Score=37.85  Aligned_cols=80  Identities=8%  Similarity=-0.093  Sum_probs=61.0

Q ss_pred             CchhhhhHhHHHHHHHHh-----cc-chh-HHHHHHHHHHHhhcCChHHHHHHHHhhcc----------Cc-cccHHHHH
Q 026720           22 GLINVRAGESIHSYAVVN-----GL-ELD-VAIGTALVEMYSKCGHVEKAFKVFNLMRE----------KN-LQSWTIMI   83 (234)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~-----g~-~~~-~~~~~~li~~~~~~g~~~~a~~~~~~m~~----------~~-~~~~~~~i   83 (234)
                      +.|+.++|..++....+.     |. .|+ ..+++.|...|...|++++|..++++...          |+ ..++|.+-
T Consensus       310 ~~g~~~eA~~~~~~~L~i~~~~lg~~Hp~~a~~~~nLa~~y~~~g~~~eA~~~~~~aL~i~~~~lG~~Hp~~a~~l~nLa  389 (433)
T 3qww_A          310 HYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALKYGQKIIKPYSKHYPVYSLNVASMWLKLG  389 (433)
T ss_dssp             TTSCHHHHHHHHHHHHHHHTTTBCTTSHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHSCSSCHHHHHHHHHHH
T ss_pred             hccCHHHHHHHHHHHHHHhhCccChhchHHHHHHHHHHHHHHhhcCHHHHHHHHHHHHHHHHHHcCCCChHHHHHHHHHH
Confidence            445678888888776653     21 233 45889999999999999999998876532          23 25788888


Q ss_pred             HHHHhcCCchhhhHhhhc
Q 026720           84 SGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~  101 (234)
                      ..|...|+.++|+.++.+
T Consensus       390 ~~~~~qg~~~eA~~~~~~  407 (433)
T 3qww_A          390 RLYMGLENKAAGEKALKK  407 (433)
T ss_dssp             HHHHHTTCHHHHHHHHHH
T ss_pred             HHHHhccCHHHHHHHHHH
Confidence            899999999999998865

>1na3_A Designed protein CTPR2; de novo protein; HET: IPT; 1.55A {Unidentified} SCOP: k.38.1.1 PDB: 2avp_A

Probab=90.07  E-value=1.7  Score=25.88  Aligned_cols=58  Identities=14%  Similarity=0.007  Sum_probs=32.8

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhh
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLM   71 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m   71 (234)
                      +..+-..+.+.+++++|...+...++... .+...+..+-..|.+.|+.++|...+++.
T Consensus        12 ~~~la~~~~~~~~~~~A~~~~~~a~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~a   69 (91)
T 1na3_A           12 WYNLGNAYYKQGDYDEAIEYYQKALELDP-NNAEAWYNLGNAYYKQGDYDEAIEYYQKA   69 (91)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCHHHHHHHHHHHHhcCC-CCHHHHHHHHHHHHHHhhHHHHHHHHHHH
Confidence            33344445556666666666666655432 13445555666666666666666666553

>3u3w_A Transcriptional activator PLCR protein; ternary complex, PLCR-PAPR7-DNA, HTH DNA-binding domain, QUO sensing; 2.40A {Bacillus thuringiensis} PDB: 2qfc_A

Probab=90.02  E-value=1.4  Score=33.58  Aligned_cols=89  Identities=9%  Similarity=-0.072  Sum_probs=44.7

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhc-cchh----HHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Ccc----cc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNG-LELD----VAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KNL----QS   78 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g-~~~~----~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~~----~~   78 (234)
                      +...+..+.+.++.++|..++....+.. ..++    ...+..+...|...|+.++|...++...+     .+.    ..
T Consensus        78 l~~~i~~~~~~~~y~~a~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~Ai~~~~~al~~~~~~~~~~~~~~~  157 (293)
T 3u3w_A           78 FKDQVIMLCKQKRYKEIYNKVWNELKKEEYHPEFQQFLQWQYYVAAYVLKKVDYEYCILELKKLLNQQLTGIDVYQNLYI  157 (293)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHTCCCCSCTTHHHHH
T ss_pred             HHHHHHHHHHHhhHHHHHHHHHHHhccccCChHHHHHHHHHHHHHHHHHcccCHHHHHHHHHHHHHHhcccccHHHHHHH
Confidence            4444445555555666666655555432 2233    33555555555555566666555554321     121    13


Q ss_pred             HHHHHHHHHhcCCchhhhHhhhc
Q 026720           79 WTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      |+.+-..|...|+.++|+..+..
T Consensus       158 ~~~lg~~y~~~g~~~~A~~~~~~  180 (293)
T 3u3w_A          158 ENAIANIYAENGYLKKGIDLFEQ  180 (293)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCHHHHHHHHHH
Confidence            45555555556666666655544

>1wao_1 Serine/threonine protein phosphatase 5; hydrolase, protein-protein interactions, TPR, super-helix,; 2.9A {Homo sapiens} SCOP: a.118.8.1 d.159.1.3

Probab=89.98  E-value=0.45  Score=39.75  Aligned_cols=91  Identities=8%  Similarity=-0.108  Sum_probs=67.8

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~   85 (234)
                      +..+|..+-.++.+.++.++|...+...++... .+...+..+-..|.+.|+.++|...+++..+  | +...|..+-.+
T Consensus        39 ~~~~~~~lg~~~~~~g~~~~A~~~~~~al~l~p-~~~~~~~~lg~~~~~~g~~~eA~~~~~~al~~~p~~~~~~~~l~~~  117 (477)
T 1wao_1           39 NAIYYGNRSLAYLRTECYGYALGDATRAIELDK-KYIKGYYRRAASNMALGKFRAALRDYETVVKVKPHDKDAKMKYQEC  117 (477)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHSCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHSTTCTTHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHHHHHH
Confidence            356677777888899999999999999987543 3566888899999999999999999987543  2 44566666444


Q ss_pred             --HHhcCCchhhhHhhh
Q 026720           86 --LADNSRGNDAISLHR  100 (234)
Q Consensus        86 --~~~~g~~~~a~~l~~  100 (234)
                        +.+.|+.++|+..+.
T Consensus       118 ~~~~~~g~~~~A~~~~~  134 (477)
T 1wao_1          118 NKIVKQKAFERAIAGDE  134 (477)
T ss_dssp             HHHHHHHHHCCC-----
T ss_pred             HHHHHHHHHHHHhcccc
Confidence              788899999999876

>3mv2_B Coatomer subunit epsilon; vesicular membrane coat COAT protein complex I, protein TRAN; 2.90A {Saccharomyces cerevisiae} PDB: 3mv3_B

Probab=89.96  E-value=1.7  Score=34.12  Aligned_cols=91  Identities=10%  Similarity=-0.028  Sum_probs=64.2

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccc---hhHHHHHHHHHH----HhhcCChHHHHHHHHhhccCcc--ccHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLE---LDVAIGTALVEM----YSKCGHVEKAFKVFNLMREKNL--QSWTI   81 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~---~~~~~~~~li~~----~~~~g~~~~a~~~~~~m~~~~~--~~~~~   81 (234)
                      -.+..++..+.+.|+.+.|++.+..|.+....   .+-.+...|..+    .-..+...+|..+|+++.+...  .+-..
T Consensus       137 ea~~l~vqi~L~~~r~d~A~k~l~~~~~~~~d~~~~~d~~l~~Laea~v~l~~g~~~~q~A~~~f~El~~~~p~~~~~~l  216 (310)
T 3mv2_B          137 ELLLLAIEVALLNNNVSTASTIFDNYTNAIEDTVSGDNEMILNLAESYIKFATNKETATSNFYYYEELSQTFPTWKTQLG  216 (310)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHHHHHHHHHTCSTTTHHHHHHHHHHTTSCSHHHHHH
T ss_pred             HHHHHHHHHHHHCCCHHHHHHHHHHHHhcCccccccchHHHHHHHHHHHHHHhCCccHHHHHHHHHHHHHhCCCcccHHH
Confidence            44557788899999999999999999775320   123333344434    3334589999999999876432  23344


Q ss_pred             HHHHHHhcCCchhhhHhhhc
Q 026720           82 MISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +++++.+.|+.++|...+..
T Consensus       217 Lln~~~~~g~~~eAe~~L~~  236 (310)
T 3mv2_B          217 LLNLHLQQRNIAEAQGIVEL  236 (310)
T ss_dssp             HHHHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHHHcCCHHHHHHHHHH
Confidence            56688899999999998865

>1na3_A Designed protein CTPR2; de novo protein; HET: IPT; 1.55A {Unidentified} SCOP: k.38.1.1 PDB: 2avp_A

Probab=89.80  E-value=0.94  Score=27.15  Aligned_cols=58  Identities=17%  Similarity=0.241  Sum_probs=47.4

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...+..+-..|.+.|+.++|...++...+   .+...|..+-..+.+.|+.++|+..+..
T Consensus         8 ~~~~~~~la~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~l~~~~~~~~~~~~A~~~~~~   68 (91)
T 1na3_A            8 SAEAWYNLGNAYYKQGDYDEAIEYYQKALELDPNNAEAWYNLGNAYYKQGDYDEAIEYYQK   68 (91)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHccCHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHHhhHHHHHHHHHH
Confidence            345677778889999999999999987543   3566788888889999999999999876

>3gyz_A Chaperone protein IPGC; asymmetric homodimer, tetratricopeptide repeat, TPR, chapero virulence; 2.15A {Shigella flexneri} PDB: 3gz1_A 3gz2_A 3ks2_A

Probab=89.75  E-value=0.77  Score=31.71  Aligned_cols=59  Identities=12%  Similarity=-0.023  Sum_probs=49.8

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                      +...+..+-..|.+.|++++|...|+....   .+...|..+-..+.+.|++++|+..|...
T Consensus        35 ~~~~~~~lg~~~~~~g~~~eA~~~~~~al~~~P~~~~~~~~lg~~~~~~g~~~~Ai~~~~~a   96 (151)
T 3gyz_A           35 MMDDIYSYAYDFYNKGRIEEAEVFFRFLCIYDFYNVDYIMGLAAIYQIKEQFQQAADLYAVA   96 (151)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHccHHHHHHHHHHH
Confidence            445677788889999999999999998653   36778888888999999999999999873

>1qqe_A Vesicular transport protein SEC17; helix-turn-helix TPR-like repeat, protein transport; 2.90A {Saccharomyces cerevisiae} SCOP: a.118.8.1

Probab=89.74  E-value=1.5  Score=33.52  Aligned_cols=90  Identities=7%  Similarity=-0.141  Sum_probs=64.9

Q ss_pred             hHHHHHHHhcCc-hhhhhHhHHHHHHHHhccch-----hHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc--cc----
Q 026720           12 TLVSLVSACTGL-INVRAGESIHSYAVVNGLEL-----DVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN--LQ----   77 (234)
Q Consensus        12 t~~~ll~~~~~~-~~~~~~~~~~~~~~~~g~~~-----~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~--~~----   77 (234)
                      +++.+=..|... |+.++|...+...++.....     ...+++.+-..|.+.|+.++|...|+...+  ++  ..    
T Consensus       119 ~~~~lg~~~~~~lg~~~~A~~~~~~Al~~~~~~~~~~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~  198 (292)
T 1qqe_A          119 FKFELGEILENDLHDYAKAIDCYELAGEWYAQDQSVALSNKCFIKCADLKALDGQYIEASDIYSKLIKSSMGNRLSQWSL  198 (292)
T ss_dssp             HHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTTSSCTTTGGGH
T ss_pred             HHHHHHHHHHHhhcCHHHHHHHHHHHHHHHHhCCChHHHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHHHhcCCcccHHH
Confidence            455556667664 88999998888877642111     134678888899999999999999887543  21  11    


Q ss_pred             --cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 --SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 --~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                        .|..+...+...|+.++|+..+..
T Consensus       199 ~~~~~~lg~~~~~~g~~~~A~~~~~~  224 (292)
T 1qqe_A          199 KDYFLKKGLCQLAATDAVAAARTLQE  224 (292)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHG
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence              355666678888999999999877

>3n71_A Histone lysine methyltransferase SMYD1; heart development, transcription; HET: SFG MES; 2.30A {Mus musculus}

Probab=89.55  E-value=0.94  Score=38.05  Aligned_cols=82  Identities=7%  Similarity=-0.178  Sum_probs=63.5

Q ss_pred             hcCchhhhhHhHHHHHHHHh-----cc-chh-HHHHHHHHHHHhhcCChHHHHHHHHhhcc----------Cc-cccHHH
Q 026720           20 CTGLINVRAGESIHSYAVVN-----GL-ELD-VAIGTALVEMYSKCGHVEKAFKVFNLMRE----------KN-LQSWTI   81 (234)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~-----g~-~~~-~~~~~~li~~~~~~g~~~~a~~~~~~m~~----------~~-~~~~~~   81 (234)
                      +-..|+.++|..++....+.     |- .|+ ..+++.|...|...|++++|..++++...          |+ ..+++.
T Consensus       319 ~~~qg~~~eA~~l~~~aL~~~~~~lg~~Hp~~a~~~~nLa~~y~~~g~~~eA~~~~~~aL~i~~~~lG~~Hp~~a~~l~n  398 (490)
T 3n71_A          319 ARSEGLYHEVVKLCRECLEKQEPVFADTNLYVLRLLSIASEVLSYLQAYEEASHYARRMVDGYMKLYHHNNAQLGMAVMR  398 (490)
T ss_dssp             HHTTTCHHHHHHHHHHHHHHHTTTBCTTSHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHSCTTCHHHHHHHHH
T ss_pred             HHhCCCHHHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHHHcCCCCHHHHHHHHH
Confidence            45678889999888777653     21 233 45889999999999999999988776432          22 357888


Q ss_pred             HHHHHHhcCCchhhhHhhhc
Q 026720           82 MISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +-..|...|+.++|..++.+
T Consensus       399 La~~~~~~G~~~eA~~~~~~  418 (490)
T 3n71_A          399 AGLTNWHAGHIEVGHGMICK  418 (490)
T ss_dssp             HHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHCCCHHHHHHHHHH
Confidence            88889999999999998865

>3ro2_A PINS homolog, G-protein-signaling modulator 2; TPR repeat, protein-protein interaction, protein-binding, PR binding; 2.30A {Mus musculus}

Probab=89.41  E-value=0.86  Score=34.72  Aligned_cols=84  Identities=20%  Similarity=0.035  Sum_probs=65.8

Q ss_pred             HHhcCchhhhhHhHHHHHHHHhccchh---HHHHHHHHHHHhhcCChHHHHHHHHhhcc---------CccccHHHHHHH
Q 026720           18 SACTGLINVRAGESIHSYAVVNGLELD---VAIGTALVEMYSKCGHVEKAFKVFNLMRE---------KNLQSWTIMISG   85 (234)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~g~~~~---~~~~~~li~~~~~~g~~~~a~~~~~~m~~---------~~~~~~~~~i~~   85 (234)
                      ..+...|++++|...+....+......   ..++..+-..|...|+.++|...++...+         .....|..+-..
T Consensus        13 ~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~l~~~   92 (338)
T 3ro2_A           13 ERLCKSGDCRAGVSFFEAAVQVGTEDLKTLSAIYSQLGNAYFYLHDYAKALEYHHHDLTLARTIGDQLGEAKASGNLGNT   92 (338)
T ss_dssp             HHHHHTTCHHHHHHHHHHHHHHCCSCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHH
T ss_pred             HHHHHhccHHHHHHHHHHHHhhCcccHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHhhcccccHHHHHHHHHHHHH
Confidence            456678899999999999988643321   46788899999999999999998876432         134567777888


Q ss_pred             HHhcCCchhhhHhhhc
Q 026720           86 LADNSRGNDAISLHRQ  101 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~  101 (234)
                      +...|+.++|+..+..
T Consensus        93 ~~~~g~~~~A~~~~~~  108 (338)
T 3ro2_A           93 LKVLGNFDEAIVCCQR  108 (338)
T ss_dssp             HHHTTCHHHHHHHHHH
T ss_pred             HHHccCHHHHHHHHHH
Confidence            8999999999988765

>3ro2_A PINS homolog, G-protein-signaling modulator 2; TPR repeat, protein-protein interaction, protein-binding, PR binding; 2.30A {Mus musculus}

Probab=89.15  E-value=1.1  Score=34.13  Aligned_cols=90  Identities=11%  Similarity=0.013  Sum_probs=42.8

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhcc----ch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Cc----cc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGL----EL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KN----LQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~----~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~----~~   77 (234)
                      ++..+-..+...|+.++|...+....+...    .+ ...++..+...|...|+.++|...++...+     .+    ..
T Consensus       225 ~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~a~~~~~~~~~~~~~~~  304 (338)
T 3ro2_A          225 AYSNLGNAYIFLGEFETASEYYKKTLLLARQLKDRAVEAQSCYSLGNTYTLLQDYEKAIDYHLKHLAIAQELKDRIGEGR  304 (338)
T ss_dssp             HHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHTCHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHHHHhhcchhHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHhcCCcHHHHH
Confidence            334444445555555555555555443211    00 133445555555566666666555544321     11    22


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +|..+-..+.+.|+.++|...+..
T Consensus       305 ~~~~la~~~~~~g~~~~A~~~~~~  328 (338)
T 3ro2_A          305 ACWSLGNAYTALGNHDQAMHFAEK  328 (338)
T ss_dssp             HHHHHHHHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCChHHHHHHHHH
Confidence            444445555555666666555544

>2ooe_A Cleavage stimulation factor 77 kDa subunit; HAT domain, structural protein; 3.00A {Mus musculus} SCOP: a.118.8.7

Probab=89.12  E-value=1.4  Score=36.83  Aligned_cols=87  Identities=10%  Similarity=0.009  Sum_probs=66.5

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--CccccHHHHHH-H
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQSWTIMIS-G   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~~~~~~i~-~   85 (234)
                      |..+|..++.. .+.++.++|..++..+++.- ..+...|..++..+.+.|..++|..+|++...  |++..|...+. .
T Consensus        12 ~~~~w~~l~~~-~~~~~~~~a~~~~e~al~~~-P~~~~~w~~~~~~~~~~~~~~~a~~~~~ral~~~p~~~lw~~~~~~~   89 (530)
T 2ooe_A           12 DLDAWSILIRE-AQNQPIDKARKTYERLVAQF-PSSGRFWKLYIEAEIKAKNYDKVEKLFQRCLMKVLHIDLWKCYLSYV   89 (530)
T ss_dssp             CHHHHHHHHHH-HHSSCHHHHHHHHHHHHTTC-TTCHHHHHHHHHHHHHTTCHHHHHHHHHHHTTTCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHH-HHhCCHHHHHHHHHHHHHHC-CCCHHHHHHHHHHHHhcCCHHHHHHHHHHHHhcCCChHHHHHHHHHH
Confidence            55678888874 66789999999999998642 23566899999999999999999999999754  56666776654 2


Q ss_pred             HHhcCCchhhhH
Q 026720           86 LADNSRGNDAIS   97 (234)
Q Consensus        86 ~~~~g~~~~a~~   97 (234)
                      ....|+..+|..
T Consensus        90 ~~~~~~~~~a~~  101 (530)
T 2ooe_A           90 RETKGKLPSYKE  101 (530)
T ss_dssp             HHHTTTSTTHHH
T ss_pred             HHHccchhhHHH
Confidence            345577777665

>3gw4_A Uncharacterized protein; structural genomics, PSI-2, protein structure initiative, no structural genomics consortium, NESG, DRR162B; 2.49A {Deinococcus radiodurans R1}

Probab=89.04  E-value=1.5  Score=30.92  Aligned_cols=91  Identities=9%  Similarity=-0.117  Sum_probs=58.1

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHh----ccc-hhHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----C-c----
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVN----GLE-LDVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----K-N----   75 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~----g~~-~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~-~----   75 (234)
                      .++..+-..+...|++++|...+....+.    +.. ....+++.+-..|...|+.++|...+++..+     + +    
T Consensus        27 ~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~  106 (203)
T 3gw4_A           27 GARFMLGYVYAFMDRFDEARASFQALQQQAQKSGDHTAEHRALHQVGMVERMAGNWDAARRCFLEERELLASLPEDPLAA  106 (203)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHSCCCHHHH
T ss_pred             HHHHHHHHHHHHhCcHHHHHHHHHHHHHHHHHcCCcHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHcCccHHHH
Confidence            34555555666777788888777776652    222 2345677777778888888888777765322     1 1    


Q ss_pred             cccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           76 LQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        76 ~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ...++.+-..+...|+.++|+..+..
T Consensus       107 ~~~~~~lg~~~~~~g~~~~A~~~~~~  132 (203)
T 3gw4_A          107 SANAYEVATVALHFGDLAGARQEYEK  132 (203)
T ss_dssp             HHHHHHHHHHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCHHHHHHHHHH
Confidence            22355555667777888888877765

>4a1s_A PINS, partner of inscuteable; cell cycle, LGN, mitotic spindle orientation, asymmetric CEL divisions; 2.10A {Drosophila melanogaster}

Probab=89.02  E-value=1.1  Score=35.64  Aligned_cols=86  Identities=20%  Similarity=0.053  Sum_probs=67.1

Q ss_pred             HHHHhcCchhhhhHhHHHHHHHHhccchh---HHHHHHHHHHHhhcCChHHHHHHHHhhcc---------CccccHHHHH
Q 026720           16 LVSACTGLINVRAGESIHSYAVVNGLELD---VAIGTALVEMYSKCGHVEKAFKVFNLMRE---------KNLQSWTIMI   83 (234)
Q Consensus        16 ll~~~~~~~~~~~~~~~~~~~~~~g~~~~---~~~~~~li~~~~~~g~~~~a~~~~~~m~~---------~~~~~~~~~i   83 (234)
                      +-..+...|++++|...+...++......   ..++..+-..|...|+.++|...+++..+         .....|..+-
T Consensus        54 ~g~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~l~  133 (411)
T 4a1s_A           54 EGERLCNAGDCRAGVAFFQAAIQAGTEDLRTLSAIYSQLGNAYFYLGDYNKAMQYHKHDLTLAKSMNDRLGEAKSSGNLG  133 (411)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHhCcHHHHHHHHHHHHHhcccChhHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHccCchHHHHHHHHHH
Confidence            33456778899999999999988754311   25788899999999999999998876432         2345777778


Q ss_pred             HHHHhcCCchhhhHhhhc
Q 026720           84 SGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~  101 (234)
                      ..+...|+.++|+..+..
T Consensus       134 ~~~~~~g~~~~A~~~~~~  151 (411)
T 4a1s_A          134 NTLKVMGRFDEAAICCER  151 (411)
T ss_dssp             HHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHCCCHHHHHHHHHH
Confidence            888999999999998765

>3sf4_A G-protein-signaling modulator 2; tetratricopeptide repeat, TPR, cell polarity, asymmetric CEL division, mitotic spindle orientation; 2.60A {Homo sapiens}

Probab=88.98  E-value=1.4  Score=34.85  Aligned_cols=91  Identities=20%  Similarity=0.040  Sum_probs=69.3

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccch-h--HHHHHHHHHHHhhcCChHHHHHHHHhhcc---------Ccccc
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLEL-D--VAIGTALVEMYSKCGHVEKAFKVFNLMRE---------KNLQS   78 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~-~--~~~~~~li~~~~~~g~~~~a~~~~~~m~~---------~~~~~   78 (234)
                      ..+...=..+.+.|+.++|...+....+..... .  ..++..+-..|...|+.++|...++....         .....
T Consensus        10 ~~l~~~g~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~l~~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~   89 (406)
T 3sf4_A           10 LELALEGERLCKSGDCRAGVSFFEAAVQVGTEDLKTLSAIYSQLGNAYFYLHDYAKALEYHHHDLTLARTIGDQLGEAKA   89 (406)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCCSCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHHHHHhccHHHHHHHHHHHHhcCcccHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHhccccHHHHHH
Confidence            344444556778899999999999998875422 1  35788889999999999999998876432         12456


Q ss_pred             HHHHHHHHHhcCCchhhhHhhhc
Q 026720           79 WTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      |..+-..+...|+.++|+..+..
T Consensus        90 ~~~la~~~~~~g~~~~A~~~~~~  112 (406)
T 3sf4_A           90 SGNLGNTLKVLGNFDEAIVCCQR  112 (406)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCHHHHHHHHHH
Confidence            77777888999999999988765

>3ro3_A PINS homolog, G-protein-signaling modulator 2; asymmetric cell division, protein binding; 1.10A {Mus musculus}

Probab=88.86  E-value=1.2  Score=29.73  Aligned_cols=90  Identities=11%  Similarity=0.008  Sum_probs=66.1

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhcc----ch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----C----ccc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGL----EL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----K----NLQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~----~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~----~~~   77 (234)
                      ++..+-..+...|+.++|...+....+..-    .+ ...++..+-..|...|+.++|...++...+     .    ...
T Consensus        51 ~~~~l~~~~~~~g~~~~A~~~~~~a~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~  130 (164)
T 3ro3_A           51 AYSNLGNAYIFLGEFETASEYYKKTLLLARQLKDRAVEAQSCYSLGNTYTLLQDYEKAIDYHLKHLAIAQELKDRIGEGR  130 (164)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHhCCcHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHccchHhHHH
Confidence            555666677888999999999888766321    11 245678888889999999999998876432     1    123


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      .+..+-..+...|+.++|...+..
T Consensus       131 ~~~~la~~~~~~g~~~~A~~~~~~  154 (164)
T 3ro3_A          131 ACWSLGNAYTALGNHDQAMHFAEK  154 (164)
T ss_dssp             HHHHHHHHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCHHHHHHHHHH
Confidence            566667778888999999988765

>2qfc_A PLCR protein; TPR, HTH, transcription regulation; 2.60A {Bacillus thuringiensis serovar ISRAELE35646}

Probab=88.00  E-value=2.4  Score=32.34  Aligned_cols=83  Identities=12%  Similarity=0.153  Sum_probs=52.7

Q ss_pred             HhcCchhhhhHhHHHHHHHHhcc---ch--hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Cc-----cccHHHHH
Q 026720           19 ACTGLINVRAGESIHSYAVVNGL---EL--DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KN-----LQSWTIMI   83 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~---~~--~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~-----~~~~~~~i   83 (234)
                      .+...++.++|...+....+...   .+  ...+++.+-..|...|+.++|...+++..+     ++     +.+|+.+-
T Consensus       124 ~~~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~lg~~y~~~~~~~~A~~~~~kal~~~~~~~~~~~~~~~~~~nlg  203 (293)
T 2qfc_A          124 YVLKKVDYEYCILELKKLLNQQLTGIDVYQNLYIENAIANIYAENGYLKKGIDLFEQILKQLEALHDNEEFDVKVRYNHA  203 (293)
T ss_dssp             HHHTSSCHHHHHHHHHHHHTTCCCSSCTTHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHSCCCHHHHHHHHHHHH
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHhcCccccchHHHHHhHH
Confidence            34556677777777766654211   11  134677777778888888888777766431     11     24666666


Q ss_pred             HHHHhcCCchhhhHhhhc
Q 026720           84 SGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        84 ~~~~~~g~~~~a~~l~~~  101 (234)
                      ..|.+.|+.++|+..+..
T Consensus       204 ~~y~~~~~y~~Al~~~~k  221 (293)
T 2qfc_A          204 KALYLDSRYEESLYQVNK  221 (293)
T ss_dssp             HHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHhhHHHHHHHHHH
Confidence            677778888888877765

>3sf4_A G-protein-signaling modulator 2; tetratricopeptide repeat, TPR, cell polarity, asymmetric CEL division, mitotic spindle orientation; 2.60A {Homo sapiens}

Probab=87.86  E-value=1.6  Score=34.50  Aligned_cols=90  Identities=18%  Similarity=0.052  Sum_probs=49.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhc-----cchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Cc----cc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNG-----LELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KN----LQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g-----~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~----~~   77 (234)
                      ++..+-..+...|+.++|...+....+..     ......++..+-..|...|+.++|...++...+     .+    ..
T Consensus       189 ~~~~la~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~  268 (406)
T 3sf4_A          189 AFGNLGNTHYLLGNFRDAVIAHEQRLLIAKEFGDKAAERRAYSNLGNAYIFLGEFETASEYYKKTLLLARQLKDRAVEAQ  268 (406)
T ss_dssp             HHHHHHHHHHHHTBHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             HHHHHHHHHHHccCHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHcCChHHHHHHHHHHHHHHHhCcCchHHHH
Confidence            55555555666666666666665555431     122355566666666666666666665554321     11    33


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +|..+-..+.+.|+.++|+..+..
T Consensus       269 ~~~~la~~~~~~g~~~~A~~~~~~  292 (406)
T 3sf4_A          269 SCYSLGNTYTLLQDYEKAIDYHLK  292 (406)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcHHHHHHHHHH
Confidence            455555556666666666665543

>3u3w_A Transcriptional activator PLCR protein; ternary complex, PLCR-PAPR7-DNA, HTH DNA-binding domain, QUO sensing; 2.40A {Bacillus thuringiensis} PDB: 2qfc_A

Probab=87.76  E-value=1.8  Score=33.03  Aligned_cols=90  Identities=9%  Similarity=-0.065  Sum_probs=66.8

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHh-----ccchh-HHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Cc----c
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVN-----GLELD-VAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KN----L   76 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~-----g~~~~-~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~----~   76 (234)
                      +++.+-..|...|+.++|...+....+.     +..+. ..++..+-..|.+.|+.++|...++...+     .+    .
T Consensus       157 ~~~~lg~~y~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~nlg~~y~~~~~y~~A~~~~~~al~~~~~~~~~~~~~  236 (293)
T 3u3w_A          157 IENAIANIYAENGYLKKGIDLFEQILKQLEALHDNEEFDVKVRYNHAKALYLDSRYEESLYQVNKAIEISCRINSMALIG  236 (293)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHSSCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTBCTTHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHHHHhcccchhHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHcCcHHHHH
Confidence            5777878889999999999999988842     22233 34788899999999999999998876432     11    3


Q ss_pred             ccHHHHHHHHHhcCC-chhhhHhhhc
Q 026720           77 QSWTIMISGLADNSR-GNDAISLHRQ  101 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~-~~~a~~l~~~  101 (234)
                      ..|..+-..+.+.|+ .++|+..+..
T Consensus       237 ~~~~~lg~~~~~~g~~~~~A~~~~~~  262 (293)
T 3u3w_A          237 QLYYQRGECLRKLEYEEAEIEDAYKK  262 (293)
T ss_dssp             HHHHHHHHHHHHTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCcHHHHHHHHHH
Confidence            456666667778885 4888887654

>2ifu_A Gamma-SNAP; membrane fusion, snare complex disassembly, protein structure initiative, PSI, center for eukaryotic structural genomics, CESG; HET: MSE; 2.60A {Danio rerio}

Probab=87.74  E-value=1.5  Score=33.86  Aligned_cols=89  Identities=9%  Similarity=-0.020  Sum_probs=64.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHh----ccc-hhHHHHHHHHHHHhhcCChHHHHHHHHhhcc----C-c----cc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVN----GLE-LDVAIGTALVEMYSKCGHVEKAFKVFNLMRE----K-N----LQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~----g~~-~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~----~-~----~~   77 (234)
                      +|+.+-..|.+.|++++|...+...++.    |-. .-..+++.+-..|.+ |+.++|...+++..+    . +    ..
T Consensus        78 ~~~~lg~~~~~~g~~~~A~~~~~~Al~l~~~~g~~~~~a~~~~~lg~~~~~-g~~~~A~~~~~~Al~~~~~~~~~~~~~~  156 (307)
T 2ifu_A           78 AFEQAGMMLKDLQRMPEAVQYIEKASVMYVENGTPDTAAMALDRAGKLMEP-LDLSKAVHLYQQAAAVFENEERLRQAAE  156 (307)
T ss_dssp             HHHHHHHHHHHTTCGGGGHHHHHHHHHHHHTTTCHHHHHHHHHHHHHHHTT-TCHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             HHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHc-CCHHHHHHHHHHHHHHHHhCCChhHHHH
Confidence            5666667777788888888888776653    211 124567777788888 999999888876432    1 1    34


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +|+.+-..+.+.|+.++|+..+..
T Consensus       157 ~~~~lg~~~~~~g~~~~A~~~~~~  180 (307)
T 2ifu_A          157 LIGKASRLLVRQQKFDEAAASLQK  180 (307)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHH
Confidence            677777888999999999998876

>2vgx_A Chaperone SYCD; alternative dimer assembly, tetratricopeptide repeat, type III secretion; HET: MLY; 1.95A {Yersinia enterocolitica} SCOP: k.38.1.1 PDB: 2vgx_B* 2vgy_A*

Probab=87.65  E-value=1.3  Score=30.14  Aligned_cols=58  Identities=14%  Similarity=-0.039  Sum_probs=48.5

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...+..+-..|.+.|++++|...|+....   .+...|..+-..+.+.|+.++|+..+..
T Consensus        20 ~~~~~~~~g~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~lg~~~~~~g~~~~A~~~~~~   80 (148)
T 2vgx_A           20 TLEQLYSLAFNQYQSGXYEDAHXVFQALCVLDHYDSRFFLGLGACRQAMGQYDLAIHSYSY   80 (148)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCChHHHHHHHHHHHHcCcccHHHHHHHHHHHHHHhhHHHHHHHHHH
Confidence            455677788889999999999999987543   3667888888889999999999999987

>2qfc_A PLCR protein; TPR, HTH, transcription regulation; 2.60A {Bacillus thuringiensis serovar ISRAELE35646}

Probab=87.52  E-value=2  Score=32.77  Aligned_cols=90  Identities=9%  Similarity=-0.078  Sum_probs=67.3

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHh---c-cch--hHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C---c----c
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVN---G-LEL--DVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K---N----L   76 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~---g-~~~--~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~---~----~   76 (234)
                      +|+.+=..|...|+.++|...+....+.   - -.+  ...+++.+-..|.+.|+.++|...+++..+  +   +    .
T Consensus       157 ~~~~lg~~y~~~~~~~~A~~~~~kal~~~~~~~~~~~~~~~~~~nlg~~y~~~~~y~~Al~~~~kal~~~~~~~~~~~~~  236 (293)
T 2qfc_A          157 IENAIANIYAENGYLKKGIDLFEQILKQLEALHDNEEFDVKVRYNHAKALYLDSRYEESLYQVNKAIEISCRINSMALIG  236 (293)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTBCSSHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHHHHhcCccccchHHHHHhHHHHHHHHhhHHHHHHHHHHHHHHHHhcCcHHHHH
Confidence            6777777888999999999999988732   1 112  235888999999999999999998876432  1   1    3


Q ss_pred             ccHHHHHHHHHhcCCchhh-hHhhhc
Q 026720           77 QSWTIMISGLADNSRGNDA-ISLHRQ  101 (234)
Q Consensus        77 ~~~~~~i~~~~~~g~~~~a-~~l~~~  101 (234)
                      .+|..+-..+.+.|+.++| ...+..
T Consensus       237 ~~~~~lg~~y~~~g~~~~Ai~~~~~~  262 (293)
T 2qfc_A          237 QLYYQRGECLRKLEYEEAEIEDAYKK  262 (293)
T ss_dssp             HHHHHHHHHHHHTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCcHHHHHHHHHH
Confidence            4666777788889999999 664543

>1p5q_A FKBP52, FK506-binding protein 4; isomerase; 2.80A {Homo sapiens} SCOP: a.118.8.1 d.26.1.1 PDB: 1qz2_A

Probab=87.40  E-value=1.2  Score=35.00  Aligned_cols=90  Identities=13%  Similarity=-0.082  Sum_probs=71.6

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHH
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLA   87 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~   87 (234)
                      ..|..+-.++.+.+++++|...+...++... .+...+..+-..|...|+.++|...|+...+   .+...|..+-..+.
T Consensus       197 ~~~~nla~~~~~~g~~~~A~~~~~~al~~~p-~~~~a~~~lg~~~~~~g~~~~A~~~~~~al~l~P~~~~a~~~l~~~~~  275 (336)
T 1p5q_A          197 ASHLNLAMCHLKLQAFSAAIESCNKALELDS-NNEKGLSRRGEAHLAVNDFELARADFQKVLQLYPNNKAAKTQLAVCQQ  275 (336)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CcHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHCCCCHHHHHHHHHHHH
Confidence            5677777888899999999999999988643 3567888999999999999999999987543   35567777777888


Q ss_pred             hcCCchhhhH-hhhc
Q 026720           88 DNSRGNDAIS-LHRQ  101 (234)
Q Consensus        88 ~~g~~~~a~~-l~~~  101 (234)
                      +.|+.++|.. ++..
T Consensus       276 ~~~~~~~a~~~~~~~  290 (336)
T 1p5q_A          276 RIRRQLAREKKLYAN  290 (336)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHH
Confidence            8888888843 4443

>3ulq_A Response regulator aspartate phosphatase F; tetratricopeptide repeat, response regulator helix-turn-HELX binding, 3-helix bundle; 2.30A {Bacillus subtilis}

Probab=87.33  E-value=1.9  Score=34.24  Aligned_cols=91  Identities=11%  Similarity=-0.053  Sum_probs=68.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhcc----ch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Cc----cc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGL----EL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KN----LQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~----~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~----~~   77 (234)
                      +++.+=..|...|+.++|...+....+..-    .+ ...+++.+-..|...|+.++|...+++..+     .+    ..
T Consensus       186 ~~~~lg~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~lg~~y~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~  265 (383)
T 3ulq_A          186 CHSLFATNFLDLKQYEDAISHFQKAYSMAEAEKQPQLMGRTLYNIGLCKNSQSQYEDAIPYFKRAIAVFEESNILPSLPQ  265 (383)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCGGGHHH
T ss_pred             HHHHHHHHHHHhcCHHHHHHHHHHHHHHHHHcCChHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHhhccchhHHH
Confidence            455566678888999999998888776421    11 234788899999999999999998876443     22    34


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                      ++..+-..+.+.|+.++|...+...
T Consensus       266 ~~~~l~~~~~~~g~~~~A~~~~~~a  290 (383)
T 3ulq_A          266 AYFLITQIHYKLGKIDKAHEYHSKG  290 (383)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCHHHHHHHHHHH
Confidence            5777778889999999999988663

>2r5s_A Uncharacterized protein VP0806; APC090868.1, vibrio parahaemolyticus RIMD 22 structural genomics, PSI-2, protein structure initiative; HET: MES; 2.14A {Vibrio parahaemolyticus}

Probab=87.21  E-value=3.2  Score=28.80  Aligned_cols=56  Identities=18%  Similarity=0.200  Sum_probs=28.3

Q ss_pred             HHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc---cccHHHHHHHHHhcCCchhhhHhhh
Q 026720           45 VAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN---LQSWTIMISGLADNSRGNDAISLHR  100 (234)
Q Consensus        45 ~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~---~~~~~~~i~~~~~~g~~~~a~~l~~  100 (234)
                      ...+..+-..|.+.|+.++|...++...+  |+   ...|..+...+...|+.++|...+.
T Consensus       108 ~~~~~~la~~~~~~g~~~~A~~~~~~~l~~~p~~~~~~a~~~l~~~~~~~g~~~~A~~~y~  168 (176)
T 2r5s_A          108 FELACELAVQYNQVGRDEEALELLWNILKVNLGAQDGEVKKTFMDILSALGQGNAIASKYR  168 (176)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHTTCTTTTTTHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccHHHHHHHHHHHHHhCcccChHHHHHHHHHHHHHhCCCCcHHHHHH
Confidence            34445555555555555555555555432  11   2245555555555555555555443

>3k9i_A BH0479 protein; putative protein binding protein, structural genomics, joint for structural genomics, JCSG; 2.71A {Bacillus halodurans}

Probab=86.99  E-value=1.9  Score=27.62  Aligned_cols=61  Identities=15%  Similarity=0.095  Sum_probs=50.2

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR   72 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~   72 (234)
                      ..+..+-..+.+.|+.++|...+...++.... +..++..+-..|.+.|+.++|...++...
T Consensus        28 ~~~~~lg~~~~~~~~~~~A~~~~~~al~~~p~-~~~~~~~l~~~~~~~g~~~~A~~~~~~al   88 (117)
T 3k9i_A           28 ECYLGLGSTFRTLGEYRKAEAVLANGVKQFPN-HQALRVFYAMVLYNLGRYEQGVELLLKII   88 (117)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTT-CHHHHHHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCC-chHHHHHHHHHHHHcCCHHHHHHHHHHHH
Confidence            45666777788899999999999999886543 46677888999999999999999888754

>1qqe_A Vesicular transport protein SEC17; helix-turn-helix TPR-like repeat, protein transport; 2.90A {Saccharomyces cerevisiae} SCOP: a.118.8.1

Probab=86.91  E-value=4.2  Score=30.99  Aligned_cols=90  Identities=7%  Similarity=-0.077  Sum_probs=63.6

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhH------HHHHHHHHHHhhcCChHHHHHHHHhhcc--Cccc------
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDV------AIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQ------   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~------~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~------   77 (234)
                      +++.+-..+.+.|+.++|...+....+.......      ..+..+...|...|+.++|...+++..+  |+..      
T Consensus       160 ~~~~lg~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~l~p~~~~~~~~~  239 (292)
T 1qqe_A          160 CFIKCADLKALDGQYIEASDIYSKLIKSSMGNRLSQWSLKDYFLKKGLCQLAATDAVAAARTLQEGQSEDPNFADSRESN  239 (292)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHTTSSCTTTGGGHHHHHHHHHHHHHHTTCHHHHHHHHHGGGCC---------HH
T ss_pred             HHHHHHHHHHHhCCHHHHHHHHHHHHHHHhcCCcccHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHhhCCCCCCcHHHH
Confidence            5667777888999999999999999886543222      1567777889999999999999988654  2211      


Q ss_pred             cHHHHHHHHH--hcCCchhhhHhhhc
Q 026720           78 SWTIMISGLA--DNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~--~~g~~~~a~~l~~~  101 (234)
                      .+..++.++.  ..++..+|+..|..
T Consensus       240 ~l~~l~~~~~~~~~~~~~~A~~~~~~  265 (292)
T 1qqe_A          240 FLKSLIDAVNEGDSEQLSEHCKEFDN  265 (292)
T ss_dssp             HHHHHHHHHHTTCTTTHHHHHHHHTT
T ss_pred             HHHHHHHHHHcCCHHHHHHHHHHhcc
Confidence            2333445554  44678888888866

>2kat_A Uncharacterized protein; NESG, structure, structural genomics, PSI-2, protein structure initiative; NMR {Bordetella parapertussis}

Probab=86.52  E-value=1.8  Score=27.48  Aligned_cols=63  Identities=11%  Similarity=-0.129  Sum_probs=51.1

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR   72 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~   72 (234)
                      +...+..+-..+...|+.++|...+...++... .+...+..+-..|.+.|+.++|...|+...
T Consensus        18 ~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~la~~~~~~g~~~~A~~~~~~al   80 (115)
T 2kat_A           18 NMLLRFTLGKTYAEHEQFDAALPHLRAALDFDP-TYSVAWKWLGKTLQGQGDRAGARQAWESGL   80 (115)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHccCHHHHHHHHHHHHHHCC-CcHHHHHHHHHHHHHcCCHHHHHHHHHHHH
Confidence            445666677778889999999999999987653 245678889999999999999999988754

>2ifu_A Gamma-SNAP; membrane fusion, snare complex disassembly, protein structure initiative, PSI, center for eukaryotic structural genomics, CESG; HET: MSE; 2.60A {Danio rerio}

Probab=86.50  E-value=2.9  Score=32.16  Aligned_cols=90  Identities=7%  Similarity=-0.050  Sum_probs=65.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccc----h-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----Cc----cc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLE----L-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----KN----LQ   77 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~----~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~~----~~   77 (234)
                      +++.+=..|.. ++.++|...+...++.-..    . -..+++.+-..|.+.|++++|...|++...     .+    ..
T Consensus       118 ~~~~lg~~~~~-g~~~~A~~~~~~Al~~~~~~~~~~~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~~~~~~~~~~~~  196 (307)
T 2ifu_A          118 ALDRAGKLMEP-LDLSKAVHLYQQAAAVFENEERLRQAAELIGKASRLLVRQQKFDEAAASLQKEKSMYKEMENYPTCYK  196 (307)
T ss_dssp             HHHHHHHHHTT-TCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             HHHHHHHHHHc-CCHHHHHHHHHHHHHHHHhCCChhHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHcCChhHHHH
Confidence            45555566777 9999999998887763211    1 145788888999999999999999887543     11    12


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhcc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                      .|..+...+...|+.++|+..+...
T Consensus       197 ~~~~~g~~~~~~g~~~~A~~~~~~a  221 (307)
T 2ifu_A          197 KCIAQVLVQLHRADYVAAQKCVRES  221 (307)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHH
Confidence            4555566677779999999999873

>3sz7_A HSC70 cochaperone (SGT); TPR domain, GET4, GET5, GET3, MDY2, SSA1, SSE1, chaperone regulator; 1.72A {Aspergillus fumigatus}

Probab=86.47  E-value=1.7  Score=29.83  Aligned_cols=59  Identities=7%  Similarity=-0.087  Sum_probs=49.5

Q ss_pred             hhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           43 LDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        43 ~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      .+...+..+-..|.+.|++++|...|+...+   .+...|..+-..+.+.|+.++|+..+..
T Consensus         9 ~~a~~~~~~g~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~l~~~~~~~g~~~~A~~~~~~   70 (164)
T 3sz7_A            9 PESDKLKSEGNAAMARKEYSKAIDLYTQALSIAPANPIYLSNRAAAYSASGQHEKAAEDAEL   70 (164)
T ss_dssp             HHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCcCHHHHHHHHHHHHHccCHHHHHHHHHH
Confidence            3456677788889999999999999988543   3667888888889999999999999977

>2xcb_A PCRH, regulatory protein PCRH; protein transport, bacterial toxin, type III secretion, protein binding; 1.85A {Pseudomonas aeruginosa} PDB: 2xcc_A

Probab=86.10  E-value=1.8  Score=28.91  Aligned_cols=58  Identities=12%  Similarity=-0.043  Sum_probs=47.2

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...+..+-..|.+.|++++|...|+....   .+...|..+-..+.+.|+.++|+..+..
T Consensus        17 ~~~~~~~~a~~~~~~g~~~~A~~~~~~al~~~p~~~~~~~~lg~~~~~~g~~~~A~~~~~~   77 (142)
T 2xcb_A           17 TLEQLYALGFNQYQAGKWDDAQKIFQALCMLDHYDARYFLGLGACRQSLGLYEQALQSYSY   77 (142)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHccHHHHHHHHHHHHHhCCccHHHHHHHHHHHHHHhhHHHHHHHHHH
Confidence            344556677788999999999999988643   3667788888889999999999999987

>2kck_A TPR repeat; tetratricopeptide repeat, structural genomics, unknown function, PSI-2, protein structure initiative; NMR {Methanococcus maripaludis}

Probab=86.09  E-value=2.6  Score=25.95  Aligned_cols=65  Identities=11%  Similarity=-0.071  Sum_probs=52.0

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccc-hhHHHHHHHHHHHhhc-CChHHHHHHHHhhcc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLE-LDVAIGTALVEMYSKC-GHVEKAFKVFNLMRE   73 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~-~~~~~~~~li~~~~~~-g~~~~a~~~~~~m~~   73 (234)
                      +...+..+-..+...++.++|...+...++.... .+...+..+...|.+. |+.++|.+.++....
T Consensus        39 ~~~~~~~~a~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~l~~~~~~~~~~~~~A~~~~~~~~~  105 (112)
T 2kck_A           39 ESKYWLMKGKALYNLERYEEAVDCYNYVINVIEDEYNKDVWAAKADALRYIEGKEVEAEIAEARAKL  105 (112)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTSCCTTCHHHHHHHHHHHTTCSSCSHHHHHHHHHHGG
T ss_pred             CHHHHHHHHHHHHHccCHHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHHhCCHHHHHHHHHHHhh
Confidence            3455666777788889999999999999876432 1467788899999999 999999999988654

>3q15_A PSP28, response regulator aspartate phosphatase H; tetratricopeptide repeat, 3-helix bundle, phosphorelay signa transduction, phosphatase; 2.19A {Bacillus subtilis}

Probab=85.70  E-value=2.6  Score=33.38  Aligned_cols=91  Identities=10%  Similarity=0.034  Sum_probs=68.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHh----ccch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----C---cccc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVN----GLEL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----K---NLQS   78 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~----g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----~---~~~~   78 (234)
                      +++.+=..|...|+.++|...+....+.    +-.+ ...+++.|-..|...|+.++|...+++..+     .   ...+
T Consensus       184 ~~~~lg~~y~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~~~~~lg~~y~~~~~~~~A~~~~~~al~~~~~~~~~~~~~~  263 (378)
T 3q15_A          184 SLFVIAGNYDDFKHYDKALPHLEAALELAMDIQNDRFIAISLLNIANSYDRSGDDQMAVEHFQKAAKVSREKVPDLLPKV  263 (378)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             HHHHHHHHHHHhCCHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHhhCChhHHHH
Confidence            4555666788889999999988887763    2212 245778888899999999999998876543     2   2345


Q ss_pred             HHHHHHHHHhcCCchhhhHhhhcc
Q 026720           79 WTIMISGLADNSRGNDAISLHRQG  102 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~~  102 (234)
                      +..+-..+.+.|+.++|+..+...
T Consensus       264 ~~~la~~~~~~g~~~~A~~~~~~a  287 (378)
T 3q15_A          264 LFGLSWTLCKAGQTQKAFQFIEEG  287 (378)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCHHHHHHHHHHH
Confidence            666677889999999999998763

>3qou_A Protein YBBN; thioredoxin-like fold, tetratricopeptide repeat, lysine dimethylation, protein binding; HET: MLY; 1.80A {Escherichia coli} PDB: 3qdn_A*

Probab=85.39  E-value=0.91  Score=34.83  Aligned_cols=115  Identities=13%  Similarity=0.054  Sum_probs=72.3

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--CccccHHHH-HHHHHhc
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KNLQSWTIM-ISGLADN   89 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~~~~~~~~-i~~~~~~   89 (234)
                      +..+-..+.+.|+.++|...+....+.... +...+..|...|.+.|+.++|...++....  |+...+... ...+.+.
T Consensus       120 ~~~~a~~~~~~g~~~~A~~~~~~al~~~P~-~~~a~~~la~~~~~~g~~~~A~~~l~~~~~~~p~~~~~~~~~~~~l~~~  198 (287)
T 3qou_A          120 XAQQAMQLMQESNYTDALPLLXDAWQLSNQ-NGEIGLLLAETLIALNRSEDAEAVLXTIPLQDQDTRYQGLVAQIELLXQ  198 (287)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHHHHTTS-CHHHHHHHHHHHHHTTCHHHHHHHHTTSCGGGCSHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCHHHHHHHHHHHHHhCCc-chhHHHHHHHHHHHCCCHHHHHHHHHhCchhhcchHHHHHHHHHHHHhh
Confidence            344455567788999999999998875432 455678888899999999999999988764  333222222 2335666


Q ss_pred             CCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEeeccccccc
Q 026720           90 SRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEI  131 (234)
Q Consensus        90 g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~~~~~a~~~  131 (234)
                      ++..+|+..+... +.  ..|++...    ...+...+++..|...
T Consensus       199 ~~~~~a~~~l~~a-l~--~~P~~~~~~~~la~~l~~~g~~~~A~~~  241 (287)
T 3qou_A          199 AADTPEIQQLQQQ-VA--ENPEDAALATQLALQLHQVGRNEEALEL  241 (287)
T ss_dssp             HTSCHHHHHHHHH-HH--HCTTCHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred             cccCccHHHHHHH-Hh--cCCccHHHHHHHHHHHHHcccHHHHHHH
Confidence            7777777776552 22  34654322    1223344555555443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=85.29  E-value=1.7  Score=37.96  Aligned_cols=100  Identities=9%  Similarity=-0.072  Sum_probs=76.4

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHH
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISG   85 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~   85 (234)
                      +...+..+-.++...|+.++|...+...++... .+...+..+-..|.+.|+.++|...|++..+   .+...|..+-..
T Consensus       432 ~~~~~~~~a~~~~~~g~~~~A~~~~~~al~~~p-~~~~a~~~lg~~~~~~g~~~~A~~~~~~al~l~P~~~~~~~~lg~~  510 (681)
T 2pzi_A          432 SVELPLMEVRALLDLGDVAKATRKLDDLAERVG-WRWRLVWYRAVAELLTGDYDSATKHFTEVLDTFPGELAPKLALAAT  510 (681)
T ss_dssp             CSHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHC-CCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHSTTCSHHHHHHHHH
T ss_pred             chhHHHHHHHHHHhcCCHHHHHHHHHHHhccCc-chHHHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCChHHHHHHHHH
Confidence            344566666778888999999999999887543 2456788888889999999999999988543   366788888888


Q ss_pred             HHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           86 LADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      +.+.|+.++ +..+.. .+.  +.|++.
T Consensus       511 ~~~~g~~~~-~~~~~~-al~--~~P~~~  534 (681)
T 2pzi_A          511 AELAGNTDE-HKFYQT-VWS--TNDGVI  534 (681)
T ss_dssp             HHHHTCCCT-TCHHHH-HHH--HCTTCH
T ss_pred             HHHcCChHH-HHHHHH-HHH--hCCchH
Confidence            899999999 888877 332  345543

>2p58_C Putative type III secretion protein YSCG; type III secretion system, structure, needle protein, YSCE, YSCF, transport protein/chaperone complex; 1.80A {Yersinia pestis}

Probab=85.17  E-value=3.7  Score=26.35  Aligned_cols=70  Identities=14%  Similarity=0.146  Sum_probs=48.1

Q ss_pred             hhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhH
Q 026720           24 INVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAIS   97 (234)
Q Consensus        24 ~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~   97 (234)
                      ...++|..+-+-....|-  ..++--.=+..++..|++++|..+.+.++.||+..|.++-.+  +.|..+++..
T Consensus        21 H~HqEA~tIAdwL~~~~~--~E~v~lIR~sSLmNrG~Yq~Al~l~~~~c~pdlepw~ALce~--rlGl~s~le~   90 (116)
T 2p58_C           21 HYHEEANCIAEWLHLKGE--EEAVQLIRLSSLMNRGDYASALQQGNKLAYPDLEPWLALCEY--RLGLGSALES   90 (116)
T ss_dssp             TCHHHHHHHHHHHHHTTC--HHHHHHHHHHHHHHTTCHHHHHHHHTTSCCGGGHHHHHHHHH--HHTCHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCc--HHHHHHHHHHHHHcchhHHHHHHhcCCCCCchHHHHHHHHHH--hcccHHHHHH
Confidence            345677777666665554  333333445668899999999999999999999999887654  3344444433

>4f3v_A ESX-1 secretion system protein ECCA1; tetratricopeptide repeat, TPR domain, ATPase, protein secret protein transport; 2.00A {Mycobacterium tuberculosis}

Probab=84.81  E-value=1.6  Score=33.82  Aligned_cols=83  Identities=8%  Similarity=-0.090  Sum_probs=58.4

Q ss_pred             HHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccC-c----cccHHHHHHHHHhcCC
Q 026720           17 VSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREK-N----LQSWTIMISGLADNSR   91 (234)
Q Consensus        17 l~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~-~----~~~~~~~i~~~~~~g~   91 (234)
                      -..+...|+.++|.+++......+  |+-.....+-..+.+.+++++|+..|+..... +    ...+..+=.++.+.|+
T Consensus       109 A~~L~~~g~y~eA~~~l~~~~~~~--p~~~~~~~~a~l~~~~~r~~dA~~~l~~a~~~~d~~~~~~a~~~LG~al~~LG~  186 (282)
T 4f3v_A          109 AACEAAQGNYADAMEALEAAPVAG--SEHLVAWMKAVVYGAAERWTDVIDQVKSAGKWPDKFLAGAAGVAHGVAAANLAL  186 (282)
T ss_dssp             HHHHHHHTCHHHHHHHHTSSCCTT--CHHHHHHHHHHHHHHTTCHHHHHHHHTTGGGCSCHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHCCCHHHHHHHHHHHHhcC--CchHHHHHHHHHHHHcCCHHHHHHHHHHhhccCCcccHHHHHHHHHHHHHHCCC
Confidence            344566778899999988887655  33325556666888889999999888765432 1    1244555666788899


Q ss_pred             chhhhHhhhc
Q 026720           92 GNDAISLHRQ  101 (234)
Q Consensus        92 ~~~a~~l~~~  101 (234)
                      .++|+..+.+
T Consensus       187 ~~eAl~~l~~  196 (282)
T 4f3v_A          187 FTEAERRLTE  196 (282)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999888876

>1elr_A TPR2A-domain of HOP; HOP, TPR-domain, peptide-complex, helical repeat, protein binding, chaperone; 1.90A {Homo sapiens} SCOP: a.118.8.1 PDB: 3esk_A 3fwv_A

Probab=84.80  E-value=2  Score=27.39  Aligned_cols=57  Identities=16%  Similarity=0.077  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           45 VAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        45 ~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ...+..+-..|...|+.++|...++...+   .+...|..+-..+.+.|+.++|+..+..
T Consensus         4 ~~~~~~l~~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~la~~~~~~~~~~~A~~~~~~   63 (131)
T 1elr_A            4 ALKEKELGNDAYKKKDFDTALKHYDKAKELDPTNMTYITNQAAVYFEKGDYNKCRELCEK   63 (131)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCHHHHHHHHHHHHhcCCccHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence            34567778889999999999999987543   3566777788888999999999999876

>2xev_A YBGF; tetratricopeptide, alpha-helical, metal binding; 1.57A {Xanthomonas campestris}

Probab=84.64  E-value=3.5  Score=26.41  Aligned_cols=62  Identities=15%  Similarity=-0.067  Sum_probs=48.6

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchh--HHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELD--VAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~--~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      .+..+-..+.+.|+.++|...+...++......  ...+..+-..|.+.|+.++|...|+....
T Consensus        41 ~~~~lg~~~~~~~~~~~A~~~~~~~~~~~p~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~~~~  104 (129)
T 2xev_A           41 ALYWLGESYYATRNFQLAEAQFRDLVSRYPTHDKAAGGLLKLGLSQYGEGKNTEAQQTLQQVAT  104 (129)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTSTTHHHHHHHHHHHHHHTTCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccHHHHHHHHHHHHHHCCCCcccHHHHHHHHHHHHHcCCHHHHHHHHHHHHH
Confidence            555566678889999999999999988653321  45567788889999999999999988654

>4gco_A Protein STI-1; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, tetratricopeptide repeat domain; 1.60A {Caenorhabditis elegans}

Probab=84.64  E-value=2.8  Score=27.50  Aligned_cols=64  Identities=8%  Similarity=-0.062  Sum_probs=52.6

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      +..+|..+=.++.+.|+.++|...+...++... .+...|..+-..|...|+.++|...|+...+
T Consensus        46 ~~~~~~~~~~~~~~~~~~~~A~~~~~~al~~~p-~~~~a~~~lg~~~~~~~~~~~A~~~~~~al~  109 (126)
T 4gco_A           46 NAILYSNRAACLTKLMEFQRALDDCDTCIRLDS-KFIKGYIRKAACLVAMREWSKAQRAYEDALQ  109 (126)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHhhHHHhhccHHHHHHHHHHHHHhhh-hhhHHHHHHHHHHHHCCCHHHHHHHHHHHHH
Confidence            456677777788899999999999999987543 2466788899999999999999999987543

>3qwp_A SET and MYND domain-containing protein 3; SMYD3,SET and MYND domain, zinc finger MYND domain-containin 1, structural genomics; HET: SAM; 1.53A {Homo sapiens} PDB: 3mek_A* 3oxg_A* 3oxf_A* 3pdn_A* 3oxl_A* 3ru0_A*

Probab=84.00  E-value=2.6  Score=34.68  Aligned_cols=86  Identities=8%  Similarity=-0.093  Sum_probs=63.9

Q ss_pred             HHHHhcCchhhhhHhHHHHHHHHh--c-c---chh-HHHHHHHHHHHhhcCChHHHHHHHHhhcc----------Cc-cc
Q 026720           16 LVSACTGLINVRAGESIHSYAVVN--G-L---ELD-VAIGTALVEMYSKCGHVEKAFKVFNLMRE----------KN-LQ   77 (234)
Q Consensus        16 ll~~~~~~~~~~~~~~~~~~~~~~--g-~---~~~-~~~~~~li~~~~~~g~~~~a~~~~~~m~~----------~~-~~   77 (234)
                      .+..+.+.|+.++|..++....+.  . +   .|+ ..+++.|...|...|++++|..++++...          |+ ..
T Consensus       293 ~ie~~~~~g~~~~a~~~~~~~L~~~~~~lg~~h~~~~~~~~~L~~~y~~~g~~~eA~~~~~~~L~i~~~~lg~~Hp~~a~  372 (429)
T 3qwp_A          293 KIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGV  372 (429)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHHHTCSSCCCCTTSHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHHSCSSCHHHHH
T ss_pred             HHHHHHhhccHHHHHHHHHHHHHhccCcCCccchHHHHHHHHHHHHHHhhccHHHHHHHHHHHHHhHHHHcCCCChHHHH
Confidence            345555667888888888777653  1 1   122 45889999999999999999988876432          22 25


Q ss_pred             cHHHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +++.+-..|...|+.++|+.++.+
T Consensus       373 ~l~nLa~~~~~~g~~~eA~~~~~~  396 (429)
T 3qwp_A          373 QVMKVGKLQLHQGMFPQAMKNLRL  396 (429)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCHHHHHHHHHH
Confidence            788888889999999999998765

>3qky_A Outer membrane assembly lipoprotein YFIO; membrane protein; 2.15A {Rhodothermus marinus}

Probab=83.81  E-value=2.8  Score=31.14  Aligned_cols=89  Identities=8%  Similarity=-0.103  Sum_probs=65.5

Q ss_pred             HHHHHHHhcCchhhhhHhHHHHHHHHhccch--hHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc----cccHHHHHH
Q 026720           13 LVSLVSACTGLINVRAGESIHSYAVVNGLEL--DVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN----LQSWTIMIS   84 (234)
Q Consensus        13 ~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~--~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~----~~~~~~~i~   84 (234)
                      +-..-..+.+.|++++|...+..+++.....  ....+..+-..|.+.|+.++|...|+...+  |+    ...|..+-.
T Consensus        18 ~~~~a~~~~~~g~~~~A~~~~~~~l~~~p~~~~~~~a~~~lg~~~~~~~~~~~A~~~~~~~l~~~p~~~~~~~a~~~lg~   97 (261)
T 3qky_A           18 AFERAMEFYNQGKYDRAIEYFKAVFTYGRTHEWAADAQFYLARAYYQNKEYLLAASEYERFIQIYQIDPRVPQAEYERAM   97 (261)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHHHGGGCSCSTTHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCTTHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCcchHHHHHHHHHHHHHhCcHHHHHHHHHHHHHHCCCCchhHHHHHHHHH
Confidence            3334445667899999999999998864321  145677788889999999999999988653  31    224444555


Q ss_pred             HHHh--------cCCchhhhHhhhc
Q 026720           85 GLAD--------NSRGNDAISLHRQ  101 (234)
Q Consensus        85 ~~~~--------~g~~~~a~~l~~~  101 (234)
                      .+.+        .|+.++|+..+..
T Consensus        98 ~~~~~~~~~~~~~~~~~~A~~~~~~  122 (261)
T 3qky_A           98 CYYKLSPPYELDQTDTRKAIEAFQL  122 (261)
T ss_dssp             HHHHHCCCTTSCCHHHHHHHHHHHH
T ss_pred             HHHHhcccccccchhHHHHHHHHHH
Confidence            5666        8999999999987

>4g1t_A Interferon-induced protein with tetratricopeptide 2; ISG, all alpha helix, antivirus, antiviral protein; 2.80A {Homo sapiens}

Probab=83.79  E-value=3.5  Score=33.50  Aligned_cols=95  Identities=11%  Similarity=-0.098  Sum_probs=55.4

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHH--HHHHH-HHHHhhcCChHHHHHHHHhhc-------------
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVA--IGTAL-VEMYSKCGHVEKAFKVFNLMR-------------   72 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~--~~~~l-i~~~~~~g~~~~a~~~~~~m~-------------   72 (234)
                      +..++..+-..+...++.++|...+....+....+...  .+..+ ...+.+.|+.++|...+.+..             
T Consensus       333 ~~~~~~~lg~~~~~~~~~~~A~~~~~kaL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ai~~y~kal~i~~~~~~~~~~~  412 (472)
T 4g1t_A          333 LFRVCSILASLHALADQYEEAEYYFQKEFSKELTPVAKQLLHLRYGNFQLYQMKCEDKAIHHFIEGVKINQKSREKEKMK  412 (472)
T ss_dssp             TCCCHHHHHHHHHHTTCHHHHHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTSSCHHHHHHHHHHHHHSCCCCHHHHHHH
T ss_pred             hhhhhhhHHHHHHHhccHHHHHHHHHHHHhcCCCChHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHhcCcccHHHHHHH
Confidence            44566677777888899999999998887765443321  12222 123456788888877765421             


Q ss_pred             --------------cCccccHHHHHHHHHhcCCchhhhHhhhccc
Q 026720           73 --------------EKNLQSWTIMISGLADNSRGNDAISLHRQGY  103 (234)
Q Consensus        73 --------------~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~  103 (234)
                                    ..+..+|+.+-..+...|+.++|+..+..-+
T Consensus       413 ~~l~~~~~~~l~~~p~~~~~~~~LG~~~~~~g~~~~A~~~y~kAL  457 (472)
T 4g1t_A          413 DKLQKIAKMRLSKNGADSEALHVLAFLQELNEKMQQADEDSERGL  457 (472)
T ss_dssp             HHHHHHHHHHHHHCC-CTTHHHHHHHHHHHHHHCC----------
T ss_pred             HHHHHHHHHHHHhCCCCHHHHHHHHHHHHHcCCHHHHHHHHHHHH
Confidence                          1245677777777788888888888887633

>1elw_A TPR1-domain of HOP; HOP, TPR-domain, peptide-complex, helical repeat, HSP70, protein binding, chaperone; 1.60A {Homo sapiens} SCOP: a.118.8.1

Probab=83.51  E-value=3.7  Score=25.45  Aligned_cols=64  Identities=9%  Similarity=-0.181  Sum_probs=51.2

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      +...+..+-..+.+.++.++|...+....+... .+...+..+...|.+.|+.++|...++...+
T Consensus        37 ~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~~A~~~~~~~~~  100 (118)
T 1elw_A           37 NHVLYSNRSAAYAKKGDYQKAYEDGCKTVDLKP-DWGKGYSRKAAALEFLNRFEEAKRTYEEGLK  100 (118)
T ss_dssp             CHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHT
T ss_pred             cHHHHHHHHHHHHhhccHHHHHHHHHHHHHhCc-ccHHHHHHHHHHHHHHhhHHHHHHHHHHHHH
Confidence            445566666778888999999999999887643 2466788888999999999999999988654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=83.20  E-value=1.2  Score=36.31  Aligned_cols=43  Identities=19%  Similarity=0.297  Sum_probs=31.5

Q ss_pred             HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeC-C----------eeeEeecccccc
Q 026720           79 WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSK-G----------VIKIGDLGMVKE  130 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~-~----------~~~~~~~~~a~~  130 (234)
                      |..++.++.         ++|..+++|+|++|.|+++.. .          ...+.|++.+-.
T Consensus       211 ~~qll~~l~---------~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          211 YADLIALIL---------RLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             HHHHHHHHH---------HHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHH---------HHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            445577777         889999999999999999942 1          145667776554

>2dba_A Smooth muscle cell associated protein-1, isoform 2; tetratricopeptide repeat, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=83.03  E-value=3  Score=27.37  Aligned_cols=58  Identities=10%  Similarity=-0.054  Sum_probs=48.2

Q ss_pred             hHHHHHHHHHHHhhcCChHHHHHHHHhhcc--Cc----cccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           44 DVAIGTALVEMYSKCGHVEKAFKVFNLMRE--KN----LQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        44 ~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~~----~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...+..+...|.+.|++++|...|+...+  ++    ...|..+-..+.+.|+.++|+..+..
T Consensus        27 ~~~~~~~~a~~~~~~~~~~~A~~~~~~a~~~~~~~~~~~~~~~~~a~~~~~~~~~~~A~~~~~~   90 (148)
T 2dba_A           27 SVEQLRKEGNELFKCGDYGGALAAYTQALGLDATPQDQAVLHRNRAACHLKLEDYDKAETEASK   90 (148)
T ss_dssp             CHHHHHHHHHHHHTTTCHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCHHHHHHHHHHHHHHcccchHHHHHHHHHHHHHHHHccHHHHHHHHHH
Confidence            456777888889999999999999988654  33    56777778888999999999999877

>3upv_A Heat shock protein STI1; TPR-fold, adaptor protein for HSP70 and HSP90, C-terminal PA HSP70, peptide binding protein; 1.60A {Saccharomyces cerevisiae}

Probab=82.88  E-value=3.7  Score=26.42  Aligned_cols=63  Identities=10%  Similarity=-0.027  Sum_probs=51.7

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR   72 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~   72 (234)
                      +...|..+-.++.+.|+.++|...+...++... .+...+..+-..|...|+.++|...|+...
T Consensus        37 ~~~~~~~~a~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~~~~~~A~~~~~~al   99 (126)
T 3upv_A           37 DARGYSNRAAALAKLMSFPEAIADCNKAIEKDP-NFVRAYIRKATAQIAVKEYASALETLDAAR   99 (126)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCC-CcHHHHHHHHHHHHHHhCHHHHHHHHHHHH
Confidence            455677777788899999999999999988643 246678888999999999999999988754

>3rjv_A Putative SEL1 repeat protein; alpha-alpha superhelix, structural genomics, joint center FO structural genomics, JCSG; HET: MSE; 1.65A {Klebsiella pneumoniae subsp}

Probab=82.84  E-value=4.1  Score=29.41  Aligned_cols=86  Identities=14%  Similarity=0.074  Sum_probs=60.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcC----ChHHHHHHHHhhcc-CccccHHHHHHHH
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCG----HVEKAFKVFNLMRE-KNLQSWTIMISGL   86 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g----~~~~a~~~~~~m~~-~~~~~~~~~i~~~   86 (234)
                      .+..+=..+...++.++|...+....+.|   +...+..|=..|.. |    +.++|.+.|+...+ .+..++..+-..|
T Consensus        20 a~~~lg~~~~~~~~~~~A~~~~~~a~~~g---~~~a~~~lg~~y~~-~g~~~~~~~A~~~~~~A~~~g~~~a~~~Lg~~y   95 (212)
T 3rjv_A           20 AQYYLADTWVSSGDYQKAEYWAQKAAAQG---DGDALALLAQLKIR-NPQQADYPQARQLAEKAVEAGSKSGEIVLARVL   95 (212)
T ss_dssp             HHHHHHHHHHHHTCHHHHHHHHHHHHHTT---CHHHHHHHHHHTTS-STTSCCHHHHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCHHHHHHHHHHHHHcC---CHHHHHHHHHHHHc-CCCCCCHHHHHHHHHHHHHCCCHHHHHHHHHHH
Confidence            34444444555678889999998888766   34455666666777 6    89999998887544 4556666665556


Q ss_pred             Hh----cCCchhhhHhhhc
Q 026720           87 AD----NSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~----~g~~~~a~~l~~~  101 (234)
                      ..    .++.++|+..+..
T Consensus        96 ~~g~g~~~d~~~A~~~~~~  114 (212)
T 3rjv_A           96 VNRQAGATDVAHAITLLQD  114 (212)
T ss_dssp             TCGGGSSCCHHHHHHHHHH
T ss_pred             HcCCCCccCHHHHHHHHHH
Confidence            55    6788899988877

>4gcn_A Protein STI-1; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, tetratricopeptide repeat domain; HET: PGE; 1.85A {Caenorhabditis elegans}

Probab=82.79  E-value=3.2  Score=27.17  Aligned_cols=56  Identities=13%  Similarity=0.089  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           46 AIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        46 ~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      ..+.-|=..|.+.|++++|...|++..+   .+...|+.+-..|.+.|+.++|+..+..
T Consensus         9 ~a~~~lG~~~~~~~~~~~A~~~y~~Al~~~p~~~~~~~nlg~~~~~~~~~~~A~~~~~~   67 (127)
T 4gcn_A            9 IAEKDLGNAAYKQKDFEKAHVHYDKAIELDPSNITFYNNKAAVYFEEKKFAECVQFCEK   67 (127)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHhHHHHHHHhhhHHHHHHHHHH
Confidence            3445555678899999999999987443   4677888888889999999999999876

>3q49_B STIP1 homology and U box-containing protein 1; E3 ubiquitin ligase, ligase-chaperone complex; 1.54A {Mus musculus} PDB: 3q47_B 3q4a_B*

Probab=82.57  E-value=3.7  Score=26.66  Aligned_cols=63  Identities=8%  Similarity=-0.128  Sum_probs=51.1

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR   72 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~   72 (234)
                      +...+..+-..+...++.++|...+...++... .+...+..+-..|...|+.++|...|+...
T Consensus        42 ~~~~~~~l~~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~l~~~~~~~~~~~~A~~~~~~a~  104 (137)
T 3q49_B           42 VAVYYTNRALCYLKMQQPEQALADCRRALELDG-QSVKAHFFLGQCQLEMESYDEAIANLQRAY  104 (137)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHhcCHHHHHHHHHHHHHhCc-hhHHHHHHHHHHHHHHhhHHHHHHHHHHHH
Confidence            345666677778889999999999999888653 256688889999999999999999988754

>2kc7_A BFR218_protein; tetratricopeptide repeat, all-alpha, GFT-structural genomics, PSI-2, protein structure initiative; NMR {Bacteroides fragilis}

Probab=82.47  E-value=2.1  Score=26.22  Aligned_cols=55  Identities=11%  Similarity=0.000  Sum_probs=41.9

Q ss_pred             HHhcCchhhhhHhHHHHHHHHhccchhHH-HHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720           18 SACTGLINVRAGESIHSYAVVNGLELDVA-IGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~-~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      ..+.+.++.++|...+...++.... +.. .+..+-..|.+.|+.++|...|+...+
T Consensus         8 ~~~~~~~~~~~A~~~~~~al~~~p~-~~~~~~~~lg~~~~~~~~~~~A~~~~~~al~   63 (99)
T 2kc7_A            8 KELINQGDIENALQALEEFLQTEPV-GKDEAYYLMGNAYRKLGDWQKALNNYQSAIE   63 (99)
T ss_dssp             HHHHHHTCHHHHHHHHHHHHHHCSS-THHHHHHHHHHHHHHHTCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHHHHHHCCC-cHHHHHHHHHHHHHHcCCHHHHHHHHHHHHh
Confidence            3455677889999999888876432 345 777888889999999999999887543

>2uwj_G Type III export protein PSCG; virulence, chaperones, coiled coil, needle formation, type III secretion, bacterial pathogenicity; 2.0A {Pseudomonas aeruginosa}

Probab=82.12  E-value=3.5  Score=26.37  Aligned_cols=69  Identities=13%  Similarity=0.052  Sum_probs=47.2

Q ss_pred             hhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhH
Q 026720           25 NVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAIS   97 (234)
Q Consensus        25 ~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~   97 (234)
                      ..++|..+-+-....|-  ..++--.=+..++..|++++|..+.+.++.||+.+|.++-.+  +.|..+++..
T Consensus        21 ~HqEA~tIAdwL~~~~~--~E~v~lIR~sSLmNrG~Yq~Al~l~~~~c~pdlepw~ALce~--rlGl~s~le~   89 (115)
T 2uwj_G           21 CHEEALCIAEWLERLGQ--DEAARLIRISSLANQGRYQEALAFAHGNPWPALEPWFALCEW--HLGLGAALDR   89 (115)
T ss_dssp             CHHHHHHHHHHHHHTTC--HHHHHHHHHHHHHHTTCHHHHHGGGTTCCCGGGHHHHHHHHH--HTTCHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCc--HHHHHHHHHHHHHcchhHHHHHHhcCCCCCchHHHHHHHHHH--hcccHHHHHH
Confidence            45677777666655554  333333445668889999999999888999999999887653  4455444443

>3qky_A Outer membrane assembly lipoprotein YFIO; membrane protein; 2.15A {Rhodothermus marinus}

Probab=81.96  E-value=5.5  Score=29.45  Aligned_cols=91  Identities=11%  Similarity=-0.157  Sum_probs=66.8

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccc--hhHHHHHHHHHHHhh--------cCChHHHHHHHHhhcc--C-ccc
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLE--LDVAIGTALVEMYSK--------CGHVEKAFKVFNLMRE--K-NLQ   77 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~--~~~~~~~~li~~~~~--------~g~~~~a~~~~~~m~~--~-~~~   77 (234)
                      ..+..+-.++.+.|+.++|...+...++....  .....+..+-..|.+        .|+.++|...|+...+  | +..
T Consensus        53 ~a~~~lg~~~~~~~~~~~A~~~~~~~l~~~p~~~~~~~a~~~lg~~~~~~~~~~~~~~~~~~~A~~~~~~~l~~~p~~~~  132 (261)
T 3qky_A           53 DAQFYLARAYYQNKEYLLAASEYERFIQIYQIDPRVPQAEYERAMCYYKLSPPYELDQTDTRKAIEAFQLFIDRYPNHEL  132 (261)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCTTHHHHHHHHHHHHHHHCCCTTSCCHHHHHHHHHHHHHHHHCTTCTT
T ss_pred             HHHHHHHHHHHHhCcHHHHHHHHHHHHHHCCCCchhHHHHHHHHHHHHHhcccccccchhHHHHHHHHHHHHHHCcCchh
Confidence            34555666788899999999999999886431  123455666677777        9999999999988654  3 333


Q ss_pred             cH-----------------HHHHHHHHhcCCchhhhHhhhc
Q 026720           78 SW-----------------TIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        78 ~~-----------------~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      .+                 ..+-..+.+.|+.++|+..+..
T Consensus       133 ~~~a~~~~~~~~~~~~~~~~~la~~~~~~g~~~~A~~~~~~  173 (261)
T 3qky_A          133 VDDATQKIRELRAKLARKQYEAARLYERRELYEAAAVTYEA  173 (261)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHccCHHHHHHHHHH
Confidence            44                 2335668889999999999977

>1xi4_A Clathrin heavy chain; alpha-ZIG-ZAG, beta-propeller, endocytosis-exocyto complex; 7.90A {Bos taurus} SCOP: i.23.1.1 PDB: 1xi5_A 3iyv_A

Probab=80.96  E-value=3.5  Score=39.45  Aligned_cols=86  Identities=15%  Similarity=0.110  Sum_probs=49.1

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHH-------------------------
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEK-------------------------   63 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~-------------------------   63 (234)
                      |...|.-+..+|.+.|+++++.+.+....+..  ++....+.+...|++.+++++                         
T Consensus      1133 D~say~eVa~~~~~lGkyEEAIeyL~mArk~~--~e~~Idt~LafaYAKl~rleele~fI~~~n~ad~~~iGd~le~eg~ 1210 (1630)
T 1xi4_A         1133 DPSSYMEVVQAANTSGNWEELVKYLQMARKKA--RESYVETELIFALAKTNRLAELEEFINGPNNAHIQQVGDRCYDEKM 1210 (1630)
T ss_pred             ChHHHHHHHHHHHHcCCHHHHHHHHHHHHhhc--ccccccHHHHHHHHhhcCHHHHHHHHhCCCHHHHHHHHHHHHhcCC
Confidence            34455667777777777777777776554433  333333346666666655554                         


Q ss_pred             ---HHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           64 ---AFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        64 ---a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                         |...|..     +-.|..+...+++.|+.++|++....
T Consensus      1211 YeeA~~~Y~k-----A~ny~rLA~tLvkLge~q~AIEaarK 1246 (1630)
T 1xi4_A         1211 YDAAKLLYNN-----VSNFGRLASTLVHLGEYQAAVDGARK 1246 (1630)
T ss_pred             HHHHHHHHHh-----hhHHHHHHHHHHHhCCHHHHHHHHHH
Confidence               3333322     23566666666666666666666544

>3urz_A Uncharacterized protein; tetratricopeptide repeats (TPR) containing protein, structur genomics, joint center for structural genomics, JCSG; HET: PG4; 2.19A {Bacteroides ovatus}

Probab=80.75  E-value=3.6  Score=29.54  Aligned_cols=74  Identities=15%  Similarity=0.026  Sum_probs=57.1

Q ss_pred             HHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcC
Q 026720           16 LVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNS   90 (234)
Q Consensus        16 ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g   90 (234)
                      +=..+.+.|+.++|...+...++... .+...+..+-..|...|+.++|...|++..+  | +...|..+-..+...|
T Consensus        60 lg~~~~~~g~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~P~~~~a~~~lg~~~~~~~  136 (208)
T 3urz_A           60 LALAYKKNRNYDKAYLFYKELLQKAP-NNVDCLEACAEMQVCRGQEKDALRMYEKILQLEADNLAANIFLGNYYYLTA  136 (208)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCHHHHHHHHHHHHHHCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHHHHHcCCCCHHHHHHHHHHHHHHh
Confidence            55667888999999999999988643 2567888899999999999999999988653  3 5567777655554433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	234
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-26
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-24
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-24
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-24
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-24
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-23
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-23
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-22
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-22
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-22
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-21
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-21
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-21
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-21
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-21
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-20
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-20
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-20
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-20
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-19
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-19
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-19
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-18
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-18
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-18
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-18
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-17
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-17
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-17
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-16
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-16
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-16
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-16
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-16
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-16
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-16
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-16
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-15
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-15
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-15
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-15
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-15
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-14
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-14
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-14
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-14
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-14
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-13
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-13
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-13
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-13
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-12
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-08

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 7e-28
 Identities = 57/177 (32%), Positives = 84/177 (47%), Gaps = 9/177 (5%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAI-------SLHRQGY 103
           ++ +    GH      VF+ M              L  +      +        LH+   
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121

Query: 104 FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPE 161
            HRDLKP+NLL+   GV+K+ D G+ K   S     T  V TRWYR PE+L  + +YG  
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWK 218
           VD WA+G I+ E+L      PG S  DQ+ +I + +G+PT++ WP    L   + +K
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-26
 Identities = 56/161 (34%), Positives = 76/161 (47%), Gaps = 4/161 (2%)

Query: 52  VEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPS 111
            ++     HV++    +     +       +   +    RG D   LH     HRDLKP 
Sbjct: 88  TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF--LHSHRVVHRDLKPQ 145

Query: 112 NLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAI 170
           N+LV S G IK+ D G+ +     +  T  V T WYR PEVLL S  Y   VD W++G I
Sbjct: 146 NILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCI 204

Query: 171 MFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL 211
             EM     LF G S  DQ+ KI  +IG P ++ WP  + L
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-26
 Identities = 61/190 (32%), Positives = 92/190 (48%), Gaps = 15/190 (7%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKP 110
            +  +     + K  K  +L  +        ++ GL           +H     HRDLKP
Sbjct: 87  YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY---------IHSANVLHRDLKP 137

Query: 111 SNLLVSK-GVIKIGDLGMVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKW 165
           SNLL++    +KI D G+ +  D +       T+YV TRWYR PE++L S+ Y   +D W
Sbjct: 138 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197

Query: 166 AMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL-ASNLNWKLPQMGG 224
           ++G I+ EMLS   +FPGK   DQ+  I  ++GSP+++     I L A N    LP    
Sbjct: 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 257

Query: 225 VNLLAVMPSA 234
           V    + P+A
Sbjct: 258 VPWNRLFPNA 267

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 1e-24
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 6/142 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYRGPEV 151
           +HR    HRD+K +N+L+++ GV+K+ D G+ +             T+ V T WYR PE+
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQL 211
           LL    YGP +D W  G IM EM +   +  G +   Q+  I QL GS T + WP     
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 212 ASNLNWKLPQMGGVNLLAVMPS 233
                 +L +     +   + +
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKA 274

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.8 bits (237), Expect = 3e-24
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 13/175 (7%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLK 109
           LV  +      +        +  + ++S+   ++ GL            H +   HRDLK
Sbjct: 78  LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG---------FCHSRNVLHRDLK 128

Query: 110 PSNLLV-SKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLFSEIYGPEVDKWAM 167
           P NLL+   G +K+ + G+ +     + C +  V T WYR P+VL  +++Y   +D W+ 
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188

Query: 168 GAIMFEMLSFGI-LFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQ 221
           G I  E+ + G  LFPG    DQ+ +I +L+G+PT++ WP   +L     + +  
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 3e-24
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 4/138 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
           +H  G  HRD+KP NLL+     V+K+ D G  K++    P   Y+ +R+YR PE++  +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
             Y   +D W+ G ++ E+L    +FPG S  DQ+ +I +++G+PT++         +  
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR--EMNPNYT 255

Query: 216 NWKLPQMGGVNLLAVMPS 233
            +K PQ+       V   
Sbjct: 256 EFKFPQIKAHPWTKVFRP 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 95.1 bits (236), Expect = 4e-24
 Identities = 33/115 (28%), Positives = 48/115 (41%), Gaps = 6/115 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH+    HRDLKP N+L+     IK+ D G   ++D      +   T  Y  PE++  S 
Sbjct: 126 LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 185

Query: 157 I-----YGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
                 YG EVD W+ G IM+ +L+    F  +     +  I           W 
Sbjct: 186 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 5e-24
 Identities = 49/139 (35%), Positives = 73/139 (52%), Gaps = 3/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFS 155
            H     HRDLKP NLL++  G IK+ D G+ +     +   T  V T WYR PE+LL  
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
           + Y   VD W++G I  EM++   LFPG S  DQ+++I + +G+P +  WP G+    + 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDY 236

Query: 216 NWKLPQMGGVNLLAVMPSA 234
               P+    +   V+P  
Sbjct: 237 KPSFPKWARQDFSKVVPPL 255

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.1 bits (231), Expect = 1e-23
 Identities = 34/173 (19%), Positives = 63/173 (36%), Gaps = 10/173 (5%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAIS-------LHRQGY 103
           ++ +Y       + + +        +      +S   +                 H +  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127

Query: 104 FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEV 162
            HRD+KP NLL+ S G +KI D G      S+   T    T  Y  PE++    ++  +V
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIE-GRMHDEKV 185

Query: 163 DKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
           D W++G + +E L     F   +  +   +I ++  +           L S L
Sbjct: 186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 94.4 bits (234), Expect = 2e-23
 Identities = 24/112 (21%), Positives = 47/112 (41%), Gaps = 4/112 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           +H   Y H DLKP N++ +      +K+ D G+   +D          T  +  PEV   
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE- 198

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            +  G   D W++G + + +LS    F G++  + +  +     +    ++ 
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 91.9 bits (227), Expect = 6e-23
 Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 9/171 (5%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAIS-------LHRQGY 103
           +V++Y      ++   VF  + +   +   +   GL   +  +  +         H +  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 104 FHRDLKP-SNLLVSKGVIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPE 161
            HRDLKP + L+  +G +KI D G+ +     +   T  + T WYR P+VL+ S+ Y   
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLA 212
           +D W++G I  EM++   LFPG S ADQ+ +I +++G+P   +WP   +L 
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 91.3 bits (226), Expect = 2e-22
 Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 4/112 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           +H     H D+KP N++        +KI D G+  +++ +        T  +  PE++  
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD- 201

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            E  G   D WA+G + + +LS    F G+   + +  + +      +D++ 
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.9 bits (220), Expect = 6e-22
 Identities = 38/148 (25%), Positives = 60/148 (40%), Gaps = 14/148 (9%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLK 109
           L   Y   G +    +    M E + Q +   +++G+           LH  G  HRD+K
Sbjct: 80  LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---------YLHGIGITHRDIK 130

Query: 110 PSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKW 165
           P NLL+  +  +KI D G+      N           T  Y  PE+L   E +   VD W
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 190

Query: 166 AMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + G ++  ML+  + +   S + Q Y  
Sbjct: 191 SCGIVLTAMLAGELPWDQPSDSCQEYSD 218

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.3 bits (221), Expect = 7e-22
 Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 6/104 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTD-YVTTRWYRGPEVLLF- 154
           LH     HRDLK  N+L    G IK+ D G+  +    +   D ++ T ++  PEV++  
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 155 ---SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
                 Y  + D W++G  + EM          +    + KI +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.0 bits (222), Expect = 7e-22
 Identities = 58/186 (31%), Positives = 84/186 (45%), Gaps = 13/186 (6%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKP 110
            +  +     +    K   L  +        ++ GL           +H     HRDLKP
Sbjct: 99  YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY---------IHSADIIHRDLKP 149

Query: 111 SNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGA 169
           SNL V++   +KI D G+ +  D     T YV TRWYR PE++L    Y   VD W++G 
Sbjct: 150 SNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207

Query: 170 IMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-LGIQLASNLNWKLPQMGGVNLL 228
           IM E+L+   LFPG    DQ+  I +L+G+P  +    +  + A N    L QM  +N  
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267

Query: 229 AVMPSA 234
            V   A
Sbjct: 268 NVFIGA 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.3 bits (221), Expect = 9e-22
 Identities = 39/191 (20%), Positives = 73/191 (38%), Gaps = 12/191 (6%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL--------HRQG 102
           +V  Y       +       M   +L         + +   G  +I++         +  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 103 YFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPE 161
             HRD+KPSN+LV S+G IK+ D G+  ++  ++    +V TR Y  PE L     Y  +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQ-GTHYSVQ 183

Query: 162 VDKWAMGAIMFEMLSFGILFPGKSSA-DQIYKICQLIGSPTKDSWPLGIQLASNLNWKLP 220
            D W+MG  + EM       P   +   ++   CQ+ G   +             ++ + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 221 QMGGVNLLAVM 231
               + +  ++
Sbjct: 244 SRPPMAIFELL 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 1e-21
 Identities = 52/139 (37%), Positives = 78/139 (56%), Gaps = 4/139 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           +H  G  HRDLKP NL V++   +KI D G+ ++ DS +  T YV TRWYR PEV+L   
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWM 194

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-LGIQLASNL 215
            Y   VD W++G IM EM++   LF G    DQ+ +I ++ G+P  +    L    A N 
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254

Query: 216 NWKLPQMGGVNLLAVMPSA 234
              LP++   +  +++ +A
Sbjct: 255 MKGLPELEKKDFASILTNA 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.7 bits (217), Expect = 2e-21
 Identities = 41/147 (27%), Positives = 63/147 (42%), Gaps = 11/147 (7%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKP 110
           LV      G ++   K F +M+ K L+SW   I       +G   +        HRDLK 
Sbjct: 89  LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL------KGLQFLHTRTPPIIHRDLKC 142

Query: 111 SNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMG 168
            N+ ++   G +KIGDLG+     ++      + T  +  PE+    E Y   VD +A G
Sbjct: 143 DNIFITGPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMY--EEKYDESVDVYAFG 199

Query: 169 AIMFEMLSFGILFPGKSSADQIYKICQ 195
             M EM +    +    +A QIY+   
Sbjct: 200 MCMLEMATSEYPYSECQNAAQIYRRVT 226

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.1 bits (218), Expect = 2e-21
 Identities = 40/176 (22%), Positives = 65/176 (36%), Gaps = 12/176 (6%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAI-------SLHRQGY 103
            V++Y      EK +   +  +   L  +   I    +                LH +G 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129

Query: 104 FHRDLKPSNLLV-SKGVIKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
            HRDLKP N+L+     I+I D G  K +           +V T  Y  PE+L       
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 188

Query: 160 PEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNL 215
              D WA+G I++++++    F   +      KI +L     +  +P    L   L
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.0 bits (215), Expect = 4e-21
 Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 4/111 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEID-SNLPCTDYVTTRWYRGPEVLLFS 155
           LH     HRD+K  N+L+   G +K+ D G   +I       +  V T ++  PEV+   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
             YGP+VD W++G +  EM+     +  ++    +Y I    G+P   +  
Sbjct: 192 A-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPE 240

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.7 bits (216), Expect = 5e-21
 Identities = 51/138 (36%), Positives = 73/138 (52%), Gaps = 2/138 (1%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH  G  HRDLKPSN++V S   +KI D G+ +   ++   T YV TR+YR PEV+L   
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GM 193

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD W++G IM EM+   ILFPG+   DQ  K+ + +G+P  +          N  
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 217 WKLPQMGGVNLLAVMPSA 234
              P+  G+    + P +
Sbjct: 254 ENRPKYAGLTFPKLFPDS 271

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 87.2 bits (215), Expect = 6e-21
 Identities = 27/124 (21%), Positives = 61/124 (49%), Gaps = 3/124 (2%)

Query: 98  LHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
            H  G  HRD+KP N+++      +++ D G+ +           V +R+++GPE+L+  
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGI-LFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASN 214
           ++Y   +D W++G ++  M+      F G  + DQ+ +I +++G+     +     +  +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 215 LNWK 218
             + 
Sbjct: 265 PRFN 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 86.6 bits (214), Expect = 8e-21
 Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 6/101 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS- 155
           LH     HRD+K  N+L+S+ G++K+GD G    +    P   +V T ++  PEV+L   
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMD 187

Query: 156 -EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
              Y  +VD W++G    E+          ++   +Y I Q
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 3e-20
 Identities = 23/112 (20%), Positives = 47/112 (41%), Gaps = 4/112 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLF 154
           LH     H D++P N++        IKI + G  +++          T   Y  PEV   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ- 176

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
            ++     D W++G +++ +LS    F  +++   I  I     +  ++++ 
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.7 bits (209), Expect = 3e-20
 Identities = 27/101 (26%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 97  SLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPC-TDYVTTRWYRGPEVLLF 154
           S       HRDLKP+N+ +  K  +K+GD G+ + ++ +      +V T +Y  PE +  
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
              Y  + D W++G +++E+ +    F   S  +   KI +
Sbjct: 189 MS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.4 bits (208), Expect = 4e-20
 Identities = 32/168 (19%), Positives = 62/168 (36%), Gaps = 13/168 (7%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISL-------HRQGY 103
           ++ ++    +      +  L+    L  +      L +         +       H    
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134

Query: 104 FHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIY 158
            H DLKP N+++      K  IKI D G+  +ID      +   T  +  PE++   E  
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-YEPL 193

Query: 159 GPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
           G E D W++G I + +LS    F G +  + +  +  +      + + 
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.5 bits (206), Expect = 7e-20
 Identities = 24/104 (23%), Positives = 48/104 (46%), Gaps = 6/104 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK---EIDSNLPCTDYVTTRWYRGPEVLL 153
           LH +   HRDLK +N+ +     +KIGD G+         +        +  +  PEV+ 
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 154 FSE--IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
             +   Y  + D +A G +++E+++  + +   ++ DQI  +  
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.2 bits (205), Expect = 1e-19
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 4/99 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH +   +RDLKP N+L+   G IKI D G  K +           T  Y  PEV+  ++
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVV-STK 176

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
            Y   +D W+ G +++EML+    F   ++     KI  
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.2 bits (205), Expect = 2e-19
 Identities = 33/104 (31%), Positives = 45/104 (43%), Gaps = 5/104 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH     HRD+KP NLL +      ++K+ D G  KE  S+   T    T +Y  PEVL 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI 197
             E Y    D W++G IM+ +L     F           +   I
Sbjct: 187 -PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.6 bits (206), Expect = 2e-19
 Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 14/160 (8%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLK 109
            +      G +        +  E +++ +   I  GL           +H +   +RDLK
Sbjct: 84  FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE---------HMHNRFVVYRDLK 134

Query: 110 PSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMG 168
           P+N+L+ + G ++I DLG+  +     P    V T  Y  PEVL     Y    D +++G
Sbjct: 135 PANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLG 193

Query: 169 AIMFEMLSFGILFPGKSSADQ--IYKICQLIGSPTKDSWP 206
            ++F++L     F    + D+  I ++   +     DS+ 
Sbjct: 194 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.1 bits (197), Expect = 1e-18
 Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 5/113 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLLF 154
           + R  Y HRDL+ +N+LV    V K+ D G+ + I+ N             +  PE  L 
Sbjct: 129 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL- 187

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
              +  + D W+ G ++ E+ + G + +PG  + + + ++ +    P     P
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 78.9 bits (194), Expect = 5e-18
 Identities = 35/113 (30%), Positives = 46/113 (40%), Gaps = 5/113 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH  G  HRDLKP NLL         I I D G+ K  D     +    T  Y  PEVL 
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
             + Y   VD W++G I + +L     F  ++ A    +I +         W 
Sbjct: 183 -QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (191), Expect = 6e-18
 Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 5/111 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           L    + HRDL   N+LVS+  V K+ D G+ KE  S            +  PE L   +
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALR-EK 175

Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
            +  + D W+ G +++E+ SFG + +P     D + ++ +       D  P
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 226

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 78.7 bits (193), Expect = 9e-18
 Identities = 34/125 (27%), Positives = 48/125 (38%), Gaps = 4/125 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSE 156
           LH     +RDLKP NLL+  +G I++ D G  K +           T     PE++L S+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIIL-SK 213

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLN 216
            Y   VD WA+G +++EM +    F          KI                 L  NL 
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

Query: 217 WKLPQ 221
                
Sbjct: 274 QVDLT 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 76.8 bits (188), Expect = 3e-17
 Identities = 24/113 (21%), Positives = 41/113 (36%), Gaps = 15/113 (13%)

Query: 98  LHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVKEIDSNL--------PCTDYVTT 143
           +H +   +RD+KP N L+ +       +I + D GMVK     +           +   T
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 144 RWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQL 196
             Y      L  E      D  A+G +    L   + + G  +A    K  ++
Sbjct: 177 ARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.7 bits (188), Expect = 4e-17
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 6/103 (5%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEVLL 153
           L  +   HRDL   N+LV    V+KI D G+ ++I S+   +   +      +  PE L 
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
              IY  + D W+ G +++E+ S G+  +PG       YK+ Q
Sbjct: 240 -EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 75.2 bits (184), Expect = 9e-17
 Identities = 33/171 (19%), Positives = 60/171 (35%), Gaps = 15/171 (8%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAIS--------LHRQG 102
           ++ +            +   M   +L S+     G     +    +         L    
Sbjct: 89  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 148

Query: 103 YFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL-----FSE 156
           Y HRDL   N+LV S  V K+ D G+ + ++ +     Y +    + P            
Sbjct: 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 208

Query: 157 IYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
            +    D W+ G +M+E++S+G   +   ++ D I  I Q    P     P
Sbjct: 209 KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (183), Expect = 1e-16
 Identities = 24/103 (23%), Positives = 50/103 (48%), Gaps = 5/103 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC---TDYVTTRWYRGPEVLL 153
           L  + + HRDL   NLL++ + ++KIGD G+++ +  N       ++    +       L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
            +  +    D W  G  ++EM ++G   + G + +  ++KI +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.2 bits (184), Expect = 1e-16
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 5/110 (4%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFS 155
           LH +G  +RDLK  N+L+ K G IKI D GM KE    +     +  T  Y  PE+LL  
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL-G 177

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW 205
           + Y   VD W+ G +++EML     F G+   +  + I     +P    W
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRW 225

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 74.5 bits (182), Expect = 2e-16
 Identities = 32/118 (27%), Positives = 54/118 (45%), Gaps = 6/118 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEVLL 153
           L  + + HRDL   N LV +  V+KI D G+ + I S        +      +  PE + 
Sbjct: 156 LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI- 214

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWPLGIQ 210
           F   Y  E D WA G +++E+ S+G+  + G +  + IY +         ++ PL + 
Sbjct: 215 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELY 272

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.0 bits (181), Expect = 2e-16
 Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 3/90 (3%)

Query: 98  LHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFS 155
            H  G  HRD+K  N+L+  ++G +K+ D G    +      TD+  TR Y  PE + + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 184

Query: 156 EIYGPEVDKWAMGAIMFEMLSFGILFPGKS 185
             +G     W++G ++++M+   I F    
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.5 bits (180), Expect = 3e-16
 Identities = 27/113 (23%), Positives = 53/113 (46%), Gaps = 5/113 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLLF 154
           +  + Y HRDL+ +N+LV      KI D G+ + I+ N             +  PE + +
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWP 206
              +  + D W+ G ++ E+++ G I +PG ++ + I  + +       D+ P
Sbjct: 185 GT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.7 bits (180), Expect = 5e-16
 Identities = 30/148 (20%), Positives = 59/148 (39%), Gaps = 15/148 (10%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLK 109
           + ++      ++   +  + +  + L +W + I  G+           L  +   HRDL 
Sbjct: 88  ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN---------YLEDRRLVHRDLA 138

Query: 110 PSNLLV-SKGVIKIGDLGMVKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKW 165
             N+LV +   +KI D G+ K + +               +   E +L   IY  + D W
Sbjct: 139 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVW 197

Query: 166 AMGAIMFEMLSFGILFPGKSSADQIYKI 193
           + G  ++E+++FG        A +I  I
Sbjct: 198 SYGVTVWELMTFGSKPYDGIPASEISSI 225

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 7e-16
 Identities = 29/99 (29%), Positives = 43/99 (43%), Gaps = 3/99 (3%)

Query: 99  HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSNLPCTDYVTTRWYRGPEVLLFSE 156
           H +   +RD+K  NL++ K G IKI D G+ KE          +  T  Y     +L   
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL-APEVLEDN 180

Query: 157 IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
            YG  VD W +G +M+EM+   + F  +        I  
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 72.4 bits (177), Expect = 9e-16
 Identities = 22/127 (17%), Positives = 50/127 (39%), Gaps = 4/127 (3%)

Query: 71  MREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK 129
              +   S  +++      S   +   L ++ + HRDL   N LV    ++K+ D G+ +
Sbjct: 106 ECNRQEVSAVVLLYMATQISSAME--YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163

Query: 130 EIDSNLPCTDY-VTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSAD 188
            +  +                   L    +  + D WA G +++E+ ++G+         
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223

Query: 189 QIYKICQ 195
           Q+Y++ +
Sbjct: 224 QVYELLE 230

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (175), Expect = 1e-15
 Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 6/100 (6%)

Query: 99  HRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCT----DYVTTRWYRGPEVLL 153
               Y HRDL   N+LV S  V K+ D G+ + ++ +   T           +  PE + 
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
               +    D W+ G +M+E++++G     + S  ++ K 
Sbjct: 187 -YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.3 bits (174), Expect = 2e-15
 Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 4/98 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLLF 154
           L      HRDL   N LV    VIK+ D GM + +  +     T       +  PEV  F
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYK 192
           S  Y  + D W+ G +M+E+ S G +     S  ++ +
Sbjct: 177 SR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.5 bits (172), Expect = 4e-15
 Identities = 33/163 (20%), Positives = 63/163 (38%), Gaps = 17/163 (10%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMI-SGLADNSRGNDAISLHRQGYFHRDLK 109
           LV   ++ G + K  +    +++KN+      +  G+           L    + HRDL 
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK---------YLEESNFVHRDLA 134

Query: 110 PSN-LLVSKGVIKIGDLGMVKEIDSNLPC----TDYVTTRWYRGPEVLLFSEIYGPEVDK 164
             N LLV++   KI D G+ K + ++       T       +  PE +     +  + D 
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFSSKSDV 193

Query: 165 WAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
           W+ G +M+E  S+G   + G   ++    + +          P
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.7 bits (170), Expect = 6e-15
 Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 13/168 (7%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAIS--------LHRQG 102
           LV++Y  C      F +   M    L ++   +       +  +           L  + 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 103 YFHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSNLPCTDYVTTRWYRGPEVLLFSEIYG 159
           + HRDL   N LV  +GV+K+ D G+ + +  D             +  PEVL+    + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-YSKFS 179

Query: 160 PEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
            + D WA G +M+E+ S G + +   ++++    I Q +         
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.3 bits (171), Expect = 6e-15
 Identities = 23/113 (20%), Positives = 44/113 (38%), Gaps = 4/113 (3%)

Query: 98  LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM---VKEIDSNLPCTDYVTTRWYRGPEVLL 153
           LH+ G  +RD+K  N+L+   G + + D G+       ++        T  +     V  
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
               +   VD W++G +M+E+L+    F      +   +I + I         
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.4 bits (169), Expect = 1e-14
 Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 5/161 (3%)

Query: 48  GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRD 107
              L++   K   +E            +  S   ++   AD +RG D   L ++ + HRD
Sbjct: 95  HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD--YLSQKQFIHRD 152

Query: 108 LKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWA 166
           L   N+LV    V KI D G+ +  +  +  T       +   E  L   +Y    D W+
Sbjct: 153 LAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES-LNYSVYTTNSDVWS 211

Query: 167 MGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
            G +++E++S G   + G + A+   K+ Q        +  
Sbjct: 212 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 69.0 bits (168), Expect = 1e-14
 Identities = 23/114 (20%), Positives = 43/114 (37%), Gaps = 6/114 (5%)

Query: 98  LHRQGYFHRDLKPSNLLVSKG-----VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL 152
            H+ G  HRD+KP+N+++S       +       +    +S       + T  Y  PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP 206
                     D +++G +++E+L+    F G S     Y+  +    P      
Sbjct: 187 RGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (168), Expect = 1e-14
 Identities = 40/170 (23%), Positives = 63/170 (37%), Gaps = 13/170 (7%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKP 110
           LV  Y + G +      + +  E  ++      SGLA +       +  +    HRDLK 
Sbjct: 78  LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA-HLHMEIVGTQGKPAIAHRDLKS 136

Query: 111 SNLLV-SKGVIKIGDLGMVKEIDS-----NLPCTDYVTTRWYRGPEVLLFSEI-----YG 159
            N+LV   G   I DLG+    DS     ++     V T+ Y  PEVL  S         
Sbjct: 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196

Query: 160 PEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPLGI 209
              D +AMG + +E+        G     Q+     +   P+ +     +
Sbjct: 197 KRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.3 bits (168), Expect = 2e-14
 Identities = 34/131 (25%), Positives = 56/131 (42%), Gaps = 12/131 (9%)

Query: 99  HRQGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLL 153
            R G  H D+KP N+L+        +I+I    +      +   T+ + TR YR PEVLL
Sbjct: 143 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL 202

Query: 154 FSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSS------ADQIYKICQLIGSPTKDSWPL 207
            +  +G   D W+   ++FE+++   LF            D I +I +L+G         
Sbjct: 203 GAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN 261

Query: 208 GIQLASNLNWK 218
           G    +  N +
Sbjct: 262 GKYTRTFFNSR 272

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.8 bits (165), Expect = 4e-14
 Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 7/115 (6%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN----LPCTDYVTTRWYRGPEVL 152
           L  + + HRDL   N+L+ ++   KI D G+ K + ++       +       +  PE +
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
                +    D W+ G  M+E LS+G   +      + +  I Q          P
Sbjct: 185 N-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (165), Expect = 5e-14
 Identities = 22/104 (21%), Positives = 47/104 (45%), Gaps = 8/104 (7%)

Query: 99  HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVK-----EIDSNLPCTDYVTTRWYRGPEVL 152
             + + HRDL   N ++ +   +K+ D G+ +     E DS    T       +   E L
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 153 LFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
             ++ +  + D W+ G +++E+++ G   +P  ++ D    + Q
Sbjct: 207 Q-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.0 bits (160), Expect = 2e-13
 Identities = 33/178 (18%), Positives = 66/178 (37%), Gaps = 23/178 (12%)

Query: 51  LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAIS------------- 97
           +V +       +    +  LM   +L+S+   +     N+      S             
Sbjct: 85  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 98  ----LHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTDYVTTRWYRGP 149
               L+   + HRDL   N +V++   +KIGD GM ++I   D        +    +  P
Sbjct: 145 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 150 EVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
           E L    ++    D W+ G +++E+ +     + G S+   +  + +       D+ P
Sbjct: 205 ESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 261

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.2 bits (158), Expect = 3e-13
 Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 5/113 (4%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSN--LPCTDYVTTRWYRGPEVLLF 154
           L  + + HRD+   N+LV S   +K+GD G+ + ++ +     +       +  PE + F
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 155 SEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP 206
              +    D W  G  M+E+L  G+  F G  + D I +I      P   + P
Sbjct: 184 RR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 65.2 bits (158), Expect = 4e-13
 Identities = 21/110 (19%), Positives = 40/110 (36%), Gaps = 13/110 (11%)

Query: 98  LHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSN--------LPCTDYVTTRW 145
           +H + + HRD+KP N L+       ++ I D G+ K+                +   T  
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 146 YRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ 195
           Y      L  E      D  ++G ++       + + G  +A +  K  +
Sbjct: 179 YASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (156), Expect = 6e-13
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 10/105 (9%)

Query: 98  LHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGP-----EV 151
           L  +   HRDL   N+L+    + KI D G+ ++I ++   ++YV     R P       
Sbjct: 161 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGNARLPVKWMAPE 217

Query: 152 LLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
            +F+ +Y  E D W+ G  ++E+ S G   +PG     + YK+ +
Sbjct: 218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (154), Expect = 1e-12
 Identities = 31/153 (20%), Positives = 62/153 (40%), Gaps = 8/153 (5%)

Query: 48  GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRD 107
              L        +    +KV      K+  +   +I      ++G +   L  +   HRD
Sbjct: 102 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF--LASRKCIHRD 159

Query: 108 LKPSNLLVSK-GVIKIGDLGMVKEI---DSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVD 163
           L   N+L+S+  V+KI D G+ ++I      +   D      +      +F  +Y  + D
Sbjct: 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRVYTIQSD 218

Query: 164 KWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQ 195
            W+ G +++E+ S G   +PG    ++  +  +
Sbjct: 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.3 bits (153), Expect = 1e-12
 Identities = 31/151 (20%), Positives = 58/151 (38%), Gaps = 9/151 (5%)

Query: 48  GTALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRD 107
              L E           +        +   S   ++S     +RG +   L  +   HRD
Sbjct: 103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY--LASKKCIHRD 160

Query: 108 LKPSNLLVS-KGVIKIGDLGMVKEIDSNLPC----TDYVTTRWYRGPEVLLFSEIYGPEV 162
           L   N+LV+   V+KI D G+ ++I             +  +W       LF  IY  + 
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM--APEALFDRIYTHQS 218

Query: 163 DKWAMGAIMFEMLSFGILFPGKSSADQIYKI 193
           D W+ G +++E+ + G         ++++K+
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 49.4 bits (117), Expect = 5e-08
 Identities = 16/81 (19%), Positives = 26/81 (32%), Gaps = 13/81 (16%)

Query: 98  LHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSN-----LPCTDYVTTRWYRGPEVL 152
            + +G  H DL   N+LVS+  I I D     E+        L         ++      
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT--- 175

Query: 153 LFSEIYGPEVDKWAMGAIMFE 173
                Y  E D  +    + +
Sbjct: 176 -----YRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	234
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.88
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.88
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.88
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.87
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.86
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.86
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.86
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.86
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.86
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.86
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.86
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.85
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.85
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.85
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.85
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.85
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.84
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.84
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.84
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.83
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.83
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.83
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.83
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.83
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.83
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.83
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.83
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.83
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.82
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.82
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.81
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.81
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.81
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.81
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.81
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.8
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.8
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.8
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.79
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.79
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.79
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.79
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.79
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.79
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.78
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.78
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.77
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.76
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.75
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.75
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.75
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.74
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.74
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.72
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.71
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.71
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.71
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.71
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.7
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.66
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.64
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.46
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	97.12
d1a17a_	159	Protein phosphatase 5 {Human (Homo sapiens) [TaxId	96.2
d1elwa_	117	Hop {Human (Homo sapiens) [TaxId: 9606]}	96.18
d2c2la1	201	STIP1 homology and U box-containing protein 1, STU	96.18
d1nzna_	122	Mitochondria fission protein Fis1 {Human (Homo sap	95.86
d1hxia_	112	Peroxin pex5 (peroxisomal targeting signal 1 (PTS1	95.78
d1w3ba_	388	O-GlcNAc transferase p110 subunit, OGT {Human (Hom	95.56
d1fcha_	323	Peroxin pex5 (peroxisomal targeting signal 1 (PTS1	95.34
d2onda1	308	Cleavage stimulation factor 77 kDa subunit CSTF3 {	95.33
d1w3ba_	388	O-GlcNAc transferase p110 subunit, OGT {Human (Hom	93.81
d1xnfa_	259	Lipoprotein NlpI {Escherichia coli [TaxId: 562]}	93.74
d1fcha_	323	Peroxin pex5 (peroxisomal targeting signal 1 (PTS1	93.16
d1elra_	128	Hop {Human (Homo sapiens) [TaxId: 9606]}	92.61
d2fbna1	153	Putative 70 kda peptidylprolyl isomerase PFL2275c	92.29
d1hh8a_	192	Neutrophil cytosolic factor 2 (NCF-2, p67-phox) {H	92.07
d1p5qa1	170	FKBP52 (FKBP4), C-terminal domain {Human (Homo sap	91.29
d2ff4a2	179	Probable regulatory protein EmbR, middle domain {M	90.01
d2h6fa1	315	Protein farnesyltransferase alpha-subunit {Human (	88.73
d2onda1	308	Cleavage stimulation factor 77 kDa subunit CSTF3 {	88.34
d1ihga1	169	Cyclophilin 40 {Cow (Bos taurus) [TaxId: 9913]}	88.21
d2h6fa1	315	Protein farnesyltransferase alpha-subunit {Human (	88.2
d2ff4a2	179	Probable regulatory protein EmbR, middle domain {M	87.89
d1kt1a1	168	FKBP51, C-terminal domain {Monkey (Saimiri bolivie	87.19
d2c2la1	201	STIP1 homology and U box-containing protein 1, STU	86.97
d2hr2a1	156	Hypothetical protein CT2138 {Chlorobium tepidum [T	84.22
d1hh8a_	192	Neutrophil cytosolic factor 2 (NCF-2, p67-phox) {H	83.93
d1nzna_	122	Mitochondria fission protein Fis1 {Human (Homo sap	83.54
d2pqrb1	124	Mitochondria fission protein Fis1 {Baker's yeast (	82.39
d1hxia_	112	Peroxin pex5 (peroxisomal targeting signal 1 (PTS1	81.11
d1elwa_	117	Hop {Human (Homo sapiens) [TaxId: 9606]}	80.44

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.6e-23  Score=161.86  Aligned_cols=172  Identities=23%  Similarity=0.280  Sum_probs=140.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|.+|+..|++.+...-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++. .+..+++|||.
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~---------~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS---------YCHSKRVIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeeeeeccccceecCCCCEeecccce
Confidence            478899999999887665555666666666666 88888         99999999999999999994 57889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      +....... .....+++.|+|||++.+ ..|+..+|+||+||++|||++|+.||++....+...++.+... +.+...++
T Consensus       153 a~~~~~~~-~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~  229 (263)
T d2j4za1         153 SVHAPSSR-RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTE  229 (263)
T ss_dssp             CSCCCCCC-CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCH
T ss_pred             eeecCCCc-ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCccCCH
Confidence            98765532 334578999999999975 4589999999999999999999999998877777666654322 23345677


Q ss_pred             hhhhhhhhccccCCCCCccccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .+..+...++..++.+|+|+++++++
T Consensus       230 ~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         230 GARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            88888899999999999999998864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=7.3e-24  Score=164.32  Aligned_cols=174  Identities=20%  Similarity=0.303  Sum_probs=130.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHh----hccCccccHHHH-HHHHHhcCCchhhhHhhhcc-----cccCCcCCCcEEee-CC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL----MREKNLQSWTIM-ISGLADNSRGNDAISLHRQG-----YFHRDLKPSNLLVS-KG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~----m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~-----~~~~~l~p~~~~~~-~~  118 (234)
                      .+|.+||..|++.+...-...    +++..+..|... +.|+.         ++|+.+     ++|+|++|+|+++. +.
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~---------ylH~~~~~~~~IiHrDiKp~NIll~~~~  151 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK---------ECHRRSDGGHTVLHRDLKPANVFLDGKQ  151 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHH---------HHHHHCC---------CCGGGEEECTTS
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHH---------HHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence            478999999999887654332    333445555544 67777         888765     89999999999994 67


Q ss_pred             eeeEeeccccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 026720          119 VIKIGDLGMVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~  197 (234)
                      ..+++|||.++.+.... ......+++.|+|||++.+ ..|+..+|+||+|+++|||++|+.||.+....+...++.+..
T Consensus       152 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~  230 (269)
T d2java1         152 NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK  230 (269)
T ss_dssp             CEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             cEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            88999999998875432 2345678999999999864 458999999999999999999999999988877777776655


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+.+..+++.+..++..++..++.+|+|+++++++
T Consensus       231 ~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            455566788899999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.88  E-value=2.5e-23  Score=164.29  Aligned_cols=172  Identities=22%  Similarity=0.315  Sum_probs=137.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|.+||..|.++....--..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++. .+..+++|||.
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~---------yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA---------YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEeccCCCcceEEECCCCCEEEeeccc
Confidence            478889988887654332223444455555555 77777         89999999999999999994 67899999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-CCCCCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG-SPTKDS  204 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~-~~~~~~  204 (234)
                      +......   ....+++.|+|||++.+.  ..|+..+|+||+||++||+++|..||.+....+.+.++..... .+....
T Consensus       162 a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  238 (309)
T d1u5ra_         162 ASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH  238 (309)
T ss_dssp             CBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTT
T ss_pred             ccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence            9876543   346789999999998542  3488999999999999999999999999988888887776433 344567


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +++.+..++..|+..++.+|+|+++++++
T Consensus       239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            88899999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=9.2e-23  Score=159.79  Aligned_cols=173  Identities=21%  Similarity=0.311  Sum_probs=138.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|++.+... -..+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++ .++..+++|||.
T Consensus        93 ~ivmEy~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~---------yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~  162 (293)
T d1yhwa1          93 WVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALE---------FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF  162 (293)
T ss_dssp             EEEEECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHH---------HHHHCCCcccCCcHHHeEECCCCcEeeccchh
Confidence            58899999999987532 123444556666655 78888         9999999999999999999 467889999999


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--CCCCC
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--PTKDS  204 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--~~~~~  204 (234)
                      ++.+... .......+++.|+|||++.+ ..|+..+|+||+|+++|+|++|..||.+....+.+..+......  +.+..
T Consensus       163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T d1yhwa1         163 CAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK  241 (293)
T ss_dssp             CEECCSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred             heeeccccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence            9987543 23455678999999999974 45899999999999999999999999998888887776654321  22344


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .++.+..++..++..++.+|+|+++++++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            56778888899999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=4.1e-23  Score=160.77  Aligned_cols=172  Identities=20%  Similarity=0.287  Sum_probs=134.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||.+|+..|++.+-.+-...+++..+..|... +.|+.         ++|+.+++|+|++|.|+++ ..+..+++|||.
T Consensus        83 ~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~---------ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK---------YLEESNFVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHh---------hHHhCCcccCCCcchhhcccccCcccccchhh
Confidence            478899999999886554333444445555444 66666         8999999999999999999 568899999999


Q ss_pred             cccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      ++.+.....    .....+++.|+|||++.+ ..|+..+|+||+|+++||+++ |+.||.+....+....+.+....+.+
T Consensus       154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p  232 (277)
T d1xbba_         154 SKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP  232 (277)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             hhhccccccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            987654321    123456788999999874 447899999999999999997 89999998877766666555445556


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ..++..+..++..||..++.+||+|++|.
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~  261 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVE  261 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            78889999999999999999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=9e-23  Score=158.16  Aligned_cols=172  Identities=25%  Similarity=0.347  Sum_probs=134.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcc--cccCCcCCCcEEee--CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQG--YFHRDLKPSNLLVS--KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~--~~~~~l~p~~~~~~--~~~~~~~~  124 (234)
                      .+|.+|+..|++.+...-...+++..+..|... +.|+.         ++|+.+  ++|+|++|+|+++.  +..++++|
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~---------yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~D  158 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ---------FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  158 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHH---------HHHHCCCCEEeCCcChhhceeeCCCCCEEEee
Confidence            478899999999887665445555555566555 77777         899887  99999999999994  46789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC--C
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPT--K  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~--~  202 (234)
                      ||.++..... ......+|+.|+|||++.+  .|+..+|+||+||++|||++|+.||++..+...+.+.......|.  .
T Consensus       159 FGla~~~~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~  235 (270)
T d1t4ha_         159 LGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD  235 (270)
T ss_dssp             TTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred             cCcceeccCC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC
Confidence            9999764432 2345678999999999863  489999999999999999999999998877766655443322222  1


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++..+..++..|+..++.+|+|+++++++
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            3455677888899999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=4.7e-23  Score=160.28  Aligned_cols=174  Identities=18%  Similarity=0.291  Sum_probs=127.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|.+|+..|++.+...-.+. ++...+..+... +.|+.         ++|+.+++|+|++|.|+++. ....+++|||
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~---------yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD---------YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHhcCCEeccccCHHHEEEcCCCCEEEcccc
Confidence            578899999998775432211 222233333333 55555         88999999999999999994 6678999999


Q ss_pred             ccccccCCC---CCCCcccCcccccccccccc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-CC
Q 026720          127 MVKEIDSNL---PCTDYVTTRWYRGPEVLLFS--EIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG-SP  200 (234)
Q Consensus       127 ~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~--~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~-~~  200 (234)
                      .++......   ......+++.|+|||++.+.  ..|+..+|+||+|+++||+++|+.||++......+..+..... .|
T Consensus       150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p  229 (276)
T d1uwha_         150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP  229 (276)
T ss_dssp             CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC
T ss_pred             ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            997764322   23345788999999998642  2478899999999999999999999999888777766655433 33


Q ss_pred             C----CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 T----KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +    ...+++.+..++..||..++.+||||.+|+.
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~  265 (276)
T d1uwha_         230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA  265 (276)
T ss_dssp             CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            2    3456778889999999999999999998864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=7.7e-23  Score=161.04  Aligned_cols=175  Identities=31%  Similarity=0.546  Sum_probs=137.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .+|.+|+..|.+.....-...+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus        76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~---------~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~  146 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE---------YLHQHWILHRDLKPNNLLLDENGVLKLADFGL  146 (299)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHH---------HhhccceecccCCcceEEecCCCccccccCcc
Confidence            567788877765543322223444556666665 77888         99999999999999999994 57889999999


Q ss_pred             cccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++...... .....++++.|+|||++.....|+..+|+||+||+++||++|.+||++....+++.++.+..+.|....|+
T Consensus       147 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         147 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  226 (299)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            98765533 23456789999999998766778999999999999999999999999999999999999998887766554


Q ss_pred             c---------------------------hhhhhhhhccccCCCCCccccccCCC
Q 026720          207 L---------------------------GIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .                           .+..+...+...++.+|+|+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            2                           33345666778889999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.3e-22  Score=158.64  Aligned_cols=171  Identities=23%  Similarity=0.275  Sum_probs=135.1

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|++.+-..-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ .++..+++|||.
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~---------ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~  154 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE---------YLHGKGIIHRDLKPENILLNEDMHIQITDFGT  154 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHH---------hhccccEEcCcCCccccccCCCceEEeccccc
Confidence            588899999999886665555666666666665 78888         9999999999999999999 467889999999


Q ss_pred             cccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          128 VKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       128 a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      ++.+....   ......+|+.|+|||++.+ ..|+..+|+||+||++|||++|+.||.+....+...++.+.-... +..
T Consensus       155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-p~~  232 (288)
T d1uu3a_         155 AKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEK  232 (288)
T ss_dssp             CEECC----------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC-CTT
T ss_pred             ceecccCCcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC-Ccc
Confidence            98764321   2345678999999999974 458999999999999999999999999988887777776543222 234


Q ss_pred             CcchhhhhhhhccccCCCCCccccccC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      .+.....++..++..++.+|+|+++++
T Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         233 FFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            566778888889999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.9e-23  Score=162.06  Aligned_cols=175  Identities=22%  Similarity=0.224  Sum_probs=130.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .||.+|+..|++.+..+--..++++.+..|..+ +.|+.         ++|+.+++|+|++|+|+++. ....+++|||.
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~---------ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---------YLHGIGITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHcCCccCcccHHHEEECCCCCEEEccchh
Confidence            478899999988765432222344445555544 77777         89999999999999999994 57889999999


Q ss_pred             cccccCC---CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC--CC
Q 026720          128 VKEIDSN---LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSP--TK  202 (234)
Q Consensus       128 a~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~--~~  202 (234)
                      ++.+...   ......++|+.|+|||++.+.+.++..+|+||+|++++||++|++||.+.................  ..
T Consensus       150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~  229 (271)
T d1nvra_         150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW  229 (271)
T ss_dssp             CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred             heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence            9876432   123456789999999999765555778999999999999999999998776655554444332221  12


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ...+.....+...++...+.+|+|+++++++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            3345566677788899999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.86  E-value=8.2e-23  Score=161.22  Aligned_cols=173  Identities=22%  Similarity=0.222  Sum_probs=125.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~~  124 (234)
                      .||.+|+..|++.+...--..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++.    .+..+++|
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~---------ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK---------YLHDLGIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHH---------hhhhceeeeEEecccceeecccCCCceEEEec
Confidence            588899999999876543233444455555555 77777         89999999999999999983    46789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.++...........++|+.|+|||++.+ ..|+..+|+||+||++|||++|..||++....+....+.+....++.  
T Consensus       154 FG~a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  232 (307)
T d1a06a_         154 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY  232 (307)
T ss_dssp             C------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTT
T ss_pred             cceeEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcc
Confidence            999987654434455679999999999874 45899999999999999999999999998888887777765544333  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                       ...+..+..+...++..++.+|+|++++++
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             455667788888899999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=6.6e-23  Score=160.36  Aligned_cols=175  Identities=18%  Similarity=0.303  Sum_probs=137.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|.+|+..|++.+-..-... +++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++. ++..+++|||
T Consensus        85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~---------ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN---------YLHDNKIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCEEEeecChhheeECCCCCEEEEech
Confidence            478899999999876443322 455556666555 78888         99999999999999999994 6778999999


Q ss_pred             ccccccCCC-CCCCcccCccccccccccc----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC--
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLF----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGS--  199 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~--  199 (234)
                      .+....... ......+++.|+|||++..    ...|+.++|+||+||++|||++|+.||.+....+.+.++......  
T Consensus       156 ~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~  235 (288)
T d2jfla1         156 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL  235 (288)
T ss_dssp             TCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred             hhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            987654321 1234678999999999842    345789999999999999999999999999888888877764322  


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +.+..++..+..++..++..++.+|+|+++++++
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2234567788888899999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.85  E-value=1.6e-22  Score=159.09  Aligned_cols=173  Identities=18%  Similarity=0.280  Sum_probs=124.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|.+|+..|++.+...-.. .++...+..|... +.|+.         ++|+.+++|+|++|.|+++ .+..++++|||
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~---------yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK---------YLADMNYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHH---------HHhhCCCccCccccceEEECCCCcEEECCcc
Confidence            57788999999987543211 1222223333322 45555         8899999999999999999 46789999999


Q ss_pred             ccccccCCCCC------CCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 026720          127 MVKEIDSNLPC------TDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       127 ~a~~~~~~~~~------~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      .++.+......      .+..+++.|+|||.+.. ..|+..+|+||+|+++||+++ |++||.+....+....+.+....
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~  252 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL  252 (299)
T ss_dssp             ----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99876543211      12345778999999874 458999999999999999997 89999999888888777776666


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      |.+..+++.+..++..||..++.+||++.+|++
T Consensus       253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~  285 (299)
T d1jpaa_         253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN  285 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            777788899999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.7e-22  Score=157.80  Aligned_cols=172  Identities=20%  Similarity=0.233  Sum_probs=133.1

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .||.+|+..|++.+-..-. ..++.+.+..+... +.|+.         ++|+.+++|+|++|.|+++ ....++++|||
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~---------ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK---------YLEEKNFVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHH---------HHHhCCeecCcCchhheeeccCCceeeccch
Confidence            4788999999987753211 12333344444444 55666         8899999999999999999 57789999999


Q ss_pred             ccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .++.+....    ......+++.|+|||++.. ..|+..+|+||+|+++||+++ |+.||.+....+....+.+....+.
T Consensus       155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~  233 (285)
T d1u59a_         155 LSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC  233 (285)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred             hhhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            998765432    1223456778999999874 348999999999999999997 8999999888777766666555555


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      +..++..+..++..||...+.+||+|.+|.
T Consensus       234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~  263 (285)
T d1u59a_         234 PPECPPELYALMSDCWIYKWEDRPDFLTVE  263 (285)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            677888999999999999999999998875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.85  E-value=9.3e-22  Score=152.93  Aligned_cols=175  Identities=22%  Similarity=0.240  Sum_probs=145.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .||.+|+..|++.+..+--..+++..+..|..+ +.|+.         ++|..+++|+|++|+|+++ .+...+++|||.
T Consensus        86 ~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~---------~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC---------ALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHH---------HHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence            589999999999998765555666677777766 88888         9999999999999999999 467889999999


Q ss_pred             cccccCCCCCCCcccCccccccccccc-----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLF-----SEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +..+..........+++.|.+||.+.+     .+.|+..+|+||+|+++++|++|+.||++....+....+.+....+..
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            998876555566788999999999853     234688999999999999999999999999888888777765433222


Q ss_pred             ---CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 ---DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                         ...++.+..+...++..++.+|+++++++++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               3566778888889999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.3e-21  Score=156.09  Aligned_cols=172  Identities=24%  Similarity=0.269  Sum_probs=135.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|++.+...--..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||.
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~---------ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE---------YLHSRDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhh---------hhhhcCccccccCHHHeEecCCCCEEEeeccc
Confidence            578899999999887665555666666666655 88888         9999999999999999999 467899999999


Q ss_pred             cccccCC-CCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          128 VKEIDSN-LPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       128 a~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ++..... ......++|+.|+|||++.+ ..|+..+|+||+||++|||++|++||.+....+....+...-... +...+
T Consensus       152 a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~-p~~~s  229 (337)
T d1o6la_         152 CKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-PRTLS  229 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-CTTSC
T ss_pred             ccccccCCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC-CccCC
Confidence            9976543 33456789999999999974 458999999999999999999999999988877776665543322 34456


Q ss_pred             chhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          207 LGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      .....+++.+...++.+|++     ++++++
T Consensus       230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            66777777788888888884     555544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=2.1e-22  Score=160.18  Aligned_cols=180  Identities=21%  Similarity=0.273  Sum_probs=131.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--------------h---ccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--------------M---REKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--------------m---~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+|.+||..|++.+..+--..              +   ......++...+.-..+...+.+  ++|+.+++|+|++|.|
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~--yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME--FLEFKSCVHRDLAARN  194 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH--HHHHTTEEETTCSGGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH--HHHhCCeeeccCchhc
Confidence            578899999999887542110              0   01123343333332222222222  8899999999999999


Q ss_pred             EEee-CCeeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 026720          113 LLVS-KGVIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSA  187 (234)
Q Consensus       113 ~~~~-~~~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~  187 (234)
                      +++. ...++++|||.++.......   .....+++.|+|||++.. ..|+..+|+||+|+++|||++ |.+||++....
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9994 67899999999987654322   123456888999999874 458999999999999999997 89999998877


Q ss_pred             HHHHHHHHhhCC-CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGS-PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+.++.+.... +.+..+++.+..++..||...+.+|||+++|++
T Consensus       274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  319 (325)
T d1rjba_         274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  319 (325)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777777665444 345677888999999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=7e-22  Score=155.04  Aligned_cols=173  Identities=19%  Similarity=0.243  Sum_probs=139.3

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CC----eeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KG----VIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~----~~~~~  123 (234)
                      .||.+|+..|++.+..+-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++. ..    ..++.
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~---------yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY---------YLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHH---------hhhhcceeecccccceEEEecCCCcccceEec
Confidence            588899999999887665445555566666555 77887         99999999999999999994 22    47999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      |||.+..+..........+++.|+|||++.+ ..|+..+|+||+|++++||++|+.||.+....+....+.+....+.. 
T Consensus       160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1jksa_         160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE  238 (293)
T ss_dssp             CCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             chhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            9999988765545556678899999999974 45899999999999999999999999998888887777664433322 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                        ...+..+..++..++..++.+|+|++++++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              345667788888899999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.84  E-value=1.4e-21  Score=157.48  Aligned_cols=172  Identities=21%  Similarity=0.301  Sum_probs=132.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|++.+...-...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~---------ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE---------HMHNRFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHH---------HHHHCCccceeeccceeEEcCCCcEEEeeece
Confidence            578899999999887654444555566666655 78888         9999999999999999999 457889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC---CCCCCC
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIG---SPTKDS  204 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~---~~~~~~  204 (234)
                      ++.+... ......+++.|+|||++.....|+..+|+||+||++|||++|+.||.+....+.. .+.+...   .+.+..
T Consensus       154 a~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (364)
T d1omwa3         154 ACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDS  231 (364)
T ss_dssp             CEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSS
T ss_pred             eeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCC
Confidence            9877654 2344678999999999875666899999999999999999999999876543322 2333222   222345


Q ss_pred             CcchhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      ++..+..++..++..++.+|++     ++++++
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            6778888888999999999998     466654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=4.2e-22  Score=153.39  Aligned_cols=174  Identities=17%  Similarity=0.292  Sum_probs=134.1

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|.+|+..|.+.+-...- ..+..+.+..|... +.|+.         ++|+.+++|++++|+|+++. ....+++|||
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~---------~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG  145 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME---------YLESKQFLHRDLAARNCLVNDQGVVKVSDFG  145 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHH---------HHHHTTBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHH---------HHhhcCcccccccceeEEEcCCCcEEECcch
Confidence            4566788888876643211 11222223333323 56666         88999999999999999994 5788999999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .++.+....  ......++..|+|||++.. ..|+..+|+||+|+++||+++ |+.||.+....+...++.+....+.+.
T Consensus       146 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~  224 (258)
T d1k2pa_         146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH  224 (258)
T ss_dssp             SCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             hheeccCCCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            998765432  2223567788999999874 448999999999999999997 789999998888887787776777778


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..++.+..++..||...+.+||||++++++
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            888899999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.83  E-value=2.2e-21  Score=153.57  Aligned_cols=170  Identities=21%  Similarity=0.230  Sum_probs=131.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHH-HHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTI-MISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~-~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|.+.....--...+...+..|.. ++.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||.
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~---------~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~  150 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---------YLHSKDIIYRDLKPENILLDKNGHIKITDFGF  150 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhh---------hhccCcEEccccCchheeEcCCCCEEEecCcc
Confidence            57888999998877655433344444445554 477777         8999999999999999999 467899999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      ++.+...  .....+++.|+|||++.+ ..|+..+|+||+|+++|||++|+.||.+....+...++...-... +...+.
T Consensus       151 a~~~~~~--~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~  226 (316)
T d1fota_         151 AKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-PPFFNE  226 (316)
T ss_dssp             CEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC-CTTSCH
T ss_pred             ceEeccc--cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-CCCCCH
Confidence            9887653  345688999999999874 458999999999999999999999999998888887777643332 344566


Q ss_pred             hhhhhhhhccccCCCCCc-----cccccCC
Q 026720          208 GIQLASNLNWKLPQMGGV-----NLLAVMP  232 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~-----~~~~~~~  232 (234)
                      .+..+.+.++..++.+|+     +++++++
T Consensus       227 ~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            677777777766666664     7777765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.83  E-value=1.7e-21  Score=156.21  Aligned_cols=171  Identities=20%  Similarity=0.254  Sum_probs=135.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+..|.+.....--..+++..+..|... +.|+.         ++|+.+++|+|++|+|+++ ..+..+++|||.
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~---------yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~  187 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHH---------HHHhCCEecCcCCHHHcccCCCCCEEeeecee
Confidence            467788888988776655445666666666666 78888         9999999999999999999 467889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      ++.+...  .....+++.|+|||++.+ ..|+..+|+||+||++|||++|..||.+........++......+ +..++.
T Consensus       188 a~~~~~~--~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~  263 (350)
T d1rdqe_         188 AKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSS  263 (350)
T ss_dssp             CEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-CTTCCH
T ss_pred             eeecccc--cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC-CccCCH
Confidence            9987653  345678999999999974 458999999999999999999999999988877777776654333 345667


Q ss_pred             hhhhhhhhccccCCCCCc-----cccccCCC
Q 026720          208 GIQLASNLNWKLPQMGGV-----NLLAVMPS  233 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~  233 (234)
                      .+..+++.++..++.+|+     ++++++++
T Consensus       264 ~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            777888777877777774     77777653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=9e-22  Score=152.05  Aligned_cols=173  Identities=22%  Similarity=0.308  Sum_probs=122.0

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|.+|+..|++.+-..--.. ++...+..|... +.|+.         ++|..+++|+|++|+|+++. ....+++|||
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~---------~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFG  146 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA---------YLEEACVIHRDLAARNCLVGENQVIKVSDFG  146 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred             EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHH---------hhhccceeecccchhheeecCCCCeEecccc
Confidence            578899999999875332111 111222233333 44555         88999999999999999994 5678999999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .++......  ......++..|+|||++.+ ..|+..+|+||+|+++||+++ +.+||.+....+....+......+.+.
T Consensus       147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~  225 (263)
T d1sm2a_         147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR  225 (263)
T ss_dssp             ------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT
T ss_pred             hheeccCCCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc
Confidence            998765432  1223567788999999874 458999999999999999998 567777777666666676665666677


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..++.+..++..||..++.+||+++++++
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~  254 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLR  254 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            78888999999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=1e-21  Score=154.99  Aligned_cols=174  Identities=31%  Similarity=0.455  Sum_probs=131.0

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .++.+|+..|.+....... ..+++..+..+... +.|+.         ++|+.+++|+|++|+|+++. ....++.+||
T Consensus        91 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~---------yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          91 TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD---------FLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             EEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHH---------HHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence            4556666665554322211 11222233444444 67777         89999999999999999994 5788999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      .+.............+|+.|+|||++.+ ..|+..+|+||+||+++||++|..||++....+.+.++.+..+.|....|+
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            9887665555566789999999999874 458999999999999999999999999999999999999888776654443


Q ss_pred             --------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 --------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                +....+...+...++.+|+|+++++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                      233445666778899999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=8e-22  Score=153.04  Aligned_cols=173  Identities=21%  Similarity=0.355  Sum_probs=129.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHh--hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL--MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~--m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      .+|.+|+..|++.+....-..  ++...+..+... ..|+.         ++|..+++|+|++|.|+++. +..++++||
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~---------~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA---------FIEERNYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH---------HHHhCCcccCccchhheeeecccceeeccc
Confidence            488999999999875322211  222233333333 44555         88999999999999999994 678899999


Q ss_pred             cccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCCC
Q 026720          126 GMVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      |.++.+....  ......++..|+|||++.. ..|+..+|+||+|+++||+++++ ++|++....+....+.+....+.+
T Consensus       154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p  232 (272)
T d1qpca_         154 GLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP  232 (272)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             cceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            9998775432  2334567788999999874 44889999999999999999965 566666666666666555555666


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+++.+..++..||..++.+|||+++|++
T Consensus       233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~  262 (272)
T d1qpca_         233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (272)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            788889999999999999999999998753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.83  E-value=6.5e-22  Score=158.76  Aligned_cols=174  Identities=17%  Similarity=0.226  Sum_probs=136.9

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~  124 (234)
                      .||.+|+..|++.+...-.. .+++..+..|... +.|+.         ++|+.+++|+|++|+|+++.   ....+++|
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~---------ylH~~~iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK---------HMHEHSIVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHCCeeecccccccccccccCCCeEEEee
Confidence            47888999999866422111 2333444555444 78888         99999999999999999994   45789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC--
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK--  202 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~--  202 (234)
                      ||.+..+..........+++.|+|||++.+ ..|+..+|+||+||++|+|++|..||.+....+.+.++.+....++.  
T Consensus       173 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  251 (352)
T d1koba_         173 FGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA  251 (352)
T ss_dssp             CTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred             cccceecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            999998766544455678899999999874 45899999999999999999999999999988888888775544443  


Q ss_pred             -CCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 -DSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                       ...+..+..++..++..++.+|+|+++++++
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             3455677778888999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.83  E-value=5.2e-22  Score=159.21  Aligned_cols=173  Identities=17%  Similarity=0.226  Sum_probs=136.4

Q ss_pred             HHHHHHhhcCChHHHHH-HHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEee
Q 026720           50 ALVEMYSKCGHVEKAFK-VFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIGD  124 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~-~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~~  124 (234)
                      .||.+|+..|++.+... -...+++..+..|... +.|+.         ++|+.+++|+|++|+|+++.   .+..+++|
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~---------ylH~~~iiHrDiKp~NIll~~~~~~~vkL~D  169 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC---------HMHENNYVHLDLKPENIMFTTKRSNELKLID  169 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHhcCCeeeeechhHeeeccCCCCeEEEee
Confidence            47888999999876542 1122444455555555 77888         99999999999999999994   35789999


Q ss_pred             ccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC-
Q 026720          125 LGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD-  203 (234)
Q Consensus       125 ~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~-  203 (234)
                      ||.++.+..........+++.|+|||++.+ ..|+..+|+||+||++++|++|+.||.+....+.+..+...-..++.. 
T Consensus       170 FG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         170 FGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             CTTCEECCTTSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG
T ss_pred             cchheecccccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence            999998776555556788999999999874 457899999999999999999999999998888888887655444443 


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                        ..++.+..++..++..++.+|+|++++++
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              34456677788888999999999999865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=8.1e-22  Score=156.61  Aligned_cols=173  Identities=28%  Similarity=0.395  Sum_probs=125.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhc-ccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~-~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|.+|+..|++.+...-...+++..+..+..+ +.|+.         ++|+. +++|+|++|+|+++ ..+..+++|||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~---------yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---------YLREKHKIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHH---------HHHHhCCEEccccCHHHeeECCCCCEEEeeCC
Confidence            578899999999887654444555555555544 77777         89964 79999999999999 46789999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhhC-------
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQ-IYKICQLIG-------  198 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~-~~~i~~~~~-------  198 (234)
                      .|+.+.... ....+++++|+|||++.+ ..|+..+|+||+||+++||++|+.||.+....+. ........+       
T Consensus       151 la~~~~~~~-~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  228 (322)
T d1s9ja_         151 VSGQLIDSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  228 (322)
T ss_dssp             CCHHHHHHT-C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred             CccccCCCc-cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence            999765432 345689999999999985 4589999999999999999999999987543321 111111000       


Q ss_pred             -------------------------------CC----CCCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          199 -------------------------------SP----TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       199 -------------------------------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                     .+    +...++..+..+...+...++.+|+|+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                           00    112344566667778889999999999998764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=2.6e-21  Score=152.16  Aligned_cols=173  Identities=18%  Similarity=0.308  Sum_probs=126.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh----------------ccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM----------------REKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m----------------~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+|.+||..|++.+..+--...                +...+..|... +.|+.         ++|+.+++|+|++|+|
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~---------ylH~~~ivHrDlKp~N  164 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME---------FLASRKCIHRDLAARN  164 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGG
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHH---------HHHhCCCcCCcCCccc
Confidence            4678899999999876543321                11223333333 55666         8999999999999999


Q ss_pred             EEe-eCCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhC-CCCCCCCChH
Q 026720          113 LLV-SKGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSF-GILFPGKSSA  187 (234)
Q Consensus       113 ~~~-~~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~-~~~f~~~~~~  187 (234)
                      +++ ....++++|||.++......   ......+++.|+|||++.+ ..|+..+|+||+|+++|||+++ .+||++....
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999 46789999999998654332   2334568889999999974 4589999999999999999986 5789887766


Q ss_pred             HHHHHHHHhhCC-CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          188 DQIYKICQLIGS-PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       188 ~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.+.++...... +.+..++..+..++..||..++.+|+|++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~  289 (299)
T d1ywna1         244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  289 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            666666554433 344567788889999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=9.2e-21  Score=150.19  Aligned_cols=173  Identities=24%  Similarity=0.256  Sum_probs=136.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      ..+|.+|+..|++.+-.+-...+++..+..|... +.|+.         ++|+.+++|+|++|.|+++. .+..++++||
T Consensus        78 ~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~---------ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ---------FLHSKGIVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH---------HHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeccCcccceeecCCCceeccccc
Confidence            4688999999999987765555655556666555 77888         99999999999999999994 5778999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .++...... ......+++.|+|||++.+ ..|+..+|+||+||++|||++|+.||.+........++...- .+-+...
T Consensus       149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~  226 (320)
T d1xjda_         149 MCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWL  226 (320)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTS
T ss_pred             hhhhcccccccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccC
Confidence            998765432 3344678999999999984 458999999999999999999999999888777766665432 2223455


Q ss_pred             cchhhhhhhhccccCCCCCcccc-ccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLL-AVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~  232 (234)
                      +..+..+++.++..++.+|++++ +++.
T Consensus       227 s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         227 EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            77888888889999999999986 5653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=3e-21  Score=149.88  Aligned_cols=173  Identities=20%  Similarity=0.298  Sum_probs=125.2

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|.+|+..|.+.+....-. .++...+..+... +.|+.         ++|+.+++|+|++|+|+++ .....+++|||
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~---------ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA---------YLESKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhh---------hhcccCeeccccchhheeecCCCcEEEccch
Confidence            57888888888876533211 1222334444444 56666         8999999999999999999 56789999999


Q ss_pred             ccccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          127 MVKEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       127 ~a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      .++.+....  ......+++.|+|||++.+ ..|+..+|+||+|+++|||++ |.+||.+....+...++.+....+.+.
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~  232 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  232 (273)
T ss_dssp             -----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             hheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            998764322  2233456788999999874 458899999999999999997 889999988888887777665566677


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+++.+..++..||...+.+|||+++|+.
T Consensus       233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~  261 (273)
T d1mp8a_         233 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  261 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            88889999999999999999999998864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=5.3e-21  Score=149.20  Aligned_cols=173  Identities=20%  Similarity=0.345  Sum_probs=117.8

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|.+|+..|.+.+...-.. .++...+..+... ..|+.         ++|+.+++|+|++|.|+++ .+..++++|||
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~---------~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK---------YLANMNYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhh---------hccccccccCccccceEEECCCCeEEEcccc
Confidence            45667787777766432211 1111222333333 44555         8899999999999999999 46789999999


Q ss_pred             ccccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCC
Q 026720          127 MVKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPT  201 (234)
Q Consensus       127 ~a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~-f~~~~~~~~~~~i~~~~~~~~  201 (234)
                      .++.+....    ......++..|+|||++.+ ..|+..+|+||+|+++||++++..| +.+....+....+.+....+.
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~  234 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  234 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC
Confidence            998764422    1223456778999999874 4589999999999999999996655 444444444444444445566


Q ss_pred             CCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +..++..+..++..||...+.+||++.+|+.
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            6778889999999999999999999998863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=7e-22  Score=157.66  Aligned_cols=173  Identities=22%  Similarity=0.242  Sum_probs=128.3

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeE
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKI  122 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~  122 (234)
                      .+|.+||..|++.+...-.  ..+++..+..|... +.|+.         ++|+.+++|+|++|.|+++.    ....++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~---------ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ---------YLHSINIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHH---------HHHHcCCccccccccccccccccccccccc
Confidence            7899999999998865421  12344445555555 77888         99999999999999999994    346899


Q ss_pred             eeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          123 GDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       123 ~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +|||.++............+++.|+|||++.+ ..|+..+|+||+||++|+|++|+.||++.........+.........
T Consensus       156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~  234 (335)
T d2ozaa1         156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  234 (335)
T ss_dssp             CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred             cccceeeeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence            99999998766555566789999999999874 45899999999999999999999999987766655555443332111


Q ss_pred             -------CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 -------DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                             ..+++.+..++..+...++.+|++++++++
T Consensus       235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   124456677778888999999999998864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.81  E-value=6.1e-21  Score=149.06  Aligned_cols=172  Identities=16%  Similarity=0.304  Sum_probs=125.9

Q ss_pred             HHHHHHhhcCChHHHHHHH--HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVF--NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~--~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~  125 (234)
                      .++.+|+..|++.+...--  ..+++..+..+... +.|+.         ++|+.+++|+|++|+|+++ ..+.++++||
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~---------yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME---------YLEKKNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHH---------HHHHCCcccCccccCeEEECCCCcEEEccc
Confidence            4778899999988764321  11111222333322 55666         8899999999999999999 4678899999


Q ss_pred             cccccccCCCC--CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-hhCCCCC
Q 026720          126 GMVKEIDSNLP--CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ-LIGSPTK  202 (234)
Q Consensus       126 ~~a~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~-~~~~~~~  202 (234)
                      |.++.......  ..+..++..|+|||++.+ ..|+..+|+||+|+++||++++..||.+..+...+.++.. ....+.+
T Consensus       160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~  238 (287)
T d1opja_         160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  238 (287)
T ss_dssp             CCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             cceeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence            99987654321  223346678999999874 4589999999999999999997766555555555555444 3344556


Q ss_pred             CCCcchhhhhhhhccccCCCCCccccccC
Q 026720          203 DSWPLGIQLASNLNWKLPQMGGVNLLAVM  231 (234)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (234)
                      ..+++.+..++..||..++.+|+|+++++
T Consensus       239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~  267 (287)
T d1opja_         239 EGCPEKVYELMRACWQWNPSDRPSFAEIH  267 (287)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            67888999999999999999999998875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=6.4e-21  Score=151.07  Aligned_cols=172  Identities=17%  Similarity=0.287  Sum_probs=126.4

Q ss_pred             HHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           51 LVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      ++.+|+..|.+.+....- ..++...+..|... +.|+.         ++|+.+++|+|++|.|+++ .....+++|||.
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~---------yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN---------YLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHH---------HHHHcCcccCcchhhcceeCCCCCeEeecccc
Confidence            455677777776543221 11222223333333 55666         8899999999999999999 567899999999


Q ss_pred             cccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          128 VKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       128 a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      ++.+.....   .....++..|+|||++.+ ..|+..+|+||+|+++||+++ |.+||.+....+....+.+....+.+.
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~  236 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  236 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred             ceecccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            987654321   223457889999999874 458999999999999999998 789998877666655555555556667


Q ss_pred             CCcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 SWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .++..+..++..||..++.+||++.+|+.
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~  265 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELII  265 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence            88889999999999999999999998864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2e-20  Score=150.12  Aligned_cols=175  Identities=26%  Similarity=0.441  Sum_probs=134.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHh---hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-C-CeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL---MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-K-GVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~---m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~-~~~~~~  123 (234)
                      .||.+|+..|...........   +++..+..|... +.|+.         ++|+.+++|+|++|+|+++. . ...+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~---------yLH~~~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA---------YIHSFGICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCCGGGEEECTTTCCEEEC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHH---------HHHhcCCcccCCCcceEEEecCCCceeEe
Confidence            467888887765555443222   333345555555 77888         99999999999999999995 3 378999


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD  203 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~  203 (234)
                      |||.+..+..........+++.|.+||.+.+...|+..+|+||+||+++|+++|++||++....+++.++++..+.+...
T Consensus       166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            99999987665556667889999999998766678999999999999999999999999999999998888766654311


Q ss_pred             ----------------------------CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 ----------------------------SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                  ..+.....+...+...++.+|+|+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                        122334455666778888899999998754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=8.1e-21  Score=147.33  Aligned_cols=173  Identities=20%  Similarity=0.334  Sum_probs=130.8

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|.+|+..|.+.+...... .++......+... +.|+.         ++|+.+++|+|++|.|+++ ....++++|||
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~---------ylH~~~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG---------YLESKRFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHH---------HhhhCCEeeeeecHHHhccccccceeeccch
Confidence            57888999998877544321 2333333333333 55555         8899999999999999999 56789999999


Q ss_pred             ccccccCCCC----CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC-C
Q 026720          127 MVKEIDSNLP----CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGS-P  200 (234)
Q Consensus       127 ~a~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~-~  200 (234)
                      .++.+.....    .....++..|+|||.+.+ ..|+..+|+||+|+++|||++ |+.||.+....+...++.+.... +
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP  235 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            9998644321    223345668999999874 458899999999999999997 89999999888888887765433 4


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..++..+..++..||..++.+||||++|++
T Consensus       236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            45678889999999999999999999998753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2.1e-20  Score=146.85  Aligned_cols=175  Identities=30%  Similarity=0.488  Sum_probs=133.7

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~  126 (234)
                      .+|.+|+..+.+....... ..+++..+..|... +.|+.         ++|+.+++|+|++|.|+++ .....+++|||
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~---------yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---------FCHSHRVLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHH---------HhhcCCEEccccCchheeecccCcceeccCC
Confidence            4666676654443322211 12444455556555 78887         9999999999999999999 45678999999


Q ss_pred             ccccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          127 MVKEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       127 ~a~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      .++...... ......+++.|.+||+......++..+|+||+|+++++|++|+.||++....+.+.++++..+.|+...|
T Consensus       148 ~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  227 (298)
T d1gz8a_         148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  227 (298)
T ss_dssp             HHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence            998765432 3345678899999999876666789999999999999999999999999999999999998888877666


Q ss_pred             cch----------------------------hhhhhhhccccCCCCCccccccCCC
Q 026720          206 PLG----------------------------IQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      +..                            +..+...+...++.+|+|+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            532                            2335556777788999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.79  E-value=1.5e-20  Score=146.19  Aligned_cols=172  Identities=18%  Similarity=0.241  Sum_probs=128.4

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      .||.+|+..|.+.+...-...+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++. ....++.+++.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~---------~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN---------FSHQNGIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHH---------HHHhCCccCccccCcccccCccccceeehhhh
Confidence            488999999999886655555665566666655 77787         89999999999999999994 56778899988


Q ss_pred             cccccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          128 VKEIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       128 a~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      +.......    ......+++.|+|||++.+ ..|+..+|+||+|++++||++|.+||++....+.+.++.+.-..+.. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  236 (277)
T ss_dssp             CEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG
T ss_pred             hhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch
Confidence            76553322    2334578999999999874 45889999999999999999999999999888888777765444332 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCc-cccccC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGV-NLLAVM  231 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  231 (234)
                        ..+++.+..+...++..++.+|+ +.+++.
T Consensus       237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~  268 (277)
T d1o6ya_         237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMR  268 (277)
T ss_dssp             TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence              35567788888888888889998 777654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.2e-20  Score=145.67  Aligned_cols=176  Identities=19%  Similarity=0.308  Sum_probs=124.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV  128 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a  128 (234)
                      .+|.+|+..|.+......-.    ....+|...+....+...+..  ++|..+++|+|++|.|+++. +..++++|||.+
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~--~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMA--YVERMNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHH--HHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEEEecCCCchhhhhhhcc----cccchHHHHHHHHHHHHHHHH--HHhhhheecccccceEEEECCCCcEEEcccchh
Confidence            47889999998776533211    112344333333332222222  88888999999999999994 567899999999


Q ss_pred             ccccCCC--CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          129 KEIDSNL--PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       129 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      +.+....  ......+++.|+|||++.. ..++..+|+||+|+++||+++++ +++.+....+.+..+.+....+.+..+
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~  239 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC  239 (285)
T ss_dssp             C--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             hhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCccc
Confidence            8764322  2233467788999999874 45799999999999999999865 566666666666666666666777888


Q ss_pred             cchhhhhhhhccccCCCCCccccccCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++.+..++..||...+.+|+++++|++
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~  266 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQA  266 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            899999999999999999999998753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=3.1e-20  Score=145.94  Aligned_cols=180  Identities=19%  Similarity=0.284  Sum_probs=128.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhh----------ccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLM----------REKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m----------~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~  118 (234)
                      .+|.+|+..|++.+...--...          ......++...+..+.+...+.+  ++|+.+++|+|++|+|+++ ...
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~--ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME--YLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHH--HHHHTTCCCSCCSGGGEEECTTC
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHH--HhhhCCEEeeeecccceeecCCC
Confidence            4678899999998875421100          00122333333333222222222  8899999999999999999 467


Q ss_pred             eeeEeeccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 026720          119 VIKIGDLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKIC  194 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~  194 (234)
                      ..+++++|.+........   .....+++.|+|||.+.. ..|+..+|+||+|+++||+++ |.+||.+.........+.
T Consensus       173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~  251 (299)
T d1fgka_         173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  251 (299)
T ss_dssp             CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence            889999999987754332   223466778999999874 558999999999999999997 678888777665554444


Q ss_pred             HhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          195 QLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +....+.+..+++.+..++..|+...+.+|||+.+++.
T Consensus       252 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            44444455677888999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.4e-20  Score=145.13  Aligned_cols=171  Identities=20%  Similarity=0.329  Sum_probs=126.4

Q ss_pred             HHHHHHhhcCChHHHHHHHH--hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeec
Q 026720           50 ALVEMYSKCGHVEKAFKVFN--LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~--~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~  125 (234)
                      ++|.+|+..|++.+-..--.  .++.+.+..+... ..|+.         ++|+.+++|++++|+|+++. .+..++++|
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~---------ylH~~~ivH~dlkp~Nil~~~~~~~kl~df  147 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME---------YLEGNNFVHRDLAARNVLVSEDNVAKVSDF  147 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcc---------ccccCceeccccchHhheecCCCCEeeccc
Confidence            58899999999988754321  1333333444443 45555         88999999999999999994 677899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKSSADQIYKICQLIGSPTKDS  204 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~~~~~~~~i~~~~~~~~~~~  204 (234)
                      |.++.....  .....++..|+|||++.. ..|+..+|+||+|+++||+++ |++||.+....+....+.+....+.+..
T Consensus       148 g~s~~~~~~--~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~  224 (262)
T d1byga_         148 GLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  224 (262)
T ss_dssp             CC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred             ccceecCCC--CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            999876553  233456778999999874 458999999999999999998 6888888777777766766555566677


Q ss_pred             CcchhhhhhhhccccCCCCCccccccCC
Q 026720          205 WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ++..+..++..||..++.+|||+.++++
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            8889999999999999999999998864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=6.8e-21  Score=151.05  Aligned_cols=174  Identities=15%  Similarity=0.192  Sum_probs=135.9

Q ss_pred             HHHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee---CCeeeEe
Q 026720           49 TALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS---KGVIKIG  123 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~---~~~~~~~  123 (234)
                      -.||.+||..|++.+...-.. .+++..+..|... +.|+.         ++|+.+++|+|++|.|+++.   ....++.
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~---------yLH~~~iiHrDlKp~NIll~~~~~~~ikl~  146 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ---------FLHSHNIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH---------HHHHcCCCcccccccceeecCCCceEEEEc
Confidence            368889999998877543211 2334445555555 78888         99999999999999999994   2357899


Q ss_pred             eccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC-
Q 026720          124 DLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK-  202 (234)
Q Consensus       124 ~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~-  202 (234)
                      |||.+.............+++.|.+||...+ ..|+..+|+||+||++|+|++|..||.+....+...++.+....++. 
T Consensus       147 DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH
T ss_pred             ccchhhccccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh
Confidence            9999988765444445567889999999864 45889999999999999999999999999888888888775544443 


Q ss_pred             --CCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          203 --DSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                        ...+..+..+...+...++.+|++++++++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              245666778888899999999999998864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.2e-20  Score=149.02  Aligned_cols=180  Identities=21%  Similarity=0.283  Sum_probs=131.2

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhc----------cCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMR----------EKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKG  118 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~----------~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~  118 (234)
                      .+|..|+..|++.+..+.-..+.          .....++...+.-..+..++.+  ++|+.+++|+|++|+|+++ ...
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~--~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD--YLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH--HHHHTTEECSCCSGGGEEECGGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHH--hhhcCCccccccccceEEEcCCC
Confidence            56788899999988754321110          1123344333333332222222  7888899999999999999 456


Q ss_pred             eeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhh
Q 026720          119 VIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLI  197 (234)
Q Consensus       119 ~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~~  197 (234)
                      ..+++|||.++............++..|.+||.+.. ..|+..+|+||+|+++|||++|. +||.+....+....+.+..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            789999999987665554455567889999999974 44889999999999999999965 6788877777666666555


Q ss_pred             CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          198 GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+.+..+++.+..++..||...+.+||+++++++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~  278 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  278 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            55556778889999999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.78  E-value=3.4e-20  Score=144.82  Aligned_cols=174  Identities=29%  Similarity=0.469  Sum_probs=127.5

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a  128 (234)
                      ++..|+..+.+....+-...+++..+..+... +.|+.         ++|+.+++|+|++|.|+++ .+...+++|||.+
T Consensus        77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~---------~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a  147 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA---------YCHDRRVLHRDLKPQNLLINREGELKIADFGLA  147 (286)
T ss_dssp             EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred             EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHH---------HhccCcEEecCCCCceeeEcCCCCEEecccccc
Confidence            44445555544443332333444444455544 77777         8999999999999999999 4678899999999


Q ss_pred             ccccCCCC-CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCcc
Q 026720          129 KEIDSNLP-CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWPL  207 (234)
Q Consensus       129 ~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  207 (234)
                      ........ .....+++.|.+||.+.+...++..+|+||+|++++||++|+.||.+....++..++++..+.|....|..
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence            87654332 33456788899999987666789999999999999999999999999999999999998888877666543


Q ss_pred             h----------------------------hhhhhhhccccCCCCCccccccCCC
Q 026720          208 G----------------------------IQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       208 ~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      .                            +..+.+.+...++.+|+|+++++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2                            2234556677788999999988764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=3.9e-20  Score=146.60  Aligned_cols=175  Identities=29%  Similarity=0.443  Sum_probs=130.6

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++..|+..|.+.........++...+..+..+ +.|+.         ++|+.+++|+|++|.|+++ .+...++++||.
T Consensus        93 ~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~---------~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          93 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY---------YIHRNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             EEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHH---------HhccCCEEecCcCchheeecCCCcEEeeecce
Confidence            356667776666544333333333344444443 66776         8999999999999999999 467889999999


Q ss_pred             cccccCCC-----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC
Q 026720          128 VKEIDSNL-----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK  202 (234)
Q Consensus       128 a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~  202 (234)
                      +..+....     .....++++.|+|||++.+...|+.++|+||+|++++|+++|+.||.+....+.+..+.+..+.++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654211     2334578999999999876667899999999999999999999999999999999999988887776


Q ss_pred             CCCcch-------------------------------hhhhhhhccccCCCCCccccccCCC
Q 026720          203 DSWPLG-------------------------------IQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 ~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ..+...                               ...++..+...++.+|+|+++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            554321                               1234556777889999999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.77  E-value=8.7e-20  Score=143.49  Aligned_cols=135  Identities=24%  Similarity=0.413  Sum_probs=109.1

Q ss_pred             HhhhcccccCCcCCCcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHH
Q 026720           97 SLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMF  172 (234)
Q Consensus        97 ~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~  172 (234)
                      ++|..+++|+|++|.|+++. +..++++|||.++.+....   ......+++.|+|||.+.+ ..|+..+|+||+|+++|
T Consensus       155 ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~  233 (301)
T d1lufa_         155 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLW  233 (301)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred             hcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHH
Confidence            78888999999999999994 5678999999998654321   2223456788999999974 45899999999999999


Q ss_pred             HHHhCC-CCCCCCChHHHHHHHHHhhCCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          173 EMLSFG-ILFPGKSSADQIYKICQLIGSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       173 e~~~~~-~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ||+++. +||.+....+....+.+....+.+...+..+..++..||...+.+||||.+|.+
T Consensus       234 ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         234 EIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999986 789888888877777665544556677888889999999999999999998853

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.1e-19  Score=140.91  Aligned_cols=167  Identities=19%  Similarity=0.260  Sum_probs=122.9

Q ss_pred             HHHHHHhhc-CChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEeec
Q 026720           50 ALVEMYSKC-GHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIGDL  125 (234)
Q Consensus        50 ~li~~~~~~-g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~  125 (234)
                      .+|.+|+.. +++.+..+--..+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++.  ....+++||
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~---------~lH~~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHH---------HHHHCCCccccCcccceEEecCCCeEEECcc
Confidence            355556543 344443333333444455556555 77777         89999999999999999995  357899999


Q ss_pred             cccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCC
Q 026720          126 GMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSW  205 (234)
Q Consensus       126 ~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~  205 (234)
                      |.+...... ......+|+.|+|||++.+.+.++..+|+||+||++|||++|+.||.+..      .+.+.. ..-+...
T Consensus       156 G~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~-~~~~~~~  227 (273)
T d1xwsa_         156 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQRV  227 (273)
T ss_dssp             TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC-CCCSSCC
T ss_pred             ccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc-cCCCCCC
Confidence            999876543 23456789999999998766656778999999999999999999997632      222222 2233456


Q ss_pred             cchhhhhhhhccccCCCCCccccccCCC
Q 026720          206 PLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                      ++.+..++..++..++.+|+|+++++++
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            7788888899999999999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.1e-19  Score=141.92  Aligned_cols=173  Identities=19%  Similarity=0.340  Sum_probs=130.8

Q ss_pred             HHHHHHhhcCChHHHHHHHHh------------------hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCC
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL------------------MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKP  110 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~------------------m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p  110 (234)
                      .+|.+|+..|++.+..+-...                  +...++..|... +.|+.         ++|..+++|+|++|
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~---------~LH~~~ivHrDLKp  173 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA---------FLASKNCIHRDLAA  173 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSG
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH---------HHHhCCeeeccccc
Confidence            568889998988876543221                  111223333333 55666         89999999999999


Q ss_pred             CcEEee-CCeeeEeeccccccccCCC---CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 026720          111 SNLLVS-KGVIKIGDLGMVKEIDSNL---PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLS-FGILFPGKS  185 (234)
Q Consensus       111 ~~~~~~-~~~~~~~~~~~a~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~-~~~~f~~~~  185 (234)
                      .|+++. ....+++|||.++......   ......+++.|+|||++. ...++..+|+||+|+++|||++ |.++|.+..
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999994 6788999999998765422   223356788899999987 3458999999999999999998 667787777


Q ss_pred             hHHHHHHHHHhh-CCCCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          186 SADQIYKICQLI-GSPTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       186 ~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      ..+.+.++.+.. ..+.+..+++.+..++..||..++.+||+|++|+.
T Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777777766543 34445678899999999999999999999998763

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=1.4e-19  Score=142.75  Aligned_cols=173  Identities=17%  Similarity=0.211  Sum_probs=122.6

Q ss_pred             HHHHHHhhcCChHHHHHHHH-hhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFN-LMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~-~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~  126 (234)
                      .+|..|+..|.+.+-..-.. ..+......+... ..|+.         ++|..+++|+|++|+|+++. ...++++|||
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~---------~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK---------FLASKKFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhh---------hhcccCcccCCccHHhEeECCCCCEEEeccc
Confidence            47788999998877532110 0111112222222 34444         78888999999999999994 5778999999


Q ss_pred             ccccccCCC-----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCC
Q 026720          127 MVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKS-SADQIYKICQLIGSP  200 (234)
Q Consensus       127 ~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~-~~~~~~~i~~~~~~~  200 (234)
                      .++.+....     ......++..|.+||.+.. ..++..+|+||+|+++||+++++.||.... ..+....+.+....+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~  254 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL  254 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC
T ss_pred             chhhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            998764432     2223457788999999873 458999999999999999999776666543 444444455554455


Q ss_pred             CCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          201 TKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      .+..+++.+..++..||..++.+||++.+|++
T Consensus       255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  286 (311)
T d1r0pa_         255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  286 (311)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            56677889999999999999999999998864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=5e-19  Score=141.75  Aligned_cols=170  Identities=33%  Similarity=0.479  Sum_probs=126.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|..|+. +++....+ -..+++..+..+... +.|+.         ++|+.+++|+|++|+|+++ .....+++|||.
T Consensus        99 ~lv~e~~~-~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~---------~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          99 YLVMPFMG-TDLGKLMK-HEKLGEDRIQFLVYQMLKGLR---------YIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             EEEEECCS-EEHHHHHH-HCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccc-ccHHHHHH-hccccHHHHHHHHHHHHHHHH---------HHHhCCCcccccCcchhhcccccccccccccc
Confidence            45556662 23333221 123444455555555 77888         8999999999999999999 467889999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC----
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD----  203 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~----  203 (234)
                      +......  .....+++.|+|||++.+...++..+|+||+||++++|++|++||.+....+.+..+....+.++..    
T Consensus       168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            9987664  3456789999999998766667899999999999999999999999999888888887766654321    


Q ss_pred             -------------------C-------CcchhhhhhhhccccCCCCCccccccCC
Q 026720          204 -------------------S-------WPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       204 -------------------~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                                         .       .+.....++..+...++.+|+|+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                               1       1223334566677888899999998864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=2.6e-18  Score=137.42  Aligned_cols=172  Identities=30%  Similarity=0.475  Sum_probs=129.3

Q ss_pred             HHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccccc
Q 026720           52 VEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVK  129 (234)
Q Consensus        52 i~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~a~  129 (234)
                      +.+|+..|++.+... ...+++..+..+... +.|+.         ++|+.+++|+|++|+|+++ .....++.|||.+.
T Consensus        88 l~~~~~~g~L~~~l~-~~~l~~~~i~~i~~qil~al~---------yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          88 LVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLK---------YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEECCCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEeecCCchhhhhh-cCCCCHHHHHHHHHHHHHHHH---------HHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            446777788876653 234555566666665 67777         9999999999999999999 46788999999988


Q ss_pred             cccCCC----CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCC---
Q 026720          130 EIDSNL----PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTK---  202 (234)
Q Consensus       130 ~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~---  202 (234)
                      ......    .....++++.|+|||++.....|+..+|+||+|+++++|++|+.||++....+...........++.   
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            654321    2344568889999999866667899999999999999999999999998888777776554444321   


Q ss_pred             --------------------C-------CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          203 --------------------D-------SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       203 --------------------~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                          .       ..+..+..+...+...++..|+++++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                1       222334456666778899999999998764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=6.2e-19  Score=138.96  Aligned_cols=181  Identities=18%  Similarity=0.258  Sum_probs=133.0

Q ss_pred             HHHHHHHhhcCChHHHHHHHHhhc----cCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEe
Q 026720           49 TALVEMYSKCGHVEKAFKVFNLMR----EKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIG  123 (234)
Q Consensus        49 ~~li~~~~~~g~~~~a~~~~~~m~----~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~  123 (234)
                      ..+|..|+..|++.+-......-.    .....+++.++....+..++..  ++|...++|++++|+|+++. ...++++
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~--~LH~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA--YLNANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH--HHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHH--HHhhCCeeeceEcCCceeecCCceEEEe
Confidence            457788999999887655432211    1122344444333332222222  78888899999999999994 5678999


Q ss_pred             eccccccccCCCC---CCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCC
Q 026720          124 DLGMVKEIDSNLP---CTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFG-ILFPGKSSADQIYKICQLIGS  199 (234)
Q Consensus       124 ~~~~a~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~-~~f~~~~~~~~~~~i~~~~~~  199 (234)
                      |||.++.+.....   .....+++.|++||.+.+ ..|+..+|+||+|+++|||+++. +||.+....+....+.+....
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~  254 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL  254 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9999986644321   223457788999999874 45788999999999999999985 888888877777777665555


Q ss_pred             CCCCCCcchhhhhhhhccccCCCCCccccccCC
Q 026720          200 PTKDSWPLGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                      +.+...++.+..++..||...+.+|||+++|++
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            556777888999999999999999999998864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=3.1e-18  Score=133.85  Aligned_cols=174  Identities=26%  Similarity=0.483  Sum_probs=124.6

Q ss_pred             HHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeecccc
Q 026720           51 LVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV  128 (234)
Q Consensus        51 li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~a  128 (234)
                      ++..|+..+.+.........+++..+..|... +.|+.         ++|..+++|+|++|+|+++. ....+++|||.+
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~---------~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a  148 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG---------FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA  148 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHH---------HhhcCCEeeecccCcccccccCCceeeeecchh
Confidence            44455555555444333333333344455555 67777         89999999999999999994 667899999999


Q ss_pred             ccccCCC-CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCCCCCCc
Q 026720          129 KEIDSNL-PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGIL-FPGKSSADQIYKICQLIGSPTKDSWP  206 (234)
Q Consensus       129 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~-f~~~~~~~~~~~i~~~~~~~~~~~~~  206 (234)
                      ....... ......+++.|.+||++.....++..+|+||+||+++||++|+.| |++.+..+...++....+.+....|+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred             hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence            8876533 233345667889999887666678999999999999999998866 56666677777787777776655443


Q ss_pred             ----------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 ----------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                  .....+...+...++.+|+|+++++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                        122334555677789999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.71  E-value=5.8e-19  Score=138.58  Aligned_cols=170  Identities=18%  Similarity=0.205  Sum_probs=116.6

Q ss_pred             HHHHHHhhcCChHHHHHHH-HhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee----CCeeeEe
Q 026720           50 ALVEMYSKCGHVEKAFKVF-NLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS----KGVIKIG  123 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~-~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~----~~~~~~~  123 (234)
                      .++..|+. |.+....... ..++...+..+... +.|+.         ++|+.+++|+|++|+|+++.    ...+++.
T Consensus        79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~---------~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~  148 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIE---------YIHSKNFIHRDVKPDNFLMGLGKKGNLVYII  148 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHH---------HHHHCCeeeccCCHhhccccccCCCceeeee
Confidence            34555553 4444332221 12333344445444 66777         89999999999999999873    3468999


Q ss_pred             eccccccccCCC--------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 026720          124 DLGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQ  195 (234)
Q Consensus       124 ~~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~  195 (234)
                      |||.++.+....        ......+++.|+|||+..+ ..|+..+|+||+|++++|+++|+.||.+....+....+.+
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             ccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            999998764322        1234578999999999874 4489999999999999999999999998765554444322


Q ss_pred             h----hCCCC---CCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          196 L----IGSPT---KDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       196 ~----~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      .    +..|.   ...++..+..++..|+..++.+||+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i  269 (299)
T d1ckia_         228 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  269 (299)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred             hhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1    12222   24677788889999999999999998765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.71  E-value=1.4e-18  Score=138.17  Aligned_cols=172  Identities=18%  Similarity=0.327  Sum_probs=127.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee--CCeeeEeecc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS--KGVIKIGDLG  126 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~--~~~~~~~~~~  126 (234)
                      .+|.+|+..|++...   .+.+++..+..+... +.|+.         ++|+.+++|+|++|+|+++.  ....+++|||
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~---------~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALD---------YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHH---------HHHHTTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHH---------HHhhcccccccccccceEEcCCCCeeeecccc
Confidence            457788888887653   234455555556555 77888         99999999999999999995  3467999999


Q ss_pred             ccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhhCCCC----
Q 026720          127 MVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGK-SSADQIYKICQLIGSPT----  201 (234)
Q Consensus       127 ~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~-~~~~~~~~i~~~~~~~~----  201 (234)
                      .+..+..........+++.|.|||...+...|+..+|+||+||+++++++|+.||... ...++...+.+..+.+.    
T Consensus       176 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         176 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             GCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             cceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            9988766555666788999999999887777899999999999999999999988754 44555555554433110    


Q ss_pred             --------------------------------CCCCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          202 --------------------------------KDSWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       202 --------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                      ....+.....+++.+...++.+|+|+++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                            01112233445666778899999999998764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=9e-18  Score=132.94  Aligned_cols=174  Identities=20%  Similarity=0.265  Sum_probs=131.7

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .++.+|+..|++.+..+-...+++..+..|..+ +.|+.         ++|+.+++|+|++|+|+++ ..+..++.|||.
T Consensus       105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~---------~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE---------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHH---------HhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence            466788899999888776666665566666554 77777         8999999999999999999 467889999999


Q ss_pred             cccccCCC--CCCCcccCccccccccccccc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh---CCCC
Q 026720          128 VKEIDSNL--PCTDYVTTRWYRGPEVLLFSE-IYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLI---GSPT  201 (234)
Q Consensus       128 a~~~~~~~--~~~~~~~~~~~~~pe~~~~~~-~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~---~~~~  201 (234)
                      ++.+....  ......+++.|.+||.+.+.. .++..+|+||+||++++|++|+.||.+....+....+.+..   ..+.
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~  255 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  255 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC
Confidence            98764322  233456788899999986544 36789999999999999999999999876555555555433   2333


Q ss_pred             CCCCcchhhhhhhhccccCCCCCcc-----ccccCC
Q 026720          202 KDSWPLGIQLASNLNWKLPQMGGVN-----LLAVMP  232 (234)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  232 (234)
                      +...+..+..+...++...+.+|++     ++++++
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            4567778888888999999999985     566654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=1e-18  Score=140.42  Aligned_cols=171  Identities=29%  Similarity=0.443  Sum_probs=120.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee-CCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS-KGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~-~~~~~~~~~~~  127 (234)
                      +++.+|+..|.+...   ...+++..+..+... +.|+.         ++|+.+++|+|++|.|+++. +...++.+|+.
T Consensus        98 ~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~---------~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          98 YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIK---------HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHH---------HhhhcccccccCCccccccccccceeeechhh
Confidence            477888876655433   333444555555555 78888         99999999999999999994 66779999998


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCCCCc-
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKDSWP-  206 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~~~~-  206 (234)
                      ++............+++.|+|||++.+ ..|+..+|+||+||+++++++|+.||++........++.+..+.+.+..|. 
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ---------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hhccccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            887766555566778899999999875 458899999999999999999999999999888888887766654332221 


Q ss_pred             ----------------------------------------chhhhhhhhccccCCCCCccccccCCC
Q 026720          207 ----------------------------------------LGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       207 ----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                              ..+..+...+...++.+|+|+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                                    122335566778899999999998764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=5.3e-18  Score=135.75  Aligned_cols=172  Identities=30%  Similarity=0.454  Sum_probs=127.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEe-eCCeeeEeeccc
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM  127 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~-~~~~~~~~~~~~  127 (234)
                      .+|.+|+..|++.+... ...+++..+..+... +.|+.         ++|+.+++|+|++|+|+++ ..+..++.+++.
T Consensus        98 ~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~---------~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLK---------YIHSADIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHH---------HHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             EEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHH---------HHHhCCCcccccCCccccccccccccccccch
Confidence            34556777777766432 223444455555555 77888         9999999999999999999 466789999999


Q ss_pred             cccccCCCCCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCCC----
Q 026720          128 VKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSADQIYKICQLIGSPTKD----  203 (234)
Q Consensus       128 a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~~~~~~i~~~~~~~~~~----  203 (234)
                      +......  .....+++.|.+||+..+...++..+|+||+|+++++|++|+.||++.........+.+..+.+...    
T Consensus       168 a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         168 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             --CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            8776542  3446778889999998766667899999999999999999999999999999998888877765431    


Q ss_pred             --------------------------CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --------------------------SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                                                ..+.....++..+...++.+|+|+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                                      122334445666778899999999998764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.66  E-value=1.1e-17  Score=130.72  Aligned_cols=170  Identities=18%  Similarity=0.190  Sum_probs=117.5

Q ss_pred             HHHHHHhhcCChHHHHHHHHh-hccCccccHHHH-HHHHHhcCCchhhhHhhhcccccCCcCCCcEEee------CCeee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNL-MREKNLQSWTIM-ISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVS------KGVIK  121 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~-m~~~~~~~~~~~-i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~------~~~~~  121 (234)
                      .+|..|+ .|.+.+..+.... ++...+..+... +.|+.         ++|+.+++|+|++|.|+++.      ....+
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~---------~lH~~giiHrDiKp~Nili~~~~~~~~~~vk  146 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ---------SIHEKSLVYRDIKPDNFLIGRPNSKNANMIY  146 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH---------HHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHH---------HHHHCCceeccCCccceeecCcccccCCceE
Confidence            4566666 4666665443222 222333344434 55666         89999999999999999994      34689


Q ss_pred             EeeccccccccCCC--------CCCCcccCcccccccccccccCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHH
Q 026720          122 IGDLGMVKEIDSNL--------PCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMGAIMFEMLSFGILFPGKSSA---DQI  190 (234)
Q Consensus       122 ~~~~~~a~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g~~l~e~~~~~~~f~~~~~~---~~~  190 (234)
                      +.|||.++......        ......+|+.|+|||.+.+ ..|+..+|+||+|++++|+++|+.||.+....   ...
T Consensus       147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~  225 (293)
T d1csna_         147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  225 (293)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence            99999998754321        2234578999999999974 45899999999999999999999999865432   233


Q ss_pred             HHHHHh-hCCCC---CCCCcchhhhhhhhccccCCCCCcccccc
Q 026720          191 YKICQL-IGSPT---KDSWPLGIQLASNLNWKLPQMGGVNLLAV  230 (234)
Q Consensus       191 ~~i~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (234)
                      .++... ...+.   ....++.+..+.+.|+...+.+||+++.+
T Consensus       226 ~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l  269 (293)
T d1csna_         226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL  269 (293)
T ss_dssp             HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             HHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            333321 11111   13456778888888999999999987654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=3.1e-17  Score=128.78  Aligned_cols=174  Identities=25%  Similarity=0.254  Sum_probs=112.9

Q ss_pred             HHHHHHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhh--------cccccCCcCCCcEEe-eCCee
Q 026720           50 ALVEMYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHR--------QGYFHRDLKPSNLLV-SKGVI  120 (234)
Q Consensus        50 ~li~~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~--------~~~~~~~l~p~~~~~-~~~~~  120 (234)
                      .+|.+|+..|++.+-.+-       .-.+|...+.-..+......  ++|.        .+++|+|++|.|+++ .+..+
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-------~~l~~~~~~~~~~~ia~gl~--~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLA--HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHH--HHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             EEEEecccCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHH--HHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence            478999999999887542       12333333222221111111  5553        479999999999999 46789


Q ss_pred             eEeeccccccccCCC-----CCCCcccCccccccccccccc-----CCCCcchHHHHHHHHHHHHhCCCCCCCC------
Q 026720          121 KIGDLGMVKEIDSNL-----PCTDYVTTRWYRGPEVLLFSE-----IYGPEVDKWAMGAIMFEMLSFGILFPGK------  184 (234)
Q Consensus       121 ~~~~~~~a~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~-----~~~~~~d~~s~g~~l~e~~~~~~~f~~~------  184 (234)
                      +++|||.++......     ......+++.|+|||++.+..     .++..+|+||+|+++||+++|..||...      
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            999999998765432     233467899999999986432     1456899999999999999998766321      


Q ss_pred             --------ChHHHHHHHHH-hhCCCCC-CCCc-----chhhhhhhhccccCCCCCccccccCC
Q 026720          185 --------SSADQIYKICQ-LIGSPTK-DSWP-----LGIQLASNLNWKLPQMGGVNLLAVMP  232 (234)
Q Consensus       185 --------~~~~~~~~i~~-~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (234)
                              ...+...+... ...+|+. ..|.     ..+..++..||..++.+|||+.+|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                    12333333322 2222332 2222     23566778899999999999998864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.46  E-value=5.4e-14  Score=112.60  Aligned_cols=134  Identities=30%  Similarity=0.411  Sum_probs=94.6

Q ss_pred             Hhhh-cccccCCcCCCcEEeeC-------CeeeEeeccccccccCCCCCCCcccCcccccccccccccCCCCcchHHHHH
Q 026720           97 SLHR-QGYFHRDLKPSNLLVSK-------GVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVLLFSEIYGPEVDKWAMG  168 (234)
Q Consensus        97 ~l~~-~~~~~~~l~p~~~~~~~-------~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~d~~s~g  168 (234)
                      ++|. .+++|+|++|.|+++..       ...++.+||.+......  .....+++.|+|||+... ..|+..+|+||+|
T Consensus       140 ~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  216 (362)
T d1q8ya_         140 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTA  216 (362)
T ss_dssp             HHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHH
T ss_pred             HHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccc-cCCCccccccchH
Confidence            7886 77999999999999841       13688999988876542  344678899999999874 4579999999999


Q ss_pred             HHHHHHHhCCCCCCCCC------hHHHHHHHHHhhCCCCCC---------------------------------------
Q 026720          169 AIMFEMLSFGILFPGKS------SADQIYKICQLIGSPTKD---------------------------------------  203 (234)
Q Consensus       169 ~~l~e~~~~~~~f~~~~------~~~~~~~i~~~~~~~~~~---------------------------------------  203 (234)
                      ++++++++|+.||.+..      ..+.+.......+.++..                                       
T Consensus       217 ~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
T d1q8ya_         217 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF  296 (362)
T ss_dssp             HHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCC
T ss_pred             HHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhccccccc
Confidence            99999999999997542      233444444443332110                                       


Q ss_pred             --CCcchhhhhhhhccccCCCCCccccccCCC
Q 026720          204 --SWPLGIQLASNLNWKLPQMGGVNLLAVMPS  233 (234)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (234)
                        .++..+..+...+...++.+|+|+.+++.+
T Consensus       297 ~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         297 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             CHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             CcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              112234445666788899999999888754

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=97.12  E-value=0.00013  Score=51.75  Aligned_cols=74  Identities=27%  Similarity=0.256  Sum_probs=49.3

Q ss_pred             HHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcEEeeCCeeeEeeccccccccCCCCCCCcccCccccccccc----cc
Q 026720           79 WTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSNLPCTDYVTTRWYRGPEVL----LF  154 (234)
Q Consensus        79 ~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~pe~~----~~  154 (234)
                      +..++.++.         ++|..+++|+|++|.|+++...-..+.|||.+.......       ...|...++.    -+
T Consensus       109 ~~ql~~~l~---------~lH~~giiHrDiKP~NILv~~~~~~liDFG~a~~~~~~~-------~~~~l~rd~~~~~~~f  172 (191)
T d1zara2         109 LDMILEEVA---------KFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEG-------WREILERDVRNIITYF  172 (191)
T ss_dssp             HHHHHHHHH---------HHHHTTEECSCCSTTSEEEETTEEEECCCTTCEETTSTT-------HHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHH---------HHhhCCEEEccCChhheeeeCCCEEEEECCCcccCCCCC-------cHHHHHHHHHHHHHHH
Confidence            344467777         899999999999999999976677899999887654321       0111111110    01


Q ss_pred             ccCCCCcchHHHHH
Q 026720          155 SEIYGPEVDKWAMG  168 (234)
Q Consensus       155 ~~~~~~~~d~~s~g  168 (234)
                      .+.|+..+|+||..
T Consensus       173 ~r~y~~~~d~~s~~  186 (191)
T d1zara2         173 SRTYRTEKDINSAI  186 (191)
T ss_dssp             HHHHCCCCCHHHHH
T ss_pred             cCCCCCcccHHHHH
Confidence            23478888999863

>d1a17a_ a.118.8.1 (A:) Protein phosphatase 5 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Protein phosphatase 5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.20  E-value=0.0085  Score=40.36  Aligned_cols=83  Identities=8%  Similarity=-0.129  Sum_probs=70.7

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhh
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDA   95 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a   95 (234)
                      .|.+.|++++|...|...++... .+...|..+-..|.+.|+.++|...|+...+   .++.+|..+..++...|+.++|
T Consensus        19 ~~~~~~~y~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~~~~~~A~~~~~kal~~~p~~~~a~~~~g~~~~~~g~~~eA   97 (159)
T d1a17a_          19 DYFKAKDYENAIKFYSQAIELNP-SNAIYYGNRSLAYLRTECYGYALGDATRAIELDKKYIKGYYRRAASNMALGKFRAA   97 (159)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHHST-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHcCCHHHHHHHhhhccccch-hhhhhhhhhHHHHHhccccchHHHHHHHHHHHcccchHHHHHHHHHHHHcCCHHHH
Confidence            46688999999999999998653 3677889999999999999999999987643   3667888889999999999999


Q ss_pred             hHhhhcc
Q 026720           96 ISLHRQG  102 (234)
Q Consensus        96 ~~l~~~~  102 (234)
                      +..+...
T Consensus        98 ~~~~~~a  104 (159)
T d1a17a_          98 LRDYETV  104 (159)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998773

>d1elwa_ a.118.8.1 (A:) Hop {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Hop
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.18  E-value=0.0091  Score=38.06  Aligned_cols=90  Identities=14%  Similarity=0.056  Sum_probs=73.2

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhh
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDA   95 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a   95 (234)
                      .+.+.|++++|...+...++... .+...|..+-..|.+.|+.++|...++...+   .+...|..+-..+...|+.++|
T Consensus        12 ~~~~~g~~~eAi~~~~~al~~~p-~~~~~~~~~a~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~~g~~~~~~~~~~~A   90 (117)
T d1elwa_          12 KALSVGNIDDALQCYSEAIKLDP-HNHVLYSNRSAAYAKKGDYQKAYEDGCKTVDLKPDWGKGYSRKAAALEFLNRFEEA   90 (117)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHcCCHHHHHHHHHHHHhcCC-cchhhhhcccccccccccccccchhhhhHHHhccchhhHHHHHHHHHHHccCHHHH
Confidence            35677899999999999987543 3566899999999999999999999887543   4778898899999999999999


Q ss_pred             hHhhhcccccCCcCCCc
Q 026720           96 ISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        96 ~~l~~~~~~~~~l~p~~  112 (234)
                      +..+...+ .  +.|++
T Consensus        91 ~~~~~~a~-~--~~p~~  104 (117)
T d1elwa_          91 KRTYEEGL-K--HEANN  104 (117)
T ss_dssp             HHHHHHHH-T--TCTTC
T ss_pred             HHHHHHHH-H--hCCCC
Confidence            99998733 2  45554

>d2c2la1 a.118.8.1 (A:24-224) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: STIP1 homology and U box-containing protein 1, STUB1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=96.18  E-value=0.014  Score=40.44  Aligned_cols=89  Identities=12%  Similarity=-0.034  Sum_probs=73.5

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~   88 (234)
                      .+--.=..+.+.|++++|...+...++... .+...|+.+-..|.+.|++++|...|+...+  | ++.+|..+-.++.+
T Consensus         6 ~l~~~Gn~~~~~g~~~~Ai~~~~kal~~~p-~~~~~~~~lg~~y~~~~~~~~Ai~~~~~al~l~p~~~~a~~~lg~~~~~   84 (201)
T d2c2la1           6 ELKEQGNRLFVGRKYPEAAACYGRAITRNP-LVAVYYTNRALCYLKMQQPEQALADCRRALELDGQSVKAHFFLGQCQLE   84 (201)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHCS-CCHHHHHHHHHHHHHTTCHHHHHHHHHHHTTSCTTCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHHHHHHHHhCC-CCHHHHHhHHHHHhhhhhhhhhhHHHHHHHHhCCCcHHHHHHHHHHHHH
Confidence            333333567788999999999999887653 3677889999999999999999999998654  3 56788888999999


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus        85 l~~~~~A~~~~~~   97 (201)
T d2c2la1          85 MESYDEAIANLQR   97 (201)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHH
Confidence            9999999999876

>d1nzna_ a.118.8.1 (A:) Mitochondria fission protein Fis1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Mitochondria fission protein Fis1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.86  E-value=0.02  Score=36.88  Aligned_cols=95  Identities=9%  Similarity=0.017  Sum_probs=69.9

Q ss_pred             HHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCCh---HHHHHHHHhhccCc-----cccHHHHHHH
Q 026720           14 VSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHV---EKAFKVFNLMREKN-----LQSWTIMISG   85 (234)
Q Consensus        14 ~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~---~~a~~~~~~m~~~~-----~~~~~~~i~~   85 (234)
                      ..+++.+...+.+++|++.+....+.+.. +..+...+-..+.+.+..   ++|+.+++.....+     +.+|..+-.+
T Consensus         3 ~~l~n~~~~~~~l~~Ae~~Y~~aL~~~p~-~~~~~~n~a~~L~~s~~~~d~~~Ai~~l~~~l~~~~~~~~~~~~~~Lg~~   81 (122)
T d1nzna_           3 EAVLNELVSVEDLLKFEKKFQSEKAAGSV-SKSTQFEYAWCLVRTRYNDDIRKGIVLLEELLPKGSKEEQRDYVFYLAVG   81 (122)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHSCC-CHHHHHHHHHHHTTSSSHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCHHHHHHHHHHHHHHHhhCCC-CHHHHHHHHHHHHHhcchHHHHHHHHHHHHHHhccCCchHHHHHHHHHHH
Confidence            46788888899999999999999886643 445666666677765544   56899998865432     2356667778


Q ss_pred             HHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           86 LADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        86 ~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      |.+.|+.++|+..+.. .+.  +.|++
T Consensus        82 y~~~g~~~~A~~~~~~-aL~--~~P~~  105 (122)
T d1nzna_          82 NYRLKEYEKALKYVRG-LLQ--TEPQN  105 (122)
T ss_dssp             HHHTTCHHHHHHHHHH-HHH--HCTTC
T ss_pred             HHHHhhhHHHHHHHHH-HHH--hCcCC
Confidence            8899999999999987 333  45654

>d1hxia_ a.118.8.1 (A:) Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor) {Trypanosoma brucei [TaxId: 5691]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor)
species: Trypanosoma brucei [TaxId: 5691]

Probab=95.78  E-value=0.0093  Score=37.69  Aligned_cols=82  Identities=13%  Similarity=0.054  Sum_probs=68.9

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhh
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDA   95 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a   95 (234)
                      .+-+.|++++|...+...++.... +...|..+-..|.+.|+.++|...++...+   .+..+|..+-..+...|+.++|
T Consensus        25 ~~~~~g~~~~A~~~~~~al~~~p~-~~~a~~~lg~~~~~~~~~~~A~~~~~~al~~~p~~~~a~~~la~~y~~~g~~~~A  103 (112)
T d1hxia_          25 SMLKLANLAEAALAFEAVCQKEPE-REEAWRSLGLTQAENEKDGLAIIALNHARMLDPKDIAVHAALAVSHTNEHNANAA  103 (112)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHHSTT-CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhhhHHHHHHHhhhcccccc-cchhhhhhhhhhhhhhhHHHhhcccccccccccccccchHHHHHHHHHCCCHHHH
Confidence            455678999999999999886532 577888999999999999999999987543   3677888888899999999999


Q ss_pred             hHhhhc
Q 026720           96 ISLHRQ  101 (234)
Q Consensus        96 ~~l~~~  101 (234)
                      +..+++
T Consensus       104 ~~~l~~  109 (112)
T d1hxia_         104 LASLRA  109 (112)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998865

>d1w3ba_ a.118.8.1 (A:) O-GlcNAc transferase p110 subunit, OGT {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: O-GlcNAc transferase p110 subunit, OGT
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.56  E-value=0.026  Score=42.59  Aligned_cols=100  Identities=13%  Similarity=0.021  Sum_probs=66.9

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ...+..+-..+.+.|+.++|...+...++... .+..++..+...|.+.|+.++|...++....   .+...+..+...+
T Consensus       237 ~~~~~~l~~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~~~~~~~~~l~~~~  315 (388)
T d1w3ba_         237 AVVHGNLACVYYEQGLIDLAIDTYRRAIELQP-HFPDAYCNLANALKEKGSVAEAEDCYNTALRLCPTHADSLNNLANIK  315 (388)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHHHHHHHTCS-SCHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCCHHHHHHHHHhhhccCCccchhhhHHHHHH
Confidence            34455566667777888888888877766432 2345677777788888888888877766432   3445666667777


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      .+.|+.++|+..+... +.  +.|+..
T Consensus       316 ~~~~~~~~A~~~~~~a-l~--~~p~~~  339 (388)
T d1w3ba_         316 REQGNIEEAVRLYRKA-LE--VFPEFA  339 (388)
T ss_dssp             HTTTCHHHHHHHHHHH-TT--SCTTCH
T ss_pred             HHCCCHHHHHHHHHHH-HH--hCCCCH
Confidence            7888888888887763 22  456543

>d1fcha_ a.118.8.1 (A:) Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.34  E-value=0.027  Score=41.96  Aligned_cols=89  Identities=10%  Similarity=-0.050  Sum_probs=50.3

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHh
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLAD   88 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~   88 (234)
                      .+..+-..+...|+.++|...+...+.... -+..+|..+-..|.+.|+.++|.+.|+...+   .+..+|..+-..|.+
T Consensus       174 ~~~~l~~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~a~~~lg~~~~~  252 (323)
T d1fcha_         174 VQCGLGVLFNLSGEYDKAVDCFTAALSVRP-NDYLLWNKLGATLANGNQSEEAVAAYRRALELQPGYIRSRYNLGISCIN  252 (323)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHH
T ss_pred             cchhhHHHHHHHHHHhhhhccccccccccc-ccccchhhhhhcccccccchhHHHHHHHHHHHhhccHHHHHHHHHHHHH
Confidence            344444455555666666666666554332 1344555666666666666666666655332   234456556666666


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .|+.++|+..+..
T Consensus       253 ~g~~~~A~~~~~~  265 (323)
T d1fcha_         253 LGAHREAVEHFLE  265 (323)
T ss_dssp             HTCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHH
Confidence            6666666666654

>d2onda1 a.118.8.7 (A:242-549) Cleavage stimulation factor 77 kDa subunit CSTF3 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: HAT/Suf repeat
domain: Cleavage stimulation factor 77 kDa subunit CSTF3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=95.33  E-value=0.024  Score=42.47  Aligned_cols=120  Identities=6%  Similarity=-0.068  Sum_probs=72.0

Q ss_pred             ehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhccCccc---cHHHHHHH-H
Q 026720           11 VTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMREKNLQ---SWTIMISG-L   86 (234)
Q Consensus        11 ~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~~~~~---~~~~~i~~-~   86 (234)
                      ..|.......-+.++.+.++.++..+.+........+|...+....+.|..+.|+.+|+........   .|...... +
T Consensus       100 ~l~~~ya~~~~~~~~~~~a~~i~~~~l~~~~~~~~~~w~~~~~~~~~~~~~~~ar~i~~~al~~~~~~~~~~~~~a~~e~  179 (308)
T d2onda1         100 LLYFAYADYEESRMKYEKVHSIYNRLLAIEDIDPTLVYIQYMKFARRAEGIKSGRMIFKKAREDARTRHHVYVTAALMEY  179 (308)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHHHHTSSSSCTHHHHHHHHHHHHHHHCHHHHHHHHHHHHTSTTCCTHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCChHHHHHHHHHHHHHcCChHHHHHHHHHHHHhCCCcHHHHHHHHHHHH
Confidence            3455555666667778888888888776544333556788888888888888888888876543222   22222111 2


Q ss_pred             HhcCCchhhhHhhhcccccCCcCCCcEEe----eCCeeeEeeccccccccC
Q 026720           87 ADNSRGNDAISLHRQGYFHRDLKPSNLLV----SKGVIKIGDLGMVKEIDS  133 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~~~~~~~l~p~~~~~----~~~~~~~~~~~~a~~~~~  133 (234)
                      ...|+.+.|..++...+.   ..|++..+    .......+++..++.+..
T Consensus       180 ~~~~~~~~a~~i~e~~l~---~~p~~~~~w~~y~~~~~~~g~~~~aR~~fe  227 (308)
T d2onda1         180 YCSKDKSVAFKIFELGLK---KYGDIPEYVLAYIDYLSHLNEDNNTRVLFE  227 (308)
T ss_dssp             HTSCCHHHHHHHHHHHHH---HHTTCHHHHHHHHHHHHTTCCHHHHHHHHH
T ss_pred             HhccCHHHHHHHHHHHHH---hhhhhHHHHHHHHHHHHHcCChHHHHHHHH
Confidence            335777888888876432   24544322    122334556666666554

>d1w3ba_ a.118.8.1 (A:) O-GlcNAc transferase p110 subunit, OGT {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: O-GlcNAc transferase p110 subunit, OGT
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.81  E-value=0.1  Score=39.10  Aligned_cols=91  Identities=10%  Similarity=0.035  Sum_probs=74.9

Q ss_pred             eehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHH
Q 026720           10 SVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGL   86 (234)
Q Consensus        10 ~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~   86 (234)
                      ..++..+-..+...+++++|...+....+... .+...+..+-..|.+.|+.++|...|++..+   .+..+|..+...+
T Consensus       203 ~~~~~~l~~~~~~~~~~~~A~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~l~~~~  281 (388)
T d1w3ba_         203 LDAYINLGNVLKEARIFDRAVAAYLRALSLSP-NHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANAL  281 (388)
T ss_dssp             HHHHHHHHHHHHTTTCTTHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHTCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHhhhhhccccHHHHHHHHHHhHHHhh-hHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHhCCCCHHHHHHHHHHH
Confidence            44677777889999999999999998877654 3455677788899999999999999987543   3567888888899


Q ss_pred             HhcCCchhhhHhhhc
Q 026720           87 ADNSRGNDAISLHRQ  101 (234)
Q Consensus        87 ~~~g~~~~a~~l~~~  101 (234)
                      .+.|+..+|+..+..
T Consensus       282 ~~~~~~~~A~~~~~~  296 (388)
T d1w3ba_         282 KEKGSVAEAEDCYNT  296 (388)
T ss_dssp             HHHSCHHHHHHHHHH
T ss_pred             HHcCCHHHHHHHHHh
Confidence            999999999999876

>d1xnfa_ a.118.8.1 (A:) Lipoprotein NlpI {Escherichia coli [TaxId: 562]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Lipoprotein NlpI
species: Escherichia coli [TaxId: 562]

Probab=93.74  E-value=0.15  Score=36.24  Aligned_cols=83  Identities=13%  Similarity=-0.074  Sum_probs=68.6

Q ss_pred             HHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-ccccHHHHHHHHHhcCCchh
Q 026720           18 SACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NLQSWTIMISGLADNSRGND   94 (234)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~~~~~~~i~~~~~~g~~~~   94 (234)
                      ..+-+.|+.++|...+...++... -+..+|+.+-..|.+.|++++|...|++..+  | +..+|..+-..+...|+.++
T Consensus        45 ~~y~~~g~~~~A~~~~~~al~l~p-~~~~a~~~lg~~~~~~g~~~~A~~~~~~al~~~p~~~~a~~~lg~~~~~~g~~~~  123 (259)
T d1xnfa_          45 VLYDSLGLRALARNDFSQALAIRP-DMPEVFNYLGIYLTQAGNFDAAYEAFDSVLELDPTYNYAHLNRGIALYYGGRDKL  123 (259)
T ss_dssp             HHHHHTTCHHHHHHHHHHHHHHCC-CCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCTHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHCCCHHHHHHHHHHhhccCC-CCHHHHhhhchHHHHHHHHHHhhhhhhHHHHHHhhhhhhHHHHHHHHHHHhhHHH
Confidence            467778899999999999887543 2566788899999999999999999988653  3 45678888888899999999


Q ss_pred             hhHhhhc
Q 026720           95 AISLHRQ  101 (234)
Q Consensus        95 a~~l~~~  101 (234)
                      |+..+..
T Consensus       124 A~~~~~~  130 (259)
T d1xnfa_         124 AQDDLLA  130 (259)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998876

>d1fcha_ a.118.8.1 (A:) Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.16  E-value=0.12  Score=38.27  Aligned_cols=81  Identities=11%  Similarity=-0.008  Sum_probs=67.6

Q ss_pred             hcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhh
Q 026720           20 CTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAI   96 (234)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~   96 (234)
                      +.+.|++++|...+...++... .+...|..+-..|...|+.++|...|++..+   .+...|..+...+...|+.++|+
T Consensus        29 ~~~~g~~~~A~~~~~~al~~~P-~~~~a~~~lg~~~~~~~~~~~A~~~~~~al~~~p~~~~~~~~la~~~~~~~~~~~A~  107 (323)
T d1fcha_          29 RLQEGDLPNAVLLFEAAVQQDP-KHMEAWQYLGTTQAENEQELLAISALRRCLELKPDNQTALMALAVSFTNESLQRQAC  107 (323)
T ss_dssp             HHHTTCHHHHHHHHHHHHHSCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHcCCHHHHHHHHHHHHHhCC-CCHHHHHHHHHHHHHcCChHHHHHHHHhhhccccccccccccccccccccccccccc
Confidence            5578899999999999987543 2466888899999999999999999987543   35677888888999999999999


Q ss_pred             Hhhhc
Q 026720           97 SLHRQ  101 (234)
Q Consensus        97 ~l~~~  101 (234)
                      ..+..
T Consensus       108 ~~~~~  112 (323)
T d1fcha_         108 EILRD  112 (323)
T ss_dssp             HHHHH
T ss_pred             cchhh
Confidence            98876

>d1elra_ a.118.8.1 (A:) Hop {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Hop
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.61  E-value=0.087  Score=33.72  Aligned_cols=82  Identities=12%  Similarity=0.051  Sum_probs=63.5

Q ss_pred             HhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---Cccc-------cHHHHHHHHHh
Q 026720           19 ACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQ-------SWTIMISGLAD   88 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~-------~~~~~i~~~~~   88 (234)
                      .+.+.+++++|...|...++... .+..++..+-..|.+.|.+++|...++...+   ++..       +|..+-..+..
T Consensus        13 ~~~~~~~y~~Ai~~y~~al~~~p-~~~~~~~~~a~~~~~~~~~~~A~~~~~~al~l~~~~~~~~~~~a~~~~~lg~~~~~   91 (128)
T d1elra_          13 DAYKKKDFDTALKHYDKAKELDP-TNMTYITNQAAVYFEKGDYNKCRELCEKAIEVGRENREDYRQIAKAYARIGNSYFK   91 (128)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHHHSTTCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHcCCHHHHHHHHHHHHHhCc-ccHHHHHhHHHHHHHcCchHHHHHHHHHHHHhCcccHHHHHHHHHHHHHHHHHHHH
Confidence            46677899999999999998654 3677889999999999999999999988543   2333       34445556677


Q ss_pred             cCCchhhhHhhhc
Q 026720           89 NSRGNDAISLHRQ  101 (234)
Q Consensus        89 ~g~~~~a~~l~~~  101 (234)
                      .++.++|+..+..
T Consensus        92 ~~~~~~A~~~~~k  104 (128)
T d1elra_          92 EEKYKDAIHFYNK  104 (128)
T ss_dssp             TTCHHHHHHHHHH
T ss_pred             hCCHHHHHHHHHH
Confidence            7888888888765

>d2fbna1 a.118.8.1 (A:22-174) Putative 70 kda peptidylprolyl isomerase PFL2275c {Plasmodium falciparum [TaxId: 5833]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Putative 70 kda peptidylprolyl isomerase PFL2275c
species: Plasmodium falciparum [TaxId: 5833]

Probab=92.29  E-value=0.15  Score=33.74  Aligned_cols=92  Identities=13%  Similarity=0.023  Sum_probs=67.6

Q ss_pred             HhcCchhhhhHhHHHHHHHHhcc---------------chhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHH
Q 026720           19 ACTGLINVRAGESIHSYAVVNGL---------------ELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWT   80 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~---------------~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~   80 (234)
                      .+.+.+++.+|...+...++.-.               .....+++.+-..|.+.|..++|.+.++...+   .++.+|-
T Consensus        26 ~~f~~~~y~~A~~~Y~~al~~~~~~~~~~~~~~~~~~~~~~~~~~~Nla~~~~~l~~~~~Al~~~~~al~~~p~~~ka~~  105 (153)
T d2fbna1          26 EFFKKNEINEAIVKYKEALDFFIHTEEWDDQILLDKKKNIEISCNLNLATCYNKNKDYPKAIDHASKVLKIDKNNVKALY  105 (153)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHTTTTCTTCCCHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTTCHHHHH
T ss_pred             HHHHcCCHHHHHHHHHHHHhhCcchhhhhhHHHHHhhhhHHHHHHhhHHHHHHHhcccchhhhhhhccccccchhhhhhH
Confidence            34456777777777776654210               11245777788899999999999999887443   4778999


Q ss_pred             HHHHHHHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           81 IMISGLADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      .+-.++...|+.++|+..|... +.  +.|++.
T Consensus       106 ~~g~~~~~lg~~~~A~~~~~~a-l~--l~P~n~  135 (153)
T d2fbna1         106 KLGVANMYFGFLEEAKENLYKA-AS--LNPNNL  135 (153)
T ss_dssp             HHHHHHHHHTCHHHHHHHHHHH-HH--HSTTCH
T ss_pred             HhHHHHHHcCCHHHHHHHHHHH-HH--hCCCCH
Confidence            9999999999999999999773 32  456553

>d1hh8a_ a.118.8.1 (A:) Neutrophil cytosolic factor 2 (NCF-2, p67-phox) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Neutrophil cytosolic factor 2 (NCF-2, p67-phox)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.07  E-value=0.096  Score=36.21  Aligned_cols=78  Identities=12%  Similarity=-0.026  Sum_probs=62.7

Q ss_pred             cCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhH
Q 026720           21 TGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAIS   97 (234)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~   97 (234)
                      ...++++.|.+.+..+.    .++..+|..+=..|.+.|++++|...|++-.+   .+...|+.+-..+.+.|+.++|+.
T Consensus        16 ~~~~d~~~Al~~~~~i~----~~~~~~~~nlG~~~~~~g~~~~A~~~~~kAl~ldp~~~~a~~~~g~~~~~~g~~~~A~~   91 (192)
T d1hh8a_          16 ADKKDWKGALDAFSAVQ----DPHSRICFNIGCMYTILKNMTEAEKAFTRSINRDKHLAVAYFQRGMLYYQTEKYDLAIK   91 (192)
T ss_dssp             HHTTCHHHHHHHHHTSS----SCCHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             HHCCCHHHHHHHHHhcC----CCCHHHHHHHHHHHHHcCCchhHHHHHHHHHHHhhhhhhhHHHHHHHHHhhccHHHHHH
Confidence            45677888888887642    35666788889999999999999999987543   466788888888999999999999


Q ss_pred             hhhcc
Q 026720           98 LHRQG  102 (234)
Q Consensus        98 l~~~~  102 (234)
                      .|...
T Consensus        92 ~~~kA   96 (192)
T d1hh8a_          92 DLKEA   96 (192)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88763

>d1p5qa1 a.118.8.1 (A:258-427) FKBP52 (FKBP4), C-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: FKBP52 (FKBP4), C-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.29  E-value=0.28  Score=32.94  Aligned_cols=83  Identities=12%  Similarity=-0.158  Sum_probs=63.8

Q ss_pred             HhcCchhhhhHhHHHHHHHHhcc--------------chhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHH
Q 026720           19 ACTGLINVRAGESIHSYAVVNGL--------------ELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTI   81 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~g~--------------~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~   81 (234)
                      .+.+.+++++|...|...++.-.              ..-..+|+.+-..|.+.|++++|...++....   .++..|..
T Consensus        22 ~~~~~~~~~~Ai~~y~~al~~~~~~~~~~~~~~~~~~~~~~~~~~nla~~y~k~~~~~~A~~~~~~al~~~p~~~~a~~~  101 (170)
T d1p5qa1          22 VYFKEGKYKQALLQYKKIVSWLEYESSFSNEEAQKAQALRLASHLNLAMCHLKLQAFSAAIESCNKALELDSNNEKGLSR  101 (170)
T ss_dssp             HHHHHTCHHHHHHHHHHHHHHTTTCCCCCSHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHH
T ss_pred             HHHHcCCHHHHHHHHHHHHHHhhhccccchHHHhhhchhHHHHHHHHHHHHHhhhhcccccchhhhhhhccccchhhhHH
Confidence            45667788888888877765311              01235667788889999999999998877432   37778888


Q ss_pred             HHHHHHhcCCchhhhHhhhc
Q 026720           82 MISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +-.++.+.|+.++|+..|..
T Consensus       102 ~g~~~~~~g~~~~A~~~~~~  121 (170)
T d1p5qa1         102 RGEAHLAVNDFELARADFQK  121 (170)
T ss_dssp             HHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHhhhHHHHHHHHHH
Confidence            88899999999999999987

>d2ff4a2 a.118.8.3 (A:105-283) Probable regulatory protein EmbR, middle domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: BTAD-like
domain: Probable regulatory protein EmbR, middle domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=90.01  E-value=0.3  Score=33.26  Aligned_cols=83  Identities=19%  Similarity=0.169  Sum_probs=62.5

Q ss_pred             HhcCchhhhhHhHHHHHHHHh--cc-c------------------hhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---C
Q 026720           19 ACTGLINVRAGESIHSYAVVN--GL-E------------------LDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---K   74 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~--g~-~------------------~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~   74 (234)
                      .....|++++|...+...+..  |- .                  .....+..+...+.+.|+.++|...++....   .
T Consensus        20 ~~~~~g~~e~A~~~~~~AL~l~rG~~l~~~~~~~w~~~~r~~l~~~~~~a~~~la~~~~~~g~~~~Al~~~~~al~~~P~   99 (179)
T d2ff4a2          20 HAAAAGRFEQASRHLSAALREWRGPVLDDLRDFQFVEPFATALVEDKVLAHTAKAEAEIACGRASAVIAELEALTFEHPY   99 (179)
T ss_dssp             HHHHTTCHHHHHHHHHHHHTTCCSSTTGGGTTSTTHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHSTT
T ss_pred             HHHHCCCHHHHHHHHHHHHhhCcccccccCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCchHHHHHHHHHHHhCCc
Confidence            345556666666666655542  11 0                  1234678889999999999999999988654   3


Q ss_pred             ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           75 NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        75 ~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +...|..++.++.+.|+..+|+..|..
T Consensus       100 ~e~~~~~l~~al~~~Gr~~eAl~~y~~  126 (179)
T d2ff4a2         100 REPLWTQLITAYYLSDRQSDALGAYRR  126 (179)
T ss_dssp             CHHHHHHHHHHHHTTTCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHhcCHHHHHHHHHH
Confidence            678999999999999999999998866

>d2h6fa1 a.118.6.1 (A:55-369) Protein farnesyltransferase alpha-subunit {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Protein prenylyltransferase
family: Protein prenylyltransferase
domain: Protein farnesyltransferase alpha-subunit
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.73  E-value=0.49  Score=35.16  Aligned_cols=75  Identities=5%  Similarity=-0.006  Sum_probs=36.4

Q ss_pred             hhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           26 VRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        26 ~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                      +++|...+...++... -+..+|+.+-..|.+.|+.++|...++...+   ++...|+.+...+.+.|+.++|+..+..
T Consensus        94 ~~eal~~~~~al~~~p-~~~~a~~~~~~~~~~l~~~~eAl~~~~kal~~dp~n~~a~~~~~~~~~~~~~~~~Al~~~~~  171 (315)
T d2h6fa1          94 LHEEMNYITAIIEEQP-KNYQVWHHRRVLVEWLRDPSQELEFIADILNQDAKNYHAWQHRQWVIQEFKLWDNELQYVDQ  171 (315)
T ss_dssp             HHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHTCCTTHHHHHHHHHHHCTTCHHHHHHHHHHHHHHTCCTTHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHH-hhhhHHHHHhHHHHhhccHHHHHHHHhhhhhhhhcchHHHHHHHHHHHHHHhhHHHHHHHHH
Confidence            4455555544444321 1334444444555555555555555544332   2444555555555555555555555544

>d2onda1 a.118.8.7 (A:242-549) Cleavage stimulation factor 77 kDa subunit CSTF3 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: HAT/Suf repeat
domain: Cleavage stimulation factor 77 kDa subunit CSTF3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=88.34  E-value=0.8  Score=33.59  Aligned_cols=78  Identities=9%  Similarity=0.037  Sum_probs=62.4

Q ss_pred             hhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc--C-cc-ccHHHHHHHHHhcCCchhhhHhhh
Q 026720           25 NVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE--K-NL-QSWTIMISGLADNSRGNDAISLHR  100 (234)
Q Consensus        25 ~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~--~-~~-~~~~~~i~~~~~~g~~~~a~~l~~  100 (234)
                      ..+++..++...++.....+...|......+-+.|..+.|+.+|+.+..  + +. ..|...+..+.+.|..++|..+|.
T Consensus        79 ~~~~a~~i~~ral~~~~p~~~~l~~~ya~~~~~~~~~~~a~~i~~~~l~~~~~~~~~~w~~~~~~~~~~~~~~~ar~i~~  158 (308)
T d2onda1          79 FSDEAANIYERAISTLLKKNMLLYFAYADYEESRMKYEKVHSIYNRLLAIEDIDPTLVYIQYMKFARRAEGIKSGRMIFK  158 (308)
T ss_dssp             HHHHHHHHHHHHHTTTTTTCHHHHHHHHHHHHHTTCHHHHHHHHHHHHTSSSSCTHHHHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCCHHHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCChHHHHHHHHHHHHHcCChHHHHHHHH
Confidence            3467778888877655555667888888999999999999999998643  2 32 368888999999999999999998


Q ss_pred             cc
Q 026720          101 QG  102 (234)
Q Consensus       101 ~~  102 (234)
                      ..
T Consensus       159 ~a  160 (308)
T d2onda1         159 KA  160 (308)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>d1ihga1 a.118.8.1 (A:197-365) Cyclophilin 40 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Cyclophilin 40
species: Cow (Bos taurus) [TaxId: 9913]

Probab=88.21  E-value=1.6  Score=28.71  Aligned_cols=91  Identities=10%  Similarity=-0.030  Sum_probs=65.5

Q ss_pred             HhcCchhhhhHhHHHHHHHHh--------------ccch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHH
Q 026720           19 ACTGLINVRAGESIHSYAVVN--------------GLEL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWT   80 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~--------------g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~   80 (234)
                      .+.+.+++++|...+.+.++.              .+.| +...++.+-..|.+.|+.++|+..++...+   .+...|.
T Consensus        36 ~~~~~~~y~~Ai~~y~~al~~~~~~~~~~~~~~~~~~~~~~~~~~~nla~~~~~~~~~~~Ai~~~~~al~~~p~~~~a~~  115 (169)
T d1ihga1          36 TFFKSQNWEMAIKKYTKVLRYVEGSRAAAEDADGAKLQPVALSCVLNIGACKLKMSDWQGAVDSCLEALEIDPSNTKALY  115 (169)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHHHHHHHHHSCHHHHGGGHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHTTCTTCHHHHH
T ss_pred             HHHHcCCHHHHHHHHHHHHHhhhhhhhhhhhHHHHHhChhhHHHHHHHHHHHHhhcccchhhhhhhhhhhhhhhhhhHHH
Confidence            455666777777776665431              1122 445667778889999999999999887543   4667888


Q ss_pred             HHHHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           81 IMISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        81 ~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      .+-.++.+.|+.++|+..|... +.  +.|++
T Consensus       116 ~~g~~~~~l~~~~~A~~~~~~a-l~--l~p~n  144 (169)
T d1ihga1         116 RRAQGWQGLKEYDQALADLKKA-QE--IAPED  144 (169)
T ss_dssp             HHHHHHHHTTCHHHHHHHHHHH-HH--HCTTC
T ss_pred             hHHHHHHHccCHHHHHHHHHHH-HH--hCCCC
Confidence            8899999999999999999773 32  44554

>d2h6fa1 a.118.6.1 (A:55-369) Protein farnesyltransferase alpha-subunit {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Protein prenylyltransferase
family: Protein prenylyltransferase
domain: Protein farnesyltransferase alpha-subunit
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.20  E-value=0.94  Score=33.50  Aligned_cols=95  Identities=7%  Similarity=-0.016  Sum_probs=71.9

Q ss_pred             HHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcC-ChHHHHHHHHhhcc---CccccHHHHHHHHHhcC
Q 026720           15 SLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCG-HVEKAFKVFNLMRE---KNLQSWTIMISGLADNS   90 (234)
Q Consensus        15 ~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g-~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g   90 (234)
                      -+=..+.+.+..++|.+++..+++... -+...|+..-..+...| ++++|...++...+   .+..+|+.+-..+.+.|
T Consensus        48 ~~~~~~~~~e~~~~Al~~~~~ai~lnP-~~~~a~~~r~~~l~~l~~~~~eal~~~~~al~~~p~~~~a~~~~~~~~~~l~  126 (315)
T d2h6fa1          48 YFRAVLQRDERSERAFKLTRDAIELNA-ANYTVWHFRRVLLKSLQKDLHEEMNYITAIIEEQPKNYQVWHHRRVLVEWLR  126 (315)
T ss_dssp             HHHHHHHHTCCCHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhCCchHHHHHHHHHHHHHCC-CChHHHHHHHHHHHHhCcCHHHHHHHHHHHHHHHHhhhhHHHHHhHHHHhhc
Confidence            333445667788999999999998543 24557787777777776 58999999887543   46789999988899999


Q ss_pred             CchhhhHhhhcccccCCcCCCcE
Q 026720           91 RGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        91 ~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      +.++|+..+... +.  +.|.+.
T Consensus       127 ~~~eAl~~~~ka-l~--~dp~n~  146 (315)
T d2h6fa1         127 DPSQELEFIADI-LN--QDAKNY  146 (315)
T ss_dssp             CCTTHHHHHHHH-HH--HCTTCH
T ss_pred             cHHHHHHHHhhh-hh--hhhcch
Confidence            999999999884 33  456654

>d2ff4a2 a.118.8.3 (A:105-283) Probable regulatory protein EmbR, middle domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: BTAD-like
domain: Probable regulatory protein EmbR, middle domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=87.89  E-value=0.72  Score=31.19  Aligned_cols=60  Identities=10%  Similarity=-0.005  Sum_probs=51.2

Q ss_pred             hHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhc
Q 026720           12 TLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMR   72 (234)
Q Consensus        12 t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~   72 (234)
                      .+..+...+.+.|+.++|...+...++... -+...|..++..|.+.|...+|.+.|+...
T Consensus        69 a~~~la~~~~~~g~~~~Al~~~~~al~~~P-~~e~~~~~l~~al~~~Gr~~eAl~~y~~~~  128 (179)
T d2ff4a2          69 AHTAKAEAEIACGRASAVIAELEALTFEHP-YREPLWTQLITAYYLSDRQSDALGAYRRVK  128 (179)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHHHHHHHHHST-TCHHHHHHHHHHHHTTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCchHHHHHHHHHHHhCC-ccHHHHHHHHHHHHHhcCHHHHHHHHHHHH
Confidence            455677888899999999999999987543 367789999999999999999999998863

>d1kt1a1 a.118.8.1 (A:254-421) FKBP51, C-terminal domain {Monkey (Saimiri boliviensis) [TaxId: 27679]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: FKBP51, C-terminal domain
species: Monkey (Saimiri boliviensis) [TaxId: 27679]

Probab=87.19  E-value=0.89  Score=30.11  Aligned_cols=91  Identities=13%  Similarity=-0.114  Sum_probs=64.4

Q ss_pred             HhcCchhhhhHhHHHHHHHHh-------------ccch-hHHHHHHHHHHHhhcCChHHHHHHHHhhcc---CccccHHH
Q 026720           19 ACTGLINVRAGESIHSYAVVN-------------GLEL-DVAIGTALVEMYSKCGHVEKAFKVFNLMRE---KNLQSWTI   81 (234)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~-------------g~~~-~~~~~~~li~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~   81 (234)
                      .+.+.|++.+|...+...+..             ...+ ...+|+-+-..|.+.|+.++|...++....   .++.+|..
T Consensus        24 ~~~~~~~~~~A~~~Y~~al~~~~~~~~~~~~~~~~~~~~~~~~~~Nla~~~~~l~~~~~Ai~~~~~al~l~p~~~~a~~~  103 (168)
T d1kt1a1          24 VYFKGGKYVQAVIQYGKIVSWLEMEYGLSEKESKASESFLLAAFLNLAMCYLKLREYTKAVECCDKALGLDSANEKGLYR  103 (168)
T ss_dssp             HHHHTTCHHHHHHHHHHHHHHHTTCCSCCHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCTTCHHHHHH
T ss_pred             HHHHcCCHHHHHHHHHHHHHHHHHhhccchhhhhhcchhHHHHHHhHHHHHHHhhhcccchhhhhhhhhcccchHHHHHH
Confidence            355667778888777665531             0011 233455677788999999999998877443   46778888


Q ss_pred             HHHHHHhcCCchhhhHhhhcccccCCcCCCc
Q 026720           82 MISGLADNSRGNDAISLHRQGYFHRDLKPSN  112 (234)
Q Consensus        82 ~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~  112 (234)
                      +-.++..-|+.++|+..+... +.  +.|++
T Consensus       104 ~~~~~~~l~~~~~A~~~~~~a-l~--l~P~n  131 (168)
T d1kt1a1         104 RGEAQLLMNEFESAKGDFEKV-LE--VNPQN  131 (168)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHH-HH--SCTTC
T ss_pred             HHHHHHHcCCHHHHHHHHHHH-HH--hCCCC
Confidence            888999999999999999873 32  44554

>d2c2la1 a.118.8.1 (A:24-224) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: STIP1 homology and U box-containing protein 1, STUB1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=86.97  E-value=0.67  Score=31.20  Aligned_cols=59  Identities=8%  Similarity=-0.047  Sum_probs=47.3

Q ss_pred             HHHHhhcCChHHHHHHHHhhcc---CccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           52 VEMYSKCGHVEKAFKVFNLMRE---KNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        52 i~~~~~~g~~~~a~~~~~~m~~---~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      =+.|.+.|++++|...|....+   .+...|+.+-.+|.+.|++++|+..+.. .+  .+.|++.
T Consensus        11 Gn~~~~~g~~~~Ai~~~~kal~~~p~~~~~~~~lg~~y~~~~~~~~Ai~~~~~-al--~l~p~~~   72 (201)
T d2c2la1          11 GNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQPEQALADCRR-AL--ELDGQSV   72 (201)
T ss_dssp             HHHHHHTTCHHHHHHHHHHHHHHCSCCHHHHHHHHHHHHHTTCHHHHHHHHHH-HT--TSCTTCH
T ss_pred             HHHHHHcCCHHHHHHHHHHHHHhCCCCHHHHHhHHHHHhhhhhhhhhhHHHHH-HH--HhCCCcH
Confidence            3568899999999999987542   4677888888899999999999999988 33  3567654

>d2hr2a1 a.118.8.8 (A:2-157) Hypothetical protein CT2138 {Chlorobium tepidum [TaxId: 1097]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: CT2138-like
domain: Hypothetical protein CT2138
species: Chlorobium tepidum [TaxId: 1097]

Probab=84.22  E-value=1.7  Score=28.15  Aligned_cols=90  Identities=11%  Similarity=0.011  Sum_probs=63.9

Q ss_pred             hHHHHHH--HhcCchhhhhHhHHHHHHHHhccc-h----------hHHHHHHHHHHHhhcCChHHHHHHHHhhcc-----
Q 026720           12 TLVSLVS--ACTGLINVRAGESIHSYAVVNGLE-L----------DVAIGTALVEMYSKCGHVEKAFKVFNLMRE-----   73 (234)
Q Consensus        12 t~~~ll~--~~~~~~~~~~~~~~~~~~~~~g~~-~----------~~~~~~~li~~~~~~g~~~~a~~~~~~m~~-----   73 (234)
                      +|..+-.  ...+.|++++|.+.+.+.+.-.-. |          ....|+.+-..|.+.|.+++|..-++....     
T Consensus         9 a~~~l~~g~~~~~~g~y~~Ai~~y~~Al~i~~~~~~~~~~~~~~~~a~~~~nlg~~~~~lg~~~~A~~~~~~al~~~~~~   88 (156)
T d2hr2a1           9 AYLALSDAQRQLVAGEYDEAAANCRRAMEISHTMPPEEAFDHAGFDAFCHAGLAEALAGLRSFDEALHSADKALHYFNRR   88 (156)
T ss_dssp             HHHHHHHHHHHHHHTCHHHHHHHHHHHHHHHTTSCTTSCCCHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCHHHHHHHHHHHHHhChhhhhhhhcccchhHHHHHHHHHHHHHHcCccchhhHhhhhhhhccccc
Confidence            4554433  344567899999999988763210 1          256788999999999999999887765331     


Q ss_pred             --C-------ccccHHHHHHHHHhcCCchhhhHhhhc
Q 026720           74 --K-------NLQSWTIMISGLADNSRGNDAISLHRQ  101 (234)
Q Consensus        74 --~-------~~~~~~~~i~~~~~~g~~~~a~~l~~~  101 (234)
                        .       ....|+.+-..|.+.|+.++|+..|..
T Consensus        89 ~~~~~~~~~~~~~a~~~~g~~~~~lg~~eeA~~~~~~  125 (156)
T d2hr2a1          89 GELNQDEGKLWISAVYSRALALDGLGRGAEAMPEFKK  125 (156)
T ss_dssp             CCTTSTHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred             ccccccccchhHHHHhhhHHHHHHHHHHHHHHHHHHH
Confidence              1       122456667789999999999998866

>d1hh8a_ a.118.8.1 (A:) Neutrophil cytosolic factor 2 (NCF-2, p67-phox) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Neutrophil cytosolic factor 2 (NCF-2, p67-phox)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.93  E-value=0.63  Score=31.76  Aligned_cols=57  Identities=5%  Similarity=-0.055  Sum_probs=47.7

Q ss_pred             HHhhcCChHHHHHHHHhhccCccccHHHHHHHHHhcCCchhhhHhhhcccccCCcCCCcE
Q 026720           54 MYSKCGHVEKAFKVFNLMREKNLQSWTIMISGLADNSRGNDAISLHRQGYFHRDLKPSNL  113 (234)
Q Consensus        54 ~~~~~g~~~~a~~~~~~m~~~~~~~~~~~i~~~~~~g~~~~a~~l~~~~~~~~~l~p~~~  113 (234)
                      .+...|+++.|.+.|+.+..++...|..+=..+...|+.++|+..|..- +.  +.|+..
T Consensus        14 ~~~~~~d~~~Al~~~~~i~~~~~~~~~nlG~~~~~~g~~~~A~~~~~kA-l~--ldp~~~   70 (192)
T d1hh8a_          14 LAADKKDWKGALDAFSAVQDPHSRICFNIGCMYTILKNMTEAEKAFTRS-IN--RDKHLA   70 (192)
T ss_dssp             HHHHTTCHHHHHHHHHTSSSCCHHHHHHHHHHHHHTTCHHHHHHHHHHH-HH--HCTTCH
T ss_pred             HHHHCCCHHHHHHHHHhcCCCCHHHHHHHHHHHHHcCCchhHHHHHHHH-HH--Hhhhhh
Confidence            3678899999999999998888888988888899999999999999883 32  456543

>d1nzna_ a.118.8.1 (A:) Mitochondria fission protein Fis1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Mitochondria fission protein Fis1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.54  E-value=2.1  Score=26.64  Aligned_cols=63  Identities=14%  Similarity=0.005  Sum_probs=45.9

Q ss_pred             ehHHHHHHHhcC---chhhhhHhHHHHHHHHhccchhH-HHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720           11 VTLVSLVSACTG---LINVRAGESIHSYAVVNGLELDV-AIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus        11 ~t~~~ll~~~~~---~~~~~~~~~~~~~~~~~g~~~~~-~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      .++..+=.++.+   .++.++|..++...++....++. .++..|-..|.+.|+.++|.+.|+...+
T Consensus        34 ~~~~n~a~~L~~s~~~~d~~~Ai~~l~~~l~~~~~~~~~~~~~~Lg~~y~~~g~~~~A~~~~~~aL~  100 (122)
T d1nzna_          34 STQFEYAWCLVRTRYNDDIRKGIVLLEELLPKGSKEEQRDYVFYLAVGNYRLKEYEKALKYVRGLLQ  100 (122)
T ss_dssp             HHHHHHHHHHTTSSSHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcchHHHHHHHHHHHHHHhccCCchHHHHHHHHHHHHHHHhhhHHHHHHHHHHHH
Confidence            344434444443   45666799999998876655553 4677888999999999999999988654

>d2pqrb1 a.118.8.1 (B:5-128) Mitochondria fission protein Fis1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Mitochondria fission protein Fis1
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=82.39  E-value=3.3  Score=26.03  Aligned_cols=53  Identities=17%  Similarity=-0.005  Sum_probs=37.7

Q ss_pred             cCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720           21 TGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      ....+.++|..++....+.......-.+-.|-.+|.+.|+++.|++.++...+
T Consensus        49 ~~~~d~~~gI~lLe~~~~~~p~~~rd~lY~Lav~yyklgdy~~A~~~~~~~L~  101 (124)
T d2pqrb1          49 TDVNDERLGVKILTDIYKEAESRRRECLYYLTIGCYKLGEYSMAKRYVDTLFE  101 (124)
T ss_dssp             SCHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHTCHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHHhcCchhHHHHHHHHHHHHHHHhhHHHHHHHHHHHHc
Confidence            34567788888888888765433344555666678888999999888877653

>d1hxia_ a.118.8.1 (A:) Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor) {Trypanosoma brucei [TaxId: 5691]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Peroxin pex5 (peroxisomal targeting signal 1 (PTS1) receptor)
species: Trypanosoma brucei [TaxId: 5691]

Probab=81.11  E-value=1.1  Score=27.45  Aligned_cols=61  Identities=13%  Similarity=-0.056  Sum_probs=50.2

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHh
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNL   70 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~   70 (234)
                      +..+|.-+=..+.+.++.++|...+...++... .+..++..|-..|...|+.++|.+.+++
T Consensus        49 ~~~a~~~lg~~~~~~~~~~~A~~~~~~al~~~p-~~~~a~~~la~~y~~~g~~~~A~~~l~~  109 (112)
T d1hxia_          49 REEAWRSLGLTQAENEKDGLAIIALNHARMLDP-KDIAVHAALAVSHTNEHNANAALASLRA  109 (112)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cchhhhhhhhhhhhhhhHHHhhccccccccccc-ccccchHHHHHHHHHCCCHHHHHHHHHH
Confidence            345666667778899999999999999887543 2567888899999999999999998876

>d1elwa_ a.118.8.1 (A:) Hop {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: TPR-like
family: Tetratricopeptide repeat (TPR)
domain: Hop
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.44  E-value=2.4  Score=25.89  Aligned_cols=64  Identities=9%  Similarity=-0.181  Sum_probs=53.2

Q ss_pred             CeehHHHHHHHhcCchhhhhHhHHHHHHHHhccchhHHHHHHHHHHHhhcCChHHHHHHHHhhcc
Q 026720            9 NSVTLVSLVSACTGLINVRAGESIHSYAVVNGLELDVAIGTALVEMYSKCGHVEKAFKVFNLMRE   73 (234)
Q Consensus         9 ~~~t~~~ll~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~li~~~~~~g~~~~a~~~~~~m~~   73 (234)
                      +...|..+=.++-+.++.++|...+...++... .+...|..+-..|...|..++|...++...+
T Consensus        36 ~~~~~~~~a~~~~~~~~~~~A~~~~~~al~~~p-~~~~~~~~~g~~~~~~~~~~~A~~~~~~a~~   99 (117)
T d1elwa_          36 NHVLYSNRSAAYAKKGDYQKAYEDGCKTVDLKP-DWGKGYSRKAAALEFLNRFEEAKRTYEEGLK   99 (117)
T ss_dssp             CHHHHHHHHHHHHHHTCHHHHHHHHHHHHHHCT-TCHHHHHHHHHHHHHTTCHHHHHHHHHHHHT
T ss_pred             chhhhhcccccccccccccccchhhhhHHHhcc-chhhHHHHHHHHHHHccCHHHHHHHHHHHHH
Confidence            344566666778889999999999999998754 3667889999999999999999999988654